Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ABCB1 "ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1" ENSG00000085563 "ATP binding cassette subfamily B member 1" P08183 7 87503633-87713323 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 57.8;intestine: 49.6" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 104.4;Enterocytes: 174.5;Paneth cells: 77.2" "Cancer enhanced" "Detected in many" "renal cancer: 14.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 19.2" "Group enriched" "Detected in many" 8 "NK-cells: 11.4;T-cells: 19.2" "Cell line enhanced" "Detected in some" "CACO-2: 30.1;HEK 293: 9.3;HEL: 16.7;Hep G2: 8.2;RPTEC TERT1: 11.5;SH-SY5Y: 36.8" "CAB001716, HPA002199, HPA074614" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA "Nucleoplasm, Plasma membrane" "Focal adhesion sites" "CAB001716: , HPA002199: AB_1844428, HPA074614: " "unprognostic (5.38e-3)" "unprognostic (2.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-2)" "unprognostic (9.99e-5)" "unprognostic (2.23e-3)" "unprognostic (5.65e-3)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "prognostic favorable (3.33e-4)" "unprognostic (5.19e-1)" "prognostic favorable (2.95e-4)" "unprognostic (2.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.83e-1)" "unprognostic (6.12e-2)" 2.6 57.8 9.4 3.2 11.5 1.2 3.4 5.1 10.5 5.5 22.7 3.8 2.0 14.4 9.4 3.5 2.0 3.2 9.0 1.8 9.2 6.6 19.1 15.6 3.8 2.2 9.4 5.7 2.2 1.5 1.7 1.3 3.1 11.1 2.7 10.7 7.6 1.5 2.1 1.1 1.3 49.6 5.7 9.0 2.4 1.7 1.3 8.6 0.1 2.4 1.4 2.2 2.6 5.9 1.9 0.0 0.1 0.0 11.4 19.2 1.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 9.3 16.7 1.9 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 11.5 0.1 0.4 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.4 3.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 7.8 0.0 19.2 0.4 2.0 4.7 0.0 1.9 1.2 4.8 0.1 11.4 0.0 0.0 0.0 1.5 9.4 11.5 5.1 10.5 9.2 6.6 9.4 5.7 11.1 8.6 0.0 4.8 5.9 0.1 0.7 0.6 2.8 104.4 1.4 1.2 47.1 0.0 5.0 5.0 10.2 21.6 23.1 174.5 23.3 1.6 0.1 0.5 0.1 3.5 32.6 0.4 0.0 0.0 3.7 1.2 2.5 0.9 0.8 0.0 0.0 8.9 0.0 11.4 77.2 0.0 44.0 0.9 0.0 0.8 0.5 0.4 0.5 8.2 27.3 1.7 0.1 ABCB11 "ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP" ENSG00000073734 "ATP binding cassette subfamily B member 11" O95342 2 168922938-169031322 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 47.4" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 38.7;Alveolar cells type 2: 58.1;Club cells: 35.2;granulocytes: 22.1;Hepatocytes: 17.9" "Cancer enriched" "Detected in single" 87 "liver cancer: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.0;NB-4: 1.7;PC-3: 1.0;THP-1: 2.6;TIME: 1.8;U-2197: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA019035 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA019035: AB_1844429" "unprognostic (7.78e-2)" "unprognostic (3.92e-1)" "unprognostic (8.31e-2)" "unprognostic (2.56e-1)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.00e-2)" "unprognostic (9.71e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-1)" "unprognostic (5.26e-6)" "unprognostic (7.12e-2)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.8 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 38.7 58.1 0.0 0.0 0.0 0.0 0.3 0.0 16.0 35.2 0.0 0.0 0.0 0.0 0.1 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.1 17.9 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 ABCC5 "EST277145, MOAT-C, MRP5, SMRP" ENSG00000114770 "ATP binding cassette subfamily C member 5" O15440 3 183919934-184018015 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 184.6;Rod photoreceptor cells: 122.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044067, HPA052295" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA044067: AB_2678797, HPA052295: AB_2681789" "unprognostic (9.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.83e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.78e-8)" "unprognostic (4.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.02e-1)" "unprognostic (5.91e-3)" "prognostic unfavorable (3.40e-4)" "unprognostic (1.10e-1)" "unprognostic (9.05e-3)" "unprognostic (1.64e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-2)" 7.9 11.2 24.7 9.6 26.2 12.0 6.7 42.8 28.6 7.7 11.4 12.0 13.4 6.8 14.1 7.0 17.1 6.1 11.6 16.0 19.1 13.7 12.8 3.6 9.4 7.3 20.5 18.5 11.8 4.9 22.4 20.5 10.8 21.7 10.6 14.4 31.1 7.4 9.3 41.0 14.5 8.5 10.5 12.9 16.3 48.5 9.4 20.9 9.3 5.5 7.3 7.4 18.1 12.7 4.2 3.5 15.8 4.5 5.0 7.0 4.5 7.3 4.1 9.4 11.2 9.4 10.7 14.6 6.0 4.7 5.4 5.9 6.3 5.7 8.0 14.1 5.7 8.2 29.9 11.6 6.6 7.1 8.7 11.2 16.9 10.3 5.7 3.9 5.1 13.2 17.0 6.7 5.8 3.8 11.1 6.3 23.7 15.7 11.1 9.2 19.5 14.1 5.9 9.7 13.4 7.9 9.8 3.1 4.7 19.6 48.0 17.2 10.2 6.1 33.9 10.1 12.7 20.5 1.6 7.2 6.3 6.2 8.0 8.2 4.3 8.3 7.4 4.6 10.3 6.4 10.7 4.5 7.7 7.0 2.1 4.5 3.2 4.0 3.1 3.5 4.2 4.6 6.3 15.8 5.0 3.5 1.3 5.0 4.5 24.7 26.2 42.8 28.6 19.1 13.7 20.5 18.5 21.7 20.9 8.9 4.0 1.9 12.9 7.9 34.3 31.9 2.5 56.2 46.6 41.8 184.6 2.7 6.6 5.0 4.8 6.7 9.5 0.0 4.0 3.9 8.0 10.9 4.7 2.4 39.9 31.8 56.9 5.5 27.9 2.2 7.5 11.2 11.8 6.4 6.3 9.4 6.1 9.3 7.4 2.7 122.3 0.0 8.6 3.1 14.7 10.7 3.8 5.0 7.2 50.3 ABHD14B "CIB, MGC15429" ENSG00000114779 "Abhydrolase domain containing 14B" Q96IU4 3 51968510-51983409 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036444, HPA036642" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA 2600000 Nucleoli "Nucleoplasm, Cytosol" "HPA036444: AB_10672221, HPA036642: AB_10672225" "unprognostic (8.97e-2)" "prognostic favorable (6.92e-5)" "unprognostic (1.84e-1)" "prognostic favorable (5.42e-5)" "unprognostic (1.07e-1)" "unprognostic (2.21e-2)" "unprognostic (2.06e-3)" "unprognostic (1.35e-3)" "unprognostic (3.95e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (2.95e-2)" "prognostic favorable (2.93e-5)" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (9.70e-2)" "unprognostic (3.70e-2)" 40.0 34.2 6.2 19.8 7.5 11.4 25.2 10.7 7.0 21.9 33.6 8.6 32.1 30.3 19.6 21.7 27.7 22.0 32.9 12.2 6.2 5.8 42.6 78.4 21.5 35.1 7.8 7.3 29.5 45.0 14.2 15.2 11.4 6.7 30.9 20.2 29.1 39.4 35.0 11.7 16.0 58.7 22.6 8.9 23.3 18.7 11.2 6.2 26.0 35.3 15.2 32.5 24.6 16.9 24.9 15.5 12.5 9.4 9.9 27.2 14.0 10.3 8.8 0.7 10.4 28.8 25.7 2.7 4.1 4.8 7.6 8.9 6.5 20.5 11.6 3.3 14.3 3.5 5.2 6.4 5.9 5.8 15.8 6.9 18.3 7.7 25.5 15.5 10.2 18.9 33.2 20.4 7.7 10.5 11.7 9.2 17.7 10.6 18.6 14.7 10.1 4.5 7.8 1.0 11.3 22.6 11.6 1.4 52.4 13.8 4.2 4.4 4.7 10.4 19.4 33.0 1.6 27.9 7.0 8.7 4.0 19.1 9.1 2.4 23.7 11.1 4.8 8.8 32.8 7.0 12.5 9.4 4.2 18.3 7.6 27.2 24.9 23.0 22.4 15.5 18.7 23.4 21.3 0.8 9.9 4.8 11.3 16.3 14.0 6.2 7.5 10.7 7.0 6.2 5.8 7.8 7.3 6.7 6.2 6.0 25.8 75.9 43.7 26.9 12.4 3.2 56.0 24.1 9.1 66.3 13.7 13.4 124.3 28.2 1.4 33.6 100.6 0.0 40.7 15.9 35.2 36.3 50.7 104.1 49.3 7.9 72.9 30.7 50.2 0.5 60.1 36.2 52.3 32.5 83.5 7.7 25.4 66.2 43.9 216.2 37.1 38.8 41.0 0.5 3.4 26.6 9.8 59.8 107.0 52.8 ABHD3 LABH3 ENSG00000158201 "Abhydrolase domain containing 3" Q8WU67 18 21650897-21704805 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 54.7;RPMI-8226: 60.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010729 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Vesicles "HPA010729: AB_1844449" "unprognostic (1.46e-1)" "unprognostic (4.61e-2)" "unprognostic (2.37e-2)" "unprognostic (3.52e-1)" "unprognostic (8.46e-2)" "unprognostic (3.14e-3)" "unprognostic (3.54e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (8.52e-4)" "unprognostic (6.21e-2)" "unprognostic (1.98e-1)" "unprognostic (6.37e-2)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (3.98e-2)" "unprognostic (4.58e-2)" 9.2 5.4 12.0 14.2 10.7 8.6 20.7 19.5 11.1 6.4 34.2 4.8 5.1 23.8 6.0 5.4 12.7 7.8 13.5 7.1 8.8 8.5 8.7 21.7 12.8 21.3 11.5 5.0 9.4 8.8 10.7 11.8 10.8 16.6 6.9 37.1 14.7 10.3 4.1 10.1 3.8 45.3 5.5 12.3 17.9 19.0 4.4 10.8 20.9 12.9 6.7 13.7 9.2 25.5 7.1 6.1 33.0 23.3 7.1 17.6 9.1 7.5 5.5 5.4 3.4 3.4 2.3 0.0 5.0 2.0 3.5 4.8 5.7 7.8 21.7 9.1 1.6 16.0 25.1 8.7 4.1 5.0 13.6 6.0 2.3 9.3 9.8 5.2 10.2 7.9 2.0 4.8 5.2 2.4 1.8 2.3 7.5 6.0 12.9 3.1 3.0 9.9 11.4 2.6 24.2 12.9 54.7 4.1 60.9 9.8 7.3 4.5 2.0 11.3 10.1 2.8 6.1 3.1 18.1 1.8 3.5 5.0 6.1 7.6 14.6 9.4 22.3 4.4 13.4 7.9 29.1 10.2 11.4 11.1 17.9 8.5 7.1 10.0 10.6 6.1 5.1 8.2 10.3 33.0 7.1 23.3 4.2 17.6 9.1 12.0 10.7 19.5 11.1 8.8 8.5 11.5 5.0 16.6 10.8 8.9 9.4 22.4 33.1 29.8 13.4 3.6 45.9 16.0 7.9 3.5 45.2 23.7 1.7 47.1 3.1 9.6 90.1 0.0 24.3 19.9 15.1 42.5 11.5 26.1 56.1 0.0 34.9 12.3 24.7 1.1 6.9 28.6 30.4 17.2 46.9 9.4 35.8 46.5 6.0 7.7 13.6 12.9 15.9 3.5 8.5 13.2 78.8 38.3 23.5 28.7 ABHD5 "CGI-58, NCIE2" ENSG00000011198 "Abhydrolase domain containing 5" Q8WTS1 3 43690108-43734371 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Cataract, Deafness, Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 70.3" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 171.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 26.1;classical monocyte: 7.6;neutrophil: 21.0" "Group enriched" "Detected in many" 5 "granulocytes: 26.1;monocytes: 7.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020685, HPA035851, HPA035852" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073" "unprognostic (2.58e-1)" "unprognostic (2.73e-1)" "prognostic favorable (8.89e-4)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.26e-1)" "unprognostic (6.13e-2)" "unprognostic (2.40e-2)" "unprognostic (5.33e-2)" "unprognostic (3.50e-3)" "unprognostic (2.56e-2)" "unprognostic (4.13e-3)" "prognostic favorable (9.17e-5)" "unprognostic (2.48e-1)" "unprognostic (8.87e-2)" "unprognostic (4.18e-2)" "unprognostic (4.18e-2)" 26.5 10.5 5.2 7.4 12.2 32.2 70.3 8.5 10.3 7.6 10.2 10.5 5.9 7.4 4.6 4.0 22.7 3.7 10.4 9.8 7.4 4.5 10.1 18.4 14.1 8.7 18.5 4.6 4.2 12.8 9.1 8.6 20.2 14.9 5.8 6.7 4.4 21.1 7.4 10.4 24.8 15.1 8.1 19.0 7.0 8.9 8.1 12.5 3.3 13.2 9.9 6.7 11.2 16.0 1.7 3.6 26.1 7.6 0.9 2.4 2.5 8.5 3.0 3.6 3.8 15.2 5.8 7.5 34.9 13.9 9.6 7.2 4.7 3.0 7.1 4.8 10.9 8.5 2.8 5.7 8.5 9.8 25.8 5.5 18.2 11.6 3.2 7.6 4.1 5.9 6.4 29.5 16.1 13.8 8.4 16.0 4.8 10.8 5.4 21.3 4.6 2.9 2.9 9.7 6.8 9.8 1.3 10.4 4.1 12.4 17.0 4.4 6.0 15.3 8.3 3.6 4.0 8.9 3.5 8.8 8.5 6.7 15.7 15.1 4.9 13.6 3.4 9.0 7.5 6.6 26.1 7.6 4.4 1.2 3.7 1.0 1.7 0.9 1.4 3.6 1.2 0.8 1.3 21.0 0.9 2.7 0.9 2.4 2.5 5.2 12.2 8.5 10.3 7.4 4.5 18.5 4.6 14.9 12.5 23.8 43.8 8.5 23.5 35.4 11.3 9.7 15.3 17.4 25.0 26.2 25.5 13.3 28.2 49.4 13.5 16.9 64.4 23.3 53.5 21.2 16.2 21.6 16.1 11.3 16.6 3.2 34.9 14.7 26.6 12.9 4.9 30.4 6.8 16.2 17.1 12.4 61.4 24.6 5.3 31.4 14.7 0.0 26.8 35.6 43.9 35.8 171.7 15.8 18.2 41.1 ABI2 "ABI-2, ABI2B, AblBP3, AIP-1, argBPIA, SSH3BP2" ENSG00000138443 "Abl interactor 2" Q9NYB9 2 203328219-203447723 "Predicted intracellular proteins" "Host-virus interaction, Neurogenesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070567 Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA070567: AB_2686281" "unprognostic (5.26e-3)" "unprognostic (5.26e-3)" "unprognostic (1.86e-1)" "unprognostic (4.11e-3)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (1.81e-3)" "unprognostic (7.05e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-3)" "unprognostic (6.19e-3)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.24e-2)" "unprognostic (2.94e-1)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" 8.6 11.6 28.8 7.7 41.8 2.8 12.8 24.4 50.7 17.2 11.5 18.7 8.4 5.1 23.3 16.1 10.5 19.4 11.4 25.1 26.0 24.0 17.8 6.3 13.4 6.4 19.1 30.2 24.3 6.5 18.6 21.5 15.9 17.6 16.4 9.5 11.7 7.1 20.3 5.9 6.4 6.9 21.2 18.8 10.2 6.9 22.2 16.8 11.6 22.2 3.2 7.3 10.2 8.4 1.7 13.8 0.4 3.7 3.9 5.3 3.4 7.2 11.2 40.2 25.3 9.5 16.4 8.8 12.6 11.2 11.0 12.7 10.3 13.7 0.0 8.7 14.8 15.3 8.0 18.2 13.3 21.9 3.6 10.4 18.2 12.0 8.0 14.6 7.8 8.3 11.6 6.4 20.0 15.6 31.8 20.3 20.9 12.8 16.3 19.3 13.1 19.5 7.4 20.8 6.8 25.0 12.9 20.3 1.3 11.3 7.5 16.1 21.2 2.4 7.4 14.0 31.7 9.7 9.1 15.1 20.2 17.1 10.8 13.7 11.5 10.5 10.0 21.8 3.2 12.8 0.2 1.5 0.0 3.8 1.7 4.1 1.7 4.3 4.4 4.3 1.7 5.3 4.5 0.4 3.9 3.7 13.8 4.6 3.4 28.8 41.8 24.4 45.2 26.0 24.0 19.1 30.2 17.6 16.8 50.6 24.5 13.0 49.7 26.8 105.5 50.4 25.5 83.0 35.2 50.6 153.2 18.7 28.2 19.2 102.1 33.4 9.5 0.0 11.6 14.1 50.4 34.8 15.1 9.8 14.0 96.9 47.3 57.7 11.1 62.2 43.1 22.6 47.2 22.6 8.6 78.1 13.9 17.5 59.4 28.0 93.6 25.8 56.7 71.0 49.9 22.8 16.5 17.5 18.0 32.3 ABLIM3 KIAA0843 ENSG00000173210 "Actin binding LIM protein family member 3" O94929 5 149141483-149260542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 58.4" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 57.0;Hepatocytes: 97.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 25.1;HHSteC: 25.7;HSkMC: 29.6;hTERT-HME1: 29.6;hTERT-RPE1: 24.8;TIME: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003245 Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "HPA003245: AB_1078083" "unprognostic (1.07e-1)" "unprognostic (1.31e-1)" "unprognostic (9.87e-2)" "unprognostic (1.75e-1)" "unprognostic (8.74e-2)" "unprognostic (4.19e-2)" "unprognostic (9.48e-3)" "unprognostic (4.37e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.28e-4)" "unprognostic (3.12e-2)" "unprognostic (8.10e-2)" "unprognostic (2.45e-3)" "unprognostic (1.20e-1)" 45.9 6.0 7.9 3.5 9.8 1.2 35.0 29.7 12.5 9.1 4.7 11.6 7.0 2.9 4.9 8.9 15.6 5.8 6.1 58.4 8.5 10.2 17.0 48.1 9.1 4.8 9.9 5.9 2.6 2.4 39.3 3.1 26.1 14.3 6.5 4.7 7.7 3.0 9.9 24.3 3.5 3.7 8.7 14.0 5.0 2.7 2.3 3.3 0.1 4.2 8.9 4.5 8.8 14.6 0.0 0.6 2.2 0.3 0.0 0.0 6.8 7.2 1.5 0.0 0.0 13.1 25.1 0.0 5.1 14.3 2.9 5.1 0.0 5.1 0.0 0.8 6.4 15.6 0.1 0.0 5.9 5.8 0.0 0.0 0.0 0.3 0.1 25.7 0.0 0.0 29.6 1.6 10.5 29.6 24.8 13.1 0.0 0.0 2.3 17.0 2.8 0.0 0.0 0.0 0.4 20.1 0.0 0.0 0.0 16.4 5.0 2.0 0.0 1.0 0.3 2.7 0.4 0.4 0.0 32.8 6.2 1.4 6.4 8.6 0.0 0.0 0.0 10.8 0.0 17.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 6.8 7.9 9.8 29.7 12.5 8.5 10.2 9.9 5.9 14.3 3.3 0.0 3.0 4.7 1.0 1.3 1.1 57.0 28.1 4.0 1.2 0.0 0.0 0.1 5.0 6.8 1.8 20.2 0.0 0.0 3.0 0.6 2.1 2.2 1.1 97.0 9.3 27.0 0.0 20.3 11.9 0.0 0.3 0.8 5.0 0.0 0.0 19.7 14.9 0.0 0.7 18.3 21.8 0.0 2.3 1.7 2.3 1.4 0.3 0.0 0.0 4.9 AC005726.1 ENSG00000258472 17 28455752-28614197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.8" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 10.4;Ciliated cells: 10.7;Club cells: 10.3;Collecting duct cells: 3.5;granulocytes: 5.8;Proximal tubular cells: 9.0;Syncytiotrophoblasts: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.5;CACO-2: 2.1;Karpas-707: 3.5;PC-3: 3.2;THP-1: 3.5" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: AB_2679710" "unprognostic (1.26e-2)" "unprognostic (1.82e-1)" "unprognostic (6.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (7.25e-2)" "unprognostic (5.96e-2)" "unprognostic (4.58e-2)" "unprognostic (9.22e-3)" "unprognostic (3.17e-3)" "unprognostic (1.49e-4)" "unprognostic (1.25e-1)" "unprognostic (2.65e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-4)" 0.5 0.6 6.3 0.4 16.4 1.6 0.5 3.5 16.8 2.8 0.9 0.0 0.0 1.6 1.3 0.6 1.4 2.3 2.4 1.0 5.1 3.6 0.9 1.5 3.6 0.5 1.6 6.6 0.8 3.6 0.2 3.1 0.4 6.9 1.0 0.2 3.6 0.5 0.2 0.6 0.5 0.5 0.8 1.1 0.5 1.0 0.6 2.1 0.0 2.6 0.0 1.3 3.5 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.5 0.2 0.8 0.0 0.0 0.2 0.3 0.0 0.2 0.0 2.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.5 3.5 0.0 0.5 0.0 1.0 0.0 0.0 3.2 0.3 0.0 0.0 0.2 1.3 0.0 0.4 0.3 0.9 0.0 0.0 0.6 3.5 0.0 0.8 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.3 16.4 3.5 16.8 5.1 3.6 1.6 6.6 6.9 2.1 8.9 10.4 0.0 0.0 0.0 0.0 0.0 0.0 10.7 10.3 3.5 0.0 1.3 1.7 1.1 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 5.8 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.0 0.8 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 AC007325.2 ENSG00000277196 Unmapped 138082-161852 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 12.8;skin 1: 12.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 5.1;Distal tubular cells: 6.6" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Group enriched" "Detected in some" 13 "OE19: 84.6;RPTEC TERT1: 44.7" HPA020361 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria NA NA Mitochondria "Nucleoplasm, Vesicles" "HPA020361: AB_10963116" 0.0 0.0 0.0 0.0 0.6 6.4 0.0 0.0 11.1 0.0 0.0 2.1 0.0 0.0 2.8 4.5 1.6 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 12.6 12.8 0.0 0.0 0.0 0.0 1.1 1.8 0.5 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 2.0 0.0 0.6 1.2 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.1 0.0 0.0 2.4 4.5 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.1 4.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 84.6 0.0 0.0 0.0 0.0 44.7 0.1 0.1 0.1 0.0 1.7 0.3 4.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 AC011455.2 ENSG00000269547 19 38915404-38949855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.6;ovary: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.7;A549: 5.2;AN3-CA: 2.8;T-47d: 4.4;U-251 MG: 6.4" "HPA052730, HPA056957" Uncertain Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (6.10e-2)" "unprognostic (3.79e-2)" 1.3 2.6 0.3 1.7 0.3 0.0 0.1 0.4 1.1 0.3 0.1 0.0 1.2 0.5 0.1 0.4 0.8 1.1 0.1 0.1 1.6 1.1 0.2 0.0 0.2 3.0 0.6 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.3 0.1 0.1 0.5 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.2 0.0 2.8 0.9 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.3 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.5 0.3 1.2 0.5 0.5 0.0 1.2 0.3 2.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 0.2 0.0 1.4 1.4 0.0 6.4 0.0 0.6 0.0 2.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC118549.1 ENSG00000036549 "ZZ-type zinc finger-containing protein 3 " Q8IYH5 1 77562416-77683419 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 19.0;Proximal tubular cells: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053663, HPA054913, HPA066197" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635" "unprognostic (1.30e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-2)" "unprognostic (2.13e-3)" "unprognostic (5.38e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (6.96e-5)" "unprognostic (2.91e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "unprognostic (2.83e-1)" "unprognostic (1.91e-1)" "unprognostic (1.71e-1)" "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (3.05e-2)" "unprognostic (1.43e-1)" 17.8 17.4 20.8 14.1 23.6 11.6 21.6 20.4 20.3 18.1 16.2 16.1 18.3 12.1 18.3 14.3 14.5 15.3 12.1 13.7 16.9 11.7 18.8 20.0 12.3 15.8 24.1 17.8 24.1 14.5 19.0 28.2 13.9 14.4 16.0 13.0 10.5 15.2 16.8 19.0 16.9 12.4 17.0 16.2 11.5 13.5 9.9 23.6 17.9 26.5 8.6 16.0 20.1 14.9 7.9 7.4 5.6 5.1 7.4 10.4 5.0 13.4 6.9 12.7 9.7 11.1 17.7 13.4 17.2 15.9 15.9 17.5 7.7 7.2 17.6 15.5 14.4 18.0 12.4 16.7 11.1 24.1 13.8 13.2 21.8 13.9 9.5 17.1 22.5 6.2 13.5 17.2 17.6 34.4 15.4 16.1 12.2 21.1 13.7 15.4 6.3 11.2 7.0 18.8 7.4 15.7 13.2 21.7 9.0 11.1 14.3 15.9 13.4 10.3 11.8 30.3 9.1 7.1 12.4 13.2 13.8 17.0 22.3 22.1 10.3 14.4 18.7 13.6 19.7 10.5 0.1 4.6 5.6 6.9 5.1 10.4 7.9 8.2 8.1 7.4 7.9 10.2 9.2 0.9 7.4 4.7 5.0 10.4 5.0 20.8 23.6 20.4 20.3 16.9 11.7 24.1 17.8 14.4 23.6 11.9 19.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 12.5 10.4 0.0 11.4 10.0 13.1 0.0 0.0 0.0 0.0 11.1 10.1 0.0 0.0 5.8 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 13.6 0.0 0.0 11.8 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 ACADS "ACAD3, SCAD" ENSG00000122971 "Acyl-CoA dehydrogenase short chain" P16219 12 120725735-120740008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.4;skeletal muscle: 50.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 312.7;Hepatocytes: 154.5;Paneth cells: 154.3;Undifferentiated cells: 144.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004799, CAB019284, HPA022271" Enhanced Enhanced Nucleoplasm,Centrosome,Mitochondria NA NA 15000 Mitochondria "Nucleoplasm, Centrosome" "CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472" "unprognostic (7.14e-2)" "unprognostic (3.03e-3)" "unprognostic (8.15e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.11e-3)" "unprognostic (5.75e-2)" "prognostic favorable (2.43e-4)" "unprognostic (5.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.14e-1)" "unprognostic (2.69e-2)" "unprognostic (4.04e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.23e-2)" "unprognostic (1.81e-1)" "unprognostic (1.21e-1)" "prognostic favorable (6.34e-5)" 19.5 14.5 5.7 10.0 5.2 5.3 18.0 2.3 4.6 2.9 26.2 4.7 4.5 35.8 2.8 5.3 5.0 2.9 9.1 32.6 3.7 3.3 13.2 58.4 5.6 7.8 5.0 4.1 2.3 14.4 3.0 2.4 4.3 3.8 4.1 9.0 5.6 8.9 4.6 50.7 3.4 35.3 6.5 3.8 8.6 9.5 10.7 5.4 4.0 8.1 16.8 4.3 5.0 3.2 6.8 11.4 7.2 14.0 15.3 14.7 10.0 2.0 7.2 0.4 6.3 8.6 3.4 7.2 3.0 3.0 3.9 2.9 5.6 5.1 0.2 7.8 2.5 1.8 3.3 4.2 1.3 0.5 10.5 5.3 5.2 2.2 11.9 6.2 0.4 23.6 10.3 2.0 1.7 0.1 1.2 3.9 13.3 4.2 0.0 1.7 4.2 7.2 12.0 1.3 6.6 3.0 5.3 2.7 1.4 7.3 11.5 0.7 4.0 6.2 0.0 9.8 0.6 5.0 8.2 4.4 0.1 3.1 3.0 0.5 10.0 5.6 2.5 6.7 4.4 2.6 7.2 13.0 6.4 12.4 14.0 8.8 5.9 11.3 13.0 11.4 6.8 14.7 13.2 1.3 15.3 8.7 9.5 11.9 10.0 5.7 5.2 2.3 4.6 3.7 3.3 5.0 4.1 3.8 5.4 11.9 10.7 10.2 10.2 6.0 1.1 32.5 30.6 2.7 5.7 17.4 0.0 60.7 43.1 26.8 15.8 14.2 312.7 23.3 28.4 26.2 16.9 7.1 19.5 154.5 47.4 1.6 43.8 12.9 27.2 26.3 19.8 11.1 16.9 32.5 94.5 13.0 25.9 154.3 17.0 74.9 0.7 6.5 13.0 29.1 8.3 4.0 63.2 20.3 144.6 9.0 ACADVL "ACAD6, LCACD, VLCAD" ENSG00000072778 "Acyl-CoA dehydrogenase very long chain" P49748 17 7217125-7225273 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019006, HPA020595" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria NA NA 19000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA019006: AB_1844478, HPA020595: AB_1844479" "unprognostic (4.81e-2)" "unprognostic (2.86e-1)" "unprognostic (2.21e-2)" "unprognostic (1.09e-2)" "unprognostic (6.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (6.87e-4)" "unprognostic (3.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (4.01e-1)" "unprognostic (2.84e-3)" 32.7 69.2 22.8 18.2 21.1 15.1 24.1 19.8 18.4 21.1 44.0 16.5 26.7 51.7 17.4 19.7 31.5 14.2 24.4 118.2 20.2 12.2 35.2 90.0 17.3 9.8 18.5 16.8 15.5 67.8 31.5 32.3 40.2 20.9 22.1 24.2 20.0 27.4 29.0 132.3 20.3 51.2 25.0 15.7 21.9 28.7 11.5 18.6 14.6 29.6 36.9 21.2 22.4 31.8 8.3 32.0 37.9 29.0 11.6 14.9 20.0 33.5 32.1 13.2 18.1 57.0 21.0 25.0 24.7 34.4 28.1 17.5 12.9 30.3 18.0 20.6 51.7 10.1 25.9 8.8 27.0 24.9 56.9 9.1 9.6 22.8 19.7 27.4 9.1 25.0 23.3 24.7 23.5 37.1 43.6 25.3 22.1 12.3 21.9 45.1 12.7 9.4 11.0 6.2 35.2 12.7 13.2 14.6 42.6 62.6 30.6 3.5 8.7 34.8 44.3 20.2 12.9 20.3 14.0 25.1 24.9 18.7 12.6 24.1 20.6 9.6 0.9 45.9 16.1 18.1 6.8 29.0 37.9 13.5 18.0 12.4 8.3 10.9 14.9 32.0 7.6 8.3 10.2 6.3 11.6 12.0 26.0 9.7 20.0 22.8 21.1 19.8 18.4 20.2 12.2 18.5 16.8 20.9 18.6 56.6 73.4 64.0 249.7 77.5 39.6 397.7 150.3 17.4 43.3 191.9 58.9 369.3 157.5 241.9 107.0 71.4 453.8 23.3 66.5 164.5 100.7 311.9 89.7 297.9 171.6 31.8 172.2 51.5 68.0 184.1 115.3 93.1 77.6 423.8 144.6 37.1 129.2 196.4 124.8 276.8 38.8 103.5 102.3 100.5 34.7 76.5 554.7 68.2 215.2 275.4 ACIN1 "ACINUS, fSAP152, KIAA0670" ENSG00000100813 "Apoptotic chromatin condensation inducer 1" Q9UKV3 14 23058564-23095614 "Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000657 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA000657: AB_1078091" "unprognostic (2.54e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.89e-3)" "prognostic unfavorable (4.88e-5)" "unprognostic (1.49e-3)" "unprognostic (9.70e-2)" "unprognostic (4.11e-2)" "unprognostic (1.00e-2)" "unprognostic (6.64e-3)" "unprognostic (1.35e-3)" "unprognostic (4.34e-2)" "unprognostic (2.78e-2)" "unprognostic (2.28e-2)" "unprognostic (7.33e-2)" 32.4 44.4 34.6 46.6 36.2 57.6 32.5 45.7 41.8 36.6 30.1 39.1 35.2 28.5 52.9 32.2 39.3 34.6 33.3 29.7 33.1 28.3 34.9 35.5 28.8 41.1 34.4 27.7 43.9 34.5 51.1 48.3 37.0 33.7 35.4 34.6 31.5 33.0 38.3 43.8 38.1 35.1 40.1 35.0 52.9 34.0 34.5 40.6 44.2 38.5 27.1 45.9 30.5 47.8 6.9 6.8 13.4 4.9 9.7 5.5 2.7 23.7 24.5 38.7 31.3 24.2 19.5 38.9 26.5 18.7 32.1 26.2 32.4 27.9 44.1 15.7 21.9 21.1 26.2 53.4 30.3 33.0 31.0 23.7 38.8 25.9 44.6 13.9 42.0 34.5 22.8 18.7 32.8 27.7 26.3 28.0 32.9 35.7 17.7 24.1 29.7 47.6 41.5 43.5 26.4 23.4 43.2 30.1 23.5 26.6 42.0 25.8 19.0 35.2 23.0 20.9 29.4 18.9 34.0 28.6 22.0 22.0 20.8 24.4 18.8 21.1 45.7 19.5 31.9 23.8 4.1 4.9 5.6 5.5 4.5 4.4 4.4 3.7 4.2 4.1 6.9 5.1 4.6 13.4 9.7 3.7 6.8 3.8 2.7 34.6 36.2 45.7 41.8 33.1 28.3 34.4 27.7 33.7 40.6 65.5 108.5 33.5 28.5 33.2 38.0 57.7 30.6 109.7 78.5 33.2 25.5 48.1 14.9 45.8 27.6 44.3 40.8 46.7 42.7 55.4 35.5 30.5 120.8 24.7 40.9 14.3 55.9 32.5 26.9 5.0 42.6 35.7 25.3 52.3 37.3 25.9 52.1 42.1 36.0 14.1 42.2 6.5 39.6 35.1 34.6 40.7 57.9 36.3 40.7 34.1 ACKR2 "CCBP2, CCR10, CCR9, CMKBR9, D6" ENSG00000144648 "Atypical chemokine receptor 2" O00590 3 42804752-42887974 "G-protein coupled receptors, Predicted membrane proteins" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "placenta: 96.2;salivary gland: 74.8" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 26.5;Extravillous trophoblasts: 87.8;Syncytiotrophoblasts: 61.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 7.3;NK-cell: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 7.3;NK-cells: 2.2" "Cell line enhanced" "Detected in some" "BEWO: 32.2;HEL: 10.3;SK-BR-3: 17.2;U-937: 6.5" "Group enriched" "Detected in many" 9 "amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6" "Not detected" "Not detected" "HPA013819, HPA073493" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "HPA013819: AB_1846126, HPA073493: AB_2686610" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.90e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (1.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.74e-1)" "unprognostic (2.99e-1)" "unprognostic (6.20e-2)" "unprognostic (8.47e-2)" "unprognostic (8.45e-2)" "unprognostic (1.13e-4)" "unprognostic (5.13e-3)" "unprognostic (3.22e-1)" "unprognostic (5.58e-3)" "unprognostic (6.09e-2)" 10.4 0.9 0.4 0.7 0.5 0.4 5.3 0.2 0.4 2.9 1.8 0.1 0.6 0.7 2.0 5.2 2.5 2.4 1.2 1.0 0.5 0.4 1.1 14.5 1.5 1.0 0.5 0.2 0.9 0.7 0.3 0.6 96.2 0.2 1.1 2.0 0.3 74.8 0.4 2.1 2.5 1.0 3.2 0.7 1.1 0.9 1.5 0.1 0.4 3.8 2.3 2.0 3.2 4.1 0.8 0.4 7.3 0.6 2.2 0.4 0.3 0.1 0.0 0.1 0.2 1.5 0.1 32.2 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 10.3 0.2 1.8 0.0 0.1 1.2 0.3 0.3 0.0 0.0 0.0 0.0 0.3 1.3 0.2 0.2 0.2 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.4 4.5 0.1 0.1 0.8 17.2 0.0 1.9 1.7 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 6.5 0.1 0.7 0.2 7.3 0.4 0.5 0.1 0.2 0.1 0.2 0.4 0.8 0.3 0.3 1.0 2.2 0.6 0.3 0.1 0.3 0.4 0.5 0.2 0.4 0.5 0.4 0.5 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.6 2.5 1.4 0.0 0.0 2.0 26.5 1.7 0.0 1.9 1.4 2.0 0.0 0.0 87.8 1.8 0.4 2.3 5.8 4.6 1.6 1.7 3.7 0.3 1.1 0.3 0.2 0.0 0.0 0.1 2.5 0.6 0.0 1.1 0.3 0.9 0.0 0.0 4.5 3.3 0.0 61.6 0.5 0.4 0.1 ACLY "ACL, ATPCL, CLATP" ENSG00000131473 "ATP citrate lyase" P53396 17 41866908-41930542 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007783, HPA022434, HPA022953, HPA022959, HPA028758" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 2100000 "Plasma membrane, Cytosol" Nucleoplasm "CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575" "unprognostic (2.21e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.41e-1)" "unprognostic (1.21e-2)" "unprognostic (2.83e-1)" "unprognostic (8.94e-3)" "prognostic unfavorable (3.66e-4)" "unprognostic (3.38e-3)" "unprognostic (4.11e-2)" "unprognostic (5.94e-3)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.88e-3)" "unprognostic (1.66e-1)" "unprognostic (9.36e-2)" "unprognostic (3.90e-2)" "unprognostic (4.67e-3)" 38.3 24.0 16.7 26.2 22.9 19.1 35.7 21.5 29.1 22.9 22.2 25.1 18.0 30.7 27.0 24.9 23.2 23.7 28.2 18.4 18.3 33.7 37.8 22.2 23.3 27.4 23.1 17.9 19.0 30.6 27.1 19.5 26.7 49.0 41.3 23.2 15.6 25.4 19.6 10.9 19.6 29.6 27.2 26.2 24.5 24.6 20.7 21.4 32.0 21.3 18.2 24.6 20.3 21.3 16.1 23.9 25.2 26.3 16.0 23.9 21.4 23.4 80.1 37.8 32.6 58.5 54.9 34.8 33.1 36.2 41.7 52.4 40.6 27.1 38.2 21.3 46.4 39.2 37.4 48.7 56.7 34.9 34.4 46.6 21.8 46.1 42.2 27.2 35.3 28.6 43.6 17.1 73.2 14.8 27.4 43.9 29.6 26.9 30.5 34.5 23.9 58.1 19.8 24.6 15.8 14.5 38.1 45.7 49.0 42.7 41.9 71.2 39.1 23.6 73.9 25.3 34.1 44.1 33.8 47.2 32.6 26.8 32.7 54.3 17.9 22.7 36.3 55.0 27.4 26.4 18.9 20.7 25.2 23.8 22.1 22.5 16.1 19.0 21.3 23.9 13.8 14.6 16.1 10.7 16.0 26.3 13.9 23.9 21.4 16.7 22.9 21.5 27.7 18.3 33.7 23.1 17.9 49.0 21.4 26.8 22.1 18.5 8.0 22.1 9.0 9.6 40.8 18.7 15.9 22.7 3.9 19.9 10.0 29.9 66.2 28.7 23.4 0.0 29.7 39.3 29.9 33.0 14.0 24.6 27.1 17.5 63.4 40.5 40.5 11.4 57.2 21.6 30.4 31.5 46.6 7.0 34.4 17.3 48.1 71.1 6.5 12.9 16.5 21.4 33.8 28.9 18.5 21.3 19.8 12.0 ACOT9 "ACATE2, CGI-16, MT-ACT48" ENSG00000123130 "Acyl-CoA thioesterase 9" Q9Y305 X 23702253-23766475 "Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "monocytes: 296.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035533 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA035533: AB_10696506" "unprognostic (5.69e-2)" "unprognostic (6.34e-2)" "unprognostic (1.59e-1)" "unprognostic (2.09e-1)" "unprognostic (1.53e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (1.12e-1)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (9.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.15e-3)" "unprognostic (6.53e-2)" "unprognostic (1.68e-1)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" 19.1 15.9 6.3 14.1 7.7 10.5 29.2 6.5 13.6 15.4 16.3 5.4 17.6 11.5 21.2 16.1 12.0 14.5 15.5 35.7 5.7 7.7 12.8 15.5 23.6 36.0 7.3 8.6 13.4 16.6 9.1 7.8 13.3 12.7 12.8 12.7 13.9 16.3 23.0 28.8 10.4 12.5 35.7 13.8 15.8 15.0 7.1 4.5 3.8 15.1 11.4 9.7 15.9 14.4 5.5 16.4 11.1 26.5 6.0 10.0 8.4 26.1 17.9 7.8 17.1 12.8 14.7 3.9 20.8 18.0 20.6 20.0 15.8 23.7 1.3 13.3 23.1 27.8 16.0 9.8 26.4 28.7 6.1 14.9 8.9 18.7 11.4 17.3 3.4 11.3 12.9 18.1 24.1 27.5 13.5 30.1 0.2 5.6 9.0 22.2 9.1 4.8 8.4 11.3 10.3 21.8 5.1 29.7 11.1 24.4 9.7 1.5 7.5 22.6 9.5 13.3 30.2 10.7 4.6 27.9 17.2 11.4 24.9 11.3 2.2 5.1 0.1 12.7 3.4 14.5 9.1 16.1 11.1 5.6 22.2 7.6 5.5 7.0 6.3 16.4 4.6 2.3 5.3 8.4 6.0 26.5 2.8 10.0 8.4 6.3 7.7 6.5 13.6 5.7 7.7 7.3 8.6 12.7 4.5 44.7 33.0 11.4 38.4 17.9 4.3 37.2 15.3 28.1 35.2 15.7 23.6 3.6 5.0 60.6 0.7 35.1 10.5 0.0 45.6 9.3 28.3 31.5 35.9 11.3 39.9 4.8 2.4 35.6 33.3 0.0 16.7 63.3 32.1 296.6 8.7 10.0 62.9 11.8 24.1 25.0 9.3 25.8 20.3 1.8 9.6 9.4 2.5 22.3 9.4 32.8 ACSF2 "ACSMW, FLJ20920" ENSG00000167107 "Acyl-CoA synthetase family member 2" Q96CM8 17 50426158-50474845 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 60.0" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 70.1;Proximal tubular cells: 99.5;Syncytiotrophoblasts: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 37.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024693 Enhanced Uncertain Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "HPA024693: AB_2671654" "unprognostic (1.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (1.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.48e-2)" "unprognostic (1.14e-2)" "unprognostic (6.49e-2)" "unprognostic (7.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (2.45e-2)" "prognostic favorable (2.41e-4)" 13.2 37.6 4.8 7.7 4.4 1.1 16.3 2.0 4.0 8.4 19.1 4.0 30.3 9.2 3.5 15.4 6.7 4.3 7.2 12.9 5.6 2.0 60.0 15.0 9.0 3.7 3.7 2.8 9.4 3.4 2.6 1.7 14.1 3.9 12.4 7.4 7.6 10.1 33.3 28.4 9.7 22.4 4.5 3.5 4.5 8.0 4.5 3.6 3.5 30.6 6.6 5.9 13.0 7.6 7.8 13.8 11.9 6.2 1.2 4.3 2.1 9.6 3.1 2.6 6.2 27.5 5.0 15.3 2.3 3.4 5.0 9.9 12.3 18.5 6.0 5.1 2.8 4.6 5.8 1.8 11.4 6.0 7.5 4.4 10.3 1.5 21.8 4.6 1.3 9.6 22.2 17.5 6.4 0.8 18.0 6.8 7.9 1.2 3.4 5.4 11.6 3.1 4.1 0.4 18.2 4.6 7.8 1.9 15.2 1.6 37.7 8.5 4.6 4.5 6.9 4.7 5.5 6.0 8.8 5.1 9.2 2.9 1.3 0.7 6.1 1.2 3.1 3.8 6.5 0.5 0.0 2.5 11.9 1.8 6.2 1.6 7.8 1.3 1.8 13.8 1.9 0.6 0.8 0.4 1.2 5.4 5.2 4.3 2.1 4.8 4.4 2.0 4.0 5.6 2.0 3.7 2.8 3.9 3.6 26.8 22.4 2.4 22.9 5.4 0.0 17.3 10.2 12.0 17.0 3.5 0.0 70.1 10.0 10.9 0.2 5.2 47.0 0.0 3.9 9.5 5.9 3.5 21.9 34.1 19.9 0.0 9.8 4.3 8.8 1.3 24.7 11.5 3.3 15.4 19.9 6.6 4.5 35.1 13.4 99.5 0.2 0.0 3.9 0.0 2.7 6.0 67.7 5.7 18.3 10.6 ACSL1 "ACS1, FACL1, FACL2, LACS, LACS1, LACS2" ENSG00000151726 "Acyl-CoA synthetase long chain family member 1" P33121 4 184755595-184826818 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.0;liver: 190.9" "Group enriched" "Detected in many" 4 "Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 80.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 80.2" "Cell line enhanced" "Detected in many" "ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011316, HPA011964" Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA011316: AB_1844536, HPA011964: AB_1844537" "unprognostic (1.10e-2)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (1.82e-3)" "unprognostic (2.75e-2)" "unprognostic (1.79e-1)" "unprognostic (5.89e-2)" "unprognostic (9.83e-2)" "unprognostic (3.15e-1)" "prognostic favorable (1.25e-5)" "unprognostic (2.77e-1)" "unprognostic (4.38e-2)" "unprognostic (6.25e-3)" "unprognostic (3.13e-2)" 105.0 6.7 4.2 14.1 13.5 46.0 54.4 3.2 9.6 7.2 12.2 16.4 5.5 4.9 5.7 12.7 8.8 6.4 5.7 24.3 6.4 4.1 32.8 190.9 20.7 18.9 24.0 3.8 4.2 7.3 5.9 8.7 4.4 11.6 14.2 2.6 9.1 17.9 4.8 89.1 20.4 4.5 6.4 18.2 16.9 6.5 6.4 15.9 2.1 8.3 10.1 5.8 7.6 11.0 0.5 2.2 80.2 8.9 0.7 0.7 2.9 6.1 1.9 1.2 3.1 151.2 36.7 1.0 3.4 1.7 2.0 1.4 0.4 1.7 2.5 0.3 4.0 4.9 3.8 5.4 2.2 1.7 12.4 1.9 1.8 1.7 5.0 24.3 4.9 4.6 80.3 18.6 1.7 8.7 3.6 2.6 0.4 0.8 7.8 9.8 3.2 0.3 6.8 0.2 4.1 2.7 0.9 1.0 3.2 47.8 17.5 4.6 4.3 3.1 9.4 10.5 0.5 3.4 5.0 2.8 1.8 2.1 4.3 1.0 3.0 1.5 1.1 5.8 6.9 2.8 2.3 8.9 2.8 0.5 5.2 0.5 0.5 0.4 0.2 2.2 0.5 0.4 0.3 80.2 0.7 3.6 0.4 0.7 2.9 4.2 13.5 3.2 9.6 6.4 4.1 24.0 3.8 11.6 15.9 23.8 107.2 14.5 16.5 18.7 5.8 89.7 28.1 13.4 21.6 29.6 17.7 8.6 79.6 3.9 359.4 5.6 2.6 0.0 11.0 1.9 9.1 56.1 23.1 1018.8 39.4 3.2 0.0 19.0 136.2 335.5 17.8 64.1 30.4 24.4 4.2 3.3 9.0 0.9 15.6 75.0 10.3 12.9 12.0 8.1 16.7 35.9 2.9 10.0 1.7 21.4 ACSS2 "ACAS2, AceCS, ACS, ACSA, dJ1161H23.1" ENSG00000131069 "Acyl-CoA synthetase short chain family member 2" Q9NR19 20 34872146-34927962 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.4" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 98.3;Mucus-secreting cells: 80.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 5 "dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6" "Cell line enhanced" "Detected in many" "RPMI-8226: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004141 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA004141: AB_1078094" "unprognostic (1.97e-2)" "unprognostic (1.33e-1)" "unprognostic (1.70e-1)" "unprognostic (2.25e-2)" "unprognostic (1.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.42e-1)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (3.92e-2)" "unprognostic (1.66e-1)" "unprognostic (1.42e-2)" "prognostic favorable (2.04e-4)" "unprognostic (2.72e-1)" "unprognostic (2.32e-1)" "unprognostic (3.08e-1)" "unprognostic (2.54e-1)" 30.3 12.6 2.8 9.2 7.0 1.9 12.4 5.6 7.0 6.8 21.0 10.6 8.3 21.4 6.6 7.0 8.1 4.5 7.7 24.8 2.9 2.5 11.2 15.7 11.7 3.2 6.8 3.2 5.1 3.2 4.7 2.5 4.6 5.5 3.4 10.4 3.5 9.8 6.8 63.4 6.8 24.1 3.0 6.1 2.7 13.4 3.1 7.1 1.1 3.9 7.3 3.0 6.5 6.1 0.7 12.6 17.0 11.6 0.3 3.0 4.7 11.9 1.6 1.2 1.6 8.5 9.0 12.4 7.1 5.5 2.0 3.5 4.3 6.6 0.0 8.1 3.1 7.7 9.0 2.9 17.9 1.5 0.1 2.8 16.6 0.8 2.0 6.2 1.6 9.1 6.1 3.9 2.9 2.8 2.9 3.1 1.2 10.5 1.3 2.7 1.4 0.5 7.3 0.8 3.6 20.3 4.4 7.8 26.2 6.8 1.2 1.1 5.4 8.7 6.4 6.9 3.4 3.1 3.6 11.7 2.4 3.3 4.3 2.3 11.3 8.2 3.8 6.7 2.6 1.9 17.0 11.6 3.0 0.6 7.2 0.5 0.4 1.6 0.7 12.6 0.7 3.0 1.5 6.5 0.3 3.4 2.1 1.1 4.7 2.8 7.0 5.6 7.0 2.9 2.5 6.8 3.2 5.5 7.1 11.9 40.9 3.0 8.5 6.9 6.0 70.4 25.5 5.3 13.6 10.4 5.9 13.6 10.0 16.5 7.2 13.2 98.3 23.3 29.5 8.5 8.9 8.8 9.2 44.8 14.7 7.9 7.5 10.4 17.2 6.0 10.6 13.8 13.5 19.8 80.6 8.8 18.1 60.0 4.2 51.2 3.4 12.9 9.9 11.6 7.3 9.5 17.5 5.0 60.0 8.9 ACVR2B ActR-IIB ENSG00000114739 "Activin A receptor type 2B" Q13705 3 38453851-38493142 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 16.4;NTERA-2: 20.3;SuSa: 12.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007398, CAB025115, HPA040384" Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" No No Cytosol "Nucleoplasm, Nuclear bodies" "CAB025115: , HPA007398: AB_2667822, HPA040384: AB_2732484" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.32e-2)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (1.64e-1)" "unprognostic (1.98e-1)" "unprognostic (1.83e-1)" "unprognostic (4.75e-1)" 2.8 7.4 5.5 4.6 7.9 1.1 5.5 13.2 7.5 5.2 3.4 7.2 4.5 2.8 4.7 5.1 2.5 5.6 3.3 3.9 5.9 5.4 5.3 5.4 6.9 2.2 5.9 5.4 8.3 6.1 11.3 5.1 16.0 6.5 3.9 3.6 5.0 4.6 4.2 15.9 2.4 2.8 4.6 4.7 3.1 4.0 9.1 9.1 12.8 4.8 1.7 2.2 4.2 10.3 0.3 0.3 0.5 0.2 0.5 1.6 0.3 0.8 1.4 16.4 1.4 0.6 0.4 8.8 0.3 0.5 0.3 0.7 2.3 1.1 0.1 1.2 0.3 0.5 1.0 6.3 1.0 0.9 2.4 4.1 4.2 2.5 3.5 0.8 2.9 1.6 0.7 0.9 0.5 1.8 1.0 1.1 6.2 6.9 1.4 0.3 1.3 5.1 1.9 20.3 0.8 0.7 1.7 5.5 1.0 1.0 1.9 3.8 6.7 0.4 2.5 2.2 12.2 1.3 3.9 0.9 0.5 2.7 0.4 1.4 3.9 5.4 0.9 0.6 2.5 1.1 0.5 0.1 0.1 0.4 0.2 0.6 0.2 1.0 0.5 0.0 0.3 1.6 1.5 0.3 0.5 0.2 0.3 0.7 0.3 5.5 7.9 13.2 7.0 5.9 5.4 5.9 5.4 6.5 9.1 6.0 6.7 0.5 3.6 3.5 20.7 11.6 5.1 6.7 4.5 0.0 21.6 6.7 0.0 3.2 9.1 6.1 2.9 0.0 3.3 5.8 3.1 3.2 1.1 7.5 2.2 20.6 6.9 4.9 2.1 12.6 10.9 3.2 6.8 0.0 3.2 9.6 3.8 2.5 7.4 2.8 25.5 0.0 5.6 8.1 19.0 3.4 5.1 2.5 4.7 3.3 ADAL ENSG00000168803 "Adenosine deaminase like" Q6DHV7 15 43330657-43354555 "Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 76.6;Rod photoreceptor cells: 77.1;Spermatogonia: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039879, HPA048175, HPA058795" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles" NA NA Nucleoplasm "Nuclear speckles, Vesicles" "HPA039879: , HPA048175: AB_2680298, HPA058795: " "unprognostic (1.65e-2)" "unprognostic (1.53e-3)" "unprognostic (9.80e-2)" "unprognostic (3.15e-3)" "unprognostic (2.46e-3)" "unprognostic (1.86e-1)" "unprognostic (2.00e-1)" "unprognostic (5.83e-2)" "unprognostic (5.90e-2)" "unprognostic (2.68e-1)" "unprognostic (6.85e-3)" "unprognostic (1.69e-1)" "prognostic favorable (7.64e-9)" "unprognostic (2.37e-3)" "unprognostic (8.77e-2)" "unprognostic (5.31e-2)" "unprognostic (2.44e-2)" 6.9 7.9 10.0 4.6 12.4 4.7 7.1 9.0 11.3 4.0 6.2 9.9 4.2 6.9 6.8 11.0 5.1 4.3 4.7 23.8 9.3 10.3 14.1 10.6 4.2 5.2 10.5 9.0 4.6 5.2 15.6 10.6 3.4 10.7 7.7 5.9 11.8 4.9 8.0 20.9 3.5 8.6 8.8 14.0 4.7 4.7 12.5 9.2 4.4 13.0 9.7 5.6 6.1 3.6 5.0 7.3 8.8 4.6 5.0 8.7 3.0 4.7 2.5 9.8 10.5 4.1 5.5 4.5 5.5 5.8 8.9 13.9 9.8 2.4 5.8 9.5 6.2 11.9 5.2 0.0 4.0 8.0 5.6 6.5 13.5 16.2 8.0 5.8 0.0 10.3 7.1 7.9 6.5 6.8 5.8 1.9 13.4 14.3 11.3 9.7 3.3 8.3 6.7 3.9 5.2 3.6 10.9 14.3 8.5 8.3 2.9 12.5 8.4 9.4 8.3 8.4 5.5 8.8 9.4 2.4 15.8 7.4 12.0 11.6 11.9 19.7 2.3 8.9 14.5 12.9 8.8 3.3 7.7 5.9 4.6 4.7 5.0 5.5 5.0 4.5 5.0 5.8 7.0 2.3 5.0 3.9 7.3 8.7 3.0 10.0 12.4 9.0 11.3 9.3 10.3 10.5 9.0 10.7 9.2 8.9 9.3 12.5 7.9 6.3 39.1 42.8 10.2 12.0 5.7 17.4 76.6 6.4 49.7 7.8 9.3 6.9 8.7 0.0 7.3 5.5 7.6 7.8 7.0 27.2 7.5 39.7 7.5 10.4 5.4 9.6 8.9 11.2 8.5 3.6 7.3 33.0 5.4 0.0 8.1 24.8 77.1 6.5 8.0 33.7 66.1 3.9 2.2 9.2 9.9 2.4 ADAM10 "CD156c, HsT18717, kuz, MADM" ENSG00000137845 "ADAM metallopeptidase domain 10" O14672 15 58588807-58749978 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 77.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001709, HPA050670" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 8200000 "Plasma membrane" "Nucleoplasm, Vesicles" "CAB001709: , HPA050670: " "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (5.04e-2)" "unprognostic (3.09e-1)" "unprognostic (2.70e-3)" "unprognostic (7.48e-2)" "prognostic unfavorable (8.46e-5)" "unprognostic (3.99e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (6.69e-2)" "unprognostic (2.57e-2)" "unprognostic (2.57e-3)" "unprognostic (9.14e-2)" "unprognostic (2.09e-2)" "unprognostic (1.60e-2)" 25.9 11.1 15.5 17.1 17.7 15.6 20.0 25.2 17.6 18.6 20.1 15.7 12.7 13.9 19.9 11.8 17.1 13.8 18.0 18.8 17.6 13.7 20.8 14.8 25.0 26.1 23.1 12.4 13.9 13.1 10.9 11.6 36.1 14.5 23.6 16.7 14.6 12.4 19.1 8.9 15.4 15.6 12.8 30.4 40.4 18.4 8.5 18.9 38.5 27.3 9.2 14.9 30.0 19.1 6.2 12.7 26.9 23.7 9.8 12.2 12.8 12.1 27.4 7.5 8.1 9.6 13.9 18.9 10.4 31.0 7.7 10.7 12.6 16.1 5.6 32.2 9.3 13.5 24.8 4.5 11.0 10.2 8.4 5.8 9.6 10.0 11.7 10.7 6.8 27.7 12.1 8.1 5.4 7.9 11.2 14.9 12.2 6.0 15.3 13.5 4.5 22.4 7.7 10.2 4.0 3.9 9.3 24.5 14.4 17.9 32.7 8.1 5.3 11.3 13.2 18.0 17.1 7.8 13.6 10.5 10.1 11.3 77.5 10.0 8.6 18.5 6.1 14.1 13.1 17.6 12.9 18.8 10.4 8.1 21.5 12.2 5.3 8.0 7.1 12.7 6.2 8.4 7.0 26.9 9.8 23.7 5.8 10.3 12.8 15.5 17.7 25.2 16.9 17.6 13.7 23.1 12.4 14.5 18.9 77.4 49.8 30.6 25.8 23.7 20.2 29.7 30.6 30.8 35.2 76.8 25.5 27.4 1.7 45.7 21.6 61.6 39.3 0.0 27.7 46.7 28.8 75.5 27.9 30.4 56.9 42.9 34.7 76.1 87.0 16.2 16.7 64.0 43.9 13.6 45.8 27.0 37.3 43.2 15.9 20.3 32.7 12.9 28.3 13.6 16.2 19.4 22.2 43.6 33.7 59.6 ADAT2 "DEADC1, dJ20N2.1, TAD2" ENSG00000189007 "Adenosine deaminase, tRNA specific 2" Q7Z6V5 6 143422832-143450673 "Enzymes, Predicted intracellular proteins" "tRNA processing" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035479 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA035479: AB_10611672" "unprognostic (2.24e-1)" "unprognostic (3.07e-3)" "unprognostic (1.55e-1)" "unprognostic (8.20e-2)" "unprognostic (3.05e-2)" "unprognostic (8.58e-2)" "unprognostic (1.07e-3)" "unprognostic (3.31e-2)" "unprognostic (1.34e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-2)" "unprognostic (9.28e-5)" "unprognostic (4.88e-2)" "unprognostic (6.96e-2)" "unprognostic (7.29e-2)" "unprognostic (4.08e-2)" 7.3 9.5 6.6 15.1 9.4 17.1 8.6 7.7 8.8 6.6 9.5 4.9 4.7 9.9 8.3 5.3 12.0 7.9 7.6 4.2 5.2 3.8 7.5 13.2 11.3 17.6 4.9 8.0 7.5 13.3 7.1 9.6 4.0 7.3 8.6 13.3 6.0 10.1 6.2 13.3 17.1 10.0 6.5 6.7 13.1 10.8 4.1 5.3 8.6 10.8 10.1 13.5 6.6 8.7 2.8 3.2 0.4 1.4 1.9 6.6 2.3 2.9 2.5 3.1 10.6 2.6 8.5 4.7 4.2 1.9 2.9 4.1 6.7 7.5 10.5 4.6 2.8 3.3 8.6 5.8 5.9 5.7 5.5 13.0 14.8 10.5 13.5 3.3 20.8 7.4 2.9 8.7 5.7 9.1 2.5 6.2 9.7 16.1 9.1 4.4 4.2 8.0 11.7 4.0 4.0 4.8 9.8 9.2 8.5 4.5 3.3 6.9 4.7 3.5 9.5 2.8 1.7 4.0 7.6 4.8 4.3 3.6 8.8 8.0 9.4 6.6 7.9 4.0 17.5 4.9 0.0 0.9 0.0 3.2 1.4 4.7 2.8 3.0 2.9 3.2 2.0 3.4 5.1 0.4 1.9 0.2 3.0 6.6 2.3 6.6 9.4 7.7 8.8 5.2 3.8 4.9 8.0 7.3 5.3 6.0 11.7 0.8 3.4 6.0 3.6 2.7 0.0 2.7 4.5 1.8 0.0 2.0 3.3 3.4 1.0 4.7 1.8 23.3 3.4 2.1 4.4 2.9 7.0 4.0 4.1 1.6 4.1 4.3 5.1 1.1 6.4 2.8 5.0 0.0 5.6 2.0 4.8 0.0 3.2 0.7 3.1 0.0 4.9 1.8 5.4 8.2 0.7 6.9 7.8 3.8 ADD2 ADDB ENSG00000075340 "Adducin 2" P35612 2 70607618-70768225 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "bone marrow: 53.6;brain: 35.0" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 28.5;Erythroid cells: 70.0;Horizontal cells: 131.9" "Cancer enhanced" "Detected in many" "testis cancer: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 4.7;non-classical monocyte: 4.4" "Group enriched" "Detected in many" 20 "B-cells: 4.7;monocytes: 4.4;T-cells: 1.9" "Cell line enhanced" "Detected in many" "HAP1: 14.3;JURKAT: 13.9;K-562: 18.7;NTERA-2: 36.9;RPMI-8226: 17.6;SCLC-21H: 18.4;U-251 MG: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009796, HPA034509, HPA034510" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 66000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202" "unprognostic (3.58e-2)" "unprognostic (2.68e-4)" "unprognostic (3.83e-2)" "unprognostic (3.01e-4)" "unprognostic (1.94e-1)" "unprognostic (2.25e-3)" "unprognostic (1.35e-1)" "unprognostic (3.26e-1)" "unprognostic (3.49e-1)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (8.93e-2)" "unprognostic (4.47e-7)" "unprognostic (2.81e-4)" "unprognostic (1.77e-1)" "unprognostic (1.71e-3)" "unprognostic (1.31e-3)" 1.9 2.6 14.0 2.6 17.9 53.6 1.5 29.7 35.0 1.3 1.3 1.2 0.0 1.0 1.3 1.2 2.3 1.4 1.2 1.5 14.1 10.7 0.9 0.9 1.8 3.1 6.0 19.7 1.0 2.1 1.3 2.8 1.6 14.0 1.3 1.2 1.7 1.1 1.1 1.6 1.2 1.2 1.9 6.0 1.9 1.1 2.9 2.7 0.0 2.3 0.0 2.9 1.5 0.5 4.7 0.1 0.1 4.4 0.0 1.9 0.6 7.1 8.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.1 5.3 0.0 14.3 0.0 0.0 0.0 8.4 0.7 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 3.4 0.0 13.9 18.7 0.0 0.0 0.0 0.1 0.6 36.9 0.0 0.2 0.0 0.2 17.6 2.4 0.0 18.4 8.3 9.1 0.0 0.0 4.2 0.0 4.4 0.3 0.0 0.4 0.0 19.4 6.0 7.0 0.0 0.3 2.9 3.3 0.1 0.1 0.0 0.0 2.4 0.1 4.7 0.0 0.0 0.1 4.0 1.9 1.0 0.1 0.0 4.4 0.0 0.0 0.6 14.0 17.9 29.7 35.0 14.1 10.7 6.0 19.7 14.0 2.7 0.0 0.3 3.4 0.1 0.1 19.8 2.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 28.5 2.9 0.0 70.0 0.9 0.2 1.0 0.7 0.0 0.0 0.2 131.9 0.0 1.3 0.3 24.0 0.9 0.0 1.7 1.0 0.0 0.5 0.5 0.0 0.7 0.0 9.4 0.0 0.0 0.7 3.2 0.1 0.2 0.0 0.0 0.6 ADGRG5 "GPR114, PGR27" ENSG00000159618 "Adhesion G protein-coupled receptor G5" Q8IZF4 16 57542421-57591681 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 37.7;lymphoid tissue: 25.6" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 2.2;Kupffer cells: 1.2;monocytes: 1.8;T-cells: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 37.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HMC-1: 28.1;OE19: 9.2" "Region enhanced" "Detected in single" "thalamus: 0.4" "Not detected" "Not detected" HPA007133 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" Nucleoplasm "HPA007133: AB_1849253" "unprognostic (6.11e-3)" "prognostic favorable (4.25e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (6.14e-2)" "unprognostic (1.14e-2)" "unprognostic (6.43e-2)" "unprognostic (1.42e-2)" "unprognostic (8.09e-4)" "unprognostic (3.80e-3)" "unprognostic (3.02e-3)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (7.69e-3)" "unprognostic (4.52e-1)" "unprognostic (1.62e-3)" "unprognostic (6.32e-3)" 0.7 0.6 2.4 20.2 2.7 1.4 0.8 0.6 2.1 0.6 2.1 2.5 0.0 4.3 0.5 0.2 1.7 0.8 0.8 0.5 1.6 1.1 0.5 0.6 2.9 12.1 2.6 0.9 0.5 0.4 0.2 0.8 0.0 2.9 1.2 1.7 0.5 4.6 0.8 0.4 0.7 7.5 0.3 3.5 12.8 0.5 1.2 3.5 3.4 1.1 0.2 25.6 2.8 0.9 4.0 21.9 37.7 0.0 8.8 11.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.4 2.6 9.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 37.7 11.1 0.0 5.6 4.0 1.6 6.4 0.7 2.8 0.4 4.0 0.1 8.8 0.0 21.9 0.0 2.3 2.4 2.7 0.6 2.1 1.6 1.1 2.6 0.9 2.9 3.5 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.7 0.4 0.0 ADK AK ENSG00000156110 "Adenosine kinase" P55263 10 74151185-74709303 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Purine salvage" "Kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 71.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032876, HPA038391, HPA038409, HPA075222" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 320000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: " "unprognostic (1.55e-3)" "unprognostic (1.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.62e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.93e-4)" "prognostic favorable (9.91e-4)" "unprognostic (2.64e-1)" "unprognostic (2.88e-1)" "unprognostic (1.55e-1)" "unprognostic (8.15e-3)" "unprognostic (2.51e-1)" "unprognostic (1.89e-3)" "unprognostic (2.03e-1)" "unprognostic (2.88e-2)" "unprognostic (4.97e-3)" "unprognostic (2.95e-2)" 13.8 10.7 11.8 13.6 25.4 12.1 14.5 11.2 11.8 9.5 9.3 9.0 9.6 8.8 6.6 10.6 29.4 8.9 6.3 15.7 9.8 11.1 19.0 71.9 15.1 17.9 12.3 9.3 5.2 12.6 15.1 23.5 43.2 11.6 8.7 10.8 8.5 13.1 11.4 18.1 20.8 6.4 8.3 13.2 11.3 7.4 11.9 10.3 13.4 20.8 24.1 21.9 12.6 14.7 49.3 23.0 5.4 21.6 6.5 15.7 9.8 38.1 8.6 9.1 12.2 9.2 14.2 21.0 33.2 26.3 25.7 28.9 24.1 39.8 20.0 8.3 13.3 12.1 34.9 10.7 35.3 41.2 13.4 12.3 12.7 14.1 25.9 10.5 20.3 5.2 13.0 23.3 18.7 46.6 19.0 22.3 9.3 10.1 6.5 19.3 21.3 23.9 27.5 2.6 17.8 60.9 23.1 15.8 17.2 28.1 21.0 7.2 8.5 14.6 56.7 11.0 8.5 37.7 15.4 19.1 8.5 15.7 22.7 27.3 9.4 10.6 22.6 16.1 29.3 5.2 1.3 10.1 1.4 4.5 18.0 10.0 29.7 9.5 8.2 23.0 49.3 7.9 6.5 5.4 6.5 21.6 16.7 15.7 9.8 11.8 25.4 11.2 11.8 9.8 11.1 12.3 9.3 11.6 10.3 77.4 57.2 37.1 62.9 83.7 14.5 53.3 35.7 34.8 76.2 29.6 53.0 120.6 77.9 60.0 55.9 14.7 5.9 0.0 58.9 113.1 27.2 33.9 19.8 112.8 36.3 11.1 10.4 14.7 21.4 22.9 15.5 40.6 45.5 31.5 11.5 10.0 45.7 14.0 11.3 48.3 27.9 6.5 32.8 13.3 12.2 84.8 89.7 20.3 19.9 57.0 ADRA1A "ADRA1C, ADRA1L1" ENSG00000120907 "Adrenoceptor alpha 1A" P35348 8 26748150-26867273 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.1" "Group enriched" "Detected in some" 15 "Early spermatids: 50.8;Hepatocytes: 14.0;Late spermatids: 20.6" "Cancer enhanced" "Detected in some" "liver cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 1.3;HAP1: 1.7;JURKAT: 2.0;NTERA-2: 2.3;U-2 OS: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029678, HPA029679, HPA076693" Approved Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: " "unprognostic (1.27e-1)" "unprognostic (1.68e-2)" "unprognostic (1.99e-1)" "unprognostic (3.57e-1)" "unprognostic (5.04e-4)" "unprognostic (1.97e-1)" "unprognostic (9.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.58e-2)" "unprognostic (7.47e-2)" "unprognostic (1.71e-2)" "unprognostic (6.06e-3)" "unprognostic (7.41e-2)" "unprognostic (1.52e-2)" "unprognostic (1.30e-1)" 14.5 0.7 7.1 1.1 3.9 0.3 3.4 6.2 4.9 0.9 1.5 5.9 4.9 1.0 1.8 2.0 0.9 0.6 0.5 10.1 11.6 2.0 0.8 45.1 3.9 1.4 4.7 4.7 1.0 0.5 0.3 0.6 0.3 3.8 10.2 0.7 0.6 4.6 11.2 0.6 0.9 1.3 2.4 1.9 7.0 1.2 0.5 4.2 0.0 0.6 0.1 0.6 0.6 0.7 0.3 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 7.1 3.9 6.2 4.9 11.6 2.0 4.7 4.7 3.8 4.2 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 1.3 0.0 20.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ADRM1 "ARM1, GP110, Rpn13" ENSG00000130706 "Adhesion regulating molecule 1" Q16186 20 62302093-62308862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Late spermatids: 1352.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 113.5" "Low region specificity" "Detected in all" HPA042266 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042266: AB_10794044" "unprognostic (5.49e-2)" "unprognostic (5.14e-3)" "unprognostic (7.34e-2)" "unprognostic (6.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-3)" "unprognostic (2.14e-2)" "unprognostic (3.56e-2)" "unprognostic (2.13e-3)" "unprognostic (8.98e-2)" "unprognostic (3.50e-1)" "prognostic unfavorable (9.02e-6)" "unprognostic (4.15e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "unprognostic (8.47e-2)" 22.9 22.9 14.8 23.4 16.8 30.5 17.0 24.1 29.3 14.7 16.9 18.8 12.4 24.0 19.9 15.3 23.9 14.0 20.4 24.6 14.6 15.1 21.7 54.5 15.7 22.1 15.5 13.4 17.2 34.9 9.5 13.4 27.6 21.4 14.8 7.9 14.8 21.0 18.3 86.6 26.4 19.5 17.3 15.4 23.5 20.1 30.0 10.1 23.8 16.4 29.1 29.4 17.3 14.6 79.2 67.2 69.4 78.0 51.7 77.6 70.9 33.9 38.1 10.7 22.8 10.2 7.5 29.1 22.5 15.3 42.2 16.9 113.5 36.0 18.3 41.1 12.8 24.1 38.4 13.4 33.0 13.0 21.3 27.5 44.4 27.6 59.8 17.3 22.9 42.4 9.5 20.3 27.5 11.0 7.0 16.3 18.2 32.4 20.0 9.7 45.7 28.7 44.9 36.2 16.5 56.9 23.1 18.8 29.0 11.3 25.6 19.2 23.9 24.2 38.5 27.0 7.6 26.8 25.3 23.9 42.2 44.7 41.1 45.0 42.7 33.6 24.4 44.4 23.1 30.5 48.3 66.3 69.4 66.0 78.0 58.9 79.2 59.8 62.7 67.2 75.5 45.1 51.4 62.2 51.7 65.0 62.7 77.6 70.9 14.8 16.8 24.1 29.3 14.6 15.1 15.5 13.4 21.4 10.1 32.8 25.1 83.4 87.4 131.7 31.3 16.5 53.5 32.1 30.7 62.8 17.7 212.4 97.8 167.4 291.0 91.6 138.0 46.7 184.0 146.0 94.9 83.7 41.5 89.8 134.3 31.8 55.5 94.5 71.8 1352.6 67.0 102.8 92.8 165.1 52.2 58.4 189.2 105.2 81.7 101.6 22.8 64.7 95.7 129.4 168.8 129.5 353.8 81.2 63.5 120.7 AEBP1 ACLP ENSG00000106624 "AE binding protein 1" Q8IUX7 7 44104361-44114562 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "Calmodulin-binding, DNA-binding, Repressor" "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 177.1" "Cell type enhanced" "Detected in many" 19 "Fibroblasts: 159.0;Leydig cells: 140.4;Peritubular cells: 478.4;Smooth muscle cells: 174.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 10.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 10.5" "Cell line enhanced" "Detected in many" "ASC diff: 34.9;BJ: 45.9;BJ hTERT+: 30.3;fHDF/TERT166: 49.3;JURKAT: 34.8;WM-115: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009966, HPA047724, HPA063595, HPA064970" Supported Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" NA NA 2300000 Vesicles "Nucleoplasm, Cytosol" "CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394" "unprognostic (1.70e-2)" "unprognostic (5.42e-2)" "unprognostic (1.66e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.13e-1)" "unprognostic (7.00e-2)" "unprognostic (8.79e-2)" "unprognostic (2.52e-1)" "unprognostic (3.27e-2)" "unprognostic (1.26e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (9.31e-9)" "unprognostic (2.88e-3)" "unprognostic (9.58e-2)" "unprognostic (1.17e-2)" "unprognostic (6.28e-3)" 46.5 19.0 8.9 23.9 9.5 3.1 90.9 1.7 5.4 78.1 20.5 17.9 15.8 5.8 73.7 39.4 20.7 43.7 47.9 35.4 12.7 6.4 19.6 6.3 35.5 13.0 12.5 10.8 84.8 8.8 2.7 10.9 26.7 17.2 46.1 7.9 33.3 11.9 70.2 11.4 19.7 16.9 42.6 43.7 16.6 17.6 30.6 9.6 48.0 19.6 12.3 7.5 58.2 177.1 2.3 10.5 0.0 0.0 0.2 1.4 0.4 0.1 0.0 10.8 0.0 34.9 12.4 0.2 45.9 30.3 5.2 1.1 0.0 0.0 1.2 5.1 49.3 0.0 0.0 0.5 0.8 2.2 0.1 0.0 3.1 0.0 0.0 9.8 0.0 0.0 18.8 0.0 17.7 0.0 0.2 2.3 34.8 1.9 0.0 0.0 0.0 19.9 3.7 4.6 0.0 0.0 16.5 0.4 0.3 1.2 0.0 1.1 6.1 0.0 0.0 20.1 10.6 0.1 3.3 8.0 0.0 21.3 0.1 0.0 0.2 0.2 24.2 0.1 0.0 28.2 0.0 0.0 0.0 0.4 0.0 0.3 2.1 0.4 0.0 0.0 2.3 1.4 0.8 0.0 0.2 0.0 10.5 0.0 0.4 8.9 9.5 1.7 5.4 12.7 6.4 12.5 10.8 17.2 9.6 0.0 4.5 6.7 5.4 30.7 0.2 15.5 0.0 4.0 2.3 7.0 0.0 1.7 0.0 0.8 2.0 14.4 0.0 0.0 0.0 2.6 159.0 2.4 2.3 0.0 3.1 0.0 0.0 38.6 1.9 9.5 140.4 3.8 81.0 1.0 0.0 0.1 0.7 0.0 478.4 0.6 0.6 38.8 174.1 2.4 4.5 24.0 2.9 0.7 0.0 2.0 AEN "FLJ12484, FLJ12562, ISG20L1" ENSG00000181026 "Apoptosis enhancing nuclease" Q8WTP8 15 88621296-88632282 "Predicted intracellular proteins" "Apoptosis, DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048599 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane" "HPA048599: AB_2756313" "unprognostic (8.64e-2)" "unprognostic (1.94e-1)" "unprognostic (2.16e-2)" "prognostic favorable (1.72e-4)" "unprognostic (1.52e-2)" "unprognostic (4.40e-2)" "unprognostic (4.08e-2)" "unprognostic (9.42e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-2)" "unprognostic (9.00e-2)" "unprognostic (7.88e-2)" "unprognostic (8.58e-3)" "unprognostic (3.39e-2)" "unprognostic (2.73e-1)" "unprognostic (8.71e-2)" "unprognostic (6.10e-2)" 9.4 10.4 6.5 10.2 7.2 14.8 11.2 2.8 5.0 8.0 7.8 4.9 13.4 5.0 9.3 10.2 8.9 7.0 23.0 8.2 4.7 8.5 7.9 17.4 9.1 15.4 13.1 3.1 11.2 18.8 6.7 21.3 11.0 7.8 11.6 9.1 4.3 14.5 9.1 18.8 5.9 8.0 10.6 9.3 14.2 11.1 14.3 4.6 14.0 16.6 10.9 13.7 12.5 5.4 9.3 4.1 0.6 3.6 3.0 15.0 7.6 4.9 22.1 13.8 11.8 6.1 7.4 29.3 17.7 16.2 13.6 16.8 18.1 9.7 21.3 5.7 9.6 12.3 7.1 50.8 14.3 11.5 5.2 20.0 11.4 8.9 29.9 15.1 9.4 11.5 9.1 12.7 17.0 14.0 4.9 11.4 7.1 17.9 12.1 16.6 11.5 11.6 7.9 33.3 10.3 12.8 15.3 9.8 15.7 5.7 10.7 10.9 10.0 7.1 8.2 13.6 33.0 6.8 10.9 10.3 13.9 19.4 5.6 23.8 23.5 15.7 18.2 12.8 10.6 27.2 0.0 1.8 0.6 5.3 3.1 10.0 9.3 9.1 6.9 4.1 9.3 10.0 8.8 0.4 3.0 3.6 2.4 15.0 7.6 6.5 7.2 2.8 5.0 4.7 8.5 13.1 3.1 7.8 4.6 6.0 7.2 11.2 18.2 16.6 0.4 3.4 10.2 2.7 12.5 1.8 0.0 3.4 3.3 12.4 19.8 4.4 2.9 0.0 6.4 13.5 6.7 23.7 2.3 5.0 4.1 1.6 8.6 1.8 5.9 39.3 4.0 5.1 13.5 20.8 5.8 2.3 9.5 5.8 2.5 5.0 0.8 12.9 17.0 6.3 15.0 24.7 5.1 7.2 6.0 24.5 AFDN "AF-6, AF6, MLLT4" ENSG00000130396 "Afadin, adherens junction formation factor" P55196 6 167826922-167972023 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cell adhesion" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 157.8;Alveolar cells type 2: 72.9;Ciliated cells: 85.6;Club cells: 75.1;Collecting duct cells: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924" "prognostic unfavorable (7.43e-5)" "unprognostic (2.66e-3)" "unprognostic (2.07e-2)" "unprognostic (2.61e-1)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (4.12e-1)" "unprognostic (3.12e-2)" "unprognostic (4.12e-1)" "unprognostic (1.09e-3)" "unprognostic (1.75e-1)" "unprognostic (1.73e-2)" "unprognostic (5.56e-2)" "unprognostic (5.43e-3)" "unprognostic (1.59e-1)" "unprognostic (4.72e-2)" "unprognostic (5.68e-2)" 17.0 7.4 14.9 13.0 17.2 1.8 23.5 17.8 19.3 19.6 26.3 16.1 25.5 22.2 15.8 17.7 59.5 27.9 18.2 13.9 15.6 7.2 20.6 29.3 26.3 5.1 17.1 12.5 16.2 29.7 16.4 27.4 18.7 16.1 20.9 27.2 15.3 38.6 18.6 12.7 24.8 42.3 17.4 13.0 13.5 21.1 16.3 15.2 2.1 25.7 13.7 24.5 16.3 27.9 3.5 0.6 2.9 0.5 0.0 1.2 0.0 18.9 5.9 41.5 14.8 4.0 3.4 30.9 7.7 4.0 6.7 8.3 25.3 11.9 3.4 14.3 4.6 10.5 9.1 17.2 15.8 12.0 21.4 17.8 0.1 2.5 19.1 6.1 2.1 9.1 2.4 10.7 11.2 26.5 10.7 12.3 7.4 38.0 13.3 4.3 8.1 0.2 0.1 10.1 27.1 2.7 12.3 10.9 14.4 12.2 9.3 19.2 11.7 7.8 29.8 11.8 40.5 3.5 0.8 18.0 3.1 15.1 13.4 12.7 0.2 16.1 6.9 9.3 4.4 27.2 0.0 0.5 0.0 1.0 0.5 0.6 3.5 1.2 0.4 0.6 2.7 0.0 0.5 2.9 0.0 0.3 0.0 0.6 0.0 14.9 17.2 17.8 19.3 15.6 7.2 17.1 12.5 16.1 15.2 157.8 72.9 0.0 0.0 0.0 0.0 0.0 0.0 85.6 75.1 90.7 0.0 27.0 18.3 58.2 0.0 0.0 0.0 0.0 34.2 28.5 0.0 0.0 8.1 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 19.0 0.0 0.0 52.1 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 AGAP2 CENTG1 ENSG00000135439 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 2" Q99490 12 57723761-57742157 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 55.9;lymphoid tissue: 18.8" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 7.5;Horizontal cells: 7.9;Sertoli cells: 32.3;T-cells: 12.1" "Cancer enriched" "Detected in many" 12 "glioma: 20.6" "Group enriched" "Detected in many" 4 "amygdala: 34.3;basal ganglia: 40.2;cerebellum: 48.2;cerebral cortex: 35.4;hippocampal formation: 37.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 18.0;Karpas-707: 17.5;RH-30: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023474, HPA075831" Enhanced Supported "Nucleoplasm,Midbody ring,Cytosol" NA NA "Nucleoplasm, Cytosol" "Midbody ring" "HPA023474: AB_1855378, HPA075831: " "unprognostic (1.87e-1)" "unprognostic (2.46e-3)" "unprognostic (9.26e-2)" "unprognostic (5.56e-4)" "unprognostic (3.95e-1)" "unprognostic (1.14e-2)" "unprognostic (5.00e-2)" "unprognostic (2.36e-2)" "unprognostic (3.39e-1)" "unprognostic (2.80e-1)" "unprognostic (1.93e-3)" "unprognostic (4.18e-1)" "unprognostic (4.81e-9)" "unprognostic (3.30e-1)" "unprognostic (2.72e-2)" "unprognostic (3.07e-1)" "unprognostic (5.75e-2)" 3.8 1.8 34.3 11.8 40.2 8.1 0.7 48.2 55.9 0.6 2.1 1.2 0.0 2.0 1.5 0.9 1.6 0.8 2.8 4.3 37.6 8.9 1.2 0.8 2.2 13.5 6.3 3.1 1.2 2.4 1.7 1.2 1.7 2.5 1.0 1.2 0.7 4.5 0.9 8.3 2.1 2.2 0.8 2.1 10.0 2.1 0.9 0.7 18.8 0.9 1.5 16.6 2.9 0.6 1.9 1.4 6.3 1.2 2.3 6.3 1.7 3.0 4.5 8.7 2.5 0.0 0.0 5.0 2.1 0.4 0.0 0.2 0.5 2.9 7.9 0.6 0.0 1.6 1.9 0.0 0.0 0.0 8.6 1.3 8.7 0.7 1.4 0.0 8.9 18.0 0.0 0.0 0.0 0.0 3.7 0.0 9.3 0.0 17.5 0.0 5.3 15.7 5.7 1.4 0.9 4.6 6.5 43.8 5.7 0.0 2.6 2.5 9.1 1.1 1.6 1.8 0.0 1.1 6.3 4.8 2.4 4.1 4.6 1.5 7.4 4.4 3.9 4.4 5.9 4.1 6.0 0.8 1.0 4.8 1.2 5.1 1.9 4.8 5.1 1.4 1.6 2.0 3.0 6.3 2.3 0.7 1.2 6.3 1.7 34.3 40.2 48.2 35.4 37.6 8.9 6.3 3.1 2.5 0.7 3.0 0.6 4.1 0.2 0.0 7.5 2.2 2.5 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.2 0.4 0.2 2.3 0.0 1.4 7.9 0.0 0.6 0.6 0.7 0.0 1.6 0.0 3.6 0.3 0.1 0.1 0.0 0.7 0.0 1.9 32.3 1.2 0.7 0.4 0.4 0.0 12.1 0.1 0.0 AGL ENSG00000162688 "Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase" P35573 1 99850084-99924023 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycogen biosynthesis" "Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 23.1;skeletal muscle: 85.6;tongue: 34.4" "Cell type enhanced" "Detected in all" 6 "Muller glia cells: 151.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028498, HPA054340" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 16000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA028498: AB_10600975, HPA054340: AB_2682455" "unprognostic (2.90e-1)" "unprognostic (5.34e-2)" "unprognostic (3.99e-3)" "unprognostic (2.18e-2)" "unprognostic (6.46e-3)" "unprognostic (5.13e-2)" "unprognostic (1.12e-1)" "unprognostic (1.92e-2)" "unprognostic (9.37e-3)" "unprognostic (1.11e-1)" "unprognostic (8.10e-3)" "unprognostic (7.61e-2)" "prognostic favorable (1.73e-10)" "unprognostic (6.38e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" "unprognostic (7.13e-2)" 5.0 4.5 2.5 4.7 3.6 2.0 4.2 5.4 6.1 3.4 4.5 2.1 5.4 3.3 4.8 4.2 9.1 4.1 2.6 8.2 2.2 2.3 5.8 23.1 4.2 5.3 2.4 4.2 3.8 3.6 8.7 4.7 4.8 2.9 5.5 4.2 3.9 5.1 8.7 85.6 3.7 4.0 5.4 2.8 4.8 4.4 2.9 1.2 7.1 4.3 34.4 3.4 6.7 3.6 3.0 2.3 3.5 1.6 6.1 4.3 2.1 12.1 3.6 4.3 7.0 7.1 6.8 14.5 3.8 5.7 3.4 6.0 13.5 4.1 15.9 7.4 6.5 3.0 6.9 25.1 7.5 6.4 8.4 7.9 9.2 12.4 7.5 4.7 8.2 5.6 8.2 4.9 4.7 3.9 4.8 5.3 5.6 15.2 1.1 3.5 3.8 9.6 2.6 6.8 5.4 4.6 0.0 1.4 0.8 10.3 16.4 10.7 7.4 11.1 10.7 6.0 8.4 7.7 5.5 5.4 4.1 5.9 5.5 3.7 4.5 3.6 18.4 7.2 2.2 2.1 0.1 1.3 3.5 4.3 1.6 4.1 3.0 3.2 2.9 2.3 2.9 3.2 3.2 1.5 6.1 0.9 2.1 3.3 2.1 2.5 3.6 5.4 6.1 2.2 2.3 2.4 4.2 2.9 1.2 20.8 23.2 15.3 15.5 9.4 36.9 94.9 20.4 29.4 29.6 15.7 51.1 77.6 19.9 11.9 1.1 10.8 15.8 23.3 11.2 17.2 13.6 9.9 10.4 84.7 15.8 49.3 16.1 16.0 16.2 1.1 9.5 9.2 15.1 10.8 18.2 151.6 14.2 10.5 20.1 16.3 47.8 6.5 14.2 8.1 11.7 8.2 24.4 15.0 17.4 16.6 AGO3 "EIF2C3, FLJ12765, hAGO3" ENSG00000126070 "Argonaute 3, RISC catalytic component" Q9H9G7 1 35930718-36072500 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048342, HPA067849, HPA075436" Uncertain Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "Nucleoplasm, Cytosol" "HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750" "unprognostic (4.10e-2)" "unprognostic (7.10e-2)" "unprognostic (4.94e-2)" "prognostic unfavorable (5.70e-4)" "unprognostic (1.89e-2)" "unprognostic (2.12e-2)" "unprognostic (4.39e-4)" "unprognostic (5.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.30e-1)" "unprognostic (4.97e-2)" "unprognostic (2.96e-2)" "unprognostic (9.28e-3)" "unprognostic (1.61e-1)" "unprognostic (4.45e-2)" "unprognostic (9.06e-2)" "unprognostic (1.81e-1)" 9.8 8.1 8.8 16.2 11.7 20.6 9.6 12.8 9.6 9.4 7.4 13.8 10.4 4.6 9.5 10.9 7.8 7.4 8.8 9.5 8.0 7.4 8.2 11.3 9.6 9.3 11.5 6.1 10.8 9.7 13.3 28.0 11.0 9.1 9.8 7.1 8.7 7.7 14.1 8.3 12.5 7.3 12.0 10.9 8.3 8.0 21.4 13.5 14.4 9.7 4.7 10.1 8.4 13.9 6.5 5.1 14.0 6.0 6.0 5.5 2.3 6.6 4.6 5.9 4.6 8.3 5.0 7.1 5.5 5.8 8.5 9.1 5.0 7.5 7.4 6.8 5.6 9.8 5.6 6.3 4.0 11.4 10.2 3.9 9.0 8.0 3.8 4.4 8.7 7.6 2.4 3.6 12.2 7.7 3.4 7.2 7.8 9.7 10.8 7.4 2.5 6.3 4.7 10.2 3.5 8.1 7.7 7.9 7.3 2.7 6.5 7.2 4.5 9.8 2.5 3.4 9.4 3.7 3.6 5.6 5.9 15.1 5.2 5.9 6.0 10.3 10.3 3.0 5.6 5.7 8.5 4.7 13.2 5.5 4.2 3.5 6.2 3.6 3.9 5.1 6.5 5.0 5.0 14.0 6.0 6.0 4.5 3.4 2.3 8.8 11.7 12.8 9.6 8.0 7.4 11.5 6.1 9.1 13.5 80.4 42.9 19.0 30.7 34.5 67.6 16.7 7.6 12.0 26.1 24.4 106.0 9.2 0.0 13.1 43.3 29.9 12.7 0.0 10.6 11.0 30.1 30.9 56.4 20.3 14.3 39.7 44.9 31.3 28.4 54.4 35.1 34.5 21.9 14.4 14.3 46.3 13.7 7.0 38.9 6.7 82.2 19.4 33.0 33.1 19.8 29.4 10.8 27.7 16.3 25.0 AIM2 PYHIN4 ENSG00000163568 "Absent in melanoma 2" O14862 1 159062484-159147096 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 44.7;lymphoid tissue: 43.8" "Group enriched" "Detected in some" 6 "B-cells: 18.9;Early spermatids: 19.7;Late spermatids: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "memory B-cell: 44.7;naive B-cell: 14.3" "Lineage enriched" "Detected in many" 9 "B-cells: 44.7" "Cell line enhanced" "Detected in some" "Daudi: 31.8;HDLM-2: 44.3;Karpas-707: 17.6;U-266/70: 14.8;U-266/84: 11.1;U-87 MG: 13.7" "Low region specificity" "Detected in all" "HPA031365, HPA040309" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA031365: AB_10601332, HPA040309: AB_2676925" "unprognostic (6.05e-2)" "unprognostic (7.68e-2)" "unprognostic (4.24e-3)" "unprognostic (2.08e-2)" "unprognostic (6.94e-2)" "unprognostic (3.44e-1)" "unprognostic (3.20e-1)" "unprognostic (1.35e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-3)" "unprognostic (7.10e-3)" "unprognostic (1.13e-1)" "unprognostic (1.23e-12)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-3)" 0.7 0.3 1.3 28.2 0.9 0.4 0.6 0.5 0.6 0.4 1.9 0.1 0.0 0.7 0.2 0.2 4.1 0.5 1.1 0.5 1.2 0.6 0.9 0.8 2.0 24.1 0.5 0.2 0.6 0.3 0.0 8.8 0.4 0.5 0.7 1.0 0.5 1.9 0.0 0.2 0.3 12.8 0.2 2.6 43.8 1.3 1.4 1.4 1.4 0.7 0.6 25.9 4.0 0.5 44.7 1.2 4.7 2.4 0.0 3.3 1.4 5.3 0.0 0.3 0.0 0.0 4.4 0.0 0.0 0.5 0.4 0.3 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 44.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 2.9 0.0 2.8 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.1 14.8 11.1 0.3 13.7 1.2 2.3 4.2 2.4 0.0 0.6 2.1 1.7 44.7 1.6 1.1 1.2 14.3 0.1 0.4 4.7 0.0 2.2 0.0 3.3 1.4 1.3 0.9 0.5 0.6 1.2 0.6 0.5 0.2 0.5 1.4 0.0 0.0 18.9 0.1 0.0 0.7 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 19.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.9 24.1 0.3 1.0 3.3 1.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.1 0.0 0.4 AKT2 ENSG00000105221 "AKT serine/threonine kinase 2" P31751 19 40230317-40285536 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Diabetes mellitus, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 109.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004204, HPA064521" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "CAB004204: AB_626659, HPA064521: AB_2685278" "unprognostic (6.13e-2)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.05e-6)" "unprognostic (2.85e-1)" "unprognostic (6.40e-3)" "unprognostic (9.59e-2)" "unprognostic (1.22e-2)" "unprognostic (2.98e-2)" "unprognostic (2.49e-2)" "unprognostic (3.02e-1)" "prognostic unfavorable (4.74e-4)" "unprognostic (1.30e-2)" "unprognostic (1.89e-1)" "unprognostic (3.28e-1)" "unprognostic (6.16e-2)" "unprognostic (2.00e-1)" 31.1 20.3 15.4 17.6 15.2 21.3 18.2 46.3 18.2 23.3 18.2 23.4 21.2 12.3 22.8 28.0 22.1 22.7 14.0 23.1 15.4 10.0 23.0 62.5 14.6 17.8 17.9 13.3 27.8 24.5 21.1 24.0 17.5 14.7 19.7 12.3 26.8 18.5 24.3 48.5 18.3 17.1 20.0 16.8 18.7 15.5 21.3 15.7 26.6 52.6 29.5 23.6 19.6 19.9 6.3 8.8 7.7 4.4 3.2 4.9 2.4 22.8 56.3 21.5 22.1 26.8 32.8 11.9 15.3 22.6 31.7 28.3 24.8 21.3 23.3 13.6 33.6 13.3 10.0 23.8 31.8 20.4 22.3 27.1 15.3 35.7 15.5 16.8 17.5 18.4 30.2 19.1 21.5 20.4 25.1 6.9 25.7 19.6 24.5 17.6 19.0 27.8 8.5 11.6 25.4 15.1 18.5 11.7 16.8 24.7 37.4 29.6 18.1 15.7 26.8 12.7 23.0 21.2 22.6 6.8 19.4 19.2 17.3 23.9 22.8 19.5 19.1 18.9 20.8 15.8 7.6 4.4 3.6 4.5 2.0 4.5 3.9 3.6 3.0 3.0 6.3 3.5 4.9 7.7 3.2 2.6 8.8 2.7 2.4 15.4 15.2 46.3 18.2 15.4 10.0 17.9 13.3 14.7 15.7 14.9 12.8 36.4 20.9 21.2 67.1 26.8 28.1 12.0 10.3 57.6 39.3 25.4 18.3 18.1 2.9 17.0 18.8 0.0 26.0 20.6 22.1 24.5 13.9 74.6 19.3 57.2 18.5 12.9 19.7 7.4 39.7 13.5 21.9 19.8 19.0 52.5 20.4 19.2 25.1 18.3 109.8 19.4 23.3 11.6 16.2 24.0 32.4 17.1 20.1 24.4 AL139011.2 ENSG00000258465 1 160217464-160285130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 14 "Alveolar cells type 2: 1.6;Club cells: 3.4;granulocytes: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 6.7;BJ hTERT+: 5.9;EFO-21: 6.6;HDLM-2: 6.0" "HPA027218, HPA027381, HPA044837" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA027218: AB_10602586, HPA027381: AB_1858808, HPA044837: AB_10962496" "unprognostic (4.71e-2)" "unprognostic (1.75e-1)" "unprognostic (2.21e-2)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (8.04e-4)" "unprognostic (4.70e-2)" "unprognostic (1.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.18e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.87e-3)" "unprognostic (2.92e-1)" "unprognostic (5.29e-1)" "unprognostic (1.06e-1)" "unprognostic (5.18e-3)" 8.6 4.0 3.7 3.0 10.2 2.0 4.4 15.4 11.4 4.8 4.7 8.6 2.5 3.5 6.3 4.2 5.3 6.4 4.6 16.7 3.8 3.9 6.2 10.8 4.1 3.2 3.6 5.9 7.6 4.0 6.7 4.1 5.0 9.1 5.5 3.5 6.1 5.5 3.0 14.6 4.0 4.2 7.8 4.1 3.7 4.3 4.8 4.1 2.5 7.9 3.8 3.4 5.8 4.7 5.8 8.9 6.7 6.5 8.0 5.0 8.0 0.1 2.1 0.3 0.5 6.7 1.9 0.6 0.9 5.9 3.3 0.8 0.0 0.8 0.2 6.6 1.0 5.2 0.8 1.1 0.2 0.0 6.0 0.0 0.3 0.7 0.2 3.4 0.0 0.3 3.2 0.2 3.0 3.4 3.5 0.5 0.8 1.0 4.7 0.5 0.3 1.1 0.0 0.3 0.6 0.6 0.5 0.0 0.3 0.3 0.8 0.6 0.8 0.2 1.4 0.0 1.0 2.8 5.6 0.0 0.8 0.8 0.0 0.2 0.8 3.4 0.5 0.4 0.3 0.3 6.4 6.3 6.2 3.6 6.5 5.0 5.8 4.4 4.7 8.9 3.9 2.5 3.2 6.7 8.0 6.3 2.5 4.9 8.0 3.7 10.2 15.4 11.4 3.8 3.9 3.6 5.9 9.1 4.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AL139300.1 ENSG00000256500 14 103562962-103685924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 37.2" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 1.4;granulocytes: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044617, HPA052450" Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (1.56e-1)" 10.2 7.5 16.6 7.8 20.3 2.8 15.5 21.9 25.1 5.9 4.8 3.2 5.1 2.0 5.5 4.6 5.8 3.9 4.2 20.0 17.2 17.2 5.3 5.6 4.2 7.7 17.3 6.2 5.0 15.8 9.9 5.8 4.2 5.2 5.0 2.9 2.7 7.7 6.3 37.2 2.0 4.2 8.5 22.6 2.9 2.8 18.5 4.0 2.2 7.8 9.2 5.4 6.6 6.9 4.2 4.9 4.2 5.1 2.3 4.4 1.3 6.3 12.0 13.2 1.2 7.3 9.0 5.8 18.5 14.3 20.9 13.2 7.3 9.7 16.2 12.1 13.4 14.1 6.3 8.8 10.6 13.3 5.4 1.0 6.2 6.3 6.8 9.7 8.5 3.7 7.0 2.9 10.0 11.4 11.8 11.9 10.7 8.3 4.2 15.0 12.1 13.3 3.1 9.1 14.3 15.1 5.9 10.4 8.7 10.7 7.4 17.3 10.6 11.0 4.6 10.3 5.5 10.2 4.9 8.4 9.2 7.3 14.7 8.7 5.4 6.3 18.5 15.5 3.5 8.3 0.7 3.2 4.2 2.8 4.3 2.9 1.9 3.4 4.1 1.9 4.2 4.4 1.9 2.8 2.3 5.1 4.9 4.2 1.3 16.6 20.3 21.9 25.1 17.2 17.2 17.3 6.2 5.2 4.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL358113.1 ENSG00000285130 9 69035750-69255187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.9;Ciliated cells: 2.7;Club cells: 1.2" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "dendritic cells: 1.3;monocytes: 2.8;T-cells: 2.6" "Cell line enhanced" "Detected in some" "HaCaT: 2.9;HUVEC TERT2: 2.2;REH: 9.8;U-2 OS: 2.2" "HPA001813, HPA068304, HPA070714" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA001813: AB_1080764, HPA068304: AB_2685970, HPA070714: AB_2732161" 1.6 4.3 2.5 1.9 2.1 2.6 2.8 3.6 2.5 1.6 2.8 3.0 2.7 1.6 2.2 1.6 1.6 3.4 1.6 5.8 1.3 2.1 8.8 2.1 3.2 2.8 1.7 3.7 9.4 1.6 1.7 1.6 2.4 4.0 1.6 2.9 2.8 3.2 7.5 1.6 3.0 4.5 1.6 3.1 3.1 3.4 2.1 0.0 2.6 2.0 2.1 2.4 1.3 0.1 1.3 0.1 2.8 0.0 2.6 0.4 0.4 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.7 0.3 0.0 2.9 0.2 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 2.2 1.5 0.1 0.0 0.2 0.0 1.2 0.2 0.8 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.4 0.0 0.4 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.2 2.6 0.2 0.1 1.3 0.1 1.0 0.1 0.6 0.3 0.1 0.0 2.8 1.3 2.6 0.4 3.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ALKBH5 "FLJ20308, OFOXD1" ENSG00000091542 "AlkB homolog 5, RNA demethylase" Q6P6C2 17 18183078-18209954 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 130.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007196 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA007196: AB_1850461" "unprognostic (1.07e-1)" "unprognostic (1.51e-1)" "unprognostic (2.23e-2)" "unprognostic (1.48e-2)" "unprognostic (1.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.94e-2)" "prognostic favorable (3.75e-4)" "unprognostic (6.54e-2)" "unprognostic (3.99e-2)" "unprognostic (2.88e-2)" "unprognostic (3.22e-2)" "unprognostic (4.68e-3)" "prognostic unfavorable (5.69e-4)" 18.0 19.5 17.1 14.6 21.9 19.1 26.2 23.4 25.3 18.2 21.8 20.1 18.8 15.1 22.1 12.1 17.3 30.5 18.7 45.8 16.5 18.9 16.0 24.2 14.7 16.9 19.0 16.9 20.9 25.0 22.7 20.2 14.8 15.4 19.4 8.9 19.9 23.7 21.1 130.4 12.7 16.9 20.4 15.3 18.8 16.2 29.7 17.6 26.8 23.5 19.5 13.7 26.8 44.8 11.5 8.9 17.6 10.6 7.6 17.0 5.7 33.1 32.0 13.0 23.4 19.1 13.3 11.3 16.0 19.8 26.3 24.5 36.1 8.8 21.0 23.7 17.6 13.9 21.9 19.6 16.9 13.6 23.9 26.7 15.4 18.2 20.1 17.8 11.1 20.7 12.7 11.5 19.7 11.7 16.7 15.2 16.4 16.7 9.6 14.6 24.6 23.9 12.4 11.0 13.9 16.4 21.7 25.7 36.8 7.7 11.4 13.4 17.7 20.0 13.9 18.2 42.7 14.0 9.6 15.4 25.4 17.7 37.2 31.3 11.2 8.5 12.7 46.1 18.2 16.6 4.3 7.2 17.6 15.1 7.4 14.0 7.9 13.6 17.0 8.9 11.5 10.9 11.0 4.6 7.6 10.6 6.6 7.9 5.7 17.1 21.9 23.4 25.3 16.5 18.9 19.0 16.9 15.4 17.6 32.8 25.7 39.8 24.5 57.5 79.0 78.7 25.5 28.1 18.2 26.2 37.3 28.1 71.3 24.0 48.1 37.6 35.4 46.7 27.3 36.7 47.3 36.0 41.4 52.9 29.7 112.8 58.5 27.6 39.9 29.1 38.0 25.6 47.2 17.2 41.8 72.5 28.5 42.4 48.8 81.8 52.8 19.4 44.3 106.7 98.2 48.9 26.3 48.4 31.6 21.6 ALMS1 KIAA0328 ENSG00000116127 "ALMS1, centrosome and basal body associated protein" 2 73385758-73610793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 23.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 55.4;Late spermatids: 63.9;Rod photoreceptor cells: 38.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RH-30: 24.2" "Low region specificity" "Detected in all" "HPA035276, HPA043200" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Centrosome, Cytosol" Nucleoplasm "HPA035276: , HPA043200: AB_10796689" "unprognostic (2.86e-1)" "unprognostic (9.67e-2)" "unprognostic (2.58e-2)" "unprognostic (4.50e-3)" "unprognostic (1.36e-1)" "unprognostic (6.39e-2)" "unprognostic (2.91e-3)" "unprognostic (7.73e-2)" "unprognostic (1.02e-1)" "unprognostic (8.58e-2)" "unprognostic (4.78e-2)" "unprognostic (1.84e-1)" "unprognostic (3.43e-2)" "unprognostic (1.63e-1)" "unprognostic (7.85e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" 3.4 1.7 3.0 6.5 5.5 6.3 3.9 5.5 4.5 6.0 4.0 5.4 4.3 2.0 7.4 3.9 2.2 7.9 4.3 1.6 3.4 3.5 2.1 2.7 2.5 2.0 5.0 11.0 4.0 6.1 6.6 3.2 3.6 3.6 3.3 4.7 2.3 5.8 2.3 1.8 2.4 4.2 3.2 2.1 2.8 23.2 3.4 6.7 5.1 1.9 3.2 2.9 4.1 0.8 1.3 1.3 0.4 0.5 1.2 0.0 8.5 3.4 6.3 4.6 2.5 4.1 3.9 2.9 3.2 4.8 3.6 3.7 1.2 8.1 1.8 4.9 6.4 3.8 10.6 3.3 7.3 4.8 2.9 5.3 3.7 3.0 2.1 7.4 2.6 3.1 2.0 6.7 3.3 2.3 4.3 7.5 6.0 4.3 4.0 2.5 7.0 3.4 8.1 2.4 3.1 7.8 24.2 3.4 1.2 3.1 5.1 6.1 6.7 1.1 2.7 5.1 1.4 1.8 2.7 6.8 7.1 5.4 7.0 5.0 2.5 8.6 2.6 4.2 3.0 0.0 0.1 1.3 1.2 0.2 0.3 0.2 0.6 0.1 0.1 0.8 0.4 0.6 0.0 0.5 0.4 1.3 0.1 0.0 6.0 9.3 0.0 2.6 2.2 23.1 5.8 2.5 21.4 12.5 10.4 23.6 2.6 0.0 3.9 55.4 8.6 3.8 0.0 3.0 2.2 4.8 3.9 4.7 2.1 2.8 20.6 7.0 0.6 3.0 63.9 7.5 3.1 3.3 2.8 5.6 5.7 2.9 0.0 8.5 1.1 38.5 6.5 3.9 25.2 24.4 2.9 1.6 2.5 4.6 1.8 ALX1 CART1 ENSG00000180318 "ALX homeobox 1" Q15699 12 85280107-85301784 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 13.9" "Cell type enriched" "Detected in some" 6 "Melanocytes: 30.4" "Cancer enriched" "Detected in some" 10 "melanoma: 16.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 6.9;HEK 293: 15.4;HUVEC TERT2: 11.3;SK-MEL-30: 18.7;THP-1: 12.2;WM-115: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001598, HPA018905" Uncertain Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Nuclear bodies" "Nucleoplasm, Golgi apparatus" "HPA001598: AB_1078400, HPA018905: AB_1844783" "unprognostic (4.92e-3)" "unprognostic (8.09e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-1)" "unprognostic (6.24e-2)" "unprognostic (2.05e-2)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-5)" "unprognostic (8.97e-2)" "unprognostic (1.43e-1)" 1.9 0.0 0.1 0.0 0.2 0.0 4.8 0.0 0.2 5.4 0.1 0.0 0.8 0.0 5.4 8.5 0.1 4.7 0.0 0.1 0.2 0.2 8.3 0.0 0.1 0.0 0.2 0.0 3.6 0.1 0.0 1.6 0.1 0.0 1.6 0.0 13.9 3.8 2.0 0.4 3.3 0.1 1.1 0.0 0.0 0.1 1.5 0.0 0.0 0.2 4.0 0.0 2.4 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.5 0.0 6.9 0.3 0.0 0.0 15.4 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 6.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 1.8 4.0 0.0 0.0 18.7 2.9 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.3 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 AMDHD1 MGC35366 ENSG00000139344 "Amidohydrolase domain containing 1" Q96NU7 12 95943293-95968716 "Enzymes, Predicted intracellular proteins" "Histidine metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 99.0" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 125.2" "Cancer enriched" "Detected in many" 14 "liver cancer: 23.4" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 19.5;HMC-1: 21.5;Karpas-707: 26.6;SiHa: 17.8;SK-BR-3: 20.0;U-266/70: 21.5;U-266/84: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039720, HPA040149" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" No NA 410000 Cytosol "Nucleoplasm, Plasma membrane" "HPA039720: AB_10672967, HPA040149: " "unprognostic (4.81e-2)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.09e-2)" "unprognostic (1.80e-2)" "unprognostic (2.88e-2)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (1.06e-1)" "unprognostic (7.01e-2)" "unprognostic (3.35e-3)" "unprognostic (1.17e-1)" "unprognostic (4.63e-3)" "unprognostic (3.98e-2)" "unprognostic (1.70e-1)" "unprognostic (4.08e-3)" "unprognostic (2.61e-1)" 1.1 5.7 0.5 2.4 0.8 2.0 0.9 0.5 1.3 0.7 0.7 0.6 0.4 1.9 0.9 0.5 0.8 0.5 0.7 1.1 0.6 0.5 4.4 99.0 1.3 1.4 0.5 0.4 0.7 1.1 0.0 1.2 0.6 1.0 0.7 0.0 0.8 1.3 0.7 11.3 2.2 1.9 0.6 0.6 2.9 1.9 6.2 0.5 0.7 0.6 0.7 0.7 0.8 0.9 1.5 1.2 3.7 3.8 5.7 1.6 1.4 19.5 4.3 0.3 2.8 0.1 0.0 4.4 0.6 0.2 0.3 0.6 1.9 2.5 1.7 1.9 0.0 1.1 3.7 0.1 0.0 0.1 6.8 0.7 1.9 3.0 3.8 0.0 2.5 21.5 0.0 0.1 0.3 0.0 0.1 0.1 1.7 1.3 26.6 0.0 3.0 1.6 4.8 2.0 0.7 1.0 3.5 0.1 2.2 0.0 1.8 2.2 3.2 17.8 20.0 2.3 0.0 2.1 3.6 0.0 2.8 9.7 3.5 2.4 21.5 25.2 2.7 1.9 5.2 3.1 0.3 1.6 3.7 1.2 1.4 1.1 1.5 0.6 1.6 1.2 1.0 1.0 1.1 1.2 5.7 3.8 0.6 0.3 1.4 0.5 0.8 0.5 0.6 0.6 0.5 0.5 0.4 1.0 0.5 0.0 0.3 2.2 0.2 0.3 0.0 0.4 0.0 0.0 1.2 3.5 0.0 0.5 3.3 0.1 0.6 0.3 0.0 0.0 1.0 0.1 0.3 0.0 0.0 125.2 4.1 1.6 1.7 11.1 3.7 0.0 0.3 1.1 3.3 0.0 0.0 1.9 0.3 0.0 0.0 23.2 0.0 0.0 0.0 1.2 1.9 0.3 0.2 2.9 0.0 0.1 AMER3 "FAM123C, FLJ38377" ENSG00000178171 "APC membrane recruitment protein 3" Q8N944 2 130755435-130768134 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.1" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 6.2;Horizontal cells: 3.2;Intestinal endocrine cells: 14.6;Rod photoreceptor cells: 5.0" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Region enhanced" "Detected in many" "cerebellum: 30.1" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045593, HPA054230" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA045593: AB_10965021, HPA054230: AB_2682423" "unprognostic (6.68e-2)" "unprognostic (3.73e-1)" "unprognostic (2.17e-2)" "unprognostic (1.83e-1)" "unprognostic (2.71e-1)" "unprognostic (5.33e-3)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (6.46e-3)" 0.5 2.4 4.8 0.7 6.0 0.8 0.5 30.1 13.9 0.5 0.8 0.0 0.0 2.0 0.6 0.5 0.5 0.5 0.5 0.5 2.7 4.3 0.5 0.5 0.5 0.6 1.8 5.6 0.6 3.3 0.4 3.4 0.5 3.0 0.6 0.8 0.7 0.5 0.5 0.5 0.7 1.2 0.5 0.8 0.6 2.5 1.6 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.3 0.3 1.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.1 0.2 1.5 0.2 0.1 0.3 0.1 0.0 4.8 6.0 30.1 10.3 2.7 4.3 1.8 5.6 3.0 0.7 0.0 0.0 0.0 0.0 0.0 6.2 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 14.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 AMHR2 "MISR2, MISRII" ENSG00000135409 "Anti-Mullerian hormone receptor type 2" Q16671 12 53423855-53431534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.1;ovary: 38.2;testis: 15.2" "Group enriched" "Detected in some" 4 "granulocytes: 25.4;Ito cells: 12.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "HEL: 28.3;K-562: 15.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "hippocampal formation: 14.3" "HPA060228, HPA069636" Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA060228: AB_2684227, HPA069636: AB_2686163" "unprognostic (5.79e-2)" "unprognostic (3.65e-1)" "unprognostic (3.98e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-3)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.32e-1)" "unprognostic (2.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.97e-1)" 0.3 27.1 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.6 0.4 0.2 0.4 0.8 0.2 0.0 0.2 1.1 0.3 0.2 0.2 0.2 38.2 8.8 0.1 0.2 0.2 0.3 0.4 0.0 0.2 0.2 0.2 2.5 0.0 0.4 0.5 0.2 3.7 0.3 15.2 0.2 0.2 0.2 0.5 0.3 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 28.3 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 2.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 25.4 0.0 0.1 0.0 0.0 12.3 2.2 1.3 4.6 0.0 0.0 0.0 0.0 0.0 4.6 0.0 3.9 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 AMZ2 ENSG00000196704 "Archaelysin family metallopeptidase 2" Q86W34 17 68247574-68257164 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 585.3;Late spermatids: 1307.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023299, HPA052406" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA023299: AB_2226909, HPA052406: AB_2681818" "unprognostic (3.04e-1)" "unprognostic (3.68e-2)" "unprognostic (3.93e-2)" "unprognostic (3.27e-3)" "unprognostic (3.32e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.43e-1)" "unprognostic (3.92e-2)" "unprognostic (2.83e-3)" "unprognostic (3.59e-3)" "unprognostic (3.37e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.37e-1)" "unprognostic (2.95e-1)" "unprognostic (3.28e-1)" "unprognostic (7.62e-2)" 22.3 21.3 29.3 13.7 43.3 14.2 20.8 29.2 35.8 19.8 19.8 20.3 19.6 11.9 19.0 25.3 22.3 24.6 17.7 33.6 26.8 23.7 26.8 16.6 14.1 22.4 26.0 27.0 23.4 20.4 29.4 25.4 18.9 28.3 21.1 15.0 19.0 17.9 25.1 39.9 15.5 13.5 19.3 27.8 16.6 15.7 77.2 20.5 15.5 28.4 20.6 22.4 20.2 14.9 20.9 17.2 31.4 21.1 34.8 31.2 19.7 23.4 26.1 22.1 18.7 17.0 29.6 34.8 17.0 23.0 29.6 24.9 10.7 15.1 35.1 19.2 26.3 27.9 11.6 18.0 50.1 38.9 12.4 17.0 12.9 11.6 20.8 32.2 11.7 22.3 25.2 56.3 27.5 51.3 29.3 29.9 30.2 13.2 22.5 37.4 17.4 26.4 10.9 10.4 12.5 24.4 10.1 60.2 26.3 17.8 12.4 22.3 17.5 15.8 32.6 31.7 47.6 25.7 8.1 15.5 39.9 19.0 14.3 18.4 31.6 29.0 60.6 28.1 16.7 20.1 31.4 14.4 19.6 22.1 16.6 28.6 17.4 27.3 29.0 17.2 20.9 24.4 26.3 25.2 34.8 21.1 15.7 31.2 19.7 29.3 43.3 29.2 35.8 26.8 23.7 26.0 27.0 28.3 20.5 11.9 14.1 28.3 32.0 16.6 13.3 73.2 22.9 57.6 21.6 22.7 7.9 54.0 92.9 25.1 585.3 25.4 8.9 0.0 22.9 56.9 31.5 18.0 32.4 13.7 37.1 17.5 20.3 22.7 19.9 1307.8 33.4 36.7 54.0 56.9 16.8 56.2 24.4 12.9 30.8 48.5 11.6 19.4 27.2 187.0 54.0 19.7 28.6 51.1 15.8 15.9 ANGEL2 "Ccr4d, FLJ12793, KIAA0759L" ENSG00000174606 "Angel homolog 2" Q5VTE6 1 212992182-213015826 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030795, HPA030796" Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" NA NA Nucleoplasm "Nuclear bodies, Mitochondria" "HPA030795: , HPA030796: AB_10600979" "unprognostic (1.26e-1)" "unprognostic (2.02e-1)" "unprognostic (8.73e-2)" "unprognostic (2.76e-1)" "unprognostic (2.04e-2)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (2.70e-3)" "unprognostic (6.46e-2)" "prognostic unfavorable (8.39e-6)" "unprognostic (9.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.20e-4)" 11.4 11.7 18.0 10.8 32.6 9.5 17.8 21.6 22.7 14.5 9.3 16.9 8.6 8.6 14.8 14.2 10.2 12.2 10.4 9.2 17.4 13.8 13.3 13.0 11.0 15.8 17.0 13.9 19.1 10.5 15.5 14.8 10.8 13.8 14.5 11.0 12.3 9.8 11.2 11.0 15.1 10.7 12.2 14.9 15.5 10.5 9.0 15.9 19.5 14.0 7.9 14.9 10.8 9.7 7.8 7.2 7.6 5.9 14.1 11.3 6.7 8.7 7.0 11.4 9.7 8.7 12.9 10.2 7.2 12.0 11.5 11.5 4.7 6.5 8.5 6.6 7.1 6.4 6.9 13.1 6.9 11.7 15.9 7.9 8.5 5.6 4.6 9.6 8.4 10.2 7.9 8.9 9.0 9.3 9.8 9.7 7.7 9.8 8.8 13.2 2.9 9.6 5.7 26.9 4.8 5.1 4.9 20.5 8.9 9.0 5.9 5.6 16.3 8.6 11.7 13.3 12.7 9.0 6.2 7.2 9.5 5.1 11.7 10.9 6.5 6.2 5.7 10.7 6.3 8.7 7.4 5.9 7.6 7.4 5.5 9.1 7.8 9.2 7.6 7.2 5.3 9.8 8.1 4.0 14.1 4.4 4.4 11.3 6.7 18.0 32.6 21.6 22.7 17.4 13.8 17.0 13.9 13.8 15.9 44.7 9.8 14.6 7.5 6.2 21.3 12.6 17.8 28.1 15.9 12.2 9.8 12.8 10.0 8.7 1.2 11.3 6.7 0.0 9.2 12.6 10.6 8.8 16.2 11.5 10.5 27.0 6.4 11.6 19.2 1.5 14.4 11.3 3.3 10.8 9.2 13.4 8.4 7.0 13.1 13.5 17.6 19.4 9.0 7.4 16.2 6.0 9.2 18.1 8.8 6.2 ANKMY1 "FLJ20499, ZMYND13" ENSG00000144504 "Ankyrin repeat and MYND domain containing 1" Q9P2S6 2 240479422-240569209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.0" "Group enriched" "Detected in many" 5 "Early spermatids: 147.5;Late spermatids: 162.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA026620, HPA048869" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026620: AB_1844834, HPA048869: " "unprognostic (2.89e-3)" "unprognostic (1.03e-1)" "unprognostic (3.83e-2)" "unprognostic (3.22e-3)" "unprognostic (3.46e-1)" "unprognostic (3.97e-5)" "unprognostic (8.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.40e-3)" "unprognostic (1.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.36e-2)" "unprognostic (2.59e-5)" "unprognostic (2.01e-1)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "prognostic favorable (3.20e-4)" 4.5 4.3 5.2 9.0 7.9 9.8 5.8 6.4 7.3 7.2 5.7 10.3 10.8 5.8 6.6 9.0 5.3 21.8 9.2 3.6 6.1 4.3 5.1 5.1 6.3 7.2 8.7 4.8 7.3 8.0 6.6 5.4 6.4 6.4 5.8 5.1 5.1 6.9 13.6 5.0 7.2 6.2 5.8 6.3 7.3 8.4 45.0 6.7 6.0 6.0 3.4 10.7 5.8 6.0 7.4 4.2 6.9 3.4 2.0 7.5 3.4 5.3 11.7 2.5 4.7 2.3 3.3 10.6 2.5 3.9 2.1 2.9 3.7 11.0 5.3 0.5 2.8 3.2 5.8 4.9 6.0 2.5 9.8 4.0 10.5 5.7 9.8 1.9 5.8 10.1 5.3 14.7 2.0 14.1 6.5 2.2 8.5 9.7 6.8 3.6 5.1 5.3 9.6 2.1 9.2 7.0 15.2 7.7 8.4 3.3 11.5 6.0 4.4 2.1 5.6 7.8 3.2 4.8 9.0 2.7 8.0 2.7 3.1 4.4 15.8 3.9 5.1 4.5 8.9 6.1 0.1 3.3 6.9 7.5 2.6 4.3 4.7 4.8 4.7 4.2 7.4 7.1 5.1 1.3 2.0 3.4 2.8 1.5 3.4 5.2 7.9 6.4 7.3 6.1 4.3 8.7 4.8 6.4 6.7 0.0 7.2 2.7 1.6 0.8 3.4 1.8 2.5 30.8 10.3 3.5 3.9 2.8 1.7 2.2 147.5 2.8 4.3 0.0 3.7 1.6 1.5 2.0 5.7 5.5 2.5 3.2 4.1 3.1 7.0 162.8 3.7 4.0 0.0 4.6 4.6 1.9 2.5 0.0 2.8 2.6 3.5 0.0 1.3 14.7 8.8 1.9 2.4 4.4 4.9 1.4 ANKRA2 ENSG00000164331 "Ankyrin repeat family A member 2" Q9H9E1 5 73552335-73565686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003968, HPA065263" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA003968: , HPA065263: AB_2685449" "unprognostic (1.75e-1)" "unprognostic (5.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-1)" "unprognostic (3.31e-1)" "unprognostic (3.89e-2)" "unprognostic (5.68e-2)" "unprognostic (6.19e-2)" "unprognostic (3.47e-2)" "unprognostic (1.09e-1)" "unprognostic (1.06e-2)" "unprognostic (1.79e-1)" "unprognostic (9.80e-3)" "unprognostic (3.36e-1)" "unprognostic (3.31e-1)" "unprognostic (6.65e-2)" "unprognostic (1.13e-3)" 13.0 19.4 11.9 9.2 17.1 18.7 20.9 22.8 18.3 15.7 13.5 16.6 13.1 15.0 20.0 21.0 13.3 18.5 15.0 12.2 18.1 15.8 9.6 15.9 20.7 13.9 20.6 12.3 23.3 19.7 11.4 30.2 15.4 23.1 19.8 16.4 17.5 19.0 14.3 14.5 13.4 15.3 17.8 30.7 13.0 16.2 10.3 15.8 18.1 22.2 4.5 14.7 14.9 13.3 10.7 5.9 16.9 7.4 7.0 15.5 7.3 5.1 3.9 5.8 6.1 10.6 16.2 17.7 7.1 10.6 6.2 9.3 1.2 8.0 4.8 5.7 7.0 7.0 3.7 2.7 12.6 8.9 10.1 4.8 4.2 3.0 5.5 8.3 2.5 8.3 16.7 17.1 7.4 7.7 11.6 6.9 6.4 4.1 8.1 7.1 3.1 4.3 6.5 3.1 1.9 2.9 2.6 6.2 6.6 4.8 6.4 7.8 6.1 5.4 4.3 8.4 9.3 6.5 4.2 8.6 2.5 3.0 4.0 5.1 16.0 11.5 4.1 6.2 4.1 7.2 16.9 5.7 11.3 8.7 4.6 10.5 10.7 10.2 12.1 4.9 8.4 15.5 14.2 9.0 7.0 7.4 5.9 11.7 7.3 11.9 17.1 22.8 18.3 18.1 15.8 20.6 12.3 23.1 15.8 3.0 8.6 26.7 25.9 14.1 25.6 7.7 35.7 16.0 12.5 17.4 9.8 22.6 23.2 10.6 0.9 12.1 16.1 23.3 14.6 18.8 13.1 25.9 18.5 19.5 9.2 22.3 23.2 16.0 16.2 1.7 30.2 11.1 11.8 12.6 19.4 15.6 14.7 18.4 27.3 14.0 21.5 25.8 14.4 23.0 15.1 10.8 40.8 18.1 16.2 31.3 ANKRD23 "DARP, FLJ32449, MARP3" ENSG00000163126 "Ankyrin repeat domain 23" Q86SG2 2 96824526-96857934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 184.5" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "Karpas-707: 29.7" "Not detected" "Not detected" HPA036201 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "HPA036201: AB_10673347" "unprognostic (2.48e-1)" "unprognostic (7.83e-4)" "unprognostic (4.93e-4)" "unprognostic (1.21e-2)" "unprognostic (4.28e-1)" "unprognostic (3.28e-1)" "unprognostic (3.27e-2)" "unprognostic (6.66e-2)" "unprognostic (2.46e-2)" "unprognostic (3.59e-2)" "unprognostic (1.81e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-6)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.54e-1)" "unprognostic (2.70e-4)" 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.1 2.6 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.7 0.0 0.1 2.2 0.1 184.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 12.2 0.9 0.1 0.1 0.4 0.2 0.5 0.0 0.9 1.2 0.4 0.3 0.5 0.3 0.6 0.0 0.2 0.8 0.2 0.0 0.2 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.2 0.2 0.1 0.8 0.7 0.4 0.4 0.1 0.1 0.6 1.4 0.2 0.3 0.4 0.0 0.1 0.1 1.1 0.6 29.7 0.2 0.7 0.3 0.6 0.3 0.1 0.2 1.0 0.0 3.7 0.1 0.7 1.1 0.1 0.2 0.5 0.0 0.1 0.8 0.0 0.2 0.3 0.5 0.5 0.0 1.3 0.5 0.2 0.3 0.8 0.3 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.9 0.0 0.2 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.6 0.7 2.1 2.5 0.0 10.7 2.3 0.0 2.0 0.3 0.0 0.3 3.0 0.6 0.4 0.0 0.9 0.1 0.9 0.4 1.1 1.0 0.2 1.6 0.0 2.5 0.8 1.5 1.4 0.0 0.0 0.0 1.1 1.8 0.1 0.0 2.8 0.0 3.6 0.0 1.9 1.0 0.4 1.1 0.2 0.0 0.6 0.1 ANKRD34B DP58 ENSG00000189127 "Ankyrin repeat domain 34B" A5PLL1 5 80556755-80570488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 31.0" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 2.0;Collecting duct cells: 3.5;Intestinal endocrine cells: 1.7;Kupffer cells: 3.2" "Cancer enhanced" "Detected in some" "prostate cancer: 2.3" "Region enriched" "Detected in many" 6 "basal ganglia: 31.0" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.2" "Cell line enriched" "Detected in some" 29 "RPTEC TERT1: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043327 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA043327: AB_10794180" "unprognostic (1.05e-1)" "unprognostic (4.16e-6)" "unprognostic (2.07e-4)" "unprognostic (1.05e-1)" "unprognostic (3.03e-1)" "unprognostic (8.25e-4)" "unprognostic (6.44e-2)" "unprognostic (1.80e-1)" "unprognostic (9.41e-2)" "unprognostic (6.52e-3)" "unprognostic (1.93e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.94e-2)" 0.1 0.3 0.9 1.5 31.0 5.7 0.3 0.0 0.9 0.5 0.1 0.4 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.0 4.1 2.8 0.1 0.2 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 0.4 1.0 0.1 1.0 5.1 0.0 0.1 0.0 4.6 0.1 0.0 0.0 0.0 7.2 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 46.9 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.9 31.0 0.0 0.9 1.0 4.1 1.2 0.2 0.7 5.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.7 0.0 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ANKRD37 Lrp2bp ENSG00000186352 "Ankyrin repeat domain 37" Q7Z713 4 185396021-185400628 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 135.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036626, HPA058127" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA036626: AB_10671963, HPA058127: AB_2683614" "unprognostic (9.08e-2)" "unprognostic (2.85e-3)" "unprognostic (3.89e-2)" "unprognostic (2.36e-3)" "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (7.51e-2)" "unprognostic (9.12e-2)" "unprognostic (1.74e-1)" "unprognostic (1.09e-1)" "unprognostic (7.36e-2)" "unprognostic (9.69e-3)" "unprognostic (2.81e-2)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (6.45e-3)" "unprognostic (1.08e-1)" 7.7 8.9 11.0 3.9 15.2 3.3 10.9 9.9 20.9 17.2 7.5 6.0 5.4 4.8 4.9 4.1 35.8 8.0 4.8 13.6 12.0 9.6 6.4 14.2 12.4 3.0 12.3 5.8 14.8 13.5 1.7 11.7 10.7 16.8 24.1 7.0 8.4 35.4 21.9 22.1 7.3 4.9 5.0 16.1 4.6 5.2 8.7 14.2 1.5 14.2 18.6 12.2 14.3 22.8 7.7 4.2 10.2 3.9 3.2 8.1 3.0 6.2 0.9 0.7 3.6 4.9 3.1 3.4 2.9 2.2 2.1 4.7 1.5 1.8 3.0 1.2 5.3 4.4 2.4 3.4 3.7 2.7 8.5 0.9 2.0 3.2 4.5 2.1 1.9 4.7 0.6 4.0 2.0 2.8 15.7 2.7 2.0 3.1 5.1 5.9 1.6 1.6 7.5 1.0 0.6 5.0 0.5 1.0 8.2 2.6 0.5 5.0 8.9 2.0 2.0 8.6 2.7 1.8 1.2 3.5 4.6 3.7 2.6 3.3 9.6 2.8 1.3 13.1 1.4 5.3 0.4 3.8 10.2 5.5 3.5 4.7 7.6 4.3 8.1 2.6 7.7 3.3 4.7 2.0 3.2 3.9 4.2 5.1 3.0 11.0 15.2 9.9 20.9 12.0 9.6 12.3 5.8 16.8 14.2 20.8 23.7 16.6 23.8 52.8 24.8 1.2 0.0 101.7 22.7 8.7 27.5 15.7 21.6 17.9 3.7 11.7 61.7 23.3 20.0 36.6 28.6 40.4 63.2 20.4 13.8 9.5 115.1 10.4 6.7 2.0 8.6 24.5 135.0 28.9 93.8 89.4 40.5 35.1 11.0 15.7 103.2 6.5 35.0 13.3 15.1 42.0 70.6 11.7 31.3 16.2 ANKRD42 "FLJ37874, PPP1R79, SARP" ENSG00000137494 "Ankyrin repeat domain 42" Q8N9B4 11 83193739-83260694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 73.6;Early spermatids: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039917 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039917: AB_10672894" "unprognostic (6.59e-2)" "unprognostic (9.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.31e-3)" "unprognostic (9.12e-2)" "unprognostic (3.78e-1)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.09e-2)" "unprognostic (3.10e-3)" "unprognostic (1.79e-1)" "unprognostic (4.25e-1)" "unprognostic (1.90e-1)" 5.6 14.5 13.9 5.4 22.1 8.3 7.1 4.8 15.1 8.2 5.4 3.0 11.6 5.8 6.9 22.2 5.6 17.2 8.7 5.4 18.1 13.4 12.3 5.2 7.4 4.5 8.2 12.4 9.9 8.6 16.8 17.9 4.5 13.1 8.4 4.8 6.5 6.7 10.3 6.1 6.2 5.3 6.7 8.7 4.8 6.4 41.8 5.3 1.0 13.0 1.5 4.5 6.8 16.1 7.1 4.8 7.9 11.1 5.8 4.3 2.1 3.9 6.9 3.3 6.8 10.7 11.2 3.0 8.1 6.3 4.8 3.0 4.2 4.8 1.7 10.5 7.2 9.7 8.5 3.5 5.5 4.0 2.2 2.8 2.8 9.4 2.7 7.4 7.8 6.6 6.6 6.6 12.1 6.5 9.4 4.9 2.8 8.1 1.6 6.9 5.8 1.1 8.6 2.8 6.1 4.4 1.9 5.0 2.0 16.0 4.7 2.7 3.5 10.5 6.6 2.1 4.6 9.9 4.4 7.1 7.5 5.2 27.2 3.7 2.1 4.7 3.3 5.9 4.9 3.1 7.9 3.6 4.3 4.1 4.1 2.8 7.1 3.7 4.3 4.8 5.2 1.9 3.0 3.0 5.8 11.1 2.0 1.4 2.1 13.9 22.1 4.8 15.1 18.1 13.4 8.2 12.4 13.1 5.3 8.9 13.6 3.2 17.5 10.0 3.0 6.7 7.6 73.6 7.9 7.0 37.3 2.7 8.3 6.6 123.0 7.1 3.6 0.0 5.8 2.7 8.7 10.0 12.8 3.8 4.4 1.6 2.9 9.2 8.2 53.0 8.1 9.0 6.8 6.4 3.2 6.7 5.4 3.6 9.9 11.4 21.3 12.9 8.7 38.6 18.1 13.4 4.6 7.0 3.1 11.2 ANKRD49 "FGIF, FLJ20189, GBIF" ENSG00000168876 "Ankyrin repeat domain 49" Q8WVL7 11 94493629-94499583 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040273, HPA048137" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA040273: AB_10674991, HPA048137: AB_2680279" "unprognostic (1.52e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "unprognostic (5.22e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-3)" "unprognostic (1.46e-2)" "unprognostic (7.21e-3)" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (4.21e-3)" "prognostic unfavorable (9.96e-4)" "unprognostic (6.32e-3)" "unprognostic (2.82e-1)" "unprognostic (3.40e-2)" "prognostic favorable (6.16e-4)" 9.8 9.0 10.2 10.7 10.8 19.6 12.7 18.6 10.9 15.6 14.8 4.5 9.5 11.2 15.1 19.6 13.2 8.2 7.9 5.7 9.5 6.9 13.3 11.0 10.4 17.5 7.2 8.5 12.3 15.6 9.1 27.9 16.3 7.7 12.6 13.1 7.7 12.1 10.7 7.9 8.8 19.2 9.6 12.5 21.3 12.1 5.3 8.5 22.6 18.0 9.9 19.2 11.9 9.3 20.5 17.7 34.7 15.1 17.3 19.6 10.5 6.4 2.9 7.6 6.5 7.5 9.6 9.2 10.2 9.1 10.7 12.7 14.2 12.7 17.0 15.7 7.2 9.3 14.1 9.2 6.9 8.6 13.3 7.4 14.7 11.4 4.8 8.6 12.9 11.8 6.7 17.4 8.2 11.5 7.9 8.4 15.1 13.9 10.1 7.0 4.4 13.7 23.4 4.4 12.2 7.3 11.1 8.5 8.5 10.1 6.8 7.5 7.8 7.0 7.0 6.3 14.2 14.2 8.7 5.2 9.7 6.8 10.6 5.1 5.9 13.6 18.1 3.2 15.6 5.5 34.7 15.1 12.6 14.9 12.5 16.3 20.5 15.9 13.1 11.4 19.6 19.6 17.9 27.1 17.3 9.3 17.7 19.1 10.5 10.2 10.8 18.6 10.9 9.5 6.9 7.2 8.5 7.7 8.5 11.9 9.4 31.8 9.7 4.9 15.9 5.3 17.8 8.1 17.0 24.4 13.7 25.3 18.3 16.9 4.4 13.5 27.1 46.7 20.0 13.5 13.3 9.6 19.8 16.6 12.2 11.1 12.9 16.0 28.9 1.5 33.1 17.8 10.1 13.6 20.3 20.2 18.8 30.3 22.3 12.6 14.5 25.8 11.8 22.3 18.8 5.9 23.5 35.0 21.1 5.1 ANKRD54 LIAR ENSG00000100124 "Ankyrin repeat domain 54" Q6NXT1 22 37830855-37849327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071287 Approved Approved Nucleoplasm,Microtubules,Midbody Yes No "Microtubules, Midbody" Nucleoplasm "HPA071287: AB_2686380" "unprognostic (5.36e-2)" "prognostic favorable (2.06e-4)" "unprognostic (1.02e-1)" "prognostic favorable (7.38e-5)" "unprognostic (1.14e-1)" "unprognostic (1.50e-1)" "unprognostic (1.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.41e-2)" "prognostic favorable (6.16e-4)" "unprognostic (2.53e-1)" "unprognostic (6.33e-2)" "unprognostic (1.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-3)" 7.8 14.8 18.4 7.9 15.8 7.5 9.1 20.0 19.5 13.5 11.9 14.1 17.4 9.8 11.2 14.9 13.6 33.5 11.4 8.9 17.1 20.6 13.0 11.9 9.3 8.1 14.2 12.1 19.0 24.6 15.3 16.4 7.9 14.8 13.1 9.4 13.4 19.1 16.3 9.3 11.8 9.5 13.5 11.7 7.5 8.9 23.7 11.0 12.3 18.2 8.7 9.8 11.6 13.9 6.2 6.7 3.5 10.0 12.8 6.9 3.8 10.9 11.1 9.4 13.8 12.7 7.1 5.0 15.2 11.7 25.8 15.8 7.0 4.3 10.6 6.3 9.9 8.3 9.8 12.0 8.4 12.5 8.5 24.2 5.3 10.1 16.7 11.3 10.5 12.8 6.4 8.8 13.9 8.2 6.3 15.7 7.9 7.0 7.4 11.7 11.5 10.2 12.1 2.7 14.7 10.2 11.9 11.5 6.6 14.2 3.6 16.4 8.8 12.7 11.3 18.0 4.4 11.6 16.7 9.1 15.0 16.2 7.8 11.1 8.3 6.7 8.4 12.5 9.0 10.8 2.6 5.4 2.4 6.8 6.4 6.8 4.5 6.6 5.2 6.7 6.2 6.9 3.4 3.5 12.8 10.0 6.7 2.8 3.8 18.4 15.8 20.0 19.5 17.1 20.6 14.2 12.1 14.8 11.0 11.9 16.4 13.9 9.0 14.1 17.4 7.1 22.9 33.5 11.4 17.4 27.5 18.3 33.2 14.5 5.0 9.0 15.5 0.0 12.7 15.1 10.4 8.9 9.2 9.6 11.6 25.4 8.6 11.1 8.1 6.0 16.7 9.5 10.1 8.2 12.6 16.9 11.3 15.2 20.1 14.7 22.1 6.5 14.4 54.6 39.2 15.4 14.1 16.0 14.4 8.8 ANKRD55 FLJ11795 ENSG00000164512 "Ankyrin repeat domain 55" Q3KP44 5 56099678-56233359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7" "Group enriched" "Detected in some" 7 "Early spermatids: 143.8;Ito cells: 52.8" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3" "Group enriched" "Detected in many" 67 "granulocytes: 13.1;T-cells: 14.3" "Group enriched" "Detected in some" 6 "HEL: 24.5;HMC-1: 12.7;NB-4: 16.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051049, HPA061649" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA051049: AB_2681326, HPA061649: " "unprognostic (1.00e-4)" "unprognostic (1.58e-4)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (7.78e-4)" "unprognostic (1.46e-3)" "unprognostic (1.47e-1)" "unprognostic (1.33e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.33e-1)" "unprognostic (1.40e-1)" "unprognostic (7.19e-6)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (1.01e-1)" 0.9 0.5 3.3 1.3 20.0 1.4 0.5 0.5 6.7 0.3 0.5 1.5 0.0 0.5 0.3 0.2 0.6 0.6 0.8 0.4 4.3 7.8 1.1 5.7 0.6 6.1 2.3 3.5 0.5 0.3 0.2 0.5 1.4 9.9 0.3 0.7 0.7 2.1 0.3 0.3 0.9 2.4 0.5 4.1 3.0 0.7 16.7 1.8 0.0 0.4 0.0 3.8 1.0 0.3 0.0 0.0 13.1 0.2 0.0 14.3 2.1 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 24.5 0.1 0.9 0.0 1.1 12.7 0.0 0.0 0.0 0.0 0.0 3.0 0.0 2.0 0.8 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.3 0.0 1.6 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.4 0.3 12.6 0.2 13.1 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 14.3 0.5 1.2 0.0 0.0 0.0 0.6 2.1 3.3 20.0 0.5 6.7 4.3 7.8 2.3 3.5 9.9 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 143.8 1.0 0.0 0.0 0.2 0.3 0.6 0.0 2.3 0.5 0.6 0.0 0.0 52.8 4.1 14.1 0.6 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.7 0.2 0.0 0.0 0.0 3.2 0.5 0.0 1.0 2.2 0.0 0.1 ANKS6 "ANKRD14, FLJ36928, NPHP16, SAMD6" ENSG00000165138 "Ankyrin repeat and sterile alpha motif domain containing 6" Q68DC2 9 98731329-98796965 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA008355 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA008355: AB_2058277" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (9.31e-2)" "unprognostic (9.15e-3)" "unprognostic (6.90e-3)" "unprognostic (1.22e-1)" "unprognostic (4.29e-3)" "unprognostic (4.10e-2)" "unprognostic (1.48e-1)" "unprognostic (3.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.94e-2)" "prognostic favorable (3.44e-5)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (3.95e-2)" "unprognostic (2.68e-1)" 5.0 3.7 5.8 4.3 9.9 1.8 4.8 31.2 9.5 7.3 6.5 9.4 2.6 5.9 6.0 7.4 7.5 7.8 7.7 2.9 6.9 6.1 7.7 1.8 7.2 3.4 10.1 4.4 9.6 18.1 10.0 2.8 2.8 11.4 3.6 7.3 4.2 3.1 3.5 3.3 4.4 5.4 8.9 6.1 2.5 7.7 6.1 9.2 1.8 13.4 2.4 4.5 5.4 6.4 0.9 0.0 0.0 0.1 0.0 2.1 0.2 5.2 7.9 7.3 12.8 6.1 5.0 4.9 3.8 6.6 4.3 5.2 4.3 3.8 9.7 2.9 5.4 6.2 15.6 5.3 6.4 2.3 13.5 5.5 2.3 4.7 1.8 6.0 1.2 1.6 6.1 8.1 5.9 6.0 5.3 4.9 9.0 16.3 2.3 3.3 8.7 0.5 2.5 11.5 23.5 8.6 6.5 18.1 0.7 7.7 3.3 4.7 5.4 1.6 9.4 4.3 6.2 0.0 2.7 4.9 4.5 4.9 12.2 3.7 4.5 7.6 1.6 6.3 4.4 6.4 0.0 0.1 0.0 1.3 0.0 0.7 0.9 0.7 2.1 0.0 0.6 1.8 0.9 0.0 0.0 0.0 0.0 1.1 0.2 5.8 9.9 31.2 9.5 6.9 6.1 10.1 4.4 11.4 9.2 6.0 8.0 2.4 0.7 1.5 6.1 4.4 12.7 5.3 4.5 12.2 7.9 2.3 3.3 3.6 2.9 3.1 4.2 0.0 7.7 2.5 3.4 3.4 1.1 1.5 1.6 0.0 4.7 1.8 1.5 4.9 2.6 1.1 0.0 1.0 6.8 1.4 7.0 3.5 4.2 5.0 0.6 0.0 2.3 4.2 4.9 1.0 0.9 2.1 7.6 2.4 ANKZF1 "FLJ10415, ZNF744" ENSG00000163516 "Ankyrin repeat and zinc finger domain containing 1" Q9H8Y5 2 219229757-219236669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035208 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA035208: AB_10602229" "unprognostic (5.23e-2)" "unprognostic (2.23e-1)" "unprognostic (1.12e-3)" "unprognostic (8.27e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (3.87e-2)" "unprognostic (9.68e-3)" "unprognostic (7.82e-3)" "unprognostic (1.24e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (2.01e-6)" "unprognostic (1.49e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.88e-3)" 10.1 11.1 14.8 19.0 19.8 13.7 12.9 38.4 25.9 13.8 15.4 17.5 21.7 17.5 14.3 14.7 17.1 21.1 11.7 13.8 12.7 9.6 15.2 15.8 13.2 23.2 19.6 13.5 19.6 19.0 12.3 22.7 11.3 16.4 16.6 10.4 13.6 18.2 22.7 18.9 21.7 19.5 9.5 18.5 21.0 15.1 8.7 18.8 18.7 14.0 8.8 19.8 16.8 16.2 11.7 8.3 10.7 10.6 20.6 17.8 11.0 19.5 3.9 5.2 7.6 7.2 5.9 20.5 6.5 6.5 9.0 11.4 9.5 8.3 4.1 11.6 2.7 9.9 14.4 6.9 11.0 6.6 8.6 7.1 9.1 11.6 8.8 7.1 5.6 9.0 6.0 21.9 6.7 10.6 14.8 6.1 10.8 15.3 9.5 4.5 8.6 8.7 14.7 8.5 8.0 7.1 8.9 6.2 13.2 4.9 5.0 6.7 6.2 6.6 15.6 12.5 13.5 4.0 13.7 6.5 7.4 5.7 5.9 8.1 20.9 11.8 7.4 12.6 8.5 3.2 8.4 7.7 8.8 14.6 7.5 15.4 11.0 14.7 14.4 7.8 11.7 17.8 16.3 10.7 20.6 10.6 8.3 14.0 11.0 14.8 19.8 38.4 25.9 12.7 9.6 19.6 13.5 16.4 18.8 14.9 15.0 12.3 13.1 8.2 34.6 8.1 10.2 54.9 22.7 12.2 29.5 8.7 11.6 17.4 3.8 7.9 16.3 23.3 10.9 18.1 7.4 12.2 21.8 10.9 6.6 30.2 9.2 6.2 10.0 3.1 22.2 9.3 10.1 12.6 19.3 22.3 13.7 17.5 15.6 9.6 53.8 6.5 6.4 9.6 15.9 8.7 9.7 31.9 16.6 9.2 ANP32A "C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32" ENSG00000140350 "Acidic nuclear phosphoprotein 32 family member A" P39687 15 68778535-68820897 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005231, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 740000 "Nucleoplasm, Centrosome" Cytosol "CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.41e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (3.03e-1)" "unprognostic (6.96e-2)" "unprognostic (2.29e-2)" "unprognostic (1.04e-2)" "unprognostic (4.44e-2)" "unprognostic (4.00e-2)" "unprognostic (3.74e-2)" "unprognostic (1.20e-1)" "unprognostic (7.83e-2)" "unprognostic (4.16e-2)" "unprognostic (3.24e-2)" "unprognostic (2.38e-2)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" 25.8 20.4 32.7 32.0 40.1 46.0 28.2 50.7 33.7 24.5 30.7 40.5 16.0 27.0 26.8 21.7 28.8 30.0 23.4 47.8 32.3 23.6 30.0 29.6 27.2 55.0 33.9 30.0 26.7 25.6 24.2 18.3 38.6 26.6 30.4 35.4 27.2 23.6 27.8 41.7 18.9 28.9 30.5 42.7 40.1 29.8 9.4 36.7 75.0 29.0 18.5 52.4 35.7 27.6 12.7 19.8 27.7 19.9 18.1 12.3 9.6 26.4 32.5 42.8 36.9 15.0 13.2 28.4 14.0 18.7 27.4 23.2 26.8 49.9 85.9 26.2 15.7 16.2 38.9 98.9 28.6 33.0 38.7 33.7 65.0 27.5 33.5 9.3 51.1 35.2 10.5 20.2 15.0 30.0 18.0 39.8 41.7 47.2 33.6 23.5 18.5 51.3 42.0 37.9 26.2 16.5 72.0 39.7 51.0 24.1 41.9 56.8 35.2 21.3 24.0 39.3 44.7 31.9 67.1 17.8 28.5 45.3 19.6 37.3 20.4 56.6 99.5 18.9 86.1 26.0 8.1 17.6 27.7 11.9 19.9 10.0 12.7 9.8 12.3 19.8 12.7 12.1 10.6 18.1 18.1 16.8 17.6 11.2 9.6 32.7 40.1 50.7 33.7 32.3 23.6 33.9 30.0 26.6 36.7 101.3 93.6 54.3 58.8 57.6 85.2 68.1 48.4 129.8 100.1 66.3 33.4 225.4 91.2 95.6 3.6 76.3 57.2 70.0 83.9 137.0 53.5 48.8 89.1 75.9 163.6 62.0 75.3 58.3 145.4 4.0 32.2 112.8 74.2 132.6 83.9 86.2 70.3 56.1 28.0 115.7 65.9 25.8 68.0 7.7 13.8 30.6 194.4 102.2 82.6 46.3 ANP32B "APRIL, PHAPI2, SSP29" ENSG00000136938 "Acidic nuclear phosphoprotein 32 family member B" Q92688 9 97983361-98015943 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063133, HPA067561, HPA069657" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 290000 Nucleoplasm "Centrosome, Cytosol" "HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: " "unprognostic (2.82e-1)" "unprognostic (2.05e-2)" "unprognostic (4.57e-2)" "unprognostic (6.74e-2)" "unprognostic (1.85e-1)" "unprognostic (5.52e-2)" "prognostic unfavorable (1.98e-7)" "unprognostic (6.76e-3)" "unprognostic (5.70e-2)" "unprognostic (7.16e-2)" "unprognostic (3.50e-1)" "unprognostic (6.39e-2)" "unprognostic (9.22e-3)" "unprognostic (5.20e-2)" "unprognostic (2.36e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-2)" 43.0 24.6 37.9 46.5 55.5 105.7 37.7 15.6 30.1 43.2 38.9 81.0 24.6 32.7 46.3 38.4 40.4 28.4 39.2 27.0 41.8 32.0 26.0 35.9 35.0 70.4 55.7 21.7 51.1 46.0 29.3 20.7 37.5 41.8 38.9 42.3 26.2 32.5 29.7 29.4 38.6 34.9 45.3 88.3 38.6 36.7 19.0 47.6 85.9 37.0 31.9 81.8 64.5 58.6 34.8 32.6 36.8 44.6 22.7 51.3 25.1 71.5 38.7 43.2 36.0 24.3 43.0 39.4 37.2 33.0 40.0 33.7 48.5 35.2 87.8 22.3 24.9 30.5 47.4 58.1 42.0 45.9 56.9 32.8 76.0 33.2 52.3 31.3 130.1 44.3 32.5 30.7 32.1 66.3 32.6 34.7 78.8 146.1 62.2 30.8 95.5 98.2 115.7 16.8 70.3 38.5 58.7 67.3 41.7 26.1 30.0 34.9 30.5 43.6 42.7 38.1 22.2 24.1 48.7 42.0 26.1 42.3 32.8 39.0 56.5 63.8 53.0 24.2 52.3 48.6 23.1 27.2 36.8 22.7 30.9 31.3 34.8 42.7 31.9 32.6 29.6 51.3 38.7 11.3 22.7 44.6 31.8 50.8 25.1 37.9 55.5 15.6 30.1 41.8 32.0 55.7 21.7 41.8 47.6 80.4 91.7 174.3 178.4 160.5 57.6 74.9 101.9 53.5 93.3 71.5 23.6 273.1 82.9 105.6 102.1 109.0 128.4 327.1 148.0 437.2 99.8 129.7 116.6 84.4 250.6 112.8 144.0 112.3 244.5 70.6 135.4 174.1 121.4 164.1 222.6 53.5 126.7 126.7 136.5 75.6 33.5 148.8 133.5 138.6 318.8 134.8 278.6 173.4 278.8 183.9 ANP32D PP32R2 ENSG00000139223 "Acidic nuclear phosphoprotein 32 family member D" O95626 12 48472665-48473624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.3;REH: 1.2" "HPA063133, HPA067561" Uncertain Enhanced Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (2.20e-1)" "unprognostic (3.75e-1)" "unprognostic (3.18e-1)" "unprognostic (3.23e-2)" "unprognostic (5.11e-2)" "unprognostic (1.72e-3)" "unprognostic (2.30e-2)" "unprognostic (3.62e-3)" "unprognostic (2.76e-2)" "unprognostic (3.48e-1)" 0.1 0.9 0.3 0.0 0.2 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.6 0.8 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.7 0.0 0.2 1.1 0.1 0.0 0.2 0.5 0.3 0.2 0.4 0.3 0.2 0.0 0.1 0.2 0.2 0.5 0.2 0.9 0.8 0.0 0.4 0.1 0.1 0.1 0.6 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.4 0.4 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ANP32E "LANP-L, LANPL, MGC5350" ENSG00000143401 "Acidic nuclear phosphoprotein 32 family member E" Q9BTT0 1 150218417-150236156 "Predicted intracellular proteins" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021114, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 18000 "Nucleoplasm, Centrosome" Cytosol "CAB021114: AB_10057407, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.04e-1)" "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (8.95e-2)" "unprognostic (1.69e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (4.50e-5)" "unprognostic (1.64e-1)" "unprognostic (6.58e-2)" "unprognostic (3.91e-2)" "unprognostic (7.73e-3)" "unprognostic (2.47e-1)" "prognostic unfavorable (3.82e-8)" "unprognostic (1.76e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-1)" "unprognostic (3.52e-1)" 11.5 18.3 31.2 21.0 30.9 38.4 10.6 50.3 20.6 14.3 11.3 18.3 13.5 12.9 16.5 21.0 12.8 12.8 11.9 19.8 22.9 25.9 18.6 16.8 13.3 38.4 26.5 19.5 19.1 6.9 20.1 14.7 12.3 21.2 14.2 10.9 20.1 9.2 20.9 25.5 12.5 14.5 25.2 32.7 20.3 9.9 6.0 17.8 52.2 18.1 13.6 34.7 20.6 12.1 24.5 8.2 20.7 10.5 14.6 27.0 15.7 34.3 22.2 46.4 23.0 3.6 5.4 17.7 18.5 10.5 17.9 17.2 16.4 24.4 62.6 16.5 10.6 10.6 12.0 26.1 11.5 25.7 71.6 15.8 43.3 27.6 23.6 3.4 87.0 22.0 4.4 1.8 16.7 15.4 8.8 13.2 30.5 41.4 37.1 16.3 35.6 35.5 22.7 46.8 11.2 10.2 37.8 25.8 32.9 12.7 13.8 15.2 26.2 38.6 6.2 10.8 21.5 16.8 44.5 13.6 9.2 25.9 9.4 36.9 47.9 48.1 61.3 10.4 62.8 16.7 20.7 10.5 16.3 18.0 7.3 27.0 24.5 24.2 19.7 8.2 17.0 17.4 21.6 7.2 14.6 8.8 5.7 25.7 15.7 31.2 30.9 50.3 20.6 22.9 25.9 26.5 19.5 21.2 17.8 11.9 78.4 61.4 38.4 86.4 117.9 90.4 22.9 60.2 30.7 69.8 31.4 37.5 72.9 27.5 1.1 45.4 12.3 140.2 23.2 113.7 65.8 16.5 60.2 48.9 46.0 60.4 13.8 39.9 41.9 1.4 28.1 57.2 64.1 62.3 11.5 131.8 20.8 17.5 31.5 44.8 110.8 25.8 85.5 9.3 21.8 86.1 34.0 89.3 28.0 19.3 ANXA1 "ANX1, LPC1" ENSG00000135046 "Annexin A1" P04083 9 73151757-73170393 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Phospholipase A2 inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 432.6;tongue: 235.4" "Cell type enhanced" "Detected in many" 10 "granulocytes: 2387.0;Syncytiotrophoblasts: 5914.0;Urothelial cells: 4139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011271, HPA011272, CAB013023, CAB035987, CAB058693" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA Yes 77000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884" "unprognostic (2.53e-2)" "unprognostic (1.31e-1)" "unprognostic (9.08e-2)" "prognostic favorable (5.71e-5)" "unprognostic (1.53e-2)" "unprognostic (4.28e-2)" "unprognostic (1.82e-2)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-3)" "unprognostic (1.47e-1)" "unprognostic (9.82e-3)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "prognostic favorable (4.57e-5)" "prognostic unfavorable (6.19e-6)" 52.7 3.5 2.7 11.5 3.3 81.4 45.9 0.9 2.5 61.5 8.5 3.6 5.5 2.4 6.9 11.2 432.6 11.9 14.9 8.9 3.2 2.5 9.1 2.1 37.3 7.6 4.3 1.9 11.7 2.4 0.5 6.3 149.5 13.5 12.9 4.4 6.4 93.0 7.2 7.9 11.6 6.4 12.3 6.5 5.9 5.9 5.6 3.1 3.9 21.7 235.4 153.3 18.0 83.1 0.7 98.9 146.2 79.1 27.3 52.5 102.8 66.2 104.7 4.7 4.9 66.8 63.6 0.3 114.8 71.8 47.5 32.2 3.0 59.9 0.1 38.0 100.1 105.0 81.6 10.1 69.5 37.7 37.5 0.7 5.1 31.1 0.1 53.3 11.0 2.5 36.6 57.6 48.0 94.4 44.0 67.3 6.0 21.0 2.8 58.5 0.2 19.5 6.0 5.9 26.5 42.6 0.0 26.7 0.2 106.8 14.0 0.0 0.0 39.5 1.0 26.5 65.5 0.2 1.7 83.1 55.7 35.1 76.5 58.9 0.4 0.1 0.2 128.7 10.3 83.8 146.2 79.1 141.1 52.2 21.5 52.5 0.7 47.0 45.9 98.9 0.2 13.7 25.4 8.6 27.3 19.3 3.5 8.3 102.8 2.7 3.3 0.9 2.5 3.2 2.5 4.3 1.9 13.5 3.1 541.9 512.9 7.3 2232.0 752.1 0.0 11.9 17.8 1060.0 889.5 59.3 0.0 1215.0 0.0 156.6 6.3 398.1 0.8 0.0 20.0 1352.9 735.1 1709.3 2387.0 2.5 570.9 0.0 5.1 113.5 449.6 2.3 206.0 1058.5 291.8 475.3 1.8 0.2 431.7 0.0 8.9 3.1 0.0 64.7 275.6 0.7 2.9 522.6 5914.0 282.4 0.5 4139.3 ANXA10 ANX14 ENSG00000109511 "Annexin A10" Q9UJ72 4 168092515-168187690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 33.5;stomach 1: 105.3" "Group enriched" "Detected in some" 14 "Exocrine glandular cells: 153.7;Hepatocytes: 62.3;Pancreatic endocrine cells: 198.3" "Group enriched" "Detected in many" 5 "pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "OE19: 72.5;PC-3: 32.8;RT4: 44.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA005469, HPA074650" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Nucleoli" Vesicles "HPA005469: AB_1844849, HPA074650: " "unprognostic (2.29e-2)" "unprognostic (8.71e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (4.69e-1)" "unprognostic (2.29e-2)" "prognostic favorable (3.64e-6)" "unprognostic (1.18e-3)" "unprognostic (2.88e-1)" "unprognostic (8.61e-4)" "unprognostic (3.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-3)" "unprognostic (8.41e-2)" "unprognostic (4.01e-1)" "unprognostic (2.04e-1)" "unprognostic (8.89e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 1.4 0.1 4.2 0.1 0.1 0.5 0.0 33.5 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 1.5 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 105.3 0.1 0.1 0.1 0.1 0.1 0.1 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.5 32.8 0.0 0.1 0.0 0.0 44.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 10.2 0.0 2.3 0.0 2.0 0.0 0.0 3.5 7.3 0.0 0.0 0.0 153.7 0.0 0.0 0.6 0.0 62.3 0.0 0.0 0.0 1.3 2.7 0.0 0.0 0.0 0.0 1.0 0.4 0.0 198.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 ANXA2R "AXIIR, C5orf39" ENSG00000177721 "Annexin A2 receptor" Q3ZCQ2 5 43039081-43043170 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.9;lymphoid tissue: 25.1" "Cell type enhanced" "Detected in many" 13 "B-cells: 27.5;Ito cells: 22.1;Kupffer cells: 18.7;T-cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 10.1;JURKAT: 12.3;MOLT-4: 10.8;REH: 11.3;U-937: 41.9" HPA051482 Uncertain Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA051482: AB_2681500" "unprognostic (3.38e-2)" "unprognostic (2.00e-3)" "unprognostic (1.21e-2)" "unprognostic (1.92e-2)" "unprognostic (1.40e-2)" "unprognostic (3.92e-3)" "unprognostic (5.65e-3)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (8.14e-2)" "unprognostic (2.13e-2)" "unprognostic (4.34e-1)" "prognostic unfavorable (6.36e-8)" "unprognostic (2.68e-1)" "unprognostic (2.77e-1)" "unprognostic (2.68e-1)" "unprognostic (1.68e-1)" 5.5 1.6 1.3 8.8 4.1 13.1 8.6 1.0 1.5 5.7 4.1 2.0 1.8 2.5 3.6 3.9 4.6 3.7 2.9 2.2 1.7 1.3 2.4 1.4 7.2 19.0 2.6 0.5 2.0 1.1 0.7 1.8 2.6 1.4 5.7 2.2 2.1 2.9 1.9 4.4 2.2 7.5 3.2 1.9 14.9 2.4 2.3 2.0 25.1 3.1 1.8 13.4 5.2 5.6 8.9 1.4 1.5 2.1 6.5 28.9 7.7 0.7 0.7 0.6 0.4 1.1 3.0 0.2 0.2 0.1 0.1 0.3 1.4 0.9 2.8 2.5 0.5 0.8 0.3 1.8 0.2 0.1 4.6 1.4 0.9 1.9 0.6 1.5 1.0 0.4 10.1 0.1 0.8 0.1 0.0 5.6 12.3 0.6 3.6 0.7 1.0 10.8 1.5 0.0 0.6 5.5 11.3 1.4 1.6 0.3 0.4 2.2 0.0 1.0 0.2 0.2 0.1 0.3 1.9 3.5 0.2 0.0 0.3 0.9 1.6 2.3 1.1 1.3 41.9 0.5 1.5 1.1 0.5 16.0 0.7 18.6 8.7 16.6 17.5 1.0 8.9 28.9 21.2 0.9 6.5 2.1 1.4 17.7 7.7 1.3 4.1 1.0 1.5 1.7 1.3 2.6 0.5 1.4 2.0 0.0 16.4 27.5 1.6 3.3 0.0 1.2 2.5 2.7 2.3 0.0 0.0 0.4 0.0 0.2 3.0 15.4 0.2 0.0 0.0 0.9 4.1 1.2 14.0 0.8 7.6 0.0 1.7 22.1 18.7 1.3 1.4 6.9 6.8 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 2.8 0.7 0.8 1.9 0.3 60.4 0.5 0.9 AP3B2 NAPTB ENSG00000103723 "Adaptor related protein complex 3 beta 2 subunit" Q13367 15 82659281-82709914 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.8" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 17.0;Cone photoreceptor cells: 25.5;Horizontal cells: 12.7;Intestinal endocrine cells: 13.4;Rod photoreceptor cells: 56.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RT4: 11.8;SCLC-21H: 19.3;SH-SY5Y: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039467, HPA039818" Enhanced Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039467: AB_10795143, HPA039818: AB_10795299" "unprognostic (3.17e-1)" "unprognostic (9.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.48e-6)" "unprognostic (8.44e-2)" "unprognostic (7.62e-2)" "unprognostic (5.82e-2)" "unprognostic (2.32e-1)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (3.57e-3)" "unprognostic (1.12e-1)" "unprognostic (8.66e-2)" "unprognostic (4.95e-2)" "unprognostic (3.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.43e-2)" 1.5 5.4 17.0 2.0 15.5 2.4 1.6 32.3 35.8 1.6 1.6 2.7 0.0 1.8 2.0 2.2 1.6 1.4 1.4 1.1 12.1 11.0 1.3 1.2 1.3 1.6 5.7 18.6 1.8 2.7 8.3 12.3 1.4 16.0 1.7 1.5 3.5 1.7 2.0 1.1 1.8 1.5 1.8 3.7 1.3 2.1 2.6 2.7 0.0 1.7 0.0 1.9 1.8 0.6 1.0 0.5 3.2 1.0 1.1 0.9 0.2 0.2 0.2 5.2 2.0 0.5 0.1 4.6 0.3 0.0 0.6 0.1 0.5 0.5 0.5 3.5 0.1 1.1 0.7 0.5 0.0 0.1 1.6 0.5 0.3 0.5 0.2 0.3 0.4 1.2 0.5 0.6 0.1 0.2 0.3 0.1 1.9 0.6 0.5 0.1 0.8 0.3 0.4 6.0 0.1 0.2 0.3 0.1 0.1 0.0 11.8 19.3 14.9 2.9 0.8 1.3 0.6 0.2 1.0 0.3 0.4 0.8 0.3 1.0 1.0 5.7 0.5 1.4 0.3 0.9 0.7 1.0 0.5 0.6 0.4 0.3 0.6 0.5 0.3 0.1 1.0 0.9 0.5 3.2 1.1 0.6 0.5 0.3 0.2 17.0 15.5 32.3 25.6 12.1 11.0 5.7 18.6 16.0 2.7 0.0 0.6 0.0 1.9 0.3 17.0 0.8 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.3 0.1 0.4 0.8 0.0 0.0 0.1 12.7 13.4 0.0 0.0 5.7 0.9 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.5 56.5 0.0 0.4 8.1 3.0 0.1 0.0 0.0 0.0 0.8 AP5B1 "AP-5, DKFZp761E198, PP1030" ENSG00000254470 "Adaptor related protein complex 5 beta 1 subunit" Q2VPB7 11 65775893-65780802 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.6" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "neutrophil: 22.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 22.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065739, HPA067880" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Vesicles" "Golgi apparatus" "HPA065739: AB_2685550, HPA067880: AB_2685914" "unprognostic (3.64e-1)" "unprognostic (9.40e-2)" "unprognostic (4.37e-3)" "unprognostic (1.45e-2)" "unprognostic (5.56e-3)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "unprognostic (2.15e-1)" "prognostic favorable (2.31e-5)" "unprognostic (2.03e-2)" "unprognostic (2.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.67e-1)" 11.2 6.8 5.3 10.2 8.2 48.6 10.3 10.7 9.1 6.3 6.7 4.0 6.9 9.6 9.8 6.8 13.2 7.2 8.2 6.6 5.7 3.5 7.7 9.3 11.3 13.3 6.0 5.5 4.5 16.1 9.9 5.5 14.8 5.3 6.4 4.2 8.0 10.9 10.7 11.9 10.3 9.5 5.1 5.6 13.0 7.9 3.1 6.2 9.2 7.9 7.4 7.8 11.0 6.5 0.2 0.3 22.5 1.3 0.3 0.4 0.5 10.1 7.9 1.8 10.3 4.9 2.5 14.8 4.3 4.1 4.5 3.6 6.8 4.7 5.8 8.3 3.7 8.4 12.1 5.0 3.3 1.4 9.2 8.7 5.3 8.9 3.3 4.0 6.8 11.1 4.8 6.2 3.1 1.6 3.5 3.5 10.1 11.9 7.6 2.3 7.0 4.3 6.8 3.6 2.4 8.9 13.9 0.3 12.7 3.3 11.5 2.4 4.3 3.2 2.0 19.3 2.1 3.9 10.0 5.5 8.3 7.5 10.6 4.4 7.8 7.9 5.8 5.9 5.8 8.0 0.6 1.3 0.5 0.4 0.8 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 22.5 0.3 1.0 0.2 0.1 0.5 5.3 8.2 10.7 9.1 5.7 3.5 6.0 5.5 5.3 6.2 0.0 9.1 5.2 10.1 2.2 5.2 1.4 5.1 1.4 0.0 7.0 13.7 6.1 1.7 7.4 1.1 2.2 9.5 0.0 11.6 14.8 2.6 4.8 2.3 5.8 13.4 11.1 2.9 1.8 8.1 0.0 0.6 6.1 6.8 7.2 2.2 3.9 8.7 6.2 3.5 6.9 9.6 0.0 3.7 0.2 3.6 1.9 29.2 4.4 3.0 9.5 APAF1 "APAF-1, CED4" ENSG00000120868 "Apoptotic peptidase activating factor 1" O14727 12 98645141-98735433 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031373, CAB069399" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "CAB069399: AB_1611908, HPA031373: AB_10602230" "unprognostic (1.32e-1)" "unprognostic (5.12e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.21e-1)" "unprognostic (3.94e-1)" "unprognostic (8.21e-3)" "unprognostic (2.03e-3)" "unprognostic (1.35e-1)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (5.63e-2)" "unprognostic (6.04e-2)" "unprognostic (9.93e-3)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.07e-2)" 10.5 4.7 10.3 11.0 11.0 36.1 8.8 13.4 11.5 10.8 11.6 8.2 5.5 7.0 10.6 7.5 6.2 6.3 11.6 5.8 10.2 8.6 5.8 6.8 11.8 11.2 8.8 6.7 10.8 7.4 5.7 6.2 10.1 8.2 9.1 12.9 8.5 8.2 6.4 6.0 7.5 14.9 7.2 10.9 15.9 8.6 6.1 9.3 15.7 7.0 3.9 14.2 9.5 9.0 2.8 6.3 33.0 8.7 1.1 1.9 1.5 4.4 6.6 20.4 7.8 7.0 12.4 5.6 11.2 8.3 8.5 8.6 4.3 3.2 6.7 3.2 9.3 3.2 7.3 14.2 8.1 10.7 4.7 5.7 12.2 6.3 5.3 2.4 11.8 15.7 5.1 2.5 8.6 4.5 9.4 14.5 4.7 5.6 3.4 12.4 1.3 6.3 12.4 5.6 5.0 3.9 7.9 16.3 2.1 5.0 7.9 3.0 5.1 8.7 3.7 3.2 13.1 6.4 17.8 11.2 5.8 4.5 6.5 3.6 2.3 4.4 7.4 2.2 16.7 7.6 6.2 8.7 7.2 1.9 3.6 1.5 2.4 1.4 1.1 6.3 2.8 1.4 0.9 33.0 1.1 3.6 4.6 0.9 1.5 10.3 11.0 13.4 11.5 10.2 8.6 8.8 6.7 8.2 9.3 11.9 8.0 5.9 4.8 3.4 6.4 1.4 2.5 5.3 4.5 7.0 13.7 3.3 0.0 7.6 0.6 9.2 14.4 0.0 7.0 6.6 8.2 7.3 5.8 5.5 10.5 4.8 11.5 14.1 39.2 0.8 5.5 26.0 10.1 6.4 16.4 2.5 14.3 19.2 4.9 1.5 10.2 0.0 5.2 3.9 11.1 2.9 1.6 9.6 11.5 9.0 APC "DP2, DP2.5, DP3, PPP1R46" ENSG00000134982 "APC, WNT signaling pathway regulator" P25054 5 112707498-112846239 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.9" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 169.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013349, HPA013362" Supported Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA013349: AB_1844913, HPA013362: " "unprognostic (4.80e-2)" "unprognostic (1.19e-1)" "unprognostic (3.72e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (7.09e-3)" "unprognostic (1.62e-1)" "unprognostic (8.10e-3)" "unprognostic (2.35e-1)" "unprognostic (4.85e-3)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.02e-2)" "unprognostic (1.07e-1)" "unprognostic (3.35e-1)" "unprognostic (2.23e-2)" "unprognostic (1.96e-1)" 7.2 5.4 40.9 6.4 21.7 8.5 6.3 19.1 39.7 6.8 7.1 10.3 2.0 6.6 6.3 3.9 8.4 5.0 5.5 7.4 37.9 12.9 6.9 6.2 6.7 5.6 23.6 20.7 7.6 4.6 13.8 7.2 5.5 39.1 5.9 6.9 4.0 4.0 4.9 7.0 6.1 8.8 8.1 19.1 6.2 5.4 5.3 20.6 3.6 6.5 2.7 6.2 6.2 3.9 3.8 3.0 12.9 2.9 3.0 3.4 1.1 8.3 7.7 12.9 9.4 10.6 8.9 5.3 13.6 6.5 7.6 9.0 6.1 6.8 16.2 13.2 17.3 11.7 6.9 13.2 11.1 12.5 9.7 9.0 12.3 11.2 4.7 5.2 6.2 6.7 7.4 7.7 12.8 8.5 5.3 10.5 7.8 15.1 5.6 10.9 5.8 7.1 3.1 4.6 4.6 2.8 6.0 16.0 7.9 7.0 10.7 13.1 7.9 12.9 5.0 5.5 5.5 7.0 5.1 16.7 15.4 7.4 15.1 10.3 4.4 6.6 6.4 8.5 11.5 8.6 10.4 2.9 5.0 3.4 1.4 2.9 3.1 1.8 2.1 2.3 3.8 2.9 2.8 12.9 3.0 2.5 3.0 1.6 1.1 40.9 21.7 19.1 31.4 37.9 12.9 23.6 20.7 39.1 20.6 47.6 17.6 10.8 8.3 10.0 169.9 48.4 12.7 20.1 26.1 0.0 62.8 4.4 0.0 16.7 6.3 21.0 24.6 0.0 17.0 5.3 10.2 10.3 18.5 12.1 13.8 74.7 26.4 28.8 14.9 4.4 16.4 14.8 16.9 19.0 15.5 21.8 16.3 25.9 18.4 4.2 37.9 38.8 14.3 14.9 26.7 10.2 2.4 10.7 14.2 7.6 APEX2 "APE2, APEXL2, XTH2, ZGRF2" ENSG00000169188 "Apurinic/apyrimidinic endodeoxyribonuclease 2" Q9UBZ4 X 55000357-55009057 "Enzymes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" "DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048577 Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA Yes "Nucleoplasm, Nucleoli fibrillar center" Vesicles "HPA048577: AB_2680448" "unprognostic (2.90e-2)" "prognostic favorable (6.17e-4)" "unprognostic (4.32e-2)" "unprognostic (2.39e-1)" "unprognostic (1.62e-1)" "unprognostic (5.62e-2)" "prognostic unfavorable (6.13e-7)" "unprognostic (5.89e-2)" "unprognostic (4.87e-2)" "prognostic favorable (5.21e-4)" "unprognostic (7.46e-2)" "unprognostic (3.16e-1)" "unprognostic (6.86e-2)" "unprognostic (1.03e-2)" "unprognostic (3.17e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.63e-4)" 11.1 12.8 8.6 12.0 12.3 11.9 10.2 8.7 11.8 10.0 12.3 13.7 8.2 12.3 11.5 12.6 20.8 10.7 13.9 10.6 8.7 7.2 15.4 18.5 10.3 14.2 9.7 6.0 14.4 10.7 10.7 12.7 17.8 8.8 11.0 15.1 9.1 10.4 10.0 10.3 16.7 18.7 10.0 9.9 18.0 10.8 7.7 8.9 21.9 10.6 10.2 27.4 11.6 12.7 6.7 9.4 9.2 9.9 26.6 7.5 6.3 22.0 19.9 7.9 11.4 11.5 7.7 13.4 9.1 12.3 17.7 17.3 10.8 18.6 14.6 14.3 8.6 20.9 16.6 18.0 17.3 13.4 11.8 13.7 17.8 19.8 11.0 7.4 10.9 16.8 7.6 14.2 24.9 9.0 8.4 14.0 15.6 9.1 9.9 13.1 21.5 14.7 14.3 15.6 10.5 24.0 13.1 13.1 15.9 9.5 11.1 7.3 8.0 17.2 20.9 8.8 18.8 16.5 8.5 8.1 10.5 15.3 21.1 11.8 10.4 13.3 12.1 11.2 18.7 12.4 9.2 7.8 8.5 7.5 9.9 6.2 6.1 7.1 7.4 9.4 6.7 6.4 6.2 2.9 26.6 8.3 5.1 7.5 6.3 8.6 12.3 8.7 11.8 8.7 7.2 9.7 6.0 8.8 8.9 3.0 16.9 15.2 10.8 11.4 3.2 4.7 10.2 12.0 9.1 10.4 0.0 43.2 13.3 21.7 0.2 7.7 13.7 70.0 13.2 28.4 7.0 7.8 8.1 10.2 21.2 6.4 5.8 8.6 8.6 0.8 5.5 13.5 0.0 29.7 11.1 5.8 15.0 14.8 8.1 15.8 2.1 19.4 4.4 1.0 10.8 11.0 39.8 15.8 11.3 10.0 APLP1 APLP ENSG00000105290 "Amyloid beta precursor like protein 1" P51693 19 35867899-35879791 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Endocytosis" Heparin-binding Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 147.5" "Group enriched" "Detected in many" 4 "Bipolar cells: 142.9;Horizontal cells: 152.6" "Cancer enhanced" "Detected in many" "glioma: 63.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 25.4;AN3-CA: 47.1;EFO-21: 24.9;HMC-1: 24.3;SCLC-21H: 27.4;SH-SY5Y: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028970, HPA028971" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 3900000 "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA028970: AB_2672847, HPA028971: AB_10601334" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (9.36e-3)" "prognostic unfavorable (3.87e-4)" "unprognostic (7.32e-3)" "unprognostic (1.26e-2)" "unprognostic (1.04e-3)" "unprognostic (2.24e-2)" "unprognostic (4.98e-2)" "unprognostic (6.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.57e-11)" "unprognostic (1.38e-3)" "unprognostic (7.12e-2)" "unprognostic (5.43e-2)" "prognostic unfavorable (2.65e-5)" 2.6 15.6 37.0 2.9 47.9 1.6 1.6 13.1 147.5 2.4 2.6 91.6 0.0 2.0 2.3 2.1 2.2 2.3 4.3 6.0 53.2 37.4 2.4 1.5 2.4 2.1 54.6 24.6 1.9 32.1 5.6 17.6 1.9 38.4 2.3 2.6 3.3 2.4 2.4 1.5 2.0 2.4 2.9 118.2 1.7 9.6 5.7 36.9 0.0 2.2 0.0 2.2 2.1 0.1 1.5 0.4 2.2 0.7 3.0 0.6 0.2 1.4 10.6 25.4 47.1 2.4 1.0 3.3 2.2 1.1 2.5 0.3 2.5 1.4 0.2 24.9 5.5 8.2 0.7 7.8 0.5 1.7 17.7 0.9 0.1 3.1 1.4 0.7 0.0 24.3 1.1 0.6 1.0 0.0 9.4 0.8 1.8 0.9 0.4 7.2 2.3 0.0 0.0 1.2 4.3 6.2 2.4 0.1 0.3 0.4 0.3 27.4 27.8 8.2 1.1 0.3 7.2 6.1 1.3 0.6 17.1 9.8 9.6 1.4 1.1 0.4 0.1 11.2 0.3 8.6 2.2 0.7 0.4 0.4 0.5 0.3 0.7 0.4 0.6 0.2 1.5 0.5 0.6 2.1 3.0 0.7 0.4 0.2 0.2 37.0 47.9 13.1 54.6 53.2 37.4 54.6 24.6 38.4 36.9 6.0 0.0 0.0 2.4 1.1 142.9 4.8 0.0 0.0 0.0 0.0 11.8 0.3 0.0 2.1 25.2 2.8 0.0 0.0 3.8 4.1 2.1 1.8 0.0 0.0 0.4 152.6 33.6 1.3 0.3 8.5 1.1 0.5 5.0 0.0 0.0 11.9 4.4 0.0 0.0 0.0 24.2 0.0 1.7 9.7 22.2 0.5 0.3 0.0 0.0 1.2 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 714.1" "Cell type enriched" "Detected in some" 60 "Hepatocytes: 64257.6" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "CACO-2: 28.5;Hep G2: 77.0" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" NA NA 106000000000 97000000000 Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: AB_2732733, HPA073918: " "prognostic favorable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 38.7 0.1 0.1 31.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.4 714.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 91.3 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 28.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 77.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.3 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 100.1 0.0 0.0 0.0 0.0 858.6 0.0 0.0 0.0 0.0 0.0 3.3 0.0 3.8 0.0 0.0 1074.6 0.4 0.3 0.0 0.0 0.0 64257.6 1.0 0.0 0.0 825.6 1072.7 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 3.2 0.0 0.0 APOL6 "APOL-VI, APOLVI" ENSG00000221963 "Apolipoprotein L6" Q9BWW8 22 35648395-35668409 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB028574, HPA029165, HPA029167" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832" "unprognostic (7.25e-3)" "unprognostic (2.67e-2)" "unprognostic (1.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.76e-1)" "unprognostic (1.55e-1)" "unprognostic (2.32e-2)" "unprognostic (8.29e-2)" "unprognostic (3.76e-2)" "unprognostic (6.26e-3)" "unprognostic (1.46e-3)" "unprognostic (1.46e-1)" "unprognostic (6.65e-3)" "unprognostic (2.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.71e-2)" "prognostic favorable (6.61e-4)" 40.6 9.2 4.8 18.8 5.5 10.1 32.3 1.9 4.2 7.4 17.9 4.1 5.0 14.0 8.8 9.5 9.8 5.9 12.5 9.3 4.0 4.3 15.4 36.9 15.8 17.0 4.6 2.2 17.0 4.7 3.7 5.1 8.9 5.9 11.7 8.9 6.4 10.1 5.6 7.4 3.6 36.6 6.4 7.6 19.5 10.1 2.5 4.5 12.7 24.8 7.7 13.4 8.5 14.1 1.2 2.8 9.2 9.0 5.9 9.1 4.2 7.2 2.3 0.2 0.9 18.1 9.1 10.2 3.1 8.2 10.2 12.9 1.1 8.2 10.0 1.5 8.0 7.5 9.4 0.0 5.0 2.7 18.9 0.1 4.2 1.5 2.3 14.3 5.8 7.4 11.6 3.4 3.5 2.0 2.3 2.1 4.6 0.4 18.3 1.9 0.7 8.1 1.8 0.3 0.5 3.1 3.4 4.0 4.8 4.5 16.6 0.2 0.1 4.9 4.2 5.6 0.7 0.7 6.8 2.2 2.5 1.5 1.7 1.6 9.7 7.7 1.0 4.8 9.3 3.6 6.4 5.6 2.9 9.1 8.9 7.7 1.2 6.1 7.2 2.8 1.0 6.0 6.7 9.2 5.9 9.0 0.3 6.3 4.2 4.8 5.5 1.9 4.2 4.0 4.3 4.6 2.2 5.9 4.5 65.5 29.3 17.5 9.9 7.1 0.1 6.6 38.2 40.2 40.9 12.2 0.0 6.7 8.3 30.0 10.4 23.9 70.1 0.0 36.3 26.7 19.5 29.2 36.8 105.8 31.4 0.0 45.4 41.7 43.9 4.6 24.2 30.8 8.5 23.4 48.8 3.1 38.3 42.1 17.7 23.8 0.0 0.0 13.4 0.2 0.2 4.5 2.1 51.7 25.8 43.1 ARFGEF1 "ARFGEP1, BIG1, DKFZP434L057, p200" ENSG00000066777 "ADP ribosylation factor guanine nucleotide exchange factor 1" Q9Y6D6 8 67173511-67343677 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 131.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023399, HPA023822" Supported Supported Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA023399: AB_1844981, HPA023822: AB_1844982" "prognostic unfavorable (8.76e-4)" "unprognostic (1.62e-1)" "unprognostic (4.60e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (4.52e-1)" "unprognostic (5.38e-2)" "unprognostic (4.67e-2)" "unprognostic (2.13e-3)" "unprognostic (1.31e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (1.62e-1)" "unprognostic (1.61e-2)" 17.0 17.1 14.5 24.3 15.6 24.9 14.0 20.4 16.3 17.7 24.7 9.5 24.7 16.8 15.4 20.3 23.8 13.1 16.0 12.0 11.3 11.7 23.9 15.3 18.6 22.7 11.4 9.5 15.1 21.4 38.6 21.8 17.4 16.7 15.8 17.7 13.2 20.7 29.4 20.9 18.4 26.9 13.8 12.0 20.1 19.5 27.1 12.6 36.7 22.9 15.7 16.8 22.9 17.7 2.1 3.7 8.4 3.7 3.7 6.1 1.3 15.8 10.3 10.1 3.7 11.7 16.0 11.9 11.2 12.5 11.4 11.6 6.3 15.5 12.0 4.9 14.0 13.9 11.4 12.1 15.7 14.0 15.4 8.5 20.2 6.3 6.8 10.1 10.3 20.2 9.8 11.3 10.2 17.5 11.8 16.2 12.7 12.4 13.1 13.1 3.5 24.2 4.9 22.1 17.4 9.5 11.9 7.2 2.4 18.9 29.5 4.0 7.8 7.2 17.5 9.8 16.1 30.2 9.2 19.7 7.9 10.5 10.3 8.3 11.5 12.5 9.0 12.4 10.6 7.3 8.0 2.6 6.6 4.8 3.7 6.1 2.1 3.2 3.9 2.6 2.1 5.3 4.5 8.4 3.7 1.5 3.7 5.9 1.3 14.5 15.6 20.4 16.3 11.3 11.7 11.4 9.5 16.7 12.6 41.7 17.2 18.8 23.7 21.1 35.4 28.2 20.4 30.8 26.1 36.6 131.6 16.1 10.0 24.5 19.5 24.8 32.5 0.0 22.1 13.2 15.8 30.7 15.0 17.8 14.2 41.3 28.3 22.1 29.5 23.4 37.2 23.8 16.9 27.9 29.9 21.4 31.5 23.0 28.3 21.0 94.9 6.5 17.5 49.4 48.5 25.7 20.8 23.0 22.7 61.6 ARFIP1 HSU52521 ENSG00000164144 "ADP ribosylation factor interacting protein 1" P53367 4 152779937-152918463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005080, HPA037375, HPA063759" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "CAB005080: AB_2058797, HPA037375: AB_2675440, HPA063759: AB_2685114" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "prognostic favorable (5.75e-5)" "unprognostic (1.49e-3)" "unprognostic (4.32e-1)" "unprognostic (1.24e-1)" "unprognostic (3.54e-2)" "unprognostic (5.34e-1)" "unprognostic (1.03e-2)" "unprognostic (3.56e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-2)" "prognostic favorable (2.83e-10)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (7.02e-2)" "unprognostic (4.22e-3)" 17.8 15.6 12.2 22.6 13.2 2.8 22.3 15.7 12.3 22.8 25.3 17.5 25.6 20.9 21.1 23.8 23.4 17.6 20.8 11.9 12.6 13.2 23.6 15.3 20.3 14.9 16.1 9.5 22.9 18.8 20.4 22.5 29.0 13.5 23.8 26.4 19.1 19.6 23.9 12.7 19.1 29.9 18.5 18.3 18.5 20.2 12.7 13.9 14.7 23.9 10.2 17.9 24.3 20.4 8.4 10.9 35.7 13.8 12.3 7.6 7.7 13.2 9.9 13.8 13.5 21.8 22.3 17.1 15.9 22.5 16.1 15.4 11.5 27.8 10.6 5.3 22.1 12.4 9.5 14.3 16.1 20.1 8.9 8.9 10.5 10.1 11.4 15.4 19.7 22.2 15.7 17.9 13.7 13.6 17.5 14.8 6.2 12.3 23.0 22.5 15.4 11.0 11.0 11.6 16.6 10.1 6.4 7.8 9.8 29.1 17.8 17.5 14.4 12.0 22.7 15.8 14.1 20.3 10.6 9.1 15.6 11.1 15.1 11.2 25.3 20.8 14.5 19.8 19.8 21.5 12.1 12.0 17.9 6.7 13.8 6.7 8.4 5.3 5.5 10.9 7.7 4.1 5.5 35.7 12.3 12.6 1.3 7.6 7.7 12.2 13.2 15.7 12.3 12.6 13.2 16.1 9.5 13.5 13.9 6.0 25.6 10.4 15.8 26.3 17.3 8.1 28.1 25.4 21.6 36.6 0.0 24.5 23.2 23.7 30.8 19.9 26.4 0.0 15.9 21.2 22.4 21.3 22.0 17.8 19.1 17.5 37.3 19.0 22.2 19.7 20.8 18.5 20.3 5.4 34.5 32.0 19.3 24.6 20.5 24.5 23.6 32.3 18.9 25.5 31.9 29.6 36.7 11.4 29.7 29.4 ARFIP2 POR1 ENSG00000132254 "ADP ribosylation factor interacting protein 2" P53365 11 6474683-6481479 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032985, HPA038156" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "CAB032985: AB_2058811, HPA038156: AB_10697243" "unprognostic (2.32e-1)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "prognostic favorable (2.00e-5)" "unprognostic (8.44e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-3)" "unprognostic (2.50e-1)" "unprognostic (2.96e-1)" "unprognostic (1.76e-1)" "unprognostic (5.70e-3)" "unprognostic (3.11e-1)" "prognostic favorable (9.53e-4)" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (2.32e-2)" "unprognostic (9.48e-3)" 13.3 20.5 19.7 15.2 19.4 12.6 33.0 24.0 32.0 24.5 22.9 16.4 29.5 20.2 17.5 23.1 22.0 25.5 21.5 13.2 16.5 17.2 21.3 32.7 17.5 13.0 15.5 22.0 20.3 36.0 36.1 29.9 27.3 16.8 30.9 31.2 18.6 46.6 29.4 12.1 21.6 23.5 17.8 14.9 15.0 31.2 14.9 16.0 12.3 28.4 16.3 24.2 16.0 19.8 11.5 17.4 7.8 12.7 15.6 15.5 10.8 14.2 19.0 11.6 11.8 18.2 17.1 16.6 11.5 31.4 25.9 31.0 17.9 23.9 11.5 4.9 23.2 14.5 20.3 14.7 24.6 21.7 8.9 26.0 6.2 25.2 17.1 22.0 10.0 12.8 18.1 19.7 12.5 30.3 19.0 16.4 11.0 9.8 13.6 16.8 28.0 11.8 11.4 19.6 32.1 21.6 9.1 6.5 10.9 18.0 14.8 15.4 18.7 14.0 62.6 7.2 11.1 25.8 9.3 10.4 11.1 10.7 11.5 8.5 20.4 9.1 7.0 19.9 6.2 12.6 7.4 12.7 7.8 15.5 8.8 15.2 10.7 14.6 12.7 17.4 11.5 14.5 14.8 5.3 15.6 5.4 13.6 14.7 10.8 19.7 19.4 24.0 32.0 16.5 17.2 15.5 22.0 16.8 16.0 6.0 5.4 21.6 37.4 24.8 31.5 3.9 28.1 10.7 7.9 12.2 27.5 68.9 49.7 42.8 17.9 17.9 60.6 0.0 74.5 52.8 24.9 63.7 32.2 17.1 24.8 20.6 60.5 20.3 9.1 30.2 19.0 15.7 23.6 33.3 78.2 31.3 48.5 52.6 23.0 26.0 27.9 25.8 17.5 32.9 16.4 28.1 94.1 16.2 40.6 54.8 ARGLU1 FLJ10154 ENSG00000134884 "Arginine and glutamate rich 1" Q9NWB6 13 106541673-106568164 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 91.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034962, HPA056792" Supported Enhanced Nucleoplasm,Mitochondria,Cytosol No No Nucleoplasm "Mitochondria, Cytosol" "HPA034962: AB_10611676, HPA056792: AB_2683236" "unprognostic (1.66e-2)" "unprognostic (3.10e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (3.97e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (3.21e-2)" "unprognostic (9.00e-2)" "unprognostic (1.52e-1)" "prognostic favorable (3.92e-5)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.91e-3)" "unprognostic (2.65e-1)" "unprognostic (2.87e-1)" "prognostic favorable (7.34e-5)" 43.5 31.8 59.1 46.5 63.6 67.5 46.1 82.1 72.8 37.9 41.7 44.9 33.5 35.2 62.2 50.9 38.1 50.2 55.0 40.4 55.7 20.6 30.5 24.4 65.3 75.7 62.5 44.5 65.2 34.1 24.0 61.1 48.3 44.0 38.9 48.6 35.5 46.8 48.2 34.1 53.0 54.3 43.3 51.8 50.4 42.8 25.9 67.2 40.2 45.5 22.0 61.0 44.0 44.9 23.7 23.2 34.7 18.0 16.5 18.6 10.9 26.6 14.8 67.4 15.1 10.7 18.6 15.0 29.7 9.0 10.0 15.2 30.2 38.8 32.4 10.2 11.6 11.7 30.2 14.2 12.2 18.8 42.1 15.1 37.2 91.5 15.5 9.5 60.0 24.8 16.6 16.1 9.1 12.3 25.0 12.7 22.5 13.4 25.2 12.8 9.4 23.7 31.9 17.8 19.6 5.6 40.9 16.9 15.4 11.2 31.1 17.6 25.3 14.0 22.5 6.7 27.9 17.7 31.1 23.0 13.4 13.4 14.9 16.6 28.3 23.3 38.8 27.7 38.5 15.3 34.7 18.0 16.7 18.6 14.6 17.2 20.7 13.8 11.6 14.4 23.7 15.8 13.8 30.3 16.5 13.4 23.2 15.5 10.9 59.1 63.6 82.1 72.8 55.7 20.6 62.5 44.5 44.0 67.2 131.0 200.7 147.3 175.2 232.4 221.8 78.3 101.9 224.9 215.0 108.2 127.6 118.5 84.6 100.9 28.5 282.9 157.6 93.5 97.9 120.4 173.1 219.9 158.9 69.6 87.5 287.6 180.1 188.4 85.6 18.1 236.2 133.0 121.4 162.3 134.2 304.1 112.4 133.3 204.7 39.4 283.1 213.4 189.5 194.6 112.8 229.2 154.9 147.4 126.3 268.6 ARHGAP10 "FLJ20896, FLJ41791, GRAF2" ENSG00000071205 "Rho GTPase activating protein 10" A1A4S6 4 147732063-148072780 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 127.4;monocytes: 96.4;Peritubular cells: 113.8;Rod photoreceptor cells: 129.8;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 9 "cerebellum: 154.3" HPA039589 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA039589: " "unprognostic (8.57e-3)" "unprognostic (1.34e-1)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (2.79e-1)" "unprognostic (3.41e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (2.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-2)" "prognostic favorable (8.15e-5)" "prognostic unfavorable (6.26e-4)" "unprognostic (1.54e-1)" "unprognostic (1.02e-3)" "unprognostic (1.09e-2)" 31.2 7.9 2.3 11.3 3.2 2.0 27.8 1.8 3.7 20.1 23.9 1.9 13.2 3.4 15.4 17.6 25.2 17.6 20.3 20.0 2.8 1.6 9.6 4.8 11.8 8.3 3.8 1.9 19.9 7.8 20.8 4.7 7.5 9.9 19.8 6.0 16.0 6.7 17.0 37.5 12.3 8.9 58.0 5.2 9.7 15.9 11.2 2.5 8.7 9.9 12.4 7.9 28.7 24.9 0.0 2.6 14.0 1.5 4.1 9.7 2.1 9.8 4.0 2.2 4.5 16.7 22.8 22.7 13.7 11.4 8.8 6.9 10.3 5.7 0.0 2.3 11.6 7.4 4.9 7.9 11.2 10.7 5.4 5.3 3.3 3.1 0.3 25.8 3.3 4.0 11.8 8.8 11.0 9.4 11.2 10.6 2.9 0.5 18.7 15.7 12.0 2.0 0.0 2.0 6.6 2.0 3.8 6.2 11.5 6.1 9.1 5.3 2.5 3.6 14.4 3.8 9.8 1.8 0.3 10.6 8.3 6.4 5.0 6.5 7.0 0.8 0.0 12.7 0.4 7.3 0.0 1.5 14.0 5.2 0.0 9.7 0.0 3.9 5.7 2.6 0.0 1.1 5.7 0.2 4.1 0.0 0.0 4.6 2.1 2.3 3.2 1.8 3.7 2.8 1.6 3.8 1.9 9.9 2.5 3.0 2.6 0.0 6.9 12.8 3.8 58.3 5.1 0.0 2.3 1.8 41.2 24.2 0.0 4.2 7.8 9.0 0.0 0.0 13.5 41.5 17.5 3.3 1.1 11.3 20.5 3.2 0.0 6.2 3.9 6.2 127.4 12.8 5.0 96.4 0.0 7.7 14.2 0.0 113.8 11.7 129.8 142.3 59.0 3.9 16.1 8.9 10.6 12.5 1.1 2.4 ARHGAP15 BM046 ENSG00000075884 "Rho GTPase activating protein 15" Q53QZ3 2 143091362-143768352 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 52.0;bone marrow: 33.5;lymphoid tissue: 94.4" "Cell type enhanced" "Detected in many" 8 "B-cells: 62.8;Early spermatids: 89.3;granulocytes: 83.5;T-cells: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 18.2;HEL: 25.4;HL-60: 35.8;MOLT-4: 23.7;NB-4: 27.8;THP-1: 37.8;U-698: 28.4;U-937: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA032125 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA032125: AB_10671370" "unprognostic (1.59e-2)" "unprognostic (2.40e-3)" "unprognostic (8.63e-2)" "unprognostic (2.19e-2)" "unprognostic (2.99e-1)" "unprognostic (6.62e-3)" "unprognostic (6.14e-2)" "unprognostic (2.18e-3)" "unprognostic (1.32e-2)" "unprognostic (3.58e-2)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (6.95e-5)" "unprognostic (4.40e-2)" "unprognostic (2.12e-2)" "unprognostic (4.58e-2)" "unprognostic (6.94e-2)" 5.5 2.7 3.6 36.6 4.6 33.5 3.7 0.6 2.9 2.4 4.3 1.5 2.1 2.7 2.1 4.3 3.6 2.4 4.9 5.0 3.8 2.1 4.5 4.8 9.1 36.9 7.8 1.7 1.5 1.2 0.4 1.3 1.6 4.6 3.9 3.3 1.0 8.1 2.2 1.1 1.7 12.2 1.6 11.3 51.8 3.0 3.5 5.9 94.4 4.2 2.2 21.7 6.0 3.9 25.2 14.5 52.0 9.6 28.7 46.0 23.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 25.4 0.1 0.0 0.0 35.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.1 1.2 0.0 0.0 23.7 27.8 0.1 0.0 0.0 13.3 0.1 6.7 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 1.2 37.8 0.1 0.1 0.9 0.0 0.0 0.3 0.1 28.4 0.2 19.0 1.1 38.6 8.6 34.9 26.6 8.8 42.3 25.2 46.0 33.3 14.5 22.5 33.9 28.4 52.0 28.7 9.6 14.4 36.5 23.2 3.6 4.6 0.6 2.9 3.8 2.1 7.8 1.7 4.6 5.9 0.0 14.8 62.8 0.0 4.9 0.0 2.0 0.0 4.0 4.5 0.0 0.0 0.1 0.0 0.0 89.3 2.6 0.0 0.0 0.0 0.3 11.5 0.2 83.5 0.4 19.7 1.6 0.0 6.7 31.4 5.3 13.8 38.9 8.5 19.8 0.0 0.2 0.0 0.0 3.2 0.3 0.2 45.3 28.6 7.1 1.0 4.0 0.2 90.6 0.0 0.1 ARHGAP22 RhoGAP2 ENSG00000128805 "Rho GTPase activating protein 22" Q7Z5H3 10 48446034-48656265 "Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 32.3" "Group enriched" "Detected in many" 5 "Early spermatids: 51.6;Late spermatids: 92.5;monocytes: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.2;myeloid DC: 2.9;naive B-cell: 2.6" "Group enriched" "Detected in many" 29 "B-cells: 2.6;dendritic cells: 2.9;monocytes: 3.2" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 28.1;LHCN-M2: 25.4;TIME: 26.9;U-87 MG: 33.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020696, HPA040391, HPA064439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266" "unprognostic (1.87e-1)" "unprognostic (3.98e-2)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.07e-1)" "unprognostic (6.74e-3)" "unprognostic (4.81e-3)" "unprognostic (2.78e-1)" "unprognostic (1.66e-1)" "unprognostic (3.03e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.16e-8)" "unprognostic (7.40e-2)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (3.66e-2)" 2.6 3.1 10.2 6.7 12.5 3.0 2.0 7.3 12.2 1.8 2.7 32.3 1.0 1.7 2.1 1.9 1.6 2.2 4.4 3.3 12.5 9.6 1.2 0.8 2.9 6.0 18.3 6.6 7.7 1.5 2.7 1.8 2.2 24.6 3.2 2.8 1.6 3.4 3.2 3.9 3.4 2.5 3.4 27.3 6.2 2.3 4.6 18.4 2.0 6.0 0.4 5.4 3.1 1.9 2.6 2.9 0.0 3.2 0.0 0.0 0.9 2.4 0.5 0.1 0.0 2.1 8.6 1.7 13.1 6.0 1.2 1.7 2.7 0.3 0.0 0.5 5.1 0.9 4.8 0.1 4.4 2.1 0.2 4.5 6.9 0.0 0.0 1.1 0.7 0.8 2.0 4.5 15.0 1.2 28.1 8.2 0.0 6.5 1.2 25.4 0.1 0.1 0.0 2.8 0.0 0.2 0.0 0.0 3.1 2.5 0.2 0.4 2.6 0.6 0.0 0.2 0.2 0.1 0.1 26.9 12.3 0.1 1.6 9.1 0.0 0.0 0.0 33.5 0.1 1.9 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 2.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 10.2 12.5 7.3 9.2 12.5 9.6 18.3 6.6 24.6 18.4 0.0 1.7 1.3 4.2 3.1 1.0 2.4 0.0 6.7 4.5 0.0 2.0 9.2 0.0 2.5 51.6 1.4 0.0 0.0 3.9 0.2 2.6 1.0 0.0 0.0 10.4 0.0 0.0 2.5 9.5 92.5 2.6 11.0 1.7 23.4 0.0 1.5 2.0 0.0 5.6 0.0 1.4 0.0 0.5 1.4 4.2 0.5 0.8 0.0 0.0 0.5 ARHGAP23 KIAA1501 ENSG00000275832 "Rho GTPase activating protein 23" Q9P227 17 38419280-38512392 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.4" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 56.6;Ito cells: 51.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 77.1;RT4: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019818, HPA047291" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA019818: AB_1844993, HPA047291: AB_2680012" "unprognostic (3.35e-1)" "unprognostic (5.11e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (6.87e-5)" "unprognostic (9.53e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (1.99e-1)" "unprognostic (5.56e-2)" "unprognostic (1.50e-3)" "prognostic unfavorable (3.24e-4)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.38e-5)" "unprognostic (8.36e-2)" "unprognostic (5.83e-2)" "unprognostic (4.57e-2)" "unprognostic (2.25e-1)" 4.3 2.7 11.7 3.5 32.1 4.2 1.7 3.6 20.1 4.4 1.4 52.4 0.0 1.0 5.1 1.5 13.3 4.0 3.6 7.8 12.6 1.6 0.5 5.7 1.3 42.3 12.6 6.1 0.8 1.5 0.0 9.5 20.2 3.7 0.9 0.9 0.7 6.6 2.1 16.3 1.1 5.5 16.3 10.5 0.5 5.2 39.0 1.4 0.9 0.5 5.0 11.6 2.3 0.0 0.8 0.0 0.1 0.0 0.1 0.1 8.2 4.4 4.0 1.3 2.5 8.5 5.0 11.3 12.8 10.0 5.8 14.7 14.5 0.1 9.4 26.3 5.0 77.1 0.4 16.0 7.1 0.9 0.8 0.0 14.1 0.1 12.8 0.8 0.0 4.9 3.1 7.2 4.6 8.2 10.2 1.5 0.1 2.2 5.6 0.0 2.4 1.5 2.4 0.3 1.7 4.3 8.7 2.7 4.2 30.0 0.9 2.3 6.8 0.0 0.1 5.9 1.7 1.9 14.8 16.9 5.9 3.4 3.0 1.7 1.7 0.4 4.2 2.0 14.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 11.9 1.0 0.0 14.3 8.9 56.6 16.3 2.5 1.4 15.9 3.5 0.0 20.8 0.0 2.6 6.7 24.5 0.0 23.3 1.2 2.1 14.3 5.3 0.0 0.2 4.2 25.4 0.0 51.5 3.7 15.8 8.3 0.9 1.7 0.0 0.2 7.5 4.4 0.0 6.7 0.0 3.3 0.0 7.2 17.6 1.9 22.6 13.8 0.0 0.0 35.6 ARHGAP32 "GC-GAP, GRIT, KIAA0712, MGC1892, RICS" ENSG00000134909 "Rho GTPase activating protein 32" A7KAX9 11 128965060-129279324 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.9" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 115.8;Muller glia cells: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 21.2;SK-BR-3: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038382, HPA038389, HPA061505" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544" "unprognostic (1.17e-1)" "unprognostic (3.58e-2)" "unprognostic (2.54e-2)" "unprognostic (1.82e-1)" "unprognostic (3.89e-2)" "unprognostic (5.64e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (1.47e-1)" "unprognostic (6.17e-3)" "unprognostic (1.17e-1)" "unprognostic (4.01e-1)" "unprognostic (5.80e-2)" "unprognostic (1.64e-2)" 4.0 5.9 22.1 3.4 32.8 1.7 9.4 4.7 46.9 8.2 12.3 5.1 1.5 18.4 7.3 8.4 21.9 12.2 6.8 3.8 9.9 6.8 6.5 4.5 5.2 1.5 6.4 21.7 10.2 13.3 14.9 5.3 7.5 5.4 6.0 14.3 4.5 13.4 4.1 6.2 16.0 19.0 5.5 4.3 2.6 10.8 9.2 8.4 5.8 3.6 12.8 12.9 8.0 13.1 1.3 1.6 0.7 2.1 3.0 1.2 0.6 6.4 3.4 10.8 0.0 3.5 3.6 7.8 2.4 3.4 1.5 1.9 7.9 13.4 0.0 3.7 4.7 7.8 14.7 4.9 6.1 3.0 0.0 1.7 0.1 1.7 2.9 1.7 0.0 0.0 3.4 8.0 1.5 9.1 3.4 1.9 5.5 0.3 0.1 2.7 5.0 5.3 0.1 2.9 19.4 3.7 13.1 3.2 1.3 1.7 21.2 10.7 4.3 3.7 23.1 4.4 4.3 12.0 2.0 3.5 5.5 2.9 3.2 4.7 0.1 0.0 0.0 2.4 14.7 3.4 0.0 0.4 0.0 0.3 2.1 1.2 0.0 0.4 0.6 1.0 1.3 0.8 0.2 0.7 3.0 0.7 1.6 0.4 0.6 22.1 32.8 4.7 46.9 9.9 6.8 6.4 21.7 5.4 8.4 6.0 12.6 0.5 10.9 16.3 25.3 3.9 12.7 41.5 28.4 10.4 115.8 17.3 1.7 6.9 12.7 4.9 46.1 0.0 23.7 3.3 11.9 19.8 1.1 13.6 5.4 17.5 39.1 6.2 4.6 10.4 6.4 3.4 15.1 0.0 61.0 120.0 20.3 45.6 12.4 8.6 31.5 19.4 5.9 8.6 5.6 27.1 23.8 1.3 46.4 48.2 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058242-131089883 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Region enriched" "Detected in many" 5 "hypothalamus: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 164 "SH-SY5Y: 64.4" "Region enhanced" "Detected in many" "hypothalamus: 104.3" "Group enriched" "Detected in many" 5 "basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Yes NA Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 6.9 58.4 1.4 0.2 3.6 0.1 1.0 0.0 2.7 0.5 0.2 0.0 0.0 0.1 0.1 2.0 0.3 0.2 0.2 0.1 1.0 25.5 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 50.3 0.3 5.4 0.3 0.2 0.6 0.2 0.2 13.7 0.1 0.1 0.1 0.8 0.1 0.2 0.6 0.0 0.5 0.5 4.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 64.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.6 0.0 0.4 1.0 25.5 0.5 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 ARHGEF12 "KIAA0382, LARG" ENSG00000196914 "Rho guanine nucleotide exchange factor 12" Q9NZN5 11 120336914-120489936 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.2;NK-cells: 1.5;T-cells: 1.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018911, CAB025581" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB025581: , HPA018911: AB_1845003" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (6.91e-3)" "unprognostic (1.28e-1)" "unprognostic (7.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.56e-1)" "unprognostic (5.55e-2)" "unprognostic (4.79e-2)" "unprognostic (7.77e-2)" "unprognostic (4.34e-3)" "unprognostic (4.78e-2)" "prognostic favorable (5.43e-6)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" 17.6 19.2 27.6 8.3 32.5 5.9 19.6 40.4 41.5 21.7 16.4 12.4 15.7 14.9 17.5 15.9 17.8 18.6 17.3 23.4 21.8 17.7 41.2 38.8 24.1 6.5 15.8 26.3 16.3 16.9 55.8 17.2 25.4 21.1 16.8 17.8 20.7 16.7 20.0 24.1 29.0 14.8 18.6 10.8 12.4 19.0 6.7 13.0 3.0 31.3 15.0 10.9 19.4 22.9 0.3 0.3 2.2 0.1 1.5 1.0 0.4 13.2 11.1 14.9 14.3 20.2 20.2 6.2 15.6 17.7 9.5 12.1 13.0 9.7 1.1 19.2 27.8 16.8 9.9 19.1 19.7 18.6 10.9 9.4 21.5 12.0 9.9 18.1 0.0 16.0 19.3 14.3 20.8 23.2 21.0 28.7 11.7 18.1 44.1 23.9 9.2 0.0 0.0 4.1 17.1 9.6 4.7 17.1 4.2 23.3 23.0 11.0 13.6 21.8 18.3 5.7 9.3 15.6 1.7 28.4 21.1 9.0 13.7 11.3 13.0 5.2 7.3 8.7 2.8 15.9 2.2 0.0 0.0 1.0 0.1 0.2 0.3 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.5 0.1 0.3 0.7 0.4 27.6 32.5 40.4 41.5 21.8 17.7 15.8 26.3 21.1 13.0 68.5 79.7 12.3 48.8 80.4 124.2 79.1 58.6 52.2 67.1 92.5 174.7 13.7 29.9 34.0 5.0 74.1 47.9 23.3 43.8 8.3 45.2 80.8 10.5 105.8 6.1 85.8 36.4 81.0 27.2 11.5 27.6 17.4 49.0 10.8 44.1 42.4 44.6 49.0 31.5 60.7 84.8 25.8 70.9 13.5 11.9 74.4 24.0 17.5 34.8 95.3 ARHGEF26 "DKFZP434D146, SGEF" ENSG00000114790 "Rho guanine nucleotide exchange factor 26" Q96DR7 3 154121003-154257827 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Alveolar cells type 1: 315.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 10.0;U-251 MG: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017722, HPA049195" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017722: AB_1856800, HPA049195: AB_2680671" "unprognostic (1.41e-1)" "unprognostic (1.43e-3)" "unprognostic (3.55e-1)" "unprognostic (7.99e-3)" "unprognostic (2.82e-1)" "unprognostic (9.42e-3)" "prognostic favorable (9.74e-4)" "unprognostic (7.06e-2)" "unprognostic (1.16e-1)" "unprognostic (6.01e-5)" "unprognostic (1.44e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-1)" "unprognostic (5.53e-3)" "unprognostic (3.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.24e-3)" 11.2 4.0 9.1 5.8 8.7 1.0 9.8 5.6 17.8 9.2 20.0 6.5 3.3 10.3 5.9 3.1 12.0 8.3 17.6 4.1 8.7 4.6 3.1 22.0 18.6 1.0 5.4 6.3 5.3 27.1 13.9 2.9 4.7 12.2 5.3 3.7 4.4 4.1 5.5 1.5 7.0 11.5 12.7 9.7 1.6 12.3 7.4 5.5 0.0 4.1 2.5 2.0 7.4 11.4 0.0 0.3 0.0 0.5 0.0 0.1 0.0 5.3 3.1 6.1 4.2 2.7 0.4 0.1 0.3 0.0 1.6 1.8 2.5 0.4 2.5 0.4 0.1 2.8 6.3 3.1 1.5 2.8 0.0 8.1 0.0 2.3 0.8 2.5 0.8 0.1 0.9 0.1 1.9 0.3 0.9 0.1 2.6 0.0 0.0 1.0 6.2 1.1 0.1 3.9 1.2 2.7 0.0 10.0 0.0 0.5 3.5 2.3 0.7 0.7 8.8 1.3 3.3 5.4 0.4 0.0 0.9 4.0 0.0 18.1 2.6 0.4 0.0 1.6 0.0 6.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.1 8.7 5.6 10.1 8.7 4.6 5.4 6.3 12.2 5.5 315.6 29.8 0.9 7.9 17.3 9.4 1.2 20.4 21.4 17.0 3.5 3.9 1.4 0.0 1.9 9.1 3.0 2.6 0.0 2.2 1.0 8.1 6.7 4.7 44.5 0.6 4.8 0.0 8.6 2.8 1.7 9.8 0.9 3.3 1.8 4.5 70.3 1.7 2.9 17.7 0.0 50.2 0.0 4.2 2.9 32.4 20.7 5.1 5.7 1.7 5.3 ARHGEF33 ENSG00000214694 "Rho guanine nucleotide exchange factor 33" A8MVX0 2 38889841-38975449 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 42.5" "Group enriched" "Detected in some" 5 "Early spermatids: 25.0;Late spermatids: 21.2;Spermatocytes: 30.7;Spermatogonia: 34.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 42.5" "Cell type enriched" "Detected in single" 8 "eosinophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Group enriched" "Detected in some" 4 "BEWO: 9.0;HeLa: 4.0;SiHa: 11.2" "Region enriched" "Detected in single" 32 "cerebellum: 314.4" "Region enriched" "Detected in all" 11 "cerebellum: 47.0" "HPA034661, HPA041051" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA034661: AB_10669679, HPA041051: AB_2677274" "unprognostic (8.38e-2)" "unprognostic (7.05e-4)" "unprognostic (1.95e-1)" "unprognostic (4.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-1)" "unprognostic (3.66e-1)" "unprognostic (3.37e-1)" "unprognostic (5.82e-2)" "unprognostic (2.05e-3)" "unprognostic (4.99e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.56e-1)" "unprognostic (2.42e-1)" "unprognostic (1.99e-1)" 0.3 4.0 3.7 1.0 8.6 0.0 1.7 42.5 3.4 2.3 0.7 0.6 0.7 0.1 2.8 5.1 0.7 2.2 1.4 0.8 3.3 3.6 1.4 0.2 1.2 0.5 2.0 2.9 6.8 0.2 2.2 3.5 0.8 3.2 1.7 0.6 0.8 0.4 1.2 0.4 1.3 0.6 1.0 1.5 0.5 0.9 10.1 2.4 0.2 1.4 0.2 0.4 1.2 0.6 0.2 0.1 6.7 0.8 0.0 0.2 0.1 0.3 0.0 0.4 0.2 0.2 0.2 9.0 0.8 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.9 1.0 0.3 4.0 0.3 0.7 0.4 0.3 0.8 1.0 0.5 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.4 0.5 0.3 11.2 0.4 0.0 1.1 0.0 0.3 0.6 0.2 1.5 0.0 0.1 0.5 0.2 0.0 0.2 0.2 0.1 0.0 0.6 6.7 0.0 0.8 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 3.7 8.6 42.5 3.4 3.3 3.6 2.0 2.9 3.2 2.4 0.0 1.0 0.0 0.1 0.0 2.5 0.4 0.0 5.3 1.2 0.0 0.0 0.8 0.0 0.1 25.0 0.3 0.0 0.0 0.0 1.3 1.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 21.2 1.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.2 0.2 3.1 0.0 0.7 30.7 34.3 0.1 0.5 0.0 0.0 0.2 ARHGEF5 "GEF5, P60, TIM, TIM1" ENSG00000050327 "Rho guanine nucleotide exchange factor 5" Q12774 7 144355288-144380632 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 44.1;Paneth cells: 42.1;Urothelial cells: 36.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "B-cells: 3.1;granulocytes: 1.1;T-cells: 4.2" "Cell line enhanced" "Detected in many" "A-431: 20.7;CAPAN-2: 14.1;hTCEpi: 15.6;WM-115: 15.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA020980, HPA029504, HPA044188, HPA045619, HPA045699" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423" "unprognostic (1.45e-1)" "unprognostic (2.05e-1)" "unprognostic (1.87e-2)" "unprognostic (1.94e-1)" "unprognostic (9.45e-2)" "unprognostic (2.69e-2)" "unprognostic (9.95e-3)" "unprognostic (9.21e-2)" "unprognostic (1.05e-2)" "unprognostic (2.27e-1)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "prognostic favorable (3.28e-7)" "unprognostic (4.67e-2)" "unprognostic (4.86e-1)" "unprognostic (2.36e-1)" "unprognostic (7.76e-2)" 2.3 1.0 1.2 5.2 1.8 0.9 7.6 1.2 1.2 4.6 7.7 1.2 7.4 8.5 3.4 7.8 16.6 2.5 8.4 1.3 1.2 0.4 9.0 6.7 4.8 3.2 1.2 1.2 3.0 8.8 7.7 4.3 14.3 2.6 6.6 4.6 4.0 17.7 9.4 1.2 21.1 16.7 2.2 1.7 2.4 6.5 1.4 1.2 1.5 11.6 10.0 4.5 3.4 6.9 3.1 0.2 1.1 0.1 0.0 4.2 0.4 20.7 2.0 0.0 0.0 0.0 0.0 7.1 2.2 1.5 1.0 1.3 7.0 14.1 0.0 6.8 0.9 1.7 9.7 0.8 9.6 1.0 0.0 2.9 0.0 3.2 1.1 2.3 0.0 0.0 3.6 15.6 0.7 7.2 3.2 0.2 0.0 0.0 0.0 0.9 8.6 0.0 0.0 4.5 9.3 3.8 0.8 0.0 0.2 11.5 7.1 0.0 0.0 8.8 8.6 3.7 2.6 5.3 1.3 0.2 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.0 15.3 0.0 0.0 0.0 0.8 0.1 1.3 1.8 2.7 2.1 0.1 3.1 2.7 0.7 1.1 0.0 0.0 0.2 4.2 0.4 1.2 1.8 1.2 1.2 1.2 0.4 1.2 1.2 2.6 1.2 6.0 15.0 0.8 31.5 16.5 0.0 1.1 7.6 18.7 12.5 21.0 3.9 9.2 5.0 12.2 1.3 0.8 44.1 0.0 14.5 11.9 2.3 16.5 0.0 5.9 1.5 0.0 9.2 1.3 0.0 0.4 1.4 0.0 5.0 0.0 15.4 3.4 19.5 42.1 1.4 3.4 2.4 0.0 1.6 0.4 0.9 14.6 11.9 0.5 15.6 36.6 ARID4A "RBBP1, RBP-1, RBP1" ENSG00000032219 "AT-rich interaction domain 4A" P29374 14 58298385-58373887 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048899 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA048899: " "unprognostic (1.57e-1)" "unprognostic (9.39e-2)" "unprognostic (5.17e-2)" "unprognostic (2.69e-1)" "unprognostic (3.70e-2)" "prognostic favorable (1.91e-4)" "unprognostic (2.71e-1)" "prognostic favorable (7.82e-4)" "unprognostic (2.08e-2)" "unprognostic (6.92e-2)" "unprognostic (3.27e-1)" "unprognostic (3.72e-2)" "unprognostic (9.32e-2)" "unprognostic (2.32e-1)" "unprognostic (2.64e-1)" "unprognostic (4.11e-2)" "unprognostic (3.52e-2)" 15.1 8.5 17.3 15.1 22.2 34.5 13.4 45.9 27.0 12.8 12.0 7.9 12.7 10.2 11.6 9.7 10.1 10.7 10.7 10.0 13.3 11.5 11.3 21.7 12.0 15.8 9.6 18.7 15.3 11.4 17.2 22.9 11.3 17.3 10.8 10.6 6.4 10.8 13.5 10.6 13.2 12.3 12.5 11.0 15.3 10.2 7.9 15.0 15.0 12.6 4.5 12.8 13.8 11.9 15.1 7.5 42.7 14.1 10.7 11.1 3.6 6.7 5.7 16.0 7.9 7.9 9.6 8.1 8.1 6.9 5.5 8.7 6.7 10.7 16.3 8.6 6.8 5.3 7.8 7.0 3.9 8.1 11.4 4.5 7.4 6.4 6.4 4.8 15.5 10.7 7.2 4.3 5.3 5.5 8.8 8.7 9.5 8.3 13.5 5.8 9.1 11.2 14.0 3.1 6.6 6.9 11.6 13.8 4.8 5.9 12.0 13.8 11.9 13.7 6.9 9.6 8.2 11.8 14.3 12.3 9.4 7.4 7.5 3.7 4.4 3.3 15.0 5.6 9.9 4.7 19.3 7.6 21.7 8.5 7.8 9.5 11.6 10.3 8.8 5.6 15.1 11.1 10.8 42.7 10.7 14.1 7.5 7.2 3.6 17.3 22.2 45.9 27.0 13.3 11.5 9.6 18.7 17.3 15.0 77.4 85.3 20.4 20.9 34.1 91.9 45.6 15.3 8.1 40.9 26.2 49.1 16.0 16.6 19.0 13.5 41.6 29.5 23.3 19.0 18.3 27.2 20.2 63.6 37.6 29.9 106.5 21.9 33.2 40.4 5.3 33.6 50.9 25.3 68.5 30.9 64.2 20.9 36.8 33.9 11.9 63.2 19.4 25.5 37.6 24.7 29.2 17.0 54.9 29.8 15.5 ARID4B "BCAA, BRCAA1, RBP1L1, SAP180" ENSG00000054267 "AT-rich interaction domain 4B" Q4LE39 1 235131634-235328219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027205, HPA027333" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoplasm "HPA027205: , HPA027333: AB_1845013" "unprognostic (2.62e-1)" "unprognostic (2.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-3)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.30e-2)" "unprognostic (1.03e-1)" "unprognostic (5.69e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (1.42e-2)" "unprognostic (1.25e-1)" "unprognostic (3.52e-2)" "unprognostic (8.84e-3)" 15.3 13.8 14.9 19.0 22.5 34.1 15.9 32.8 17.6 19.7 13.4 19.2 18.2 9.1 18.7 18.1 12.0 15.0 15.2 10.6 15.2 14.5 13.1 14.0 15.5 22.3 26.9 13.9 21.8 16.8 23.8 25.7 14.7 20.3 17.9 10.7 12.0 16.7 17.0 12.3 12.3 14.2 14.6 19.8 19.8 14.7 19.5 23.4 33.7 20.2 8.2 18.9 18.2 18.6 17.1 11.7 35.9 11.8 16.6 17.0 6.0 12.2 9.2 16.2 12.5 11.9 12.5 13.3 14.0 12.3 9.7 9.5 9.5 13.1 14.4 16.3 10.5 6.9 10.9 13.1 5.9 14.1 18.5 14.2 11.6 11.1 7.9 9.1 12.4 17.1 8.4 8.0 11.9 10.2 12.7 13.1 9.2 15.0 20.7 9.1 5.5 18.5 11.3 14.8 8.8 6.1 6.9 11.5 12.0 10.6 10.3 13.2 18.3 17.8 14.8 13.8 4.9 15.6 20.1 18.0 12.0 9.1 14.6 13.6 20.2 16.0 14.4 8.2 9.1 16.0 24.6 7.1 19.5 16.1 7.6 14.7 15.6 17.0 13.7 6.8 17.1 16.9 14.4 35.9 16.6 11.8 11.7 13.6 6.0 14.9 22.5 32.8 17.6 15.2 14.5 26.9 13.9 20.3 23.4 95.3 99.9 54.7 68.9 110.4 111.2 62.2 35.7 91.0 101.2 29.6 113.9 55.7 16.6 62.0 329.6 108.9 41.9 46.7 41.8 58.1 114.7 81.5 105.3 23.1 39.4 106.5 86.4 65.7 52.4 349.2 93.7 99.4 79.2 108.2 45.8 77.7 57.3 49.9 72.9 15.0 150.5 45.3 129.6 212.6 167.8 93.1 131.0 129.6 39.6 111.5 ARMC5 FLJ13063 ENSG00000140691 "Armadillo repeat containing 5" Q96C12 16 31458080-31467166 "Disease related genes, Predicted intracellular proteins" "Cushing syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041524, HPA063706" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA041524: AB_10796676, HPA063706: AB_2685098" "unprognostic (1.37e-1)" "unprognostic (1.68e-3)" "unprognostic (8.22e-3)" "unprognostic (9.96e-2)" "unprognostic (2.59e-1)" "unprognostic (2.94e-3)" "unprognostic (4.09e-2)" "unprognostic (6.14e-3)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" "prognostic favorable (1.97e-6)" "unprognostic (4.70e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" 8.3 8.1 6.6 8.1 11.6 35.3 8.4 13.1 13.6 5.3 5.7 7.8 5.5 9.7 9.1 6.0 8.4 7.1 4.9 6.6 8.4 7.5 6.7 16.1 8.4 7.3 8.9 5.4 8.6 9.3 9.2 9.4 7.3 9.1 7.2 2.9 6.5 10.4 5.8 14.2 13.2 8.3 4.5 5.9 8.6 8.0 6.0 8.9 6.8 9.9 6.8 5.3 5.1 16.8 4.0 10.0 2.8 3.1 9.8 4.9 3.2 2.9 4.7 2.1 3.0 1.3 1.0 5.3 3.9 1.7 2.3 1.9 4.4 3.1 2.9 8.2 2.2 2.3 4.5 2.4 3.5 0.4 4.1 6.0 1.3 7.1 10.1 2.5 8.8 8.9 2.4 4.0 2.3 0.6 2.6 3.5 4.9 6.5 7.1 1.6 7.4 3.3 35.4 3.3 1.3 3.0 5.9 3.0 10.8 1.7 3.5 6.7 5.9 3.6 4.9 2.7 1.3 3.2 10.5 6.5 5.0 3.7 2.0 3.2 6.5 5.6 1.8 3.3 7.4 3.5 2.8 3.1 0.9 4.9 1.6 4.1 4.0 3.8 3.8 4.1 3.5 3.4 3.8 1.8 9.8 1.7 10.0 4.6 3.2 6.6 11.6 13.1 13.6 8.4 7.5 8.9 5.4 9.1 8.9 6.0 14.7 4.5 7.9 5.8 3.9 5.6 10.2 1.4 7.9 0.0 5.9 6.2 3.3 4.7 1.0 8.5 10.3 0.0 4.0 4.6 5.8 5.6 9.2 23.6 5.3 12.7 7.5 6.2 4.8 0.0 4.0 3.0 1.7 2.8 5.2 6.8 3.3 3.6 5.3 3.7 5.2 0.0 6.4 3.9 6.1 5.5 9.6 5.0 3.8 4.8 ARMC8 "DKFZP434A043, GID5, HSPC056, VID28" ENSG00000114098 "Armadillo repeat containing 8" Q8IUR7 3 138187248-138298389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036996, HPA044869" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA036996: AB_10672786, HPA044869: AB_2679123" "unprognostic (2.04e-1)" "unprognostic (1.60e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (3.51e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (8.90e-5)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (7.48e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (3.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.06e-2)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" 19.4 13.5 16.9 14.3 21.9 43.5 14.5 52.6 26.4 17.1 14.4 16.8 9.4 9.9 15.2 10.8 18.0 13.7 13.0 14.4 16.9 20.9 16.6 13.8 13.9 16.3 17.6 16.1 14.3 11.9 20.5 26.1 16.3 26.3 14.5 15.9 12.5 11.9 15.8 34.6 11.8 13.1 20.6 18.7 16.7 14.2 14.7 19.1 21.3 18.2 12.1 18.4 16.9 12.9 25.6 25.4 40.1 23.8 25.3 26.5 19.3 20.4 10.0 13.2 10.7 16.7 14.8 17.8 15.9 15.4 21.8 21.4 15.7 10.9 19.4 16.4 13.6 25.6 10.8 17.0 15.5 27.0 13.0 12.0 34.5 6.6 10.6 21.2 26.7 38.7 22.0 9.9 14.0 20.2 11.9 17.0 17.0 12.8 11.0 27.0 18.0 18.7 12.6 18.3 15.5 8.8 14.7 21.3 15.4 14.3 19.1 15.4 11.2 22.8 7.9 13.2 18.0 15.7 14.1 18.4 11.7 9.5 15.4 11.6 21.2 16.2 29.7 10.5 12.8 11.5 32.3 22.1 40.1 22.8 23.8 26.0 25.6 21.0 24.0 25.4 22.0 24.6 24.4 15.6 25.3 23.5 11.2 26.5 19.3 16.9 21.9 52.6 26.4 16.9 20.9 17.6 16.1 26.3 19.1 26.8 13.1 26.2 26.3 27.5 36.5 20.9 20.4 10.7 29.6 12.2 31.4 25.9 10.0 17.4 5.7 22.2 15.9 70.0 12.8 23.2 20.3 19.7 33.6 21.2 20.1 41.3 22.5 23.4 25.0 5.8 28.1 27.7 18.6 15.4 15.1 24.5 11.5 20.4 20.8 23.7 42.0 12.9 28.9 44.1 30.6 24.8 28.5 26.1 16.1 24.0 ARMCX1 "ALEX1, GASP7" ENSG00000126947 "Armadillo repeat containing, X-linked 1" Q9P291 X 101550531-101554700 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 9.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 26.9;ASC TERT1: 24.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;LHCN-M2: 24.4;RH-30: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000268, HPA005685, CAB020695" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "CAB020695: , HPA000268: , HPA005685: AB_10600781" "unprognostic (2.31e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.25e-2)" "unprognostic (2.39e-1)" "unprognostic (2.18e-3)" "unprognostic (2.13e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.32e-5)" "unprognostic (1.02e-1)" "unprognostic (2.85e-2)" "unprognostic (2.20e-3)" "unprognostic (8.77e-2)" "unprognostic (2.12e-2)" "unprognostic (1.09e-2)" 17.5 29.8 13.6 7.4 16.5 2.7 18.9 13.4 21.5 24.4 18.7 9.6 15.9 6.2 27.3 19.0 12.3 16.3 14.8 26.6 13.3 18.4 12.1 3.8 11.6 4.4 13.7 14.6 42.6 10.2 20.1 18.0 12.5 16.4 25.8 7.0 13.0 12.0 21.1 22.7 8.1 7.6 26.3 9.1 11.4 10.0 8.1 10.5 3.5 14.0 11.6 3.3 26.8 29.7 0.2 9.9 0.5 4.3 2.1 3.7 2.1 0.7 0.2 5.6 0.0 26.9 24.2 0.0 8.7 17.2 11.0 27.8 0.0 0.1 0.0 7.5 13.4 12.1 0.7 0.0 1.2 6.2 0.0 0.0 5.0 1.7 0.0 14.2 0.0 0.0 20.2 1.7 8.3 0.0 9.1 6.6 0.0 0.1 0.1 24.4 0.3 0.0 0.0 8.0 0.0 0.0 0.0 30.8 0.0 7.5 0.0 5.5 4.6 0.0 0.1 15.0 1.6 0.9 3.7 8.7 6.7 3.5 19.4 0.1 0.0 0.1 0.0 6.5 0.0 4.1 0.0 4.3 0.5 0.0 3.9 0.7 0.0 0.6 0.3 9.9 0.2 1.5 3.7 0.1 2.1 1.1 5.1 0.9 2.1 13.6 16.5 13.4 19.9 13.3 18.4 13.7 14.6 16.4 10.5 23.8 6.1 0.0 23.8 29.5 26.3 54.8 7.6 5.3 5.7 22.7 5.9 1.4 11.6 14.6 0.3 23.2 0.5 0.0 6.0 2.1 52.1 21.0 24.2 0.4 23.6 20.6 5.2 17.8 9.4 0.9 43.7 11.0 55.6 6.4 1.0 31.1 7.5 0.0 41.8 11.4 13.3 45.3 48.4 1.7 0.7 19.1 2.2 1.0 0.6 7.4 ARMCX3 "ALEX3, GASP6" ENSG00000102401 "Armadillo repeat containing, X-linked 3" Q9UH62 X 101622797-101627843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000325, HPA000967, HPA001530" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349" "unprognostic (1.67e-1)" "unprognostic (2.14e-1)" "unprognostic (5.23e-2)" "unprognostic (8.69e-3)" "unprognostic (1.73e-2)" "unprognostic (1.47e-2)" "unprognostic (9.72e-3)" "unprognostic (2.19e-2)" "unprognostic (4.77e-2)" "unprognostic (6.80e-2)" "unprognostic (3.38e-3)" "unprognostic (2.12e-2)" "prognostic favorable (1.55e-5)" "unprognostic (3.29e-2)" "unprognostic (3.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.55e-2)" 21.0 39.2 26.6 14.8 32.9 8.5 20.5 20.5 36.9 30.6 18.8 21.0 37.1 13.3 26.9 67.8 12.7 17.1 22.0 31.7 28.0 26.6 24.0 17.8 19.1 12.7 27.8 29.6 26.7 38.2 62.0 37.9 28.5 35.4 29.1 14.8 13.6 34.8 31.6 25.5 7.9 13.8 24.6 25.7 24.1 19.0 9.2 22.8 8.2 31.9 17.1 13.7 21.4 21.3 11.6 18.8 25.2 11.8 10.2 14.8 9.4 8.8 6.0 16.4 9.1 37.8 42.2 3.7 19.5 18.8 8.6 24.9 7.1 8.2 3.4 11.2 22.7 17.5 1.7 12.3 7.1 10.5 6.7 7.8 6.3 20.4 10.2 30.0 6.1 15.0 23.3 9.6 10.3 11.1 21.6 16.2 3.8 4.8 30.2 23.3 3.9 5.0 0.2 8.3 16.2 1.3 6.4 21.4 3.0 12.0 3.7 7.6 6.5 9.4 0.6 20.2 23.8 7.1 6.3 22.7 11.4 7.4 25.7 3.8 24.5 6.6 0.0 17.3 4.9 9.6 25.2 11.2 9.5 10.9 11.3 14.8 11.6 10.8 9.5 11.3 7.9 12.2 8.5 4.1 10.2 11.8 18.8 6.6 9.4 26.6 32.9 20.5 36.9 28.0 26.6 27.8 29.6 35.4 22.8 41.7 29.7 51.4 69.7 33.7 60.9 87.7 56.0 14.7 34.2 71.5 55.0 47.1 31.5 41.8 0.5 61.9 17.9 46.7 26.6 17.4 93.4 96.0 76.3 43.1 44.4 58.8 78.9 51.5 46.4 1.1 59.8 60.8 92.8 22.6 46.0 98.2 30.2 24.6 68.2 33.5 12.2 32.3 93.7 1.9 0.4 18.7 96.1 34.6 28.6 71.5 ARMCX6 "FLJ20811, GASP10" ENSG00000198960 "Armadillo repeat containing, X-linked 6" Q7L4S7 X 101615118-101618001 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043030, HPA048125" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear membrane" "HPA043030: AB_2678277, HPA048125: AB_2680275" "unprognostic (1.20e-1)" "unprognostic (2.80e-1)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.80e-2)" "unprognostic (1.73e-3)" "unprognostic (1.92e-3)" "unprognostic (4.13e-2)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (3.31e-1)" "unprognostic (3.74e-1)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (7.82e-3)" "unprognostic (2.38e-2)" 15.1 17.2 11.7 12.1 12.1 7.6 12.7 10.9 12.1 18.7 12.0 15.4 22.6 6.7 17.3 25.9 17.3 14.1 12.4 15.6 11.3 12.6 14.1 12.2 11.2 12.1 13.1 10.3 21.3 27.2 23.4 21.0 16.3 13.1 17.7 9.0 11.8 39.2 23.5 6.5 11.3 10.4 17.1 16.7 22.6 10.6 9.0 11.4 17.9 17.3 9.7 19.3 18.8 13.7 12.8 14.1 10.0 7.0 8.1 8.7 6.4 6.6 7.9 12.4 7.0 25.4 15.1 2.4 14.1 13.7 12.6 24.7 4.8 6.5 7.1 14.4 13.2 13.2 7.0 12.0 5.7 9.9 6.1 7.3 6.7 11.0 6.3 11.7 6.5 8.4 9.4 5.8 7.7 4.0 17.6 12.8 3.7 5.5 9.2 18.9 16.4 9.5 0.0 8.9 8.7 1.6 9.8 16.6 2.6 9.1 0.9 6.8 6.4 8.2 0.0 10.5 9.9 5.8 3.1 9.9 15.4 6.9 21.4 3.2 11.4 6.1 0.0 4.6 1.7 5.0 10.0 3.8 6.3 6.5 7.0 8.7 12.8 7.0 7.3 8.1 9.1 8.4 7.8 0.5 8.1 5.0 14.1 3.9 6.4 11.7 12.1 10.9 12.1 11.3 12.6 13.1 10.3 13.1 11.4 8.9 7.8 28.4 14.8 11.8 4.8 8.1 12.7 1.4 6.8 29.6 15.7 31.9 19.9 36.6 0.4 25.1 3.1 0.0 24.2 14.6 30.1 15.7 13.9 13.4 60.4 9.5 15.7 23.4 19.6 1.3 17.3 28.6 35.4 30.7 15.5 28.2 25.6 14.0 18.7 17.2 4.1 25.8 15.6 2.6 2.2 14.1 28.8 33.1 13.8 15.9 ARMT1 "C6orf211, FLJ12910" ENSG00000146476 "Acidic residue methyltransferase 1" Q9H993 6 151452258-151470101 "Predicted intracellular proteins" "DNA damage" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003004, HPA005819" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 3200000 "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA003004: AB_1078358, HPA005819: AB_1845741" "unprognostic (5.16e-3)" "prognostic unfavorable (7.09e-4)" "prognostic favorable (4.14e-4)" "unprognostic (6.39e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (1.37e-2)" "unprognostic (9.47e-2)" "unprognostic (2.33e-2)" "unprognostic (2.16e-1)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.16e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-2)" "unprognostic (4.12e-1)" "unprognostic (1.22e-1)" 15.5 15.8 10.7 11.5 16.2 3.9 20.5 17.5 18.2 13.7 12.8 7.5 9.9 14.7 13.0 13.4 11.5 10.6 9.0 13.4 11.4 13.0 34.7 33.2 15.4 15.0 10.9 8.6 15.3 7.7 7.7 13.8 26.7 18.6 11.6 14.2 9.2 8.8 10.6 14.9 7.0 16.2 11.8 10.6 16.2 10.9 10.8 9.4 13.2 26.5 11.9 14.0 14.1 10.6 9.6 12.3 26.9 18.6 10.8 13.2 10.8 8.2 6.3 13.3 11.9 10.9 17.2 21.5 15.5 13.5 13.0 17.3 16.4 6.8 12.3 10.4 10.9 11.9 8.4 39.3 11.6 22.0 13.6 12.3 8.9 7.5 19.0 13.6 16.6 11.2 13.8 8.2 17.4 10.3 10.8 18.4 9.3 12.7 15.9 16.2 34.3 10.4 16.0 22.7 8.1 5.3 13.8 11.5 9.7 39.8 10.5 5.5 3.6 12.9 12.2 7.9 24.9 34.6 13.1 15.2 6.4 8.9 23.5 12.3 7.4 9.3 14.7 11.3 20.6 7.4 22.8 14.7 26.9 7.8 18.6 10.3 9.6 10.2 8.3 12.3 7.1 9.5 8.7 12.2 10.8 16.6 4.6 13.2 10.8 10.7 16.2 17.5 18.2 11.4 13.0 10.9 8.6 18.6 9.4 23.8 36.8 8.9 7.0 0.0 8.9 16.5 7.6 20.1 11.4 22.7 7.9 26.6 38.1 17.4 0.9 7.7 12.9 23.3 15.6 32.5 8.4 5.6 3.5 43.3 30.5 7.9 4.7 17.2 35.4 2.3 17.8 24.7 0.0 31.5 10.6 14.5 16.3 7.0 13.8 56.4 19.8 0.0 13.7 18.9 17.0 0.0 30.1 12.8 13.8 8.4 ARRB2 "ARR2, BARR2, DKFZp686L0365" ENSG00000141480 "Arrestin beta 2" P32121 17 4710489-4721499 "Predicted intracellular proteins" "Protein transport, Transport" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 102.8;lymphoid tissue: 66.6" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 226.1;Kupffer cells: 213.1;Macrophages: 203.0;monocytes: 348.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 42.4;HMC-1: 71.5;NB-4: 43.0;U-937: 61.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075177 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA075177: " "unprognostic (1.12e-1)" "prognostic favorable (2.93e-5)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" "unprognostic (7.43e-2)" "unprognostic (3.37e-2)" "unprognostic (2.62e-3)" "unprognostic (3.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.58e-1)" "unprognostic (1.66e-3)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.32e-2)" "unprognostic (8.61e-2)" "unprognostic (4.92e-2)" "unprognostic (1.49e-1)" "unprognostic (1.88e-1)" 21.6 15.6 23.7 47.8 18.3 102.8 10.0 28.1 26.3 8.7 16.1 20.4 1.9 23.0 7.4 7.8 7.1 10.8 14.8 10.2 27.3 20.9 10.5 15.6 35.0 31.3 20.1 19.6 8.7 8.3 6.6 10.2 16.0 19.7 7.4 13.2 10.7 8.7 6.2 5.5 5.8 21.0 13.7 21.7 66.6 12.5 5.0 18.3 23.5 6.4 3.2 17.0 15.7 7.1 2.2 18.0 52.9 32.8 5.9 11.4 16.0 3.7 19.9 7.8 7.5 1.5 2.2 4.1 2.9 4.0 8.7 10.9 6.8 3.1 10.4 2.7 2.2 4.2 6.3 12.9 4.1 9.0 24.8 18.8 42.4 10.1 12.0 2.3 18.8 71.5 2.0 5.3 10.7 4.3 5.7 6.6 19.7 2.8 10.5 1.9 6.6 18.8 43.0 4.2 10.0 4.1 22.2 6.9 11.6 3.0 2.0 8.1 11.2 6.6 11.5 5.1 3.4 5.5 8.9 5.7 3.3 6.6 5.6 11.1 4.4 5.9 5.9 8.7 61.3 4.8 22.6 30.4 52.5 11.0 31.5 7.8 2.2 7.1 11.4 18.0 1.9 6.8 9.0 52.9 5.9 32.8 4.4 6.0 16.0 23.7 18.3 28.1 26.3 27.3 20.9 20.1 19.6 19.7 18.3 20.8 44.9 18.5 7.0 10.2 17.4 8.1 10.2 8.1 18.2 3.5 2.0 4.8 13.3 8.8 0.4 9.2 10.3 0.0 6.2 9.4 8.1 3.9 91.4 12.1 226.1 20.6 8.1 19.6 213.1 1.8 4.6 203.0 10.1 348.1 14.3 4.7 7.6 17.3 4.6 12.9 7.5 19.4 5.4 0.5 11.8 7.3 5.0 76.9 11.9 10.5 ASB2 ASB-2 ENSG00000100628 "Ankyrin repeat and SOCS box containing 2" Q96Q27 14 93934153-93976791 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 96.9" "Cell type enhanced" "Detected in some" 17 "Cardiomyocytes: 40.8;Early spermatids: 26.4;Late spermatids: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 8 "eosinophil: 23.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.1" "Cell line enhanced" "Detected in some" "Karpas-707: 8.8;RPMI-8226: 8.0;U-266/70: 24.0;U-266/84: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001546 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA001546: AB_1078224" "unprognostic (5.65e-4)" "unprognostic (8.19e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.62e-6)" "unprognostic (4.11e-2)" "unprognostic (1.61e-1)" "unprognostic (5.29e-2)" "unprognostic (1.05e-3)" "unprognostic (4.25e-2)" "unprognostic (1.48e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (2.49e-7)" "unprognostic (2.51e-3)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.27e-1)" 3.1 0.5 0.2 7.9 0.8 0.4 0.5 0.2 1.7 7.4 14.0 0.0 4.6 2.2 11.9 5.7 7.2 6.5 7.7 17.2 0.2 0.2 0.3 0.3 0.8 2.3 0.3 0.6 2.3 0.3 0.3 0.2 0.3 0.5 8.5 1.5 1.5 1.6 5.8 96.9 0.5 4.4 24.4 0.3 1.5 5.0 0.3 0.0 0.0 0.7 25.7 4.7 14.3 4.5 0.9 2.6 23.1 3.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 24.0 5.3 0.8 0.2 2.5 0.5 0.0 0.0 23.1 0.8 1.0 0.1 0.9 0.8 1.7 2.6 0.2 0.1 0.2 0.0 0.0 3.0 0.1 1.1 0.5 0.2 0.8 0.2 1.7 0.2 0.2 0.3 0.6 0.5 0.0 0.0 0.0 1.4 0.0 0.3 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 26.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 20.6 0.3 1.0 1.7 9.0 0.0 0.9 0.3 0.0 0.4 0.0 1.1 0.0 3.1 0.9 5.9 0.1 2.4 6.9 0.0 0.1 ASB7 ENSG00000183475 "Ankyrin repeat and SOCS box containing 7" Q9H672 15 100602534-100651705 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003300 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA003300: AB_1845071" "unprognostic (1.38e-1)" "unprognostic (3.48e-2)" "unprognostic (3.91e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.82e-1)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" 8.6 8.9 8.9 15.5 11.9 20.2 10.2 12.7 10.2 10.3 12.1 8.1 13.5 8.3 11.6 12.5 10.0 10.9 9.5 7.0 10.4 8.3 12.5 12.1 8.8 12.9 10.6 6.7 11.2 11.0 13.7 11.8 14.0 9.4 10.1 11.8 7.6 10.3 11.3 8.0 9.5 15.5 11.2 9.7 10.4 8.3 13.8 9.2 21.2 11.5 9.6 11.1 11.6 9.2 6.6 7.0 13.6 8.0 5.5 9.4 6.3 6.2 14.0 6.4 7.7 8.6 9.3 7.5 7.0 12.6 11.6 12.2 8.4 12.8 10.3 6.4 8.9 11.5 14.1 8.9 9.0 12.2 7.2 9.6 13.7 9.3 8.3 13.0 8.0 12.1 8.9 10.1 9.5 15.7 11.2 10.7 11.4 8.0 8.7 6.6 6.8 6.2 8.1 6.1 14.1 6.8 8.5 14.0 8.5 11.5 14.2 6.4 9.2 10.7 10.5 14.4 12.8 7.4 10.1 8.1 10.3 9.6 7.1 9.7 10.5 21.6 9.9 7.9 7.4 8.0 1.7 8.0 13.6 7.6 6.5 6.1 6.3 6.7 9.3 7.0 6.6 9.4 6.7 7.3 5.5 4.1 4.5 7.7 6.3 8.9 11.9 12.7 10.2 10.4 8.3 10.6 6.7 9.4 9.2 0.0 4.8 3.2 2.1 5.8 4.0 3.4 10.2 9.4 6.8 3.5 5.9 3.1 1.7 5.3 1.7 3.7 8.4 0.0 4.3 2.1 3.3 4.3 10.4 6.8 5.0 12.7 8.1 6.2 6.3 1.7 4.6 4.8 3.3 2.8 6.6 3.3 4.6 8.2 4.9 6.2 4.6 0.0 3.5 8.9 6.1 4.0 4.9 6.1 5.5 4.7 ASCC2 "ASC1p100, DKFZp586O0223, FLJ21588" ENSG00000100325 "Activating signal cointegrator 1 complex subunit 2" Q9H1I8 22 29788608-29838304 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 128.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001439, HPA052879" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites, Cytosol" Nucleoplasm "HPA001439: AB_1078229, HPA052879: AB_2732577" "unprognostic (1.70e-1)" "unprognostic (1.02e-2)" "unprognostic (8.58e-2)" "unprognostic (3.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.45e-3)" "unprognostic (3.01e-3)" "unprognostic (1.16e-1)" "unprognostic (1.35e-1)" "unprognostic (5.39e-2)" "unprognostic (1.56e-2)" "unprognostic (1.24e-1)" "unprognostic (3.97e-3)" "unprognostic (5.19e-2)" "unprognostic (7.53e-2)" "unprognostic (3.81e-1)" "unprognostic (2.05e-3)" 19.5 24.2 13.1 22.1 15.1 32.3 23.1 13.4 14.0 16.8 16.9 17.9 22.5 16.5 17.1 17.7 31.1 14.6 19.0 17.7 10.8 8.2 15.8 35.3 19.2 20.2 15.4 9.1 16.2 18.4 17.5 20.6 23.2 12.5 20.1 17.8 17.6 22.2 30.9 50.0 21.7 22.3 14.2 12.9 22.7 25.8 41.0 13.0 28.9 21.9 25.0 26.6 19.1 21.2 11.3 21.1 28.5 27.6 17.3 18.8 10.9 19.7 11.5 12.5 16.9 18.8 16.7 18.0 20.6 15.9 21.4 21.5 13.4 10.7 19.7 14.9 19.8 13.6 24.0 16.0 23.4 18.1 25.2 28.0 16.9 14.6 16.0 23.6 30.3 51.5 17.9 21.3 24.3 22.4 12.6 18.7 13.3 17.4 19.2 19.3 24.4 18.5 16.0 9.1 27.9 15.7 22.4 15.4 20.6 13.1 32.7 19.4 17.1 19.1 21.1 15.3 13.4 15.0 15.9 18.4 30.0 5.1 18.1 20.3 23.0 17.5 23.4 17.5 17.0 21.6 18.2 16.7 28.5 18.8 27.6 16.8 11.3 14.2 15.8 21.1 8.9 14.7 14.8 5.1 17.3 22.5 12.0 16.4 10.9 13.1 15.1 13.4 14.0 10.8 8.2 15.4 9.1 12.5 13.0 17.9 14.3 24.0 18.4 26.7 9.0 16.5 25.5 18.7 18.2 38.4 3.9 37.6 10.0 24.0 92.7 20.5 38.5 23.3 21.6 52.8 23.3 15.9 34.6 23.2 27.5 4.8 14.9 17.8 24.8 128.4 28.7 33.0 27.0 22.6 17.2 11.8 22.4 24.6 23.3 15.2 13.6 19.4 16.0 39.1 19.2 34.4 37.1 35.9 20.3 30.8 ASPSCR1 "ASPL, ASPS, TUG, UBXD9, UBXN9" ENSG00000169696 "ASPSCR1, UBX domain containing tether for SLC2A4" Q9BZE9 17 81976807-82017406 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 151.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "Hep G2: 82.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026749 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA026749: AB_1845114" "unprognostic (5.01e-2)" "unprognostic (1.19e-3)" "unprognostic (7.61e-2)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "prognostic favorable (8.55e-4)" "unprognostic (2.02e-1)" "unprognostic (2.07e-2)" "unprognostic (3.43e-1)" "unprognostic (1.71e-3)" "prognostic favorable (2.67e-4)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (3.16e-2)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (1.01e-2)" 10.3 12.6 14.3 12.6 14.5 16.8 10.6 16.5 20.8 9.9 12.9 16.7 11.8 17.5 10.1 15.8 11.9 9.3 15.1 11.5 13.1 12.6 15.8 31.9 14.1 14.8 18.9 12.9 8.8 17.8 17.0 19.7 21.8 14.8 13.2 7.1 14.4 22.6 9.9 25.1 15.5 14.4 9.1 12.6 13.2 13.0 16.9 14.6 9.8 16.4 12.9 13.0 9.7 8.3 8.1 14.6 15.7 11.3 7.2 10.5 5.2 5.1 9.0 3.5 5.1 2.2 2.8 15.3 4.9 3.7 5.9 5.8 5.2 5.9 5.2 5.0 3.5 4.5 2.5 3.8 3.7 1.8 3.6 11.5 5.8 7.3 82.6 7.3 5.1 8.5 3.2 4.0 2.9 2.1 3.1 5.6 4.4 5.8 7.5 3.3 17.3 4.7 11.1 4.4 9.5 6.6 5.2 5.1 10.6 5.7 4.7 9.4 9.6 3.9 12.6 9.0 4.2 7.5 12.2 4.6 10.1 7.0 7.4 6.1 5.4 3.2 5.8 5.4 5.2 6.0 15.7 11.3 8.0 6.7 7.6 4.0 7.9 10.5 9.0 14.6 8.1 8.0 6.0 2.9 7.2 9.3 9.1 4.9 5.2 14.3 14.5 16.5 20.8 13.1 12.6 18.9 12.9 14.8 14.6 8.9 46.0 18.6 20.7 11.8 21.4 11.4 17.8 10.7 9.1 14.0 39.3 64.7 33.2 21.2 40.2 16.0 26.7 0.0 22.9 151.3 16.6 19.3 20.8 45.6 39.1 47.7 24.0 15.4 16.6 63.2 10.9 17.1 18.6 18.0 24.4 56.7 16.2 20.1 16.6 44.0 32.8 12.9 15.3 43.6 48.7 12.5 49.7 23.6 23.8 19.7 ASRGL1 "ALP, ALP1, FLJ22316" ENSG00000162174 "Asparaginase like 1" Q7L266 11 62337448-62393412 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.4;cervix, uterine: 68.7;testis: 57.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 275.4;Late spermatids: 421.8;Spermatocytes: 320.2" "Cancer enhanced" "Detected in all" "endometrial cancer: 53.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 51.4;eosinophil: 52.4" "Group enriched" "Detected in many" 4 "granulocytes: 52.4;monocytes: 14.2" "Cell line enhanced" "Detected in many" "EFO-21: 30.5;HAP1: 29.4;RPTEC TERT1: 26.0;SCLC-21H: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029725, HPA055572, CAB070192" Enhanced Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" NA NA Microtubules "Nucleoplasm, Cytokinetic bridge" "CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854" "unprognostic (1.14e-1)" "unprognostic (8.38e-3)" "prognostic favorable (6.14e-4)" "prognostic favorable (1.56e-5)" "unprognostic (5.35e-2)" "unprognostic (8.19e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (8.67e-2)" "unprognostic (1.85e-1)" "unprognostic (3.54e-2)" "unprognostic (2.71e-1)" "unprognostic (4.44e-1)" "prognostic favorable (4.32e-7)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (5.43e-3)" "unprognostic (1.40e-1)" 3.6 2.6 27.8 3.8 37.0 7.1 4.6 12.3 22.3 68.7 7.9 9.9 2.0 4.1 15.3 7.9 1.4 36.8 9.5 1.7 19.5 19.0 23.8 2.4 6.6 3.3 30.8 11.8 1.6 5.1 1.5 5.7 2.3 16.4 8.6 9.9 4.9 6.4 4.8 2.3 1.2 3.1 3.0 9.6 2.4 5.6 57.6 11.3 2.8 3.7 0.0 3.0 2.9 1.0 0.5 8.2 52.4 14.2 2.5 0.7 4.9 0.8 6.7 7.4 9.6 0.0 0.0 5.8 0.8 0.3 1.3 1.2 11.0 3.0 0.7 30.5 0.1 3.3 0.6 29.4 0.3 1.5 1.1 12.1 0.4 9.1 8.0 0.2 8.1 11.0 0.3 0.1 0.6 0.1 0.4 13.8 16.7 8.2 7.6 0.3 12.8 21.8 5.4 10.1 4.6 5.3 8.9 4.4 4.1 26.0 2.1 40.1 5.7 5.7 9.9 4.9 8.0 5.3 4.1 0.7 0.1 5.6 0.4 3.3 11.7 11.1 1.0 0.3 4.2 3.4 51.4 14.2 52.4 0.6 10.3 0.4 0.5 0.2 0.7 8.2 0.4 0.5 0.7 3.3 2.5 7.2 1.4 0.1 4.9 27.8 37.0 12.3 22.3 19.5 19.0 30.8 11.8 16.4 11.3 6.0 26.7 10.4 1.9 3.1 21.7 1.6 53.5 1.4 3.4 21.0 31.4 1.4 112.7 25.5 275.4 23.3 4.1 0.0 19.3 1.8 3.8 54.4 76.5 2.6 22.5 15.9 45.3 31.9 9.1 421.8 8.1 27.7 1.7 0.0 35.8 78.6 8.8 5.8 6.7 99.6 37.4 12.9 2.3 320.2 48.6 1.1 0.7 6.9 26.0 5.3 ATG13 KIAA0652 ENSG00000175224 "Autophagy related 13" O75143 11 46617527-46674818 "Cancer-related genes, Predicted intracellular proteins, Transporters" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039350 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA039350: AB_10673142" "unprognostic (3.66e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-1)" "unprognostic (5.36e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.59e-5)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (7.57e-2)" "unprognostic (2.44e-2)" "unprognostic (2.41e-1)" "unprognostic (2.14e-1)" "unprognostic (7.68e-2)" "unprognostic (3.47e-1)" 13.8 15.8 20.2 11.9 27.3 25.8 12.5 32.8 37.0 13.2 12.6 39.5 9.2 14.3 12.9 16.8 14.9 16.6 14.5 17.8 19.5 16.3 14.3 21.1 11.5 13.6 31.8 18.2 15.6 19.7 24.4 23.1 13.5 27.2 12.8 12.0 21.3 17.0 13.5 20.9 16.3 12.4 12.3 15.7 16.2 16.5 60.6 34.9 14.8 18.6 8.8 15.8 12.5 13.0 15.8 20.0 38.9 24.0 17.0 24.7 20.3 13.8 25.5 19.6 11.5 27.3 32.1 19.8 16.2 28.7 20.0 25.7 17.3 13.9 13.0 11.5 24.4 26.0 17.0 18.8 21.9 20.3 24.6 35.9 14.0 17.8 30.4 30.7 18.6 24.3 38.6 26.2 13.8 30.5 28.6 19.7 30.4 24.4 29.8 17.9 20.8 18.5 27.6 24.5 25.5 22.1 17.7 25.4 22.8 13.4 15.3 18.7 18.8 22.4 18.0 23.9 19.7 25.7 38.5 19.4 24.7 15.1 22.7 17.6 27.2 30.1 16.5 30.6 16.9 18.1 21.2 20.7 26.9 21.3 24.0 17.2 15.8 19.2 16.8 20.0 12.7 16.6 18.3 38.9 17.0 18.7 14.9 24.7 20.3 20.2 27.3 32.8 37.0 19.5 16.3 31.8 18.2 27.2 34.9 14.9 15.2 10.4 10.0 8.2 22.0 12.4 5.1 2.7 10.3 12.2 37.3 8.7 6.6 16.3 35.8 11.7 19.0 46.7 28.1 18.9 8.4 17.1 8.1 19.4 13.5 31.8 17.2 12.9 15.2 36.4 10.6 13.5 11.8 22.6 19.5 15.2 26.0 12.2 10.6 11.2 29.7 12.9 13.7 31.1 10.4 10.0 22.1 10.9 10.4 14.3 ATG7 "APG7L, DKFZp434N0735, GSA7" ENSG00000197548 "Autophagy related 7" O95352 3 11272309-11557665 "Predicted intracellular proteins, Transporters" "Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 78.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 13.1;classical monocyte: 39.7;eosinophil: 24.5;intermediate monocyte: 22.9;myeloid DC: 23.8;neutrophil: 31.3;non-classical monocyte: 16.3" "Group enriched" "Detected in all" 5 "dendritic cells: 23.8;granulocytes: 31.3;monocytes: 39.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007639, CAB018771" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 13000 Cytosol "Nucleoplasm, Plasma membrane" "CAB018771: AB_2062165, HPA007639: AB_1845162" "unprognostic (3.97e-2)" "unprognostic (2.83e-2)" "prognostic favorable (9.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.79e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.82e-1)" "unprognostic (2.40e-1)" "unprognostic (1.80e-3)" "unprognostic (2.30e-2)" "unprognostic (2.67e-1)" "prognostic favorable (9.55e-4)" "unprognostic (1.61e-1)" "unprognostic (3.65e-2)" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" 27.0 18.6 14.8 21.1 21.9 37.5 16.6 14.1 29.2 16.4 15.2 26.2 13.4 11.6 28.9 15.9 18.9 17.4 15.1 12.3 14.0 13.1 13.1 11.8 18.4 18.8 14.8 17.1 15.5 13.1 18.7 23.0 18.7 21.6 12.9 17.8 19.3 16.6 11.6 15.8 22.2 16.9 18.3 16.6 19.7 13.1 19.7 13.9 17.7 12.7 12.2 21.6 16.5 15.2 4.0 23.8 31.3 39.7 5.9 4.8 14.2 18.4 14.6 6.5 3.4 11.5 15.2 32.4 17.4 22.7 17.4 20.3 6.2 16.8 8.5 10.6 15.4 18.1 5.7 7.2 24.4 30.0 7.5 9.1 6.1 14.1 7.4 15.2 17.6 20.3 15.6 11.3 33.7 21.2 18.0 24.0 5.4 9.0 7.0 24.1 12.0 5.0 8.2 5.1 8.5 18.9 6.3 7.8 7.5 13.1 13.3 5.8 5.7 12.4 10.5 6.7 8.4 11.4 17.2 16.3 14.3 10.4 9.4 24.3 4.5 11.7 14.3 23.2 16.6 19.3 13.1 39.7 24.5 4.8 22.9 3.7 4.0 4.0 4.5 23.8 3.7 3.5 4.2 31.3 5.9 16.3 4.2 3.4 14.2 14.8 21.9 14.1 29.2 14.0 13.1 14.8 17.1 21.6 13.9 0.0 9.8 6.1 6.1 9.8 11.1 3.9 0.0 12.0 5.7 7.0 17.7 13.7 6.6 10.0 41.0 10.5 6.9 23.3 11.3 14.0 8.9 5.5 14.9 7.8 50.1 19.1 10.9 20.9 20.3 78.6 9.5 19.9 3.3 9.0 7.0 9.3 12.7 7.0 9.2 5.4 12.5 6.5 5.1 19.5 11.5 6.8 16.0 10.0 7.3 7.3 ATOH1 "bHLHa14, HATH1, MATH-1, Math1" ENSG00000172238 "Atonal bHLH transcription factor 1" Q92858 4 93828753-93830964 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "intestine: 29.5" "Cell type enriched" "Detected in some" 36 "Mucus-secreting cells: 198.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.7;HL-60: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA049400 Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA049400: " "prognostic favorable (3.26e-5)" "unprognostic (5.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.70e-1)" 0.0 0.0 0.1 6.4 0.1 0.0 0.1 0.1 0.1 0.1 22.5 0.0 0.0 8.8 0.1 0.0 0.1 0.1 2.7 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 15.0 0.0 0.1 0.0 0.0 0.1 29.5 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.2 0.5 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 198.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 ATP6V1A "ATP6A1, ATP6V1A1, VA68, Vma1, VPP2" ENSG00000114573 "ATPase H+ transporting V1 subunit A" P38606 3 113747019-113812056 "Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Translocase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 467.9;Late spermatids: 569.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.6" "Group enriched" "Detected in all" 6 "dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006910, HPA035084" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA 2700000 "Vesicles, Cytosol" Nucleoplasm "CAB006910: , HPA035084: AB_2674454" "unprognostic (1.32e-1)" "unprognostic (8.68e-2)" "unprognostic (5.87e-2)" "unprognostic (4.70e-2)" "unprognostic (1.36e-1)" "unprognostic (2.00e-1)" "unprognostic (3.43e-2)" "unprognostic (2.90e-2)" "unprognostic (1.42e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-2)" "unprognostic (5.19e-3)" "prognostic favorable (3.82e-12)" "unprognostic (8.82e-2)" "unprognostic (2.46e-3)" "unprognostic (2.43e-1)" "unprognostic (1.52e-2)" 12.8 19.8 24.1 10.4 33.2 7.4 12.7 34.8 52.8 14.0 11.1 10.3 5.6 9.3 7.5 8.2 13.2 10.0 10.8 4.7 26.2 38.2 47.9 18.2 12.3 11.4 25.4 25.0 6.2 10.5 39.3 13.5 12.3 52.0 11.2 11.8 14.7 18.0 8.4 4.5 12.6 7.9 8.2 13.6 13.7 10.9 8.9 8.3 9.6 21.0 5.7 13.6 10.2 8.2 3.8 16.4 33.6 15.4 3.8 3.4 6.0 25.4 11.6 14.6 12.7 30.9 13.8 15.6 13.8 21.1 14.5 20.1 21.8 20.5 20.9 32.9 20.1 16.1 16.6 33.0 18.2 19.1 9.5 9.1 18.5 18.0 16.8 25.5 13.6 21.7 18.6 12.6 18.8 13.2 22.6 23.6 10.6 21.1 15.8 21.5 16.7 9.9 6.1 18.3 17.8 14.6 8.6 10.6 23.7 39.8 24.3 28.3 10.4 24.2 16.5 18.1 21.0 25.0 11.0 21.7 13.6 10.1 9.3 8.2 16.6 17.8 19.3 26.6 17.2 15.0 9.2 15.4 5.2 2.8 11.7 2.6 3.8 2.6 2.7 16.4 2.9 2.5 2.9 33.6 3.8 9.5 4.6 3.4 6.0 24.1 33.2 34.8 52.8 26.2 38.2 25.4 25.0 52.0 8.3 26.8 28.3 28.9 13.2 27.0 92.7 7.9 33.1 14.7 19.4 94.2 39.3 18.1 69.6 25.2 467.9 26.0 24.0 0.0 23.9 18.8 17.8 28.2 10.4 64.4 67.8 95.3 53.6 36.2 95.4 569.6 16.7 67.0 43.9 49.5 25.8 42.1 22.3 24.6 21.5 62.8 37.3 6.5 14.6 25.3 14.3 41.9 36.7 17.1 21.3 21.1 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2" "Group enriched" "Detected in many" 4 "Early spermatids: 23.4;granulocytes: 19.6;Hofbauer cells: 12.9;Kupffer cells: 29.9;Late spermatids: 19.9;Macrophages: 17.3;T-cells: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 6.9;NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 19.1;NB-4: 7.3;THP-1: 12.3;U-937: 38.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040254 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 2.3 1.2 1.6 1.5 2.1 28.1 1.0 0.6 0.9 26.0 1.5 1.7 1.6 0.4 18.2 3.5 0.6 9.5 3.1 0.8 2.5 0.9 1.0 1.2 3.2 0.7 2.7 0.1 3.9 0.4 0.2 1.1 2.9 2.1 0.7 1.2 0.8 0.9 0.6 0.4 0.5 1.1 2.7 3.1 2.3 0.6 0.9 4.6 0.8 0.5 0.8 2.1 1.3 1.5 0.0 2.2 6.9 1.7 10.6 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 5.2 0.0 3.0 0.6 0.0 0.0 5.3 19.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 38.5 0.0 6.9 1.7 2.4 0.5 0.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.8 10.6 0.3 0.0 0.0 0.8 1.6 2.1 0.6 0.9 2.5 0.9 2.7 0.1 2.1 4.6 0.0 3.4 1.3 0.1 1.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 23.4 0.5 0.4 0.0 0.0 1.6 3.3 0.5 19.6 2.8 12.9 0.0 0.0 1.8 29.9 19.9 1.7 17.3 1.7 1.0 0.3 0.5 0.0 0.0 0.7 0.8 0.0 0.0 4.3 0.4 0.6 0.3 2.4 8.6 0.0 0.1 ATXN1 "ATX1, D6S504E, SCA1" ENSG00000124788 "Ataxin 1" P54253 6 16299112-16761491 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008335, HPA070756" Approved Supported Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA008335: AB_1845129, HPA070756: AB_2686306" "unprognostic (1.01e-1)" "unprognostic (4.77e-2)" "unprognostic (1.23e-1)" "unprognostic (5.64e-3)" "unprognostic (4.54e-1)" "unprognostic (1.95e-2)" "unprognostic (7.74e-2)" "unprognostic (4.51e-2)" "unprognostic (4.06e-1)" "unprognostic (1.11e-2)" "unprognostic (3.87e-2)" "unprognostic (2.69e-2)" "unprognostic (1.41e-3)" "unprognostic (1.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (3.29e-3)" 8.1 9.1 17.7 11.9 25.1 5.5 9.1 33.7 29.5 14.8 13.5 12.9 10.3 8.2 20.5 9.8 11.1 11.0 12.1 11.8 18.0 11.0 9.1 10.1 14.8 11.6 21.1 17.7 10.7 10.3 18.4 11.6 10.3 16.4 14.2 8.5 9.8 8.4 14.0 26.3 12.0 8.3 19.1 16.1 11.4 10.3 8.1 25.6 4.6 11.8 12.5 7.4 11.7 11.3 0.4 0.8 4.4 1.7 0.1 2.5 0.8 3.4 2.0 0.7 0.0 3.5 4.8 4.6 3.7 8.7 2.3 2.7 2.1 2.2 0.1 5.0 7.1 3.0 3.2 0.2 2.3 3.3 1.9 3.6 0.5 3.2 6.7 5.7 3.2 5.6 3.7 4.5 4.8 4.1 8.9 4.6 0.7 0.0 4.1 1.9 1.7 0.2 3.6 0.7 1.1 3.3 0.2 4.6 3.0 3.1 5.8 0.2 2.0 3.4 4.3 7.0 7.0 2.8 5.5 7.0 3.2 4.9 3.7 3.3 24.3 13.9 0.1 2.0 3.3 7.8 0.7 1.7 0.4 2.5 1.3 1.9 0.4 1.7 2.4 0.8 0.1 0.2 1.5 4.4 0.1 0.7 0.4 1.3 0.8 17.7 25.1 33.7 29.5 18.0 11.0 21.1 17.7 16.4 25.6 44.7 20.4 14.9 54.4 81.3 39.6 30.2 25.5 22.7 26.1 10.4 94.2 0.3 6.6 15.9 3.6 15.7 12.5 0.0 7.4 3.0 26.7 57.3 38.1 25.3 20.8 36.5 1.2 20.3 33.9 1.8 9.8 33.2 30.4 28.9 12.3 24.2 22.2 13.5 26.5 7.7 108.3 51.8 35.3 0.9 1.3 42.7 0.3 44.9 6.8 52.7 ATXN3 "ATX3, JOS, MJD, SCA3" ENSG00000066427 "Ataxin 3" P54252 14 92044496-92106625 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB021976, HPA024123, HPA069338" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124" "unprognostic (1.06e-2)" "unprognostic (2.93e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-2)" "unprognostic (5.76e-2)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (9.85e-3)" "unprognostic (1.69e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-2)" "unprognostic (3.06e-2)" "unprognostic (2.03e-2)" "unprognostic (8.94e-3)" "unprognostic (4.22e-1)" "unprognostic (1.64e-1)" "unprognostic (1.11e-1)" 17.8 10.3 10.2 9.1 11.6 14.3 12.8 18.7 12.1 16.0 11.8 12.2 11.9 6.4 17.9 12.4 17.7 9.5 11.2 10.4 9.0 9.9 9.9 16.0 12.3 11.6 16.3 9.5 14.0 10.3 11.9 17.2 11.7 13.8 15.8 11.7 8.6 11.4 10.2 6.1 21.0 8.7 20.6 16.5 12.6 9.0 14.8 14.3 16.2 11.5 12.0 15.6 15.4 13.6 9.8 14.5 11.4 18.8 7.0 8.5 5.3 5.6 11.1 10.1 9.3 14.7 14.4 19.7 6.4 10.5 8.2 11.5 8.1 15.7 11.5 12.8 10.5 9.7 9.9 7.7 14.1 18.2 13.1 2.3 4.9 5.4 11.8 12.1 8.6 8.8 11.6 12.6 14.3 15.0 11.0 12.6 12.9 6.5 8.6 12.4 22.0 9.0 7.8 7.1 18.8 9.2 7.2 18.5 6.5 10.5 12.8 3.4 6.0 15.6 6.6 8.8 14.1 12.3 6.1 6.7 8.1 11.9 5.2 3.4 7.5 12.5 10.6 6.0 8.5 4.7 11.4 13.4 9.4 5.9 14.5 7.0 7.1 6.9 6.5 14.5 9.8 7.6 8.5 11.3 7.0 18.8 8.4 6.8 5.3 10.2 11.6 18.7 12.1 9.0 9.9 16.3 9.5 13.8 14.3 14.9 14.3 18.1 26.1 22.6 32.4 17.3 17.8 12.0 12.5 40.1 47.1 17.4 13.3 17.7 18.3 43.4 11.7 0.0 15.0 23.8 25.4 29.1 23.2 19.1 20.8 25.4 15.4 39.3 27.2 18.5 62.7 31.8 21.9 30.7 16.0 20.6 17.6 17.5 61.2 14.6 45.6 45.3 35.8 30.5 60.9 26.5 21.2 23.0 19.4 25.1 AURKA "AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7" ENSG00000087586 "Aurora kinase A" O14965 20 56369389-56392337 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 32.3;testis: 41.1" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.5;granulocytes: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001454, HPA002636" Enhanced Approved Nucleoplasm,Centrosome,Cytosol Yes Yes "Nucleoplasm, Centrosome, Cytosol" "CAB001454: AB_563420, HPA002636: AB_1845217" "unprognostic (7.73e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (9.40e-5)" "unprognostic (1.92e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.69e-3)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.47e-8)" "unprognostic (1.67e-1)" "unprognostic (6.83e-2)" "unprognostic (9.00e-2)" "unprognostic (5.14e-2)" 3.7 2.3 1.5 12.7 1.3 8.3 3.0 1.3 1.8 1.4 6.7 1.3 0.8 7.3 1.8 1.2 7.7 1.1 3.7 4.1 1.1 1.1 2.4 5.1 2.9 12.3 1.6 0.9 8.3 1.4 0.3 0.7 6.1 1.5 1.0 8.3 1.5 2.7 0.5 6.9 2.1 7.2 2.7 1.3 7.4 4.3 41.1 1.1 32.3 1.2 5.9 13.3 2.4 2.4 3.9 5.2 6.0 8.7 2.0 6.6 2.6 33.0 24.4 16.3 11.5 0.9 2.1 20.7 27.1 12.7 65.7 27.7 68.2 23.2 10.8 18.7 11.1 34.1 26.7 29.0 18.2 70.0 9.8 11.1 19.3 25.0 42.5 0.5 25.8 27.2 1.0 1.9 22.7 20.4 5.2 15.3 17.7 21.9 8.6 27.9 33.7 15.4 20.0 14.9 27.1 25.1 11.7 31.5 12.0 10.5 8.7 14.1 7.6 37.9 43.6 18.2 15.6 25.8 16.1 8.8 28.6 28.3 15.8 38.2 12.1 14.0 18.8 15.4 15.0 23.6 0.2 5.3 6.0 1.9 8.7 2.9 3.9 3.3 1.9 5.2 1.4 1.5 1.5 3.7 2.0 4.8 1.2 6.6 2.6 1.5 1.3 1.3 1.8 1.1 1.1 1.6 0.9 1.5 1.1 0.0 3.2 4.5 1.1 1.0 1.0 3.4 2.5 1.4 2.3 3.5 2.0 9.8 1.7 3.9 16.9 1.6 5.3 70.0 4.2 59.5 3.8 0.7 55.2 2.4 14.8 1.6 5.8 3.1 2.4 9.5 1.4 5.5 0.0 18.0 5.7 3.5 3.6 3.5 0.4 1.9 2.5 6.5 2.1 16.2 31.6 1.0 6.9 4.9 9.8 1.4 AXIN2 "DKFZp781B0869, MGC126582" ENSG00000168646 "Axin 2" Q9Y2T1 17 65528563-65561647 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 87.1" "Cancer enhanced" "Detected in all" "colorectal cancer: 33.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 11.8;CACO-2: 22.1;Hep G2: 32.9;OE19: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012283, CAB017783" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB012283: AB_2290204, CAB017783: " "unprognostic (1.31e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.48e-1)" "unprognostic (9.81e-2)" "unprognostic (1.12e-2)" "unprognostic (1.82e-1)" "unprognostic (4.57e-2)" "unprognostic (8.84e-3)" "prognostic favorable (6.58e-4)" "unprognostic (1.98e-1)" "unprognostic (1.42e-1)" "unprognostic (3.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.74e-1)" "unprognostic (1.25e-1)" 7.4 10.1 9.0 7.0 8.9 0.9 5.2 8.2 13.1 16.5 12.2 8.7 10.5 7.2 29.0 7.7 6.5 18.6 6.9 7.3 7.9 5.7 3.5 2.5 15.2 3.4 5.3 10.3 14.7 3.9 3.2 5.8 18.2 10.6 14.8 15.2 7.8 4.6 9.8 12.4 14.9 7.5 18.0 4.8 6.9 14.6 6.8 9.0 27.6 11.3 3.6 3.8 11.8 8.7 4.1 0.0 4.4 0.0 1.9 5.1 0.8 0.0 5.9 11.8 0.2 4.3 1.8 5.2 0.1 0.5 0.4 0.7 22.1 2.1 0.4 0.7 3.4 0.4 0.1 2.4 0.0 0.8 1.0 1.3 0.0 1.0 32.9 0.4 0.0 0.0 1.0 0.9 0.9 0.2 0.7 1.0 2.2 0.0 0.5 0.6 0.1 5.7 0.0 2.3 36.5 0.2 4.1 0.6 0.0 1.1 0.1 3.7 2.4 0.2 0.1 2.0 9.1 0.4 0.1 2.6 2.3 4.3 3.3 0.7 0.0 1.2 1.5 1.1 0.2 1.1 4.4 0.0 0.0 0.3 0.0 0.8 1.0 2.3 0.4 0.0 4.1 5.1 0.8 0.0 1.9 0.0 0.0 0.0 0.8 9.0 8.9 8.2 13.1 7.9 5.7 5.3 10.3 10.6 9.0 0.0 7.0 0.0 1.2 10.0 3.8 8.1 2.5 1.4 10.3 0.0 3.9 14.3 0.0 1.0 27.8 3.8 2.8 0.0 0.7 87.1 17.5 4.1 0.0 1.9 3.3 1.6 5.2 1.3 0.0 11.2 6.1 0.3 16.9 1.8 18.7 3.5 0.7 3.5 10.3 0.6 1.9 12.9 5.9 5.4 12.6 4.8 11.9 0.0 16.8 1.1 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369796-382116 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1;ovary: 18.6" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 17.5;Cardiomyocytes: 11.2;Horizontal cells: 31.8;Muller glia cells: 40.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.2;NTERA-2: 18.0;SCLC-21H: 22.4;SH-SY5Y: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043276, HPA053126" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA No "Nucleoplasm, Cytosol" Vesicles "HPA043276: , HPA053126: AB_2682049" "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 1.6 2.5 20.6 2.8 16.7 1.2 3.5 26.5 35.1 5.9 2.0 8.6 0.8 2.4 8.6 2.4 1.8 8.7 2.1 1.4 17.6 16.8 1.2 1.1 1.3 1.6 11.5 14.9 18.6 1.8 6.3 6.1 1.1 13.0 3.8 1.6 2.3 4.0 3.7 1.1 3.8 2.9 3.1 8.3 1.5 1.5 1.8 11.0 0.0 1.1 0.0 1.7 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 20.2 11.5 0.0 0.0 4.7 3.6 0.9 1.6 0.5 2.0 0.0 0.0 2.7 0.4 3.2 0.7 2.7 4.8 0.5 0.0 6.8 0.0 6.4 6.2 0.2 0.0 4.9 0.4 2.9 0.1 2.2 7.3 0.2 1.0 6.1 0.0 0.0 5.9 0.2 0.0 18.0 0.3 7.9 0.0 0.0 2.6 0.2 0.0 22.4 27.3 1.3 1.0 0.2 2.2 7.9 0.0 4.9 1.1 6.4 1.9 0.2 0.0 0.9 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.6 16.7 26.5 21.2 17.6 16.8 11.5 14.9 13.0 11.0 0.0 0.0 0.0 1.3 0.7 17.5 11.2 0.0 0.0 0.0 1.8 3.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.2 31.8 1.7 0.0 0.0 0.0 2.8 0.0 3.3 0.0 0.0 40.9 0.3 0.0 1.1 0.0 8.1 0.0 0.2 0.0 0.2 0.3 0.2 0.0 0.0 0.4 BABAM1 "C19orf62, FLJ20571, HSPC142, MERIT40, NBA1" ENSG00000105393 "BRISC and BRCA1 A complex member 1" Q9NWV8 19 17267350-17281249 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA054386, HPA068786, HPA077609" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: " "unprognostic (5.60e-2)" "unprognostic (1.08e-3)" "unprognostic (6.77e-2)" "unprognostic (1.06e-1)" "unprognostic (1.44e-1)" "unprognostic (2.18e-2)" "unprognostic (9.45e-3)" "unprognostic (2.05e-2)" "unprognostic (7.30e-2)" "unprognostic (2.03e-2)" "unprognostic (5.12e-2)" "unprognostic (7.21e-2)" "unprognostic (3.31e-3)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.79e-1)" "unprognostic (5.74e-2)" 23.2 26.7 39.8 24.2 33.6 37.3 23.7 32.5 50.0 25.6 25.6 24.5 18.7 25.5 24.9 20.5 26.3 22.0 26.8 36.8 35.2 33.3 24.0 31.2 21.6 30.7 34.4 33.8 23.6 29.2 22.2 15.7 31.9 25.8 22.7 23.8 20.8 30.5 25.5 72.7 25.0 23.4 23.9 23.3 29.1 24.5 24.6 22.2 34.5 19.2 33.5 31.3 21.4 19.8 44.7 51.6 51.6 50.1 33.2 55.2 59.7 35.4 19.9 20.1 19.1 22.5 16.0 45.9 21.3 28.4 43.1 43.0 22.8 42.5 25.2 50.9 29.5 19.2 17.7 23.6 29.5 27.7 36.1 37.6 22.1 26.4 27.6 18.3 39.7 28.3 24.2 20.6 28.5 17.0 23.6 36.2 36.1 36.8 29.6 31.1 29.0 39.9 37.7 52.6 29.9 42.9 26.9 26.6 33.2 31.6 17.5 19.5 35.4 25.8 27.0 23.3 24.1 23.7 32.1 26.0 26.2 16.6 32.0 35.4 39.7 47.5 33.1 37.2 52.6 24.6 50.0 50.1 51.6 45.4 46.0 43.4 44.7 42.0 43.8 51.6 43.3 39.2 38.6 12.6 33.2 43.4 42.8 55.2 59.7 39.8 33.6 32.5 50.0 35.2 33.3 34.4 33.8 25.8 22.2 11.9 33.8 59.1 31.8 31.0 19.2 29.8 35.7 16.0 21.6 33.2 13.7 144.3 86.2 64.8 47.6 38.0 52.1 23.3 63.0 136.2 53.0 40.9 45.1 42.0 86.6 15.9 42.1 35.6 36.2 68.8 33.9 46.9 62.4 98.2 53.3 27.8 60.0 57.5 41.8 72.1 12.0 38.8 52.6 40.7 69.5 36.1 132.2 58.6 59.6 34.3 BANK1 "BANK, FLJ20706" ENSG00000153064 "B cell scaffold protein with ankyrin repeats 1" Q8NDB2 4 101411286-102074812 "Disease related genes, Predicted intracellular proteins" "B-cell activation" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0" "Cell type enriched" "Detected in many" 6 "B-cells: 268.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 15 "memory B-cell: 61.4;naive B-cell: 46.2" "Lineage enriched" "Detected in many" 17 "B-cells: 61.4" "Cell line enhanced" "Detected in some" "Daudi: 10.4;HEL: 8.1;HL-60: 7.3;U-266/70: 25.0" "Low region specificity" "Detected in many" HPA037002 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA037002: AB_10672383" "unprognostic (1.59e-2)" "unprognostic (2.08e-2)" "unprognostic (6.43e-2)" "unprognostic (1.60e-1)" "unprognostic (1.28e-3)" "unprognostic (1.73e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-2)" "unprognostic (1.01e-1)" "unprognostic (9.97e-2)" "unprognostic (4.25e-2)" "unprognostic (7.89e-2)" "unprognostic (2.80e-1)" "unprognostic (2.18e-1)" "unprognostic (2.75e-2)" "unprognostic (6.09e-3)" "unprognostic (1.75e-1)" 3.3 2.9 0.7 45.4 0.9 2.0 1.9 2.1 0.7 0.7 1.3 0.7 1.4 0.7 0.4 1.2 6.0 1.0 1.6 0.9 0.8 0.7 2.0 0.5 4.9 30.3 0.7 0.2 0.9 0.6 0.0 3.7 0.5 0.6 2.2 1.1 0.5 7.7 1.8 0.4 0.6 18.0 0.3 0.8 67.0 2.5 1.3 0.7 4.8 5.5 0.4 42.3 6.5 1.1 61.4 2.0 3.6 0.3 0.2 0.0 2.1 0.0 2.3 0.0 0.0 2.7 1.1 0.0 0.1 0.0 0.3 0.5 0.0 3.6 10.4 1.0 0.0 0.0 0.1 0.1 1.1 0.3 0.0 0.0 8.1 2.1 0.0 0.1 7.3 0.0 0.5 0.3 0.0 0.0 0.9 0.1 0.0 0.0 3.1 0.5 0.4 0.0 0.4 0.0 0.3 4.4 0.1 0.5 0.0 0.3 4.8 2.1 0.0 0.2 0.1 0.0 0.0 0.4 1.9 1.0 0.0 0.5 0.0 0.0 25.0 0.0 1.7 0.1 4.1 0.0 1.5 0.3 3.6 0.0 0.1 0.0 61.4 0.0 0.0 2.0 46.2 0.0 0.0 0.1 0.2 0.0 1.0 0.0 2.1 0.7 0.9 2.1 0.7 0.8 0.7 0.7 0.2 0.6 0.7 41.7 21.9 268.2 2.1 0.1 0.2 0.4 0.0 2.7 17.0 3.5 0.0 1.8 0.0 0.2 1.9 0.4 0.0 0.0 0.2 0.6 1.0 5.2 1.1 0.0 1.2 0.0 0.0 0.0 2.7 1.8 0.0 7.7 5.0 0.0 0.0 1.1 2.5 0.2 0.4 2.4 0.0 0.0 0.0 1.4 3.2 1.0 0.2 2.5 0.4 4.0 BARX2 ENSG00000043039 "BARX homeobox 2" Q9UMQ3 11 129375940-129452279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 99.1;Suprabasal keratinocytes: 72.1;Urothelial cells: 102.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB033311, HPA064966, HPA068414" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984" "unprognostic (4.25e-2)" "unprognostic (2.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.22e-5)" "unprognostic (3.85e-2)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (1.43e-3)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.15e-1)" "unprognostic (8.39e-2)" "unprognostic (3.48e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.06e-4)" 0.1 0.0 0.3 1.6 0.5 0.0 6.0 0.6 0.9 8.7 4.4 1.4 0.3 7.1 0.6 1.8 49.8 6.8 5.0 0.1 0.5 0.4 1.9 0.1 0.5 0.1 0.7 0.2 1.0 6.9 0.0 0.6 1.5 4.1 1.5 1.9 0.0 78.3 0.7 1.0 11.2 7.9 0.0 1.6 0.0 2.6 1.2 0.2 0.4 0.5 40.7 36.4 0.2 22.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.4 7.8 0.0 1.9 0.0 60.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.7 0.0 1.5 0.0 2.3 0.0 0.0 0.0 7.7 0.3 0.0 0.0 14.7 0.0 0.1 0.1 0.0 0.0 7.4 0.0 0.1 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.6 0.9 0.5 0.4 0.7 0.2 4.1 0.2 0.0 1.4 0.0 99.1 38.2 0.4 0.4 2.5 6.7 6.8 0.0 0.0 10.6 6.6 18.2 6.5 0.3 27.5 0.0 0.6 6.4 2.3 15.2 0.0 0.0 1.6 0.0 1.7 0.0 0.0 1.3 0.0 0.8 10.1 0.0 12.2 0.8 5.0 22.1 0.4 1.4 0.2 0.0 0.7 0.0 1.1 72.1 3.5 0.0 15.8 102.1 BATF3 "JDP1, JUNDM1, SNFT" ENSG00000123685 "Basic leucine zipper ATF-like transcription factor 3" Q9NR55 1 212686418-212699985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.8" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 36.2;Macrophages: 24.9;monocytes: 98.2;Smooth muscle cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 18.0;myeloid DC: 16.5;non-classical monocyte: 26.8" "Group enriched" "Detected in many" 36 "dendritic cells: 16.5;monocytes: 26.8" "Cell line enriched" "Detected in some" 12 "HDLM-2: 93.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075858 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA075858: " "unprognostic (3.87e-2)" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (6.85e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (3.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.08e-1)" "unprognostic (6.47e-2)" "unprognostic (1.28e-2)" "unprognostic (1.75e-1)" "unprognostic (6.43e-10)" "unprognostic (9.88e-2)" "unprognostic (5.19e-2)" "unprognostic (3.90e-1)" "unprognostic (7.08e-2)" 10.4 1.3 6.7 6.3 9.4 5.4 3.5 0.4 5.2 2.0 2.4 3.3 0.2 1.4 1.8 0.4 1.8 2.6 3.8 4.1 5.5 2.1 2.6 2.3 7.2 8.7 9.5 2.8 3.1 3.2 1.2 1.3 4.6 4.3 2.3 1.6 0.5 2.2 1.2 1.5 1.1 4.3 3.7 4.7 9.5 3.2 1.1 7.1 5.0 2.1 2.6 4.9 3.0 6.0 0.2 16.5 0.6 26.8 0.3 0.4 2.4 0.3 0.9 0.1 0.0 0.0 0.6 0.7 0.5 1.1 1.1 1.2 0.0 0.3 0.0 0.2 0.0 1.8 0.0 1.1 0.2 0.8 93.1 2.2 0.0 0.3 0.0 0.2 4.2 0.6 0.1 0.0 2.2 0.3 0.1 0.0 7.7 0.1 1.1 0.2 0.0 3.2 1.7 0.4 0.0 1.5 0.6 0.4 0.0 1.0 0.0 0.2 0.1 0.3 0.0 0.0 0.4 0.0 3.0 0.0 0.5 2.1 0.1 2.4 0.1 0.2 0.5 1.5 3.8 1.1 0.0 4.1 0.0 0.0 18.0 0.0 0.2 0.0 0.0 16.5 0.0 0.0 0.0 0.6 0.3 26.8 0.0 0.4 2.4 6.7 9.4 0.4 5.2 5.5 2.1 9.5 2.8 4.3 7.1 3.0 1.1 0.5 2.2 5.0 0.1 0.3 0.0 4.0 2.3 0.0 0.0 0.8 0.0 0.7 0.3 5.8 0.0 0.0 0.3 36.2 8.5 6.6 4.7 0.2 4.6 0.0 0.0 6.2 10.5 0.8 0.9 24.9 1.7 98.2 0.0 0.2 1.3 0.0 0.0 0.5 0.4 0.0 25.8 1.1 4.3 2.5 3.8 1.0 0.0 0.9 BBOF1 "C14orf45, CCDC176" ENSG00000119636 "Basal body orientation factor 1" Q8ND07 14 74019353-74082863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.7" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 326.6;Early spermatids: 164.7;Late spermatids: 84.6;Spermatocytes: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA003090, HPA003136, HPA075108" Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA "Nucleoplasm, Plasma membrane" "Centriolar satellite" "HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: " "unprognostic (1.84e-2)" "unprognostic (1.31e-1)" "unprognostic (5.71e-2)" "prognostic favorable (6.34e-4)" "unprognostic (1.11e-2)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (2.08e-1)" "unprognostic (1.85e-1)" "unprognostic (4.62e-2)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (1.40e-3)" "unprognostic (6.14e-2)" "unprognostic (2.57e-1)" "unprognostic (7.93e-2)" "unprognostic (6.04e-3)" 5.3 3.5 9.4 4.1 12.5 6.0 8.4 4.3 12.5 7.7 6.5 4.4 8.5 2.5 8.2 16.4 6.1 24.1 6.6 4.8 11.5 8.2 10.6 2.8 7.6 2.2 7.3 9.2 5.8 3.2 6.1 17.4 3.0 22.3 6.4 4.2 5.8 4.4 8.9 5.3 3.7 2.7 7.7 13.8 1.8 3.9 37.7 6.7 2.5 14.5 2.6 2.6 7.0 3.4 1.5 5.0 2.4 0.1 2.1 4.2 3.0 4.8 2.8 1.2 8.0 5.4 12.0 1.0 4.2 6.0 4.3 4.1 1.0 3.3 4.7 1.2 5.1 1.8 1.2 1.6 0.7 4.9 0.7 0.9 0.5 2.7 1.0 4.6 2.3 0.3 5.7 4.0 9.6 1.2 6.8 1.5 8.9 2.5 0.9 3.1 3.8 7.4 1.2 0.4 0.4 2.0 2.7 3.1 0.8 7.4 1.2 4.9 3.1 8.2 3.3 2.2 1.3 8.5 0.2 3.5 5.3 3.8 7.1 1.2 1.8 4.2 2.9 15.7 0.3 1.5 2.4 0.1 0.2 3.4 0.0 4.0 1.3 3.2 2.2 0.2 1.5 4.2 3.4 2.4 2.1 0.0 5.0 0.6 3.0 9.4 12.5 4.3 12.5 11.5 8.2 7.3 9.2 22.3 6.7 11.9 7.2 0.0 4.2 0.0 7.2 0.0 5.1 326.6 55.7 3.5 27.5 1.6 13.3 7.3 164.7 2.2 0.4 23.3 3.1 2.2 3.0 3.9 1.1 2.5 2.0 6.4 2.4 4.9 0.6 84.6 10.0 1.7 0.0 1.0 3.2 5.7 2.4 0.0 5.6 14.4 27.4 0.0 0.0 82.2 13.0 0.0 0.8 3.2 0.8 2.8 BCL3 "BCL4, D19S37" ENSG00000069399 "B cell CLL/lymphoma 3" P20749 19 44747705-44760044 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 16.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.5" "Cell line enhanced" "Detected in many" "HDLM-2: 27.0;Karpas-707: 22.4;SiHa: 28.7;U-266/70: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002051, HPA047514" Approved Supported Nucleoplasm,Vesicles,Midbody Yes No Nucleoplasm "Vesicles, Midbody" "CAB002051: AB_563428, HPA047514: AB_2680074" "prognostic favorable (9.67e-4)" "unprognostic (8.82e-2)" "unprognostic (2.81e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (3.49e-2)" "unprognostic (2.34e-3)" "unprognostic (2.79e-1)" "prognostic favorable (3.74e-4)" "unprognostic (2.09e-2)" "unprognostic (9.23e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.13e-14)" "unprognostic (8.24e-2)" "unprognostic (1.36e-1)" "unprognostic (3.77e-2)" "unprognostic (3.04e-2)" 17.7 13.0 4.0 21.1 5.6 35.2 18.7 1.4 4.7 11.7 14.9 2.4 5.9 24.5 10.4 9.7 27.1 12.5 22.7 20.1 3.9 2.0 17.8 52.1 36.4 20.5 4.3 0.5 26.5 13.2 2.4 9.2 9.5 5.6 16.0 8.0 8.8 13.7 13.7 20.2 9.0 35.5 11.5 6.5 41.6 15.0 8.3 4.0 6.5 13.9 22.9 37.0 18.7 11.9 1.3 2.6 16.5 2.4 1.8 1.5 0.7 3.9 13.6 0.3 7.2 2.6 5.5 0.7 2.4 2.6 1.5 2.2 2.8 7.2 3.9 5.6 4.8 8.0 4.4 0.9 4.1 1.0 27.0 0.2 0.5 7.1 3.6 6.3 0.3 11.6 9.6 3.2 3.4 4.3 7.1 4.1 0.0 0.5 22.4 0.9 3.3 0.0 3.0 0.3 6.0 5.7 1.8 2.7 1.4 6.9 8.2 0.0 0.4 28.7 14.7 0.7 0.5 5.1 3.0 6.9 4.9 5.1 7.6 0.9 21.3 8.3 4.0 9.1 0.5 3.7 0.2 2.4 4.2 0.7 1.6 1.0 1.3 0.9 1.1 2.1 1.1 0.5 0.6 16.5 1.8 0.9 2.6 1.5 0.7 4.0 5.6 1.4 4.7 3.9 2.0 4.3 0.5 5.6 4.0 17.9 53.0 18.6 32.7 41.4 1.7 2.4 25.5 18.7 31.8 12.2 0.0 0.3 8.3 26.4 9.3 39.0 55.4 0.0 58.8 5.9 33.8 37.5 36.9 31.7 13.9 7.9 20.6 35.6 31.1 1.3 12.4 45.8 38.8 36.9 31.6 2.3 42.1 35.1 4.2 17.7 0.5 6.5 57.5 0.5 1.2 53.3 1.1 14.6 22.9 44.4 BCR "ALL, BCR1, CML, D22S11, D22S662, PHL" ENSG00000186716 "BCR, RhoGEF and GTPase activating protein" P11274 22 23179704-23318037 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ito cells: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 44.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010421, CAB018545, HPA038337" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795" "unprognostic (7.46e-3)" "unprognostic (2.43e-2)" "unprognostic (2.15e-3)" "unprognostic (1.16e-1)" "unprognostic (5.35e-2)" "unprognostic (1.45e-1)" "unprognostic (5.08e-2)" "unprognostic (1.44e-1)" "unprognostic (7.55e-2)" "unprognostic (1.81e-1)" "unprognostic (9.46e-2)" "unprognostic (2.39e-2)" "prognostic favorable (9.15e-10)" "unprognostic (1.47e-1)" "unprognostic (7.10e-2)" "unprognostic (4.10e-2)" "unprognostic (7.43e-2)" 14.5 8.4 24.0 9.1 41.2 26.7 10.5 14.2 26.5 13.6 9.7 10.3 10.6 8.7 9.2 13.9 19.3 10.8 8.3 7.8 20.9 13.0 16.3 8.3 11.3 10.9 16.0 15.6 8.8 12.9 14.5 14.9 15.7 14.2 7.0 6.8 8.3 15.5 9.7 3.4 12.8 8.7 9.0 9.5 9.1 14.0 9.6 15.4 11.8 16.6 5.5 9.2 9.2 8.8 1.5 0.8 1.2 1.0 2.8 6.6 2.5 19.0 8.2 12.7 13.0 7.6 5.2 19.2 6.9 6.5 6.4 5.2 14.4 7.7 13.3 12.9 5.9 6.2 19.6 1.3 19.2 1.8 25.4 13.2 11.6 11.3 11.4 9.9 10.7 6.1 4.4 13.0 9.5 8.4 11.4 22.3 9.6 44.4 6.3 2.9 12.5 10.0 8.4 10.7 15.1 8.1 13.2 5.1 8.7 9.9 12.1 11.7 11.1 12.6 10.9 5.2 8.5 6.9 8.8 25.1 3.8 0.4 6.2 5.7 1.4 5.8 4.7 9.9 8.1 5.9 0.0 1.0 0.0 6.6 0.4 2.3 1.4 3.3 3.3 0.8 1.5 2.6 3.6 1.2 2.8 1.0 0.8 1.6 2.5 24.0 41.2 14.2 24.9 20.9 13.0 16.0 15.6 14.2 15.4 8.9 11.5 3.0 9.5 13.7 24.0 7.3 20.4 2.7 19.4 17.4 21.6 10.5 8.3 12.4 3.9 22.4 11.1 0.0 14.1 5.9 7.3 10.2 10.4 18.4 6.0 22.3 19.1 62.0 10.8 7.7 8.1 5.4 5.0 6.4 12.0 13.4 21.8 5.8 5.3 14.3 8.0 0.0 8.6 1.6 6.8 13.8 9.0 9.2 11.2 11.5 BEGAIN KIAA1446 ENSG00000183092 "Brain enriched guanylate kinase associated" Q9BUH8 14 100537147-100587413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Cell type enriched" "Detected in many" 15 "Horizontal cells: 135.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "eosinophil: 6.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.8" "Group enriched" "Detected in some" 7 "HeLa: 21.8;SH-SY5Y: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002899 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA002899: AB_1078277" "unprognostic (2.98e-4)" "unprognostic (2.75e-3)" "unprognostic (2.66e-2)" "unprognostic (2.66e-4)" "unprognostic (2.77e-3)" "unprognostic (1.93e-2)" "unprognostic (5.16e-2)" "unprognostic (6.35e-2)" "unprognostic (3.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.15e-2)" "unprognostic (5.47e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (3.11e-1)" "unprognostic (2.75e-1)" "unprognostic (2.60e-1)" 1.8 5.5 16.4 1.1 10.8 6.4 1.5 24.9 21.6 1.3 1.3 0.9 0.0 4.6 2.0 1.8 1.4 3.0 2.5 1.5 15.3 7.1 0.9 0.8 1.0 1.3 4.4 6.0 3.5 13.0 2.3 8.2 3.1 3.6 2.6 0.9 2.1 2.8 2.7 0.9 1.3 3.0 1.7 2.0 3.3 1.0 2.6 1.4 5.4 1.0 0.4 1.3 0.8 0.6 0.6 1.0 6.8 1.5 0.0 0.4 0.1 0.3 1.3 0.7 4.5 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.2 0.2 1.0 0.1 0.2 0.0 0.0 0.0 0.4 2.0 21.8 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.5 0.0 0.0 0.3 0.2 0.0 0.0 1.7 0.1 0.6 0.5 0.1 0.7 0.0 0.1 2.7 0.0 0.0 1.2 53.1 1.2 0.0 1.2 0.0 0.3 5.4 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 3.8 1.0 0.1 1.3 0.1 6.8 0.0 1.5 0.0 0.6 0.4 0.0 0.0 0.2 0.1 0.0 0.6 0.0 1.4 1.0 0.0 0.1 16.4 10.8 24.9 17.3 15.3 7.1 4.4 6.0 3.6 1.4 0.0 1.1 0.0 1.4 2.2 1.5 1.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.0 0.3 0.6 0.7 0.0 6.9 0.2 1.4 0.5 9.2 0.0 0.2 135.1 0.0 0.0 0.0 0.6 1.7 0.7 1.7 1.8 0.0 0.7 4.1 0.0 6.3 0.0 2.4 0.0 0.3 0.9 0.4 1.8 0.1 0.0 0.2 0.3 BEND4 "CCDC4, FLJ35632, FLJ43965" ENSG00000188848 "BEN domain containing 4" Q6ZU67 4 42110938-42152878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 26.7" "Group enriched" "Detected in some" 7 "Muller glia cells: 10.2;Spermatogonia: 35.8" "Group enriched" "Detected in some" 43 "prostate cancer: 6.3;testis cancer: 5.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "memory B-cell: 1.1;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 12 "B-cells: 3.3" "Cell line enhanced" "Detected in some" "HAP1: 23.9;HEK 293: 5.8;HEL: 14.6;MOLT-4: 8.9;SuSa: 11.8;U-698: 9.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036850 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA036850: AB_10600787" "unprognostic (3.62e-4)" "unprognostic (3.82e-1)" "unprognostic (4.82e-2)" "unprognostic (5.96e-3)" "unprognostic (2.97e-3)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (4.00e-1)" "unprognostic (2.97e-1)" "unprognostic (5.58e-2)" "unprognostic (6.71e-3)" "unprognostic (1.68e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (1.49e-1)" "unprognostic (4.58e-3)" "unprognostic (4.24e-1)" 0.4 0.3 3.9 5.0 1.0 1.6 0.3 0.2 2.6 0.2 0.6 0.0 0.0 0.5 0.4 0.2 0.3 0.2 0.4 0.3 2.8 1.9 0.3 0.5 1.0 3.7 2.8 1.1 0.6 0.3 0.1 3.8 0.8 1.8 6.4 0.7 0.2 0.8 0.2 0.2 0.2 2.8 0.4 0.4 4.8 0.5 26.7 0.3 4.8 0.3 0.0 3.0 0.7 2.3 3.3 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 23.9 0.0 0.0 0.0 5.8 14.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 4.9 0.0 0.0 0.0 0.0 8.9 0.0 4.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 11.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 3.9 1.0 0.2 2.6 2.8 1.9 2.8 1.1 1.8 0.3 0.0 0.0 0.9 0.1 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.2 0.0 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 35.8 0.0 0.0 0.0 0.0 0.0 BEND7 "C10orf30, FLJ40283" ENSG00000165626 "BEN domain containing 7" Q8N7W2 10 13438484-13528974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 129.1;Late spermatids: 176.1" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037835 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" Yes No "Nucleoplasm, Nucleoli fibrillar center, Vesicles" "HPA037835: AB_10669722" "unprognostic (6.22e-2)" "unprognostic (1.80e-1)" "unprognostic (1.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-2)" "unprognostic (4.62e-3)" "unprognostic (3.24e-3)" "unprognostic (3.52e-2)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.06e-1)" "unprognostic (4.19e-3)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (5.20e-3)" 2.3 1.7 1.1 0.3 1.3 0.0 3.0 5.4 0.8 3.0 3.6 7.4 2.9 6.2 0.5 5.7 2.6 1.5 0.8 1.4 8.4 3.6 3.3 0.0 1.2 3.3 5.4 9.8 4.4 1.5 2.1 2.6 5.3 2.6 4.5 0.8 8.7 2.4 0.6 0.9 3.5 8.1 11.2 0.0 2.1 1.4 0.0 0.0 2.7 0.0 0.1 0.0 0.0 7.6 4.4 5.6 2.4 0.1 0.0 7.3 2.9 0.1 8.5 5.0 3.5 14.4 0.0 4.1 6.4 4.2 0.4 8.0 2.2 7.3 0.0 7.2 0.1 0.0 10.8 3.2 0.0 0.0 0.2 5.0 1.3 0.0 13.7 8.1 1.4 4.4 0.0 7.4 5.7 0.1 0.0 2.5 0.1 1.0 0.0 4.0 0.0 6.0 1.3 0.5 4.3 8.7 0.0 0.2 7.7 0.2 3.6 6.7 1.7 11.2 10.4 4.0 0.0 0.0 0.0 2.7 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 20.8 12.3 2.2 15.3 3.1 14.2 8.9 28.1 14.7 15.9 19.2 7.9 1.9 3.3 11.2 129.1 9.8 8.7 0.0 14.1 2.1 5.8 19.6 5.8 8.2 2.4 1.6 7.5 16.0 7.9 176.1 4.6 2.1 3.3 1.8 10.4 19.0 17.4 6.2 5.6 41.7 31.7 0.0 7.5 15.3 17.8 1.6 2.1 5.7 9.0 26.7 BICDL1 "BICDR-1, CCDC64, FLJ26450" ENSG00000135127 "BICD family like cargo adaptor 1" Q6ZP65 12 119989869-120094494 "Predicted intracellular proteins" "Neurogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 29.9;skin 1: 20.5" "Group enriched" "Detected in some" 6 "Collecting duct cells: 12.2;Distal tubular cells: 19.9;Proximal tubular cells: 20.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 27.4;MCF7: 14.8;SCLC-21H: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061116 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA061116: AB_2684433" "unprognostic (2.17e-1)" "prognostic favorable (6.50e-4)" "unprognostic (1.68e-3)" "unprognostic (3.05e-2)" "unprognostic (6.81e-4)" "prognostic favorable (3.15e-4)" "prognostic unfavorable (6.84e-4)" "unprognostic (5.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.63e-2)" "unprognostic (3.31e-3)" "unprognostic (7.26e-2)" "prognostic favorable (3.93e-5)" "prognostic favorable (1.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.15e-1)" 4.0 0.8 2.7 3.8 2.3 0.7 0.9 11.9 6.5 0.8 0.9 1.3 0.0 16.5 7.5 0.7 1.4 0.0 3.1 5.1 29.9 0.5 0.7 8.7 1.5 0.0 1.1 1.2 18.4 0.1 0.9 1.0 1.4 0.1 0.0 20.5 1.1 0.0 0.7 2.3 8.6 8.0 6.3 6.0 1.2 3.5 0.5 0.1 0.9 0.8 0.2 3.4 0.7 1.8 5.7 0.3 0.0 0.5 0.0 7.0 0.0 0.0 0.0 0.0 5.1 3.2 9.0 2.4 0.0 5.1 4.3 0.7 0.9 0.0 0.6 0.9 0.0 2.5 9.8 0.0 1.1 9.5 0.0 27.4 0.0 0.3 0.0 0.0 7.8 0.3 1.1 0.0 14.8 6.4 0.1 11.7 13.6 2.7 0.7 0.5 2.4 3.5 4.6 17.3 1.2 2.0 5.4 1.4 3.0 12.4 4.5 0.0 0.1 1.6 0.0 0.1 2.3 8.7 3.5 0.3 1.3 0.9 0.9 0.0 0.0 3.4 0.0 1.3 0.5 3.4 2.9 0.0 0.5 2.6 2.0 0.0 0.2 0.8 0.1 0.6 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 12.2 0.0 0.5 19.9 0.8 0.0 0.0 0.0 0.0 2.9 0.6 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.7 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 BIRC2 "API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48" ENSG00000110330 "Baculoviral IAP repeat containing 2" Q13490 11 102347211-102378670 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005513, CAB020661" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" Nucleoplasm "CAB020661: , HPA005513: AB_1846746" "unprognostic (1.36e-1)" "unprognostic (3.29e-1)" "unprognostic (9.52e-3)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (7.02e-2)" "unprognostic (2.72e-2)" "unprognostic (1.04e-2)" "unprognostic (1.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.05e-2)" "unprognostic (3.02e-2)" "unprognostic (1.84e-2)" "unprognostic (1.07e-1)" "unprognostic (9.20e-2)" "unprognostic (5.00e-2)" "unprognostic (1.64e-2)" 20.9 25.8 19.1 23.3 24.1 25.9 57.0 20.5 28.5 25.1 22.2 18.4 18.7 19.3 24.6 31.1 18.6 17.0 21.1 39.2 19.1 18.3 24.3 36.8 34.0 47.2 23.3 15.8 21.5 40.8 22.0 27.3 24.3 22.3 19.6 22.2 14.3 21.9 22.1 38.8 17.3 24.4 23.8 26.3 27.6 19.0 19.7 15.5 51.2 18.9 17.3 21.9 22.2 20.2 5.8 12.6 37.5 16.6 12.2 12.0 9.8 9.8 7.3 11.3 8.8 14.3 19.9 7.2 38.3 14.6 22.0 13.4 9.1 24.6 10.9 37.9 17.5 12.3 10.9 7.3 10.1 26.4 14.5 3.7 10.9 5.4 11.0 14.6 6.6 7.0 12.7 19.7 12.5 16.1 20.3 15.0 6.6 9.8 0.0 39.5 3.1 6.9 5.8 5.4 11.8 7.1 3.5 14.7 7.2 17.0 11.4 4.7 6.2 13.3 8.1 11.4 18.1 12.8 8.0 24.6 46.5 10.5 14.0 24.6 4.5 6.1 7.4 10.0 8.3 33.8 31.7 16.6 37.5 9.1 15.2 7.5 5.8 8.7 8.4 12.6 5.6 11.3 11.3 25.5 12.2 16.3 7.6 12.0 9.8 19.1 24.1 20.5 28.5 19.1 18.3 23.3 15.8 22.3 15.5 38.7 40.9 33.3 88.5 59.6 24.1 51.6 63.7 60.2 44.3 61.1 27.5 32.6 36.5 42.3 11.1 49.4 69.1 23.3 63.8 22.6 51.4 66.2 61.2 138.2 36.5 19.1 46.6 67.5 96.7 7.4 33.6 60.1 49.0 85.6 48.7 27.5 44.2 49.9 27.3 66.5 29.1 25.8 53.9 31.1 41.3 54.8 29.4 45.8 37.3 65.0 BIRC7 "KIAP, ML-IAP, mliap, RNF50" ENSG00000101197 "Baculoviral IAP repeat containing 7" Q96CA5 20 63235883-63240507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.4;placenta: 13.6;retina: 21.1" "Group enriched" "Detected in some" 5 "Hofbauer cells: 56.9;Melanocytes: 25.3;Muller glia cells: 46.0" "Cancer enriched" "Detected in many" 10 "melanoma: 73.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 9 "T-cells: 2.0" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 63.7" "Not detected" "Not detected" "HPA047850, HPA061283" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA047850: AB_2680181, HPA061283: " "unprognostic (3.60e-1)" "unprognostic (7.94e-2)" "unprognostic (2.70e-2)" "unprognostic (1.78e-3)" "unprognostic (1.15e-1)" "unprognostic (8.11e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.62e-3)" "unprognostic (1.24e-2)" "unprognostic (6.90e-2)" "unprognostic (2.27e-1)" "unprognostic (8.82e-3)" "unprognostic (1.22e-2)" "unprognostic (4.77e-2)" "unprognostic (2.55e-2)" "unprognostic (4.84e-2)" 1.6 1.3 1.0 0.7 1.0 0.3 0.7 0.1 2.2 3.0 1.3 0.5 0.1 0.4 0.8 14.4 0.3 0.3 0.5 2.8 0.9 1.1 2.6 0.8 2.3 2.2 4.9 1.0 0.2 0.1 0.1 0.6 13.6 1.5 0.4 0.3 21.1 0.8 0.1 0.1 4.9 0.3 0.2 4.3 1.6 0.3 0.4 0.3 0.3 0.3 1.0 0.5 0.4 1.8 0.0 0.0 0.0 0.2 0.0 2.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.2 0.4 0.0 6.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 63.7 1.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.0 0.1 2.2 0.9 1.1 4.9 1.0 1.5 0.3 0.0 0.6 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 1.8 0.0 1.4 0.0 0.6 0.1 0.0 0.0 0.0 0.6 8.2 0.5 0.0 2.3 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 46.0 2.3 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 BLMH BH ENSG00000108578 "Bleomycin hydrolase" Q13867 17 30248195-30292056 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 67.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039548, HPA064307" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No 59000000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA039548: AB_10805479, HPA064307: AB_2685241" "unprognostic (6.85e-2)" "unprognostic (2.79e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (2.54e-2)" "unprognostic (3.91e-3)" "unprognostic (2.07e-1)" "unprognostic (2.05e-3)" "unprognostic (6.69e-3)" "unprognostic (1.95e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" 11.2 8.3 9.0 17.1 10.2 8.5 14.2 12.1 14.5 10.5 9.8 8.5 9.6 6.7 13.1 12.2 15.7 8.4 10.1 9.7 7.5 7.2 13.6 7.5 13.6 20.3 9.5 8.5 8.8 15.3 15.0 8.3 14.6 9.2 8.4 8.5 7.3 12.8 9.5 15.0 67.5 10.0 15.7 11.1 13.2 9.2 12.4 8.6 24.7 9.3 15.5 13.6 10.8 11.7 4.6 6.6 0.9 5.7 9.8 17.3 6.3 10.2 16.2 15.6 10.8 10.7 11.5 7.6 9.5 5.9 15.1 13.0 23.7 3.0 30.4 17.0 7.7 6.8 7.1 33.8 13.0 12.8 8.0 26.6 18.6 14.5 20.1 15.7 33.9 11.5 13.6 0.9 11.8 6.8 12.4 22.1 25.5 39.7 12.4 6.2 7.7 42.0 24.8 15.0 0.0 7.6 36.4 40.6 20.1 12.0 9.1 36.1 12.9 8.4 16.5 10.4 28.2 11.2 17.5 14.0 9.3 18.8 4.1 16.8 15.0 30.9 41.1 7.1 0.0 12.4 0.0 5.7 0.9 10.5 3.9 17.3 4.6 12.6 13.7 6.5 4.2 11.6 12.3 0.7 9.8 1.9 6.6 12.4 6.3 9.0 10.2 12.1 14.5 7.5 7.2 9.5 8.5 9.2 8.6 3.0 13.0 12.3 14.0 14.2 18.2 16.5 12.7 6.7 2.3 10.4 11.8 41.1 6.6 14.9 8.2 17.9 8.9 0.0 12.2 31.7 13.3 8.5 43.8 6.6 22.1 12.7 17.2 28.3 21.8 5.2 15.0 10.4 10.1 10.0 7.6 10.9 8.9 8.6 23.3 17.0 16.0 6.5 15.3 9.7 16.7 11.0 23.0 18.7 10.7 5.9 BMP7 OP-1 ENSG00000101144 "Bone morphogenetic protein 7" P18075 20 57168748-57266629 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.0;thyroid gland: 44.3" "Cell type enhanced" "Detected in many" 16 "Cytotrophoblasts: 108.5;Muller glia cells: 38.0;Syncytiotrophoblasts: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.4" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "Daudi: 42.0;MCF7: 48.6;OE19: 22.8;RPMI-8226: 18.6;SK-BR-3: 31.7;U-698: 57.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057757 Approved Nucleoplasm,Nucleoli,Vesicles "Secreted to blood" NA NA 248000 Vesicles "Nucleoplasm, Nucleoli" "HPA057757: AB_2683518" "unprognostic (1.67e-1)" "unprognostic (9.72e-3)" "unprognostic (9.67e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.62e-1)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (4.63e-3)" "unprognostic (4.03e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (4.30e-2)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (1.59e-1)" 1.5 7.2 16.8 2.4 17.5 0.7 2.1 3.8 19.7 9.2 2.3 23.6 6.0 2.7 1.9 17.7 17.2 10.0 1.2 8.5 13.9 9.9 4.5 0.7 1.8 1.6 14.3 11.2 0.8 1.0 0.8 1.9 24.4 12.2 5.0 2.4 37.0 2.6 10.3 1.0 15.5 2.4 1.0 13.8 1.3 4.1 1.4 13.4 1.8 44.3 5.7 4.9 7.8 7.0 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 5.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.7 42.0 10.8 0.0 2.2 12.2 1.3 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.6 0.0 0.0 3.0 22.8 0.0 0.0 0.0 18.6 0.0 0.0 0.1 4.6 1.3 31.7 0.1 4.0 0.2 0.1 0.1 0.0 2.9 0.0 0.0 0.0 0.0 57.4 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 16.8 17.5 3.8 12.5 13.9 9.9 14.3 11.2 12.2 13.4 6.0 2.1 0.0 11.4 12.2 3.8 12.4 0.0 2.7 2.3 1.8 0.0 108.5 0.0 0.0 3.9 1.5 0.0 0.0 0.0 14.4 10.8 4.9 21.8 0.0 9.3 1.6 2.4 0.0 0.0 3.3 0.3 0.0 3.3 0.0 0.0 38.0 0.0 0.0 0.4 1.6 2.4 0.0 0.9 1.4 1.4 8.4 47.6 0.5 0.2 10.6 BMS1 "BMS1L, KIAA0187" ENSG00000165733 "BMS1, ribosome biogenesis factor" Q14692 10 42782801-42834937 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036589, HPA043081" Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli, Mitotic chromosome" "HPA036589: AB_10601460, HPA043081: AB_2678305" "unprognostic (1.46e-2)" "unprognostic (4.31e-1)" "unprognostic (7.09e-2)" "unprognostic (3.56e-2)" "unprognostic (3.11e-2)" "unprognostic (7.25e-3)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (3.81e-3)" "unprognostic (1.32e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.43e-1)" "unprognostic (4.82e-2)" 17.8 15.3 10.4 15.8 19.7 17.4 16.2 22.5 20.6 15.5 12.9 13.7 11.2 11.8 23.1 13.4 17.8 14.0 10.0 14.4 10.8 13.3 17.8 16.8 14.1 17.2 12.6 15.4 17.5 16.2 24.7 28.0 15.3 22.8 14.1 15.4 12.3 18.8 14.0 29.9 18.1 13.8 14.7 15.0 18.3 13.5 14.8 13.4 20.7 14.0 17.2 19.2 14.4 15.9 9.8 8.4 3.4 9.1 6.2 11.6 5.6 16.8 14.4 14.0 15.9 10.6 8.8 13.6 14.2 15.0 16.8 14.5 19.8 13.3 9.0 10.1 12.2 9.4 14.8 22.8 18.3 22.1 13.1 16.0 12.0 11.2 16.8 9.2 32.4 11.4 7.9 9.4 18.1 17.6 9.4 12.7 10.5 21.0 9.7 11.9 14.2 18.0 10.7 17.7 11.7 15.3 16.6 14.7 9.6 9.3 14.9 10.7 11.4 12.3 13.8 11.7 15.3 16.7 9.4 15.3 7.9 28.3 15.7 23.0 7.8 9.6 26.3 11.5 24.0 6.0 3.4 5.1 2.9 8.6 9.1 10.2 9.8 10.6 9.3 8.4 7.4 11.6 10.0 0.7 6.2 7.4 4.4 7.5 5.6 10.4 19.7 22.5 20.6 10.8 13.3 12.6 15.4 22.8 13.4 29.8 24.9 24.6 24.5 20.4 21.0 41.4 22.9 68.3 44.3 22.7 9.8 24.5 18.3 25.0 12.0 26.4 7.9 0.0 30.5 25.1 21.9 17.4 20.9 17.1 17.5 20.6 16.1 23.9 18.6 8.1 21.9 21.0 32.1 41.5 10.4 11.4 29.2 7.0 15.6 23.2 25.6 19.4 20.3 35.2 53.5 22.2 20.8 20.0 16.8 36.0 BOC CDON2 ENSG00000144857 "BOC cell adhesion associated, oncogene regulated" Q9BWV1 3 113211003-113287459 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 18.8;Leydig cells: 78.6;Peritubular cells: 44.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 8 "B-cells: 1.3" "Cell line enhanced" "Detected in many" "AN3-CA: 31.2;ASC diff: 46.2;BJ hTERT+: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025806 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Intracellular and membrane" NA No 4500000 "Nuclear bodies, Plasma membrane" Nucleoplasm "CAB025806: " "unprognostic (6.89e-3)" "unprognostic (1.34e-2)" "unprognostic (2.62e-3)" "unprognostic (1.03e-2)" "unprognostic (5.03e-3)" "prognostic favorable (4.89e-4)" "unprognostic (8.66e-5)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (4.78e-3)" "unprognostic (3.42e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-3)" "unprognostic (4.94e-3)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.18e-5)" 19.4 4.8 5.3 10.4 8.1 0.4 21.6 4.2 6.0 26.6 23.8 5.4 10.6 3.9 25.8 25.3 19.6 33.2 14.5 20.3 13.3 2.9 4.7 1.0 3.6 3.6 5.5 2.2 26.1 12.0 1.9 12.5 1.9 26.2 21.2 3.9 45.6 17.9 17.4 4.6 25.7 9.6 35.2 36.7 3.5 11.8 9.2 7.6 1.2 13.4 12.9 4.9 28.4 25.0 1.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 2.9 11.0 31.2 46.2 2.4 0.3 5.0 16.5 1.2 1.1 0.0 0.0 0.0 3.1 8.4 0.7 0.0 2.2 1.0 0.4 0.0 1.3 0.0 1.0 0.0 0.2 0.1 0.1 8.0 0.7 0.7 0.1 10.3 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.5 2.8 0.0 2.7 0.0 4.9 0.0 0.3 0.0 3.3 4.7 0.0 0.2 0.1 3.4 1.3 0.1 0.0 1.8 2.9 0.0 1.6 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 5.3 8.1 4.2 6.0 13.3 2.9 5.5 2.2 26.2 7.6 0.0 0.3 0.0 2.3 18.8 0.4 0.8 0.0 0.0 1.2 5.2 0.0 4.4 0.0 0.0 1.3 3.3 0.0 0.0 0.0 4.0 12.4 2.8 0.0 0.0 0.7 0.0 1.7 2.5 0.0 1.1 78.6 0.9 10.1 0.0 0.0 14.1 0.5 0.0 44.9 0.0 0.5 0.0 8.3 1.1 3.0 9.7 1.6 0.0 0.0 0.3 BORA "C13orf34, FLJ22624" ENSG00000136122 "Bora, aurora kinase A activator" Q6PGQ7 13 72727749-72756198 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.5" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 9.8;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040866 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA Yes "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA040866: AB_10794868" "unprognostic (9.93e-2)" "unprognostic (7.18e-2)" "unprognostic (4.57e-2)" "unprognostic (7.09e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-2)" "unprognostic (1.37e-4)" "unprognostic (2.65e-2)" "unprognostic (2.82e-3)" "unprognostic (6.18e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-2)" "unprognostic (5.32e-12)" "unprognostic (7.04e-3)" "unprognostic (2.88e-1)" "unprognostic (9.93e-2)" "unprognostic (2.28e-2)" 3.7 3.0 2.3 10.9 3.2 10.9 6.8 5.8 4.2 3.3 9.0 1.8 6.3 6.9 3.1 5.9 7.1 3.2 3.2 2.3 2.6 2.2 4.3 4.3 7.7 11.8 4.3 1.5 3.1 5.6 0.8 6.3 6.8 4.4 4.0 9.1 2.2 4.6 6.7 2.1 6.1 10.6 3.5 5.3 8.9 5.5 7.0 4.6 26.5 5.0 5.8 12.4 5.6 4.5 5.0 5.7 7.2 5.4 4.6 8.3 3.7 22.3 3.9 12.7 8.6 1.6 1.6 9.0 7.5 6.7 11.8 12.9 10.3 12.9 14.6 4.3 4.3 6.9 9.6 11.4 7.3 15.7 13.5 6.3 18.0 6.3 8.4 1.5 33.9 11.7 1.3 1.9 5.3 11.6 2.6 9.8 15.5 8.2 6.3 8.5 5.2 15.2 9.8 5.6 23.3 4.6 11.1 7.5 6.5 4.0 5.8 3.4 4.0 7.5 7.3 5.4 10.1 4.9 12.4 3.5 3.3 7.5 5.7 9.5 5.4 4.9 10.5 9.2 16.1 8.2 7.2 3.1 1.6 6.6 5.4 5.8 4.6 5.7 6.4 5.7 5.0 4.7 8.3 0.7 4.6 3.3 3.2 5.9 3.7 2.3 3.2 5.8 4.2 2.6 2.2 4.3 1.5 4.4 4.6 3.0 3.2 2.4 1.3 0.6 1.9 0.2 0.0 2.7 2.3 1.8 2.0 3.9 0.0 1.5 1.0 0.2 2.3 0.0 2.2 9.8 0.7 1.4 1.1 0.0 3.8 7.9 0.0 3.1 5.1 0.8 0.9 2.9 0.0 1.8 1.9 1.0 1.4 2.6 1.1 0.5 2.1 12.9 1.9 1.2 4.7 1.0 2.4 2.5 4.0 1.3 BORCS8-MEF2B MEF2BNB-MEF2B ENSG00000064489 "BORCS8-MEF2B readthrough" 19 19145567-19192158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 19 "Club cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "PC-3: 11.1;U-266/70: 11.2" HPA004734 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (2.74e-1)" "unprognostic (5.77e-3)" "unprognostic (8.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.46e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.75e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (6.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "unprognostic (5.29e-2)" 4.8 3.5 7.0 5.8 7.4 7.4 4.6 5.6 8.6 5.4 5.4 8.1 6.7 3.2 6.7 7.4 5.4 10.5 7.2 3.4 6.8 6.2 7.5 5.9 4.8 7.1 8.0 5.5 9.8 7.8 5.5 4.9 5.0 7.3 5.7 5.5 6.2 5.6 7.2 5.3 8.8 4.0 8.9 5.9 5.8 5.0 5.5 5.8 5.6 5.9 4.9 7.5 5.8 5.8 0.0 0.4 0.6 0.1 0.0 0.3 0.0 1.6 0.0 0.7 1.2 1.0 2.5 1.3 1.1 1.0 1.5 1.5 0.0 3.1 3.4 0.5 0.0 0.5 0.6 0.7 0.6 0.3 0.5 2.5 1.1 0.1 0.3 2.3 0.0 0.2 0.0 2.3 0.7 3.7 0.6 0.4 3.2 0.2 2.0 0.6 3.1 0.7 0.4 0.0 0.0 11.1 3.3 0.9 0.9 0.0 0.2 0.0 1.1 2.0 0.0 0.9 0.1 0.3 0.6 0.3 0.7 1.2 5.7 0.4 11.2 1.7 5.6 2.4 2.7 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.1 0.0 7.0 7.4 5.6 8.6 6.8 6.2 8.0 5.5 7.3 5.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 BPGM ENSG00000172331 "Bisphosphoglycerate mutase" P07738 7 134646808-134679813 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 184.7" "Group enriched" "Detected in all" 5 "Distal tubular cells: 109.5;Erythroid cells: 303.7;Syncytiotrophoblasts: 308.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 38.0;RT4: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016493, HPA028735" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA 69000000 "Nucleoli, Nucleoli rim" Nucleoplasm "HPA016493: AB_1845414, HPA028735: AB_10600791" "unprognostic (2.56e-1)" "prognostic favorable (7.95e-4)" "unprognostic (3.19e-1)" "unprognostic (3.94e-1)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (3.81e-3)" "unprognostic (1.96e-1)" "unprognostic (7.74e-2)" "unprognostic (4.67e-3)" "unprognostic (7.42e-2)" "unprognostic (5.69e-2)" "prognostic favorable (1.54e-8)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.78e-2)" 6.1 7.3 13.6 4.5 11.1 37.7 6.9 11.7 11.6 7.1 6.9 9.1 6.1 4.3 5.4 10.2 14.6 4.7 6.9 7.3 12.5 14.2 19.1 8.1 8.0 5.2 13.9 7.8 5.7 5.4 16.5 14.4 184.7 12.4 7.5 5.4 6.7 10.6 10.3 17.7 5.5 6.0 6.6 15.9 8.6 6.8 7.4 8.8 8.5 7.5 22.2 13.3 24.9 9.5 11.6 10.2 28.2 12.8 9.8 14.5 12.8 4.5 5.5 7.4 9.9 8.5 5.0 7.4 13.7 16.6 5.3 8.0 2.2 6.1 5.5 4.1 7.6 10.6 3.7 7.8 7.5 9.4 38.0 6.8 3.2 5.1 2.5 5.8 6.0 4.2 4.9 6.9 10.0 5.5 8.2 19.3 7.0 9.2 7.0 12.6 2.2 9.8 8.4 7.6 9.3 5.3 7.5 5.3 4.0 12.1 61.1 6.3 10.7 6.3 7.7 6.8 8.2 5.1 3.9 14.7 8.5 2.0 11.4 11.1 11.5 13.2 6.9 14.7 5.8 14.5 28.2 9.8 27.6 14.5 12.8 10.4 11.6 9.5 12.7 10.2 10.5 13.2 13.4 18.0 9.8 12.5 6.7 12.0 12.8 13.6 11.1 11.7 11.6 12.5 14.2 13.9 7.8 12.4 8.8 8.9 26.7 14.4 18.4 34.7 20.3 20.5 15.3 29.4 14.8 26.2 2.0 35.3 109.5 38.4 2.2 11.9 5.1 303.7 15.9 28.0 17.1 21.1 24.3 4.3 13.3 19.1 12.6 8.0 7.3 5.1 9.5 11.3 21.9 19.8 3.8 18.6 36.1 3.5 11.3 47.1 11.6 6.5 24.7 27.9 22.5 11.5 308.5 21.5 4.5 13.7 BROX "C1orf58, FLJ32421" ENSG00000162819 "BRO1 domain and CAAX motif containing" Q5VW32 1 222712553-222735196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031445 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 190000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA031445: AB_10602697" "unprognostic (1.27e-1)" "unprognostic (4.32e-1)" "unprognostic (3.43e-2)" "unprognostic (4.60e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-1)" "unprognostic (3.31e-2)" "unprognostic (2.83e-2)" "unprognostic (2.52e-2)" "unprognostic (6.72e-2)" "unprognostic (4.27e-2)" "unprognostic (2.53e-2)" "unprognostic (4.84e-2)" "unprognostic (1.09e-1)" "unprognostic (6.56e-2)" "unprognostic (1.83e-2)" "unprognostic (2.50e-2)" 24.0 21.1 22.7 15.7 25.3 33.0 22.2 21.6 24.9 17.8 23.6 22.0 13.8 19.8 18.2 15.6 30.1 17.7 18.3 14.9 22.5 20.2 22.6 21.0 18.5 22.7 30.2 22.7 21.4 16.2 28.3 21.8 28.1 29.6 17.0 23.7 11.8 21.3 17.9 23.7 23.5 33.0 16.8 27.5 22.9 23.2 12.6 30.1 24.4 25.0 22.5 19.7 21.1 19.8 8.8 13.4 30.9 21.7 14.2 15.3 8.5 25.6 15.4 9.5 8.3 13.9 14.8 18.5 17.6 22.1 14.5 16.7 8.6 33.6 8.5 21.2 21.8 7.9 22.6 10.6 16.9 22.2 10.6 9.5 12.7 17.2 8.5 15.7 14.5 12.1 13.0 16.7 18.1 21.6 16.6 13.1 5.6 19.2 11.7 17.8 7.7 6.1 7.5 12.0 21.1 18.4 6.4 28.9 19.1 17.2 25.6 10.7 16.9 19.3 22.2 13.1 9.5 26.9 14.9 18.9 20.0 11.6 20.6 19.9 8.8 14.7 7.7 16.2 12.3 18.2 30.9 15.8 18.3 12.0 21.7 13.3 8.8 15.3 12.0 13.4 8.3 10.3 13.0 27.3 14.2 21.0 7.5 13.8 8.5 22.7 25.3 21.6 24.9 22.5 20.2 30.2 22.7 29.6 30.1 68.5 33.2 19.3 26.5 43.0 16.4 34.1 30.6 77.6 30.7 48.8 7.9 23.9 48.0 33.6 16.0 24.8 34.2 46.7 28.3 27.0 25.7 39.8 15.1 22.1 32.3 33.4 30.6 33.7 50.9 16.7 22.5 40.8 47.2 35.1 45.9 31.0 43.0 40.3 30.1 41.6 19.5 51.8 26.8 21.8 22.2 40.8 43.1 43.7 38.4 39.3 BRWD1 "C21orf107, DCAF19, FLJ11315, N143, WDR9" ENSG00000185658 "Bromodomain and WD repeat domain containing 1" Q9NSI6 21 39184176-39321559 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030943, HPA030944, HPA030945, CAB034184" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161" "unprognostic (6.00e-2)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-1)" "unprognostic (8.39e-3)" "unprognostic (4.94e-2)" "unprognostic (5.01e-2)" "unprognostic (8.90e-2)" "unprognostic (2.26e-1)" "unprognostic (4.82e-3)" "unprognostic (5.45e-2)" "unprognostic (2.58e-3)" "unprognostic (6.48e-2)" "unprognostic (1.19e-1)" "unprognostic (3.88e-2)" "unprognostic (2.56e-2)" 10.9 16.7 33.0 15.4 36.8 13.4 16.3 15.5 40.2 12.3 12.0 14.3 10.5 8.8 13.0 21.1 10.2 11.8 9.9 12.9 29.1 32.9 13.9 21.8 10.0 12.9 24.3 17.7 16.2 17.2 12.8 12.0 15.2 13.4 13.2 11.5 13.0 9.3 11.8 14.6 11.9 9.6 13.1 16.1 9.6 9.9 17.2 10.5 22.4 17.7 9.3 13.2 12.1 11.6 8.5 7.2 11.6 6.1 10.2 11.1 3.8 10.2 4.1 10.1 5.6 6.5 9.8 10.4 5.9 6.9 4.6 5.4 3.9 7.0 32.9 6.2 8.0 5.5 5.1 9.4 6.8 7.3 7.6 7.7 22.3 7.2 7.1 8.2 12.3 6.3 6.7 11.2 6.3 16.0 10.7 6.8 21.0 16.5 16.6 6.4 7.9 8.4 14.5 10.6 12.4 5.8 14.9 7.8 10.4 5.6 6.6 8.0 10.3 12.6 15.2 8.7 3.9 12.9 17.2 7.5 6.1 2.9 3.5 4.4 18.5 12.7 16.0 7.3 13.2 4.8 4.4 5.2 11.6 10.7 6.1 8.3 8.5 9.2 11.0 7.2 6.3 11.1 9.0 5.7 10.2 3.8 6.8 10.3 3.8 33.0 36.8 15.5 40.0 29.1 32.9 24.3 17.7 13.4 10.5 44.7 40.4 19.5 36.5 56.1 63.7 54.9 17.8 49.5 39.8 17.4 110.0 50.0 38.1 24.8 41.9 37.6 30.2 23.3 30.0 38.8 37.9 51.4 31.3 31.6 22.1 69.9 34.0 33.2 35.6 16.8 40.0 27.5 28.7 23.4 35.9 35.9 32.0 28.1 42.1 28.1 103.4 25.8 37.3 85.4 77.1 61.5 83.5 38.9 34.2 55.4 BTRC "beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1" ENSG00000166167 "Beta-transducin repeat containing E3 ubiquitin protein ligase" Q9Y297 10 101354033-101557321 "Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031156, CAB032986" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB032986: AB_2243598, HPA031156: AB_2673764" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (8.88e-2)" "unprognostic (2.09e-1)" "unprognostic (3.55e-1)" "unprognostic (2.73e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-2)" "unprognostic (8.80e-3)" "unprognostic (5.05e-1)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (3.07e-2)" "unprognostic (2.23e-1)" 6.6 11.2 16.0 7.3 23.1 3.6 11.8 16.2 28.0 10.2 6.6 10.7 13.7 5.4 8.8 14.5 11.5 10.8 8.1 18.6 15.7 18.3 11.6 7.1 6.8 5.3 14.3 15.3 15.5 8.6 21.5 17.3 10.4 13.5 12.2 7.0 11.9 9.0 8.7 14.1 9.0 5.4 9.7 10.2 7.5 6.4 17.9 9.0 6.3 11.4 7.1 7.5 7.3 9.8 5.2 4.8 3.9 3.7 5.1 8.1 3.4 6.3 9.7 13.7 15.8 13.4 11.7 4.9 9.1 14.8 9.6 8.0 6.8 5.0 10.4 9.3 7.8 9.9 9.9 11.2 9.9 10.4 6.8 8.9 7.5 6.1 8.8 7.1 11.0 4.1 7.1 11.6 8.2 14.7 19.0 11.8 9.7 8.1 3.5 9.2 5.4 7.4 5.5 6.3 7.1 7.7 9.3 19.2 2.1 8.8 4.1 10.2 8.7 6.0 2.7 8.5 16.6 7.4 3.8 9.9 5.1 8.0 6.5 6.4 5.8 12.6 6.6 5.0 5.5 3.4 3.8 3.7 3.9 6.1 3.1 6.1 5.2 6.5 5.5 4.8 4.4 8.1 6.5 2.4 5.1 3.1 2.4 5.6 3.4 16.0 23.1 16.2 23.3 15.7 18.3 14.3 15.3 13.5 9.0 3.0 10.3 4.2 3.6 4.9 29.4 27.1 10.2 12.0 10.3 3.5 27.5 9.5 6.6 8.4 26.8 6.6 4.5 0.0 6.3 6.2 8.2 6.1 12.8 4.9 4.9 15.9 2.9 5.5 2.8 14.1 8.3 3.3 1.7 3.6 4.1 14.1 7.2 3.5 9.9 8.0 24.9 6.5 3.1 31.8 17.1 6.1 10.4 5.1 4.5 5.9 BUB1B-PAK6 ENSG00000259288 "BUB1B-PAK6 readthrough" 15 40217428-40276396 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031124 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.83e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-2)" 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BUD31 "Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W" ENSG00000106245 "BUD31 homolog" P41223 7 99408641-99419616 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028943 Approved Approved Nucleoplasm,Microtubules,Centrosome NA NA Nucleoplasm "Microtubules, Centrosome" "HPA028943: AB_10602396" "unprognostic (1.68e-1)" "unprognostic (2.73e-2)" "unprognostic (2.89e-2)" "unprognostic (2.63e-2)" "unprognostic (5.29e-2)" "unprognostic (2.38e-2)" "unprognostic (2.02e-3)" "unprognostic (2.16e-2)" "unprognostic (4.02e-2)" "unprognostic (1.46e-2)" "unprognostic (8.71e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (9.66e-4)" "unprognostic (1.42e-1)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (1.71e-1)" 26.4 31.9 43.6 26.1 44.8 66.6 29.5 28.3 36.4 25.6 31.3 25.6 31.6 27.0 25.1 32.2 35.2 35.7 28.1 30.8 39.2 36.3 37.9 33.2 26.2 34.5 39.5 27.4 28.8 31.4 21.0 35.2 33.7 32.3 27.3 22.7 22.0 31.5 28.9 20.7 23.5 31.2 25.4 34.5 29.1 26.7 51.2 27.0 24.1 40.1 29.0 31.6 35.3 26.5 39.1 32.2 91.2 42.7 34.1 37.6 56.6 25.2 29.8 16.7 37.4 16.8 18.9 16.2 24.3 23.4 27.9 30.7 34.8 25.2 19.4 29.7 23.4 30.4 15.1 18.4 22.2 23.5 23.4 24.9 14.1 21.2 22.8 35.0 24.0 18.7 18.4 27.5 25.4 48.1 16.3 21.7 20.4 34.6 44.5 25.6 66.3 31.5 65.1 36.7 27.0 37.4 16.5 16.9 33.5 24.4 20.2 29.4 35.4 24.0 27.7 50.5 11.3 17.4 30.3 17.7 26.6 33.9 52.7 37.9 28.0 46.9 51.7 23.5 35.9 48.1 59.1 39.3 91.2 34.1 40.5 31.9 39.1 32.8 33.0 32.2 36.6 27.9 29.2 83.0 34.1 42.7 31.1 37.6 56.6 43.6 44.8 28.3 36.4 39.2 36.3 39.5 27.4 32.3 27.0 77.4 75.2 90.6 127.0 171.3 30.4 11.1 68.8 149.9 61.4 87.2 9.8 144.5 202.2 156.4 106.4 90.4 143.8 23.3 162.5 137.0 129.0 115.9 89.0 77.4 132.0 15.9 140.8 71.8 86.2 82.8 75.9 103.3 129.9 174.1 105.3 65.9 188.4 119.3 69.6 168.4 26.3 58.2 153.3 197.9 133.6 160.7 152.5 126.4 87.3 146.8 C10orf62 bA548K23.1 ENSG00000203942 "Chromosome 10 open reading frame 62" Q5T681 10 97589727-97590934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 81.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 7737.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;Hep G2: 2.9;T-47d: 2.1" HPA072947 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA072947: AB_2686562" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (2.81e-1)" "unprognostic (5.36e-2)" "unprognostic (3.62e-1)" "unprognostic (1.20e-1)" "unprognostic (3.63e-2)" "unprognostic (2.53e-2)" "unprognostic (2.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.8 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.5 2.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1574.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7737.3 36.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.3 0.0 6.5 0.0 33.1 18.8 0.0 0.0 0.0 0.0 0.0 C10orf90 "bA422P15.2, FATS, FLJ32938" ENSG00000154493 "Chromosome 10 open reading frame 90" Q96M02 10 126424997-126670446 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3" "Group enriched" "Detected in some" 27 "Early spermatids: 96.0;Late spermatids: 93.2" "Cancer enriched" "Detected in some" 5 "melanoma: 4.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Cell line enhanced" "Detected in some" "SK-MEL-30: 49.5;U-2197: 15.1;U-266/84: 10.6;U-87 MG: 15.7;WM-115: 12.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038648, HPA075229" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA038648: AB_10672721, HPA075229: " "unprognostic (1.21e-2)" "unprognostic (3.34e-1)" "unprognostic (7.50e-2)" "unprognostic (2.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.30e-2)" "unprognostic (1.98e-3)" "unprognostic (5.06e-2)" "unprognostic (9.34e-3)" "unprognostic (3.73e-2)" "unprognostic (9.52e-2)" "unprognostic (1.22e-1)" "unprognostic (5.06e-11)" "unprognostic (2.69e-3)" "unprognostic (9.91e-3)" "unprognostic (1.26e-1)" "unprognostic (2.88e-1)" 1.9 0.8 7.5 1.0 21.5 0.8 9.2 1.4 18.7 0.9 0.9 30.9 0.0 0.7 0.8 0.8 0.9 0.7 1.1 0.8 10.8 5.9 0.9 0.8 0.8 0.7 26.0 5.9 0.9 1.1 0.7 0.5 1.3 14.4 0.9 1.0 1.7 18.6 0.7 0.9 1.9 0.8 0.8 17.2 0.8 0.7 12.3 28.0 0.0 1.3 0.0 2.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.1 0.0 2.0 0.0 15.1 0.3 0.0 10.6 0.0 15.7 0.0 12.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 21.5 1.4 11.3 10.8 5.9 26.0 5.9 14.4 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 96.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 93.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.4 0.0 3.5 0.0 0.0 0.0 C11orf24 DM4E3 ENSG00000171067 "Chromosome 11 open reading frame 24" Q96F05 11 68261335-68272001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 65.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 99.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 63.4" "HPA012411, HPA012748" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA012411: , HPA012748: AB_1845526" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (2.31e-2)" "unprognostic (7.91e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.56e-1)" "unprognostic (2.68e-2)" "unprognostic (4.99e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.60e-9)" "unprognostic (2.18e-2)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (8.67e-3)" 12.9 9.3 6.6 12.9 10.6 2.7 14.7 6.7 13.7 14.1 32.6 23.3 8.4 35.2 21.8 12.3 8.6 12.2 19.2 19.1 9.1 6.5 10.0 44.3 12.6 14.4 10.3 8.1 14.1 17.5 5.8 8.1 12.6 14.5 12.2 11.8 14.7 22.1 12.6 6.9 8.9 65.7 21.5 13.8 11.3 13.5 7.8 10.3 3.4 9.2 11.4 18.8 14.6 10.5 23.7 16.4 9.3 11.0 5.5 9.2 6.9 12.5 13.0 7.7 15.0 18.7 19.0 9.0 30.3 19.7 15.3 15.8 27.4 7.8 5.7 9.4 37.6 13.9 14.2 11.4 13.6 9.9 6.2 6.7 6.0 13.2 18.3 15.1 5.1 20.3 15.7 10.2 23.2 9.5 9.2 6.1 3.0 10.5 9.4 12.9 15.6 1.2 7.4 12.9 20.4 15.8 2.3 13.2 29.3 6.9 6.0 5.1 9.5 9.9 7.9 63.4 6.7 7.4 4.3 6.7 24.1 14.9 30.3 13.3 11.6 11.3 5.3 19.3 4.0 23.1 9.3 7.2 7.5 9.2 11.0 6.2 17.3 5.3 5.7 12.0 23.7 5.0 5.3 1.1 5.5 8.1 16.4 4.8 6.9 6.6 10.6 6.7 13.7 9.1 6.5 10.3 8.1 14.5 10.3 8.9 2.2 11.5 8.0 12.5 3.7 8.5 12.7 10.7 4.5 8.7 2.0 12.7 1.7 14.5 2.8 6.4 37.3 0.0 27.1 24.7 18.1 10.2 43.9 99.7 14.5 0.0 4.6 9.2 12.1 5.6 13.0 12.4 27.0 21.6 33.5 6.6 21.8 12.4 15.2 8.8 2.9 12.9 17.9 12.7 20.6 9.8 8.8 4.9 12.8 7.9 C11orf68 "BLES03, P5326" ENSG00000175573 "Chromosome 11 open reading frame 68" Q9H3H3 11 65916808-65919117 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045938 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" No Yes "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA045938: AB_10961633" "unprognostic (3.18e-1)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (1.23e-1)" "unprognostic (9.25e-2)" "unprognostic (1.15e-2)" "unprognostic (9.88e-2)" "unprognostic (5.98e-2)" "unprognostic (9.88e-2)" "unprognostic (2.73e-1)" "unprognostic (1.50e-3)" "prognostic favorable (5.02e-6)" "unprognostic (2.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.07e-2)" "unprognostic (1.18e-1)" 20.1 13.1 23.5 11.0 23.5 6.9 15.4 44.0 42.9 24.5 19.7 20.0 16.6 13.6 26.3 33.0 19.0 25.3 16.4 24.5 22.9 18.8 13.7 12.1 15.4 17.3 18.3 23.7 32.9 17.6 20.6 11.0 19.5 18.6 23.3 12.9 14.8 24.2 27.5 37.0 19.6 13.1 22.2 15.5 19.0 14.1 21.5 18.5 23.0 21.5 13.1 16.4 22.3 23.1 6.6 3.6 12.6 5.2 4.9 7.5 2.8 20.4 9.2 5.7 6.2 20.2 19.6 4.9 16.4 25.2 21.0 12.9 3.4 23.3 4.2 11.5 24.6 33.7 6.7 4.4 10.1 11.4 6.5 4.4 5.0 6.2 8.9 16.1 3.9 6.7 18.1 15.2 15.2 16.9 21.9 15.6 7.2 6.6 10.6 38.1 9.3 5.2 9.6 5.7 4.5 46.3 7.7 6.5 11.8 11.1 3.9 3.9 6.1 6.3 8.4 15.8 6.2 10.8 3.8 16.8 33.6 16.4 45.6 8.3 7.1 3.1 3.5 19.9 3.0 26.1 8.7 3.5 4.9 7.4 5.2 5.2 4.2 4.8 6.1 2.6 6.6 7.4 7.5 12.6 4.9 2.6 3.6 5.6 2.8 23.5 23.5 44.0 42.9 22.9 18.8 18.3 23.7 18.6 18.5 14.9 6.1 6.7 24.0 13.6 10.2 13.7 15.3 0.0 1.2 15.7 9.8 13.0 6.6 11.6 6.3 10.5 10.0 0.0 10.0 13.3 15.8 19.5 3.5 9.6 12.3 15.9 4.6 16.0 11.5 19.9 19.8 6.6 10.1 14.4 11.6 22.3 13.9 0.0 33.2 5.1 7.2 19.4 12.5 13.9 14.3 11.2 18.3 8.7 8.4 22.4 C11orf96 AG2 ENSG00000187479 "Chromosome 11 open reading frame 96" 11 43942505-43944338 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 152.0" "Cell type enhanced" "Detected in many" 19 "Peritubular cells: 445.9;Sertoli cells: 297.5;Smooth muscle cells: 1129.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 65.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038843 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" No NA "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA038843: AB_10673296" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.28e-2)" "unprognostic (8.15e-3)" "unprognostic (5.49e-2)" "unprognostic (3.42e-3)" "unprognostic (8.11e-3)" "unprognostic (1.15e-2)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (2.34e-5)" "unprognostic (2.65e-2)" "unprognostic (2.07e-1)" "unprognostic (1.18e-2)" "unprognostic (3.19e-2)" 68.2 81.2 4.9 23.4 17.4 3.4 42.6 2.6 10.5 39.7 32.2 3.3 6.6 12.4 35.1 41.5 16.3 69.3 70.0 34.3 8.8 7.9 17.9 67.7 61.9 4.9 7.6 4.7 152.0 18.1 3.8 14.2 14.6 32.8 28.6 6.2 7.6 2.3 12.8 38.2 10.1 17.2 22.9 15.3 12.7 31.3 41.7 4.2 0.0 16.7 14.0 2.3 62.9 32.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.9 2.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.4 0.6 0.7 0.0 0.0 0.0 0.7 0.8 0.5 0.0 0.3 3.3 0.2 1.4 0.0 0.0 0.7 65.3 0.0 0.0 6.0 1.9 0.0 0.7 0.9 3.1 1.3 0.8 0.0 7.6 0.0 1.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 17.4 2.6 7.1 8.8 7.9 7.6 4.7 32.8 4.2 6.0 166.6 0.0 14.6 82.5 15.3 5.3 0.0 1.4 2.3 0.0 2.0 1.1 0.0 2.2 3.5 30.5 0.0 0.0 0.5 3.5 142.9 42.4 12.8 2.5 3.3 1.6 0.0 114.8 6.9 5.8 199.6 9.5 165.4 0.0 0.0 2.3 2.8 0.0 445.9 0.0 7.6 297.5 1129.9 1.6 1.4 77.3 2.6 2.5 0.0 35.8 C12orf65 "FLJ38663, SPG55" ENSG00000130921 "Chromosome 12 open reading frame 65" Q9H3J6 12 123232916-123257959 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057595 Approved Approved Nucleoplasm,Mitochondria,Cytosol No Yes "Nucleoplasm, Cytosol" Mitochondria "HPA057595: " "unprognostic (9.07e-3)" "unprognostic (1.51e-2)" "unprognostic (5.30e-2)" "unprognostic (8.19e-3)" "unprognostic (1.23e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (4.29e-9)" "unprognostic (9.33e-3)" "unprognostic (2.39e-1)" "unprognostic (2.50e-2)" "unprognostic (6.33e-3)" "unprognostic (1.20e-2)" "unprognostic (2.01e-2)" "unprognostic (3.89e-2)" "unprognostic (3.19e-2)" "unprognostic (9.83e-3)" "prognostic favorable (7.82e-5)" 7.8 15.7 13.2 11.3 15.1 9.6 9.0 21.6 18.2 14.1 10.8 12.3 11.6 13.8 14.9 16.5 10.7 11.7 11.1 17.4 13.2 15.2 12.1 15.6 10.6 18.8 11.5 13.2 21.3 12.4 8.8 24.6 9.2 15.0 15.1 9.7 13.1 21.2 10.8 14.3 17.7 12.6 10.5 14.2 14.7 11.7 17.3 12.2 80.9 15.3 7.9 15.5 14.3 13.7 23.6 10.0 22.6 4.6 17.1 28.9 10.0 14.2 9.9 11.2 21.9 5.6 6.0 6.8 11.9 7.6 12.1 8.9 10.6 8.5 17.8 10.3 3.8 12.3 10.5 12.1 6.5 11.6 13.3 10.8 21.0 9.7 9.2 12.6 9.7 10.6 6.3 15.8 8.8 18.2 18.7 7.8 25.5 22.1 7.4 8.0 6.2 23.3 18.0 8.5 12.1 15.2 17.4 13.3 16.5 11.3 8.2 23.8 10.3 13.3 6.8 12.4 8.4 10.8 11.4 8.8 13.2 15.8 11.9 12.0 12.2 14.0 16.3 8.6 12.9 17.2 22.6 3.5 14.0 15.9 3.8 19.8 23.6 22.0 21.1 6.0 20.2 28.9 24.7 3.7 17.1 4.6 10.0 18.5 10.0 13.2 15.1 21.6 18.2 13.2 15.2 11.5 13.2 15.0 12.2 38.7 45.0 27.9 34.0 40.3 32.8 41.3 15.3 17.4 20.5 24.4 13.7 36.6 51.4 17.6 17.3 20.3 14.7 23.3 9.4 19.4 29.7 17.7 14.0 27.0 12.6 42.9 9.2 16.5 7.5 5.0 35.1 13.2 23.6 37.9 16.9 33.9 12.4 13.3 39.6 23.9 34.3 12.9 33.9 63.0 26.2 31.6 9.0 44.9 20.0 7.1 C12orf74 ENSG00000214215 "Chromosome 12 open reading frame 74" Q32Q52 12 92702843-92708549 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 6.9;lung: 6.6;lymphoid tissue: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "memory B-cell: 3.7;naive B-cell: 3.1" "Lineage enriched" "Detected in single" 21 "B-cells: 3.7" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.7;RT4: 2.5;SK-BR-3: 2.8" HPA062856 Approved "Nucleoplasm,Nuclear bodies,Aggresome" NA NA Nucleoplasm "Nuclear bodies, Aggresome" "HPA062856: " "unprognostic (2.75e-2)" "unprognostic (4.33e-2)" "unprognostic (2.28e-3)" "unprognostic (4.55e-3)" "unprognostic (7.95e-4)" "unprognostic (2.23e-1)" "unprognostic (2.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.15e-1)" "unprognostic (5.84e-2)" "unprognostic (5.83e-4)" "unprognostic (3.03e-1)" "unprognostic (5.89e-2)" "unprognostic (1.42e-2)" 0.2 0.1 0.1 12.3 0.1 0.0 0.2 0.1 0.1 2.1 0.7 0.0 3.6 0.3 0.7 6.9 1.7 4.5 0.3 0.2 0.1 0.1 1.3 0.5 6.6 1.9 0.1 0.0 1.0 1.1 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.9 0.9 0.1 0.2 1.8 0.0 0.1 2.6 2.1 0.5 0.0 0.1 0.2 0.0 10.5 2.5 1.4 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 2.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C17orf100 LOC388327 ENSG00000256806 "Chromosome 17 open reading frame 100" 17 6651718-6693202 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 18.4" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 26.3;Late spermatids: 35.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 11.6;SH-SY5Y: 11.5" HPA046824 Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA046824: AB_2679825" "unprognostic (9.24e-3)" "unprognostic (1.79e-1)" "unprognostic (3.16e-1)" "unprognostic (6.37e-3)" "unprognostic (1.56e-1)" "unprognostic (1.90e-2)" "unprognostic (1.19e-1)" "unprognostic (8.99e-2)" "unprognostic (2.69e-1)" "unprognostic (2.02e-3)" "unprognostic (2.58e-3)" "unprognostic (4.72e-2)" "unprognostic (5.54e-3)" "unprognostic (4.52e-2)" "unprognostic (9.68e-2)" "unprognostic (9.44e-2)" "unprognostic (7.65e-2)" 0.8 1.5 1.4 1.6 3.3 0.1 1.4 3.8 5.6 2.3 2.4 4.0 1.2 3.6 1.5 2.8 2.1 1.7 1.5 0.3 1.5 2.2 18.4 1.2 3.5 1.3 2.5 1.1 8.5 2.5 9.1 0.6 3.0 2.2 1.6 0.8 5.2 1.1 0.3 9.3 4.3 0.7 1.6 2.2 2.8 3.6 2.3 1.6 3.3 0.2 1.1 1.7 0.5 5.7 3.1 7.5 2.4 2.5 5.5 1.9 1.3 2.5 5.7 1.8 0.8 1.6 2.7 0.7 4.1 1.7 3.4 3.8 1.8 1.5 2.9 1.3 4.4 4.9 1.1 2.6 2.5 6.5 7.5 1.4 2.6 11.6 2.0 0.2 3.9 2.3 2.5 0.8 1.8 5.0 1.0 8.0 1.8 1.5 2.2 2.8 1.6 2.4 0.8 2.3 1.7 3.1 0.9 2.3 3.4 1.1 5.9 11.5 3.4 0.4 3.9 1.8 3.0 0.4 1.5 1.6 3.3 0.9 1.3 2.1 1.4 1.0 1.4 0.5 3.7 5.7 1.9 7.5 2.5 2.4 3.4 4.3 4.6 2.9 3.1 5.7 5.5 3.0 1.8 2.5 2.3 1.0 3.0 1.9 0.0 1.7 0.0 4.6 2.5 3.7 0.3 0.0 2.7 5.7 0.0 2.0 1.3 1.7 3.4 26.3 1.0 5.9 0.0 2.9 1.4 1.5 3.9 9.2 0.0 1.1 1.6 7.5 0.0 0.0 35.6 0.9 1.0 1.7 1.0 5.4 5.2 2.8 3.5 1.8 2.1 5.2 6.5 2.5 11.1 4.2 2.6 1.3 0.5 3.0 4.7 C17orf51 "FLJ12977, FLJ31874, FLJ33618" ENSG00000212719 "Chromosome 17 open reading frame 51" A8MQB3 17 21524790-21574458 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 41.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 20.9;Early spermatids: 18.9;Horizontal cells: 23.8;Rod photoreceptor cells: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052106 Enhanced Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA052106: AB_2681728" "unprognostic (1.99e-1)" "unprognostic (5.29e-2)" "unprognostic (6.35e-3)" "unprognostic (2.78e-3)" "unprognostic (3.72e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-3)" "unprognostic (5.80e-2)" "unprognostic (2.55e-1)" "unprognostic (1.53e-1)" "unprognostic (2.51e-3)" "unprognostic (7.42e-3)" "unprognostic (2.29e-2)" "unprognostic (1.23e-1)" "unprognostic (3.17e-1)" "unprognostic (6.42e-5)" "unprognostic (9.05e-3)" 6.1 7.2 8.0 4.2 8.4 0.8 3.0 41.2 20.5 5.3 4.5 5.2 3.1 3.2 8.3 10.1 3.2 6.7 3.6 6.5 8.6 7.3 4.0 3.8 3.0 3.0 5.9 8.1 5.9 6.6 7.8 8.9 2.1 5.5 6.3 3.2 3.8 5.0 7.0 7.3 3.0 2.4 6.6 5.0 3.3 4.1 9.2 5.9 1.2 2.9 2.2 3.0 4.0 4.7 4.2 4.1 1.2 3.9 2.6 6.0 1.8 2.6 6.2 2.3 8.0 7.4 7.0 2.2 7.2 3.6 5.2 6.0 12.2 0.4 3.5 4.1 3.9 6.4 0.3 9.9 3.8 8.7 11.1 15.4 0.7 5.7 5.1 13.8 0.9 3.9 6.6 3.4 10.6 11.6 1.9 3.7 9.5 1.9 0.8 4.4 0.0 7.7 0.4 4.4 3.3 5.2 7.5 4.9 0.5 1.9 0.5 5.2 0.9 6.7 0.2 5.3 8.7 0.1 0.3 6.7 6.2 6.3 14.7 8.6 2.3 2.8 13.7 7.4 1.3 7.2 0.0 3.9 0.0 4.0 1.8 3.1 2.2 1.9 1.8 1.9 4.2 6.0 5.1 1.2 2.6 1.0 4.1 1.7 1.8 8.0 8.4 41.2 14.5 8.6 7.3 5.9 8.1 5.5 5.9 0.0 0.6 1.5 4.4 4.4 20.9 3.3 0.0 4.0 2.3 1.8 15.7 0.4 5.0 1.8 18.9 2.8 0.0 0.0 3.1 1.5 6.1 2.9 0.0 2.6 1.1 23.8 1.2 1.3 0.3 11.5 5.8 1.3 5.0 0.0 1.3 5.2 1.6 0.0 7.8 2.1 28.0 0.0 7.9 13.0 6.5 1.9 0.2 0.9 0.9 1.2 C19orf33 "H2RSP, IMUP, IMUP-1, IMUP-2" ENSG00000167644 "Chromosome 19 open reading frame 33" Q9GZP8 19 38304161-38305009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 105.8;tongue: 78.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 1588.2;Exocrine glandular cells: 683.1;Mucus-secreting cells: 800.2;Pancreatic endocrine cells: 1532.5;Paneth cells: 1006.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 11 "myeloid DC: 15.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.1" "Cell line enhanced" "Detected in some" "A-431: 70.1;A549: 108.2;CAPAN-2: 66.8;HBEC3-KT: 64.8;hTCEpi: 67.9;OE19: 57.5;PC-3: 61.8" "HPA054406, HPA059696" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA054406: AB_2682478, HPA059696: AB_2684105" "unprognostic (9.31e-2)" "unprognostic (2.06e-1)" "unprognostic (4.34e-2)" "unprognostic (1.44e-2)" "unprognostic (3.92e-3)" "unprognostic (2.37e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.09e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (6.92e-2)" "unprognostic (5.50e-2)" "unprognostic (4.82e-2)" "unprognostic (1.61e-1)" "unprognostic (3.63e-2)" "unprognostic (6.01e-2)" 6.9 0.6 0.5 16.4 0.7 0.3 5.0 0.5 0.8 14.5 58.8 0.6 3.5 34.6 3.9 4.3 88.4 18.2 45.2 9.9 0.8 0.3 5.8 1.0 34.8 0.6 0.7 1.4 4.9 0.8 0.0 2.0 10.0 1.7 10.3 18.2 1.2 21.5 6.8 2.8 53.3 105.8 2.9 3.1 1.9 28.7 1.5 0.5 1.5 4.4 78.5 39.2 16.2 35.1 0.1 15.1 1.4 0.6 0.3 0.4 14.6 70.1 108.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 66.8 0.0 40.1 0.0 0.0 26.3 0.0 64.8 0.0 0.0 0.0 0.0 22.7 1.8 0.5 0.0 0.0 0.0 67.9 0.0 43.6 0.1 1.1 0.0 0.0 0.0 0.0 18.1 0.0 0.1 0.1 57.5 61.8 0.0 0.0 0.0 41.0 20.8 0.1 0.0 41.0 29.7 0.0 0.1 9.2 0.2 14.6 0.0 20.4 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.6 1.4 0.3 0.0 0.3 0.1 0.2 0.1 15.1 0.1 0.4 0.3 0.9 0.3 0.0 0.9 0.0 14.6 0.5 0.7 0.5 0.8 0.8 0.3 0.7 1.4 1.7 0.5 497.3 155.5 7.0 25.1 200.2 0.0 1.4 298.1 195.4 353.8 52.4 0.0 5.2 1.7 144.5 0.4 9.8 1588.2 0.0 683.1 1.0 5.6 22.7 39.1 0.0 1.3 0.0 73.3 4.9 1.6 2.8 3.7 8.2 1.7 4.6 800.2 0.0 1532.5 1006.5 0.0 21.6 0.0 0.0 5.0 1.4 1.9 304.5 2.6 0.0 506.3 112.5 C1orf100 ENSG00000173728 "Chromosome 1 open reading frame 100" Q5SVJ3 1 244352635-244389663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 65.3" "Group enriched" "Detected in some" 119 "Early spermatids: 1095.9;Late spermatids: 535.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 51 "K-562: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031179, HPA031180" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA031179: AB_10599995, HPA031180: AB_10599026" "unprognostic (9.84e-2)" "unprognostic (2.14e-3)" "unprognostic (3.37e-2)" "unprognostic (9.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.49e-2)" "unprognostic (5.45e-3)" "unprognostic (2.17e-2)" "unprognostic (4.00e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-5)" "unprognostic (1.85e-2)" "unprognostic (2.08e-3)" "unprognostic (2.53e-2)" "unprognostic (1.79e-1)" "unprognostic (2.85e-1)" "unprognostic (1.27e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1095.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 535.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 6.9 1.6 0.0 0.0 0.0 0.0 0.0 C1orf109 FLJ20508 ENSG00000116922 "Chromosome 1 open reading frame 109" Q9NX04 1 37681570-37692249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 44.6;Suprabasal keratinocytes: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027110, HPA027127" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA027110: AB_10611813, HPA027127: AB_1845628" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-3)" "unprognostic (1.71e-2)" "unprognostic (7.13e-3)" "prognostic unfavorable (1.76e-7)" "unprognostic (1.93e-1)" "unprognostic (1.48e-2)" "unprognostic (8.38e-2)" "unprognostic (1.73e-1)" "unprognostic (3.79e-3)" "unprognostic (9.96e-2)" "unprognostic (1.66e-2)" "unprognostic (2.25e-1)" "unprognostic (7.96e-3)" "unprognostic (1.69e-1)" 13.8 15.1 12.0 9.3 15.0 9.3 14.5 17.9 20.5 12.9 11.1 11.4 16.2 11.0 15.9 14.3 13.7 13.9 10.5 11.1 13.1 12.9 12.8 12.0 8.8 14.1 13.6 15.0 19.7 19.6 20.5 10.9 14.6 15.9 15.0 7.8 12.9 20.3 14.8 15.2 14.9 8.5 11.6 9.9 10.1 11.1 11.2 12.2 13.1 15.7 9.1 12.6 13.7 12.8 11.4 27.5 3.3 5.0 12.2 16.2 7.5 8.3 9.6 8.3 13.6 7.3 5.2 18.9 10.0 7.1 15.2 11.2 14.6 10.1 11.9 12.1 4.4 7.0 12.2 15.3 10.2 15.6 18.9 17.2 13.5 9.7 9.1 14.1 14.7 8.9 7.1 12.6 14.9 19.5 6.6 7.6 10.5 26.5 14.5 8.6 5.7 14.2 6.5 25.8 8.6 18.5 14.2 17.4 32.5 8.0 7.2 25.1 12.1 8.8 13.7 20.3 8.7 7.7 6.6 5.1 15.3 9.6 12.3 20.3 11.8 13.1 24.3 7.6 14.4 16.0 1.7 5.0 3.3 10.3 3.9 16.1 11.4 12.4 9.9 5.9 10.3 16.2 13.8 0.9 12.2 4.2 27.5 6.2 7.5 12.0 15.0 17.9 20.5 13.1 12.9 13.6 15.0 15.9 12.2 6.0 6.4 16.6 16.0 44.6 9.7 4.5 7.6 6.7 15.9 3.5 9.8 11.8 11.6 8.2 1.2 10.5 4.0 23.3 6.3 11.6 13.5 9.8 11.5 4.9 4.9 15.9 4.1 5.5 4.3 0.2 9.2 4.9 11.8 7.2 4.5 10.1 8.1 7.0 13.1 6.8 12.2 0.0 10.3 10.1 26.6 54.3 6.6 13.8 7.3 9.6 C1orf189 ENSG00000163263 "Chromosome 1 open reading frame 189" Q5VU69 1 154199372-154206333 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 11.9;fallopian tube: 41.8;testis: 21.0" "Cell type enhanced" "Detected in some" 31 "Ciliated cells: 28.1;Early spermatids: 63.9;Late spermatids: 12.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045779 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Golgi apparatus, Plasma membrane" "HPA045779: AB_2679448" "unprognostic (8.23e-3)" "unprognostic (5.55e-3)" "unprognostic (2.39e-2)" "unprognostic (2.01e-3)" "unprognostic (2.50e-3)" "unprognostic (2.02e-1)" "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.24e-2)" "unprognostic (8.78e-3)" "unprognostic (1.36e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (3.75e-2)" "unprognostic (2.06e-1)" "unprognostic (9.79e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.4 0.1 0.6 0.5 0.1 0.1 0.2 2.2 0.1 0.8 0.1 0.0 0.7 11.9 0.1 41.8 0.1 0.1 0.8 1.1 0.1 0.3 5.6 0.1 0.1 0.1 4.2 0.1 0.0 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 21.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.3 3.2 1.0 0.0 1.6 0.3 0.1 0.0 1.8 0.0 1.4 0.0 1.0 0.6 0.8 2.1 0.0 3.4 0.9 1.3 0.4 0.0 0.2 0.5 1.4 2.3 0.0 1.4 2.1 0.8 2.7 2.3 2.1 0.6 0.8 2.6 1.9 0.8 0.0 0.0 0.0 1.4 1.2 0.4 1.0 3.7 0.8 0.3 3.3 1.3 3.8 0.4 1.5 0.9 0.0 0.0 0.9 0.0 0.0 0.0 2.7 0.3 2.5 0.0 1.9 0.0 2.0 1.3 1.2 2.3 2.3 0.5 0.4 0.5 0.0 0.0 0.1 1.5 0.2 1.0 0.0 0.2 0.1 0.4 0.3 0.8 0.2 1.6 3.2 0.0 0.5 0.0 0.4 0.3 0.4 0.6 0.1 0.2 0.8 1.1 0.1 0.1 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 63.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 C2orf91 ENSG00000205086 "Chromosome 2 open reading frame 91" Q6ZV80 2 41935368-41954266 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;lung: 4.7" "Cell type enhanced" "Detected in single" 22 "Alveolar cells type 1: 3.0" "Cancer enriched" "Detected in single" 9 "testis cancer: 0.8" "Region enhanced" "Detected in some" "midbrain: 5.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "AN3-CA: 5.2;HDLM-2: 17.9" HPA042517 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" Nucleoplasm "HPA042517: AB_10795508" "unprognostic (9.49e-3)" "unprognostic (2.24e-2)" "unprognostic (1.73e-1)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (8.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-2)" "unprognostic (3.37e-1)" "unprognostic (3.92e-2)" "unprognostic (1.16e-1)" "unprognostic (4.79e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (7.61e-2)" "unprognostic (2.78e-2)" "unprognostic (1.47e-1)" 0.3 2.1 0.3 0.3 1.3 1.5 0.3 0.3 0.8 0.4 0.3 0.8 0.2 0.0 0.4 1.0 0.3 0.3 0.3 0.5 0.3 0.4 0.9 0.3 4.7 0.9 5.1 0.2 0.4 0.4 0.4 0.5 0.2 1.9 0.8 0.2 0.8 3.5 0.2 0.2 1.3 0.3 0.2 2.2 0.6 1.3 1.1 0.2 0.2 0.2 0.2 0.6 0.2 0.3 1.2 1.4 2.8 1.2 1.2 0.9 0.3 0.2 0.4 0.7 5.2 0.2 0.1 0.3 0.1 0.1 0.0 0.3 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.0 0.1 0.1 17.9 0.3 0.2 0.4 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 1.8 0.1 0.3 0.1 0.1 0.3 0.4 0.1 0.0 0.6 0.1 0.1 0.3 0.2 1.8 0.0 0.0 0.2 0.9 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.2 1.3 1.2 1.4 0.6 0.9 0.5 0.6 0.7 0.5 1.4 1.2 0.7 0.9 2.8 1.2 1.0 1.3 0.4 0.3 0.3 1.3 0.3 0.8 0.3 0.4 5.1 0.2 1.9 0.2 3.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 C3orf36 FLJ22173 ENSG00000221972 "Chromosome 3 open reading frame 36" Q3SXR2 3 133928145-133929812 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "lung: 8.2;seminal vesicle: 14.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 6.6;HeLa: 1.7;TIME: 5.2" HPA046432 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA046432: AB_2679664" "unprognostic (3.56e-1)" "unprognostic (3.28e-2)" "unprognostic (1.87e-1)" "unprognostic (5.29e-3)" "unprognostic (4.64e-4)" "unprognostic (5.05e-3)" "unprognostic (8.18e-5)" "unprognostic (1.22e-1)" "unprognostic (2.74e-2)" "unprognostic (2.03e-2)" "unprognostic (1.15e-2)" "unprognostic (2.22e-1)" "unprognostic (7.85e-2)" "unprognostic (4.79e-3)" "unprognostic (2.08e-1)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" 1.1 1.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.2 1.3 0.0 0.6 1.1 0.8 0.7 0.0 0.0 1.9 0.0 8.2 0.1 0.0 0.0 0.7 1.6 0.2 0.1 2.3 0.3 0.4 14.7 0.0 0.1 1.4 1.0 0.0 1.5 0.8 0.0 2.7 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf38 MGC26717 ENSG00000179021 "Chromosome 3 open reading frame 38" Q5JPI3 3 88149743-88168729 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 252.0;Late spermatids: 238.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 59.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034736, HPA034737" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA034736: AB_2674307, HPA034737: AB_10671505" "unprognostic (1.93e-1)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (1.48e-2)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (2.26e-3)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "prognostic favorable (3.55e-4)" "unprognostic (9.28e-3)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.95e-2)" "unprognostic (2.88e-3)" "unprognostic (1.63e-1)" "unprognostic (4.57e-2)" "unprognostic (3.67e-2)" 12.2 11.7 13.7 12.8 16.1 35.2 12.3 12.9 12.8 11.6 11.9 13.6 8.4 9.5 11.5 10.7 14.6 10.7 9.4 9.7 11.3 11.1 10.2 13.5 10.6 19.2 15.1 9.4 12.1 9.3 7.1 15.8 12.5 11.4 11.2 11.2 9.0 10.6 10.2 9.7 11.6 11.4 10.9 11.3 17.0 10.1 33.2 13.5 29.5 11.6 9.0 17.1 12.4 11.6 20.0 17.7 25.8 24.2 17.1 17.4 15.3 6.4 6.7 13.2 7.0 8.8 8.0 6.1 10.5 12.6 15.7 21.3 7.7 8.9 8.7 9.4 9.7 7.5 4.7 9.5 7.7 13.6 15.6 4.5 10.6 5.2 6.5 12.6 14.5 9.2 11.4 7.8 10.5 9.0 10.3 9.0 9.5 6.7 10.0 17.0 7.5 14.6 6.1 16.0 12.1 7.6 9.2 4.6 8.2 10.4 8.8 4.0 5.8 9.6 5.3 15.8 11.2 10.2 11.1 8.2 9.8 10.7 59.4 11.5 9.2 13.6 12.9 7.6 11.5 9.2 25.8 16.8 17.5 13.5 24.2 17.4 20.0 12.6 13.8 17.7 15.9 12.6 12.8 7.5 17.1 19.7 12.3 15.1 15.3 13.7 16.1 12.9 12.8 11.3 11.1 15.1 9.4 11.4 13.5 17.9 6.9 32.0 16.6 10.4 21.8 5.6 0.0 14.7 11.4 5.2 21.6 19.3 16.6 14.7 252.0 8.7 11.8 0.0 12.0 18.8 15.4 14.2 13.9 7.4 23.4 6.4 15.5 8.6 17.2 238.1 15.3 21.8 15.1 27.1 10.7 22.8 11.6 13.3 14.2 9.8 21.7 12.9 12.2 25.9 12.0 12.3 21.4 28.7 9.0 18.6 C3orf52 "FLJ23186, TTMP" ENSG00000114529 "Chromosome 3 open reading frame 52" Q5BVD1 3 112086335-112131004 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 41.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 112.5;Glandular cells: 75.6;Syncytiotrophoblasts: 62.7;Urothelial cells: 119.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 14.9;U-698: 20.8" "HPA007678, HPA008119, HPA011968" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826" "unprognostic (8.86e-2)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.45e-2)" "unprognostic (3.87e-3)" "unprognostic (3.49e-4)" "unprognostic (2.54e-1)" "unprognostic (1.39e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.71e-2)" "unprognostic (3.76e-6)" "unprognostic (3.14e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-2)" "unprognostic (9.59e-2)" 1.1 1.0 0.3 5.3 0.7 0.4 1.9 0.3 0.4 1.0 9.1 0.0 6.9 2.8 1.7 1.5 2.7 1.0 12.4 3.0 0.4 0.4 7.1 0.5 6.3 0.8 0.3 0.0 0.6 41.2 0.0 8.7 6.1 0.5 5.4 9.0 0.6 3.9 9.6 1.5 22.3 12.7 4.2 0.3 0.8 10.6 1.0 0.0 20.8 10.7 4.3 3.6 6.1 6.1 0.8 0.8 0.0 0.0 0.0 2.7 1.0 8.7 1.4 2.4 0.0 0.3 0.0 3.2 6.9 2.9 4.0 4.6 14.9 4.7 0.3 1.3 2.0 4.6 6.2 2.8 1.7 7.6 0.0 2.3 6.0 2.0 0.7 1.8 0.0 0.0 0.5 3.5 3.6 6.1 2.8 0.9 0.0 1.5 1.5 3.0 0.6 0.2 0.0 5.2 5.6 1.9 0.2 7.9 0.0 7.1 7.7 0.3 0.6 2.6 2.7 2.5 2.9 4.0 0.0 2.2 1.4 2.4 0.0 0.0 5.5 0.0 20.8 1.2 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.4 0.8 2.7 1.3 0.5 0.3 1.5 0.6 0.0 0.0 0.0 0.8 0.0 1.0 0.3 0.7 0.3 0.4 0.4 0.4 0.3 0.0 0.5 0.0 14.9 7.7 0.5 112.5 28.8 0.0 1.4 5.1 13.4 22.7 17.4 0.0 15.2 0.0 29.6 24.4 0.3 14.6 0.0 31.2 16.0 1.7 75.6 0.0 0.0 1.6 0.0 11.3 0.6 0.3 18.2 0.3 0.3 1.7 4.6 32.5 0.0 53.5 5.9 0.4 1.7 0.0 0.0 3.3 1.8 5.5 29.4 62.7 0.8 5.4 119.7 C5orf67 ENSG00000225940 "Chromosome 5 open reading frame 67" F2Z3F1 5 56511567-56606232 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 17.9;kidney: 9.3;retina: 16.3" "Group enriched" "Detected in some" 4 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Proximal tubular cells: 1.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Region enriched" "Detected in some" 5 "pons and medulla: 6.1" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 3.3;monocytes: 1.9" "Group enriched" "Detected in some" 7 "CACO-2: 3.2;EFO-21: 9.3;U-266/70: 10.4" HPA054214 Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoli "Nucleoplasm, Vesicles" "HPA054214: " "unprognostic (7.28e-2)" "unprognostic (1.41e-1)" "unprognostic (2.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.12e-3)" "unprognostic (6.58e-2)" "unprognostic (7.93e-2)" "unprognostic (2.91e-1)" "unprognostic (2.18e-1)" "unprognostic (8.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (3.62e-2)" 0.4 0.0 0.2 0.2 1.2 0.4 1.0 0.2 0.2 0.4 0.8 0.4 0.2 1.5 0.6 17.9 0.4 0.4 0.2 0.2 0.6 0.2 9.3 0.2 0.4 0.6 0.7 0.2 0.2 0.2 0.0 0.2 0.2 6.1 0.2 0.0 16.3 1.1 0.2 0.2 0.8 1.6 0.2 0.2 1.5 0.1 0.2 0.2 0.2 2.1 0.2 0.2 0.2 0.2 0.1 1.5 3.3 1.9 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.3 0.0 9.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.2 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 3.3 0.0 1.9 1.5 0.4 0.1 0.2 1.2 0.2 0.2 0.6 0.2 0.7 0.2 6.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C7orf31 ENSG00000153790 "Chromosome 7 open reading frame 31" Q8N865 7 25134697-25180356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 60.9" "Group enriched" "Detected in many" 17 "Early spermatids: 399.0;Late spermatids: 665.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 18.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA020346 Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA020346: AB_1845758" "unprognostic (3.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (1.19e-1)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (2.90e-1)" "unprognostic (1.06e-1)" "unprognostic (3.12e-3)" "unprognostic (8.26e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.15e-2)" 2.4 6.2 1.5 4.8 3.1 1.3 2.3 4.0 1.6 3.3 5.1 2.9 2.0 3.3 3.3 2.9 2.4 2.6 3.7 3.1 1.9 1.5 2.6 1.2 2.8 7.0 2.0 2.2 4.6 1.8 4.3 2.1 1.1 2.3 3.2 3.6 4.1 6.0 2.3 0.9 1.8 3.9 2.4 2.9 3.7 3.4 60.9 2.4 5.9 4.6 0.9 3.3 3.5 5.1 3.0 5.9 2.3 1.3 2.8 2.8 0.9 2.8 2.0 4.5 5.2 1.8 1.0 2.5 1.2 4.9 3.7 5.6 3.9 2.7 7.2 1.9 2.2 14.6 1.1 5.0 1.4 4.0 3.4 4.9 3.4 0.2 5.2 4.3 5.5 8.3 3.1 3.9 3.0 0.7 2.6 0.7 6.2 5.1 4.0 0.9 0.0 5.6 7.0 1.8 6.6 1.8 7.0 5.2 1.1 2.5 3.6 1.3 3.8 1.2 4.9 4.6 6.6 0.8 9.2 1.0 2.3 6.2 0.0 1.8 18.0 5.7 10.3 0.7 5.3 10.6 1.4 1.3 2.3 1.7 0.6 2.3 3.0 1.1 1.5 1.7 2.1 2.8 2.2 0.1 2.8 0.8 5.9 2.8 0.9 1.5 3.1 4.0 1.6 1.9 1.5 2.0 2.2 2.3 2.4 0.0 5.3 2.9 2.3 1.0 0.9 1.0 2.5 5.3 0.0 0.0 0.0 2.8 3.3 1.0 399.0 2.2 2.5 0.0 3.4 2.1 2.5 0.9 0.0 1.0 2.4 0.0 4.1 1.8 5.0 665.4 6.6 2.9 3.3 4.6 2.8 7.7 3.2 6.5 4.9 0.6 0.5 0.0 2.1 31.4 12.4 0.5 1.9 4.3 6.0 0.9 C8orf34 "vest-1, VEST1" ENSG00000165084 "Chromosome 8 open reading frame 34" Q49A92 8 68330722-68819022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.3;parathyroid gland: 19.9" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 16.0;Ciliated cells: 28.1;Club cells: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.5;HEK 293: 5.8;LHCN-M2: 5.1;RH-30: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044420, HPA053065" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus" No NA "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA044420: AB_10963791, HPA053065: AB_2682030" "unprognostic (1.75e-1)" "unprognostic (2.20e-1)" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (3.07e-1)" "unprognostic (2.85e-2)" "unprognostic (3.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.80e-1)" "unprognostic (1.74e-1)" "unprognostic (8.55e-2)" "unprognostic (5.86e-2)" "unprognostic (1.80e-4)" "unprognostic (5.21e-2)" "unprognostic (8.87e-2)" "unprognostic (2.84e-4)" "unprognostic (1.33e-1)" 4.2 0.9 7.4 0.8 10.6 1.1 1.5 9.6 8.4 4.0 0.7 9.6 0.2 0.7 1.5 2.5 2.1 15.3 3.2 1.6 8.9 7.0 1.0 0.7 8.3 0.8 3.7 5.0 1.4 2.1 19.9 2.7 0.9 10.4 3.9 0.9 3.5 1.4 2.2 0.9 1.8 0.8 1.7 3.2 0.8 1.7 1.4 6.7 0.0 1.0 1.1 0.7 1.2 1.1 1.8 2.0 2.9 0.7 1.3 1.8 0.5 0.3 0.0 0.8 0.4 1.2 2.3 0.2 1.4 4.5 0.7 0.6 0.3 0.4 0.2 0.9 1.2 0.2 0.3 0.3 0.8 0.2 0.1 5.8 0.7 1.0 0.4 0.3 0.1 0.5 0.1 0.6 0.8 1.6 0.3 0.1 0.7 0.3 1.0 5.1 0.6 0.1 0.5 2.6 0.0 0.1 0.2 5.4 0.1 0.6 0.4 1.1 0.2 0.3 0.3 0.0 0.6 2.6 0.2 0.1 1.0 0.6 3.4 0.2 0.8 0.0 0.1 0.4 0.3 0.8 2.1 0.7 1.2 1.4 0.3 1.1 1.0 1.2 1.1 0.3 1.8 1.5 1.8 2.9 1.3 0.5 2.0 0.8 0.5 7.4 10.6 9.6 8.4 8.9 7.0 3.7 5.0 10.4 6.7 14.9 16.0 0.0 0.6 1.4 1.2 1.2 0.0 28.1 6.8 0.0 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.2 0.9 1.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.6 0.0 1.0 0.2 0.2 0.6 0.3 0.0 0.0 0.4 C8orf59 ENSG00000176731 "Chromosome 8 open reading frame 59" Q8N0T1 8 85214076-85220421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044805, HPA071903" Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA044805: AB_2679095, HPA071903: AB_2686469" "unprognostic (1.61e-2)" "unprognostic (2.98e-1)" "unprognostic (4.51e-1)" "unprognostic (1.63e-3)" "unprognostic (2.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-3)" "unprognostic (1.63e-1)" "unprognostic (1.69e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (2.29e-1)" "unprognostic (3.84e-3)" 28.1 28.2 25.3 25.3 21.9 33.0 46.1 18.9 26.5 33.0 38.4 12.6 36.3 28.1 32.0 45.5 44.8 28.7 25.8 41.5 20.6 24.1 32.3 47.1 20.8 30.7 26.3 27.2 45.1 35.1 19.5 36.0 27.7 24.4 35.5 27.7 14.7 37.8 36.2 43.9 24.8 37.1 33.7 27.0 32.2 36.9 16.7 25.7 39.1 43.5 53.6 32.0 39.1 35.2 33.3 42.7 21.3 25.3 36.5 38.0 23.9 38.9 19.9 29.6 19.2 18.4 35.7 23.2 26.0 25.0 30.4 30.0 23.2 33.8 9.7 21.5 17.2 28.5 27.2 20.5 28.5 34.3 27.4 22.4 57.6 18.8 34.2 21.8 21.6 26.1 30.2 33.9 19.6 24.8 33.1 25.8 35.0 25.8 24.0 25.2 30.7 47.7 40.6 8.5 88.2 34.8 20.4 24.8 44.2 29.5 25.0 10.0 21.5 19.7 32.4 35.7 37.3 37.3 32.3 19.7 19.4 40.7 21.5 24.6 27.9 32.7 45.8 38.7 27.7 21.5 21.3 20.5 13.4 24.7 25.3 29.5 33.3 32.7 30.1 34.8 29.9 38.0 36.3 5.1 36.5 21.5 42.7 32.1 23.9 25.3 21.9 18.9 26.5 20.6 24.1 26.3 27.2 24.4 25.7 80.4 65.2 124.2 47.1 48.2 25.9 26.3 86.6 147.2 103.5 34.9 9.8 86.5 56.3 152.0 93.6 67.1 76.6 46.7 240.4 102.1 84.3 40.2 75.1 136.0 90.6 22.3 36.9 108.6 132.2 20.6 173.2 92.3 54.0 180.3 112.7 58.4 213.9 84.2 122.0 90.6 33.5 155.2 88.6 128.1 91.8 40.0 64.3 104.7 101.8 39.3 C9orf40 FLJ10110 ENSG00000135045 "Chromosome 9 open reading frame 40" Q8IXQ3 9 74946581-74952886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 43.7;Spermatocytes: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042167 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA 290000 "Nucleoplasm, Cytosol" Centrosome "HPA042167: AB_10797382" "unprognostic (2.10e-1)" "unprognostic (7.65e-2)" "unprognostic (2.94e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.43e-4)" "unprognostic (6.12e-2)" "unprognostic (1.11e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" "unprognostic (6.15e-3)" "unprognostic (6.78e-3)" "unprognostic (3.74e-2)" "unprognostic (4.21e-2)" "unprognostic (5.38e-2)" "unprognostic (2.20e-2)" 6.2 4.0 8.3 9.7 8.0 9.0 18.8 8.1 12.4 5.1 9.9 5.6 2.8 14.3 5.2 3.0 5.2 3.6 5.0 3.6 7.4 8.4 4.1 5.1 2.8 8.4 8.4 5.6 4.2 3.5 6.6 4.4 6.5 6.7 3.9 9.2 2.2 3.0 4.8 4.7 3.5 18.7 4.9 11.2 5.4 3.6 31.1 5.1 10.5 3.0 3.4 8.0 5.0 16.0 1.8 0.9 5.3 0.5 0.0 2.1 0.3 16.8 3.7 9.7 3.9 3.9 5.1 18.1 13.5 4.2 9.4 10.2 1.0 5.3 15.3 4.0 3.3 15.8 5.0 7.6 0.7 15.1 20.6 11.8 8.1 6.8 6.4 3.2 9.7 12.9 2.5 5.1 5.2 3.7 3.8 2.9 11.2 11.4 10.4 12.3 4.7 17.1 11.4 11.4 8.9 11.4 16.0 7.6 3.7 3.9 4.1 10.6 4.7 5.9 5.0 4.0 9.0 6.1 7.5 3.7 8.5 9.6 11.6 11.7 20.0 14.9 9.7 6.5 10.9 9.1 1.8 0.2 5.3 1.0 0.4 0.4 1.8 1.1 1.0 0.2 1.3 2.1 1.3 0.5 0.0 0.5 0.9 1.2 0.3 8.3 8.0 8.1 12.4 7.4 8.4 8.4 5.6 6.7 5.1 3.0 0.3 6.0 3.5 2.2 7.2 43.7 0.0 1.4 0.0 3.5 7.9 15.9 1.7 2.7 9.5 8.6 12.7 0.0 2.7 19.6 4.0 2.4 0.0 3.4 9.3 1.6 1.2 9.2 3.3 1.3 4.0 1.7 1.7 3.6 4.9 4.5 2.9 8.6 4.9 1.4 13.1 0.0 4.2 46.8 10.7 4.5 10.3 3.2 15.2 3.8 C9orf85 MGC61599 ENSG00000155621 "Chromosome 9 open reading frame 85" Q96MD7 9 71911510-71986054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050767, HPA076627" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA050767: AB_2681229, HPA076627: " "unprognostic (7.81e-2)" "unprognostic (2.80e-1)" "unprognostic (6.21e-2)" "unprognostic (3.04e-1)" "unprognostic (2.89e-2)" "unprognostic (2.87e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (3.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.48e-1)" "unprognostic (1.10e-2)" "unprognostic (8.10e-2)" "unprognostic (6.60e-2)" "unprognostic (4.02e-1)" "unprognostic (6.18e-2)" 13.4 12.7 15.5 10.1 26.0 8.9 14.7 11.2 18.8 12.8 12.9 18.2 15.0 19.3 14.1 14.3 18.4 11.6 12.0 10.5 14.9 13.8 12.3 13.1 10.4 13.0 24.5 13.3 16.9 14.7 9.8 16.9 13.9 15.2 13.1 13.7 14.3 14.7 9.8 14.6 18.4 16.3 15.2 21.1 10.7 11.2 9.2 21.9 14.5 14.8 15.9 12.9 18.8 15.5 11.3 13.1 16.1 9.9 17.1 14.6 9.3 7.7 5.1 9.1 7.4 9.6 17.4 9.3 10.0 15.5 8.1 7.9 1.1 4.7 12.7 5.1 8.6 8.5 14.3 9.5 9.5 11.2 8.9 4.7 7.8 7.5 6.4 10.3 11.4 6.4 14.1 13.0 8.1 17.8 12.7 9.9 12.3 9.2 8.6 10.2 4.0 13.7 8.0 8.6 12.5 12.6 8.1 15.8 0.3 11.5 11.3 7.6 10.0 4.9 12.7 16.5 10.4 4.5 6.6 8.7 7.5 9.6 16.9 7.3 8.6 14.1 5.8 10.1 8.7 4.8 16.1 8.9 12.6 13.4 9.9 13.7 10.9 11.5 11.5 9.3 11.3 14.0 14.6 9.9 17.1 8.3 13.1 10.5 9.3 15.5 26.0 11.2 18.8 14.9 13.8 24.5 13.3 15.2 21.9 6.0 14.2 13.0 11.4 6.8 10.6 10.8 5.1 9.4 11.4 5.2 7.9 17.8 18.3 12.3 6.1 11.6 23.0 0.0 17.3 15.9 12.4 13.2 18.4 8.7 12.9 4.8 6.3 16.0 12.4 4.5 19.2 13.3 3.3 11.8 17.8 11.2 14.2 17.5 12.4 15.1 11.5 12.9 12.7 13.0 14.2 8.5 9.0 12.2 16.3 17.9 CA13 "CAXIII, FLJ37995, MGC59868" ENSG00000185015 "Carbonic anhydrase 13" Q8N1Q1 8 85220587-85284073 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.7" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 12.5;OE19: 24.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024689, CAB025567" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles NA NA 100000 Nucleoli "Nucleoplasm, Vesicles" "CAB025567: , HPA024689: AB_1846004" "unprognostic (1.12e-2)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (9.16e-5)" "unprognostic (2.21e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (7.90e-3)" "unprognostic (1.97e-1)" "unprognostic (1.34e-2)" "unprognostic (3.58e-2)" "unprognostic (3.13e-1)" "prognostic favorable (9.40e-4)" "unprognostic (7.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-2)" "unprognostic (3.00e-1)" 2.6 2.6 2.0 1.9 3.1 0.5 2.9 2.4 2.4 3.2 18.2 0.8 0.0 14.2 1.8 1.7 6.7 1.4 25.6 5.8 1.6 1.9 10.4 17.1 9.5 2.4 2.0 0.1 2.2 1.6 9.3 6.5 1.0 5.7 2.6 3.7 1.9 7.0 1.0 1.9 7.1 56.7 1.9 5.2 2.2 7.0 0.9 0.9 0.4 10.3 3.9 5.6 2.9 5.2 0.8 2.1 3.2 2.5 0.5 0.5 1.0 0.2 0.3 0.7 0.1 0.5 0.5 0.3 0.8 0.9 0.1 2.4 5.8 4.5 0.3 0.4 1.0 5.1 1.9 1.8 2.3 0.1 1.3 0.8 12.5 1.6 5.3 1.2 0.2 0.5 1.9 0.4 0.2 1.0 1.5 1.3 0.5 3.1 2.4 2.1 0.0 0.2 0.2 0.3 24.6 0.3 0.2 1.8 0.1 6.7 0.2 0.2 0.0 0.4 0.0 1.3 0.9 0.4 0.6 1.2 2.3 3.3 0.1 1.3 1.0 0.4 1.5 4.8 1.8 2.2 3.2 2.5 1.3 0.4 0.7 0.2 0.2 0.2 0.1 2.1 0.8 0.3 0.5 0.9 0.5 0.8 0.9 0.1 1.0 2.0 3.1 2.4 2.4 1.6 1.9 2.0 0.1 5.7 0.9 3.0 7.7 1.4 2.1 1.5 1.5 5.2 5.1 10.7 12.5 12.2 31.4 0.2 8.3 3.2 9.1 2.1 16.9 0.0 1.4 0.2 3.1 2.1 0.0 4.7 0.9 0.0 4.6 9.8 3.0 10.4 0.0 2.2 5.0 0.0 3.2 2.0 3.1 4.9 0.0 16.1 5.1 0.0 1.0 1.2 2.3 2.8 0.2 1.0 3.4 1.8 CABCOCO1 "bA63A2.1, C10orf107, Em:AC022398.2, MGC44593" ENSG00000183346 "Ciliary associated calcium binding coiled-coil 1" Q8IVU9 10 61662961-61766766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 33.1;testis: 18.6" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 163.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041398 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA041398: AB_10794374" "unprognostic (1.89e-3)" "unprognostic (7.37e-2)" "unprognostic (2.23e-1)" "prognostic favorable (1.79e-4)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (5.52e-2)" "unprognostic (4.43e-2)" "unprognostic (3.31e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.52e-3)" "unprognostic (2.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.33e-2)" 1.5 1.2 6.3 0.7 5.7 0.5 2.1 0.4 6.8 6.1 1.6 9.5 3.0 1.0 5.2 7.6 0.9 33.1 3.8 0.7 8.1 7.3 2.6 0.9 10.3 0.9 8.1 5.8 4.1 1.6 10.0 5.2 1.4 13.7 5.9 1.3 1.5 1.7 3.7 0.6 0.8 0.9 3.0 14.8 1.9 0.9 18.6 5.6 0.0 1.9 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 2.4 0.0 0.4 1.6 0.3 0.5 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.1 0.9 0.9 0.5 0.1 0.0 0.1 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 5.7 0.4 6.8 8.1 7.3 8.1 5.8 13.7 5.6 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 163.3 13.6 3.5 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CABLES2 "C20orf150, dJ908M14.2, ik3-2" ENSG00000149679 "Cdk5 and Abl enzyme substrate 2" Q9BTV7 20 62388632-62407285 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.9" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 33.1;Late spermatids: 16.4;Spermatocytes: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052138 Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Nuclear bodies" "Nucleoplasm, Cell Junctions" "HPA052138: AB_2681743" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.26e-5)" "unprognostic (1.45e-2)" "unprognostic (1.51e-1)" "unprognostic (2.71e-2)" "unprognostic (5.07e-2)" "unprognostic (5.37e-3)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.09e-2)" "prognostic unfavorable (1.24e-6)" "unprognostic (1.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.67e-1)" "unprognostic (2.94e-2)" 2.3 3.3 5.9 5.6 5.6 8.3 2.8 15.1 10.2 3.4 4.4 3.6 1.3 3.6 3.7 3.6 3.7 4.7 3.0 10.5 4.3 5.5 2.6 3.6 2.9 5.7 4.9 5.3 4.3 3.7 4.1 5.8 4.3 7.2 4.1 4.1 3.1 3.6 4.2 5.4 5.2 4.9 4.3 3.5 4.1 3.8 34.9 5.4 5.1 5.7 2.6 5.2 4.1 3.2 1.4 1.1 1.0 1.1 1.5 4.1 0.5 9.3 7.0 12.2 12.4 1.9 2.7 1.7 5.3 5.3 14.9 6.9 25.4 5.4 9.4 4.6 3.4 20.4 6.0 7.4 3.5 5.8 4.2 4.1 11.0 3.7 6.1 3.4 4.4 5.7 1.7 4.0 4.3 1.6 2.6 3.4 12.3 2.8 8.3 3.3 11.5 11.6 3.5 4.0 9.4 8.1 16.1 10.3 4.1 2.2 6.2 6.6 10.2 7.8 10.4 2.1 4.8 7.0 6.8 3.5 13.8 4.2 18.1 5.5 8.0 6.5 11.2 12.4 5.1 7.2 0.0 0.9 0.2 2.7 1.1 1.5 1.4 1.9 2.1 1.1 1.1 1.0 1.2 1.0 1.5 1.1 0.9 4.1 0.5 5.9 5.6 15.1 10.2 4.3 5.5 4.9 5.3 7.2 5.4 3.0 1.7 2.2 0.5 0.8 6.4 6.7 0.0 0.0 3.4 0.0 3.9 0.9 1.7 1.7 33.1 1.5 1.5 0.0 2.0 0.5 2.1 0.9 0.0 1.5 1.7 12.7 3.4 1.8 2.4 16.4 1.7 1.5 0.0 0.0 3.3 1.6 1.9 2.9 3.2 0.7 2.9 0.0 0.9 16.7 7.3 1.8 1.9 0.0 2.5 0.5 CACTIN "C19orf29, cactin, fSAPc, NY-REN-24" ENSG00000105298 "Cactin, spliceosome C complex subunit" Q8WUQ7 19 3610641-3626815 "Predicted intracellular proteins" "Immunity, Innate immunity, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042504, HPA042548" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA042504: AB_10797501, HPA042548: AB_10794760" "unprognostic (1.18e-1)" "unprognostic (7.90e-3)" "unprognostic (1.09e-1)" "prognostic favorable (3.69e-5)" "unprognostic (5.93e-2)" "unprognostic (2.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (7.22e-3)" "unprognostic (3.88e-2)" "unprognostic (4.98e-3)" "unprognostic (5.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.55e-3)" 16.1 14.4 18.3 19.4 17.8 19.8 16.2 19.2 19.9 11.8 12.4 13.1 12.3 14.5 14.2 9.6 11.9 13.0 13.0 10.3 14.2 10.9 11.9 14.8 11.7 16.5 14.3 9.9 21.4 14.9 8.9 11.1 11.3 13.4 13.4 8.5 10.3 15.5 12.8 28.6 22.0 16.2 12.2 9.8 23.0 15.7 14.4 15.0 13.9 12.6 11.9 12.7 11.3 18.5 2.1 4.3 0.8 2.9 0.9 3.7 1.3 14.5 8.4 7.1 12.1 5.2 5.2 10.8 10.5 4.2 6.3 7.0 8.3 6.6 12.2 9.0 6.5 7.4 13.6 7.4 8.7 3.8 12.3 9.8 7.6 11.5 9.9 7.3 10.2 11.1 5.0 8.5 5.8 4.1 3.8 9.0 10.7 16.8 13.7 3.3 8.8 18.3 8.9 15.2 8.9 9.9 19.4 9.2 11.5 5.8 7.4 9.8 13.7 11.7 8.3 8.4 4.0 6.6 11.8 11.6 8.5 10.7 18.5 18.2 21.0 14.0 13.5 10.5 16.5 11.4 0.0 1.2 0.0 3.7 2.9 1.3 2.0 1.8 1.7 1.0 2.1 2.0 2.5 0.8 0.9 0.4 4.3 1.4 1.3 18.3 17.8 19.2 19.1 14.2 10.9 14.3 9.9 13.4 15.0 0.0 2.4 4.2 3.8 5.4 4.8 2.8 10.2 0.0 1.2 1.8 2.0 3.0 0.0 4.6 2.1 3.0 4.6 0.0 4.2 4.4 3.7 4.6 4.6 4.3 4.4 0.0 1.2 3.1 4.1 3.6 5.5 2.8 1.7 9.0 5.6 5.6 4.8 3.5 5.3 2.8 5.6 0.0 4.5 9.1 9.1 6.9 2.7 3.5 5.2 3.5 CALHM2 FAM26B ENSG00000138172 "Calcium homeostasis modulator family member 2" Q9HA72 10 103446786-103452402 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 63.7;Hofbauer cells: 47.4;Leydig cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.8;BJ: 18.8;BJ hTERT+: 19.1;fHDF/TERT166: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014706 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA014706: AB_2243916" "unprognostic (2.45e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (2.48e-1)" "unprognostic (3.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (8.85e-2)" "unprognostic (5.78e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (8.59e-2)" "unprognostic (2.47e-1)" "unprognostic (3.56e-1)" "unprognostic (4.74e-1)" 24.2 10.5 3.7 10.2 3.8 1.8 28.7 1.9 7.1 34.1 9.2 3.9 8.0 5.6 36.0 18.4 13.4 19.7 18.2 17.0 3.9 2.2 5.7 3.7 11.1 15.9 4.8 5.4 32.5 4.5 1.9 4.0 23.6 4.8 18.2 4.0 10.7 7.6 10.0 8.9 8.9 9.0 19.8 5.5 24.4 7.2 14.1 3.1 3.0 11.0 9.2 10.8 19.9 24.1 7.1 36.6 11.2 47.9 14.0 21.5 17.1 5.3 3.8 0.9 1.2 14.3 23.8 4.6 18.8 19.1 5.8 8.2 1.6 2.6 1.6 2.1 21.5 0.3 2.5 1.9 0.0 1.1 0.2 10.8 3.8 1.1 0.3 6.5 0.6 0.3 8.1 0.0 1.7 0.0 10.8 6.8 4.1 0.8 10.0 3.7 12.3 1.4 1.7 2.4 1.1 3.4 4.5 1.5 3.6 0.5 0.4 2.7 1.2 0.7 3.1 1.0 0.4 0.6 1.2 12.1 1.8 2.3 6.4 1.3 1.5 3.5 1.9 15.9 11.8 0.3 11.2 22.7 0.4 21.5 42.2 17.5 7.1 14.8 17.6 36.6 1.5 2.9 11.2 0.9 14.0 47.9 4.2 18.9 17.1 3.7 3.8 1.9 7.1 3.9 2.2 4.8 5.4 4.8 3.1 3.0 1.1 3.4 2.8 4.7 0.0 2.8 2.5 0.0 0.0 3.5 0.0 2.0 0.0 3.1 0.8 20.4 0.0 0.0 0.2 63.7 23.4 0.8 8.1 0.0 47.4 0.0 1.2 28.3 27.5 0.8 42.3 14.7 8.5 1.8 0.0 0.3 0.2 0.0 15.2 0.3 0.0 19.4 29.8 0.7 0.2 3.3 16.0 17.3 0.0 1.0 CALML4 "MGC4809, NY-BR-20" ENSG00000129007 "Calmodulin like 4" Q96GE6 15 68190705-68206110 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.0;gallbladder: 28.4;intestine: 91.6" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 174.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "intermediate monocyte: 39.2;non-classical monocyte: 44.0" "Lineage enriched" "Detected in many" 10 "monocytes: 44.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051109 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA051109: AB_2681346" "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (4.97e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (3.71e-2)" "unprognostic (4.05e-2)" "unprognostic (6.53e-2)" "unprognostic (6.77e-2)" "unprognostic (2.10e-1)" "unprognostic (4.19e-3)" "unprognostic (6.24e-2)" "unprognostic (3.85e-2)" "unprognostic (7.92e-3)" "unprognostic (2.46e-1)" "unprognostic (7.49e-2)" "unprognostic (1.32e-1)" 2.4 2.5 1.8 12.0 1.1 0.8 2.2 2.6 1.0 3.2 40.3 2.2 7.7 34.0 1.5 7.8 5.1 7.3 28.4 1.4 2.6 0.7 12.6 12.3 3.1 2.6 0.9 1.3 2.3 5.3 0.0 3.1 2.1 8.4 4.3 21.8 3.1 1.9 6.7 1.4 1.7 91.6 2.7 1.0 5.3 5.4 2.4 0.6 1.1 1.5 1.3 1.3 1.9 2.0 0.0 4.5 1.8 44.0 0.0 0.0 2.8 2.5 7.8 5.7 3.5 0.6 1.0 4.0 1.6 1.5 2.6 2.6 14.9 16.1 2.5 2.0 1.1 2.3 10.8 12.8 2.3 1.0 2.1 12.4 4.1 13.3 5.2 2.3 3.5 5.5 1.1 3.4 1.5 2.2 2.1 2.9 5.2 3.9 2.9 0.6 7.2 5.7 7.7 4.9 12.0 2.3 8.5 5.6 5.1 0.9 4.3 2.9 3.4 2.5 2.3 6.8 1.8 1.7 3.4 2.5 3.8 3.5 6.6 6.3 10.6 6.3 7.0 2.4 6.9 1.3 0.0 6.5 0.0 0.0 39.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.8 0.0 44.0 0.2 0.0 2.8 1.8 1.1 2.6 1.0 2.6 0.7 0.9 1.3 8.4 0.6 0.0 1.0 0.9 0.6 1.3 8.8 0.3 15.3 174.0 26.1 3.5 0.0 0.4 0.0 2.0 4.8 1.9 38.6 0.0 3.9 0.4 1.0 1.2 0.0 7.2 3.1 7.9 7.5 6.7 11.9 0.0 3.4 3.4 0.0 0.0 15.0 1.7 1.8 38.6 6.3 5.8 2.2 0.0 0.3 0.0 0.5 1.8 0.1 1.8 18.3 1.1 CAMLG "CAML, GET2" ENSG00000164615 "Calcium modulating ligand" P49069 5 134738501-134752160 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 658.5;Late spermatids: 1206.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052636, HPA056472" Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA052636: AB_2681893, HPA056472: AB_2683143" "unprognostic (9.23e-2)" "unprognostic (8.54e-2)" "unprognostic (2.95e-1)" "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (3.68e-2)" "unprognostic (5.41e-3)" "unprognostic (3.07e-1)" "unprognostic (8.54e-2)" "unprognostic (5.34e-3)" "unprognostic (4.58e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (3.26e-2)" "unprognostic (1.43e-2)" "unprognostic (2.19e-1)" "unprognostic (3.16e-1)" 24.2 29.0 37.6 14.3 32.4 22.7 29.3 28.2 39.3 33.3 32.7 15.5 20.2 26.1 31.7 45.2 21.4 23.0 21.8 22.3 32.4 38.3 20.1 19.7 18.9 18.4 36.2 22.7 53.0 25.7 14.8 21.9 14.0 22.4 27.5 14.3 21.7 15.9 26.2 32.5 19.7 22.2 30.4 26.0 15.1 17.7 36.6 14.0 21.1 21.6 18.5 19.3 40.3 20.0 25.0 16.1 32.1 23.3 16.6 28.6 17.4 9.6 7.5 12.8 23.8 28.5 44.2 5.8 13.7 19.9 10.2 19.4 13.7 14.7 39.3 20.1 9.5 15.9 12.5 10.5 16.7 14.6 18.3 19.5 10.4 13.6 11.1 21.0 5.5 33.0 35.8 18.2 12.6 21.7 33.9 19.3 17.4 6.6 18.3 15.2 10.7 14.5 23.3 6.6 12.0 7.6 16.4 17.0 15.1 17.5 9.4 19.0 13.3 9.8 6.3 32.7 17.2 17.3 11.5 18.4 10.0 6.2 15.2 12.4 17.2 18.6 15.0 16.8 17.4 5.4 32.1 15.2 32.1 18.3 17.3 24.6 25.0 26.4 22.9 16.1 22.4 27.8 26.8 27.6 16.6 23.3 14.7 28.6 17.4 37.6 32.4 28.2 39.3 32.4 38.3 36.2 22.7 22.4 14.0 35.7 31.3 84.3 104.0 148.5 76.2 38.6 76.5 32.1 48.9 40.1 23.6 43.8 77.9 53.1 658.5 74.5 44.2 0.0 78.9 53.3 107.2 105.7 119.1 66.0 62.6 52.4 60.0 81.6 102.8 1206.3 155.6 92.2 91.1 124.4 64.9 79.0 61.6 59.6 124.5 149.1 63.7 97.0 161.7 114.4 74.5 176.2 61.2 108.0 83.2 90.1 CAND1 "DKFZp434M1414, KIAA0829, TIP120, TIP120A" ENSG00000111530 "Cullin associated and neddylation dissociated 1" Q86VP6 12 67269281-67319951 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055748, HPA062833, HPA069053" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No 4200000 "Nucleoplasm, Golgi apparatus, Cytosol" "HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074" "unprognostic (1.50e-2)" "unprognostic (1.60e-1)" "unprognostic (1.39e-3)" "unprognostic (2.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.02e-2)" "unprognostic (2.17e-2)" "unprognostic (3.02e-1)" "unprognostic (3.38e-3)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" "unprognostic (2.88e-1)" "unprognostic (1.58e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" 21.3 26.7 28.7 19.1 38.3 19.6 27.0 34.6 32.6 23.9 20.0 17.5 17.0 19.7 22.8 29.9 26.6 20.6 19.0 15.2 24.8 27.0 25.4 27.7 18.7 25.4 23.3 29.0 29.0 22.1 33.2 27.1 23.3 33.2 24.1 21.7 15.8 19.6 22.0 11.1 29.5 19.5 22.4 21.5 20.2 19.3 26.9 23.8 39.4 27.0 17.0 30.2 21.1 22.1 11.9 7.8 6.1 10.1 14.7 15.2 4.3 22.5 23.2 35.4 25.1 27.2 21.3 23.8 22.4 19.4 23.7 20.9 21.5 12.9 48.7 19.6 22.4 14.9 21.6 38.0 25.5 27.2 18.4 22.8 27.4 18.7 20.3 17.8 32.3 15.6 20.1 19.4 21.6 20.0 29.1 22.0 23.9 21.7 27.3 25.5 22.1 29.2 21.9 37.4 17.4 16.2 28.6 30.4 20.6 21.8 38.5 36.4 18.1 27.9 25.7 18.1 31.1 27.6 14.9 18.7 18.8 12.2 12.9 16.9 9.0 11.0 41.5 22.4 19.2 19.3 6.1 5.0 5.5 11.6 5.9 14.1 8.6 14.2 12.7 7.8 11.9 15.2 12.7 2.2 14.7 10.1 6.6 14.7 4.3 28.7 38.3 34.6 31.8 24.8 27.0 23.3 29.0 33.2 23.8 56.6 27.6 42.6 43.5 51.6 88.5 14.7 45.9 34.8 29.6 41.8 110.0 31.5 11.6 27.1 2.8 38.6 46.3 0.0 24.9 36.0 41.4 44.6 7.0 41.5 27.1 82.6 43.6 38.1 40.0 7.7 63.9 30.4 32.1 52.3 46.0 63.0 29.9 24.6 57.3 27.3 106.8 25.8 34.2 72.7 42.4 55.8 37.3 47.9 38.5 52.1 CAP2 ENSG00000112186 "Cyclase associated actin cytoskeleton regulatory protein 2" P40123 6 17393216-17557792 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 165.7" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 110.1;Ciliated cells: 48.2;Sertoli cells: 32.3;Smooth muscle cells: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "LHCN-M2: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050530, HPA054147" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA050530: AB_2681159, HPA054147: AB_2682400" "unprognostic (7.27e-2)" "unprognostic (5.71e-3)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (4.86e-1)" "unprognostic (2.23e-2)" "unprognostic (9.94e-2)" "unprognostic (3.58e-2)" "unprognostic (7.72e-2)" "unprognostic (1.65e-1)" "unprognostic (6.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-1)" "unprognostic (8.05e-2)" "unprognostic (1.75e-3)" 5.8 4.1 13.8 3.0 20.1 0.7 3.9 7.5 26.4 5.6 7.7 1.9 2.0 1.9 9.2 5.9 7.0 5.8 3.8 31.2 19.9 8.7 3.3 2.0 2.1 1.1 5.3 17.3 2.1 1.6 3.2 1.7 6.2 8.6 8.4 3.6 2.9 2.5 10.1 165.7 0.9 2.6 13.1 2.0 1.6 3.3 1.1 1.3 0.0 2.3 14.5 1.3 4.6 6.4 0.0 0.0 0.0 0.0 0.0 2.9 0.1 5.1 8.1 15.7 18.7 0.1 0.0 3.4 18.5 13.5 15.2 13.9 2.6 2.3 0.0 17.4 19.8 21.3 2.7 6.9 6.9 22.1 0.0 2.6 0.0 5.2 8.8 1.5 0.0 0.0 1.1 3.4 7.7 3.3 24.9 0.7 0.0 0.0 0.0 32.1 8.3 0.0 0.0 5.9 0.2 4.6 1.7 20.8 0.3 8.0 2.1 2.0 3.9 6.2 20.1 10.9 30.1 22.2 3.7 0.0 12.3 11.7 0.3 16.2 0.0 0.0 0.0 4.1 0.0 16.8 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 20.1 7.5 26.4 19.9 8.7 5.3 17.3 8.6 1.3 3.0 1.0 0.0 3.5 1.6 13.5 110.1 2.5 48.2 5.7 1.8 3.9 14.9 3.3 2.4 0.1 1.0 0.0 0.0 0.6 10.7 8.2 1.4 0.0 1.8 1.9 7.9 5.8 4.9 0.0 0.0 0.6 0.0 0.0 0.0 1.1 5.0 3.6 2.0 4.6 16.1 2.0 32.3 40.1 0.1 2.1 0.6 31.4 0.0 1.5 0.7 CAPN6 "CalpM, CANPX, CAPNX" ENSG00000077274 "Calpain 6" Q9Y6Q1 X 111245103-111270523 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 62.9;placenta: 173.5" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 165.5;Syncytiotrophoblasts: 117.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 25.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 1.2;plasmacytoid DC: 2.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HDLM-2: 10.1;NTERA-2: 15.8;SuSa: 14.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA040259 Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA040259: " "unprognostic (1.27e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-2)" "unprognostic (5.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.93e-2)" "unprognostic (8.39e-3)" "unprognostic (1.06e-1)" "unprognostic (2.08e-1)" "unprognostic (9.45e-3)" "unprognostic (5.12e-1)" "unprognostic (6.25e-2)" "unprognostic (7.67e-2)" "unprognostic (6.50e-2)" "unprognostic (5.02e-3)" "unprognostic (2.66e-1)" "unprognostic (6.30e-2)" 1.7 0.0 0.2 1.7 0.2 0.0 6.0 0.3 0.3 3.9 4.2 0.2 23.4 0.2 18.2 62.9 2.4 2.9 2.6 0.4 0.2 0.0 5.1 0.4 0.3 1.1 0.2 0.4 1.9 4.1 0.0 0.2 173.5 0.3 3.6 2.2 2.1 5.6 21.7 1.7 1.0 1.3 2.0 0.3 1.0 7.2 2.8 0.2 0.5 1.7 4.7 2.9 1.4 2.6 0.1 2.0 0.8 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 15.8 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.3 0.4 0.3 0.0 14.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.2 0.2 0.3 0.3 0.2 0.0 0.2 0.4 0.3 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.3 10.2 0.0 0.0 7.0 0.0 35.2 3.3 5.0 0.0 0.0 0.0 0.0 0.6 165.5 2.6 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 2.7 0.0 20.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 117.5 0.0 0.0 0.3 CAPN8 nCL-2 ENSG00000203697 "Calpain 8" A6NHC0 1 223538007-223665734 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 32.0;stomach 1: 85.8" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 123.4;Club cells: 94.4;Mucus-secreting cells: 49.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 28.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "OE19: 51.0;RT4: 30.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA073939 Approved "Nucleoplasm,Nuclear membrane,Vesicles" No NA "Nucleoplasm, Nuclear membrane, Vesicles" "HPA073939: AB_2686646" "unprognostic (4.87e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-1)" "unprognostic (2.06e-2)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (7.97e-3)" "unprognostic (1.19e-1)" "unprognostic (1.26e-1)" "unprognostic (8.08e-2)" "unprognostic (2.72e-3)" "unprognostic (3.55e-1)" "unprognostic (4.12e-6)" "unprognostic (6.95e-2)" "unprognostic (5.59e-2)" "unprognostic (3.83e-2)" "unprognostic (5.44e-3)" 0.2 0.0 0.5 10.3 0.3 0.0 7.5 0.2 0.3 1.0 7.9 0.6 0.2 2.2 0.3 3.3 0.6 0.4 32.0 0.2 0.2 0.1 2.5 0.2 13.0 0.2 0.2 0.2 0.2 8.0 0.0 0.2 0.8 0.2 4.6 9.9 0.2 4.6 0.3 0.3 1.5 4.0 3.2 0.2 0.2 85.8 0.4 0.2 0.3 0.2 1.5 1.2 15.1 3.9 0.4 0.0 1.1 0.0 0.0 1.4 1.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.8 0.0 0.0 0.0 0.1 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 51.0 1.6 0.0 0.0 0.0 0.6 30.2 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.9 0.7 0.0 0.0 0.1 1.4 1.1 0.0 0.0 0.0 0.0 1.5 0.5 0.3 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 26.8 123.4 0.0 6.0 0.1 0.0 2.2 15.3 24.1 94.4 24.4 0.0 0.1 0.0 0.4 1.4 0.0 30.0 0.0 19.7 0.0 0.0 3.3 10.4 0.0 0.5 0.0 2.9 0.0 0.0 3.5 1.7 0.4 0.0 0.0 49.6 0.0 21.9 16.9 3.2 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.1 0.0 13.2 15.4 CAPRIN2 "C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140" ENSG00000110888 "Caprin family member 2" Q6IMN6 12 30709552-30754951 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Protein synthesis inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039746 Supported Supported Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA039746: AB_10672902" "unprognostic (7.45e-2)" "unprognostic (6.38e-2)" "unprognostic (2.83e-3)" "unprognostic (1.08e-1)" "unprognostic (5.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-1)" "unprognostic (8.91e-2)" "unprognostic (9.90e-2)" "unprognostic (3.09e-1)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.50e-5)" "unprognostic (1.91e-1)" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "prognostic favorable (8.36e-4)" 5.5 7.8 12.5 5.3 20.6 9.3 5.0 19.9 15.7 7.3 5.3 4.4 9.5 4.0 8.6 10.5 3.6 4.9 6.1 17.4 11.8 19.0 6.5 5.3 6.5 5.4 11.2 11.6 8.3 5.5 22.4 11.0 4.2 18.2 7.4 5.7 6.1 3.1 10.0 5.6 10.6 4.6 8.4 11.5 6.7 6.5 22.3 9.4 4.3 5.7 3.9 5.0 6.1 8.1 4.1 4.2 7.5 1.5 2.6 5.4 0.9 4.5 3.2 6.0 5.1 6.0 6.3 3.6 8.5 7.1 3.7 5.0 1.7 2.9 2.7 7.5 8.8 7.4 3.6 3.2 13.8 6.7 4.0 3.5 11.1 5.2 6.4 3.3 1.7 1.1 7.3 5.5 11.8 9.5 15.4 8.3 4.9 0.7 2.7 8.7 0.9 2.2 2.9 7.1 2.4 9.7 1.0 9.1 1.3 1.6 16.4 7.5 4.6 3.1 2.2 3.6 15.0 2.0 0.5 11.2 7.1 3.9 21.6 15.5 5.2 3.6 2.4 8.6 0.5 4.6 7.5 1.5 1.2 4.4 0.6 5.4 3.7 2.8 4.6 0.6 4.1 3.1 2.8 0.3 2.6 0.7 4.2 1.8 0.9 12.5 20.6 19.9 13.7 11.8 19.0 11.2 11.6 18.2 9.4 20.8 23.0 1.4 4.6 6.4 28.8 21.4 0.0 18.7 9.1 3.5 21.6 6.4 8.3 4.4 7.4 8.5 5.1 0.0 9.6 1.5 5.4 2.6 20.9 5.9 7.7 11.1 16.0 7.4 6.1 10.7 6.4 4.6 3.3 3.6 3.0 12.2 21.7 2.6 8.1 9.5 36.8 6.5 7.7 7.5 23.0 4.0 10.3 5.2 3.2 2.4 CAPS "CAPS1, MGC126562" ENSG00000105519 Calcyphosine 19 5911707-5915877 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4;fallopian tube: 116.0" "Cell type enriched" "Detected in many" 8 "Ciliated cells: 1030.6" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 171.3" "Region enhanced" "Detected in all" "pons and medulla: 71.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 36.6;U-266/70: 10.1" "Low region specificity" "Detected in many" HPA043520 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA043520: AB_10964138" "unprognostic (2.06e-1)" "unprognostic (1.13e-2)" "unprognostic (7.94e-3)" "prognostic favorable (7.63e-5)" "unprognostic (5.18e-1)" "prognostic favorable (8.60e-4)" "unprognostic (7.07e-2)" "unprognostic (2.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (9.99e-2)" "unprognostic (4.01e-2)" "unprognostic (8.47e-2)" "unprognostic (3.25e-1)" "unprognostic (6.86e-3)" "unprognostic (5.96e-3)" 2.6 4.1 8.0 4.3 14.7 4.3 2.8 1.4 3.3 12.4 3.3 34.4 15.6 3.1 9.1 49.4 2.8 116.0 13.6 2.0 13.4 6.6 8.9 5.0 25.4 4.4 8.0 7.8 26.7 6.5 2.5 7.5 17.7 71.4 9.4 2.0 3.3 7.7 12.7 2.0 5.7 5.0 2.9 7.5 7.6 9.4 2.1 17.9 0.4 7.8 0.9 2.5 8.8 11.3 4.9 4.0 5.2 2.2 5.3 4.8 2.4 1.1 1.1 0.7 3.5 1.3 1.8 2.2 0.6 0.4 0.2 0.3 0.8 7.5 0.8 2.2 0.9 0.5 1.4 0.3 0.3 0.1 2.4 1.0 0.6 2.2 2.0 1.2 0.6 1.8 2.3 2.1 0.2 0.5 2.5 0.5 2.6 0.5 2.9 0.4 2.1 1.4 2.0 0.6 8.8 5.7 1.7 0.3 2.3 1.0 3.2 0.7 2.6 0.5 36.6 3.7 2.0 2.3 2.3 1.0 0.6 0.4 2.7 9.7 10.1 3.4 0.7 4.3 1.0 1.4 3.3 2.2 1.6 4.8 1.8 2.6 3.1 3.0 3.6 2.1 4.9 2.4 2.0 5.2 5.3 1.6 4.0 3.2 2.4 8.0 14.7 1.4 3.3 13.4 6.6 8.0 7.8 71.4 17.9 11.9 16.8 0.8 29.9 4.2 2.2 1.9 0.0 1030.6 124.0 115.1 3.9 21.6 29.9 26.7 4.7 3.8 3.9 0.0 5.2 16.2 21.6 27.6 5.8 0.0 4.6 6.4 18.4 0.0 0.0 4.0 4.4 4.4 10.1 1.8 19.7 7.2 24.2 2.9 4.6 3.6 3.9 6.5 4.2 0.5 0.4 3.6 17.2 0.0 7.4 100.9 CAPZB ENSG00000077549 "Capping actin protein of muscle Z-line beta subunit" P47756 1 19338776-19485539 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Late spermatids: 2817.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031531 Approved Approved Nucleoplasm,Vesicles,Cytosol No No 35000000 "Nucleoplasm, Cytosol" Vesicles "HPA031531: AB_10603556" "unprognostic (7.52e-2)" "unprognostic (2.13e-1)" "unprognostic (5.25e-2)" "unprognostic (1.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (1.85e-4)" "unprognostic (4.55e-2)" "unprognostic (7.70e-2)" "unprognostic (3.08e-1)" "unprognostic (4.15e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.57e-4)" "unprognostic (1.18e-1)" "unprognostic (2.41e-1)" "unprognostic (4.00e-1)" "unprognostic (3.78e-1)" 29.6 24.8 57.1 38.4 47.3 27.9 28.1 23.0 39.7 34.8 84.1 34.3 19.3 29.2 40.3 28.2 41.8 29.2 29.3 80.3 53.8 40.7 29.3 37.5 29.7 50.4 53.5 33.6 38.6 24.9 23.7 18.1 36.9 29.5 42.2 43.5 30.4 23.7 35.9 160.5 27.0 43.7 49.5 72.0 42.1 32.6 70.5 22.3 51.2 34.2 35.3 54.3 56.9 32.3 39.8 55.6 155.9 96.3 27.1 57.2 78.0 48.6 29.0 52.2 37.5 71.6 92.3 36.7 82.9 86.5 73.5 75.7 36.1 68.7 33.6 36.2 103.6 44.9 41.4 44.8 57.2 82.8 52.9 31.8 65.9 38.9 56.3 73.5 43.6 108.9 85.1 47.7 62.9 59.6 63.2 66.9 39.9 23.4 48.1 73.4 34.6 48.3 50.8 39.2 64.8 31.4 43.7 36.7 44.2 92.7 28.1 31.8 24.5 48.7 40.8 54.8 49.6 44.8 38.2 68.9 49.5 40.7 81.1 39.4 29.8 35.7 42.4 65.0 57.5 53.4 53.8 54.4 155.9 49.1 79.4 41.8 39.8 51.1 52.3 55.6 29.1 43.1 46.1 87.8 27.1 96.3 30.2 57.2 78.0 57.1 47.3 23.0 39.7 53.8 40.7 53.5 33.6 29.5 22.3 92.3 61.8 162.3 259.9 138.7 89.2 77.5 127.4 100.4 63.7 96.0 39.3 284.3 252.0 312.1 989.2 166.8 227.5 23.3 225.6 329.7 194.7 191.6 142.2 80.4 668.4 73.1 135.5 131.3 269.2 2817.9 215.4 313.1 136.7 740.4 212.2 119.4 260.5 192.9 284.2 184.2 70.1 239.3 175.9 100.8 73.9 159.6 286.2 286.6 157.4 234.8 CASP14 "MGC119078, MGC119079, MICE" ENSG00000105141 "Caspase 14" P31944 19 15049384-15058293 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Hydrolase, Protease, Thiol protease" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 109.4" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 83.9" "Cancer enhanced" "Detected in many" "cervical cancer: 62.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "hTCEpi: 33.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010059, HPA027062" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA 2200000 "Nucleoplasm, Cytosol" Mitochondria "CAB010059: AB_626800, HPA027062: AB_2672101" "unprognostic (1.17e-2)" "unprognostic (6.44e-3)" "unprognostic (6.22e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (9.42e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (5.96e-4)" "unprognostic (2.68e-1)" "unprognostic (4.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.97e-1)" 0.2 0.2 0.2 0.0 0.3 0.0 1.9 0.2 0.3 17.9 0.2 0.0 0.8 0.0 1.1 0.3 1.2 0.1 0.0 0.2 0.3 0.2 0.4 0.3 0.2 0.0 0.2 0.0 0.1 0.3 0.0 0.2 0.5 0.0 7.7 0.0 0.0 0.8 2.7 0.3 109.4 0.2 0.0 0.2 0.1 0.2 1.6 0.0 2.3 0.2 0.9 0.0 0.6 4.0 0.8 0.5 2.3 0.6 0.1 0.6 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.6 0.4 0.4 0.2 0.4 0.3 0.6 0.4 0.1 0.8 0.5 0.4 2.3 0.1 0.2 0.5 0.6 0.0 0.2 0.3 0.2 0.3 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 16.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 83.9 0.6 0.0 0.0 0.1 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Group enriched" "Detected in many" 7 "Early spermatids: 23.9;Enterocytes: 14.0;Late spermatids: 27.8;Spermatocytes: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HMC-1: 5.3;MCF7: 4.3" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.5 0.2 1.8 0.8 0.0 4.2 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.7 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.3 0.0 0.8 0.0 0.5 0.5 0.1 0.8 0.0 1.4 0.0 4.3 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.8 2.0 0.1 0.4 0.6 0.4 0.9 0.2 0.7 0.4 0.0 0.3 0.0 1.0 0.7 0.0 0.8 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 0.0 2.4 1.7 1.9 2.3 1.1 2.4 2.5 0.0 0.0 1.8 0.0 1.0 0.0 0.8 23.9 1.5 14.0 0.0 0.6 0.2 1.5 1.8 1.1 0.5 2.8 1.6 1.7 1.8 0.8 27.8 1.7 2.6 0.0 1.8 1.5 1.9 0.5 3.5 2.1 1.1 1.1 0.0 1.0 31.9 2.7 1.6 1.1 2.5 2.0 1.4 CAVIN4 "cavin-4, MURC" ENSG00000170681 "Caveolae associated protein 4" Q5BKX8 9 100578079-100587906 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 83.8;tongue: 52.4" "Cell type enhanced" "Detected in some" 13 "Cytotrophoblasts: 1.2;Pancreatic endocrine cells: 1.0" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NTERA-2: 10.3;SCLC-21H: 15.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA020973, HPA020987, HPA021021" Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082" "unprognostic (9.54e-5)" "unprognostic (1.68e-2)" "unprognostic (2.50e-2)" "unprognostic (3.76e-2)" "unprognostic (4.92e-2)" "unprognostic (4.56e-3)" "unprognostic (1.14e-4)" "unprognostic (3.36e-2)" "unprognostic (2.23e-1)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (4.02e-1)" "unprognostic (1.74e-8)" "unprognostic (1.14e-1)" "unprognostic (3.39e-1)" "unprognostic (3.68e-3)" "unprognostic (1.55e-3)" 3.5 0.0 0.3 0.1 0.6 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 0.0 0.2 2.7 1.9 0.0 0.1 16.4 0.5 0.3 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 2.8 0.0 83.8 0.1 0.0 0.1 0.7 0.0 0.1 1.4 0.0 0.1 0.2 52.4 1.6 0.0 0.0 0.4 0.3 1.4 0.4 0.7 0.7 0.0 0.5 0.4 7.4 2.7 1.6 2.4 5.3 1.3 1.0 1.0 1.2 0.0 0.5 0.3 0.3 0.6 2.6 0.3 3.5 0.1 2.1 1.7 2.5 0.0 1.2 0.0 0.5 0.3 0.4 5.9 0.3 1.0 0.6 1.8 1.3 1.8 0.2 0.3 4.6 0.1 2.0 0.3 10.3 1.1 0.8 3.0 6.9 0.0 0.8 0.4 15.8 4.2 0.2 0.3 1.4 5.0 0.2 0.2 1.3 1.8 1.5 1.3 1.1 0.4 1.3 0.7 2.0 0.1 1.3 0.6 0.3 0.2 0.5 0.4 0.2 0.2 0.7 0.5 0.1 0.4 0.5 0.5 1.4 0.7 0.3 0.3 0.2 0.0 0.3 0.6 0.5 0.3 0.5 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: AB_2681128" "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 42.1 23.4 11.1 15.4 10.3 5.4 50.3 17.2 12.9 17.5 35.2 8.5 18.1 15.0 24.9 28.6 22.4 18.2 31.5 31.3 10.2 11.0 13.0 15.0 14.0 14.1 9.7 7.9 15.3 80.2 7.6 10.5 10.8 8.4 22.8 13.7 11.5 14.6 24.5 29.3 9.6 16.0 44.8 9.7 13.5 24.2 9.2 8.8 19.3 14.0 8.8 10.9 38.9 24.1 20.7 32.5 7.6 11.0 16.4 46.9 18.3 7.9 7.2 6.0 7.5 30.2 19.4 3.5 13.4 12.2 8.6 8.1 3.3 2.4 5.2 6.0 17.6 22.3 2.6 4.4 6.5 6.4 15.3 7.1 2.4 10.9 8.1 7.1 3.7 9.5 11.4 7.7 9.2 7.2 16.1 6.0 8.8 3.2 10.0 10.8 5.1 4.2 5.6 4.4 5.7 22.2 6.1 1.4 4.1 28.6 4.3 3.9 6.5 6.9 9.7 6.6 4.7 5.1 4.7 7.5 13.9 7.7 10.0 12.2 4.5 6.6 10.3 25.6 6.0 12.1 7.6 10.6 5.1 36.1 11.0 46.9 20.7 31.7 31.4 11.8 20.1 15.5 21.3 2.1 16.4 6.4 32.5 35.2 18.3 11.1 10.3 17.2 12.9 10.2 11.0 9.7 7.9 8.4 8.8 62.5 23.5 48.4 32.4 62.4 31.1 0.6 61.1 25.4 15.9 78.5 7.9 12.3 14.9 64.0 5.7 40.2 115.3 0.0 122.5 55.2 43.7 39.9 34.5 68.4 86.5 30.2 84.6 43.0 48.7 20.1 55.0 66.1 108.0 39.7 73.5 46.8 82.6 80.7 96.2 54.7 32.0 116.4 97.8 27.9 59.2 58.5 11.6 95.8 40.0 23.7 CCDC112 MGC39633 ENSG00000164221 "Coiled-coil domain containing 112" Q8NEF3 5 115267188-115296831 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.4" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 227.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 50.4" "Low region specificity" "Detected in all" "HPA045120, HPA050621" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in male reproductive system" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA045120: AB_2679222, HPA050621: AB_2681191" "unprognostic (1.88e-2)" "unprognostic (5.10e-2)" "unprognostic (4.63e-2)" "unprognostic (5.60e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.32e-6)" "unprognostic (4.30e-2)" "unprognostic (3.24e-1)" "unprognostic (4.41e-2)" "unprognostic (3.33e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (1.51e-6)" "unprognostic (7.00e-2)" "unprognostic (2.79e-2)" "unprognostic (8.61e-2)" "unprognostic (4.10e-3)" 5.5 4.3 9.7 5.7 13.2 7.0 7.7 12.6 12.8 6.5 9.8 7.0 4.3 8.1 6.6 7.3 6.3 4.9 3.9 6.4 11.0 9.0 3.5 1.7 6.1 4.8 9.7 7.6 2.9 13.2 6.5 12.1 3.0 12.6 7.7 10.6 1.9 6.8 8.6 4.5 5.5 6.8 7.7 14.0 5.3 7.0 40.4 11.8 3.7 4.7 3.2 4.7 7.1 4.8 5.3 11.0 11.6 5.5 3.1 3.8 2.1 5.4 2.7 5.5 8.7 3.5 6.8 1.3 4.9 2.6 3.7 4.3 1.2 3.1 6.7 4.1 3.4 5.5 3.5 5.7 2.8 7.8 5.3 4.4 4.4 4.1 1.7 4.7 5.8 2.3 3.1 3.4 4.8 6.4 4.3 5.7 6.1 1.8 5.5 4.9 4.2 8.7 5.0 6.0 5.1 4.8 9.3 6.8 50.4 3.6 2.0 8.3 10.8 5.3 3.4 14.6 3.9 5.7 8.5 5.6 4.9 3.3 9.3 6.8 6.1 5.9 1.4 3.3 4.6 2.9 0.2 5.5 11.6 3.4 4.4 3.8 3.2 2.6 2.9 5.9 5.3 3.4 2.3 3.6 3.1 5.0 11.0 0.1 2.1 9.7 13.2 12.6 12.8 11.0 9.0 9.7 7.6 12.6 11.8 14.9 12.3 12.3 4.6 12.6 28.3 14.6 2.5 12.0 9.1 5.2 9.8 0.6 5.0 24.4 6.8 8.0 11.9 0.0 22.6 1.7 8.5 6.1 9.2 2.6 28.4 9.5 38.9 6.7 23.9 13.4 3.7 28.0 13.5 42.3 28.0 10.3 27.1 14.0 3.9 2.9 24.3 12.9 13.0 227.3 60.7 19.7 0.5 5.3 31.6 3.4 CCDC117 FLJ33814 ENSG00000159873 "Coiled-coil domain containing 117" Q8IWD4 22 28772674-28789301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 75.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000826 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA000826: AB_1078417" "unprognostic (1.71e-1)" "unprognostic (2.04e-2)" "unprognostic (1.61e-3)" "unprognostic (9.07e-2)" "unprognostic (3.84e-2)" "unprognostic (1.26e-1)" "unprognostic (1.62e-1)" "unprognostic (1.35e-2)" "unprognostic (8.43e-2)" "unprognostic (7.74e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-3)" "unprognostic (8.25e-2)" 10.7 14.2 12.3 13.6 13.6 19.2 25.2 19.3 12.7 15.9 13.1 9.6 16.6 12.1 15.3 8.9 11.5 10.7 10.0 9.0 12.2 10.6 10.3 26.1 12.5 17.0 14.6 8.3 14.9 13.3 12.4 14.1 20.7 11.9 13.0 11.9 9.5 21.0 16.5 20.2 9.1 10.9 15.2 13.1 13.8 12.3 35.9 15.4 24.2 18.1 7.4 20.1 12.3 31.3 13.4 13.9 14.0 13.9 23.3 15.2 12.6 8.7 7.3 14.9 14.5 9.7 8.5 11.8 8.9 10.9 15.5 13.7 11.0 4.2 27.5 4.0 8.1 6.6 9.2 21.8 3.5 14.8 14.9 14.4 11.2 8.3 16.2 6.6 17.9 14.4 5.8 7.7 8.9 5.5 6.9 10.7 9.1 15.6 12.2 6.9 11.3 10.5 14.5 12.1 15.7 3.5 21.2 23.5 11.9 6.9 3.4 5.7 7.6 13.7 12.9 5.5 18.4 16.0 7.7 6.2 19.5 13.4 6.1 6.8 28.6 29.7 23.1 6.8 9.7 8.2 10.7 13.9 14.0 10.2 12.3 10.5 10.0 8.6 9.9 13.9 13.4 15.2 12.2 6.7 23.3 11.7 12.2 10.7 12.6 12.3 13.6 19.3 12.7 12.2 10.6 14.6 8.3 11.9 15.4 20.8 11.0 24.2 10.8 9.4 7.3 9.2 12.7 13.4 9.1 14.0 13.7 14.4 6.6 8.8 75.2 13.7 8.4 23.3 8.7 15.2 15.8 18.4 17.3 38.0 8.0 3.2 19.7 11.6 16.2 24.0 11.8 9.1 16.9 4.6 12.4 5.4 9.2 11.5 7.4 8.4 14.4 0.0 16.0 44.0 41.7 9.5 20.6 14.9 11.8 16.4 CCDC125 KENAE ENSG00000183323 "Coiled-coil domain containing 125" Q86Z20 5 69280175-69332809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 87.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 5.8;eosinophil: 13.0;neutrophil: 10.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.0" "Cell line enhanced" "Detected in many" "T-47d: 19.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA041878 Approved Uncertain "Nucleoplasm,Nuclear membrane,Intermediate filaments" NA NA "Nuclear membrane, Intermediate filaments" Nucleoplasm "HPA041878: AB_10796787" "prognostic unfavorable (8.06e-4)" "unprognostic (1.01e-1)" "unprognostic (2.35e-2)" "prognostic favorable (4.40e-4)" "unprognostic (1.05e-1)" "unprognostic (1.91e-2)" "unprognostic (8.21e-2)" "unprognostic (3.08e-2)" "unprognostic (4.06e-2)" "unprognostic (5.07e-2)" "unprognostic (2.52e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (5.40e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "prognostic favorable (2.51e-4)" 4.3 6.1 4.9 6.1 5.6 13.6 10.0 4.9 4.7 4.1 7.9 5.8 7.8 6.7 5.9 4.0 6.6 5.5 10.0 3.0 4.8 4.9 5.0 17.6 5.8 6.2 6.4 4.9 4.8 14.9 4.2 10.4 5.5 6.7 10.1 7.9 3.6 15.9 12.3 2.8 5.3 10.6 4.5 4.7 5.2 8.3 3.4 4.1 3.1 5.5 4.7 5.5 7.3 5.6 0.9 1.5 13.0 2.3 1.1 1.1 0.8 2.1 3.6 0.7 10.1 1.2 0.7 13.0 1.3 1.9 0.9 0.5 3.2 10.9 3.9 7.6 1.4 0.8 2.8 7.4 3.8 0.8 13.6 5.9 2.5 5.8 6.1 3.1 2.6 1.4 4.2 1.9 4.2 1.3 2.1 1.4 4.7 7.2 1.7 0.7 8.7 3.4 4.3 0.1 2.8 2.3 5.0 0.0 5.3 5.0 2.5 4.2 2.7 2.6 5.9 1.9 0.1 19.4 2.8 1.7 0.8 1.5 2.5 2.0 7.9 12.1 1.5 2.6 14.5 0.4 5.8 1.1 13.0 1.1 0.9 0.9 0.9 1.0 0.8 1.5 0.9 0.9 0.5 10.9 1.1 2.3 1.2 0.7 0.8 4.9 5.6 4.9 4.7 4.8 4.9 6.4 4.9 6.7 4.1 23.8 14.8 4.2 3.6 0.9 4.4 5.5 5.1 87.0 19.4 1.8 2.0 26.8 5.0 10.6 0.8 2.9 9.3 0.0 10.4 6.6 1.3 8.6 15.1 15.3 5.4 3.2 1.2 1.8 4.5 1.5 2.0 3.9 1.7 8.2 12.3 5.4 7.8 13.5 2.1 6.9 7.4 0.0 1.4 1.4 2.3 0.9 10.4 3.1 7.4 4.6 CCDC148 MGC125588 ENSG00000153237 "Coiled-coil domain containing 148" Q8NFR7 2 158171081-158456753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 5.9;testis: 6.5" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 40.2;Cone photoreceptor cells: 53.0;Early spermatids: 22.4;Rod photoreceptor cells: 29.6" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 9 "basophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.1;HBF TERT88: 4.3;hTEC/SVTERT24-B: 2.8;RPTEC TERT1: 3.3;SCLC-21H: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042626 Uncertain Uncertain "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA042626: AB_10806244" "unprognostic (1.88e-1)" "unprognostic (5.90e-2)" "unprognostic (3.31e-2)" "unprognostic (1.94e-4)" "unprognostic (3.29e-1)" "unprognostic (7.65e-2)" "unprognostic (1.23e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (7.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (5.77e-2)" "unprognostic (3.35e-2)" "prognostic favorable (2.54e-4)" "unprognostic (6.57e-3)" 0.1 0.5 0.6 0.0 0.8 0.0 1.8 1.9 0.3 1.4 0.0 0.0 0.6 2.4 0.0 3.3 0.4 0.0 0.7 0.8 4.3 0.1 0.6 0.0 0.5 1.3 0.1 5.9 1.9 0.0 0.4 0.0 1.0 0.7 0.0 0.2 0.0 0.0 1.0 0.0 0.0 6.5 1.8 0.0 0.1 0.3 0.0 0.0 1.9 0.0 0.0 0.2 0.0 1.3 0.0 0.8 1.0 0.0 0.0 0.1 0.9 0.0 1.1 2.3 1.1 6.1 0.1 0.1 0.9 0.4 0.5 0.0 0.3 4.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.4 0.0 0.2 0.0 0.1 0.5 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 3.3 0.4 4.2 0.2 0.3 0.4 0.5 1.3 2.4 0.3 0.0 0.4 0.5 0.1 0.2 0.6 0.7 0.0 1.0 0.0 0.4 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.2 0.0 9.1 2.0 0.0 40.2 3.4 7.0 53.0 0.0 11.6 5.6 22.4 0.2 0.0 0.0 1.6 0.0 0.5 0.8 0.0 1.0 0.1 4.8 0.0 1.8 0.0 3.8 0.9 0.0 0.0 1.0 0.0 5.2 3.4 0.0 1.8 4.8 29.6 6.5 0.3 7.5 1.5 0.4 0.0 0.0 0.0 1.6 CCDC159 ENSG00000183401 "Coiled-coil domain containing 159" P0C7I6 19 11344684-11354944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 270.6;Late spermatids: 182.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 21.8" "Low region specificity" "Detected in all" "HPA047126, HPA054655" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA047126: AB_10961722, HPA054655: AB_2682558" "unprognostic (1.46e-1)" "unprognostic (3.05e-3)" "unprognostic (2.35e-3)" "prognostic favorable (1.87e-7)" "unprognostic (5.02e-2)" "unprognostic (1.06e-3)" "unprognostic (9.23e-3)" "unprognostic (2.40e-2)" "unprognostic (6.68e-2)" "prognostic favorable (9.46e-4)" "prognostic favorable (1.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.97e-2)" "unprognostic (5.09e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-2)" "prognostic favorable (8.62e-4)" 7.9 24.6 21.0 13.4 35.1 22.2 10.9 15.5 28.6 14.8 12.9 30.6 28.3 17.8 13.9 21.1 11.8 14.2 19.0 13.6 22.8 11.9 13.4 18.9 12.8 14.7 38.5 22.9 19.2 15.1 34.3 20.8 7.3 28.0 24.7 9.5 17.7 14.5 17.4 6.3 14.6 14.3 12.5 24.2 24.1 16.1 28.2 43.5 7.5 17.8 8.5 11.2 13.7 12.6 9.9 16.5 21.2 28.0 15.7 15.2 11.8 2.2 2.0 1.7 5.2 6.8 9.9 1.7 3.7 3.9 4.4 5.9 0.6 2.4 1.9 9.6 7.0 1.3 1.9 1.0 5.9 2.7 9.2 1.4 4.5 1.6 2.4 12.0 1.7 6.8 11.8 15.6 3.2 4.3 4.6 12.3 3.4 4.0 21.8 2.2 2.8 2.7 3.6 0.9 3.1 7.4 3.0 0.0 12.2 4.0 3.2 0.7 2.8 3.7 4.3 6.8 3.2 6.3 7.5 8.1 3.5 1.0 6.0 3.4 20.0 4.8 3.8 4.7 9.2 5.0 21.2 28.0 19.1 12.1 23.6 11.7 8.1 8.2 11.0 16.5 9.9 7.5 5.9 13.2 15.7 16.4 4.3 15.2 11.8 21.0 35.1 15.5 28.6 22.8 11.9 38.5 22.9 28.0 43.5 14.9 9.9 9.0 13.1 6.6 11.2 9.8 12.7 21.4 14.8 17.4 39.3 4.9 21.6 7.6 270.6 9.1 14.8 0.0 8.4 4.4 8.4 23.8 33.5 9.6 20.4 6.4 10.4 12.9 26.0 182.1 10.6 15.7 11.8 13.6 10.6 14.8 7.5 23.0 12.7 31.6 28.9 0.0 8.2 4.8 3.8 7.0 5.0 21.5 8.1 17.5 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.1;pituitary gland: 6.6;testis: 8.2" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 13.4;Cone photoreceptor cells: 7.9;Early spermatids: 7.0;Rod photoreceptor cells: 11.8;Spermatocytes: 16.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;SCLC-21H: 1.7" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.2 0.1 0.9 0.2 2.9 0.5 0.2 17.1 3.3 0.2 0.9 1.2 0.0 0.3 0.2 1.0 0.2 1.3 0.5 0.2 0.8 0.5 0.4 0.2 0.5 0.2 0.8 0.9 0.2 0.1 0.3 6.6 0.1 3.0 0.2 1.8 0.6 0.2 0.2 0.2 0.3 0.9 0.2 0.4 0.4 0.2 8.2 1.5 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.5 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.4 0.9 2.9 17.1 3.3 0.8 0.5 0.8 0.9 3.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.4 1.2 0.0 7.9 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 11.8 0.0 0.0 16.5 1.3 0.0 0.0 0.0 2.6 0.0 CCDC25 FLJ10853 ENSG00000147419 "Coiled-coil domain containing 25" Q86WR0 8 27733311-27772653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023256 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA023256: AB_2072067" "unprognostic (1.43e-1)" "unprognostic (5.48e-2)" "unprognostic (3.10e-3)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (6.62e-3)" "unprognostic (2.34e-1)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (8.49e-3)" "unprognostic (3.50e-1)" "unprognostic (2.69e-2)" "prognostic favorable (1.11e-7)" "unprognostic (3.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-1)" 12.7 25.4 16.8 10.6 22.4 4.0 16.7 14.2 26.1 10.3 26.0 13.1 12.0 32.5 13.2 14.2 13.7 14.6 11.3 11.1 16.5 14.0 21.5 30.4 8.5 12.8 19.9 15.8 10.9 16.0 15.6 12.7 9.9 29.4 11.4 15.1 9.8 14.1 12.4 23.3 10.9 39.7 10.5 19.0 12.1 18.0 12.0 17.2 9.7 17.8 13.8 12.8 13.2 10.5 19.2 18.9 14.9 13.2 13.8 21.8 9.1 24.0 13.1 13.2 12.3 11.8 17.1 8.9 20.2 19.6 12.5 12.3 5.4 8.6 26.0 14.0 10.2 10.7 11.4 11.7 19.7 18.1 9.7 7.8 32.4 12.3 9.4 19.8 11.3 10.5 19.1 13.1 13.5 19.0 14.3 26.8 17.0 15.2 12.5 13.9 8.8 27.5 9.6 18.9 23.9 7.3 9.0 22.4 13.7 16.4 14.1 7.6 21.2 13.6 10.5 20.6 10.4 12.0 6.4 21.6 11.5 18.2 19.6 10.6 13.6 15.9 9.5 17.8 15.1 11.8 14.9 10.4 7.3 14.6 13.2 19.8 19.2 21.2 17.8 12.1 14.0 18.8 20.9 4.0 13.8 12.5 18.9 21.8 9.1 16.8 22.4 14.2 26.1 16.5 14.0 19.9 15.8 29.4 17.2 23.8 29.3 26.0 34.6 19.1 41.2 55.6 56.0 65.6 43.3 50.6 11.8 67.5 92.9 63.1 135.8 56.8 64.2 23.3 117.7 46.6 43.3 42.8 61.3 122.8 39.7 52.4 25.4 48.5 33.2 96.8 43.7 30.4 35.4 50.5 50.8 46.3 68.5 45.6 44.6 91.6 36.5 45.3 35.0 69.9 62.9 19.4 35.5 34.9 50.9 23.7 CCDC51 FLJ12436 ENSG00000164051 "Coiled-coil domain containing 51" Q96ER9 3 48432164-48440456 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010980, HPA011408" Supported Supported Nucleoplasm,Centrosome,Mitochondria NA NA "Nucleoplasm, Mitochondria" Centrosome "HPA010980: AB_1846155, HPA011408: AB_2072212" "unprognostic (1.24e-2)" "unprognostic (5.23e-2)" "unprognostic (5.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-1)" "unprognostic (2.75e-3)" "unprognostic (4.71e-3)" "unprognostic (1.26e-2)" "unprognostic (3.04e-1)" "unprognostic (3.26e-2)" "unprognostic (7.70e-2)" "unprognostic (1.47e-3)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" 9.9 14.9 10.1 7.1 12.7 4.5 9.6 10.4 15.9 8.9 12.8 7.5 12.4 11.6 8.2 11.4 15.9 9.7 8.4 12.3 9.2 8.2 15.2 17.8 7.1 9.0 9.9 15.4 8.7 8.5 9.4 7.4 8.5 10.6 7.7 15.1 9.9 11.0 11.2 16.3 10.9 8.8 11.6 8.8 14.7 7.9 10.7 8.9 10.4 11.3 16.1 12.0 8.8 9.7 19.2 18.2 4.8 10.4 10.6 14.8 9.7 9.7 11.9 7.2 8.4 10.6 11.3 19.7 6.5 6.0 13.1 10.7 18.8 16.4 21.2 9.3 5.1 9.8 14.3 17.6 21.2 8.0 9.9 11.6 18.1 18.9 14.1 16.4 8.8 8.3 8.5 48.2 16.1 17.7 7.1 7.4 12.5 10.0 6.2 12.3 9.3 10.2 11.4 15.7 21.0 19.3 7.1 8.4 16.3 17.7 12.2 5.9 12.5 10.7 11.7 17.4 7.0 12.6 13.7 5.6 7.6 10.3 18.8 12.4 10.0 14.6 11.1 10.1 19.1 7.1 2.0 10.4 4.8 12.0 10.2 12.1 19.2 11.2 14.8 18.2 15.4 11.7 13.4 4.5 10.6 6.1 15.2 13.4 9.7 10.1 12.7 10.4 15.9 9.2 8.2 9.9 15.4 10.6 8.9 11.9 1.6 8.9 3.0 4.1 6.8 7.3 22.9 5.3 5.7 8.7 0.0 35.3 19.9 13.2 2.5 5.3 12.6 0.0 10.8 15.3 10.7 3.7 3.5 11.9 14.1 7.9 5.2 3.1 3.8 2.2 11.2 4.1 13.5 13.6 6.3 10.1 12.4 5.8 12.4 27.0 9.5 6.5 3.1 4.8 17.3 4.1 5.6 4.3 12.4 3.1 CCDC63 "FLJ35843, ODA5" ENSG00000173093 "Coiled-coil domain containing 63" Q8NA47 12 110846769-110907535 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 26.2" "Group enriched" "Detected in some" 54 "Early spermatids: 233.1;Late spermatids: 164.1" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "MCF7: 9.9" "Region enriched" "Detected in single" 9 "cerebellum: 10.3" "Not detected" "Not detected" HPA061568 Approved "Nucleoplasm,Nuclear bodies,Vesicles" No NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA061568: AB_2684561" "unprognostic (1.98e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.09e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 233.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 164.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 3.7 3.4 0.0 0.1 0.0 0.0 0.0 CCDC8 "3M3, DKFZp564K0322, PPP1R20" ENSG00000169515 "Coiled-coil domain containing 8" Q9H0W5 19 46410372-46413584 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 39.4" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 25.5;Distal tubular cells: 33.2;Leydig cells: 65.6;Peritubular cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.6" "Cell line enhanced" "Detected in many" "AF22: 12.0;AN3-CA: 14.3;HSkMC: 13.1;K-562: 12.5;RH-30: 16.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041993 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041993: AB_10795388" "unprognostic (3.05e-3)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.39e-3)" "unprognostic (3.69e-1)" "unprognostic (6.64e-2)" "unprognostic (5.16e-2)" "unprognostic (7.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (5.72e-2)" "prognostic favorable (1.72e-5)" "unprognostic (5.43e-3)" "unprognostic (5.77e-2)" "unprognostic (4.09e-2)" "unprognostic (4.18e-3)" 2.7 13.3 3.0 2.1 3.8 0.6 7.6 0.9 2.3 18.9 2.4 5.1 6.2 0.8 15.5 17.3 2.9 19.0 9.7 18.9 3.1 2.3 7.9 0.7 7.1 0.9 2.4 2.9 39.4 19.2 8.5 9.9 5.6 4.6 12.1 1.1 10.0 8.7 7.5 3.0 2.2 1.6 6.7 2.0 1.8 1.7 9.0 2.6 4.2 11.8 2.6 1.4 4.8 5.8 0.4 0.3 3.6 0.4 0.2 0.2 0.1 1.2 0.1 12.0 14.3 3.2 4.0 5.8 6.1 0.0 1.4 0.6 0.0 0.1 0.1 8.2 4.8 0.2 0.1 0.1 9.5 0.6 0.0 6.0 0.0 0.1 0.6 10.7 0.0 0.1 13.1 0.0 3.4 10.0 0.2 0.0 0.1 12.5 0.0 4.4 0.0 0.0 0.8 8.7 0.0 0.0 0.4 16.2 0.0 10.5 0.0 1.9 0.1 0.0 0.0 0.0 9.7 0.1 2.9 1.1 0.8 3.2 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.4 0.2 0.2 0.2 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.2 3.6 0.2 0.3 0.3 0.1 0.1 3.0 3.8 0.9 2.3 3.1 2.3 2.4 2.9 4.6 2.6 0.0 0.6 0.0 5.7 0.8 0.0 25.5 10.2 2.7 6.8 10.4 0.0 5.8 33.2 11.1 0.3 0.4 0.0 0.0 0.9 7.8 9.9 0.5 1.1 0.0 1.5 0.0 0.0 1.3 0.0 1.3 65.6 0.9 1.7 0.0 0.0 13.3 5.9 0.0 54.5 0.8 0.4 12.9 7.2 0.3 4.5 0.1 1.7 0.0 0.0 0.5 CCDC82 FLJ23518 ENSG00000149231 "Coiled-coil domain containing 82" Q8N4S0 11 96352769-96389956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 343.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038704, HPA070631" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA038704: AB_10674835, HPA070631: " "unprognostic (3.04e-1)" "unprognostic (1.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" "unprognostic (4.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.37e-1)" "unprognostic (9.94e-3)" "unprognostic (5.94e-2)" "unprognostic (3.68e-1)" "unprognostic (3.41e-1)" "unprognostic (7.68e-3)" "unprognostic (1.42e-1)" "unprognostic (9.84e-2)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" 19.4 12.5 22.8 14.6 32.7 12.1 15.3 34.5 29.6 13.6 12.7 18.3 6.7 9.8 18.4 12.2 9.0 14.9 13.9 10.4 23.7 9.0 13.7 17.8 15.7 17.4 31.9 20.3 16.5 13.5 11.7 22.3 14.3 25.6 12.2 11.6 8.1 11.9 13.7 10.8 10.5 15.5 14.1 26.0 16.5 13.6 19.4 35.5 7.5 15.9 6.2 15.8 15.4 16.9 14.3 12.2 28.6 10.8 22.7 19.2 11.0 5.4 8.2 25.4 9.8 16.9 14.5 9.4 21.2 13.1 13.9 20.4 13.5 19.1 11.3 20.0 11.0 23.0 12.8 9.0 7.7 20.7 19.3 5.5 23.1 17.6 11.5 12.1 18.1 15.4 8.8 4.1 28.1 10.6 13.1 16.6 11.6 13.8 12.3 18.7 0.2 15.3 17.6 5.0 9.6 5.9 10.5 21.6 10.1 10.6 14.2 4.0 10.8 11.7 1.2 10.4 17.8 1.9 9.0 19.2 24.8 13.6 20.6 11.2 4.2 12.6 16.5 7.4 14.3 17.5 28.6 8.3 15.5 16.5 10.2 17.2 14.3 17.6 16.1 8.9 12.1 19.2 18.2 11.6 22.7 10.8 12.2 18.4 11.0 22.8 32.7 34.5 29.6 23.7 9.0 31.9 20.3 25.6 35.5 17.9 35.6 25.2 24.5 27.1 51.9 30.7 12.7 84.3 29.6 29.6 94.2 15.2 23.2 29.3 343.9 53.7 8.0 0.0 15.0 15.4 39.1 12.2 38.3 31.4 21.5 30.2 19.0 33.2 26.0 42.3 40.6 33.9 25.3 42.3 7.7 32.4 24.5 11.5 40.3 27.0 45.9 32.3 28.9 80.2 51.2 17.9 6.9 39.2 8.6 18.0 CCDC83 "CT148, FLJ42119, MGC34732" ENSG00000150676 "Coiled-coil domain containing 83" Q8IWF9 11 85855101-85920021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 27.7" "Group enriched" "Detected in some" 11 "Early spermatids: 142.1;Late spermatids: 149.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "MCF7: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039707, HPA039882" Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039707: AB_10795259, HPA039882: AB_10795410" "unprognostic (1.14e-1)" "unprognostic (4.09e-1)" "unprognostic (1.49e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-6)" "unprognostic (3.52e-1)" "unprognostic (2.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.8 0.8 0.3 0.6 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.7 0.3 0.3 0.2 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.3 7.9 0.1 0.4 0.0 1.3 0.0 0.1 0.0 0.1 0.6 0.3 0.1 0.1 0.1 0.5 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.4 0.8 0.6 0.3 0.6 0.4 0.4 0.3 0.3 0.3 0.3 0.4 0.3 0.5 1.8 0.3 0.8 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 142.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.4 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 13.1 1.3 0.0 0.0 0.0 0.0 0.0 CCDC88B "BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3" ENSG00000168071 "Coiled-coil domain containing 88B" A6NC98 11 64340223-64357534 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 10.1;HMC-1: 40.7;Karpas-707: 10.6;THP-1: 16.2;U-937: 11.7" "Not detected" "Not detected" HPA026652 Approved Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA Centrosome "Nucleoplasm, Cytosol" "HPA026652: AB_1846168" "unprognostic (1.18e-2)" "unprognostic (3.33e-3)" "unprognostic (3.65e-1)" "unprognostic (1.58e-2)" "unprognostic (2.36e-1)" "prognostic favorable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (1.55e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" "prognostic unfavorable (7.65e-5)" "unprognostic (3.77e-2)" "unprognostic (7.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.83e-2)" 3.5 2.5 5.2 29.5 5.4 32.5 2.7 23.7 2.8 2.6 6.1 4.5 6.9 3.2 2.0 1.3 4.2 2.5 8.5 2.3 4.1 2.6 2.0 1.6 11.4 18.6 8.6 2.2 1.3 2.1 0.7 1.6 1.4 6.5 2.9 2.9 1.7 7.5 8.9 0.8 1.9 11.1 1.3 7.2 26.6 3.3 7.3 6.5 16.8 1.9 2.7 20.8 4.1 2.8 3.0 3.5 11.3 6.5 7.1 4.6 1.6 0.1 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 1.6 9.3 1.4 0.5 0.2 0.8 0.0 0.2 0.0 10.1 0.0 7.0 1.8 0.5 0.4 4.3 40.7 0.0 0.0 0.1 0.0 0.6 0.2 3.0 0.2 10.6 0.3 0.4 5.8 3.6 0.3 1.7 0.2 5.5 0.1 8.6 0.1 0.1 2.3 0.0 0.0 0.2 0.5 0.0 1.2 16.2 0.0 0.0 0.3 0.0 0.1 2.3 0.7 7.5 0.5 11.7 0.2 3.6 6.5 7.6 4.6 4.7 1.4 2.2 2.7 3.8 2.1 3.0 2.6 3.2 11.3 7.1 3.1 3.5 0.8 1.6 5.2 5.4 23.7 2.8 4.1 2.6 8.6 2.2 6.5 6.5 0.0 12.5 29.6 3.8 2.4 39.7 11.9 0.0 8.1 3.4 8.7 0.0 2.6 0.0 11.0 9.4 4.3 33.2 0.0 24.8 4.1 2.6 3.4 25.5 7.2 12.7 0.0 17.3 8.0 22.4 10.9 1.4 23.3 5.0 22.6 20.8 11.7 25.7 31.7 0.7 2.3 4.4 0.0 2.3 12.5 1.5 1.4 1.1 31.6 17.9 14.8 CCDC97 "FLJ40267, MGC20255" ENSG00000142039 "Coiled-coil domain containing 97" Q96F63 19 41310189-41324883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043320, HPA043572" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA043320: AB_10964344, HPA043572: AB_10962488" "unprognostic (9.25e-3)" "unprognostic (7.26e-2)" "unprognostic (1.68e-1)" "unprognostic (5.10e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.09e-4)" "unprognostic (8.40e-2)" "unprognostic (1.91e-2)" "unprognostic (2.44e-1)" "unprognostic (5.93e-3)" "unprognostic (4.51e-2)" "unprognostic (2.16e-1)" "unprognostic (2.96e-1)" "unprognostic (4.08e-1)" "unprognostic (7.92e-2)" "unprognostic (1.65e-2)" 20.4 15.3 15.5 20.7 18.8 21.5 16.8 16.1 24.7 21.3 16.7 26.7 17.8 15.1 21.3 26.6 22.9 24.5 15.8 16.4 14.6 14.1 16.5 13.3 15.4 23.2 16.0 16.2 27.4 20.6 20.8 21.9 22.9 18.6 19.0 12.6 20.9 21.1 17.2 28.8 21.5 18.4 15.6 21.0 24.2 17.3 39.9 16.8 27.7 17.9 20.4 27.2 17.7 19.7 13.6 7.6 14.6 13.3 11.5 16.8 8.3 13.1 28.9 15.3 17.8 20.2 16.2 11.1 8.9 7.2 14.1 12.1 17.1 12.7 12.6 9.6 7.4 9.5 9.0 21.0 17.7 10.8 23.0 20.3 11.5 13.0 11.2 15.4 19.0 24.9 15.7 22.8 16.4 13.8 11.6 9.7 13.9 14.6 24.1 13.4 9.6 17.3 4.6 7.1 16.0 10.4 19.6 12.2 9.1 12.9 25.2 13.8 12.2 19.8 21.9 8.7 10.7 14.9 14.5 11.5 12.2 12.3 6.3 14.7 24.8 21.2 12.1 11.6 14.0 16.1 9.0 8.3 9.7 15.3 9.2 16.8 11.3 10.3 10.9 6.8 13.6 11.4 10.0 14.6 11.5 13.3 7.6 8.5 8.3 15.5 18.8 16.1 24.7 14.6 14.1 16.0 16.2 18.6 16.8 11.9 7.9 9.3 10.0 4.0 11.7 5.9 10.2 6.7 3.4 8.7 11.8 9.6 6.6 10.7 2.5 7.5 12.9 0.0 22.5 4.4 7.6 7.8 16.1 4.9 13.4 9.5 11.1 10.4 11.6 7.8 11.8 7.7 1.7 18.0 11.1 6.4 17.7 2.9 10.6 7.2 8.8 0.0 8.3 20.6 11.7 5.1 15.3 16.0 9.6 10.9 CCNI CCNI1 ENSG00000118816 "Cyclin I" Q14094 4 77047158-77076005 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 248.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010206, HPA039853, HPA061470" Uncertain Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533" "unprognostic (3.68e-1)" "unprognostic (2.25e-1)" "unprognostic (7.59e-2)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (1.38e-1)" "unprognostic (8.57e-3)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.10e-4)" "unprognostic (3.81e-2)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" 49.0 26.6 48.1 47.1 45.8 50.3 121.1 101.3 248.9 66.3 56.8 21.6 36.9 25.6 56.7 69.0 56.2 50.7 45.2 87.7 44.8 34.1 48.2 34.5 64.7 70.1 55.8 33.5 94.9 65.4 36.5 33.1 35.4 46.7 61.4 34.9 32.7 45.5 62.9 64.3 38.5 45.8 61.6 58.1 41.3 42.4 53.0 20.3 55.4 81.2 28.2 60.0 82.7 62.6 49.2 42.9 70.5 39.8 33.6 56.2 24.3 24.6 14.8 48.4 42.2 72.8 66.6 18.5 19.1 46.7 30.2 29.2 18.2 37.6 45.6 29.3 47.8 18.9 12.9 33.0 66.7 48.2 32.3 13.0 27.3 17.3 17.3 71.5 46.8 55.2 52.0 79.9 27.8 68.4 86.9 42.3 24.1 23.3 49.7 42.9 28.4 60.8 44.3 21.2 17.3 9.2 38.2 45.7 19.2 45.0 28.2 61.4 33.6 25.3 38.9 30.8 35.4 22.1 20.0 28.6 37.0 22.1 39.3 25.9 27.6 12.5 48.2 31.3 32.4 23.9 43.1 32.9 70.5 31.7 33.4 44.9 46.6 52.4 47.2 37.3 49.2 56.2 47.4 47.0 33.6 39.8 42.9 44.8 24.3 48.1 45.8 101.3 248.9 44.8 34.1 55.8 33.5 46.7 20.3 160.8 205.6 381.1 554.3 375.7 387.2 381.6 262.4 87.0 102.4 186.7 64.8 225.4 673.1 338.9 56.4 305.8 254.0 186.9 291.0 357.2 371.0 733.0 274.5 108.3 295.2 171.6 395.9 297.7 542.3 122.9 559.2 420.6 381.3 312.8 295.3 254.5 414.7 272.5 929.9 450.1 187.1 543.3 450.1 159.5 349.2 345.0 317.4 433.7 302.4 523.8 CCNI2 FLJ16793 ENSG00000205089 "Cyclin I family member 2" Q6ZMN8 5 132747445-132754403 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 17.4;seminal vesicle: 15.7" "Cell type enhanced" "Detected in some" 6 "Distal tubular cells: 3.3;Mucus-secreting cells: 3.3;Muller glia cells: 4.2;Paneth cells: 2.9;Undifferentiated cells: 3.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.0" HPA056288 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA056288: AB_2683086" "unprognostic (3.84e-2)" "unprognostic (2.44e-3)" "prognostic favorable (8.21e-4)" "unprognostic (5.97e-2)" "unprognostic (3.39e-1)" "unprognostic (6.71e-3)" "unprognostic (1.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (1.77e-1)" "unprognostic (4.95e-1)" "unprognostic (1.71e-7)" "unprognostic (1.58e-1)" 0.3 0.7 3.4 5.6 3.5 0.3 0.3 8.4 4.7 1.2 5.8 3.5 17.4 7.8 0.2 0.7 0.5 0.8 5.2 0.6 3.9 2.6 3.8 0.3 0.7 1.7 3.9 0.5 0.3 7.4 0.4 0.9 0.5 4.1 1.7 6.5 1.5 8.4 15.7 0.7 0.7 8.9 0.4 7.2 0.8 5.5 1.4 3.9 7.0 0.8 0.7 2.1 2.4 0.3 0.3 0.1 0.7 0.1 0.2 2.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.4 0.0 0.6 24.0 0.1 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 1.4 1.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 3.7 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.3 0.1 2.7 0.3 2.1 2.1 0.0 0.3 1.8 0.9 0.3 0.2 0.1 0.1 2.7 0.3 3.4 3.5 8.4 2.8 3.9 2.6 3.9 0.5 4.1 3.9 0.0 0.3 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.4 1.7 0.0 1.7 0.0 1.4 0.1 0.0 0.9 1.1 0.0 0.1 1.6 1.2 0.0 0.0 1.5 0.3 0.0 0.0 0.0 3.3 4.2 1.2 2.9 0.0 0.3 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 3.5 0.6 CCNT2 ENSG00000082258 "Cyclin T2" O60583 2 134918235-134959342 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005559 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA005559: AB_1078608" "unprognostic (2.49e-2)" "unprognostic (1.19e-1)" "unprognostic (9.57e-2)" "unprognostic (1.25e-1)" "unprognostic (4.92e-2)" "unprognostic (2.65e-3)" "unprognostic (1.85e-2)" "unprognostic (1.00e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (2.44e-4)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.33e-1)" "unprognostic (8.51e-2)" "unprognostic (9.94e-2)" "prognostic favorable (3.28e-4)" 15.8 14.1 21.0 15.2 19.9 32.5 21.1 30.5 22.2 16.4 14.2 16.9 17.8 17.6 22.6 20.9 15.4 16.1 12.9 14.2 16.1 14.3 12.9 20.8 17.5 18.9 18.6 16.2 22.8 24.0 25.1 29.6 17.9 20.0 18.0 16.7 11.5 16.9 19.4 14.5 20.3 17.2 18.0 17.1 19.8 18.9 15.8 19.1 23.0 18.7 9.4 18.2 18.9 19.5 3.8 4.9 6.9 4.5 6.2 8.4 3.4 6.7 3.4 22.1 8.2 11.0 11.2 16.8 9.3 7.7 8.9 11.1 9.1 7.8 11.1 7.1 7.7 4.3 8.8 13.2 7.0 13.0 5.9 8.9 11.9 8.7 12.8 10.8 10.7 10.6 10.2 14.0 8.7 10.8 11.5 13.0 8.4 9.9 11.4 10.3 4.6 11.8 16.0 17.9 5.6 7.0 11.5 7.9 8.8 13.7 18.7 15.1 12.5 6.9 8.0 10.7 16.8 8.4 13.1 11.8 11.5 12.6 4.9 6.8 8.1 4.9 11.6 7.1 8.6 9.7 6.9 3.7 4.5 4.3 4.5 5.3 3.8 4.8 5.1 4.9 3.1 8.4 6.4 4.8 6.2 2.3 4.5 5.9 3.4 21.0 19.9 30.5 22.2 16.1 14.3 18.6 16.2 20.0 19.1 23.8 24.2 24.6 28.3 13.4 32.7 19.5 17.8 9.4 20.5 14.0 31.4 9.1 6.6 13.6 4.7 18.2 17.4 0.0 13.0 7.4 12.5 26.7 10.5 18.4 8.6 39.7 17.7 20.3 12.9 11.8 13.0 20.9 8.5 14.4 14.5 16.7 12.3 17.5 20.8 4.8 32.8 19.4 11.3 16.8 19.9 15.8 11.4 20.0 14.3 38.3 CCT8 "C21orf112, Cctq, PRED71" ENSG00000156261 "Chaperonin containing TCP1 subunit 8" P50990 21 29055805-29073797 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018520, HPA021051, HPA029426" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" No No 2700000 "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (4.25e-3)" "prognostic unfavorable (1.56e-5)" "unprognostic (8.78e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" "unprognostic (1.02e-2)" "unprognostic (2.91e-1)" "unprognostic (3.01e-2)" "unprognostic (8.26e-2)" "unprognostic (3.50e-2)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" 33.5 62.5 28.9 36.1 43.8 28.2 39.7 47.9 46.4 34.5 33.7 15.7 41.9 29.6 37.4 36.4 47.6 33.6 23.6 43.9 33.0 36.0 43.6 42.1 33.2 48.8 28.8 39.2 39.3 47.2 35.4 42.6 41.0 39.6 30.9 38.3 17.0 34.7 38.6 68.4 35.5 30.1 38.3 29.5 39.8 35.2 30.2 30.2 66.6 36.1 52.0 57.6 38.5 47.8 25.6 41.7 17.5 38.1 22.8 27.2 33.9 50.1 28.5 36.5 26.2 27.0 37.2 40.7 40.2 25.7 45.7 38.2 60.4 31.1 99.2 27.0 27.8 56.9 20.3 75.2 46.5 52.0 41.9 39.1 137.2 34.3 26.9 28.0 67.8 38.4 28.3 28.7 53.8 44.7 33.6 43.6 44.2 105.7 58.0 46.6 26.0 51.0 26.5 65.7 50.2 35.5 45.9 71.9 61.7 46.7 26.4 36.6 26.3 39.5 41.7 34.5 40.6 37.3 59.4 31.5 26.0 73.4 24.4 50.1 37.8 72.8 78.2 30.4 77.1 39.6 17.5 33.7 16.7 18.5 36.9 25.5 25.6 24.0 24.3 41.7 19.2 27.2 24.5 3.7 22.8 38.1 24.6 26.6 33.9 28.9 43.8 47.9 46.4 33.0 36.0 28.8 39.2 39.6 30.2 59.6 50.7 145.9 155.3 127.2 80.5 66.6 81.5 101.7 63.7 71.5 17.7 231.9 122.7 173.0 13.3 94.7 74.3 23.3 120.5 222.9 82.2 111.0 110.8 53.3 152.3 73.1 93.1 52.2 97.5 17.8 77.9 129.4 109.6 186.7 93.1 81.5 121.5 94.7 87.4 163.4 64.8 103.5 99.4 175.3 178.0 114.8 238.6 86.3 148.0 143.1 CD163L1 "CD163B, M160, SCARI2, WC1" ENSG00000177675 "CD163 molecule like 1" Q9NR16 12 7346685-7479897 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.4;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 6.9;Melanocytes: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 9.2;HDLM-2: 8.2;HUVEC TERT2: 8.9;TIME: 8.3;U-87 MG: 19.4" HPA015663 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA 170000 "Centrosome, Cytosol" Nucleoplasm "HPA015663: AB_2072575" "unprognostic (1.25e-3)" "unprognostic (1.77e-1)" "unprognostic (1.42e-2)" "unprognostic (7.46e-3)" "unprognostic (2.29e-2)" "unprognostic (7.79e-2)" "unprognostic (9.39e-2)" "unprognostic (4.44e-3)" "unprognostic (1.07e-1)" "unprognostic (8.35e-2)" "unprognostic (1.08e-1)" "unprognostic (3.08e-1)" "unprognostic (1.26e-6)" "unprognostic (8.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.69e-1)" 5.0 1.7 1.2 19.1 1.2 0.0 2.5 0.8 1.6 1.4 9.2 0.3 1.0 5.5 1.2 8.5 1.8 1.3 2.6 3.2 1.2 1.0 1.7 1.5 2.8 14.6 1.1 0.7 1.0 1.0 0.1 1.4 6.8 3.3 1.4 15.1 2.7 2.5 1.4 1.1 1.4 18.4 1.8 1.0 31.2 2.6 4.6 0.2 9.5 1.7 6.4 12.9 4.3 1.2 0.2 0.7 0.7 0.8 0.0 0.0 0.2 0.2 0.4 0.2 0.0 1.0 0.3 0.0 0.8 1.8 0.2 0.8 0.0 1.4 0.0 0.3 0.8 9.2 0.0 0.0 1.1 1.4 8.2 0.0 0.0 0.4 1.2 0.0 0.5 0.0 0.3 0.0 0.2 3.3 0.6 8.9 0.0 0.1 4.7 5.2 0.0 0.0 6.6 0.2 0.0 0.0 1.5 1.5 1.8 0.0 0.0 1.2 5.6 4.3 6.8 0.0 0.3 0.0 5.5 8.3 3.0 2.7 0.3 0.0 0.1 0.1 0.0 19.4 0.4 5.7 0.0 0.8 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.2 0.8 1.6 1.2 1.0 1.1 0.7 3.3 0.2 0.0 0.0 0.0 0.0 1.1 2.9 0.7 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 2.2 0.7 0.0 0.0 1.2 0.3 0.5 0.1 0.0 0.4 6.9 0.0 0.0 0.0 4.1 1.1 0.0 3.3 13.5 0.0 0.0 1.0 2.0 1.1 0.0 0.0 1.7 19.4 8.0 3.4 0.7 1.1 0.2 0.0 0.0 0.1 CD226 "DNAM-1, DNAM1, PTA1, TLiSA1" ENSG00000150637 "CD226 molecule" Q15762 18 69831158-69961803 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.9;parathyroid gland: 82.5" "Cell type enhanced" "Detected in many" 10 "granulocytes: 12.8;Kupffer cells: 11.2;monocytes: 21.6;T-cells: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 19.4;MAIT T-cell: 7.3;memory CD4 T-cell: 16.1;memory CD8 T-cell: 11.8;naive CD4 T-cell: 9.0;naive CD8 T-cell: 9.7;NK-cell: 14.0;T-reg: 5.5" "Group enriched" "Detected in many" 11 "NK-cells: 14.0;T-cells: 19.4" "Group enriched" "Detected in some" 6 "HEL: 45.3;HMC-1: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA015715, HPA015865" Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" NA No 27000000 "Plasma membrane" "Nucleoplasm, Centriolar satellite" "HPA015715: AB_1846278, HPA015865: " "unprognostic (1.42e-4)" "unprognostic (1.30e-3)" "unprognostic (9.01e-3)" "unprognostic (3.49e-5)" "unprognostic (4.15e-1)" "unprognostic (9.52e-4)" "unprognostic (3.68e-3)" "unprognostic (2.93e-2)" "unprognostic (3.43e-1)" "unprognostic (3.31e-3)" "unprognostic (8.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (2.27e-1)" "unprognostic (3.58e-2)" 1.2 0.6 1.0 7.5 2.0 1.7 0.8 0.7 0.9 1.5 2.9 0.3 0.1 1.1 1.0 1.4 0.8 0.8 1.4 0.9 1.9 1.3 1.3 3.1 5.2 14.0 1.7 0.0 1.0 0.6 82.5 2.4 0.6 1.3 0.9 1.2 2.4 5.4 0.6 1.1 0.4 6.0 1.3 4.2 31.9 1.4 1.8 0.5 6.4 1.8 2.6 10.1 2.0 1.6 0.4 1.5 0.9 0.6 14.0 19.4 6.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 2.4 0.0 45.3 0.1 0.0 0.0 0.3 20.2 0.0 0.5 0.1 0.3 0.0 0.0 0.4 0.1 4.7 0.2 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.1 5.5 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.5 19.4 0.4 7.3 0.4 16.1 11.8 1.5 0.1 9.0 9.7 0.9 14.0 0.6 0.1 5.5 6.6 1.0 2.0 0.7 0.9 1.9 1.3 1.7 0.0 1.3 0.5 3.0 5.1 0.8 0.3 0.0 2.4 1.6 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 6.6 0.1 0.0 0.0 0.3 0.0 0.4 0.2 12.8 0.5 1.4 0.0 0.0 2.5 11.2 7.5 0.9 7.8 0.0 21.6 0.0 1.4 0.2 0.0 0.7 0.0 3.7 0.0 0.3 0.3 0.5 0.4 0.0 25.4 0.0 0.1 CD274 "B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1" ENSG00000120217 "CD274 molecule" Q9NZQ7 9 5450503-5470566 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 23.9;placenta: 56.0" "Cell type enhanced" "Detected in many" 14 "granulocytes: 26.7;monocytes: 73.9;Syncytiotrophoblasts: 37.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.4" "Group enriched" "Detected in many" 6 "granulocytes: 8.4;T-cells: 2.4" "Cell line enhanced" "Detected in many" "HDLM-2: 34.2;HHSteC: 22.8;U-251 MG: 37.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003528, CAB076385" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB076385: AB_2687655, HPA003528: " "prognostic favorable (8.89e-4)" "unprognostic (4.54e-2)" "prognostic favorable (1.64e-5)" "unprognostic (1.27e-2)" "unprognostic (2.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.61e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (5.67e-4)" "unprognostic (7.39e-3)" "unprognostic (1.69e-2)" "unprognostic (1.24e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-2)" "unprognostic (2.67e-1)" "unprognostic (9.02e-2)" 3.4 2.1 1.7 10.8 3.2 1.4 2.2 2.5 3.3 2.0 2.3 2.5 2.8 2.6 1.7 2.4 3.0 1.9 4.3 9.5 1.4 3.7 3.0 3.6 23.9 6.4 2.3 0.7 1.7 2.7 3.8 7.4 56.0 3.2 2.9 2.2 3.3 1.7 1.6 4.3 1.3 2.7 2.3 2.4 12.8 1.9 1.2 1.0 11.6 3.7 2.1 5.8 3.1 1.9 0.9 0.0 8.4 0.1 0.4 2.4 0.7 5.9 0.1 0.0 0.2 0.0 0.0 0.0 11.9 10.1 3.0 4.2 0.0 1.9 0.0 0.2 0.3 1.5 0.2 0.0 5.2 9.9 34.2 0.0 3.4 0.1 0.0 22.8 0.0 0.0 0.2 0.0 6.3 9.3 3.1 5.9 0.3 0.0 1.1 9.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.3 0.6 0.1 0.0 0.1 0.1 0.9 0.7 0.9 0.0 0.1 10.9 6.5 2.0 0.2 37.9 0.2 0.1 0.1 2.1 0.1 0.0 8.4 0.1 0.3 1.2 0.1 2.1 0.9 2.4 1.8 0.0 0.2 1.3 0.7 5.7 0.4 0.0 0.0 1.1 0.7 1.7 3.2 2.5 3.3 1.4 3.7 2.3 0.7 3.2 1.0 11.9 10.7 0.5 1.2 4.0 1.4 6.5 0.0 4.0 3.4 0.0 0.0 4.9 0.0 6.4 0.2 6.3 0.8 0.0 3.7 20.2 1.9 0.9 26.7 1.0 4.9 0.0 0.0 10.4 1.9 0.0 0.3 7.7 3.3 73.9 0.1 0.6 12.0 0.0 0.4 0.4 0.1 0.0 0.9 0.5 0.7 2.3 37.2 1.3 0.2 2.2 CD34 ENSG00000174059 "CD34 molecule" P28906 1 207880972-207911402 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 214.1;Ito cells: 81.0;Leydig cells: 135.4;Peritubular cells: 115.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 32.6;MOLT-4: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000018, HPA036722, HPA036723" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 69000000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272" "unprognostic (3.82e-1)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.09e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.93e-5)" "unprognostic (1.25e-2)" "unprognostic (7.74e-2)" "unprognostic (7.65e-2)" "unprognostic (3.53e-1)" "unprognostic (1.37e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (1.60e-1)" "unprognostic (1.01e-2)" 61.9 8.8 4.6 12.8 7.6 1.9 37.5 3.1 6.7 38.3 15.9 5.2 20.5 5.0 41.4 40.3 33.8 22.3 20.6 51.2 5.4 4.9 18.8 2.2 25.0 11.9 8.1 6.7 20.7 8.6 7.8 3.6 78.9 6.3 21.0 7.4 12.8 12.4 20.5 39.7 21.2 12.1 42.3 4.7 9.2 11.3 23.1 4.7 3.5 25.8 35.9 11.0 33.6 33.1 0.6 1.7 1.6 0.3 0.6 0.5 1.5 0.0 0.0 0.1 0.0 1.6 0.1 0.1 0.2 1.2 0.3 0.9 0.0 0.0 0.0 3.2 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 32.6 0.5 0.0 0.0 0.8 0.0 32.1 0.1 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.2 1.1 0.0 4.9 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.6 0.2 0.3 0.5 0.2 0.5 0.3 0.3 0.2 0.2 0.6 0.3 0.3 1.1 0.6 0.3 1.7 0.2 1.5 4.6 7.6 3.1 6.7 5.4 4.9 8.1 6.7 6.3 4.7 3.0 8.5 0.0 0.1 14.8 0.4 12.3 2.5 0.0 0.0 3.5 2.0 0.2 0.0 0.2 10.9 214.1 0.0 0.0 0.2 0.3 22.6 0.2 1.1 0.5 0.3 0.0 0.0 81.0 0.3 4.2 135.4 2.2 16.9 0.0 0.0 0.3 0.2 0.0 115.6 0.0 0.0 6.5 4.1 0.7 0.5 11.3 0.1 0.0 0.0 0.3 CD3EAP "ASE-1, CAST, PAF49" ENSG00000117877 "CD3e molecule associated protein" O15446 19 45406209-45410766 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 109.3;Suprabasal keratinocytes: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-251 MG: 65.8" "Low region specificity" "Detected in all" "HPA041664, HPA041734" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA041664: AB_10795693, HPA041734: AB_10794489" "unprognostic (1.03e-1)" "unprognostic (8.98e-2)" "unprognostic (9.28e-2)" "unprognostic (1.37e-3)" "unprognostic (2.46e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (4.79e-9)" "unprognostic (1.62e-3)" "unprognostic (3.21e-1)" "unprognostic (5.01e-2)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (6.29e-9)" "unprognostic (1.02e-1)" "unprognostic (2.81e-1)" "unprognostic (1.38e-2)" "unprognostic (4.53e-2)" 7.3 5.9 7.7 8.4 9.7 4.0 7.1 14.9 9.0 5.6 5.5 6.5 2.9 4.9 6.4 3.0 9.9 7.1 6.4 6.7 7.1 6.4 5.2 6.8 4.5 7.2 8.1 6.0 8.7 18.3 6.6 7.3 5.1 8.0 5.2 4.9 3.1 7.2 4.6 14.2 8.4 4.3 6.6 5.6 5.8 4.3 5.2 9.3 3.6 6.1 7.8 8.5 5.5 5.8 3.5 15.9 1.3 3.7 3.2 4.1 2.1 10.4 10.8 1.7 7.9 2.6 2.1 7.0 5.0 1.7 8.9 5.2 10.6 7.5 16.3 5.3 3.7 7.2 10.1 15.6 14.3 6.3 8.0 10.1 9.0 4.1 7.8 4.4 9.1 3.2 3.2 9.2 12.9 7.1 2.2 6.4 6.0 20.5 3.3 8.6 12.3 6.9 2.6 12.7 11.6 9.1 9.4 6.9 10.7 3.5 7.8 10.8 4.0 10.7 14.3 2.3 3.8 7.2 5.5 6.2 12.7 13.3 7.3 65.8 5.9 23.4 17.3 6.3 13.0 9.1 0.9 2.8 0.3 1.7 3.7 3.4 2.8 2.2 2.4 5.0 3.5 3.1 4.1 1.3 3.2 3.3 15.9 1.2 2.1 7.7 9.7 14.9 9.0 7.1 6.4 8.1 6.0 8.0 9.3 6.0 12.8 10.0 23.3 109.3 4.5 1.2 7.6 6.7 12.5 1.8 9.8 13.7 1.7 15.9 0.2 9.0 1.7 0.0 5.8 19.4 6.6 7.7 5.7 4.2 10.0 11.1 4.6 4.9 2.6 0.5 8.9 7.0 11.8 2.8 4.3 3.5 11.0 0.0 10.6 6.1 5.8 0.0 8.9 0.5 18.9 96.7 6.4 0.0 9.5 11.5 CD79B "B29, IGB" ENSG00000007312 "CD79b molecule" P40259 17 63928740-63932354 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 138.8;lymphoid tissue: 56.6" "Cell type enriched" "Detected in many" 8 "B-cells: 486.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 100.6;naive B-cell: 138.8" "Lineage enriched" "Detected in many" 6 "B-cells: 138.8" "Cell line enhanced" "Detected in some" "Daudi: 117.7;REH: 38.7;U-698: 161.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009178, CAB009751, HPA044107" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: " "unprognostic (3.90e-3)" "unprognostic (1.61e-3)" "unprognostic (5.21e-2)" "unprognostic (3.45e-3)" "unprognostic (4.22e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.82e-1)" "unprognostic (9.25e-3)" "unprognostic (3.89e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (2.87e-2)" "unprognostic (2.50e-3)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (2.75e-1)" 1.7 0.7 0.4 50.6 0.4 11.1 1.2 0.3 0.4 0.6 1.7 0.3 0.3 0.7 0.6 0.5 2.6 0.6 1.4 3.4 0.4 0.2 2.3 1.7 1.3 56.6 0.4 0.3 0.6 1.6 0.0 9.0 0.5 0.3 1.0 1.3 0.8 8.9 0.9 1.2 0.9 22.4 0.5 0.4 56.0 1.8 0.6 0.3 3.7 1.4 1.7 46.6 4.5 0.9 138.8 4.2 0.5 25.0 3.4 9.2 9.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 38.7 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.8 0.1 0.0 0.4 0.0 0.0 5.9 5.7 161.1 0.0 0.2 0.0 0.5 1.1 0.0 4.2 16.5 4.8 100.6 5.4 2.8 4.2 138.8 3.7 2.2 0.5 3.4 25.0 0.6 9.2 9.0 0.4 0.4 0.3 0.4 0.4 0.2 0.4 0.3 0.3 0.3 0.0 2.2 486.9 0.3 3.9 0.0 0.8 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 7.1 0.0 23.3 0.0 0.4 4.3 0.3 15.0 0.5 4.7 0.0 1.2 62.0 14.1 1.1 1.1 3.5 20.3 1.0 0.0 0.0 0.0 0.0 1.8 0.8 0.0 0.0 3.3 0.7 0.1 2.8 0.3 34.6 0.0 0.1 CDC123 "C10orf7, D123" ENSG00000151465 "Cell division cycle 123" O75794 10 12195965-12250589 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037830, HPA057540" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA037830: AB_10671368, HPA057540: AB_2732614" "unprognostic (5.35e-3)" "unprognostic (9.06e-2)" "unprognostic (2.42e-1)" "unprognostic (5.09e-3)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "prognostic unfavorable (3.16e-7)" "unprognostic (2.63e-1)" "unprognostic (2.22e-1)" "unprognostic (3.20e-2)" "unprognostic (2.74e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (2.42e-6)" "unprognostic (5.35e-2)" "unprognostic (1.40e-1)" "unprognostic (3.88e-2)" "unprognostic (6.19e-2)" 26.1 28.0 30.8 28.8 50.8 35.7 25.5 24.6 35.0 25.8 32.0 24.2 16.3 21.5 26.1 27.2 34.1 25.3 18.4 36.5 28.5 25.1 33.2 45.1 21.5 34.7 25.9 27.6 19.5 26.0 18.4 26.9 28.8 36.6 20.7 31.8 16.1 22.4 22.9 29.2 29.8 24.7 30.2 24.9 36.2 21.8 22.5 24.6 39.0 24.4 20.5 41.9 29.2 23.4 43.7 40.7 66.4 34.0 32.3 38.8 40.6 31.0 41.6 29.7 36.0 28.6 28.2 24.4 27.0 18.8 39.0 42.0 57.5 39.8 53.6 28.5 34.1 25.3 35.0 54.1 49.5 32.6 37.6 42.5 41.8 33.6 52.7 35.3 32.6 36.3 30.1 25.8 49.3 29.2 19.4 42.6 69.8 43.0 25.8 33.9 28.7 41.6 27.4 52.3 47.7 15.6 43.3 24.8 47.6 35.7 18.1 15.3 30.2 28.9 37.6 33.5 27.3 39.2 36.8 45.7 24.1 29.5 36.6 34.1 25.4 46.6 65.8 30.2 31.2 15.6 28.6 28.7 66.4 31.4 32.4 32.4 43.7 35.3 34.6 40.7 42.1 29.0 30.9 64.6 32.3 34.0 33.2 38.8 40.6 30.8 50.8 24.6 35.0 28.5 25.1 25.9 27.6 36.6 24.6 29.8 31.0 35.7 38.0 48.1 27.6 45.3 30.6 52.2 30.7 33.2 5.9 108.7 72.9 73.7 3.9 34.2 23.6 0.0 72.5 115.3 36.6 29.6 47.4 34.5 85.2 25.4 20.1 36.2 19.4 7.0 38.6 50.4 43.9 112.8 26.7 40.1 66.8 37.7 43.2 54.7 26.4 38.8 43.2 42.1 28.9 64.6 64.9 50.3 44.3 45.3 CDC14A "cdc14, Cdc14A1, Cdc14A2, DFNB105" ENSG00000079335 "Cell division cycle 14A" Q9UNH5 1 100345001-100520278 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Hearing" "Hydrolase, Protein phosphatase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.2" "Group enriched" "Detected in many" 6 "Early spermatids: 165.7;Late spermatids: 161.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 30.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023783 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA023783: AB_1846352" "unprognostic (3.72e-2)" "unprognostic (2.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.98e-2)" "unprognostic (1.54e-3)" "unprognostic (1.38e-1)" "unprognostic (9.27e-4)" "unprognostic (4.88e-3)" "unprognostic (6.30e-2)" "unprognostic (3.97e-3)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (6.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (6.66e-2)" 6.2 2.4 5.8 6.5 5.5 13.7 12.2 1.8 6.2 7.7 11.8 4.8 2.2 7.2 15.1 4.8 3.4 13.7 3.6 4.1 8.8 3.5 6.6 2.4 12.3 15.4 3.8 5.4 5.8 6.7 9.8 8.1 7.6 4.6 10.0 6.3 8.3 7.7 3.9 4.3 5.6 22.6 5.0 3.2 9.6 6.0 38.2 4.7 12.0 6.1 3.4 11.3 5.8 8.4 4.8 6.1 11.6 3.7 3.9 13.0 4.1 2.2 1.8 5.9 6.7 2.2 1.6 4.1 2.9 1.9 2.9 2.3 6.2 1.9 1.1 2.1 1.7 2.3 1.7 4.0 1.6 2.9 2.3 9.9 4.0 1.7 2.0 0.8 5.4 7.1 1.3 0.4 3.1 1.0 1.4 5.1 2.4 30.6 3.5 4.2 1.0 4.3 6.0 3.6 1.4 2.3 4.7 7.6 1.1 2.0 5.1 1.1 1.9 3.0 2.9 4.0 3.0 1.3 7.0 2.2 1.6 3.6 2.7 1.7 1.7 0.6 1.7 1.9 5.0 0.9 11.6 3.7 8.4 7.3 3.3 13.0 4.8 11.3 8.4 3.5 3.1 11.0 5.8 5.5 3.9 2.3 6.1 5.6 4.1 5.8 5.5 1.8 6.2 8.8 3.5 3.8 5.4 4.6 4.7 3.0 5.6 2.2 4.2 3.3 0.2 5.3 0.0 28.1 5.7 1.8 3.9 1.7 0.0 2.7 165.7 9.3 12.8 0.0 1.7 0.8 4.7 6.6 14.0 1.5 2.3 0.0 4.6 6.2 4.6 161.3 4.6 4.3 5.0 5.4 4.7 9.1 2.5 8.7 0.7 1.7 3.6 0.0 2.8 1.9 3.0 2.0 1.8 10.2 2.7 2.3 CDC34 "E2-CDC34, UBC3, UBE2R1" ENSG00000099804 "Cell division cycle 34" P49427 19 531712-542092 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 170.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002382, CAB005109, CAB047311, HPA074334" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370, HPA074334: " "unprognostic (4.65e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (2.84e-1)" "unprognostic (5.73e-2)" "prognostic unfavorable (7.57e-4)" "unprognostic (2.20e-1)" "unprognostic (3.11e-1)" "unprognostic (3.83e-2)" "unprognostic (2.09e-2)" "unprognostic (3.06e-2)" "unprognostic (3.02e-2)" "unprognostic (8.87e-3)" "unprognostic (9.68e-2)" "unprognostic (7.82e-3)" "unprognostic (3.33e-2)" 16.5 15.9 21.3 11.3 19.1 24.7 20.4 25.7 30.9 16.0 20.5 19.5 10.5 15.4 13.3 13.4 15.6 14.5 13.6 35.6 21.1 18.2 12.1 36.0 13.0 9.9 18.5 19.8 17.0 37.4 11.3 17.0 24.9 16.2 17.2 10.6 15.3 26.4 18.5 63.9 19.0 13.2 18.6 14.3 12.7 15.7 43.6 15.0 12.2 13.1 17.0 8.7 19.2 16.4 2.9 2.8 11.5 4.5 1.5 4.1 1.3 18.7 18.8 24.1 19.8 10.9 10.5 24.1 16.9 13.0 18.2 19.0 29.0 11.5 10.3 17.7 12.0 11.0 13.0 18.9 14.2 9.3 16.9 50.8 9.5 12.4 31.4 27.3 13.4 11.6 13.5 21.3 15.4 16.1 14.3 21.7 14.6 40.8 20.8 12.0 26.9 18.3 17.9 30.4 13.9 18.2 16.9 12.4 17.4 13.7 11.2 31.4 23.3 14.7 15.2 28.0 20.7 12.2 19.8 17.7 13.3 15.9 30.9 22.5 20.7 15.9 13.8 18.2 19.0 13.7 4.5 3.5 6.2 2.3 3.4 1.7 2.9 3.2 4.1 2.8 1.7 2.5 2.4 11.5 1.5 4.5 2.3 3.1 1.3 21.3 19.1 25.7 30.9 21.1 18.2 18.5 19.8 16.2 15.0 0.0 4.8 9.7 16.8 41.6 35.9 25.8 38.2 1.4 1.2 14.0 23.6 38.5 11.6 17.9 55.3 20.2 34.4 0.0 17.3 40.4 28.2 30.2 0.0 35.2 23.7 15.9 12.7 14.7 12.6 170.3 16.7 12.9 18.6 10.0 25.9 67.6 35.7 21.2 14.2 15.9 36.1 12.9 30.1 18.4 52.8 47.8 52.7 10.0 21.2 26.8 CDC42EP1 "Borg5, CEP1, MSE55" ENSG00000128283 "CDC42 effector protein 1" Q00587 22 37560447-37569405 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 199.1;Exocrine glandular cells: 194.9;Pancreatic endocrine cells: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 9.4;intermediate monocyte: 2.9;myeloid DC: 3.5" "Group enriched" "Detected in many" 10 "dendritic cells: 3.5;monocytes: 9.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006379, HPA076536" Approved Supported "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA006379: AB_1078486, HPA076536: " "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.44e-1)" "unprognostic (3.79e-3)" "unprognostic (5.82e-2)" "unprognostic (4.06e-2)" "unprognostic (4.38e-2)" "unprognostic (5.57e-2)" "unprognostic (9.45e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.85e-2)" "unprognostic (3.81e-2)" "unprognostic (1.09e-3)" 19.1 26.2 12.1 10.6 29.4 1.9 21.9 2.9 27.3 17.2 13.0 68.7 7.2 19.7 21.0 6.2 25.0 20.4 31.9 12.2 18.3 10.1 14.6 57.4 18.6 6.9 41.4 13.1 31.7 80.8 7.4 5.7 24.9 28.7 11.5 9.9 12.0 36.5 16.9 7.2 22.4 13.8 13.2 34.5 9.7 69.5 8.8 34.2 0.4 9.7 14.2 14.2 10.3 19.2 0.6 3.5 0.4 9.4 0.6 0.3 3.5 30.5 8.9 3.9 17.3 6.2 10.6 18.8 17.6 10.4 20.3 14.1 21.8 4.0 0.0 6.2 20.3 6.5 23.9 4.5 8.8 6.8 3.8 15.3 0.1 8.6 13.1 44.4 0.0 0.1 19.7 13.4 16.7 16.0 16.4 15.1 0.0 19.1 0.1 8.3 10.5 0.0 0.1 3.4 23.9 20.1 0.1 7.0 0.6 7.1 0.4 0.1 0.7 12.9 28.7 27.5 5.6 12.8 2.7 23.0 42.7 25.5 20.5 24.3 0.0 0.1 0.0 16.9 0.1 34.4 0.4 9.4 0.0 0.2 2.9 0.2 0.0 0.1 0.1 3.5 0.6 0.1 0.3 0.3 0.6 0.2 0.4 0.0 3.5 12.1 29.4 2.9 27.3 18.3 10.1 41.4 13.1 28.7 34.2 6.0 24.5 3.4 55.6 41.7 0.0 1.6 91.7 1.4 12.5 12.2 0.0 83.5 1.7 199.1 3.2 31.5 19.5 0.0 194.9 83.2 32.7 99.5 2.3 31.4 11.9 1.6 11.1 61.4 2.9 1.2 36.5 3.9 20.3 10.0 60.1 9.5 199.6 49.1 33.2 4.4 0.0 38.8 53.1 2.4 0.2 45.5 93.8 2.6 57.5 135.8 CDC45 "CDC45L, CDC45L2" ENSG00000093009 "Cell division cycle 45" O75419 22 19479459-19520612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 88.0;Erythroid cells: 46.7;Spermatocytes: 23.9;Spermatogonia: 49.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 87.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000614, CAB009459" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA Yes Nucleoplasm "Centrosome, Cytosol" "CAB009459: AB_2078507, HPA000614: AB_1078487" "unprognostic (5.56e-2)" "unprognostic (6.12e-3)" "unprognostic (1.17e-3)" "unprognostic (3.42e-3)" "unprognostic (3.57e-1)" "unprognostic (7.42e-2)" "prognostic unfavorable (6.95e-6)" "unprognostic (6.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (8.94e-4)" "unprognostic (7.28e-2)" "unprognostic (0.00e+0)" "unprognostic (7.62e-3)" "unprognostic (2.02e-1)" "unprognostic (8.52e-2)" "unprognostic (1.10e-1)" 0.9 0.9 0.3 8.4 0.5 15.7 0.9 0.3 0.6 1.3 3.4 0.3 0.2 2.2 0.6 1.4 6.2 0.4 0.8 1.6 0.7 0.3 0.8 1.4 1.3 7.5 0.4 0.2 0.7 0.5 0.1 0.4 3.5 0.4 0.7 4.3 0.2 1.3 0.2 0.4 2.1 3.1 1.1 0.4 4.2 1.8 43.5 0.2 25.4 0.5 7.2 10.2 1.3 1.9 0.7 0.9 1.6 0.5 1.8 3.2 1.9 13.2 11.1 13.9 10.9 0.6 1.3 5.9 16.4 7.7 18.9 18.8 8.5 7.4 14.8 5.8 4.9 7.5 12.8 14.8 10.8 17.0 18.0 25.0 19.8 12.6 9.3 0.7 28.7 10.9 0.4 0.5 14.5 6.5 1.8 9.5 15.3 87.8 18.7 11.0 17.7 23.3 13.6 4.2 25.7 8.4 19.4 23.1 6.5 4.4 12.7 18.0 9.5 8.9 9.8 2.8 6.5 6.4 12.8 3.6 14.8 23.7 11.2 14.9 6.4 11.8 17.2 7.8 14.4 19.7 0.0 0.2 0.0 2.2 0.0 0.0 0.7 1.4 2.3 0.6 0.0 1.0 0.7 1.6 1.8 0.5 0.9 3.2 1.9 0.3 0.5 0.3 0.6 0.7 0.3 0.4 0.2 0.4 0.2 0.0 0.0 0.8 0.4 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.9 88.0 0.3 0.4 46.7 0.0 16.8 1.0 0.2 0.0 0.0 6.2 0.0 0.0 3.7 0.6 6.1 0.6 0.9 0.0 0.0 0.8 0.0 0.1 0.0 0.7 0.0 0.0 6.5 0.9 23.9 49.8 1.6 4.1 1.3 2.5 0.4 CDC7 "CDC7L1, HsCdc7, Hsk1, huCdc7" ENSG00000097046 "Cell division cycle 7" O00311 1 91500893-91525764 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 28.3;Spermatocytes: 28.4;Spermatogonia: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002669, HPA035831" Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes No Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "CAB002669: , HPA035831: AB_2674807" "unprognostic (6.84e-2)" "unprognostic (6.01e-2)" "unprognostic (4.64e-2)" "unprognostic (7.02e-3)" "unprognostic (5.57e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (3.15e-6)" "unprognostic (6.52e-2)" "unprognostic (2.23e-2)" "unprognostic (1.36e-3)" "unprognostic (2.04e-2)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.89e-15)" "unprognostic (9.44e-3)" "unprognostic (2.49e-2)" "unprognostic (1.09e-1)" "unprognostic (5.39e-2)" 2.5 3.7 5.7 7.6 8.9 15.4 4.3 19.4 10.3 2.5 4.2 1.4 0.9 4.2 2.8 2.6 4.7 1.7 2.6 1.9 6.8 5.2 3.6 2.3 5.1 11.7 4.0 4.7 3.7 2.4 2.2 12.3 7.9 5.2 2.7 6.8 2.3 2.5 2.3 1.0 6.8 4.9 3.3 5.9 15.1 2.6 21.2 4.7 18.7 2.5 4.5 12.0 4.2 3.0 1.6 3.5 0.1 1.6 2.4 6.5 2.1 14.2 4.2 27.6 7.8 0.6 3.7 8.8 5.4 4.3 10.7 11.7 8.9 5.1 9.9 7.6 3.4 9.3 6.2 18.1 6.1 14.8 16.4 15.5 15.0 12.2 4.1 1.0 16.3 5.5 1.9 1.8 9.8 5.6 1.9 4.1 13.9 19.8 14.5 7.3 5.2 14.0 14.6 22.9 7.8 10.1 17.3 22.9 6.3 4.6 10.7 21.9 8.6 17.1 4.7 9.6 7.1 4.4 8.0 3.4 12.1 10.7 9.4 8.1 5.3 6.7 26.5 4.3 15.9 4.4 0.0 1.6 0.0 5.9 1.2 5.2 1.5 4.5 5.6 3.5 1.6 2.5 5.1 0.1 2.4 0.3 2.1 6.5 2.1 5.7 8.9 19.4 10.3 6.8 5.2 4.0 4.7 5.2 4.7 0.0 0.6 2.2 1.1 5.3 7.6 1.3 0.0 1.4 1.2 1.8 0.0 5.3 3.3 1.1 28.3 2.8 0.2 0.0 2.2 5.1 4.6 0.7 4.6 0.0 2.2 3.2 0.0 3.1 1.8 12.9 0.9 1.0 3.3 1.0 1.3 1.3 1.0 1.1 0.7 0.1 4.7 6.5 3.1 28.4 20.6 3.1 1.8 5.1 2.9 0.9 CDCA4 "FLJ20764, Hepp" ENSG00000170779 "Cell division cycle associated 4" Q9BXL8 14 105009573-105021148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 38.3" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 133.3;Spermatogonia: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064971 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA Yes Nucleoplasm "Plasma membrane, Cytosol" "HPA064971: AB_2685395" "unprognostic (2.22e-3)" "unprognostic (1.84e-1)" "unprognostic (2.69e-1)" "unprognostic (9.93e-3)" "unprognostic (1.42e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (4.19e-4)" "prognostic unfavorable (7.94e-4)" "unprognostic (4.20e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (7.50e-2)" "unprognostic (1.24e-2)" 4.5 2.6 1.7 11.5 2.6 38.3 4.1 8.3 3.2 8.7 3.7 2.6 4.5 4.1 5.6 4.0 16.6 4.1 4.2 2.4 1.5 1.3 2.8 3.0 5.1 9.1 2.7 1.4 5.0 6.2 1.6 1.9 12.4 3.3 4.6 2.7 3.3 5.3 2.2 1.3 21.8 4.4 3.1 2.3 6.7 3.6 12.8 2.3 24.9 5.1 11.2 15.0 3.7 8.8 7.4 4.2 8.3 4.3 10.6 14.7 5.5 15.2 15.9 18.4 13.9 3.1 5.2 24.1 22.8 7.0 17.9 15.7 19.4 19.5 20.0 12.5 8.0 13.7 24.5 12.8 26.3 10.5 21.9 10.1 12.7 13.6 16.2 3.9 22.4 10.7 3.7 8.2 13.8 13.0 6.0 12.1 17.5 13.9 20.8 12.4 37.4 20.8 15.1 13.6 13.3 36.4 20.2 26.8 7.4 6.0 17.7 10.8 13.3 21.8 8.8 17.5 8.5 17.2 15.1 18.7 15.9 20.2 21.7 30.2 7.7 9.5 20.5 13.3 11.4 26.2 0.9 3.6 8.3 10.9 3.9 13.3 7.4 11.4 14.7 3.9 5.2 6.8 8.0 1.3 10.6 4.3 4.2 8.9 5.5 1.7 2.6 8.3 3.2 1.5 1.3 2.7 1.4 3.3 2.3 0.0 2.1 10.4 19.9 57.1 3.0 0.6 0.0 8.1 3.4 1.8 0.0 53.6 3.3 12.9 6.4 9.0 1.1 23.3 6.2 133.3 12.5 7.7 28.8 2.1 21.5 12.7 2.9 7.4 6.2 4.3 7.8 10.6 16.9 10.8 4.4 3.4 9.1 3.5 5.6 1.4 2.7 6.5 10.3 31.0 64.2 58.6 21.6 17.5 6.0 48.5 CDCA7L "JPO2, R1, RAM2" ENSG00000164649 "Cell division cycle associated 7 like" Q96GN5 7 21900900-21946084 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.9" "Cell type enhanced" "Detected in many" 7 "Spermatogonia: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 5 "olfactory region: 22.0" "HPA027169, HPA074623" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA027169: AB_1856058, HPA074623: " "unprognostic (5.13e-3)" "unprognostic (5.94e-2)" "unprognostic (1.91e-1)" "unprognostic (4.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.36e-6)" "unprognostic (4.09e-2)" "unprognostic (2.86e-1)" "unprognostic (3.87e-2)" "unprognostic (3.22e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.60e-1)" "unprognostic (1.73e-1)" "unprognostic (2.83e-3)" 6.2 1.2 3.7 19.9 9.6 24.2 8.0 6.5 4.2 8.4 9.0 7.8 3.9 5.2 11.1 3.6 6.0 7.0 5.4 12.5 3.9 2.5 2.7 4.5 7.3 18.7 6.2 4.0 13.9 17.4 1.0 1.6 2.2 3.7 7.6 10.2 5.8 10.5 8.0 2.7 13.6 8.7 6.6 3.0 9.3 12.7 12.6 5.3 47.9 20.0 5.1 16.5 6.0 9.4 38.5 21.8 11.8 1.3 0.8 9.7 3.3 19.7 6.8 6.4 0.1 3.5 4.5 0.0 16.2 13.9 12.6 17.9 2.5 18.0 41.3 5.3 13.9 25.1 12.2 10.1 16.6 25.5 0.0 6.7 9.9 20.1 1.6 4.5 25.9 0.1 8.3 3.0 9.7 28.5 13.0 24.8 32.3 13.6 0.0 9.7 7.4 32.7 9.3 36.5 3.9 8.4 32.9 22.9 27.5 3.5 3.7 23.5 19.2 7.3 4.5 7.4 8.5 11.0 11.7 10.5 13.8 17.0 23.9 19.5 21.3 14.6 53.4 13.2 35.0 13.5 0.3 0.6 11.8 0.6 0.9 0.1 28.6 1.9 0.9 4.3 38.5 9.7 3.9 1.1 0.8 1.3 21.8 2.7 3.3 3.7 9.6 6.5 4.2 3.9 2.5 6.2 4.0 3.7 5.3 17.9 20.3 28.9 22.5 24.2 0.2 26.3 2.5 6.7 31.8 0.0 2.0 0.5 3.3 6.7 2.6 3.7 1.5 0.0 5.3 0.2 4.3 7.7 8.1 3.4 9.6 12.7 10.3 2.5 10.2 3.6 3.7 3.5 8.5 0.0 26.4 2.4 4.9 3.5 2.5 0.0 2.1 12.9 12.3 2.7 61.1 6.8 0.2 2.5 24.4 3.9 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692418-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 20.9;Spermatocytes: 82.1;Spermatogonia: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Supported "Nucleoplasm,Nucleoli,Cytokinetic bridge" Yes Yes Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavorable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.2 1.4 0.9 12.9 1.7 19.0 1.7 0.8 1.6 1.8 6.0 1.1 0.7 5.3 1.4 1.3 9.6 0.7 2.4 0.8 0.9 0.9 1.3 1.5 2.0 12.2 1.8 1.3 0.9 1.0 0.1 0.8 3.7 1.3 1.0 7.7 0.7 2.1 1.0 0.9 4.0 5.4 1.6 1.2 5.4 3.5 44.7 1.7 51.6 0.9 6.5 14.6 1.6 2.9 2.8 1.8 4.5 5.0 6.3 8.9 2.5 28.4 12.4 23.5 17.0 1.0 2.0 15.8 21.5 10.8 38.0 27.0 19.4 21.3 34.6 8.7 13.7 15.3 16.2 27.0 14.2 40.4 23.0 12.1 31.1 13.3 15.3 0.2 29.9 16.1 0.8 1.0 21.4 19.0 4.3 16.8 24.9 26.2 37.2 27.4 12.7 27.5 18.4 27.2 16.6 17.2 26.9 32.1 19.8 8.6 11.9 20.9 9.2 23.6 11.1 14.5 21.1 16.3 11.4 10.1 18.7 19.9 10.7 33.5 25.3 32.9 47.2 8.8 27.8 21.4 0.0 1.1 1.8 2.5 2.2 4.5 2.8 5.7 3.3 1.0 2.5 1.9 3.8 4.5 6.3 5.0 1.8 8.9 2.5 0.9 1.7 0.8 1.6 0.9 0.9 1.8 1.3 1.3 1.7 0.0 0.3 9.3 0.8 3.0 1.1 0.4 5.1 8.1 0.0 0.0 0.0 2.2 0.0 1.1 0.8 0.2 4.2 0.0 0.6 20.9 0.9 0.6 0.0 1.0 9.5 1.6 3.5 1.8 3.1 2.2 1.4 4.6 1.7 2.8 5.1 0.0 1.6 4.9 1.1 0.5 0.8 19.4 0.0 82.1 41.4 2.4 2.4 3.2 6.3 0.9 CDH5 "7B4, CD144" ENSG00000179776 "Cadherin 5" P33151 16 66366622-66404786 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 96.6" "Cell type enhanced" "Detected in many" 15 "Endothelial cells: 155.1;Ito cells: 190.9;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 113.8;TIME: 97.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB028366, HPA075875" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA 1000000000 "Plasma membrane" "Nucleoplasm, Nuclear membrane" "CAB028366: AB_2276033, HPA075875: " "unprognostic (1.05e-1)" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (4.89e-2)" "unprognostic (4.96e-2)" "unprognostic (5.50e-3)" "unprognostic (9.38e-2)" "unprognostic (5.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.33e-2)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.14e-4)" "unprognostic (9.49e-3)" "unprognostic (3.01e-2)" "unprognostic (2.22e-1)" "unprognostic (3.15e-2)" 48.7 5.6 4.0 6.2 5.8 0.6 28.1 2.6 4.8 11.1 6.6 3.4 5.5 3.7 18.7 11.2 8.4 7.2 12.6 21.7 4.5 4.3 7.8 12.7 43.7 9.7 6.5 2.8 7.7 3.6 5.0 3.5 96.6 7.6 9.0 4.8 8.5 5.2 4.4 19.0 7.0 6.8 12.1 5.4 10.8 5.7 6.7 3.3 1.2 16.6 15.7 4.5 11.7 11.3 0.0 0.6 0.4 0.8 0.1 0.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 97.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 1.1 4.0 5.8 2.6 4.8 4.5 4.3 6.5 2.8 7.6 3.3 0.0 10.4 0.0 0.0 3.7 0.0 14.6 7.6 0.0 1.2 1.8 0.0 3.3 0.0 0.1 33.0 155.1 0.0 0.0 0.0 40.7 3.1 0.1 3.5 1.5 2.1 0.0 0.0 190.9 29.5 47.7 5.8 2.3 11.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.1 13.4 0.2 2.6 67.5 0.0 0.0 0.0 CDIPT "PIS, PIS1" ENSG00000103502 "CDP-diacylglycerol--inositol 3-phosphatidyltransferase" O14735 16 29858357-29863736 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056597 Enhanced Approved "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA "Nucleoplasm, Nuclear membrane, Plasma membrane" "HPA056597: AB_2683182" "unprognostic (7.81e-2)" "prognostic favorable (9.40e-4)" "unprognostic (1.93e-3)" "unprognostic (8.08e-3)" "unprognostic (1.50e-2)" "unprognostic (2.84e-2)" "unprognostic (7.60e-2)" "unprognostic (1.09e-2)" "unprognostic (7.03e-2)" "unprognostic (8.75e-2)" "unprognostic (5.56e-3)" "unprognostic (1.61e-1)" "unprognostic (6.17e-2)" "unprognostic (3.36e-2)" "unprognostic (6.95e-2)" "unprognostic (1.56e-1)" "unprognostic (2.48e-1)" 40.4 40.8 24.3 20.2 28.1 15.3 42.9 50.7 39.5 37.1 37.2 21.5 33.9 24.8 33.4 23.0 39.4 30.1 34.5 44.4 23.1 27.9 34.8 66.3 27.1 22.4 24.1 26.4 52.7 40.0 47.1 24.9 43.7 21.8 36.8 16.1 29.3 42.2 38.8 21.0 29.6 32.6 31.8 21.0 25.6 29.5 20.2 16.4 30.4 47.1 19.9 17.3 41.8 42.8 4.8 6.1 20.6 6.5 8.2 8.4 2.7 12.5 27.3 7.7 15.4 42.0 29.1 22.8 22.1 24.8 15.7 15.7 15.9 24.2 8.4 41.9 25.4 13.9 19.8 12.4 14.3 7.2 21.1 25.0 6.0 20.4 23.2 29.3 8.9 15.7 49.2 25.2 21.1 9.7 24.9 19.6 16.1 9.0 21.9 14.1 40.1 12.1 17.7 18.3 13.2 20.3 23.7 9.6 24.5 20.7 12.1 31.7 17.8 11.7 24.9 17.4 14.1 18.6 24.4 17.0 23.3 7.4 18.9 11.3 16.3 18.4 6.0 25.4 14.5 14.0 7.5 6.5 20.6 6.9 4.6 4.6 4.7 6.4 7.3 3.0 4.8 6.3 5.9 16.4 8.2 5.7 6.1 8.4 2.7 24.3 28.1 50.7 39.5 23.1 27.9 24.1 26.4 21.8 16.4 23.8 21.2 20.5 35.7 36.7 46.6 49.2 30.6 18.7 10.3 43.6 43.2 92.1 34.9 59.1 22.5 43.2 44.6 46.7 62.9 107.9 45.5 34.0 13.8 36.5 56.9 55.6 35.8 33.2 37.3 11.0 71.1 25.7 21.9 47.7 34.8 54.4 41.4 37.1 58.0 30.1 42.9 45.3 43.2 8.6 14.0 44.4 61.2 40.6 37.0 35.3 CDK10 PISSLRE ENSG00000185324 "Cyclin dependent kinase 10" Q15131 16 89680737-89696364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007451, HPA059634, HPA067060" Uncertain Supported "Nucleoplasm,Midbody,Midbody ring" Yes Yes Nucleoplasm "Midbody, Midbody ring" "HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (3.74e-3)" "unprognostic (9.87e-2)" "unprognostic (1.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.53e-1)" "unprognostic (9.06e-2)" "unprognostic (2.99e-1)" "unprognostic (2.13e-1)" "prognostic favorable (2.69e-4)" "unprognostic (2.58e-2)" "unprognostic (2.93e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (6.88e-2)" "prognostic favorable (3.63e-4)" 12.3 19.9 16.8 16.4 23.8 17.3 10.1 14.8 21.9 11.1 18.3 8.1 16.4 23.4 12.1 21.7 14.4 14.4 19.4 8.7 15.3 12.6 22.2 33.9 11.8 14.0 13.3 19.4 11.3 22.2 21.6 27.7 13.6 15.8 13.6 12.6 8.1 17.2 8.9 17.5 14.1 20.7 9.0 10.7 15.9 19.0 8.7 13.6 8.0 27.1 10.1 12.1 10.8 14.5 7.8 14.5 3.4 15.3 15.2 13.3 8.8 14.7 9.6 7.7 3.1 3.2 6.1 8.1 12.2 6.9 8.7 2.9 7.4 11.2 13.1 6.2 10.5 5.4 10.3 3.3 17.0 5.5 2.9 8.1 5.1 10.8 0.8 13.4 8.3 9.4 7.5 5.7 5.5 8.3 5.8 15.1 8.7 13.4 1.8 9.9 19.2 10.0 23.8 15.8 16.0 7.3 14.6 10.5 18.4 15.6 11.7 7.6 16.5 15.3 7.1 3.6 9.1 16.7 13.2 13.4 5.9 15.3 6.1 8.3 6.6 3.6 4.0 9.0 14.3 8.4 3.2 11.7 3.4 12.9 15.3 10.9 6.8 11.4 8.9 14.5 7.8 13.3 10.9 1.5 15.2 11.2 10.0 8.8 8.8 16.8 23.8 14.8 21.9 15.3 12.6 13.3 19.4 15.8 13.6 11.9 28.2 16.7 22.2 13.7 17.3 4.8 45.9 18.7 9.1 26.2 23.6 25.3 36.5 23.6 5.0 17.5 42.9 0.0 11.0 16.4 18.6 26.1 9.2 37.6 16.3 17.5 65.1 19.6 16.7 5.4 22.2 13.0 18.6 14.4 38.5 10.3 14.2 35.1 11.7 45.1 33.8 6.5 11.3 23.1 29.8 13.6 23.3 17.5 50.1 18.6 CDK2 ENSG00000123374 "Cyclin dependent kinase 2" P24941 12 55966769-55972784 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 78.7;Extravillous trophoblasts: 67.5;Melanocytes: 82.7;Syncytiotrophoblasts: 142.8" "Cancer enhanced" "Detected in all" "melanoma: 88.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 107.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013115, HPA066915" Enhanced Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "CAB013115: AB_2536375, HPA066915: AB_2685748" "unprognostic (2.36e-2)" "unprognostic (2.60e-1)" "unprognostic (3.71e-2)" "unprognostic (1.83e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.94e-4)" "prognostic unfavorable (8.61e-5)" "unprognostic (3.48e-2)" "unprognostic (1.31e-1)" "unprognostic (4.67e-2)" "unprognostic (5.38e-3)" "unprognostic (4.69e-3)" "prognostic unfavorable (1.46e-10)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (6.75e-2)" 10.7 7.6 4.5 20.8 6.5 18.7 11.5 4.2 4.3 12.6 11.6 3.5 6.0 6.1 10.7 6.4 13.6 10.8 12.6 10.1 5.4 2.2 8.3 16.7 19.5 12.2 6.0 2.0 14.2 8.3 5.2 4.2 49.0 7.3 10.8 9.1 51.2 9.3 9.9 10.8 14.6 9.3 11.8 5.0 12.5 10.1 7.8 5.1 39.3 9.5 10.7 14.7 16.7 10.1 9.3 10.8 5.2 3.9 4.5 7.6 4.3 16.8 9.1 20.1 11.1 4.1 5.3 37.0 21.0 11.0 26.2 24.5 19.2 16.3 16.1 15.8 7.8 10.5 10.8 15.3 9.2 26.6 18.9 15.0 18.5 15.1 7.3 1.3 14.6 13.4 2.8 2.3 17.7 6.1 7.6 13.2 16.7 17.5 14.7 18.1 13.0 30.3 12.4 8.0 11.5 13.6 29.6 19.3 12.1 7.6 16.6 8.3 10.7 24.0 8.8 107.8 12.0 19.0 10.7 7.3 18.1 17.5 13.9 15.3 8.3 9.6 20.0 10.3 10.7 15.6 5.2 3.6 3.1 7.0 3.9 7.0 9.3 3.2 5.0 2.7 6.1 3.0 5.3 1.7 4.5 1.6 10.8 7.6 4.3 4.5 6.5 4.2 4.3 5.4 2.2 6.0 2.0 7.3 5.1 14.9 3.7 5.2 20.1 24.8 0.0 2.6 12.7 5.3 9.1 1.8 0.0 78.7 1.7 10.5 0.4 15.0 2.1 0.0 5.0 67.5 17.6 10.9 10.4 8.9 11.6 1.6 5.2 8.6 4.8 0.2 13.8 6.3 82.7 47.7 6.3 3.8 9.0 0.0 4.2 3.8 3.4 0.0 14.4 2.9 7.7 27.5 142.8 5.7 6.8 18.0 CDK5 PSSALRE ENSG00000164885 "Cyclin dependent kinase 5" Q00535 7 151053812-151058530 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Lissencephaly, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008909, HPA064535" Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB008909: , HPA064535: AB_2685280" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (4.22e-2)" "unprognostic (1.43e-1)" "unprognostic (1.10e-1)" "unprognostic (3.48e-1)" "unprognostic (5.67e-3)" "unprognostic (1.05e-2)" "unprognostic (1.22e-1)" "unprognostic (5.78e-3)" "unprognostic (6.25e-3)" "unprognostic (3.35e-1)" "unprognostic (4.47e-2)" "unprognostic (1.46e-2)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" 4.5 11.3 24.4 6.9 30.4 6.1 5.3 13.6 36.1 5.3 6.1 6.7 4.5 7.9 4.5 17.4 6.5 5.0 6.2 5.8 25.0 19.7 9.0 7.7 5.3 6.0 15.4 15.4 3.2 5.8 8.9 7.9 5.3 20.8 5.8 6.3 3.2 6.0 6.3 5.7 6.5 6.2 6.0 8.6 5.2 5.7 3.1 7.7 6.8 6.0 3.6 6.9 6.7 3.1 6.6 21.5 9.0 21.7 9.5 14.9 10.6 11.7 14.1 13.2 21.5 14.6 10.7 6.6 7.8 12.8 15.3 12.6 10.0 11.0 11.6 27.9 9.6 22.8 8.4 21.2 11.8 7.0 9.1 12.6 12.7 12.4 9.9 9.6 10.2 23.9 11.6 8.9 12.6 3.9 21.4 10.3 18.2 12.9 8.5 15.3 22.7 27.6 21.0 14.5 18.9 22.3 13.5 5.4 12.9 13.3 8.9 8.4 35.9 11.2 13.8 14.7 12.6 6.4 9.0 8.7 15.1 3.9 11.3 14.5 19.7 21.5 4.5 23.7 14.8 27.0 7.8 19.0 9.0 6.9 21.7 5.4 6.6 6.8 6.8 21.5 5.9 5.1 6.2 2.8 9.5 16.4 12.8 14.9 10.6 24.4 30.4 13.6 36.1 25.0 19.7 15.4 15.4 20.8 7.7 0.0 5.9 11.5 6.4 3.2 11.5 3.2 7.6 8.1 7.9 10.4 2.0 20.0 33.2 19.0 0.6 6.3 7.1 0.0 16.6 10.2 6.6 5.0 31.0 9.6 37.8 0.0 8.6 6.2 21.6 0.9 4.4 14.3 10.1 20.8 9.1 11.5 18.7 14.4 10.6 24.0 4.7 6.5 5.0 2.6 9.7 5.5 7.6 8.5 9.6 7.6 CDKN1C "BWCR, BWS, KIP2, P57" ENSG00000129757 "Cyclin dependent kinase inhibitor 1C" P49918 11 2883213-2885773 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.3;placenta: 105.6" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 482.4;Extravillous trophoblasts: 1267.0;Syncytiotrophoblasts: 1874.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 26.1;non-classical monocyte: 60.3" "Lineage enriched" "Detected in many" 12 "monocytes: 60.3" "Cell line enhanced" "Detected in many" "EFO-21: 8.4;HeLa: 8.7;RPMI-8226: 11.4;SH-SY5Y: 23.3;SiHa: 16.3;SK-MEL-30: 8.9" HPA002924 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA002924: AB_1079548" "unprognostic (5.49e-3)" "unprognostic (2.62e-1)" "unprognostic (9.82e-3)" "unprognostic (5.79e-3)" "unprognostic (4.15e-1)" "unprognostic (2.84e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-1)" "unprognostic (3.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.95e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-1)" "unprognostic (3.31e-2)" "unprognostic (8.53e-2)" "unprognostic (1.93e-1)" "unprognostic (2.94e-1)" 53.6 20.7 3.3 5.4 11.9 3.4 13.0 0.9 9.2 10.6 6.9 18.4 3.9 3.3 8.3 5.2 9.9 8.5 7.7 6.9 8.5 5.4 22.7 3.0 5.1 1.8 28.7 4.9 30.9 7.9 1.5 4.0 105.6 11.5 7.2 1.9 8.3 3.1 5.9 27.6 3.0 7.9 6.3 27.9 7.1 7.4 4.3 14.5 0.3 2.0 7.6 2.1 11.2 9.8 0.0 5.0 1.4 60.3 0.0 0.3 2.5 0.1 0.0 1.1 0.0 0.3 0.3 1.2 0.2 0.4 0.2 0.0 2.2 0.2 0.0 8.4 0.1 0.1 0.3 0.2 0.2 0.1 3.8 0.8 0.1 8.7 0.0 2.3 0.0 1.0 1.7 1.1 0.0 0.1 0.1 0.2 0.0 1.8 0.6 0.3 0.0 0.0 4.0 7.5 0.3 2.7 1.5 0.0 11.4 0.5 0.0 2.5 23.3 16.3 0.2 8.9 0.6 0.1 1.9 0.3 0.0 1.6 0.0 0.0 4.9 0.0 0.0 0.0 1.3 4.6 1.4 0.2 0.2 0.1 26.1 0.3 0.0 0.1 0.1 5.0 0.0 0.2 0.0 0.3 0.0 60.3 0.0 0.1 2.5 3.3 11.9 0.9 5.6 8.5 5.4 28.7 4.9 11.5 14.5 3.0 7.2 0.8 96.5 9.5 7.1 23.0 22.9 5.3 10.3 29.6 5.9 482.4 13.3 9.2 178.7 49.1 4.0 0.0 0.5 1267.0 69.5 86.8 0.0 3.0 79.4 7.9 102.1 54.6 16.1 196.4 68.7 19.6 33.7 1.0 14.2 61.0 3.5 2.5 41.8 39.1 25.4 32.3 35.6 1.4 2.7 10.3 1874.3 3.9 5.2 72.7 CDR1 "CDR, CDR34, CDR62A" ENSG00000184258 "Cerebellar degeneration related protein 1" P51861 X 140782405-140784871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 56.2" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 139.0;Horizontal cells: 33.4;Muller glia cells: 111.9;Rod photoreceptor cells: 30.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.4;BJ: 6.6;MOLT-4: 4.2;U-87 MG: 24.4" "Low region specificity" "Detected in all" HPA073147 Approved "Nucleoplasm,Golgi apparatus,Centrosome" NA NA "Nucleoplasm, Golgi apparatus, Centrosome" "HPA073147: AB_2686574" "unprognostic (7.10e-2)" "unprognostic (2.87e-2)" "unprognostic (2.85e-1)" "unprognostic (3.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-3)" "unprognostic (1.46e-4)" "unprognostic (1.55e-1)" "unprognostic (1.84e-1)" 3.2 1.3 9.1 0.5 26.3 0.0 0.0 56.2 28.7 0.0 0.1 0.2 0.4 0.0 0.6 0.2 1.5 1.5 9.2 2.8 0.1 0.0 0.6 0.1 3.7 0.1 3.9 0.0 7.1 0.4 0.1 0.0 0.6 0.0 0.2 9.4 0.1 0.0 3.6 0.9 0.5 0.1 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 3.4 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 1.4 0.0 1.2 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 139.0 0.0 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.9 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 CDX4 ENSG00000131264 "Caudal type homeobox 4" O14627 X 73447254-73455245 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "skin 1: 5.3;testis: 3.3" "Cell type enhanced" "Detected in some" 22 "Spermatogonia: 1.4;Suprabasal keratinocytes: 1.0" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEK 293: 2.0;SuSa: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043714, HPA056528" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA043714: , HPA056528: AB_2683166" "unprognostic (1.97e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.4 1.0 0.0 0.0 0.0 0.0 CEACAM19 CEAL1 ENSG00000186567 "Carcinoembryonic antigen related cell adhesion molecule 19" Q7Z692 19 44662278-44684359 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 10.7;RPTEC TERT1: 13.7;TIME: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA014462, HPA052865" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA014462: AB_2669006, HPA052865: AB_2681976" "unprognostic (2.91e-1)" "unprognostic (5.29e-3)" "unprognostic (6.96e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-2)" "unprognostic (8.43e-2)" "unprognostic (5.22e-2)" "unprognostic (1.15e-2)" "unprognostic (9.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.77e-1)" "unprognostic (3.26e-9)" "unprognostic (8.01e-3)" "unprognostic (9.62e-2)" "unprognostic (1.31e-1)" "unprognostic (2.70e-1)" 1.6 2.9 1.1 0.8 1.9 1.0 2.4 4.3 1.7 3.1 2.4 2.7 2.7 1.4 2.4 4.3 2.1 4.1 1.2 1.8 3.3 4.3 3.8 0.6 0.6 4.0 4.7 1.2 3.9 1.8 4.1 3.3 2.9 3.0 12.5 10.8 2.9 3.0 0.9 1.8 2.0 3.0 3.4 1.7 1.0 4.4 1.7 0.5 1.7 1.0 1.0 0.7 0.6 4.2 8.8 1.3 0.9 3.1 3.6 3.3 2.4 3.6 0.8 1.6 0.3 1.0 0.1 0.8 3.2 0.9 5.3 2.2 0.9 0.7 1.2 5.0 0.1 4.6 1.4 3.2 0.2 0.8 1.1 8.7 2.2 5.4 10.7 2.0 0.6 0.3 0.2 1.2 1.0 0.0 0.5 0.8 1.1 1.0 0.0 1.6 0.2 13.7 1.0 1.7 0.4 0.9 0.9 0.8 1.3 1.2 0.3 17.7 0.3 6.1 1.3 0.7 0.1 0.3 0.0 0.4 1.7 1.4 1.7 1.0 0.6 0.6 0.4 0.3 0.5 0.3 0.6 0.2 1.7 0.4 0.7 1.6 1.0 0.5 0.5 0.3 0.6 3.0 2.1 0.0 0.9 1.8 2.6 4.1 2.5 1.4 2.3 0.0 0.0 0.0 0.0 1.6 0.7 3.1 1.7 0.0 2.9 0.1 0.9 1.3 0.0 1.9 0.2 0.0 1.7 4.9 1.2 0.2 2.8 0.5 0.0 0.0 2.6 0.1 3.5 3.5 2.5 0.2 0.5 0.0 2.8 3.2 0.4 5.3 0.0 0.0 2.2 0.9 CELF2 "BRUNOL3, CUGBP2, Etr-3, NAPOR-2" ENSG00000048740 "CUGBP Elav-like family member 2" O95319 10 10798397-11336675 "Predicted intracellular proteins" "mRNA processing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 242.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 52.8;HMC-1: 51.4;REH: 22.8" "Low region specificity" "Detected in all" "CAB016395, HPA035813" Enhanced Supported "Nucleoplasm,Vesicles,Midbody ring" Yes No Nucleoplasm "Vesicles, Midbody ring" "CAB016395: AB_2086271, HPA035813: AB_2674797" "unprognostic (1.62e-2)" "unprognostic (1.52e-2)" "unprognostic (1.90e-2)" "unprognostic (3.55e-2)" "unprognostic (9.00e-2)" "prognostic favorable (7.61e-4)" "unprognostic (1.57e-1)" "unprognostic (3.77e-2)" "unprognostic (4.20e-2)" "unprognostic (5.22e-2)" "unprognostic (2.60e-3)" "unprognostic (2.83e-2)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (2.31e-2)" "unprognostic (1.45e-1)" 27.0 4.9 26.5 21.0 35.2 49.5 14.6 23.6 35.7 11.7 12.2 10.1 4.5 7.1 11.6 5.1 16.3 10.6 12.9 26.8 24.0 14.9 3.8 3.6 20.8 31.4 11.0 20.0 35.7 3.8 2.2 6.7 6.6 11.6 11.2 13.8 8.5 9.1 10.0 14.8 6.5 18.9 17.3 15.8 22.7 9.4 5.9 15.0 36.9 6.8 6.3 20.9 13.0 11.0 22.7 23.1 51.0 27.2 30.6 31.9 22.9 0.0 0.0 13.0 0.0 2.0 0.7 1.4 1.9 0.0 0.3 0.0 0.0 0.0 0.0 1.4 1.6 0.0 0.0 1.8 0.0 0.1 10.6 3.2 52.8 0.2 0.0 0.5 15.1 51.4 0.8 0.1 0.1 0.0 0.2 1.8 19.0 2.4 22.0 16.2 0.0 18.6 11.0 5.2 0.0 0.0 22.8 13.9 4.7 0.9 0.0 1.9 0.1 0.0 0.0 13.8 4.4 0.0 10.3 0.0 2.4 0.7 8.1 0.0 8.4 7.6 2.5 0.8 18.3 5.8 25.4 18.1 37.8 25.3 24.9 31.9 21.5 25.2 27.7 23.1 22.7 26.6 24.7 51.0 30.6 27.2 16.4 25.8 22.9 26.5 35.2 23.6 33.9 24.0 14.9 11.0 20.0 11.6 15.0 148.9 136.7 93.8 3.2 17.6 71.9 103.5 7.6 6.7 34.2 12.2 96.2 1.0 13.3 1.4 110.6 43.2 3.5 0.0 1.8 0.7 43.6 7.5 123.7 2.4 77.4 127.1 57.0 17.2 242.8 76.2 103.3 121.5 109.6 224.6 40.3 91.1 1.8 14.0 84.1 0.4 90.1 51.8 23.0 3.4 12.1 12.7 1.6 176.6 20.4 1.4 CENPC "CENP-C, CENPC1, hcp-4, MIF2" ENSG00000145241 "Centromere protein C" Q03188 4 67468748-67545606 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049740, HPA058252" Supported "Nucleoplasm,Nuclear bodies,Midbody" NA NA "Nuclear bodies" "Nucleoplasm, Midbody" "HPA049740: , HPA058252: AB_2683654" "unprognostic (4.35e-1)" "unprognostic (6.41e-3)" "unprognostic (4.31e-3)" "unprognostic (7.85e-2)" "unprognostic (6.31e-2)" "unprognostic (3.85e-3)" "unprognostic (6.40e-2)" "prognostic favorable (9.67e-4)" "unprognostic (3.22e-2)" "unprognostic (7.13e-2)" "unprognostic (8.35e-2)" "unprognostic (4.32e-2)" "prognostic favorable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-3)" 9.4 8.6 9.3 11.9 14.6 12.9 13.5 26.9 12.2 12.6 7.3 4.6 6.2 5.6 12.6 10.1 9.1 10.1 6.6 6.9 8.0 5.8 9.0 6.6 8.7 7.7 11.8 7.7 20.9 16.4 8.0 21.2 6.3 9.1 12.3 6.0 5.0 10.2 13.4 5.3 9.8 9.1 10.3 13.4 10.5 9.5 7.5 12.6 17.7 13.0 9.1 6.8 10.2 10.4 5.1 2.4 2.8 1.5 1.6 5.0 1.2 0.8 1.0 2.9 1.6 3.4 2.1 1.6 1.0 0.9 1.3 1.1 1.2 2.3 4.5 1.6 1.3 0.7 1.5 3.7 1.7 2.0 1.7 0.7 3.5 1.8 1.6 1.2 6.3 1.5 2.5 0.6 1.0 2.2 2.2 0.7 3.1 5.0 3.1 1.9 1.5 8.6 5.8 3.1 1.6 0.7 4.2 7.0 1.5 1.7 1.5 4.8 2.4 2.2 4.2 1.2 3.0 1.4 2.4 1.0 1.8 1.3 1.3 0.9 2.3 1.0 4.8 2.1 3.7 1.1 2.7 1.3 2.8 3.2 1.5 1.9 3.3 3.6 3.4 1.1 5.1 5.0 3.7 1.0 1.6 1.1 2.4 2.0 1.2 9.3 14.6 26.9 12.2 8.0 5.8 11.8 7.7 9.1 12.6 29.8 31.5 29.9 25.5 13.5 51.4 20.0 15.3 36.1 38.7 15.7 13.7 15.9 10.0 9.7 3.1 19.2 14.8 23.3 14.6 11.7 14.6 15.2 25.5 13.2 11.0 49.3 12.6 19.0 16.4 4.2 32.2 15.1 15.1 15.4 15.8 42.4 12.3 11.5 24.1 13.9 28.4 19.4 15.5 33.5 46.1 8.2 15.3 44.5 14.3 20.9 CENPE "KIF10, PPP1R61" ENSG00000138778 "Centromere protein E" Q02224 4 103105806-103198409 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein, Motor protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.3;lymphoid tissue: 25.1" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 93.5;Spermatocytes: 69.2;Spermatogonia: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA042294 Enhanced Approved Nucleoplasm,Microtubules,Cytosol NA Yes "Microtubules, Cytosol" Nucleoplasm "HPA042294: AB_10797386" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "unprognostic (5.64e-3)" "unprognostic (2.55e-2)" "unprognostic (1.65e-1)" "unprognostic (3.44e-2)" "unprognostic (2.40e-8)" "unprognostic (2.49e-3)" "unprognostic (1.59e-2)" "unprognostic (3.38e-1)" "unprognostic (4.88e-5)" "unprognostic (1.15e-2)" "unprognostic (0.00e+0)" "unprognostic (9.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (2.37e-1)" 2.7 0.9 0.6 9.4 1.5 11.3 0.7 0.2 1.3 1.0 2.1 0.5 0.0 1.9 0.7 1.9 5.9 0.5 0.8 2.5 2.0 0.8 1.3 0.6 1.4 7.3 1.9 0.6 0.7 0.5 0.1 0.4 3.1 1.4 0.7 2.7 0.2 2.2 0.8 0.4 2.2 2.4 1.4 1.3 3.3 1.6 6.6 0.6 25.1 0.6 5.9 6.4 1.5 1.9 0.6 0.5 5.7 3.0 0.8 1.4 0.2 20.9 6.0 21.9 10.6 1.5 3.4 4.3 19.1 9.6 14.3 9.5 9.5 11.4 14.2 4.9 7.0 10.0 9.4 15.7 7.7 22.6 17.7 5.8 16.7 12.6 6.9 0.2 19.8 9.7 1.0 0.6 11.4 9.6 3.2 12.0 13.0 17.3 17.0 18.3 7.6 15.6 8.9 7.0 8.5 9.4 10.5 20.5 4.7 4.0 4.2 10.1 6.0 16.9 11.8 4.6 8.8 6.7 7.0 13.0 13.8 14.5 14.3 19.5 8.3 14.2 14.8 7.7 11.1 14.6 5.7 0.1 0.7 0.2 0.6 0.0 0.6 0.4 0.4 0.2 0.2 0.1 0.3 0.1 0.8 3.0 0.5 1.4 0.2 0.6 1.5 0.2 1.3 2.0 0.8 1.9 0.6 1.4 0.6 3.0 2.1 0.0 1.0 3.2 7.1 1.4 0.0 0.0 1.2 0.0 7.9 2.4 0.0 0.4 3.4 2.8 0.5 93.5 0.0 22.1 1.5 1.3 6.9 0.8 11.2 0.0 1.2 4.3 7.3 0.7 0.9 5.5 0.0 8.2 1.4 1.4 1.3 0.6 2.5 0.0 2.5 0.0 2.5 69.2 47.7 2.5 3.0 2.5 4.7 0.6 CENPH ENSG00000153044 "Centromere protein H" Q9H3R5 5 69189548-69210357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.8;testis: 37.3" "Cell type enhanced" "Detected in many" 15 "Erythroid cells: 70.0;Spermatocytes: 122.1;Spermatogonia: 250.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036494 Approved Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "HPA036494: AB_10673354" "unprognostic (1.49e-1)" "prognostic favorable (6.86e-4)" "unprognostic (1.73e-2)" "unprognostic (3.16e-2)" "unprognostic (2.32e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.22e-5)" "unprognostic (6.14e-3)" "unprognostic (6.85e-2)" "prognostic favorable (2.50e-4)" "unprognostic (4.21e-2)" "unprognostic (8.80e-2)" "prognostic unfavorable (5.11e-15)" "unprognostic (1.17e-1)" "unprognostic (3.94e-1)" "unprognostic (2.58e-1)" "unprognostic (2.20e-1)" 4.0 1.9 2.9 15.2 3.1 19.1 5.5 2.1 3.0 3.9 4.7 1.2 0.7 4.2 2.9 3.1 7.7 2.5 2.8 4.4 2.7 2.1 1.9 2.2 3.6 11.1 2.6 3.7 3.6 1.6 1.6 2.7 6.8 1.8 2.4 5.5 1.6 3.0 1.5 3.6 6.0 4.0 2.4 2.6 6.2 2.5 37.3 1.8 31.8 1.8 10.2 12.2 3.1 4.3 12.1 6.1 2.5 3.6 7.5 9.8 4.2 18.4 5.7 26.8 20.9 1.7 5.6 14.3 9.1 9.7 20.3 22.0 7.8 23.5 39.7 10.9 5.3 11.8 13.8 17.5 21.0 26.0 12.0 12.0 9.2 9.8 7.7 0.6 13.3 9.5 2.2 4.3 13.2 14.6 5.8 6.8 21.7 16.3 15.8 15.6 10.3 42.8 19.1 23.2 6.0 4.9 26.7 35.3 30.6 6.4 6.8 18.5 24.7 10.0 6.8 8.0 15.2 9.5 9.0 3.3 10.1 17.0 13.4 22.6 19.5 29.5 31.8 15.6 27.0 19.1 0.6 1.8 2.5 4.5 3.0 7.3 11.8 7.6 5.7 2.8 12.1 9.8 8.3 0.4 7.5 3.6 6.1 8.7 4.2 2.9 3.1 2.1 3.0 2.7 2.1 2.6 3.7 1.8 1.8 0.0 1.6 22.3 12.1 32.5 3.6 2.2 5.1 13.4 6.8 0.0 0.0 23.0 0.0 5.8 21.9 5.7 1.2 70.0 7.9 41.3 7.8 4.5 4.7 0.8 15.0 0.0 1.2 5.5 5.6 22.4 3.4 11.0 8.5 5.4 7.2 5.2 5.5 2.9 4.6 2.9 3.0 19.4 6.6 122.1 250.2 16.8 8.4 13.1 13.0 6.2 CENPJ "BM032, CPAP, LAP, LIP1, MCPH6, Sas-4, SASS4, SCKL4" ENSG00000151849 "Centromere protein J" Q9HC77 13 24882284-24922889 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dwarfism, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 115.8;Spermatocytes: 61.7;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060426 Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Plasma membrane, Centrosome" "HPA060426: AB_2684278" "unprognostic (2.69e-1)" "unprognostic (3.17e-1)" "unprognostic (2.68e-1)" "unprognostic (1.01e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-2)" "unprognostic (2.15e-5)" "unprognostic (7.41e-2)" "unprognostic (1.50e-2)" "unprognostic (9.83e-2)" "unprognostic (2.44e-1)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (7.36e-2)" "unprognostic (5.51e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" 5.0 3.5 6.6 6.7 11.9 10.2 6.2 18.4 6.4 10.3 7.6 5.0 7.2 7.5 8.8 4.8 6.6 6.0 3.3 4.2 5.4 4.4 3.9 2.9 4.9 8.5 9.7 3.8 8.1 3.2 2.1 4.6 7.6 7.2 6.3 8.8 2.4 4.6 12.0 3.6 7.6 9.0 9.1 11.6 7.4 4.6 24.3 10.1 14.6 20.8 5.7 7.8 7.9 7.8 4.3 2.4 3.8 1.3 2.2 2.1 0.7 5.3 5.2 17.7 16.5 2.5 3.6 10.0 12.5 5.7 7.8 7.3 6.7 9.5 9.7 3.7 4.5 5.6 13.0 13.3 7.0 12.0 8.9 6.6 35.2 12.3 5.6 1.2 16.1 11.6 2.2 2.0 6.8 3.8 3.6 5.9 9.3 9.9 18.1 8.1 5.1 11.0 22.0 10.0 14.2 4.0 12.3 12.3 5.0 3.1 6.0 9.0 8.4 6.3 6.8 5.1 16.3 3.4 11.0 5.5 9.2 6.3 12.7 8.2 5.0 9.1 10.5 4.3 11.8 14.2 1.9 0.8 3.8 2.1 1.3 0.9 4.3 1.4 1.6 0.9 4.1 1.8 0.9 0.4 2.2 0.9 2.4 1.5 0.7 6.6 11.9 18.4 6.4 5.4 4.4 9.7 3.8 7.2 10.1 3.0 8.0 3.0 3.6 1.8 7.2 5.3 0.0 9.4 14.8 3.5 3.9 5.6 0.0 1.5 115.8 5.3 5.2 0.0 2.6 11.2 2.7 2.0 4.7 1.5 3.7 3.2 0.0 1.3 2.4 17.0 6.1 4.6 0.0 9.0 2.5 2.6 1.7 6.2 5.3 0.8 2.0 6.5 7.2 61.7 32.4 1.1 2.4 6.9 3.3 1.4 CENPV "CENP-V, p30, PRR6" ENSG00000166582 "Centromere protein V" Q7Z7K6 17 16342534-16353656 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Paneth cells: 96.8;Spermatogonia: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.6;memory B-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 33.0;HEK 293: 27.0;JURKAT: 32.1;NTERA-2: 32.4" "Low region specificity" "Detected in all" "HPA042529, HPA042616" Enhanced Approved Nucleoplasm,Midbody,Cytosol Yes No Nucleoplasm "Midbody, Cytosol" "HPA042529: AB_10793882, HPA042616: AB_10794050" "unprognostic (7.64e-2)" "unprognostic (4.41e-2)" "unprognostic (5.92e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (6.47e-2)" "unprognostic (1.21e-1)" "unprognostic (4.00e-2)" "unprognostic (7.73e-3)" "unprognostic (7.93e-2)" "unprognostic (4.09e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-2)" "unprognostic (2.54e-2)" "unprognostic (3.60e-3)" 4.6 5.6 13.7 4.0 14.7 6.2 6.6 12.0 17.3 4.2 19.5 6.7 2.8 13.6 8.0 5.5 1.3 9.1 3.5 5.7 10.2 10.1 5.2 14.6 2.5 2.3 7.8 11.8 9.1 5.9 3.7 7.3 2.2 5.8 4.6 11.5 2.4 1.6 6.4 25.4 0.9 29.1 6.1 7.3 1.5 18.0 10.6 6.1 22.5 4.0 2.9 2.1 3.2 2.3 3.3 1.0 3.6 0.0 0.0 1.0 0.3 3.1 6.2 33.0 16.6 0.9 0.8 5.7 2.6 2.6 8.3 6.4 6.2 1.4 12.6 5.3 1.9 1.5 0.9 21.3 0.2 5.2 0.0 27.0 2.9 1.6 12.2 9.3 3.0 0.0 2.4 0.8 10.0 5.8 0.9 4.6 32.1 5.1 0.0 2.4 0.5 23.6 10.0 32.4 20.5 0.0 17.0 1.2 1.4 1.9 4.7 17.7 13.5 6.6 0.1 1.5 15.9 0.1 7.4 0.3 0.0 2.7 0.3 0.0 0.0 0.0 7.3 0.0 4.1 0.2 0.0 0.0 3.6 0.3 0.0 0.1 3.3 0.1 0.1 0.7 0.3 1.0 0.9 0.0 0.0 0.0 1.0 0.2 0.3 13.7 14.7 12.0 17.3 10.2 10.1 7.8 11.8 5.8 6.1 0.0 2.4 6.0 17.3 0.9 40.2 3.7 28.1 4.0 6.8 1.8 3.9 11.5 26.6 7.1 12.4 3.6 48.0 0.0 20.1 10.7 2.9 19.6 5.7 43.9 5.4 11.1 37.8 1.3 2.2 6.1 8.1 2.7 8.5 1.0 52.7 28.8 13.5 96.8 11.0 31.1 13.8 25.8 15.6 48.8 116.2 2.3 5.4 4.3 71.8 42.2 CEP162 "C6orf84, KIAA1009, QN1" ENSG00000135315 "Centrosomal protein 162" Q5TB80 6 84124241-84227635 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 72.3;Early spermatids: 103.7;Spermatocytes: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030170, HPA030171, HPA030172, HPA030173" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206" "unprognostic (1.75e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-3)" "unprognostic (2.95e-4)" "unprognostic (1.03e-1)" "unprognostic (6.73e-2)" "unprognostic (1.21e-3)" "unprognostic (1.57e-3)" "unprognostic (3.98e-2)" "unprognostic (2.87e-3)" "unprognostic (3.27e-2)" "unprognostic (6.32e-2)" "unprognostic (3.58e-1)" "unprognostic (1.44e-3)" 5.9 4.3 4.2 5.3 6.0 3.8 5.4 9.4 7.8 6.4 6.3 4.8 6.6 2.1 9.1 4.4 4.1 7.2 5.2 4.0 4.5 2.6 7.7 2.6 5.3 4.6 4.8 3.2 7.9 4.1 9.6 19.1 4.5 5.8 4.7 4.9 2.7 5.5 4.6 4.1 4.1 4.2 6.4 7.6 5.8 4.9 14.4 6.4 11.6 7.7 2.1 4.2 7.3 5.4 2.5 1.8 2.2 1.3 0.1 2.6 0.8 2.9 1.3 8.8 9.5 5.2 7.8 5.5 3.3 3.2 4.7 5.8 3.8 4.0 3.2 3.2 2.6 8.4 4.6 5.1 3.1 7.5 8.1 3.6 5.8 5.9 2.8 2.9 6.3 5.6 3.6 2.3 4.8 1.8 6.3 5.2 4.8 11.8 3.7 3.4 1.5 1.6 4.1 5.8 2.1 2.1 9.0 11.3 1.7 3.5 2.7 6.0 7.5 2.4 1.4 2.5 6.6 3.1 4.6 4.2 4.7 4.2 4.1 3.7 2.9 3.9 1.9 2.9 3.5 5.8 0.0 1.3 1.5 1.9 1.2 2.6 2.5 1.5 1.7 0.7 1.6 1.2 2.0 2.2 0.1 1.0 1.8 0.3 0.8 4.2 6.0 9.4 7.8 4.5 2.6 4.8 3.2 5.8 6.4 29.8 14.5 5.0 6.4 0.0 5.2 7.6 0.0 72.3 12.5 8.7 11.8 5.8 5.0 10.5 103.7 6.3 5.1 23.3 6.2 4.6 5.0 3.5 17.4 2.6 4.7 27.0 10.9 8.6 5.6 39.3 10.9 6.1 0.0 1.8 4.5 11.2 5.3 14.0 11.3 5.0 13.8 12.9 3.6 62.7 22.4 0.0 3.2 7.5 5.2 3.3 CEP70 "BITE, FLJ13036" ENSG00000114107 "Centrosomal protein 70" Q8NHQ1 3 138494344-138594538 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 163.4;Late spermatids: 214.6;Spermatocytes: 140.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0" "Group enriched" "Detected in many" 8 "B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036941, HPA036942" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA036941: AB_10670567, HPA036942: AB_10670957" "unprognostic (1.61e-1)" "prognostic favorable (2.93e-4)" "unprognostic (2.27e-2)" "unprognostic (3.59e-2)" "unprognostic (3.31e-2)" "unprognostic (3.44e-2)" "unprognostic (1.95e-2)" "unprognostic (9.92e-3)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (5.01e-3)" "prognostic unfavorable (9.60e-5)" "unprognostic (8.90e-3)" "unprognostic (8.07e-3)" "unprognostic (1.46e-1)" "unprognostic (8.71e-3)" "unprognostic (6.43e-2)" 5.5 8.3 11.0 5.7 15.8 3.5 9.0 14.7 15.6 20.8 12.2 7.1 22.8 35.7 14.0 14.8 10.2 20.3 8.9 11.3 10.9 15.9 17.0 18.8 11.5 4.2 12.6 10.2 14.4 17.4 16.6 27.8 2.7 14.4 14.3 12.1 12.6 6.1 28.7 10.6 4.6 11.5 14.0 19.1 3.9 8.6 41.5 15.3 24.2 26.2 6.7 4.5 13.3 9.1 2.9 0.2 0.5 0.1 3.6 6.4 2.0 21.6 4.5 10.7 13.0 6.7 7.5 10.0 4.3 8.1 6.0 8.9 6.3 11.8 5.1 10.3 8.0 22.8 9.6 9.7 8.6 13.5 9.0 6.4 14.6 10.5 8.2 10.5 0.7 5.4 40.3 5.0 4.5 11.2 16.0 8.6 16.8 10.6 17.1 9.8 8.2 15.3 0.8 6.3 5.7 10.2 16.9 13.9 13.1 11.4 9.7 13.0 8.5 22.5 5.4 25.5 12.8 27.1 7.1 5.0 4.4 8.4 9.0 5.2 15.9 8.7 17.4 9.8 1.4 15.0 0.4 0.1 0.2 4.2 0.1 5.0 2.9 3.4 3.7 0.1 2.0 5.9 6.4 0.5 3.6 0.0 0.2 2.0 2.0 11.0 15.8 14.7 15.6 10.9 15.9 12.6 10.2 14.4 15.3 29.8 54.7 0.8 31.2 8.7 15.6 23.2 17.8 48.2 38.7 19.2 33.4 5.9 61.3 18.3 163.4 7.1 4.6 0.0 15.5 3.6 6.2 27.5 19.7 12.4 2.2 20.6 15.0 4.9 0.8 214.6 9.2 3.3 10.1 1.0 9.5 19.7 13.7 7.0 12.0 17.0 29.1 6.5 11.8 140.5 9.1 7.0 8.0 4.9 22.3 24.8 CERCAM "CEECAM1, CerCAM, GLT25D3" ENSG00000167123 "Cerebral endothelial cell adhesion molecule" Q5T4B2 9 128411751-128437351 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.1" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 48.9;Fibroblasts: 70.1;Melanocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 55.6;ASC TERT1: 59.3;fHDF/TERT166: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021657, HPA051595" Uncertain Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA021657: AB_1846507, HPA051595: AB_2681545" "unprognostic (2.87e-2)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" "unprognostic (2.19e-1)" "unprognostic (4.68e-3)" "unprognostic (7.79e-3)" "unprognostic (3.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (1.59e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (3.33e-16)" "unprognostic (1.34e-2)" "unprognostic (1.04e-1)" "unprognostic (6.05e-3)" "prognostic unfavorable (3.30e-5)" 12.7 5.1 40.0 7.2 65.5 1.6 9.0 10.0 62.1 19.1 6.9 61.2 5.0 4.8 11.4 10.9 8.2 6.0 17.3 8.8 72.8 34.7 4.9 1.8 5.3 2.3 59.5 28.1 14.1 18.8 15.8 21.6 27.4 31.4 11.1 5.2 3.5 13.2 13.6 4.3 8.9 6.0 27.7 78.1 3.3 5.4 5.2 62.1 0.0 6.7 2.4 2.7 15.1 6.6 0.3 2.0 0.3 1.6 1.1 5.3 2.2 9.5 6.1 6.9 7.3 55.6 59.3 5.9 30.9 29.2 8.1 6.1 2.2 0.4 0.0 12.7 50.4 6.9 6.5 3.0 4.1 3.1 2.4 4.9 0.5 5.6 3.3 17.0 1.1 17.3 32.8 2.2 8.8 2.1 33.5 9.1 0.6 2.8 7.6 10.5 18.1 0.4 11.7 0.4 0.4 4.7 0.9 4.8 1.3 3.8 3.6 1.0 1.9 6.9 8.4 3.5 2.3 6.8 2.3 10.1 21.6 5.9 29.6 4.7 8.9 6.9 0.1 20.4 3.4 4.2 0.3 1.1 0.1 3.8 1.6 0.3 0.3 0.3 4.7 1.5 0.1 0.1 5.3 0.3 1.1 0.1 2.0 0.0 2.2 40.0 65.5 10.0 24.5 72.8 34.7 59.5 28.1 31.4 62.1 6.0 13.0 0.0 6.2 7.9 1.1 3.2 0.0 6.7 21.6 10.4 0.0 14.3 0.0 10.7 2.0 7.1 0.0 0.0 2.9 48.9 70.1 3.9 8.1 0.0 5.9 6.4 0.0 18.4 0.6 1.5 22.5 4.7 38.8 1.0 0.0 0.1 6.9 0.0 24.8 0.5 0.7 6.5 15.6 1.0 19.0 3.6 16.4 2.5 0.0 2.0 CFAP73 "CCDC42B, MIA2" ENSG00000186710 "Cilia and flagella associated protein 73" A6NFT4 12 113149858-113159276 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;epididymis: 17.8;fallopian tube: 35.5" "Group enriched" "Detected in some" 8 "Ciliated cells: 42.8;Club cells: 11.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Region enhanced" "Detected in many" "pons and medulla: 27.2" "Cell type enhanced" "Detected in some" "naive B-cell: 1.0;naive CD4 T-cell: 1.3" "Group enriched" "Detected in many" 9 "B-cells: 1.0;T-cells: 1.3" "Cell line enhanced" "Detected in some" "Daudi: 6.4;REH: 3.3;T-47d: 3.9;U-698: 13.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA048539 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA048539: AB_2680434" "unprognostic (2.42e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.90e-3)" "prognostic favorable (5.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.18e-3)" "unprognostic (6.49e-2)" "unprognostic (2.94e-1)" "unprognostic (1.33e-1)" "unprognostic (3.14e-1)" "unprognostic (5.68e-2)" "unprognostic (3.43e-2)" "unprognostic (1.62e-4)" "unprognostic (2.03e-4)" "unprognostic (1.60e-1)" "unprognostic (4.03e-2)" "unprognostic (1.55e-2)" 0.2 0.3 4.3 0.5 16.9 2.0 0.3 0.5 0.9 3.1 0.3 15.3 1.0 0.5 1.0 17.8 0.6 35.5 0.4 0.2 5.8 6.1 0.6 0.2 5.7 0.9 0.2 0.9 6.8 0.3 0.7 0.9 0.2 27.2 0.3 0.3 0.0 2.2 0.9 0.5 4.5 0.6 0.2 1.1 0.5 3.9 1.5 4.7 0.0 0.5 0.5 1.3 0.4 0.0 1.0 0.1 0.0 0.0 0.0 1.3 0.2 0.3 0.1 0.4 0.4 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 3.1 6.4 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.5 0.3 2.2 0.2 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.4 0.0 0.0 1.1 0.3 1.1 0.4 1.2 0.2 3.3 0.0 0.5 0.9 0.7 0.6 0.1 0.0 0.9 0.0 0.3 3.9 0.0 0.2 0.1 1.1 0.3 0.2 0.6 0.2 13.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.3 16.9 0.5 0.9 5.8 6.1 0.2 0.9 27.2 4.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 42.8 11.4 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CFL2 NEM7 ENSG00000165410 "Cofilin 2" Q9Y281 14 34706769-34714823 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 88.5;skeletal muscle: 185.9" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 498.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037078, HPA045599" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 90000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB037078: AB_259128, HPA045599: AB_2679383" "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.02e-2)" "unprognostic (2.80e-3)" "unprognostic (3.82e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.48e-2)" "unprognostic (1.27e-1)" "unprognostic (1.65e-2)" "unprognostic (3.13e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (2.16e-5)" 14.0 16.5 15.9 8.8 17.7 5.0 6.7 13.6 16.6 13.7 23.2 25.8 9.2 4.7 21.3 10.2 20.7 11.2 7.2 88.5 19.0 14.5 8.7 33.0 7.8 3.7 22.7 10.6 12.9 3.0 9.3 4.5 10.3 28.9 22.4 8.6 7.8 5.4 31.8 185.9 2.6 6.7 38.1 24.6 4.2 11.9 6.9 20.1 0.5 9.0 30.8 3.4 34.7 9.3 8.5 2.9 3.6 1.8 3.2 5.8 1.6 17.8 16.1 10.4 6.7 10.6 39.5 5.8 31.2 36.0 29.9 31.9 12.1 7.7 6.4 12.8 49.7 22.4 3.5 22.1 6.6 52.7 0.9 9.2 1.3 19.1 28.6 17.3 1.6 1.0 29.9 2.3 25.5 14.1 21.0 29.6 0.9 2.0 5.1 36.7 5.0 1.3 0.9 3.4 3.1 24.8 1.1 32.9 1.0 10.8 3.7 2.1 8.9 20.3 4.4 10.5 8.0 9.7 1.6 26.0 29.8 19.8 14.0 14.9 7.1 4.6 2.4 10.9 2.4 7.0 3.6 1.8 2.1 3.7 1.8 5.8 8.5 4.3 4.0 2.9 5.0 3.4 3.5 0.7 3.2 0.8 2.8 3.6 1.6 15.9 17.7 13.6 16.6 19.0 14.5 22.7 10.6 28.9 20.1 98.3 34.5 15.9 86.3 17.7 51.4 498.3 15.3 6.7 14.8 21.0 19.6 25.2 51.4 41.2 2.2 46.0 0.9 0.0 34.0 52.6 52.9 52.5 5.7 99.2 13.2 73.1 9.1 43.6 14.0 6.5 52.9 10.4 28.7 7.2 3.4 80.2 30.0 4.2 92.6 79.1 57.2 32.3 125.1 51.4 51.5 16.9 17.8 14.9 3.7 53.3 CHAMP1 "C13orf8, CAMP, CHAMP, ZNF828" ENSG00000198824 "Chromosome alignment maintaining phosphoprotein 1" Q96JM3 13 114314335-114337626 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006623, HPA008900" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Midbody ring" Yes No Nucleoplasm "Nuclear bodies, Midbody ring" "HPA006623: AB_1845548, HPA008900: AB_1845547" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (1.67e-1)" "unprognostic (3.89e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (1.13e-2)" "unprognostic (4.40e-2)" "unprognostic (3.50e-2)" "unprognostic (3.67e-1)" "unprognostic (4.62e-2)" "unprognostic (2.40e-1)" 13.7 16.8 11.8 12.7 18.5 16.5 13.3 25.2 19.8 12.4 13.3 15.9 10.9 13.7 16.7 11.7 12.6 16.7 10.7 10.3 11.6 12.2 12.7 20.6 12.3 19.9 12.5 12.4 17.8 20.8 12.8 9.5 13.5 16.6 14.5 14.3 12.4 13.2 14.7 16.1 12.6 16.4 14.2 11.4 16.8 16.3 11.6 11.9 35.0 15.2 9.8 23.1 14.3 11.2 7.9 14.5 7.0 6.8 3.7 5.7 2.5 15.4 6.7 24.9 10.5 8.9 13.9 10.7 16.4 13.8 15.6 17.5 9.9 9.4 31.9 6.7 12.8 9.8 9.9 18.1 13.1 23.3 12.3 22.3 20.9 9.7 8.7 10.1 30.4 12.5 13.6 8.2 12.3 12.1 5.5 7.5 11.1 13.2 8.8 19.9 6.1 20.2 8.9 18.7 19.0 8.8 20.3 11.7 11.0 11.8 9.6 12.1 14.4 9.4 21.4 15.5 18.1 12.3 25.7 8.2 8.6 13.8 9.1 10.0 11.3 11.5 34.7 17.1 18.0 16.4 7.0 4.0 5.2 4.7 4.6 5.7 6.8 4.3 4.5 4.5 7.9 3.5 3.9 1.0 3.7 6.8 14.5 2.8 2.5 11.8 18.5 25.2 19.8 11.6 12.2 12.5 12.4 16.6 11.9 8.9 8.1 18.2 6.1 3.0 10.9 5.3 15.3 9.4 1.2 12.2 3.9 11.4 11.6 10.4 0.8 8.6 9.6 0.0 9.9 14.5 8.3 14.3 9.3 18.8 18.9 14.3 10.4 10.4 17.7 1.0 10.9 12.0 11.8 14.4 12.5 8.1 10.8 8.0 10.6 14.0 9.6 6.5 6.2 8.8 20.5 3.3 6.6 8.2 10.4 3.0 CHCHD1 "C10orf34, FLJ25854" ENSG00000172586 "Coiled-coil-helix-coiled-coil-helix domain containing 1" Q96BP2 10 73782047-73783652 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 114.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039046 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Mitochondria" "Nucleoli fibrillar center" "HPA039046: AB_10673234" "unprognostic (4.97e-2)" "unprognostic (1.90e-3)" "unprognostic (2.96e-1)" "unprognostic (1.31e-3)" "unprognostic (1.80e-1)" "unprognostic (9.85e-2)" "unprognostic (1.75e-2)" "unprognostic (3.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.24e-2)" "unprognostic (4.53e-1)" "unprognostic (1.91e-2)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (1.54e-1)" "unprognostic (5.58e-2)" "prognostic favorable (5.42e-4)" 16.4 33.6 22.6 21.7 21.5 16.5 32.0 21.3 29.4 16.4 24.7 9.2 25.9 28.0 16.8 38.6 29.5 17.8 25.3 36.1 19.3 18.4 32.9 37.8 28.9 23.8 19.4 20.9 15.6 47.2 16.3 19.7 25.3 21.2 21.5 20.8 12.7 31.9 28.7 45.1 16.6 24.3 22.0 15.3 24.8 23.4 24.8 15.6 21.0 29.5 31.6 20.6 17.0 18.1 30.7 38.2 22.2 27.3 17.9 32.1 18.2 22.5 17.2 14.5 20.5 12.0 11.7 14.6 11.8 13.8 11.9 16.1 15.4 20.6 11.2 13.1 10.4 12.2 16.0 14.1 15.3 9.9 17.1 26.9 8.6 14.4 23.7 14.1 13.1 13.8 10.9 19.1 10.1 6.9 18.1 16.5 15.6 13.0 12.8 15.7 22.8 16.1 29.0 13.8 21.5 114.1 15.4 11.2 14.6 19.4 12.7 7.2 14.1 7.3 51.5 24.1 12.4 28.8 18.3 9.7 7.6 16.6 12.5 20.2 12.8 13.3 17.7 17.7 26.6 5.9 22.2 27.0 15.9 19.7 27.3 23.7 30.7 24.2 23.5 26.6 26.1 20.3 20.5 11.1 17.9 21.5 38.2 32.1 18.2 22.6 21.5 21.3 29.4 19.3 18.4 19.4 20.9 21.2 15.6 38.7 36.6 58.1 32.1 31.1 26.0 66.9 33.1 77.6 54.6 57.6 21.6 127.4 169.1 72.5 37.4 31.2 94.4 46.7 76.3 142.6 26.2 45.5 28.9 109.7 118.2 19.1 59.4 50.3 55.3 7.6 52.3 50.1 38.8 82.0 88.4 53.2 83.5 89.6 51.9 145.7 27.7 51.8 26.8 44.5 49.1 38.0 107.1 39.9 89.5 42.2 CHD3 "Mi-2a, Mi2-ALPHA, ZFH" ENSG00000170004 "Chromodomain helicase DNA binding protein 3" Q12873 17 7884806-7912760 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043368, HPA076524" Supported Approved "Nucleoplasm,Nucleoli,Centriolar satellite" No No "Nucleoplasm, Nucleoli, Centriolar satellite" "HPA043368: AB_2678448, HPA076524: AB_2686804" "unprognostic (1.77e-2)" "unprognostic (8.01e-2)" "prognostic unfavorable (2.43e-4)" "prognostic favorable (7.68e-5)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (2.83e-2)" "unprognostic (5.25e-3)" "prognostic favorable (8.36e-4)" "unprognostic (9.11e-2)" "unprognostic (8.31e-2)" "unprognostic (3.98e-2)" "unprognostic (1.50e-1)" "unprognostic (8.90e-3)" "unprognostic (2.20e-3)" 10.4 12.9 31.7 24.3 26.0 18.7 12.5 12.1 28.3 41.1 21.1 4.1 22.5 8.2 46.3 16.1 15.1 25.0 20.0 8.7 30.4 14.2 15.2 2.3 13.1 19.0 8.4 28.4 27.3 15.1 28.5 21.0 8.0 10.7 32.9 11.1 20.7 19.4 23.0 3.3 16.2 14.0 23.3 6.9 14.6 15.8 11.3 5.1 40.6 19.7 7.5 17.7 20.6 28.9 1.6 4.0 4.1 3.5 2.7 7.8 3.6 12.2 30.5 17.9 23.7 21.8 18.3 9.6 14.3 19.2 12.1 13.0 5.9 10.3 34.5 10.9 21.0 9.8 16.6 33.6 15.1 15.3 17.5 19.6 16.7 39.6 0.7 11.7 4.8 32.9 24.1 8.1 16.3 10.9 32.3 22.5 15.8 11.1 0.6 11.3 12.1 13.1 5.5 2.8 12.9 11.3 38.6 21.8 5.2 12.1 29.8 12.2 16.5 35.5 13.8 6.9 5.1 15.9 7.8 28.1 26.3 20.7 6.4 20.5 2.6 0.4 19.5 13.4 13.5 22.4 0.6 2.7 4.1 7.0 1.7 5.5 1.5 6.7 6.6 2.1 1.6 7.8 5.1 2.1 2.7 3.5 4.0 3.6 3.6 31.7 26.0 12.1 28.3 30.4 14.2 8.4 28.4 10.7 5.1 29.8 57.4 11.5 44.3 32.4 61.2 9.7 17.8 24.1 37.5 76.8 7.9 15.1 14.9 21.3 8.9 17.5 12.0 0.0 20.6 16.7 30.0 67.6 38.2 2.1 8.4 42.9 54.5 18.4 21.1 13.0 41.1 14.7 8.5 54.1 12.6 11.3 23.7 7.0 53.7 7.5 15.6 25.8 27.2 12.9 50.5 17.9 13.7 34.6 25.9 53.1 CHD5 ENSG00000116254 "Chromodomain helicase DNA binding protein 5" Q8TDI0 1 6101793-6180123 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.4;pituitary gland: 22.3;testis: 16.4" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 60.3;Early spermatids: 202.3;Horizontal cells: 212.9;Late spermatids: 67.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 17.0;U-2 OS: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015809 Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA015809: " "unprognostic (5.03e-4)" "unprognostic (1.89e-1)" "unprognostic (2.47e-3)" "unprognostic (9.40e-6)" "unprognostic (1.91e-2)" "unprognostic (2.98e-2)" "unprognostic (1.06e-1)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.95e-2)" "unprognostic (6.64e-4)" "unprognostic (1.34e-1)" "unprognostic (1.34e-4)" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" 1.1 7.9 19.8 1.3 17.1 1.0 1.0 12.1 41.4 1.2 1.4 0.7 0.0 1.3 1.2 1.2 1.5 1.2 1.2 1.6 15.3 10.1 1.3 1.0 1.2 1.0 4.3 19.1 1.1 1.4 1.3 22.3 1.0 8.0 1.9 1.3 2.3 1.2 4.8 1.2 1.0 1.4 1.2 1.6 1.1 1.2 16.4 0.8 0.0 1.0 0.0 1.0 1.1 0.4 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.8 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.2 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.3 1.5 0.0 0.1 0.3 1.3 0.0 0.0 0.0 0.0 17.0 0.2 0.2 0.0 0.0 0.0 2.9 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.8 17.1 12.1 34.2 15.3 10.1 4.3 19.1 8.0 0.8 0.0 0.0 0.0 0.0 0.1 60.3 1.7 0.0 0.0 0.0 3.5 11.8 0.0 0.0 0.0 202.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 212.9 0.0 0.0 0.0 67.4 0.9 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.4 0.0 48.3 0.0 0.9 3.4 17.0 0.4 0.0 0.0 0.0 0.0 CHMP2A "BC-2, CHMP2, VPS2, VPS2A" ENSG00000130724 "Charged multivesicular body protein 2A" O43633 19 58551566-58555124 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041153, HPA042031" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 49000 Cytosol "Nucleoplasm, Plasma membrane" "HPA041153: AB_10964358, HPA042031: AB_10961727" "unprognostic (1.80e-1)" "unprognostic (4.70e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (2.54e-1)" "unprognostic (3.86e-2)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-2)" "unprognostic (2.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.98e-1)" "unprognostic (2.21e-1)" "unprognostic (3.09e-2)" "unprognostic (4.23e-2)" "unprognostic (2.71e-2)" 40.7 59.6 52.5 37.3 56.7 55.1 41.2 36.3 44.8 39.0 53.2 37.8 50.4 43.5 36.9 61.7 57.4 41.9 60.4 80.6 45.0 40.1 64.8 66.5 36.4 55.8 48.2 38.7 36.9 59.8 46.9 39.1 79.2 38.5 35.2 49.2 33.0 62.4 64.8 75.7 54.9 72.0 42.4 48.5 43.4 45.2 29.4 35.1 34.0 49.8 53.9 44.4 42.5 34.0 17.5 30.5 117.2 34.7 17.0 29.4 24.9 18.0 48.6 15.7 14.4 24.3 30.5 19.4 16.7 34.7 8.9 9.7 14.3 26.9 4.8 24.7 27.9 25.8 14.7 12.9 31.9 7.6 16.1 106.0 11.8 35.6 21.9 47.1 19.5 18.5 35.3 45.3 13.9 44.7 30.4 25.8 22.8 14.0 23.1 26.9 30.5 24.7 18.1 6.5 50.0 37.3 10.7 13.5 36.2 38.8 41.0 18.5 31.4 27.2 36.4 20.0 10.3 27.9 20.0 29.0 45.6 6.6 13.2 19.3 58.9 64.4 15.7 32.1 23.2 29.9 33.5 34.7 46.6 20.2 31.7 17.0 17.5 22.3 22.7 30.5 15.8 15.7 17.7 117.2 17.0 31.6 27.8 29.4 24.9 52.5 56.7 36.3 44.8 45.0 40.1 48.2 38.7 38.5 35.1 92.3 99.1 97.2 231.9 147.1 67.2 100.3 152.8 155.2 81.9 157.1 15.7 253.5 374.7 261.4 89.0 137.1 466.3 70.0 457.0 242.2 112.6 224.1 116.8 190.9 235.9 49.3 149.1 122.8 143.9 66.0 134.3 151.3 204.1 239.9 215.7 135.6 375.5 326.1 125.2 436.3 71.4 84.1 139.8 101.7 97.9 173.4 384.7 105.5 183.9 310.0 CHRND ACHRD ENSG00000135902 "Cholinergic receptor nicotinic delta subunit" Q07001 2 232525993-232536667 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 49.1" "Cell type enriched" "Detected in single" 11 "Muller glia cells: 4.3" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 72 "RH-30: 43.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "olfactory region: 1.4" "HPA056404, HPA065404" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA056404: AB_2732603, HPA065404: AB_2732734" "unprognostic (1.69e-2)" "unprognostic (7.93e-2)" "unprognostic (3.28e-3)" "unprognostic (7.75e-3)" "unprognostic (6.04e-2)" "unprognostic (1.10e-1)" "unprognostic (7.25e-2)" "unprognostic (1.90e-1)" "unprognostic (4.97e-8)" "unprognostic (7.52e-2)" "unprognostic (2.86e-1)" "unprognostic (2.46e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 49.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHST2 C6ST ENSG00000175040 "Carbohydrate sulfotransferase 2" Q9Y4C5 3 143119331-143124014 "Predicted membrane proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9" "Group enriched" "Detected in many" 4 "Muller glia cells: 106.5;Sertoli cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.4" "Group enriched" "Detected in many" 4 "monocytes: 11.4;NK-cells: 4.8" "Cell line enhanced" "Detected in many" "ASC diff: 20.5;ASC TERT1: 21.0;HEL: 16.2;HHSteC: 42.2;HMC-1: 19.4;HSkMC: 22.1;U-266/70: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013620 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA013620: AB_2668861" "unprognostic (1.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.64e-3)" "unprognostic (2.75e-1)" "unprognostic (8.97e-3)" "unprognostic (2.83e-1)" "unprognostic (2.70e-2)" "unprognostic (2.06e-1)" "unprognostic (2.76e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-3)" "unprognostic (9.15e-2)" "unprognostic (1.31e-2)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.58e-3)" "unprognostic (1.34e-1)" 6.5 2.6 8.2 11.6 16.6 20.0 4.1 9.8 15.1 4.6 3.1 6.5 2.6 3.6 6.4 2.7 2.0 1.6 3.1 2.6 7.3 10.4 4.8 1.6 5.1 10.2 10.6 5.8 3.6 2.0 1.5 5.5 15.3 14.0 7.6 2.3 5.9 4.0 15.9 2.7 3.0 4.9 6.0 32.9 17.0 5.4 2.3 4.8 24.7 5.4 0.1 8.1 7.4 5.4 1.4 1.8 0.8 11.4 4.8 0.8 0.9 0.0 0.1 1.0 0.9 20.5 21.0 0.0 1.1 3.2 0.8 0.7 0.0 0.0 0.2 0.7 0.7 1.1 0.0 0.7 2.7 0.4 0.2 0.5 16.2 0.0 0.0 42.2 0.4 19.4 22.1 3.4 1.0 3.5 1.2 1.2 2.5 1.8 1.0 5.3 0.0 3.0 4.1 5.8 0.0 2.7 0.1 0.3 0.0 0.6 0.7 1.3 0.0 0.2 0.0 1.8 1.0 0.0 0.6 4.2 2.5 1.4 3.3 4.7 18.6 0.2 1.1 4.8 3.1 12.8 0.7 0.6 0.8 0.4 4.5 0.0 1.4 0.1 0.2 1.8 1.0 0.8 0.6 0.3 4.8 11.4 0.1 0.5 0.9 8.2 16.6 9.8 15.1 7.3 10.4 10.6 5.8 14.0 4.8 0.0 0.0 14.2 7.0 2.2 20.1 1.2 0.0 0.0 2.3 3.5 2.0 0.4 0.0 0.3 0.1 6.4 0.0 23.3 0.2 0.3 7.1 9.4 11.5 0.0 2.8 1.6 0.0 4.3 6.4 0.4 11.8 13.0 16.9 9.0 0.0 106.5 3.5 0.0 2.1 0.0 19.2 90.5 5.5 0.0 1.9 0.5 0.8 8.7 0.0 15.6 CIPC KIAA1737 ENSG00000198894 "CLOCK interacting pacemaker" Q9C0C6 14 77098097-77117287 "Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA000644 Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA000644: AB_1079206" "unprognostic (3.93e-2)" "unprognostic (6.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (6.67e-3)" "unprognostic (3.73e-2)" "unprognostic (1.74e-1)" "unprognostic (2.31e-2)" "unprognostic (3.20e-1)" "prognostic favorable (1.77e-10)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "unprognostic (1.13e-1)" "unprognostic (1.21e-1)" 8.9 7.3 20.8 5.9 20.7 3.1 11.4 29.0 24.2 12.8 14.1 27.9 9.9 7.5 10.7 10.0 15.5 21.2 6.7 26.1 21.6 17.5 10.4 10.9 7.9 5.8 22.2 14.9 7.1 7.1 15.8 9.4 6.6 20.5 18.3 14.1 10.6 13.3 18.2 77.7 8.6 7.9 11.8 21.6 6.3 7.1 8.0 23.4 3.4 14.4 13.1 7.1 11.4 8.8 11.4 7.2 7.7 6.7 7.6 5.8 4.2 6.2 8.3 17.6 11.8 7.2 5.7 10.9 4.2 6.5 7.4 6.8 6.6 13.4 15.3 4.0 6.6 6.9 9.5 16.4 6.3 10.2 7.9 4.4 10.2 6.3 6.1 6.8 5.6 7.5 6.6 12.6 7.3 4.6 10.0 8.6 12.4 8.8 6.2 5.6 13.5 13.2 6.8 7.4 14.3 7.2 13.3 7.7 9.2 7.6 10.5 25.1 9.3 7.4 12.1 9.7 7.8 18.9 5.7 10.3 4.9 10.5 6.9 5.0 5.5 3.8 7.4 9.3 4.8 10.3 5.8 5.8 2.1 3.7 6.7 5.8 11.4 5.2 3.9 7.2 9.4 5.6 3.9 7.7 7.6 4.8 2.7 5.3 4.2 20.8 20.7 29.0 22.4 21.6 17.5 22.2 14.9 20.5 23.4 14.9 13.6 0.8 7.0 8.0 24.6 44.8 7.6 14.7 14.8 10.4 55.0 5.6 8.3 4.2 8.7 5.8 18.6 0.0 4.7 3.7 6.0 7.5 1.1 23.6 12.8 11.1 16.7 6.7 14.3 9.9 3.7 5.8 8.5 3.6 15.6 18.9 3.9 10.5 13.4 4.9 36.3 12.9 9.5 14.9 6.1 8.5 11.3 3.9 9.5 5.8 CLBA1 C14orf79 ENSG00000140104 "Clathrin binding box of aftiphilin containing 1" Q96F83 14 104985775-105010482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 14.9;Ciliated cells: 34.8;Collecting duct cells: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042052, HPA061117" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA042052: AB_2677822, HPA061117: AB_2684434" "unprognostic (1.49e-2)" "unprognostic (4.04e-2)" "unprognostic (4.84e-2)" "unprognostic (2.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.49e-1)" "unprognostic (5.77e-2)" "unprognostic (9.43e-3)" "unprognostic (1.78e-1)" "unprognostic (8.21e-2)" "unprognostic (3.50e-2)" "unprognostic (2.30e-1)" "unprognostic (4.39e-3)" "unprognostic (3.12e-2)" "unprognostic (1.11e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" 2.1 5.3 5.4 2.6 12.5 2.0 6.6 3.5 13.5 7.6 3.4 5.2 11.8 2.3 6.8 15.1 5.1 18.9 6.5 2.4 6.2 6.5 8.9 6.1 7.4 1.8 3.3 5.9 6.8 11.3 13.2 15.3 2.4 5.3 7.6 3.5 7.6 6.3 8.3 1.3 9.2 2.2 4.4 2.1 2.4 5.9 23.9 1.8 1.8 17.6 1.0 2.3 4.2 3.3 1.8 2.3 2.4 1.1 1.0 1.4 0.5 4.0 7.3 2.2 6.9 2.2 3.3 3.4 3.3 3.1 4.0 1.8 0.7 7.2 0.4 7.0 3.3 2.1 8.8 0.8 4.9 2.5 3.3 2.6 0.3 6.3 0.3 7.9 1.7 1.8 2.1 11.4 4.3 8.5 6.8 2.3 3.5 2.4 1.1 2.3 13.8 0.7 5.2 2.9 4.0 7.0 2.6 1.2 2.3 8.6 2.4 14.4 7.5 4.7 2.1 3.8 1.5 15.0 2.5 2.4 5.0 2.3 10.1 2.5 1.4 0.9 0.3 6.4 0.5 3.5 1.8 1.1 0.4 1.4 1.1 0.3 1.2 1.4 0.3 0.5 1.8 0.6 1.3 2.4 1.0 1.0 2.3 0.6 0.5 5.4 12.5 3.5 13.5 6.2 6.5 3.3 5.9 5.3 1.8 14.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 34.8 4.5 15.7 0.0 1.2 3.3 6.2 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 2.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 4.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 CLCA2 CLCRG2 ENSG00000137975 "Chloride channel accessory 2" Q9UQC9 1 86424086-86456558 "Predicted membrane proteins" "Cell adhesion, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 42.1;Club cells: 22.7;Early spermatids: 20.6;Suprabasal keratinocytes: 47.9;Urothelial cells: 35.8" "Group enriched" "Detected in many" 6 "cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "hTCEpi: 68.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047192 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 66000 "Plasma membrane, Cell Junctions" Nucleoplasm "HPA047192: AB_2679977" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.96e-3)" "unprognostic (6.99e-2)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (9.99e-3)" "unprognostic (1.97e-8)" "unprognostic (3.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 2.0 0.1 0.1 27.7 0.2 0.1 0.4 0.1 1.1 0.7 105.2 0.1 0.2 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 1.4 0.3 0.1 5.1 0.1 0.1 36.4 0.3 0.1 0.2 0.1 0.0 0.2 0.1 0.7 0.1 42.1 33.9 6.1 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 12.6 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 10.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 68.6 0.3 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 6.0 42.1 0.0 0.3 0.0 10.7 22.7 0.0 0.0 0.2 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 47.9 0.1 0.0 0.0 35.8 CLCA4 CaCC2 ENSG00000016602 "Chloride channel accessory 4" Q14CN2 1 86547078-86580754 "Predicted membrane proteins" Transport "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 182.1;intestine: 64.2" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 115.2" "Cancer enhanced" "Detected in many" "cervical cancer: 21.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 988 "RT4: 98.7" "HPA017045, HPA064770" Uncertain Approved "Nucleoplasm,Plasma membrane,Aggresome" "Intracellular and membrane" NA NA 210000 "Plasma membrane" "Nucleoplasm, Aggresome" "HPA017045: AB_2291679, HPA064770: " "unprognostic (1.38e-4)" "unprognostic (1.52e-1)" "prognostic favorable (7.47e-4)" "unprognostic (2.73e-2)" "unprognostic (7.03e-2)" "prognostic favorable (8.63e-4)" "unprognostic (7.59e-2)" "unprognostic (3.35e-1)" "unprognostic (1.26e-1)" "unprognostic (6.01e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-2)" "unprognostic (2.29e-1)" "unprognostic (5.69e-2)" "unprognostic (3.43e-2)" 0.2 0.1 2.2 8.8 3.0 0.1 0.6 0.0 2.0 12.3 64.2 2.0 0.0 0.1 0.3 0.1 182.1 0.1 0.1 0.1 2.2 0.6 0.1 0.1 0.1 0.1 3.2 1.6 0.1 0.0 0.1 0.0 0.1 3.0 1.8 38.4 0.0 5.9 0.1 0.1 4.5 6.1 0.8 2.4 0.1 0.1 0.1 5.0 0.0 0.1 8.6 21.5 9.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.0 0.0 2.0 2.2 0.6 3.2 1.6 3.0 5.0 0.0 0.0 0.0 13.3 3.0 0.0 0.2 0.0 2.7 5.7 1.8 0.0 0.0 0.0 0.0 0.3 0.0 18.6 0.0 0.0 0.0 0.0 3.9 9.2 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 4.1 115.2 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 22.9 14.0 27.7 21.6 12.5 14.2 19.6 20.0 27.7 14.8 18.3 9.0 19.2 13.6 38.0 24.3 17.6 10.8 35.1 21.2 7.5 18.7 5.2 13.2 22.2 16.8 18.7 25.2 58.3 15.6 16.8 21.5 21.7 17.9 9.3 27.7 28.1 9.4 12.3 11.1 19.9 7.8 15.6 8.3 30.8 11.4 18.7 8.1 8.3 22.8 19.6 6.6 28.1 32.1 6.6 14.3 20.1 26.1 24.1 17.7 18.4 36.7 15.7 14.5 43.6 16.2 33.3 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 32.8 39.6 30.5 103.2 128.0 19.7 48.0 12.7 16.0 23.9 26.2 23.6 44.0 24.9 18.4 58.8 63.1 19.7 46.7 14.2 132.7 70.7 85.5 35.8 18.7 31.6 14.3 27.5 54.0 25.9 62.2 47.8 38.0 108.0 43.3 18.8 28.6 24.0 11.5 43.9 18.2 31.4 51.8 126.4 168.0 50.6 171.8 80.1 103.6 17.1 110.7 CLIC2 XAP121 ENSG00000155962 "Chloride intracellular channel 2" O15247 X 155276211-155334657 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 62.3;vagina: 66.1" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 83.4;Alveolar cells type 2: 48.6;Endothelial cells: 49.6;Kupffer cells: 47.8;monocytes: 118.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5" "Group enriched" "Detected in many" 14 "dendritic cells: 24.5;monocytes: 9.5" "Group enriched" "Detected in some" 5 "HDLM-2: 37.3;K-562: 20.2;Karpas-707: 18.6;RPMI-8226: 31.8" "Low region specificity" "Detected in all" "HPA047381, HPA060101" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 290000 "Plasma membrane, Cytosol" Nucleoplasm "HPA047381: AB_2680022, HPA060101: AB_2684204" "unprognostic (3.27e-2)" "unprognostic (5.21e-3)" "unprognostic (9.70e-2)" "unprognostic (7.25e-2)" "unprognostic (9.71e-2)" "unprognostic (3.78e-2)" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.95e-1)" "unprognostic (1.74e-1)" "unprognostic (1.97e-1)" "unprognostic (3.31e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (1.97e-2)" "unprognostic (2.97e-2)" "unprognostic (6.63e-2)" "unprognostic (1.54e-1)" 26.5 3.7 3.8 7.5 6.1 3.4 24.1 2.6 4.8 15.5 6.8 0.6 3.3 4.0 11.3 10.5 10.4 6.5 9.8 9.4 3.7 3.4 5.4 6.3 31.0 15.6 7.5 1.4 12.5 2.6 2.0 7.8 4.5 6.8 9.1 6.9 3.0 5.4 3.2 10.3 5.2 7.3 10.2 5.2 32.1 4.7 5.6 4.3 6.9 62.3 8.7 12.4 14.0 66.1 0.0 24.5 0.6 9.5 1.1 0.1 1.0 0.2 0.0 0.4 0.3 0.3 2.1 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 37.3 0.2 5.2 0.1 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.2 0.0 0.2 20.2 18.6 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 31.8 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.7 0.6 0.7 0.3 1.2 1.6 0.0 0.9 1.1 0.6 0.0 1.8 0.1 0.0 9.5 0.1 0.0 0.0 0.1 24.5 0.0 0.0 0.0 0.6 1.1 6.5 2.5 0.0 1.0 3.8 6.1 2.6 4.8 3.7 3.4 7.5 1.4 6.8 4.3 83.4 48.6 0.8 0.7 11.7 1.1 2.8 0.0 2.7 10.3 0.0 0.0 0.0 0.0 0.0 0.1 49.6 0.0 23.3 0.2 0.1 22.3 0.4 3.5 1.0 4.8 0.0 1.2 19.0 47.8 0.4 12.7 29.8 16.9 118.2 0.0 0.0 0.1 0.0 8.9 0.2 0.3 6.5 4.8 0.0 0.0 12.0 0.0 2.2 0.0 1.4 CLNS1A "CLCI, ICln" ENSG00000074201 "Chloride nucleotide-sensitive channel 1A" P54105 11 77514936-77637805 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017840, HPA031707, HPA031708, HPA032045" Approved Supported Nucleoplasm,Microtubules,Cytosol No No Cytosol "Nucleoplasm, Microtubules" "CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123" "unprognostic (1.30e-1)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (1.30e-2)" "unprognostic (5.12e-3)" "unprognostic (5.09e-2)" "unprognostic (9.63e-2)" "unprognostic (5.56e-2)" "unprognostic (2.06e-3)" "unprognostic (5.56e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.05e-1)" "unprognostic (9.19e-2)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" 22.6 44.7 43.0 31.3 37.3 27.8 36.4 24.5 45.6 30.0 31.9 41.8 26.2 22.1 29.3 47.4 41.5 34.5 29.9 33.2 37.2 39.5 26.8 90.9 20.8 41.2 45.3 31.2 49.2 44.9 26.5 28.9 29.0 38.5 28.7 35.7 29.6 28.2 27.4 43.1 24.4 26.3 26.1 48.5 32.5 28.5 21.7 31.7 47.0 40.5 36.8 45.1 31.9 28.8 33.4 45.9 12.8 34.1 31.8 32.7 30.6 24.2 23.8 39.8 29.6 29.8 42.9 16.1 21.4 33.0 34.9 31.5 58.2 34.7 54.7 35.6 25.9 27.4 29.5 48.1 44.4 42.8 30.6 29.3 53.6 30.0 33.5 25.1 79.3 24.9 34.4 51.9 30.7 58.4 34.6 39.6 33.7 70.3 16.9 34.2 36.0 52.0 64.7 37.6 81.2 44.8 28.1 77.5 58.6 25.2 34.0 40.6 46.2 28.8 32.7 19.8 30.1 44.4 34.7 25.9 26.1 31.9 50.8 20.6 34.0 47.3 58.6 10.3 29.8 20.9 12.8 33.1 12.2 21.0 34.1 24.0 32.1 26.8 23.1 45.9 33.4 32.7 27.5 2.3 31.8 28.7 28.2 23.0 30.6 43.0 37.3 24.5 45.6 37.2 39.5 45.3 31.2 38.5 31.7 14.9 16.9 79.3 88.6 73.5 68.6 66.7 50.9 33.5 48.9 55.8 47.1 114.2 71.3 64.7 13.3 56.2 37.1 0.0 75.8 112.7 69.2 58.1 76.2 62.5 82.7 55.6 30.5 48.5 94.8 10.9 81.1 78.8 72.6 146.9 56.2 179.4 61.9 45.6 64.3 70.3 55.1 51.8 46.4 90.1 100.9 75.3 67.4 77.1 110.2 89.9 CLPX ENSG00000166855 "Caseinolytic mitochondrial matrix peptidase chaperone subunit" O76031 15 65148219-65185342 "Predicted intracellular proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.9" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 189.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040262, HPA048199" Approved Supported Nucleoplasm,Mitochondria,Cytosol "Intracellular and membrane" NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA040262: AB_10793961, HPA048199: AB_2680312" "unprognostic (2.78e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-2)" "unprognostic (2.00e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-3)" "unprognostic (2.64e-1)" "unprognostic (3.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.53e-2)" "unprognostic (6.99e-2)" "prognostic favorable (1.93e-9)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (5.95e-2)" "unprognostic (3.50e-2)" 10.4 12.8 11.3 8.9 12.7 7.7 10.2 10.9 10.7 11.7 13.4 11.2 4.7 9.3 9.8 10.3 15.5 8.9 9.6 15.9 10.7 9.2 16.8 50.9 9.4 8.8 12.8 8.1 10.8 10.6 11.0 6.3 10.6 9.8 9.7 8.9 7.4 8.9 7.1 25.8 15.6 12.6 10.8 9.7 9.7 9.9 9.3 12.6 17.8 12.9 14.7 10.2 12.5 9.5 7.7 9.8 11.4 7.1 8.2 9.2 4.4 5.3 9.1 8.0 10.1 8.5 11.0 8.6 6.1 6.9 6.8 7.1 9.1 7.5 16.6 5.2 8.2 5.0 11.5 29.3 8.1 7.3 6.5 5.3 12.5 8.9 11.5 12.2 15.9 7.3 13.1 11.2 6.2 11.9 7.8 8.6 9.0 11.4 5.9 7.9 6.8 7.5 14.1 9.0 10.6 4.1 14.8 9.5 17.1 12.7 12.4 7.0 5.7 8.3 13.3 9.0 11.0 6.1 13.5 7.5 6.9 6.0 5.5 5.7 6.3 9.6 8.7 6.7 20.2 5.3 3.5 7.1 10.3 7.6 5.7 7.0 7.7 6.7 5.6 6.4 7.2 9.2 7.3 11.4 8.2 5.1 9.8 5.7 4.4 11.3 12.7 10.9 10.7 10.7 9.2 12.8 8.1 9.8 12.6 32.8 28.6 14.9 17.9 17.1 27.3 62.7 28.1 33.5 33.0 31.4 13.7 35.1 18.3 32.5 87.1 17.9 15.6 0.0 27.4 27.2 19.7 20.0 15.1 79.9 19.8 30.2 9.9 22.1 23.9 189.0 26.7 16.0 16.9 26.2 22.4 24.3 27.3 17.5 28.0 28.4 24.1 25.8 16.0 33.9 29.6 26.3 74.6 19.1 23.3 18.4 CNGA1 "CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49" ENSG00000198515 "Cyclic nucleotide gated channel alpha 1" P29973 4 47935977-48016672 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.7" "Cell type enriched" "Detected in many" 9 "Rod photoreceptor cells: 880.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.4;RT4: 10.7;U-2 OS: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA076168 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA076168: AB_2686781" "unprognostic (2.68e-2)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (8.59e-2)" "unprognostic (2.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-2)" "unprognostic (3.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.48e-6)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.66e-2)" "unprognostic (8.23e-2)" 4.9 1.1 0.6 2.7 1.0 0.1 2.9 0.3 0.5 5.7 6.1 0.2 1.6 2.1 0.6 12.1 13.7 3.9 1.5 1.0 0.6 0.6 4.9 23.7 0.5 0.0 1.3 0.0 1.6 2.1 5.2 4.2 21.3 0.4 6.2 2.3 14.7 4.9 1.7 4.2 5.3 12.7 0.5 0.9 8.2 2.5 1.4 0.2 0.1 2.2 3.6 2.7 8.2 8.8 0.7 2.7 1.2 0.4 1.9 1.6 0.1 3.2 1.2 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.2 2.9 13.4 0.1 0.7 0.0 3.6 2.1 0.3 0.4 0.1 0.0 0.9 0.0 0.3 1.0 0.0 0.1 0.3 0.1 0.6 0.0 0.1 1.6 0.0 1.1 0.9 0.7 0.2 1.3 0.1 0.2 0.6 2.0 3.1 0.1 0.0 0.1 0.6 10.7 0.3 0.1 0.2 0.6 0.2 0.3 1.2 0.0 0.6 0.3 4.2 0.1 0.1 0.9 1.0 0.1 0.1 0.1 2.4 0.2 0.4 0.0 0.5 0.4 0.1 0.3 0.2 1.6 0.3 0.7 0.3 0.6 1.2 1.9 0.2 2.7 0.1 0.1 0.6 1.0 0.3 0.5 0.6 0.6 1.3 0.0 0.4 0.2 0.0 0.0 0.0 1.4 0.1 78.5 0.4 2.5 0.0 0.0 59.3 86.4 0.0 0.0 7.8 0.4 0.1 8.4 0.0 5.9 0.0 0.2 4.0 0.0 30.0 1.3 42.9 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 3.2 100.9 1.6 10.5 0.0 0.3 880.8 0.0 3.1 0.3 1.3 2.4 0.2 0.0 2.9 15.6 CNN2 ENSG00000064666 "Calponin 2" Q99439 19 1026581-1039068 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 231.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049095 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA 39000000 Cytosol "Nucleoplasm, Actin filaments" "HPA049095: AB_2680627" "unprognostic (2.52e-2)" "unprognostic (2.69e-1)" "unprognostic (1.74e-1)" "unprognostic (4.49e-2)" "unprognostic (3.89e-1)" "unprognostic (5.31e-2)" "unprognostic (1.33e-1)" "unprognostic (2.56e-1)" "unprognostic (4.58e-2)" "unprognostic (6.56e-2)" "unprognostic (3.60e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (4.70e-7)" "unprognostic (1.28e-2)" "unprognostic (1.87e-1)" "unprognostic (2.50e-1)" "unprognostic (1.54e-1)" 36.6 6.5 1.3 46.2 2.5 44.2 29.2 2.0 3.0 38.2 16.9 5.4 22.2 5.5 35.5 24.5 39.4 25.0 40.1 18.7 1.5 1.5 24.6 15.8 54.7 61.5 3.5 1.5 81.1 26.8 1.9 6.9 21.5 4.8 35.6 7.8 26.3 40.9 34.4 6.1 21.3 17.7 28.2 2.9 59.4 21.1 15.9 2.1 37.0 68.1 27.3 78.6 37.9 51.2 33.6 29.3 115.7 26.3 27.1 57.0 43.1 36.9 12.5 34.9 43.4 18.0 34.3 27.1 33.5 37.1 42.3 32.9 43.0 32.0 24.4 34.4 60.5 9.9 36.5 20.7 53.5 28.2 16.9 1.7 16.9 20.1 33.6 72.2 15.8 39.0 58.3 25.5 26.8 20.2 69.2 23.8 18.4 10.1 38.0 34.4 7.0 1.4 14.5 43.1 30.0 5.5 8.3 12.3 27.5 41.6 44.5 0.0 2.4 42.4 5.8 4.8 26.6 42.1 26.6 58.3 23.2 24.0 35.4 34.1 17.7 13.5 48.5 13.6 19.0 37.0 61.3 18.6 81.0 34.8 24.2 57.0 33.6 43.7 46.4 29.3 30.8 37.3 36.3 115.7 27.1 26.3 13.0 45.6 43.1 1.3 2.5 2.0 3.0 1.5 1.5 3.5 1.5 4.8 2.1 56.6 58.7 76.0 231.3 86.7 0.2 4.8 15.3 20.1 38.7 34.9 9.8 9.0 53.0 56.6 0.4 15.5 36.0 0.0 120.7 81.2 48.8 45.2 57.8 28.4 49.6 0.0 14.8 38.1 67.6 0.6 7.5 75.9 13.5 120.8 32.3 0.8 137.6 21.2 72.2 4.0 6.6 32.3 72.9 1.7 3.1 76.8 9.5 91.5 26.0 151.9 CNOT10 "FLJ12890, FLJ13165" ENSG00000182973 "CCR4-NOT transcription complex subunit 10" Q9H9A5 3 32685145-32773875 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 66.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035614, HPA041450" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA035614: AB_10669975, HPA041450: AB_2677487" "unprognostic (3.75e-1)" "unprognostic (4.57e-2)" "unprognostic (4.45e-3)" "unprognostic (6.01e-2)" "unprognostic (9.88e-2)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.88e-1)" "unprognostic (1.50e-1)" "unprognostic (5.09e-3)" "unprognostic (1.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.44e-2)" "unprognostic (1.84e-2)" "unprognostic (8.75e-3)" "unprognostic (3.43e-1)" 12.3 12.6 11.3 15.2 12.4 16.6 14.0 14.2 13.4 13.4 14.0 12.5 12.8 10.8 19.8 13.5 14.8 16.1 9.8 13.0 10.5 9.4 13.1 13.5 11.4 14.7 9.7 11.9 14.7 14.0 16.0 23.0 11.3 13.3 13.1 15.7 12.2 12.0 10.9 13.5 14.9 14.7 12.8 10.5 15.1 12.2 40.5 10.9 30.2 13.8 11.9 17.4 13.0 12.6 15.0 14.1 16.0 21.0 9.0 18.5 11.2 8.4 9.5 9.9 9.3 4.8 5.5 66.1 7.1 7.2 10.2 11.5 7.2 7.3 13.9 4.8 5.1 6.6 7.4 11.7 9.4 10.2 12.0 12.0 17.8 8.6 6.9 14.0 14.6 6.9 4.0 8.5 11.2 14.9 6.8 8.3 13.0 18.5 10.8 5.9 6.9 13.0 7.1 14.9 9.8 9.1 13.2 6.7 13.8 6.5 9.9 5.6 10.9 10.5 14.8 8.6 7.3 14.4 16.6 5.1 6.3 9.0 8.3 11.8 11.2 22.9 13.9 6.5 11.1 7.6 12.8 11.2 16.0 11.4 15.7 12.3 14.8 18.5 13.6 14.1 15.0 18.5 16.2 8.8 9.0 21.0 7.8 14.4 11.2 11.3 12.4 14.2 13.4 10.5 9.4 9.7 11.9 13.3 10.9 14.9 21.4 14.3 5.8 9.3 15.9 10.8 7.6 32.1 15.9 14.0 31.4 11.6 5.0 11.2 42.3 11.4 11.8 0.0 11.7 14.6 9.8 6.0 10.4 8.5 10.3 14.3 15.0 11.1 14.8 29.1 8.9 12.9 11.8 47.7 8.3 8.0 9.9 14.4 9.9 5.6 18.7 6.5 10.6 35.7 32.4 12.7 6.9 18.3 13.6 6.7 CNTD1 "CNTD, FLJ40137" ENSG00000176563 "Cyclin N-terminal domain containing 1" Q8N815 17 42798792-42811587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 31.0" "Group enriched" "Detected in many" 12 "Ciliated cells: 80.3;Early spermatids: 53.3;Late spermatids: 75.8;Spermatocytes: 135.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 6.3;ASC diff: 4.3;SiHa: 3.3;T-47d: 2.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA023324 Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA023324: AB_1848931" "unprognostic (5.92e-2)" "unprognostic (1.99e-3)" "unprognostic (3.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.25e-1)" "unprognostic (6.29e-3)" "unprognostic (6.61e-2)" "unprognostic (1.09e-2)" "unprognostic (7.82e-2)" "unprognostic (6.18e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (5.89e-7)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.81e-4)" 0.2 0.1 0.7 0.0 1.4 0.0 1.6 0.2 1.7 0.2 0.6 0.4 0.0 0.0 0.1 0.9 0.1 0.5 0.0 0.1 1.5 0.3 1.2 0.1 0.3 0.0 0.5 0.8 0.3 0.8 0.0 0.1 0.0 0.9 1.1 1.5 0.1 0.5 0.0 0.2 0.1 0.2 0.7 0.8 0.1 2.3 31.0 1.6 0.0 0.1 0.0 0.0 0.2 0.1 0.9 0.1 2.7 0.3 0.1 0.3 0.3 6.3 0.7 0.5 1.3 4.3 1.5 0.0 0.0 0.3 0.4 1.4 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.0 1.1 0.2 0.0 0.4 0.6 1.3 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.0 3.3 0.3 0.8 0.1 2.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.4 0.0 0.3 0.0 0.3 0.2 0.3 0.4 0.1 0.0 0.1 0.9 0.0 0.0 2.7 0.1 0.1 0.0 0.0 0.3 0.7 1.4 0.2 1.7 1.5 0.3 0.5 0.8 0.9 1.6 3.0 2.9 0.0 0.4 0.3 1.6 0.8 0.0 80.3 3.4 0.0 0.0 0.2 5.0 0.2 53.3 0.3 0.5 0.0 0.3 0.3 0.6 7.4 5.8 0.9 0.3 6.4 0.0 0.0 1.0 75.8 2.3 0.7 0.0 0.0 4.6 1.2 0.3 0.0 1.1 0.3 0.4 6.5 0.9 135.1 2.7 0.5 0.2 0.5 2.1 0.9 CNTLN "bA340N12.1, C9orf101, C9orf39, FLJ20276" ENSG00000044459 Centlein Q9NXG0 9 17134982-17503923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 58.9;Spermatogonia: 51.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.9" "Lineage enriched" "Detected in many" 4 "monocytes: 6.9" "Cell line enhanced" "Detected in many" "HEL: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007201, HPA036728, HPA036729" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240" "unprognostic (1.97e-2)" "unprognostic (2.81e-3)" "unprognostic (1.81e-1)" "unprognostic (2.48e-1)" "unprognostic (1.55e-1)" "unprognostic (1.60e-1)" "unprognostic (7.71e-2)" "unprognostic (1.68e-1)" "unprognostic (7.71e-3)" "unprognostic (5.07e-3)" "unprognostic (1.06e-1)" "unprognostic (6.65e-2)" "unprognostic (2.47e-1)" "unprognostic (5.38e-2)" "unprognostic (3.35e-2)" "unprognostic (1.37e-1)" "unprognostic (5.80e-2)" 13.2 5.6 4.3 5.2 5.1 12.5 7.4 15.5 4.5 16.6 8.6 4.2 6.7 2.2 22.6 6.0 6.0 8.0 7.4 4.9 4.2 3.8 5.0 20.0 5.4 4.8 4.9 2.6 15.2 3.6 10.0 13.2 6.1 6.3 9.8 4.0 7.0 3.8 6.3 5.9 3.5 4.4 11.9 8.1 8.6 4.4 8.2 6.8 4.4 5.5 5.8 2.8 11.7 13.5 0.3 1.5 0.8 6.9 1.2 0.2 0.5 5.9 4.1 9.0 5.1 4.5 10.5 0.3 7.0 4.7 5.2 7.2 0.3 2.0 4.3 1.1 4.8 5.7 0.3 10.4 2.9 8.2 0.2 3.7 25.5 8.7 1.5 4.9 3.5 5.6 6.6 1.5 4.4 4.3 4.9 7.4 1.6 0.9 1.0 8.3 0.5 2.8 5.6 7.0 1.0 7.7 4.2 8.3 2.1 3.0 1.5 5.7 5.9 8.5 0.2 2.2 3.7 1.7 8.9 5.4 7.2 2.8 7.8 6.0 3.6 4.3 0.1 3.4 4.4 3.2 0.6 2.7 0.1 0.1 3.3 0.0 0.3 0.2 0.1 1.5 0.3 0.1 0.1 0.8 1.2 6.9 1.5 0.2 0.5 4.3 5.1 15.5 4.5 4.2 3.8 4.9 2.6 6.3 6.8 6.0 14.5 0.8 12.1 7.8 9.1 10.6 5.1 2.7 2.3 8.7 0.0 1.5 5.0 7.5 13.2 20.3 1.3 23.3 10.4 4.0 13.6 3.2 7.0 35.9 15.7 19.1 2.4 19.6 34.5 6.5 42.3 18.3 8.5 26.2 2.6 25.0 4.2 0.0 29.0 6.3 8.4 12.9 15.0 58.9 51.1 4.8 0.8 3.2 3.0 3.5 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein like 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.4" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 5.6;Cardiomyocytes: 1.4;Distal tubular cells: 1.7;Horizontal cells: 1.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.3;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.4" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: AB_2686083, HPA069356: AB_2686127" "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.7 2.8 12.9 0.7 7.9 1.0 0.7 3.3 22.4 0.6 0.8 1.5 0.0 1.0 0.7 0.7 0.7 0.6 4.2 0.7 14.0 4.0 1.2 0.7 0.7 0.7 2.2 8.4 0.6 1.1 0.7 0.8 0.7 15.2 0.8 0.8 0.4 0.6 1.0 0.7 0.8 0.9 0.8 1.9 0.7 0.7 0.9 2.8 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.3 7.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 7.9 3.3 22.4 14.0 4.0 2.2 8.4 15.2 2.8 0.0 0.0 0.0 0.0 0.0 5.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 COA4 "CHCHD8, CMC3, E2IG2" ENSG00000181924 "Cytochrome c oxidase assembly factor 4 homolog" Q9NYJ1 11 73872667-73876988 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040126 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA040126: AB_10795415" "unprognostic (7.30e-2)" "unprognostic (8.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.64e-3)" "unprognostic (1.49e-1)" "unprognostic (2.22e-2)" "prognostic favorable (3.87e-4)" "unprognostic (1.31e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (8.17e-2)" 19.0 46.2 18.9 17.0 17.3 10.8 18.1 12.2 20.2 17.5 23.9 25.7 27.0 24.7 18.0 22.4 24.9 20.1 31.5 35.3 17.7 17.0 33.2 74.7 14.7 20.2 20.5 16.3 23.2 37.1 17.6 17.2 18.3 19.4 21.5 21.1 17.6 21.2 28.0 33.2 14.4 31.2 16.2 21.5 20.1 19.2 13.5 19.4 16.3 38.7 27.6 18.2 21.5 18.9 23.4 32.3 5.3 20.6 16.7 21.2 15.0 20.9 39.1 16.1 23.5 14.3 17.8 16.3 21.4 14.9 25.4 21.5 28.5 26.1 17.8 43.4 17.6 20.5 21.1 24.6 28.6 19.8 23.3 22.4 29.9 24.3 26.7 27.2 20.3 23.5 22.6 27.4 42.4 27.7 14.5 23.3 17.7 25.7 17.6 22.7 39.9 16.0 31.8 21.2 82.8 40.5 18.7 34.7 47.1 26.9 19.4 14.6 24.5 19.8 22.7 57.5 16.5 31.8 20.6 15.9 21.0 18.7 42.2 27.9 21.8 23.6 60.5 11.5 25.4 23.7 5.3 20.5 4.7 15.9 20.6 20.2 23.4 18.7 16.5 24.6 20.4 20.1 21.2 1.4 16.7 19.1 32.3 19.0 15.0 18.9 17.3 12.2 20.2 17.7 17.0 20.5 16.3 19.4 19.4 32.8 29.0 44.7 53.9 47.6 19.8 62.1 89.2 49.5 36.4 52.4 21.6 140.3 109.5 72.0 22.0 43.6 113.7 46.7 82.4 84.7 46.3 77.6 61.1 154.9 85.2 17.5 69.7 28.8 37.8 8.2 50.9 50.0 27.0 51.3 90.6 41.3 87.3 73.7 36.0 190.6 16.4 6.5 34.3 51.0 36.1 44.8 102.3 34.8 108.4 86.3 COMMD9 "FLJ31106, HSPC166" ENSG00000110442 "COMM domain containing 9" Q9P000 11 36269284-36289449 "Predicted intracellular proteins" "Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009142 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA009142: AB_1847105" "unprognostic (1.56e-2)" "unprognostic (4.75e-3)" "unprognostic (7.57e-2)" "unprognostic (4.40e-3)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-3)" "unprognostic (2.62e-1)" "unprognostic (6.15e-2)" "prognostic favorable (8.54e-4)" "unprognostic (4.94e-2)" "unprognostic (2.40e-1)" "unprognostic (6.08e-3)" "unprognostic (7.24e-2)" "unprognostic (1.71e-1)" "unprognostic (7.31e-3)" "unprognostic (1.88e-1)" 26.9 25.4 28.0 15.8 25.4 32.6 18.5 18.1 36.9 14.3 15.0 26.5 9.5 16.2 12.4 20.4 18.4 16.2 15.8 23.1 25.4 25.7 34.5 28.0 20.4 24.8 27.7 23.8 15.8 23.3 19.4 18.9 18.9 22.8 12.6 19.1 16.0 16.7 11.1 43.6 19.6 16.4 17.0 28.4 26.0 14.8 14.6 17.2 24.7 19.8 21.1 23.6 16.6 12.2 22.5 66.3 28.8 66.2 14.8 18.9 46.4 10.8 13.0 14.3 15.0 22.1 15.5 7.9 13.0 16.9 29.7 28.0 10.5 9.3 12.6 13.0 25.9 23.0 16.1 25.1 17.5 28.1 15.1 29.5 6.9 24.3 18.3 20.8 26.9 20.8 19.5 19.7 16.2 10.0 15.4 24.3 17.0 17.0 13.6 23.3 14.0 17.9 18.7 15.2 21.4 27.6 19.8 32.4 14.9 30.9 10.2 17.5 19.6 18.6 18.5 16.6 12.2 40.4 10.3 16.2 18.0 13.8 42.7 19.0 9.6 19.5 14.2 20.7 25.4 17.2 12.2 66.2 28.8 16.8 59.6 15.7 21.8 16.2 16.1 66.3 22.5 18.7 15.7 7.4 14.8 47.5 25.0 18.9 46.4 28.0 25.4 18.1 36.9 25.4 25.7 27.7 23.8 22.8 17.2 20.8 21.9 17.1 14.2 13.6 18.7 25.5 10.2 6.7 7.9 17.4 9.8 36.2 66.3 59.6 7.5 21.8 19.7 0.0 40.5 47.0 19.1 4.8 18.5 15.5 95.4 4.8 24.6 15.4 46.2 23.1 16.4 57.6 23.6 52.3 18.1 27.7 40.4 17.5 11.0 51.2 20.1 12.9 11.8 28.8 29.3 18.9 20.8 27.7 23.0 8.8 COPA HEP-COP ENSG00000122218 "Coatomer protein complex subunit alpha" P53621 1 160289273-160343400 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" Hormone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028024 Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA NA 260000 "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA028024: AB_10603787" "unprognostic (1.59e-2)" "prognostic unfavorable (6.54e-4)" "unprognostic (2.77e-2)" "unprognostic (2.34e-2)" "unprognostic (3.54e-2)" "unprognostic (5.41e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.42e-2)" "unprognostic (3.14e-1)" "unprognostic (2.21e-1)" "unprognostic (5.03e-2)" "unprognostic (3.10e-1)" "unprognostic (2.05e-2)" "unprognostic (8.70e-2)" "unprognostic (2.03e-1)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" 38.3 32.7 29.2 28.9 41.0 22.9 32.4 43.1 48.4 46.3 34.3 53.2 24.5 38.4 37.0 33.1 28.4 31.5 28.6 38.4 33.3 35.2 36.3 64.3 33.8 26.6 42.7 29.3 36.8 47.8 49.1 57.4 45.1 56.2 35.3 39.9 28.8 42.1 33.9 40.5 28.7 50.3 40.4 42.8 36.6 32.8 21.2 35.8 36.0 42.8 21.0 34.1 30.3 27.5 15.4 31.4 25.1 29.1 18.1 21.2 25.3 28.2 22.2 23.6 22.9 60.8 50.1 27.7 38.9 46.3 33.2 39.2 28.9 19.3 20.8 25.3 59.1 19.1 28.5 27.2 28.0 38.3 23.6 18.4 23.9 30.6 30.4 45.7 29.1 25.1 46.8 17.1 44.3 41.3 41.1 38.9 19.9 22.1 23.3 39.6 20.7 18.7 12.6 25.8 37.2 26.0 16.8 27.1 32.0 27.2 26.8 19.6 24.8 44.0 38.7 41.1 41.4 43.1 39.3 45.8 25.0 19.5 33.5 25.5 38.4 26.6 32.1 32.6 15.2 37.2 25.1 29.1 20.1 17.1 27.3 21.2 15.4 14.3 18.3 31.4 12.1 13.2 15.2 10.8 18.1 27.9 13.3 17.5 25.3 29.2 41.0 43.1 48.4 33.3 35.2 42.7 29.3 56.2 35.8 71.5 41.2 52.3 29.9 25.0 49.9 41.1 48.4 53.5 42.1 38.4 76.6 33.9 11.6 44.6 11.0 42.1 70.4 0.0 43.3 55.4 50.4 56.4 43.9 64.8 46.0 42.9 53.2 53.4 85.0 4.5 65.9 62.1 25.3 31.5 79.0 38.2 46.4 45.6 53.4 38.5 48.0 38.8 52.3 37.9 23.8 27.9 57.9 41.5 60.4 44.0 COPG1 COPG ENSG00000181789 "Coatomer protein complex subunit gamma 1" Q9Y678 3 129249606-129277773 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037866, HPA037867, HPA045712" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No 110000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428" "unprognostic (8.86e-2)" "unprognostic (2.22e-2)" "unprognostic (4.22e-3)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (1.22e-6)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-3)" "unprognostic (3.29e-1)" "unprognostic (1.23e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (2.99e-1)" "unprognostic (1.60e-1)" 25.2 39.4 21.1 22.2 28.0 20.1 37.3 23.6 50.3 43.3 42.1 24.3 50.6 34.2 27.6 66.5 29.5 24.4 34.5 33.4 24.2 26.7 32.4 72.1 36.5 39.4 23.0 21.6 28.6 75.6 47.6 49.7 49.3 34.9 45.1 45.1 22.4 59.9 45.5 24.1 24.3 32.4 29.1 20.7 29.0 36.3 23.6 16.2 26.9 33.0 22.0 27.7 19.9 24.1 15.7 31.9 34.9 33.0 31.1 31.8 26.0 32.7 16.7 24.4 21.1 57.2 46.4 26.0 53.5 51.1 36.9 46.7 30.6 20.4 18.0 31.2 75.9 30.0 19.8 20.1 31.5 40.2 21.9 8.3 29.9 22.1 49.4 52.1 22.6 32.2 48.4 27.8 29.5 48.7 40.6 33.2 13.9 10.4 43.6 44.4 49.8 13.2 23.1 14.5 48.1 20.5 14.4 22.9 34.8 46.0 27.3 15.2 17.8 41.1 30.7 49.0 28.0 34.0 33.1 44.8 20.1 19.1 42.4 20.6 34.1 16.2 31.6 49.1 17.3 38.5 34.9 26.8 20.2 26.2 33.0 31.8 15.0 23.7 25.7 31.9 15.7 18.5 21.6 21.3 31.1 29.7 29.4 23.6 26.0 21.1 28.0 23.6 50.3 24.2 26.7 23.0 21.6 34.9 16.2 14.9 29.8 27.4 13.9 7.8 8.7 19.3 17.8 16.0 18.2 26.2 3.9 52.4 36.5 39.6 7.8 19.4 69.2 46.7 40.7 53.3 25.8 24.8 14.0 53.3 34.3 4.8 37.1 35.6 31.0 3.1 38.0 19.0 21.9 44.1 67.9 14.2 35.7 37.4 29.4 28.8 7.5 19.4 17.3 21.1 16.4 8.9 60.4 20.1 38.2 17.5 COPRS "C17orf79, COPR5, HSA272196, TTP1" ENSG00000172301 "Coordinator of PRMT5 and differentiation stimulator" Q9NQ92 17 31851864-31859337 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 410.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA052552 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA052552: AB_2681868" "unprognostic (1.65e-2)" "unprognostic (4.88e-2)" "unprognostic (2.46e-1)" "unprognostic (4.01e-3)" "unprognostic (3.12e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (3.69e-4)" "unprognostic (6.88e-2)" "unprognostic (3.10e-1)" "unprognostic (4.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.01e-2)" "unprognostic (1.19e-3)" "unprognostic (1.02e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (3.11e-2)" 20.9 19.0 32.6 9.7 31.0 6.3 30.3 23.0 37.6 15.3 24.2 11.8 15.6 8.0 15.2 57.3 10.5 24.9 14.9 24.7 28.2 35.5 22.7 31.0 12.3 9.2 29.7 31.3 24.3 20.7 12.2 18.9 9.4 23.9 27.5 13.6 16.0 14.6 23.5 19.9 7.8 7.9 21.2 16.0 8.1 14.1 75.0 14.4 2.6 28.1 11.2 12.7 16.1 18.5 5.8 4.5 3.5 3.5 0.0 3.0 0.4 21.0 27.8 14.0 14.3 22.9 22.1 9.8 23.7 29.8 27.2 27.8 17.4 5.7 12.0 13.3 28.3 53.7 12.7 24.6 14.2 30.9 4.1 36.9 3.3 16.0 20.4 23.4 11.2 9.6 14.1 18.7 36.6 20.1 29.7 14.5 16.1 16.3 10.0 29.6 18.3 16.6 35.6 10.6 13.7 14.0 13.3 26.0 21.7 15.9 13.1 12.6 9.8 14.0 6.8 21.6 12.7 22.3 12.0 8.1 71.6 19.4 25.5 32.8 17.1 15.9 12.1 37.4 10.4 9.6 3.5 3.5 0.0 1.1 3.3 3.0 3.8 1.1 0.2 4.5 5.8 0.6 0.7 1.2 0.0 1.6 1.8 1.5 0.4 32.6 31.0 23.0 37.6 28.2 35.5 29.7 31.3 23.9 14.4 20.8 8.8 21.9 52.7 30.6 43.8 64.8 45.9 28.1 9.1 82.0 9.8 25.3 190.6 93.7 161.6 50.8 5.1 0.0 70.1 45.2 52.1 108.4 3.5 85.5 75.8 25.4 18.9 44.2 26.0 212.9 57.8 35.0 55.6 70.3 14.8 79.2 64.6 3.5 61.2 173.3 30.2 19.4 62.1 410.0 65.8 27.7 22.9 10.1 19.7 32.5 CORO7-PAM16 ENSG00000103426 "CORO7-PAM16 readthrough" 16 4340251-4420494 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Ciliated cells: 1.4;Club cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;HDLM-2: 2.4;THP-1: 1.9;TIME: 1.5" "HPA041657, HPA053586, HPA062721" Uncertain Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA041657: AB_10796351, HPA053586: AB_2682201, HPA062721: AB_2684849" "unprognostic (2.95e-2)" "unprognostic (2.46e-1)" "unprognostic (1.44e-1)" "unprognostic (2.46e-1)" "unprognostic (2.11e-1)" "unprognostic (1.24e-2)" "unprognostic (2.11e-4)" "unprognostic (4.39e-2)" "unprognostic (9.83e-3)" "unprognostic (1.20e-1)" "unprognostic (8.75e-3)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.59e-2)" "unprognostic (2.19e-1)" "unprognostic (3.85e-1)" 2.4 3.4 5.4 5.2 7.4 6.7 2.0 3.0 6.0 2.0 2.5 10.0 0.6 3.2 2.2 2.4 2.2 2.9 3.1 2.2 4.8 4.1 2.0 2.9 3.4 11.2 10.9 3.2 2.0 2.0 2.0 1.7 2.4 4.1 2.2 2.0 1.1 2.0 3.0 2.4 3.1 2.5 2.2 10.1 4.5 2.5 4.3 9.9 4.7 2.0 1.2 4.1 2.8 1.8 0.4 0.6 2.7 1.3 0.5 0.8 1.3 0.0 0.0 0.0 0.4 0.0 0.3 0.8 0.2 0.4 0.0 0.0 1.7 0.3 0.0 0.2 0.0 0.3 0.9 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.7 0.0 0.5 0.0 0.2 1.4 0.2 0.7 0.7 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.2 0.0 1.9 1.5 0.0 0.0 0.6 0.1 0.6 1.2 0.1 0.0 0.1 0.0 0.0 1.3 0.9 0.8 0.7 0.7 0.3 0.4 0.3 0.6 0.4 0.3 0.3 2.7 0.5 0.4 0.3 0.3 1.3 5.4 7.4 3.0 6.0 4.8 4.1 10.9 3.2 4.1 9.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COX6B2 "COXVIB2, CT59, FLJ32865" ENSG00000160471 "Cytochrome c oxidase subunit 6B2" Q6YFQ2 19 55349306-55354814 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 66.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 23.6;Late spermatids: 19.1;Spermatocytes: 77.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 22.6;SCLC-21H: 9.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA035014 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA035014: AB_10601261" "unprognostic (7.43e-3)" "unprognostic (8.72e-2)" "unprognostic (1.42e-1)" "unprognostic (5.75e-2)" "unprognostic (2.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (6.82e-2)" "prognostic unfavorable (9.70e-5)" "unprognostic (8.11e-2)" "unprognostic (1.81e-6)" "unprognostic (9.91e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-2)" "unprognostic (2.02e-1)" 0.3 0.0 0.4 0.6 0.6 0.7 0.5 0.3 0.6 0.2 3.3 0.2 0.2 0.0 0.2 0.8 0.5 0.4 0.2 0.2 0.2 0.5 0.5 0.2 0.2 0.6 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.6 0.2 3.5 0.7 0.6 0.2 0.2 1.8 0.2 0.2 0.7 0.2 0.0 66.5 0.3 0.2 0.2 0.2 1.2 0.2 0.4 1.3 1.4 5.7 1.0 1.6 0.9 0.8 2.7 0.4 0.1 0.1 0.0 0.0 0.2 0.4 0.1 0.3 0.5 0.1 22.6 0.1 0.2 0.2 0.3 1.8 0.7 0.2 0.2 0.8 0.7 0.0 1.7 0.1 0.3 0.2 1.8 0.2 2.5 0.4 0.5 1.7 0.0 0.1 0.4 0.2 0.0 0.5 0.1 0.2 0.6 2.3 0.5 0.1 0.0 0.2 0.0 0.4 9.7 0.3 0.3 0.1 0.0 0.6 0.4 0.0 0.4 0.3 0.5 0.1 0.2 1.5 1.2 0.1 0.1 0.3 0.2 1.9 1.0 1.0 0.8 0.5 0.5 0.7 0.7 0.6 0.3 1.3 0.7 0.9 5.7 1.6 0.7 1.4 0.6 0.8 0.4 0.6 0.3 0.6 0.2 0.5 0.4 0.2 0.6 0.3 0.0 0.3 0.0 0.6 0.5 2.1 0.4 0.0 0.0 0.0 0.0 3.9 0.5 0.0 0.6 23.6 0.0 3.2 0.0 0.6 0.2 0.4 0.2 0.0 0.0 0.1 3.2 1.2 0.0 0.0 19.1 0.6 0.0 0.0 0.0 1.3 0.9 5.6 3.5 0.0 0.0 4.1 0.0 0.0 77.8 1.3 0.4 0.3 0.0 4.4 2.5 CPA4 CPA3 ENSG00000128510 "Carboxypeptidase A4" Q9UI42 7 130293134-130324180 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.0;skin 1: 41.0" "Cell type enhanced" "Detected in some" 18 "Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0" "Cancer enhanced" "Detected in many" "cervical cancer: 10.0;head and neck cancer: 9.8" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0" "Low region specificity" "Detected in single" HPA021030 Approved Nucleoplasm,Centrosome,Cytosol "Secreted in other tissues" NA Yes 480000 Nucleoplasm "Centrosome, Cytosol" "HPA021030: AB_1846010" "unprognostic (7.60e-3)" "unprognostic (4.00e-2)" "unprognostic (1.59e-3)" "unprognostic (3.63e-3)" "unprognostic (2.24e-2)" "unprognostic (2.91e-2)" "unprognostic (2.78e-2)" "unprognostic (4.36e-3)" "unprognostic (3.23e-1)" "unprognostic (5.79e-2)" "unprognostic (2.37e-3)" "unprognostic (6.49e-2)" "unprognostic (6.21e-10)" "unprognostic (2.39e-1)" "unprognostic (1.67e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (1.31e-4)" 2.7 2.3 0.1 0.4 0.4 0.2 2.8 0.1 0.4 8.1 1.1 0.3 0.1 0.1 1.1 1.2 18.0 0.2 0.2 4.4 0.1 1.2 1.2 0.2 0.8 0.3 0.1 0.1 1.8 6.9 0.1 1.1 8.8 0.9 0.3 0.1 0.6 4.4 0.1 0.3 41.0 0.5 0.7 0.7 1.7 0.2 2.2 0.1 0.8 0.1 12.3 2.3 1.7 6.7 0.4 0.4 1.6 0.4 1.5 0.4 0.1 19.4 1.0 0.0 0.0 0.1 0.3 0.0 15.6 29.6 15.9 3.9 0.1 1.7 0.0 3.0 6.6 16.1 1.1 0.0 8.6 16.5 0.0 0.0 0.0 6.3 0.4 0.4 0.0 0.0 0.2 13.9 1.4 2.0 55.9 0.0 0.0 0.0 0.0 60.1 0.0 0.0 0.0 0.1 0.1 2.3 0.0 16.1 0.0 7.5 0.8 0.0 0.0 10.3 4.9 0.1 6.3 0.1 0.0 11.9 3.9 32.8 1.3 1.5 0.0 0.0 0.0 59.0 0.0 0.1 1.0 0.4 0.4 0.4 0.1 0.2 0.3 0.2 0.3 0.0 0.4 0.3 0.3 1.6 1.5 0.2 0.4 0.3 0.1 0.1 0.4 0.1 0.3 0.1 1.2 0.1 0.1 0.9 0.1 3.0 0.3 0.0 0.5 15.8 0.0 0.3 0.0 2.7 2.3 0.0 0.0 3.7 0.0 0.5 0.3 0.1 0.0 0.0 45.1 1.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 27.0 7.9 0.0 0.0 0.9 CPD GP180 ENSG00000108582 "Carboxypeptidase D" O75976 17 30378905-30469989 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 178.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052796, HPA055465" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear speckles" NA NA 930000 "Nucleoplasm, Nuclear speckles" "Nuclear membrane" "HPA052796: AB_2681953, HPA055465: AB_2682823" "unprognostic (1.05e-1)" "unprognostic (1.31e-1)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (6.13e-2)" "unprognostic (1.65e-1)" "unprognostic (7.97e-3)" "unprognostic (4.45e-2)" "unprognostic (2.07e-2)" "unprognostic (2.96e-1)" "unprognostic (1.62e-1)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.25e-2)" "unprognostic (3.36e-1)" "unprognostic (1.08e-1)" 16.4 8.0 9.8 12.3 12.4 18.1 17.9 9.1 13.3 28.6 16.2 18.5 10.1 12.9 12.6 10.1 10.0 15.2 33.6 10.5 12.8 10.4 13.4 26.8 20.0 14.2 22.1 11.4 7.8 14.7 21.2 14.9 22.3 13.9 11.4 13.3 7.5 59.7 7.9 10.0 7.8 22.0 15.1 25.9 7.9 24.6 25.0 13.5 5.8 37.2 7.7 10.0 11.5 11.6 0.4 3.4 19.3 5.5 2.1 3.8 2.5 12.2 18.7 16.2 16.7 16.9 32.2 5.8 16.9 24.8 11.7 14.5 21.9 7.9 1.5 21.6 19.4 14.9 8.8 10.5 21.4 19.9 5.8 15.0 3.5 11.5 13.5 20.6 22.7 9.2 57.4 9.6 15.0 14.6 19.6 23.8 5.3 6.7 18.1 9.4 2.4 7.3 6.2 4.5 28.2 4.3 7.0 18.8 4.7 22.0 14.0 4.1 10.3 20.2 17.5 8.8 19.8 16.5 15.8 28.3 11.7 7.7 18.2 16.1 7.3 15.2 5.2 15.0 14.9 9.9 2.8 5.5 6.4 3.4 2.8 3.8 0.2 1.7 2.8 3.4 0.4 1.4 1.7 19.3 2.1 2.3 0.4 1.1 2.5 9.8 12.4 9.1 13.3 12.8 10.4 22.1 11.4 13.9 13.5 29.8 19.2 7.5 28.1 19.6 23.1 10.4 178.3 18.7 27.3 27.9 43.2 20.5 1.7 21.2 75.9 48.4 31.6 0.0 21.4 9.1 26.2 58.6 24.2 67.2 14.9 44.5 31.0 51.0 34.9 41.5 15.5 20.5 28.7 10.0 69.1 11.1 30.2 20.1 15.2 17.7 35.0 0.0 22.6 15.6 24.2 16.3 20.1 20.8 31.5 38.6 CPE ENSG00000109472 "Carboxypeptidase E" P16870 4 165361194-165498320 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 203.7" "Group enriched" "Detected in many" 4 "Bipolar cells: 533.2;Cone photoreceptor cells: 585.1;Glandular cells: 402.2;Intestinal endocrine cells: 564.2;Leydig cells: 463.7;Muller glia cells: 511.1;Peritubular cells: 583.8;Rod photoreceptor cells: 443.0;Sertoli cells: 840.8;Smooth muscle cells: 614.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Cell line enhanced" "Detected in many" "Hep G2: 49.0;SCLC-21H: 69.0;SiHa: 101.3;SuSa: 59.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003819, CAB024907" Supported Approved Nucleoplasm,Vesicles,Centrosome "Intracellular and membrane" NA NA 470000 Centrosome "Nucleoplasm, Vesicles" "CAB024907: , HPA003819: AB_2667054" "unprognostic (1.84e-1)" "unprognostic (5.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-2)" "unprognostic (2.51e-1)" "unprognostic (1.44e-2)" "unprognostic (1.65e-1)" "unprognostic (9.52e-2)" "unprognostic (2.91e-3)" "unprognostic (9.01e-2)" "unprognostic (4.84e-3)" "unprognostic (5.56e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (4.35e-3)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" "prognostic unfavorable (2.12e-4)" 27.7 33.8 123.1 4.4 135.5 0.9 21.5 82.9 203.7 10.7 9.6 31.6 5.3 5.0 13.3 94.3 16.4 15.7 14.0 19.6 116.9 56.3 12.0 6.3 11.0 7.6 56.9 70.7 23.4 35.5 33.9 40.0 2.2 53.0 66.5 8.8 13.2 12.0 20.1 11.0 5.5 6.2 18.5 40.5 2.8 19.2 30.4 53.3 0.9 40.7 4.3 7.7 6.3 9.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 8.9 1.7 7.1 0.7 0.4 0.0 3.6 1.3 2.9 0.0 0.0 0.0 2.6 0.0 0.3 0.2 3.4 0.7 0.7 0.0 13.0 0.0 3.6 49.0 0.5 0.0 0.0 17.3 3.6 0.0 0.0 17.2 0.0 0.0 0.0 0.3 1.8 2.4 0.0 0.4 5.6 0.0 2.0 0.0 0.0 0.1 0.1 0.5 69.0 22.8 101.3 12.7 0.0 59.1 7.6 0.3 0.0 2.7 7.0 0.2 0.2 3.9 0.0 0.3 2.6 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 123.1 135.5 82.9 82.2 116.9 56.3 56.9 70.7 53.0 53.3 0.0 9.3 0.0 67.8 23.2 533.2 32.3 40.8 0.0 3.4 21.0 585.1 0.4 0.0 15.1 5.5 57.1 1.6 0.0 1.5 0.1 129.4 402.2 0.0 7.9 0.8 66.7 564.2 115.4 9.2 11.5 463.7 12.5 82.7 1.8 12.7 511.1 19.3 2.9 583.8 9.6 443.0 840.8 614.9 17.7 9.6 18.2 0.7 1.9 3.7 11.3 CPEB4 KIAA1673 ENSG00000113742 "Cytoplasmic polyadenylation element binding protein 4" Q17RY0 5 173888280-173961976 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.1" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 9.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.6" "Cell line enhanced" "Detected in many" "U-266/70: 39.1;U-266/84: 56.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038394 Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA038394: AB_10671226" "unprognostic (2.12e-1)" "unprognostic (3.05e-1)" "unprognostic (1.12e-1)" "unprognostic (3.99e-1)" "unprognostic (8.80e-2)" "unprognostic (2.91e-1)" "unprognostic (4.58e-1)" "unprognostic (8.75e-2)" "unprognostic (2.54e-1)" "unprognostic (9.37e-3)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "prognostic favorable (4.99e-8)" "unprognostic (2.66e-1)" "unprognostic (4.73e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" 11.9 42.2 25.9 10.3 21.0 39.7 11.5 29.7 30.9 11.3 7.5 10.5 9.8 8.1 8.6 6.0 18.6 6.4 12.1 26.4 22.3 14.7 30.3 44.6 12.5 6.9 15.1 20.7 6.6 21.1 45.7 20.5 17.8 33.3 7.7 8.0 14.4 17.3 13.5 106.1 10.8 8.8 12.5 38.4 9.7 11.3 8.4 18.9 1.5 20.0 16.9 9.3 11.6 15.8 1.6 0.8 9.6 2.3 0.8 1.3 0.6 4.0 5.5 2.7 1.5 5.0 2.9 5.5 7.2 6.7 2.5 3.0 5.2 2.7 5.0 5.2 4.0 8.0 0.3 2.4 3.8 4.1 10.0 2.8 3.3 13.3 3.0 10.7 1.1 6.6 4.5 8.7 6.5 10.0 11.3 2.4 1.8 10.9 12.3 5.7 2.9 0.9 1.0 1.5 1.7 5.5 0.9 2.2 16.6 3.6 7.3 3.1 3.5 0.8 10.1 13.0 4.9 7.0 2.3 7.1 4.1 2.0 2.0 4.6 39.1 56.1 2.6 10.1 2.3 5.2 0.5 1.8 2.0 1.0 1.7 1.0 1.6 1.1 0.8 0.6 1.2 1.3 0.7 9.6 0.8 2.3 0.8 1.0 0.6 25.9 21.0 29.7 30.9 22.3 14.7 15.1 20.7 33.3 18.9 71.5 29.3 27.4 12.7 37.7 148.4 204.8 101.9 49.5 43.3 50.6 127.6 9.5 19.9 29.9 46.6 42.1 41.8 303.7 22.7 4.8 24.4 44.9 87.8 135.7 55.5 138.2 60.1 69.3 106.0 36.0 8.1 47.3 70.9 28.9 21.7 91.5 33.7 35.1 20.1 36.6 121.5 0.0 63.5 43.8 7.5 44.8 51.8 22.9 14.9 35.9 CPNE2 CPN2 ENSG00000140848 "Copine 2" Q96FN4 16 57092537-57148367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.6" "Cell type enhanced" "Detected in many" 8 "Ito cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041132 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA041132: AB_2677316" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.93e-3)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (9.14e-2)" "unprognostic (2.10e-3)" "unprognostic (8.78e-3)" "unprognostic (2.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.53e-3)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" 14.1 3.9 8.4 4.6 15.1 22.8 11.4 7.9 15.4 16.4 12.0 40.6 1.1 2.0 8.8 3.1 6.4 12.0 5.6 5.9 10.6 11.6 4.8 4.3 15.5 8.2 20.8 9.8 5.1 3.3 3.7 4.9 11.5 12.9 5.1 11.9 4.6 3.7 7.4 4.9 4.0 6.6 10.5 13.5 6.0 3.7 15.3 20.1 0.2 5.8 2.2 3.2 6.4 8.3 0.0 2.1 4.0 4.2 0.5 1.2 0.9 8.4 16.3 25.2 13.9 4.5 4.4 4.2 9.2 14.6 21.1 14.8 4.5 9.8 5.0 8.5 13.9 11.7 13.3 9.9 5.5 11.5 6.2 5.8 2.1 6.5 3.8 8.2 1.7 0.2 4.2 6.2 8.2 4.0 15.8 31.0 2.8 5.6 0.1 5.3 3.9 2.5 24.7 5.7 4.1 3.5 31.5 7.9 4.2 14.0 3.2 0.5 10.2 11.7 2.5 7.0 11.9 2.7 33.7 21.8 19.3 10.5 4.8 11.9 1.2 1.0 11.3 12.5 7.4 13.5 0.0 4.2 1.9 0.7 1.2 0.7 0.0 0.4 1.2 2.1 0.0 0.3 0.6 4.0 0.5 0.4 0.1 0.5 0.9 8.4 15.1 7.9 15.4 10.6 11.6 20.8 9.8 12.9 20.1 17.9 6.1 2.9 13.5 2.1 0.0 2.2 2.5 1.4 2.3 5.2 0.0 0.6 5.0 3.9 14.0 20.4 28.0 0.0 3.4 2.1 10.4 9.0 0.0 1.6 20.0 0.0 3.5 72.4 21.2 4.7 6.4 6.9 6.8 3.6 15.7 3.3 5.9 21.0 7.1 1.6 0.0 32.3 14.4 0.5 1.7 3.8 0.7 4.4 15.9 9.9 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 64.6;Hepatocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoplasm, Mitochondria" Nucleoli "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favorable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.7 3.2 7.5 7.3 6.5 3.8 8.5 4.8 4.9 6.9 6.4 1.6 6.5 13.2 7.3 2.2 7.8 7.7 14.0 11.0 5.9 7.3 8.2 7.5 4.3 1.3 9.5 7.1 7.3 8.2 9.4 5.0 4.2 7.7 4.7 11.7 9.6 4.7 4.2 4.5 5.5 5.8 14.0 14.4 8.6 6.4 7.2 13.9 8.6 7.2 11.2 7.6 9.6 12.2 18.1 18.1 14.2 15.2 4.5 3.9 3.1 6.8 3.9 14.5 8.9 8.1 5.0 8.2 5.7 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 11.9 20.8 8.9 5.1 1.5 3.1 12.4 15.3 4.0 3.4 10.4 13.7 64.6 21.6 10.7 1.1 3.6 39.8 0.0 9.3 16.0 2.8 4.8 2.3 80.0 23.6 14.3 13.9 6.7 13.5 2.1 6.4 8.2 6.8 26.2 26.9 10.5 9.8 21.0 4.9 28.3 9.9 6.5 3.2 29.8 16.3 2.3 45.7 7.1 25.3 4.6 CRAMP1 "CRAMP1L, KIAA1426" ENSG00000007545 "Cramped chromatin regulator homolog 1" Q96RY5 16 1612325-1677908 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041752 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA041752: AB_10796459" "unprognostic (3.67e-1)" "unprognostic (9.97e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.41e-2)" "unprognostic (2.25e-3)" "unprognostic (5.78e-4)" "unprognostic (4.17e-2)" "unprognostic (8.53e-3)" "unprognostic (6.01e-2)" "unprognostic (1.55e-2)" "unprognostic (9.93e-2)" "unprognostic (3.86e-3)" "prognostic favorable (4.93e-4)" "unprognostic (8.57e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" 8.5 6.4 9.2 10.5 9.3 13.9 11.6 24.2 11.0 8.4 8.8 11.1 5.1 7.2 11.4 8.3 8.6 9.9 6.5 7.2 8.6 5.4 6.5 4.7 9.2 8.0 9.7 10.5 12.3 9.2 10.2 10.9 8.4 9.4 9.8 7.1 9.8 8.4 9.5 8.9 13.7 8.4 8.8 7.9 9.4 8.5 21.9 9.8 18.1 11.8 4.4 7.5 10.6 11.7 0.8 2.1 0.5 0.6 2.5 1.9 0.5 5.3 8.7 11.0 10.4 7.4 7.4 12.8 6.2 5.5 8.5 6.1 8.0 9.1 5.3 6.0 7.1 5.1 9.0 13.2 6.4 7.8 6.4 13.7 8.4 10.0 4.9 5.4 11.8 13.6 6.4 8.7 10.1 8.2 8.1 8.4 12.0 11.2 4.2 4.6 8.8 7.8 7.3 8.8 3.5 5.4 30.3 5.2 9.3 5.6 5.4 11.5 8.2 9.3 7.7 4.9 8.2 6.2 16.4 9.5 8.1 7.9 6.9 7.9 7.1 10.2 13.6 2.8 7.9 7.2 0.4 0.6 0.0 1.9 0.6 0.9 0.8 0.6 0.6 0.3 0.8 0.9 0.9 0.5 2.5 0.2 2.1 0.3 0.5 9.2 9.3 24.2 11.0 8.6 5.4 9.7 10.5 9.4 9.8 14.9 13.4 0.0 4.3 0.0 7.3 0.0 7.6 5.3 15.9 8.7 17.7 3.5 1.7 4.1 21.2 4.3 3.9 0.0 1.6 2.5 3.3 6.1 4.7 3.4 4.4 3.2 2.4 8.6 6.5 7.6 4.0 2.8 0.0 1.8 8.7 4.5 5.3 3.5 6.3 1.4 17.5 6.5 0.0 13.5 19.0 0.0 4.5 6.4 6.4 4.2 CREB3L4 "AIbZIP, ATCE1, CREB3, CREB4, hJAL" ENSG00000143578 "CAMP responsive element binding protein 3 like 4" Q8TEY5 1 153967534-153974363 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 49.9" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 54.0;Mucus-secreting cells: 48.0" "Group enriched" "Detected in all" 5 "breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 24.9;OE19: 25.3;SK-BR-3: 55.0;T-47d: 44.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038122 Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" No No "Nucleoplasm, Nuclear membrane" Mitochondria "HPA038122: AB_10669516" "unprognostic (1.35e-1)" "unprognostic (4.71e-2)" "unprognostic (8.13e-3)" "prognostic favorable (7.21e-4)" "unprognostic (2.04e-1)" "unprognostic (1.40e-2)" "unprognostic (5.51e-3)" "unprognostic (5.02e-2)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-1)" "unprognostic (7.12e-3)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-2)" "unprognostic (9.34e-3)" 4.3 5.0 3.2 5.4 4.0 2.9 22.6 5.7 3.5 14.6 5.1 4.3 18.3 5.0 8.5 12.1 5.1 8.8 7.9 3.2 2.5 1.4 4.5 8.4 4.7 5.5 3.2 3.0 9.3 7.9 3.7 3.4 6.6 4.0 49.9 6.9 4.7 24.7 11.4 6.1 5.9 5.3 3.4 3.3 4.5 13.2 4.3 3.0 12.9 12.5 6.6 8.3 4.5 15.1 6.6 7.3 2.6 3.5 10.9 6.0 3.1 2.3 3.3 3.1 3.4 2.2 3.3 7.8 1.9 2.2 2.6 2.3 1.5 9.7 4.2 10.1 0.8 2.0 3.7 4.6 3.0 1.4 3.4 1.8 3.1 3.6 2.7 1.8 1.4 2.7 3.5 2.9 2.5 5.7 2.4 2.3 5.1 2.4 5.3 1.2 24.9 2.7 1.1 2.1 25.3 4.0 6.2 3.2 7.8 2.8 1.6 5.9 6.3 2.0 55.0 5.2 4.2 44.1 4.5 1.4 0.8 2.4 1.6 1.5 10.0 5.1 3.1 1.7 2.6 2.5 2.2 3.5 2.6 4.5 1.5 6.0 6.3 2.6 3.3 6.4 6.6 2.5 4.8 0.1 10.9 2.1 7.3 2.1 3.1 3.2 4.0 5.7 3.5 2.5 1.4 3.2 3.0 4.0 3.0 6.0 12.5 2.0 15.5 2.6 4.7 1.7 10.2 18.7 12.5 1.8 2.0 11.1 8.3 11.1 0.0 4.9 3.2 0.0 11.8 13.3 3.3 54.0 5.7 12.3 4.8 0.0 8.6 3.1 7.9 0.0 6.6 2.2 5.0 1.8 48.0 6.0 7.4 3.5 2.1 3.6 7.5 19.4 3.3 3.6 8.7 2.6 3.5 4.4 11.8 3.5 CREB5 "CRE-BPA, H_GS165L15.1" ENSG00000146592 "CAMP responsive element binding protein 5" Q02930 7 28299321-28825894 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.3;brain: 38.0" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 116.6;Macrophages: 74.2;monocytes: 74.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 53.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 53.3" "Cell line enhanced" "Detected in many" "HL-60: 32.2;Karpas-707: 13.5;U-2 OS: 14.2;U-2197: 15.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050020, HPA061622" Approved "Nucleoplasm,Vesicles,Plasma membrane" NA Yes Nucleoplasm "Vesicles, Plasma membrane" "HPA050020: AB_2680993, HPA061622: AB_2684569" "unprognostic (3.59e-2)" "unprognostic (3.80e-1)" "unprognostic (1.06e-1)" "unprognostic (6.46e-2)" "unprognostic (1.01e-1)" "unprognostic (4.90e-3)" "unprognostic (2.01e-3)" "unprognostic (2.87e-1)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "unprognostic (3.49e-1)" "unprognostic (2.67e-1)" "unprognostic (4.91e-3)" "unprognostic (6.61e-2)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" 20.0 3.6 12.1 15.4 19.5 11.5 9.0 10.4 17.8 4.6 5.6 38.0 0.9 2.8 16.3 6.9 7.7 4.7 23.1 10.4 16.7 8.7 6.6 4.6 9.5 6.1 17.9 12.1 2.4 7.0 1.5 2.8 19.5 18.3 3.1 4.3 1.1 6.5 3.0 6.2 5.5 4.2 9.8 14.6 12.6 3.2 2.3 22.7 0.0 3.8 7.0 2.5 5.5 5.0 0.3 4.8 53.3 7.8 0.0 0.0 1.5 0.0 0.3 3.9 0.2 0.2 5.7 0.1 0.3 0.8 2.4 3.6 2.2 1.4 9.9 0.7 0.9 2.4 0.4 0.1 3.4 7.6 0.0 2.7 10.7 2.1 0.2 0.2 32.2 0.4 0.7 0.7 10.2 11.0 0.5 1.6 0.0 1.2 13.5 0.8 0.0 0.0 0.0 4.9 0.0 3.9 0.2 3.7 0.2 4.9 1.0 0.4 2.8 0.1 0.2 1.1 5.7 0.1 0.7 0.4 4.7 14.2 15.5 4.5 0.8 2.2 0.1 5.2 0.2 8.0 0.0 7.8 0.0 0.0 2.7 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.0 53.3 0.0 0.8 0.0 0.0 1.5 12.1 19.5 10.4 15.6 16.7 8.7 17.9 12.1 18.3 22.7 6.0 11.1 4.5 116.6 19.5 0.0 14.1 22.9 5.3 6.8 12.2 0.0 2.5 1.7 61.9 0.4 14.9 0.0 0.0 23.7 9.2 31.3 32.4 13.9 0.5 8.1 4.8 0.0 7.4 46.4 1.1 5.5 74.2 28.7 74.9 0.0 16.6 30.3 0.0 0.4 18.3 0.6 19.4 10.7 12.5 3.3 11.5 20.7 1.3 0.0 28.7 CREBL2 ENSG00000111269 "CAMP responsive element binding protein like 2" O60519 12 12611827-12645108 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 77.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043738 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA043738: AB_10795041" "unprognostic (2.87e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" "unprognostic (7.51e-2)" "unprognostic (7.38e-2)" "unprognostic (4.51e-1)" "unprognostic (1.44e-1)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (5.82e-3)" "unprognostic (6.73e-2)" "prognostic favorable (2.26e-5)" "unprognostic (6.31e-2)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.53e-1)" 21.9 77.6 24.3 16.5 31.9 3.0 18.9 21.4 24.6 16.4 13.4 14.6 13.5 13.2 11.4 17.5 10.4 14.9 16.4 14.3 19.8 23.0 28.7 28.2 18.5 18.8 20.2 19.8 22.6 14.2 31.7 31.5 13.8 19.7 17.1 14.2 20.5 15.4 14.4 6.6 14.1 13.3 12.0 20.0 20.2 14.1 17.1 18.3 8.6 25.9 6.7 16.6 17.7 14.0 2.0 4.2 3.6 8.7 1.6 8.1 2.2 5.5 7.2 6.3 7.1 22.3 22.6 12.2 10.9 18.4 8.0 11.1 5.2 8.1 4.8 4.2 13.2 12.2 4.7 9.5 8.3 13.7 26.8 5.7 3.8 7.2 6.3 14.6 5.3 7.1 14.6 15.0 9.4 15.5 27.5 11.7 3.8 3.8 7.6 13.5 8.9 2.8 4.4 18.9 5.3 6.6 3.8 10.9 3.0 15.4 16.1 7.4 8.5 11.0 5.4 19.0 28.5 3.0 6.1 9.4 11.1 7.1 10.9 10.7 6.4 8.5 1.2 13.2 4.6 11.4 1.7 3.8 3.6 2.8 8.7 5.0 1.5 5.5 4.4 4.2 2.0 5.5 4.5 0.7 1.6 3.6 2.1 8.1 2.2 24.3 31.9 21.4 24.6 19.8 23.0 20.2 19.8 19.7 18.3 23.8 21.6 14.3 16.0 19.7 16.9 12.3 22.9 16.0 12.5 31.4 2.0 14.7 34.9 16.6 23.6 20.4 18.6 0.0 19.2 14.9 18.4 35.5 10.3 38.9 36.4 35.0 28.8 22.7 83.1 5.0 33.4 54.7 32.1 45.9 18.1 28.7 18.7 10.5 33.2 48.0 11.0 38.8 9.1 30.0 17.4 25.5 23.0 15.3 15.1 19.2 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 180.3" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 702.6;Endothelial cells: 478.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 24.0;T-reg: 29.2" "Group enriched" "Detected in many" 19 "B-cells: 17.9;T-cells: 29.2" "Cell line enhanced" "Detected in many" "A549: 38.5;EFO-21: 39.4;HUVEC TERT2: 36.8;MCF7: 56.5;SK-BR-3: 44.3;T-47d: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA 490000 Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 22.8 11.5 27.5 9.1 24.6 1.6 16.9 3.6 30.3 20.2 10.1 9.4 33.7 7.9 15.3 30.6 25.6 29.5 24.5 180.3 22.6 18.7 20.0 6.9 28.5 9.3 13.5 16.9 12.5 12.6 4.3 20.4 29.1 10.4 14.6 3.8 8.8 18.4 28.0 10.7 28.4 9.1 24.9 10.3 13.0 11.3 10.9 7.8 1.0 17.8 23.8 13.3 23.8 17.5 17.9 0.9 0.2 0.5 1.2 29.2 3.4 0.4 38.5 5.6 15.3 0.9 4.0 1.6 1.7 0.4 0.5 0.1 1.2 7.1 0.0 39.4 12.6 0.8 22.0 0.7 9.3 0.0 0.2 0.2 0.0 24.2 14.6 4.1 0.0 3.3 1.9 0.8 0.9 5.3 7.2 36.8 0.0 0.0 0.3 5.5 56.5 0.1 0.1 1.5 7.8 23.1 0.0 0.7 1.6 25.9 0.1 8.5 21.4 2.5 44.3 0.3 0.9 37.9 0.0 14.3 12.8 6.0 0.3 7.1 0.1 0.1 0.1 3.7 0.0 25.7 0.0 0.5 0.0 2.4 0.2 2.3 14.4 24.0 5.3 0.9 17.9 5.9 1.6 0.2 1.2 0.1 0.1 29.2 3.4 27.5 24.6 3.6 30.3 22.6 18.7 13.5 16.9 10.4 7.8 145.9 41.3 6.5 66.0 136.0 2.2 702.6 96.8 105.7 131.9 179.7 3.9 0.9 131.0 90.2 30.6 478.7 0.0 0.0 80.2 15.4 145.8 41.0 7.0 27.0 2.6 89.0 24.2 229.6 13.7 62.0 25.9 11.3 148.5 2.8 0.0 55.2 33.3 0.0 13.8 9.8 3.7 271.7 208.1 5.9 44.5 172.0 26.8 6.4 0.0 77.0 CRP PTX1 ENSG00000132693 "C-reactive protein" P02741 1 159712289-159714589 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "liver: 1139.7" "Cell type enriched" "Detected in some" 14 "Hepatocytes: 2991.5" "Cancer enriched" "Detected in some" 13 "liver cancer: 1010.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.2;HDLM-2: 7.8;SiHa: 2.7;U-2 OS: 5.5;U-266/84: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005036, HPA027367, HPA027396" Supported Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Secreted to blood" NA NA 2920000000 5400000000 "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217" "unprognostic (3.74e-1)" "unprognostic (5.31e-2)" "unprognostic (2.97e-2)" "unprognostic (1.27e-1)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (4.17e-10)" "unprognostic (3.39e-2)" "unprognostic (3.48e-1)" "unprognostic (5.60e-2)" "unprognostic (6.61e-2)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 17.2 0.1 0.1 0.0 0.1 1139.7 0.1 0.1 0.1 0.1 0.1 7.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.3 0.0 0.0 0.0 7.8 0.0 0.3 0.0 0.0 0.0 0.3 0.1 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.1 0.9 0.0 13.1 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 55.9 0.0 0.0 0.0 0.0 109.5 0.0 0.0 0.0 0.0 0.0 0.0 220.4 1.2 0.0 0.0 23.3 52.3 0.0 0.0 0.0 0.0 2991.5 0.1 0.0 0.0 82.9 72.1 0.0 0.0 0.0 0.0 17.2 0.0 0.0 97.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRY1 PHLL1 ENSG00000008405 "Cryptochrome circadian regulator 1" Q16526 12 106991364-107093829 "Disease related genes, Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 107.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018762 Approved Supported "Nucleoplasm,Nuclear membrane,Microtubules" NA NA "Nucleoplasm, Nuclear membrane, Microtubules" "CAB018762: AB_2083970" "unprognostic (1.21e-3)" "unprognostic (4.74e-2)" "unprognostic (6.50e-2)" "unprognostic (9.03e-2)" "unprognostic (1.79e-1)" "unprognostic (2.84e-1)" "unprognostic (3.48e-2)" "unprognostic (3.61e-1)" "unprognostic (4.29e-3)" "unprognostic (1.34e-2)" "unprognostic (6.85e-3)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.82e-2)" "unprognostic (5.08e-1)" "unprognostic (1.85e-1)" "unprognostic (2.25e-1)" 12.2 12.2 8.7 8.5 12.6 9.5 18.3 29.2 10.3 12.4 14.3 12.4 5.0 10.7 14.3 12.9 10.7 15.8 16.3 12.2 10.5 8.7 16.0 13.7 18.0 5.0 17.4 7.3 10.7 12.9 8.6 10.0 13.4 13.1 11.2 8.3 8.7 9.4 11.8 10.8 8.7 17.6 15.9 15.4 10.1 14.6 37.6 15.1 26.5 20.1 6.2 7.5 9.5 18.4 1.7 3.5 6.8 6.4 4.7 13.9 4.7 8.6 8.9 10.9 12.0 7.8 4.9 19.5 9.3 9.9 19.1 12.9 10.1 5.3 0.0 5.9 8.6 12.2 6.0 14.0 4.7 20.9 8.7 8.7 8.5 7.9 7.1 10.1 8.7 7.5 4.6 5.0 14.0 13.3 9.5 15.8 16.3 9.6 7.7 11.7 6.1 19.5 9.9 13.3 8.4 13.0 17.5 27.6 3.1 13.3 10.2 19.8 10.2 17.6 11.5 5.5 11.2 8.1 4.9 7.0 11.2 12.0 7.6 8.3 14.2 13.2 4.0 5.4 8.3 9.1 6.8 2.5 4.4 11.2 3.8 13.9 1.6 8.5 7.0 3.5 1.7 8.0 7.8 1.1 4.7 6.4 2.3 11.0 4.7 8.7 12.6 29.2 10.3 10.5 8.7 17.4 7.3 13.1 15.1 14.9 14.4 5.1 37.9 61.5 15.5 9.3 10.2 17.4 5.7 10.4 19.6 7.7 14.9 9.5 8.6 13.1 8.8 0.0 14.4 10.4 26.7 29.3 4.7 18.5 5.5 25.4 18.8 12.3 5.4 2.7 10.6 7.7 15.1 21.6 6.8 21.9 15.1 3.6 16.3 13.9 11.9 6.5 11.3 107.6 21.1 51.9 12.6 12.9 5.2 23.3 CRYBG1 "AIM1, ST4" ENSG00000112297 "Crystallin beta-gamma domain containing 1" Q9Y4K1 6 106360808-106571978 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.7;placenta: 96.6" "Group enriched" "Detected in many" 11 "Cytotrophoblasts: 184.0;Syncytiotrophoblasts: 501.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 9 "pons and medulla: 10.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 32.1;HBEC3-KT: 40.2;hTERT-HME1: 31.1" "Region enriched" "Detected in single" 5 "olfactory region: 5.1" "Low region specificity" "Detected in single" "CAB026378, HPA030948, HPA030949" Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671" "unprognostic (1.66e-1)" "unprognostic (3.44e-2)" "unprognostic (9.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.40e-1)" "unprognostic (2.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (3.69e-3)" "unprognostic (5.61e-2)" "unprognostic (8.97e-2)" "unprognostic (3.53e-2)" "unprognostic (8.89e-2)" "unprognostic (8.60e-2)" "unprognostic (3.25e-2)" 4.6 0.8 0.6 6.8 0.7 6.5 11.3 0.6 0.9 7.4 7.4 1.6 2.5 7.6 1.5 10.8 61.7 2.0 2.0 0.9 1.1 0.6 9.8 3.6 4.0 5.6 0.7 0.7 2.0 5.5 5.0 0.9 96.6 10.3 12.6 5.9 16.0 10.2 4.3 0.8 16.6 7.6 4.4 0.8 6.5 2.5 1.8 0.5 2.3 1.8 24.6 35.8 11.5 13.1 6.8 8.7 3.1 4.4 5.7 10.9 3.9 10.6 0.0 0.0 0.0 9.0 32.1 3.3 1.5 11.8 3.4 3.2 0.7 3.8 16.7 0.7 7.3 4.8 17.2 0.1 40.2 1.7 22.7 0.7 0.0 0.5 5.2 4.2 10.1 0.0 16.0 23.5 6.5 31.1 0.0 14.7 13.2 0.5 2.4 9.2 1.2 2.9 4.0 0.1 0.0 7.1 5.0 0.1 0.1 5.4 25.3 0.7 0.0 6.5 11.1 0.1 1.0 5.5 7.7 4.2 3.9 0.5 0.0 10.6 1.8 1.4 18.2 18.4 12.8 8.3 0.3 3.8 0.4 8.1 4.4 10.9 6.8 10.5 8.9 8.7 3.8 6.7 6.3 3.1 5.7 4.4 1.0 9.9 3.9 0.6 0.7 0.6 0.9 1.1 0.6 0.7 0.7 10.3 0.5 11.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 23.9 31.4 0.0 184.0 3.3 8.8 0.0 0.0 0.0 0.0 10.8 7.2 0.0 0.0 1.1 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 16.4 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 501.8 0.0 0.0 0.0 CTAG2 "CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803" ENSG00000126890 "Cancer/testis antigen 2" O75638 X 154651972-154653579 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 72.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 22.0;K-562: 27.8;OE19: 41.0;RPMI-8226: 61.9;SK-BR-3: 40.5;U-266/84: 70.1" "HPA071467, HPA076586" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA071467: AB_2686402, HPA076586: " "prognostic unfavorable (2.35e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (1.25e-2)" 0.2 1.0 0.4 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.2 0.0 0.0 0.0 1.0 2.9 0.0 8.5 0.0 0.0 0.1 0.8 0.2 0.0 0.2 0.8 3.6 0.0 0.4 4.4 0.2 0.0 0.1 0.0 5.7 0.2 0.0 0.0 0.0 0.3 0.6 11.9 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.6 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 40.5 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.5 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.3 0.0 0.1 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.8 72.0 0.0 0.9 0.0 0.0 0.0 CTCFL "BORIS, CT27, dJ579F20.2" ENSG00000124092 "CCCTC-binding factor like" Q8NI51 20 57495966-57525652 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.4" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 114.6" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 33 "HMC-1: 33.3;K-562: 45.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA001472 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA001472: AB_1078583" "unprognostic (2.50e-1)" "unprognostic (4.01e-2)" "unprognostic (7.70e-2)" "unprognostic (1.85e-5)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-2)" "unprognostic (5.26e-3)" "unprognostic (3.60e-1)" "unprognostic (2.20e-1)" "unprognostic (9.00e-2)" "unprognostic (4.16e-2)" "unprognostic (4.75e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.84e-2)" 0.2 0.1 0.1 0.1 0.4 1.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.3 0.1 0.1 0.1 0.4 0.0 0.5 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.1 35.4 0.1 0.1 0.4 0.1 0.1 0.1 0.1 2.1 1.0 4.3 0.8 0.8 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 1.2 0.1 0.1 0.2 1.8 0.7 1.2 0.6 0.7 0.5 1.3 0.4 0.5 0.3 2.1 0.7 0.8 4.3 0.8 0.8 1.0 0.5 0.2 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.4 18.5 114.6 0.0 0.0 0.0 0.0 0.1 CTNNBL1 "C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L" ENSG00000132792 "Catenin beta like 1" Q8WYA6 20 37693955-37872129 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 296.8;granulocytes: 250.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 76.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004742, HPA027906, HPA027907" Approved Enhanced Nucleoplasm,Centrosome,Cytosol No No Nucleoplasm "Centrosome, Cytosol" "HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362" "unprognostic (2.81e-1)" "unprognostic (3.42e-1)" "unprognostic (8.80e-2)" "unprognostic (1.88e-3)" "unprognostic (1.93e-1)" "unprognostic (2.55e-2)" "unprognostic (1.44e-1)" "unprognostic (5.11e-2)" "unprognostic (1.02e-1)" "unprognostic (3.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (2.06e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (2.81e-1)" "unprognostic (5.31e-2)" 21.0 14.7 19.6 25.8 21.4 27.3 18.9 20.9 21.3 20.3 23.5 18.4 31.7 16.1 25.4 25.2 18.9 21.0 17.7 25.6 17.5 15.8 19.3 35.3 19.3 26.9 17.9 14.7 21.7 14.6 14.5 22.6 22.4 17.5 19.4 18.1 16.1 15.5 34.3 27.3 20.1 19.7 23.8 16.6 49.5 25.9 35.5 20.6 31.0 15.9 15.5 29.7 22.2 29.3 24.9 31.4 60.3 29.1 21.7 18.2 18.4 15.6 14.4 13.8 10.8 10.0 8.3 21.9 10.0 10.5 24.1 21.3 53.9 12.7 17.4 14.7 10.1 23.3 16.8 18.6 23.7 26.0 8.4 9.2 57.1 7.9 26.3 10.4 18.0 76.0 8.7 14.1 13.6 13.6 8.4 14.3 25.0 15.4 7.2 12.8 12.9 29.2 24.0 12.5 17.6 21.0 20.6 26.8 13.1 10.5 13.1 11.1 13.3 17.4 24.9 17.6 13.4 12.3 14.5 10.6 24.1 14.4 15.8 16.2 8.4 10.6 20.3 17.0 11.3 12.7 60.3 22.3 27.9 15.8 29.1 15.0 24.9 15.4 16.2 31.4 23.4 15.5 16.6 4.9 21.7 28.7 24.7 18.2 18.4 19.6 21.4 20.9 21.3 17.5 15.8 17.9 14.7 17.5 20.6 26.8 26.6 37.0 27.7 20.3 25.3 35.5 20.4 21.4 31.8 17.4 17.7 122.6 31.5 25.9 296.8 26.1 24.4 0.0 30.3 56.0 26.8 18.9 250.2 39.2 44.0 17.5 20.1 31.3 29.7 86.0 31.7 43.3 25.3 129.0 23.0 28.3 25.6 19.8 31.5 32.3 21.0 19.4 40.1 76.5 43.0 19.6 44.3 32.4 19.5 18.6 CTNND2 "GT24, NPRAP" ENSG00000169862 "Catenin delta 2" Q9UQB3 5 10971840-11904043 "Disease related genes, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 74.3" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 18.0;Cholangiocytes: 38.2;Early spermatids: 21.0;Late spermatids: 23.3;Muller glia cells: 39.5" "Cancer enriched" "Detected in many" 16 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.1;MCF7: 8.2;SK-BR-3: 5.4;U-266/84: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015077, CAB037339, HPA071124" Enhanced Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "CAB037339: , HPA015077: AB_2669150, HPA071124: " "unprognostic (7.32e-2)" "unprognostic (1.51e-3)" "unprognostic (2.23e-1)" "unprognostic (5.16e-2)" "unprognostic (5.66e-2)" "unprognostic (2.06e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-2)" "unprognostic (9.13e-2)" "unprognostic (9.86e-2)" "unprognostic (8.95e-3)" "unprognostic (2.66e-1)" "unprognostic (9.55e-4)" "unprognostic (5.87e-2)" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (4.76e-2)" 1.7 2.4 30.9 1.8 26.3 1.4 2.8 21.6 74.3 1.7 1.8 16.6 0.0 1.7 1.6 1.9 1.6 1.7 4.8 6.0 26.0 17.7 1.5 1.7 2.4 1.6 22.8 20.2 2.1 12.5 1.5 5.7 1.9 11.0 2.6 1.9 2.6 1.7 1.7 1.6 1.5 2.0 1.6 13.3 5.7 1.9 4.2 14.7 0.0 1.7 0.0 1.5 1.6 0.1 0.0 0.0 0.8 0.4 0.0 0.3 0.6 0.0 0.1 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 15.4 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.6 30.9 26.3 21.6 29.1 26.0 17.7 22.8 20.2 11.0 14.7 0.0 0.0 0.0 0.0 0.0 18.0 8.4 38.2 0.0 0.0 1.8 0.0 0.0 3.3 5.4 21.0 0.3 0.0 0.0 5.4 0.0 0.0 3.6 0.0 0.0 0.1 7.9 4.7 0.0 0.0 23.3 1.4 0.0 0.0 0.0 0.0 39.5 3.5 0.0 0.0 0.3 2.6 0.0 0.0 1.4 3.1 0.0 0.0 0.0 0.0 0.1 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924485-7926166 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 91.1" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 14.7;Late spermatids: 13.4;Spermatogonia: 10.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 33.9;HEK 293: 23.6;NTERA-2: 25.7;REH: 19.5;SCLC-21H: 20.0;SH-SY5Y: 33.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 2.1 4.8 47.7 2.5 91.1 1.6 2.1 0.0 74.2 5.2 6.1 5.0 3.6 2.6 17.5 5.1 2.4 16.4 1.8 1.6 49.4 16.8 3.1 1.5 3.0 1.6 15.7 20.1 2.7 2.1 2.3 6.5 2.0 4.0 5.5 2.1 0.0 2.1 16.5 1.6 2.8 2.1 7.1 1.5 2.0 2.2 6.1 8.3 0.0 1.8 0.0 1.6 2.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 2.8 7.3 33.9 0.0 0.1 1.7 2.9 0.8 1.4 0.8 0.8 1.7 0.0 5.8 0.7 0.8 12.3 1.6 0.3 0.0 1.0 23.6 0.2 1.9 0.5 0.3 0.6 0.6 0.0 0.9 0.5 0.3 3.5 1.9 3.2 7.1 0.1 0.1 13.7 6.2 4.6 25.7 0.8 11.9 19.5 0.0 2.2 5.2 0.5 20.0 33.6 1.8 0.9 3.1 0.6 7.4 0.2 2.8 0.7 11.9 1.3 1.6 0.2 0.3 1.6 2.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 91.1 0.0 63.8 49.4 16.8 15.7 20.1 4.0 8.3 0.0 0.0 0.0 3.6 1.0 0.2 0.2 0.0 0.0 0.0 8.7 3.9 0.1 3.3 5.0 7.3 0.5 0.0 0.0 0.3 0.4 0.9 14.7 0.0 0.0 0.2 0.0 8.7 0.6 0.0 13.4 1.1 0.1 1.7 0.0 0.0 0.1 2.0 0.2 1.8 7.2 0.4 0.0 4.2 3.6 10.4 1.8 0.2 0.0 0.0 5.9 CUTC CGI-32 ENSG00000119929 "CutC copper transporter" Q9NTM9 10 99702558-99756134 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.1" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038619, HPA058231" Enhanced Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Cytosol" Nucleoli "HPA038619: AB_10672649, HPA058231: " "unprognostic (1.25e-2)" "unprognostic (5.92e-2)" "unprognostic (2.70e-1)" "unprognostic (8.66e-2)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (3.55e-3)" "unprognostic (8.67e-2)" "unprognostic (5.36e-2)" "unprognostic (1.81e-1)" "unprognostic (5.87e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.81e-7)" "unprognostic (1.00e-1)" "unprognostic (3.42e-2)" "unprognostic (2.41e-1)" "unprognostic (3.97e-1)" 11.6 4.9 5.7 9.8 8.7 7.9 9.8 3.5 6.5 5.3 5.9 7.2 3.5 4.4 4.9 8.0 6.2 5.1 5.8 13.2 5.9 4.7 5.3 11.0 5.1 7.9 8.6 6.6 4.6 4.5 3.5 3.6 4.5 5.5 6.0 6.4 6.9 5.7 5.4 122.1 5.8 6.2 11.6 7.4 9.2 6.0 14.1 8.3 9.2 4.3 25.1 7.3 13.5 11.4 32.8 24.2 47.1 19.4 25.5 36.3 19.3 9.5 20.5 7.2 21.9 26.8 12.3 3.9 7.8 10.1 7.9 8.9 9.4 7.3 34.7 7.0 13.3 3.9 8.2 14.7 13.0 8.8 10.2 14.0 11.5 9.2 14.8 12.4 21.3 5.6 12.7 8.1 12.6 26.2 9.8 13.5 20.2 10.1 7.7 5.9 6.6 19.1 22.0 7.2 9.7 7.7 13.0 8.5 13.3 8.3 3.9 2.4 5.4 3.6 5.7 9.8 10.4 9.1 12.2 7.5 3.3 4.4 3.6 10.3 12.7 16.5 24.3 10.8 45.8 2.9 26.5 19.4 47.1 27.2 15.2 28.3 32.8 25.9 25.9 21.0 29.0 36.3 27.8 30.8 25.5 18.5 24.2 24.7 19.3 5.7 8.7 3.5 6.5 5.9 4.7 8.6 6.6 5.5 8.3 8.9 12.2 21.9 13.0 10.8 16.5 35.8 10.2 20.1 10.3 5.2 7.9 15.9 18.3 14.6 8.1 21.5 4.9 0.0 15.0 10.7 15.3 11.4 30.0 20.2 18.3 11.1 11.6 22.7 17.8 6.8 12.0 15.9 28.7 27.9 7.8 17.8 10.1 10.1 15.2 24.5 27.1 19.4 15.6 105.8 35.1 9.5 11.3 20.1 9.7 10.7 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153449-54173973 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 21.1;Basal keratinocytes: 20.3;Club cells: 29.6;Proximal tubular cells: 33.5;Suprabasal keratinocytes: 17.1;Urothelial cells: 39.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Group enriched" "Detected in some" 16 "A549: 95.1;Hep G2: 27.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022261, HPA063771" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" NA Yes "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: AB_2685120" "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.1 0.1 0.4 0.2 0.7 0.0 2.5 0.1 0.4 2.5 0.1 0.0 0.3 0.0 11.2 0.4 4.4 0.3 0.0 0.1 0.4 0.8 38.8 0.3 1.6 0.1 0.2 0.0 0.1 0.1 0.0 0.7 7.0 0.3 7.0 0.0 0.1 0.3 1.5 0.1 1.0 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.4 1.4 5.9 25.8 31.2 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 95.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.7 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.6 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.4 0.4 0.8 0.2 0.0 0.3 0.0 0.0 0.0 1.5 21.1 20.3 0.0 0.3 0.0 8.1 29.6 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.0 39.9 CYP2B6 "CPB6, CYP2B, CYPIIB6" ENSG00000197408 "Cytochrome P450 family 2 subfamily B member 6" P20813 19 40991250-41018398 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 137.3" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 326.3" "Cancer enhanced" "Detected in many" "liver cancer: 28.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;OE19: 4.9" "Not detected" "Not detected" "CAB033866, HPA048124, HPA062973" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914" "unprognostic (1.86e-1)" "unprognostic (1.23e-2)" "unprognostic (1.13e-2)" "unprognostic (6.13e-2)" "unprognostic (4.59e-2)" "unprognostic (4.63e-2)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (9.43e-2)" "unprognostic (5.44e-1)" 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.0 3.0 137.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 1.8 3.1 0.8 0.7 0.9 0.1 0.4 0.4 0.5 0.4 0.1 0.0 0.4 0.2 0.3 0.0 0.1 1.5 0.0 0.3 0.3 0.2 0.1 7.0 0.4 0.1 0.1 0.3 0.6 0.4 0.7 0.4 0.4 0.4 0.4 0.0 0.4 0.3 0.1 0.3 0.5 0.7 0.4 0.1 0.2 0.1 0.8 1.8 0.6 4.9 0.4 0.2 0.5 0.4 1.7 0.1 0.9 0.2 0.3 0.1 0.5 0.3 0.7 1.1 0.8 0.6 0.3 0.7 0.5 0.3 0.7 0.9 0.2 1.1 0.3 3.1 0.8 0.4 0.4 0.5 0.4 0.6 0.6 0.4 0.1 1.9 0.5 0.8 2.7 0.7 0.3 1.8 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.2 2.5 1.4 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.9 46.7 0.2 0.0 0.0 0.1 0.0 326.3 0.0 0.0 0.0 10.4 11.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 7.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.2 0.6 CYP2U1 SPG49 ENSG00000155016 "Cytochrome P450 family 2 subfamily U member 1" Q7Z449 4 107931369-107953457 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 122.7" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 18.6;Peritubular cells: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041622, HPA046754, HPA064827" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362" "unprognostic (3.54e-1)" "unprognostic (2.45e-1)" "unprognostic (3.08e-1)" "unprognostic (2.84e-1)" "unprognostic (5.16e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (1.20e-3)" "unprognostic (3.19e-1)" "unprognostic (8.97e-3)" "unprognostic (5.41e-3)" "unprognostic (3.02e-1)" "prognostic favorable (2.75e-5)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.19e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.6 7.9 7.7 4.4 9.1 0.4 7.3 11.3 9.2 7.8 7.3 7.0 4.1 4.0 9.5 4.6 6.3 9.8 6.6 8.8 7.1 7.9 6.4 6.8 6.6 6.7 8.3 5.2 12.0 2.6 10.3 8.1 2.7 7.8 12.4 4.7 8.6 4.5 11.0 4.3 3.1 6.0 12.3 7.0 8.5 4.6 3.9 7.4 122.7 4.7 3.5 5.4 7.3 5.3 2.6 2.7 0.7 5.9 1.6 1.7 0.4 2.5 1.2 3.4 6.3 18.8 9.0 0.5 10.8 16.3 6.6 10.5 0.0 1.7 6.9 0.8 6.4 5.2 0.1 5.3 4.0 10.4 1.9 1.6 1.4 2.4 0.3 7.5 2.0 0.0 10.1 3.4 3.1 2.1 13.5 2.5 7.8 0.1 3.3 5.5 1.8 7.4 0.0 3.5 0.2 3.0 4.2 4.1 0.0 2.1 4.3 6.7 5.0 2.7 4.7 11.5 3.0 2.3 1.0 6.8 4.3 0.5 6.1 4.3 14.0 13.2 2.2 3.5 0.0 4.8 0.0 0.3 0.7 1.2 1.1 0.9 2.0 0.9 1.0 2.2 2.6 1.7 1.3 0.0 1.6 5.9 2.7 0.0 0.4 7.7 9.1 11.3 6.9 7.1 7.9 8.3 5.2 7.8 7.4 3.0 3.8 3.2 3.2 1.0 4.3 3.4 2.5 13.4 3.4 8.7 3.9 0.4 0.0 0.9 9.6 5.8 2.6 0.0 1.7 0.3 5.1 1.7 4.6 6.8 1.9 1.6 2.9 6.7 6.1 6.1 16.4 4.6 18.6 3.6 1.1 9.9 0.4 0.0 16.6 2.4 3.3 0.0 5.2 0.9 4.3 1.3 0.2 1.3 1.6 0.7 DAAM2 KIAA0381 ENSG00000146122 "Dishevelled associated activator of morphogenesis 2" Q86T65 6 39792298-39904877 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 83.3" "Cell type enriched" "Detected in many" 5 "Sertoli cells: 148.8" "Cancer enhanced" "Detected in all" "melanoma: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 29 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.8" "Cell line enhanced" "Detected in some" "HSkMC: 25.8;JURKAT: 13.8;LHCN-M2: 25.3;SK-MEL-30: 31.3;WM-115: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051300, HPA054630" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA051300: AB_2681430, HPA054630: AB_2682549" "unprognostic (7.53e-2)" "unprognostic (6.02e-3)" "unprognostic (4.49e-2)" "unprognostic (7.93e-2)" "unprognostic (8.24e-2)" "unprognostic (4.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.05e-3)" "unprognostic (1.33e-1)" "unprognostic (5.89e-2)" "unprognostic (2.17e-1)" "unprognostic (5.24e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.67e-2)" "unprognostic (8.54e-2)" "unprognostic (7.94e-2)" "unprognostic (8.54e-4)" 21.5 17.8 34.8 6.7 43.0 1.7 7.8 4.4 52.2 9.3 6.4 83.3 8.0 7.6 7.5 8.5 28.3 8.9 5.9 6.1 40.4 25.2 5.9 4.0 8.4 2.8 42.8 24.8 7.3 5.2 3.5 2.1 9.4 41.3 8.7 7.1 5.1 4.3 17.6 23.8 4.4 8.9 13.7 48.8 15.5 7.0 8.7 51.9 0.0 5.0 2.1 2.2 4.6 4.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.7 0.1 0.1 4.4 5.9 1.0 0.5 0.4 0.0 0.0 0.2 6.6 2.1 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 4.1 0.0 0.0 25.8 0.0 0.1 0.0 7.2 0.0 13.8 0.0 0.0 25.3 0.0 0.6 0.0 0.7 1.3 0.0 0.0 4.6 3.5 0.0 0.0 0.9 1.0 0.0 0.3 31.3 5.6 0.0 0.0 0.2 9.6 2.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 34.8 43.0 4.4 28.9 40.4 25.2 42.8 24.8 41.3 51.9 8.9 9.8 0.0 0.8 1.5 1.7 2.1 0.0 2.7 6.8 0.0 0.0 0.4 0.0 0.4 3.6 2.0 0.0 0.0 3.0 0.4 11.3 0.8 0.0 1.0 0.2 0.0 0.0 3.1 15.2 4.2 21.9 3.1 8.5 0.0 0.0 8.2 0.4 0.0 20.8 0.0 1.5 148.8 28.3 0.7 1.1 1.0 0.2 0.0 0.0 1.0 DAG1 "156DAG, A3a, AGRNR, DAG" ENSG00000173402 "Dystroglycan 1" Q14118 3 49468703-49535618 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 62.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001960, CAB016353, HPA070563" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 70000000 "Vesicles, Plasma membrane" Nucleoplasm "CAB001960: , CAB016353: AB_627292, HPA070563: " "unprognostic (1.58e-1)" "unprognostic (5.14e-1)" "unprognostic (6.71e-3)" "unprognostic (3.32e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" "unprognostic (1.67e-1)" "unprognostic (3.27e-2)" "unprognostic (8.18e-2)" "unprognostic (3.91e-2)" "unprognostic (5.70e-3)" "unprognostic (1.10e-1)" "prognostic favorable (2.59e-4)" "unprognostic (9.22e-2)" "unprognostic (1.99e-2)" "unprognostic (7.43e-2)" "unprognostic (1.57e-2)" 19.2 17.4 16.5 10.1 21.1 2.8 16.2 17.3 27.1 17.3 23.9 24.1 13.1 14.1 23.4 14.3 19.1 19.6 19.7 40.9 19.9 10.3 22.7 31.7 18.9 6.3 16.7 15.7 22.6 35.0 32.7 15.8 45.6 18.1 18.6 18.9 22.2 19.9 24.3 57.3 18.7 17.5 27.9 14.0 7.3 22.2 29.4 16.3 6.0 15.3 24.0 14.3 20.4 15.0 3.2 3.6 1.8 6.1 1.9 3.7 3.3 19.5 19.5 13.6 33.6 18.2 8.9 62.0 13.8 20.5 23.7 15.3 16.0 20.8 2.7 14.1 22.5 20.1 36.7 11.8 17.9 14.7 2.6 3.9 1.8 19.6 18.2 8.1 2.4 3.9 7.8 16.2 22.5 7.5 21.7 21.2 3.3 2.8 2.1 6.4 15.7 2.0 1.6 14.6 24.1 6.5 1.2 13.2 4.6 18.6 27.5 4.8 9.9 16.6 45.8 22.4 41.3 38.6 4.8 11.1 9.0 14.3 16.7 19.7 2.4 4.9 1.7 10.9 2.6 54.3 1.8 2.8 1.1 3.3 3.5 3.7 3.2 2.8 2.5 1.8 2.6 3.0 2.4 0.6 1.9 6.1 3.6 1.9 3.3 16.5 21.1 17.3 27.1 19.9 10.3 16.7 15.7 18.1 16.3 50.6 13.6 9.0 8.0 12.7 7.8 50.0 30.6 10.7 11.4 33.2 3.9 95.1 1.7 26.2 25.8 16.8 20.6 0.0 69.3 96.3 24.2 13.2 6.9 48.8 18.3 3.2 31.7 17.8 7.2 13.6 19.8 4.0 32.1 5.4 27.5 30.3 50.2 25.1 34.6 6.8 8.7 45.3 23.7 7.0 18.6 14.9 80.2 5.0 26.4 9.0 DALRD3 FLJ10496 ENSG00000178149 "DALR anticodon binding domain containing 3" Q5D0E6 3 49015488-49022293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 129.7;Late spermatids: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036862 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA036862: AB_10673507" "unprognostic (2.76e-2)" "unprognostic (8.44e-3)" "unprognostic (3.56e-1)" "prognostic favorable (9.03e-4)" "unprognostic (3.77e-1)" "unprognostic (1.52e-1)" "unprognostic (3.33e-3)" "unprognostic (1.19e-2)" "unprognostic (5.33e-2)" "unprognostic (9.52e-2)" "unprognostic (8.07e-2)" "unprognostic (1.11e-1)" "prognostic favorable (2.79e-5)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" 9.4 14.1 9.3 13.9 9.0 4.4 21.6 10.2 11.9 11.3 9.5 7.7 14.9 7.2 7.7 14.7 13.1 34.3 14.2 8.6 8.6 7.3 16.0 9.3 10.8 9.1 7.2 9.4 13.5 29.3 12.6 11.1 8.7 6.3 8.4 7.5 8.4 13.2 18.5 7.5 13.0 10.2 6.5 5.1 8.5 9.9 32.0 6.8 21.1 21.1 13.5 12.7 9.5 14.1 17.7 8.2 7.3 9.3 14.5 19.2 9.3 6.2 8.5 5.3 10.5 15.4 20.5 6.6 5.3 14.3 8.8 8.4 6.0 7.8 2.5 7.5 14.0 7.6 4.1 7.0 13.5 6.1 3.8 4.7 2.7 7.9 11.2 10.0 7.5 5.4 13.8 14.0 11.0 24.6 22.3 13.5 5.8 2.1 6.2 8.5 10.6 3.4 5.1 8.9 12.9 8.1 1.7 0.7 17.9 23.3 9.8 3.4 11.4 5.7 15.8 11.9 9.3 11.2 8.3 8.4 3.4 5.4 12.1 4.7 19.9 10.9 1.3 13.0 3.5 6.7 7.1 7.7 3.7 10.2 9.3 18.8 17.7 17.0 12.7 8.2 15.5 14.4 9.3 7.3 14.5 8.6 5.6 19.2 9.3 9.3 9.0 10.2 11.9 8.6 7.3 7.2 9.4 6.3 6.8 14.9 9.8 15.9 21.0 22.8 29.2 1.2 15.3 65.6 19.4 26.2 17.7 23.7 31.5 33.6 129.7 14.3 30.3 0.0 34.6 30.0 20.5 9.2 24.3 5.8 17.2 38.1 18.3 15.4 10.8 227.2 22.5 15.9 20.3 29.7 19.2 23.2 22.0 17.5 17.3 36.2 53.2 45.3 15.5 91.9 33.3 29.7 15.3 17.5 25.0 13.2 DAP ENSG00000112977 "Death associated protein" P51397 5 10679230-10761272 "Predicted intracellular proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 178.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA029456 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" Nucleoplasm "HPA029456: AB_10601262" "unprognostic (2.70e-2)" "unprognostic (3.48e-1)" "unprognostic (2.25e-1)" "unprognostic (1.88e-2)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (4.05e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.91e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.39e-1)" "unprognostic (8.58e-3)" "unprognostic (2.04e-2)" 17.4 36.6 13.7 17.9 12.7 10.6 23.1 3.9 11.6 23.5 25.4 11.4 63.4 26.5 21.1 34.7 14.3 18.6 44.0 22.9 13.4 9.1 40.1 78.2 21.6 22.6 10.2 10.1 26.1 178.8 30.0 28.4 26.4 21.8 24.8 20.2 22.7 71.1 76.0 5.9 15.2 42.6 18.3 10.8 23.8 31.6 23.2 9.8 15.5 31.2 12.8 18.6 25.9 16.9 18.1 32.8 27.3 33.2 13.1 17.6 22.5 19.2 14.1 17.5 16.1 32.8 39.7 19.4 47.4 73.7 35.9 41.7 10.0 16.5 8.4 31.2 58.5 22.7 3.8 10.8 28.1 40.0 44.3 7.9 11.3 27.3 24.6 31.0 21.1 8.4 20.4 9.8 23.5 42.7 20.8 66.9 9.5 13.1 28.6 35.1 15.3 11.3 13.5 6.3 26.2 32.3 15.5 7.7 13.9 47.3 35.9 11.9 16.0 48.3 19.7 12.6 14.0 15.6 31.0 32.7 22.3 24.2 14.7 25.1 16.1 20.8 12.4 22.0 41.2 33.4 14.9 33.2 18.6 14.8 29.4 17.6 18.1 15.3 13.0 32.8 12.0 11.3 11.2 27.3 13.1 28.5 26.9 16.1 22.5 13.7 12.7 3.9 11.6 13.4 9.1 10.2 10.1 21.8 9.8 14.9 40.1 32.0 53.6 17.1 8.1 11.0 56.0 12.0 30.7 50.6 5.9 59.1 112.7 83.0 10.9 31.6 98.3 0.0 168.9 84.1 36.6 77.8 35.6 106.2 46.0 4.8 42.5 36.2 35.6 22.8 27.6 32.0 27.0 38.7 87.4 19.0 105.6 63.3 32.2 50.2 7.2 0.0 21.7 33.1 6.1 15.8 84.4 24.1 65.2 69.2 DAPL1 ENSG00000163331 "Death associated protein like 1" A0PJW8 2 158795317-158862781 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 522.1" "Group enriched" "Detected in all" 7 "cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HaCaT: 3.7;hTCEpi: 22.1;SCLC-21H: 5.7;U-87 MG: 8.1" "Not detected" "Not detected" "HPA046937, HPA058635" Enhanced Approved "Nucleoplasm,Nuclear bodies,Microtubules" NA NA "Nucleoplasm, Nuclear bodies, Microtubules" "HPA046937: AB_2679870, HPA058635: AB_2732625" "unprognostic (3.95e-5)" "prognostic favorable (8.43e-4)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (4.63e-2)" "unprognostic (8.59e-2)" "unprognostic (5.24e-2)" "unprognostic (4.59e-2)" "unprognostic (2.44e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-3)" "unprognostic (4.09e-2)" "unprognostic (6.68e-2)" "unprognostic (3.00e-2)" "unprognostic (2.30e-3)" 0.3 14.7 1.4 0.4 1.3 0.0 7.4 0.4 1.0 11.7 1.0 0.8 1.6 0.0 2.1 53.5 75.6 21.1 0.6 0.2 1.5 3.6 1.3 0.2 0.8 0.4 2.8 0.3 3.8 5.7 0.0 5.6 0.2 1.5 2.3 0.0 63.9 6.8 0.4 0.2 61.3 0.5 1.1 0.4 0.2 0.2 2.1 0.8 0.8 21.5 37.3 16.9 2.0 21.1 1.4 4.0 2.9 2.6 2.8 1.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.2 22.1 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.3 5.7 0.0 0.0 0.0 0.6 0.0 0.6 1.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 8.1 0.0 0.0 2.9 2.6 1.6 0.5 1.9 1.0 1.2 0.8 0.4 1.0 1.4 0.4 0.5 2.2 2.8 0.6 4.0 1.3 0.5 1.4 1.3 0.4 1.0 1.5 3.6 2.8 0.3 1.5 0.8 0.0 0.0 14.6 31.4 94.9 6.8 0.0 5.1 1.4 17.0 8.7 5.9 5.5 3.3 8.0 10.6 0.5 2.5 0.0 5.1 10.7 4.1 10.8 4.6 12.1 12.9 3.2 2.9 0.6 7.9 43.8 3.7 5.5 11.8 2.8 1.6 522.1 5.7 3.5 2.1 5.8 16.3 0.0 5.1 9.8 4.1 110.7 3.8 1.9 2.5 25.5 DAW1 "FLJ25955, ODA16, WDR69" ENSG00000123977 "Dynein assembly factor with WD repeats 1" Q8N136 2 227871054-227924344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 14.9;fallopian tube: 24.4;testis: 49.9" "Group enriched" "Detected in some" 12 "Ciliated cells: 69.6;Early spermatids: 83.7;Late spermatids: 157.9;Spermatocytes: 115.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 6.2;HUVEC TERT2: 15.2;U-2197: 28.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 25.4" HPA046118 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA Nucleoplasm "Nuclear bodies, Plasma membrane" "HPA046118: AB_10961428" "unprognostic (1.23e-1)" "unprognostic (1.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (4.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-3)" "unprognostic (2.90e-2)" "unprognostic (9.92e-3)" "unprognostic (1.54e-5)" "unprognostic (1.52e-1)" "unprognostic (6.83e-3)" "unprognostic (1.70e-1)" "unprognostic (3.08e-1)" 0.4 0.1 2.5 0.3 14.9 0.4 0.5 0.0 1.8 0.7 0.3 3.1 0.0 0.1 0.3 3.1 0.6 24.4 0.4 0.4 3.9 3.0 0.3 0.5 2.4 0.3 0.3 2.7 1.3 0.1 0.7 0.2 0.8 14.3 0.2 0.2 0.0 0.3 0.2 2.6 0.3 0.2 0.2 0.3 0.3 0.2 49.9 1.1 0.0 0.2 0.0 0.3 0.3 0.0 0.5 0.5 1.2 0.5 0.2 0.8 0.0 0.6 0.0 0.1 0.0 0.2 0.9 0.4 0.6 0.3 0.6 0.4 3.7 0.3 0.2 0.0 0.1 6.2 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 1.3 0.0 0.7 0.5 4.1 15.2 0.0 0.1 0.2 0.2 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.2 0.1 0.3 1.5 0.1 1.4 28.5 0.0 0.0 0.1 0.2 2.7 0.0 0.2 1.2 0.0 0.2 0.2 0.5 0.8 0.3 0.4 0.4 0.0 0.5 0.6 0.3 0.0 0.2 0.5 0.5 0.6 0.0 2.5 14.9 0.0 1.8 3.9 3.0 0.3 2.7 14.3 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 69.6 9.1 0.0 3.9 0.0 0.0 0.0 83.7 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 157.9 3.1 0.0 0.0 0.0 0.0 0.2 1.7 0.0 2.5 0.0 0.2 0.0 0.0 115.4 1.4 0.1 0.2 0.0 0.0 0.0 DCP2 NUDT20 ENSG00000172795 "Decapping mRNA 2" Q8IU60 5 112976702-113020970 "Enzymes, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 52.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011677, HPA057676" Approved Approved "Nucleoplasm,Cell Junctions,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "Cell Junctions" "CAB011677: AB_731858, HPA057676: AB_2683500" "unprognostic (2.76e-1)" "unprognostic (3.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-1)" "unprognostic (3.86e-3)" "prognostic unfavorable (4.84e-4)" "unprognostic (1.87e-1)" "unprognostic (3.64e-2)" "unprognostic (6.26e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-2)" "prognostic unfavorable (2.66e-5)" "unprognostic (8.39e-2)" "unprognostic (2.84e-1)" "unprognostic (3.25e-2)" "unprognostic (5.75e-2)" 8.0 7.5 8.1 16.3 9.5 22.9 15.0 16.8 10.9 9.1 6.6 6.4 6.6 6.3 10.5 6.8 7.4 8.0 6.5 6.1 8.1 8.9 8.1 8.1 13.2 19.8 6.9 6.1 12.8 6.2 7.0 12.2 40.2 8.3 8.1 7.3 6.5 9.6 8.6 8.3 9.8 8.7 7.3 7.4 19.9 6.7 6.8 6.5 52.9 7.0 4.1 20.0 8.7 9.1 5.1 6.5 16.3 8.3 3.9 5.9 3.2 3.6 3.1 14.1 11.3 2.8 3.1 22.8 3.3 2.7 4.2 6.1 14.6 7.8 19.1 5.3 1.9 3.4 4.5 16.2 4.5 5.1 5.1 7.0 17.9 2.7 5.8 3.2 10.9 9.3 2.9 3.1 5.1 5.1 4.0 7.1 14.7 13.2 7.5 3.8 4.6 16.0 11.6 12.2 2.2 1.9 15.7 13.4 7.1 6.5 9.3 3.3 7.0 4.6 5.2 6.7 15.3 15.4 14.6 4.6 4.7 8.4 2.4 5.0 5.1 11.2 14.6 2.7 15.3 3.6 12.2 7.2 5.5 4.0 7.1 5.5 5.1 4.9 4.2 6.5 3.6 4.6 4.7 16.3 3.9 8.3 3.5 5.9 3.2 8.1 9.5 16.8 10.9 8.1 8.9 6.9 6.1 8.3 6.5 17.9 15.6 38.9 16.7 24.6 21.6 11.4 5.1 18.7 22.7 19.2 74.6 53.4 16.6 8.9 23.5 21.8 10.0 0.0 10.3 41.1 27.2 25.6 18.5 5.9 27.7 27.0 15.5 27.6 71.2 42.2 17.5 46.5 25.3 36.9 9.1 34.4 12.8 10.5 10.3 11.2 35.2 6.5 17.9 29.3 19.0 23.2 53.9 38.8 11.3 37.6 DDIT4L "REDD2, Rtp801L" ENSG00000145358 "DNA damage inducible transcript 4 like" Q96D03 4 100185870-100190782 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 106.4" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 21.0;Distal tubular cells: 18.3;Extravillous trophoblasts: 14.7;Sertoli cells: 19.4;Smooth muscle cells: 16.0" "Cancer enhanced" "Detected in many" "testis cancer: 19.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 7 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 12.9;BJ: 18.8;fHDF/TERT166: 10.2;HSkMC: 9.8;hTERT-RPE1: 21.5;RPTEC TERT1: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050903 Uncertain "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA050903: " "unprognostic (2.21e-1)" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.77e-4)" "unprognostic (1.66e-3)" "unprognostic (5.92e-2)" "unprognostic (2.72e-2)" "unprognostic (3.12e-1)" "unprognostic (3.21e-1)" "unprognostic (7.18e-2)" "unprognostic (2.59e-1)" "unprognostic (1.41e-1)" "unprognostic (4.47e-2)" "unprognostic (4.82e-3)" "unprognostic (2.09e-2)" "unprognostic (7.53e-5)" "unprognostic (4.99e-3)" 1.4 0.5 1.5 0.3 6.3 0.3 0.6 2.0 1.6 7.9 0.6 1.7 0.0 0.2 0.9 3.0 2.6 0.9 0.3 3.5 2.1 0.7 6.2 0.2 0.4 0.3 1.5 1.6 2.8 0.2 0.3 1.2 1.3 2.7 3.8 0.5 5.2 6.3 2.6 106.4 0.4 0.3 0.8 2.4 0.5 0.2 1.1 1.7 0.0 0.6 18.6 1.2 0.5 0.9 0.2 0.0 0.0 0.2 0.0 2.0 0.2 0.0 1.4 5.5 0.0 2.5 12.9 0.8 18.8 1.6 0.3 0.1 0.1 0.5 0.0 0.4 10.2 0.4 0.0 3.9 0.3 0.3 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 9.8 0.1 0.2 1.0 21.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 6.2 0.0 0.0 0.3 0.0 0.0 13.4 0.0 0.0 0.0 0.3 0.7 2.5 1.4 0.0 0.0 0.1 0.0 0.0 0.0 1.4 2.5 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.1 2.0 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 1.0 0.2 1.5 6.3 2.0 1.6 2.1 0.7 1.5 1.6 2.7 1.7 0.0 0.0 0.0 0.1 2.4 0.0 4.7 0.0 0.0 0.0 21.0 0.0 1.7 18.3 0.1 0.6 1.5 0.0 0.0 0.0 14.7 5.0 0.8 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 6.8 0.0 0.0 8.3 0.5 0.0 2.1 1.3 0.0 19.4 16.0 0.7 0.1 1.3 3.3 0.0 0.0 0.1 DDX11 "CHL1, CHLR1, KRG2, WABS" ENSG00000013573 "DEAD/H-box helicase 11" Q96FC9 12 31073845-31104791 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA065197 Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Centrosome" No Yes Nucleoplasm "Nucleoli fibrillar center, Centrosome" "HPA065197: AB_2685430" "unprognostic (6.10e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.79e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (4.87e-2)" "unprognostic (3.89e-3)" "unprognostic (3.53e-1)" "unprognostic (5.66e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.23e-8)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (8.03e-3)" 6.3 5.3 6.4 8.0 8.7 21.0 5.9 18.1 10.5 7.6 6.1 6.0 8.8 7.1 11.0 3.7 7.6 7.5 5.1 4.0 7.0 2.7 6.5 7.0 4.9 14.9 8.4 4.6 9.6 19.0 7.7 9.3 5.6 7.1 8.0 8.6 5.0 11.3 7.1 8.8 14.2 12.1 8.0 6.7 10.9 8.0 8.2 9.4 33.2 7.2 6.4 11.1 5.8 7.8 5.8 4.9 1.3 7.3 4.3 5.5 1.9 12.5 12.2 14.2 12.7 2.2 4.8 20.9 7.8 3.9 9.1 9.8 14.5 21.4 16.4 10.9 4.1 8.5 12.4 11.2 10.7 7.3 15.0 23.0 19.5 20.3 8.9 0.8 13.7 12.7 4.5 4.8 11.6 9.1 5.9 4.4 19.7 9.5 36.8 6.5 10.4 23.5 20.5 29.9 15.3 6.6 18.9 22.2 22.8 4.8 14.3 10.2 7.5 8.0 12.3 3.9 24.8 10.4 8.7 3.6 8.0 15.7 15.4 14.1 14.9 11.5 39.2 9.4 11.0 7.2 0.0 2.3 1.3 4.2 2.5 3.3 5.2 4.0 3.1 3.1 5.8 4.1 5.5 1.1 4.3 7.3 4.9 3.4 1.9 6.4 8.7 18.1 10.5 7.0 2.7 8.4 4.6 7.1 9.4 3.0 7.4 12.7 4.5 5.4 7.7 2.2 5.1 6.7 5.7 0.0 13.7 5.2 0.0 2.2 1.3 3.0 4.0 0.0 2.9 5.8 4.3 5.0 5.7 6.6 4.3 7.9 0.0 6.2 4.6 0.9 6.6 4.6 6.8 5.4 5.0 2.3 2.5 2.9 4.2 1.1 25.5 0.0 3.5 3.2 17.6 5.6 2.2 6.9 7.4 4.1 DDX20 "DP103, GEMIN3" ENSG00000064703 "DEAD-box helicase 20" Q9UHI6 1 111755245-111768016 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 81.7" "Group enriched" "Detected in many" 13 "Early spermatids: 570.4;Late spermatids: 538.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005516, CAB015427" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB015427: AB_629518, HPA005516: AB_1849612" "unprognostic (3.71e-2)" "unprognostic (5.25e-2)" "prognostic favorable (9.85e-5)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (6.35e-6)" "unprognostic (1.17e-1)" "unprognostic (5.87e-2)" "unprognostic (7.46e-3)" "unprognostic (4.21e-1)" "unprognostic (5.22e-2)" "unprognostic (1.05e-3)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (4.23e-1)" "unprognostic (1.30e-2)" 3.1 2.8 2.9 2.7 4.3 5.9 9.8 5.8 5.1 2.7 2.6 1.8 2.6 2.0 4.0 2.9 2.6 3.7 1.7 2.0 4.3 1.6 2.7 2.4 4.1 3.8 2.4 1.9 3.9 2.9 4.0 3.9 2.7 3.4 2.9 2.6 1.2 2.6 2.7 5.1 2.5 3.5 2.9 5.6 4.5 2.8 81.7 3.3 5.1 3.2 1.7 4.1 2.9 5.0 11.9 7.4 12.7 7.4 10.5 14.1 7.8 11.4 4.7 12.2 11.0 8.8 7.0 11.4 11.2 8.7 16.1 15.7 7.0 4.0 26.8 8.8 7.6 5.7 9.2 14.4 11.3 18.0 12.2 13.0 13.0 9.2 7.2 8.8 12.8 9.6 7.0 9.9 13.7 13.9 4.5 11.1 10.5 12.4 9.8 12.2 10.8 15.7 13.0 15.3 6.9 9.6 15.4 20.1 6.7 10.5 9.0 12.7 11.5 10.8 13.5 18.0 10.6 8.4 13.6 9.8 9.8 14.5 17.5 13.0 4.9 6.9 20.5 10.2 13.2 22.1 12.7 7.0 6.9 10.0 7.3 13.3 11.9 11.7 11.8 7.4 10.1 14.1 12.3 5.0 10.5 7.4 5.2 11.7 7.8 2.9 4.3 5.8 5.1 4.3 1.6 2.4 1.9 3.4 3.3 11.9 6.5 3.7 7.8 9.6 12.2 5.9 2.5 13.4 12.5 5.2 2.0 8.6 3.3 8.9 570.4 7.1 2.4 0.0 6.0 6.8 4.8 3.0 7.0 4.9 8.0 6.4 4.1 3.7 9.1 538.8 15.3 8.7 1.7 3.6 5.7 6.3 6.3 2.9 12.4 6.9 8.9 6.5 10.3 41.2 25.6 6.4 4.2 7.0 5.8 5.5 DDX21 "GURDB, RH-II/GU" ENSG00000165732 "DExD-box helicase 21" Q9NR30 10 68956128-68985073 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 515.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036592, HPA036593" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No 14000 "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA036592: AB_10673625, HPA036593: AB_2675208" "unprognostic (3.04e-1)" "unprognostic (6.81e-3)" "unprognostic (1.13e-2)" "unprognostic (1.21e-2)" "unprognostic (1.75e-2)" "unprognostic (6.71e-3)" "unprognostic (1.34e-2)" "unprognostic (1.99e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (3.12e-4)" "unprognostic (1.64e-1)" "unprognostic (1.39e-2)" "unprognostic (9.33e-2)" "unprognostic (5.41e-2)" "unprognostic (1.24e-2)" "unprognostic (5.74e-3)" 37.5 16.0 10.0 26.6 13.3 46.8 24.4 8.0 11.8 18.5 20.1 7.2 16.2 13.3 18.7 13.7 28.3 20.1 17.6 19.1 11.4 8.0 25.1 48.0 25.9 24.4 14.9 7.2 30.2 27.9 15.6 20.7 22.8 18.3 14.0 17.6 5.9 18.0 17.8 61.2 22.5 18.5 19.0 20.4 43.5 19.0 12.9 13.3 27.1 18.1 24.1 25.8 33.2 22.4 12.6 11.5 17.1 17.3 7.7 15.0 6.2 33.1 19.7 11.5 35.6 10.4 13.8 24.4 22.8 18.4 29.5 25.1 63.7 22.8 50.0 14.1 18.9 13.9 29.6 44.3 28.4 39.6 15.5 31.2 35.0 14.0 26.4 22.3 83.2 33.3 14.1 37.0 35.2 59.0 13.7 21.4 18.8 66.6 25.0 20.7 15.1 32.6 18.1 31.5 15.8 42.1 29.2 18.9 24.6 19.6 17.9 23.9 25.6 20.5 45.5 26.6 14.5 25.8 17.5 22.0 17.3 24.6 23.2 40.0 28.9 38.2 73.9 14.4 63.2 11.7 5.0 9.7 17.1 8.4 15.0 15.0 12.6 10.9 11.0 11.5 10.4 10.3 11.3 4.5 7.7 17.3 10.8 7.9 6.2 10.0 13.3 8.0 11.8 11.4 8.0 14.9 7.2 18.3 13.3 95.3 139.8 208.1 223.1 488.7 27.0 59.4 112.1 83.0 195.7 68.0 39.3 72.5 61.3 111.8 41.5 139.6 52.0 23.3 160.6 118.9 142.8 222.8 164.0 182.5 102.7 23.8 83.2 113.5 149.3 13.6 82.8 170.5 118.1 66.7 97.0 22.8 171.9 92.1 72.5 73.0 27.4 25.8 155.6 101.9 142.2 515.4 115.0 93.8 113.1 301.9 DDX51 ENSG00000185163 "DEAD-box helicase 51" Q8N8A6 12 132136594-132144335 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039503 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA039503: AB_10796328" "unprognostic (2.84e-3)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (8.66e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (4.88e-1)" "unprognostic (3.05e-3)" "unprognostic (5.31e-2)" "unprognostic (3.97e-2)" "unprognostic (2.48e-1)" "unprognostic (4.69e-2)" "unprognostic (3.28e-1)" "unprognostic (1.65e-3)" 10.5 8.5 12.7 12.7 17.1 17.2 10.3 23.5 18.9 8.8 8.4 11.8 10.6 7.8 11.5 12.2 8.5 12.4 10.0 8.1 11.6 9.9 9.5 7.2 8.9 11.1 10.5 16.9 19.6 14.8 10.1 9.8 7.2 11.8 9.3 7.3 8.9 10.7 12.4 13.8 18.0 8.2 10.4 10.5 10.6 9.3 6.7 12.0 9.5 9.9 7.1 10.4 9.3 8.6 2.5 2.3 2.6 2.1 1.6 2.0 1.0 6.2 10.1 4.2 5.3 4.0 3.9 8.0 4.8 2.9 7.2 3.0 6.2 3.1 10.9 4.2 2.9 1.7 6.6 10.5 7.7 3.5 2.6 10.1 12.9 5.4 2.0 4.9 9.0 7.5 3.4 5.7 4.0 3.6 8.1 3.8 12.2 9.5 3.6 2.1 6.2 11.0 18.5 7.4 5.3 17.4 13.1 5.8 12.1 4.9 5.0 10.3 5.4 5.3 7.5 5.3 3.7 6.6 8.3 6.7 2.7 8.3 6.6 11.1 10.2 5.9 12.8 5.6 6.9 6.3 1.1 2.1 1.2 2.0 1.0 0.7 1.5 1.3 0.9 0.6 2.5 1.2 1.6 2.6 1.6 1.0 2.3 0.6 1.0 12.7 17.1 23.5 18.9 11.6 9.9 10.5 16.9 11.8 12.0 3.0 15.9 3.0 6.8 11.1 27.9 4.0 10.2 4.0 13.6 3.5 23.6 6.0 1.7 4.0 0.9 7.7 3.5 0.0 4.5 4.9 6.5 7.3 5.8 6.4 4.9 31.8 8.1 7.4 6.2 0.7 7.8 5.7 10.1 3.6 8.3 11.1 5.4 7.0 7.8 2.9 27.4 0.0 6.4 5.7 9.4 12.3 3.4 6.9 12.1 5.8 DDX53 "CAGE, CT26" ENSG00000184735 "DEAD-box helicase 53" Q86TM3 X 22999961-23003589 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 11.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 47.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.6;K-562: 6.3;RPMI-8226: 3.3;U-2197: 2.1;U-266/84: 14.1" "Low region specificity" "Detected in many" HPA003186 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003186: AB_1078637" "unprognostic (5.76e-1)" "unprognostic (1.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.4 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.0 8.8 0.0 0.0 0.0 0.0 0.0 DDX54 "APR-5, DP97, MGC2835" ENSG00000123064 "DEAD-box helicase 54" Q8TDD1 12 113157174-113185479 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028244, HPA070786" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA028244: AB_10603885, HPA070786: AB_2686311" "unprognostic (1.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (8.54e-2)" "unprognostic (8.57e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (2.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.83e-2)" "unprognostic (1.15e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" 17.2 17.6 9.2 20.7 12.8 25.4 17.2 9.9 13.6 17.9 16.4 12.4 18.1 20.3 18.0 19.4 19.5 17.2 17.9 20.1 8.8 7.9 22.3 28.6 14.0 19.9 8.1 9.4 22.4 27.0 18.3 7.4 22.6 10.0 16.6 9.0 13.4 17.4 13.9 45.4 18.7 19.4 14.8 8.1 22.2 16.1 11.4 8.6 26.6 23.1 21.6 22.2 16.7 17.5 12.1 13.3 8.0 15.2 11.9 13.0 10.0 26.8 28.1 10.5 19.3 7.0 8.5 27.1 14.6 13.6 20.0 11.0 28.9 13.1 34.9 17.2 12.2 14.9 20.0 18.6 19.0 7.6 20.0 22.8 20.9 15.1 19.7 12.4 34.9 24.8 13.9 15.1 19.3 11.9 16.4 16.3 21.2 30.3 12.5 10.2 24.8 30.0 49.8 24.5 18.9 20.0 22.3 15.5 35.6 10.9 28.1 13.6 12.4 20.7 31.8 13.2 9.0 27.3 27.3 12.1 17.0 19.0 20.1 30.4 18.3 20.8 39.2 15.0 19.5 17.8 8.0 10.0 2.3 12.4 15.2 13.0 11.6 11.4 12.2 13.3 12.1 11.8 12.5 0.6 11.9 9.8 10.0 9.4 10.0 9.2 12.8 9.9 13.6 8.8 7.9 8.1 9.4 10.0 8.6 29.8 28.0 32.1 27.0 15.3 20.2 12.4 20.4 10.7 21.6 12.2 2.0 51.4 21.6 35.0 0.9 19.7 30.2 23.3 43.1 46.0 18.7 23.5 24.3 35.5 34.5 25.4 27.1 15.4 31.7 2.1 27.3 23.0 11.8 23.4 28.6 23.8 38.0 38.2 22.6 34.9 18.1 6.5 18.9 15.4 18.9 17.1 60.5 37.3 38.2 32.3 DENND1A "FAM31A, FLJ21129, KIAA1608" ENSG00000119522 "DENN domain containing 1A" Q8TEH3 9 123379654-123930152 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020481 Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "HPA020481: AB_2092106" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "unprognostic (2.00e-1)" "unprognostic (4.25e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.19e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (2.48e-3)" "unprognostic (5.63e-2)" "prognostic favorable (4.11e-5)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (9.66e-2)" "unprognostic (4.31e-2)" 11.4 12.2 17.4 13.9 19.8 32.5 10.0 18.6 21.2 10.9 14.8 12.8 10.3 15.8 13.3 9.0 11.3 13.0 10.5 10.3 15.9 12.8 16.4 14.5 9.4 11.6 11.8 14.9 12.0 8.9 20.1 19.0 23.9 13.9 11.0 14.1 14.5 8.5 11.8 11.0 9.3 17.2 14.4 10.1 20.2 9.9 12.1 13.2 10.6 15.5 5.6 9.5 10.6 17.4 1.5 8.4 11.2 15.2 0.5 1.3 3.2 14.8 8.8 7.9 14.9 5.4 8.5 36.8 14.4 21.8 12.3 10.7 12.0 6.6 11.9 3.0 11.6 16.3 8.4 6.7 10.5 12.0 5.0 5.1 5.6 21.3 8.8 7.2 6.7 3.8 7.8 9.5 10.2 17.5 4.3 10.9 11.6 15.4 9.2 9.9 8.5 8.0 9.7 15.7 17.2 13.4 12.5 7.7 10.1 6.1 5.3 16.8 13.7 11.6 7.7 9.0 5.4 10.5 17.0 5.1 13.3 5.1 15.5 7.5 14.0 10.9 8.2 11.2 13.4 8.8 11.2 15.2 2.8 1.3 10.1 0.7 1.1 0.9 0.6 8.4 1.5 0.6 0.7 9.3 0.5 8.2 1.3 0.4 3.2 17.4 19.8 18.6 21.2 15.9 12.8 11.8 14.9 13.9 13.2 0.0 1.0 7.3 2.3 4.5 15.9 7.7 7.6 1.4 1.2 15.7 15.7 8.6 5.0 4.0 28.4 10.1 17.6 0.0 4.4 27.4 5.2 4.7 4.6 12.1 14.5 30.2 11.5 7.4 15.9 67.9 13.6 10.8 3.3 2.8 6.6 13.5 5.2 10.7 10.6 11.5 12.3 0.0 5.2 3.4 1.1 2.5 7.3 3.8 6.7 3.1 DENND1C "FAM31C, FLJ22757" ENSG00000205744 "DENN domain containing 1C" Q8IV53 19 6467207-6482557 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.7;lymphoid tissue: 32.9" "Cell type enhanced" "Detected in many" 10 "B-cells: 28.3;Erythroid cells: 23.3;granulocytes: 16.1;T-cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 13.2;HEL: 8.8;HMC-1: 27.4;MOLT-4: 8.4;THP-1: 8.1;U-937: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042758, HPA042839" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042758: AB_10962357, HPA042839: AB_10959898" "unprognostic (5.94e-2)" "unprognostic (1.41e-3)" "unprognostic (4.26e-2)" "unprognostic (1.93e-3)" "unprognostic (1.21e-1)" "unprognostic (1.72e-3)" "unprognostic (3.91e-2)" "prognostic favorable (1.23e-4)" "unprognostic (7.76e-3)" "unprognostic (4.45e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (8.95e-4)" "prognostic favorable (7.51e-14)" "unprognostic (1.37e-3)" "unprognostic (1.27e-1)" "unprognostic (4.53e-2)" "prognostic favorable (5.62e-4)" 2.1 1.3 1.5 22.0 2.5 14.1 2.0 0.5 1.6 1.0 2.8 2.5 0.0 3.4 1.0 1.5 1.7 1.7 3.4 1.0 1.3 1.3 2.2 2.0 5.2 30.1 3.1 0.6 0.8 1.0 0.0 1.1 1.3 2.2 1.7 0.8 1.4 5.4 0.8 0.6 1.0 12.1 0.8 2.7 31.3 3.5 0.5 2.7 32.9 1.8 1.2 25.2 3.0 1.5 16.3 12.2 19.0 20.6 14.1 26.7 20.2 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 13.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 8.8 0.0 0.9 0.0 4.3 27.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 5.7 0.1 0.0 8.4 6.7 0.0 0.3 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.1 0.0 18.3 0.0 10.4 11.6 19.0 26.7 20.6 23.4 16.3 19.1 22.9 12.2 13.7 24.8 21.6 17.6 14.1 20.0 7.1 21.9 20.2 1.5 2.5 0.5 1.6 1.3 1.3 3.1 0.6 2.2 2.7 3.0 4.8 28.3 0.0 0.3 0.0 0.9 2.5 2.7 0.0 1.8 0.0 0.1 1.7 0.4 0.6 0.0 1.1 23.3 0.0 0.2 0.2 0.0 16.1 0.0 12.9 0.0 0.0 1.8 9.9 0.4 0.0 9.2 3.3 3.6 0.6 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.3 0.2 0.7 0.1 0.2 32.3 0.8 0.1 DENND4A "IRLB, MYCPBP" ENSG00000174485 "DENN domain containing 4A" Q7Z401 15 65658046-65792293 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 93.5;Horizontal cells: 104.9;Rod photoreceptor cells: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065343 Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA065343: AB_2685476" "unprognostic (1.10e-1)" "unprognostic (8.43e-2)" "unprognostic (4.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-1)" "unprognostic (8.02e-2)" "unprognostic (2.30e-2)" "unprognostic (8.88e-2)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (7.83e-2)" "unprognostic (3.45e-1)" "unprognostic (2.24e-1)" "unprognostic (3.48e-1)" 13.7 15.7 9.5 13.9 11.3 32.9 9.5 26.7 12.6 10.0 9.6 12.2 6.8 6.9 11.5 6.6 8.0 9.3 13.2 8.2 10.7 8.5 9.8 19.1 12.8 20.8 12.1 9.7 16.3 19.9 17.9 21.2 9.9 11.6 8.1 8.2 14.6 9.5 7.2 15.3 7.6 10.2 12.5 16.6 13.6 10.2 9.0 11.9 16.9 12.7 5.6 20.1 13.4 10.1 9.3 3.1 6.8 3.6 4.4 8.0 1.9 4.8 4.6 2.4 2.5 7.3 8.1 3.0 5.1 6.8 3.4 5.0 2.6 3.9 25.2 3.5 7.4 4.2 9.2 4.7 4.5 6.0 27.9 5.5 23.9 6.0 5.0 4.2 8.1 8.5 5.4 5.1 4.7 10.0 6.0 9.1 5.7 7.2 15.6 3.9 2.6 3.7 4.3 0.7 14.6 3.5 1.8 8.6 21.7 4.0 9.4 3.9 3.7 4.9 3.4 4.4 3.0 3.3 20.7 9.8 4.7 5.3 8.5 7.0 8.5 9.5 9.5 6.7 17.7 3.8 3.1 3.6 6.8 5.3 1.5 8.0 7.8 4.6 6.7 3.1 9.3 4.9 4.7 1.9 4.4 1.2 1.2 4.2 1.9 9.5 11.3 26.7 12.6 10.7 8.5 12.1 9.7 11.6 11.9 14.9 23.9 21.9 25.1 24.7 75.6 10.9 15.3 21.4 21.6 8.7 56.9 4.2 0.0 7.8 1.5 23.3 5.1 93.5 11.3 5.7 14.1 17.9 47.4 23.2 16.5 104.9 16.7 17.8 20.8 2.9 12.0 24.7 23.6 7.2 10.1 24.1 12.2 10.4 11.7 8.7 124.0 6.5 16.4 10.7 9.6 14.9 10.5 29.9 8.9 14.1 DEPDC1B "BRCC3, XTP1" ENSG00000035499 "DEP domain containing 1B" Q8WUY9 5 60596912-60700190 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6;placenta: 71.5" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 17.8;Extravillous trophoblasts: 18.7;Spermatocytes: 32.0;Syncytiotrophoblasts: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA038255, HPA072558" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA038255: AB_10669521, HPA072558: AB_2686534" "unprognostic (1.38e-1)" "unprognostic (1.99e-2)" "prognostic favorable (2.42e-4)" "prognostic unfavorable (8.55e-4)" "unprognostic (2.23e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (3.08e-4)" "prognostic unfavorable (6.93e-5)" "unprognostic (2.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.47e-3)" "unprognostic (2.44e-2)" "unprognostic (1.11e-16)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (8.62e-2)" 0.6 0.6 0.6 3.7 1.5 7.9 0.6 0.8 1.4 1.2 3.3 0.6 0.1 4.8 0.9 0.5 5.2 0.4 19.0 0.4 0.8 0.8 3.3 0.9 1.0 6.9 2.3 0.7 0.6 0.5 0.0 0.3 71.5 1.4 0.5 4.6 0.4 1.3 0.1 0.2 2.1 5.1 0.5 3.2 3.3 2.0 17.0 1.2 21.6 1.5 2.3 7.6 0.9 2.2 1.0 0.6 3.3 0.3 1.4 6.4 0.9 24.0 8.2 25.0 15.2 0.5 0.8 27.4 6.5 4.4 11.5 15.0 13.6 15.3 13.7 16.1 2.0 14.9 8.0 20.0 14.6 15.5 19.5 14.5 17.1 9.4 16.9 0.4 14.4 16.7 0.5 1.5 3.7 5.4 2.2 10.6 14.7 12.2 18.8 10.1 15.1 23.2 12.6 18.4 5.2 13.3 25.8 20.3 11.7 9.3 12.0 13.9 6.4 15.3 5.5 7.2 11.7 10.2 11.5 4.9 4.9 14.4 3.9 16.5 9.5 16.6 27.1 6.1 21.2 13.6 3.3 0.3 1.7 0.5 0.0 0.4 1.0 2.2 1.5 0.6 0.1 0.3 0.3 0.0 1.4 0.0 0.1 6.4 0.9 0.6 1.5 0.8 1.4 0.8 0.8 2.3 0.7 1.4 1.2 0.0 2.6 0.8 0.8 4.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 1.9 0.0 0.3 1.4 0.1 1.7 0.0 0.2 18.7 0.4 0.5 3.5 0.0 5.2 0.0 0.0 0.0 1.2 1.8 0.3 2.2 0.0 0.0 1.0 0.2 0.7 2.0 0.0 0.5 0.0 6.5 0.4 32.0 8.7 1.8 39.2 0.0 6.3 0.3 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015864-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 51.8;liver: 42.2" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 30.9;Early spermatids: 98.0;Extravillous trophoblasts: 40.1;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 27.2;RH-30: 20.6;SiHa: 18.8;U-2197: 17.5" "Low region specificity" "Detected in many" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.5 2.0 1.4 4.1 0.9 2.0 0.5 2.6 1.7 15.3 4.3 1.2 14.1 1.2 1.4 3.1 0.8 3.1 0.9 2.6 1.4 10.9 42.2 0.7 0.4 4.0 1.5 1.3 2.7 3.5 0.8 1.2 2.8 1.4 3.1 1.2 1.7 1.0 3.3 3.4 51.8 1.0 3.2 0.5 2.2 15.6 3.3 1.8 0.6 2.0 0.9 0.9 2.4 0.0 4.4 9.0 0.7 3.0 3.1 0.6 4.5 2.5 3.7 1.6 2.0 1.9 2.5 8.2 2.7 5.0 6.8 6.7 0.4 0.0 1.9 8.1 2.3 4.7 5.4 1.9 6.0 0.0 7.5 1.3 7.9 9.4 1.6 4.4 5.6 2.4 2.9 2.9 2.1 2.7 0.0 0.0 3.0 0.0 27.2 0.5 0.0 7.1 2.4 3.8 0.0 0.0 20.6 0.0 1.6 0.6 0.8 2.1 18.8 3.3 16.3 2.7 0.8 2.3 0.0 3.2 5.4 17.5 5.2 0.0 0.0 0.0 1.2 0.0 15.9 4.0 0.7 9.0 0.3 0.2 0.0 0.0 0.6 0.3 4.4 0.0 2.9 3.1 0.0 3.0 0.0 1.8 0.0 0.6 2.0 4.1 0.5 2.6 2.6 1.4 4.0 1.5 2.8 3.3 0.0 0.0 0.0 8.3 30.9 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.3 3.3 0.4 98.0 0.1 8.6 0.0 0.5 40.1 1.6 0.8 2.3 19.4 2.7 0.0 3.4 2.5 0.3 6.3 1.4 2.4 1.7 1.8 1.0 0.0 1.0 0.0 1.1 11.2 0.0 0.0 1.4 27.7 7.6 6.5 1.3 0.0 2.1 0.7 DGCR8 "C22orf12, DGCRK6, Gy1, pasha" ENSG00000128191 "DGCR8, microprocessor complex subunit" Q8WYQ5 22 20080232-20111877 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 46.8;Rod photoreceptor cells: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076916, HPA079351" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA076916: , HPA079351: " "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" "unprognostic (2.75e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.34e-1)" "unprognostic (5.72e-3)" "unprognostic (2.83e-1)" "unprognostic (1.09e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.02e-2)" "unprognostic (4.20e-1)" "unprognostic (4.68e-2)" "unprognostic (2.26e-2)" 7.9 7.8 9.9 10.3 10.1 10.1 9.4 29.8 14.1 9.7 10.3 11.8 13.4 7.6 14.5 8.1 11.7 11.5 10.5 7.8 10.0 6.9 7.9 7.9 8.1 8.9 10.6 9.7 13.9 15.2 11.6 16.8 17.9 10.4 9.5 7.9 11.3 10.5 10.3 19.9 11.3 10.1 12.6 7.4 10.3 10.0 22.4 10.9 11.1 9.8 11.9 9.0 11.5 12.6 1.7 3.3 1.2 6.8 3.2 4.6 2.7 12.1 8.6 11.2 6.6 4.4 7.2 14.3 11.7 7.0 7.9 5.6 9.2 6.2 10.8 6.5 10.9 5.3 11.7 10.2 9.7 6.9 10.6 15.1 11.8 9.1 7.5 11.7 21.7 9.8 5.7 12.2 8.3 6.1 7.3 6.9 6.6 41.6 7.9 9.2 7.8 13.0 6.4 10.9 8.8 6.5 15.6 11.9 3.7 4.8 11.4 12.5 8.0 10.7 6.3 6.8 7.0 6.0 9.3 10.3 11.6 9.7 7.2 11.8 4.4 6.0 10.9 8.6 9.9 11.2 0.0 2.1 1.2 4.5 1.9 3.5 1.7 2.2 4.6 2.9 1.5 2.3 2.6 0.4 3.2 6.8 3.3 2.7 2.7 9.9 10.1 29.8 14.1 10.0 6.9 10.6 9.7 10.4 10.9 6.0 9.3 8.0 4.5 8.5 34.3 2.5 5.1 6.7 6.8 5.2 37.3 11.0 0.0 5.6 46.8 6.7 6.3 0.0 8.7 9.5 5.6 7.7 3.5 11.3 4.6 41.3 7.0 8.6 7.0 31.3 17.0 3.8 5.0 6.4 9.2 15.8 8.6 6.0 9.9 2.8 59.4 6.5 4.7 16.9 13.0 8.2 11.3 6.9 8.2 4.7 DGKA "DAGK, DAGK1, DGK-alpha" ENSG00000065357 "Diacylglycerol kinase alpha" P23743 12 55927319-55954027 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 117.1" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 42.2;hTERT-HME1: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041645, HPA045462" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA Vesicles "Nucleoplasm, Mitochondria" "HPA041645: AB_2677595, HPA045462: AB_2679335" "unprognostic (1.12e-3)" "unprognostic (1.43e-2)" "unprognostic (1.62e-2)" "unprognostic (2.63e-2)" "unprognostic (5.23e-2)" "unprognostic (2.04e-1)" "unprognostic (3.62e-1)" "unprognostic (3.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (1.66e-5)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (7.02e-2)" 4.9 4.7 7.1 31.8 8.2 9.7 4.8 6.0 10.8 8.4 13.4 3.6 3.1 20.5 6.9 4.1 42.0 4.9 7.9 3.8 4.6 2.4 3.9 1.5 7.6 28.6 2.1 4.1 4.9 6.4 6.2 3.1 10.2 3.3 10.6 11.0 4.1 16.2 5.3 1.0 33.0 27.2 5.7 3.7 23.1 4.8 4.4 2.6 117.1 4.5 9.6 57.0 13.0 15.1 7.6 4.0 5.4 2.8 5.2 30.2 10.9 6.7 4.3 3.0 4.0 7.5 9.8 0.9 15.2 15.6 6.0 4.4 2.0 11.5 3.8 3.6 10.1 2.0 12.4 3.2 42.2 7.2 3.2 0.7 6.1 9.1 1.1 6.5 1.9 6.0 8.4 22.8 8.3 44.8 20.0 12.2 22.7 0.7 5.9 16.1 0.7 12.5 2.4 0.6 5.6 5.1 5.8 1.0 0.6 14.2 19.5 0.5 1.7 5.0 0.2 0.5 8.2 2.7 2.0 10.9 3.9 2.8 0.8 0.5 0.7 0.3 9.2 4.7 5.2 1.1 5.2 2.8 5.4 6.5 2.0 11.7 7.6 24.3 11.7 4.0 6.4 30.2 18.1 5.2 5.2 1.2 4.0 26.7 10.9 7.1 8.2 6.0 10.8 4.6 2.4 2.1 4.1 3.3 2.6 3.0 6.2 15.6 8.5 13.4 0.8 2.0 0.0 0.0 11.4 5.2 0.0 13.4 0.0 4.1 6.5 3.3 38.4 0.0 8.4 4.0 3.8 8.2 6.9 0.0 3.7 0.0 2.4 4.9 4.1 4.7 3.4 10.2 0.0 16.2 7.5 4.9 15.8 6.2 2.8 0.1 0.4 6.5 3.1 3.8 2.7 12.2 22.1 20.6 5.2 18.0 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 72.4" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 5.9 4.2 4.7 8.8 5.1 2.9 5.0 2.7 5.0 5.9 4.4 6.1 1.4 3.4 6.6 2.3 5.1 5.2 2.3 11.5 4.3 3.0 6.6 72.4 3.4 5.5 4.8 2.7 6.2 9.9 7.1 4.0 2.6 5.2 3.9 4.8 5.9 6.0 4.4 11.7 4.0 3.0 7.5 4.0 3.5 3.4 4.3 5.4 4.0 3.6 7.1 5.1 3.5 3.3 11.2 13.4 3.9 8.1 9.3 12.9 6.8 7.4 15.5 4.5 7.5 2.4 3.2 8.6 6.4 2.6 9.7 7.5 12.2 6.8 16.8 8.7 3.5 5.4 7.9 8.9 6.9 11.5 3.8 8.4 9.2 7.5 12.0 6.8 12.7 6.8 3.1 7.1 11.7 12.3 3.1 7.0 11.4 14.0 3.1 5.9 19.8 12.0 12.2 10.2 12.7 6.1 15.2 5.9 17.7 5.8 4.9 5.4 6.3 8.6 9.2 4.2 5.8 8.2 6.4 3.0 8.9 5.5 8.4 9.3 5.9 10.9 28.4 4.6 14.0 8.1 3.9 8.1 0.9 9.3 7.7 12.7 11.2 8.9 9.0 13.3 10.6 12.4 12.9 2.1 9.3 5.6 13.4 7.1 6.8 4.7 5.1 2.7 5.0 4.3 3.0 4.8 2.7 5.2 5.4 3.0 9.6 9.5 6.4 4.9 5.7 12.1 7.6 9.4 1.2 7.0 3.9 12.0 5.0 6.6 2.1 6.7 0.7 0.0 4.4 9.6 6.0 5.0 8.1 106.1 6.9 3.2 1.2 2.5 5.3 2.3 2.6 3.4 11.8 3.6 4.4 4.8 5.2 2.9 2.1 20.1 4.2 0.0 9.9 7.9 8.0 3.3 2.4 5.0 6.2 4.1 DHPS MIG13 ENSG00000095059 "Deoxyhypusine synthase" P49366 19 12675717-12681902 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hypusine biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014461, HPA029413" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA014461: AB_1847651, HPA029413: AB_10602217" "unprognostic (4.17e-2)" "unprognostic (2.55e-2)" "unprognostic (2.05e-2)" "unprognostic (2.61e-1)" "unprognostic (3.10e-1)" "unprognostic (1.01e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.59e-2)" "unprognostic (1.20e-2)" "unprognostic (4.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (1.56e-1)" "unprognostic (8.83e-2)" 16.4 30.3 26.9 18.6 31.2 17.0 24.8 43.3 38.8 20.7 25.7 27.5 25.3 23.1 20.9 16.9 21.3 32.3 18.2 26.0 26.3 28.0 23.4 30.3 18.9 24.2 27.5 28.0 34.8 32.0 28.8 32.6 23.2 22.4 24.1 24.5 20.2 24.8 24.6 65.1 25.6 21.5 24.5 29.1 19.5 24.2 13.3 26.3 31.9 24.9 22.9 26.9 23.5 19.2 39.6 29.5 35.8 30.5 27.8 38.1 29.7 20.6 15.3 24.8 13.1 11.1 18.5 5.8 13.3 19.5 25.4 25.6 10.9 10.1 21.4 15.1 14.5 23.4 12.6 17.0 18.8 17.6 18.8 12.0 14.3 16.7 14.2 13.7 17.1 22.9 14.8 23.2 15.3 26.5 25.8 17.8 42.8 13.0 15.3 18.5 41.1 30.4 24.8 19.4 27.0 26.0 20.2 9.3 30.9 19.5 11.1 32.4 43.9 13.4 19.5 22.6 15.7 18.0 28.6 8.9 29.9 12.1 29.2 20.2 48.8 52.5 14.5 18.4 21.0 28.2 14.5 27.0 35.8 24.7 24.2 25.9 39.6 28.9 25.6 29.0 36.9 38.1 28.1 9.7 27.8 30.5 29.5 34.3 29.7 26.9 31.2 43.3 38.8 26.3 28.0 27.5 28.0 22.4 26.3 38.7 21.2 44.9 67.5 49.3 77.6 7.7 22.9 34.8 9.1 31.4 43.2 43.4 72.9 48.6 15.6 35.9 36.2 0.0 32.3 43.6 36.5 53.0 23.1 29.4 38.0 39.7 39.6 18.4 36.3 21.8 41.7 38.3 47.2 71.3 54.9 114.9 45.5 63.3 32.5 75.5 92.9 45.3 55.6 29.6 70.0 44.5 60.1 50.3 52.4 59.7 DHRS1 "FLJ25430, MGC20204, SDR19C1" ENSG00000157379 "Dehydrogenase/reductase 1" Q96LJ7 14 24290598-24299833 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000599, HPA076886" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA000599: AB_1078655, HPA076886: " "unprognostic (2.08e-3)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (2.75e-1)" "unprognostic (3.57e-1)" "unprognostic (6.57e-2)" "prognostic favorable (1.18e-5)" "prognostic favorable (6.83e-4)" "unprognostic (3.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (9.88e-2)" "unprognostic (2.25e-3)" "unprognostic (1.32e-2)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" 6.5 8.9 3.0 6.1 5.0 3.3 7.4 6.3 6.0 8.6 12.0 9.8 8.4 16.1 6.7 8.9 35.7 5.4 10.2 3.7 2.7 3.1 8.5 47.1 6.7 4.8 3.6 5.3 4.2 10.7 11.5 5.2 4.1 6.0 5.5 5.4 7.1 14.0 15.6 1.8 20.8 25.7 4.8 4.4 6.3 6.1 2.8 3.7 5.6 6.6 25.6 16.5 6.0 13.0 10.4 10.7 17.3 9.5 4.2 11.7 4.7 11.1 2.7 2.9 1.1 6.8 7.2 0.7 4.0 8.8 9.5 10.3 1.0 10.9 5.2 1.7 6.2 1.5 9.1 2.2 18.5 4.6 3.5 2.3 1.6 6.5 17.6 3.2 3.1 1.2 6.5 10.9 2.3 1.7 7.7 7.1 4.3 3.2 5.0 7.7 4.5 1.2 1.1 0.5 8.9 4.0 4.0 2.0 7.2 7.3 4.2 2.5 1.9 5.7 7.7 1.9 2.1 3.9 0.9 2.7 0.7 1.8 1.1 1.3 2.8 2.2 2.5 3.4 2.7 0.9 10.0 8.7 17.3 6.9 9.5 7.5 10.4 7.5 6.3 10.7 7.0 7.6 4.2 5.7 4.2 5.9 6.4 11.7 4.7 3.0 5.0 6.3 6.0 2.7 3.1 3.6 5.3 6.0 3.7 20.8 17.9 18.2 23.9 29.2 10.8 13.9 45.9 16.0 18.2 33.2 17.7 40.2 33.2 24.7 15.1 15.7 74.2 0.0 26.8 7.7 17.9 21.4 5.8 70.1 24.0 14.3 18.5 14.1 11.6 27.0 18.7 16.2 43.9 11.8 37.9 14.1 42.2 46.0 19.4 44.2 44.1 25.8 21.7 26.2 9.3 40.0 21.9 26.1 38.6 36.3 DHRS12 "FLJ13639, SDR40C1" ENSG00000102796 "Dehydrogenase/reductase 12" A0PJE2 13 51767993-51804157 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 36.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.6" "Low region specificity" "Detected in all" "CAB034238, HPA057028, HPA058315" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "CAB034238: AB_2091845, HPA057028: AB_2683314, HPA058315: AB_2683678" "prognostic favorable (1.41e-4)" "unprognostic (1.98e-2)" "unprognostic (2.98e-1)" "unprognostic (7.57e-2)" "unprognostic (2.98e-1)" "unprognostic (1.42e-1)" "unprognostic (8.47e-3)" "unprognostic (1.70e-1)" "unprognostic (3.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.21e-2)" "unprognostic (3.98e-1)" "prognostic favorable (2.22e-16)" "unprognostic (2.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.03e-2)" "unprognostic (3.44e-1)" 15.6 6.4 6.9 4.1 7.1 3.9 11.1 5.2 10.9 9.5 7.6 13.8 7.1 5.5 8.4 16.0 7.7 7.5 7.4 8.3 6.0 6.0 14.2 15.8 8.7 4.8 5.8 6.2 10.4 37.6 11.1 10.0 7.3 8.0 7.7 4.7 14.0 11.5 13.0 10.4 10.1 12.2 8.3 7.2 8.3 7.3 3.9 6.5 4.4 10.2 6.9 9.2 6.4 5.7 6.0 4.5 36.3 7.3 1.6 11.6 5.7 0.9 3.1 5.6 7.6 2.5 5.4 5.2 1.7 3.9 2.2 1.2 3.5 15.6 3.9 1.2 3.2 3.5 1.9 0.1 0.8 0.3 3.6 2.7 1.2 1.0 3.2 6.7 0.7 1.1 3.4 6.0 0.7 3.2 7.1 5.2 3.6 1.6 4.4 2.5 4.5 1.5 3.2 6.7 7.0 0.5 0.5 0.7 6.4 8.8 2.6 3.4 7.1 2.6 5.7 6.8 8.3 5.9 3.9 9.1 1.3 1.9 0.3 1.8 2.1 1.5 1.9 4.0 2.1 4.9 2.9 7.3 0.2 6.4 6.2 11.6 6.0 9.9 8.0 4.0 5.6 8.8 6.2 36.3 1.6 7.0 4.5 8.6 5.7 6.9 7.1 5.2 10.9 6.0 6.0 5.8 6.2 8.0 6.5 11.9 15.0 11.1 11.1 10.1 10.7 13.2 17.8 16.0 7.9 15.7 7.9 20.5 44.7 8.8 21.4 11.2 6.8 0.0 14.6 15.3 9.1 9.3 11.5 27.6 14.7 3.2 9.9 8.6 10.7 43.5 10.3 9.4 13.5 9.0 12.3 24.0 14.0 13.1 9.2 51.9 18.3 0.0 12.3 1.6 6.3 13.0 19.9 13.3 11.5 9.2 DHX35 "C20orf15, DDX35, FLJ22759, KAIA0875" ENSG00000101452 "DEAH-box helicase 35" Q9H5Z1 20 38962299-39039723 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054451, HPA062700" Uncertain Approved "Nucleoplasm,Nuclear bodies,Centrosome" No No "Nuclear bodies" "Nucleoplasm, Centrosome" "HPA054451: AB_2682491, HPA062700: AB_2684838" "unprognostic (8.31e-2)" "unprognostic (2.34e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (4.25e-5)" "unprognostic (1.29e-2)" "unprognostic (8.38e-2)" "prognostic unfavorable (5.63e-6)" "unprognostic (9.83e-2)" "unprognostic (2.21e-1)" "unprognostic (6.22e-2)" "unprognostic (4.47e-2)" "unprognostic (5.67e-2)" "unprognostic (8.57e-2)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (3.31e-1)" 10.4 7.3 9.7 6.9 14.6 13.9 9.8 9.7 14.3 12.2 23.2 14.8 10.7 9.9 19.7 13.9 13.9 12.5 9.2 16.9 9.0 5.8 10.4 7.5 8.7 12.6 8.2 6.7 13.9 6.5 12.1 13.5 8.4 10.9 13.3 14.3 12.4 10.4 12.6 12.5 11.1 12.4 14.7 9.9 8.4 13.4 12.5 9.4 12.1 8.5 7.6 11.2 15.9 11.8 4.6 6.7 2.0 4.9 5.8 8.2 4.4 7.3 4.5 12.0 4.9 4.6 6.0 8.5 4.4 7.9 10.2 7.8 21.2 7.2 8.5 7.9 8.4 7.9 11.7 8.3 13.0 10.1 2.1 4.1 11.3 10.1 12.0 5.5 13.1 5.9 7.0 8.4 9.0 8.4 6.3 4.5 14.5 11.4 4.9 5.4 6.0 21.4 10.1 6.9 13.4 9.9 10.5 17.5 6.8 3.7 8.5 10.6 8.3 12.1 7.3 11.2 7.8 10.0 10.8 4.4 14.7 8.1 5.8 9.2 4.9 6.4 8.8 8.6 6.0 7.6 0.0 4.9 2.0 5.3 4.5 5.2 4.6 4.5 5.6 6.7 4.3 8.2 4.3 1.0 5.8 3.8 2.4 2.8 4.4 9.7 14.6 9.7 14.3 9.0 5.8 8.2 6.7 10.9 9.4 0.0 3.0 0.8 1.2 0.5 5.8 4.8 5.1 4.0 4.5 1.8 3.9 3.1 1.7 2.5 2.9 2.4 3.3 0.0 1.0 2.0 2.4 2.1 8.1 5.5 4.3 4.8 5.2 5.5 3.7 0.4 5.8 3.1 3.3 2.8 6.2 2.6 1.7 2.9 6.0 1.7 4.6 0.0 2.3 1.7 10.0 1.8 2.5 1.7 4.4 1.0 DHX58 "D11LGP2, LGP2" ENSG00000108771 "DExH-box helicase 58" Q96C10 17 42101404-42112733 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "monocytes: 65.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 24.6;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;SK-MEL-30: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018670, HPA019570" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "HPA018670: AB_1847665, HPA019570: AB_1847666" "prognostic favorable (3.45e-4)" "unprognostic (1.03e-2)" "unprognostic (3.56e-3)" "unprognostic (1.54e-2)" "unprognostic (2.45e-2)" "unprognostic (4.82e-2)" "unprognostic (2.05e-3)" "unprognostic (5.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.15e-1)" "unprognostic (6.02e-2)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (8.65e-2)" "unprognostic (8.01e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 12.7 16.3 6.7 15.3 7.8 11.1 9.8 2.8 8.4 7.9 9.8 9.6 15.0 8.2 9.6 16.2 8.7 12.0 12.6 5.3 6.5 5.3 11.0 20.9 21.7 14.4 5.9 9.0 12.9 7.4 4.3 9.6 7.0 8.2 10.6 5.0 13.4 18.0 17.1 6.9 7.8 10.5 9.2 7.9 17.1 9.1 10.7 5.1 17.2 7.5 5.6 12.9 10.9 7.6 6.4 7.6 8.6 12.0 7.6 7.1 5.9 1.2 0.0 0.0 0.7 6.2 5.4 0.2 1.7 11.9 24.6 28.8 0.1 7.7 0.1 1.8 2.8 5.6 1.0 0.1 1.9 0.9 4.8 0.1 2.0 1.1 0.4 7.0 1.8 4.6 8.7 3.2 2.1 2.1 4.3 2.9 12.5 0.0 6.8 1.3 0.0 11.0 2.3 0.2 0.3 0.0 4.0 0.0 0.5 2.7 4.5 0.2 0.0 0.8 3.1 14.0 0.0 4.2 1.9 1.2 1.2 0.0 0.4 0.6 2.3 1.9 0.1 2.5 1.7 1.3 3.1 9.9 8.6 4.5 12.0 6.5 6.4 6.4 4.0 7.6 4.9 7.1 5.3 4.0 7.6 10.5 2.5 5.5 5.9 6.7 7.8 2.8 8.4 6.5 5.3 5.9 9.0 8.2 5.1 8.9 4.3 2.7 4.8 1.3 0.6 0.8 5.1 8.1 6.8 7.0 0.0 2.8 1.7 4.9 5.4 4.5 2.4 0.0 6.0 2.8 2.8 5.0 1.1 10.5 8.8 0.0 0.0 5.5 6.0 8.3 8.1 5.0 3.3 65.9 2.8 2.0 5.1 4.9 8.5 3.8 0.6 0.0 2.3 9.6 0.7 1.4 0.7 7.7 1.6 1.8 DIDO1 "BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333" ENSG00000101191 "Death inducer-obliterator 1" Q9BTC0 20 62877738-62937952 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004374, HPA049904" Supported Approved Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "CAB004374: AB_2093108, HPA049904: AB_2680944" "unprognostic (9.56e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-1)" "unprognostic (7.47e-2)" "unprognostic (2.68e-1)" "prognostic favorable (5.13e-4)" "unprognostic (9.92e-3)" "unprognostic (4.57e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "prognostic favorable (3.88e-4)" "unprognostic (2.20e-2)" "unprognostic (1.50e-3)" "unprognostic (1.06e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-2)" "unprognostic (9.82e-2)" 25.1 15.9 19.7 21.5 21.3 22.8 26.9 38.1 23.2 29.7 24.0 27.0 26.7 18.4 33.2 26.9 20.7 29.2 27.0 23.2 17.9 14.7 18.2 18.3 22.9 27.5 22.9 18.8 37.4 21.4 28.0 25.1 30.6 17.6 24.3 19.2 27.0 26.3 25.5 27.6 34.0 25.2 27.5 17.5 25.8 21.2 24.1 23.1 35.1 25.1 20.5 29.6 26.1 35.6 9.7 8.6 20.9 7.6 10.1 15.3 7.1 11.7 9.1 15.3 8.7 7.9 9.7 8.2 8.9 7.6 33.3 9.7 39.0 12.3 11.7 12.4 10.9 19.3 18.5 13.9 17.3 21.6 6.4 9.4 16.8 15.0 27.8 10.0 15.0 17.4 10.0 23.8 11.5 6.5 7.6 9.1 22.5 16.4 10.7 8.4 11.4 30.3 13.2 12.2 14.4 13.3 21.5 19.6 7.4 5.5 10.5 18.9 11.2 17.9 17.4 11.7 9.6 17.3 17.2 11.3 27.2 19.0 9.0 12.6 7.1 4.6 15.6 12.4 7.6 9.8 20.9 5.6 15.1 12.9 7.6 13.3 9.7 11.3 12.3 4.1 8.2 15.3 14.1 8.6 10.1 5.8 8.6 9.0 7.1 19.7 21.3 38.1 23.2 17.9 14.7 22.9 18.8 17.6 23.1 23.8 26.7 14.9 30.5 21.5 23.5 22.9 17.8 49.5 23.9 24.4 31.4 23.6 19.9 15.5 30.5 21.1 20.9 0.0 12.0 13.2 18.7 23.2 22.0 17.4 12.1 36.5 18.5 19.6 13.2 7.9 32.5 16.3 20.3 17.2 22.7 15.8 17.0 21.0 31.8 9.2 22.1 6.5 17.6 18.9 31.8 22.3 16.5 26.1 20.8 28.8 DIO2 "SelY, TXDI2" ENSG00000211448 "Iodothyronine deiodinase 2" Q92813 14 80197527-80387757 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 67.7;thyroid gland: 128.7" "Group enriched" "Detected in many" 14 "Extravillous trophoblasts: 495.6;Muller glia cells: 220.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 34.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 26.7;fHDF/TERT166: 14.7;HeLa: 30.6;HHSteC: 15.2;SiHa: 55.9;SK-BR-3: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048002 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA048002: AB_2680230" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "prognostic favorable (1.67e-4)" "prognostic favorable (4.62e-6)" "unprognostic (2.76e-1)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (2.07e-1)" "unprognostic (8.78e-2)" "unprognostic (3.68e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-3)" "unprognostic (5.08e-2)" "unprognostic (3.43e-1)" "unprognostic (8.40e-2)" "unprognostic (7.15e-2)" 1.3 1.8 13.0 0.9 12.3 0.7 6.1 1.0 19.7 67.7 1.2 1.6 1.9 1.2 15.6 1.1 36.1 0.9 2.5 4.7 14.2 2.7 2.4 0.7 1.2 1.0 4.1 7.6 0.7 1.3 0.9 35.9 5.9 13.2 5.0 1.3 13.1 17.7 12.4 3.0 3.3 1.2 2.4 1.2 0.9 2.5 2.5 1.4 0.0 128.7 15.8 12.0 2.6 13.7 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.4 0.0 26.7 5.7 2.4 0.3 0.0 0.1 0.0 0.1 14.7 0.1 0.5 0.9 0.0 1.9 0.0 0.0 0.0 30.6 0.0 15.2 0.0 0.0 1.7 0.0 0.5 0.0 1.3 0.5 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.5 0.0 0.1 0.2 1.2 0.0 0.0 0.2 0.0 0.0 55.9 11.7 0.1 2.5 0.0 0.0 0.3 0.1 2.4 5.6 6.7 0.9 0.0 0.0 2.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 13.0 12.3 1.0 19.7 14.2 2.7 4.1 7.6 13.2 1.4 0.0 0.3 0.0 0.1 2.6 2.9 1.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 18.5 1.4 0.0 0.0 0.0 495.6 26.0 0.2 0.0 0.0 8.2 1.6 0.0 0.6 1.0 9.6 3.1 0.3 5.0 0.0 0.0 220.7 0.6 0.0 3.9 0.0 6.2 0.0 8.2 3.3 0.6 2.6 23.6 0.0 0.0 0.0 DIP2C KIAA0934 ENSG00000151240 "Disco interacting protein 2 homolog C" Q9Y2E4 10 274190-689668 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.8" "Group enriched" "Detected in many" 5 "B-cells: 3.8;T-cells: 1.3" "Cell line enhanced" "Detected in many" "U-2197: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030264, HPA059325" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA030264: AB_10600903, HPA059325: AB_2683979" "unprognostic (1.72e-2)" "unprognostic (3.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (8.32e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (1.58e-1)" "unprognostic (2.00e-1)" "unprognostic (6.28e-3)" "unprognostic (5.94e-2)" "unprognostic (3.65e-2)" "prognostic favorable (2.46e-6)" "unprognostic (8.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.09e-3)" "unprognostic (9.10e-3)" 15.4 8.1 19.9 5.0 25.0 0.9 9.9 23.0 24.7 12.6 20.8 21.2 6.4 6.2 14.1 7.8 12.2 9.1 11.3 17.3 16.3 10.1 19.2 11.5 6.7 3.4 21.7 14.4 18.1 10.4 10.4 7.4 6.3 16.5 11.5 6.3 13.0 5.6 12.7 38.2 5.5 7.3 16.1 14.9 4.5 8.3 9.4 23.1 0.0 7.3 2.9 2.5 11.6 13.0 3.8 0.5 0.1 0.3 0.3 1.3 0.4 0.4 4.0 7.5 4.0 12.7 13.9 6.2 8.9 5.6 6.8 5.6 1.1 1.2 0.3 2.4 14.3 1.8 0.1 4.6 0.7 4.2 0.2 4.1 0.1 2.7 1.2 6.2 0.0 5.6 11.3 3.6 4.3 0.0 10.8 1.5 0.1 0.0 0.8 5.1 10.9 0.4 0.0 1.9 3.4 1.6 6.2 3.1 1.2 4.9 4.6 3.8 5.4 1.5 3.2 12.8 4.1 4.3 0.0 0.1 7.3 1.9 21.7 2.9 0.5 8.6 4.6 9.2 0.2 4.1 0.0 0.3 0.0 0.4 0.0 0.4 2.6 0.8 1.0 0.0 3.8 1.2 1.3 0.1 0.3 0.0 0.5 0.5 0.4 19.9 25.0 23.0 24.7 16.3 10.1 21.7 14.4 16.5 23.1 8.9 4.3 3.7 4.5 7.0 18.1 25.0 22.9 8.1 6.8 3.5 21.6 4.4 0.0 6.9 11.0 6.0 2.8 0.0 3.5 3.4 12.1 4.9 19.7 21.7 4.7 1.6 10.4 8.0 3.5 3.8 10.6 2.0 21.9 1.0 4.1 20.4 6.5 0.0 18.4 14.7 18.0 6.5 17.8 21.3 16.5 3.3 3.2 1.0 6.1 8.1 DLC1 "ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12" ENSG00000164741 "DLC1 Rho GTPase activating protein" Q96QB1 8 13083361-13604610 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 232.3;Alveolar cells type 2: 178.8;Ito cells: 219.1;Sertoli cells: 219.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 6.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.5" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 19.1;hTERT-HME1: 14.0;HUVEC TERT2: 19.2;U-138 MG: 13.7;U-2197: 18.9;WM-115: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017753 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA017753: AB_10600805" "unprognostic (1.83e-1)" "unprognostic (1.67e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.11e-4)" "unprognostic (7.47e-2)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (1.12e-1)" "unprognostic (8.46e-3)" "unprognostic (6.49e-2)" "unprognostic (2.02e-2)" "unprognostic (3.56e-3)" "unprognostic (2.79e-2)" "unprognostic (7.33e-2)" "unprognostic (1.67e-1)" 33.9 8.0 8.5 8.8 15.4 4.9 31.9 3.1 11.4 13.6 13.1 16.0 2.0 6.1 12.4 7.4 8.6 10.4 13.1 15.1 10.0 7.3 9.2 24.1 32.4 5.6 18.0 6.8 8.0 6.3 6.3 4.4 22.3 16.2 5.7 4.5 13.6 4.9 4.1 7.6 5.4 8.5 18.7 15.0 16.6 11.1 5.5 16.5 0.0 12.0 6.1 2.9 17.1 17.2 0.0 0.2 6.5 1.3 0.0 0.1 0.0 0.0 0.1 1.7 0.0 12.5 7.1 6.0 0.6 0.1 0.3 0.6 3.9 2.4 0.0 0.2 11.9 5.5 2.0 1.0 1.7 1.1 0.0 0.9 0.3 0.0 4.2 6.5 0.0 3.6 5.5 0.1 19.1 14.0 0.5 19.2 0.0 1.0 0.0 5.7 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 6.0 0.0 0.8 0.0 0.2 6.3 6.5 0.0 0.0 1.9 13.7 7.5 18.9 4.5 0.0 0.0 0.0 10.6 0.0 13.9 6.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 8.5 15.4 3.1 11.0 10.0 7.3 18.0 6.8 16.2 16.5 232.3 178.8 4.3 2.6 13.2 0.5 31.1 22.9 5.3 35.2 3.5 0.0 6.3 1.7 3.0 6.6 118.2 1.0 0.0 3.9 1.5 53.2 1.2 63.8 21.3 3.0 12.7 1.2 219.1 20.0 2.5 67.0 4.3 23.6 0.0 0.1 1.0 3.9 0.2 33.9 1.3 1.6 219.9 63.1 4.9 11.7 8.2 2.3 0.7 0.4 1.8 DLGAP4 "DAP4, KIAA0964, SAPAP4" ENSG00000080845 "DLG associated protein 4" Q9Y2H0 20 36306336-36528637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 64.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054105, HPA056378" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA054105: AB_2682381, HPA056378: " "unprognostic (1.11e-1)" "unprognostic (1.42e-1)" "unprognostic (9.00e-2)" "prognostic unfavorable (2.24e-5)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.73e-6)" "unprognostic (1.23e-1)" "prognostic favorable (9.88e-5)" "unprognostic (1.28e-1)" "unprognostic (2.18e-2)" "unprognostic (8.45e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.07e-1)" "unprognostic (1.13e-1)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" 18.8 16.6 25.7 14.3 32.9 4.5 18.0 16.2 31.9 19.0 20.1 9.0 14.9 13.5 23.1 13.1 16.8 18.5 17.0 25.9 23.7 12.7 10.2 11.0 21.6 9.8 9.5 20.7 18.9 30.2 7.7 10.2 16.9 8.8 15.7 10.1 15.4 19.3 21.2 58.0 27.1 13.6 27.2 6.8 14.5 12.2 12.6 10.9 8.3 13.8 16.8 10.8 29.0 15.0 16.1 13.5 19.5 13.1 6.9 12.5 9.1 14.1 12.9 15.8 13.0 15.0 24.6 15.9 21.4 19.6 21.0 14.6 19.4 9.1 4.0 11.6 30.0 18.6 13.7 4.2 21.9 15.7 6.4 1.5 9.1 6.6 13.1 21.7 3.6 7.9 16.2 17.0 24.8 17.4 16.3 20.6 5.7 6.3 11.0 15.8 10.6 7.4 13.9 6.8 10.4 27.6 7.4 4.2 5.5 9.8 7.0 10.4 14.3 14.0 28.5 17.6 16.8 16.3 6.4 20.7 64.1 19.5 27.5 11.7 3.8 2.7 4.3 25.6 4.6 25.1 2.1 12.8 19.5 12.5 13.1 9.8 16.1 11.3 8.7 11.3 14.9 8.8 7.0 18.5 6.9 12.6 13.5 8.7 9.1 25.7 32.9 16.2 31.9 23.7 12.7 9.5 20.7 8.8 10.9 14.9 18.6 15.9 41.2 59.0 31.9 25.0 25.5 17.4 13.6 12.2 7.9 19.6 6.6 45.3 63.3 34.3 19.2 0.0 47.9 41.6 32.7 58.9 11.6 16.3 24.9 69.9 60.7 24.5 18.1 119.1 27.6 21.1 10.1 63.1 29.8 36.4 66.0 24.6 24.8 16.3 27.9 71.1 41.0 13.6 16.2 62.7 46.1 15.0 16.9 46.3 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 19.3" "Cell type enriched" "Detected in some" 7 "Basal glandular cells: 79.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 16.5;HBEC3-KT: 9.0;hTCEpi: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles No No Nucleoplasm "Nucleoli, Vesicles" "HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 1.0 1.1 4.5 1.4 7.9 1.7 4.3 12.2 8.2 2.2 0.7 0.9 6.4 1.1 1.4 3.8 10.5 1.1 0.9 1.8 4.1 4.6 0.7 0.7 1.1 1.7 1.5 4.8 1.7 1.5 0.4 0.5 1.3 0.9 10.4 0.5 0.3 12.4 13.0 0.7 19.3 1.0 0.6 1.5 1.5 1.1 1.1 1.2 1.3 0.8 4.7 3.9 2.2 5.3 0.8 1.8 1.0 0.5 2.5 3.2 0.3 5.2 1.9 0.5 7.9 0.0 0.4 1.8 1.9 2.1 2.2 1.0 1.8 0.2 1.0 1.2 0.4 2.7 16.5 5.6 9.0 0.5 1.0 2.1 0.4 0.9 2.8 0.6 0.3 1.1 0.9 27.2 0.6 5.1 0.7 0.0 3.1 0.4 0.8 0.8 2.0 0.4 0.4 0.7 2.0 2.0 1.1 1.0 0.5 0.3 1.8 5.9 0.6 0.6 0.2 0.3 0.4 0.5 1.6 0.5 0.8 2.5 0.6 3.8 1.2 0.3 1.7 0.1 0.7 0.5 0.9 0.4 0.4 0.7 0.3 3.2 0.6 2.2 2.2 0.1 0.8 0.9 0.4 1.0 2.5 0.5 1.8 0.3 0.3 4.5 7.9 12.2 8.2 4.1 4.6 1.5 4.8 0.9 1.2 0.0 0.3 0.0 79.5 9.0 0.6 0.5 0.0 0.0 7.9 0.0 0.0 0.8 0.0 0.1 0.2 0.3 0.0 0.0 0.0 2.1 0.2 4.3 0.0 0.0 0.1 11.1 1.2 0.0 0.0 0.2 0.3 0.0 1.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.9 0.0 0.3 1.2 5.5 2.3 0.2 0.0 0.0 3.9 DNAH17 "DNAHL1, DNEL2, FLJ40457" ENSG00000187775 "Dynein axonemal heavy chain 17" Q9UFH2 17 78423697-78577394 "Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 39.4" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 44.2;Cone photoreceptor cells: 82.5;Early spermatids: 36.7;Late spermatids: 24.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 10.0;MOLT-4: 4.8" "Not detected" "Not detected" "HPA024354, HPA076261" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA024354: AB_1847911, HPA076261: AB_2732305" "unprognostic (4.98e-4)" "unprognostic (2.26e-1)" "unprognostic (2.30e-3)" "unprognostic (8.70e-3)" "unprognostic (6.66e-2)" "unprognostic (9.23e-2)" "unprognostic (3.72e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-1)" "unprognostic (1.20e-3)" "unprognostic (8.35e-3)" "unprognostic (1.58e-10)" "unprognostic (5.25e-2)" "unprognostic (1.54e-1)" "unprognostic (5.12e-1)" "unprognostic (6.04e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.1 0.0 39.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.0 0.0 10.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.1 4.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 6.0 0.3 0.5 0.2 0.6 44.2 2.0 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 36.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 24.9 0.6 1.3 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 7.2 0.0 0.2 16.2 0.5 0.1 0.0 0.0 0.0 0.1 DNAJB4 HLJ1 ENSG00000162616 "DnaJ heat shock protein family (Hsp40) member B4" Q9UDY4 1 77979175-78017964 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 89.8" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 28.6;HUVEC TERT2: 43.5;LHCN-M2: 73.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004995, HPA028383, HPA028385" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944" "unprognostic (1.21e-1)" "unprognostic (4.36e-2)" "unprognostic (2.19e-1)" "unprognostic (5.50e-3)" "unprognostic (3.40e-2)" "unprognostic (4.76e-3)" "unprognostic (4.32e-3)" "unprognostic (3.93e-3)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (2.00e-1)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (7.12e-3)" "unprognostic (1.01e-2)" 23.3 39.0 19.2 8.4 20.7 4.9 16.6 22.7 24.1 21.3 12.7 7.2 9.3 5.4 20.8 10.1 25.0 11.7 25.2 42.0 18.0 16.8 16.0 15.5 21.7 7.0 25.7 9.1 15.3 18.5 16.4 19.1 19.5 23.8 19.4 9.4 5.1 7.0 12.2 33.3 7.6 8.8 23.0 29.5 30.3 11.9 7.8 22.5 2.8 35.1 29.4 5.1 22.1 89.8 3.6 5.0 4.5 1.9 3.1 7.2 2.6 1.4 2.8 3.5 2.1 15.3 28.6 1.6 27.8 7.1 12.4 14.0 0.9 1.8 2.1 4.7 13.2 5.1 2.1 4.5 2.4 21.2 2.3 1.2 1.0 8.3 6.7 20.8 0.5 0.5 11.8 6.7 16.0 4.6 6.9 43.5 0.7 4.5 1.5 73.8 0.1 0.6 1.5 2.2 0.4 1.3 1.1 6.2 1.3 2.9 0.7 2.5 0.8 3.2 2.3 2.6 3.8 0.9 0.9 20.7 17.5 4.3 12.4 3.6 1.3 0.4 1.8 2.3 1.2 3.0 4.5 1.7 2.7 2.6 1.7 4.4 3.6 3.2 3.1 1.7 3.0 7.2 5.1 0.4 3.1 1.9 5.0 4.2 2.6 19.2 20.7 22.7 24.1 18.0 16.8 25.7 9.1 23.8 22.5 56.6 4.6 13.3 77.1 37.1 28.0 82.6 10.2 30.8 20.5 17.4 64.8 46.9 31.5 10.5 126.4 66.1 19.8 23.3 12.8 18.9 83.6 23.4 57.5 18.1 15.9 28.6 20.5 33.2 21.3 48.4 22.7 19.0 62.4 6.4 4.0 35.7 14.8 17.5 32.9 22.8 56.8 25.8 119.1 21.1 13.2 34.4 151.4 15.2 6.5 27.1 DNAJC6 "KIAA0473, PARK19" ENSG00000116675 "DnaJ heat shock protein family (Hsp40) member C6" O75061 1 65248219-65415869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chaperone, Hydrolase, Protein phosphatase" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 91.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 29.6;Cardiomyocytes: 26.1;Erythroid cells: 23.3;Horizontal cells: 49.3;Rod photoreceptor cells: 21.6" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 21.2;HEL: 56.7;K-562: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031182, HPA054917" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA031182: AB_10611957, HPA054917: AB_2682641" "unprognostic (6.99e-2)" "unprognostic (2.00e-3)" "unprognostic (3.19e-1)" "unprognostic (7.94e-7)" "unprognostic (1.59e-1)" "unprognostic (7.61e-3)" "unprognostic (1.87e-4)" "unprognostic (2.98e-1)" "unprognostic (1.89e-1)" "unprognostic (4.14e-1)" "unprognostic (4.22e-3)" "unprognostic (1.53e-1)" "prognostic favorable (2.81e-4)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-1)" "unprognostic (8.67e-3)" 2.1 12.1 18.6 2.2 28.5 5.0 2.0 24.2 91.4 2.2 2.8 26.9 0.0 2.3 1.9 1.8 1.7 2.4 2.3 9.0 25.0 26.7 8.5 1.6 2.7 1.6 28.8 23.8 1.9 3.4 2.1 7.5 8.0 40.5 2.5 3.0 2.2 1.7 2.1 1.6 2.1 2.3 2.2 28.7 3.2 2.9 3.2 21.1 0.0 3.0 0.0 1.7 1.8 0.6 0.5 0.5 0.0 0.0 0.6 1.5 0.3 3.5 1.0 0.0 1.6 0.8 0.2 8.4 7.1 11.6 11.7 11.5 0.9 0.1 3.4 0.6 2.9 2.9 0.9 5.1 1.1 9.2 21.2 2.4 56.7 1.9 0.2 0.0 1.9 1.4 1.0 0.8 1.1 5.0 2.2 0.2 2.8 22.0 0.4 2.4 0.6 0.7 0.0 2.3 0.0 0.8 0.0 1.7 0.1 8.9 0.0 14.2 9.7 4.1 5.6 1.9 14.1 2.7 0.1 2.2 1.7 1.2 0.2 2.0 2.1 1.4 1.0 4.8 1.4 2.9 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.5 0.9 0.0 0.0 0.4 0.6 0.0 0.6 0.0 0.5 0.0 0.3 18.6 28.5 24.2 37.4 25.0 26.7 28.8 23.8 40.5 21.1 0.0 0.3 0.0 0.2 1.1 29.6 26.1 0.0 0.0 0.0 0.0 13.7 4.8 1.7 0.8 1.8 0.7 0.0 23.3 0.6 1.9 1.7 1.3 0.0 0.0 1.1 49.3 6.9 0.0 0.0 1.4 0.0 0.8 6.8 1.8 1.3 3.1 0.4 0.0 0.0 5.9 21.6 0.0 2.3 1.0 2.3 0.3 6.2 0.0 0.5 0.1 DOC2A ENSG00000149927 "Double C2 domain alpha" Q14183 16 30005509-30023270 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.0;testis: 12.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 72.3;Early spermatids: 196.5;Late spermatids: 146.0" "Cancer enhanced" "Detected in many" "renal cancer: 5.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.8;SCLC-21H: 26.6;U-937: 12.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 13.5;cerebral cortex: 30.8;hippocampal formation: 24.4" HPA065676 Uncertain "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Nucleoli" "HPA065676: AB_2685528" "unprognostic (1.46e-3)" "unprognostic (3.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (4.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.66e-2)" "unprognostic (9.14e-2)" "unprognostic (3.90e-2)" "unprognostic (2.89e-2)" "unprognostic (1.28e-3)" "unprognostic (5.13e-2)" "unprognostic (8.29e-3)" "unprognostic (1.71e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" "unprognostic (2.61e-1)" 1.2 2.7 18.5 1.0 17.5 3.9 2.3 24.0 49.0 1.3 3.1 0.9 0.3 1.7 1.6 2.4 1.1 3.3 1.8 1.0 15.3 8.3 1.6 1.4 3.5 1.4 2.8 27.4 5.7 1.0 1.3 3.2 1.2 13.1 2.5 2.4 0.0 1.6 1.4 1.1 2.0 2.3 1.8 4.2 3.1 1.7 12.6 1.8 0.0 1.6 0.0 1.2 1.4 0.6 0.6 1.1 1.0 0.4 0.2 0.5 0.3 0.7 1.5 1.1 0.8 0.3 0.0 9.8 0.4 0.7 0.5 0.3 4.0 2.7 0.0 0.9 0.4 1.4 0.2 5.0 2.0 0.2 0.1 0.5 0.8 0.5 0.3 0.7 0.9 2.9 1.2 0.8 0.1 1.1 5.0 0.0 3.3 0.3 0.0 0.0 7.8 2.1 3.6 1.5 3.1 4.2 8.0 0.1 0.4 0.5 0.8 26.6 2.1 0.6 2.8 0.2 2.4 2.7 1.7 0.8 0.3 1.5 0.3 0.3 0.5 0.1 0.1 0.3 12.8 0.3 0.8 0.4 0.0 0.0 0.3 0.1 0.5 0.1 0.3 1.1 0.6 0.5 0.5 1.0 0.2 0.0 0.0 0.1 0.3 18.5 17.5 24.0 36.2 15.3 8.3 2.8 27.4 13.1 1.8 0.0 5.8 0.5 3.1 0.6 1.2 0.6 2.5 72.3 12.5 1.8 21.6 0.3 1.7 0.0 196.5 0.7 0.9 0.0 0.0 0.9 0.7 1.8 0.0 0.0 0.4 0.0 1.2 1.8 1.3 146.0 0.6 1.3 1.7 0.0 2.2 3.1 0.0 0.0 1.8 0.0 1.8 0.0 0.3 1.7 4.1 0.6 0.1 0.0 4.1 0.7 DOHH "HLRC1, MGC4293" ENSG00000129932 "Deoxyhypusine hydroxylase" Q9BU89 19 3490822-3500940 "Enzymes, Predicted intracellular proteins" "Hypusine biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041953, HPA076271" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041953: AB_10795386, HPA076271: " "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (8.63e-2)" "prognostic favorable (2.24e-4)" "unprognostic (3.66e-1)" "unprognostic (2.01e-2)" "unprognostic (9.45e-2)" "unprognostic (7.26e-2)" "unprognostic (4.65e-2)" "unprognostic (1.13e-1)" "prognostic favorable (3.58e-4)" "unprognostic (9.87e-3)" "unprognostic (1.14e-3)" "unprognostic (4.35e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.76e-3)" 8.1 6.5 10.5 6.6 13.0 9.3 3.4 5.5 13.0 3.9 5.5 6.9 2.6 18.9 3.7 4.1 4.1 3.1 4.9 5.1 14.9 9.1 6.0 6.4 4.0 4.5 18.2 6.2 3.8 7.6 3.8 3.9 3.8 8.4 5.1 2.0 3.2 6.0 4.0 23.1 7.0 12.3 2.4 25.5 5.9 7.3 4.2 6.1 4.7 2.9 7.8 4.5 3.1 4.7 11.6 11.0 1.8 6.6 6.9 12.3 4.4 9.2 11.0 1.7 3.6 0.9 1.1 7.4 8.8 1.8 4.3 3.4 15.3 3.8 7.2 6.9 1.3 3.9 9.6 2.7 3.0 0.9 10.6 12.4 7.5 6.2 18.2 3.5 10.0 10.5 1.2 3.0 4.2 1.8 1.5 2.2 8.0 16.3 8.5 1.7 10.5 10.8 11.4 9.8 3.7 14.9 12.3 4.0 10.4 2.6 5.2 10.5 7.7 6.2 5.5 8.8 0.8 7.5 5.5 5.0 5.4 7.4 14.3 16.1 11.3 8.2 9.6 6.4 22.8 6.4 1.1 5.3 1.8 6.2 6.2 8.1 8.1 8.5 12.3 8.7 11.6 12.3 10.4 0.3 6.9 6.6 11.0 9.6 4.4 10.5 13.0 5.5 13.0 14.9 9.1 18.2 6.2 8.4 6.1 6.0 2.1 18.5 14.9 20.9 17.4 7.1 10.2 1.4 2.3 5.2 9.8 25.8 18.3 21.7 7.1 12.1 9.7 0.0 18.5 26.0 13.9 16.8 13.8 8.2 19.0 23.8 12.6 11.1 7.2 17.2 13.0 8.6 18.6 24.4 11.0 13.1 19.1 14.4 14.2 23.9 11.8 0.0 13.7 11.1 12.3 24.1 29.1 12.8 16.1 15.3 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947619 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA066767: AB_2732751, HPA068706: AB_2732118" "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favorable (6.88e-5)" "unprognostic (6.13e-3)" 11.0 20.2 7.9 7.8 13.8 1.4 9.5 7.0 18.6 9.8 8.6 14.9 7.1 8.8 12.4 16.8 10.9 10.8 10.8 12.0 7.6 9.9 17.5 22.0 10.6 10.6 8.1 6.7 13.2 16.9 19.2 8.0 19.5 16.3 12.3 8.0 14.2 15.5 12.8 7.9 11.4 10.9 11.1 5.9 11.6 12.4 22.4 6.0 12.5 11.0 11.9 12.1 10.4 7.3 9.4 14.2 5.6 16.4 9.8 13.7 9.0 5.1 19.3 6.8 10.1 20.2 10.7 9.3 10.8 17.5 13.3 9.9 15.1 8.2 2.8 5.7 15.6 18.8 36.7 9.3 13.5 6.9 4.7 8.1 3.5 13.3 10.9 20.5 3.8 6.3 14.8 12.5 14.3 7.9 7.8 12.9 4.1 8.6 4.6 14.3 25.4 3.1 3.2 8.8 14.8 12.0 3.2 9.0 11.2 11.9 7.8 6.3 7.0 14.3 11.8 6.3 6.7 20.6 5.1 10.7 12.0 4.3 15.1 8.8 4.4 10.8 2.9 11.3 3.5 9.1 2.3 13.5 5.6 10.2 13.3 9.1 9.4 9.2 11.2 14.2 9.2 12.1 12.3 2.1 9.8 16.4 8.1 13.7 9.0 7.9 13.8 7.0 18.6 7.6 9.9 8.1 6.7 16.3 6.0 6.0 2.6 1.5 3.2 1.5 9.0 3.0 7.6 6.7 3.4 7.0 7.9 21.7 0.0 14.1 10.7 8.3 6.2 0.0 12.3 14.0 5.6 3.1 1.1 8.3 11.4 4.8 1.2 17.2 6.9 2.8 11.2 2.7 3.3 1.8 3.8 11.2 10.4 5.8 5.6 7.2 6.5 0.0 4.1 24.0 14.9 1.1 15.2 1.9 5.5 1.7 DONSON "B17, C21orf60, C2TA, DKFZP434M035" ENSG00000159147 "Downstream neighbor of SON" Q9NYP3 21 33559542-33588708 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 44.4;Spermatocytes: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039558, HPA049033" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA039558: AB_2676570, HPA049033: AB_2680608" "unprognostic (9.90e-3)" "unprognostic (1.01e-3)" "unprognostic (6.58e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (8.22e-4)" "unprognostic (4.00e-2)" "unprognostic (5.93e-3)" "prognostic favorable (2.17e-4)" "unprognostic (1.25e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.77e-2)" "unprognostic (1.66e-1)" "unprognostic (2.07e-1)" "unprognostic (8.83e-2)" 6.4 3.5 4.1 9.2 8.0 9.4 10.2 7.8 5.6 6.8 7.1 3.3 3.5 6.1 6.7 5.8 8.3 6.3 5.9 7.5 5.5 4.4 5.6 16.2 5.2 11.1 4.7 4.0 13.5 5.7 11.7 6.9 12.2 8.1 5.7 7.4 4.4 4.8 4.3 5.9 9.1 9.3 5.4 5.2 8.2 5.8 24.0 3.0 26.4 5.0 8.1 10.7 4.5 9.7 0.7 0.5 0.1 0.9 0.4 1.4 0.3 27.4 6.4 13.5 11.8 4.2 7.8 10.5 21.9 9.5 16.8 19.1 18.0 7.5 14.9 5.7 10.9 12.7 8.2 18.2 7.8 18.5 14.9 15.7 27.9 14.1 16.3 3.1 14.8 6.8 5.5 2.5 19.0 4.6 5.0 10.7 7.8 26.6 26.0 14.4 5.6 13.5 5.3 14.0 13.1 7.9 12.1 27.9 15.9 7.5 7.4 14.7 6.1 32.9 10.5 9.6 7.0 13.8 7.5 6.2 16.0 11.2 11.7 15.4 23.6 23.2 24.5 8.9 19.8 18.0 0.0 0.3 0.1 1.4 0.9 0.7 0.2 1.4 0.6 0.2 0.7 0.8 0.1 0.0 0.4 0.0 0.5 0.6 0.3 4.1 8.0 7.8 5.6 5.5 4.4 4.7 4.0 8.1 3.0 3.0 3.4 0.8 7.7 7.2 3.5 3.4 7.6 0.0 1.2 3.5 9.8 8.0 1.7 3.0 44.4 4.5 2.7 0.0 4.0 22.1 6.4 4.6 8.1 5.5 7.6 6.4 1.2 8.6 2.7 16.6 9.5 5.1 6.8 3.6 3.8 2.4 3.7 2.9 13.1 4.2 2.7 0.0 8.1 53.1 21.1 8.5 13.8 5.7 5.1 8.1 DPF1 "BAF45b, NEUD4, neuro-d4" ENSG00000011332 "Double PHD fingers 1" Q92782 19 38211006-38229714 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 31.6" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 18.4;Early spermatids: 23.8;Horizontal cells: 42.9;Late spermatids: 17.6" "Cancer enhanced" "Detected in some" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 15.7;SCLC-21H: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049148 Enhanced Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA049148: AB_2680653" "unprognostic (7.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.38e-2)" "unprognostic (4.11e-3)" "unprognostic (8.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-4)" "unprognostic (1.40e-2)" "unprognostic (2.72e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-3)" "unprognostic (2.87e-2)" "unprognostic (1.11e-16)" "unprognostic (2.56e-1)" "unprognostic (3.75e-1)" "unprognostic (6.96e-2)" "unprognostic (8.20e-4)" 1.1 1.5 11.8 1.5 15.7 1.0 0.9 6.4 31.6 0.8 1.0 0.9 0.0 0.9 1.0 0.8 0.8 1.0 1.0 1.0 12.4 7.7 0.8 0.8 1.0 1.1 4.5 11.3 0.9 0.9 0.9 1.3 1.1 2.0 0.9 0.9 0.0 1.2 0.8 1.1 1.2 1.0 1.3 2.1 1.1 0.8 2.5 1.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.5 3.0 12.8 9.3 0.9 0.6 1.3 3.8 2.2 6.5 5.5 2.1 0.3 5.8 2.6 2.9 2.6 2.3 15.7 2.1 2.9 5.5 3.0 1.9 1.4 0.8 0.3 1.4 1.6 0.7 0.0 3.8 1.2 0.8 1.2 4.4 4.3 0.3 6.1 4.9 3.1 0.3 2.3 1.0 3.5 5.8 6.5 1.2 0.6 1.1 18.5 6.4 4.2 0.4 0.8 1.6 1.9 0.3 1.4 9.4 3.0 2.2 3.4 2.3 7.7 7.7 4.9 2.0 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.8 15.7 6.4 19.6 12.4 7.7 4.5 11.3 2.0 1.2 0.0 0.0 0.0 0.0 2.1 18.4 1.1 0.0 1.4 0.0 0.0 7.9 0.1 0.0 0.0 23.8 0.3 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 0.2 42.9 0.0 0.0 0.0 17.6 0.6 0.0 0.0 0.0 0.0 2.6 0.1 0.0 2.5 0.0 2.9 0.0 1.3 4.9 6.8 1.0 0.1 0.0 0.0 0.0 DPH6 "ATPBD4, MGC14798" ENSG00000134146 "Diphthamine biosynthesis 6" Q7L8W6 15 35217345-35546193 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042976, HPA055496" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042976: AB_10964890, HPA055496: AB_2682835" "unprognostic (9.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.92e-1)" "unprognostic (1.14e-1)" "unprognostic (1.82e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (9.94e-2)" "unprognostic (1.76e-1)" "unprognostic (1.49e-3)" "unprognostic (7.92e-3)" "unprognostic (1.13e-1)" "unprognostic (4.65e-6)" "unprognostic (9.70e-2)" "unprognostic (5.61e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" 13.3 12.7 8.0 6.8 16.1 6.4 15.3 11.6 15.8 14.7 9.2 15.5 10.8 8.5 23.9 17.1 14.7 11.5 10.5 14.4 7.8 7.2 14.7 11.2 8.7 9.3 9.7 12.0 16.7 19.5 15.8 31.7 11.1 13.4 8.5 10.2 14.6 11.5 14.7 24.9 15.2 8.7 16.8 11.1 8.3 9.6 11.3 10.6 7.1 15.3 16.5 10.0 11.0 11.3 8.4 6.3 0.3 6.5 13.2 10.8 4.4 10.5 5.7 9.6 8.1 1.7 7.9 9.4 4.0 7.0 9.7 5.1 7.6 9.9 3.3 9.8 3.7 11.8 12.2 11.1 11.5 11.6 2.6 7.0 12.3 6.5 12.0 10.3 6.5 8.0 6.6 14.6 3.9 18.9 6.0 9.3 7.1 13.5 13.4 8.9 4.1 8.0 6.1 8.5 16.1 5.3 10.0 9.0 4.5 8.4 13.5 7.0 6.9 7.5 8.4 6.4 5.9 29.0 9.1 2.8 9.5 9.2 9.4 6.3 12.0 19.0 8.3 8.2 11.3 9.0 0.0 6.5 0.3 6.2 6.0 7.7 8.4 8.3 8.6 6.3 6.5 10.8 9.5 0.3 13.2 5.6 5.4 5.4 4.4 8.0 16.1 11.6 15.8 7.8 7.2 9.7 12.0 13.4 10.6 14.9 6.9 12.6 16.6 27.5 31.5 11.0 17.8 5.3 17.0 8.7 37.3 22.9 11.6 12.0 2.1 9.5 10.1 23.3 21.1 18.8 11.6 7.6 3.5 7.3 15.0 17.5 5.2 6.7 10.0 1.6 13.0 10.9 15.1 15.4 6.0 16.6 15.1 7.0 6.3 16.4 22.2 0.0 11.3 8.3 15.1 20.3 18.9 5.0 9.2 11.1 DRG2 ENSG00000108591 "Developmentally regulated GTP binding protein 2" P55039 17 18087886-18107971 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007716 Approved Supported Nucleoplasm,Vesicles,Cytosol No No "Vesicles, Cytosol" Nucleoplasm "HPA007716: AB_1078705" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "prognostic favorable (1.56e-4)" "unprognostic (1.26e-3)" "unprognostic (7.86e-2)" "unprognostic (8.85e-2)" "unprognostic (5.72e-2)" "unprognostic (8.49e-2)" "unprognostic (1.25e-1)" "unprognostic (2.88e-3)" "prognostic unfavorable (7.34e-4)" "unprognostic (3.10e-1)" "unprognostic (2.18e-1)" "unprognostic (1.49e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" 19.9 19.9 16.1 17.5 21.8 17.4 19.3 14.7 30.8 19.3 19.3 22.9 16.6 19.2 23.5 22.8 21.6 25.2 18.2 22.4 15.7 17.0 19.1 31.9 15.7 21.2 17.6 16.1 27.6 23.9 20.6 18.8 22.4 17.9 21.1 13.4 18.4 21.7 21.7 33.3 19.4 17.9 18.3 17.1 20.7 17.6 14.6 17.2 21.6 23.6 21.2 25.6 20.5 18.0 12.6 18.4 17.0 20.9 20.0 19.8 14.0 14.9 21.4 7.3 7.2 13.6 14.5 13.9 10.6 10.5 17.2 16.0 22.7 9.0 14.5 13.8 12.2 9.2 15.9 12.0 14.6 11.6 12.8 32.9 6.3 11.4 12.6 14.8 5.8 10.1 16.1 13.0 17.2 14.5 10.0 16.3 19.5 11.1 5.7 10.0 16.9 15.4 9.7 5.4 21.2 15.8 16.6 17.7 26.9 10.2 8.8 4.1 11.8 10.5 6.2 12.9 45.9 12.4 8.8 12.2 8.3 7.9 9.7 17.4 6.5 7.9 8.1 12.0 10.6 15.2 11.6 15.9 17.0 19.8 17.2 16.4 12.2 14.7 15.8 18.4 12.6 14.0 15.3 2.1 20.0 20.9 10.3 18.3 14.0 16.1 21.8 14.7 30.8 15.7 17.0 17.6 16.1 17.9 17.2 0.0 7.7 15.6 18.9 14.8 10.8 3.2 15.3 4.0 6.8 7.0 2.0 32.2 24.9 23.5 5.9 15.7 22.3 0.0 23.6 33.6 16.4 17.5 11.5 14.5 28.1 6.4 20.7 15.4 16.4 10.0 19.8 15.6 11.8 24.4 16.3 18.8 21.1 14.0 23.0 22.6 13.8 6.5 19.6 11.2 10.4 10.2 32.8 24.2 20.9 12.6 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364181-49396016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "adrenal gland: 13.9;brain: 8.0" "Cell type enriched" "Detected in single" 4 "Melanocytes: 1.7" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 8.2;SH-SY5Y: 37.4;U-2197: 13.5" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low region specificity" "Detected in all" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.2 13.9 0.0 0.4 0.2 0.3 0.1 0.4 3.3 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.5 0.1 2.0 0.6 0.0 0.0 0.0 0.9 0.0 4.8 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.3 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 3.3 0.2 0.3 2.0 0.6 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DST "BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2" ENSG00000151914 Dystonin Q03001 6 56457987-56954628 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Basal glandular cells: 1024.4;Basal keratinocytes: 2104.0;Cone photoreceptor cells: 1319.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 5 "dendritic cells: 5.3;monocytes: 1.7;NK-cells: 2.1" "Cell line enhanced" "Detected in many" "hTCEpi: 94.5;hTERT-HME1: 70.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030200 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules" Cytosol "HPA030200: AB_10601901" "unprognostic (4.87e-3)" "unprognostic (1.29e-1)" "unprognostic (3.40e-1)" "unprognostic (1.54e-1)" "unprognostic (1.25e-2)" "unprognostic (3.60e-2)" "unprognostic (5.78e-2)" "unprognostic (2.35e-2)" "unprognostic (1.09e-1)" "unprognostic (2.75e-2)" "unprognostic (1.13e-1)" "unprognostic (3.69e-1)" "unprognostic (4.39e-2)" "unprognostic (5.13e-3)" "unprognostic (1.46e-1)" "unprognostic (2.66e-1)" "unprognostic (7.62e-2)" 26.5 29.2 43.4 11.7 57.1 2.5 59.2 43.6 52.4 53.8 31.5 32.1 11.5 15.1 53.6 21.7 37.1 19.4 16.8 28.1 41.2 36.2 18.0 26.6 29.4 5.4 56.5 28.9 30.3 14.0 32.1 28.2 15.1 53.9 22.6 17.4 8.4 23.6 25.3 57.5 81.8 16.9 53.6 54.9 12.8 14.8 11.7 66.5 6.1 7.6 33.6 7.7 19.7 23.7 0.6 5.3 0.3 1.7 2.1 0.4 0.3 12.2 5.9 7.9 4.4 13.1 20.7 4.5 16.5 15.8 6.8 7.6 3.4 3.2 1.9 6.8 37.2 6.8 8.6 6.7 29.0 13.5 11.6 9.9 3.4 10.6 6.2 11.8 3.3 0.0 9.1 94.5 16.6 70.1 11.9 12.9 1.9 2.8 8.1 17.7 3.4 1.0 1.3 6.0 6.8 4.3 0.0 6.1 2.8 20.6 15.8 10.5 7.9 7.0 2.4 11.2 14.1 3.7 5.3 34.5 15.1 12.7 7.2 13.6 9.1 6.4 1.0 10.7 1.8 7.2 0.3 1.7 0.0 0.3 1.3 0.1 0.2 0.4 0.0 3.2 0.6 0.1 0.2 0.1 2.1 1.0 5.3 0.0 0.3 43.4 57.1 43.6 52.4 41.2 36.2 56.5 28.9 53.9 66.5 312.7 10.2 2.2 1024.4 2104.0 540.0 729.3 79.0 49.5 257.0 52.4 1319.4 36.7 6.6 171.1 26.9 93.9 163.1 23.3 56.2 11.1 132.5 139.6 16.2 67.6 21.5 290.8 43.1 50.3 48.7 7.9 123.4 67.7 204.1 62.3 71.1 216.1 150.7 84.2 143.2 6.7 103.8 64.7 142.4 7.1 9.1 749.3 22.2 6.1 19.2 121.2 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 17.8;Erythroid cells: 23.3;Extravillous trophoblasts: 13.2;Spermatocytes: 35.9;Spermatogonia: 19.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD8 T-cell: 1.5;T-reg: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028016, HPA032023, HPA032031" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119" "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 1.3 0.7 0.4 5.4 0.6 10.8 1.3 0.4 0.5 1.2 2.8 0.3 0.1 1.7 1.0 0.6 4.0 0.4 1.5 0.6 0.4 0.4 0.8 1.0 1.6 4.4 0.4 0.1 0.6 0.5 0.6 0.7 5.4 0.2 0.6 4.2 0.2 1.1 0.1 0.4 1.6 3.3 1.4 0.4 4.6 1.1 37.2 0.1 41.2 0.9 5.7 7.5 0.9 1.6 0.7 0.3 0.0 0.4 0.6 5.2 0.7 12.6 10.8 18.5 9.2 1.1 2.3 9.1 15.9 9.9 15.1 22.5 6.7 11.2 9.6 6.0 6.1 9.7 9.9 24.4 13.4 21.8 11.6 11.7 15.3 14.3 8.1 0.0 20.1 9.6 1.0 0.4 24.4 13.0 2.7 6.9 17.0 18.2 19.6 17.4 5.1 26.8 9.2 21.4 9.6 12.5 21.3 32.7 18.5 4.3 8.8 11.6 18.2 15.1 14.5 6.5 19.7 12.4 9.2 3.7 15.1 11.3 15.6 17.9 7.2 11.2 22.2 7.6 13.3 14.6 0.0 0.0 0.0 0.6 0.4 0.0 0.7 0.8 1.5 0.3 0.1 0.0 0.3 0.0 0.6 0.0 0.0 5.2 0.7 0.4 0.6 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.0 7.8 0.4 2.1 0.0 6.1 2.5 0.0 1.2 0.0 0.0 7.5 0.0 0.2 17.8 1.8 0.5 23.3 0.0 13.2 1.2 0.2 0.0 0.0 3.9 0.0 0.0 1.3 0.3 7.9 1.1 1.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 35.9 19.1 1.5 1.3 1.9 2.9 0.0 DTNA "D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3" ENSG00000134769 "Dystrobrevin alpha" Q9Y4J8 18 34493290-34891844 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2" "Cell type enhanced" "Detected in many" 18 "Cardiomyocytes: 121.0;Muller glia cells: 42.7" "Cancer enriched" "Detected in many" 9 "glioma: 28.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;T-cells: 6.7" "Cell line enhanced" "Detected in many" "MCF7: 17.7;NTERA-2: 19.8;SCLC-21H: 27.8;U-87 MG: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015196, HPA071177" Enhanced Approved "Nucleoplasm,Cell Junctions,Intermediate filaments" NA NA "Cell Junctions, Intermediate filaments" Nucleoplasm "CAB015196: AB_2261797, HPA071177: " "unprognostic (1.57e-1)" "unprognostic (4.57e-2)" "unprognostic (3.13e-3)" "unprognostic (7.82e-6)" "unprognostic (5.03e-1)" "unprognostic (2.43e-3)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (1.23e-1)" "unprognostic (6.27e-2)" "unprognostic (1.35e-4)" "unprognostic (6.89e-2)" "prognostic favorable (2.64e-7)" "unprognostic (6.08e-3)" "unprognostic (3.93e-2)" "unprognostic (1.12e-1)" "unprognostic (7.27e-5)" 9.3 5.3 51.5 4.0 47.6 1.6 7.3 37.7 69.1 4.5 5.4 38.7 0.9 3.4 4.3 13.9 13.9 7.6 7.1 82.8 42.3 46.5 2.7 2.5 4.8 2.3 44.7 21.0 5.4 12.3 1.4 6.1 3.6 51.0 14.6 5.6 3.4 5.7 15.9 90.2 1.8 3.9 15.2 106.3 3.9 3.6 4.7 39.5 0.0 9.3 6.5 2.4 12.8 1.7 1.4 7.0 0.4 1.3 1.0 6.7 1.7 0.3 0.1 7.6 0.0 4.9 13.6 1.2 2.0 7.4 0.3 0.9 1.7 0.0 0.0 4.5 0.8 7.0 0.6 0.9 3.9 0.7 0.0 5.3 0.0 0.4 3.5 3.9 0.1 0.1 10.3 0.8 6.4 2.2 7.3 3.3 0.0 1.1 1.0 2.1 17.7 0.1 0.0 19.8 0.3 4.0 0.0 3.7 12.1 0.3 0.1 27.8 3.2 0.0 0.7 2.0 12.5 10.9 2.6 0.1 8.8 4.8 0.1 2.7 0.6 0.9 0.4 28.4 0.0 3.8 0.4 1.3 0.0 1.4 0.0 1.9 1.4 2.7 1.9 7.0 1.1 2.8 2.0 0.1 1.0 0.0 0.2 6.7 1.7 51.5 47.6 37.7 35.7 42.3 46.5 44.7 21.0 51.0 39.5 0.0 1.4 0.0 0.0 1.3 10.2 121.0 22.9 4.0 1.2 0.0 5.9 0.0 5.0 9.9 3.1 0.7 0.0 0.0 21.8 0.1 2.8 0.9 0.0 0.0 7.1 1.6 0.0 0.0 4.1 1.9 5.5 8.8 5.0 0.0 0.0 42.7 12.5 0.0 0.4 1.5 4.2 12.9 22.8 0.5 1.5 0.9 0.0 0.0 0.0 0.1 DTX1 "hDx-1, RNF140" ENSG00000135144 "Deltex E3 ubiquitin ligase 1" Q86Y01 12 113056709-113098028 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 9.7;lymphoid tissue: 13.3" "Cell type enriched" "Detected in many" 15 "Horizontal cells: 162.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "Daudi: 40.9;REH: 16.8;U-698: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051249, HPA055275" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA051249: , HPA055275: AB_2682769" "unprognostic (2.13e-3)" "unprognostic (3.20e-3)" "unprognostic (4.24e-4)" "unprognostic (2.01e-1)" "unprognostic (7.48e-3)" "unprognostic (1.59e-3)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (9.55e-2)" "unprognostic (6.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.02e-5)" "unprognostic (2.41e-2)" "unprognostic (4.70e-1)" "unprognostic (1.63e-1)" "unprognostic (4.78e-3)" 9.7 2.3 6.1 8.9 7.0 3.2 3.9 7.3 8.3 0.8 0.7 1.1 0.5 1.6 2.0 0.5 1.2 1.7 1.0 2.7 5.4 5.9 1.7 6.4 0.5 13.3 3.7 4.2 0.5 2.0 0.0 2.2 0.9 4.6 0.8 0.2 1.4 3.2 0.5 0.5 0.5 2.2 0.5 1.1 9.8 1.0 4.9 0.5 0.5 1.3 0.5 8.1 0.5 0.5 2.3 0.0 0.0 0.0 1.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 1.7 0.0 0.8 0.0 0.0 16.8 0.0 1.0 0.0 0.0 1.0 2.7 0.1 0.1 1.0 0.0 0.0 0.1 0.4 0.0 1.6 0.0 0.0 0.2 0.0 41.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.0 0.0 2.3 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.2 6.1 7.0 7.3 7.1 5.4 5.9 3.7 4.2 4.6 0.5 0.0 0.0 2.9 0.0 0.9 1.5 0.7 0.0 0.0 0.0 1.8 7.9 0.0 6.6 1.6 0.6 0.7 0.0 0.0 0.0 0.0 0.8 0.1 6.9 10.5 0.6 162.1 0.0 0.0 0.0 1.1 7.2 0.0 3.3 0.0 0.0 10.3 0.2 0.0 7.1 0.0 2.1 0.0 0.9 0.7 1.2 0.4 0.0 0.0 0.0 0.0 DTX3 "FLJ34766, RNF154" ENSG00000178498 "Deltex E3 ubiquitin ligase 3" Q8N9I9 12 57604622-57609804 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 66.7" "Cancer enhanced" "Detected in all" "glioma: 54.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 2.0;T-cells: 5.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059654 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA059654: AB_2684097" "unprognostic (2.31e-2)" "unprognostic (8.80e-2)" "unprognostic (2.06e-2)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.58e-2)" "unprognostic (6.91e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.84e-1)" "unprognostic (4.26e-2)" "prognostic favorable (1.44e-4)" "unprognostic (8.62e-2)" "unprognostic (5.44e-3)" "unprognostic (7.99e-2)" "unprognostic (8.81e-2)" "unprognostic (9.51e-2)" "unprognostic (3.48e-2)" 7.2 18.8 22.7 9.0 35.2 3.5 9.4 47.8 53.6 17.6 22.8 23.7 11.0 6.7 29.7 30.6 9.7 31.8 14.1 20.5 23.8 19.8 11.4 2.4 12.2 11.0 18.3 28.4 36.3 12.0 23.9 32.7 16.0 22.5 21.1 10.1 20.4 13.2 29.5 10.9 7.9 9.4 28.7 16.9 11.2 11.2 7.8 21.6 6.8 16.8 5.1 8.8 11.8 13.5 0.3 0.6 0.0 0.0 2.0 5.5 1.8 3.1 8.2 24.4 0.0 0.0 0.0 0.1 5.0 12.9 11.0 11.2 4.2 13.2 4.4 7.6 10.8 0.1 5.1 0.0 0.6 7.8 11.0 1.5 2.5 12.6 4.4 18.8 0.0 0.0 9.3 6.1 8.4 0.1 31.5 12.3 0.0 0.0 15.0 8.4 6.8 13.4 0.1 19.2 2.5 0.7 0.0 20.3 0.2 1.0 8.2 17.7 28.1 3.9 1.1 2.4 6.1 14.1 6.7 0.0 14.4 5.8 6.6 7.1 24.6 18.4 0.0 9.2 0.0 7.5 0.0 0.0 0.0 5.5 0.0 1.3 0.3 2.1 2.5 0.2 0.3 1.9 3.5 0.0 2.0 0.0 0.6 4.2 1.8 22.7 35.2 47.8 53.6 23.8 19.8 18.3 28.4 22.5 21.6 14.9 14.1 2.2 9.6 5.6 45.2 9.4 5.1 32.1 15.9 12.2 47.1 0.3 11.6 7.6 1.0 4.5 0.0 0.0 1.7 0.2 9.3 8.6 5.7 0.8 0.6 66.7 15.0 14.1 1.6 1.6 31.7 0.5 3.3 1.0 1.1 25.9 3.3 0.0 29.7 2.9 41.2 45.3 29.3 3.5 4.1 2.5 1.0 10.1 0.3 2.5 DUSP10 "MKP-5, MKP5" ENSG00000143507 "Dual specificity phosphatase 10" Q9Y6W6 1 221701424-221742176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 35.4" "Cell type enhanced" "Detected in many" 9 "granulocytes: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 15.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.2;HaCaT: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016758 Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No Nucleoplasm "Golgi apparatus, Cytosol" "HPA016758: AB_1847880" "unprognostic (1.55e-1)" "unprognostic (2.73e-1)" "unprognostic (1.44e-1)" "unprognostic (6.65e-2)" "unprognostic (3.83e-2)" "unprognostic (2.85e-3)" "prognostic favorable (5.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.89e-2)" "unprognostic (9.68e-2)" "unprognostic (2.38e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (4.18e-2)" "unprognostic (2.57e-1)" "unprognostic (8.88e-3)" "unprognostic (1.97e-2)" 7.4 4.7 6.0 7.1 11.2 23.2 8.2 5.9 11.1 5.7 10.8 21.1 0.3 2.1 4.9 2.7 7.0 8.5 7.6 3.8 7.2 4.0 2.8 35.4 8.0 9.0 14.0 5.6 2.8 18.3 1.8 2.5 4.5 8.4 3.6 4.9 8.5 9.5 1.7 21.0 8.0 6.2 9.7 10.1 6.4 4.5 3.9 14.1 5.6 5.3 10.6 8.6 8.5 4.1 0.8 5.4 4.6 4.2 15.1 12.7 1.6 6.1 2.6 0.2 0.2 19.2 9.9 0.2 4.1 10.8 6.9 5.3 0.1 1.7 4.8 1.4 10.7 5.0 42.3 0.9 4.0 6.0 12.3 0.5 8.2 1.2 0.7 4.5 3.6 5.6 13.8 2.9 7.4 7.5 3.2 0.2 1.2 0.8 1.7 6.5 0.1 0.7 2.8 0.6 1.3 0.3 0.4 11.7 0.3 2.3 3.7 15.8 1.2 0.5 0.5 17.5 2.5 0.9 2.1 1.5 3.5 0.9 5.3 5.1 2.9 2.0 2.6 5.4 1.6 3.6 4.6 4.2 0.2 3.6 3.7 3.3 0.7 2.5 2.5 5.4 0.8 0.8 1.5 0.3 15.1 1.4 0.2 12.7 1.6 6.0 11.2 5.9 11.1 7.2 4.0 14.0 5.6 8.4 14.1 0.0 1.7 1.9 12.6 45.2 4.5 3.3 10.2 8.1 6.8 3.5 19.6 2.2 0.0 27.3 29.1 6.3 1.0 0.0 7.8 2.7 8.3 10.9 135.7 50.4 22.0 1.6 42.1 1.8 11.0 2.7 23.0 23.9 21.9 13.6 9.9 13.5 21.9 0.0 12.0 0.7 32.3 0.0 5.1 3.8 2.0 36.1 2.9 29.9 2.2 14.4 DUSP11 PIR1 ENSG00000144048 "Dual specificity phosphatase 11" O75319 2 73762184-73780157 "Predicted intracellular proteins" "Hydrolase, Protein phosphatase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021052 Supported "Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge" Yes Yes "Nucleoplasm, Nucleoli fibrillar center" "Cytokinetic bridge" "HPA021052: AB_2670577" "unprognostic (2.45e-3)" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (7.87e-3)" "unprognostic (9.14e-2)" "unprognostic (5.28e-3)" "prognostic unfavorable (2.10e-7)" "unprognostic (7.20e-2)" "unprognostic (5.43e-2)" "unprognostic (5.85e-2)" "unprognostic (8.67e-3)" "unprognostic (3.84e-2)" "unprognostic (7.56e-3)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "unprognostic (1.47e-3)" "unprognostic (1.46e-1)" 19.6 16.1 15.1 15.1 17.9 29.5 21.4 31.8 21.5 23.1 16.8 16.4 16.2 16.3 29.9 19.8 38.7 37.4 15.2 15.2 17.2 13.9 19.3 16.5 17.2 21.5 12.7 15.8 26.4 14.9 11.6 28.2 19.1 14.0 18.2 16.8 16.5 22.3 20.3 16.2 27.9 19.7 18.9 13.4 21.5 15.4 19.7 13.8 28.7 16.8 16.2 29.3 20.4 27.3 29.9 20.9 42.6 19.1 28.0 37.6 29.2 19.4 8.4 9.1 9.6 16.5 20.7 16.3 14.3 18.7 18.6 19.1 12.1 14.8 25.3 9.2 15.4 16.7 13.6 11.2 28.8 18.0 17.4 11.7 15.5 6.4 18.5 17.3 17.4 14.6 16.7 35.0 16.6 23.1 16.2 20.6 12.4 16.4 14.9 20.6 10.8 16.7 18.6 14.6 18.3 11.7 6.7 24.5 22.7 15.0 16.2 13.5 7.3 13.2 15.8 16.8 11.4 8.4 9.3 11.7 13.3 16.4 15.2 16.8 15.9 12.6 33.4 12.3 17.7 12.9 24.7 19.1 42.6 26.8 16.9 34.6 29.9 31.7 31.6 20.9 28.1 33.9 31.8 29.1 28.0 16.9 15.9 37.6 29.2 15.1 17.9 31.8 21.5 17.2 13.9 12.7 15.8 14.0 13.8 8.9 11.8 34.3 47.9 73.8 9.4 6.9 33.1 26.8 22.7 12.2 3.9 27.8 43.1 24.2 5.9 29.2 13.5 23.3 24.2 35.1 26.6 23.0 41.4 12.9 27.5 4.8 11.5 29.4 22.3 5.6 26.7 20.5 21.9 42.3 19.0 9.3 22.5 17.8 24.1 38.5 13.9 6.5 22.8 23.6 31.8 72.5 32.3 32.4 17.2 54.2 DXO DOM3Z ENSG00000204348 "Decapping exoribonuclease" O77932 6 31969810-31972292 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.8" "Group enriched" "Detected in many" 5 "Early spermatids: 374.6;Late spermatids: 209.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046708 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA046708: AB_2679764" "unprognostic (4.56e-2)" "unprognostic (2.21e-1)" "unprognostic (1.80e-1)" "unprognostic (4.07e-3)" "unprognostic (1.93e-1)" "unprognostic (2.00e-3)" "unprognostic (3.43e-3)" "unprognostic (4.18e-3)" "unprognostic (3.10e-2)" "unprognostic (2.64e-3)" "prognostic favorable (5.87e-4)" "unprognostic (4.29e-2)" "prognostic unfavorable (4.77e-6)" "unprognostic (9.17e-2)" "unprognostic (7.24e-2)" "unprognostic (2.01e-1)" "unprognostic (2.23e-3)" 4.3 18.4 8.3 8.0 11.0 4.2 7.0 15.5 12.4 7.1 5.0 6.5 8.6 7.8 6.4 6.4 4.0 7.9 6.0 8.4 7.7 6.5 8.5 8.7 5.1 4.3 9.0 6.5 10.5 12.3 9.4 12.4 4.7 7.4 7.6 4.2 5.8 5.5 6.8 5.6 3.4 4.1 6.3 4.9 7.2 7.6 32.8 7.3 3.4 8.8 4.7 4.3 6.4 5.5 2.2 3.2 1.5 1.9 3.0 3.3 1.5 3.0 1.3 0.5 14.3 1.7 1.0 1.5 1.7 2.7 4.5 3.7 2.2 2.9 1.0 3.2 5.8 0.8 4.1 1.5 3.2 1.6 1.9 4.4 2.0 2.9 2.9 3.9 0.0 2.7 2.2 2.9 1.8 3.0 2.2 6.6 1.1 2.5 3.2 1.8 4.4 0.1 2.4 0.7 1.9 0.1 0.1 2.0 1.8 5.3 0.8 7.4 5.6 3.3 1.4 3.7 0.5 0.0 4.5 0.9 0.8 4.9 2.8 3.7 1.9 3.4 2.4 2.6 4.6 2.2 0.0 1.0 1.5 1.1 1.9 3.3 1.4 1.4 1.8 3.2 2.2 1.3 1.6 0.6 3.0 1.2 1.2 0.6 1.5 8.3 11.0 15.5 9.4 7.7 6.5 9.0 6.5 7.4 7.3 6.0 11.1 11.2 13.5 7.6 12.9 6.5 7.6 8.1 6.8 3.5 15.7 12.3 16.6 7.5 374.6 6.3 6.1 0.0 10.8 7.9 10.8 9.4 5.8 9.7 5.9 4.8 15.5 6.7 4.9 209.7 16.4 6.7 11.8 4.6 7.0 16.2 6.4 8.6 11.7 11.7 14.7 12.9 10.8 58.1 11.8 4.8 16.8 13.1 6.8 7.3 DYNC2H1 "DHC1b, DHC2, DNCH2, DYH1B, hdhc11" ENSG00000187240 "Dynein cytoplasmic 2 heavy chain 1" Q8NCM8 11 103109431-103479863 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 35.7" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 167.3;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 86.1;Spermatocytes: 64.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Group enriched" "Detected in many" 5 "NK-cells: 2.9;T-cells: 2.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.0" "Low region specificity" "Detected in all" "HPA039015, HPA039016" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA039015: AB_2676309, HPA039016: AB_10673410" "unprognostic (3.11e-1)" "unprognostic (2.60e-1)" "unprognostic (1.28e-2)" "unprognostic (1.54e-1)" "unprognostic (7.11e-2)" "unprognostic (2.08e-1)" "unprognostic (4.14e-3)" "unprognostic (2.07e-2)" "unprognostic (2.05e-1)" "unprognostic (4.10e-2)" "unprognostic (2.87e-2)" "unprognostic (7.13e-2)" "prognostic favorable (8.49e-5)" "unprognostic (3.75e-3)" "unprognostic (1.62e-1)" "unprognostic (3.88e-2)" "unprognostic (4.11e-3)" 7.3 5.7 6.3 3.8 8.9 1.4 8.4 13.2 9.3 11.5 4.8 5.5 11.0 4.1 11.3 9.6 3.9 14.6 7.8 3.7 7.1 7.1 8.5 2.6 10.2 2.6 4.8 7.9 11.4 5.1 24.2 35.7 3.9 11.2 7.6 2.6 6.2 4.5 10.7 1.6 5.7 3.4 7.8 5.1 4.8 4.2 14.3 5.2 1.1 10.7 3.0 2.4 6.1 6.6 0.5 0.4 0.4 0.2 2.9 2.2 0.0 1.0 2.2 5.7 2.8 8.0 18.0 0.3 3.2 5.2 5.4 5.8 1.2 1.1 0.0 4.5 6.2 2.5 4.3 4.4 6.0 4.3 0.0 4.1 0.8 3.7 0.1 7.7 1.7 1.0 11.2 2.3 12.1 13.9 8.4 2.1 1.1 0.1 0.0 6.9 4.1 0.5 0.4 1.5 0.0 6.1 0.0 4.7 0.1 5.8 0.7 4.1 2.9 5.1 1.4 2.4 1.4 5.3 1.1 5.1 6.5 2.6 6.1 2.1 0.0 0.0 0.0 1.9 5.2 1.9 0.4 0.2 0.0 0.9 0.1 2.2 0.5 0.7 1.1 0.4 0.3 0.8 1.1 0.0 2.9 0.1 0.2 0.0 0.0 6.3 8.9 13.2 9.3 7.1 7.1 4.8 7.9 11.2 5.2 0.0 12.5 0.0 11.5 6.0 22.2 9.4 2.5 167.3 23.9 26.2 106.0 0.3 1.7 5.6 13.4 9.0 0.0 0.0 3.1 0.4 14.8 5.9 3.5 0.8 2.0 30.2 16.6 6.7 1.5 6.5 19.2 3.8 8.5 0.0 0.8 17.7 6.8 1.1 17.3 14.8 86.1 19.4 11.3 64.2 10.4 4.8 0.5 2.5 0.9 5.7 DYNLL1 "DLC1, DLC8, DNCL1, hdlc1, LC8, PIN" ENSG00000088986 "Dynein light chain LC8-type 1" P63167 12 120469850-120498493 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport" "Activator, Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 2849.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA Yes 650000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (2.88e-2)" "unprognostic (5.63e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (4.41e-3)" "unprognostic (4.64e-2)" "unprognostic (6.17e-3)" "unprognostic (1.61e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (7.97e-7)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (7.91e-2)" "unprognostic (1.62e-1)" 45.5 48.5 128.5 34.4 97.8 21.9 54.3 48.4 120.5 50.6 61.8 61.9 31.1 31.6 47.2 64.9 113.7 107.1 46.7 44.2 124.1 105.2 49.7 40.7 40.3 41.2 92.9 90.7 49.0 45.7 30.4 46.4 49.8 67.4 39.9 64.5 24.8 34.0 54.9 15.0 117.3 38.9 75.2 93.6 30.4 45.1 59.4 56.8 35.4 37.1 84.3 65.6 59.0 63.0 55.0 80.6 73.6 55.0 46.7 63.4 50.8 78.6 89.9 89.2 68.4 78.4 83.2 28.7 108.9 50.3 88.9 53.4 84.7 53.1 44.1 58.8 104.0 87.0 71.0 106.0 91.0 88.9 58.4 69.4 43.1 64.5 114.6 79.2 45.0 71.7 50.5 97.5 66.6 54.7 98.8 92.3 47.8 54.0 50.9 117.3 104.1 58.6 97.8 73.2 101.0 104.9 59.9 46.2 54.7 127.0 72.9 61.3 45.3 88.7 77.1 98.8 97.4 76.4 65.8 71.0 68.5 58.5 60.4 93.7 30.6 58.8 43.8 75.9 70.3 87.6 73.6 49.5 63.6 37.7 51.4 28.7 55.0 39.0 39.0 49.1 36.5 25.2 31.5 9.1 46.7 55.0 80.6 63.4 50.8 128.5 97.8 48.4 120.5 124.1 105.2 92.9 90.7 67.4 56.8 181.7 88.8 250.9 293.4 819.1 137.3 144.1 321.0 1203.2 211.5 378.6 78.5 490.2 943.3 628.7 1147.1 421.8 466.9 116.8 472.1 694.2 640.5 264.0 307.3 460.6 658.6 81.0 461.6 421.7 304.4 2849.5 478.4 414.2 565.2 861.2 700.1 95.2 648.6 662.9 659.7 842.5 153.7 362.2 584.0 638.3 583.5 1407.5 841.8 195.6 373.7 348.8 DYNLL2 "Dlc2, DNCL1B, MGC17810, RSPH22" ENSG00000264364 "Dynein light chain LC8-type 2" Q96FJ2 17 58083415-58095536 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 366.0;Late spermatids: 723.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (7.22e-2)" "unprognostic (7.76e-2)" "unprognostic (3.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.93e-1)" "unprognostic (3.72e-2)" "unprognostic (6.78e-2)" "unprognostic (2.91e-2)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "prognostic favorable (5.26e-4)" "unprognostic (1.24e-1)" "prognostic favorable (1.12e-12)" "unprognostic (2.87e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-1)" "unprognostic (7.02e-2)" 15.4 28.3 38.6 11.1 55.2 9.9 11.6 41.1 41.1 12.9 14.5 22.6 16.3 16.2 12.0 15.6 11.9 13.5 13.3 43.8 32.2 40.2 28.1 23.1 11.8 9.4 48.3 28.7 14.4 11.8 36.2 15.0 19.7 40.6 20.6 13.7 15.5 19.2 18.8 64.8 12.6 15.6 14.3 32.5 11.2 12.7 19.0 27.2 7.6 22.0 15.1 11.8 9.9 16.4 1.5 0.8 3.5 3.0 1.5 3.1 0.8 20.7 14.1 29.1 13.2 18.1 10.0 46.3 21.0 8.4 10.2 8.0 31.3 10.1 18.6 23.9 13.0 12.2 11.2 13.4 16.6 17.6 18.3 9.7 20.1 8.3 18.3 14.4 21.5 12.5 10.0 11.4 11.8 9.4 10.7 6.7 15.8 20.0 11.3 9.8 31.4 24.3 8.9 20.0 13.7 14.5 22.5 17.1 7.7 8.8 22.7 19.9 15.9 18.8 7.6 16.0 15.7 22.5 10.1 12.2 20.1 25.3 13.3 15.4 21.2 25.7 22.7 10.3 17.3 14.0 3.5 1.1 2.0 2.6 0.6 2.9 1.3 2.1 2.3 0.5 1.5 2.2 3.1 1.7 1.5 3.0 0.8 1.4 0.8 38.6 55.2 41.1 41.1 32.2 40.2 48.3 28.7 40.6 27.2 11.9 49.9 27.4 30.9 43.6 58.8 158.5 38.2 14.7 29.6 57.6 37.3 88.3 26.6 31.4 366.0 29.3 47.1 23.3 27.0 62.0 29.2 30.1 22.0 85.9 36.0 66.7 64.5 22.1 21.7 723.4 27.3 23.1 62.4 27.1 52.5 69.7 32.5 40.3 25.1 66.7 36.2 25.8 38.5 40.0 41.2 40.3 50.2 19.2 44.1 28.3 DZIP1 "DZIP, KIAA0996" ENSG00000134874 "DAZ interacting zinc finger protein 1" Q86YF9 13 95578202-95644703 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 9 "Early spermatids: 313.9;Late spermatids: 570.8;Spermatocytes: 228.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054891, HPA057272, HPA070194" Uncertain Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Cytosol" "Centriolar satellite" "HPA054891: AB_2682631, HPA057272: AB_2683390, HPA070194: AB_2686233" "unprognostic (6.74e-3)" "unprognostic (7.65e-2)" "unprognostic (1.94e-1)" "unprognostic (4.64e-3)" "unprognostic (4.82e-2)" "unprognostic (5.52e-3)" "unprognostic (6.34e-2)" "unprognostic (2.49e-1)" "unprognostic (3.34e-2)" "unprognostic (8.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.67e-1)" "unprognostic (1.36e-2)" "unprognostic (2.41e-3)" "unprognostic (1.48e-1)" "unprognostic (3.64e-2)" "unprognostic (3.89e-3)" 5.0 6.3 17.2 4.4 17.4 0.4 3.7 13.9 16.1 11.5 6.7 4.1 3.8 2.2 16.2 10.7 6.2 10.7 8.5 3.8 13.1 18.1 16.2 1.7 4.0 3.6 8.7 13.5 24.2 9.6 0.9 8.9 4.6 8.8 7.7 3.7 5.8 3.2 13.3 1.7 1.1 2.6 12.3 5.6 2.8 3.6 27.3 4.5 0.6 1.7 1.8 3.5 5.0 5.2 0.4 0.2 1.2 0.2 0.3 0.3 0.0 1.3 5.0 16.9 17.2 13.1 16.3 3.4 12.2 14.2 13.7 16.5 0.1 0.0 0.0 2.8 9.7 6.2 0.0 11.2 4.5 15.5 0.9 10.0 15.6 3.8 10.6 9.1 0.0 0.1 11.5 0.3 4.2 5.6 22.2 9.2 1.1 0.0 0.0 10.0 0.0 0.0 0.0 7.7 0.0 0.4 0.0 11.6 0.0 13.1 1.8 4.2 11.0 9.3 0.0 0.5 20.8 0.0 5.8 0.7 13.6 6.6 1.8 10.0 0.0 0.0 0.0 3.5 0.0 2.4 1.2 0.2 0.2 0.3 0.1 0.2 0.2 0.1 0.2 0.0 0.4 0.1 0.3 1.1 0.3 0.1 0.2 0.1 0.0 17.2 17.4 13.9 16.1 13.1 18.1 8.7 13.5 8.8 4.5 0.0 0.0 0.0 1.1 0.6 17.7 2.9 0.0 17.4 5.7 1.8 3.9 3.9 6.6 13.1 313.9 2.7 0.0 0.0 0.2 1.8 10.6 0.5 0.0 0.0 0.5 6.4 0.0 3.1 0.0 570.8 35.9 1.2 3.3 3.6 0.0 6.2 0.8 0.0 41.1 19.5 1.2 19.4 13.2 228.9 7.0 0.9 1.5 0.0 0.0 0.3 DZIP1L "DZIP2, FLJ32844" ENSG00000158163 "DAZ interacting zinc finger protein 1 like" Q8IYY4 3 138061990-138115818 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 93.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "classical monocyte: 1.8;eosinophil: 1.7;intermediate monocyte: 1.3;myeloid DC: 1.5" "Group enriched" "Detected in many" 17 "dendritic cells: 1.5;granulocytes: 1.7;monocytes: 1.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030404 Approved Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA030404: AB_10601548" "unprognostic (3.65e-2)" "unprognostic (8.37e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-2)" "unprognostic (6.50e-2)" "unprognostic (6.47e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-2)" "unprognostic (2.35e-3)" "unprognostic (2.72e-1)" "unprognostic (9.98e-2)" "unprognostic (2.77e-2)" 5.3 2.0 2.2 6.1 2.5 10.9 5.5 12.1 3.3 17.4 5.1 5.3 3.1 2.9 14.8 6.5 4.3 15.2 7.9 3.8 2.4 2.1 5.1 1.2 6.4 2.0 2.6 1.6 12.4 8.3 6.2 5.6 2.7 6.1 9.3 2.1 10.9 2.5 5.0 1.7 10.4 2.3 11.3 3.4 3.1 10.0 4.2 3.4 0.1 4.2 4.2 2.5 8.0 17.8 0.0 1.5 1.7 1.8 0.0 0.0 0.4 5.2 3.1 6.2 5.2 4.0 5.3 1.4 8.6 5.2 5.1 6.5 2.1 0.4 0.0 4.4 7.9 7.1 1.7 4.5 2.0 2.5 1.1 4.4 2.3 6.4 0.3 3.2 1.7 4.0 5.6 2.1 5.6 2.7 5.2 2.8 1.4 1.7 0.0 6.9 0.3 0.0 0.7 7.5 0.0 1.1 0.0 7.2 0.0 2.3 8.4 2.2 4.9 8.8 0.0 4.4 3.6 2.3 3.6 2.1 12.7 5.8 6.1 4.4 0.0 0.0 0.1 5.0 2.5 4.9 0.0 1.8 1.7 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 2.2 2.5 12.1 3.3 2.4 2.1 2.6 1.6 6.1 3.4 3.0 1.3 0.0 0.6 3.2 6.5 2.7 2.5 93.7 11.4 1.8 7.9 0.0 5.0 3.1 15.6 1.8 0.0 0.0 1.1 0.1 3.5 0.5 0.0 0.0 1.4 3.2 0.0 0.0 1.0 1.0 5.8 2.7 0.0 1.0 0.0 2.3 3.7 0.0 3.9 0.5 17.8 0.0 4.7 0.4 1.5 3.8 0.0 0.0 0.0 0.1 E2F3 ENSG00000112242 "E2F transcription factor 3" O00716 6 20401906-20493715 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029779, HPA065012" Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA029779: AB_2732448, HPA065012: AB_2685403" "unprognostic (4.10e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.80e-3)" "unprognostic (2.96e-1)" "unprognostic (9.14e-2)" "unprognostic (8.99e-3)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "prognostic favorable (1.69e-4)" "unprognostic (1.14e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (1.63e-8)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (3.50e-1)" "unprognostic (5.99e-3)" 9.5 8.4 7.6 12.2 13.4 22.1 10.8 1.7 10.1 4.8 7.1 2.9 3.2 6.8 6.3 6.9 8.0 4.9 9.9 11.1 8.3 6.8 14.6 6.1 7.8 19.7 5.8 7.3 4.0 3.6 2.9 3.2 7.4 7.9 5.0 8.6 5.1 4.7 4.5 15.1 4.3 8.0 7.9 5.0 16.9 5.0 8.9 3.1 17.7 11.4 10.2 12.0 9.2 4.8 0.7 3.7 10.3 3.1 4.8 3.6 1.5 6.8 5.6 16.1 17.3 5.4 6.0 11.2 9.3 8.1 8.9 9.9 6.9 4.3 15.4 18.0 8.6 8.3 7.2 18.4 8.3 15.0 6.0 13.0 27.9 9.3 7.7 5.8 18.3 16.8 4.8 6.2 8.7 10.7 9.2 6.1 14.7 30.9 9.5 10.1 7.1 20.7 20.5 12.1 5.3 5.8 22.6 14.2 17.7 10.6 11.9 11.6 21.3 8.6 11.9 12.2 10.3 6.1 11.1 8.2 14.4 9.0 7.1 14.7 6.0 19.0 19.3 3.5 11.3 20.4 6.9 3.1 1.4 2.3 2.3 3.1 0.7 1.5 3.6 3.7 0.7 1.3 2.8 10.3 4.8 1.5 1.6 2.2 1.5 7.6 13.4 1.7 10.1 8.3 6.8 5.8 7.3 7.9 3.1 0.0 1.6 8.2 10.8 8.1 35.1 8.9 7.6 0.0 12.5 7.0 21.6 6.3 8.3 7.0 10.2 5.2 7.9 0.0 5.9 11.3 10.4 18.4 19.7 5.0 14.5 30.2 11.5 19.0 49.7 5.0 2.6 18.9 5.0 8.2 11.3 2.1 11.2 11.6 2.8 20.5 9.2 0.0 8.2 2.7 3.2 7.9 2.6 9.6 12.7 14.2 E2F5 ENSG00000133740 "E2F transcription factor 5" Q15329 8 85177225-85217158 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "B-cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 13.3;naive B-cell: 7.6" "Lineage enriched" "Detected in many" 9 "B-cells: 13.3" "Cell line enhanced" "Detected in many" "AF22: 27.5;Daudi: 54.2;U-698: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055723, HPA065441" Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA055723: AB_2682897, HPA065441: " "unprognostic (8.73e-2)" "unprognostic (3.45e-1)" "unprognostic (3.15e-2)" "unprognostic (1.02e-3)" "unprognostic (6.73e-3)" "unprognostic (1.62e-1)" "unprognostic (3.36e-5)" "unprognostic (1.23e-1)" "unprognostic (9.53e-2)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (2.88e-2)" "unprognostic (3.25e-2)" "unprognostic (3.64e-1)" "unprognostic (2.95e-3)" 3.0 9.0 6.4 22.2 8.1 1.5 5.9 2.6 5.3 5.0 5.9 4.0 3.4 4.6 5.4 7.4 4.7 7.2 6.6 3.2 5.6 5.6 9.0 4.5 5.1 22.4 4.6 2.7 8.3 14.6 12.7 10.6 4.3 3.8 5.1 7.2 3.4 5.7 5.9 1.1 1.7 7.3 3.8 4.5 9.9 5.1 10.5 3.2 13.6 10.2 3.0 26.0 6.0 7.6 13.3 1.4 0.0 0.0 1.1 0.6 0.6 4.9 5.3 27.5 10.2 0.5 0.7 8.8 1.0 2.2 0.8 2.4 3.2 5.8 54.2 3.8 1.1 9.9 1.0 16.0 1.3 1.0 5.6 7.3 5.5 3.0 7.4 4.4 1.6 0.0 1.0 2.2 1.1 3.9 5.4 0.8 5.7 11.5 0.4 1.5 3.2 5.5 3.6 8.8 9.2 4.7 4.4 1.1 5.8 8.9 3.5 3.4 10.6 0.6 1.9 8.1 11.5 11.6 1.7 0.0 1.3 1.0 1.6 3.6 10.2 6.8 25.9 1.5 1.4 2.7 0.0 0.0 0.0 0.1 0.0 0.0 13.3 0.0 0.0 0.1 7.6 0.2 0.4 0.0 1.1 0.0 1.4 0.6 0.6 6.4 8.1 2.6 4.5 5.6 5.6 4.6 2.7 3.8 3.2 0.0 6.2 16.3 2.8 2.1 0.4 1.0 2.5 9.4 3.4 5.2 9.8 2.7 0.0 2.9 5.2 1.5 1.3 0.0 2.1 0.6 3.0 2.7 1.1 2.4 0.4 0.0 7.5 0.6 1.0 2.9 1.4 0.4 3.3 0.0 3.4 4.3 2.8 0.0 1.8 4.9 1.1 0.0 1.7 11.1 3.4 2.5 0.9 1.9 3.7 1.6 E2F8 FLJ23311 ENSG00000129173 "E2F transcription factor 8" A0AVK6 11 19224063-19241620 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.3" "Group enriched" "Detected in some" 5 "Ciliated cells: 8.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.9" "Lineage enriched" "Detected in single" 24 "T-cells: 2.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA064882, HPA076614" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoli "Nucleoplasm, Cytosol" "HPA064882: AB_2685381, HPA076614: " "unprognostic (5.62e-2)" "unprognostic (5.24e-2)" "unprognostic (3.17e-2)" "unprognostic (6.99e-3)" "unprognostic (2.86e-2)" "unprognostic (1.66e-2)" "unprognostic (1.29e-5)" "unprognostic (1.94e-2)" "unprognostic (3.90e-3)" "unprognostic (2.41e-1)" "unprognostic (7.29e-4)" "unprognostic (1.16e-2)" "unprognostic (9.13e-8)" "unprognostic (1.02e-3)" "unprognostic (1.37e-1)" "unprognostic (3.81e-1)" "unprognostic (4.28e-3)" 1.0 0.4 0.4 7.2 0.2 11.5 0.3 0.2 0.4 1.6 3.6 0.2 0.2 3.3 1.2 1.4 8.2 0.9 2.0 3.4 0.2 0.2 0.4 0.5 0.8 6.1 0.2 0.2 0.7 0.3 0.0 0.2 4.0 0.2 0.6 4.8 1.2 1.8 0.9 11.5 2.6 4.6 0.7 0.2 2.4 5.1 4.7 0.2 30.3 0.3 8.0 12.5 3.4 2.1 0.0 0.1 0.0 0.0 0.0 2.9 0.4 14.2 4.2 4.4 6.1 0.2 0.6 18.9 7.9 2.2 9.3 10.1 14.7 4.7 14.1 3.3 2.5 5.5 12.6 10.7 1.0 8.4 9.5 8.7 4.9 2.4 4.0 0.0 7.4 11.8 0.2 0.0 1.9 0.6 0.5 13.0 10.1 10.3 13.7 3.7 6.9 14.6 9.3 4.0 16.1 6.0 15.9 8.2 9.5 4.0 9.6 3.8 4.3 3.5 7.0 0.8 2.4 4.8 8.0 2.5 4.5 5.6 11.0 7.1 4.7 9.5 17.9 5.7 14.7 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 1.5 0.0 1.0 0.0 2.0 0.0 8.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 23.3 0.0 1.4 0.6 0.0 0.0 0.0 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.1 0.3 0.2 0.0 2.6 0.6 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427355-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.7" "Group enriched" "Detected in many" 6 "Early spermatids: 229.6;Late spermatids: 321.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 56.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Nuclear bodies" Vesicles "HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147" "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 15.6 11.5 13.9 12.2 20.0 55.7 11.4 18.1 19.1 9.8 11.7 13.3 11.5 12.7 10.1 9.9 13.1 9.4 12.9 7.6 14.3 18.1 13.7 22.2 12.0 12.4 14.7 13.0 8.0 11.8 13.0 17.6 18.9 18.6 12.7 12.4 9.6 9.5 15.4 8.6 15.9 12.5 10.4 13.7 15.1 13.7 9.7 10.1 14.0 13.0 9.1 12.9 11.9 9.0 5.1 9.9 7.1 7.4 8.1 15.4 4.3 4.0 6.6 7.0 7.1 4.1 3.5 56.2 5.9 4.2 6.8 6.7 9.0 4.5 11.3 3.8 4.3 4.5 3.4 9.0 5.2 7.9 9.2 6.5 9.7 6.0 8.1 9.2 9.1 7.9 4.6 9.3 9.9 6.7 5.2 6.8 9.3 10.3 8.3 5.6 8.3 9.0 5.1 12.4 7.6 6.8 8.3 5.8 6.2 5.9 7.1 7.2 12.6 7.2 6.8 6.9 9.4 10.1 7.3 6.6 7.2 5.3 6.3 8.5 11.0 22.1 11.9 7.0 10.9 8.5 7.1 7.4 4.5 12.0 5.4 15.4 5.1 10.1 9.3 4.3 3.8 6.0 9.8 6.7 8.1 6.5 9.9 10.5 4.3 13.9 20.0 18.1 19.1 14.3 18.1 14.7 13.0 18.6 10.1 8.9 12.9 2.9 7.7 41.7 6.8 4.5 7.6 6.7 10.3 12.2 5.9 7.2 8.3 7.8 229.6 11.7 13.6 0.0 7.0 11.7 16.0 15.1 10.3 27.0 14.1 20.6 33.0 11.6 21.8 321.2 10.6 14.6 21.9 5.4 11.2 4.8 11.8 10.5 11.3 18.9 6.0 25.8 11.3 18.6 11.5 47.4 30.0 20.4 10.9 14.5 EAPP "BM036, C14orf11, FLJ20578" ENSG00000129518 "E2F associated phosphoprotein" Q56P03 14 34515929-34539711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002916 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA002916: AB_1078715" "unprognostic (8.76e-3)" "unprognostic (1.27e-3)" "unprognostic (2.08e-3)" "unprognostic (1.94e-1)" "unprognostic (4.59e-2)" "unprognostic (1.64e-1)" "unprognostic (2.80e-1)" "prognostic favorable (9.34e-4)" "unprognostic (1.81e-1)" "unprognostic (6.38e-2)" "unprognostic (2.05e-1)" "unprognostic (7.80e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.64e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.96e-4)" "unprognostic (3.24e-2)" 30.1 32.8 24.4 23.1 23.5 53.4 36.5 32.4 30.1 30.0 35.0 20.6 25.3 24.7 27.9 33.0 26.3 28.5 19.9 19.9 22.8 26.4 30.1 34.4 20.5 23.2 21.8 25.3 37.3 22.5 31.1 28.1 33.8 27.8 29.4 36.8 21.6 27.3 27.8 41.3 39.1 43.2 23.8 20.9 26.5 23.5 21.6 24.2 34.8 34.1 22.6 24.8 27.7 31.2 36.8 19.3 50.2 26.2 33.6 42.3 24.8 15.1 18.6 17.4 10.2 20.7 21.2 27.1 14.0 21.5 17.5 18.4 8.8 20.2 15.9 19.9 17.0 10.5 14.3 12.8 18.6 20.7 19.8 11.3 11.6 14.6 37.1 28.2 20.6 12.9 24.3 24.0 10.0 26.0 23.2 17.4 22.5 11.5 17.7 16.3 35.5 28.5 16.7 10.2 28.3 20.9 18.1 20.9 15.9 21.1 20.7 14.0 15.5 19.8 19.2 29.8 17.5 33.4 13.2 18.8 9.2 7.8 11.8 9.0 22.4 25.0 16.9 8.6 11.4 11.5 40.7 22.0 45.2 24.8 20.1 29.7 36.8 31.1 28.0 19.3 33.7 31.8 28.8 50.2 33.6 26.2 16.9 42.3 24.8 24.4 23.5 32.4 30.1 22.8 26.4 21.8 25.3 27.8 24.2 20.8 44.0 56.1 67.2 41.2 75.1 29.7 53.5 104.4 45.5 78.5 29.5 102.7 147.6 71.8 11.9 52.6 81.1 23.3 74.0 64.7 52.1 52.3 71.6 87.3 51.6 23.8 63.4 45.4 51.6 7.4 82.8 55.7 86.0 63.1 99.8 110.6 51.5 112.6 88.8 94.6 66.9 71.1 50.1 103.2 38.4 58.2 158.4 91.3 92.5 44.8 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487828 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;ovary: 57.1" "Group enriched" "Detected in some" 19 "Muller glia cells: 76.3;Peritubular cells: 19.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Region enriched" "Detected in many" 5 "hypothalamus: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 30.1;HeLa: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 0.9 2.6 0.5 0.9 4.0 0.2 0.4 0.7 1.2 0.3 0.4 0.5 0.1 0.3 0.6 4.9 0.3 1.7 1.0 1.1 0.1 28.6 1.0 0.7 0.2 1.2 0.3 0.1 57.1 0.6 0.3 8.9 0.4 5.5 0.3 0.2 11.5 0.3 1.2 1.8 0.3 0.3 1.1 4.5 2.0 0.3 0.8 1.6 0.1 0.5 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.7 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.0 0.7 1.2 0.1 28.6 0.3 0.1 5.5 1.6 0.0 0.0 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 76.3 0.2 0.0 19.8 0.0 1.7 0.0 2.1 0.2 1.7 0.0 0.0 0.0 0.0 0.0 ECSCR "ARIA, ECSM2" ENSG00000249751 "Endothelial cell surface expressed chemotaxis and apoptosis regulator" Q19T08 5 139448556-139462743 "Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 20 "Endothelial cells: 271.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.7" "Lineage enhanced" "Detected in single" "T-cells: 2.7" "Group enriched" "Detected in some" 121 "EFO-21: 49.7;HUVEC TERT2: 125.6;TIME: 92.7" HPA063337 Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA063337: AB_2732701" "unprognostic (5.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.69e-2)" "unprognostic (2.15e-3)" "unprognostic (3.95e-2)" "unprognostic (1.12e-1)" "unprognostic (2.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.78e-2)" "unprognostic (1.91e-1)" "unprognostic (1.83e-3)" "unprognostic (2.41e-3)" "unprognostic (1.36e-1)" "unprognostic (9.90e-2)" "unprognostic (2.91e-1)" 14.8 1.9 0.8 5.7 1.6 0.0 17.5 0.4 0.7 13.7 6.1 1.0 5.1 1.9 14.3 14.4 11.0 7.9 8.6 26.9 0.8 5.6 4.3 23.4 26.9 1.4 0.7 7.9 1.0 1.3 0.4 19.6 2.9 9.3 4.3 6.8 3.6 5.5 13.4 2.9 3.4 14.3 4.3 12.1 1.1 6.8 1.1 0.1 11.5 14.5 4.6 13.2 13.1 0.6 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 49.7 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 125.6 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 92.7 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.6 1.1 1.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 4.6 0.0 0.2 13.3 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.5 0.0 271.3 0.0 0.0 1.0 0.1 2.6 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 5.8 10.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 12.2 0.2 0.0 0.0 0.7 EDN1 ET1 ENSG00000078401 "Endothelin 1" P05305 6 12290363-12297194 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 804.7;Ductal cells: 273.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.9" "Lineage enriched" "Detected in many" 6 "monocytes: 7.9" "Cell line enhanced" "Detected in many" "EFO-21: 109.7;HUVEC TERT2: 72.7;T-47d: 22.4;TIME: 53.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031976, CAB032500, CAB037291" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted to blood" NA Yes 9740 "Nucleoli, Golgi apparatus" Nucleoplasm "CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "unprognostic (9.72e-2)" "unprognostic (3.40e-1)" "unprognostic (1.91e-1)" "unprognostic (6.24e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (8.92e-2)" "unprognostic (4.19e-2)" "unprognostic (3.17e-1)" "unprognostic (8.02e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (3.47e-1)" 35.7 1.5 8.4 6.2 30.8 3.6 19.2 3.2 22.0 8.2 9.2 4.2 1.1 9.0 7.2 15.3 10.8 8.6 11.9 5.2 19.0 6.2 5.7 2.8 25.1 6.7 10.9 5.5 4.3 8.2 1.6 1.0 16.0 25.1 5.4 12.9 6.9 9.7 8.5 25.6 8.2 6.7 9.7 13.5 10.2 6.8 4.8 5.6 0.2 2.9 3.8 2.1 5.3 4.1 0.2 0.2 1.2 7.9 0.0 0.2 0.0 1.6 9.2 0.1 0.0 0.0 0.0 0.0 2.9 2.6 2.4 2.0 11.9 1.4 0.0 109.7 1.1 1.5 0.8 0.0 1.7 1.8 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 1.0 0.4 0.3 0.7 72.7 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.1 1.6 0.1 0.0 0.8 0.0 5.8 1.5 0.1 0.0 0.3 8.7 0.0 20.3 22.4 0.1 53.8 6.2 4.9 0.1 3.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 7.9 0.1 0.0 0.0 8.4 30.8 3.2 22.0 19.0 6.2 10.9 5.5 25.1 5.6 160.8 31.6 0.8 804.7 168.7 0.0 2.0 5.1 0.0 46.6 36.6 0.0 1.4 3.3 273.4 11.4 170.8 145.3 0.0 195.7 0.6 8.2 167.4 1.1 0.8 1.7 1.6 15.0 109.2 6.3 10.0 5.2 3.6 8.5 19.0 12.9 0.2 217.0 147.3 0.4 5.7 0.0 6.5 6.2 1.1 0.4 56.3 0.7 5.7 34.9 116.8 EDRF1 "C10orf137, DKFZp586F1019, FLJ21617" ENSG00000107938 "Erythroid differentiation regulatory factor 1" Q3B7T1 10 125719515-125764143 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031820 Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA031820: AB_10600753" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (1.53e-1)" "unprognostic (3.64e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-2)" "unprognostic (8.84e-4)" "unprognostic (4.76e-3)" "unprognostic (8.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.63e-3)" "unprognostic (4.62e-2)" "prognostic unfavorable (3.16e-5)" "unprognostic (3.44e-3)" "unprognostic (5.51e-2)" "unprognostic (1.38e-1)" "unprognostic (7.68e-3)" 9.2 6.7 6.3 16.6 9.7 27.9 9.0 20.3 10.0 10.5 8.1 7.7 6.8 7.1 12.2 8.3 7.5 9.8 6.4 7.5 7.4 5.4 5.9 5.0 7.2 12.5 8.8 7.3 13.4 14.0 6.3 18.1 8.2 8.0 10.0 7.3 5.2 19.7 12.7 12.7 8.3 9.0 9.5 7.8 9.3 8.4 21.2 9.0 20.2 7.7 4.5 10.7 10.1 8.7 9.6 9.9 9.1 7.0 6.9 9.7 3.5 9.0 8.8 11.1 12.1 5.2 8.6 5.8 11.4 11.1 13.2 15.0 11.2 7.7 12.2 5.7 7.2 7.3 11.5 17.5 2.7 15.0 8.0 13.9 8.5 7.5 6.5 8.8 12.8 8.8 5.3 4.4 12.6 5.7 11.5 6.2 6.2 8.0 9.4 7.4 3.6 12.7 8.8 16.4 5.6 8.0 10.1 10.6 7.9 4.6 4.2 6.0 11.8 8.5 4.3 7.7 10.7 7.8 4.8 3.9 7.0 7.2 9.2 12.9 12.2 8.1 19.2 7.5 6.3 3.9 9.1 7.0 6.5 7.8 5.8 9.7 9.6 6.9 7.1 6.8 8.1 7.3 7.5 8.4 6.9 4.2 9.9 7.4 3.5 6.3 9.7 20.3 10.0 7.4 5.4 8.8 7.3 8.0 9.0 11.9 8.9 5.6 5.1 5.3 21.0 11.4 10.2 6.7 10.3 10.4 31.4 5.9 0.0 3.9 140.9 7.1 4.7 0.0 6.2 4.9 6.6 5.1 19.7 7.4 3.6 19.1 4.1 6.7 5.3 46.0 19.5 5.8 6.8 4.6 5.7 12.8 7.6 6.5 18.7 2.6 23.7 6.5 6.1 26.7 19.4 7.2 3.8 12.5 6.5 4.2 EEF1AKMT3 "DKFZP586D0919, FAM119B, METTL21B" ENSG00000123427 "EEF1A lysine methyltransferase 3" Q96AZ1 12 57771492-57782541 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 39.7" "Cell type enhanced" "Detected in some" 10 "Exocrine glandular cells: 10.8;Hofbauer cells: 6.6;monocytes: 15.4;Proximal tubular cells: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 7 "RH-30: 59.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043020, HPA045492" Uncertain Approved "Nucleoplasm,Mitotic chromosome,Centrosome" NA NA Centrosome "Nucleoplasm, Mitotic chromosome" "HPA043020: AB_2678274, HPA045492: " "unprognostic (2.00e-1)" "unprognostic (6.52e-2)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (1.06e-1)" "unprognostic (7.34e-3)" "unprognostic (7.52e-3)" "unprognostic (1.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.54e-3)" "unprognostic (5.77e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-2)" "unprognostic (1.23e-1)" 9.3 6.1 3.1 3.8 3.0 1.6 10.1 3.7 3.8 8.9 5.4 2.5 8.7 2.8 10.1 8.1 6.4 7.2 8.3 3.9 2.5 1.6 10.8 6.1 7.2 5.5 2.1 2.7 10.7 34.4 6.0 3.6 4.5 3.5 7.7 3.7 6.1 39.7 14.6 2.8 6.2 3.3 7.0 2.9 3.8 6.0 4.3 1.4 1.5 8.4 5.1 6.2 7.7 6.9 0.7 3.9 1.2 5.4 1.8 10.6 2.6 1.9 3.5 1.8 2.2 5.3 5.0 1.5 2.2 4.4 3.7 3.7 2.1 3.3 1.1 2.5 3.0 2.6 1.9 1.4 1.3 3.7 1.2 2.1 5.6 1.9 3.5 4.7 1.4 2.4 5.3 3.5 3.8 4.0 6.0 3.9 5.2 3.3 8.9 2.2 1.5 1.6 3.9 1.3 1.4 3.2 3.3 59.3 3.8 2.5 2.2 1.7 2.4 3.9 2.8 2.4 1.7 4.7 3.7 3.7 5.5 3.1 2.2 2.3 1.9 0.8 1.5 4.2 6.0 3.7 0.5 3.9 0.1 2.5 1.5 10.6 0.7 4.9 2.9 3.9 0.7 2.5 1.9 1.2 1.8 5.4 2.0 3.0 2.6 3.1 3.0 3.7 3.8 2.5 1.6 2.1 2.7 3.5 1.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 2.7 5.0 4.7 0.0 0.0 0.0 0.0 10.8 4.0 0.0 0.0 2.3 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 15.4 0.0 0.0 6.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 EEFSEC "eEFSec, EFSEC, SELB" ENSG00000132394 "Eukaryotic elongation factor, selenocysteine-tRNA specific" P57772 3 128153454-128408646 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.4;GAMG: 10.3;SH-SY5Y: 8.8;SK-BR-3: 14.7;SK-MEL-30: 12.7;T-47d: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035795 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA035795: AB_10696512" "unprognostic (1.01e-1)" "prognostic favorable (2.98e-5)" "unprognostic (2.53e-1)" "unprognostic (1.32e-3)" "unprognostic (1.12e-1)" "unprognostic (3.03e-1)" "unprognostic (4.37e-3)" "unprognostic (6.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.84e-1)" "unprognostic (1.61e-2)" "unprognostic (3.83e-2)" "unprognostic (1.12e-2)" "unprognostic (4.31e-2)" "unprognostic (1.99e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" 8.2 6.8 5.6 7.9 7.9 3.1 7.9 8.4 9.8 11.6 8.6 9.3 7.3 2.5 10.8 5.4 8.0 9.4 7.1 18.7 7.6 6.4 9.4 18.1 7.1 15.5 5.4 4.2 11.5 8.4 23.9 9.2 9.7 6.9 9.0 4.9 7.2 10.7 11.2 20.3 15.9 15.7 10.0 5.0 9.2 6.9 11.5 6.2 17.2 8.4 6.7 10.5 7.7 7.9 7.1 10.9 7.3 7.8 9.7 7.0 3.8 0.4 0.1 3.4 1.4 0.1 0.2 0.4 0.0 0.2 0.2 0.2 0.3 5.7 12.4 0.1 3.1 10.3 0.9 0.3 0.1 0.1 0.3 0.2 0.0 0.1 0.1 4.9 0.2 0.3 0.1 0.1 3.4 0.1 0.1 0.2 0.0 0.0 0.2 2.9 0.1 6.2 0.3 0.4 0.0 0.1 0.2 0.2 0.8 0.0 0.0 0.3 8.8 0.0 14.7 12.7 0.3 7.9 0.5 0.0 0.1 0.0 0.1 0.2 0.4 0.6 0.3 0.1 0.4 0.2 0.5 7.5 7.3 6.7 7.8 5.6 7.1 5.9 5.8 10.9 5.8 5.6 6.5 0.0 9.7 6.2 4.6 7.0 3.8 5.6 7.9 8.4 9.8 7.6 6.4 5.4 4.2 6.9 6.2 0.0 5.9 11.8 7.7 5.7 8.7 9.4 0.0 2.7 1.2 15.7 2.0 19.4 13.3 5.9 21.8 7.1 5.5 0.0 6.2 14.9 10.0 7.4 27.7 11.9 13.0 12.7 10.9 6.2 6.0 63.4 12.0 8.6 11.8 3.6 8.7 8.3 5.4 0.0 8.1 21.4 6.6 25.8 7.5 26.5 16.0 8.7 24.8 10.2 8.7 5.6 EFCAB12 C3orf25 ENSG00000172771 "EF-hand calcium binding domain 12" Q6NXP0 3 129401321-129428651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.4;fallopian tube: 29.9;testis: 24.8" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 58.9;Early spermatids: 23.2;Late spermatids: 14.5" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "basal ganglia: 14.9;pons and medulla: 24.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 4.7;RPTEC TERT1: 3.8;SCLC-21H: 2.9" "Region enhanced" "Detected in many" "midbrain: 14.2" "HPA037694, HPA057532" Uncertain Supported Approved "Nucleoplasm,Nuclear bodies,Midbody ring" NA NA Nucleoplasm "Nuclear bodies, Midbody ring" "HPA037694: AB_10672605, HPA057532: " "unprognostic (2.06e-3)" "unprognostic (1.87e-2)" "unprognostic (2.96e-2)" "unprognostic (4.34e-3)" "unprognostic (1.81e-1)" "unprognostic (7.59e-4)" "unprognostic (2.37e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-1)" "unprognostic (1.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.27e-1)" "unprognostic (1.57e-2)" "unprognostic (4.59e-2)" 0.7 0.6 2.2 0.7 14.9 1.5 0.9 1.7 3.0 2.0 0.6 7.8 0.0 0.5 1.8 10.1 0.6 29.9 1.5 0.7 4.2 4.3 1.2 2.1 3.6 0.8 0.5 3.5 6.1 1.0 3.1 15.2 0.7 24.4 4.1 0.6 1.5 0.6 0.9 0.5 0.5 0.5 0.6 1.0 0.7 1.0 24.8 1.6 0.0 2.4 0.0 0.9 0.5 0.1 1.4 0.0 1.3 0.4 0.3 0.6 0.0 0.4 2.2 0.7 2.2 0.4 0.1 0.4 0.0 0.2 0.3 0.1 0.8 1.2 0.5 0.4 0.0 0.0 0.3 0.0 0.4 0.3 0.6 0.5 0.6 0.6 4.7 0.3 0.3 0.9 0.5 0.0 0.5 0.0 0.4 0.0 1.3 1.4 0.9 0.0 0.3 0.1 1.7 0.3 0.2 0.1 0.8 0.0 0.5 3.8 0.0 2.9 0.1 0.0 0.0 0.1 0.0 0.8 0.3 0.0 0.0 0.5 1.1 0.2 1.4 1.8 2.2 0.5 0.8 0.2 0.0 0.4 0.8 0.1 0.0 0.3 0.3 0.0 0.6 0.0 1.4 0.3 0.2 1.3 0.3 0.0 0.0 0.2 0.0 2.2 14.9 1.7 3.0 4.2 4.3 0.5 3.5 24.4 1.6 3.0 1.7 0.0 0.1 0.5 0.2 1.1 2.5 58.9 2.3 0.0 2.0 0.0 0.0 0.1 23.2 0.3 0.0 0.0 0.2 0.0 0.2 0.8 0.0 0.8 0.1 4.8 0.0 0.0 0.0 14.5 0.3 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.8 5.2 0.0 0.0 8.2 2.5 0.3 0.0 0.0 0.0 0.1 EFCAB13 "C17orf57, FLJ40342" ENSG00000178852 "EF-hand calcium binding domain 13" Q8IY85 17 47323290-47441312 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 29.9" "Group enriched" "Detected in many" 4 "Early spermatids: 161.3;Late spermatids: 143.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "CAB002501, HPA021633, HPA023249, HPA026561" Uncertain Enhanced "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear speckles" "CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596" "unprognostic (1.66e-1)" "unprognostic (3.48e-1)" "unprognostic (1.24e-2)" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.40e-1)" "unprognostic (7.43e-2)" "unprognostic (8.79e-3)" "unprognostic (8.75e-2)" "unprognostic (1.75e-2)" "unprognostic (1.46e-5)" "unprognostic (1.68e-1)" "unprognostic (1.61e-1)" "unprognostic (8.10e-2)" "unprognostic (1.90e-3)" 4.1 2.8 2.9 12.2 3.4 3.4 6.5 2.8 3.8 6.5 4.7 2.3 3.5 4.8 8.9 4.4 2.4 4.2 4.1 3.5 2.3 1.5 7.5 4.0 3.1 4.3 3.6 0.4 5.5 2.8 8.4 7.6 5.4 3.2 9.3 3.4 2.6 5.4 2.0 1.3 2.2 6.3 9.9 3.5 4.6 3.5 20.0 2.7 2.4 14.9 0.7 4.3 5.5 29.9 5.6 1.0 5.3 2.1 0.8 2.6 0.8 0.9 4.0 1.7 0.2 2.1 7.3 3.1 2.2 0.5 0.7 1.2 1.7 5.6 0.3 6.6 0.8 0.0 1.1 0.0 0.4 4.0 0.2 0.6 5.2 3.3 0.5 2.1 4.0 0.6 1.3 1.9 2.7 0.0 5.0 4.5 4.1 1.5 9.9 2.4 0.1 1.7 2.3 0.9 2.8 3.2 4.7 1.3 1.8 9.2 3.2 1.2 0.6 1.2 0.1 2.6 1.3 6.6 4.7 1.6 0.3 1.3 0.4 1.1 10.2 7.0 0.9 6.3 7.8 4.3 5.3 2.1 0.6 1.1 1.2 0.9 4.3 0.9 0.6 1.0 5.6 2.6 1.2 0.0 0.8 0.7 0.4 0.1 0.8 2.9 3.4 2.8 3.8 2.3 1.5 3.6 0.4 3.2 2.7 8.9 2.1 2.0 1.7 0.7 2.3 3.8 0.0 5.3 1.2 0.0 0.0 0.2 0.0 0.7 161.3 6.3 0.5 0.0 0.7 0.2 1.3 1.0 5.8 0.8 1.7 3.2 2.9 3.7 2.1 143.2 1.7 1.3 0.0 1.8 0.2 1.1 1.2 0.0 3.5 0.8 2.6 0.0 2.3 34.1 7.9 0.5 0.0 0.0 0.6 1.0 EFHC2 "FLJ22843, MRX74" ENSG00000183690 "EF-hand domain containing 2" Q5JST6 X 44147882-44343672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6;fallopian tube: 20.8" "Group enriched" "Detected in many" 4 "Ciliated cells: 64.3;Early spermatids: 62.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 20.6" "Group enriched" "Detected in some" 5 "basophil: 14.1;NK-cell: 6.6" "Group enriched" "Detected in many" 5 "granulocytes: 14.1;NK-cells: 6.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.2;HEL: 5.4;HMC-1: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034492 Approved Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Plasma membrane" "HPA034492: AB_10671227" "unprognostic (1.93e-1)" "unprognostic (7.80e-3)" "unprognostic (7.35e-2)" "unprognostic (2.75e-1)" "unprognostic (6.83e-3)" "unprognostic (5.07e-2)" "unprognostic (4.29e-2)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "unprognostic (2.90e-2)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (7.89e-2)" "unprognostic (1.06e-1)" "unprognostic (6.13e-4)" "unprognostic (1.64e-3)" "unprognostic (4.97e-2)" 0.7 0.6 4.0 0.8 6.2 1.9 1.2 1.6 3.1 4.6 1.6 6.5 3.7 0.6 5.4 12.6 2.9 20.8 3.0 6.0 4.8 3.9 2.0 0.1 4.5 0.5 1.5 2.0 5.2 0.3 0.9 6.9 1.3 20.6 2.9 0.6 0.6 9.6 5.8 0.1 4.7 0.8 2.6 1.4 0.6 1.6 10.1 3.1 0.4 3.7 1.4 0.9 1.7 1.4 0.1 0.4 14.1 0.0 6.6 2.1 1.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 5.2 0.0 0.1 0.0 1.7 0.0 0.4 0.0 0.1 0.0 0.1 5.4 0.0 0.0 0.0 0.0 18.0 0.3 0.3 0.3 0.0 0.2 0.0 0.8 1.5 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.1 0.3 0.0 0.0 1.5 0.0 0.3 0.6 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 14.1 0.0 0.0 2.1 0.0 0.8 0.1 0.8 0.1 0.4 0.1 0.7 1.0 1.9 6.6 0.0 0.0 0.0 1.4 4.0 6.2 1.6 3.1 4.8 3.9 1.5 2.0 20.6 3.1 0.0 4.6 0.0 5.2 2.7 0.1 12.2 5.1 64.3 2.3 0.0 2.0 0.0 1.7 0.5 62.9 0.0 1.3 0.0 5.3 0.0 1.0 0.7 15.1 0.0 0.2 0.0 0.0 0.0 0.0 12.0 6.4 0.2 0.0 0.0 1.3 4.9 0.7 0.0 6.7 0.0 0.0 6.5 2.1 8.6 10.4 2.5 0.2 0.5 3.5 6.5 EFTUD2 "SNRNP116, Snrp116, Snu114, U5-116KD" ENSG00000108883 "Elongation factor Tu GTP binding domain containing 2" Q15029 17 44849943-44899662 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022021 Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA022021: AB_1848032" "unprognostic (4.28e-2)" "unprognostic (4.12e-2)" "unprognostic (1.98e-3)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (4.98e-2)" "prognostic unfavorable (2.71e-6)" "unprognostic (6.94e-2)" "unprognostic (4.52e-1)" "unprognostic (2.37e-1)" "unprognostic (4.11e-3)" "unprognostic (5.19e-2)" "unprognostic (5.48e-3)" "unprognostic (1.62e-2)" "unprognostic (5.30e-2)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" 22.5 26.5 16.0 23.1 27.0 25.0 17.7 13.4 34.9 14.8 20.3 22.0 10.4 16.6 22.1 15.4 27.0 20.2 12.7 22.6 16.6 16.7 21.5 27.7 17.3 25.2 15.8 19.8 15.3 20.0 21.2 15.3 27.5 22.6 14.9 23.2 19.1 27.2 15.7 49.6 22.0 20.3 18.5 15.7 25.9 18.5 30.2 13.1 36.9 18.6 17.9 34.9 18.6 16.0 12.8 31.8 31.6 31.5 15.6 16.9 23.3 22.7 45.6 22.3 36.0 17.1 16.9 26.2 18.1 24.3 45.8 39.8 35.1 19.6 39.4 21.4 22.8 35.3 26.1 48.3 31.7 53.6 39.6 40.1 39.1 28.5 37.3 18.9 46.0 29.1 18.3 18.2 42.4 23.1 17.7 39.6 35.7 48.1 15.4 26.1 22.7 46.1 30.4 22.9 53.8 38.2 32.5 45.3 34.2 26.1 25.6 36.7 21.9 17.8 13.2 18.8 34.1 35.0 29.1 24.0 34.5 26.6 20.8 45.6 16.3 20.4 39.6 27.7 25.7 35.1 12.3 31.5 31.6 15.2 31.0 16.9 12.8 13.5 14.6 31.8 12.5 12.0 13.3 5.1 15.6 29.7 13.7 13.2 23.3 16.0 27.0 13.4 34.9 16.6 16.7 15.8 19.8 22.6 13.1 0.0 12.3 16.4 10.8 10.4 13.9 15.9 28.1 14.7 12.5 17.4 31.4 30.5 3.3 25.5 9.7 16.3 14.6 0.0 23.3 26.0 12.2 9.3 19.6 18.4 34.2 25.4 10.4 17.2 31.7 4.9 11.8 22.3 5.0 49.5 12.0 14.3 21.4 10.5 8.5 10.1 16.1 19.4 9.2 24.7 36.5 12.8 22.8 13.1 20.5 10.3 EIF1AD "haponin, MGC11102" ENSG00000175376 "Eukaryotic translation initiation factor 1A domain containing" Q8N9N8 11 65996545-66002176 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054991, HPA058735" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA "Nucleoplasm, Vesicles" "Intermediate filaments" "HPA054991: AB_2682664, HPA058735: AB_2683802" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.59e-5)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.86e-2)" "unprognostic (1.17e-1)" "unprognostic (8.76e-2)" "unprognostic (1.36e-3)" "unprognostic (2.31e-1)" "unprognostic (1.59e-3)" "unprognostic (7.63e-3)" "unprognostic (1.40e-1)" "unprognostic (1.28e-3)" "unprognostic (3.96e-1)" 16.8 18.4 15.5 17.9 18.8 38.7 16.3 21.8 23.7 16.0 15.3 15.4 19.9 15.0 18.3 16.4 22.1 16.0 15.3 15.6 15.1 16.1 15.2 18.5 16.2 21.1 18.8 11.1 21.5 23.7 22.0 24.0 25.5 17.7 15.8 14.8 17.5 17.8 16.2 27.1 23.4 17.6 14.9 18.2 22.2 16.6 22.3 19.9 21.2 16.0 18.1 27.0 15.5 23.8 14.8 16.1 28.2 15.5 11.6 14.7 9.4 22.4 19.7 16.6 16.5 13.3 13.9 15.6 16.5 16.3 21.2 18.0 18.9 21.7 17.1 29.0 18.9 18.1 15.6 19.7 22.0 19.7 15.8 10.2 24.2 22.6 20.4 16.6 22.1 19.0 11.6 19.3 31.7 21.7 14.5 14.1 18.2 36.0 25.0 30.0 30.0 20.4 24.6 12.4 10.4 21.5 22.5 16.8 33.5 11.9 14.1 12.2 15.0 18.6 25.4 19.3 13.7 24.8 13.7 16.8 27.6 18.7 22.5 15.9 30.6 36.0 35.9 20.1 15.5 18.3 28.2 15.5 10.0 14.7 12.7 11.3 14.8 12.6 10.7 16.1 14.5 12.0 11.0 10.6 11.6 15.3 9.7 11.3 9.4 15.5 18.8 21.8 23.7 15.1 16.1 18.8 11.1 17.7 19.9 3.0 4.8 11.2 10.4 33.5 6.9 13.4 12.7 6.7 2.3 5.2 13.7 14.0 13.3 11.8 12.0 12.7 10.2 0.0 11.3 20.1 11.8 10.7 12.7 13.6 22.0 11.1 2.4 14.7 8.2 11.4 11.2 19.8 11.8 15.4 10.7 6.0 20.7 14.4 5.3 12.8 18.0 6.5 18.9 25.6 21.3 42.8 21.2 17.5 8.0 11.2 EIF2B2 "EIF-2Bbeta, EIF2B" ENSG00000119718 "Eukaryotic translation initiation factor 2B subunit beta" P49770 14 75002911-75012366 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 138.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005841, CAB037105, HPA048028" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: AB_2680235" "unprognostic (1.10e-1)" "unprognostic (4.41e-2)" "unprognostic (5.70e-2)" "unprognostic (6.71e-2)" "unprognostic (7.64e-2)" "unprognostic (3.45e-3)" "prognostic unfavorable (2.26e-6)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "prognostic favorable (2.95e-4)" "unprognostic (4.15e-2)" "unprognostic (2.74e-1)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" 11.8 20.1 11.6 9.2 12.3 9.1 11.6 11.0 16.4 13.2 13.9 13.2 9.2 9.8 11.6 15.8 14.3 10.4 12.6 15.0 11.5 12.0 19.6 18.8 10.3 11.6 13.6 11.4 12.3 12.9 32.3 11.9 20.4 15.7 13.6 12.2 11.7 11.1 14.8 29.0 12.5 13.1 11.0 14.8 12.1 10.9 20.1 11.0 17.7 33.4 11.2 12.7 14.9 9.7 4.2 5.1 7.7 3.9 6.5 8.1 4.8 5.1 6.3 5.1 5.8 5.9 4.9 6.8 3.3 5.5 6.5 7.6 7.9 5.3 4.6 2.1 5.2 4.1 3.9 7.9 7.7 9.8 2.8 5.9 4.0 5.5 5.4 7.7 3.0 4.8 4.5 7.4 8.3 8.6 5.6 22.3 4.0 3.6 4.5 13.9 15.2 4.7 3.7 3.6 6.4 9.3 3.0 6.0 3.8 9.2 6.2 5.5 4.4 3.5 5.0 7.4 6.6 8.1 2.8 5.7 5.0 4.9 2.2 4.2 7.7 6.3 5.4 5.5 3.7 3.8 7.7 3.9 2.8 6.7 3.9 5.6 4.2 5.9 5.4 5.1 4.1 4.4 4.6 2.2 6.5 3.7 4.2 8.1 4.8 11.6 12.3 11.0 16.4 11.5 12.0 13.6 11.4 15.7 11.0 17.9 8.6 15.1 16.5 15.8 25.7 16.1 28.1 10.7 14.8 24.4 43.2 42.7 34.9 31.8 7.6 18.8 14.3 0.0 28.8 47.0 15.5 14.3 20.8 10.5 29.7 27.0 15.0 12.9 16.5 7.8 14.7 14.0 13.5 34.3 9.1 24.2 26.4 12.4 15.2 35.2 27.5 25.8 21.2 39.0 22.8 19.2 138.4 13.8 17.8 15.9 EIF4E "EIF4E1, EIF4EL1, EIF4F" ENSG00000151247 "Eukaryotic translation initiation factor 4E" P06730 4 98871684-98930637 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Autism, Autism spectrum disorder, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 945.1;Late spermatids: 1606.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004077, CAB016316, HPA068358" Supported Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA 580000 "Cytosol, Cytoplasmic bodies" Nucleoplasm "CAB004077: AB_823488, CAB016316: AB_627502, HPA068358: " "unprognostic (3.07e-3)" "unprognostic (1.43e-1)" "unprognostic (6.53e-3)" "unprognostic (7.52e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-3)" "unprognostic (2.03e-5)" "unprognostic (6.55e-3)" "unprognostic (1.09e-2)" "unprognostic (1.33e-1)" "unprognostic (1.28e-1)" "unprognostic (1.63e-1)" "unprognostic (1.10e-3)" "unprognostic (5.40e-2)" "unprognostic (1.43e-1)" "unprognostic (2.31e-2)" "unprognostic (1.28e-1)" 22.3 26.8 25.7 20.1 35.3 25.2 23.1 40.8 38.4 21.4 27.2 23.3 19.1 19.8 21.7 21.4 39.6 19.9 18.8 23.0 26.0 29.9 29.3 26.2 18.8 24.4 27.7 28.4 18.8 16.1 24.7 25.6 21.8 35.3 19.9 33.2 15.4 23.2 21.0 29.8 19.1 19.5 24.8 31.0 19.4 20.6 39.1 23.4 22.4 33.4 27.1 34.2 22.1 24.2 31.3 25.4 36.6 32.0 32.6 32.2 30.0 25.8 22.7 38.7 25.7 22.0 23.2 23.2 49.3 30.9 40.8 30.7 30.4 32.7 52.4 15.9 30.3 25.5 13.1 53.2 37.0 49.9 34.5 15.5 35.6 15.8 27.7 19.0 51.2 27.0 16.5 23.7 31.4 24.9 23.4 31.3 26.3 59.2 24.5 36.1 22.2 47.4 19.8 30.4 50.5 21.1 30.0 26.2 23.3 35.9 23.0 32.8 21.6 22.9 48.8 15.9 27.2 23.8 20.2 23.0 29.5 31.7 26.5 39.7 18.3 46.5 47.4 26.4 26.3 33.4 23.3 22.3 36.6 26.3 25.9 30.5 31.3 29.2 27.0 25.4 26.9 32.2 31.9 16.2 32.6 32.0 21.4 28.7 30.0 25.7 35.3 40.8 38.4 26.0 29.9 27.7 28.4 35.3 23.4 29.8 42.3 104.6 137.6 321.7 85.9 22.3 43.3 40.2 38.7 57.6 33.4 94.3 217.2 77.3 945.1 55.4 92.4 93.5 59.1 125.0 82.5 155.3 50.7 67.4 112.0 81.0 62.0 39.3 59.2 1606.7 46.9 94.3 183.9 85.6 57.3 60.6 65.2 66.6 46.3 112.9 57.1 51.8 118.5 94.7 83.0 324.2 99.5 64.2 72.3 177.8 EIF4H "KIAA0038, WBSCR1, WSCR1" ENSG00000106682 "Eukaryotic translation initiation factor 4H" Q15056 7 74174245-74197101 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 1039.9;Late spermatids: 2062.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030542 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 520000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA030542: AB_10601368" "unprognostic (2.83e-1)" "unprognostic (9.50e-2)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (3.89e-4)" "prognostic unfavorable (2.15e-4)" "unprognostic (1.61e-2)" "unprognostic (2.72e-3)" "unprognostic (1.79e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-2)" "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (5.68e-2)" "unprognostic (1.27e-2)" 46.8 42.7 47.6 37.6 52.8 82.3 42.8 56.0 89.5 39.8 44.5 46.6 36.2 43.1 48.1 37.9 58.6 44.4 40.7 47.4 45.6 41.4 34.5 50.7 37.4 42.8 45.4 54.6 54.2 74.3 54.3 30.1 72.2 47.6 44.8 35.1 35.6 60.3 45.4 89.6 53.0 41.5 43.4 59.9 34.6 45.4 52.5 32.1 46.8 43.5 57.9 44.2 43.4 41.4 38.4 57.6 60.2 64.2 46.7 52.0 80.6 87.4 58.3 44.5 53.9 39.7 42.3 50.6 62.6 47.6 51.9 51.1 71.4 67.5 75.2 17.1 57.8 75.1 46.5 49.0 83.2 49.1 50.5 57.4 41.9 54.8 57.3 45.5 70.6 42.3 49.5 52.9 57.6 82.0 61.0 56.8 45.0 73.6 32.7 53.1 74.7 55.7 83.8 59.4 72.7 57.8 65.4 59.7 67.9 43.1 56.0 45.3 57.2 58.4 73.8 49.6 61.4 83.4 45.8 59.0 74.4 50.6 62.2 78.7 38.9 46.4 128.4 58.1 74.2 76.3 45.7 58.4 60.2 43.5 64.2 44.9 38.4 44.7 43.0 57.6 35.3 52.0 42.4 39.0 46.7 63.6 24.4 47.6 80.6 47.6 52.8 56.0 89.5 45.6 41.4 45.4 54.6 47.6 32.1 77.4 68.6 90.9 132.2 105.9 91.7 38.9 66.2 53.5 59.1 41.8 23.6 170.5 91.2 122.8 1039.9 93.3 74.9 46.7 138.2 310.9 112.7 87.9 121.1 74.9 110.6 92.2 86.8 73.6 90.7 2062.3 96.1 91.0 69.2 181.3 80.6 92.2 119.2 69.1 104.0 54.1 63.7 84.1 131.0 55.4 62.9 101.5 330.6 89.7 87.9 119.5 EIPR1 "EIPR-1, TSSC1" ENSG00000032389 "EARP complex and GARP complex interacting protein 1" Q53HC9 2 3188925-3377882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 43.9;Distal tubular cells: 43.1;Extravillous trophoblasts: 29.7;Hofbauer cells: 29.7;monocytes: 28.9;Proximal tubular cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031231, HPA031232, HPA031233, HPA031234" Approved Supported "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli" "Intermediate filaments" "HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803" "unprognostic (2.16e-1)" "unprognostic (2.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.66e-1)" "unprognostic (4.27e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (3.67e-7)" "unprognostic (1.94e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (1.78e-1)" "unprognostic (1.02e-2)" "unprognostic (3.43e-1)" "unprognostic (2.24e-2)" "unprognostic (3.83e-2)" 7.3 12.3 20.1 17.3 24.4 14.2 9.0 26.0 22.9 8.3 11.9 12.1 10.0 10.7 7.7 18.4 14.5 12.0 7.9 10.3 17.7 19.3 12.4 11.4 7.9 15.2 15.1 14.5 5.8 11.6 14.2 20.8 8.0 13.6 7.7 10.9 10.5 9.9 7.4 10.9 9.2 9.3 9.4 12.4 12.0 9.3 9.9 11.5 14.5 20.4 15.5 15.3 11.1 7.7 15.7 23.4 13.9 13.3 16.3 16.9 14.0 10.6 20.1 10.7 12.1 6.8 9.2 24.3 11.2 11.7 13.5 10.3 13.4 13.5 18.7 19.9 11.4 12.8 11.0 8.4 16.2 7.5 14.5 15.9 16.5 12.5 30.9 13.0 16.1 20.6 8.4 14.7 13.7 17.8 7.5 17.1 33.4 18.4 13.0 12.4 19.9 14.9 23.5 12.4 25.2 16.1 17.5 11.4 25.1 16.8 14.8 23.4 27.2 7.9 13.3 12.2 6.0 12.3 15.1 12.0 10.9 5.6 8.9 15.0 14.9 36.0 15.5 12.9 16.8 10.0 13.9 11.8 9.4 16.1 13.3 16.3 13.9 13.4 16.8 21.3 15.7 14.7 15.8 5.0 16.3 11.9 23.4 16.9 14.0 20.1 24.4 26.0 22.9 17.7 19.3 15.1 14.5 13.6 11.5 3.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 11.4 19.2 0.0 43.9 43.1 25.6 0.0 0.0 0.0 0.0 13.9 29.7 0.0 0.0 3.5 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 28.9 0.0 0.0 17.8 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 ELAVL1 "Hua, HuR, MelG" ENSG00000066044 "ELAV like RNA binding protein 1" Q15717 19 7958579-8005659 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005256, HPA046298" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 210000 Nucleoplasm "Nucleoli, Cytosol" "CAB005256: AB_2096342, HPA046298: AB_2679618" "unprognostic (1.19e-1)" "unprognostic (9.66e-3)" "unprognostic (2.46e-2)" "unprognostic (3.98e-1)" "unprognostic (1.04e-1)" "unprognostic (6.37e-3)" "unprognostic (1.81e-2)" "unprognostic (8.44e-2)" "unprognostic (3.75e-2)" "prognostic favorable (4.93e-4)" "unprognostic (2.09e-1)" "unprognostic (1.59e-2)" "unprognostic (7.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 19.7 23.8 28.0 22.4 34.1 17.2 22.4 35.4 28.0 23.1 21.4 21.2 19.6 17.9 27.5 19.7 24.4 25.7 16.9 25.2 23.6 17.6 20.8 21.4 19.4 26.5 27.5 22.2 25.7 20.4 29.4 25.4 23.3 26.5 20.4 20.2 19.7 21.2 23.0 27.6 19.2 18.4 30.4 17.7 21.9 19.7 46.7 26.5 40.4 20.6 18.7 30.7 23.4 32.2 17.1 17.6 24.3 14.7 23.2 19.6 9.4 36.1 24.0 40.3 30.3 15.8 15.9 22.7 27.0 22.7 40.2 31.5 34.7 21.1 43.6 38.0 29.6 22.6 25.3 44.9 30.9 34.1 38.9 41.7 38.2 17.7 32.3 23.2 36.2 30.6 19.7 18.6 28.0 17.1 19.1 30.7 33.3 39.2 32.7 27.7 26.8 60.5 29.2 35.9 27.2 30.6 68.1 26.3 28.7 25.5 26.7 29.0 21.2 25.6 25.9 20.4 25.4 29.5 28.6 23.0 37.7 26.4 34.9 46.4 33.4 32.3 45.8 21.1 43.6 32.5 16.4 13.0 24.3 12.2 11.7 12.9 14.0 17.8 19.6 17.6 17.1 16.1 12.4 3.8 23.2 14.7 8.8 13.5 9.4 28.0 34.1 35.4 28.0 23.6 17.6 27.5 22.2 26.5 26.5 23.8 23.9 31.2 59.2 64.3 42.6 27.2 30.6 14.7 13.6 45.4 53.0 76.4 56.3 31.1 188.6 49.4 29.5 0.0 29.2 87.0 49.8 55.0 20.7 78.0 55.5 57.2 40.4 43.0 50.2 108.9 46.6 53.3 49.0 30.7 47.6 43.8 29.8 48.6 53.4 49.4 54.8 51.8 58.0 132.2 59.8 62.0 62.6 49.8 53.0 69.3 ELL "C19orf17, ELL1, Men, PPP1R68" ENSG00000105656 "Elongation factor for RNA polymerase II" P55199 19 18442663-18522127 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 301.9;Late spermatids: 183.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004202, HPA046076" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA004202: , HPA046076: AB_2679526" "unprognostic (9.49e-2)" "unprognostic (1.38e-1)" "unprognostic (3.26e-3)" "unprognostic (2.07e-1)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (8.26e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-1)" "unprognostic (3.00e-2)" "unprognostic (6.28e-3)" "unprognostic (2.38e-2)" "unprognostic (1.57e-1)" "unprognostic (2.07e-1)" "unprognostic (5.12e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 19.9 7.7 5.1 13.4 9.9 38.4 10.8 17.0 9.7 11.9 13.5 7.7 8.6 10.4 12.6 9.5 9.3 9.1 10.9 9.5 5.8 4.4 9.8 11.6 14.2 10.7 6.2 3.5 12.7 14.6 6.2 10.5 27.0 6.3 10.4 4.4 9.1 10.6 9.0 20.3 13.3 10.9 10.0 5.1 15.9 9.3 31.7 7.7 11.0 7.8 7.2 13.6 18.5 13.2 3.1 8.6 17.2 5.6 2.1 7.9 3.3 8.9 4.4 2.3 4.9 2.5 3.2 17.0 7.1 6.3 5.4 5.2 5.0 7.1 11.3 8.8 4.7 3.7 6.3 3.4 7.8 2.7 9.2 8.0 6.8 4.4 4.3 3.8 7.4 8.7 6.5 6.7 7.0 5.5 4.2 3.8 6.2 9.4 15.6 2.8 7.6 8.7 8.1 7.7 5.4 12.6 7.5 3.7 11.9 3.8 6.3 4.2 4.6 5.2 9.0 7.7 3.1 4.5 9.3 6.3 6.3 4.9 8.6 6.6 25.5 16.0 8.4 8.3 12.6 8.9 0.3 5.6 3.8 4.7 4.1 7.9 3.1 2.9 4.2 4.7 2.3 1.9 2.9 17.2 2.1 2.1 8.6 3.0 3.3 5.1 9.9 17.0 9.7 5.8 4.4 6.2 3.5 6.3 7.7 6.0 6.7 6.0 22.3 24.8 4.1 4.0 10.2 6.7 3.4 3.5 3.9 37.4 10.0 7.0 301.9 11.7 10.5 0.0 7.0 14.6 16.0 13.8 10.5 13.4 16.6 1.6 18.9 8.6 11.5 183.8 6.1 13.8 6.8 11.8 9.0 4.2 8.8 2.9 2.8 5.7 3.5 19.4 28.8 19.0 21.8 26.6 57.4 11.4 6.4 18.6 ELL3 FLJ22637 ENSG00000128886 "Elongation factor for RNA polymerase II 3" Q9HB65 15 43772600-43777543 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.3;lymphoid tissue: 24.2" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 5.3;Early spermatids: 1.5;Enterocytes: 1.7;Late spermatids: 1.8;Mucus-secreting cells: 2.0;Undifferentiated cells: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "memory B-cell: 5.3;naive B-cell: 8.5" "Lineage enriched" "Detected in many" 7 "B-cells: 8.5" "Cell line enhanced" "Detected in some" "Daudi: 7.9;U-698: 19.2" "Region enriched" "Detected in single" 11 "olfactory region: 2.4" "Not detected" "Not detected" "HPA028938, HPA073494" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" NA NA "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA028938: AB_10795352, HPA073494: " "unprognostic (2.59e-2)" "unprognostic (4.41e-1)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (3.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.17e-1)" "unprognostic (2.42e-3)" "unprognostic (1.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.19e-1)" "unprognostic (3.53e-1)" "unprognostic (1.87e-1)" "unprognostic (3.67e-2)" "unprognostic (8.95e-2)" "unprognostic (1.08e-1)" "unprognostic (1.24e-2)" 0.7 1.1 1.0 24.2 0.6 0.4 2.5 4.7 0.6 2.3 10.6 0.5 1.6 4.8 1.0 1.0 5.5 1.3 0.9 0.6 1.0 0.6 1.8 0.5 0.9 7.5 1.3 0.0 1.3 0.7 0.6 1.2 0.8 2.6 2.1 1.8 0.8 2.0 0.7 1.0 7.0 13.3 0.9 0.6 1.5 1.1 12.3 0.5 0.8 1.1 2.8 16.7 1.3 1.7 8.5 1.0 0.1 0.1 0.1 1.2 0.6 0.6 0.1 0.6 0.2 1.6 0.1 0.1 0.2 0.5 0.8 1.3 0.1 0.5 7.9 0.1 0.7 0.1 2.9 0.3 0.0 0.5 0.7 3.4 0.3 2.6 0.8 0.5 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.1 1.2 0.3 0.9 0.0 1.1 0.8 0.8 0.1 0.1 0.2 0.0 3.6 0.2 0.3 1.5 0.3 0.1 3.6 0.2 0.1 0.2 0.0 0.3 0.2 0.0 0.0 19.2 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.2 5.3 0.5 0.2 0.0 8.5 1.2 0.3 0.1 0.1 0.0 1.0 0.3 0.6 1.0 0.6 4.7 0.6 1.0 0.6 1.3 0.0 2.6 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 1.7 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.0 2.0 0.1 ELMOD2 MGC10084 ENSG00000179387 "ELMO domain containing 2" Q8IZ81 4 140524158-140553770 "Predicted intracellular proteins" "Antiviral defense" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047600 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA047600: AB_2680098" "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (6.70e-3)" "unprognostic (2.10e-3)" "unprognostic (4.91e-2)" "unprognostic (3.93e-1)" "unprognostic (1.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-1)" "unprognostic (7.93e-2)" "unprognostic (1.05e-2)" "unprognostic (3.65e-1)" "prognostic favorable (1.17e-8)" "unprognostic (3.17e-1)" "unprognostic (4.03e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (1.82e-2)" 11.6 20.8 9.2 11.9 14.0 8.5 16.7 14.0 10.6 13.8 17.9 10.4 24.7 14.4 15.4 15.8 13.9 13.9 10.9 18.0 10.4 11.2 20.6 19.3 14.5 13.9 13.6 9.2 13.0 17.2 20.2 24.1 17.3 13.6 15.5 15.2 12.1 13.5 21.2 8.4 10.5 31.0 12.4 14.4 11.6 12.1 9.1 12.3 18.2 19.6 10.5 11.2 12.1 11.6 6.0 10.6 17.0 7.8 7.8 8.6 4.8 6.6 7.4 15.2 11.6 15.9 18.4 9.8 15.8 15.0 8.8 10.6 7.3 14.2 10.9 7.0 9.8 10.7 6.1 14.4 10.0 10.9 10.5 8.5 8.9 5.8 9.4 14.5 13.6 8.0 12.6 16.7 7.4 7.7 13.9 9.6 13.3 11.4 18.0 15.0 4.8 14.8 4.7 8.0 9.7 6.1 17.4 11.7 7.0 12.7 10.6 7.2 26.8 10.3 10.6 11.3 17.8 10.4 5.7 9.6 20.3 7.3 9.4 16.2 18.9 26.8 13.8 14.8 10.8 15.2 2.6 7.2 8.7 7.5 7.8 8.6 3.8 6.9 8.3 6.1 6.0 7.1 7.0 17.0 7.8 5.9 10.6 8.0 4.8 9.2 14.0 14.0 10.6 10.4 11.2 13.6 9.2 13.6 12.3 26.8 15.3 5.2 9.6 8.1 19.0 12.3 5.1 25.4 5.7 17.4 17.7 19.0 1.7 20.2 2.0 11.7 15.3 0.0 22.7 7.3 13.3 8.8 19.6 24.6 17.2 14.3 8.7 11.1 17.4 1.0 12.0 13.4 16.9 11.8 12.5 18.5 21.7 12.2 10.3 15.1 22.8 6.5 6.1 25.6 19.4 10.2 16.8 10.7 10.8 4.8 ELP6 "C3orf75, FLJ20211, TMEM103" ENSG00000163832 "Elongator acetyltransferase complex subunit 6" Q0PNE2 3 47495640-47513761 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046358, HPA064545" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA046358: AB_10961011, HPA064545: AB_2685282" "unprognostic (2.00e-3)" "unprognostic (2.27e-1)" "unprognostic (7.41e-3)" "unprognostic (2.41e-2)" "unprognostic (2.67e-1)" "unprognostic (8.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (1.24e-2)" "unprognostic (2.07e-2)" "unprognostic (5.38e-2)" "prognostic favorable (3.42e-6)" "unprognostic (1.54e-1)" "unprognostic (9.05e-2)" "unprognostic (2.30e-1)" "unprognostic (6.29e-2)" 10.8 25.9 15.6 16.3 18.5 8.8 15.3 23.2 24.6 12.8 13.3 22.7 19.0 13.3 17.5 22.1 14.2 16.0 13.3 17.0 16.3 15.7 16.4 18.7 11.6 17.5 16.7 21.8 20.8 18.8 16.6 18.8 12.9 19.9 18.1 13.0 18.5 14.8 17.5 23.6 14.7 11.7 16.4 18.6 14.9 13.9 24.9 13.6 23.7 17.8 13.7 17.8 15.5 11.9 20.4 19.5 10.4 12.0 18.4 21.3 14.2 16.9 16.0 21.5 21.7 17.3 16.0 12.2 20.5 14.2 26.2 23.8 15.6 18.0 32.0 12.8 17.7 24.8 10.5 20.8 29.9 16.1 17.8 16.1 28.9 24.8 17.4 19.0 21.8 18.0 17.2 16.2 29.9 19.1 15.3 22.6 27.6 30.2 10.0 26.1 18.7 26.0 24.8 25.7 16.4 27.5 13.1 10.4 19.5 18.4 15.0 19.2 18.7 17.5 14.1 10.6 18.2 19.2 17.6 14.7 26.9 19.2 13.9 25.6 21.1 27.7 29.3 13.9 26.7 27.4 10.4 12.0 8.4 19.5 11.0 15.1 18.7 18.3 19.5 15.0 20.4 17.3 17.4 1.7 18.4 7.6 19.5 21.3 14.2 15.6 18.5 23.2 24.6 16.3 15.7 16.7 21.8 19.9 13.6 6.0 10.5 27.4 16.0 7.4 23.6 21.6 25.5 14.7 13.6 31.4 13.7 38.8 51.4 24.8 6.1 18.9 16.3 0.0 20.7 32.8 14.8 8.1 21.9 25.2 24.9 36.5 16.7 25.8 14.9 10.7 21.3 12.1 15.1 23.4 12.0 39.0 16.7 14.7 28.7 36.1 25.6 6.5 19.3 55.3 23.8 7.3 22.4 26.2 20.4 7.3 EMG1 ENSG00000126749 "EMG1, N1-specific pseudouridine methyltransferase" Q92979 12 6970893-6979941 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, rRNA-binding, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039304, HPA039666" Supported Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA039304: AB_2676432, HPA039666: AB_10672891" "unprognostic (1.23e-1)" "unprognostic (1.17e-1)" "unprognostic (6.77e-2)" "unprognostic (1.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (2.70e-1)" "unprognostic (1.03e-1)" "unprognostic (2.12e-1)" "unprognostic (9.03e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (2.83e-6)" "unprognostic (2.13e-1)" "unprognostic (2.34e-1)" "unprognostic (6.75e-2)" "unprognostic (1.62e-1)" 8.1 10.1 4.9 12.4 6.6 7.3 8.8 3.6 6.3 5.8 7.5 4.8 11.5 7.5 6.9 9.9 8.1 5.8 7.4 11.6 5.0 7.2 8.3 6.4 8.8 6.4 4.2 8.9 9.4 2.7 5.6 12.6 6.2 7.2 6.8 5.1 8.6 11.4 14.9 5.6 6.7 6.3 5.5 7.7 6.0 4.8 6.1 9.0 8.7 9.5 10.8 7.5 8.7 33.3 20.5 7.7 29.6 20.8 30.1 28.5 17.1 17.1 6.6 8.1 5.2 3.8 27.5 12.8 5.7 10.2 7.0 33.6 18.4 17.3 4.8 7.9 18.6 12.6 6.0 14.6 11.5 12.5 9.8 24.0 16.9 30.9 6.7 24.3 15.6 6.1 8.8 14.8 16.9 5.3 4.4 12.3 11.8 3.9 9.5 20.3 12.6 15.0 54.8 14.2 9.0 17.5 13.4 13.8 6.4 21.8 3.9 11.6 13.5 14.2 12.3 19.7 3.9 18.1 9.2 10.6 13.9 8.7 29.0 4.7 5.3 30.1 11.4 10.6 16.9 4.4 16.6 7.7 24.0 23.8 24.8 30.7 25.5 26.3 18.8 33.3 30.1 27.7 2.3 20.8 29.6 20.5 24.1 28.5 14.9 42.4 35.6 63.8 32.4 13.1 0.0 20.4 42.8 40.9 40.1 7.9 97.4 41.4 64.5 5.3 31.5 18.7 23.3 58.0 98.9 31.9 43.5 60.0 31.0 57.4 15.9 9.2 21.5 24.6 11.1 35.1 40.5 27.0 54.1 22.4 15.6 60.5 17.5 24.4 66.2 13.8 38.8 20.2 28.2 53.8 34.9 62.1 32.8 31.6 55.2 ENPP2 "ATX, PD-IALPHA, PDNP2" ENSG00000136960 "Ectonucleotide pyrophosphatase/phosphodiesterase 2" Q13822 8 119557086-119673453 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 103.7;placenta: 79.0" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 38.2;Fibroblasts: 51.0;Hofbauer cells: 50.0;Intestinal endocrine cells: 51.9;Melanocytes: 43.9;Proximal tubular cells: 45.6" "Cancer enhanced" "Detected in all" "renal cancer: 46.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 26.8" "Cell line enhanced" "Detected in some" "AF22: 25.2;ASC diff: 34.5;ASC TERT1: 73.7;BJ hTERT+: 42.4;fHDF/TERT166: 27.3;HSkMC: 33.8;U-2197: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023700, HPA053652" Approved Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Intracellular and membrane" NA NA 1100000000 "Nucleoplasm, Golgi apparatus" "Actin filaments" "HPA023700: AB_1848170, HPA053652: AB_2682218" "unprognostic (1.17e-2)" "unprognostic (6.29e-2)" "unprognostic (3.63e-2)" "unprognostic (3.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-1)" "unprognostic (9.70e-3)" "unprognostic (7.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "prognostic favorable (2.07e-5)" "unprognostic (5.54e-2)" "unprognostic (3.14e-1)" "unprognostic (2.37e-1)" "unprognostic (5.18e-2)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" 29.9 15.4 24.0 18.2 42.0 0.7 26.2 4.4 33.3 19.6 8.1 103.7 1.7 20.8 44.8 6.4 2.9 18.7 12.7 3.6 39.8 21.5 24.9 8.9 13.5 31.0 71.5 20.9 5.3 5.2 0.9 4.1 79.0 59.7 8.5 10.6 67.6 3.4 9.2 3.0 5.4 12.1 28.9 102.4 17.3 8.3 9.7 63.9 3.6 3.7 0.8 26.1 13.4 5.7 0.2 3.8 26.8 0.1 0.2 1.8 0.3 0.0 0.0 25.2 0.0 34.5 73.7 0.0 23.2 42.4 10.0 9.6 0.0 0.0 0.0 0.3 27.3 0.0 0.0 0.5 0.0 7.1 1.8 0.7 0.0 0.0 0.6 15.4 0.0 0.1 33.8 0.2 20.4 1.0 0.1 0.1 0.0 0.0 4.1 0.5 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 20.3 0.4 24.4 0.1 0.2 0.0 0.0 17.1 0.1 0.5 26.8 0.1 5.2 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 1.8 0.6 0.3 0.2 0.0 3.8 0.0 0.3 24.0 42.0 4.4 33.3 39.8 21.5 71.5 20.9 59.7 63.9 11.9 5.1 3.2 0.5 9.4 1.1 1.2 38.2 6.7 1.2 1.8 0.0 3.4 1.7 0.0 34.3 16.3 0.9 0.0 0.0 1.5 51.0 0.1 5.8 0.4 50.0 0.0 51.9 19.0 12.5 3.6 2.8 8.9 43.9 0.0 0.6 3.3 1.2 0.3 3.2 45.6 1.2 0.0 5.1 1.1 0.4 4.5 5.4 0.5 0.6 0.9 ENTPD8 "NTPDase-8, UNQ2492" ENSG00000188833 "Ectonucleoside triphosphate diphosphohydrolase 8" Q5MY95 9 137434364-137441816 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 48.1" "Group enriched" "Detected in some" 6 "Enterocytes: 107.0;Mucus-secreting cells: 160.6;Paneth cells: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.1;OE19: 3.0;RPMI-8226: 8.8;T-47d: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA021509 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA021509: AB_1848185" "unprognostic (3.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "unprognostic (1.40e-1)" "unprognostic (6.46e-3)" "unprognostic (8.70e-2)" "unprognostic (3.87e-2)" "unprognostic (8.48e-2)" "unprognostic (1.69e-1)" "unprognostic (2.34e-2)" "unprognostic (1.08e-5)" "prognostic favorable (7.17e-4)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-1)" 0.4 0.0 0.4 2.6 0.4 0.0 0.4 0.4 0.4 0.4 19.2 0.4 0.4 18.5 0.4 0.4 0.4 0.3 2.2 0.4 0.5 0.0 2.1 9.8 0.8 0.4 0.4 0.4 0.4 1.8 0.0 4.2 0.5 0.4 0.4 7.5 0.8 4.1 0.4 0.4 0.0 48.1 0.4 0.4 0.4 6.1 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.0 9.1 0.0 0.6 0.0 0.7 0.1 0.0 0.0 0.0 1.5 0.2 0.0 0.6 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 1.6 0.0 0.2 0.1 3.0 0.4 0.0 0.0 8.8 1.4 0.0 0.3 0.9 0.2 0.0 0.1 0.7 4.8 0.2 0.1 0.0 2.4 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.5 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 12.7 0.0 0.0 19.2 0.0 0.0 0.0 0.8 0.0 0.0 107.0 0.0 6.8 0.1 0.0 1.0 0.0 8.2 0.1 0.0 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 160.6 0.0 0.5 49.1 0.0 4.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 12.7 0.6 EOGT "AER61, C3orf64, FLJ33770" ENSG00000163378 "EGF domain specific O-linked N-acetylglucosamine transferase" Q5NDL2 3 68975214-69013961 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 39.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019460 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA019460: AB_1844628" "unprognostic (2.62e-1)" "unprognostic (3.72e-1)" "unprognostic (1.07e-1)" "unprognostic (1.95e-2)" "unprognostic (8.96e-2)" "unprognostic (6.30e-2)" "unprognostic (2.18e-3)" "unprognostic (6.66e-2)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" "unprognostic (1.68e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (8.97e-5)" "unprognostic (7.41e-2)" "unprognostic (4.67e-1)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" 14.9 5.8 3.4 10.1 4.4 3.0 11.9 2.5 4.8 16.8 12.1 4.4 10.2 4.8 23.3 10.4 15.1 11.4 18.1 18.2 3.9 3.6 6.6 5.5 15.8 9.6 4.2 5.0 12.7 7.8 3.9 5.5 15.2 5.1 18.9 5.8 8.7 14.0 24.0 28.0 6.1 7.7 29.4 4.9 10.2 10.1 7.4 2.4 8.3 5.4 14.2 7.3 27.0 9.8 1.7 3.4 5.5 2.2 3.3 9.2 1.8 8.2 2.8 5.4 6.6 7.7 15.2 4.0 11.2 13.7 7.1 9.4 3.7 4.7 0.4 1.7 12.1 6.1 2.7 3.7 14.6 9.0 26.7 2.6 8.6 6.3 5.3 8.6 4.8 3.6 12.6 12.4 9.2 11.7 8.7 39.1 0.3 2.3 5.1 23.8 2.1 0.7 1.5 6.3 2.7 1.3 0.3 5.7 3.5 6.1 19.0 0.5 3.0 12.9 1.0 10.1 6.0 2.8 6.6 20.7 20.1 6.1 2.3 10.8 2.6 8.4 4.0 8.0 7.5 11.2 5.5 2.2 0.0 3.0 1.9 3.5 1.7 4.8 6.4 3.4 1.2 4.1 4.1 0.3 3.3 0.7 0.6 9.2 1.8 3.4 4.4 2.5 4.8 3.9 3.6 4.2 5.0 5.1 2.4 11.9 10.1 1.5 10.1 6.4 2.2 13.7 7.6 8.1 14.8 1.8 15.7 0.8 0.0 4.0 13.9 15.0 2.5 0.0 7.0 3.8 7.5 7.5 0.0 3.8 5.9 0.0 5.8 21.5 5.1 12.0 2.8 7.7 8.5 9.0 3.4 1.3 9.0 2.9 38.2 1.5 4.8 0.0 23.8 1.1 2.4 4.0 0.7 4.4 2.5 5.8 EOMES TBR2 ENSG00000163508 Eomesodermin O95936 3 27715949-27722711 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.9;brain: 22.6;lymphoid tissue: 21.4" "Group enriched" "Detected in some" 8 "Erythroid cells: 23.3;T-cells: 32.6" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Region enriched" "Detected in some" 20 "cerebellum: 22.6" "Group enriched" "Detected in many" 7 "gdT-cell: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9" "Group enriched" "Detected in many" 102 "NK-cells: 17.9;T-cells: 16.5" "Cell line enhanced" "Detected in some" "HDLM-2: 10.2;JURKAT: 12.3;SCLC-21H: 5.7" "Region enriched" "Detected in some" 8 "olfactory region: 95.2" "Group enriched" "Detected in many" 13 "cerebellum: 44.2;olfactory region: 21.9" HPA028896 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA028896: AB_10601370" "unprognostic (1.53e-4)" "unprognostic (5.95e-3)" "unprognostic (3.01e-2)" "unprognostic (1.60e-4)" "unprognostic (4.13e-2)" "unprognostic (9.63e-4)" "unprognostic (4.29e-4)" "unprognostic (3.14e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-2)" "unprognostic (9.96e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (6.32e-3)" "unprognostic (1.49e-2)" 1.4 0.7 0.5 6.8 0.4 1.6 1.6 22.6 0.4 1.8 0.8 0.0 0.0 0.3 3.2 0.9 1.4 0.6 5.0 0.7 0.4 0.7 1.0 4.9 10.1 15.6 0.5 0.3 1.3 0.9 0.0 0.6 1.6 1.1 2.1 0.9 3.3 2.2 0.1 0.4 0.4 1.8 0.7 0.9 21.4 1.4 0.5 0.0 1.8 1.1 0.9 11.2 3.3 0.8 0.0 0.0 0.1 0.0 17.9 16.5 1.4 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 2.6 2.0 0.0 10.2 1.5 0.0 0.1 0.8 0.0 1.2 0.0 0.1 1.2 0.0 1.4 0.5 0.0 12.3 0.3 0.0 0.0 3.0 2.7 0.0 0.3 0.2 1.2 1.9 0.0 0.0 1.0 0.0 5.7 0.0 0.0 0.0 1.2 0.5 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 10.0 0.0 16.5 0.0 1.9 12.0 0.0 0.0 0.1 7.5 0.1 17.9 0.0 0.0 0.0 1.4 0.5 0.4 22.6 0.4 0.4 0.7 0.5 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 3.7 3.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 1.6 0.1 0.0 32.6 0.0 0.0 EPB41L2 4.1-G ENSG00000079819 "Erythrocyte membrane protein band 4.1 like 2" O43491 6 130839347-131063322 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 18 "Muller glia cells: 499.6;Rod photoreceptor cells: 1331.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005730, HPA006642" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 170000 "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA005730: AB_1848195, HPA006642: AB_1848194" "unprognostic (3.18e-2)" "unprognostic (1.04e-1)" "unprognostic (8.34e-3)" "unprognostic (3.40e-3)" "unprognostic (1.41e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (2.41e-5)" "unprognostic (1.25e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (3.24e-1)" "unprognostic (1.63e-1)" "unprognostic (5.63e-2)" "unprognostic (3.64e-2)" "unprognostic (3.82e-1)" "unprognostic (3.48e-2)" "unprognostic (9.19e-2)" 50.2 16.5 29.6 17.3 42.8 3.9 21.1 6.5 40.1 20.5 23.1 32.3 7.2 12.3 23.0 13.7 13.2 25.6 18.0 22.8 33.4 24.6 11.5 12.1 24.4 15.4 50.5 33.1 44.4 9.1 8.2 8.4 26.2 34.8 11.2 23.2 52.0 10.1 15.8 16.0 7.1 21.4 20.6 59.5 25.3 11.7 32.2 51.9 6.8 15.2 14.6 11.6 15.2 16.6 10.5 8.6 0.5 8.8 1.0 2.5 1.3 8.3 8.8 20.0 27.4 13.9 22.3 6.1 14.2 18.0 14.5 20.3 16.8 11.9 10.2 26.7 19.5 11.8 4.3 7.6 13.1 29.0 43.3 17.7 18.3 10.5 9.6 8.2 0.0 22.3 10.9 0.2 25.6 9.9 23.5 22.3 15.6 49.5 29.3 9.2 2.1 14.3 3.1 18.5 35.8 9.6 22.3 24.0 0.9 24.4 8.0 2.1 0.0 5.9 0.1 11.5 21.4 3.0 19.1 27.0 17.1 32.3 28.9 42.7 24.3 0.4 9.5 11.7 0.1 26.0 0.1 3.1 0.5 1.0 8.8 0.9 2.9 1.0 1.2 8.6 10.5 1.7 0.7 0.0 1.0 3.3 2.3 2.5 1.3 29.6 42.8 6.5 39.6 33.4 24.6 50.5 33.1 34.8 51.9 6.0 11.8 15.4 12.1 13.7 52.8 12.6 22.9 20.1 28.4 1.8 212.1 2.8 0.0 28.2 273.7 47.2 31.6 0.0 14.3 5.1 74.8 3.3 42.8 3.4 29.8 27.0 9.8 39.3 104.6 245.3 67.6 61.1 10.1 17.2 36.8 499.6 37.8 21.0 43.5 9.8 1331.8 116.4 56.7 54.3 79.8 8.9 2.1 5.0 21.6 6.8 EPGN "ALGV3072, EPG, epigen, PRO9904" ENSG00000182585 "Epithelial mitogen" Q6UW88 4 74308473-74315307 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.3;esophagus: 39.6;tongue: 25.7" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 3.2;Basal keratinocytes: 5.4;Early spermatids: 1.7;Late spermatids: 2.2;Melanocytes: 1.7;Urothelial cells: 2.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "hTCEpi: 62.6;U-2197: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014420 Approved Nucleoplasm,Vesicles,Cytosol "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" Vesicles "HPA014420: AB_10601551" "unprognostic (7.51e-2)" "unprognostic (8.08e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-4)" "unprognostic (2.20e-1)" "unprognostic (2.01e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (4.06e-4)" "unprognostic (3.84e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (2.40e-4)" 1.1 0.0 0.0 1.3 0.0 0.1 1.0 0.0 0.0 7.9 0.3 0.0 1.0 0.0 0.0 14.3 39.6 1.2 0.3 0.6 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.7 0.0 0.3 0.0 0.0 2.5 2.8 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 25.7 5.4 0.6 6.5 0.4 0.1 0.0 0.6 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.1 1.2 0.0 1.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.1 0.0 62.6 1.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.3 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.2 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 2.2 EPOP "C17orf96, LOC100170841, PRR28" ENSG00000273604 "Elongin BC and polycomb repressive complex 2 associated protein" A6NHQ4 17 38671703-38675421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5" "Cell type enhanced" "Detected in some" 17 "Ductal cells: 3.3;Exocrine glandular cells: 3.4;monocytes: 4.6;Pancreatic endocrine cells: 3.5;Syncytiotrophoblasts: 11.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 8 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 16.1;Hep G2: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055190, HPA056555" Enhanced Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA055190: AB_2682731, HPA056555: AB_2683172" "unprognostic (9.08e-2)" "unprognostic (3.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.75e-3)" "unprognostic (1.83e-1)" "unprognostic (1.84e-2)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (2.17e-2)" "unprognostic (2.63e-2)" "unprognostic (1.78e-10)" "unprognostic (8.97e-2)" "unprognostic (2.51e-1)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" 1.2 2.0 2.5 1.5 5.1 0.4 1.1 0.0 13.5 0.3 0.2 0.0 2.5 0.2 0.7 0.7 0.7 0.4 0.8 0.4 1.1 0.3 3.4 0.4 2.4 0.3 3.2 0.1 3.6 3.0 0.0 1.2 0.4 0.7 0.3 0.2 0.5 1.2 0.1 1.0 0.2 0.5 0.8 0.6 0.5 5.8 0.8 1.7 0.1 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 2.9 3.5 2.3 16.1 0.5 0.1 3.9 0.6 0.2 0.7 1.1 3.5 1.1 5.6 3.9 0.4 2.0 2.4 7.5 1.5 1.2 5.8 5.7 1.2 0.6 18.4 1.0 0.6 3.0 0.3 2.6 0.7 1.5 1.5 0.5 6.3 3.8 8.7 0.4 4.7 5.0 1.6 0.5 1.9 3.2 12.0 1.3 12.2 0.4 0.7 3.5 5.4 1.9 2.6 0.6 3.9 3.8 2.3 0.8 0.6 0.7 0.7 0.6 4.6 5.0 7.1 1.3 8.3 2.3 0.0 0.0 0.0 0.4 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.8 0.0 1.4 0.0 3.3 0.0 0.0 0.0 0.0 3.4 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 3.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 ERAP1 "A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP" ENSG00000164307 "Endoplasmic reticulum aminopeptidase 1" Q9NZ08 5 96760810-96808100 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025095, HPA042317" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 27000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB025095: , HPA042317: AB_2677946" "unprognostic (2.33e-3)" "unprognostic (3.45e-1)" "unprognostic (1.84e-3)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.38e-1)" "unprognostic (1.88e-3)" "unprognostic (5.37e-2)" "unprognostic (1.45e-1)" "unprognostic (7.94e-2)" "unprognostic (4.52e-2)" "unprognostic (3.23e-1)" "unprognostic (7.09e-2)" "unprognostic (1.36e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (5.14e-2)" 23.8 13.6 9.3 22.7 11.9 11.6 23.3 14.2 14.6 14.5 23.8 10.1 11.2 30.8 14.7 13.4 12.3 14.3 19.9 16.1 9.7 6.8 13.3 23.7 17.8 16.4 13.5 7.6 15.5 16.5 11.1 39.4 28.2 11.4 13.4 21.9 8.5 13.9 15.2 23.1 17.7 39.7 10.6 17.1 19.5 16.5 5.4 13.8 55.5 13.5 9.8 17.8 15.9 14.1 14.9 15.2 19.8 17.5 19.8 21.8 10.7 7.4 4.7 6.4 6.0 35.4 34.7 18.6 5.5 17.7 13.3 23.3 5.9 27.0 22.3 11.5 10.6 18.7 7.6 5.3 11.2 8.3 40.2 2.2 7.2 3.2 4.0 40.6 3.4 13.4 14.4 4.9 15.2 4.7 19.6 18.2 14.5 3.7 21.6 7.9 3.5 32.0 3.6 3.2 0.9 3.1 23.8 8.7 11.1 9.9 11.5 2.4 1.6 8.7 5.9 8.5 4.6 5.1 16.6 14.5 11.4 3.9 1.9 9.0 8.1 15.1 17.3 12.2 11.8 6.7 19.8 13.2 15.6 21.2 11.4 19.7 13.0 18.5 18.2 9.5 14.9 21.8 17.4 14.4 19.8 17.5 15.2 12.3 10.7 9.3 11.9 14.2 14.6 9.7 6.8 13.5 7.6 11.4 13.8 8.9 12.3 13.7 12.1 22.1 11.6 8.5 10.2 22.7 14.8 8.7 2.0 8.0 0.0 10.8 20.0 11.3 25.8 0.0 13.4 9.1 16.1 9.2 14.0 27.0 16.2 3.2 9.9 18.4 31.2 5.2 9.2 18.5 6.8 21.6 25.9 9.7 11.2 17.5 15.2 5.0 7.2 0.0 9.5 1.2 0.7 9.7 7.7 20.0 19.1 12.2 ERCC4 "FANCQ, RAD1, XPF" ENSG00000175595 "ERCC excision repair 4, endonuclease catalytic subunit" Q92889 16 13920157-13952345 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Disease mutation, Dwarfism, Fanconi anemia, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 121.2;Late spermatids: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000156, HPA045828" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "CAB000156: , HPA045828: AB_2679463" "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.12e-3)" "unprognostic (9.41e-2)" "unprognostic (3.35e-1)" "unprognostic (1.40e-2)" "unprognostic (1.64e-2)" "unprognostic (2.26e-1)" "unprognostic (3.59e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (5.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (6.30e-2)" "unprognostic (5.88e-4)" 8.4 12.7 8.6 7.0 11.3 5.3 6.4 8.9 9.7 8.1 6.7 9.9 6.0 4.1 8.5 6.8 6.7 8.5 6.8 7.8 7.2 7.1 6.9 7.2 6.9 6.8 10.5 8.8 9.9 7.6 13.3 13.0 5.9 9.6 8.3 5.4 7.1 6.4 7.0 31.3 6.9 5.7 8.5 10.3 7.7 6.6 14.2 8.9 13.7 9.7 5.6 6.4 9.1 7.8 8.4 7.9 8.3 6.8 8.9 7.4 2.6 5.4 7.0 6.4 9.2 10.7 10.1 5.0 7.2 7.7 6.5 8.3 2.4 5.4 9.1 10.4 6.3 5.7 6.9 9.5 4.9 10.1 12.3 5.6 4.5 7.8 6.0 9.8 6.1 5.1 7.6 6.9 8.6 7.3 6.3 8.6 5.5 7.0 10.7 9.1 4.5 8.0 4.1 4.7 2.8 3.7 9.2 13.0 11.2 4.0 3.7 5.3 6.3 8.8 7.2 6.7 5.4 9.1 4.6 9.7 9.6 7.1 8.6 6.3 9.5 11.2 6.3 9.2 7.3 9.8 8.3 6.2 5.4 6.8 6.8 7.4 6.2 6.4 5.1 5.5 8.4 6.4 6.9 7.2 8.9 5.7 7.9 5.8 2.6 8.6 11.3 8.9 9.7 7.2 7.1 10.5 8.8 9.6 8.9 17.9 15.7 9.7 6.8 4.2 0.0 7.9 12.7 18.7 5.7 5.2 0.0 13.6 8.3 10.4 121.2 9.5 2.8 0.0 7.3 5.9 9.9 7.6 1.1 15.7 10.5 0.0 9.2 16.0 11.3 71.5 13.8 10.6 10.1 11.8 5.3 0.0 8.2 0.0 19.8 9.3 0.0 25.8 5.9 46.6 16.7 4.8 10.3 16.0 6.1 4.0 ERCC6L "FLJ20105, PICH, RAD26L" ENSG00000186871 "ERCC excision repair 6 like, spindle assembly checkpoint helicase" Q2NKX8 X 72204657-72239047 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 2.5;Extravillous trophoblasts: 1.5;Spermatocytes: 1.7;Spermatogonia: 2.0" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "NK-cell: 5.3" "Lineage enriched" "Detected in many" 5 "NK-cells: 5.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA050492 Approved Uncertain Nucleoplasm,Centrosome,Cytosol No No Centrosome "Nucleoplasm, Cytosol" "HPA050492: AB_2681145" "prognostic unfavorable (1.80e-4)" "unprognostic (2.93e-1)" "unprognostic (1.95e-2)" "unprognostic (5.76e-3)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (9.23e-6)" "unprognostic (8.63e-3)" "unprognostic (1.57e-2)" "unprognostic (1.99e-2)" "unprognostic (3.68e-5)" "unprognostic (4.61e-2)" "unprognostic (0.00e+0)" "unprognostic (2.97e-3)" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" 0.4 0.5 0.2 3.1 0.2 6.0 3.0 0.9 0.8 1.5 2.2 0.2 0.2 1.5 0.9 0.8 4.6 0.6 1.0 0.2 0.2 0.3 0.5 0.5 0.8 4.7 0.7 0.2 1.2 0.5 0.0 0.6 0.9 0.9 0.7 2.5 0.2 1.1 0.2 2.6 1.3 2.1 0.5 1.3 4.0 1.5 2.0 0.2 13.1 0.5 2.8 5.6 0.7 1.6 0.5 0.3 0.5 0.2 5.3 1.1 0.4 11.0 9.7 8.9 5.6 0.6 1.1 4.9 11.9 5.5 10.4 11.0 7.9 6.9 17.9 4.5 4.2 14.1 9.2 16.8 8.8 18.6 10.2 12.2 6.2 3.4 4.6 0.0 12.0 8.7 0.1 0.5 14.5 2.7 1.7 5.8 9.1 8.1 4.4 10.6 8.7 11.4 7.0 16.2 10.8 15.0 9.6 16.0 3.2 2.6 6.9 7.4 5.3 8.8 5.9 2.2 7.6 4.5 2.7 3.5 7.1 11.4 13.3 7.7 3.5 5.3 15.5 5.0 8.3 7.0 0.0 0.2 0.5 0.1 0.1 0.6 0.2 0.5 0.1 0.1 0.5 0.4 1.1 0.3 5.3 0.2 0.3 1.1 0.4 0.2 0.2 0.9 0.8 0.2 0.3 0.7 0.2 0.9 0.2 0.0 0.0 0.8 0.2 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.0 0.1 0.3 0.0 0.1 0.1 ERICH1 ENSG00000104714 "Glutamate rich 1" Q86X53 8 614746-738106 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003725 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA003725: AB_1853023" "unprognostic (7.19e-2)" "unprognostic (1.38e-2)" "unprognostic (7.73e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-2)" "unprognostic (1.02e-1)" "unprognostic (7.51e-3)" "unprognostic (1.55e-1)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (8.45e-2)" "unprognostic (5.11e-2)" "unprognostic (1.27e-1)" "unprognostic (8.63e-2)" "unprognostic (3.07e-1)" "unprognostic (1.42e-1)" 20.2 11.7 12.3 35.7 16.9 30.5 18.1 9.0 15.6 13.6 16.0 13.9 13.7 13.1 21.7 25.6 15.3 13.7 17.1 14.7 15.1 11.4 17.6 15.3 19.4 29.3 14.5 14.0 16.9 12.2 13.8 16.1 16.9 16.9 15.4 11.7 14.0 13.5 19.4 17.2 17.0 15.8 16.2 17.0 22.2 14.9 11.8 14.0 21.8 18.2 13.3 25.0 17.1 15.3 11.7 10.2 18.5 20.9 7.2 6.2 6.0 9.1 13.3 7.1 8.5 7.7 9.4 14.8 8.8 4.7 8.1 8.9 8.4 5.9 21.0 4.2 7.4 15.4 15.5 13.0 13.6 5.8 9.1 16.9 14.7 8.6 12.0 8.6 8.9 13.8 10.8 8.9 6.1 7.9 8.4 8.8 18.6 15.0 12.2 8.1 7.6 17.2 15.9 11.2 10.3 5.9 15.6 4.6 14.4 8.9 17.0 3.3 9.2 6.4 8.3 11.7 12.2 3.5 10.7 14.0 6.0 2.8 0.3 9.4 7.9 20.7 22.7 12.2 14.4 6.2 11.4 20.9 7.2 5.4 19.0 4.8 9.7 6.2 5.3 10.2 11.7 5.3 4.7 18.5 7.2 16.8 7.8 4.4 6.0 12.3 16.9 9.0 15.6 15.1 11.4 14.5 14.0 16.9 14.0 41.7 35.5 50.9 39.7 32.4 21.9 18.6 22.9 28.1 23.9 31.4 11.8 51.9 92.9 32.4 12.1 68.4 34.3 23.3 31.9 51.8 34.0 36.4 39.4 27.6 37.0 46.1 18.9 63.8 70.8 7.5 55.8 69.4 33.7 101.0 32.1 18.6 42.9 38.6 38.2 35.4 20.8 38.8 32.3 46.1 50.7 35.8 45.2 57.3 28.7 29.2 ERICH5 "C8orf47, FLJ39553" ENSG00000177459 "Glutamate rich 5" Q6P6B1 8 98064311-98093610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 27.9;retina: 26.7" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 84.1;Ciliated cells: 72.3;Ductal cells: 42.6" "Cancer enhanced" "Detected in many" "liver cancer: 23.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "myeloid DC: 5.3" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.3" "Cell line enhanced" "Detected in some" "A549: 6.5;HAP1: 6.0;HEK 293: 8.8;JURKAT: 11.6;RPTEC TERT1: 5.8;RT4: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA025070, HPA025293, HPA027233" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780" "unprognostic (2.88e-3)" "unprognostic (1.49e-1)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (6.86e-2)" "unprognostic (2.39e-1)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (4.66e-1)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (5.73e-1)" "prognostic favorable (3.76e-4)" "unprognostic (4.36e-2)" "unprognostic (9.22e-2)" "unprognostic (3.17e-2)" "prognostic favorable (9.38e-4)" 0.5 0.2 2.3 0.2 6.7 0.0 0.8 0.4 2.2 2.0 3.3 0.1 3.6 4.3 1.1 0.6 0.7 8.8 13.1 5.4 0.7 2.6 8.7 8.1 1.7 0.7 1.0 2.2 1.6 27.9 0.6 1.7 4.1 1.9 2.2 3.0 26.7 1.3 1.9 0.1 0.6 1.3 0.4 1.0 0.2 9.5 3.4 0.5 0.3 0.6 0.0 0.5 3.1 0.5 0.0 5.3 0.0 0.0 0.0 0.5 0.0 0.0 6.5 0.0 0.0 0.1 0.0 3.8 3.4 1.3 1.8 1.4 0.1 2.0 0.0 5.0 0.9 2.8 0.3 6.0 0.1 2.2 0.0 8.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 11.6 0.0 0.0 0.1 0.1 0.0 0.7 1.4 0.1 2.6 0.0 0.0 0.1 5.8 15.3 3.5 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 6.7 0.4 2.2 0.7 2.6 1.0 2.2 1.9 0.5 3.0 0.0 0.0 1.1 0.0 0.0 5.9 84.1 72.3 5.7 7.0 0.0 0.3 0.0 42.6 0.3 0.0 0.7 0.0 16.3 1.5 0.0 3.1 0.0 3.9 0.1 0.0 17.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 2.3 5.8 17.1 0.0 0.0 19.3 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 3.3 1.3 ESCO2 "EFO2, RBS" ENSG00000171320 "Establishment of sister chromatid cohesion N-acetyltransferase 2" Q56NI9 8 27771949-27812640 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3" "Group enriched" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 30.1;Spermatogonia: 77.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027243, HPA053679" Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes Yes "Nucleoplasm, Golgi apparatus" "Cell Junctions" "HPA027243: AB_2672175, HPA053679: AB_2682227" "unprognostic (7.86e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.04e-4)" "unprognostic (5.13e-3)" "unprognostic (9.50e-2)" "unprognostic (8.67e-3)" "unprognostic (7.30e-4)" "unprognostic (5.24e-3)" "unprognostic (2.24e-2)" "unprognostic (2.54e-2)" "unprognostic (7.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.65e-14)" "unprognostic (6.65e-3)" "unprognostic (5.32e-1)" "unprognostic (5.85e-2)" "unprognostic (4.06e-1)" 1.0 1.7 0.5 7.1 0.5 5.5 1.0 0.4 0.6 1.2 9.6 0.1 0.5 11.9 0.6 1.0 5.0 0.3 1.8 1.1 0.7 0.5 1.6 1.4 1.1 4.2 0.5 0.6 0.6 1.0 0.3 0.3 1.5 0.5 0.5 4.5 0.1 1.4 1.4 0.4 1.1 23.2 0.4 0.8 4.7 2.4 10.3 0.2 39.8 0.5 5.3 5.7 1.0 1.8 1.3 1.9 0.8 1.5 0.9 4.6 0.8 25.1 19.1 8.6 10.4 1.1 1.8 4.8 15.1 6.4 14.1 16.1 6.7 5.0 9.3 8.0 3.9 11.8 13.9 10.4 4.1 21.4 7.2 4.4 11.0 8.6 7.1 0.1 5.6 10.3 0.3 0.4 8.2 2.1 1.4 5.2 7.2 8.8 14.2 8.1 4.9 22.6 2.5 5.8 13.8 6.4 10.0 25.7 6.8 4.6 15.2 3.7 5.5 7.6 9.2 3.8 3.3 6.3 6.2 2.3 8.7 18.0 17.5 11.8 1.9 5.0 11.5 4.8 9.4 12.0 0.1 0.7 0.4 0.3 1.5 0.1 1.3 0.7 1.0 1.9 0.1 0.5 0.4 0.8 0.9 0.4 0.2 4.6 0.8 0.5 0.5 0.4 0.6 0.7 0.5 0.5 0.6 0.5 0.2 0.0 6.6 2.2 0.7 2.1 1.5 1.1 0.0 2.7 5.7 0.0 3.9 1.0 0.0 0.3 3.9 0.1 5.3 70.0 0.0 5.5 0.9 0.2 1.1 1.1 4.5 0.0 1.2 0.6 4.1 0.4 1.7 3.5 0.0 0.0 2.3 0.0 0.1 0.8 0.0 0.0 1.8 6.5 0.3 30.1 77.3 0.5 0.8 2.9 4.0 0.9 ESD ENSG00000139684 "Esterase D" P10768 13 46771256-46797232 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039700 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 16000000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039700: AB_10697553" "unprognostic (3.05e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (7.66e-2)" "unprognostic (1.75e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.73e-2)" "unprognostic (3.31e-1)" "unprognostic (1.01e-1)" "unprognostic (2.12e-2)" "unprognostic (1.49e-2)" "unprognostic (1.08e-1)" "unprognostic (2.91e-2)" "unprognostic (2.71e-2)" "unprognostic (2.18e-1)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" 58.5 30.9 32.0 28.6 29.8 24.2 44.5 23.7 32.0 54.4 37.3 29.0 34.2 31.8 53.2 50.4 54.1 40.6 30.3 45.6 30.7 29.3 58.8 82.2 28.2 31.4 31.7 32.1 61.3 24.9 27.5 47.5 26.4 28.6 55.2 41.7 32.5 31.5 45.2 47.4 29.7 38.4 50.8 37.4 31.1 32.1 32.4 26.7 65.5 78.9 50.9 31.7 62.5 36.9 30.1 48.7 15.1 37.1 29.8 35.7 26.4 22.1 12.9 39.1 26.9 45.9 75.9 10.5 31.9 46.3 44.5 34.7 21.8 27.2 25.2 9.6 38.2 33.3 22.7 43.0 37.7 57.0 28.8 44.7 32.6 13.0 33.5 37.6 63.6 14.0 51.8 35.0 28.7 38.7 53.7 41.7 43.5 31.8 6.8 73.6 21.7 56.4 42.3 10.1 28.7 24.5 44.9 23.0 17.0 63.1 9.0 19.4 22.0 14.2 12.1 25.6 28.1 23.2 36.5 27.8 16.4 19.4 31.5 29.4 4.6 9.9 21.8 35.4 36.5 21.9 7.7 37.1 15.1 15.0 31.5 24.6 30.1 30.0 23.0 40.8 25.3 35.7 27.9 4.3 29.8 28.0 48.7 24.9 26.4 32.0 29.8 23.7 32.0 30.7 29.3 31.7 32.1 28.6 26.7 50.6 42.5 68.7 203.4 119.1 47.0 89.2 124.9 77.6 61.4 146.5 39.3 134.7 305.1 153.5 36.2 95.8 72.1 46.7 90.4 115.2 195.1 96.4 94.6 148.9 197.0 20.6 104.5 112.3 138.2 18.5 247.9 128.5 156.9 100.0 108.9 147.8 82.8 115.8 198.7 400.9 62.5 148.8 210.1 67.4 44.1 113.0 62.2 82.2 173.0 130.7 ETNK1 "EKI, EKI1" ENSG00000139163 "Ethanolamine kinase 1" Q9HBU6 12 22625075-22690665 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 201.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010712, HPA029407" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA010712: AB_2668349, HPA029407: AB_2673026" "unprognostic (2.06e-1)" "unprognostic (7.48e-2)" "unprognostic (1.23e-3)" "unprognostic (2.19e-1)" "unprognostic (8.79e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (3.98e-3)" "unprognostic (8.30e-2)" "unprognostic (7.97e-3)" "unprognostic (2.01e-1)" "unprognostic (1.64e-2)" "unprognostic (4.53e-3)" "unprognostic (2.77e-1)" "unprognostic (2.91e-1)" "unprognostic (3.01e-1)" "prognostic favorable (1.75e-4)" 15.7 17.7 15.2 41.1 19.4 13.7 16.9 19.7 22.2 12.9 33.2 16.4 14.6 27.2 16.6 24.1 14.7 13.1 27.3 10.4 15.6 23.9 22.0 30.2 19.6 18.5 17.2 15.8 17.2 14.9 15.8 30.6 13.4 18.9 13.8 19.5 15.9 16.7 14.7 8.2 17.8 24.5 10.0 17.1 18.3 53.7 22.3 17.5 33.4 17.6 8.2 16.5 14.2 18.6 16.2 10.7 28.1 17.6 14.0 15.7 13.4 6.7 14.0 15.6 14.4 11.3 11.4 11.6 8.0 6.0 8.3 8.6 10.8 17.1 20.1 7.2 5.2 8.7 5.1 13.7 3.8 15.0 16.7 11.1 16.6 6.2 9.3 10.8 15.9 15.3 7.4 3.7 11.2 9.5 13.3 10.3 7.9 19.9 8.5 11.0 4.6 17.3 32.4 30.2 8.7 9.2 15.6 13.8 16.1 13.8 9.2 5.0 8.8 8.7 7.6 12.5 22.4 11.8 15.4 8.8 6.6 10.6 8.9 12.0 6.2 7.7 21.6 8.4 10.4 11.0 28.1 11.7 12.1 12.9 17.5 12.7 16.2 14.1 11.9 10.7 13.0 15.7 15.5 11.5 14.0 17.6 9.7 15.3 13.4 15.2 19.4 19.7 22.2 15.6 23.9 17.2 15.8 18.9 17.5 44.7 25.1 40.9 63.3 128.1 40.4 11.0 53.5 72.3 35.2 41.8 47.1 27.9 23.2 26.3 201.9 28.7 55.0 0.0 39.6 20.3 28.6 70.5 33.5 38.4 37.5 25.4 103.9 27.6 78.9 26.1 22.5 44.7 64.1 22.6 52.6 21.4 29.0 46.1 20.1 26.4 35.5 38.8 44.3 47.7 15.1 148.8 63.0 39.2 36.0 60.2 ETS2 ENSG00000157557 "ETS proto-oncogene 2, transcription factor" P15036 21 38805307-38824955 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 580.2;Suprabasal keratinocytes: 425.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 16.5;granulocytes: 18.5;monocytes: 14.9" "Cell line enhanced" "Detected in many" "HEL: 60.5;hTCEpi: 55.4;hTERT-HME1: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003176 Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003176: AB_2666824" "unprognostic (2.06e-1)" "unprognostic (5.91e-2)" "unprognostic (9.16e-3)" "unprognostic (5.33e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.88e-3)" "unprognostic (7.36e-2)" "unprognostic (8.99e-3)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.89e-1)" "unprognostic (8.10e-2)" "unprognostic (7.10e-2)" 33.6 10.4 25.8 29.6 12.8 44.7 28.5 5.5 36.5 28.4 38.1 7.3 13.7 39.7 27.0 20.3 30.1 21.8 42.6 42.9 16.2 10.8 21.2 75.5 58.3 56.9 13.8 18.2 23.6 11.7 20.0 19.7 23.2 14.2 31.4 50.6 12.9 17.6 17.4 64.2 72.4 59.0 43.3 13.6 68.7 25.8 8.3 11.0 7.2 21.5 28.4 13.7 40.8 35.5 0.2 16.5 18.5 14.9 0.1 2.5 3.6 23.4 5.0 3.5 1.1 4.0 13.6 9.4 5.5 32.0 7.3 9.7 4.4 6.7 5.1 2.7 4.9 10.7 7.0 5.9 14.7 14.0 4.7 2.3 60.5 30.4 11.0 41.2 3.7 5.9 8.0 55.4 10.3 45.2 4.7 5.8 3.4 6.2 0.0 3.2 3.4 11.2 4.0 11.3 7.8 3.3 36.8 2.2 4.7 10.3 15.2 2.7 3.6 15.6 6.4 1.2 1.3 0.3 6.9 6.2 17.6 2.5 11.2 12.0 0.1 0.0 5.1 4.2 12.5 14.6 10.1 9.2 3.3 1.7 12.3 2.0 0.2 1.6 2.5 16.5 0.2 1.6 1.6 18.5 0.1 14.9 4.0 0.1 3.6 25.8 12.8 5.5 36.5 16.2 10.8 13.8 18.2 14.2 11.0 47.6 133.7 24.2 580.2 379.6 2.1 25.0 45.9 141.8 183.1 48.8 0.0 42.0 10.0 60.7 3.0 196.3 148.0 23.3 94.2 94.1 55.2 133.5 49.7 211.1 50.3 0.0 88.0 256.6 144.5 1.7 16.7 174.6 64.1 29.7 182.6 1.0 94.1 98.2 23.3 27.9 1.1 51.8 93.5 0.6 2.9 425.2 148.5 18.1 194.6 292.4 EVI2B "CD361, D17S376, EVDB" ENSG00000185862 "Ecotropic viral integration site 2B" P34910 17 31303766-31314112 "CD markers, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 133.6;lymphoid tissue: 72.8" "Cell type enhanced" "Detected in many" 16 "B-cells: 217.4;Kupffer cells: 447.5;Macrophages: 274.7;T-cells: 178.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 133.6" "Group enriched" "Detected in all" 4 "granulocytes: 133.6;monocytes: 34.3" "Cell line enhanced" "Detected in many" "Daudi: 24.2;HHSteC: 19.9;HL-60: 27.3;HMC-1: 38.5;Karpas-707: 27.3;NB-4: 21.6;RPMI-8226: 39.9;THP-1: 34.4" "Low region specificity" "Detected in all" HPA007436 Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA007436: AB_1848307" "unprognostic (1.07e-2)" "unprognostic (1.20e-2)" "unprognostic (5.97e-2)" "unprognostic (4.09e-3)" "unprognostic (2.99e-2)" "unprognostic (1.41e-2)" "unprognostic (3.06e-1)" "unprognostic (3.36e-2)" "unprognostic (1.93e-2)" "unprognostic (1.48e-1)" "unprognostic (1.78e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.56e-2)" "unprognostic (3.32e-2)" "unprognostic (8.64e-2)" "unprognostic (2.73e-2)" 15.0 3.6 4.4 37.7 5.8 44.0 4.2 1.7 4.4 3.7 10.7 6.5 0.3 6.0 2.8 4.8 7.1 4.7 8.1 6.7 6.4 4.4 7.8 7.1 38.5 37.5 10.2 2.6 3.8 2.7 0.4 2.1 4.8 7.8 5.3 8.1 2.5 6.6 1.5 2.3 2.4 23.3 4.2 22.0 72.8 8.0 3.7 6.7 26.1 4.0 3.0 43.0 13.0 7.6 18.6 14.6 133.6 34.3 4.1 16.4 19.8 0.1 0.1 0.0 0.0 1.9 2.5 0.0 0.2 1.7 2.0 3.7 0.0 0.9 24.2 0.0 1.5 7.5 0.1 0.0 0.3 2.2 0.0 0.0 0.5 0.0 0.0 19.9 27.3 38.5 4.6 0.0 1.1 1.5 0.6 1.9 2.0 0.3 27.3 5.7 0.0 7.9 21.6 0.0 0.0 0.0 13.9 0.1 39.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.4 2.1 0.5 0.0 0.2 1.9 5.3 0.2 5.3 2.5 9.4 0.6 78.9 30.5 74.5 8.2 23.2 7.9 18.6 12.6 10.6 14.6 14.3 9.7 9.1 133.6 4.1 34.3 8.4 16.4 19.8 4.4 5.8 1.7 4.4 6.4 4.4 10.2 2.6 7.8 6.7 0.0 17.9 217.4 0.6 4.7 0.2 0.4 2.5 4.0 11.4 1.8 0.0 0.5 0.0 0.0 5.3 2.7 0.2 0.0 0.0 0.5 2.8 0.3 78.7 1.7 88.8 0.0 0.0 9.8 447.5 4.7 0.0 274.7 35.4 10.8 0.0 0.0 0.7 0.0 0.4 0.7 0.8 19.4 4.1 0.3 0.5 3.1 0.2 178.5 0.0 1.1 EXOC6B "KIAA0919, SEC15B, SEC15L2" ENSG00000144036 "Exocyst complex component 6B" Q9Y2D4 2 72175984-72826041 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 51.7" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034546, HPA063991" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA034546: AB_2674218, HPA063991: AB_2685168" "unprognostic (5.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.18e-3)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "unprognostic (1.06e-2)" "unprognostic (9.34e-2)" "unprognostic (1.32e-1)" "unprognostic (2.16e-3)" "unprognostic (3.38e-2)" "unprognostic (2.61e-1)" "unprognostic (4.35e-3)" "unprognostic (4.38e-3)" "unprognostic (1.55e-1)" "unprognostic (1.18e-1)" "unprognostic (5.29e-2)" 12.1 14.2 17.9 5.7 23.0 1.9 9.5 19.8 23.3 10.2 7.2 18.0 6.0 8.4 11.8 7.5 16.5 8.7 7.8 51.7 18.3 14.4 8.8 4.8 7.9 3.8 18.5 17.0 17.4 6.0 18.6 11.2 34.7 19.8 9.7 7.0 7.3 7.6 10.9 11.2 27.5 10.7 11.6 15.0 6.0 8.0 7.7 20.4 3.1 11.7 7.8 7.3 9.5 12.6 3.0 1.7 3.2 2.0 1.6 3.4 1.2 11.0 8.4 7.8 9.4 22.4 9.3 13.5 8.1 11.5 7.0 4.6 11.4 1.7 2.9 5.1 13.5 10.5 18.5 6.5 13.4 10.2 2.1 5.3 8.5 5.9 6.5 12.1 1.2 2.9 7.9 19.5 7.9 12.4 11.1 11.4 4.5 0.9 0.0 9.2 3.8 3.2 1.5 8.1 7.6 4.7 1.7 14.0 1.1 6.8 26.0 3.9 3.4 13.9 4.3 5.6 9.0 3.0 1.1 12.6 8.2 7.0 6.9 4.9 2.9 2.9 0.0 9.5 0.6 6.5 3.2 1.9 0.2 2.7 1.7 2.1 2.4 2.1 1.7 1.7 3.0 2.4 3.4 0.0 1.6 2.0 0.6 2.6 1.2 17.9 23.0 19.8 22.8 18.3 14.4 18.5 17.0 19.8 20.4 0.0 5.5 0.0 9.0 23.2 16.7 77.2 15.3 8.1 2.3 8.7 23.6 12.0 5.0 7.6 41.6 13.1 12.8 0.0 10.1 10.9 6.2 6.3 8.1 4.9 4.0 15.9 2.9 9.2 9.1 4.0 7.8 4.5 5.0 1.0 4.1 9.1 8.3 8.6 7.1 4.1 9.9 0.0 8.9 8.7 4.8 32.6 20.6 2.5 3.8 7.8 EXOSC4 "FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p" ENSG00000178896 "Exosome component 4" Q9NPD3 8 144078626-144080647 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 251.1;Late spermatids: 557.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 91.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024792, HPA065103" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA024792: AB_1848325, HPA065103: " "unprognostic (2.32e-1)" "unprognostic (1.55e-2)" "unprognostic (3.06e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.58e-3)" "unprognostic (1.26e-1)" "unprognostic (8.36e-2)" "prognostic favorable (2.23e-4)" "unprognostic (4.32e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "unprognostic (5.18e-2)" "unprognostic (1.23e-1)" "unprognostic (2.71e-1)" "unprognostic (5.11e-2)" 12.3 16.7 12.8 11.4 17.6 13.8 8.9 13.9 20.6 8.1 12.0 10.5 13.6 15.8 9.8 10.4 14.5 10.0 9.3 16.5 11.4 11.2 14.9 21.5 8.7 11.4 11.5 13.0 10.3 15.0 8.0 10.2 11.5 12.0 12.1 6.5 11.6 28.0 14.7 12.1 12.7 11.1 6.7 9.3 13.4 13.9 45.0 9.7 14.8 10.8 10.4 11.1 8.7 7.8 24.7 38.2 19.0 31.8 17.1 16.1 18.8 10.3 22.9 4.1 9.8 3.5 2.7 11.2 8.2 3.4 6.4 6.5 16.0 7.3 6.3 12.0 3.4 4.6 8.6 7.5 8.9 1.9 8.3 25.5 9.0 17.1 17.7 5.9 6.7 10.8 3.8 9.2 7.4 5.9 2.5 3.3 6.9 14.1 4.3 5.2 37.9 10.4 13.3 10.6 11.0 91.9 4.6 6.7 16.3 6.1 10.6 12.9 17.0 10.2 13.2 18.8 2.2 15.0 10.2 3.2 6.6 14.5 15.8 13.8 11.4 13.6 7.9 9.5 10.8 10.3 19.0 31.8 12.5 15.9 29.4 16.1 22.0 12.4 15.4 29.8 24.7 15.9 15.4 9.2 17.1 16.1 38.2 13.7 18.8 12.8 17.6 13.9 20.6 11.4 11.2 11.5 13.0 12.0 9.7 8.9 24.2 15.2 27.4 83.9 8.8 18.2 20.4 18.7 12.5 26.2 7.9 39.9 104.5 49.6 251.1 24.8 32.9 0.0 40.1 34.1 31.5 24.7 13.9 52.3 40.4 6.4 24.9 20.9 31.4 557.6 17.3 24.1 33.7 54.1 29.8 14.1 51.1 45.6 19.8 81.3 6.8 12.9 40.6 52.4 33.8 76.9 40.3 13.8 40.1 33.2 FAAP20 "C1orf86, FLJ31031" ENSG00000162585 "Fanconi anemia core complex associated protein 20" Q6NZ36 1 2184461-2212720 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038829 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA Nucleoplasm "Nuclear bodies, Cell Junctions" "HPA038829: AB_10673476" "unprognostic (1.36e-2)" "unprognostic (2.86e-2)" "unprognostic (2.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.64e-1)" "unprognostic (6.11e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (2.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.88e-4)" "unprognostic (1.59e-1)" "unprognostic (1.96e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (4.93e-2)" "unprognostic (8.55e-2)" 33.1 18.8 15.4 14.3 12.1 15.2 20.5 15.4 16.4 17.8 19.1 13.8 19.1 14.6 17.8 17.7 20.3 12.6 14.2 17.0 15.4 14.8 27.7 20.9 15.0 22.5 14.9 10.3 16.9 17.2 8.0 26.4 11.7 13.3 21.8 7.3 20.9 21.4 23.9 27.3 28.1 14.9 15.0 14.3 24.4 30.5 20.2 11.5 35.1 30.5 11.4 16.5 17.1 19.3 13.2 22.0 31.0 8.7 5.1 12.6 5.6 10.4 1.6 2.3 2.8 1.4 1.9 13.8 11.8 4.4 3.9 5.1 2.5 6.9 12.2 17.5 1.8 3.5 5.1 1.6 1.7 1.9 26.0 24.0 10.1 2.7 5.3 5.4 7.0 9.8 3.3 3.9 2.3 2.5 2.4 4.7 9.7 13.9 2.9 2.6 4.3 10.2 21.9 8.2 2.0 21.9 13.7 7.2 11.4 1.8 1.6 18.9 25.3 7.7 3.3 20.2 2.2 3.3 2.9 9.9 6.0 14.3 7.4 6.7 27.5 14.6 17.8 11.2 4.4 2.5 3.6 8.7 31.0 10.1 8.1 10.0 13.2 9.2 10.9 8.8 13.1 12.6 10.4 11.2 5.1 7.5 22.0 7.8 5.6 15.4 12.1 15.4 14.1 15.4 14.8 14.9 10.3 13.3 11.5 6.0 11.0 59.7 76.1 0.0 25.1 17.1 50.9 14.7 12.5 92.5 3.9 105.4 144.2 110.3 81.6 33.1 20.8 23.3 96.1 118.9 7.2 104.6 7.0 78.0 115.2 14.3 42.1 73.1 106.0 249.7 79.7 47.3 0.0 185.8 72.9 43.5 131.8 46.3 77.8 221.5 25.4 64.7 14.6 118.4 32.4 0.0 75.1 55.3 55.7 99.4 FABP7 "B-FABP, BLBP" ENSG00000164434 "Fatty acid binding protein 7" O15540 6 122779475-122784074 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 62.7;breast: 26.8" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 827.1" "Group enriched" "Detected in many" 6 "glioma: 139.3;renal cancer: 51.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Group enriched" "Detected in many" 5 "granulocytes: 3.1;NK-cells: 1.1" "Group enriched" "Detected in some" 8 "AF22: 38.7;U-251 MG: 10.5;WM-115: 23.3" "Region enriched" "Detected in all" 6 "olfactory region: 1471.1" "Low region specificity" "Detected in all" "CAB025488, HPA028825, CAB058697" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130" "prognostic favorable (2.49e-4)" "unprognostic (1.56e-2)" "unprognostic (2.53e-3)" "unprognostic (5.80e-2)" "unprognostic (2.29e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (2.09e-2)" "unprognostic (3.42e-2)" "prognostic unfavorable (1.65e-6)" "unprognostic (9.83e-2)" "unprognostic (1.30e-2)" "unprognostic (2.50e-1)" "unprognostic (8.66e-2)" 2.1 1.3 34.8 1.1 15.5 1.3 26.8 51.6 62.7 1.1 1.5 13.0 0.0 1.2 1.2 1.3 1.6 1.2 1.2 1.2 32.0 16.4 1.6 1.4 1.1 1.1 11.4 30.3 1.1 1.1 1.0 2.1 1.3 11.2 1.3 1.2 5.7 7.0 3.7 6.7 10.5 1.1 1.1 8.1 1.1 1.3 1.2 6.9 0.0 1.1 0.0 1.1 1.4 0.0 0.4 0.2 3.1 0.3 1.1 0.4 0.0 0.0 0.0 38.7 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.4 0.0 23.3 3.1 0.3 0.1 0.3 0.1 0.3 0.2 0.3 0.4 0.1 0.4 0.3 0.3 0.5 1.1 0.2 0.2 0.1 0.0 34.8 15.5 51.6 27.3 32.0 16.4 11.4 30.3 11.2 6.9 0.0 0.0 0.0 0.1 10.9 6.8 0.4 0.0 0.0 0.0 0.0 11.8 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 162.7 1.1 0.0 0.0 0.0 2.5 4.8 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 827.1 0.0 0.0 0.0 0.2 37.4 0.0 0.8 0.0 0.0 16.6 5.9 0.0 0.0 0.0 FAM110A "bA371L19.3, C20orf55" ENSG00000125898 "Family with sequence similarity 110 member A" Q9BQ89 20 833715-857463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.4" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 131.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 83.4;eosinophil: 24.8;intermediate monocyte: 25.1;non-classical monocyte: 37.7" "Group enriched" "Detected in all" 9 "granulocytes: 83.4;monocytes: 37.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034110, HPA069240" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol Yes Yes "Nucleoplasm, Vesicles" Cytosol "CAB034110: AB_1562838, HPA069240: AB_2686103" "unprognostic (6.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.57e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "unprognostic (4.90e-3)" "unprognostic (5.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.78e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (9.64e-3)" "unprognostic (1.17e-2)" "unprognostic (6.42e-3)" "unprognostic (4.21e-3)" 5.2 3.6 1.7 17.7 4.2 7.4 7.7 1.9 3.9 6.5 8.8 2.0 7.7 10.0 4.0 6.1 22.1 1.9 6.9 4.8 1.7 2.5 4.8 3.9 15.2 18.7 2.1 1.9 2.6 3.5 9.3 5.1 11.1 3.6 11.1 3.4 3.1 12.7 10.5 3.7 39.9 9.2 1.3 1.6 15.1 5.5 2.8 1.3 22.9 7.7 8.0 18.9 7.8 9.7 1.9 5.8 83.4 37.7 1.0 6.4 3.2 12.7 3.4 1.9 3.6 2.2 0.9 13.4 4.0 2.2 2.6 2.3 7.5 8.0 4.1 1.8 2.5 3.6 20.7 1.6 10.5 2.1 3.3 1.1 8.6 2.2 1.9 1.0 2.3 3.0 0.6 13.1 3.5 3.5 0.8 1.7 3.8 4.6 10.3 2.3 7.6 6.5 6.4 2.5 8.2 5.9 6.5 3.4 5.4 1.9 9.2 3.7 4.4 3.4 40.4 1.8 0.8 16.7 3.5 2.2 6.1 4.5 5.5 4.4 3.8 3.2 1.7 0.9 6.1 4.4 83.4 4.4 24.8 2.2 25.1 2.0 1.1 4.0 4.6 5.8 1.9 4.9 4.7 2.5 1.0 37.7 0.6 6.4 3.2 1.7 4.2 1.9 3.9 1.7 2.5 2.1 1.9 3.6 1.3 0.0 6.5 19.9 14.7 29.0 0.2 2.4 5.1 4.0 0.0 10.4 0.0 36.4 1.7 8.3 6.0 5.8 6.9 46.7 5.2 131.1 4.7 17.7 52.8 0.8 17.4 4.8 10.4 18.4 36.5 13.5 3.1 27.8 6.8 6.4 7.5 0.2 10.7 8.0 1.8 2.1 2.5 6.5 5.2 1.9 5.3 32.1 26.2 26.2 7.8 20.9 FAM114A1 Noxp20 ENSG00000197712 "Family with sequence similarity 114 member A1" Q8IWE2 4 38867677-38945739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 102.6;Peritubular cells: 109.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.1;intermediate monocyte: 6.3;myeloid DC: 4.3;neutrophil: 3.8;non-classical monocyte: 2.2" "Group enriched" "Detected in many" 6 "dendritic cells: 4.3;granulocytes: 3.8;monocytes: 6.3" "Cell line enhanced" "Detected in many" "ASC diff: 42.5;ASC TERT1: 44.4;BJ hTERT+: 50.7;fHDF/TERT166: 56.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA067948, HPA069104, HPA069701" Uncertain Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No "Golgi apparatus, Cytosol" Nucleoplasm "HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175" "unprognostic (2.13e-3)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (4.66e-2)" "unprognostic (9.40e-3)" "unprognostic (6.77e-2)" "unprognostic (2.54e-1)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.63e-6)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (3.44e-3)" 15.8 27.3 4.4 11.8 7.3 0.3 17.9 2.5 5.1 23.3 18.9 8.0 17.1 9.0 34.1 23.5 19.9 11.4 24.1 14.1 7.0 4.2 9.6 31.8 14.5 6.1 5.8 5.0 21.7 33.4 8.8 18.7 19.1 6.5 22.0 14.0 13.0 59.9 12.6 9.3 10.1 15.8 36.7 6.2 6.3 13.9 10.8 5.8 1.5 11.5 16.7 15.1 29.1 17.8 0.7 4.3 3.8 6.3 0.1 0.2 1.3 8.7 6.3 3.8 4.5 42.5 44.4 1.2 34.6 50.7 14.7 22.5 1.6 6.8 0.0 4.8 56.0 25.1 2.4 0.0 11.0 17.0 0.0 0.9 0.6 6.7 8.1 15.2 0.0 1.2 26.2 3.5 21.3 4.9 33.4 21.0 0.0 0.6 0.0 21.4 2.2 0.0 0.4 0.8 3.7 3.2 0.1 19.1 0.6 4.9 1.7 0.1 1.9 6.9 0.1 7.1 9.4 4.3 0.7 32.0 16.0 7.5 20.0 8.0 0.1 0.0 0.0 26.2 0.6 13.0 0.8 5.1 0.1 0.2 6.3 0.1 0.7 0.2 0.1 4.3 0.3 0.2 0.2 3.8 0.1 2.2 0.5 0.1 1.3 4.4 7.3 2.5 5.1 7.0 4.2 5.8 5.0 6.5 5.8 14.9 10.4 0.0 39.8 10.9 0.1 14.4 10.2 40.2 23.9 7.0 0.0 1.5 8.3 41.1 0.9 28.7 35.9 0.0 54.0 35.9 79.4 79.1 1.1 66.9 14.7 0.0 15.1 30.1 6.7 2.2 102.6 9.9 20.3 5.4 70.8 10.6 41.7 35.1 109.3 8.4 1.0 19.4 25.7 0.5 1.1 8.9 2.9 2.5 27.3 53.6 FAM129B "bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA" ENSG00000136830 "Family with sequence similarity 129 member B" Q96TA1 9 127505339-127578989 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 95.6;placenta: 103.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 3.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021284, HPA021417, HPA023261, HPA024312" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA 1200000 "Plasma membrane, Cytosol" Nucleoplasm "HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376" "unprognostic (3.05e-3)" "unprognostic (9.47e-2)" "unprognostic (1.14e-3)" "unprognostic (4.07e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (2.57e-3)" "unprognostic (1.40e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-3)" "unprognostic (6.45e-2)" "unprognostic (3.75e-2)" "unprognostic (1.24e-2)" "unprognostic (1.31e-1)" "unprognostic (8.40e-2)" "unprognostic (8.20e-3)" 7.8 17.9 4.5 8.4 5.6 5.1 6.7 6.5 4.2 19.1 13.9 4.2 12.3 11.9 9.6 7.3 95.6 8.9 22.9 8.2 4.8 4.1 9.9 5.5 24.0 5.1 6.9 3.1 9.3 24.8 6.8 5.7 103.7 9.1 12.8 7.2 9.4 23.6 11.7 4.1 17.3 17.1 10.5 7.0 6.8 13.8 5.4 4.2 1.3 39.8 44.6 48.8 11.8 28.3 0.0 2.4 0.5 3.7 0.0 0.5 1.7 22.1 25.3 5.1 6.7 15.6 30.4 24.0 44.1 41.0 24.4 15.1 8.0 24.5 0.0 17.5 49.8 30.1 37.0 4.4 32.6 8.1 4.2 4.7 3.8 37.5 8.3 30.8 0.1 10.8 33.2 20.5 40.1 14.1 44.9 36.6 1.4 7.1 0.2 46.1 26.1 0.2 6.2 5.3 38.1 33.3 2.6 17.3 11.6 20.9 17.8 8.2 3.8 36.0 25.7 15.6 7.6 16.9 1.2 47.3 25.1 10.9 31.5 36.4 0.4 0.8 0.0 70.6 3.6 46.3 0.5 3.7 0.0 0.2 1.3 0.0 0.0 0.5 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 1.7 4.5 5.6 6.5 4.2 4.8 4.1 6.9 3.1 9.1 4.2 65.5 43.5 0.0 30.8 28.7 0.4 4.2 38.2 10.7 36.4 36.6 0.0 59.0 3.3 72.5 1.0 28.6 94.2 0.0 92.9 33.5 19.8 56.7 28.9 1.0 21.5 0.0 21.4 28.8 11.8 1.8 29.7 23.3 21.9 2.8 41.6 12.6 107.3 42.4 47.4 1.5 1.5 12.9 32.0 0.3 1.1 32.6 101.1 2.2 37.3 104.7 FAM155A ENSG00000204442 "Family with sequence similarity 155 member A" B1AL88 13 107163510-107866735 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0;pituitary gland: 10.3" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 18.2;Bipolar cells: 15.9;Early spermatids: 42.2;Horizontal cells: 35.0;Late spermatids: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.4;RPTEC TERT1: 11.7;SCLC-21H: 7.2;SH-SY5Y: 16.3;U-87 MG: 10.4" "Low region specificity" "Detected in all" "HPA039453, HPA058768" Enhanced Approved Nucleoplasm,Vesicles,Centrosome NA NA "Nucleoplasm, Vesicles" Centrosome "HPA039453: AB_10795290, HPA058768: AB_2683813" "unprognostic (8.40e-2)" "unprognostic (9.98e-3)" "unprognostic (1.48e-1)" "unprognostic (3.38e-3)" "unprognostic (2.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.26e-1)" "unprognostic (9.06e-2)" "unprognostic (1.02e-5)" "unprognostic (5.56e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-2)" "unprognostic (3.69e-3)" 0.9 2.7 10.7 0.6 4.3 0.4 0.6 6.9 19.0 1.5 0.7 0.6 0.0 0.5 1.7 4.0 0.7 0.7 1.3 0.7 8.8 10.8 0.7 0.4 1.2 0.5 6.4 4.9 0.7 0.5 0.4 10.3 1.2 2.0 2.7 0.7 0.7 0.3 3.8 0.4 0.5 0.7 1.2 2.7 0.6 0.7 2.3 0.5 0.0 1.3 0.0 0.9 1.4 0.2 0.2 0.0 0.4 0.1 0.8 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.7 0.0 2.5 0.1 5.4 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 4.4 0.0 0.0 0.2 0.0 11.7 1.9 7.2 16.3 0.0 0.0 0.0 0.2 4.1 0.0 0.2 5.0 2.0 1.7 0.2 0.0 0.0 0.0 10.4 0.0 3.5 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.8 0.0 0.0 0.0 0.0 10.7 4.3 6.9 12.3 8.8 10.8 6.4 4.9 2.0 0.5 3.0 18.2 0.0 0.4 0.1 15.9 0.7 0.0 0.0 3.4 3.5 0.0 0.0 0.0 1.4 42.2 2.9 0.0 0.0 0.0 0.1 1.8 0.8 0.0 0.0 0.2 35.0 0.0 1.8 0.0 14.6 1.7 0.0 0.0 0.0 0.0 7.0 0.3 0.0 1.1 0.0 1.5 6.5 0.2 1.1 0.9 0.0 0.0 0.0 0.0 0.1 FAM184A "C6orf60, FLJ13942" ENSG00000111879 "Family with sequence similarity 184 member A" Q8NB25 6 118959763-119149387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.4" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 90.2;Spermatocytes: 64.6;Syncytiotrophoblasts: 222.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 15.9;HEK 293: 9.4;JURKAT: 13.4;K-562: 13.0;SCLC-21H: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034571, HPA034572, HPA041955" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768" "unprognostic (1.21e-1)" "unprognostic (4.11e-3)" "unprognostic (6.95e-2)" "unprognostic (3.40e-3)" "unprognostic (6.80e-2)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.18e-4)" "unprognostic (2.59e-1)" "unprognostic (3.19e-1)" "unprognostic (5.16e-4)" "unprognostic (8.38e-3)" "unprognostic (4.02e-2)" "unprognostic (9.11e-3)" "unprognostic (8.16e-3)" "unprognostic (5.70e-2)" "unprognostic (2.32e-1)" 4.0 2.8 14.2 3.7 13.7 0.6 6.1 13.9 16.0 2.8 3.0 4.6 0.4 3.8 3.9 3.6 2.6 3.9 2.3 2.4 11.3 10.5 6.7 6.4 15.3 4.9 9.1 10.0 7.1 5.1 14.2 15.4 31.4 11.9 4.0 1.9 2.7 2.9 4.1 1.2 2.3 2.6 3.1 4.6 1.0 1.7 23.2 7.1 0.1 8.5 1.1 5.8 2.1 2.0 0.5 0.0 0.0 0.2 0.3 1.9 0.0 0.1 0.2 15.9 1.6 0.2 0.2 0.0 0.5 0.3 0.5 0.8 2.1 1.2 1.1 0.0 0.2 6.0 0.0 4.9 0.0 0.2 1.2 9.4 0.5 1.4 7.0 0.1 0.0 1.5 0.3 0.2 0.1 0.0 0.3 0.0 13.4 13.0 0.5 0.2 0.3 0.3 0.0 5.3 0.6 1.2 0.0 0.0 0.0 0.1 0.1 10.4 7.7 0.5 0.5 1.5 3.0 2.1 1.8 0.2 0.8 0.4 0.1 4.0 4.0 4.3 0.3 1.2 0.0 2.0 0.0 0.0 0.0 0.2 0.2 0.6 0.5 0.2 0.0 0.0 0.1 1.5 1.2 0.0 0.3 0.0 0.0 1.9 0.0 14.2 13.7 13.9 12.9 11.3 10.5 9.1 10.0 11.9 7.1 44.7 90.2 0.0 6.1 2.2 36.7 3.9 5.1 60.2 31.8 3.5 27.5 45.2 14.9 0.8 12.9 1.9 0.1 0.0 1.0 13.5 5.0 0.9 5.8 3.4 4.9 12.7 5.8 3.1 0.3 5.4 3.4 0.8 0.0 0.0 0.0 12.5 0.5 0.0 6.7 1.3 27.8 6.5 2.3 64.6 15.4 3.0 222.8 4.1 0.4 1.0 FAM198B "C4orf18, DKFZp434L142, ENED, FLJ38155" ENSG00000164125 "Family with sequence similarity 198 member B" Q6UWH4 4 158124474-158173318 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 83.8" "Cell type enhanced" "Detected in many" 13 "Endothelial cells: 51.3;Hofbauer cells: 56.1;Ito cells: 49.7;Kupffer cells: 140.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 23.8;intermediate monocyte: 14.8;myeloid DC: 7.6;non-classical monocyte: 6.8" "Group enriched" "Detected in many" 37 "dendritic cells: 7.6;monocytes: 23.8" "Cell line enhanced" "Detected in many" "ASC diff: 21.5;ASC TERT1: 40.6;HSkMC: 46.6;HUVEC TERT2: 52.0;WM-115: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007227 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA007227: AB_1847689" "unprognostic (4.87e-2)" "unprognostic (7.79e-2)" "unprognostic (6.60e-3)" "unprognostic (9.42e-3)" "unprognostic (2.37e-2)" "unprognostic (7.47e-2)" "unprognostic (2.13e-2)" "unprognostic (7.49e-2)" "unprognostic (9.20e-3)" "unprognostic (1.71e-1)" "unprognostic (1.60e-1)" "unprognostic (1.89e-1)" "unprognostic (3.25e-3)" "unprognostic (3.74e-3)" "unprognostic (3.85e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-2)" 24.1 83.8 13.9 12.9 12.6 0.9 15.9 22.9 16.0 16.7 8.9 12.1 6.2 4.5 27.5 13.2 6.0 10.6 12.6 25.8 24.2 9.0 4.2 2.9 6.9 7.1 18.6 20.2 50.1 4.8 4.4 2.7 9.5 12.4 8.3 8.1 4.2 7.9 10.8 3.8 3.5 6.3 23.9 25.9 15.7 7.5 7.0 17.5 0.0 8.2 3.1 2.3 14.2 7.3 0.0 7.6 0.4 23.8 0.0 0.0 7.3 3.2 2.6 1.6 0.3 21.5 40.6 3.1 0.8 0.6 0.1 1.0 3.5 1.3 0.0 0.1 1.3 1.4 0.0 19.0 5.0 0.5 0.0 0.0 0.2 0.0 9.7 14.4 0.1 0.0 46.6 1.2 6.6 0.7 2.2 52.0 0.0 3.3 0.0 9.6 0.2 0.0 0.0 0.1 11.3 0.0 0.0 0.1 0.0 0.0 7.3 0.1 0.0 0.0 7.5 2.1 9.6 1.4 0.0 2.5 4.4 4.8 2.6 1.6 0.0 0.0 11.8 0.6 0.0 20.0 0.0 23.8 0.0 0.0 14.8 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.4 0.0 6.8 0.3 0.0 7.3 13.9 12.6 22.9 16.0 24.2 9.0 18.6 20.2 12.4 17.5 8.9 3.8 1.7 1.7 8.1 0.0 30.3 0.0 2.7 2.3 3.5 0.0 3.6 0.0 0.5 2.4 51.3 2.6 0.0 5.0 0.9 14.8 2.4 1.1 0.8 56.1 6.4 1.7 49.7 140.4 4.3 32.5 27.2 8.5 0.0 6.5 0.0 3.2 1.9 39.6 0.0 0.0 6.5 10.3 4.4 0.5 6.5 4.9 2.2 2.9 1.0 FAM199X CXorf39 ENSG00000123575 "Family with sequence similarity 199, X-linked" Q6PEV8 X 104166620-104195902 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003093 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA003093: AB_1078597" "unprognostic (2.03e-3)" "unprognostic (4.39e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-2)" "unprognostic (1.47e-1)" "unprognostic (1.18e-2)" "unprognostic (1.89e-2)" "unprognostic (6.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (1.18e-1)" "unprognostic (9.13e-2)" "unprognostic (6.07e-3)" "unprognostic (1.08e-2)" "unprognostic (4.73e-2)" "unprognostic (4.00e-2)" "unprognostic (2.39e-2)" 19.5 13.4 19.6 7.5 24.4 13.0 13.1 17.1 25.9 11.1 9.3 14.2 21.0 8.7 13.0 39.2 9.0 10.5 7.8 8.0 17.4 19.2 17.1 8.6 9.0 8.7 19.3 17.9 13.9 13.1 24.9 11.8 9.9 22.6 11.8 9.7 8.7 10.8 16.6 10.7 10.4 8.2 9.9 16.9 9.2 8.9 10.9 12.9 6.5 19.4 5.6 8.5 9.5 12.8 3.8 2.3 2.6 2.0 1.5 3.9 1.3 16.8 10.8 9.8 10.7 7.3 8.8 9.9 9.0 8.5 11.8 11.1 8.3 14.2 9.4 11.2 8.3 9.3 12.9 17.6 13.3 19.4 4.5 9.8 7.4 13.8 9.4 10.4 14.0 10.5 6.8 17.0 11.6 11.7 18.4 11.9 6.1 8.0 21.2 13.0 12.1 7.5 10.0 9.7 15.0 12.6 8.0 6.4 11.7 20.1 11.4 5.3 6.5 21.7 14.6 15.5 10.1 7.3 7.0 14.5 13.2 4.8 10.2 9.6 10.0 8.3 10.5 14.9 15.2 9.6 2.2 2.0 1.1 2.8 1.5 3.2 1.6 2.6 3.4 2.3 3.8 3.9 2.3 2.6 1.5 2.0 1.2 2.9 1.3 19.6 24.4 17.1 23.3 17.4 19.2 19.3 17.9 22.6 12.9 14.9 12.6 15.2 9.5 21.3 22.7 11.8 17.8 6.7 9.1 59.3 13.7 9.6 19.9 10.2 0.5 13.2 14.0 0.0 16.4 9.6 11.0 12.5 9.2 15.7 14.7 31.8 16.1 14.1 16.6 2.7 10.9 14.1 10.1 6.4 20.2 19.1 13.4 15.9 13.8 20.7 14.6 25.8 10.5 2.6 10.9 23.1 12.2 8.5 14.3 12.7 FAM206A "C9orf6, CG-8, FLJ20457, Simiate" ENSG00000119328 "Family with sequence similarity 206 member A" Q9NX38 9 108934181-108950744 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035917, HPA035918" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No "Nucleoplasm, Cytosol" "Cytokinetic bridge" "HPA035917: AB_2674860, HPA035918: AB_10670593" "unprognostic (4.89e-2)" "unprognostic (2.62e-1)" "unprognostic (1.85e-1)" "unprognostic (4.00e-3)" "unprognostic (1.05e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-3)" "unprognostic (1.10e-2)" "unprognostic (1.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.16e-2)" "unprognostic (3.50e-2)" "unprognostic (1.57e-2)" "unprognostic (3.25e-2)" "unprognostic (2.03e-1)" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" 12.0 11.4 16.8 9.0 28.8 12.9 17.8 12.3 19.2 11.6 13.3 12.8 10.3 13.8 12.6 22.9 16.0 18.9 9.9 13.3 16.2 16.0 14.1 12.6 12.0 9.9 16.7 20.0 13.7 13.7 23.3 28.5 10.6 16.0 11.9 15.1 7.6 16.9 13.5 12.2 22.9 15.1 14.4 16.6 7.5 13.0 16.7 14.8 8.4 20.9 10.2 10.6 10.5 11.7 10.6 23.6 24.4 20.7 12.4 16.1 11.9 8.7 9.4 10.3 11.3 18.3 25.5 13.8 8.9 9.6 8.3 6.9 13.9 4.8 8.5 4.9 7.9 11.4 21.2 8.2 8.7 8.3 5.2 8.6 5.2 12.8 13.1 15.3 18.6 7.3 13.4 16.4 10.1 23.3 10.7 11.3 12.6 18.2 8.9 9.8 24.5 13.3 7.5 11.6 26.4 13.8 6.6 16.7 8.9 10.8 9.7 13.2 7.2 12.8 11.2 14.0 10.2 15.2 10.1 7.4 4.6 8.5 20.6 10.5 7.2 18.7 6.3 14.9 7.4 6.8 19.9 20.6 19.0 9.9 20.6 15.2 10.6 15.8 13.1 22.6 6.9 16.1 12.1 24.4 12.4 20.7 23.6 13.0 11.9 16.8 28.8 12.3 19.2 16.2 16.0 16.7 20.0 16.0 14.8 3.0 11.8 0.0 6.0 13.5 3.6 17.7 15.3 56.2 18.2 0.0 9.8 4.9 8.3 4.9 5.5 7.1 6.5 0.0 7.9 8.4 9.1 3.9 2.3 2.9 6.9 6.4 4.1 3.7 2.7 5.5 15.8 5.9 10.1 1.8 7.2 6.0 6.4 8.4 17.3 6.5 6.9 19.4 8.5 29.5 8.8 12.2 6.1 2.2 6.3 4.8 FAM210A "C18orf19, HsT2329, MGC24180" ENSG00000177150 "Family with sequence similarity 210 member A" Q96ND0 18 13663347-13726663 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014324, HPA051564" Uncertain Approved "Nucleoplasm,Golgi apparatus,Mitochondria" NA NA "Nucleoplasm, Golgi apparatus, Mitochondria" "HPA014324: AB_2668972, HPA051564: AB_2681536" "unprognostic (1.32e-1)" "unprognostic (6.98e-2)" "unprognostic (5.78e-2)" "unprognostic (9.18e-3)" "unprognostic (4.13e-2)" "prognostic unfavorable (8.14e-4)" "unprognostic (2.23e-3)" "unprognostic (1.11e-2)" "unprognostic (2.26e-1)" "unprognostic (5.53e-3)" "unprognostic (6.79e-3)" "unprognostic (2.98e-2)" "unprognostic (3.27e-3)" "unprognostic (7.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" "unprognostic (4.82e-2)" 10.5 8.1 7.5 8.9 7.1 4.0 9.4 8.3 8.8 5.8 9.9 7.2 5.8 11.5 6.6 4.4 13.5 5.7 5.4 27.5 6.4 7.8 12.0 17.6 5.6 7.4 7.4 6.4 8.7 5.6 7.8 7.5 9.3 8.2 7.1 8.5 6.5 7.0 7.6 27.9 5.6 10.9 8.2 9.1 6.4 6.1 10.2 7.3 5.9 8.4 16.3 8.9 14.7 7.9 9.2 8.6 4.3 10.7 7.6 9.7 5.0 12.2 7.0 4.9 4.6 5.8 6.1 7.2 8.5 7.9 9.6 11.2 9.4 6.0 12.7 10.7 6.0 17.8 6.0 9.4 10.6 15.7 8.7 4.4 8.9 5.1 6.8 6.9 15.1 8.4 5.2 8.4 9.2 32.6 6.7 6.1 7.7 12.0 7.0 11.1 8.4 9.3 9.8 5.5 24.1 7.0 7.6 11.7 14.7 7.9 7.8 3.2 5.5 7.4 11.0 20.3 7.4 5.8 7.2 6.7 24.7 24.2 15.2 10.4 7.9 9.8 14.7 13.1 7.9 9.8 3.4 7.0 4.3 8.9 10.7 9.7 8.1 7.6 7.7 8.6 9.2 9.6 9.0 1.2 7.6 5.3 5.6 7.2 5.0 7.5 7.1 8.3 8.8 6.4 7.8 7.4 6.4 8.2 7.3 8.9 8.8 20.4 10.4 49.1 53.0 60.1 5.1 1.4 11.4 7.0 19.6 19.1 18.3 16.3 6.1 15.8 11.7 0.0 7.8 31.2 17.4 9.1 6.9 19.0 18.1 28.6 10.9 5.5 8.4 3.1 8.6 16.6 8.5 11.8 8.4 17.4 10.7 0.0 9.6 21.9 29.7 6.5 16.0 27.0 29.8 50.1 21.5 11.4 17.7 10.4 FAM212B "C1orf183, FLJ31105, INKA2" ENSG00000197852 "Family with sequence similarity 212 member B" Q9NTI7 1 111680630-111739424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "Hofbauer cells: 3.6" "Cancer enhanced" "Detected in many" "glioma: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 13 "neutrophil: 19.2" "Lineage enriched" "Detected in many" 13 "granulocytes: 19.2" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.2;U-87 MG: 37.5;WM-115: 14.2" "HPA027809, HPA027810, HPA027811" Approved Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA027809: AB_10599616, HPA027810: , HPA027811: AB_10600872" "unprognostic (1.92e-1)" "unprognostic (9.70e-3)" "unprognostic (1.84e-1)" "unprognostic (1.85e-2)" "unprognostic (2.81e-2)" "prognostic favorable (4.51e-5)" "unprognostic (9.96e-4)" "unprognostic (1.15e-1)" "unprognostic (1.36e-2)" "unprognostic (9.50e-3)" "unprognostic (9.92e-5)" "unprognostic (8.66e-2)" "unprognostic (1.31e-3)" "unprognostic (2.84e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-3)" "unprognostic (5.07e-2)" 12.1 1.4 14.9 4.6 11.5 4.0 8.6 5.5 22.4 2.6 3.7 2.9 1.5 1.8 4.9 1.8 11.1 7.9 4.7 12.9 13.1 3.5 3.9 1.4 6.9 2.4 4.8 13.4 3.2 1.7 4.5 0.9 9.4 3.9 4.6 3.3 1.8 2.7 6.3 8.3 8.8 2.9 8.1 3.9 6.3 4.9 4.3 3.7 0.5 3.8 3.5 2.9 3.1 3.9 0.4 0.8 19.2 1.4 0.0 0.0 0.4 1.2 1.1 2.1 1.6 10.7 3.8 0.9 0.9 2.0 1.7 4.0 2.1 0.0 0.9 0.4 0.8 0.8 1.1 1.1 2.4 1.5 2.3 1.1 7.4 0.7 1.9 3.6 0.3 1.2 2.6 10.7 18.2 0.8 0.4 4.5 1.1 0.0 1.7 2.0 1.1 0.4 0.3 0.3 0.9 1.0 1.1 9.9 0.3 0.5 1.7 5.6 1.6 0.5 0.0 4.9 2.3 1.4 1.2 1.7 3.8 6.0 2.0 0.7 10.8 1.9 0.9 37.5 1.8 14.2 0.0 1.3 1.0 0.0 1.1 0.0 0.2 0.0 0.0 0.8 0.4 0.0 0.0 19.2 0.0 1.4 0.3 0.0 0.4 14.9 11.5 5.5 22.4 13.1 3.5 4.8 13.4 3.9 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 FAM212B "C1orf183, FLJ31105, INKA2" ENSG00000284755 "Family with sequence similarity 212 member B" 1 111722064-111755824 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.4" "Group enriched" "Detected in many" 5 "Early spermatids: 52.0;Late spermatids: 39.5;Sertoli cells: 32.3" "Cell type enriched" "Detected in single" 5 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 5 "NK-cells: 3.4" "Cell line enhanced" "Detected in some" "AF22: 2.5;HHSteC: 3.7;HSkMC: 2.9;LHCN-M2: 3.5;SuSa: 3.5;THP-1: 2.5;U-87 MG: 2.5" "HPA027810, HPA027811" Uncertain Uncertain Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Vesicles" Nucleoli "HPA027810: , HPA027811: AB_10600872" 0.1 0.3 0.1 0.4 2.8 0.2 0.1 0.1 1.7 0.1 0.2 1.5 0.1 0.3 1.7 2.0 0.1 0.0 0.3 0.4 0.1 0.7 0.1 0.5 0.2 0.1 0.1 0.1 1.0 0.0 0.1 1.0 1.6 0.8 1.3 0.1 0.1 1.2 0.1 0.0 1.0 2.5 2.6 2.2 0.0 0.7 1.2 2.6 0.8 0.1 0.1 1.9 0.1 0.1 0.2 0.7 0.1 3.4 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 3.7 1.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 3.5 1.3 0.5 1.9 1.8 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 3.5 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 2.5 2.2 0.0 0.7 0.0 0.0 0.2 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.3 0.3 0.0 3.4 0.1 0.2 0.2 0.0 0.0 0.0 0.5 3.1 6.2 6.2 0.0 0.0 2.7 0.0 0.0 7.9 0.0 0.0 0.0 52.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 6.9 1.3 2.8 39.5 2.0 2.0 6.8 0.0 4.6 1.2 0.0 1.1 5.3 0.0 5.9 32.3 6.1 4.2 2.1 3.4 0.0 0.0 0.9 0.6 FAM219A "bA573M23.5, C9orf25, FLJ39031" ENSG00000164970 "Family with sequence similarity 219 member A" Q8IW50 9 34398184-34458570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.9" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019338, HPA052909" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA019338: AB_1845819, HPA052909: AB_2681986" "unprognostic (9.96e-3)" "unprognostic (2.16e-1)" "unprognostic (1.50e-2)" "unprognostic (1.23e-2)" "unprognostic (6.81e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (1.98e-5)" "unprognostic (2.71e-2)" "unprognostic (2.50e-1)" "unprognostic (2.95e-1)" "prognostic favorable (2.46e-4)" "unprognostic (3.46e-3)" "prognostic unfavorable (5.54e-5)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (3.34e-1)" "unprognostic (2.76e-1)" 13.6 10.3 27.8 10.9 27.0 4.9 7.1 26.3 56.9 7.5 6.3 23.3 3.7 7.2 13.2 8.6 6.3 6.5 7.6 17.5 25.4 27.6 6.1 5.0 11.0 7.8 30.8 31.0 10.7 8.4 9.4 10.6 16.3 34.0 9.2 6.6 5.4 7.1 9.7 28.6 12.3 6.7 15.0 25.2 9.8 7.2 6.9 25.6 2.9 7.2 4.0 6.6 6.5 6.4 0.5 0.6 3.8 0.7 0.7 1.5 0.3 12.6 4.9 11.6 6.6 10.8 4.1 11.3 7.7 5.8 6.7 8.5 3.4 2.9 2.8 8.0 7.4 13.3 5.3 9.2 4.9 6.7 43.6 5.2 1.1 6.3 3.6 6.1 2.7 6.5 4.3 5.0 10.0 5.6 8.3 11.0 5.0 2.7 14.0 5.2 2.5 4.2 3.8 7.5 1.7 7.3 5.5 1.9 2.4 4.8 2.7 3.7 11.8 6.6 4.8 3.8 11.1 2.4 2.8 13.0 7.4 5.8 15.3 10.6 3.7 5.3 2.4 21.2 6.4 13.0 2.3 0.6 3.8 1.5 0.4 0.8 0.5 0.8 0.4 0.5 0.4 0.6 0.8 2.0 0.7 0.7 0.6 1.4 0.3 27.8 27.0 26.3 40.8 25.4 27.6 30.8 31.0 34.0 25.6 6.0 3.5 2.2 2.9 5.6 18.4 10.5 0.0 1.4 1.2 3.5 3.9 8.2 0.0 5.2 12.0 14.3 0.9 0.0 4.2 12.1 5.6 5.6 2.3 2.4 5.2 50.9 10.4 5.5 4.6 25.8 3.4 2.3 8.5 3.6 1.6 8.5 5.6 1.4 5.3 2.1 10.5 6.5 8.2 10.3 2.4 5.6 17.3 4.4 0.8 2.6 FAM229B "C6orf225, DKFZp586F0922, LOC619208" ENSG00000203778 "Family with sequence similarity 229 member B" Q4G0N7 6 112087599-112102790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 118.9" "Group enriched" "Detected in many" 10 "Early spermatids: 2880.3;Late spermatids: 5153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036068 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA036068: AB_10673495" "unprognostic (1.65e-1)" "unprognostic (9.41e-2)" "unprognostic (4.29e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (2.71e-2)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-3)" "unprognostic (4.74e-2)" "prognostic favorable (8.76e-4)" "unprognostic (3.74e-3)" "unprognostic (1.36e-1)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" 4.7 7.4 18.4 2.1 16.8 2.0 7.7 5.8 14.8 8.2 4.2 17.3 4.3 2.2 9.6 17.0 3.8 23.7 8.8 16.8 15.7 16.2 11.6 11.0 5.2 2.0 20.7 11.2 10.7 4.3 10.0 15.4 5.2 15.3 7.3 3.1 8.6 3.9 11.0 5.9 1.9 2.3 8.6 21.7 2.3 4.3 118.9 13.6 1.6 9.7 2.6 2.0 4.6 2.6 4.0 3.4 2.7 0.3 5.4 8.1 2.8 1.6 4.2 17.4 8.5 15.4 15.3 0.8 6.4 24.5 9.2 19.5 0.7 4.1 1.3 19.0 11.8 9.6 1.0 3.6 9.3 14.8 0.4 12.0 1.5 1.9 6.5 9.6 3.3 0.8 9.3 6.3 15.2 2.6 21.5 9.0 15.2 2.0 3.4 11.2 0.4 6.2 5.4 4.5 1.2 10.1 9.7 4.3 1.3 13.5 0.2 16.2 6.8 5.1 0.6 9.9 9.8 8.3 3.1 5.1 7.7 3.3 29.4 8.5 2.5 0.1 11.7 12.3 2.8 10.2 0.1 0.1 2.7 4.2 0.0 5.3 2.5 3.7 3.3 0.5 4.0 8.1 7.2 0.4 5.4 0.3 3.4 0.4 2.8 18.4 16.8 5.8 14.0 15.7 16.2 20.7 11.2 15.3 13.6 3.0 10.7 4.7 14.7 7.4 29.1 81.9 22.9 313.2 31.8 48.8 11.8 1.2 112.7 25.4 2880.3 27.2 0.0 0.0 9.2 4.2 30.9 16.9 1.1 39.9 2.7 15.9 2.9 34.4 1.9 5153.7 67.3 6.2 23.6 2.8 0.3 63.3 6.5 0.0 85.2 62.8 30.9 58.2 24.7 416.7 35.0 7.5 0.5 4.4 0.6 7.9 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630251-69633599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5" "Cell type enhanced" "Detected in some" 10 "Collecting duct cells: 15.7;Distal tubular cells: 10.0;Ductal cells: 23.4;Exocrine glandular cells: 15.9;Pancreatic endocrine cells: 15.7;Proximal tubular cells: 10.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.2" "Lineage enriched" "Detected in single" 25 "T-cells: 14.2" "Cell line enhanced" "Detected in many" "PC-3: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavorable (8.64e-4)" "prognostic unfavorable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favorable (9.72e-4)" 1.4 3.3 13.1 2.0 13.5 1.1 5.3 34.5 23.9 1.3 3.0 3.2 0.6 3.0 2.7 13.0 4.0 4.8 2.1 6.9 15.0 17.8 4.7 2.3 4.1 2.7 10.8 14.4 2.0 7.9 5.6 5.3 1.3 8.3 7.8 2.6 5.1 5.6 5.6 1.6 2.4 2.2 4.5 4.6 0.8 4.2 11.4 2.4 0.7 6.0 0.1 2.4 2.6 1.6 0.3 0.0 0.5 0.0 0.2 14.2 2.8 13.3 14.5 1.8 14.9 0.0 0.0 6.5 1.3 0.3 2.4 2.6 10.5 11.0 0.0 20.4 0.3 8.6 5.5 7.8 4.5 3.4 13.2 10.7 0.0 3.2 4.0 3.9 0.0 4.8 0.0 4.4 0.1 2.3 1.8 0.0 20.1 4.9 0.0 0.2 17.9 0.1 0.0 9.0 5.4 26.9 0.0 0.0 0.1 5.1 7.6 7.6 10.4 5.5 14.0 8.5 3.9 9.6 2.3 0.6 0.3 9.3 0.0 3.9 2.4 6.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 8.9 0.1 8.5 5.6 0.0 0.3 14.2 4.9 0.5 0.2 0.0 0.0 5.3 2.8 13.1 13.5 34.5 23.9 15.0 17.8 10.8 14.4 8.3 2.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 5.7 15.7 0.0 5.6 10.0 23.4 0.0 0.0 0.0 0.0 15.9 4.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 15.7 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 FAM3A "2-19, DXS560S, XAP-7" ENSG00000071889 "Family with sequence similarity 3 member A" P98173 X 154506159-154516242 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025016, HPA035268, HPA056991" Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" "Secreted - unknown location" Yes No "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "CAB025016: , HPA035268: , HPA056991: AB_2683303" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.19e-2)" "unprognostic (4.73e-2)" "unprognostic (5.19e-2)" "unprognostic (2.54e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (6.27e-2)" "unprognostic (3.42e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (2.74e-1)" "unprognostic (1.41e-1)" "unprognostic (4.04e-1)" "unprognostic (9.71e-2)" 18.9 18.9 18.9 14.7 20.9 13.7 17.3 13.4 25.7 22.3 21.2 31.1 16.3 37.0 18.2 16.2 19.3 19.1 25.3 31.4 21.3 18.7 19.8 28.5 16.1 16.7 23.0 16.4 29.1 35.5 18.2 22.1 21.0 18.5 20.6 9.9 17.3 29.4 34.7 33.4 15.3 33.7 14.4 25.4 18.4 23.6 10.7 16.8 13.5 28.8 16.1 12.2 16.9 16.9 8.0 13.3 21.2 11.5 8.5 13.3 8.9 16.6 16.0 4.0 13.5 12.2 6.2 11.4 8.5 5.9 5.9 7.0 7.3 10.1 10.8 43.4 14.2 11.5 12.1 6.3 7.5 1.4 8.8 8.6 4.2 14.0 5.1 19.1 2.8 6.8 7.7 6.8 12.1 8.5 7.0 4.1 7.0 8.0 8.0 6.7 17.4 5.2 12.3 1.7 18.1 20.1 6.5 4.0 29.7 6.4 6.9 8.0 6.1 3.9 9.5 14.0 3.1 7.2 4.4 4.5 7.9 4.8 21.4 11.5 30.8 16.8 13.2 14.6 7.4 8.1 21.2 9.9 12.5 13.3 11.5 12.9 6.2 8.2 9.3 9.9 8.0 10.2 11.9 5.0 8.5 9.5 13.3 8.5 8.9 18.9 20.9 13.4 25.7 21.3 18.7 23.0 16.4 18.5 16.8 11.9 14.7 8.0 19.3 14.4 23.0 20.5 25.5 8.1 6.8 21.0 13.7 39.7 23.2 22.8 0.6 17.7 66.7 23.3 37.0 40.6 24.2 23.6 5.7 27.2 26.3 20.6 16.8 20.3 14.9 1.6 31.1 13.9 32.1 19.0 45.1 25.5 24.3 49.1 27.6 26.2 15.2 6.5 16.0 3.7 8.6 18.4 59.6 19.3 33.2 20.3 FAM50B "D6S2654E, X5L" ENSG00000145945 "Family with sequence similarity 50 member B" Q9Y247 6 3849386-3851317 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 42.6;MCF7: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA064111, HPA067817" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Midbody" Yes NA Nucleoplasm "Cytokinetic bridge, Midbody" "HPA064111: AB_2685191, HPA067817: AB_2685904" "unprognostic (1.15e-1)" "unprognostic (7.76e-2)" "unprognostic (4.28e-2)" "unprognostic (4.43e-2)" "unprognostic (2.12e-3)" "unprognostic (2.69e-1)" "unprognostic (2.38e-2)" "unprognostic (7.13e-2)" "unprognostic (1.60e-1)" "unprognostic (1.79e-1)" "unprognostic (2.15e-1)" "unprognostic (2.90e-1)" "prognostic favorable (4.01e-6)" "unprognostic (1.60e-1)" "unprognostic (3.22e-1)" "unprognostic (1.34e-1)" "unprognostic (9.39e-2)" 7.2 9.5 13.4 5.7 20.6 3.1 5.7 18.7 16.7 6.7 6.8 11.0 8.4 10.1 8.3 6.7 5.5 11.2 8.1 16.0 12.8 14.2 12.9 12.0 6.2 7.1 11.4 14.9 14.4 12.7 5.8 7.7 3.4 9.7 8.2 3.0 5.9 15.2 9.8 41.1 7.9 6.9 10.2 10.8 7.7 7.9 10.2 9.9 5.8 11.8 5.7 5.5 7.5 13.3 14.9 10.1 3.4 9.1 19.4 20.5 5.6 3.1 4.3 0.0 0.0 2.6 2.4 0.2 3.8 1.8 2.6 3.3 0.0 5.9 3.4 4.1 2.7 1.0 2.4 0.0 1.5 1.9 42.6 2.3 0.0 10.2 0.0 2.7 0.0 0.0 2.7 3.0 2.0 0.6 0.8 2.6 0.0 0.0 0.0 2.3 13.4 0.0 4.7 0.9 2.0 2.0 0.0 0.0 0.0 1.2 0.0 6.0 5.3 6.2 3.9 0.2 0.0 4.2 3.8 3.5 0.0 0.4 5.1 0.0 0.0 9.2 0.0 1.4 0.3 7.1 3.4 4.7 2.4 7.1 6.1 16.8 14.9 13.6 9.2 6.1 12.9 11.3 7.1 1.9 19.4 9.1 10.1 20.5 5.6 13.4 20.6 18.7 16.7 12.8 14.2 11.4 14.9 9.7 9.9 14.9 6.5 6.5 5.9 5.7 17.4 15.7 5.1 4.0 7.9 12.2 3.9 3.3 28.2 10.7 24.9 4.1 2.2 0.0 9.9 4.8 5.8 2.7 3.5 18.8 8.7 14.3 1.2 8.6 4.1 25.0 7.8 4.0 11.8 10.0 3.3 19.1 7.9 3.6 10.3 32.6 12.6 0.0 7.9 34.4 39.6 5.8 0.8 4.5 3.3 1.6 FAM69B "C9orf136, MGC20262" ENSG00000165716 "Family with sequence similarity 69 member B" Q5VUD6 9 136712570-136724050 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 15.8;Horizontal cells: 25.4;Ito cells: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "naive B-cell: 7.3;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 34 "B-cells: 7.3;dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "EFO-21: 28.7;HEK 293: 25.7;HUVEC TERT2: 31.9;REH: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054443 Approved "Nucleoplasm,Nuclear bodies,Vesicles" No No "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA054443: AB_2682489" "unprognostic (2.78e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (1.77e-5)" "unprognostic (3.82e-1)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (6.80e-2)" "unprognostic (2.10e-2)" "prognostic favorable (9.48e-5)" "unprognostic (2.77e-1)" "unprognostic (6.67e-3)" "unprognostic (4.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.84e-1)" "unprognostic (2.78e-1)" 8.0 3.8 12.3 3.6 14.2 8.2 5.6 19.8 21.4 6.1 4.6 4.9 2.3 4.7 9.6 5.0 4.7 11.0 5.9 18.8 12.3 14.6 6.6 5.5 11.0 4.5 12.4 15.9 5.4 11.9 7.9 11.4 24.5 14.2 6.5 1.3 17.5 11.2 4.5 9.9 13.0 4.4 4.1 5.3 7.9 3.5 7.5 3.2 1.6 7.6 4.1 2.1 3.2 3.1 7.3 1.9 0.0 0.1 0.0 0.0 0.7 0.5 3.4 9.6 9.4 0.0 0.0 8.6 0.3 0.0 0.4 0.4 9.7 1.6 0.8 28.7 0.0 3.1 2.9 4.9 0.1 0.0 1.3 25.7 5.4 0.4 0.3 0.1 0.8 2.9 0.1 0.0 0.1 0.0 1.4 31.9 6.9 6.4 0.9 0.0 4.2 3.7 8.6 14.8 2.1 2.1 20.5 0.2 9.6 0.5 1.0 16.4 17.7 0.4 1.9 7.1 3.1 5.3 5.0 16.3 0.8 7.1 1.3 0.6 5.7 0.5 2.5 0.6 0.8 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.7 12.3 14.2 19.8 21.4 12.3 14.6 12.4 15.9 14.2 3.2 0.0 5.3 1.4 1.3 0.9 10.5 4.4 0.0 0.0 1.2 0.0 9.8 0.5 3.3 0.6 1.2 15.8 0.0 0.0 0.0 5.3 2.1 1.3 1.1 3.9 0.4 25.4 0.0 20.3 0.6 3.7 4.4 0.2 11.8 0.0 0.0 9.7 0.2 0.0 2.5 1.1 8.3 0.0 0.8 1.2 5.5 0.3 0.2 0.0 0.0 0.0 FAM89A "C1orf153, MGC15887" ENSG00000182118 "Family with sequence similarity 89 member A" Q96GI7 1 231018958-231040246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 39.6;placenta: 48.3" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 143.5;Extravillous trophoblasts: 248.1;Rod photoreceptor cells: 96.4;Syncytiotrophoblasts: 232.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 52.2;SK-MEL-30: 27.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA059052, HPA059578" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA059052: AB_2683890, HPA059578: AB_2684070" "unprognostic (7.80e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-3)" "unprognostic (1.32e-2)" "unprognostic (2.77e-1)" "unprognostic (1.41e-2)" "unprognostic (1.98e-2)" "unprognostic (1.10e-1)" "unprognostic (8.05e-3)" "unprognostic (4.85e-1)" "unprognostic (1.54e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.01e-1)" "unprognostic (9.26e-2)" 39.6 12.9 8.0 3.7 8.5 3.9 32.8 3.9 5.4 5.1 3.6 4.9 2.0 1.6 5.7 2.1 3.4 2.7 4.6 4.7 7.9 11.2 8.7 5.7 10.5 6.7 14.0 2.3 4.7 15.0 4.0 4.2 48.3 13.1 4.7 2.4 12.0 3.5 3.9 4.2 14.1 1.8 3.5 10.9 9.6 3.1 2.8 8.3 0.8 3.9 5.0 3.6 4.3 9.7 1.2 0.0 4.3 0.7 0.3 3.0 0.8 0.3 4.8 2.2 4.7 5.5 1.1 52.2 2.7 2.0 1.0 1.8 7.3 4.3 0.0 0.6 1.7 6.0 2.9 4.2 0.6 0.8 14.5 10.2 2.3 0.1 0.3 21.2 1.7 12.6 18.4 9.5 0.0 4.8 0.0 2.6 5.3 18.0 3.0 0.9 1.7 1.1 3.0 3.3 4.3 1.5 5.7 7.3 5.5 3.6 5.1 2.0 5.8 0.9 0.4 27.3 5.2 0.2 10.1 0.4 8.2 0.0 0.1 5.0 6.6 7.9 4.0 2.4 3.4 16.1 4.3 0.7 0.0 0.6 0.1 1.1 1.2 0.8 1.5 0.0 0.6 1.3 3.0 0.0 0.3 0.2 0.0 0.0 0.8 8.0 8.5 3.9 5.4 7.9 11.2 14.0 2.3 13.1 8.3 0.0 1.6 2.7 15.8 26.8 32.0 3.0 2.5 0.0 1.2 0.0 72.6 143.5 3.3 2.1 1.1 20.1 0.0 0.0 2.9 248.1 6.4 12.7 4.6 10.6 41.7 7.9 0.0 5.5 13.1 1.8 2.6 3.0 20.3 0.0 0.4 22.8 4.3 0.0 1.4 4.4 96.4 0.0 2.1 3.8 8.9 28.7 232.7 2.2 0.9 13.3 FAM98C FLJ44669 ENSG00000130244 "Family with sequence similarity 98 member C" Q17RN3 19 38403135-38409088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040930, HPA041730" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA040930: AB_10795484, HPA041730: AB_10804114" "unprognostic (3.01e-2)" "unprognostic (6.44e-3)" "unprognostic (5.15e-2)" "unprognostic (1.94e-1)" "unprognostic (3.18e-1)" "unprognostic (8.10e-3)" "unprognostic (3.06e-1)" "unprognostic (2.15e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (8.51e-5)" "unprognostic (2.82e-2)" "unprognostic (8.91e-3)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (2.43e-1)" "unprognostic (2.96e-1)" "prognostic favorable (5.53e-4)" 10.8 8.9 18.3 9.3 16.9 11.0 9.8 17.0 19.9 8.7 14.2 12.8 9.0 19.6 9.9 7.2 14.3 13.8 9.1 11.6 16.0 13.1 9.1 13.4 8.7 9.5 12.3 16.9 10.2 22.4 10.6 8.1 7.6 13.0 12.5 7.0 8.2 17.7 9.5 2.5 17.0 22.2 6.8 12.7 10.1 19.2 5.4 9.7 5.3 11.8 7.7 11.2 9.4 9.5 6.0 3.2 12.6 3.4 3.3 5.6 1.6 10.9 11.9 1.4 6.9 1.5 5.2 6.1 6.4 5.4 6.3 6.7 2.0 8.0 10.0 7.2 3.7 2.2 5.3 2.7 4.6 1.0 16.1 5.6 3.2 2.0 4.6 6.8 2.8 6.0 5.0 9.6 3.2 5.8 3.5 3.7 16.4 9.0 11.0 3.7 12.1 4.0 2.1 1.0 18.2 12.8 8.3 2.9 5.9 7.7 5.8 2.4 7.1 6.4 11.4 3.8 0.7 8.6 8.7 4.8 2.8 7.8 8.8 7.6 11.9 6.0 4.2 7.4 6.5 4.5 0.0 2.3 12.6 3.1 3.3 4.2 2.6 5.6 4.6 3.2 6.0 4.3 3.4 2.0 3.3 3.4 1.2 4.4 1.6 18.3 16.9 17.0 19.9 16.0 13.1 12.3 16.9 13.0 9.7 8.9 9.9 17.1 21.7 19.2 13.2 4.3 10.2 6.7 5.7 22.7 11.8 10.3 18.3 17.4 5.0 9.3 43.8 0.0 28.7 9.4 10.0 14.8 15.0 11.9 9.9 11.1 24.6 10.4 10.5 2.1 17.3 14.7 21.9 12.6 32.7 11.1 19.7 34.5 17.3 15.9 11.6 12.9 11.4 27.3 41.1 26.1 5.1 20.3 33.5 22.0 FAN1 "KIAA1018, MTMR15" ENSG00000198690 "FANCD2 and FANCI associated nuclease 1" Q9Y2M0 15 30903852-30943108 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048198 Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA048198: AB_2680311" "unprognostic (7.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (3.30e-2)" "unprognostic (6.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.97e-1)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (3.53e-2)" "unprognostic (3.53e-2)" "unprognostic (9.67e-2)" "prognostic favorable (1.42e-6)" "unprognostic (3.73e-1)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" "unprognostic (1.29e-1)" 5.9 8.9 11.6 6.9 17.4 6.3 12.7 19.6 18.4 15.0 11.4 17.7 11.9 4.6 11.6 22.9 6.5 8.5 8.5 13.0 12.6 11.0 14.7 14.4 6.9 5.5 18.5 11.8 12.5 18.2 7.2 17.0 10.6 15.4 16.4 9.7 8.6 17.3 8.3 16.8 9.3 6.7 11.5 13.0 7.3 8.5 9.4 15.0 5.1 14.3 6.3 5.8 9.0 9.1 4.0 3.6 0.6 1.7 4.5 5.4 1.6 6.3 10.9 3.6 2.0 12.9 11.5 2.4 4.5 1.9 4.8 5.0 7.5 3.3 1.4 8.0 4.8 10.0 12.9 6.1 9.4 4.7 5.1 2.9 1.1 11.2 1.3 5.6 0.9 6.1 3.4 7.0 2.9 7.6 10.4 2.3 6.6 5.4 10.0 7.8 1.4 9.9 4.4 2.8 10.2 2.5 8.4 11.8 2.7 7.0 5.0 8.3 5.8 9.9 6.8 3.5 13.6 6.1 7.6 8.2 15.0 3.6 4.1 5.7 13.8 9.6 1.7 6.5 4.8 1.3 0.1 0.8 0.6 3.7 1.3 4.7 2.8 3.5 1.7 2.7 4.0 5.4 2.8 0.3 4.5 1.7 3.6 3.2 1.6 11.6 17.4 19.6 18.4 12.6 11.0 18.5 11.8 15.4 15.0 14.9 9.6 0.8 4.9 3.7 20.0 15.7 0.0 16.0 13.6 8.7 19.6 5.5 8.3 3.3 8.7 6.7 3.8 0.0 2.5 1.8 3.5 4.6 8.1 11.0 3.2 25.4 7.5 8.0 4.1 5.8 9.8 4.1 5.0 2.8 9.7 14.7 3.3 2.9 6.3 5.1 24.3 6.5 4.2 19.5 12.9 2.0 3.4 6.9 8.3 3.1 FBRSL1 KIAA1545 ENSG00000112787 "Fibrosin like 1" Q9HCM7 12 132489551-132585188 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 34.7" "Low region specificity" "Detected in all" HPA049880 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA049880: AB_2680930" "unprognostic (2.02e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-2)" "unprognostic (7.75e-2)" "unprognostic (3.21e-1)" "unprognostic (2.59e-2)" "unprognostic (1.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-3)" "prognostic unfavorable (9.82e-4)" "prognostic favorable (1.17e-4)" "unprognostic (1.13e-1)" "unprognostic (3.39e-1)" "unprognostic (1.09e-2)" "prognostic favorable (7.21e-4)" 7.6 4.7 4.3 4.9 6.6 5.2 3.2 13.0 9.9 3.4 4.9 2.9 2.9 7.0 4.8 4.6 4.5 4.7 9.6 4.4 4.8 3.1 4.3 5.2 4.2 4.5 9.8 5.5 5.1 12.7 3.9 7.9 4.5 4.5 5.4 1.8 5.0 9.7 4.4 17.9 4.7 7.3 2.9 2.9 10.9 6.1 6.1 4.5 8.0 4.0 2.9 8.6 4.5 3.2 2.8 3.6 4.1 2.0 0.7 1.9 0.9 4.6 7.5 3.4 6.0 1.4 1.8 26.1 4.4 1.1 2.8 1.7 13.6 2.7 7.0 7.7 1.3 2.5 8.7 3.6 2.2 0.9 6.1 18.5 9.0 4.3 10.3 3.0 9.4 9.8 1.6 4.2 2.8 1.9 2.5 2.7 6.0 19.5 1.6 1.2 11.9 12.2 34.7 9.4 3.1 13.2 19.3 3.9 4.9 2.3 4.3 13.9 10.7 4.2 6.6 5.3 1.5 7.2 9.7 4.3 3.1 8.0 5.8 5.5 9.5 4.9 4.6 3.5 9.5 3.9 2.3 1.5 4.1 1.2 1.3 1.3 2.8 1.2 1.2 1.2 2.6 1.1 1.6 1.7 0.7 2.0 3.6 1.9 0.9 4.3 6.6 13.0 9.9 4.8 3.1 9.8 5.5 4.5 4.5 3.0 6.9 0.8 5.2 8.1 22.6 11.3 5.1 5.3 3.4 10.4 39.3 5.8 6.6 5.3 1.3 6.2 15.4 23.3 6.5 4.7 5.2 12.1 1.1 16.3 5.8 11.1 29.7 8.6 12.1 0.4 15.0 8.0 5.0 4.6 19.2 8.6 8.3 15.9 14.5 4.9 22.2 6.5 5.1 6.3 6.1 9.2 9.6 5.7 17.7 7.6 FBXL14 "Fbl14, MGC40195" ENSG00000171823 "F-box and leucine rich repeat protein 14" Q8N1E6 12 1565993-1594165 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Early spermatids: 38.0;Late spermatids: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053889 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA053889: AB_2682293" "unprognostic (8.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.82e-1)" "unprognostic (4.00e-1)" "unprognostic (2.66e-1)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.27e-1)" "unprognostic (5.90e-2)" "unprognostic (8.98e-2)" "prognostic favorable (9.04e-6)" "unprognostic (5.60e-3)" "unprognostic (1.76e-1)" "unprognostic (9.99e-2)" "unprognostic (3.12e-3)" 6.0 6.0 12.5 8.1 13.0 7.4 4.9 10.2 15.8 5.9 11.7 9.3 4.2 7.3 5.1 3.4 7.2 9.2 7.5 5.7 11.4 9.3 5.4 4.8 6.2 10.4 9.7 7.2 6.8 17.4 9.9 11.3 6.2 7.9 5.2 5.3 6.2 8.2 6.8 3.4 3.6 8.0 3.7 10.5 8.9 14.1 20.1 9.9 21.2 9.4 1.8 6.2 6.3 19.4 3.8 0.6 2.2 0.5 2.4 4.6 0.5 7.8 11.5 3.4 6.0 3.0 3.1 10.1 1.8 3.3 1.7 1.9 12.1 10.4 10.8 2.1 2.0 2.9 5.5 2.8 4.2 0.3 17.8 13.1 13.3 3.3 3.8 3.9 10.0 9.8 4.8 2.0 3.2 2.7 3.1 3.0 9.4 5.4 30.9 2.1 8.6 10.0 5.0 14.3 4.5 4.8 8.8 5.5 6.8 2.8 7.3 6.5 6.4 4.3 6.8 6.7 3.7 5.2 8.4 4.2 3.9 11.9 4.8 6.3 3.6 3.9 13.4 8.2 6.0 5.8 2.2 0.5 0.0 0.4 0.4 0.4 0.9 1.4 1.5 0.6 3.8 1.5 0.7 1.1 2.4 0.5 0.6 4.6 0.5 12.5 13.0 10.2 15.8 11.4 9.3 9.7 7.2 7.9 9.9 0.0 0.0 0.0 0.4 0.0 3.9 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 38.0 1.0 0.7 0.0 0.5 0.1 0.3 0.6 0.0 0.9 0.6 9.5 0.0 3.1 0.3 69.2 0.3 0.4 0.0 1.0 0.7 2.7 0.2 0.0 1.4 0.6 2.9 0.0 0.0 1.2 0.2 0.0 0.1 0.0 1.1 0.2 FBXL2 "FBL2, FBL3" ENSG00000153558 "F-box and leucine rich repeat protein 2" Q9UKC9 3 33277025-33403662 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 23.6;Early spermatids: 41.5;Late spermatids: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 8.9;LHCN-M2: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061783 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA061783: AB_2684605" "unprognostic (5.73e-2)" "unprognostic (4.47e-2)" "unprognostic (7.92e-2)" "unprognostic (7.21e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.10e-2)" "unprognostic (2.09e-1)" "unprognostic (3.16e-1)" "unprognostic (2.00e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "prognostic favorable (3.35e-4)" "unprognostic (3.30e-3)" "unprognostic (9.72e-2)" "unprognostic (4.28e-2)" "unprognostic (5.90e-2)" 3.2 5.2 8.0 2.2 15.0 1.9 4.1 7.2 18.1 3.7 2.9 4.1 1.8 3.2 5.2 8.2 2.3 6.0 3.0 2.7 8.7 11.3 5.5 1.4 4.6 1.8 6.6 13.4 4.5 3.5 7.7 16.1 5.5 13.1 4.3 1.5 6.4 3.1 6.5 1.5 2.9 2.0 3.5 4.5 2.3 2.5 4.3 2.8 0.0 8.6 0.6 1.5 2.6 2.5 1.3 0.9 2.8 1.0 0.9 1.1 0.1 3.9 1.1 1.6 1.8 2.3 3.8 0.6 3.1 2.5 2.8 4.1 0.8 4.7 0.2 0.9 2.0 1.3 1.0 1.4 3.4 1.9 0.4 1.9 0.7 3.2 0.8 2.8 0.3 0.7 1.5 2.5 1.8 1.3 8.9 5.0 2.8 0.9 0.3 9.4 0.4 0.8 0.7 1.2 0.5 0.9 0.1 1.0 0.1 7.1 1.1 2.0 2.0 1.3 0.8 2.3 2.7 2.2 1.2 3.9 1.4 1.3 1.1 1.7 0.4 0.2 0.2 1.3 0.3 0.9 1.5 1.0 0.7 0.9 0.5 0.7 0.5 0.7 0.9 0.3 1.3 1.1 1.1 2.8 0.9 0.7 0.9 0.4 0.1 8.0 15.0 7.2 18.1 8.7 11.3 6.6 13.4 13.1 2.8 3.0 8.2 0.0 5.1 1.0 16.5 2.0 2.5 13.4 4.5 5.2 23.6 0.4 3.3 3.5 41.5 2.2 0.0 0.0 0.3 1.0 3.6 2.9 0.0 0.0 0.4 17.5 0.0 3.1 0.3 37.9 1.4 1.2 1.7 0.0 0.1 6.7 3.4 0.0 3.9 2.1 14.2 6.5 2.9 11.7 7.9 1.0 0.6 1.3 0.0 3.3 FBXO31 "FBX14, Fbx31, FBXO14, MGC15419" ENSG00000103264 "F-box protein 31" Q5XUX0 16 87326987-87392142 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA030150 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA030150: AB_10670559" "unprognostic (4.85e-1)" "unprognostic (5.76e-3)" "unprognostic (1.67e-1)" "unprognostic (1.53e-2)" "unprognostic (4.04e-1)" "unprognostic (2.25e-1)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.65e-2)" "prognostic favorable (9.16e-5)" "unprognostic (3.00e-2)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.57e-3)" "unprognostic (2.26e-3)" 25.7 11.5 10.5 6.1 12.1 5.4 22.3 39.7 18.7 10.4 14.1 5.9 9.3 9.0 13.3 7.4 10.8 11.1 6.7 17.2 8.3 8.2 5.3 11.3 5.6 6.3 6.9 10.4 13.9 13.5 8.8 16.6 5.4 8.5 9.4 6.4 7.9 10.3 12.0 50.4 8.9 11.4 14.8 4.6 5.3 8.3 9.1 5.6 4.5 6.0 7.0 5.4 12.2 22.6 2.4 0.9 1.4 0.7 0.2 3.7 1.4 4.9 9.4 3.1 8.5 16.2 9.8 9.2 8.6 8.6 8.6 4.5 8.5 4.2 11.5 9.5 9.1 4.3 7.6 6.0 7.2 5.8 5.3 11.1 3.9 5.7 23.9 9.1 3.7 3.3 11.6 6.1 11.2 10.6 5.6 5.2 6.0 11.0 4.5 4.5 7.1 8.7 5.0 6.1 5.1 8.4 11.3 3.7 4.9 3.8 3.5 14.6 7.1 19.2 3.9 5.9 2.4 6.1 3.2 7.2 8.3 6.3 7.8 6.7 10.5 8.1 14.3 6.6 6.9 5.1 1.4 0.6 0.2 1.0 0.6 1.8 2.4 1.7 2.4 0.4 1.6 1.8 1.9 0.9 0.2 0.7 0.9 3.7 1.4 10.5 12.1 39.7 18.7 8.3 8.2 6.9 10.4 8.5 5.6 0.0 2.9 3.7 4.3 13.1 12.3 19.4 0.0 4.0 1.2 5.2 31.4 8.8 0.0 3.1 6.9 8.4 17.0 0.0 4.3 2.7 7.1 3.8 0.0 23.7 3.5 0.0 8.6 3.7 5.1 22.2 7.5 1.9 3.3 4.6 10.4 3.9 3.7 11.5 10.6 4.4 11.8 19.4 9.0 13.5 5.1 11.3 6.1 5.0 13.6 3.5 FBXO41 "Fbx41, KIAA1940" ENSG00000163013 "F-box protein 41" Q8TF61 2 73254682-73284431 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 10.8;Horizontal cells: 6.4;Intestinal endocrine cells: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055246, HPA058386" Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA055246: AB_2682758, HPA058386: AB_2683701" "unprognostic (1.15e-3)" "unprognostic (9.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (5.76e-4)" "unprognostic (1.74e-2)" "unprognostic (5.85e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-1)" "unprognostic (7.97e-3)" "unprognostic (7.55e-2)" "unprognostic (9.13e-3)" "unprognostic (4.35e-2)" "prognostic unfavorable (1.08e-5)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-2)" 1.5 3.6 21.9 5.9 19.3 4.2 2.1 21.7 33.3 1.2 2.1 1.7 0.9 2.2 1.9 3.6 1.6 2.0 2.7 1.1 18.8 10.6 0.8 1.1 2.2 9.4 5.9 17.8 2.5 4.1 9.8 7.3 1.1 6.8 3.0 2.4 0.8 3.7 3.3 0.6 3.4 2.7 2.1 2.1 7.5 2.5 2.4 3.5 2.1 1.5 0.0 9.0 2.8 0.8 0.5 0.9 0.0 2.6 1.1 0.7 0.4 3.6 1.8 0.6 0.0 0.1 0.1 0.8 0.7 0.6 1.2 1.5 4.1 2.1 27.0 0.1 0.1 2.7 3.0 3.8 2.4 1.2 11.2 0.3 8.2 4.1 1.7 0.9 12.4 6.3 1.5 0.9 0.0 0.9 3.3 0.2 7.4 1.6 4.4 1.2 0.9 4.3 11.6 2.7 1.3 1.6 15.2 7.0 13.1 0.8 1.3 9.4 3.5 4.6 2.0 2.9 0.2 2.6 5.2 0.2 4.2 3.7 3.8 0.7 5.3 2.2 12.8 1.1 13.7 1.7 0.0 0.5 0.0 0.6 2.6 0.7 0.5 0.4 0.0 0.9 0.2 0.4 0.4 0.0 1.1 0.1 0.7 0.2 0.4 21.9 19.3 21.7 33.3 18.8 10.6 5.9 17.8 6.8 3.5 0.0 1.1 1.7 0.3 0.2 10.8 1.7 2.5 1.4 0.0 1.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.2 0.1 0.6 0.7 2.3 0.0 1.7 6.4 11.5 1.3 2.6 0.9 0.3 0.9 1.7 1.8 0.0 0.6 1.0 0.0 0.7 0.0 2.2 0.0 0.5 0.5 1.7 0.3 0.0 1.3 0.4 0.1 FBXO46 "20D7-FC4, Fbx46, FBXO34L" ENSG00000177051 "F-box protein 46" Q6PJ61 19 45710629-45730904 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049390 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA049390: AB_2680742" "unprognostic (9.02e-3)" "unprognostic (1.01e-2)" "unprognostic (2.82e-2)" "prognostic unfavorable (2.13e-5)" "unprognostic (9.33e-2)" "prognostic favorable (5.44e-4)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.08e-1)" "unprognostic (2.06e-1)" "unprognostic (6.13e-2)" "prognostic favorable (8.11e-4)" "unprognostic (9.77e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (5.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.27e-2)" "prognostic favorable (5.09e-6)" 7.4 7.4 13.8 12.9 13.1 10.4 9.8 10.4 15.7 11.2 10.3 8.6 10.6 9.6 15.7 10.0 20.7 10.7 7.3 8.7 13.3 4.8 7.6 10.5 7.7 17.2 13.9 10.1 17.1 12.6 8.4 10.4 12.3 10.2 10.1 9.7 8.6 11.0 9.0 12.8 12.8 11.4 10.9 9.7 15.8 13.3 11.5 13.0 13.6 12.8 9.2 17.1 10.0 12.4 5.9 2.6 7.1 2.3 1.1 3.7 1.2 7.0 11.0 8.5 9.9 2.2 4.0 9.7 3.7 2.1 2.9 3.4 9.1 9.3 12.3 5.0 2.0 4.2 10.3 6.3 4.7 2.2 15.1 13.3 10.0 37.1 4.9 3.3 4.4 12.9 3.3 4.3 5.0 3.1 7.5 4.4 15.3 7.8 15.0 2.4 6.7 10.2 5.1 5.4 6.6 3.8 13.8 4.7 11.4 3.5 8.5 8.5 7.5 5.9 12.5 4.9 8.5 10.6 5.5 4.9 6.3 5.7 3.4 6.0 14.4 19.9 8.2 7.0 6.2 5.1 7.1 2.3 2.3 3.7 1.8 2.5 4.0 2.8 2.5 1.5 5.9 2.6 3.0 6.7 1.1 2.1 2.6 2.6 1.2 13.8 13.1 10.4 15.7 13.3 4.8 13.9 10.1 10.2 13.0 8.9 4.5 6.0 9.3 23.1 2.8 4.5 7.6 5.3 4.5 7.0 2.0 7.1 1.7 5.5 2.3 4.5 10.4 0.0 4.2 13.6 3.8 7.1 3.5 16.3 3.1 11.1 7.0 4.9 4.3 2.2 5.2 3.6 5.0 3.6 11.7 4.0 5.8 11.8 1.8 1.7 2.7 0.0 3.9 6.0 3.8 31.2 10.4 4.8 8.6 9.6 FBXW11 "BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696" ENSG00000072803 "F-box and WD repeat domain containing 11" Q9UKB1 5 171861549-172006873 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072204 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA072204: AB_2686493" "unprognostic (4.04e-3)" "unprognostic (1.27e-1)" "unprognostic (2.69e-2)" "unprognostic (5.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (6.87e-2)" "unprognostic (9.43e-2)" "unprognostic (1.53e-1)" "unprognostic (8.14e-3)" "unprognostic (2.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.54e-1)" "unprognostic (3.76e-3)" "unprognostic (1.76e-1)" 15.0 17.1 28.1 11.5 29.4 7.9 17.2 29.7 34.4 17.5 11.2 24.7 9.4 10.2 19.2 10.7 20.0 22.7 14.5 30.3 28.9 26.3 19.5 16.5 14.0 14.0 28.8 20.1 21.8 24.1 37.8 15.8 11.2 23.3 16.2 13.3 12.4 11.6 18.1 24.5 11.0 10.3 21.6 30.6 13.6 15.8 11.3 21.2 12.0 17.5 7.0 17.0 12.9 16.0 9.0 8.2 19.1 7.0 12.9 6.2 5.5 15.8 16.3 24.3 21.2 19.1 19.5 12.4 17.1 24.6 21.5 26.9 16.7 10.8 14.6 21.1 21.9 34.2 10.5 17.4 25.8 35.8 19.3 17.3 11.8 17.0 12.8 17.4 13.1 16.9 14.0 18.0 17.2 28.3 23.0 17.8 12.8 7.3 14.7 26.0 11.9 9.1 6.9 9.3 9.4 18.2 13.4 20.5 9.9 16.5 13.5 10.2 17.9 15.1 12.8 31.5 19.1 16.0 14.1 15.5 21.3 10.6 12.8 16.8 15.1 17.0 10.2 14.9 12.6 16.1 19.1 7.0 6.5 5.7 4.7 6.2 8.7 4.9 5.7 6.9 9.0 4.7 5.8 6.7 12.9 5.1 8.2 5.3 5.5 28.1 29.4 29.7 29.9 28.9 26.3 28.8 20.1 23.3 21.2 23.8 16.8 19.4 11.2 16.9 36.7 51.5 45.9 10.7 20.5 26.2 7.9 7.3 36.5 28.4 22.6 21.7 20.1 23.3 31.8 6.4 15.5 19.1 19.7 38.4 11.3 33.4 27.6 25.2 23.9 30.0 27.3 14.9 11.8 18.0 18.3 56.5 43.0 15.8 26.9 26.9 29.9 45.3 18.9 29.7 15.2 20.7 10.1 17.1 15.1 32.6 FCMR "FAIM3, TOSO" ENSG00000162894 "Fc fragment of IgM receptor" O60667 1 206904386-206923247 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9" "Group enriched" "Detected in many" 11 "B-cells: 125.3;T-cells: 41.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 99.6;T-cells: 60.0" "Group enriched" "Detected in some" 5 "RPMI-8226: 53.0;U-266/70: 26.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA003910 Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 2400000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA003910: AB_1078798" "prognostic favorable (4.23e-4)" "unprognostic (1.16e-3)" "unprognostic (7.48e-2)" "unprognostic (3.06e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-3)" "unprognostic (1.15e-1)" "unprognostic (4.85e-3)" "unprognostic (1.03e-1)" "unprognostic (3.97e-1)" "unprognostic (3.23e-2)" "unprognostic (2.01e-1)" "unprognostic (8.15e-3)" "unprognostic (8.06e-2)" "unprognostic (2.12e-2)" "unprognostic (3.74e-2)" "unprognostic (5.05e-3)" 15.5 0.6 0.5 42.9 0.5 2.9 1.5 0.4 0.4 0.8 2.5 0.4 0.3 1.2 1.2 0.8 3.4 1.3 2.6 1.0 0.5 0.5 2.4 1.5 3.9 77.2 0.5 0.0 1.3 0.7 0.0 0.9 0.8 0.2 1.4 2.3 1.3 10.1 0.3 1.9 0.6 30.1 0.4 0.6 78.8 2.8 0.5 0.0 51.8 1.8 1.2 84.9 8.5 1.2 99.6 1.4 5.3 0.4 18.4 60.0 28.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.1 0.0 0.0 3.4 0.0 0.1 0.3 0.1 0.0 0.4 0.2 0.0 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 2.7 0.0 7.4 0.0 0.1 1.0 0.1 0.0 0.0 0.0 1.7 0.2 53.0 0.0 0.1 0.0 0.0 1.0 0.2 5.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 26.7 1.9 7.4 0.3 0.0 0.2 0.5 0.2 0.2 20.3 0.4 26.4 80.3 28.1 26.2 0.2 99.6 49.5 33.3 5.3 18.4 0.3 1.4 60.0 28.2 0.5 0.5 0.4 0.4 0.5 0.5 0.5 0.0 0.2 0.0 0.0 4.6 125.3 3.9 0.0 0.0 3.0 7.6 1.4 2.3 0.0 0.0 0.0 0.0 1.3 0.1 0.1 0.0 0.0 2.6 0.1 0.6 2.6 0.0 1.1 3.8 0.0 0.0 5.5 5.1 0.0 0.3 1.2 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.3 0.1 1.0 0.0 0.0 41.7 1.2 7.1 FEM1A ENSG00000141965 "Fem-1 homolog A" Q9BSK4 19 4791681-4801273 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 103.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016565, HPA063622" Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA016565: AB_1848489, HPA063622: AB_2685063" "unprognostic (4.62e-2)" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" "unprognostic (3.60e-1)" "unprognostic (2.42e-3)" "unprognostic (2.04e-1)" "unprognostic (6.74e-2)" "unprognostic (1.25e-2)" "unprognostic (9.21e-2)" "unprognostic (2.28e-3)" "unprognostic (6.25e-2)" "unprognostic (6.18e-5)" "unprognostic (3.72e-3)" "unprognostic (1.25e-1)" "unprognostic (1.91e-1)" "unprognostic (4.70e-2)" 3.0 2.4 3.3 2.2 4.4 3.3 4.0 4.1 5.0 2.0 2.7 3.0 0.9 2.2 2.7 4.0 4.2 2.1 1.9 8.6 3.3 2.6 2.2 4.4 2.3 3.8 3.2 2.5 2.1 4.2 4.4 2.3 4.5 3.1 2.8 2.0 2.7 3.1 2.1 103.9 6.9 2.3 2.3 2.2 2.7 2.2 2.2 3.2 4.2 2.1 18.6 3.0 2.5 2.3 7.2 6.8 9.1 8.2 6.8 6.9 4.2 7.2 5.0 4.7 10.1 5.2 3.1 6.8 4.3 3.6 7.0 4.9 7.8 3.3 8.2 4.4 5.3 3.8 7.5 8.2 7.2 4.6 9.7 9.4 8.0 4.0 5.8 7.9 13.2 10.3 4.5 11.1 5.4 7.8 3.3 5.0 11.3 11.7 15.8 4.8 7.3 11.0 4.8 14.4 4.5 12.1 10.3 6.1 8.6 6.3 9.3 15.2 10.8 5.7 10.8 8.1 3.8 8.3 11.5 7.0 6.4 4.6 10.0 11.4 18.4 15.2 7.1 6.6 9.5 9.0 9.1 7.3 7.1 6.9 8.2 6.0 5.3 5.5 6.3 6.8 7.2 5.0 5.7 6.6 6.8 7.3 6.6 3.9 4.2 3.3 4.4 4.1 5.0 3.3 2.6 3.2 2.5 3.1 3.2 23.8 42.3 20.9 12.5 17.9 16.3 5.6 7.6 16.0 21.6 1.8 15.7 18.1 11.6 9.6 4.0 8.8 10.0 23.3 10.1 12.1 7.1 11.5 22.0 13.9 11.0 11.1 12.6 14.1 17.0 2.7 8.3 8.1 3.3 15.4 14.8 11.4 9.9 7.0 7.8 7.9 17.0 6.5 10.3 12.1 5.7 25.7 22.7 12.1 11.9 15.0 FERMT2 "KIND2, mig-2, PLEKHC1, UNC112B" ENSG00000073712 "Fermitin family member 2" Q96AC1 14 52857268-52952435 "Predicted intracellular proteins" "Cell adhesion, Cell shape, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "MAIT T-cell: 3.8" "Lineage enriched" "Detected in single" 39 "T-cells: 3.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040505, HPA072965" Uncertain Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 58000 "Focal adhesion sites" "Nucleoplasm, Cytosol" "HPA040505: AB_10673300, HPA072965: " "unprognostic (4.38e-2)" "unprognostic (4.25e-2)" "unprognostic (8.00e-3)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "unprognostic (4.89e-3)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.58e-1)" "unprognostic (1.99e-1)" "unprognostic (3.87e-2)" "unprognostic (3.96e-3)" "unprognostic (7.69e-2)" "unprognostic (3.14e-1)" "unprognostic (1.73e-3)" 45.9 7.2 15.5 12.3 14.3 0.1 24.4 7.9 12.8 24.1 36.6 12.7 16.0 4.2 41.6 14.2 20.6 22.2 22.2 21.8 18.3 7.5 18.4 35.3 18.1 5.4 15.0 9.1 23.3 6.7 5.8 7.2 37.9 10.7 24.1 11.5 11.0 7.1 41.3 14.5 5.0 11.0 56.7 12.9 11.7 21.4 10.2 15.5 0.6 13.3 6.2 2.1 49.5 16.5 0.0 0.0 0.0 0.0 0.0 3.8 0.0 4.8 4.3 22.8 10.4 37.3 30.7 19.0 32.6 21.1 38.8 24.5 7.3 3.9 0.0 11.1 33.3 7.6 2.1 17.7 2.4 29.2 0.0 4.9 6.8 19.5 8.6 47.9 0.1 2.8 29.5 5.2 21.3 28.3 17.7 20.0 3.7 0.1 34.4 29.0 5.9 1.6 0.1 14.4 0.0 11.3 0.8 23.2 0.0 13.6 4.5 1.4 29.3 34.5 7.7 8.0 24.2 6.7 0.2 25.0 30.6 21.0 24.3 12.0 5.1 6.1 0.1 7.0 0.0 7.3 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 14.3 7.9 12.4 18.3 7.5 15.0 9.1 10.7 15.5 71.5 50.2 0.0 111.7 16.6 32.8 53.2 20.4 14.7 37.5 38.4 35.3 69.7 26.6 48.1 59.4 87.9 0.0 0.0 28.6 138.3 102.2 34.3 56.6 71.6 9.0 14.3 0.0 120.9 9.2 20.6 69.3 6.2 43.9 8.2 0.0 57.0 23.6 0.0 164.4 37.4 57.4 148.8 146.8 3.4 10.0 7.0 85.8 4.3 0.0 35.6 FES FPS ENSG00000182511 "FES proto-oncogene, tyrosine kinase" P07332 15 90883695-90895776 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.8;lymphoid tissue: 49.7" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 40.6;Kupffer cells: 93.1;Macrophages: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 60.8" "Group enriched" "Detected in many" 4 "dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5" "Cell line enhanced" "Detected in many" "HEL: 21.3;HL-60: 19.0;HMC-1: 40.7;NB-4: 24.9;THP-1: 37.4;U-937: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001376 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA001376: AB_1078847" "unprognostic (1.07e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (2.31e-2)" "unprognostic (4.05e-3)" "unprognostic (7.33e-2)" "unprognostic (1.74e-1)" "unprognostic (2.22e-1)" "unprognostic (1.58e-3)" "unprognostic (1.35e-1)" "unprognostic (4.66e-2)" "unprognostic (5.15e-3)" "unprognostic (1.78e-3)" "unprognostic (2.53e-3)" "unprognostic (6.08e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-1)" 14.9 3.4 4.8 9.7 4.1 38.3 12.7 2.4 5.7 6.8 5.4 3.2 4.7 3.0 7.4 5.6 4.9 7.6 7.3 7.9 4.2 2.2 5.2 11.8 12.7 23.3 3.7 0.9 6.4 3.7 1.8 2.7 8.1 7.2 7.7 2.4 5.3 33.8 6.3 3.4 3.5 5.2 5.4 6.9 49.7 4.3 3.2 4.7 3.1 7.2 4.1 4.5 7.2 9.4 1.1 32.6 60.8 30.5 9.3 0.1 13.8 0.1 0.2 0.3 3.6 1.0 3.1 6.1 0.9 0.0 1.8 1.0 0.9 0.0 2.3 0.1 2.0 0.0 0.5 0.6 0.1 0.5 1.2 0.3 21.3 0.0 3.8 2.1 19.0 40.7 3.1 0.0 2.6 0.0 0.0 10.8 3.2 0.6 0.0 0.0 6.9 0.6 24.9 1.0 0.8 0.0 2.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.9 1.1 0.0 37.4 8.4 0.0 3.7 0.1 0.0 0.0 2.7 0.8 0.1 16.1 0.8 10.4 30.5 60.8 0.1 17.6 0.0 1.1 0.0 0.0 32.6 0.9 0.0 0.0 20.0 9.3 7.3 12.9 0.0 13.8 4.8 4.1 2.4 5.7 4.2 2.2 3.7 0.9 7.2 4.7 3.0 8.0 6.4 4.7 3.4 0.0 2.5 5.1 0.0 0.0 1.8 0.0 4.5 3.3 4.8 1.1 24.5 0.4 0.0 3.9 3.8 6.2 4.0 28.8 8.2 40.6 0.0 2.9 22.7 93.1 4.7 8.3 37.3 6.8 27.1 2.1 2.3 2.0 0.0 9.6 1.3 1.9 12.9 7.2 3.5 9.1 2.5 3.8 10.2 2.6 5.2 FGF5 ENSG00000138675 "Fibroblast growth factor 5" P12034 4 80266599-80336680 "Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 38.2" "Cell type enhanced" "Detected in some" 16 "Club cells: 1.2;Distal tubular cells: 1.7;Proximal tubular cells: 2.6" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "cerebellum: 38.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 20.2;BJ hTERT+: 38.1;fHDF/TERT166: 27.5;HBF TERT88: 28.7;LHCN-M2: 25.7;U-138 MG: 35.6;U-251 MG: 17.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB010313, HPA042442" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Secreted in brain" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010313: AB_2102677, HPA042442: AB_2678001" "unprognostic (6.44e-2)" "unprognostic (6.24e-3)" "unprognostic (8.49e-4)" "unprognostic (1.10e-1)" "unprognostic (2.91e-1)" "unprognostic (2.80e-3)" "unprognostic (6.87e-4)" "unprognostic (2.53e-1)" "unprognostic (1.69e-1)" "unprognostic (3.57e-3)" "unprognostic (1.17e-2)" "unprognostic (3.33e-16)" "unprognostic (3.02e-3)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" 0.1 0.1 0.1 1.7 0.1 0.5 0.1 38.2 1.3 0.1 3.1 0.0 0.0 0.4 0.4 0.1 1.3 0.1 9.2 0.3 1.6 0.2 2.3 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 1.3 0.1 4.1 0.2 0.1 0.0 0.1 0.0 0.5 0.4 2.8 2.4 0.3 0.1 0.8 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.7 1.7 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 2.0 7.2 0.0 20.2 38.1 5.3 3.9 0.0 0.0 0.0 0.0 27.5 0.4 0.0 0.0 7.0 28.7 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.0 2.0 0.0 15.6 7.5 9.0 1.8 0.0 0.0 0.1 25.7 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 6.5 35.6 1.4 1.7 17.0 0.0 0.0 0.0 2.0 0.0 0.7 1.7 0.3 0.3 0.4 0.2 0.5 0.2 0.3 0.4 0.2 0.7 0.5 0.5 0.9 0.2 0.2 0.7 0.2 0.0 0.1 0.1 38.2 1.3 1.6 0.2 0.2 0.2 4.1 0.1 0.0 0.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGFR2 "BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25" ENSG00000066468 "Fibroblast growth factor receptor 2" P21802 10 121478334-121598458 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.8" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 191.1;Club cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 10.8;eosinophil: 4.6" "Lineage enriched" "Detected in single" 35 "granulocytes: 10.8" "Cell line enhanced" "Detected in some" "AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010886, HPA035305" Uncertain Supported "Nucleoplasm,Vesicles,Cell Junctions" "Secreted - unknown location" NA NA 500000 "Cell Junctions" "Nucleoplasm, Vesicles" "CAB010886: AB_259379, HPA035305: AB_10672862" "unprognostic (5.53e-2)" "prognostic favorable (8.79e-4)" "unprognostic (1.08e-1)" "unprognostic (5.23e-2)" "unprognostic (1.73e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.53e-1)" "unprognostic (4.96e-3)" "unprognostic (1.74e-1)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "unprognostic (2.54e-1)" "unprognostic (6.93e-2)" "unprognostic (2.25e-1)" 2.1 8.8 16.4 3.0 30.3 0.0 9.9 15.8 21.3 6.8 14.1 55.7 5.6 4.2 22.0 6.6 10.2 12.5 12.5 1.4 20.6 11.1 11.4 16.1 13.1 1.0 41.2 13.3 7.4 12.8 25.5 2.5 6.2 30.2 11.7 8.7 16.4 23.8 24.3 0.4 45.4 4.7 18.3 74.8 0.5 9.3 2.9 32.1 0.8 23.4 1.6 3.4 6.9 8.5 0.1 0.1 10.8 0.1 0.1 0.3 0.0 2.2 0.1 9.2 58.9 0.0 0.0 19.8 0.1 0.0 0.0 0.0 15.4 0.3 0.0 4.2 0.9 0.0 17.8 19.1 4.0 0.0 0.0 4.1 0.0 0.0 0.3 0.4 0.0 3.8 0.0 8.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 18.9 2.7 0.0 0.0 0.0 2.3 5.7 5.0 0.1 0.1 0.1 10.8 0.0 11.5 15.8 0.0 0.0 0.1 2.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 10.8 0.1 4.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 16.4 30.3 15.8 21.3 20.6 11.1 41.2 13.3 30.2 32.1 17.9 31.8 0.0 29.5 35.6 0.0 2.7 191.1 18.7 52.4 34.9 0.0 12.6 0.0 4.0 2.9 0.5 2.6 0.0 0.2 2.7 17.5 9.8 0.0 4.3 2.0 0.0 2.4 3.1 0.3 6.5 1.1 1.3 5.0 1.0 32.0 1.6 0.6 1.4 5.6 11.5 0.1 0.0 2.1 0.9 7.7 24.2 3.3 1.5 3.0 27.7 FKBP14 "FKBP22, FLJ20731" ENSG00000106080 "FK506 binding protein 14" Q9NWM8 7 30010587-30026684 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Isomerase, Rotamase" "Deafness, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013329, HPA026829" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA Cytosol "Nucleoplasm, Golgi apparatus" "HPA013329: AB_1848613, HPA026829: AB_10601651" "prognostic unfavorable (1.60e-4)" "unprognostic (1.12e-3)" "unprognostic (6.84e-2)" "unprognostic (1.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.41e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (6.06e-2)" "unprognostic (7.00e-2)" "unprognostic (6.99e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-1)" "unprognostic (1.93e-3)" "prognostic unfavorable (4.57e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-3)" "prognostic unfavorable (4.25e-4)" 8.8 7.4 8.7 9.2 7.3 5.1 8.8 17.6 7.7 14.9 7.8 4.1 6.9 4.2 12.1 14.2 8.0 8.1 8.5 9.8 7.1 5.2 5.4 9.2 7.6 8.1 9.2 5.2 13.0 9.8 8.6 27.8 10.7 7.1 9.8 6.9 8.4 7.6 10.9 3.3 6.4 5.3 18.8 8.1 6.7 7.2 4.2 7.1 2.6 5.6 5.9 7.7 13.4 8.7 1.6 3.3 2.7 1.2 1.0 1.6 0.6 3.4 2.6 7.4 17.2 19.3 24.8 3.4 17.7 16.6 6.2 12.1 2.2 2.2 1.2 8.4 15.5 7.6 7.6 4.1 6.4 12.4 0.6 5.9 2.8 5.0 6.5 9.8 2.0 4.9 15.5 6.7 10.8 12.8 14.6 13.7 1.8 4.5 2.6 11.1 1.4 1.0 2.4 3.9 3.8 4.8 0.0 5.0 4.0 6.1 3.1 1.9 6.5 6.2 14.2 4.3 9.2 3.2 2.6 11.0 6.6 7.7 11.3 7.0 3.9 4.0 2.1 9.4 1.9 20.6 1.9 1.2 1.2 1.3 0.8 1.0 1.1 1.6 1.1 2.2 1.6 1.5 1.3 2.7 1.0 0.5 3.3 1.4 0.6 8.7 7.3 17.6 7.7 7.1 5.2 9.2 5.2 7.1 7.1 17.9 16.5 3.7 19.2 24.4 15.5 13.5 7.6 2.7 10.3 17.4 25.5 9.5 1.7 6.7 0.3 7.4 3.3 0.0 3.2 24.1 26.4 15.0 2.3 6.6 5.3 14.3 1.2 8.6 2.8 0.0 12.0 5.8 10.1 2.8 7.9 31.5 5.3 14.4 19.4 2.9 19.8 6.5 10.5 0.7 3.3 15.9 13.2 4.3 4.8 24.8 FKRP "LGMD2I, MDC1C" ENSG00000181027 "Fukutin related protein" Q9H9S5 19 46746046-46776988 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cardiomyopathy, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043115, HPA060454" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA043115: AB_2678324, HPA060454: AB_2684281" "unprognostic (4.44e-2)" "unprognostic (5.20e-2)" "unprognostic (2.19e-2)" "unprognostic (8.37e-3)" "unprognostic (1.83e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "unprognostic (2.99e-2)" "unprognostic (4.59e-3)" "prognostic favorable (8.98e-4)" "unprognostic (3.53e-1)" "unprognostic (2.30e-2)" "unprognostic (2.53e-1)" "unprognostic (2.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.53e-2)" 13.7 10.7 12.4 12.5 17.5 12.6 9.6 7.4 25.2 10.5 11.5 12.8 13.7 7.8 15.7 8.7 8.3 12.7 10.1 13.1 9.8 12.2 10.7 10.8 11.6 11.0 11.5 11.1 13.3 13.2 12.9 16.9 16.5 14.1 13.6 7.3 13.0 17.8 13.2 23.6 9.6 9.7 13.4 9.1 14.7 10.3 13.0 11.1 8.8 13.5 7.8 7.9 12.3 10.2 6.9 5.0 5.4 4.2 5.6 4.5 2.4 8.4 18.1 12.4 8.7 11.0 12.2 11.1 21.6 14.6 8.9 14.0 11.5 14.7 7.6 12.1 12.4 14.7 9.0 4.6 10.1 8.2 14.9 15.4 8.0 8.7 7.2 9.7 6.2 13.8 13.5 8.7 10.9 10.7 10.4 11.6 4.2 8.0 7.7 8.9 3.8 4.5 15.2 12.1 5.3 4.5 12.3 7.7 2.8 5.6 18.1 8.5 16.2 10.8 5.3 7.1 8.6 6.4 4.9 11.9 13.2 14.0 4.8 17.3 8.2 9.8 7.2 10.7 5.0 17.6 3.4 4.2 2.5 4.1 2.5 2.8 4.6 3.0 4.5 2.6 6.9 3.7 4.5 5.4 5.6 2.6 5.0 1.6 2.4 12.4 17.5 7.4 25.2 9.8 12.2 11.5 11.1 14.1 11.1 8.9 6.1 0.8 4.3 0.7 9.7 13.7 7.6 10.7 6.8 5.2 5.9 7.9 5.0 4.3 7.3 3.9 3.5 23.3 2.1 4.7 4.1 3.6 1.1 13.4 6.3 3.2 7.5 9.2 11.4 9.9 5.2 1.8 5.0 4.6 4.6 6.8 4.9 3.1 3.9 5.8 10.7 6.5 4.7 9.1 4.3 1.4 15.7 5.0 3.6 3.4 FLII "FLI, Fli1, FLIL, MGC39265" ENSG00000177731 "FLII, actin remodeling protein" Q13045 17 18244836-18258916 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007084, HPA008903, CAB016132" Approved Enhanced "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 1800000 "Nucleoplasm, Centriolar satellite, Cytosol" "CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640" "unprognostic (8.09e-2)" "unprognostic (1.09e-2)" "unprognostic (6.89e-2)" "unprognostic (2.53e-2)" "unprognostic (4.22e-2)" "unprognostic (4.78e-2)" "unprognostic (1.88e-2)" "unprognostic (1.23e-2)" "unprognostic (4.91e-2)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-3)" "unprognostic (4.03e-2)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.39e-2)" 21.2 16.8 8.6 16.9 12.4 16.6 21.7 11.7 11.4 17.5 18.5 12.8 14.3 14.6 17.3 16.3 25.9 13.7 15.6 28.3 9.3 7.4 19.0 18.8 17.3 13.4 15.0 6.1 15.3 20.0 15.4 13.5 15.8 13.6 17.2 10.7 11.0 21.3 17.0 78.4 14.4 18.9 19.1 11.1 20.0 15.4 15.6 11.9 21.2 15.1 25.4 17.5 21.5 16.3 5.3 16.0 12.9 24.9 5.2 7.2 10.3 58.1 21.0 6.0 9.1 13.8 12.5 9.0 16.2 19.6 18.3 11.4 26.8 13.3 11.4 17.0 18.5 10.6 26.0 8.0 26.9 10.7 9.5 12.5 6.2 15.5 10.6 15.6 6.9 13.2 11.3 16.4 14.9 22.5 11.7 17.6 10.6 5.0 4.6 10.7 17.3 10.2 5.8 6.2 25.7 11.0 10.0 26.8 14.1 13.6 16.5 2.1 3.1 18.8 16.1 8.7 39.0 27.4 5.4 21.7 16.3 16.8 31.3 19.0 4.8 3.5 3.4 15.4 6.7 8.8 4.8 13.6 12.9 7.0 21.4 7.2 5.3 5.8 7.2 16.0 3.6 4.3 4.6 12.0 5.2 24.9 4.7 6.6 10.3 8.6 12.4 11.7 11.4 9.3 7.4 15.0 6.1 13.6 11.9 56.6 34.6 18.1 20.3 20.1 16.0 33.1 25.5 45.5 44.3 24.4 17.7 22.0 13.3 53.5 34.8 28.6 52.0 0.0 48.6 24.9 20.8 27.1 45.1 16.9 44.4 25.4 23.0 27.0 42.1 5.3 30.0 48.8 15.1 55.1 23.3 10.6 95.0 43.3 32.9 17.6 11.3 32.3 21.1 39.6 18.8 17.1 21.3 28.0 32.6 31.1 FLYWCH1 DKFZp761A132 ENSG00000059122 "FLYWCH-type zinc finger 1" Q4VC44 16 2911937-2951208 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040753, HPA041001" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA040753: AB_10794880, HPA041001: AB_10794259" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" "unprognostic (2.93e-1)" "unprognostic (2.06e-3)" "unprognostic (1.71e-1)" "unprognostic (2.68e-2)" "unprognostic (3.51e-2)" "unprognostic (1.92e-1)" "unprognostic (7.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-3)" "unprognostic (6.61e-2)" "unprognostic (1.61e-1)" "unprognostic (3.84e-2)" "unprognostic (7.33e-2)" "unprognostic (2.19e-3)" "unprognostic (7.91e-2)" 15.6 16.6 13.1 12.6 17.2 12.5 10.2 24.4 27.4 13.6 12.2 17.7 9.5 14.7 14.3 13.4 11.8 11.9 15.0 16.7 12.1 15.9 10.1 5.9 10.7 11.6 15.8 18.5 21.4 12.2 22.6 12.2 9.5 18.8 13.9 4.7 25.3 14.4 15.6 28.1 22.8 14.4 14.1 16.2 19.9 11.0 5.1 10.9 8.5 11.5 8.4 10.3 17.1 15.7 4.6 1.6 2.3 1.6 0.9 5.5 2.1 5.1 18.1 4.1 12.3 6.7 6.9 12.6 9.5 7.5 4.8 4.9 3.0 16.7 12.5 25.4 7.2 7.9 10.7 3.4 6.4 1.0 20.8 10.3 4.2 15.2 10.0 15.1 5.5 14.6 6.1 20.2 10.1 7.4 8.9 6.8 8.4 9.3 13.3 3.7 12.2 12.6 6.7 6.7 3.8 12.4 22.2 6.2 22.4 5.6 3.5 8.9 8.3 10.0 10.9 12.7 2.4 8.5 10.1 12.7 8.1 7.4 15.6 6.3 19.7 16.9 11.2 8.8 9.1 9.4 2.3 1.6 0.6 3.0 0.7 4.9 2.0 4.5 5.5 1.6 4.6 3.9 3.4 0.2 0.9 0.8 1.0 2.2 2.1 13.1 17.2 24.4 27.4 12.1 15.9 15.8 18.5 18.8 10.9 0.0 3.4 2.2 9.5 11.0 41.7 10.2 10.2 4.0 2.3 21.0 33.4 15.4 1.7 6.0 0.4 11.3 5.9 0.0 5.7 6.9 10.4 4.2 0.0 5.5 7.4 31.8 2.4 11.1 13.3 0.9 10.3 5.3 8.5 9.0 4.4 16.6 5.4 3.5 13.4 4.8 36.2 0.0 15.1 0.7 3.2 12.2 7.3 7.2 6.2 5.9 FNDC11 "C20orf195, MGC5356" ENSG00000125531 "Fibronectin type III domain containing 11" Q9BVV2 20 63547891-63556708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 52.5" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 12.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 3.2;naive B-cell: 6.6" "Lineage enriched" "Detected in many" 6 "B-cells: 6.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.5;EFO-21: 4.9;HaCaT: 2.7;OE19: 3.2;SH-SY5Y: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA041341 Approved Nucleoplasm,Vesicles,Aggresome NA NA "Nucleoplasm, Vesicles" Aggresome "HPA041341: AB_10794991" "unprognostic (2.01e-1)" "unprognostic (6.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (9.99e-3)" "unprognostic (7.94e-2)" "unprognostic (8.30e-4)" "unprognostic (3.68e-1)" "unprognostic (8.33e-2)" "unprognostic (3.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (3.75e-1)" "unprognostic (6.81e-2)" 0.1 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 2.2 0.2 1.1 0.2 0.1 0.1 0.3 0.2 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.3 52.5 0.2 0.1 0.1 0.1 0.3 0.2 0.2 6.6 0.0 1.0 0.0 0.0 0.8 0.2 0.3 0.0 1.8 0.0 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.1 9.5 0.6 4.9 0.1 0.2 2.7 0.2 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.0 1.2 0.0 0.2 0.7 0.0 0.0 0.9 0.0 0.7 0.0 0.0 1.0 0.0 0.1 0.2 3.2 0.8 0.0 0.0 0.1 1.7 0.0 0.4 6.0 0.0 0.0 0.3 0.4 0.1 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.6 0.3 0.0 0.0 1.0 0.1 0.0 0.0 3.2 0.2 0.6 0.0 6.6 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 2.3 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FNDC4 "FLJ22362, FRCP1" ENSG00000115226 "Fibronectin type III domain containing 4" Q9H6D8 2 27491883-27495245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.9;liver: 57.6" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 165.4;Hepatocytes: 113.4;Late spermatids: 388.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 17.0;ASC diff: 17.4;HUVEC TERT2: 20.9;SH-SY5Y: 16.3;TIME: 19.0;U-87 MG: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051804, HPA063581" Uncertain Approved Nucleoplasm,Aggresome,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Aggresome, Cytosol" "HPA051804: AB_2681617, HPA063581: AB_2685048" "unprognostic (2.57e-1)" "unprognostic (1.19e-3)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.07e-4)" "unprognostic (1.46e-3)" "unprognostic (1.27e-1)" "unprognostic (4.77e-3)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (9.64e-2)" "unprognostic (8.28e-3)" "unprognostic (4.41e-2)" "unprognostic (1.28e-2)" "unprognostic (1.13e-2)" "unprognostic (5.74e-3)" "unprognostic (2.40e-3)" "prognostic unfavorable (6.11e-4)" 18.5 45.9 13.4 2.7 13.7 0.7 9.1 10.8 29.5 3.8 2.0 4.0 0.5 1.5 2.8 2.8 11.8 1.5 10.0 3.1 15.6 8.5 2.3 57.6 2.0 1.4 12.0 8.6 16.5 4.6 18.6 2.8 2.5 22.2 6.3 2.1 1.9 2.1 3.3 1.3 2.4 1.4 4.7 5.4 3.5 3.2 10.2 3.8 0.0 1.8 0.7 2.7 4.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 17.0 17.4 10.7 0.1 3.9 7.8 2.8 2.5 0.7 0.2 0.0 0.4 12.3 3.7 0.0 6.5 2.3 2.5 0.0 1.0 0.8 0.0 8.7 6.5 0.0 0.1 9.1 1.1 4.9 1.0 12.9 20.9 0.0 0.9 0.0 10.3 0.0 0.0 0.0 6.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.1 16.3 0.1 0.0 0.1 1.3 0.0 0.0 19.0 2.7 1.2 1.0 3.0 0.0 0.0 0.0 14.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.7 10.8 29.5 15.6 8.5 12.0 8.6 22.2 3.8 0.0 0.3 0.0 2.8 3.1 8.2 2.5 10.2 0.0 0.0 0.0 3.9 0.1 3.3 68.5 165.4 5.8 0.0 0.0 41.6 0.1 8.1 14.7 5.7 113.4 0.5 0.0 0.0 6.2 1.3 388.8 14.4 0.6 3.3 1.8 0.0 12.3 60.5 0.0 11.0 0.2 11.8 0.0 11.3 4.9 3.6 2.0 0.0 0.0 0.0 1.0 FOXJ3 KIAA1041 ENSG00000198815 "Forkhead box J3" Q9UPW0 1 42176539-42335877 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067284 Approved "Nucleoplasm,Nuclear speckles,Vesicles" NA NA "Nucleoplasm, Nuclear speckles" Vesicles "HPA067284: AB_2685817" "unprognostic (5.60e-2)" "unprognostic (2.26e-2)" "unprognostic (4.24e-2)" "unprognostic (5.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.17e-6)" "unprognostic (3.65e-3)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "prognostic unfavorable (4.51e-7)" "unprognostic (2.10e-1)" "unprognostic (1.83e-1)" "unprognostic (1.87e-2)" "unprognostic (5.43e-2)" 24.8 15.1 21.2 20.1 31.3 31.6 25.6 38.2 30.9 22.3 18.4 22.9 15.4 18.8 24.9 18.9 17.4 19.8 16.2 23.5 21.5 20.2 16.8 17.6 20.4 19.6 22.9 19.2 29.5 22.6 31.6 28.7 33.5 21.2 21.7 22.5 18.4 19.0 23.7 44.3 24.3 20.0 22.0 20.7 19.6 20.8 19.0 22.6 29.0 23.7 15.2 22.2 22.8 21.4 12.3 9.7 10.9 9.4 11.6 13.1 4.3 13.8 11.7 12.9 13.4 14.0 17.2 18.6 10.5 15.6 14.2 15.9 10.8 16.7 21.3 11.3 14.7 12.2 13.3 18.0 17.3 24.2 16.0 10.1 23.5 14.9 9.1 12.1 21.5 16.2 12.8 17.2 21.2 26.4 15.2 15.4 17.1 14.1 15.5 16.9 7.9 21.7 12.3 20.1 11.1 10.7 20.4 33.9 14.5 12.1 20.2 18.0 16.9 19.0 22.0 19.1 19.3 11.0 32.1 14.3 14.9 20.0 15.0 17.4 15.4 18.9 17.4 13.5 18.0 11.9 6.0 5.7 6.1 9.0 4.8 10.9 8.0 11.0 9.5 4.6 12.3 11.8 13.1 10.9 11.6 9.4 9.7 7.0 4.3 21.2 31.3 38.2 30.9 21.5 20.2 22.9 19.2 21.2 22.6 11.9 17.6 20.1 9.7 31.5 18.4 37.6 7.6 12.0 15.9 15.7 17.7 11.1 14.9 9.7 14.9 23.2 22.8 46.7 12.6 26.0 14.6 16.6 12.7 14.9 10.3 20.6 25.9 14.1 19.0 14.2 20.8 12.7 10.1 6.4 26.0 14.1 13.7 17.3 18.7 11.0 32.9 6.5 12.3 22.8 22.7 29.2 23.3 12.5 17.9 19.2 FOXK2 "ILF, ILF1" ENSG00000141568 "Forkhead box K2" Q01167 17 82519713-82644662 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027523, HPA073491" Approved Supported Nucleoplasm,Vesicles,Mitochondria NA NA Nucleoplasm "Vesicles, Mitochondria" "HPA027523: AB_10601013, HPA073491: " "unprognostic (2.39e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (9.52e-2)" "unprognostic (3.11e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.24e-6)" "unprognostic (3.35e-2)" "unprognostic (2.25e-1)" "unprognostic (5.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "unprognostic (3.80e-3)" "unprognostic (2.24e-2)" "unprognostic (4.89e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" 16.8 21.2 17.5 14.3 19.2 8.7 19.1 21.3 30.5 17.7 17.1 17.1 16.9 11.2 22.2 13.7 24.2 14.6 13.4 17.1 14.9 14.9 13.0 13.6 15.2 13.6 13.7 17.2 17.6 19.2 25.4 19.8 18.6 15.6 14.9 11.7 13.8 17.1 16.3 41.5 21.6 12.6 19.9 10.3 13.2 15.5 32.3 15.8 21.8 18.6 12.4 13.9 16.4 16.4 4.0 5.9 4.1 2.9 4.1 4.4 1.6 21.7 23.3 21.8 23.8 12.6 13.9 14.6 12.8 14.8 22.5 22.9 22.6 14.0 18.6 9.3 15.8 24.8 12.7 23.2 14.8 21.3 12.7 22.2 19.2 15.4 22.2 19.9 21.4 12.9 13.1 27.1 23.7 27.1 14.0 22.7 20.2 25.6 19.1 12.3 13.0 36.3 13.6 12.5 18.0 17.8 23.9 18.6 15.4 10.3 18.4 36.2 26.7 12.7 32.4 30.2 24.3 22.8 24.8 17.7 29.7 20.8 19.9 25.8 22.1 19.5 24.1 16.0 17.9 15.6 4.1 2.9 3.3 4.4 2.2 3.5 4.0 3.3 4.2 3.3 2.8 2.6 2.9 0.5 4.1 2.3 5.9 3.4 1.6 17.5 19.2 21.3 30.5 14.9 14.9 13.7 17.2 15.6 15.8 47.6 21.9 9.3 7.3 33.1 18.1 17.3 5.1 13.4 18.2 14.0 11.8 10.2 3.3 8.5 11.5 12.8 10.5 0.0 9.1 7.5 13.1 10.0 2.3 11.4 16.3 44.5 10.5 12.9 14.6 18.8 8.6 9.2 11.8 9.0 13.5 9.1 10.2 11.5 12.4 5.4 16.1 0.0 19.6 13.2 9.5 37.6 8.1 6.9 12.1 8.9 FOXN4 ENSG00000139445 "Forkhead box N4" Q96NZ1 12 109277979-109309220 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.1" "Cell type enhanced" "Detected in some" 21 "Spermatocytes: 1.8;Spermatogonia: 2.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Region enriched" "Detected in single" 11 "basal ganglia: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.4;SCLC-21H: 6.4;SH-SY5Y: 6.6;U-266/70: 9.1" "Not detected" "Not detected" HPA050018 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA050018: AB_2680992" "unprognostic (1.09e-3)" "unprognostic (9.63e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (2.52e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (7.93e-3)" "unprognostic (2.30e-1)" "unprognostic (1.02e-3)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (6.00e-2)" 0.2 0.0 0.1 0.1 2.7 0.0 0.1 0.2 0.1 1.4 0.3 0.1 0.1 0.0 0.6 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.9 2.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.4 0.1 0.4 0.1 0.1 0.0 13.1 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 6.6 0.0 0.1 0.0 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.0 9.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.6 0.0 0.0 0.0 0.0 0.0 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 213.3;lymphoid tissue: 64.4" "Cell type enhanced" "Detected in many" 21 "Hofbauer cells: 97.2;Kupffer cells: 262.0;Macrophages: 111.7" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 213.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 213.3" "Cell line enriched" "Detected in some" 5 "U-87 MG: 35.0" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: AB_2679694, HPA061744: AB_2684600" "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 22.6 3.7 5.2 52.2 12.4 54.5 2.9 1.1 6.3 2.6 2.4 5.9 0.0 1.1 2.3 2.3 3.3 8.4 9.6 11.2 15.7 4.3 6.0 7.5 28.8 58.4 15.5 0.8 1.9 3.5 0.8 2.3 13.0 9.7 1.8 1.2 2.4 2.4 0.9 3.2 1.1 2.2 12.8 14.3 64.4 3.2 2.9 10.1 0.9 2.7 0.7 3.2 7.9 4.6 0.0 8.9 213.3 36.3 0.0 0.0 16.9 0.3 0.5 0.2 0.3 0.4 1.1 0.3 0.2 0.0 0.3 1.0 0.2 0.3 0.6 0.3 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 2.8 0.2 0.4 2.4 0.1 0.9 0.8 4.2 0.0 0.2 0.1 0.4 7.1 0.5 0.1 0.2 0.2 0.2 0.4 0.2 0.4 0.0 0.6 0.3 0.1 0.2 0.4 0.1 0.3 0.1 0.6 0.6 0.5 1.2 0.3 0.0 1.7 0.1 0.0 0.3 35.0 0.9 0.1 13.0 36.3 10.0 0.0 15.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 213.3 0.0 9.5 0.3 0.0 16.9 5.2 12.4 1.1 6.3 15.7 4.3 15.5 0.8 9.7 10.1 14.9 40.8 6.2 0.2 0.6 0.4 0.2 0.0 16.0 28.4 0.0 0.0 0.9 0.0 0.0 1.2 0.4 0.0 0.0 0.0 1.2 0.9 0.2 24.4 1.7 97.2 0.0 0.0 4.3 262.0 1.3 0.3 111.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 6.5 1.0 0.5 0.6 0.0 2.5 0.0 0.0 0.0 FRMD3 "EPB41L4O, MGC20553" ENSG00000172159 "FERM domain containing 3" A2A2Y4 9 83242990-83538546 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.5;skeletal muscle: 42.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 102.0;Cardiomyocytes: 66.5;Cone photoreceptor cells: 74.6;Early spermatids: 112.3;Horizontal cells: 95.3;Late spermatids: 100.0;Sertoli cells: 71.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 27.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1" "Group enriched" "Detected in many" 6 "granulocytes: 3.8;monocytes: 4.7" "Cell line enhanced" "Detected in some" "HEL: 11.2;OE19: 23.5;RPMI-8226: 37.7;SCLC-21H: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017285 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA017285: AB_2669569" "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "unprognostic (6.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.93e-1)" "unprognostic (3.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.23e-1)" "unprognostic (5.87e-2)" "prognostic favorable (7.24e-4)" "unprognostic (3.12e-1)" "unprognostic (1.88e-1)" "prognostic favorable (1.79e-4)" "unprognostic (1.68e-3)" 12.7 4.6 3.5 2.8 2.3 3.0 16.8 2.0 3.0 4.6 7.1 1.7 14.3 1.9 5.5 9.8 4.1 1.9 2.9 48.5 3.2 4.5 11.7 0.7 2.9 0.9 3.6 1.7 1.4 1.4 8.9 6.1 8.7 2.9 5.1 4.1 5.3 2.1 35.3 42.1 1.6 10.9 3.5 2.8 4.3 2.2 6.1 0.8 0.0 8.8 11.1 0.7 3.8 5.0 0.6 0.6 3.8 4.7 0.4 0.6 9.2 0.0 2.1 1.8 0.1 0.3 0.1 0.1 2.0 0.1 0.0 0.0 0.2 2.5 0.4 2.3 0.9 0.4 0.1 0.1 0.0 0.0 0.1 0.1 11.2 2.4 1.3 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.2 23.5 3.5 0.0 1.5 37.7 3.1 4.9 13.9 6.7 0.7 0.1 0.4 0.3 0.8 0.4 2.1 0.1 0.3 0.0 1.4 0.2 0.1 0.0 0.5 3.6 1.4 0.0 2.8 0.0 0.4 4.7 0.6 0.5 0.2 0.1 0.4 0.6 0.1 0.0 3.8 0.4 2.1 0.6 0.0 9.2 3.5 2.3 2.0 3.0 3.2 4.5 3.6 1.7 2.9 0.8 20.8 0.6 0.0 1.0 0.9 102.0 66.5 10.2 0.0 2.3 1.8 74.6 0.3 14.9 2.5 112.3 13.1 26.2 0.0 1.7 0.9 2.1 1.0 0.0 0.2 0.8 95.3 1.2 3.1 4.6 100.0 2.0 1.5 0.0 0.0 19.4 2.0 2.0 7.0 4.6 8.7 4.7 71.1 28.9 1.6 1.4 1.1 0.1 0.0 1.6 1.3 FRMD7 "FLJ43346, NYS, NYS1" ENSG00000165694 "FERM domain containing 7" Q6ZUT3 X 132076993-132128020 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5" "Cell type enriched" "Detected in single" 30 "Distal tubular cells: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;HSkMC: 1.6;SuSa: 3.6;U-87 MG: 5.5" "Region enriched" "Detected in single" 29 "olfactory region: 80.8" "Region enriched" "Detected in single" 103 "olfactory region: 45.5" HPA000886 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA000886: AB_1079269" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (1.64e-2)" "unprognostic (2.28e-1)" "unprognostic (2.18e-2)" "unprognostic (3.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.00e-1)" 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 7.4 1.1 0.0 1.1 0.0 0.1 0.0 0.1 6.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.5 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FUT10 ENSG00000172728 "Fucosyltransferase 10" Q6P4F1 8 33370824-33473422 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 187.5;Late spermatids: 217.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053970, HPA058655" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Endoplasmic reticulum, Golgi apparatus" "HPA053970: AB_2682327, HPA058655: AB_2683789" "unprognostic (6.02e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-3)" "unprognostic (6.24e-2)" "unprognostic (1.01e-1)" "unprognostic (4.80e-2)" "unprognostic (5.40e-3)" "unprognostic (6.07e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (9.10e-3)" "unprognostic (2.76e-4)" "unprognostic (3.06e-3)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-3)" "unprognostic (6.01e-3)" 5.6 7.2 7.9 3.9 10.9 2.0 8.9 18.8 8.6 10.9 6.3 6.9 5.0 6.4 10.5 5.3 5.8 8.4 4.8 5.4 7.4 4.5 8.3 5.2 6.0 4.1 5.8 7.2 13.6 10.9 14.5 11.7 8.2 6.8 6.0 6.9 12.4 6.7 5.9 2.4 9.7 6.1 7.3 5.1 3.8 5.7 4.1 4.6 5.8 6.9 2.2 6.0 6.6 7.2 2.4 3.5 1.9 1.5 3.8 4.1 2.1 2.2 4.4 7.1 8.4 11.1 11.3 3.7 4.5 7.3 4.4 5.9 6.7 3.9 2.5 5.5 5.6 3.7 6.1 10.2 4.1 4.4 5.7 3.9 8.4 3.7 7.3 5.1 1.8 3.0 7.9 7.4 1.1 5.4 9.4 8.7 4.6 7.6 3.4 4.1 1.3 6.5 2.8 10.0 6.3 2.9 4.9 5.5 1.4 6.2 5.5 2.4 2.3 2.5 3.8 4.9 7.8 3.8 1.9 7.1 3.3 1.5 8.5 3.5 1.4 2.2 1.7 2.0 5.4 3.4 1.1 1.5 1.9 3.7 0.7 4.0 2.4 2.2 3.5 3.5 1.0 2.5 2.4 1.1 3.8 0.5 2.0 4.1 2.1 7.9 10.9 18.8 8.6 7.4 4.5 5.8 7.2 6.8 4.6 3.0 1.3 0.0 2.6 2.4 3.1 2.2 5.1 1.4 3.4 3.5 9.8 9.6 1.7 4.1 187.5 3.0 2.6 0.0 3.5 5.8 4.1 1.1 5.7 3.9 3.0 3.2 3.5 4.3 1.8 217.3 6.4 1.9 1.7 2.8 2.9 31.7 3.1 0.0 4.6 2.8 10.8 0.0 2.8 1.6 2.4 1.5 5.0 0.5 2.9 1.3 FUT8 ENSG00000033170 "Fucosyltransferase 8" Q9BYC5 14 65410592-65744121 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.5;NK-cells: 12.0;T-cells: 8.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017129, HPA043410" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB017129: , HPA043410: AB_2678467" "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (3.28e-2)" "unprognostic (1.65e-3)" "unprognostic (2.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.41e-1)" "unprognostic (8.81e-2)" "unprognostic (2.00e-2)" "unprognostic (1.33e-3)" "unprognostic (8.09e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-3)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" 7.2 7.6 16.2 12.0 21.1 3.3 9.4 24.1 18.1 6.7 9.8 29.1 16.1 15.4 8.7 5.0 6.5 14.0 10.1 5.2 19.8 12.9 6.2 2.9 7.0 11.2 20.5 11.2 7.2 10.5 6.2 5.2 18.8 17.3 5.4 10.4 7.1 33.7 13.7 3.5 4.9 15.1 9.5 39.8 8.5 27.6 13.1 23.6 8.4 7.5 2.4 15.2 14.4 5.6 13.5 2.2 0.5 1.7 12.0 8.2 2.5 34.4 6.8 3.3 30.3 14.6 11.0 20.5 11.1 17.0 7.7 8.6 5.3 12.7 9.2 9.5 10.9 21.2 2.6 7.8 3.0 11.8 34.0 3.4 9.2 2.5 6.9 7.5 2.0 7.6 27.7 2.0 10.6 5.0 33.8 19.5 4.5 3.4 7.8 5.5 17.7 9.8 5.1 4.4 16.0 23.9 6.7 2.9 5.3 13.8 9.7 7.0 5.3 5.9 2.8 2.4 20.7 2.8 3.3 42.5 10.1 10.9 4.5 8.9 15.7 6.0 21.9 20.5 3.6 3.2 0.5 1.7 0.5 3.5 0.6 3.5 13.5 5.6 5.1 2.2 6.8 6.1 6.0 0.2 12.0 1.1 2.2 8.2 2.5 16.2 21.1 24.1 17.3 19.8 12.9 20.5 11.2 17.3 23.6 11.9 33.3 42.9 6.7 10.8 10.6 5.6 10.2 16.0 22.7 12.2 3.9 38.8 0.0 7.7 28.3 11.3 6.8 0.0 28.1 24.2 15.8 5.7 7.0 3.2 11.0 7.9 5.2 15.4 12.1 10.9 11.8 7.0 1.7 1.8 17.5 35.8 36.1 8.5 12.7 7.8 8.0 0.0 10.3 31.6 26.2 8.5 11.8 13.8 9.4 4.6 FXYD1 PLM ENSG00000266964 "FXYD domain containing ion transport regulator 1" O00168 19 35138808-35143109 "Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8" "Group enriched" "Detected in many" 4 "Fibroblasts: 170.5;Hepatocytes: 393.6;Leydig cells: 398.4;Muller glia cells: 148.5;Peritubular cells: 120.6;Sertoli cells: 116.4;Smooth muscle cells: 231.4" "Cancer enhanced" "Detected in many" "liver cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 11.7" "Group enriched" "Detected in many" 5 "B-cells: 11.7;T-cells: 7.1" "Cell line enhanced" "Detected in some" "ASC diff: 31.0;ASC TERT1: 9.0;HSkMC: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026873 Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Cytosol" Nucleoli "HPA026873: AB_1855471" "unprognostic (5.58e-3)" "unprognostic (6.60e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.91e-4)" "unprognostic (1.54e-2)" "unprognostic (1.72e-2)" "unprognostic (3.54e-3)" "unprognostic (8.13e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (7.59e-8)" "unprognostic (9.97e-3)" "unprognostic (2.25e-1)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" 28.2 8.1 35.7 5.2 40.7 2.0 21.8 16.8 34.7 46.5 16.9 25.5 7.1 5.0 26.3 17.9 18.8 31.1 14.8 134.1 23.8 19.9 4.5 137.1 14.1 3.0 36.1 23.7 34.0 6.2 2.1 4.3 8.6 21.5 21.6 7.9 14.1 6.4 20.7 299.8 5.8 7.5 27.7 19.0 6.2 8.4 7.5 14.8 0.0 3.9 29.0 3.5 12.7 23.7 11.7 0.7 1.2 0.7 2.0 7.1 0.7 0.7 0.0 0.0 0.1 31.0 9.0 0.8 3.7 0.1 0.0 0.0 0.0 0.2 2.4 1.0 0.0 0.1 0.6 0.7 0.4 0.0 2.2 0.9 0.4 0.0 1.2 3.5 0.2 0.2 12.8 0.0 0.1 0.3 0.3 0.1 0.1 0.6 2.5 0.1 0.0 0.0 0.5 0.1 1.8 0.4 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.1 1.0 0.2 0.1 4.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.6 0.4 5.1 1.2 0.3 0.0 1.4 0.7 0.9 11.7 4.1 1.7 0.3 6.6 0.8 1.0 0.6 2.0 0.7 0.7 7.1 0.7 35.7 40.7 16.8 34.7 23.8 19.9 36.1 23.7 21.5 14.8 0.0 0.0 3.7 5.1 26.2 1.4 0.3 2.5 5.3 0.0 24.4 3.9 1.3 0.0 0.1 1.2 6.0 1.3 0.0 4.2 1.5 170.5 2.1 0.0 393.6 4.2 0.0 0.0 49.1 11.0 5.1 398.4 4.1 50.6 0.0 0.4 148.5 1.6 2.5 120.6 0.0 7.0 116.4 231.4 3.8 11.7 23.8 2.4 4.9 0.6 2.3 FZD2 ENSG00000180340 "Frizzled class receptor 2" Q14332 17 44557459-44559570 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 17.9;Kupffer cells: 11.1;Leydig cells: 21.6;Peritubular cells: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.5;myeloid DC: 5.6;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 6 "dendritic cells: 5.6;monocytes: 3.5" "Cell line enhanced" "Detected in many" "A549: 25.9;BJ hTERT+ SV40 Large T+: 25.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057667 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Nucleoplasm, Nuclear bodies" "Cell Junctions" "HPA057667: AB_2683497" "unprognostic (6.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.04e-2)" "unprognostic (8.83e-3)" "unprognostic (2.04e-1)" "unprognostic (5.29e-3)" "unprognostic (1.44e-2)" "unprognostic (2.29e-1)" "unprognostic (9.45e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-2)" "unprognostic (1.86e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-2)" "unprognostic (6.35e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 2.3 2.8 2.3 3.9 5.8 0.9 3.2 0.7 3.1 16.1 2.9 2.1 3.0 2.9 10.8 7.6 2.4 6.6 7.7 5.8 3.2 1.5 5.0 0.5 6.9 3.1 2.1 2.9 12.1 2.7 1.6 1.9 8.4 4.9 4.2 0.8 14.3 2.9 7.9 1.8 1.1 3.6 3.3 2.0 3.7 2.1 6.5 1.8 1.1 5.3 2.4 3.1 3.8 4.3 0.2 5.6 0.0 3.5 0.0 0.8 0.6 7.6 25.9 14.9 8.5 3.3 2.9 0.3 21.5 13.1 25.8 18.6 20.0 4.4 0.0 6.8 5.3 7.8 3.6 1.7 1.8 6.2 1.9 5.0 0.8 4.2 0.1 4.3 0.1 4.4 5.5 1.4 6.2 4.2 15.2 1.1 2.7 1.6 0.2 6.5 4.0 3.4 2.0 16.3 0.0 4.8 9.9 4.5 1.3 3.3 0.3 1.9 6.4 2.7 0.7 1.6 9.7 8.3 3.6 0.4 13.9 12.4 2.6 12.6 0.6 0.4 1.9 2.6 1.4 6.3 0.0 3.5 0.0 0.1 0.2 0.0 0.0 0.0 0.8 5.6 0.2 0.0 0.2 0.0 0.0 0.2 2.6 0.0 0.6 2.3 5.8 0.7 2.1 3.2 1.5 2.1 2.9 4.9 1.8 17.9 0.0 0.0 0.2 0.6 0.0 1.7 0.0 0.0 0.0 1.8 0.0 1.4 0.0 0.3 0.4 0.6 0.0 0.0 1.6 0.4 5.1 0.1 0.0 0.0 4.5 0.0 1.2 1.3 11.1 0.0 21.6 4.2 0.0 2.8 0.0 6.4 0.5 0.0 17.0 0.1 0.2 0.0 1.0 0.3 0.9 0.4 1.9 0.0 0.0 0.0 GABARAPL2 "ATG8, ATG8C, GATE-16, GATE16, GEF2" ENSG00000034713 "GABA type A receptor associated protein like 2" P60520 16 75566351-75577881 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036726 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA036726: AB_10672476" "unprognostic (3.29e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-2)" "unprognostic (7.00e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.58e-1)" "unprognostic (6.85e-2)" "unprognostic (2.13e-1)" "unprognostic (4.95e-2)" "unprognostic (9.86e-3)" "unprognostic (1.33e-2)" "prognostic favorable (5.95e-8)" "unprognostic (3.11e-3)" "unprognostic (3.84e-3)" "unprognostic (1.37e-2)" "unprognostic (3.85e-1)" 29.6 47.4 69.0 18.0 70.5 24.7 33.8 52.3 61.4 29.4 23.9 54.2 26.0 18.7 25.7 47.1 21.7 30.9 23.7 76.6 59.6 69.5 42.0 31.4 25.4 23.4 73.4 52.5 28.9 25.8 46.2 33.6 31.8 52.4 33.4 23.6 30.8 27.3 31.0 52.7 24.3 19.4 28.2 72.0 25.7 21.8 20.2 45.4 17.5 35.7 22.4 26.8 22.6 19.3 38.2 47.0 87.8 25.4 18.9 35.1 35.9 23.9 20.4 34.9 16.4 54.2 47.8 17.7 28.2 40.9 38.7 43.6 18.7 31.1 34.6 34.8 32.1 23.4 20.7 25.9 26.4 47.9 14.9 49.4 20.4 18.8 27.7 29.6 19.5 36.9 33.0 37.5 32.5 24.3 35.3 31.4 31.4 29.8 14.2 38.6 33.9 28.8 37.4 20.9 27.0 22.9 32.5 16.8 41.7 40.4 15.7 41.1 43.0 44.1 10.6 40.5 29.1 34.0 30.8 28.6 16.8 25.7 24.4 15.1 40.5 38.3 72.4 40.5 19.0 24.7 47.8 25.3 61.1 23.9 23.4 30.6 38.2 25.6 27.3 30.4 32.1 23.3 21.8 87.8 18.9 25.4 47.0 35.1 35.9 69.0 70.5 52.3 61.4 59.6 69.5 73.4 52.5 52.4 45.4 80.4 128.3 143.1 246.6 244.3 234.3 274.6 119.8 196.7 104.6 165.7 43.2 221.0 581.9 172.6 40.2 247.2 151.5 210.2 153.9 100.3 212.4 297.8 105.3 119.0 199.3 290.8 266.6 200.1 176.9 47.4 225.5 212.5 244.6 505.9 147.5 338.5 185.4 241.8 245.4 443.3 155.9 155.2 146.3 296.3 235.3 239.5 326.2 159.2 111.7 275.4 GALNT10 GalNAc-T10 ENSG00000164574 "Polypeptide N-acetylgalactosaminyltransferase 10" Q86SR1 5 154190730-154420984 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.7" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 74.0;TIME: 40.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007525 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 830000 "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA007525: AB_1849443" "unprognostic (6.99e-2)" "unprognostic (4.33e-2)" "unprognostic (9.85e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.63e-1)" "unprognostic (6.98e-2)" "unprognostic (6.95e-3)" "unprognostic (2.38e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (5.69e-4)" "unprognostic (2.88e-3)" "unprognostic (2.63e-1)" "unprognostic (1.54e-1)" "unprognostic (7.76e-3)" "unprognostic (1.22e-1)" "unprognostic (1.61e-2)" "unprognostic (3.08e-1)" 9.5 13.5 8.4 15.4 9.1 10.1 8.7 3.2 6.2 15.9 10.6 14.4 1.0 8.8 4.9 11.5 5.9 9.2 17.8 7.7 6.9 7.5 6.8 3.4 10.1 11.5 7.2 5.2 43.7 9.2 14.1 9.7 5.2 10.1 8.3 9.4 31.6 11.6 2.4 5.6 4.0 12.4 14.1 7.7 16.7 13.8 4.3 9.2 5.6 10.6 4.2 9.3 7.5 10.0 4.7 3.1 5.7 3.8 3.9 7.5 2.1 6.2 21.4 5.2 4.5 11.1 9.9 4.0 18.1 10.1 7.2 6.9 3.0 14.4 4.1 12.8 30.4 12.9 1.1 2.4 14.1 6.6 10.6 1.7 11.2 4.1 4.0 8.5 2.4 10.9 12.3 3.3 5.8 8.6 74.0 13.8 3.1 2.5 13.0 12.3 6.5 0.2 1.6 2.0 17.6 4.4 1.2 2.7 4.1 10.0 4.3 0.7 1.7 8.0 30.0 2.3 8.0 11.6 1.8 40.5 17.6 4.2 4.3 19.2 3.7 3.6 2.2 11.5 4.8 5.3 3.4 2.7 5.3 7.5 3.6 6.6 4.5 4.3 4.8 3.1 4.7 1.9 5.3 5.7 3.9 3.8 2.7 3.5 2.1 8.4 9.1 3.2 6.2 6.9 7.5 7.2 5.2 10.1 9.2 8.9 36.1 12.3 3.5 4.2 3.5 4.1 5.1 0.0 12.5 14.0 3.9 0.6 8.3 9.3 10.6 13.4 15.5 23.3 26.2 1.2 9.1 9.9 10.3 4.7 7.2 0.0 2.9 19.0 15.4 16.0 35.4 9.7 0.0 6.4 16.1 20.8 26.5 11.5 47.0 2.9 11.4 6.5 7.3 1.7 3.1 3.1 0.7 13.8 9.3 2.8 GBA2 "AD035, DKFZp762K054, KIAA1605, SPG46" ENSG00000070610 "Glucosylceramidase beta 2" Q9HCG7 9 35736866-35749228 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism" "Glycosidase, Glycosyltransferase, Hydrolase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 95.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024026 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA024026: AB_1849530" "unprognostic (3.34e-2)" "unprognostic (2.90e-1)" "unprognostic (2.99e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (2.09e-2)" "unprognostic (3.99e-2)" "unprognostic (8.69e-2)" "prognostic favorable (6.00e-4)" "unprognostic (9.01e-3)" "prognostic favorable (1.24e-11)" "unprognostic (7.62e-3)" "unprognostic (2.94e-1)" "unprognostic (7.69e-2)" "prognostic favorable (6.60e-4)" 15.6 19.3 28.9 17.0 23.3 11.0 24.3 42.3 41.6 14.8 35.1 17.0 28.4 41.5 19.0 22.3 16.6 16.8 21.4 34.6 22.4 21.0 34.8 25.0 20.9 17.3 23.7 19.5 16.4 20.9 27.9 27.1 19.3 36.6 23.9 32.8 28.4 27.7 25.5 46.1 23.5 51.1 23.3 21.0 23.4 26.9 11.6 19.5 10.9 25.4 15.5 16.4 18.2 16.9 5.6 6.8 12.2 6.1 3.1 7.3 3.1 7.9 13.2 18.2 17.6 8.9 5.4 18.5 10.8 8.5 11.0 11.7 14.6 6.4 8.5 7.9 6.6 23.8 8.3 17.4 7.3 5.6 12.1 11.9 9.2 34.4 15.6 9.8 13.6 22.8 9.3 13.7 9.3 9.8 26.9 28.8 8.6 8.9 16.4 10.2 7.9 3.7 14.1 18.8 16.2 20.9 6.8 7.3 7.2 15.3 18.8 14.9 19.9 6.1 15.2 10.7 23.3 10.4 12.4 20.1 12.0 14.5 10.2 13.1 11.2 7.1 7.1 15.0 5.0 9.3 12.2 4.4 2.9 6.0 6.1 4.1 5.0 5.8 7.3 4.2 5.6 3.7 3.2 4.9 3.1 3.7 6.8 4.0 3.1 28.9 23.3 42.3 41.6 22.4 21.0 23.7 19.5 36.6 19.5 11.9 10.1 8.0 16.1 6.5 73.4 10.9 20.4 21.4 14.8 26.2 108.0 8.7 18.3 9.9 12.7 13.7 68.4 0.0 10.4 7.6 7.4 14.9 13.9 16.3 7.9 49.3 34.3 26.4 15.4 17.0 11.5 10.1 11.8 7.2 32.8 15.5 12.6 56.1 9.2 16.5 95.2 12.9 9.9 8.6 4.9 8.7 18.5 12.5 30.3 22.5 GCAT KBL ENSG00000100116 "Glycine C-acetyltransferase" O75600 22 37807905-37817176 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 81.6" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 68.0;Hepatocytes: 55.7;Proximal tubular cells: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020460, HPA063924" Approved Supported "Nucleoplasm,Nuclear speckles,Mitochondria" Yes No Nucleoplasm "Nuclear speckles, Mitochondria" "HPA020460: AB_1849548, HPA063924: " "unprognostic (1.61e-1)" "unprognostic (1.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-2)" "unprognostic (4.17e-2)" "unprognostic (2.40e-1)" "unprognostic (1.37e-2)" "unprognostic (3.56e-2)" "unprognostic (2.76e-3)" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.36e-3)" "unprognostic (8.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.73e-3)" "unprognostic (3.99e-1)" 2.9 6.0 8.9 2.4 8.8 8.1 4.2 8.3 12.3 4.5 4.7 5.2 8.0 3.5 3.0 4.0 6.3 3.9 6.0 21.5 8.6 8.4 8.1 19.1 2.3 2.1 10.1 7.4 4.0 81.6 3.5 3.7 2.2 7.4 12.2 3.5 4.3 12.0 5.0 10.3 3.2 3.2 3.1 6.3 1.1 4.4 5.9 4.3 2.8 10.7 9.3 4.3 3.3 2.2 0.3 2.5 0.8 1.3 2.3 7.1 2.8 8.8 2.3 5.9 33.9 12.3 10.0 4.2 12.7 13.4 9.7 8.2 5.1 1.0 2.8 6.0 5.7 5.7 5.2 5.9 9.0 2.2 1.2 10.8 6.2 7.4 20.3 20.1 10.9 8.1 11.7 5.5 6.4 14.1 3.1 7.9 11.4 15.7 3.3 4.5 7.8 11.4 20.2 2.5 13.9 9.4 12.0 1.3 16.2 12.2 7.0 12.3 8.4 9.9 16.1 6.8 2.2 12.9 5.3 5.9 9.8 5.3 6.5 4.4 10.8 5.3 5.8 6.7 10.2 10.2 0.2 1.3 0.8 1.5 1.2 0.6 0.3 3.4 1.0 2.4 0.1 7.1 2.9 0.6 2.3 0.8 2.5 3.3 2.8 8.9 8.8 8.3 12.3 8.6 8.4 10.1 7.4 7.4 4.3 6.0 12.5 2.9 15.2 6.9 9.8 43.3 7.6 4.0 6.8 10.4 3.9 12.8 68.0 6.1 3.6 5.6 6.3 0.0 8.8 17.8 7.5 19.5 9.2 55.7 4.0 7.9 2.4 3.1 2.2 4.3 3.4 1.6 20.3 1.8 23.9 17.3 6.8 3.5 9.2 62.4 1.9 6.5 10.8 13.4 27.1 5.3 23.2 4.9 25.5 11.2 GCH1 "DYT14, DYT5, DYT5a, GCH, GTPCH1" ENSG00000131979 "GTP cyclohydrolase 1" P30793 14 54842008-54902852 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" "Allosteric enzyme, Hydrolase" "Disease mutation, Dystonia, Parkinsonism, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.8;liver: 58.2" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 82.5;Intestinal endocrine cells: 203.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 11.8;Daudi: 13.3;SH-SY5Y: 29.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 15.7" HPA028612 Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" No No Nucleoplasm "Nuclear membrane, Cytosol" "HPA028612: AB_10602135" "unprognostic (3.77e-2)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (2.39e-1)" "unprognostic (9.26e-2)" "unprognostic (1.27e-1)" "unprognostic (7.26e-2)" "unprognostic (1.75e-1)" "unprognostic (3.97e-1)" "prognostic favorable (8.69e-4)" "prognostic favorable (1.41e-4)" "unprognostic (1.23e-1)" "unprognostic (1.96e-2)" "unprognostic (7.22e-3)" "unprognostic (1.76e-2)" "unprognostic (2.23e-1)" "prognostic favorable (6.67e-4)" 4.8 5.2 1.3 5.7 4.5 26.8 2.1 0.6 1.1 2.2 5.5 1.2 1.5 7.5 1.8 1.9 3.8 1.3 1.6 1.5 1.6 4.3 7.9 58.2 11.6 6.7 2.9 0.7 1.4 3.2 0.3 2.5 2.5 2.8 2.9 4.0 5.2 2.5 4.7 1.4 2.5 9.1 2.0 1.7 10.0 4.2 3.6 1.1 13.0 2.3 2.0 8.5 2.9 2.5 1.6 3.0 0.4 11.5 2.3 3.2 1.3 1.9 0.6 0.7 3.5 0.0 0.0 11.8 0.0 1.2 0.8 2.2 0.9 0.6 13.3 3.3 0.1 1.8 2.0 5.7 0.9 0.0 5.2 5.0 0.3 0.2 1.9 5.7 0.0 1.2 1.4 1.6 1.9 0.0 0.0 0.4 9.1 0.8 0.0 0.0 6.8 7.2 0.2 1.1 2.9 4.5 5.9 1.4 0.0 1.7 2.8 5.9 29.7 2.5 1.5 0.7 0.3 5.7 1.6 0.2 0.1 2.0 3.7 2.3 5.7 4.3 3.2 2.5 4.6 0.0 0.0 3.0 0.2 3.0 6.3 2.5 0.8 1.6 2.1 3.0 1.6 3.2 1.8 0.4 2.3 11.5 0.1 2.3 1.3 1.3 4.5 0.6 1.1 1.6 4.3 2.9 0.7 2.8 1.1 3.0 4.5 8.1 28.1 66.2 0.0 3.3 5.1 2.7 7.9 5.2 2.0 1.8 6.6 8.3 0.4 11.7 16.0 23.3 8.1 40.5 8.2 17.3 0.0 82.5 5.6 0.0 203.8 6.2 24.0 0.6 0.3 13.3 10.1 6.4 15.2 0.3 9.8 14.0 4.6 38.4 0.2 0.0 15.5 1.1 4.7 66.6 3.5 22.3 8.9 32.9 GCLC "GCS, GLCL, GLCLC" ENSG00000001084 "Glutamate-cysteine ligase catalytic subunit" P48506 6 53497341-53616970 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 102.4;Intestinal endocrine cells: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 49.2;Hep G2: 42.0;OE19: 68.1;RT4: 45.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009569, HPA036359, HPA036360" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 3600000 Nucleoplasm "Nucleoli, Cytosol" "CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789" "unprognostic (8.41e-2)" "unprognostic (1.27e-2)" "unprognostic (5.65e-2)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (2.76e-1)" "unprognostic (2.60e-1)" "unprognostic (7.50e-2)" "unprognostic (9.94e-3)" "unprognostic (4.67e-3)" "unprognostic (1.30e-1)" "unprognostic (5.23e-2)" "prognostic favorable (3.83e-6)" "unprognostic (3.78e-2)" "unprognostic (8.91e-2)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.30e-2)" 15.8 11.1 12.9 9.0 16.0 14.4 13.0 5.4 15.1 6.8 16.2 21.6 8.2 18.9 9.2 5.3 20.0 29.1 14.9 7.4 13.1 10.6 15.4 69.2 12.9 10.1 21.6 12.2 6.2 12.4 6.6 5.4 6.2 13.0 13.0 12.2 5.2 11.2 10.1 7.0 8.6 14.8 11.9 13.6 16.8 14.8 5.2 17.5 3.1 14.1 32.4 10.6 34.4 12.3 1.6 4.2 2.2 1.9 8.0 2.3 0.6 7.3 49.2 4.0 9.5 4.8 2.2 5.4 3.7 6.0 2.8 3.3 7.2 17.1 14.0 7.1 3.3 21.5 10.5 12.3 27.1 3.8 11.0 7.6 9.3 9.5 42.0 5.5 12.3 5.8 3.4 11.5 3.1 14.1 3.7 4.2 12.3 5.1 4.4 1.3 7.7 10.5 4.9 7.5 68.1 4.6 3.5 2.5 12.3 9.1 45.4 11.7 5.7 6.2 10.0 6.5 6.1 6.8 5.8 5.9 2.5 8.8 6.4 5.5 5.9 9.1 8.1 6.3 8.8 4.2 2.2 1.1 0.6 1.2 1.9 0.8 1.6 1.0 2.3 4.2 1.0 0.6 1.3 0.5 8.0 1.8 3.0 1.6 0.6 12.9 16.0 5.4 11.9 13.1 10.6 21.6 12.2 13.0 17.5 0.0 3.7 7.8 42.9 30.9 12.8 17.8 25.5 48.2 47.8 0.0 23.6 5.2 10.0 12.8 1.4 13.5 19.9 46.7 11.0 6.5 8.7 44.8 2.3 102.4 19.8 7.9 212.1 9.2 60.1 1.0 6.1 16.4 8.5 6.4 16.3 13.8 17.1 8.5 8.9 19.8 4.0 12.9 10.3 3.3 8.1 21.8 6.5 10.7 13.8 89.1 GCLM GLCLR ENSG00000023909 "Glutamate-cysteine ligase modifier subunit" P48507 1 93885205-93909456 "Cancer-related genes, Predicted intracellular proteins" "Glutathione biosynthesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 210.2;Glandular cells: 272.8;Urothelial cells: 201.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009568, HPA023696, CAB040554" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 1000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (8.85e-3)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (4.64e-2)" "prognostic unfavorable (9.83e-6)" "unprognostic (2.37e-1)" "unprognostic (1.07e-1)" "unprognostic (3.53e-1)" "unprognostic (3.51e-2)" "unprognostic (3.89e-2)" "unprognostic (2.19e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (2.34e-3)" 10.3 17.5 7.0 6.0 7.7 11.3 23.9 5.7 8.9 4.5 22.8 4.2 11.5 16.6 3.5 6.5 8.8 12.8 12.5 7.7 6.8 8.9 17.8 41.7 8.4 10.4 9.2 5.7 4.6 6.9 6.3 5.1 10.3 8.7 5.3 5.2 6.4 6.7 6.4 19.2 3.4 20.0 3.4 7.7 6.9 6.1 3.2 2.8 5.6 15.0 23.0 8.6 8.9 8.0 3.2 1.9 3.3 0.7 4.6 6.7 1.2 13.1 20.9 2.3 4.5 7.8 4.9 8.9 15.8 9.8 12.0 9.0 3.5 7.8 5.0 31.6 10.2 39.2 13.3 3.4 6.4 9.7 13.5 4.6 34.9 14.2 15.0 14.6 12.8 5.6 6.0 2.4 24.4 3.9 4.8 13.1 5.7 13.8 7.4 8.6 2.5 9.2 3.0 7.9 12.6 10.0 4.3 7.0 7.3 8.5 15.4 5.4 2.2 14.8 11.7 5.5 27.5 2.6 8.0 13.7 12.6 7.4 23.6 23.6 6.7 8.5 5.2 10.4 7.2 4.4 3.3 0.7 1.3 5.3 0.4 3.1 2.6 5.0 6.7 0.6 3.2 3.2 3.2 2.9 4.6 0.5 1.9 1.3 1.2 7.0 7.7 5.7 8.9 6.8 8.9 9.2 5.7 8.7 2.8 38.7 18.4 13.3 119.7 10.2 23.7 13.5 53.5 49.5 19.4 27.9 5.9 60.1 21.6 24.6 3.0 14.5 25.6 210.2 10.7 16.4 25.0 272.8 19.6 71.6 16.8 31.8 50.4 41.7 17.7 1.9 19.8 15.4 8.5 10.8 9.3 19.3 22.5 7.0 11.7 45.8 12.6 0.0 44.3 22.8 40.4 8.2 37.6 34.6 13.2 201.0 GDF6 "BMP13, KFS, KFS1, SGM1" ENSG00000156466 "Growth differentiation factor 6" Q6KF10 8 96142330-96160792 "Disease related genes, Predicted secreted proteins" Apoptosis "Cytokine, Developmental protein, Growth factor" "Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 11.8;placenta: 16.9" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 2.0;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in some" "renal cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Group enriched" "Detected in some" 6 "hTERT-RPE1: 15.4;LHCN-M2: 24.5;SuSa: 12.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.6" HPA045206 Uncertain Supported "Nucleoplasm,Nuclear membrane,Vesicles" "Secreted to blood" NA NA Vesicles "Nucleoplasm, Nuclear membrane" "HPA045206: AB_10962508" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (9.66e-9)" "unprognostic (6.49e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-3)" "unprognostic (5.37e-2)" "unprognostic (8.13e-3)" "prognostic unfavorable (2.17e-4)" "unprognostic (5.88e-4)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (1.71e-1)" 2.5 0.2 1.4 1.5 0.9 0.0 0.8 0.1 1.7 0.3 1.4 0.3 1.5 0.6 3.0 0.7 0.8 1.0 6.6 11.8 0.9 1.0 0.4 0.7 0.4 1.9 0.9 0.1 2.2 1.3 0.1 0.3 16.9 1.1 0.6 0.5 2.9 0.1 2.7 0.8 0.0 1.6 1.8 0.2 0.1 1.4 1.1 1.1 0.1 1.4 0.1 0.1 3.2 2.1 0.1 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.4 2.9 1.9 0.0 1.7 1.5 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 2.4 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.2 0.0 15.4 0.1 0.0 0.0 0.0 24.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 0.9 0.1 1.7 0.9 1.0 0.9 0.1 1.1 1.1 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.2 0.0 0.0 0.0 GDPD3 MGC4171 ENSG00000102886 "Glycerophosphodiester phosphodiesterase domain containing 3" Q7L5L3 16 30104810-30113856 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 50.9;Extravillous trophoblasts: 52.5;Late spermatids: 201.8;Proximal tubular cells: 62.4" "Cancer enhanced" "Detected in all" "urothelial cancer: 21.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "eosinophil: 1.6;neutrophil: 5.1" "Lineage enriched" "Detected in single" 19 "granulocytes: 5.1" "Group enriched" "Detected in many" 5 "MCF7: 13.7;OE19: 16.9;SK-BR-3: 48.5" "Region enhanced" "Detected in single" "cerebellum: 0.9" "Low region specificity" "Detected in many" "HPA041148, HPA041470" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041148: AB_10794545, HPA041470: AB_10795121" "unprognostic (4.12e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (9.99e-2)" "unprognostic (2.53e-1)" "unprognostic (4.57e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.53e-1)" "unprognostic (8.86e-3)" "unprognostic (6.59e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.89e-9)" "unprognostic (3.11e-1)" "unprognostic (3.13e-1)" "unprognostic (1.12e-1)" "unprognostic (8.79e-3)" 3.0 0.9 1.2 10.5 1.2 0.5 2.5 5.7 1.3 9.4 11.3 1.2 1.2 4.0 2.8 3.4 30.8 2.1 3.6 1.7 1.2 0.7 5.9 1.2 3.7 2.3 1.2 1.2 3.3 1.2 0.4 2.3 12.9 2.5 2.4 7.4 1.2 4.9 1.2 1.3 5.3 8.6 2.4 1.2 4.1 8.3 1.2 1.2 1.9 2.3 36.6 40.8 2.7 9.2 0.1 0.0 5.1 0.2 0.0 0.2 0.0 5.3 0.0 1.9 0.5 0.5 2.8 1.6 0.5 0.4 0.5 0.6 0.6 3.7 0.6 0.7 0.3 0.1 0.5 0.5 0.2 0.5 1.0 1.5 0.1 0.8 2.5 0.5 0.2 0.4 0.1 0.7 1.5 0.1 1.5 2.1 2.0 0.4 0.9 0.7 13.7 0.4 0.9 1.1 16.9 0.2 2.5 0.6 2.9 1.1 2.4 0.5 0.9 0.0 48.5 0.3 0.5 0.9 1.0 1.5 0.5 0.5 1.1 0.5 1.6 0.3 0.6 1.4 0.8 0.3 0.1 0.0 1.6 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 5.1 0.0 0.1 0.0 0.1 0.0 1.2 1.2 5.7 1.3 1.2 0.7 1.2 1.2 2.5 1.2 6.0 0.6 0.0 0.6 1.1 1.1 0.9 0.0 1.4 1.2 5.2 0.0 20.4 5.0 1.0 50.9 4.0 43.6 0.0 1.2 52.5 2.1 1.4 0.0 0.0 2.8 1.6 3.4 3.7 3.0 201.8 3.1 0.7 1.7 1.0 28.5 0.2 11.2 12.9 2.8 62.4 1.7 6.5 1.4 1.2 1.2 1.8 7.8 1.5 4.7 3.9 GEMIN2 SIP1 ENSG00000092208 "Gem nuclear organelle associated protein 2" O14893 14 39114223-39136973 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015426, HPA046570, HPA057114" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340" "unprognostic (4.53e-1)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.88e-6)" "unprognostic (8.62e-3)" "unprognostic (3.05e-2)" "unprognostic (1.99e-3)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (4.53e-3)" "unprognostic (1.52e-1)" "unprognostic (1.58e-1)" "unprognostic (3.95e-1)" "unprognostic (6.78e-2)" 10.0 8.2 13.2 8.1 16.9 15.2 13.3 15.7 15.2 10.1 9.5 10.9 5.2 11.4 9.3 12.5 10.2 9.9 7.2 12.4 13.8 10.1 8.2 9.2 9.1 14.1 11.0 13.8 11.3 8.5 4.3 16.1 9.0 13.4 8.4 10.9 8.9 7.7 7.7 18.9 10.4 8.0 12.6 12.4 9.5 8.4 13.2 12.8 11.9 9.8 9.9 13.3 11.3 9.6 17.1 15.8 8.9 12.6 11.6 15.5 8.7 11.6 16.7 16.5 12.0 5.8 6.7 8.5 5.5 4.4 14.9 14.8 14.6 13.7 17.2 11.6 4.7 5.3 8.9 22.1 9.4 15.7 8.8 12.9 10.0 10.2 36.2 11.8 15.2 6.6 3.6 9.0 9.4 13.5 4.4 13.0 15.2 11.9 12.6 8.3 23.1 16.6 14.6 11.5 14.1 18.8 15.5 18.0 10.8 8.3 7.6 16.1 3.2 11.7 9.0 6.0 9.4 20.5 6.7 5.3 6.9 10.2 6.7 9.0 13.2 20.5 25.2 3.3 16.2 9.6 8.1 12.3 8.9 14.3 12.6 10.1 15.4 13.2 14.0 15.6 17.1 14.9 15.5 3.4 11.6 10.4 15.8 11.4 8.7 13.2 16.9 15.7 15.2 13.8 10.1 11.0 13.8 13.4 12.8 6.0 3.0 7.5 7.2 7.6 6.3 5.2 2.5 13.4 6.8 5.2 9.8 12.3 10.0 9.9 33.1 8.0 1.8 0.0 5.6 15.4 11.2 5.3 5.7 5.8 10.0 4.8 3.5 9.8 10.0 32.0 8.3 6.6 6.8 7.2 6.7 7.1 6.1 0.0 9.2 11.5 6.4 6.5 5.2 19.3 14.7 6.9 3.2 10.2 8.8 4.2 GFOD1 "ADG-90, C6orf114, FLJ20330" ENSG00000145990 "Glucose-fructose oxidoreductase domain containing 1" Q9NXC2 6 13357830-13487662 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 12.8;NK-cell: 11.4" "Group enriched" "Detected in many" 5 "granulocytes: 12.8;NK-cells: 11.4" "Cell line enhanced" "Detected in many" "HEL: 18.8;HMC-1: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029096 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted - unknown location" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029096: AB_10602320" "unprognostic (5.00e-2)" "unprognostic (1.34e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.29e-5)" "unprognostic (8.49e-2)" "unprognostic (1.95e-3)" "unprognostic (1.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.34e-2)" "unprognostic (3.11e-2)" "unprognostic (6.49e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (6.72e-5)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (4.66e-3)" 15.7 3.8 9.4 4.6 11.5 17.5 8.7 28.5 22.3 5.4 5.0 4.0 0.5 3.5 4.0 2.6 12.1 4.3 11.8 18.5 11.9 7.1 2.1 6.6 8.2 6.6 6.3 14.2 1.7 2.3 3.9 3.3 6.8 6.6 4.4 5.2 1.5 3.4 3.0 15.5 4.7 5.6 8.3 4.2 12.0 8.2 1.5 4.1 1.9 3.9 4.5 6.9 4.7 7.6 2.3 0.2 12.8 0.8 11.4 1.4 0.8 7.4 0.7 0.6 1.3 1.1 1.1 0.8 0.6 0.3 0.4 0.2 0.2 0.5 10.2 10.6 0.7 0.6 6.6 2.0 3.2 0.4 0.7 3.8 18.8 3.9 3.9 1.5 5.4 29.1 0.6 2.5 1.0 2.8 1.6 5.7 2.7 0.6 0.9 0.8 2.4 1.2 3.3 1.0 2.5 2.2 4.1 1.4 5.2 0.3 1.4 3.5 0.6 2.5 0.4 2.4 1.4 0.6 0.5 7.7 0.9 2.0 2.2 3.3 8.5 4.8 12.2 0.8 3.2 0.2 0.1 0.4 12.8 1.4 0.7 0.2 2.3 0.2 0.6 0.2 1.9 0.1 0.5 0.3 11.4 0.8 0.0 0.1 0.8 9.4 11.5 28.5 18.7 11.9 7.1 6.3 14.2 6.6 4.1 0.0 2.6 12.7 4.9 18.0 38.9 87.7 12.7 12.0 0.0 0.0 0.0 0.4 0.0 4.3 0.0 36.2 13.5 46.7 2.7 27.6 5.8 2.3 4.6 16.8 2.4 1.6 8.1 33.2 15.8 0.0 2.3 10.4 11.8 0.0 11.8 2.0 18.1 31.7 1.1 0.5 3.0 12.9 20.8 0.0 1.7 19.6 0.6 34.8 3.3 4.7 GFPT1 "GFA, GFAT, GFAT1, GFPT" ENSG00000198380 "Glutamine--fructose-6-phosphate transaminase 1" Q06210 2 69319769-69387254 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms" "Aminotransferase, Transferase" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Mucus-secreting cells: 215.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047240 Approved "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli" "Nucleoli fibrillar center" "HPA047240: " "unprognostic (4.38e-3)" "unprognostic (8.20e-2)" "prognostic favorable (7.13e-5)" "unprognostic (2.97e-1)" "unprognostic (1.32e-1)" "unprognostic (2.40e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (2.99e-1)" "unprognostic (3.14e-1)" "unprognostic (4.84e-2)" "unprognostic (5.00e-2)" "unprognostic (3.83e-2)" "unprognostic (9.49e-2)" "unprognostic (1.78e-1)" "unprognostic (1.63e-1)" "unprognostic (2.58e-1)" 16.7 11.4 6.4 12.7 7.8 5.6 18.3 7.8 10.1 16.8 27.0 6.4 41.2 14.5 10.1 18.7 11.6 9.5 19.4 11.3 6.0 9.8 17.8 49.1 14.1 4.7 6.5 5.7 11.1 34.9 13.9 39.6 36.5 7.0 17.2 27.5 7.7 39.7 34.0 9.2 6.1 28.2 8.7 6.2 8.2 24.6 13.9 4.8 8.5 35.2 7.7 18.1 10.6 16.2 5.6 4.1 5.9 3.4 4.1 6.8 3.0 9.6 6.7 8.7 5.4 24.2 16.7 18.7 18.5 17.2 8.7 11.1 21.4 8.8 8.7 6.7 17.1 10.9 4.7 10.8 5.6 14.4 7.9 4.1 10.1 5.0 22.1 28.7 6.9 4.0 10.5 27.6 16.9 32.4 12.1 8.1 7.5 8.4 14.2 17.0 5.7 7.2 7.2 11.2 19.9 5.6 7.3 18.0 4.4 14.2 7.7 5.3 3.0 6.9 12.8 24.7 18.7 5.1 4.3 12.4 7.8 10.4 13.3 8.8 10.2 6.8 6.6 12.7 4.7 8.9 5.9 2.8 3.4 6.8 3.2 6.5 5.6 6.1 6.6 3.6 3.4 6.1 5.6 1.3 4.1 3.4 4.1 4.3 3.0 6.4 7.8 7.8 10.1 6.0 9.8 6.5 5.7 7.0 4.8 47.6 43.8 21.6 18.1 25.2 14.6 39.1 43.3 62.9 45.5 41.8 11.8 23.5 14.9 29.0 71.7 15.1 126.6 0.0 78.9 58.2 37.0 83.5 24.2 49.7 15.2 6.4 72.2 19.6 8.8 12.1 21.6 14.3 50.6 39.7 215.3 10.9 58.8 74.8 26.5 24.3 13.7 19.4 31.7 89.0 45.3 18.3 28.7 16.6 120.1 30.1 GGA1 ENSG00000100083 "Golgi associated, gamma adaptin ear containing, ARF binding protein 1" Q9UJY5 22 37608475-37633564 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.8" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 173.5;Spermatocytes: 198.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048280, HPA051016" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA048280: AB_2680338, HPA051016: AB_2681312" "unprognostic (1.64e-1)" "unprognostic (1.42e-2)" "unprognostic (4.08e-1)" "unprognostic (9.23e-3)" "unprognostic (2.00e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.42e-2)" "unprognostic (1.53e-2)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.16e-3)" 10.7 15.8 13.5 12.2 14.0 17.3 10.8 21.8 18.4 11.6 10.6 19.3 14.5 13.1 12.9 14.1 13.3 13.8 11.8 10.2 12.5 10.6 12.0 14.1 10.9 14.0 17.7 13.2 18.1 13.9 20.6 19.4 12.5 13.5 12.0 9.6 17.7 16.7 16.7 17.1 17.1 12.0 9.3 14.2 15.8 12.8 83.8 16.6 12.1 15.4 9.9 14.2 10.6 11.0 6.4 5.0 4.9 7.7 7.6 18.0 7.6 18.4 12.9 16.2 15.7 14.2 11.7 17.8 15.2 12.3 13.5 15.0 11.5 10.5 28.3 10.4 10.9 8.3 17.2 14.3 17.0 12.4 24.2 23.8 11.2 23.2 12.3 13.9 27.5 21.9 14.2 15.2 19.1 12.1 22.1 12.6 14.4 22.6 18.4 13.8 17.6 12.2 29.5 12.7 18.6 13.3 13.6 13.0 12.1 13.9 15.0 14.9 26.5 9.7 20.4 23.6 16.1 21.3 20.0 15.1 18.4 18.0 16.5 12.1 39.7 15.9 29.3 20.6 16.7 16.1 4.9 7.7 4.3 14.0 7.6 17.3 6.4 5.6 18.0 5.0 4.1 4.2 13.0 3.3 7.6 5.5 4.3 5.8 7.6 13.5 14.0 21.8 18.4 12.5 10.6 17.7 13.2 13.5 16.6 23.8 36.3 43.5 27.8 21.5 53.9 15.9 15.3 34.8 22.7 41.8 78.5 30.7 5.0 30.2 118.6 26.2 53.9 0.0 17.7 31.6 17.1 20.5 48.5 18.1 69.1 23.8 31.2 32.5 44.8 173.5 24.5 44.5 15.1 46.9 35.7 41.0 27.7 42.1 21.2 10.3 73.2 25.8 21.2 198.9 40.2 25.0 47.5 91.4 34.6 30.1 GIPC1 "C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2" ENSG00000123159 "GIPC PDZ domain containing family member 1" O14908 19 14477760-14496149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 262.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043958, HPA061786" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA043958: AB_10963436, HPA061786: AB_2756319" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (8.21e-2)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (4.82e-2)" "unprognostic (3.53e-2)" "unprognostic (7.72e-2)" "unprognostic (1.04e-2)" "unprognostic (7.17e-3)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" 16.4 15.1 17.4 12.0 21.0 2.0 11.2 12.1 28.8 19.4 51.0 29.7 15.3 14.2 11.9 14.9 71.2 14.4 21.2 17.9 16.9 14.8 18.7 16.9 20.5 7.9 18.3 23.0 10.2 15.1 6.5 12.4 24.0 23.0 14.0 23.9 15.2 22.1 19.6 26.8 40.4 13.3 15.8 21.8 10.8 35.7 6.5 16.6 11.1 18.2 26.0 24.7 17.1 26.3 2.0 4.0 2.4 1.2 1.5 12.1 1.9 66.0 30.7 9.4 14.7 8.7 8.8 7.4 24.8 12.6 20.5 18.6 16.4 25.1 0.9 46.8 17.5 13.7 38.0 8.0 20.8 7.0 6.8 14.4 12.9 21.0 16.0 26.8 1.3 16.0 10.1 20.8 12.4 10.9 12.2 13.8 9.8 6.0 11.4 10.4 49.3 4.2 2.6 10.2 37.0 30.8 4.4 7.9 8.8 25.2 57.9 8.8 9.8 13.9 34.3 31.8 5.1 21.5 7.2 23.8 29.0 16.0 40.4 26.5 10.7 13.6 3.3 24.3 10.5 30.4 2.4 0.8 0.1 5.8 1.2 5.4 2.0 5.9 5.9 1.2 1.0 4.9 3.9 0.3 1.5 0.5 4.0 12.1 1.9 17.4 21.0 12.1 28.8 16.9 14.8 18.3 23.0 23.0 16.6 26.8 14.6 11.5 47.9 101.2 65.6 12.9 17.8 4.0 15.9 78.5 33.4 29.4 44.7 162.1 0.8 27.0 262.4 0.0 146.8 55.5 40.6 96.5 10.3 16.4 46.4 71.5 41.3 19.0 9.5 1.9 19.0 13.8 55.6 37.9 62.6 60.8 195.2 130.6 23.7 38.4 38.1 19.4 38.2 7.4 20.6 148.3 21.5 13.8 65.5 154.2 GIPC3 "C19orf64, DFNB15, DFNB72, DFNB95" ENSG00000179855 "GIPC PDZ domain containing family member 3" Q8TF64 19 3585553-3593541 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Ito cells: 16.0;Rod photoreceptor cells: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Lineage enriched" "Detected in single" 9 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 12.3;HMC-1: 7.9;THP-1: 14.8;WM-115: 29.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067765 Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA 13000 Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA067765: " "unprognostic (1.77e-1)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (6.99e-2)" "unprognostic (1.22e-1)" "unprognostic (1.76e-2)" "unprognostic (1.41e-1)" "unprognostic (3.67e-3)" "unprognostic (4.76e-2)" "unprognostic (2.97e-1)" "unprognostic (5.06e-3)" "unprognostic (2.26e-2)" "unprognostic (1.51e-3)" "unprognostic (1.96e-2)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (9.06e-2)" 5.5 2.4 1.3 1.3 1.3 0.0 3.0 1.3 1.3 3.4 1.5 1.9 5.0 1.0 4.5 3.2 6.0 2.2 2.1 2.7 1.3 0.6 4.1 1.6 4.5 2.0 1.3 1.3 1.3 1.3 4.6 1.3 1.3 1.3 4.3 1.3 1.9 1.3 5.2 1.3 1.1 5.4 9.3 1.3 4.8 2.0 1.3 2.2 2.0 3.8 1.3 1.4 1.3 13.0 0.1 0.1 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 1.0 0.0 0.1 4.4 12.3 0.0 0.5 0.0 7.9 0.1 0.0 0.7 0.0 0.0 1.4 0.1 2.0 0.0 0.2 0.0 0.0 0.7 0.5 0.0 0.8 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.3 0.0 3.0 0.8 0.0 14.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 29.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.3 1.3 1.3 1.3 1.3 1.3 0.6 1.3 1.3 1.3 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 16.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 20.5 0.0 1.2 0.0 0.4 0.3 0.1 0.0 0.0 0.0 GJA1 "CX43, GJAL, ODD, ODDD, ODOD, SDTY3" ENSG00000152661 "Gap junction protein alpha 1" P17302 6 121435692-121449727 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cancer-related genes, Cataract, Disease mutation, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 232.3;Basal keratinocytes: 208.6;Cardiomyocytes: 174.1;Fibroblasts: 139.5;Suprabasal keratinocytes: 330.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 73.4;HUVEC TERT2: 56.2;NTERA-2: 57.2;SuSa: 74.9;U-87 MG: 55.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010753, HPA035097, HPA047551, HPA069245" Enhanced Supported Supported "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" Nucleoplasm "CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: " "unprognostic (3.37e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-1)" "unprognostic (4.18e-2)" "unprognostic (1.48e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (2.89e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.00e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (3.00e-3)" 19.7 65.2 78.6 5.5 69.7 0.4 14.2 32.4 44.4 64.5 4.0 23.8 6.1 4.2 23.5 5.5 17.3 7.8 23.0 36.0 87.3 25.5 3.6 2.5 15.2 4.4 42.9 39.9 10.5 4.5 94.7 5.7 63.8 53.7 20.0 4.8 26.3 7.1 35.7 3.4 86.3 4.4 25.6 38.7 1.1 6.4 8.3 64.3 0.5 38.9 9.9 7.6 14.8 32.2 0.5 0.5 0.4 0.5 0.0 0.4 0.0 0.0 6.6 29.3 0.0 16.0 9.9 0.0 21.9 44.6 7.4 18.1 0.1 0.0 0.0 2.4 8.5 6.3 2.8 0.7 13.4 24.1 0.0 8.0 0.3 2.7 0.0 20.0 0.0 0.0 26.4 14.5 27.1 9.8 73.4 56.2 0.0 0.0 0.6 1.4 1.2 0.0 11.7 57.2 0.0 7.3 0.0 0.0 0.5 29.6 3.2 0.0 0.4 0.0 0.0 0.0 74.9 2.3 0.0 41.3 22.8 6.3 19.2 14.1 0.0 0.0 0.0 55.7 0.0 3.2 0.4 0.5 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.5 0.4 0.4 0.0 0.0 0.1 0.5 0.1 0.0 78.6 69.7 32.4 42.8 87.3 25.5 42.9 39.9 53.7 64.3 232.3 73.8 0.0 121.0 208.6 0.2 174.1 0.0 5.3 14.8 1.8 2.0 46.7 0.0 69.9 0.3 111.0 0.0 0.0 3.5 8.1 139.5 19.9 8.1 0.0 7.5 0.0 0.0 22.7 0.3 1.1 2.3 2.8 42.2 1.0 0.0 0.1 17.0 0.0 3.9 0.0 0.2 0.0 27.8 0.3 0.1 330.6 16.7 0.0 0.0 45.0 GLI3 "ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV" ENSG00000106571 "GLI family zinc finger 3" P10071 7 41960950-42237870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 31.6" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 20.8;Syncytiotrophoblasts: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.6;WM-115: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005534 Approved Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA005534: AB_1078973" "unprognostic (2.53e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (8.22e-3)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.35e-3)" "unprognostic (2.24e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-1)" "unprognostic (3.54e-2)" "unprognostic (1.48e-5)" "unprognostic (9.13e-3)" "unprognostic (5.41e-2)" "unprognostic (3.21e-3)" "unprognostic (7.00e-2)" 7.3 2.6 4.6 6.8 5.4 0.3 9.4 0.8 6.4 21.1 13.1 2.9 10.9 1.4 31.6 10.0 7.3 10.8 7.0 2.0 4.2 1.7 2.3 0.7 5.8 2.4 1.8 2.1 17.6 1.5 0.8 1.9 13.4 1.8 10.6 3.8 5.1 3.7 14.3 2.2 9.7 4.2 13.8 0.9 1.8 3.8 2.3 3.0 1.7 6.1 8.7 4.0 6.4 9.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 26.6 0.2 6.9 12.6 1.7 1.6 5.6 4.8 5.6 0.1 0.0 0.0 1.0 11.1 6.2 5.5 3.6 4.3 4.1 0.0 3.3 0.0 3.3 0.0 4.4 0.0 0.1 10.4 6.3 5.0 4.0 2.8 4.4 2.9 0.0 0.1 2.2 2.4 0.3 0.0 12.0 0.0 10.1 6.3 0.1 0.7 0.0 4.4 0.7 0.0 2.6 3.3 2.0 11.4 4.4 0.0 4.6 5.9 8.5 8.2 2.8 0.0 0.0 0.0 4.4 0.1 19.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 5.4 0.8 6.4 4.2 1.7 1.8 2.1 1.8 3.0 0.0 4.8 0.0 6.8 20.8 1.8 1.4 0.0 1.4 1.2 1.8 0.0 17.7 0.0 0.0 11.6 2.8 0.0 0.0 0.0 12.0 18.1 3.2 1.1 0.0 2.8 0.0 0.0 2.5 0.3 4.3 17.8 0.0 8.5 0.0 0.0 11.8 0.1 0.0 3.2 3.4 0.8 12.9 14.6 0.4 0.9 13.6 28.6 0.0 0.0 3.7 GLO1 GLOD1 ENSG00000124767 "Glyoxalase I" Q04760 6 38675925-38703141 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HMC-1: 249.9" "Low region specificity" "Detected in all" "CAB040541, CAB040542, HPA059791" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 1600000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB040541: , CAB040542: , HPA059791: AB_2684126" "unprognostic (4.33e-2)" "unprognostic (1.09e-1)" "unprognostic (4.37e-2)" "unprognostic (1.08e-2)" "unprognostic (3.96e-3)" "unprognostic (2.51e-1)" "prognostic unfavorable (5.21e-4)" "unprognostic (5.09e-2)" "unprognostic (2.10e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (8.71e-2)" "unprognostic (1.20e-2)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (2.54e-1)" "unprognostic (6.21e-2)" 22.2 30.5 42.1 19.5 42.3 11.4 32.0 25.4 42.3 27.1 42.1 19.7 22.9 48.1 25.3 49.2 28.2 31.5 17.8 39.2 37.8 37.7 37.1 65.3 30.7 31.6 38.9 29.7 37.6 25.9 33.2 12.6 26.7 40.6 74.0 22.7 21.7 21.7 28.2 57.5 31.3 64.3 28.9 37.6 25.6 21.3 12.9 21.4 19.8 32.6 42.5 24.3 28.6 24.7 25.9 28.6 8.5 15.6 10.8 24.4 14.7 18.5 8.6 24.8 24.6 11.8 21.3 21.9 16.2 15.4 22.8 23.8 20.9 7.1 20.7 12.8 12.9 27.2 12.3 21.2 20.9 28.9 18.8 32.7 30.6 11.1 19.5 17.7 11.6 249.9 18.2 12.9 21.6 15.5 14.9 24.6 14.7 24.1 13.8 21.3 15.7 18.1 14.8 17.8 16.6 16.9 15.8 30.0 13.5 20.8 14.1 19.3 19.5 11.4 15.9 30.5 17.8 18.4 58.4 10.1 17.8 16.4 15.4 25.6 10.9 20.5 56.8 6.4 30.1 28.5 8.5 9.8 6.9 18.0 15.6 24.4 24.7 18.1 18.3 18.3 25.9 17.1 17.9 1.2 10.8 12.1 28.6 15.7 14.7 42.1 42.3 25.4 42.3 37.8 37.7 38.9 29.7 40.6 21.4 122.1 136.6 86.9 79.7 57.5 55.3 121.3 48.4 88.3 91.0 85.5 19.6 91.3 210.5 107.2 3.6 70.9 36.2 0.0 64.3 264.4 68.8 192.8 67.2 86.8 68.4 65.2 35.1 200.1 112.1 4.7 77.6 69.2 99.5 129.8 41.3 160.8 66.2 35.7 103.3 107.3 50.7 45.3 65.9 11.9 15.7 77.0 61.2 59.9 55.5 125.1 GMFB GMF ENSG00000197045 "Glia maturation factor beta" P60983 14 54474484-54489196 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Approved Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 1000000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (7.93e-2)" "unprognostic (7.69e-3)" "unprognostic (4.81e-3)" "unprognostic (2.99e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.48e-2)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "prognostic favorable (9.48e-5)" "unprognostic (1.80e-1)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (9.09e-2)" 14.2 13.2 37.9 12.9 26.7 14.2 15.3 25.1 41.6 11.8 19.8 23.9 6.1 19.1 11.6 8.5 9.3 8.4 9.7 9.6 36.7 30.1 19.9 14.7 13.8 13.3 36.9 28.3 9.8 7.3 10.1 13.6 17.9 25.6 9.0 20.7 6.6 7.0 8.0 4.1 7.8 17.5 10.5 54.4 10.1 10.7 6.2 21.7 6.4 12.8 6.1 13.5 10.0 7.4 9.1 12.8 16.4 14.5 9.0 8.8 6.8 30.9 12.6 25.1 18.4 27.2 34.0 18.8 31.8 23.4 23.1 28.9 14.4 27.5 28.5 15.0 31.2 13.9 11.5 25.3 22.0 36.6 10.3 8.7 14.3 14.1 13.3 23.2 19.9 12.5 25.7 20.6 20.0 19.8 24.1 20.8 13.2 10.4 10.1 36.5 15.4 12.1 7.7 16.2 17.6 13.4 12.3 29.5 8.2 29.5 29.5 14.9 23.2 22.1 18.9 24.1 21.7 20.8 15.8 16.4 33.6 25.5 17.0 19.7 3.6 6.3 17.8 28.3 12.3 21.2 8.7 11.0 9.2 6.1 13.5 8.5 7.6 7.2 6.0 12.8 9.1 7.8 8.2 16.4 9.0 14.5 5.2 8.8 6.8 37.9 26.7 25.1 33.5 36.7 30.1 36.9 28.3 25.6 21.7 23.8 14.4 20.4 43.8 53.1 17.7 15.0 22.9 8.1 19.4 24.4 3.9 33.3 18.3 34.4 20.5 17.5 29.2 0.0 20.1 73.0 27.8 40.5 21.8 23.6 41.6 20.6 28.7 16.0 30.4 3.9 18.7 44.4 43.9 37.9 30.3 17.7 30.2 31.6 14.9 40.9 14.6 12.9 26.8 12.6 9.8 38.1 48.7 22.4 32.6 39.2 GMFG ENSG00000130755 "Glia maturation factor gamma" O60234 19 39328353-39342372 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 276.5;bone marrow: 80.9;lymphoid tissue: 109.5" "Cell type enhanced" "Detected in many" 8 "B-cells: 303.1;Hofbauer cells: 397.1;Ito cells: 301.4;Kupffer cells: 575.9;Macrophages: 461.8;T-cells: 456.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 77.0;JURKAT: 55.8;Karpas-707: 59.8;NB-4: 43.6;REH: 49.0;THP-1: 76.8;U-937: 52.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Uncertain Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 1500000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (1.22e-2)" "prognostic favorable (7.35e-4)" "unprognostic (2.37e-2)" "unprognostic (1.21e-3)" "unprognostic (9.93e-2)" "unprognostic (2.14e-2)" "unprognostic (1.19e-1)" "unprognostic (4.84e-2)" "unprognostic (1.00e-1)" "unprognostic (2.09e-1)" "unprognostic (3.09e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.11e-6)" "unprognostic (3.01e-1)" "unprognostic (8.76e-3)" "unprognostic (1.06e-1)" "unprognostic (5.27e-3)" 22.6 6.1 7.3 29.6 7.4 80.9 16.8 2.2 4.8 6.0 8.8 4.0 1.7 5.3 4.4 9.4 6.4 7.3 8.7 7.5 6.0 4.9 9.4 9.7 28.5 42.2 8.6 2.3 4.7 3.6 1.1 3.1 18.0 5.8 6.1 7.9 4.9 8.1 2.3 5.4 4.2 17.8 6.8 8.2 86.0 5.9 2.9 5.6 109.5 9.8 7.0 37.1 11.1 7.5 39.1 57.2 276.5 79.4 41.6 88.0 106.7 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.8 33.5 0.3 0.0 0.0 0.2 0.0 0.1 0.1 11.3 0.0 36.4 0.0 0.5 0.6 39.0 77.0 0.1 0.0 0.0 0.1 0.1 2.0 55.8 1.3 59.8 0.3 0.0 35.5 43.6 0.0 0.0 0.0 49.0 0.4 21.9 0.0 5.2 0.1 0.0 0.1 0.2 0.2 0.0 0.1 76.8 20.0 0.0 0.4 0.1 0.1 3.4 11.6 38.3 0.2 52.7 0.3 185.2 79.4 178.1 37.7 72.3 40.0 39.1 56.7 46.6 57.2 35.0 55.9 46.4 276.5 41.6 78.9 22.2 88.0 106.7 7.3 7.4 2.2 4.8 6.0 4.9 8.6 2.3 5.8 5.6 26.8 152.0 303.1 2.8 16.6 0.0 3.1 10.2 16.0 31.8 0.0 0.0 3.0 0.0 0.8 9.5 165.1 0.3 23.3 0.6 3.4 16.0 1.1 229.0 5.5 397.1 0.0 0.0 301.4 575.9 18.8 1.7 461.8 70.9 127.2 0.3 0.3 0.3 0.0 0.4 3.9 0.0 45.3 14.6 8.1 3.0 12.9 4.6 456.6 0.3 1.4 GMIP ARHGAP46 ENSG00000089639 "GEM interacting protein" Q9P107 19 19629476-19643667 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 20.7;Kupffer cells: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042484, HPA045481" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042484: AB_2678018, HPA045481: AB_2679343" "unprognostic (7.54e-2)" "unprognostic (5.35e-3)" "unprognostic (3.10e-3)" "unprognostic (4.54e-3)" "unprognostic (1.44e-1)" "unprognostic (1.24e-3)" "unprognostic (1.23e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.85e-2)" "unprognostic (6.75e-3)" "prognostic unfavorable (3.97e-5)" "prognostic favorable (3.03e-4)" "unprognostic (4.92e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.15e-4)" 6.1 2.8 3.5 20.3 4.9 31.0 4.0 0.9 4.1 2.9 6.9 4.3 2.7 7.0 2.7 3.2 6.2 4.4 7.9 3.3 4.3 3.4 4.2 3.9 11.7 28.0 4.2 2.5 2.4 4.6 10.6 3.0 3.9 3.4 4.1 4.6 2.7 6.0 4.5 1.5 4.9 15.3 2.9 4.9 40.0 11.1 2.2 3.1 26.8 6.2 2.7 23.2 6.1 4.5 6.6 6.7 32.7 13.9 4.2 6.4 4.6 4.4 2.1 2.8 3.0 3.1 1.6 11.2 2.8 2.5 1.7 1.6 1.7 6.1 11.0 5.8 2.0 2.2 5.4 1.8 3.1 1.1 3.8 2.8 3.5 3.3 1.8 0.9 9.8 43.8 2.0 2.1 1.8 1.0 2.0 3.8 9.9 2.3 4.0 1.8 6.6 6.1 16.2 1.6 5.8 3.8 10.6 1.2 6.3 3.2 10.7 2.4 7.2 3.9 4.1 1.6 2.2 3.8 14.1 7.0 3.2 1.8 3.6 2.1 2.0 0.8 9.1 2.0 12.9 2.1 2.9 8.3 21.5 6.4 10.6 5.9 5.9 4.0 5.7 6.7 6.6 4.5 4.6 32.7 4.2 13.9 6.1 4.5 4.6 3.5 4.9 0.9 4.1 4.3 3.4 4.2 2.5 3.4 3.1 0.0 15.1 15.6 1.1 1.0 0.0 0.6 2.5 1.4 2.3 0.0 0.0 0.5 0.0 3.8 0.1 1.4 13.3 0.0 4.2 4.6 0.9 1.6 6.9 0.9 20.7 0.0 0.0 2.5 34.3 0.0 0.6 16.5 1.7 17.2 6.3 0.2 9.4 12.2 0.7 0.6 0.0 0.0 0.9 0.1 1.5 1.0 0.7 15.9 5.8 2.6 GNAI1 ENSG00000127955 "G protein subunit alpha i1" P63096 7 80133955-80219402 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 195.4;Suprabasal keratinocytes: 187.2;Syncytiotrophoblasts: 153.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "NK-cell: 20.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 20.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022449, HPA042141" Approved Supported Nucleoplasm,Nucleoli,Centrosome NA NA 9000000 Centrosome "Nucleoplasm, Nucleoli" "CAB022449: , HPA042141: AB_2677870" "unprognostic (2.29e-1)" "unprognostic (2.83e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-1)" "unprognostic (7.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (5.09e-4)" "unprognostic (9.78e-2)" "unprognostic (1.26e-1)" "unprognostic (4.48e-1)" "unprognostic (9.41e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.12e-1)" "unprognostic (1.94e-2)" "unprognostic (1.53e-1)" 33.2 23.4 17.2 5.4 26.2 1.5 14.4 14.4 33.7 9.4 10.5 36.9 3.0 6.9 10.0 3.0 16.6 9.0 8.6 5.7 23.8 18.3 25.9 13.1 10.3 3.4 40.3 21.9 14.3 5.4 2.5 7.3 30.4 26.2 10.1 9.0 2.8 4.9 9.5 4.2 32.4 5.3 12.2 49.7 5.7 8.3 11.1 32.0 0.9 11.1 3.2 4.6 15.5 9.0 0.1 3.7 2.1 1.5 20.0 2.3 0.7 2.9 20.8 19.0 0.1 23.7 15.2 8.7 12.6 15.2 11.2 13.9 0.0 3.2 0.1 4.1 13.5 9.6 3.0 10.6 12.9 14.9 0.1 9.7 17.8 18.3 1.3 24.0 2.3 3.8 16.3 32.8 6.0 17.3 9.1 7.5 0.0 1.4 0.0 21.0 0.5 0.1 0.1 5.5 0.1 7.5 8.3 7.3 8.9 33.5 10.0 13.9 9.6 13.5 0.2 10.8 16.3 2.6 0.4 13.3 25.1 17.7 5.8 4.7 0.1 0.0 0.1 6.6 1.3 11.1 2.1 0.7 0.7 0.1 0.7 0.0 0.0 0.3 0.2 3.7 0.1 2.3 0.9 0.3 20.0 1.5 0.3 0.2 0.7 17.2 26.2 14.4 25.5 23.8 18.3 40.3 21.9 26.2 32.0 17.9 14.4 0.8 17.7 195.4 3.7 6.1 15.3 36.1 13.6 27.9 0.0 72.1 74.6 6.5 0.9 24.0 2.9 0.0 3.3 66.5 57.4 6.1 27.9 16.8 8.7 25.4 19.1 18.4 1.0 3.5 31.1 5.8 97.8 4.6 7.3 46.1 6.8 7.0 70.0 9.8 5.0 109.9 38.2 6.2 40.1 187.2 153.4 0.0 8.5 14.5 GNAI2 "GIP, GNAI2B" ENSG00000114353 "G protein subunit alpha i2" P04899 3 50226292-50259355 "Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007704 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 53000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA007704: AB_1849230" "prognostic favorable (1.03e-4)" "unprognostic (3.89e-1)" "unprognostic (3.35e-2)" "unprognostic (8.40e-3)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (2.59e-2)" "unprognostic (3.23e-1)" "unprognostic (1.08e-3)" "unprognostic (6.01e-2)" "unprognostic (7.00e-3)" "unprognostic (1.12e-1)" "unprognostic (6.24e-3)" "unprognostic (1.44e-1)" "unprognostic (4.30e-2)" "unprognostic (4.33e-2)" "unprognostic (1.38e-1)" 81.9 37.8 50.8 69.5 47.2 102.5 53.4 17.7 45.3 56.2 47.9 67.2 34.5 22.6 51.4 41.1 44.4 47.1 55.5 57.0 44.6 48.0 34.1 50.9 72.8 78.7 53.3 34.3 54.0 21.4 24.9 42.1 81.3 46.8 44.3 22.5 38.5 25.8 60.0 29.6 29.0 35.7 53.6 81.8 96.7 30.1 28.5 45.9 70.0 37.7 32.4 55.5 60.7 49.8 5.3 14.2 35.8 19.4 6.1 8.4 5.6 15.3 8.3 25.2 25.2 31.0 38.9 4.5 33.5 54.1 48.4 49.8 9.3 21.7 18.3 14.7 75.6 26.2 12.3 17.9 46.8 31.0 39.1 6.3 46.2 22.6 14.5 30.6 42.2 61.6 37.7 20.9 43.7 17.9 40.0 113.3 15.7 3.0 39.9 48.2 19.9 35.6 45.6 13.5 7.5 32.6 22.4 12.1 26.8 31.1 17.4 6.1 10.6 24.5 7.4 15.4 21.6 11.7 43.8 98.5 41.7 24.5 39.3 33.5 25.2 32.2 16.1 47.0 57.6 49.9 2.6 16.5 23.4 8.4 19.4 4.9 5.0 6.3 7.6 14.2 5.3 5.0 5.7 35.8 6.1 15.0 11.7 6.6 5.6 50.8 47.2 17.7 45.3 44.6 48.0 53.3 34.3 46.8 45.9 38.7 40.4 91.6 50.8 50.5 26.8 19.8 53.5 14.7 25.0 41.8 13.7 65.7 5.0 114.9 164.1 226.6 12.0 23.3 53.2 68.9 80.2 40.6 86.7 69.5 291.0 6.4 88.5 179.9 279.9 235.2 84.0 263.9 79.2 299.4 19.5 264.2 106.8 32.8 89.8 22.6 18.1 51.8 75.6 14.0 24.7 55.0 97.4 119.3 13.3 55.9 GNAI3 87U6 ENSG00000065135 "G protein subunit alpha i3" P08754 1 109548611-109618321 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 329.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022099, HPA042141" Approved Approved Nucleoplasm,Nucleoli,Centrosome NA NA 8400000 Centrosome "Nucleoplasm, Nucleoli" "CAB022099: , HPA042141: AB_2677870" "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "prognostic favorable (1.62e-4)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (9.45e-3)" "prognostic unfavorable (5.30e-6)" "unprognostic (2.56e-3)" "unprognostic (2.18e-2)" "prognostic favorable (4.59e-4)" "unprognostic (1.83e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (7.27e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.66e-2)" 25.2 13.0 12.3 15.5 11.3 26.4 15.8 12.8 10.7 19.0 14.7 10.3 14.3 12.1 19.7 15.7 34.8 12.5 13.2 9.3 12.3 9.4 18.1 25.8 13.2 23.8 13.1 8.3 18.4 13.7 10.7 11.0 22.4 11.5 17.2 13.8 8.0 16.2 14.4 8.6 27.9 17.0 15.9 12.9 21.6 12.1 14.0 12.0 22.2 12.9 25.2 20.6 20.0 20.4 6.1 9.6 16.8 13.1 5.8 7.2 9.3 14.1 5.0 9.6 5.6 9.2 11.1 7.9 10.7 8.6 10.9 10.9 7.6 4.9 7.6 7.1 11.4 6.7 7.5 9.0 10.9 15.3 8.5 5.5 6.6 8.6 6.5 7.9 10.3 6.1 8.2 9.3 12.6 8.7 7.6 13.1 5.8 8.6 7.5 10.8 9.6 7.9 8.4 9.6 6.8 5.8 5.7 22.6 4.9 12.1 10.8 6.2 10.8 7.5 8.5 11.7 7.8 6.5 9.1 11.8 9.2 12.7 13.8 12.1 8.0 9.0 8.8 15.3 10.2 14.3 8.5 9.1 16.6 6.8 13.1 7.2 6.1 6.7 6.5 9.6 5.0 5.6 6.4 16.8 5.8 12.3 4.3 6.9 9.3 12.3 11.3 12.8 10.7 12.3 9.4 13.1 8.3 11.5 12.0 41.7 29.8 72.9 89.8 134.3 27.1 11.7 28.1 46.8 34.2 55.8 329.9 74.3 54.7 94.8 7.0 65.3 47.7 23.3 88.0 115.2 72.4 62.2 45.1 49.5 96.4 23.8 80.9 47.9 103.4 6.0 45.1 89.9 70.9 77.5 58.1 44.4 82.3 52.6 44.6 40.9 23.4 51.8 82.4 64.2 49.4 164.6 89.4 82.8 47.9 147.8 GNAS "GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI" ENSG00000087460 "GNAS complex locus" "O95467, P63092, P84996, Q5JWF2" 20 58839718-58911192 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transducer "Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 303.3;thyroid gland: 304.5" "Cell type enhanced" "Detected in all" 5 "Horizontal cells: 1781.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010337, HPA018122, HPA027478, HPA028386" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (3.90e-2)" "unprognostic (4.77e-2)" "unprognostic (8.37e-3)" "unprognostic (2.82e-2)" "unprognostic (4.53e-3)" "unprognostic (8.01e-2)" "unprognostic (4.29e-2)" "prognostic favorable (8.76e-4)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (5.24e-3)" "unprognostic (1.61e-1)" "unprognostic (8.25e-2)" "unprognostic (1.36e-1)" 56.2 79.0 84.2 34.4 44.5 42.1 87.4 86.0 107.4 43.2 42.3 25.4 27.0 33.2 37.2 44.7 41.0 43.6 34.4 106.0 71.0 144.0 39.6 35.3 46.6 44.6 75.8 64.7 43.6 118.1 120.9 303.3 49.8 85.6 36.3 31.5 42.7 171.6 31.1 172.9 26.3 34.9 40.5 61.4 36.9 42.4 18.2 27.4 56.0 304.5 80.6 41.0 37.3 44.6 27.3 41.5 29.9 36.2 25.3 24.2 24.6 9.7 32.8 55.4 25.8 94.2 43.0 49.8 56.4 51.6 64.5 46.3 95.8 50.6 32.0 87.9 73.2 46.2 42.3 50.8 75.1 43.7 21.1 30.6 35.6 49.9 62.7 43.5 20.7 22.4 51.3 38.2 31.3 42.2 51.2 48.9 39.5 31.2 43.7 42.5 133.6 105.4 50.6 17.6 6.4 34.7 64.9 48.5 56.5 51.7 38.7 68.7 157.4 78.4 77.9 62.9 50.7 59.5 56.7 53.7 85.7 77.0 30.8 53.1 76.8 49.5 67.6 37.6 10.1 43.7 29.9 24.8 29.5 20.7 35.7 22.1 26.7 22.0 22.2 37.8 27.3 21.3 24.2 29.1 25.3 36.2 41.5 23.3 24.6 84.2 44.5 86.0 107.4 71.0 144.0 75.8 64.7 85.6 27.4 205.4 224.1 189.5 151.9 115.9 363.0 884.0 242.0 250.3 255.9 247.7 53.0 672.6 376.4 220.5 577.5 343.9 323.7 303.7 196.1 292.5 221.9 260.9 133.0 165.2 333.8 1781.3 444.7 335.7 327.9 1338.6 245.7 276.8 210.9 147.9 250.3 861.2 313.5 239.3 185.3 130.9 175.1 207.0 226.4 48.2 25.4 103.0 1013.3 142.4 268.2 212.5 GNL3L "FLJ10613, GNL3B" ENSG00000130119 "G protein nucleolar 3 like" Q9NVN8 X 54530211-54561071 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036314, HPA036315" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA036314: AB_10669986, HPA036315: AB_2675055" "unprognostic (9.71e-3)" "unprognostic (6.58e-2)" "unprognostic (6.24e-2)" "unprognostic (1.99e-2)" "unprognostic (1.13e-2)" "unprognostic (1.38e-1)" "unprognostic (2.92e-2)" "unprognostic (5.46e-2)" "unprognostic (8.44e-2)" "unprognostic (9.97e-2)" "unprognostic (4.91e-3)" "unprognostic (7.87e-2)" "unprognostic (8.05e-3)" "unprognostic (2.99e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.10e-1)" 12.7 12.9 10.3 16.1 12.3 19.2 12.5 8.6 13.1 10.8 10.2 14.8 10.5 8.5 15.2 10.2 16.3 11.0 10.1 15.3 8.1 8.0 12.0 12.5 13.0 15.5 13.0 10.8 13.2 17.5 15.9 16.9 12.0 10.2 10.6 13.3 12.3 13.3 12.4 24.0 13.2 13.5 15.0 11.5 17.6 11.7 5.9 13.9 20.5 18.0 12.0 18.6 13.7 13.1 17.2 11.4 20.2 15.2 21.8 17.7 11.5 11.2 28.0 5.8 11.9 6.0 4.1 10.7 6.7 4.9 7.6 6.0 23.6 9.3 15.8 13.0 9.7 9.9 11.0 19.3 8.4 10.5 10.9 10.0 15.9 22.4 11.1 4.6 24.6 15.7 5.8 4.1 17.7 10.7 3.1 8.1 9.0 10.3 16.0 7.6 21.8 13.9 5.1 16.7 6.7 15.7 15.0 13.2 15.3 5.7 17.8 9.4 5.7 22.0 13.6 6.3 12.2 17.9 6.3 11.6 13.8 13.8 13.3 11.4 12.0 15.3 20.3 7.1 20.4 15.3 18.9 14.2 15.1 17.7 12.6 16.1 15.0 16.2 15.4 11.4 17.2 12.4 13.0 20.2 21.8 15.2 9.6 8.6 11.5 10.3 12.3 8.6 13.1 8.1 8.0 13.0 10.8 10.2 13.9 11.9 21.0 11.9 2.9 1.1 9.4 7.0 5.1 12.0 18.2 3.5 11.8 6.4 3.3 6.0 0.2 6.0 4.6 0.0 7.6 5.4 3.3 2.8 10.4 3.9 4.4 7.9 3.4 7.4 11.9 0.0 5.2 6.1 0.0 6.4 4.3 3.7 7.8 3.5 2.8 3.3 8.0 6.5 4.1 1.2 7.4 1.8 4.6 8.2 3.9 3.1 GOLGA6A "GLP, GOLGA6" ENSG00000159289 "Golgin A6 family member A" Q9NYA3 15 74069857-74082550 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 29 "liver: 6.2;testis: 15.7" "Cell type enriched" "Detected in some" 16 "Early spermatids: 37.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.9;SuSa: 2.3;U-266/70: 5.2" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (1.68e-1)" "unprognostic (2.09e-2)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" "unprognostic (6.70e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.3 0.1 0.1 0.0 0.0 0.2 0.3 0.0 5.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 GOLGA6B ENSG00000215186 "Golgin A6 family member B" A6NDN3 15 72654738-72666394 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 34 "liver: 8.4;testis: 10.5" "Cell type enriched" "Detected in single" 60 "Early spermatids: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;SuSa: 1.3;U-266/70: 2.5;U-266/84: 1.1" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (5.47e-3)" "unprognostic (1.88e-2)" "unprognostic (2.07e-1)" "unprognostic (2.01e-1)" "unprognostic (2.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.6 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.5 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6C ENSG00000167195 "Golgin A6 family member C" A6NDK9 15 75258599-75270199 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 12.5" "Cell type enriched" "Detected in single" 72 "Early spermatids: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.3;SuSa: 1.6" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (6.53e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.0 0.1 0.0 0.3 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 1.3 0.0 0.1 0.3 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 1.6 0.3 0.0 0.7 0.0 0.1 0.1 0.0 0.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6D ENSG00000140478 "Golgin A6 family member D" P0CG33 15 75282835-75295807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 14.2" "Cell type enriched" "Detected in some" 6 "Early spermatids: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.6;Karpas-707: 1.1;NTERA-2: 1.5;SuSa: 3.2;U-266/70: 2.9;U-266/84: 1.3" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (7.95e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.2 0.3 0.0 0.0 2.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 GP9 "CD42a, GPIX" ENSG00000169704 "Glycoprotein IX platelet" P14770 3 129060767-129062406 "CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5" "Group enriched" "Detected in some" 11 "Early spermatids: 14.0;Late spermatids: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 8.8;neutrophil: 7.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.8" "Cell line enriched" "Detected in some" 14 "HEL: 43.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063182 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 68000000 "Plasma membrane, Cytosol" Nucleoplasm "HPA063182: AB_2684956" "unprognostic (1.70e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (3.80e-2)" "unprognostic (2.50e-2)" "unprognostic (3.24e-1)" "unprognostic (2.53e-2)" "unprognostic (8.47e-2)" "unprognostic (8.70e-2)" 0.2 0.1 0.1 0.1 0.1 10.0 0.1 0.0 0.6 0.4 0.5 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 5.0 0.8 0.1 0.1 0.4 4.8 0.0 0.8 0.2 0.5 0.1 0.0 0.3 1.5 0.4 0.1 0.4 0.2 0.0 0.6 0.2 0.0 0.1 0.0 0.1 24.5 0.3 2.2 0.0 0.0 0.6 0.6 0.0 0.6 3.0 0.1 1.5 8.8 0.6 0.0 0.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.6 0.1 0.1 0.3 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.0 7.5 0.0 0.0 1.5 0.0 27.1 0.1 0.1 0.0 0.6 0.8 0.1 0.8 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 13.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPATCH1 "ECGP, FLJ10206, FLJ38686, GPATC1" ENSG00000076650 "G-patch domain containing 1" Q9BRR8 19 33080880-33130542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043430, HPA043604" Approved Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA043430: AB_10960493, HPA043604: AB_10960499" "unprognostic (2.38e-2)" "unprognostic (1.71e-2)" "unprognostic (9.95e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.41e-1)" "unprognostic (1.28e-2)" "unprognostic (4.60e-3)" "unprognostic (3.54e-2)" "unprognostic (5.17e-2)" "unprognostic (3.56e-2)" "unprognostic (6.53e-2)" "unprognostic (5.37e-3)" "unprognostic (8.10e-2)" "unprognostic (4.57e-2)" "unprognostic (1.25e-1)" "unprognostic (1.45e-2)" "unprognostic (6.88e-3)" 8.8 8.0 11.0 10.0 12.2 6.9 9.8 21.2 15.7 9.7 9.9 13.8 8.3 11.0 13.0 9.6 9.1 8.9 8.2 7.8 11.1 7.9 9.6 7.3 7.1 9.4 10.5 7.1 15.9 8.8 13.5 11.8 12.9 10.3 10.1 9.7 8.6 9.6 10.8 10.3 11.4 10.6 9.7 7.5 9.6 10.2 8.9 11.1 13.6 10.0 5.6 13.1 10.3 11.4 6.5 5.7 17.4 6.4 3.0 9.7 4.4 7.4 15.8 7.5 7.9 5.0 5.7 6.2 6.8 4.8 10.5 8.8 11.2 7.0 10.6 8.8 5.4 4.9 6.6 9.4 5.6 9.1 18.3 5.8 10.0 5.9 8.2 6.5 17.3 6.7 4.9 6.6 7.1 6.5 5.0 5.8 8.4 10.5 6.7 5.1 9.6 9.9 5.7 5.2 9.9 6.7 10.1 9.5 4.7 4.8 4.6 8.3 5.6 10.8 6.8 3.8 6.8 5.6 12.5 6.5 9.1 6.8 5.0 9.7 5.7 9.2 9.2 5.7 8.8 8.3 17.4 6.0 6.5 6.1 6.4 4.2 6.2 5.7 7.6 5.7 6.5 9.7 6.1 4.4 3.0 3.3 5.0 8.4 4.4 11.0 12.2 21.2 15.7 11.1 7.9 10.5 7.1 10.3 11.1 8.9 6.4 5.7 4.7 5.5 9.4 8.5 2.5 5.3 11.4 7.0 13.7 9.0 13.3 6.2 2.0 4.5 8.1 0.0 3.9 4.6 5.2 3.1 16.1 4.5 3.5 3.2 4.1 8.6 8.2 1.5 9.5 4.8 8.5 5.4 6.5 7.4 6.6 5.7 7.8 4.8 11.2 0.0 4.9 14.4 11.6 3.1 4.6 7.4 5.6 2.6 GPI "AMF, NLK" ENSG00000105220 "Glucose-6-phosphate isomerase" P06744 19 34359480-34402413 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Gluconeogenesis, Glycolysis" "Cytokine, Growth factor, Isomerase" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 321.8;Late spermatids: 797.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018655, HPA024305, CAB040563, HPA052171" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" No No 140000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748" "unprognostic (1.03e-1)" "unprognostic (8.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.38e-2)" "unprognostic (4.52e-2)" "unprognostic (6.45e-3)" "unprognostic (1.95e-2)" "unprognostic (8.52e-3)" "unprognostic (3.18e-1)" "unprognostic (1.45e-1)" "unprognostic (4.93e-2)" "unprognostic (2.75e-1)" "unprognostic (3.24e-3)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (2.60e-3)" "unprognostic (2.88e-2)" 62.1 66.6 43.4 27.6 58.2 83.3 34.8 62.6 88.7 20.6 36.6 20.8 23.7 48.2 21.1 20.6 45.3 24.2 33.5 107.2 42.0 45.6 51.3 77.9 19.6 29.6 39.3 64.3 22.5 21.4 66.9 33.7 20.4 50.2 23.7 37.2 36.2 34.6 33.9 144.7 29.4 44.3 34.2 22.8 23.1 26.7 19.7 19.0 23.8 26.1 68.5 32.6 32.5 25.2 16.2 26.3 74.8 40.9 14.5 27.5 24.6 76.8 108.3 9.5 74.2 31.2 23.2 22.7 29.7 23.5 37.5 45.2 61.0 27.3 50.7 44.1 29.0 25.5 53.6 57.3 64.5 42.6 56.3 23.2 65.0 52.2 64.2 20.2 84.2 42.4 31.8 26.7 44.2 23.0 47.4 35.0 34.4 33.1 40.1 26.3 65.2 36.6 29.5 25.7 69.7 38.4 34.3 25.1 95.7 46.9 51.8 51.9 30.2 59.8 105.5 21.6 17.8 23.9 26.9 30.1 14.2 31.2 40.1 45.7 74.2 42.1 46.0 47.2 64.1 28.6 38.5 22.9 74.8 22.5 35.2 27.5 16.2 20.7 25.5 26.3 13.3 17.5 20.7 1.6 14.5 40.9 8.7 21.6 24.6 43.4 58.2 62.6 88.7 42.0 45.6 39.3 64.3 50.2 19.0 26.8 40.2 23.1 22.0 23.0 92.5 198.3 38.2 21.4 25.0 54.1 70.7 38.6 97.8 77.9 321.8 30.6 90.3 0.0 57.9 60.0 36.8 27.8 22.0 68.1 78.6 224.1 61.2 47.9 41.6 797.8 34.2 41.9 33.7 45.9 67.6 28.6 75.7 25.9 28.7 79.1 62.2 19.4 38.7 6.9 7.6 28.7 32.8 47.1 102.1 32.5 GPN1 "ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1" ENSG00000198522 "GPN-loop GTPase 1" Q9HCN4 2 27628247-27651508 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036793, HPA036794, CAB037303" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230" "unprognostic (9.42e-2)" "unprognostic (1.44e-1)" "unprognostic (5.64e-2)" "prognostic unfavorable (2.88e-5)" "unprognostic (2.57e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.71e-5)" "unprognostic (3.50e-2)" "unprognostic (8.27e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-3)" "unprognostic (2.34e-1)" "unprognostic (1.21e-2)" "unprognostic (2.51e-1)" "unprognostic (1.13e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" 24.3 24.3 18.8 18.7 23.2 28.1 26.3 22.9 27.2 18.3 21.6 20.7 13.7 19.3 21.3 21.2 26.7 21.0 18.2 21.5 17.2 22.1 29.7 29.2 18.2 29.2 20.0 16.1 24.6 35.4 19.8 18.5 31.1 23.3 18.8 25.6 14.3 23.0 17.6 30.9 25.0 25.3 22.1 16.4 26.6 20.8 30.2 15.9 29.0 26.9 22.5 28.3 21.5 24.3 29.1 35.8 28.5 28.2 39.6 38.6 29.7 32.7 18.6 17.6 12.7 16.6 17.0 17.9 18.3 18.3 26.0 19.3 20.3 17.2 20.5 17.9 20.0 24.1 14.3 24.4 22.8 26.4 19.1 17.0 23.4 15.0 24.7 21.6 34.3 12.3 17.5 20.1 26.7 25.1 18.1 27.1 18.7 29.0 19.3 30.7 19.1 20.7 25.7 30.4 25.0 18.4 20.9 52.1 21.4 21.0 18.9 15.7 24.9 20.1 22.6 20.3 17.1 13.6 19.9 22.0 22.7 33.6 11.2 42.9 22.3 24.0 55.2 32.7 29.8 18.6 28.5 24.7 21.1 33.4 28.2 36.0 29.1 31.1 38.6 35.8 25.2 27.7 34.1 3.7 39.6 26.3 18.5 30.3 29.7 18.8 23.2 22.9 27.2 17.2 22.1 20.0 16.1 23.3 15.9 11.9 7.2 7.2 18.2 19.3 7.9 9.7 17.8 10.7 14.8 14.0 3.9 36.5 19.9 46.3 69.8 14.5 10.8 0.0 31.4 38.5 20.1 18.3 24.3 8.6 29.3 11.1 16.7 15.4 18.9 67.5 13.8 19.3 21.9 33.3 13.3 12.0 35.5 10.5 10.3 15.6 9.1 12.9 20.8 26.2 22.6 16.3 27.7 33.0 19.5 16.6 GPR1 ENSG00000183671 "G protein-coupled receptor 1" P46091 2 206175316-206218047 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.1" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 10.0;Muller glia cells: 4.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 10.7;pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HHSteC: 53.7;hTCEpi: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010525 Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles" "HPA010525: AB_1078919" "unprognostic (5.32e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (2.25e-2)" "unprognostic (3.27e-5)" "unprognostic (1.36e-1)" "unprognostic (4.00e-3)" "unprognostic (1.49e-2)" "unprognostic (7.89e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-3)" "unprognostic (5.65e-2)" "unprognostic (4.29e-4)" "unprognostic (8.48e-4)" "unprognostic (1.21e-1)" "unprognostic (2.68e-2)" "unprognostic (3.06e-3)" 2.3 5.0 0.5 0.6 10.7 0.1 1.7 0.4 1.2 4.1 0.6 4.8 1.6 0.2 1.3 0.7 6.6 1.1 2.7 3.8 1.6 0.5 0.7 0.0 0.5 3.1 0.2 0.3 3.2 0.1 0.0 0.4 19.1 6.6 0.7 0.6 1.1 1.5 0.4 1.5 6.7 0.5 2.3 0.3 0.2 0.2 1.6 1.0 0.0 0.7 2.2 1.2 3.1 7.7 0.5 0.1 1.4 0.2 0.5 0.2 0.6 0.8 0.1 0.7 0.0 0.1 3.0 0.2 5.5 9.5 3.4 2.9 0.0 0.0 0.0 0.3 2.7 0.2 0.1 0.2 0.0 1.1 0.0 0.1 0.0 1.8 0.0 53.7 0.0 0.0 2.2 24.2 4.9 7.9 4.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 2.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 2.4 1.1 0.0 0.0 0.6 0.0 0.0 0.1 4.1 1.9 4.8 0.4 0.0 0.0 0.0 1.5 0.0 0.1 1.3 0.2 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.5 0.2 0.2 1.4 0.5 0.1 0.1 0.2 0.6 0.5 10.7 0.4 1.2 1.6 0.5 0.2 0.3 6.6 1.0 0.0 0.0 0.0 0.6 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.9 0.6 0.0 0.0 0.3 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 157.3;Late spermatids: 445.6;Spermatocytes: 157.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" NA NA "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: AB_2684889" "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favorable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 10.3 12.2 18.6 12.8 21.8 10.4 12.0 20.0 23.1 8.9 10.5 13.2 13.8 11.2 9.0 10.4 10.5 13.3 10.3 9.7 18.5 14.3 14.0 14.1 9.3 10.8 15.4 9.1 7.3 9.4 16.4 10.1 28.9 16.5 10.5 5.8 12.4 13.9 12.8 9.9 15.9 11.4 7.1 12.7 11.3 13.6 64.8 14.4 9.9 14.3 5.5 9.3 9.5 16.2 3.9 3.4 15.7 3.0 1.9 3.4 1.4 9.0 20.3 7.0 20.2 13.7 7.3 29.7 10.8 9.1 10.8 7.0 14.9 12.8 9.3 18.8 6.8 19.4 18.2 9.8 6.0 3.1 29.5 12.3 8.9 20.8 9.5 7.8 5.8 17.3 9.1 9.5 9.4 7.2 7.4 5.8 11.2 7.9 22.8 6.4 23.0 6.5 15.8 9.5 7.4 20.2 13.2 7.5 15.1 7.5 12.4 11.2 13.6 13.1 18.0 11.7 7.4 19.7 2.5 9.3 30.0 20.8 22.6 7.8 18.3 33.5 7.8 21.4 5.0 18.2 1.7 3.0 5.3 2.7 2.8 3.4 2.8 2.3 2.0 3.1 3.9 2.6 2.2 15.7 1.9 2.3 3.4 1.6 1.4 18.6 21.8 20.0 23.1 18.5 14.3 15.4 9.1 16.5 14.4 3.0 9.1 11.8 16.0 12.8 13.4 4.4 10.2 9.4 4.5 12.2 11.8 40.6 13.3 33.8 157.3 14.0 21.2 0.0 23.3 58.9 21.7 17.8 2.3 8.9 21.4 19.1 15.5 9.8 9.1 445.6 17.8 11.8 13.5 20.8 13.8 33.6 24.9 14.0 15.2 15.2 6.0 25.8 12.5 157.6 37.2 13.2 100.0 12.8 13.4 18.0 GPR63 "PSP24(beta), PSP24B" ENSG00000112218 "G protein-coupled receptor 63" Q9BZJ6 6 96794126-96837463 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Early spermatids: 21.8;Late spermatids: 26.5;Spermatocytes: 22.8;Spermatogonia: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 7.8;HHSteC: 12.8;Karpas-707: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039103 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039103: AB_10672841" "unprognostic (8.22e-2)" "unprognostic (2.77e-1)" "unprognostic (1.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (1.33e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (3.39e-1)" "unprognostic (2.53e-2)" "unprognostic (7.29e-3)" "unprognostic (3.00e-1)" "unprognostic (2.03e-3)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-2)" 1.8 3.4 3.8 3.1 11.0 0.8 1.6 7.5 10.7 3.3 3.9 1.6 1.0 5.1 1.9 1.5 2.0 2.8 2.7 1.9 3.2 2.2 1.4 0.5 1.4 0.9 2.2 6.4 4.0 5.0 3.9 4.3 2.5 10.1 3.3 6.2 2.5 1.7 2.2 1.0 1.7 3.6 3.6 1.4 1.3 4.1 8.0 5.2 2.5 2.3 0.0 0.9 2.2 4.8 0.8 0.9 2.6 0.6 1.4 1.1 0.1 0.0 0.1 1.5 0.3 2.2 0.8 0.4 0.9 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.1 1.2 1.1 4.9 2.3 0.0 7.8 3.8 4.7 0.4 0.0 12.8 2.9 0.5 2.4 0.4 0.0 3.5 0.3 0.0 7.0 3.4 19.2 0.4 0.4 2.2 0.0 5.0 0.0 0.7 0.0 1.8 3.8 0.3 0.2 2.3 1.4 0.3 3.1 0.5 1.7 1.2 0.6 0.0 1.3 2.0 0.2 1.8 1.5 0.8 0.1 0.8 1.8 1.0 0.8 0.6 0.2 0.6 0.2 0.3 0.7 1.1 0.6 0.1 0.8 1.0 0.9 2.6 1.4 0.2 0.9 0.3 0.1 3.8 11.0 7.5 10.7 3.2 2.2 2.2 6.4 10.1 5.2 0.0 0.0 0.0 0.8 1.6 1.1 0.5 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.4 21.8 0.1 0.0 0.0 0.8 0.6 0.9 1.0 0.0 0.0 0.2 0.0 2.9 1.8 0.0 26.5 3.1 0.0 1.7 0.0 0.4 0.3 0.5 0.0 4.6 0.0 0.2 0.0 1.1 22.8 9.3 0.3 0.1 0.0 0.5 0.3 GPR87 GPR95 ENSG00000138271 "G protein-coupled receptor 87" Q9BY21 3 151294086-151316952 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 24.8;skin 1: 19.7;tongue: 21.9" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 127.1;Suprabasal keratinocytes: 59.6;Syncytiotrophoblasts: 171.4;Urothelial cells: 178.7" "Group enriched" "Detected in many" 6 "cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3" "Region enriched" "Detected in single" 12 "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 31.5;HaCaT: 25.2;HBEC3-KT: 33.5;hTCEpi: 44.8;hTERT-HME1: 18.8;RT4: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066313 Approved "Nucleoplasm,Lipid droplets,Mitochondria" No No "Lipid droplets, Mitochondria" Nucleoplasm "HPA066313: AB_2685656" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (4.07e-3)" "unprognostic (8.60e-2)" "unprognostic (1.28e-2)" "unprognostic (4.61e-3)" "unprognostic (3.28e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (4.62e-6)" "unprognostic (8.64e-2)" "unprognostic (1.50e-3)" "unprognostic (3.66e-4)" "unprognostic (8.73e-2)" "unprognostic (3.80e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.4 6.5 0.0 0.0 2.8 0.0 0.4 2.1 24.8 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 11.1 5.1 4.5 0.0 0.0 9.5 4.0 0.0 19.7 0.0 0.4 0.0 0.0 0.2 0.7 0.0 2.0 0.0 21.9 13.5 6.2 13.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.2 0.0 0.0 11.5 0.0 0.0 0.0 0.1 25.2 0.0 33.5 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 44.8 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 1.1 13.2 0.0 0.0 5.6 0.1 0.0 0.9 0.1 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.6 0.0 127.1 52.7 0.0 0.0 0.0 4.0 20.5 3.5 0.0 46.3 0.0 1.3 0.1 0.2 0.0 0.0 0.6 10.3 2.1 36.4 1.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 59.6 171.4 0.0 0.0 178.7 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 172.9;Late spermatids: 145.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Cell line enhanced" "Detected in many" "EFO-21: 39.2;HHSteC: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.6 12.5 2.2 12.9 0.9 2.3 0.1 3.1 1.2 0.8 11.5 0.4 0.0 39.2 0.4 8.2 0.6 9.2 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.8 0.0 0.0 1.1 0.0 2.1 0.0 3.3 6.1 0.3 2.6 0.2 2.8 0.6 0.0 0.0 13.7 0.0 6.0 3.6 0.0 0.0 0.4 5.8 9.7 0.8 1.4 0.8 11.3 4.1 0.0 0.2 1.2 0.0 1.5 6.1 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 0.0 4.0 0.9 4.6 1.1 30.1 13.4 35.7 5.3 7.9 29.6 0.0 3.9 1.7 47.7 172.9 30.1 0.0 0.0 56.2 1.2 9.7 4.3 0.0 0.0 3.3 0.0 0.0 6.2 1.0 145.0 22.2 1.1 15.1 1.8 0.0 20.5 53.7 0.0 25.1 0.1 5.7 12.9 9.2 2.8 1.5 1.5 2.1 0.0 0.0 1.7 GPRC5C RAIG-3 ENSG00000170412 "G protein-coupled receptor class C group 5 member C" Q9NQ84 17 74424851-74451653 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 76.2" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 193.6;Hepatocytes: 148.3;Paneth cells: 149.7;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 31.1" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 10.2" "Group enriched" "Detected in many" 9 "dendritic cells: 10.2;monocytes: 4.7" "Cell line enhanced" "Detected in many" "Hep G2: 24.0;HMC-1: 42.2;RPTEC TERT1: 56.9;RT4: 26.3;T-47d: 32.0" "Region enriched" "Detected in many" 9 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA029776 Enhanced Uncertain "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA029776: AB_10602324" "unprognostic (1.48e-1)" "unprognostic (3.35e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-3)" "unprognostic (1.80e-2)" "unprognostic (1.09e-2)" "unprognostic (4.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (9.61e-3)" "unprognostic (1.05e-1)" "prognostic favorable (1.58e-5)" "unprognostic (7.58e-2)" "unprognostic (3.70e-2)" "unprognostic (2.75e-2)" "unprognostic (1.54e-3)" 4.3 4.1 5.2 2.2 5.3 0.0 7.7 31.1 5.7 19.7 15.4 4.4 17.0 10.0 5.8 9.9 5.3 12.5 17.6 7.7 5.3 2.6 43.8 46.1 11.5 2.8 4.8 4.9 12.3 76.2 12.0 3.4 4.5 6.1 15.1 6.2 18.0 16.8 11.7 25.4 9.2 15.2 3.9 4.6 5.1 44.7 4.4 4.1 1.9 42.2 10.2 3.5 12.6 8.0 0.7 10.2 0.1 4.7 0.0 0.1 0.3 4.6 16.7 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 21.4 0.0 13.3 0.1 5.4 14.7 2.2 0.3 0.0 0.0 2.7 0.0 1.2 24.0 4.9 0.0 42.2 0.4 7.6 0.0 0.0 22.7 0.0 0.0 1.2 0.3 0.0 5.2 0.1 4.5 2.7 23.1 19.4 0.0 0.0 1.1 56.9 26.3 8.1 0.7 0.8 1.8 0.0 10.9 32.0 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 2.1 0.6 0.1 0.0 1.7 0.1 0.0 3.4 0.0 0.7 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 4.7 10.2 0.0 0.3 5.2 5.3 31.1 5.7 5.3 2.6 4.8 4.9 6.1 4.1 3.0 48.9 1.5 39.6 12.0 0.8 193.6 68.8 22.7 18.2 129.1 0.0 0.7 24.9 53.1 0.1 8.7 61.7 0.0 58.9 7.1 19.9 46.9 10.3 148.3 9.6 4.8 43.7 25.8 8.5 0.5 16.7 4.2 3.3 5.4 47.3 18.8 37.9 149.7 20.8 51.6 0.8 142.3 56.7 0.4 3.0 9.8 21.2 1.5 44.1 40.9 GRAMD2B "FLJ21313, GRAMD3, NS3TP2" ENSG00000155324 "GRAM domain containing 2B" Q96HH9 5 126360132-126496494 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 89.7;Club cells: 84.2;Collecting duct cells: 38.4;Extravillous trophoblasts: 38.4;Syncytiotrophoblasts: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.6;MAIT T-cell: 4.8;memory CD4 T-cell: 2.6;memory CD8 T-cell: 3.9;myeloid DC: 2.5;naive CD4 T-cell: 5.1;naive CD8 T-cell: 3.1;NK-cell: 1.7;plasmacytoid DC: 6.5;T-reg: 3.8" "Group enriched" "Detected in many" 6 "dendritic cells: 6.5;NK-cells: 1.7;T-cells: 5.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 39.4;CAPAN-2: 26.5;fHDF/TERT166: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009678, HPA010095" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Cytosol "Nucleoplasm, Golgi apparatus" "HPA009678: AB_2112580, HPA010095: AB_1849952" "unprognostic (2.34e-1)" "unprognostic (4.01e-1)" "unprognostic (4.63e-2)" "unprognostic (3.42e-2)" "unprognostic (6.82e-2)" "unprognostic (1.95e-2)" "unprognostic (6.76e-2)" "unprognostic (3.84e-2)" "unprognostic (9.90e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-2)" "unprognostic (3.78e-1)" "unprognostic (2.20e-3)" "unprognostic (3.56e-3)" "unprognostic (2.39e-1)" "unprognostic (9.24e-2)" "unprognostic (1.12e-2)" 8.3 12.0 30.8 5.2 31.6 1.3 29.5 10.2 25.3 27.5 21.8 38.7 9.7 22.5 24.0 11.9 7.7 26.8 8.7 9.2 38.8 15.9 25.9 18.0 7.8 5.1 21.8 28.3 21.1 6.8 9.0 7.2 44.3 26.4 14.2 23.4 14.9 15.5 20.9 2.8 17.5 26.1 17.6 29.7 4.3 12.9 3.3 31.8 3.6 35.6 3.7 8.6 11.6 11.1 0.8 6.5 0.5 0.7 1.7 5.1 2.1 21.4 1.2 1.0 4.8 21.7 7.5 6.5 22.5 39.4 10.7 14.6 1.0 26.5 0.0 9.7 25.2 0.2 5.5 0.3 9.1 11.4 1.8 1.6 1.0 2.5 1.3 5.1 0.0 0.7 12.6 4.1 9.8 3.3 13.5 0.0 0.0 0.0 0.0 18.5 2.2 0.0 0.3 1.1 4.9 1.5 0.4 6.4 5.0 14.4 23.8 0.4 0.0 4.1 2.3 7.0 5.1 8.1 1.3 1.9 2.1 0.7 3.9 4.2 1.4 1.1 0.0 0.4 0.0 6.4 0.5 0.5 0.0 4.6 0.7 4.8 0.8 2.6 3.9 2.5 0.4 5.1 3.1 0.5 1.7 0.5 6.5 3.8 2.1 30.8 31.6 10.2 25.3 38.8 15.9 21.8 28.3 26.4 31.8 14.9 17.1 0.0 0.0 0.0 0.0 0.0 0.0 89.7 84.2 38.4 0.0 23.4 19.9 13.1 0.0 0.0 0.0 0.0 7.5 38.4 0.0 0.0 3.5 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.8 0.0 0.0 18.5 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 GRAP2 "GADS, GRBLG, GrbX, Grf40, Mona" ENSG00000100351 "GRB2-related adaptor protein 2" O75791 22 39901082-39973721 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 138.0" "Group enriched" "Detected in many" 4 "granulocytes: 142.1;T-cells: 44.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "gdT-cell: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0" "Lineage enriched" "Detected in many" 9 "T-cells: 22.5" "Cell line enhanced" "Detected in some" "HEL: 14.4;JURKAT: 57.1;K-562: 13.9;MOLT-4: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA005788, CAB022073" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 260000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022073: , HPA005788: AB_1079021" "unprognostic (1.96e-4)" "unprognostic (1.82e-4)" "unprognostic (4.19e-2)" "unprognostic (8.91e-4)" "unprognostic (2.92e-2)" "unprognostic (5.56e-5)" "unprognostic (1.27e-2)" "unprognostic (8.41e-3)" "unprognostic (4.69e-2)" "unprognostic (9.29e-2)" "unprognostic (5.17e-3)" "unprognostic (2.83e-2)" "unprognostic (1.75e-3)" "unprognostic (2.10e-1)" "unprognostic (2.20e-2)" "unprognostic (1.34e-1)" "unprognostic (8.06e-2)" 1.6 0.4 0.3 7.7 0.7 7.6 1.5 0.3 0.4 1.1 2.3 0.6 0.4 2.9 2.3 1.6 1.6 1.2 3.5 2.8 0.6 0.4 1.2 1.8 6.4 12.6 0.9 0.4 1.0 0.8 0.0 0.6 1.1 0.6 2.4 1.9 1.2 2.4 1.2 0.5 1.4 6.2 2.0 2.2 13.2 2.9 2.4 0.3 138.0 1.3 1.5 11.3 3.0 1.9 2.1 0.4 2.5 0.2 1.7 22.5 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 14.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 57.1 13.9 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.8 0.2 0.0 19.5 0.1 14.4 1.0 14.4 21.1 0.4 2.1 12.2 22.5 2.5 1.7 0.1 0.3 12.0 25.9 0.3 0.7 0.3 0.4 0.6 0.4 0.9 0.4 0.6 0.3 0.0 10.7 1.3 0.0 1.4 0.7 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.1 0.0 23.3 0.2 0.0 1.1 0.6 142.1 1.7 0.2 0.0 1.2 1.8 1.8 2.1 0.3 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 4.4 1.5 1.0 0.1 44.5 0.0 0.3 GRWD1 "GRWD, RRB1, WDR28" ENSG00000105447 "Glutamate rich WD repeat containing 1" Q9BQ67 19 48445773-48457022 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042643, HPA055680" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042643: AB_10795510, HPA055680: AB_2682884" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (4.99e-2)" "unprognostic (1.00e-1)" "unprognostic (3.46e-1)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.71e-2)" "unprognostic (5.68e-2)" "unprognostic (2.69e-2)" "unprognostic (7.70e-2)" "unprognostic (2.83e-2)" "unprognostic (8.10e-2)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.02e-1)" "unprognostic (5.07e-2)" 16.9 15.5 9.2 15.7 11.1 14.8 15.5 12.9 14.1 13.6 14.1 10.4 11.9 15.6 18.7 12.8 20.0 15.0 16.2 16.9 7.8 8.6 13.0 26.3 12.5 17.5 11.0 10.3 19.3 35.5 16.5 10.3 14.7 9.5 13.8 8.0 12.0 18.6 14.4 29.1 18.3 11.5 13.3 8.2 19.4 14.7 13.1 10.9 18.6 17.3 19.0 17.3 14.1 18.0 21.1 18.4 1.4 17.8 17.4 22.6 16.5 17.0 45.1 7.7 14.4 6.3 6.2 6.6 13.3 6.4 19.2 16.1 25.3 12.7 24.4 11.6 8.3 10.8 14.6 19.1 20.6 7.6 18.2 25.8 22.2 15.3 18.0 7.3 20.9 14.3 7.4 11.4 18.1 9.2 4.3 9.5 13.4 31.0 15.4 8.0 17.7 22.0 52.6 20.9 18.2 13.2 27.4 8.6 17.5 8.0 21.1 17.3 9.6 15.0 21.3 6.6 4.8 10.5 10.6 10.1 17.9 15.1 7.8 31.6 15.7 35.9 22.8 6.0 18.9 20.8 0.1 11.0 1.4 19.6 17.8 22.6 21.1 18.1 19.5 18.4 20.4 21.3 19.7 0.8 17.4 13.5 13.6 15.6 16.5 9.2 11.1 12.9 14.1 7.8 8.6 11.0 10.3 9.5 10.9 3.0 17.4 22.9 20.9 41.1 12.6 6.5 15.3 18.7 14.8 12.2 0.0 35.6 19.9 28.0 1.7 18.0 7.3 0.0 15.7 30.6 18.6 13.5 19.6 14.7 21.5 20.6 18.4 11.6 10.7 14.6 15.8 12.4 27.0 35.1 9.0 5.3 18.5 7.0 11.7 15.3 13.0 19.4 20.2 6.1 34.7 35.5 29.3 20.0 13.4 17.6 GSX1 "Gsh-1, GSH1" ENSG00000169840 "GS homeobox 1" Q9H4S2 13 27792643-27794768 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "brain: 7.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 29 "glioma: 3.9" "Region enhanced" "Detected in many" "hypothalamus: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA047096 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA047096: AB_2679929" "unprognostic (1.62e-1)" 0.1 0.1 1.6 0.1 3.2 0.1 0.1 0.9 4.0 0.1 0.1 2.5 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.7 7.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.9 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.9 1.5 0.7 7.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GVQW3 ENSG00000179240 "GVQW motif containing 3" Q3ZCU0 11 76381313-76414619 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 3.8;Ciliated cells: 4.0;Club cells: 4.5;Distal tubular cells: 8.3;granulocytes: 3.5;Proximal tubular cells: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057405 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Centrosome" NA NA "Nucleoplasm, Centrosome" "Endoplasmic reticulum" "HPA057405: AB_2683429" "unprognostic (8.90e-2)" "unprognostic (1.16e-1)" "unprognostic (8.27e-2)" "unprognostic (1.92e-1)" "unprognostic (9.04e-3)" "unprognostic (8.56e-2)" "unprognostic (8.87e-2)" "unprognostic (2.91e-2)" "unprognostic (7.28e-3)" "unprognostic (2.21e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (4.05e-4)" "unprognostic (7.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.28e-2)" "unprognostic (2.13e-1)" 3.3 5.8 7.0 4.7 11.8 3.5 5.8 13.9 14.3 5.0 3.2 5.0 2.2 4.5 6.7 4.0 1.8 7.1 2.5 3.2 6.2 5.2 5.1 2.5 2.9 6.0 4.0 7.2 8.4 16.0 3.2 15.9 3.0 8.7 3.5 4.9 7.6 9.1 3.3 2.9 4.5 3.6 3.5 4.2 5.0 4.2 9.6 4.6 5.5 5.5 0.4 5.7 2.8 4.0 3.1 1.7 5.1 1.2 3.8 4.1 1.2 1.7 2.2 9.4 5.0 2.3 4.7 2.5 1.2 1.0 2.2 2.1 6.5 3.9 7.4 3.3 1.2 3.6 5.3 5.1 1.3 3.0 5.1 3.0 3.8 8.4 2.1 1.2 3.4 2.0 1.1 1.5 3.4 1.3 2.1 1.4 9.6 2.4 4.4 0.7 2.1 4.7 5.6 1.5 2.3 3.3 6.9 5.5 4.6 0.7 1.8 12.2 4.3 2.9 1.3 0.8 3.7 3.8 1.0 0.8 3.9 3.8 6.1 1.4 4.8 2.3 6.8 1.2 3.0 2.2 3.5 1.2 1.2 3.7 0.7 2.5 3.1 3.8 1.7 1.7 3.1 4.1 4.1 5.1 3.8 0.8 1.2 3.3 1.2 7.0 11.8 13.9 14.3 6.2 5.2 4.0 7.2 8.7 4.6 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 1.8 0.0 0.9 8.3 1.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 3.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 GXYLT2 GLT8D4 ENSG00000172986 "Glucoside xylosyltransferase 2" A0PJZ3 3 72888073-72998138 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 37.7;Fibroblasts: 14.2;Late spermatids: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 14.6;JURKAT: 14.1;MOLT-4: 22.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA068429 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Midbody ring" Yes No Nucleoplasm "Cytokinetic bridge, Midbody ring" "HPA068429: AB_2685988" "unprognostic (9.43e-2)" "unprognostic (8.87e-3)" "unprognostic (1.90e-1)" "unprognostic (4.77e-2)" "unprognostic (3.33e-2)" "unprognostic (7.04e-2)" "unprognostic (4.79e-3)" "unprognostic (5.29e-2)" "unprognostic (5.25e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (1.46e-7)" "unprognostic (3.22e-3)" "unprognostic (4.70e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (2.42e-5)" 8.7 7.2 3.1 6.2 4.0 2.1 5.2 1.1 4.0 10.2 4.5 8.1 3.4 0.9 8.4 9.3 4.2 6.7 12.4 20.6 3.4 2.4 2.2 1.0 5.2 2.4 5.6 4.7 24.8 11.9 2.8 3.8 4.9 4.2 11.3 2.7 10.7 8.0 5.2 2.2 2.6 2.5 12.0 5.4 1.0 2.6 8.4 4.7 14.9 12.1 3.7 2.3 12.2 6.9 0.4 3.0 1.7 0.1 0.8 1.4 0.1 0.1 1.1 0.0 7.2 6.6 13.0 1.1 1.1 2.7 2.6 6.4 0.3 0.8 0.0 2.0 3.0 14.6 0.1 0.7 1.4 2.5 0.0 0.8 0.0 4.8 7.7 8.4 3.0 0.0 12.5 0.7 6.3 1.0 3.9 0.0 14.1 3.5 0.1 1.5 1.6 22.3 0.1 4.3 0.1 1.4 0.1 6.1 0.0 0.8 1.1 0.7 3.3 6.2 0.3 0.8 1.4 2.4 0.9 0.0 2.8 9.0 8.7 4.1 0.6 0.1 0.1 7.3 1.4 4.9 0.4 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.4 0.2 0.2 1.7 0.8 0.1 3.0 1.4 0.1 3.1 4.0 1.1 4.0 3.4 2.4 5.6 4.7 4.2 4.7 3.0 1.6 0.0 1.5 1.6 0.6 9.8 2.5 1.4 1.2 0.0 0.0 0.1 0.0 0.0 37.7 0.0 0.9 0.0 1.0 0.2 14.2 1.3 0.0 0.0 0.3 0.0 3.4 1.3 0.0 17.8 7.5 0.3 0.0 0.0 2.3 2.5 1.2 0.0 6.7 0.4 0.4 0.0 1.0 2.9 3.2 0.4 0.7 0.0 1.5 0.4 GYG2 GN-2 ENSG00000056998 "Glycogenin 2" O15488 X 2828788-2882820 "Enzymes, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 76.7;brain: 21.2;breast: 30.4" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 15.8;Intestinal endocrine cells: 19.5" "Cancer enhanced" "Detected in all" "melanoma: 42.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 17.1;Hep G2: 13.7;NTERA-2: 16.9;SK-MEL-30: 36.5;SuSa: 27.1" "Low region specificity" "Detected in all" "HPA005495, HPA064686" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoli, Cytosol" Nucleoplasm "HPA005495: AB_1079035, HPA064686: AB_2685323" "unprognostic (4.45e-2)" "unprognostic (4.21e-2)" "unprognostic (6.41e-3)" "unprognostic (8.50e-2)" "unprognostic (2.07e-3)" "unprognostic (5.16e-1)" "unprognostic (1.74e-2)" "unprognostic (1.18e-1)" "unprognostic (7.43e-3)" "unprognostic (6.74e-2)" "prognostic favorable (3.01e-5)" "unprognostic (9.76e-2)" "unprognostic (6.10e-5)" "unprognostic (1.78e-1)" "unprognostic (5.05e-3)" "unprognostic (5.41e-2)" "unprognostic (6.60e-2)" 76.7 1.4 4.6 1.3 4.6 0.5 30.4 2.1 3.7 2.1 3.5 8.2 0.7 1.2 4.2 0.9 1.0 3.6 1.7 1.7 3.9 2.9 1.4 9.9 0.7 0.7 5.5 2.9 1.9 3.2 0.4 0.5 1.6 12.9 2.7 2.0 4.2 2.8 4.4 0.5 1.2 1.3 2.8 21.2 0.5 2.2 0.8 5.1 0.0 1.3 0.5 0.6 2.9 1.4 1.0 0.6 0.6 0.4 1.2 0.7 0.0 0.0 5.2 17.1 0.0 10.2 0.0 12.4 0.5 3.0 3.0 3.8 12.7 0.3 0.0 1.4 2.1 3.1 0.0 9.6 0.2 2.9 0.1 2.7 0.0 0.2 13.7 3.0 0.0 4.2 3.7 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.8 0.0 0.4 16.9 0.1 0.0 2.8 5.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 36.5 27.1 1.6 10.4 0.0 0.0 3.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.7 0.5 0.4 0.3 0.1 1.0 0.3 0.2 0.6 1.2 0.4 0.6 0.4 0.0 4.6 4.6 2.1 3.7 3.9 2.9 5.5 2.9 12.9 5.1 0.0 0.0 0.0 0.9 0.3 0.9 0.6 2.5 0.0 0.0 0.0 3.9 5.3 5.0 0.8 0.3 0.0 0.2 0.0 3.4 7.0 1.9 1.7 0.0 15.8 0.9 0.0 19.5 0.0 1.3 0.0 0.6 0.0 3.3 0.0 1.3 1.8 2.8 0.0 2.8 2.1 0.0 0.0 0.9 0.3 0.4 0.3 1.9 0.0 2.0 0.5 GYPA "CD235a, GPA, MN, MNS" ENSG00000170180 "Glycophorin A (MNS blood group)" P02724 4 144109303-144140786 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 56.9" "Cell type enriched" "Detected in some" 311 "Erythroid cells: 1331.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "HEL: 57.0" "CAB002658, HPA014811" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB002658: , HPA014811: AB_1849827" "unprognostic (1.60e-1)" "unprognostic (2.47e-2)" 0.1 0.0 0.2 0.1 0.4 56.9 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 1.7 1.3 3.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 4.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.3 0.4 0.2 0.2 0.6 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.2 0.9 0.1 0.2 0.2 1.5 0.2 0.6 0.2 0.2 0.2 0.3 0.0 0.8 0.2 0.4 0.1 0.5 0.2 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.3 0.0 0.0 1331.6 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 H1FX "H1X, MGC15959, MGC8350" ENSG00000184897 "H1 histone family member X" Q92522 3 129314771-129316277 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "bone marrow: 381.6;lymphoid tissue: 238.6" "Cell type enhanced" "Detected in all" 6 "Basal glandular cells: 485.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 139.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012235, HPA040099, HPA068431" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB012235: , HPA040099: AB_2676846, HPA068431: " "unprognostic (1.01e-2)" "unprognostic (1.12e-2)" "unprognostic (4.13e-2)" "unprognostic (8.48e-2)" "unprognostic (6.94e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.46e-2)" "unprognostic (1.16e-1)" "unprognostic (5.51e-2)" "unprognostic (5.28e-3)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (3.24e-1)" "unprognostic (2.50e-2)" 23.1 13.1 11.9 19.0 14.5 381.6 33.7 29.0 22.9 30.9 21.0 9.6 13.4 21.1 26.0 19.6 34.5 25.1 24.0 27.5 11.3 11.2 12.9 24.9 30.9 44.2 6.7 16.3 39.0 22.4 18.4 20.5 15.0 6.9 26.2 7.8 18.4 32.3 16.3 30.8 40.5 26.0 19.1 9.6 29.9 29.0 14.2 6.3 238.6 21.9 18.1 20.5 35.6 25.0 5.7 10.8 15.9 5.3 4.8 8.3 2.2 19.9 10.6 20.1 8.7 2.0 2.4 19.1 8.8 6.4 10.5 11.1 6.3 11.0 2.5 9.7 3.1 7.0 20.1 8.4 5.6 1.6 18.3 16.3 7.6 8.2 8.6 8.7 8.8 2.0 4.9 7.7 4.2 9.7 4.7 6.0 35.4 11.7 45.5 1.4 20.9 40.7 17.5 18.8 3.6 12.0 29.4 8.6 23.7 3.2 4.2 32.1 37.2 9.3 4.6 26.6 4.0 18.2 17.8 5.9 8.1 42.6 7.9 7.3 139.5 53.3 21.5 6.6 8.4 8.9 0.4 5.3 15.9 4.3 3.7 4.0 4.4 6.7 5.1 7.4 5.7 8.3 4.3 1.2 4.8 3.3 10.8 5.1 2.2 11.9 14.5 29.0 22.9 11.3 11.2 6.7 16.3 6.9 6.3 14.9 12.8 95.3 485.3 89.5 119.1 25.5 63.7 2.7 3.4 89.0 29.5 60.0 94.5 42.6 7.4 89.9 34.4 70.0 71.0 93.0 97.3 173.5 5.7 38.5 77.7 138.2 153.1 85.3 93.5 8.0 92.0 75.7 118.1 25.2 86.3 209.9 59.2 48.9 48.8 25.1 84.3 122.9 82.1 13.2 36.5 96.0 57.2 72.6 52.5 312.3 HABP4 "IHABP4, SERBP1L" ENSG00000130956 "Hyaluronan binding protein 4" Q5JVS0 9 96450201-96491336 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.8" "Group enriched" "Detected in many" 11 "Early spermatids: 193.7;Late spermatids: 710.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.1;T-cells: 4.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055969, HPA062366" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA055969: AB_2682991, HPA062366: " "unprognostic (1.67e-1)" "unprognostic (7.99e-2)" "unprognostic (2.12e-3)" "unprognostic (2.40e-1)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.36e-2)" "unprognostic (3.63e-2)" "unprognostic (3.49e-1)" "unprognostic (2.42e-2)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "prognostic favorable (1.10e-7)" "unprognostic (2.25e-1)" "unprognostic (1.40e-1)" "unprognostic (4.93e-2)" "unprognostic (3.62e-2)" 13.2 11.9 31.2 6.1 44.8 1.7 6.5 14.1 40.6 7.9 5.5 12.4 1.5 3.0 8.2 6.8 7.2 5.3 8.1 19.1 26.1 24.9 23.5 5.7 6.1 6.8 27.1 20.5 11.7 4.8 13.8 7.4 3.4 31.6 8.3 4.2 8.4 4.1 10.6 9.4 6.1 3.3 10.6 19.4 5.0 5.0 21.8 13.0 0.4 11.2 2.2 4.9 7.6 6.5 4.1 0.1 0.3 0.8 1.0 4.0 0.7 7.3 8.4 10.7 11.4 23.7 20.3 7.6 10.0 11.2 7.5 8.2 12.5 12.3 3.7 5.0 14.8 24.0 5.4 8.9 1.9 6.1 4.5 5.3 1.4 4.0 20.8 12.1 0.3 1.5 8.2 3.4 8.6 6.8 11.5 5.3 4.3 1.7 11.1 13.5 7.5 0.1 2.3 5.0 10.3 8.2 3.8 9.3 0.1 12.8 3.2 6.8 4.6 5.3 3.2 15.9 8.3 2.3 1.6 9.1 10.4 2.4 19.0 8.4 7.0 6.9 1.6 8.3 2.9 15.3 0.0 0.1 0.0 1.4 0.3 1.4 4.1 4.0 3.2 0.0 1.7 2.8 2.8 0.3 1.0 0.8 0.1 3.0 0.7 31.2 44.8 14.1 33.8 26.1 24.9 27.1 20.5 31.6 13.0 0.0 6.1 3.4 7.8 10.2 22.0 10.6 15.3 1.4 9.1 17.4 0.0 2.2 14.9 3.7 193.7 17.8 0.8 0.0 5.0 6.7 7.8 8.5 1.1 5.0 5.5 22.3 12.6 13.5 1.5 710.5 12.7 4.0 16.9 3.6 0.9 17.1 4.8 0.0 22.3 39.6 11.3 6.5 17.6 18.6 5.9 6.9 1.1 7.5 1.1 5.1 HAUS2 "C15orf25, CEP27, FLJ10460, HsT17025" ENSG00000137814 "HAUS augmin like complex subunit 2" Q9NVX0 15 42548810-42569994 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039965 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA039965: AB_10673025" "unprognostic (5.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (6.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-3)" "unprognostic (1.47e-3)" "unprognostic (1.62e-2)" "unprognostic (2.24e-1)" "unprognostic (2.17e-1)" "unprognostic (1.17e-3)" "unprognostic (1.33e-1)" "unprognostic (6.81e-3)" "unprognostic (4.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.22e-1)" "unprognostic (2.62e-3)" 18.7 11.3 13.1 12.1 11.5 49.9 18.6 13.3 15.4 9.9 11.9 11.1 5.6 8.9 14.0 10.4 12.8 9.7 9.3 10.8 14.1 13.6 10.3 11.0 16.8 16.6 14.6 13.9 12.1 12.1 8.4 9.9 11.6 13.1 8.8 10.8 8.5 10.5 8.5 13.5 11.8 9.5 12.3 18.7 11.2 9.7 13.7 11.7 18.4 10.1 11.8 13.0 10.8 14.0 10.3 7.2 7.5 13.5 4.4 8.7 4.3 11.4 6.1 11.2 7.2 5.6 6.4 10.9 11.7 7.0 11.0 9.3 12.4 7.3 7.4 5.7 6.4 10.7 19.3 11.9 7.5 11.1 9.6 6.9 10.1 10.7 9.6 8.1 17.7 9.3 5.5 5.7 8.8 9.1 5.7 11.1 9.9 17.6 9.1 10.7 7.2 13.0 14.3 9.8 16.1 8.0 14.7 13.7 9.6 7.0 8.3 9.1 7.6 11.7 11.3 6.9 8.5 11.3 13.2 8.7 17.0 12.4 26.2 21.7 13.9 39.0 22.2 10.6 19.5 12.9 7.3 7.7 7.5 8.4 9.0 8.3 10.3 8.3 6.0 6.5 8.9 6.1 8.3 3.8 4.4 13.5 7.2 8.7 4.3 13.1 11.5 13.3 15.4 14.1 13.6 14.6 13.9 13.1 11.7 11.9 15.6 14.6 18.4 12.0 7.6 4.0 7.6 21.4 11.4 3.5 15.7 11.4 3.3 13.3 21.6 11.3 6.5 0.0 14.3 22.8 9.4 20.3 23.2 7.3 19.4 15.9 16.6 10.4 15.8 5.3 10.3 19.4 1.7 21.6 9.7 6.1 15.3 8.6 10.6 11.0 15.2 19.4 11.2 23.2 8.5 13.4 11.2 15.3 9.0 16.0 HCFC2 HCF-2 ENSG00000111727 "Host cell factor C2" Q9Y5Z7 12 104064457-104106524 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 190.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006227 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA006227: AB_1079042" "unprognostic (4.22e-3)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (7.66e-2)" "unprognostic (3.15e-2)" "unprognostic (2.11e-2)" "unprognostic (1.46e-1)" "unprognostic (1.07e-2)" "unprognostic (1.59e-1)" "unprognostic (1.43e-2)" "unprognostic (2.71e-2)" "unprognostic (4.54e-2)" "unprognostic (4.23e-3)" "unprognostic (1.16e-2)" "unprognostic (2.24e-1)" "unprognostic (1.19e-2)" "unprognostic (7.23e-2)" 11.5 10.0 11.9 4.7 13.2 3.2 12.9 3.8 11.1 11.5 14.4 9.1 8.7 7.2 12.6 7.5 9.1 8.5 8.1 7.7 9.3 5.8 8.5 10.2 9.1 5.9 12.5 8.1 11.8 9.1 10.4 14.3 10.6 10.0 10.8 6.3 6.8 8.0 14.6 17.5 7.4 7.5 19.0 10.2 6.8 9.9 19.2 11.0 9.1 10.1 5.1 5.0 12.8 10.3 1.8 2.2 2.8 5.0 2.5 3.2 1.7 1.9 2.1 2.2 1.9 12.4 12.4 1.6 8.5 3.9 6.6 3.8 1.0 0.9 1.9 3.0 6.6 2.4 2.1 2.7 1.5 7.1 3.2 2.6 1.9 2.0 0.9 8.4 1.6 3.1 7.7 4.2 4.1 3.4 9.5 5.0 3.0 2.2 4.1 11.7 1.7 2.8 3.7 0.4 1.2 4.4 2.3 7.3 1.2 2.9 1.3 3.2 2.4 4.2 3.0 3.2 1.6 4.8 1.7 7.5 10.4 1.4 5.3 2.9 5.2 1.5 1.7 4.9 2.1 4.1 1.3 2.0 2.8 2.6 3.7 3.1 1.6 2.5 3.2 2.2 1.8 3.0 3.2 0.5 2.5 5.0 1.2 2.8 1.7 11.9 13.2 3.8 11.1 9.3 5.8 12.5 8.1 10.0 11.0 11.9 16.0 8.4 6.6 7.1 18.4 9.6 0.0 10.7 11.4 5.2 19.6 4.3 8.3 4.8 190.7 11.3 6.9 0.0 2.9 3.5 9.5 3.2 16.2 9.0 6.3 22.3 8.1 15.4 9.4 44.6 20.1 6.9 6.8 4.6 3.3 13.8 2.7 3.2 26.2 7.0 22.6 12.9 10.3 57.9 10.2 6.4 9.0 9.6 3.3 3.1 HDAC4 "BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288" ENSG00000068024 "Histone deacetylase 4" P56524 2 239048168-239401654 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Autism spectrum disorder, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 73.9;Late spermatids: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3" "Group enriched" "Detected in many" 8 "granulocytes: 28.3;monocytes: 7.4" "Cell line enhanced" "Detected in many" "JURKAT: 30.4;MOLT-4: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048723, HPA071448" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nucleoplasm, Cytosol" "HPA048723: AB_2680501, HPA071448: " "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.39e-3)" "unprognostic (3.06e-4)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.33e-4)" "prognostic favorable (1.13e-4)" "unprognostic (1.40e-1)" "unprognostic (4.82e-3)" "unprognostic (2.40e-1)" "unprognostic (3.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.04e-2)" 7.9 6.8 6.1 6.8 5.2 17.1 4.6 6.4 12.3 11.3 21.4 4.6 4.3 2.5 10.2 6.4 8.8 9.0 24.6 5.2 5.0 6.0 3.2 3.1 4.2 4.3 6.1 5.4 8.5 5.8 4.9 8.3 2.5 5.2 7.5 4.8 8.3 3.7 7.3 54.6 6.9 6.5 15.8 4.2 5.4 7.0 8.1 4.3 6.5 4.8 13.2 5.6 10.2 4.6 0.5 1.7 28.3 7.4 2.1 1.2 0.4 3.8 3.8 4.9 5.9 2.8 4.7 5.8 4.0 2.7 3.2 3.1 1.7 7.0 1.8 1.6 3.4 4.6 3.8 3.4 1.6 1.6 10.6 1.8 2.8 4.7 5.6 3.7 4.3 2.6 3.2 4.1 5.9 4.7 1.6 3.4 30.4 4.0 4.1 1.5 4.7 28.1 5.9 3.8 4.8 2.0 7.3 9.2 2.8 3.7 4.9 3.9 6.9 5.6 2.5 9.8 2.9 1.3 11.9 5.4 3.7 0.3 6.4 5.4 2.9 2.7 3.5 5.4 6.0 7.4 10.5 7.4 1.1 0.9 2.4 1.1 0.5 0.9 0.8 0.8 0.5 0.5 1.0 28.3 2.1 1.0 1.7 1.2 0.4 6.1 5.2 6.4 7.5 5.0 6.0 6.1 5.4 5.2 4.3 3.0 9.0 3.7 2.2 7.0 11.5 10.1 7.6 0.0 3.4 10.4 2.0 1.2 0.0 2.4 73.9 5.8 4.5 0.0 1.8 1.5 8.0 5.0 2.3 5.8 2.9 15.9 5.8 13.5 22.7 47.3 10.9 5.5 5.0 0.0 5.5 10.1 1.7 0.0 11.7 1.2 7.1 0.0 5.6 2.2 2.1 8.4 1.1 8.7 5.7 2.2 HELLS "LSH, Nbla10143, PASG, SMARCA6" ENSG00000119969 "Helicase, lymphoid specific" Q9NRZ9 10 94501434-94613905 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Developmental protein, Helicase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.4" "Cell type enhanced" "Detected in many" 13 "Spermatocytes: 69.2;Spermatogonia: 174.0" "Cancer enhanced" "Detected in all" "testis cancer: 16.1" "Region enhanced" "Detected in many" "cerebellum: 11.9" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004491, HPA063242" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" No Yes Nucleoplasm "Golgi apparatus, Vesicles" "CAB004491: AB_627895, HPA063242: AB_2684968" "unprognostic (1.94e-1)" "prognostic favorable (1.36e-4)" "unprognostic (9.85e-2)" "unprognostic (3.38e-2)" "unprognostic (8.65e-2)" "unprognostic (4.85e-3)" "unprognostic (1.76e-5)" "unprognostic (7.59e-3)" "unprognostic (7.03e-3)" "unprognostic (6.49e-2)" "unprognostic (2.05e-2)" "unprognostic (9.45e-5)" "unprognostic (9.93e-13)" "unprognostic (2.25e-2)" "unprognostic (1.72e-1)" "unprognostic (6.24e-2)" "unprognostic (3.03e-2)" 1.4 2.0 1.2 28.8 1.5 14.8 3.0 11.9 3.2 4.2 5.0 0.7 3.3 3.5 5.8 6.0 8.6 2.5 3.6 2.1 1.3 2.0 3.9 2.0 2.5 11.9 1.4 1.7 4.3 1.9 2.7 4.7 9.0 1.3 3.4 5.5 3.3 2.8 2.0 0.6 5.2 5.3 2.1 1.7 8.3 3.6 18.7 0.7 46.4 1.7 8.1 15.1 3.6 4.4 13.6 22.0 0.7 0.8 5.6 10.9 1.5 19.9 19.7 25.5 32.3 1.0 2.4 13.8 15.3 9.9 12.8 20.2 26.0 16.2 24.7 6.1 5.1 10.8 20.2 14.6 12.2 18.3 23.9 16.8 13.1 20.0 20.8 0.6 24.7 11.9 1.3 0.7 15.3 7.3 3.5 8.8 16.7 7.1 15.8 15.1 20.1 26.0 12.3 26.4 14.6 8.8 24.3 22.7 5.7 8.7 25.8 10.2 8.3 18.1 5.2 2.7 22.2 22.1 8.0 6.2 14.0 7.1 12.8 18.3 8.2 15.6 26.4 7.0 15.3 6.4 0.1 0.5 0.0 4.4 0.8 1.5 10.9 7.2 6.2 1.3 13.6 3.5 5.0 0.7 5.6 0.6 22.0 10.9 1.5 1.2 1.5 11.9 3.2 1.3 2.0 1.4 1.7 1.3 0.7 8.9 3.8 23.8 8.2 19.2 13.6 0.8 7.6 8.1 17.0 21.0 0.0 25.8 3.3 5.8 0.8 4.9 2.1 23.3 5.5 31.3 11.0 3.1 5.7 2.6 12.8 6.4 10.4 8.0 1.3 3.6 8.3 6.2 1.7 9.0 6.5 5.0 3.9 0.0 5.3 1.4 9.4 19.4 6.2 69.2 174.0 8.7 9.3 12.5 23.7 4.4 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188586-93226524 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 43.4;kidney: 24.5;pituitary gland: 16.1" "Group enriched" "Detected in some" 23 "Intestinal endocrine cells: 209.3;Mucus-secreting cells: 364.1;Paneth cells: 298.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 37 "SCLC-21H: 63.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes NA 89000 "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favorable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.2 0.2 8.5 0.2 0.6 3.4 0.1 0.1 0.1 29.4 0.1 5.3 11.8 0.1 0.4 0.2 0.1 0.8 0.3 0.2 0.2 24.5 0.2 0.4 0.1 0.2 0.1 0.1 5.5 0.0 16.1 0.4 0.2 0.7 38.9 0.1 4.1 1.2 0.1 0.1 43.4 0.4 0.2 0.2 4.0 1.4 0.1 0.3 0.1 0.1 2.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 8.3 0.0 2.1 0.0 6.7 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 209.3 0.0 0.0 1.9 0.0 0.0 6.8 0.0 364.1 0.0 0.0 298.7 0.0 0.0 0.0 0.0 0.0 4.5 0.7 0.1 0.1 0.0 12.4 0.0 HES4 bHLHb42 ENSG00000188290 "Hes family bHLH transcription factor 4" Q9HCC6 1 998962-1000172 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 291.1;Glandular cells: 254.1;Paneth cells: 238.4;Smooth muscle cells: 271.9;Urothelial cells: 423.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 12.4" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.4" "Cell line enriched" "Detected in some" 8 "HEK 293: 66.9" "Low region specificity" "Detected in all" HPA062465 Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA062465: AB_2684771" "unprognostic (6.23e-2)" "unprognostic (3.77e-2)" "unprognostic (7.07e-2)" "prognostic favorable (3.85e-4)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.99e-4)" "unprognostic (6.25e-3)" "unprognostic (2.34e-1)" "unprognostic (1.62e-2)" "unprognostic (3.77e-1)" "unprognostic (7.76e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (3.97e-1)" "unprognostic (3.87e-2)" "unprognostic (1.86e-1)" "unprognostic (5.08e-3)" 14.8 4.0 8.3 3.9 15.6 2.8 8.7 2.5 16.9 7.6 10.8 2.9 4.8 5.4 7.8 9.0 7.5 6.8 9.6 13.6 5.9 9.4 5.3 3.2 9.1 2.2 7.3 4.0 4.2 14.8 3.1 5.7 6.1 7.2 10.4 2.6 12.8 5.6 9.4 8.0 7.8 4.2 12.1 3.4 8.6 6.1 3.4 3.1 9.0 3.6 8.4 3.3 10.6 5.6 0.0 0.3 12.4 1.4 0.0 0.0 0.0 4.6 0.5 0.5 0.0 0.0 0.0 5.9 2.8 0.3 1.7 1.8 0.7 1.5 0.0 6.7 0.2 0.8 8.2 0.7 0.1 0.0 0.0 66.9 0.0 0.7 0.9 0.6 0.0 0.5 0.0 0.7 0.1 0.1 0.2 0.2 0.8 1.3 0.1 0.0 2.4 3.7 0.2 0.0 1.0 6.5 0.0 0.6 1.4 0.6 0.0 0.4 1.5 1.9 4.7 8.4 0.2 3.5 0.0 0.3 0.5 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 12.4 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 8.3 15.6 2.5 7.0 5.9 9.4 7.3 4.0 7.2 3.1 0.0 0.0 0.0 291.1 46.2 3.5 11.8 22.9 0.0 2.3 55.8 0.0 0.9 26.6 14.8 0.8 15.3 10.3 0.0 2.5 35.2 22.6 254.1 55.1 0.0 4.4 0.0 10.3 16.0 3.5 0.8 6.9 13.3 109.6 1.0 10.5 119.5 9.0 238.4 14.5 0.6 10.7 161.7 271.9 2.3 28.1 72.3 2.9 0.7 11.0 423.0 HES5 bHLHb38 ENSG00000197921 "Hes family bHLH transcription factor 5" Q5TA89 1 2528745-2530245 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.7" "Cell type enriched" "Detected in some" 22 "Muller glia cells: 105.2" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.7;HaCaT: 5.1;HAP1: 1.1;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065458, HPA076164" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" No NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA065458: AB_2685492, HPA076164: AB_2732303" "unprognostic (2.04e-3)" "unprognostic (2.83e-2)" "unprognostic (4.26e-2)" "unprognostic (2.75e-3)" "unprognostic (5.26e-3)" "unprognostic (1.60e-4)" "unprognostic (1.76e-4)" "unprognostic (1.60e-1)" "unprognostic (5.30e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (4.67e-1)" "unprognostic (9.95e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (3.89e-2)" "unprognostic (1.72e-1)" 1.1 0.9 11.1 1.1 12.7 1.4 2.8 3.5 16.7 1.0 1.9 1.2 0.4 1.2 1.9 2.7 1.6 1.1 1.2 2.3 9.7 11.2 1.0 1.0 1.4 1.1 4.1 15.8 1.0 0.9 1.0 2.4 2.2 1.6 1.3 1.4 6.3 1.2 1.1 1.6 6.2 1.2 0.9 0.9 1.0 1.2 2.0 1.9 0.0 1.1 1.9 1.4 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 5.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 12.7 3.5 16.7 9.7 11.2 4.1 15.8 1.6 1.9 0.0 0.0 0.0 0.2 0.1 2.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 105.2 0.0 3.5 0.0 0.0 4.8 0.0 0.7 0.0 0.0 1.3 0.0 0.0 1.1 0.1 HEY1 "bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1" ENSG00000164683 "Hes related family bHLH transcription factor with YRPW motif 1" Q9Y5J3 8 79764010-79767863 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.6" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 39.4;Extravillous trophoblasts: 39.7;Intestinal endocrine cells: 35.4;Melanocytes: 32.1" "Cancer enhanced" "Detected in all" "glioma: 43.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.9" "Cell line enhanced" "Detected in many" "HEK 293: 49.4;PC-3: 11.2;SK-MEL-30: 33.8;WM-115: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055599, HPA063472" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Cytosol" "HPA055599: AB_2682858, HPA063472: AB_2685018" "unprognostic (1.15e-1)" "unprognostic (5.06e-2)" "unprognostic (5.13e-3)" "unprognostic (2.12e-1)" "unprognostic (1.86e-3)" "unprognostic (8.47e-2)" "unprognostic (4.21e-3)" "unprognostic (9.56e-2)" "unprognostic (1.72e-1)" "unprognostic (7.22e-2)" "unprognostic (1.25e-2)" "unprognostic (6.71e-3)" "unprognostic (5.92e-3)" "unprognostic (5.77e-2)" "unprognostic (8.53e-2)" "unprognostic (1.74e-2)" "unprognostic (1.00e-1)" 13.3 3.8 13.7 3.6 22.9 1.8 8.8 11.2 60.6 8.9 4.4 10.7 0.0 3.3 3.8 2.4 4.6 3.9 5.7 13.4 11.3 11.6 3.8 2.9 16.4 3.3 11.9 9.3 2.6 4.3 3.0 9.9 20.3 12.5 4.5 3.9 10.3 4.5 3.0 10.3 3.5 3.2 4.4 9.1 2.8 3.6 3.9 10.5 1.3 5.0 3.7 3.7 5.2 2.5 0.0 0.0 9.9 1.7 0.0 0.3 0.1 0.6 0.0 0.4 3.5 0.3 0.3 9.0 0.8 0.8 0.1 0.1 0.1 0.0 1.6 0.9 0.3 0.4 2.2 1.8 0.1 0.2 0.1 49.4 0.0 1.6 0.9 0.5 0.0 0.4 0.5 1.4 0.0 6.2 0.3 1.6 0.0 3.2 1.4 0.5 0.1 0.0 0.2 0.2 0.1 11.2 0.0 1.9 1.4 0.1 1.5 2.0 5.7 0.0 1.0 33.8 8.4 0.0 0.0 1.1 0.2 0.9 0.0 0.6 1.2 0.2 0.0 1.2 0.0 11.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.9 0.0 1.7 0.0 0.0 0.1 13.7 22.9 11.2 12.3 11.3 11.6 11.9 9.3 12.5 10.5 0.0 2.6 0.0 2.2 2.9 5.3 3.2 0.0 8.1 3.4 0.0 0.0 5.4 13.3 2.1 3.3 39.4 0.9 0.0 1.0 39.7 2.7 1.6 10.4 0.5 1.6 20.6 35.4 13.5 0.6 1.6 0.0 2.1 32.1 0.0 1.9 6.0 0.5 5.8 0.4 0.3 11.5 0.0 6.1 0.7 4.1 2.6 19.6 0.0 2.3 1.8 HGH1 "Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236" ENSG00000235173 "HGH1 homolog" Q9BTY7 8 144137769-144140843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042470 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" Nucleoplasm "HPA042470: AB_2678013" "unprognostic (2.13e-2)" "prognostic unfavorable (3.12e-4)" "unprognostic (9.72e-2)" "unprognostic (2.63e-1)" "unprognostic (9.82e-2)" "unprognostic (2.17e-1)" "unprognostic (7.89e-3)" "unprognostic (1.16e-1)" "unprognostic (2.42e-1)" "unprognostic (1.30e-2)" "unprognostic (4.39e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (4.62e-3)" "unprognostic (3.10e-1)" "unprognostic (2.27e-1)" "unprognostic (1.48e-1)" 13.4 12.3 6.3 7.7 5.5 4.6 7.6 7.3 8.6 5.5 11.8 5.2 4.9 5.0 6.5 3.8 8.7 5.1 5.5 5.1 5.2 3.6 8.2 15.1 5.1 9.5 5.7 7.3 9.7 12.8 6.8 4.4 3.8 6.1 8.6 4.5 5.9 10.5 6.4 13.2 8.9 5.9 5.8 3.8 8.8 15.7 7.9 4.7 11.3 11.0 4.7 8.6 4.9 7.7 2.1 0.9 0.0 0.9 2.2 2.9 0.6 4.8 1.6 1.2 2.2 1.7 1.1 3.0 8.3 0.7 1.8 1.2 2.1 1.3 14.3 11.5 1.5 0.7 5.1 2.3 1.1 0.5 6.8 8.8 5.4 1.4 1.0 1.6 3.0 3.6 0.7 3.6 2.0 1.2 0.6 0.8 3.0 15.4 0.5 1.1 4.1 10.3 2.8 3.3 1.8 28.4 12.9 1.0 2.1 1.0 1.1 2.5 2.7 3.8 2.1 2.8 0.4 1.8 1.1 2.9 1.0 8.8 3.1 9.9 8.6 5.5 3.5 1.0 5.1 1.7 0.0 0.6 0.0 1.5 0.9 0.9 0.5 1.9 2.9 0.9 2.1 1.8 1.3 0.0 2.2 0.7 0.7 0.6 0.6 6.3 5.5 7.3 8.6 5.2 3.6 5.7 7.3 6.1 4.7 0.0 3.7 7.0 2.2 0.0 4.0 2.0 2.5 2.7 1.2 5.2 0.0 9.8 10.0 2.8 9.3 0.4 2.0 0.0 1.6 10.1 0.9 2.8 0.0 8.3 10.9 6.4 4.7 1.3 1.3 15.4 6.9 2.8 0.0 1.0 5.2 8.6 2.5 4.9 3.2 8.4 3.8 6.5 0.3 6.5 15.2 0.0 2.6 4.3 6.8 1.6 HIF1A "bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8" ENSG00000100644 "Hypoxia inducible factor 1 alpha subunit" Q16665 14 61695513-61748259 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 47.8" "Lineage enriched" "Detected in all" 6 "granulocytes: 47.8" "Cell line enhanced" "Detected in many" "LHCN-M2: 119.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000907, HPA001275, CAB017442" Approved Enhanced "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057" "unprognostic (1.07e-2)" "unprognostic (1.13e-3)" "unprognostic (9.41e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (2.94e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.77e-2)" "unprognostic (8.39e-2)" "unprognostic (1.24e-1)" "unprognostic (3.23e-2)" "unprognostic (3.58e-1)" "unprognostic (7.35e-2)" "unprognostic (3.88e-2)" 31.9 62.0 15.6 45.2 17.8 125.2 24.9 22.7 18.5 45.7 15.3 12.3 23.5 10.8 17.7 31.3 31.2 21.7 50.0 19.4 17.5 16.5 76.4 42.7 42.8 27.3 18.3 11.0 34.5 12.7 13.7 26.8 24.2 25.1 17.6 13.9 14.0 24.6 36.2 8.0 17.4 16.9 18.7 27.2 57.3 16.0 21.1 12.4 24.7 26.9 18.4 28.8 37.8 21.5 6.6 6.0 47.8 6.8 6.2 7.9 5.1 38.0 15.2 15.3 43.7 24.3 39.2 20.7 31.7 38.2 39.9 36.0 6.6 12.6 9.3 23.9 39.1 11.4 9.0 9.8 52.0 50.0 4.0 5.1 5.7 14.0 11.4 54.2 2.4 6.2 68.3 16.5 29.3 31.4 53.9 25.1 5.4 3.8 0.0 119.1 7.9 7.4 2.9 13.8 6.0 20.1 0.5 34.3 2.7 51.5 25.3 12.9 14.3 59.4 8.5 20.9 21.8 8.9 4.5 14.9 90.7 20.3 30.0 26.6 5.0 7.2 10.6 47.8 4.7 24.5 11.2 6.8 47.8 3.8 5.5 4.9 6.5 5.0 4.4 6.0 6.6 7.9 5.1 18.2 6.2 5.6 2.9 3.4 5.1 15.6 17.8 22.7 13.2 17.5 16.5 18.3 11.0 25.1 12.4 65.5 115.1 54.6 71.5 94.4 49.4 37.3 86.6 33.5 69.4 247.7 47.1 22.6 87.9 226.7 3.1 113.7 30.7 0.0 216.2 57.6 82.5 54.8 217.2 23.7 123.2 147.8 63.8 177.4 143.9 3.6 22.5 156.8 97.8 76.7 36.5 141.2 213.6 23.0 45.6 116.2 52.0 51.8 129.7 27.4 24.9 76.9 21.3 60.6 34.8 75.6 HIF3A "bHLHe17, IPAS, MOP7, PASD7" ENSG00000124440 "Hypoxia inducible factor 3 alpha subunit" Q9Y2N7 19 46297046-46343433 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Apoptosis, Stress response, Transcription, Transcription regulation" "Developmental protein, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 39.5;Leydig cells: 126.2;Muller glia cells: 84.5;Peritubular cells: 97.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.3;HHSteC: 16.9;HSkMC: 14.9;TIME: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041141 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041141: AB_10803997" "unprognostic (9.20e-2)" "unprognostic (2.99e-1)" "unprognostic (5.48e-2)" "prognostic unfavorable (6.90e-9)" "unprognostic (4.12e-2)" "unprognostic (2.35e-2)" "unprognostic (3.57e-3)" "unprognostic (1.30e-1)" "unprognostic (3.32e-2)" "unprognostic (1.38e-2)" "unprognostic (3.76e-2)" "unprognostic (7.07e-2)" "unprognostic (3.41e-4)" "unprognostic (1.55e-2)" "unprognostic (1.61e-1)" "unprognostic (4.45e-4)" "unprognostic (5.98e-2)" 15.8 7.7 17.9 4.9 9.8 2.5 8.7 10.6 11.1 15.8 16.1 4.7 6.7 3.1 8.1 10.3 11.6 9.8 9.2 31.2 21.4 6.8 4.5 2.1 13.5 5.2 10.8 8.3 17.7 5.1 2.1 12.1 42.4 9.8 9.7 4.5 10.0 4.3 13.1 12.3 3.6 7.0 26.9 11.2 21.7 14.1 3.3 11.4 0.0 3.2 5.6 2.0 18.8 14.6 1.0 1.3 3.3 1.1 0.5 0.7 0.1 0.0 0.0 1.3 0.3 3.8 8.3 0.4 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 16.9 0.1 0.6 14.9 0.0 0.0 0.0 0.1 2.9 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.1 0.0 2.1 0.0 0.2 13.6 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.7 0.2 0.1 3.3 0.4 0.8 0.4 0.4 0.4 0.5 0.4 0.4 0.2 1.0 0.6 0.7 3.1 0.5 1.1 1.3 0.2 0.1 17.9 9.8 10.6 11.1 21.4 6.8 10.8 8.3 9.8 11.4 3.0 2.6 0.0 2.1 1.0 1.4 39.5 10.2 0.0 1.2 0.0 0.0 0.2 1.7 0.0 1.4 36.8 0.0 0.0 0.0 0.2 7.5 1.3 0.0 0.5 0.5 0.0 1.2 28.8 1.0 2.6 126.2 0.2 3.3 0.0 1.1 84.5 0.1 1.5 97.2 0.0 2.1 6.5 4.2 1.2 3.1 1.9 0.5 0.0 1.4 0.5 HIKESHI "C11orf73, HSPC138, HSPC179, OPI10" ENSG00000149196 "Hikeshi, heat shock protein nuclear import factor" Q53FT3 11 86302211-86345931 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 123.6;Extravillous trophoblasts: 118.1;Hofbauer cells: 82.9;monocytes: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012708, HPA035063, HPA035064" Approved Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA012708: , HPA035063: AB_10601143, HPA035064: AB_2674441" "unprognostic (1.10e-3)" "unprognostic (5.09e-2)" "unprognostic (1.92e-1)" "unprognostic (2.40e-2)" "unprognostic (1.50e-1)" "unprognostic (2.18e-1)" "prognostic unfavorable (8.81e-4)" "unprognostic (9.92e-2)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (8.24e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (4.01e-12)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.33e-3)" "unprognostic (1.71e-1)" 23.4 24.1 25.7 16.0 23.3 15.5 31.1 19.1 24.0 21.1 23.5 20.1 14.5 10.2 27.4 24.9 24.6 18.2 15.5 36.1 23.9 23.8 11.7 20.0 16.9 22.0 30.2 18.9 26.2 22.6 18.7 32.0 26.6 25.9 18.1 19.2 15.7 15.4 29.2 46.9 20.2 13.0 30.0 25.1 18.1 15.9 15.3 26.6 23.8 20.8 23.6 28.1 21.6 24.0 30.0 33.3 20.6 26.7 25.9 39.5 20.7 9.0 9.7 23.8 13.1 20.2 25.2 12.6 13.9 16.9 14.6 17.5 29.0 25.2 9.2 32.3 18.4 27.8 19.4 17.6 30.7 15.6 19.6 15.5 14.8 16.1 21.5 27.3 18.1 12.2 17.8 31.2 17.4 20.8 18.9 27.9 17.7 15.8 21.1 29.8 24.6 21.6 43.1 19.5 59.2 6.6 16.7 11.7 20.6 25.0 17.1 14.8 12.8 17.4 13.0 9.4 25.2 20.9 12.2 14.1 17.3 12.2 34.7 10.3 9.1 20.6 17.7 8.8 17.2 17.0 19.6 26.7 20.6 25.2 24.7 27.7 30.0 30.9 27.3 33.3 24.9 27.2 27.6 5.5 25.9 24.3 25.9 39.5 20.7 25.7 23.3 19.1 24.0 23.9 23.8 30.2 18.9 25.9 26.6 35.7 27.2 0.0 0.0 0.0 0.0 0.0 0.0 50.9 27.3 26.2 0.0 123.6 34.9 65.4 0.0 0.0 0.0 0.0 58.0 118.1 0.0 0.0 20.9 0.0 82.9 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 87.4 0.0 0.0 48.4 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 64.8 0.0 0.0 0.0 HINT1 "HINT, PKCI-1, PRKCNH1" ENSG00000169567 "Histidine triad nucleotide binding protein 1" P49773 5 131159027-131171735 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Hydrolase "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044577 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3600000 Cytosol "Nucleoplasm, Plasma membrane" "HPA044577: AB_10795618" "unprognostic (2.00e-1)" "unprognostic (9.27e-2)" "unprognostic (2.04e-2)" "unprognostic (1.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.35e-1)" "unprognostic (8.30e-3)" "unprognostic (2.48e-1)" "unprognostic (1.30e-2)" "unprognostic (6.49e-2)" "unprognostic (6.50e-3)" "unprognostic (4.43e-2)" "unprognostic (4.39e-3)" "unprognostic (2.08e-1)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (3.68e-1)" 28.5 46.5 56.6 46.2 51.6 50.5 64.7 42.9 78.4 29.8 53.3 20.4 49.1 36.5 30.6 43.8 44.3 42.3 36.7 61.4 47.3 43.9 65.4 124.4 38.9 54.7 48.7 50.6 32.2 62.9 43.9 39.6 24.6 40.8 41.3 50.0 22.6 44.4 41.8 84.0 38.3 41.3 37.9 37.5 32.5 32.5 30.5 25.1 29.4 47.5 56.6 39.4 29.1 45.1 26.6 46.5 19.2 25.3 20.9 40.3 52.9 37.7 55.2 43.5 88.9 30.9 33.6 40.1 28.8 26.9 29.1 33.8 53.9 52.9 52.0 57.4 36.8 60.7 23.3 34.6 75.7 26.9 45.4 63.6 20.0 78.3 69.0 64.9 31.2 6.4 44.8 66.9 34.8 58.6 58.2 36.3 80.5 30.4 113.7 37.2 41.6 52.6 78.5 42.1 42.2 44.1 38.1 43.4 94.0 54.6 48.7 53.3 33.4 38.1 26.1 45.4 61.9 31.6 45.6 39.9 38.4 21.8 30.5 58.4 32.7 41.8 45.1 53.8 50.4 35.4 19.2 25.3 9.6 21.7 12.8 29.7 26.6 40.3 28.6 39.2 25.7 32.0 25.3 5.0 20.9 12.9 46.5 27.0 52.9 56.6 51.6 42.9 78.4 47.3 43.9 48.7 50.6 40.8 25.1 262.0 219.1 629.2 1214.3 1155.8 179.6 456.1 1044.6 465.7 406.0 678.7 43.2 639.6 1409.2 899.0 635.9 429.8 1359.9 186.9 676.8 1374.0 368.2 1313.3 104.1 1865.9 757.5 139.8 670.7 421.1 431.2 132.3 363.3 562.9 916.1 1617.7 889.8 207.2 821.7 984.4 393.5 2245.6 149.7 239.3 466.3 357.2 194.1 1001.8 382.0 568.5 1197.2 1396.9 HIPK1 "KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2" ENSG00000163349 "Homeodomain interacting protein kinase 1" Q86Z02 1 113929192-113977869 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 90.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016664 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA016664: AB_1850725" "unprognostic (2.98e-1)" "unprognostic (3.94e-2)" "unprognostic (4.89e-3)" "unprognostic (2.52e-2)" "unprognostic (6.47e-2)" "unprognostic (9.84e-3)" "unprognostic (4.64e-3)" "unprognostic (7.22e-2)" "unprognostic (7.52e-2)" "unprognostic (1.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.15e-1)" "unprognostic (8.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.64e-1)" "unprognostic (1.94e-2)" "unprognostic (1.99e-2)" 15.1 16.8 21.2 14.7 23.0 90.1 13.6 38.1 20.4 20.4 14.4 20.7 14.5 10.2 15.5 14.2 18.7 27.3 17.5 27.9 22.9 17.2 14.8 13.8 19.3 14.7 15.0 16.4 18.7 16.8 20.7 23.8 13.8 21.3 14.4 15.2 20.7 13.0 14.9 19.7 18.5 13.4 15.1 18.3 15.9 14.8 33.5 21.3 47.2 23.3 13.1 15.5 17.3 26.7 2.3 6.2 9.8 4.2 4.3 6.0 2.3 8.2 6.7 9.3 7.1 10.9 5.7 6.3 5.7 6.9 8.1 7.8 7.7 3.2 11.1 7.8 9.0 3.0 5.6 12.0 6.6 11.8 8.0 6.0 16.1 8.4 8.1 9.1 12.8 20.0 6.2 9.7 10.4 10.6 7.7 12.0 19.7 11.0 12.0 11.6 62.4 16.8 7.3 9.5 6.2 6.0 10.2 27.3 3.9 7.3 7.1 4.1 5.5 10.4 11.2 7.3 10.8 6.5 18.5 11.6 8.0 10.8 13.0 8.6 7.5 5.8 9.6 9.0 10.4 18.2 3.4 4.2 8.2 5.5 3.7 5.2 1.7 4.9 4.9 3.1 2.3 5.0 6.0 9.8 4.3 2.6 6.2 3.6 2.3 21.2 23.0 38.1 20.4 22.9 17.2 15.0 16.4 21.3 21.3 50.6 37.0 12.9 14.8 54.6 47.6 27.1 22.9 64.3 20.5 26.2 66.8 9.7 5.0 12.5 82.7 29.3 18.8 70.0 18.3 7.9 25.0 26.7 45.1 33.6 19.9 69.9 35.7 23.9 54.6 73.8 20.4 35.5 20.3 15.4 24.2 28.9 17.0 17.3 35.0 13.4 60.3 25.8 37.0 35.4 26.0 70.4 11.9 47.3 22.4 23.0 HMBOX1 "FLJ21616, HNF1LA, HOT1, PBHNF" ENSG00000147421 "Homeobox containing 1" Q6NT76 8 28890394-29064764 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055855, HPA058586, CAB070418" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "CAB070418: AB_11154826, HPA055855: AB_2682945, HPA058586: AB_2683764" "unprognostic (2.68e-3)" "unprognostic (2.30e-3)" "unprognostic (4.52e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.03e-3)" "unprognostic (1.20e-1)" "unprognostic (2.75e-3)" "unprognostic (1.49e-1)" "unprognostic (4.25e-2)" "unprognostic (1.89e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (3.84e-2)" "unprognostic (2.81e-1)" "unprognostic (1.02e-1)" "unprognostic (1.47e-1)" 10.8 23.1 16.4 10.5 15.5 21.2 10.4 18.6 15.8 9.2 8.4 13.9 8.5 6.7 14.9 8.6 9.6 8.7 9.4 12.7 14.6 8.2 10.1 10.0 15.9 11.0 16.6 10.1 13.9 10.9 13.5 13.6 14.6 15.9 7.6 8.8 9.9 11.7 12.5 9.7 12.1 10.2 11.6 20.0 11.8 9.3 16.8 18.2 13.0 13.7 5.6 12.6 10.4 14.3 6.6 4.8 5.0 9.0 2.2 5.5 2.6 5.1 5.6 6.2 7.1 5.8 6.1 5.2 2.2 2.9 3.5 4.0 2.5 3.3 12.6 5.5 3.8 5.1 4.4 12.1 4.5 4.9 4.6 2.1 13.1 10.5 3.4 4.6 4.4 8.8 2.9 6.5 4.6 8.7 4.3 7.8 7.6 18.5 12.5 4.9 2.9 8.0 2.2 4.3 5.5 1.4 6.6 6.1 2.9 2.5 9.5 2.7 8.0 4.3 3.3 4.7 5.3 3.3 4.0 11.1 3.2 14.9 3.3 3.1 3.8 3.9 4.9 4.3 5.4 4.6 5.0 4.8 2.0 4.0 4.9 5.5 6.6 3.9 3.5 4.8 5.7 5.0 4.8 2.7 2.2 9.0 3.8 1.7 2.6 16.4 15.5 18.6 15.8 14.6 8.2 16.6 10.1 15.9 18.2 14.9 18.6 25.2 14.5 14.8 25.2 15.7 17.8 10.7 7.9 27.9 37.3 10.8 13.3 6.7 69.0 38.3 15.5 0.0 12.5 9.2 16.2 17.3 16.2 11.9 9.1 28.6 16.7 55.9 16.7 24.1 33.1 25.5 15.1 5.4 12.9 28.7 10.4 14.0 29.7 6.9 30.0 19.4 16.5 36.7 13.2 17.2 16.0 21.8 12.1 16.0 HMGA2 "BABL, HMGIC, LIPO" ENSG00000149948 "High mobility group AT-hook 2" P52926 12 65824131-65966295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.3" "Cell type enhanced" "Detected in some" 10 "Early spermatids: 15.7;Hofbauer cells: 6.8;Late spermatids: 6.8;Pancreatic endocrine cells: 11.8;Undifferentiated cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 63.0;hTERT-RPE1: 46.0;SuSa: 44.3" "Not detected" "Not detected" "CAB017809, HPA039076" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB017809: , HPA039076: AB_2676335" "unprognostic (2.39e-1)" "unprognostic (6.00e-2)" "unprognostic (2.08e-1)" "unprognostic (3.68e-3)" "unprognostic (5.21e-3)" "prognostic unfavorable (4.79e-4)" "unprognostic (4.05e-3)" "unprognostic (6.17e-3)" "unprognostic (6.71e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-6)" "unprognostic (3.33e-2)" "unprognostic (4.55e-5)" "unprognostic (4.22e-2)" "unprognostic (2.53e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (2.86e-4)" 6.5 0.3 0.5 3.8 0.8 8.1 2.1 0.2 0.6 2.5 7.6 0.4 0.0 2.4 2.7 0.1 1.1 2.4 3.3 0.5 0.3 0.4 1.0 0.4 0.5 0.1 0.3 1.3 2.1 1.7 0.0 1.7 0.3 0.6 0.5 4.6 0.4 0.5 1.8 2.0 0.7 5.1 0.7 1.7 0.8 2.1 25.3 0.0 0.8 1.1 3.0 0.1 0.8 2.8 0.7 0.3 3.8 2.1 1.3 0.7 0.1 9.1 4.0 63.0 9.0 3.0 16.5 0.0 29.1 13.3 5.1 5.1 5.2 3.9 0.0 18.9 1.3 24.0 4.0 10.4 25.1 24.5 0.0 10.9 0.0 0.1 31.5 1.7 0.8 0.1 12.5 1.5 11.0 19.8 46.0 20.1 0.0 0.0 0.1 29.1 0.0 0.0 5.1 36.9 0.8 18.1 2.4 3.1 0.0 13.6 0.0 0.0 0.0 0.0 0.0 16.0 44.3 0.1 0.1 23.5 18.5 5.5 14.1 8.7 0.0 0.0 0.0 22.4 0.0 4.2 3.8 1.0 0.7 0.5 0.6 0.3 0.3 0.4 0.5 0.2 0.7 0.4 0.7 2.5 1.3 2.1 0.3 0.3 0.1 0.5 0.8 0.2 0.6 0.3 0.4 0.3 1.3 0.6 0.0 0.0 1.4 0.0 2.2 0.0 0.0 1.2 0.0 4.0 0.0 0.0 0.0 0.8 0.0 3.0 15.7 0.1 3.3 0.0 0.7 0.3 0.9 0.4 0.0 0.0 6.8 0.0 0.0 0.6 0.0 6.8 0.3 0.0 0.0 0.0 4.7 0.0 11.8 3.5 0.0 0.0 0.0 0.0 0.8 0.5 0.2 0.1 0.7 0.0 8.5 0.9 HMGCS1 HMGCS ENSG00000112972 "3-hydroxy-3-methylglutaryl-CoA synthase 1" Q01581 5 43289395-43313512 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 117.0" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 206.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 120.5;GAMG: 80.3;HBEC3-KT: 69.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032907, HPA036913, HPA036914" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 310000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751" "unprognostic (1.31e-1)" "unprognostic (5.12e-3)" "unprognostic (6.82e-3)" "unprognostic (4.59e-2)" "unprognostic (8.39e-2)" "unprognostic (2.49e-2)" "unprognostic (1.03e-1)" "unprognostic (3.14e-2)" "unprognostic (1.27e-2)" "unprognostic (3.13e-1)" "unprognostic (6.40e-3)" "unprognostic (9.15e-2)" "prognostic favorable (3.87e-6)" "unprognostic (1.09e-1)" "unprognostic (9.22e-2)" "unprognostic (3.03e-2)" "unprognostic (2.37e-2)" 6.0 16.5 13.3 8.1 24.4 4.3 12.8 8.4 38.2 16.9 15.5 16.9 9.5 27.8 6.8 11.5 53.0 4.1 7.5 5.1 19.4 18.8 10.5 117.0 26.9 6.2 10.4 20.7 15.4 8.4 10.8 5.0 6.9 59.3 12.9 14.2 13.0 18.5 7.7 5.0 25.2 17.1 6.3 25.8 4.4 13.4 9.8 8.1 3.3 7.5 58.1 23.3 6.1 21.4 9.3 7.8 6.9 7.7 6.7 7.9 3.3 14.9 7.2 120.5 13.8 7.0 27.9 8.1 2.4 9.5 3.4 6.9 12.5 21.6 15.9 5.4 3.4 80.3 11.8 30.0 69.5 3.6 3.4 36.0 5.9 6.6 16.9 11.1 12.8 4.2 15.3 8.4 18.1 7.2 2.1 3.5 14.8 10.5 43.5 2.8 6.9 11.5 15.6 21.6 6.0 3.8 8.3 16.9 17.6 53.4 23.2 10.3 5.0 12.3 6.2 3.6 18.2 9.6 17.0 4.2 2.6 13.0 2.7 2.2 5.9 8.9 21.7 2.3 15.4 2.3 5.5 4.0 3.7 5.6 7.4 5.6 9.3 6.2 7.9 7.8 7.5 5.3 7.3 6.9 6.7 7.7 6.5 5.7 3.3 13.3 24.4 8.4 32.1 19.4 18.8 10.4 20.7 59.3 8.1 62.5 124.5 45.6 35.9 96.3 27.9 7.4 56.0 48.2 36.4 45.4 49.1 20.4 11.6 30.6 5.0 19.7 86.8 0.0 52.0 35.5 35.0 65.2 59.8 78.4 20.7 46.1 88.4 23.4 20.8 1.8 11.8 17.2 25.3 78.5 44.0 19.7 36.3 30.9 13.4 17.7 43.3 0.0 24.9 14.1 7.8 206.6 37.2 20.1 31.2 65.0 HNMT ENSG00000150540 "Histamine N-methyltransferase" P50135 2 137964020-138016364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 259.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 19 "classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6" "Group enriched" "Detected in many" 22 "dendritic cells: 20.9;monocytes: 34.6" "Cell line enhanced" "Detected in many" "Hep G2: 60.9;HSkMC: 24.9;RT4: 31.6;SuSa: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035480, HPA035481, HPA073754" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA 64000 "Nucleoplasm, Cytosol" Centrosome "HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: " "unprognostic (1.32e-1)" "unprognostic (3.53e-1)" "unprognostic (5.44e-2)" "unprognostic (2.09e-2)" "unprognostic (2.81e-1)" "unprognostic (2.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.02e-2)" "unprognostic (5.69e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.41e-4)" "unprognostic (5.24e-2)" "unprognostic (1.34e-2)" "unprognostic (1.76e-2)" "unprognostic (5.34e-2)" "unprognostic (1.21e-1)" "prognostic favorable (4.68e-4)" 41.4 5.8 12.2 12.3 11.1 3.3 28.8 10.7 11.3 27.6 16.3 8.6 13.9 8.7 22.2 21.4 11.6 14.6 21.6 14.7 12.7 7.8 33.4 74.2 21.9 17.0 13.7 9.2 33.1 14.1 24.5 5.5 14.3 11.2 22.3 17.7 8.7 14.1 20.1 4.9 8.1 11.1 13.2 14.8 18.5 11.5 11.7 14.6 1.0 7.3 8.5 6.5 21.3 12.0 0.5 20.9 1.2 34.6 0.1 0.2 9.2 0.2 0.3 1.5 4.1 17.5 18.8 0.1 1.1 1.7 0.1 0.7 7.8 4.4 0.2 13.8 4.5 0.3 0.4 3.2 0.0 0.0 0.2 1.6 0.1 13.0 60.9 7.9 0.0 0.2 24.9 0.0 6.2 0.0 1.4 4.4 0.1 0.2 0.3 13.1 0.9 0.0 0.2 7.8 10.4 1.6 0.1 0.5 0.0 18.8 31.6 0.1 0.4 5.9 7.7 0.0 31.3 0.2 14.3 1.2 1.3 3.4 1.8 4.4 0.1 0.0 0.2 5.9 7.5 0.9 0.8 34.6 0.2 0.2 26.7 0.1 0.5 0.1 0.1 20.9 0.3 0.1 0.2 1.2 0.1 14.6 0.6 0.2 9.2 12.2 11.1 10.7 11.3 12.7 7.8 13.7 9.2 11.2 14.6 26.8 39.0 13.7 77.1 31.6 0.5 1.6 140.1 52.2 86.4 57.6 0.0 45.4 104.5 84.7 1.2 4.9 45.2 0.0 42.0 69.7 45.8 47.7 0.0 146.0 259.0 0.0 15.7 23.4 235.2 1.6 121.7 155.2 54.0 68.5 65.8 22.3 57.9 100.1 99.0 189.5 0.5 77.6 52.5 0.5 0.6 22.6 31.5 5.0 76.2 102.7 HNRNPLL HNRPLL ENSG00000143889 "Heterogeneous nuclear ribonucleoprotein L like" Q8WVV9 2 38561978-38603586 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 114.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046084 Approved Approved Nucleoplasm,Mitochondria,Cytosol No No Nucleoplasm "Mitochondria, Cytosol" "HPA046084: AB_10960895" "unprognostic (2.27e-2)" "unprognostic (1.75e-1)" "unprognostic (3.63e-2)" "unprognostic (5.18e-1)" "unprognostic (2.10e-3)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.22e-4)" "unprognostic (1.52e-2)" "unprognostic (1.52e-1)" "unprognostic (1.80e-1)" "unprognostic (4.20e-2)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.28e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-2)" 16.6 19.5 14.9 13.3 16.2 47.3 20.0 22.1 17.5 18.2 16.4 10.8 17.0 16.2 21.9 19.4 14.4 17.6 16.5 14.3 17.8 11.8 12.5 11.6 17.6 12.1 13.2 19.2 19.9 16.8 18.8 16.4 13.8 10.9 16.8 13.0 13.5 14.0 22.8 13.1 12.0 13.6 14.2 12.8 12.0 16.3 24.8 12.4 40.0 19.2 11.5 11.5 20.8 26.4 1.0 6.9 5.3 3.6 3.6 21.7 3.5 16.8 7.9 23.2 13.6 11.3 10.7 14.5 15.9 13.1 14.0 11.7 8.9 9.8 0.2 14.3 14.2 14.9 10.8 14.6 11.9 14.4 25.1 12.7 12.3 14.9 22.5 10.7 22.9 12.7 8.4 9.5 11.5 12.9 13.8 14.5 11.3 20.8 38.2 16.3 7.8 24.9 12.5 23.3 16.3 14.5 4.9 16.3 8.2 11.9 22.2 15.9 17.8 14.0 12.3 11.7 13.5 10.4 9.9 15.0 10.5 15.7 11.4 13.0 20.9 20.9 0.1 9.0 5.7 12.7 5.3 3.6 5.1 6.2 1.8 11.0 0.2 15.1 11.6 6.9 1.0 4.6 2.9 2.5 3.6 0.7 0.1 21.7 3.5 14.9 16.2 22.1 17.5 17.8 11.8 13.2 19.2 10.9 12.4 17.9 18.9 4.2 29.5 25.4 12.6 14.4 2.5 10.7 19.4 26.2 7.9 22.8 16.6 20.6 114.5 19.1 12.9 0.0 21.3 24.7 25.6 21.8 9.2 6.4 22.1 6.4 13.8 19.6 15.4 35.0 25.6 26.7 37.1 31.5 16.9 24.6 17.7 17.5 49.1 16.3 10.4 38.8 23.7 68.1 29.6 18.6 18.5 17.5 18.7 17.6 HORMAD2 "CT46.2, MGC26710" ENSG00000176635 "HORMA domain containing 2" Q8N7B1 22 30080174-30177075 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 21.3" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 115.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 1.2;U-2197: 3.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA003074, HPA043880" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA003074: AB_1850916, HPA043880: " "unprognostic (1.43e-1)" "unprognostic (6.77e-3)" "unprognostic (2.33e-1)" "unprognostic (1.36e-2)" "unprognostic (8.19e-3)" "unprognostic (1.96e-1)" "unprognostic (2.50e-2)" "unprognostic (2.12e-1)" 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 115.1 2.7 0.0 0.0 0.0 0.0 0.0 HOXA13 "HOX1, HOX1J" ENSG00000106031 "Homeobox A13" P31271 7 27193503-27200106 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 48.5;prostate: 25.1" "Group enriched" "Detected in some" 15 "Basal glandular cells: 2.9;Enterocytes: 7.7;Fibroblasts: 3.5;Glandular cells: 4.8;Intestinal endocrine cells: 8.1;Mucus-secreting cells: 9.8;Paneth cells: 5.8;Undifferentiated cells: 9.7;Urothelial cells: 2.8" "Cancer enhanced" "Detected in many" "prostate cancer: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 15.5;HEK 293: 21.6;PC-3: 10.7;RT4: 23.9;THP-1: 10.2;U-937: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046098, HPA069061" Supported "Nucleoplasm,Mitotic chromosome,Intermediate filaments" NA NA Nucleoplasm "Mitotic chromosome, Intermediate filaments" "HPA046098: AB_2679536, HPA069061: " "unprognostic (7.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (8.04e-4)" "unprognostic (1.06e-3)" "unprognostic (2.24e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-2)" "unprognostic (9.22e-3)" "unprognostic (7.30e-3)" "unprognostic (8.39e-3)" "unprognostic (1.54e-1)" "unprognostic (1.42e-11)" "unprognostic (2.58e-3)" "unprognostic (1.38e-1)" "unprognostic (1.72e-1)" "unprognostic (1.36e-2)" 0.6 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 48.5 6.9 0.0 7.1 0.0 5.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 16.5 0.0 25.1 8.6 0.0 0.1 17.9 1.2 0.4 0.1 15.7 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 12.1 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 1.4 0.1 0.0 0.0 7.6 8.3 3.0 1.9 1.5 0.1 0.0 0.9 3.5 0.4 0.0 15.5 0.0 2.5 0.0 21.6 1.0 4.1 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 4.9 0.0 6.6 10.7 1.5 0.4 0.0 0.0 23.9 0.4 0.0 1.9 0.0 0.1 1.2 0.0 10.2 0.0 0.3 2.7 0.1 0.1 0.0 0.0 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.7 0.0 0.0 0.1 3.5 4.8 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 9.7 2.8 HOXB5 "HOX2, HOX2A" ENSG00000120075 "Homeobox B5" P09067 17 48591257-48593961 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6" "Cell type enhanced" "Detected in some" 16 "Collecting duct cells: 50.6;Distal tubular cells: 21.6;Mucus-secreting cells: 13.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 28.1" "Region enriched" "Detected in single" 33 "pons and medulla: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 21.5;RPTEC TERT1: 16.1" "Region enriched" "Detected in single" 90 "pons and medulla: 24.0" "Region enriched" "Detected in single" 128 "pons and medulla: 14.7" "HPA043851, HPA074454" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA043851: AB_2732509, HPA074454: AB_2686690" "unprognostic (6.50e-2)" "unprognostic (1.63e-1)" "unprognostic (4.22e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.48e-3)" "unprognostic (7.12e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.47e-1)" "unprognostic (1.47e-3)" "unprognostic (5.10e-2)" "unprognostic (9.64e-2)" "unprognostic (7.61e-3)" "unprognostic (8.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "prognostic favorable (8.59e-5)" 3.4 3.1 0.2 2.1 0.2 0.0 5.0 0.2 0.7 5.4 10.5 0.2 25.9 1.5 2.2 18.5 0.6 7.2 0.2 0.7 0.2 0.0 16.0 0.4 5.2 0.8 0.2 0.2 1.9 0.5 0.9 0.2 1.2 25.4 1.3 4.7 0.2 0.6 27.6 0.2 0.5 9.5 1.6 22.5 2.0 4.3 0.7 0.2 0.2 0.7 0.2 0.2 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.8 0.0 2.5 2.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 5.2 2.7 0.6 0.0 0.2 0.0 0.0 0.0 21.5 0.9 5.6 0.0 4.2 0.0 1.2 1.4 0.0 2.9 0.0 0.8 1.4 0.1 1.6 0.0 3.3 0.0 0.0 0.0 0.0 2.7 1.7 0.0 1.0 0.0 16.1 1.6 0.0 0.0 0.1 0.0 2.3 0.1 0.4 0.0 5.3 0.7 2.1 0.5 0.3 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 25.4 0.2 0.0 0.6 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 50.6 0.0 0.0 21.6 0.0 0.6 2.4 8.9 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.5 0.0 4.1 9.2 5.0 0.0 0.0 0.0 1.7 0.0 13.9 0.0 0.0 3.5 0.4 0.4 0.0 0.0 1.0 7.2 10.8 0.3 0.0 0.0 11.5 0.0 HOXB7 "HOX2, HOX2C" ENSG00000260027 "Homeobox B7" P09629 17 48607227-48633572 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 62.3" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 82.0;Distal tubular cells: 126.0;Enterocytes: 102.1;Mucus-secreting cells: 73.3;Paneth cells: 56.1;Undifferentiated cells: 65.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 30.4;OE19: 26.5;RPTEC TERT1: 24.2;SK-MEL-30: 28.8" "Region enriched" "Detected in single" 45 "pons and medulla: 6.0" "Region enriched" "Detected in single" 14 "pons and medulla: 1.5" HPA049940 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA049940: AB_2616461" "unprognostic (6.76e-2)" "unprognostic (6.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-3)" "unprognostic (1.42e-2)" "unprognostic (1.69e-2)" "unprognostic (8.05e-3)" "unprognostic (9.16e-2)" "unprognostic (9.91e-2)" "unprognostic (7.01e-3)" "unprognostic (7.81e-3)" "unprognostic (1.17e-2)" "unprognostic (1.56e-2)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" "prognostic favorable (2.39e-4)" 8.3 8.3 0.0 7.3 0.3 0.1 17.2 0.1 0.6 10.0 8.1 0.1 24.1 0.5 4.1 62.3 0.8 4.2 0.3 1.1 0.0 0.0 23.7 0.8 1.7 2.4 0.1 0.3 2.3 0.6 0.4 0.5 4.1 4.1 5.2 7.0 0.1 0.1 22.1 2.4 2.2 12.4 3.5 20.1 2.2 4.6 3.0 0.2 0.1 0.5 0.1 0.6 5.8 15.1 2.2 1.8 0.0 0.0 2.0 4.7 0.5 16.9 7.4 0.0 0.1 5.3 8.0 0.0 0.0 0.0 0.1 0.3 11.3 0.3 0.3 30.4 7.1 8.8 2.5 0.0 0.0 0.0 7.8 5.5 2.6 5.8 0.0 4.4 0.0 5.5 5.2 2.3 5.2 0.0 1.3 16.0 5.3 2.8 0.1 16.8 4.4 0.3 0.1 0.0 26.5 0.0 0.0 14.4 1.9 24.2 5.7 0.0 0.0 5.7 0.0 28.8 0.4 1.4 1.6 13.7 0.0 9.3 7.5 13.1 0.9 2.2 0.0 0.1 0.0 21.3 0.0 0.0 0.0 3.8 0.0 1.9 1.9 0.7 2.1 0.0 2.2 0.0 1.4 0.0 2.0 0.0 1.8 4.7 0.5 0.0 0.3 0.1 0.6 0.0 0.0 0.1 0.3 4.1 0.2 0.0 0.0 3.7 0.8 4.8 0.0 0.3 0.0 0.0 0.0 82.0 0.0 6.2 126.0 0.0 0.1 2.2 102.1 0.0 1.1 14.9 8.2 0.7 4.7 0.0 8.8 0.0 35.1 1.3 7.8 0.0 0.6 2.8 23.6 2.8 73.3 0.0 0.5 56.1 0.0 27.8 0.0 0.0 8.0 1.4 23.4 1.8 1.5 1.0 65.0 3.1 HOXD10 "HOX4, HOX4D" ENSG00000128710 "Homeobox D10" P28358 2 176108790-176119942 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 21.7;endometrium 1: 38.2" "Cell type enhanced" "Detected in some" 16 "Collecting duct cells: 14.0;Distal tubular cells: 13.3;Intestinal endocrine cells: 23.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 7.3;HEK 293: 26.0;RPTEC TERT1: 18.7;SCLC-21H: 7.3;SiHa: 10.9;U-251 MG: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA065871 Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" No NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA065871: AB_2685573" "unprognostic (4.29e-3)" "unprognostic (2.51e-1)" "unprognostic (2.98e-3)" "unprognostic (1.69e-1)" "unprognostic (1.80e-3)" "unprognostic (6.82e-2)" "unprognostic (1.04e-5)" "unprognostic (1.19e-2)" "unprognostic (1.99e-1)" "unprognostic (2.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.92e-6)" "unprognostic (2.15e-3)" "unprognostic (4.57e-2)" "unprognostic (4.86e-1)" "unprognostic (1.27e-1)" 0.9 0.0 0.1 1.2 0.1 0.0 21.7 0.1 0.1 10.3 9.5 0.1 1.4 0.0 38.2 2.8 1.2 1.6 0.6 0.6 0.1 0.0 16.3 0.1 0.8 0.2 0.1 0.1 2.7 0.1 0.0 0.1 3.0 0.1 9.5 4.3 0.1 0.5 5.1 0.2 1.0 0.1 14.2 0.1 0.1 0.0 3.9 0.1 0.2 0.3 0.4 1.4 2.1 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 7.3 0.0 0.0 0.3 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 18.7 0.0 7.3 1.9 10.9 0.0 0.0 1.4 0.0 0.0 1.6 0.0 1.4 0.6 8.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 4.6 0.8 0.0 0.3 0.0 0.0 0.0 14.0 0.0 0.0 13.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.1 0.0 23.2 0.0 0.0 0.0 1.7 0.0 1.7 0.0 3.9 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 5.2 2.0 HPGDS "GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS" ENSG00000163106 "Hematopoietic prostaglandin D synthase" O60760 4 94298535-94342876 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.8" "Group enriched" "Detected in many" 10 "granulocytes: 1000.1;Hofbauer cells: 476.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 15.8" "Lineage enriched" "Detected in single" 25 "granulocytes: 15.8" "Group enriched" "Detected in some" 8 "HEL: 32.4;HMC-1: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA024035 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 170000 "Vesicles, Cytosol" Nucleoplasm "HPA024035: AB_1855743" "unprognostic (5.71e-2)" "unprognostic (5.80e-3)" "unprognostic (1.17e-1)" "unprognostic (5.36e-3)" "unprognostic (2.76e-1)" "unprognostic (2.38e-4)" "unprognostic (1.01e-2)" "unprognostic (4.41e-3)" "unprognostic (1.35e-1)" "unprognostic (7.75e-4)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (5.15e-3)" "unprognostic (4.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" 14.3 2.9 8.0 1.6 12.1 1.6 5.8 2.0 7.7 5.4 6.9 4.4 0.2 7.5 4.7 3.3 4.1 2.5 9.3 3.0 8.4 3.6 2.5 1.3 12.7 0.9 9.6 2.4 1.5 1.8 1.7 1.5 24.8 9.0 6.4 7.5 2.9 3.8 2.2 1.4 5.8 8.6 5.8 14.6 1.4 4.4 1.8 12.1 1.5 1.2 2.8 1.5 4.5 3.5 0.0 0.1 15.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 2.5 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 8.0 12.1 2.0 7.7 8.4 3.6 9.6 2.4 9.0 12.1 11.9 75.3 0.0 0.8 3.7 0.0 0.0 0.0 2.7 6.8 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.5 4.1 4.0 1000.1 0.0 476.4 0.0 6.8 0.0 3.9 0.0 0.3 14.5 3.3 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.1 4.6 4.6 0.0 0.0 0.1 HSCB "DNAJC20, HSC20, Jac1" ENSG00000100209 "HscB mitochondrial iron-sulfur cluster cochaperone" Q8IWL3 22 28742031-28757515 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018447, HPA031518" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA018447: AB_1853867, HPA031518: AB_2673919" "unprognostic (8.19e-3)" "unprognostic (6.48e-2)" "unprognostic (9.62e-3)" "prognostic favorable (3.78e-4)" "unprognostic (3.30e-1)" "unprognostic (7.02e-2)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "unprognostic (5.83e-2)" "unprognostic (7.38e-3)" "unprognostic (4.44e-1)" "unprognostic (2.81e-1)" "unprognostic (1.54e-3)" "unprognostic (2.19e-1)" "unprognostic (3.39e-1)" "unprognostic (2.12e-1)" "prognostic favorable (8.38e-4)" 9.6 18.8 13.1 9.2 13.9 4.9 12.4 13.7 12.9 14.1 11.6 9.1 20.3 13.7 11.5 8.8 11.8 10.4 11.4 9.6 12.3 8.3 12.9 29.5 7.3 15.5 15.8 9.0 16.5 15.2 6.2 16.1 8.7 10.6 15.9 7.7 8.2 28.2 17.5 14.6 9.2 10.0 8.9 12.2 10.9 12.8 6.0 13.2 6.9 14.4 8.1 10.3 15.0 10.5 12.9 11.3 7.7 14.4 9.7 8.5 5.8 9.3 6.0 2.5 3.8 4.6 11.8 4.8 6.9 9.7 10.3 6.3 2.6 3.4 10.6 3.3 3.8 2.5 6.6 4.8 4.5 4.9 10.0 19.5 3.6 4.7 7.4 9.8 6.6 5.4 7.9 9.9 5.7 9.0 5.3 7.8 3.2 5.6 9.3 4.1 13.5 3.0 6.1 6.0 10.3 14.8 6.0 7.8 11.9 11.1 2.7 8.5 7.7 3.8 14.6 18.4 2.1 6.0 4.1 4.1 14.1 7.4 13.3 6.2 13.1 10.7 9.1 9.9 4.9 9.3 7.7 7.9 3.6 6.3 14.4 7.6 12.9 6.4 7.4 11.3 9.9 7.0 8.5 0.4 9.7 11.0 5.9 4.8 5.8 13.1 13.9 13.7 12.9 12.3 8.3 15.8 9.0 10.6 13.2 20.8 15.8 20.1 22.7 10.3 4.8 6.0 22.9 32.1 26.1 19.2 5.9 13.2 24.9 21.9 3.3 15.8 10.3 0.0 24.7 12.0 16.6 18.9 22.0 33.0 23.7 4.8 19.0 17.2 14.9 2.6 17.3 18.5 13.5 19.8 13.1 9.7 21.0 7.0 11.0 37.1 8.1 6.5 15.6 12.2 16.1 13.7 11.1 17.8 19.7 12.8 HSPA1A "HSP70-1, HSPA1" ENSG00000204389 "Heat shock protein family A (Hsp70) member 1A" P0DMV8 6 31815464-31817946 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "breast: 216.1;vagina: 741.6" "Cell type enhanced" "Detected in many" 13 "Basal glandular cells: 6419.7;Glandular cells: 2245.3;Urothelial cells: 2114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5" "Cell line enriched" "Detected in some" 10 "HEK 293: 310.1" "CAB017451, CAB032815, HPA052504" Supported Approved Nucleoplasm,Vesicles,Cytosol NA Yes 77000000 "Nucleoplasm, Vesicles" Cytosol "CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854" "unprognostic (2.44e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (6.17e-3)" "unprognostic (2.47e-2)" "unprognostic (1.74e-2)" "unprognostic (8.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" "unprognostic (6.48e-2)" "unprognostic (4.12e-2)" "unprognostic (1.51e-1)" 29.1 74.5 35.3 18.4 48.0 3.5 216.1 40.4 36.0 8.8 22.6 27.4 41.1 3.6 33.1 32.3 36.7 14.5 14.6 40.3 37.5 28.8 35.3 49.5 54.7 14.1 89.2 10.8 15.1 31.2 3.5 23.8 22.1 67.4 47.8 11.4 6.1 28.3 52.7 66.7 57.9 17.3 36.4 47.0 35.6 19.3 10.9 85.9 1.3 26.8 16.3 11.8 41.3 741.6 1.0 0.5 8.8 4.7 1.2 4.5 0.5 0.0 31.3 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.7 0.0 0.0 0.0 2.3 0.0 0.2 310.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.4 4.5 1.8 4.7 1.0 1.0 2.5 2.3 0.5 0.4 1.2 1.1 8.8 1.2 2.5 0.5 4.5 0.5 35.3 48.0 40.4 36.0 37.5 28.8 89.2 10.8 67.4 85.9 137.0 84.3 135.2 6419.7 321.9 290.0 857.6 71.4 100.4 76.2 120.4 357.4 38.6 34.9 77.7 73.7 681.4 145.3 0.0 18.8 85.4 940.7 2245.3 456.0 74.4 220.0 193.9 449.0 109.9 284.5 25.8 558.4 1365.8 796.3 117.2 187.3 954.1 43.5 340.1 151.0 60.4 639.2 148.8 1629.0 48.6 175.8 294.0 87.2 208.8 111.9 2114.2 HSPA1B HSP70-2 ENSG00000204388 "Heat shock protein family A (Hsp70) member 1B" P0DMV9 6 31827735-31830255 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 508.1" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 2896.7;Glandular cells: 1002.7;Smooth muscle cells: 978.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A549: 24.5;Karpas-707: 72.8" "CAB008640, HPA052504" Approved Approved Nucleoplasm,Vesicles,Cytosol NA Yes "Vesicles, Cytosol" Nucleoplasm "CAB008640: AB_1617331, HPA052504: AB_2681854" "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (4.23e-3)" "unprognostic (3.23e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.76e-3)" "unprognostic (9.50e-2)" "unprognostic (3.45e-1)" "unprognostic (4.42e-2)" "unprognostic (6.92e-2)" "unprognostic (4.88e-2)" "unprognostic (5.74e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-3)" "unprognostic (4.69e-2)" "unprognostic (5.99e-2)" 21.9 89.9 25.0 20.3 31.1 5.7 129.4 30.8 23.6 8.4 14.6 17.0 36.6 6.2 19.9 40.5 24.4 13.2 12.6 29.2 25.5 22.5 18.6 28.7 30.8 6.3 61.9 8.5 29.3 36.7 35.1 21.6 6.4 53.8 31.1 8.4 5.6 39.7 48.5 102.8 11.3 11.0 27.9 33.4 10.0 20.5 11.8 55.1 0.9 32.1 14.3 9.7 43.4 508.1 1.1 0.6 1.4 1.3 0.4 0.4 0.3 0.2 24.5 0.1 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.2 7.6 1.3 0.0 1.0 0.0 0.0 0.0 0.5 7.6 0.0 0.2 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 72.8 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.0 0.1 5.1 0.0 0.1 11.9 0.1 0.1 0.0 0.0 0.0 0.5 1.3 1.4 0.1 0.2 0.1 0.2 0.4 0.0 0.6 1.1 0.0 0.0 0.8 0.4 0.7 0.5 0.3 0.3 25.0 31.1 30.8 23.6 25.5 22.5 61.9 8.5 53.8 55.1 104.2 64.8 61.6 2896.7 212.6 40.4 440.6 20.4 54.9 58.0 66.3 123.7 73.9 16.6 33.6 1.7 185.0 221.9 0.0 13.7 87.7 515.0 1002.7 354.9 16.3 116.6 44.5 304.9 19.6 74.0 3.1 204.3 481.3 609.0 26.2 172.9 237.3 22.8 291.0 51.6 32.9 140.4 103.5 978.7 12.8 50.3 194.0 217.2 75.6 121.8 675.8 HSPB8 "CMT2L, E2IG1, H11, HSP22, HspB8" ENSG00000152137 "Heat shock protein family B (small) member 8" Q9UJY1 12 119178642-119221131 "Disease related genes, Predicted intracellular proteins" "Stress response" Chaperone "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 152.6" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 553.3;Syncytiotrophoblasts: 1120.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 28.7;HeLa: 21.4;MCF7: 37.7;SuSa: 24.7;U-87 MG: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015876 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear bodies" "HPA015876: AB_1850458" "unprognostic (1.52e-2)" "unprognostic (6.97e-2)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" "unprognostic (1.99e-3)" "prognostic unfavorable (2.98e-4)" "unprognostic (2.47e-1)" "unprognostic (4.03e-2)" "unprognostic (7.91e-2)" "unprognostic (6.48e-3)" "unprognostic (1.11e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.36e-2)" "unprognostic (2.17e-2)" 12.2 4.4 19.3 8.2 22.7 0.7 6.8 2.0 18.1 15.3 52.7 34.1 13.1 2.8 18.6 7.2 42.9 9.6 12.0 107.9 17.4 17.6 16.3 1.7 13.4 3.3 27.4 14.7 5.7 7.7 73.3 3.0 64.3 24.5 40.1 11.9 21.7 11.4 79.4 152.6 10.0 7.9 65.5 35.0 13.6 20.6 3.6 19.3 5.4 8.0 42.1 26.7 55.6 18.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.3 4.9 0.2 0.0 5.7 4.5 18.8 10.6 9.4 2.1 0.1 11.8 0.2 0.0 28.7 14.6 16.9 0.7 0.1 0.0 0.3 0.0 0.4 0.0 21.4 1.0 3.9 0.0 0.0 4.9 1.7 7.1 0.6 7.8 4.3 0.0 0.0 0.0 5.2 37.7 0.0 0.1 2.2 0.0 7.0 0.0 7.8 1.0 15.5 2.0 0.1 0.3 4.0 0.5 2.2 24.7 9.7 0.0 6.0 5.2 13.2 6.8 0.5 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 22.7 2.0 16.0 17.4 17.6 27.4 14.7 24.5 19.3 41.7 54.8 0.5 84.4 90.9 0.6 553.3 10.2 4.0 6.8 5.2 7.9 125.9 0.0 51.2 12.3 27.0 0.0 0.0 9.8 10.9 43.0 15.6 1.1 0.0 16.9 1.6 0.0 27.0 1.8 8.5 1.4 3.2 11.8 1.8 0.0 46.4 18.4 0.0 0.4 38.9 2.2 6.5 115.6 0.2 0.0 25.1 1120.5 3.2 0.0 73.8 HSPG2 "perlecan, PRCAN, SJS1" ENSG00000142798 "Heparan sulfate proteoglycan 2" P98160 1 21822245-21937297 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 104.4" "Cell type enriched" "Detected in many" 7 "Ito cells: 621.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 12 "dendritic cells: 3.0" "Cell line enhanced" "Detected in many" "EFO-21: 46.8;HUVEC TERT2: 103.4;TIME: 82.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009820, HPA018892, CAB020718, HPA072690" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 1700000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: " "unprognostic (1.61e-1)" "unprognostic (1.57e-2)" "unprognostic (4.93e-2)" "unprognostic (9.60e-2)" "unprognostic (2.38e-2)" "unprognostic (8.56e-2)" "unprognostic (4.55e-1)" "unprognostic (1.90e-2)" "unprognostic (9.35e-2)" "unprognostic (2.19e-3)" "unprognostic (5.82e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-3)" "unprognostic (1.17e-2)" "unprognostic (4.86e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (2.82e-4)" 54.8 12.8 1.1 22.9 1.5 0.2 19.8 0.8 1.5 37.3 32.3 2.4 37.2 6.2 62.8 37.6 32.7 20.6 60.0 30.2 1.2 1.2 15.7 8.9 12.5 7.8 2.5 1.2 19.8 9.4 4.6 3.4 24.6 3.8 32.0 2.5 24.6 15.5 22.3 20.8 12.2 13.7 104.4 1.8 16.4 18.9 11.4 0.7 3.4 16.9 20.1 8.5 66.2 28.2 0.2 3.0 0.0 0.0 0.0 0.2 0.0 7.0 6.5 2.2 7.7 22.6 17.2 8.6 10.7 2.7 3.1 2.8 7.9 14.5 0.5 46.8 16.5 0.1 4.4 0.5 5.2 0.7 0.1 0.7 2.4 7.0 5.7 4.7 0.0 0.6 10.4 1.6 3.2 0.9 4.7 103.4 0.0 3.1 0.9 4.2 1.9 0.0 3.2 1.9 3.2 2.9 1.0 9.2 0.9 6.0 0.9 0.2 0.6 8.1 3.4 4.7 2.0 1.3 1.2 82.5 6.1 8.0 4.7 0.3 0.0 1.0 0.4 1.6 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 3.0 0.0 0.0 1.1 1.5 0.8 1.5 1.2 1.2 2.5 1.2 3.8 0.7 65.5 28.7 5.2 10.9 23.5 0.7 4.5 40.8 1.4 12.5 87.2 0.0 9.4 0.0 63.1 1.0 75.0 34.2 0.0 21.9 85.1 58.4 6.6 22.0 2.8 6.1 3.2 2.4 621.2 31.6 2.2 69.6 3.5 57.3 2.8 12.8 1.4 55.1 20.7 65.0 0.5 0.5 32.3 38.8 0.4 4.1 15.6 7.8 6.4 13.9 8.3 ICAM3 "CD50, CDW50, ICAM-R" ENSG00000076662 "Intercellular adhesion molecule 3" P32942 19 10333776-10339823 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5" "Cell type enhanced" "Detected in many" 7 "B-cells: 138.5;Hepatocytes: 150.6;Kupffer cells: 110.3;T-cells: 189.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 172.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 172.3" "Cell line enhanced" "Detected in many" "Karpas-707: 65.6;NB-4: 42.3;RPMI-8226: 49.2;U-266/84: 34.9;U-937: 34.5" "CAB002498, HPA049820" Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA 370000000 Mitochondria "Nucleoplasm, Nuclear membrane" "CAB002498: AB_563593, HPA049820: AB_2680897" "unprognostic (6.85e-4)" "unprognostic (5.28e-3)" "unprognostic (3.09e-3)" "unprognostic (1.57e-2)" "unprognostic (5.34e-3)" "unprognostic (5.79e-6)" "unprognostic (5.05e-3)" "unprognostic (3.73e-2)" "unprognostic (1.73e-3)" "unprognostic (7.93e-2)" "unprognostic (3.45e-2)" "unprognostic (2.54e-1)" "unprognostic (5.62e-4)" "unprognostic (1.13e-1)" "unprognostic (1.06e-2)" "unprognostic (3.43e-1)" "unprognostic (1.84e-1)" 6.8 2.8 1.7 23.5 1.9 51.5 5.5 0.6 1.5 3.0 6.8 1.1 1.2 4.3 1.7 3.0 4.0 2.9 7.2 6.4 1.1 0.9 5.1 28.7 13.2 68.5 1.8 1.4 1.7 6.8 0.2 0.4 4.8 1.5 2.8 3.3 2.4 10.3 1.3 5.0 1.6 11.9 1.8 1.0 39.4 5.4 1.4 1.0 47.6 3.0 5.7 38.4 4.5 4.9 25.5 28.4 172.3 33.5 31.0 41.0 43.1 2.7 1.3 1.0 3.0 1.6 1.3 1.7 1.7 1.1 1.4 1.2 1.1 1.8 0.0 5.8 1.5 0.0 1.1 0.0 1.2 0.4 20.3 0.8 5.2 1.2 5.1 0.8 18.7 21.1 1.1 1.0 1.6 0.6 1.5 0.6 10.9 2.8 65.6 1.6 5.5 2.4 42.3 0.7 6.9 9.2 1.5 0.6 49.2 1.4 2.4 0.3 1.3 1.4 4.6 3.7 0.5 4.0 5.3 1.1 6.5 0.5 7.1 1.6 3.2 34.9 7.8 4.6 34.5 5.0 15.3 33.1 72.0 33.8 24.4 41.0 25.5 32.7 31.2 28.4 23.9 29.3 27.4 172.3 31.0 33.5 4.8 36.9 43.1 1.7 1.9 0.6 1.5 1.1 0.9 1.8 1.4 1.5 1.0 3.0 43.3 138.5 7.1 7.2 0.1 0.0 25.5 9.4 4.5 5.2 0.0 10.4 53.0 13.7 4.2 18.0 53.5 0.0 30.7 20.6 13.1 14.3 30.0 150.6 21.1 1.6 5.2 26.4 110.3 7.2 5.8 19.9 52.3 12.6 29.1 1.5 17.7 45.3 3.9 54.2 1.2 0.0 13.3 0.5 0.9 7.3 3.9 189.2 31.2 8.4 ID2 "bHLHb26, GIG8" ENSG00000115738 "Inhibitor of DNA binding 2" Q02363 2 8678845-8684453 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 274.1" "Cell type enhanced" "Detected in all" 12 "monocytes: 3286.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 110.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 108.1;HEK 293: 69.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027612 Approved "Nucleoplasm,Nuclear bodies,Centrosome" NA NA "Nucleoplasm, Nuclear bodies" Centrosome "HPA027612: AB_10599729" "unprognostic (2.53e-1)" "unprognostic (8.16e-3)" "unprognostic (8.51e-2)" "unprognostic (6.66e-2)" "unprognostic (2.24e-1)" "prognostic favorable (9.95e-4)" "unprognostic (4.39e-2)" "unprognostic (6.31e-2)" "unprognostic (1.95e-1)" "unprognostic (2.07e-1)" "unprognostic (1.11e-1)" "unprognostic (2.81e-1)" "unprognostic (5.98e-2)" "unprognostic (2.42e-2)" "unprognostic (1.74e-1)" "unprognostic (1.38e-3)" "unprognostic (1.92e-3)" 34.2 37.4 24.9 19.1 20.6 69.8 31.5 11.3 57.3 21.9 34.0 22.9 13.2 20.7 18.6 11.6 12.1 28.1 33.5 46.1 20.0 14.6 31.2 117.5 25.4 22.4 19.0 35.3 59.7 15.0 274.1 17.2 14.8 20.0 27.2 26.4 13.3 24.5 72.7 8.8 16.6 20.4 19.2 15.8 21.3 16.2 7.1 14.2 19.0 46.8 15.1 10.2 31.8 38.0 0.3 25.0 110.4 26.0 90.9 42.4 18.0 0.2 20.0 8.2 10.1 13.3 2.1 31.5 22.8 2.7 10.2 4.3 40.0 1.0 0.5 27.1 39.0 2.6 17.2 5.3 0.1 3.0 108.1 69.9 14.4 12.3 48.9 3.9 10.7 40.5 3.6 0.4 4.7 0.2 2.8 0.2 1.0 0.8 17.1 15.8 6.7 1.1 1.2 15.0 47.9 15.7 1.4 5.7 10.7 10.2 9.0 15.6 22.1 1.2 17.3 1.7 21.7 2.9 6.4 4.1 12.6 2.2 18.7 1.3 1.3 1.0 12.4 16.0 33.0 6.8 9.0 8.2 110.4 42.4 24.2 25.3 0.3 13.1 29.5 25.0 0.2 16.4 31.4 11.2 90.9 26.0 1.1 1.0 18.0 24.9 20.6 11.3 57.3 20.0 14.6 19.0 35.3 20.0 14.2 131.0 257.3 44.9 93.2 116.7 9.4 147.7 272.6 71.0 147.9 96.0 15.7 219.0 470.9 258.1 11.1 189.7 226.3 46.7 138.3 130.1 269.8 153.6 916.1 393.6 669.0 6.4 409.1 414.4 336.8 15.3 115.1 499.1 268.2 3286.8 521.6 478.8 95.2 300.6 30.8 190.8 24.4 19.4 173.1 1.6 4.7 91.5 557.0 879.8 224.4 39.6 IFI16 "IFNGIP1, PYHIN2" ENSG00000163565 "Interferon gamma inducible protein 16" Q16666 1 158999968-159055155 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA002134, CAB016293" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "CAB016293: AB_627775, HPA002134: AB_1079099" "unprognostic (7.23e-3)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (7.70e-3)" "unprognostic (1.87e-1)" "unprognostic (6.08e-2)" "unprognostic (1.80e-1)" "unprognostic (5.83e-2)" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.11e-16)" "unprognostic (5.07e-2)" "unprognostic (4.08e-1)" "unprognostic (7.97e-2)" "unprognostic (1.14e-1)" 64.2 21.0 10.9 42.5 18.0 10.2 34.8 6.7 11.4 28.5 18.6 9.6 7.8 7.5 32.5 21.8 32.8 25.0 33.4 24.8 16.5 7.5 13.3 10.2 32.1 51.0 19.5 6.3 32.6 5.5 3.2 7.0 21.4 18.0 23.0 15.2 10.9 33.6 11.2 14.6 23.7 21.6 29.1 32.2 63.2 11.8 14.2 16.0 81.8 19.1 24.2 41.8 30.9 27.6 28.9 20.8 51.2 21.0 27.9 24.6 16.9 7.0 0.5 2.4 0.1 17.0 56.4 0.0 15.0 40.3 42.3 56.3 0.0 9.1 41.5 12.9 9.2 13.6 20.5 0.3 15.2 16.9 12.8 0.1 10.6 3.1 0.0 31.9 3.6 0.7 53.1 27.3 21.6 30.8 20.3 44.4 36.7 0.2 30.4 23.4 0.0 48.7 3.4 6.5 0.0 5.5 23.0 15.6 47.9 5.9 2.7 1.1 0.0 19.6 0.1 42.6 10.2 0.0 4.3 25.0 10.9 5.1 30.6 6.3 28.4 13.2 39.0 31.3 12.0 26.2 2.5 21.0 0.1 18.9 20.5 16.9 27.6 18.1 19.3 20.8 28.9 11.5 14.6 51.2 27.9 18.5 15.6 24.6 16.9 10.9 18.0 6.7 11.4 16.5 7.5 19.5 6.3 18.0 16.0 35.7 66.1 149.1 95.2 84.3 0.2 6.9 22.9 58.9 119.4 40.1 0.0 3.0 1.7 32.6 4.0 196.0 5.6 0.0 40.2 1.9 91.8 23.0 129.9 2.9 175.9 0.0 11.6 126.4 165.6 4.9 108.7 168.3 79.2 49.5 16.2 31.8 42.0 24.6 49.8 4.4 0.9 84.1 124.0 2.6 1.9 59.6 2.7 201.5 21.7 108.0 IFI35 IFP35 ENSG00000068079 "Interferon induced protein 35" P80217 17 43006725-43014456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 132.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 50.9;BJ hTERT+ SV40 Large T+ RasG12V: 75.1;GAMG: 27.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045946, HPA075580" Approved Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA 93000 "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA045946: AB_2679509, HPA075580: " "prognostic favorable (1.41e-4)" "unprognostic (1.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.16e-1)" "unprognostic (1.32e-1)" "unprognostic (3.26e-1)" "unprognostic (3.90e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-2)" "unprognostic (9.78e-3)" "unprognostic (6.51e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.03e-5)" "unprognostic (3.55e-1)" "unprognostic (3.62e-2)" "unprognostic (1.34e-2)" "unprognostic (1.49e-1)" 24.9 27.9 9.3 18.1 12.4 14.6 15.1 5.0 9.3 10.7 20.5 9.4 12.8 15.9 13.6 17.4 11.3 14.0 15.5 13.2 7.7 7.0 21.8 26.2 17.7 20.2 9.4 8.1 19.2 11.0 8.3 10.1 15.8 9.5 24.2 13.6 19.5 18.7 10.8 6.4 7.3 33.6 14.1 9.2 31.5 14.9 5.7 9.7 19.5 30.3 8.3 17.8 13.2 10.1 13.2 23.3 22.2 43.2 18.6 17.6 24.9 2.9 7.0 0.0 0.3 6.1 7.4 1.5 2.0 20.7 50.9 75.1 2.5 11.2 0.9 4.0 5.9 27.0 1.7 0.3 3.1 4.1 7.9 1.4 2.2 2.5 9.3 15.1 2.4 4.8 10.2 1.2 7.1 0.9 4.6 4.6 1.9 1.2 15.0 2.0 2.9 5.1 1.9 0.0 2.7 3.1 4.3 0.0 5.5 6.3 2.6 1.3 0.0 3.9 1.5 20.4 0.1 6.5 4.7 2.2 3.7 0.0 1.1 3.1 13.3 4.9 0.2 6.7 1.9 3.6 19.1 35.9 20.5 16.6 43.2 15.2 12.9 12.9 15.4 21.7 13.2 10.4 12.8 22.2 18.6 39.3 23.3 17.6 24.9 9.3 12.4 5.0 9.3 7.7 7.0 9.4 8.1 9.5 9.7 14.9 8.9 23.1 25.1 9.3 0.8 4.8 10.2 6.7 10.3 17.4 2.0 20.6 34.9 37.8 8.8 26.3 85.0 0.0 56.2 27.8 22.8 23.2 7.0 27.6 74.5 1.6 30.4 32.5 38.4 27.5 26.7 42.9 23.6 77.5 32.6 8.6 36.2 132.5 22.3 67.8 0.8 6.5 13.0 0.3 0.1 8.2 8.7 29.8 22.2 28.2 IGF2 "C11orf43, FLJ44734, IGF-II" ENSG00000167244 "Insulin like growth factor 2" P01344 11 2129112-2149603 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism, Osteogenesis" "Growth factor, Hormone, Mitogen" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 330.5" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 871.9;Extravillous trophoblasts: 2792.3;Syncytiotrophoblasts: 1348.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 115.4;Hep G2: 79.2;LHCN-M2: 45.5;RH-30: 56.5;SH-SY5Y: 68.8" "Low region specificity" "Detected in all" "HPA007556, HPA007993" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 609000000 1700000000 Vesicles "Nucleoplasm, Cytosol" "HPA007556: AB_2667860, HPA007993: AB_1851474" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" "unprognostic (7.08e-2)" "unprognostic (2.30e-3)" "unprognostic (2.59e-1)" "prognostic favorable (7.12e-4)" "unprognostic (7.92e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (3.69e-2)" "unprognostic (1.85e-1)" "unprognostic (1.79e-3)" "unprognostic (2.00e-2)" "unprognostic (8.98e-2)" "unprognostic (8.93e-3)" "unprognostic (5.78e-2)" 16.6 8.0 1.3 4.5 2.0 0.5 23.3 2.3 1.9 23.4 5.0 3.4 4.7 1.0 9.9 32.0 5.2 17.2 4.5 20.5 1.5 1.6 8.1 39.7 1.9 1.1 3.5 1.6 20.4 5.5 0.7 5.0 330.5 7.6 10.4 1.0 33.2 2.6 6.7 21.9 1.7 2.3 7.5 17.0 2.0 3.2 12.4 0.2 1.8 2.6 14.5 1.8 15.2 14.1 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 15.2 0.1 0.4 0.0 115.4 0.0 0.0 1.1 0.0 0.3 0.0 0.1 0.9 1.1 0.0 0.0 0.0 0.0 79.2 20.3 0.0 0.0 24.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 45.5 0.3 0.0 0.1 0.1 0.0 0.2 0.0 56.5 0.1 0.0 0.1 4.5 68.8 0.0 0.0 0.0 12.0 0.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 1.3 2.0 2.3 1.4 1.5 1.6 3.5 1.6 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 871.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2792.3 0.0 0.0 0.0 0.0 192.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1348.9 0.0 0.0 0.0 IGFBP3 "BP-53, IBP3" ENSG00000146674 "Insulin like growth factor binding protein 3" P17936 7 45912245-45921874 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 320.7" "Cell type enhanced" "Detected in many" 19 "Basal keratinocytes: 406.6;Extravillous trophoblasts: 1874.7;Urothelial cells: 581.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 28.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 422.0;U-2197: 175.0;U-87 MG: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB010360 Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 3250000000 5600000000 Vesicles "Nucleoplasm, Cytosol" "CAB010360: AB_2233528" "unprognostic (4.46e-3)" "unprognostic (4.84e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.30e-1)" "unprognostic (1.15e-1)" "unprognostic (6.54e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (8.14e-3)" "unprognostic (3.31e-2)" "unprognostic (2.03e-1)" "unprognostic (9.67e-3)" "unprognostic (2.80e-1)" "prognostic unfavorable (5.07e-7)" "unprognostic (2.36e-2)" "unprognostic (4.14e-2)" "unprognostic (2.37e-3)" "unprognostic (2.63e-1)" 47.4 1.6 4.4 10.6 2.7 0.0 52.1 2.7 4.1 44.3 21.3 1.7 3.2 6.9 58.4 8.1 11.7 14.9 5.4 41.6 4.4 2.6 11.1 80.4 11.7 12.7 3.7 1.9 49.2 2.2 0.6 19.2 320.7 4.1 22.5 6.1 9.1 6.4 9.3 13.9 23.9 10.2 22.9 3.8 18.7 8.3 12.1 3.1 2.2 5.6 8.6 8.3 32.0 26.3 0.0 28.9 0.0 0.0 0.0 6.0 1.7 9.6 2.9 5.7 0.0 4.3 1.8 0.0 42.1 7.6 3.6 1.9 0.0 7.8 0.0 13.4 422.0 1.8 23.2 0.0 0.1 1.5 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 14.8 0.6 0.7 2.7 5.7 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 3.9 2.6 20.8 0.6 1.6 14.6 0.5 0.7 13.3 0.0 0.0 0.0 41.7 0.0 175.0 2.3 0.6 0.0 0.0 90.6 0.0 14.0 0.0 0.0 0.0 5.2 0.0 4.3 0.0 6.0 5.6 0.0 0.0 2.8 4.7 0.0 0.0 0.0 28.9 0.3 1.7 4.4 2.7 2.7 4.1 4.4 2.6 3.7 1.9 4.1 3.1 3.0 4.6 0.0 95.2 406.6 0.6 9.7 7.6 33.5 117.2 216.3 0.0 45.9 10.0 71.8 0.8 62.6 0.4 0.0 1.7 1874.7 137.7 80.4 1.1 1.7 72.5 0.0 263.4 181.7 8.2 1.9 266.9 3.0 15.1 12.6 1.6 0.4 19.7 2.9 6.3 0.7 0.6 0.0 28.8 0.4 0.4 213.8 129.0 8.2 0.6 581.2 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;ovary: 21.1;testis: 39.9" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 70.7;Early spermatids: 226.0;Late spermatids: 237.3" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;HEL: 4.4;SK-MEL-30: 26.2;U-266/70: 9.1;U-266/84: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 1.1 10.5 12.5 1.4 14.6 0.9 1.2 3.4 23.9 1.3 2.6 27.8 0.0 1.1 1.6 2.3 2.0 1.6 1.9 2.2 12.3 6.0 10.6 0.9 1.0 1.0 25.2 8.9 21.1 5.1 3.8 1.4 1.1 15.3 1.3 1.8 7.0 1.4 2.0 2.9 2.6 1.6 1.5 20.5 1.0 1.4 39.9 20.7 0.0 5.0 0.0 1.1 1.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 6.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 2.0 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 26.2 1.7 0.5 0.1 0.0 0.0 1.0 0.0 0.0 9.1 10.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.6 3.4 13.6 12.3 6.0 25.2 8.9 15.3 20.7 0.0 0.0 0.0 0.1 0.3 5.1 1.1 0.0 0.0 0.0 0.0 70.7 0.1 0.0 0.3 226.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 237.3 3.4 0.2 3.3 0.0 0.0 24.3 0.2 0.0 1.8 5.1 24.8 0.0 0.0 11.7 5.9 0.0 0.1 0.0 0.0 0.2 IKZF2 "Helios, ZNFN1A2" ENSG00000030419 "IKAROS family zinc finger 2" Q9UKS7 2 212999691-213152427 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.8" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 21.4;T-cells: 23.3;Urothelial cells: 48.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 7.2;T-cells: 7.1" "Cell line enhanced" "Detected in many" "JURKAT: 36.7;MOLT-4: 15.5;RT4: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059142 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA059142: AB_2683923" "unprognostic (2.29e-1)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.87e-2)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (3.03e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.21e-1)" "unprognostic (3.56e-3)" "unprognostic (4.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.93e-3)" "unprognostic (7.09e-2)" 3.4 2.4 6.1 4.1 12.4 5.9 4.0 8.0 8.6 4.9 2.6 5.3 7.6 1.0 2.3 3.9 24.8 3.4 3.6 2.8 6.3 2.6 2.1 2.1 3.7 7.4 11.8 3.4 2.5 3.0 9.7 6.9 3.2 8.6 5.4 2.0 2.3 13.5 9.2 4.3 10.4 2.5 1.2 9.1 5.9 5.2 2.8 13.4 55.8 9.2 5.5 7.5 11.9 11.6 1.5 0.7 5.7 0.0 7.2 7.1 0.3 1.4 0.5 2.8 0.1 9.2 9.4 1.7 1.7 2.0 0.4 0.9 0.7 2.4 1.9 2.3 1.0 0.2 3.4 0.0 0.9 1.4 0.0 0.4 1.0 1.8 0.2 0.1 4.5 0.3 9.1 0.8 0.0 0.2 2.3 0.0 36.7 0.5 1.6 0.8 2.6 15.5 4.5 0.5 1.1 0.4 9.2 1.8 0.0 0.8 14.7 0.8 0.5 0.0 1.9 0.0 2.4 2.5 0.4 4.7 2.6 2.0 1.2 0.3 3.1 0.9 10.6 1.3 0.0 0.5 4.1 0.0 5.7 2.5 0.0 6.5 0.2 0.8 1.9 0.0 1.5 0.4 1.9 0.0 7.2 0.0 0.7 7.1 0.3 6.1 12.4 8.0 8.6 6.3 2.6 11.8 3.4 8.6 13.4 8.9 9.3 3.9 11.1 5.3 4.0 6.2 0.0 21.4 15.9 7.0 3.9 3.0 0.0 1.6 1.0 2.2 1.1 0.0 2.6 1.1 1.5 14.9 3.5 1.7 1.6 0.0 2.9 1.3 1.3 0.0 1.7 1.8 1.7 1.0 2.3 2.4 3.4 0.0 2.1 0.9 7.0 0.0 2.7 0.7 0.4 7.5 3.3 23.3 1.0 48.0 IKZF5 "FLJ22973, Pegasus, ZNFN1A5" ENSG00000095574 "IKAROS family zinc finger 5" Q9H5V7 10 122990806-123008817 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015297, HPA051574" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA015297: AB_1855183, HPA051574: AB_2681538" "unprognostic (2.42e-1)" "unprognostic (1.08e-1)" "unprognostic (4.64e-2)" "unprognostic (2.76e-2)" "unprognostic (1.44e-2)" "unprognostic (1.66e-3)" "unprognostic (2.68e-1)" "unprognostic (9.14e-3)" "unprognostic (5.43e-2)" "unprognostic (2.99e-1)" "unprognostic (6.88e-2)" "unprognostic (1.63e-2)" "unprognostic (3.98e-3)" "unprognostic (4.17e-2)" "unprognostic (6.03e-2)" "unprognostic (6.96e-2)" "unprognostic (3.15e-2)" 11.7 11.7 20.3 9.2 23.5 38.0 16.6 24.9 20.5 12.0 9.2 22.1 7.5 8.8 12.5 13.6 9.4 9.9 8.4 9.4 18.0 14.5 11.8 14.7 10.6 13.4 28.9 13.5 19.3 14.8 14.2 22.9 10.7 21.2 11.6 9.8 11.2 10.6 8.8 12.3 13.7 10.8 9.8 21.8 11.6 9.9 13.4 26.8 14.7 13.6 7.0 12.4 9.4 11.1 7.6 6.7 8.2 8.0 9.7 13.4 6.7 6.0 3.0 6.1 10.3 9.8 9.0 6.7 5.1 10.9 6.8 8.3 4.8 7.1 15.2 3.8 6.2 3.7 8.3 10.7 7.6 10.0 8.4 9.5 9.7 5.0 7.2 6.5 11.7 8.8 7.1 10.5 8.1 17.6 9.4 7.4 10.1 13.3 10.2 7.3 4.4 10.6 12.9 5.6 4.5 4.2 8.7 7.6 8.6 5.6 4.2 6.6 5.9 4.2 5.2 9.8 5.1 4.3 7.5 7.5 4.9 4.1 7.1 8.1 9.5 5.1 14.3 6.3 20.6 2.9 7.5 6.3 8.2 9.4 8.0 10.9 6.2 8.6 9.0 6.7 7.6 11.9 13.4 6.1 9.7 7.7 4.7 10.9 6.7 20.3 23.5 24.9 20.5 18.0 14.5 28.9 13.5 21.2 26.8 11.9 12.5 11.4 9.2 28.6 11.6 12.9 7.6 14.7 14.8 5.2 13.7 5.2 8.3 4.5 3.4 10.1 6.6 0.0 4.5 5.0 9.9 14.8 16.2 13.2 5.6 11.1 17.2 6.7 9.7 2.0 12.4 9.8 15.1 4.6 8.4 7.7 3.6 6.5 9.9 8.9 14.1 12.9 11.3 24.0 22.1 28.2 12.0 15.8 6.0 7.6 IL18 "IGIF, IL-18, IL-1g, IL1F4" ENSG00000150782 "Interleukin 18" Q14116 11 112143251-112164117 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9;skin 1: 57.2" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 160.8;Kupffer cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 17.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 26.5;CAPAN-2: 42.1;HaCaT: 38.5;HBEC3-KT: 29.0;hTCEpi: 44.4;PC-3: 25.8;U-2 OS: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003980, CAB007772" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA Yes 196000 "Nucleoplasm, Golgi apparatus" Cytosol "CAB007772: AB_562304, HPA003980: AB_1851670" "unprognostic (2.31e-3)" "unprognostic (3.25e-1)" "prognostic favorable (2.78e-4)" "unprognostic (3.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (8.15e-2)" "unprognostic (3.23e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-3)" "unprognostic (4.13e-1)" "unprognostic (3.58e-2)" "unprognostic (1.51e-1)" "unprognostic (3.19e-2)" "unprognostic (3.15e-2)" "unprognostic (9.01e-2)" 9.4 2.6 5.3 12.5 7.9 10.8 5.2 1.3 5.3 18.5 13.1 6.4 2.5 8.6 2.1 3.7 53.9 3.3 11.9 2.1 5.7 3.1 17.5 3.6 15.2 22.6 7.4 1.4 1.4 7.0 0.3 3.3 2.6 8.2 5.5 11.6 2.2 8.3 1.4 3.8 57.2 9.1 4.0 24.7 26.6 5.1 1.7 7.5 3.9 1.8 21.2 26.5 9.1 35.4 0.5 17.1 10.4 6.9 13.8 0.3 1.6 26.5 9.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 5.1 42.1 0.0 6.1 0.0 0.7 38.5 0.0 29.0 0.0 0.0 0.2 4.0 9.5 2.1 0.9 2.1 7.7 0.0 44.4 0.0 10.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 7.3 25.8 0.0 0.0 0.0 19.0 5.7 0.0 0.0 18.3 12.2 0.1 0.2 7.3 5.8 0.0 0.1 50.0 0.3 8.2 0.1 0.0 0.1 0.0 15.4 0.0 3.5 6.0 10.4 0.1 6.9 0.0 0.4 0.0 0.0 17.1 0.5 0.0 0.3 6.7 13.8 3.7 3.8 0.0 1.6 5.3 7.9 1.3 5.3 5.7 3.1 7.4 1.4 8.2 7.5 160.8 35.5 7.5 33.3 109.2 1.7 0.7 22.9 73.6 43.3 8.7 0.0 2.1 68.0 27.4 1.8 2.4 69.7 0.0 126.1 2.6 5.4 10.6 97.2 2.0 69.6 0.0 13.9 6.2 163.5 0.9 0.0 66.1 3.3 30.7 23.3 1.7 111.9 97.0 4.2 13.2 37.2 6.5 2.2 0.6 0.5 97.2 1.5 27.7 45.4 67.4 IL1RN "ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430" ENSG00000136689 "Interleukin 1 receptor antagonist" P18510 2 113107214-113134016 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 163.8;Hofbauer cells: 319.3;Suprabasal keratinocytes: 294.2;Urothelial cells: 333.6" "Cancer enhanced" "Detected in all" "head and neck cancer: 92.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2" "Group enriched" "Detected in many" 332 "dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1" "Cell line enhanced" "Detected in some" "A-431: 21.1;HaCaT: 41.7;RT4: 40.8;THP-1: 11.8" "Not detected" "Not detected" "HPA001482, CAB009633" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Secreted to blood" NA NA 291000 Nucleoplasm "Centrosome, Cytosol" "CAB009633: AB_2125576, HPA001482: AB_1078437" "unprognostic (3.85e-3)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.00e-4)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (3.15e-2)" "unprognostic (2.55e-1)" "unprognostic (4.46e-2)" "unprognostic (9.54e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (5.59e-3)" "prognostic unfavorable (2.66e-6)" "unprognostic (2.05e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (4.25e-2)" "unprognostic (1.03e-1)" 17.3 0.2 0.2 7.2 0.3 32.9 1.1 0.2 0.5 27.2 3.8 0.6 1.4 1.1 1.5 0.7 217.8 0.2 4.1 0.5 0.2 0.0 0.5 23.5 2.9 1.9 0.3 0.2 0.4 0.4 0.1 0.3 3.1 0.6 1.6 0.3 0.4 30.9 1.3 0.5 14.4 3.7 0.7 0.2 3.6 5.7 1.4 0.2 1.0 0.7 123.7 194.7 3.3 42.2 0.0 17.1 65.2 17.1 0.0 0.0 4.9 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.4 41.7 0.0 1.2 0.0 0.0 0.0 0.1 0.0 7.0 0.0 0.1 7.9 0.0 5.4 0.2 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.2 0.0 5.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.8 0.1 0.5 0.0 0.3 0.0 0.3 0.0 0.1 4.0 4.7 0.1 0.0 17.1 0.3 0.0 7.6 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 65.2 0.0 3.4 0.1 0.0 4.9 0.2 0.3 0.2 0.5 0.2 0.0 0.3 0.2 0.6 0.2 6.0 10.6 0.5 50.9 163.8 0.0 0.3 12.7 18.7 17.0 3.5 0.0 1.3 0.0 17.2 35.3 2.2 6.5 0.0 25.2 2.5 6.6 30.8 9.3 38.4 319.3 0.0 0.0 3.1 35.8 72.7 0.6 100.5 23.6 1.0 0.6 0.0 89.0 0.0 0.4 0.0 0.0 0.0 6.6 0.7 0.1 294.2 3.8 0.9 2.2 333.6 IL4R CD124 ENSG00000077238 "Interleukin 4 receptor" P24394 16 27313668-27364778 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 107.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 34.4" "Group enriched" "Detected in all" 6 "B-cells: 34.4;granulocytes: 11.9" "Cell line enhanced" "Detected in many" "Daudi: 36.5;HBEC3-KT: 35.1;U-698: 34.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004451, HPA050124, HPA070380" Enhanced Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" "Secreted to blood" NA NA 49000 "Nucleoplasm, Plasma membrane" "Centriolar satellite" "CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: " "unprognostic (6.80e-2)" "unprognostic (6.35e-2)" "unprognostic (2.84e-1)" "prognostic favorable (6.43e-4)" "unprognostic (1.12e-1)" "unprognostic (1.14e-1)" "unprognostic (2.33e-2)" "unprognostic (1.95e-3)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.49e-2)" "unprognostic (1.73e-1)" "unprognostic (1.36e-1)" "unprognostic (9.58e-2)" 20.7 14.8 8.7 31.6 10.6 36.9 12.0 4.4 7.7 20.8 30.3 5.9 11.5 10.9 18.0 12.8 24.7 13.6 25.1 12.3 6.7 4.4 13.3 39.1 40.9 44.8 10.8 1.7 14.7 11.3 3.8 5.5 16.1 10.1 18.8 15.1 12.3 7.7 11.5 7.2 9.9 18.6 39.6 13.6 31.8 21.1 10.4 9.8 9.1 8.6 13.7 38.4 31.6 15.4 34.4 1.6 11.9 2.6 3.3 4.0 1.8 11.5 3.0 2.0 3.9 1.0 4.6 4.2 7.3 8.5 2.9 2.4 6.2 32.0 36.5 9.1 11.5 5.7 12.3 2.1 35.1 2.5 31.6 1.0 6.8 1.8 9.5 13.2 1.8 19.4 7.0 14.2 13.5 8.0 15.5 15.7 2.1 2.9 3.1 4.7 5.1 0.1 5.5 2.4 10.4 2.7 0.1 15.2 2.9 13.6 13.2 0.6 0.3 1.0 7.0 1.6 5.3 2.7 7.0 23.5 6.7 3.0 5.9 5.1 1.8 0.5 34.0 0.7 6.1 0.0 0.5 2.6 4.7 1.7 1.1 1.3 7.7 2.6 1.7 1.6 34.4 4.0 1.9 11.9 3.3 0.6 1.6 1.8 1.8 8.7 10.6 4.4 7.7 6.7 4.4 10.8 1.7 10.1 9.8 26.8 51.7 49.6 35.5 11.7 0.0 2.2 20.4 17.4 30.7 1.8 0.0 15.0 0.0 31.7 0.1 31.5 27.6 0.0 28.2 3.5 13.9 27.2 107.5 47.4 22.9 0.0 22.4 54.6 31.1 0.2 0.3 21.3 13.5 40.5 32.8 0.0 35.6 22.1 0.0 1.1 0.0 38.8 27.4 0.5 1.9 13.0 20.8 20.3 15.0 38.2 ILF3 "DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1" ENSG00000129351 "Interleukin enhancer binding factor 3" Q12906 19 10654261-10692417 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001897 Supported Enhanced Nucleoplasm,Nucleoli,Mitochondria No No 1100000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA001897: AB_1078703" "unprognostic (2.39e-1)" "unprognostic (9.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (5.55e-3)" "unprognostic (1.11e-3)" "unprognostic (2.96e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.45e-2)" "unprognostic (1.04e-1)" "unprognostic (4.38e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (7.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.03e-1)" "unprognostic (6.20e-2)" 31.0 39.0 29.6 45.5 26.8 88.2 34.5 48.3 35.2 34.2 30.2 30.8 35.2 30.3 45.4 31.7 40.5 41.9 32.5 34.0 25.5 20.0 28.1 25.6 34.1 44.9 24.7 27.8 52.8 36.8 34.9 34.9 31.8 32.3 34.9 27.3 35.5 35.1 46.2 50.1 37.7 37.2 33.2 33.3 44.5 32.6 54.3 28.0 58.6 43.4 32.4 41.1 38.5 32.1 18.7 18.7 11.5 14.3 15.4 19.4 8.0 45.7 37.3 60.4 55.2 13.1 18.0 35.2 29.3 24.9 49.2 38.6 42.7 26.6 57.2 29.1 26.3 30.1 41.0 65.2 39.6 44.4 36.5 58.0 74.2 32.9 39.8 18.8 53.4 37.1 17.0 17.7 39.0 43.8 18.8 42.0 33.4 63.3 45.0 28.6 37.7 88.5 85.8 72.5 24.2 41.0 65.2 57.5 39.5 19.6 48.6 66.7 48.5 37.7 30.0 21.8 28.6 25.4 34.3 33.7 40.4 38.4 41.8 57.7 38.6 52.8 69.4 22.6 57.1 43.5 11.5 13.4 7.1 19.4 10.4 16.1 14.7 15.9 17.3 16.8 18.7 15.7 16.0 2.1 15.4 14.3 18.7 15.0 8.0 29.6 26.8 48.3 35.2 25.5 20.0 24.7 27.8 32.3 28.0 92.3 128.4 63.8 84.3 76.5 92.4 59.0 50.9 96.4 131.9 40.1 80.5 65.6 23.2 66.6 12.8 60.9 40.0 46.7 69.0 90.4 57.8 80.9 92.6 46.1 63.0 89.0 109.3 33.7 53.5 14.4 70.8 66.0 37.1 46.9 68.0 70.5 72.3 56.1 58.7 38.2 92.6 32.3 67.0 108.6 117.8 67.2 59.3 68.2 82.6 87.0 ILK ENSG00000166333 "Integrin linked kinase" Q13418 11 6603708-6610874 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004041, HPA048437" Enhanced Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA 130000000 "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB004041: AB_2127050, HPA048437: AB_2680391" "unprognostic (1.78e-1)" "unprognostic (2.26e-2)" "unprognostic (5.26e-2)" "unprognostic (2.12e-2)" "unprognostic (7.57e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-3)" "unprognostic (5.25e-3)" "unprognostic (1.49e-2)" "unprognostic (9.65e-2)" "unprognostic (2.64e-1)" "unprognostic (8.12e-2)" "prognostic favorable (2.44e-4)" "unprognostic (4.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.42e-1)" "unprognostic (6.36e-3)" 20.9 17.6 11.0 22.3 11.9 7.5 37.0 9.4 14.6 40.2 75.1 14.7 41.9 13.5 75.4 25.2 35.7 33.2 41.1 35.1 11.1 9.2 21.6 15.1 21.9 18.9 11.5 14.0 24.2 22.3 20.4 10.9 22.2 11.5 39.9 24.6 19.3 19.4 89.9 18.5 12.4 22.2 103.5 10.6 20.2 33.2 14.2 11.0 8.2 17.5 14.1 13.6 60.8 25.9 19.5 45.9 76.5 49.4 45.3 25.8 63.7 23.9 18.5 29.2 10.1 45.2 32.1 13.3 35.3 69.8 41.8 51.0 19.3 28.3 9.0 9.4 57.7 41.0 19.3 16.3 29.9 42.0 15.7 14.8 13.0 17.7 15.0 30.3 10.4 14.9 30.8 14.1 28.2 21.6 42.9 39.8 7.8 11.9 10.7 54.5 18.0 9.2 17.8 18.4 20.4 21.8 9.6 15.3 9.6 30.6 19.2 5.1 11.5 16.7 23.1 19.4 29.8 16.1 11.9 46.0 52.5 23.7 21.7 17.1 7.8 4.8 12.7 38.9 15.7 24.4 48.3 49.4 76.5 25.8 47.9 25.1 19.5 23.3 24.4 45.9 17.1 14.7 18.5 31.7 45.3 44.4 18.5 25.7 63.7 11.0 11.9 9.4 14.6 11.1 9.2 11.5 14.0 11.5 11.0 41.7 17.0 28.3 58.4 44.9 13.9 0.3 66.2 18.7 15.9 54.1 7.9 94.6 49.7 120.2 46.5 56.1 64.4 46.7 108.6 153.9 93.0 39.7 29.0 24.9 111.6 7.9 36.5 84.1 50.9 110.9 66.2 80.3 81.0 196.6 43.0 50.2 101.4 57.5 138.6 74.7 29.6 155.2 137.9 31.1 15.7 37.8 92.0 54.3 41.7 41.9 IMPAD1 "FLJ20421, gPAPP, IMPA3" ENSG00000104331 "Inositol monophosphatase domain containing 1" Q9NX62 8 56957933-56993844 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009411 Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 560000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA009411: AB_1079138" "unprognostic (1.62e-2)" "unprognostic (7.89e-3)" "unprognostic (6.58e-2)" "unprognostic (6.42e-2)" "unprognostic (2.00e-1)" "unprognostic (8.59e-2)" "unprognostic (1.88e-1)" "unprognostic (1.67e-2)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (4.24e-3)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (1.68e-3)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" 30.6 33.9 17.8 13.9 23.7 9.6 17.6 23.6 33.1 24.7 17.7 30.9 17.8 11.7 23.2 15.2 17.7 15.6 18.0 25.2 19.9 21.6 21.3 32.6 16.5 10.3 23.6 21.1 16.0 25.2 30.4 20.4 23.3 27.2 28.8 16.2 25.2 28.7 22.5 41.4 13.4 12.3 23.0 21.7 13.0 14.7 19.0 19.5 12.0 24.4 18.1 13.0 17.2 14.9 1.9 2.0 6.1 4.6 6.8 2.4 0.6 17.4 14.5 11.2 11.5 34.5 23.7 15.4 26.6 25.9 19.1 16.7 7.2 12.5 10.9 20.4 28.2 13.6 14.3 13.5 17.9 28.4 15.0 9.7 21.3 10.3 12.9 21.5 13.5 15.2 19.0 18.0 17.1 27.8 17.7 25.3 10.3 9.1 19.9 20.9 9.3 16.4 8.1 8.3 20.0 5.4 11.5 10.1 12.3 19.8 10.4 4.3 12.2 14.9 18.4 15.1 12.3 16.4 9.9 21.1 25.9 14.9 25.5 19.0 20.5 17.1 11.7 35.4 11.3 15.8 2.9 1.9 1.1 2.0 1.2 1.6 1.3 1.3 1.2 1.4 1.9 1.5 2.4 6.1 6.8 4.6 2.0 0.9 0.6 17.8 23.7 23.6 33.1 19.9 21.6 23.6 21.1 27.2 19.5 20.8 18.6 9.0 24.5 48.3 29.9 43.1 25.5 8.1 12.5 45.4 15.7 15.1 5.0 17.1 13.5 27.0 19.0 0.0 23.5 68.2 45.0 43.5 9.2 61.6 24.1 38.1 33.4 38.1 25.6 4.2 23.6 23.8 15.1 5.4 33.4 25.1 24.0 17.5 33.6 16.8 27.4 32.3 38.9 34.6 22.2 52.2 28.3 14.9 16.0 33.9 INO80 "hINO80, Ino80, INO80A, INOC1, KIAA1259" ENSG00000128908 "INO80 complex subunit" Q9ULG1 15 40978880-41116354 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis" "Actin-binding, DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041484, HPA048601" Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA041484: AB_2677506, HPA048601: " "unprognostic (5.39e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (3.92e-2)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.93e-1)" "unprognostic (6.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.69e-2)" "prognostic favorable (6.30e-4)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.72e-2)" "unprognostic (1.47e-2)" 14.0 10.6 11.8 13.9 13.4 20.7 13.9 29.5 13.0 12.3 13.2 17.4 11.5 11.3 14.9 13.4 15.1 12.6 12.4 10.6 12.8 7.8 12.1 12.9 14.8 13.4 10.2 10.3 15.4 17.8 18.8 13.3 16.4 12.1 12.5 13.9 13.8 11.9 15.7 23.0 16.4 13.2 13.3 9.5 14.5 12.3 13.9 11.6 18.1 13.3 12.6 15.8 13.9 13.3 5.2 2.3 0.9 2.7 5.7 3.4 1.5 9.2 9.2 8.0 7.8 12.6 10.6 9.3 8.6 14.1 13.1 11.4 11.2 7.8 9.9 7.0 13.1 16.3 18.2 14.7 15.0 13.9 11.4 7.5 12.3 12.7 8.4 12.1 12.1 12.1 10.5 13.9 10.5 27.9 8.7 12.5 10.8 13.7 8.5 8.7 7.7 8.8 8.0 8.4 15.8 10.1 13.6 8.5 7.9 9.9 19.4 10.6 7.3 6.3 13.9 5.8 8.3 7.8 14.7 14.3 10.4 9.5 13.2 13.8 9.4 6.4 16.2 12.2 18.0 8.6 0.9 2.7 0.6 2.7 1.7 3.3 3.2 3.4 3.0 2.3 5.2 3.4 3.2 0.9 5.7 1.2 1.8 2.6 1.5 11.8 13.4 29.5 13.0 12.8 7.8 10.2 10.3 12.1 11.6 8.9 25.5 24.6 15.0 7.6 28.4 14.9 12.7 24.1 23.9 15.7 21.6 11.1 6.6 14.7 1.7 13.7 9.7 0.0 11.5 9.4 10.4 13.3 15.1 8.7 8.7 25.4 12.6 11.6 14.9 1.2 13.6 9.5 6.8 18.0 9.2 11.8 12.4 11.0 14.9 9.4 28.8 6.5 11.3 18.4 22.0 11.2 16.0 12.1 11.9 12.8 INPP5E "CORS1, JBTS1, pharbin, PPI5PIV" ENSG00000148384 "Inositol polyphosphate-5-phosphatase E" Q9NRR6 9 136428619-136439823 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Ciliopathy, Disease mutation, Joubert syndrome, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065758 Approved Supported "Nucleoplasm,Golgi apparatus,Focal adhesion sites" NA NA "Golgi apparatus, Focal adhesion sites" Nucleoplasm "HPA065758: AB_2685554" "unprognostic (1.99e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-2)" "unprognostic (1.23e-2)" "unprognostic (4.00e-1)" "unprognostic (6.92e-2)" "unprognostic (9.60e-3)" "unprognostic (3.21e-1)" "unprognostic (5.81e-2)" "unprognostic (2.65e-2)" "prognostic favorable (1.82e-4)" "unprognostic (2.03e-1)" "unprognostic (3.04e-2)" "unprognostic (3.76e-1)" "unprognostic (5.48e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" 14.3 11.2 14.9 15.3 10.4 8.9 19.2 19.9 19.1 10.5 10.7 11.5 11.1 10.3 13.1 10.1 8.4 17.2 9.4 11.9 12.6 12.0 10.2 9.0 10.1 13.5 8.4 12.3 14.7 11.6 11.4 12.3 9.8 13.2 9.9 5.2 11.0 14.4 12.9 11.6 18.2 10.7 10.7 6.6 19.4 8.6 15.2 10.3 8.5 12.5 6.2 10.7 8.8 19.3 2.6 1.0 1.9 0.5 0.0 2.4 0.6 6.2 7.2 8.5 8.4 4.3 5.6 10.5 7.5 4.4 5.8 3.7 7.4 4.4 7.8 7.7 6.3 8.3 17.5 3.7 5.1 2.2 24.3 14.7 5.2 12.4 4.9 7.3 6.1 8.5 6.0 4.8 6.4 5.7 6.9 5.6 10.0 8.8 7.2 4.9 10.3 7.8 13.4 5.5 3.9 12.0 14.3 6.5 5.8 5.2 6.1 8.9 8.0 7.2 6.8 5.2 6.1 10.9 9.1 8.0 17.9 6.7 7.2 13.0 7.8 6.3 3.3 9.2 5.4 6.5 0.0 0.5 1.9 2.0 0.0 1.3 2.6 2.3 1.5 0.5 1.7 0.8 1.6 0.4 0.0 0.3 1.0 2.4 0.6 14.9 10.4 19.9 19.1 12.6 12.0 8.4 12.3 13.2 10.3 3.0 5.8 2.9 1.5 4.8 7.1 4.1 7.6 6.7 3.4 3.5 2.0 2.0 1.7 4.5 0.3 5.8 2.8 0.0 4.8 2.0 3.9 2.0 9.2 3.0 2.6 14.3 5.8 2.5 3.8 0.7 6.9 3.5 5.0 4.6 2.9 8.5 5.3 0.0 5.3 2.2 11.4 0.0 4.8 9.8 7.8 4.3 0.7 4.3 4.3 1.6 INTS13 "ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30" ENSG00000064102 "Integrator complex subunit 13" Q9NVM9 12 26905181-26938326 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 20.8;Extravillous trophoblasts: 13.8;Hofbauer cells: 13.1;Pancreatic endocrine cells: 13.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039543, HPA040109, HPA073020" Uncertain Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA039543: AB_10795150, HPA040109: , HPA073020: " "unprognostic (2.09e-1)" "unprognostic (8.48e-3)" "unprognostic (2.75e-2)" "unprognostic (1.40e-3)" "unprognostic (3.94e-2)" "unprognostic (3.01e-2)" "prognostic unfavorable (1.17e-10)" "unprognostic (5.22e-3)" "unprognostic (5.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.78e-3)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.16e-6)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (4.37e-2)" "unprognostic (4.78e-2)" 10.0 20.9 10.5 11.5 14.7 15.3 11.5 11.4 11.4 10.5 10.0 22.3 4.6 9.0 10.6 10.4 14.1 8.1 7.5 10.2 12.3 9.8 12.6 14.3 8.0 14.1 18.8 7.4 9.2 11.9 9.3 17.6 9.2 22.4 10.1 10.4 8.9 9.4 6.6 16.9 11.4 8.5 11.6 30.2 17.9 14.1 10.9 14.1 26.6 10.7 11.6 15.1 16.9 9.6 7.4 6.8 5.1 5.4 16.4 18.7 7.1 9.4 10.5 6.4 13.6 9.2 14.8 9.1 13.2 8.0 12.5 14.2 15.7 12.6 24.0 13.9 7.3 12.4 13.6 15.6 12.4 21.3 11.0 9.6 18.7 13.0 12.9 16.5 31.7 11.6 8.1 9.6 20.4 43.4 16.6 16.2 10.6 19.8 9.5 13.7 10.9 16.6 58.3 27.8 13.0 18.9 11.7 18.7 32.1 10.7 8.7 5.1 4.9 11.6 9.2 13.3 23.2 12.5 6.9 10.6 14.9 11.0 24.9 16.0 4.9 5.6 35.1 9.9 22.0 10.4 4.2 5.4 5.1 10.5 3.7 15.5 6.8 13.1 12.9 6.8 7.4 9.4 11.5 1.8 16.4 3.2 4.6 18.7 7.1 10.5 14.7 11.4 11.4 12.3 9.8 18.8 7.4 22.4 14.1 20.8 8.5 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.5 5.2 0.0 10.1 3.3 12.3 0.0 0.0 0.0 0.0 10.4 13.8 0.0 0.0 7.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 10.0 0.0 0.0 13.3 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 IP6K1 "IHPK1, KIAA0263" ENSG00000176095 "Inositol hexakisphosphate kinase 1" Q92551 3 49724294-49786542 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040825 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA040825: AB_10960426" "unprognostic (6.18e-2)" "unprognostic (1.33e-1)" "unprognostic (3.58e-2)" "unprognostic (4.71e-2)" "unprognostic (1.99e-1)" "prognostic favorable (2.08e-4)" "unprognostic (9.97e-3)" "unprognostic (8.45e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "prognostic favorable (6.85e-4)" "unprognostic (1.29e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.75e-2)" "unprognostic (1.67e-1)" "unprognostic (9.24e-2)" "unprognostic (1.64e-2)" 14.2 17.5 23.5 12.9 26.9 12.1 15.8 38.6 40.4 17.7 16.1 20.7 16.1 13.6 21.4 14.5 19.6 20.0 14.7 13.7 23.8 23.5 16.3 15.9 16.9 16.3 17.9 18.3 30.2 21.9 30.3 16.7 18.3 21.2 14.3 13.2 18.6 18.3 21.1 9.0 18.2 12.7 19.5 16.9 16.9 13.7 27.3 14.8 22.3 17.1 8.4 14.4 16.3 15.6 6.8 4.1 24.0 4.8 6.9 9.7 6.0 12.3 15.0 17.6 20.6 18.4 14.2 14.2 16.5 17.4 27.1 23.8 19.5 12.9 10.8 10.7 18.2 18.4 9.2 24.8 14.9 15.4 21.7 19.8 24.4 23.0 13.1 20.4 14.9 17.1 16.5 18.6 29.2 17.7 15.3 22.6 12.6 16.0 12.7 13.3 11.0 18.1 15.6 18.9 9.8 25.0 11.5 12.5 21.6 17.5 18.9 9.5 19.0 21.0 13.7 18.9 10.6 11.0 22.0 20.2 15.2 15.3 20.8 19.1 15.5 20.8 11.5 13.9 17.3 15.5 2.5 4.8 8.2 8.7 3.9 8.8 4.6 8.0 9.6 4.1 6.8 9.7 9.5 24.0 6.9 4.8 2.9 8.2 6.0 23.5 26.9 38.6 40.4 23.8 23.5 17.9 18.3 21.2 14.8 23.8 10.5 11.8 13.7 13.9 37.4 8.9 15.3 17.4 10.3 12.2 84.4 15.7 5.0 12.1 69.3 16.6 12.9 23.3 11.3 13.2 13.6 16.1 19.6 10.6 10.8 28.6 26.5 17.8 11.8 11.8 19.5 10.7 18.6 14.4 12.2 22.0 16.3 8.6 15.6 10.3 70.3 19.4 11.5 17.9 22.6 16.4 23.0 23.5 11.0 13.3 IP6K2 IHPK2 ENSG00000068745 "Inositol hexakisphosphate kinase 2" Q9UHH9 3 48688003-48740353 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007532, HPA070811" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA007532: AB_1851542, HPA070811: AB_2732165" "prognostic favorable (1.25e-4)" "unprognostic (2.55e-2)" "unprognostic (8.86e-2)" "unprognostic (6.69e-3)" "unprognostic (1.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.76e-3)" "prognostic favorable (2.95e-4)" "unprognostic (6.57e-3)" "unprognostic (1.56e-1)" "unprognostic (1.92e-3)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.64e-1)" "unprognostic (3.50e-2)" "prognostic favorable (1.83e-4)" 18.3 31.1 40.4 20.0 55.9 51.7 28.2 74.1 37.3 29.5 32.5 23.7 34.0 36.9 34.6 56.1 30.0 28.1 24.0 19.0 30.7 19.2 32.4 24.3 18.4 22.5 35.4 27.6 33.9 28.1 23.5 42.3 20.7 29.4 34.9 41.9 22.2 28.3 32.1 19.1 50.0 31.6 21.1 28.3 25.5 27.6 26.0 37.4 31.7 35.7 21.6 19.5 24.1 34.0 27.3 22.8 50.7 25.7 27.9 35.1 19.0 8.5 16.7 34.7 24.4 19.6 24.5 25.1 16.3 18.3 18.7 21.7 13.8 22.9 15.1 13.4 15.2 23.5 22.3 17.3 24.4 17.5 17.8 15.2 17.3 51.7 29.6 15.9 16.4 16.9 23.2 35.6 25.4 21.0 24.9 25.9 49.1 12.9 19.0 21.7 19.0 35.0 22.5 26.6 16.7 31.0 14.7 11.5 16.5 25.4 41.0 21.7 32.8 35.3 24.0 17.3 28.8 23.2 27.7 18.4 20.4 20.3 12.8 16.1 17.6 20.8 21.3 18.5 19.2 17.8 50.7 22.5 38.5 29.7 21.6 26.5 27.3 25.8 27.7 21.7 25.7 24.2 24.9 35.3 27.9 25.7 22.8 35.1 19.0 40.4 55.9 74.1 37.3 30.7 19.2 35.4 27.6 29.4 37.4 65.5 38.7 24.2 78.6 73.7 63.9 10.1 33.1 69.6 69.4 94.2 37.3 101.3 64.6 51.7 30.9 42.0 85.6 0.0 41.6 64.1 64.4 60.2 53.1 20.7 35.7 19.1 105.7 35.0 15.3 14.2 75.1 31.2 25.3 34.3 96.2 28.0 50.1 90.2 64.3 55.6 50.0 51.8 35.7 56.7 54.0 72.5 103.7 47.2 78.7 75.6 IRF2 ENSG00000168310 "Interferon regulatory factor 2" P14316 4 184387713-184474580 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 173.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 50.9;Karpas-707: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030813, CAB032306, HPA057327" Supported Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410" "prognostic favorable (6.95e-5)" "unprognostic (1.69e-3)" "unprognostic (5.43e-2)" "unprognostic (1.59e-3)" "unprognostic (2.70e-2)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-3)" "unprognostic (2.90e-2)" "unprognostic (4.00e-2)" "unprognostic (2.35e-1)" "unprognostic (6.87e-3)" "unprognostic (8.55e-3)" "unprognostic (5.25e-2)" "prognostic favorable (8.34e-5)" "unprognostic (1.31e-3)" 27.5 30.6 15.2 31.0 19.3 11.3 21.0 21.5 16.4 21.5 23.7 28.8 16.6 21.2 19.8 16.5 20.5 18.1 17.3 16.1 15.3 12.1 15.3 26.1 24.0 38.7 22.8 9.7 28.0 14.9 12.4 24.5 19.7 17.8 20.5 20.4 16.8 22.1 16.1 21.9 18.1 27.7 21.2 22.4 39.4 21.3 8.4 22.0 36.1 24.0 12.6 34.5 28.8 26.4 22.2 16.2 83.9 27.5 18.1 21.9 17.2 6.1 4.5 5.6 3.7 12.3 12.7 3.3 4.5 14.2 11.1 11.7 1.3 11.9 3.8 2.4 6.7 9.1 5.7 3.8 8.6 7.2 50.9 2.1 10.5 2.5 8.2 12.2 6.4 8.9 13.6 7.9 6.3 16.5 9.6 8.4 4.6 2.0 53.1 4.6 4.3 12.3 7.8 1.2 5.6 3.3 16.2 2.1 16.9 8.5 9.5 2.4 3.7 6.4 5.3 9.3 2.4 4.1 5.8 6.9 3.2 3.5 3.6 3.9 15.2 12.1 3.3 6.7 6.3 5.6 17.7 19.4 34.5 16.4 25.3 16.9 21.2 16.3 17.6 16.2 22.2 17.5 17.3 83.9 18.1 27.5 4.1 21.9 17.2 15.2 19.3 21.5 16.4 15.3 12.1 22.8 9.7 17.8 22.0 35.7 23.2 51.9 43.4 43.6 11.8 19.6 28.1 64.3 26.1 24.4 5.9 27.6 31.5 24.5 0.1 35.9 32.5 23.3 26.4 13.4 30.4 57.1 26.5 32.6 42.8 19.1 29.4 37.4 73.6 1.3 34.5 47.6 18.6 173.1 25.9 25.5 27.3 37.4 49.8 23.7 7.8 38.8 24.7 0.2 1.1 38.9 22.3 58.6 20.9 59.3 IRS1 HIRS-1 ENSG00000169047 "Insulin receptor substrate 1" P35568 2 226731317-226799759 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 56.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.0;naive B-cell: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005261, HPA046433" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005261: AB_649615, HPA046433: AB_2732524" "unprognostic (2.20e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.59e-2)" "unprognostic (3.86e-3)" "unprognostic (1.61e-1)" "unprognostic (1.44e-1)" "unprognostic (1.80e-3)" "unprognostic (5.47e-2)" "unprognostic (2.24e-2)" "unprognostic (5.48e-3)" "unprognostic (1.10e-1)" "unprognostic (1.36e-3)" "unprognostic (1.46e-2)" "unprognostic (6.92e-2)" "unprognostic (3.23e-2)" "unprognostic (7.55e-3)" 7.0 9.9 3.1 5.0 2.7 0.6 11.7 9.6 5.4 13.3 14.2 1.4 3.9 4.0 17.2 5.0 3.8 13.9 11.5 6.3 3.9 2.2 5.2 12.0 5.0 2.5 2.3 2.6 21.9 7.1 3.4 2.5 9.1 4.2 9.8 2.9 5.5 3.3 7.5 23.3 5.1 6.5 11.7 2.6 3.3 5.8 2.4 1.7 17.1 23.4 5.6 2.5 14.6 15.8 1.2 0.4 0.0 0.2 0.0 0.3 0.2 3.2 15.0 10.9 0.4 15.1 9.0 0.0 9.0 7.1 12.0 7.8 8.5 8.3 1.3 1.5 6.1 8.3 5.7 0.7 8.6 6.9 3.3 0.6 0.0 1.0 4.0 7.5 0.3 0.0 12.5 4.8 9.5 8.6 7.3 0.0 1.3 1.6 13.3 8.1 12.8 2.7 3.7 4.4 2.0 8.3 0.6 14.2 0.1 5.5 10.8 1.9 0.3 2.9 2.1 4.8 9.2 8.0 0.1 0.7 16.0 14.6 12.2 8.6 6.2 2.5 2.0 15.8 0.3 4.7 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.1 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.3 0.2 3.1 2.7 9.6 5.4 3.9 2.2 2.3 2.6 4.2 1.7 17.9 5.8 0.5 24.9 31.5 18.2 11.5 12.7 4.0 6.8 0.0 0.0 5.2 14.9 12.8 1.3 2.0 11.1 0.0 9.5 0.7 21.2 13.8 0.0 56.3 1.6 19.1 2.4 3.1 1.0 0.0 21.0 0.6 15.1 0.0 7.5 7.6 8.9 10.4 13.8 2.2 1.9 12.9 14.2 1.1 0.7 20.7 15.3 0.0 5.7 21.8 ISL1 "Isl-1, ISLET1" ENSG00000016082 "ISL LIM homeobox 1" P61371 5 51383391-51394738 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 30.3" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 118.7;Horizontal cells: 41.3;Intestinal endocrine cells: 87.9;Syncytiotrophoblasts: 28.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.1" "Group enriched" "Detected in some" 5 "basal ganglia: 4.0;hypothalamus: 5.5;pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 82.3" "Group enriched" "Detected in some" 8 "basal ganglia: 13.8;hypothalamus: 17.5;thalamus: 6.5" "Group enriched" "Detected in some" 11 "basal ganglia: 8.5;hypothalamus: 8.6" "HPA048613, HPA057416" Approved Approved "Nucleoplasm,Nuclear speckles,Mitochondria" NA NA Nucleoplasm "Nuclear speckles, Mitochondria" "HPA048613: , HPA057416: AB_2683431" "unprognostic (4.97e-2)" "unprognostic (2.22e-2)" "unprognostic (1.69e-1)" "unprognostic (2.41e-3)" "unprognostic (5.52e-2)" "unprognostic (6.79e-2)" "unprognostic (9.21e-2)" "unprognostic (9.42e-2)" "unprognostic (5.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.48e-1)" "unprognostic (9.11e-3)" "unprognostic (4.39e-3)" 2.2 1.5 0.0 0.0 4.0 0.0 0.1 0.0 0.2 14.4 1.6 0.0 4.2 2.3 1.3 0.5 0.2 0.0 0.2 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.4 0.0 2.8 10.0 2.0 13.2 2.5 6.4 1.0 30.3 0.1 1.1 0.7 0.6 0.1 0.0 10.7 1.6 0.7 3.1 0.3 0.2 0.4 2.4 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.6 1.2 0.9 0.0 0.0 1.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.8 0.0 0.0 0.0 5.3 82.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.0 0.0 0.2 0.0 5.5 0.0 0.0 2.0 0.7 0.0 0.0 0.0 3.5 1.3 118.7 0.3 0.0 0.0 0.0 0.0 3.9 20.5 0.0 0.0 13.2 0.1 0.0 0.0 0.0 8.9 0.4 1.2 0.0 0.0 2.3 41.3 87.9 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.6 3.4 6.8 0.0 0.0 0.0 11.3 0.0 0.1 0.7 0.7 0.9 28.6 0.0 0.0 3.7 ITFG2 "FGGAP1, MDS028" ENSG00000111203 "Integrin alpha FG-GAP repeat containing 2" Q969R8 12 2812622-2859791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038664, HPA038665" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Cytokinetic bridge" Yes No "Nucleoplasm, Endoplasmic reticulum" "Cytokinetic bridge" "HPA038664: AB_10672722, HPA038665: AB_2676138" "unprognostic (5.70e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (2.96e-1)" "unprognostic (2.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-2)" "unprognostic (3.64e-2)" "unprognostic (1.60e-2)" "unprognostic (4.36e-2)" "unprognostic (5.05e-3)" "unprognostic (8.40e-2)" "unprognostic (2.60e-1)" "unprognostic (4.24e-1)" "unprognostic (5.89e-1)" "unprognostic (4.35e-2)" "unprognostic (7.43e-2)" 12.2 16.1 11.1 15.4 14.0 12.0 14.3 17.8 17.2 16.2 13.2 23.2 21.3 11.8 19.6 16.6 13.2 17.2 14.7 12.0 8.7 9.8 15.0 11.4 14.4 14.0 13.3 9.9 29.0 28.4 22.7 23.0 13.8 13.3 13.8 14.7 22.1 23.0 19.5 7.8 10.9 13.9 13.5 10.6 20.3 14.8 10.6 15.2 25.4 26.2 9.3 23.0 14.4 15.3 17.7 12.9 5.4 21.2 13.8 14.4 10.0 4.8 7.1 8.3 6.6 7.2 8.3 7.7 10.8 6.1 13.1 9.7 15.3 12.0 11.1 3.0 10.1 6.6 6.2 12.7 10.7 9.8 9.8 7.6 15.7 8.1 6.1 13.3 14.2 8.5 11.1 12.8 11.9 18.4 10.8 8.9 10.7 8.4 12.1 7.4 14.6 20.5 8.3 16.9 11.0 5.5 10.4 9.2 6.4 7.8 8.2 4.0 12.7 13.4 11.8 4.8 11.7 7.3 6.6 9.1 8.7 5.4 8.3 20.6 1.6 0.9 16.9 5.7 8.3 8.6 2.8 10.9 5.4 13.7 14.3 12.8 17.7 10.5 13.4 12.9 17.1 14.4 13.5 1.3 13.8 21.2 9.8 8.5 10.0 11.1 14.0 17.8 17.2 8.7 9.8 13.3 9.9 13.3 15.2 11.9 19.9 25.1 8.5 3.0 34.9 15.1 15.3 9.4 13.6 12.2 60.9 23.3 10.0 7.9 42.6 6.0 13.5 0.0 6.3 8.5 9.4 7.3 5.8 10.2 11.3 30.2 9.1 13.5 7.2 9.0 15.5 9.8 1.7 9.0 12.6 14.7 6.1 16.1 12.4 4.4 52.4 6.5 8.4 12.6 17.9 3.4 14.5 25.9 16.4 4.6 ITGB1BP1 "ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B" ENSG00000119185 "Integrin subunit beta 1 binding protein 1" O14713 2 9403475-9423547 "Predicted intracellular proteins" "Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation" Mitogen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Distal tubular cells: 331.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067348, HPA071538" Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA067348: AB_2732765, HPA071538: AB_2686413" "unprognostic (2.21e-1)" "unprognostic (8.31e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (4.39e-2)" "unprognostic (5.88e-3)" "prognostic unfavorable (4.67e-5)" "unprognostic (3.13e-1)" "unprognostic (1.24e-1)" "unprognostic (2.33e-1)" "unprognostic (6.46e-2)" "unprognostic (4.66e-2)" "prognostic unfavorable (7.10e-5)" "unprognostic (3.75e-2)" "unprognostic (2.01e-1)" "unprognostic (1.14e-3)" "unprognostic (4.08e-3)" 61.1 15.0 19.0 11.6 29.2 16.1 73.0 17.6 24.0 24.5 16.3 9.9 10.2 7.7 18.0 16.6 13.3 15.0 14.4 23.9 17.1 15.6 23.6 7.7 13.4 12.1 19.7 18.7 14.3 7.6 14.8 9.7 14.1 19.4 11.1 14.8 11.4 7.7 15.1 16.0 16.6 8.6 22.1 19.2 8.6 11.2 5.6 17.0 10.2 11.2 12.1 14.8 12.8 33.6 20.7 29.5 35.2 27.3 24.1 31.3 24.9 16.2 11.7 13.8 15.8 49.4 41.9 7.5 29.9 20.5 27.1 21.1 15.5 10.2 18.0 13.5 41.0 17.7 15.4 21.1 19.6 30.0 48.6 10.6 16.4 13.8 19.4 17.2 12.6 17.9 23.6 16.2 24.8 17.7 23.5 23.6 13.8 9.1 14.9 33.5 14.5 22.3 8.2 11.2 27.0 19.7 12.8 19.0 16.7 27.4 13.4 15.0 14.5 16.6 12.9 20.2 13.4 9.4 9.6 15.0 24.3 17.9 32.3 33.2 15.0 32.2 26.3 33.3 17.4 16.8 35.2 23.0 27.9 30.4 27.3 28.9 20.7 26.5 29.4 29.5 17.5 20.6 26.5 5.0 24.1 20.0 26.6 31.3 24.9 19.0 29.2 17.6 24.0 17.1 15.6 19.7 18.7 19.4 17.0 26.8 17.8 55.0 30.0 54.4 22.1 77.9 25.5 26.8 17.0 36.6 2.0 41.1 331.5 76.9 20.7 75.2 19.2 23.3 63.1 65.6 89.2 30.0 39.4 18.4 81.8 33.4 31.9 48.5 32.7 17.0 50.3 60.8 92.8 103.6 36.3 33.6 74.4 28.1 53.7 63.2 23.3 90.5 99.4 10.4 19.0 55.2 26.3 45.7 35.3 48.0 ITGB6 ENSG00000115221 "Integrin subunit beta 6" P18564 2 160099666-160200313 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Amelogenesis imperfecta, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 62.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 142.9;Alveolar cells type 2: 159.2;Pancreatic endocrine cells: 133.9;Spermatocytes: 219.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.5;RPTEC TERT1: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023626, CAB073536" Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA "Nucleoplasm, Cell Junctions" Centrosome "CAB073536: , HPA023626: AB_2671267" "unprognostic (1.27e-1)" "unprognostic (1.57e-2)" "unprognostic (6.90e-2)" "unprognostic (8.22e-3)" "unprognostic (3.61e-3)" "unprognostic (1.50e-2)" "unprognostic (1.72e-3)" "unprognostic (2.04e-2)" "unprognostic (1.72e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (1.00e-1)" 0.3 0.3 0.3 3.1 0.3 0.0 8.7 0.3 0.3 4.1 8.3 0.1 4.5 3.5 2.1 2.5 18.7 1.2 12.0 0.7 0.3 0.3 62.1 0.3 28.8 0.1 0.3 0.1 1.5 3.8 7.0 2.2 18.7 0.2 7.5 3.0 0.1 3.8 4.8 31.5 1.9 11.7 2.0 0.3 0.3 7.9 0.6 0.1 0.1 4.9 6.8 5.9 12.8 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 37.5 0.0 0.2 0.0 0.0 7.7 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 2.4 0.0 0.0 2.9 0.0 74.9 12.4 0.0 0.0 0.0 11.8 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 142.9 159.2 0.0 106.9 9.3 0.0 37.4 10.2 8.1 77.3 68.0 0.0 6.6 0.0 51.3 71.2 2.2 10.3 0.0 92.6 5.2 3.3 42.3 3.5 0.8 2.0 0.0 0.0 1.8 0.8 24.4 2.6 2.5 1.7 3.6 14.1 0.8 133.9 21.0 1.1 0.2 0.0 0.0 2.7 219.5 2.4 7.4 3.9 0.0 11.2 104.4 JAK2 JTK10 ENSG00000096968 "Janus kinase 2" O60674 9 4984390-5128183 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 40.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 40.8" "Group enriched" "Detected in many" 5 "ASC diff: 19.4;HDLM-2: 27.4;HEL: 56.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013089, HPA040820, HPA043870" Approved Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" No No Nucleoplasm "Plasma membrane, Focal adhesion sites" "CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708" "unprognostic (2.24e-3)" "unprognostic (2.76e-2)" "unprognostic (1.50e-2)" "unprognostic (7.67e-2)" "unprognostic (5.50e-2)" "unprognostic (3.09e-2)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.72e-2)" "unprognostic (3.85e-1)" "unprognostic (4.53e-2)" "unprognostic (3.43e-2)" "unprognostic (1.96e-1)" "unprognostic (7.37e-3)" 19.8 8.8 11.5 19.0 10.5 19.0 17.7 14.7 14.4 17.8 10.6 7.0 10.3 7.2 14.8 13.6 12.4 13.4 14.6 27.6 10.3 6.7 7.7 5.6 16.1 19.4 7.0 10.5 15.9 6.7 10.1 7.5 12.0 10.0 12.0 7.4 9.4 7.2 7.4 14.4 19.0 12.3 10.4 11.7 21.5 14.1 10.1 9.0 13.6 8.6 6.5 13.5 13.9 15.6 2.1 9.6 40.8 7.5 3.4 2.1 2.5 2.5 1.5 1.5 2.5 19.4 5.0 0.4 3.5 3.0 2.7 1.8 0.1 0.8 0.1 0.8 2.1 2.2 0.9 1.6 2.1 2.0 27.4 0.5 56.1 3.0 0.7 4.0 3.8 2.9 4.1 0.9 1.1 1.8 3.3 2.5 2.0 4.0 6.5 4.8 0.9 0.9 5.4 1.3 1.3 1.7 1.9 2.8 0.8 2.0 1.3 1.7 0.9 1.0 1.5 1.1 1.6 0.8 6.7 5.1 4.1 1.4 4.2 2.4 1.2 2.3 0.5 5.3 1.9 2.0 40.8 7.5 13.4 2.1 7.3 1.7 2.1 1.6 1.2 9.6 1.9 0.9 1.1 7.1 3.4 5.8 3.6 1.6 2.5 11.5 10.5 14.7 14.4 10.3 6.7 7.0 10.5 10.0 9.0 14.9 6.4 6.9 2.8 8.7 7.4 22.0 0.0 5.3 7.9 7.0 7.9 1.8 1.7 3.0 7.4 8.7 3.9 23.3 3.4 0.8 7.0 1.7 13.9 1.6 11.9 7.9 2.9 4.9 36.0 5.3 21.9 27.7 5.0 16.2 4.2 12.2 5.4 14.4 31.5 2.5 11.1 0.0 5.0 14.9 5.7 7.3 2.9 5.0 3.3 4.1 JPT1 "ARM2, HN1, HN1A" ENSG00000189159 "Jupiter microtubule associated homolog 1" Q9UK76 17 75135248-75168281 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 109.4;testis: 101.3" "Cell type enhanced" "Detected in many" 13 "Ductal cells: 365.7;Exocrine glandular cells: 382.5;Extravillous trophoblasts: 1210.3;monocytes: 655.6;Pancreatic endocrine cells: 967.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 109.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059729 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA059729: AB_2684114" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-3)" "unprognostic (3.57e-3)" "unprognostic (6.71e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (1.58e-7)" "unprognostic (3.58e-2)" "unprognostic (1.37e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.25e-3)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.77e-7)" "unprognostic (1.83e-1)" "unprognostic (8.99e-2)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" 8.0 18.5 15.6 25.9 22.2 23.0 8.1 30.7 25.4 9.4 43.3 4.6 7.7 37.5 6.1 5.4 52.8 4.3 23.7 6.1 17.9 19.6 15.5 12.8 13.9 26.3 11.1 15.0 5.6 6.5 1.2 6.6 29.2 13.7 7.0 23.7 3.3 15.9 17.6 23.7 9.3 51.3 7.3 8.3 26.2 42.5 101.3 4.9 32.6 5.8 28.9 28.7 17.9 17.0 15.4 14.5 109.4 28.4 10.2 28.7 14.6 92.5 92.3 48.6 48.2 10.3 10.6 38.8 48.7 14.5 47.9 36.9 75.5 55.6 26.1 31.3 39.0 50.4 55.4 45.3 60.7 36.2 26.0 57.0 41.9 36.7 74.7 24.2 31.4 40.5 16.2 29.1 39.0 40.1 14.1 87.1 49.7 23.6 53.7 43.8 67.0 100.7 30.7 28.3 76.6 121.7 64.4 58.0 40.4 51.2 58.2 60.4 49.1 69.8 37.0 25.9 53.6 99.1 19.3 50.1 27.5 77.6 38.5 56.6 21.0 33.9 39.0 23.9 29.5 31.3 27.5 18.5 51.6 12.4 26.6 8.9 15.4 17.2 14.9 14.5 8.0 8.2 12.0 109.4 10.2 28.4 9.6 28.7 14.6 15.6 22.2 30.7 25.4 17.9 19.6 11.1 15.0 13.7 4.9 23.8 17.8 0.0 0.0 0.0 0.0 0.0 0.0 30.8 33.0 233.8 0.0 95.9 84.6 365.7 0.0 0.0 0.0 0.0 382.5 1210.3 0.0 0.0 7.0 0.0 299.4 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 655.6 0.0 0.0 967.6 0.0 0.0 121.9 0.0 0.0 0.0 0.0 0.0 0.0 81.0 0.0 0.0 0.0 JRK "jerky, JH8" ENSG00000234616 "Jrk helix-turn-helix protein" 8 142657460-142681968 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3;Spermatogonia: 21.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052675 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" No No "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA052675: AB_2681910" "unprognostic (3.65e-2)" "unprognostic (5.30e-2)" "unprognostic (9.67e-2)" "unprognostic (3.90e-3)" "unprognostic (1.27e-1)" "unprognostic (1.84e-2)" "unprognostic (6.58e-6)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.90e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (7.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.53e-1)" "unprognostic (1.22e-2)" "unprognostic (1.69e-2)" 2.6 3.3 6.4 4.0 6.5 1.6 3.7 11.1 7.1 2.8 2.8 6.1 6.8 2.9 5.4 3.6 3.1 4.7 2.6 3.7 4.4 2.9 0.7 2.6 5.3 5.2 5.2 9.6 4.6 5.6 4.4 3.0 4.3 4.5 2.8 5.4 4.1 4.5 6.2 6.5 3.2 4.9 3.5 4.8 4.3 6.1 5.3 4.3 4.2 2.6 6.1 2.6 7.9 4.5 2.3 3.3 2.3 2.0 4.4 1.2 5.5 6.0 7.0 5.7 6.8 10.0 4.4 8.6 3.6 10.6 6.1 5.3 11.5 9.5 3.7 7.1 7.3 7.5 6.2 5.3 5.4 7.2 10.5 9.5 19.0 6.2 2.8 7.3 6.7 6.4 4.7 6.7 3.9 5.3 5.9 11.2 10.1 4.2 8.9 9.5 8.4 4.1 6.0 3.9 8.5 11.1 4.4 5.3 3.7 9.5 12.9 8.6 15.8 6.5 3.7 4.6 6.4 4.6 7.0 8.3 17.7 8.1 4.7 5.6 6.2 5.6 6.2 9.2 7.9 3.3 2.3 2.9 3.1 1.6 1.8 1.4 3.5 3.1 2.3 4.5 4.4 3.5 2.5 2.0 0.8 2.2 2.0 1.2 6.0 0.6 5.1 1.9 0.0 12.9 9.6 7.6 1.4 1.2 7.0 19.6 3.6 3.3 2.7 1.3 6.2 2.3 23.3 2.2 2.1 1.1 3.6 1.1 2.4 2.6 9.5 8.7 10.4 5.6 1.1 10.6 1.9 0.0 1.8 3.1 5.4 4.1 0.0 11.0 2.4 10.2 0.0 1.4 9.8 21.3 0.0 1.8 0.0 4.5 4.1 KANSL2 "C12orf41, FLJ20436, NSL2" ENSG00000139620 "KAT8 regulatory NSL complex subunit 2" Q9H9L4 12 48653401-48682238 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038497, HPA038498" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA038497: AB_10674685, HPA038498: AB_2676046" "unprognostic (3.87e-3)" "unprognostic (6.18e-2)" "unprognostic (3.67e-1)" "unprognostic (8.89e-2)" "unprognostic (5.37e-2)" "unprognostic (4.73e-2)" "prognostic unfavorable (4.98e-4)" "unprognostic (5.46e-2)" "unprognostic (1.35e-3)" "unprognostic (6.16e-2)" "unprognostic (6.75e-3)" "unprognostic (4.19e-3)" "unprognostic (8.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "prognostic favorable (4.32e-4)" 11.4 12.3 9.8 9.0 14.0 41.3 14.5 19.7 14.7 12.0 10.7 15.6 8.9 8.9 14.9 14.3 13.7 12.0 9.0 12.8 8.6 8.6 13.8 10.2 11.0 16.8 13.0 11.2 17.4 14.3 10.6 21.0 18.2 11.3 12.5 11.3 14.1 13.2 10.4 36.3 13.1 11.6 13.5 11.2 14.0 10.8 16.5 12.7 20.1 16.4 12.6 16.5 11.8 12.8 23.6 21.3 28.2 18.4 19.8 26.8 18.7 9.5 13.0 11.7 5.6 13.1 11.6 24.6 10.9 8.7 17.8 10.2 22.8 12.4 15.6 19.4 12.9 7.5 9.7 19.0 12.7 14.9 14.0 11.3 18.2 11.6 6.4 14.7 20.1 7.1 12.1 16.1 13.5 23.7 9.8 8.6 13.5 21.1 10.4 12.9 8.9 19.7 15.4 15.1 14.1 13.1 17.0 11.5 17.8 9.6 13.3 13.3 9.2 21.1 15.7 12.9 13.1 20.6 19.7 7.4 13.6 10.0 5.8 9.9 15.8 23.3 22.8 6.7 45.9 6.9 28.2 16.8 19.3 23.0 17.4 22.0 23.6 22.9 23.8 21.3 21.1 26.8 25.5 7.7 19.8 18.4 17.3 25.1 18.7 9.8 14.0 19.7 14.7 8.6 8.6 13.0 11.2 11.3 12.7 3.0 11.0 11.3 11.5 10.5 13.7 8.9 7.6 12.0 14.8 14.0 27.5 18.9 8.3 10.4 20.7 12.1 9.3 0.0 8.7 9.9 12.8 9.0 11.5 8.7 10.5 14.3 8.6 14.7 13.9 11.8 11.5 13.8 15.1 13.6 8.4 6.6 9.4 3.5 9.6 12.2 21.4 25.8 15.9 26.4 33.2 9.8 21.2 22.3 11.4 8.6 KAZN "FLJ43806, KAZRIN, KIAA1026" ENSG00000189337 "Kazrin, periplakin interacting protein" Q674X7 1 13892792-15118043 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 64.9" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 72.8;Suprabasal keratinocytes: 79.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "neutrophil: 6.9" "Lineage enriched" "Detected in single" 21 "granulocytes: 6.9" "Cell line enhanced" "Detected in many" "AN3-CA: 40.6;SK-BR-3: 22.0" "HPA032095, HPA032096" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA032095: AB_2674146, HPA032096: AB_10670826" "unprognostic (2.81e-1)" "unprognostic (5.82e-2)" "unprognostic (1.12e-1)" "unprognostic (2.42e-3)" "unprognostic (5.34e-2)" "unprognostic (2.15e-3)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (3.21e-1)" "unprognostic (4.96e-3)" "unprognostic (1.10e-1)" "unprognostic (5.55e-2)" "prognostic favorable (1.20e-6)" "unprognostic (3.61e-2)" "unprognostic (7.93e-2)" "unprognostic (3.21e-1)" "unprognostic (1.06e-2)" 8.0 11.0 13.4 3.0 17.4 1.2 7.6 41.1 21.9 8.0 3.8 27.5 5.7 4.6 3.1 11.1 18.8 11.0 7.0 4.1 12.4 12.4 13.2 5.2 8.5 1.5 25.1 12.1 10.4 8.0 22.9 2.7 11.0 15.0 4.1 4.0 10.5 16.8 7.2 1.7 14.2 4.9 3.7 25.0 64.9 4.9 4.1 18.9 0.0 6.6 7.0 6.3 7.9 9.4 0.3 0.0 6.9 0.0 0.0 0.0 0.0 8.0 1.4 8.8 40.6 3.8 4.0 3.0 3.8 3.2 7.2 5.2 1.8 4.3 0.0 10.1 8.2 1.3 2.9 2.0 6.3 3.6 0.2 3.9 4.6 4.8 12.0 2.8 0.0 2.4 5.6 8.5 1.6 1.1 3.2 0.0 1.1 1.8 9.4 5.7 5.9 0.0 0.4 2.4 3.6 1.2 2.7 0.2 4.9 12.1 2.5 4.7 3.4 0.7 22.0 15.1 5.3 1.3 3.1 0.0 6.0 5.6 9.4 4.6 1.6 1.3 0.0 5.6 8.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 13.4 17.4 41.1 21.4 12.4 12.4 25.1 12.1 15.0 18.9 3.0 2.6 0.9 12.5 44.8 9.3 3.0 5.1 12.0 6.8 47.1 7.9 1.1 14.9 1.8 4.5 8.1 3.0 0.0 1.4 5.8 10.8 8.1 3.5 0.0 0.7 0.0 6.8 40.5 1.2 5.8 17.5 2.1 43.9 0.0 3.7 72.8 1.4 0.0 16.3 11.4 2.4 6.5 21.7 0.1 4.0 79.0 38.8 2.9 2.8 24.0 KBTBD4 "BKLHD4, FLJ10450, HSPC252" ENSG00000123444 "Kelch repeat and BTB domain containing 4" Q9NVX7 11 47572197-47579015 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037792, HPA037793" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA037792: AB_10671633, HPA037793: AB_2675671" "unprognostic (5.52e-2)" "unprognostic (2.23e-1)" "unprognostic (8.36e-3)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (7.32e-2)" "unprognostic (1.21e-1)" "unprognostic (2.09e-1)" "unprognostic (8.73e-3)" "unprognostic (2.78e-1)" "unprognostic (4.04e-2)" "unprognostic (7.22e-2)" "prognostic favorable (2.70e-7)" "unprognostic (4.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.07e-1)" "unprognostic (4.25e-2)" 8.4 13.4 7.9 6.7 15.9 11.7 9.0 16.2 25.8 9.0 9.7 13.6 13.3 6.5 12.3 13.7 8.0 15.5 7.6 9.5 7.5 8.7 12.0 9.4 8.6 10.7 7.0 7.1 13.2 8.4 23.0 11.9 10.0 11.7 12.1 9.2 13.6 8.6 10.5 19.1 10.8 10.3 10.0 6.2 9.9 9.0 11.6 4.6 13.5 12.4 9.4 14.2 10.9 8.1 12.4 6.6 11.8 5.3 12.3 14.7 10.4 5.1 10.6 11.4 9.6 7.0 9.4 4.0 8.6 10.2 11.2 9.7 4.4 9.5 9.3 4.9 9.8 9.0 8.4 6.3 11.3 9.5 12.1 10.2 6.8 14.7 4.9 5.2 14.1 13.7 8.6 7.9 4.5 6.1 8.6 11.3 6.9 5.4 7.3 8.7 12.7 10.3 4.5 6.2 12.4 7.6 10.3 15.5 5.9 11.9 10.7 15.9 10.5 7.4 9.9 6.5 4.4 16.6 4.5 10.3 8.1 9.0 11.1 8.5 11.3 17.4 12.9 11.2 4.1 8.3 10.7 5.3 11.8 13.7 4.3 14.7 12.4 11.0 12.6 6.6 11.0 11.7 12.5 8.0 12.3 4.1 3.1 12.8 10.4 7.9 15.9 16.2 25.8 7.5 8.7 7.0 7.1 11.7 4.6 6.0 2.2 2.4 5.9 4.2 14.7 0.1 7.6 12.0 6.8 10.4 7.9 10.2 19.9 11.8 9.0 5.2 4.4 23.3 11.9 5.9 6.4 4.0 10.4 7.7 7.1 12.7 6.9 7.4 3.7 13.8 4.6 4.3 1.7 13.6 4.8 22.8 7.7 3.5 8.9 9.1 10.4 12.9 4.2 18.0 16.4 4.0 11.8 11.7 5.0 2.8 KCNAB1 "AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3" ENSG00000169282 "Potassium voltage-gated channel subfamily A member regulatory beta subunit 1" Q14722 3 156037701-156539138 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.1;thyroid gland: 25.7" "Group enriched" "Detected in many" 5 "Bipolar cells: 54.8;Cone photoreceptor cells: 29.5;Sertoli cells: 77.6;Smooth muscle cells: 66.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 5.9;hTEC/SVTERT24-B: 9.2" "Region enhanced" "Detected in many" "basal ganglia: 300.5" "Low region specificity" "Detected in all" "HPA036110, HPA044550" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA036110: , HPA044550: AB_10797032" "unprognostic (1.52e-1)" "unprognostic (3.73e-1)" "unprognostic (1.33e-1)" "unprognostic (2.98e-4)" "unprognostic (1.24e-2)" "unprognostic (1.64e-1)" "unprognostic (1.81e-1)" "unprognostic (2.83e-2)" "unprognostic (8.51e-2)" "unprognostic (3.72e-2)" "unprognostic (5.87e-2)" "unprognostic (9.70e-2)" "unprognostic (2.17e-3)" "unprognostic (2.60e-1)" "unprognostic (1.95e-1)" "unprognostic (1.06e-1)" "unprognostic (4.00e-1)" 12.6 5.9 7.5 1.1 41.1 1.4 3.5 10.7 16.4 5.7 2.9 4.6 2.5 1.6 3.4 11.9 2.1 2.7 2.7 4.8 12.3 4.3 1.8 2.3 3.1 0.9 3.7 10.3 2.8 3.7 1.8 1.2 1.3 3.0 21.1 1.8 7.2 3.4 17.9 1.7 1.3 1.9 2.6 2.6 4.3 1.3 2.7 12.3 0.0 25.7 1.0 0.5 2.0 3.0 1.0 4.3 2.4 1.2 0.9 2.7 0.4 0.9 0.8 1.3 0.3 0.1 0.0 2.5 2.2 0.0 0.0 0.2 1.7 0.2 0.6 1.2 0.0 0.5 0.6 0.0 0.0 0.0 0.7 1.7 5.9 1.1 2.7 0.0 1.7 0.5 0.0 0.0 9.2 0.0 2.1 3.7 0.9 0.2 0.5 0.4 0.2 0.5 1.0 1.9 2.6 0.5 0.9 1.3 4.7 0.0 0.4 1.4 1.4 0.5 1.1 1.2 0.9 1.5 0.9 3.8 1.5 0.9 2.5 2.0 3.2 0.7 0.7 4.5 1.9 1.7 2.4 0.6 0.2 1.5 0.7 2.7 0.9 1.4 1.3 0.9 1.0 1.2 1.3 0.1 0.9 1.2 4.3 1.7 0.4 7.5 41.1 10.7 16.4 12.3 4.3 3.7 10.3 3.0 12.3 0.0 0.0 0.5 0.1 0.7 54.8 4.1 0.0 0.0 1.2 0.0 29.5 0.1 0.0 0.4 11.9 1.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 3.6 0.0 0.0 1.3 9.3 4.7 0.0 1.1 1.7 0.0 0.0 1.6 0.0 0.0 2.5 0.0 6.1 77.6 66.2 0.1 0.9 0.6 0.1 0.0 0.0 0.1 KCNF1 "IK8, KCNF, kH1, Kv5.1" ENSG00000162975 "Potassium voltage-gated channel modifier subfamily F member 1" Q9H3M0 2 10911937-10914225 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 36.9" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 10.2;Syncytiotrophoblasts: 6.4" "Cancer enriched" "Detected in many" 7 "glioma: 27.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 16.9;MCF7: 6.0;T-47d: 7.3" "Group enriched" "Detected in many" 4 "amygdala: 70.7;basal ganglia: 55.9;cerebral cortex: 78.2;hippocampal formation: 69.5;olfactory region: 141.1" "Low region specificity" "Detected in all" "HPA014738, HPA062278" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA014738: AB_1852114, HPA062278: AB_2732679" "unprognostic (2.54e-1)" "unprognostic (6.06e-3)" "unprognostic (1.37e-1)" "unprognostic (3.07e-2)" "unprognostic (4.39e-2)" "unprognostic (7.41e-4)" "unprognostic (1.54e-3)" "unprognostic (4.83e-5)" "unprognostic (1.57e-1)" "unprognostic (6.95e-2)" "unprognostic (1.60e-2)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (3.10e-4)" "unprognostic (2.37e-1)" "unprognostic (4.28e-2)" "unprognostic (4.08e-2)" 0.9 0.9 11.5 1.0 25.5 0.8 1.2 0.8 36.9 0.9 1.2 2.4 0.0 1.2 1.9 0.8 1.6 1.1 1.0 1.1 13.1 4.7 1.1 0.9 1.0 1.0 3.1 10.5 0.9 2.2 0.8 0.2 0.9 3.6 1.0 1.2 0.0 0.8 1.4 0.8 0.8 1.1 1.0 1.0 1.5 1.1 1.0 3.1 0.5 0.8 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 16.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.0 2.6 0.1 1.8 0.0 0.1 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.2 7.3 0.8 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 11.5 25.5 0.8 28.5 13.1 4.7 3.1 10.5 3.6 3.1 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 KCNH5 "eag2, H-EAG2, Kv10.2" ENSG00000140015 "Potassium voltage-gated channel subfamily H member 5" Q8NCM2 14 62699454-63102037 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 9.2;retina: 5.7" "Cell type enriched" "Detected in some" 15 "Bipolar cells: 64.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 10.1;RT4: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030487, HPA072351" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA030487: AB_10609995, HPA072351: " "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-2)" "unprognostic (8.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" 0.9 4.6 1.7 0.5 3.6 0.3 0.4 0.2 9.2 0.3 0.4 0.4 0.0 0.3 0.4 0.5 0.3 0.3 0.3 0.3 1.3 3.0 0.4 0.3 0.3 0.3 1.2 4.2 0.3 0.3 0.3 1.5 1.2 6.5 0.7 0.3 5.7 0.3 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 1.7 0.0 0.0 0.3 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 1.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.1 0.0 1.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.6 0.2 9.2 1.3 3.0 1.2 4.2 6.5 0.0 0.0 0.0 0.0 0.1 0.0 64.7 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.4 0.7 0.0 1.0 0.0 0.0 0.0 KCNJ12 "hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v" ENSG00000184185 "Potassium voltage-gated channel subfamily J member 12" Q14500 17 21376197-21419872 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 39.4;skeletal muscle: 47.8" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 84.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 39.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.6;HeLa: 5.9;PC-3: 6.3;SCLC-21H: 7.3;SiHa: 3.7;SuSa: 8.0;U-2197: 6.3" "Low region specificity" "Detected in all" HPA027021 Approved Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (3.81e-3)" "unprognostic (2.69e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (4.91e-2)" "unprognostic (8.12e-2)" "unprognostic (1.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-1)" "unprognostic (5.90e-2)" "unprognostic (9.70e-3)" 1.2 1.3 1.9 0.9 2.9 0.7 0.9 39.4 5.8 1.2 0.8 1.1 0.5 0.5 0.8 1.4 1.5 2.1 0.7 5.1 0.9 1.4 1.2 0.5 1.3 0.4 1.3 3.4 0.7 0.5 10.6 0.7 0.7 4.0 0.9 0.6 1.7 0.6 0.9 47.8 6.0 0.6 1.0 0.9 1.3 0.9 1.3 0.9 0.0 1.0 7.5 1.1 0.8 1.5 0.0 0.9 0.0 0.5 0.0 0.1 0.0 0.0 1.1 0.4 2.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 3.6 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 5.9 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.1 0.0 1.5 0.0 6.3 0.0 1.0 1.6 0.0 0.0 7.3 0.4 3.7 0.0 1.5 8.0 0.0 0.0 2.8 0.0 0.5 6.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 1.9 2.9 39.4 5.8 0.9 1.4 1.3 3.4 4.0 0.9 0.0 0.0 0.0 0.0 1.3 0.8 12.5 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.4 1.4 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.2 84.2 1.2 5.5 0.0 0.2 6.9 0.0 0.0 0.0 0.4 11.2 0.0 0.0 3.9 0.6 1.4 0.0 0.5 0.5 1.3 1.9 0.1 0.0 0.6 0.0 KCNJ18 "KIR2.6, TTPP2" ENSG00000260458 "Potassium voltage-gated channel subfamily J member 18" B7U540 17 21692523-21704612 "Disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "lymphoid tissue: 3.5;skin 1: 8.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.0;HDLM-2: 2.1;HeLa: 1.7;RPMI-8226: 1.0;U-266/70: 3.3" "Region enhanced" "Detected in many" "cerebellum: 75.1" HPA027021 Uncertain Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (2.41e-1)" "unprognostic (3.90e-5)" "unprognostic (2.56e-1)" "unprognostic (1.95e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 KCNK17 "K2p17.1, TALK-2, TALK2, TASK-4, TASK4" ENSG00000124780 "Potassium two pore domain channel subfamily K member 17" Q96T54 6 39299001-39314553 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.1;retina: 20.0" "Group enriched" "Detected in some" 4 "Exocrine glandular cells: 7.3;granulocytes: 5.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 34 "plasmacytoid DC: 29.1" "Lineage enriched" "Detected in single" 34 "dendritic cells: 29.1" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 42.5" "Not detected" "Not detected" HPA043892 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA043892: AB_10962838" "unprognostic (5.33e-3)" "unprognostic (6.42e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "unprognostic (4.09e-2)" "unprognostic (4.95e-1)" "unprognostic (2.35e-1)" "unprognostic (1.71e-2)" "unprognostic (2.54e-1)" "unprognostic (3.77e-11)" "unprognostic (5.89e-2)" "unprognostic (5.36e-1)" "unprognostic (2.82e-1)" "unprognostic (3.86e-3)" 0.7 0.4 0.3 0.6 1.1 1.4 3.3 0.3 0.8 0.7 1.3 0.8 1.9 3.0 1.9 0.5 1.0 1.3 6.5 7.9 0.6 0.6 0.3 4.6 10.4 0.9 2.6 0.8 0.4 6.1 0.4 2.7 6.3 1.9 1.1 0.6 20.0 2.9 1.0 0.2 0.1 1.7 1.5 0.6 1.1 5.4 0.6 0.1 3.4 9.3 2.6 2.4 0.9 0.5 0.0 29.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 29.1 0.0 0.1 0.3 1.1 0.3 0.8 0.6 0.6 2.6 0.8 1.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCTD14 MGC2376 ENSG00000151364 "Potassium channel tetramerization domain containing 14" Q9BQ13 11 78015715-78046191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 14.8;Mucus-secreting cells: 15.2;Pancreatic endocrine cells: 12.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 5.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 15.4;Hep G2: 16.8;RPTEC TERT1: 27.3;U-2 OS: 12.4" "HPA041118, HPA042181" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA041118: AB_10963117, HPA042181: AB_10968059" "unprognostic (7.37e-3)" "unprognostic (4.27e-2)" "unprognostic (7.03e-2)" "unprognostic (6.93e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-2)" "unprognostic (2.04e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.96e-5)" "prognostic favorable (8.01e-4)" "prognostic unfavorable (1.05e-4)" "unprognostic (3.19e-1)" "prognostic favorable (6.92e-5)" "unprognostic (2.42e-2)" "unprognostic (2.05e-1)" "prognostic favorable (5.93e-4)" "unprognostic (1.63e-1)" 2.6 18.9 1.2 1.5 0.8 0.0 11.6 5.5 0.8 6.5 4.8 1.2 40.8 2.5 2.3 10.8 2.1 6.8 10.3 0.7 1.0 1.3 10.7 14.4 9.6 0.3 0.9 0.5 2.4 42.8 6.2 2.5 5.1 1.3 5.3 6.9 5.8 43.9 47.8 0.7 1.5 6.1 0.9 0.8 0.7 12.1 1.9 0.8 0.7 12.4 2.9 3.6 1.4 1.1 0.4 1.4 0.6 1.1 1.1 1.8 0.4 0.0 2.1 0.3 0.3 0.8 0.5 2.1 1.1 1.0 2.1 5.1 8.0 5.2 0.0 5.7 0.6 0.2 0.6 0.3 15.4 5.4 0.2 7.8 0.0 1.8 16.8 3.1 0.1 0.1 2.4 0.4 8.4 6.6 1.5 0.5 0.1 0.1 0.0 0.8 0.1 0.2 0.4 3.9 0.2 0.3 0.2 0.0 0.0 27.3 2.0 1.4 0.1 0.0 0.1 2.5 0.5 0.8 0.6 0.4 0.1 12.4 0.4 0.2 0.1 0.1 0.1 0.1 0.1 2.2 0.0 0.7 0.6 0.7 0.9 0.5 0.0 0.7 1.8 1.4 0.4 0.8 1.8 0.2 1.1 1.1 1.3 0.0 0.4 1.2 0.8 5.5 0.8 1.0 1.3 0.9 0.5 1.3 0.8 3.0 9.6 0.0 9.5 0.3 0.0 0.0 2.5 0.0 5.7 5.2 0.0 0.6 3.3 2.0 0.1 0.0 2.5 0.0 14.8 1.2 0.8 10.5 1.1 4.0 0.2 0.0 4.6 0.0 0.0 0.0 3.1 0.0 1.7 0.0 15.2 1.7 12.8 7.0 4.9 11.3 0.0 0.0 1.9 0.2 0.2 0.1 0.6 0.0 8.5 5.8 KCTD9 "BTBD27, FLJ20038" ENSG00000104756 "Potassium channel tetramerization domain containing 9" Q7L273 8 25427847-25458476 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042468, HPA047902" Supported "Nucleoplasm,Intermediate filaments,Cytosol" No No Nucleoplasm "Intermediate filaments, Cytosol" "HPA042468: , HPA047902: AB_2680205" "unprognostic (4.18e-2)" "unprognostic (3.90e-2)" "prognostic favorable (7.88e-4)" "unprognostic (7.04e-2)" "unprognostic (7.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.20e-2)" "unprognostic (6.01e-2)" "unprognostic (4.33e-1)" "unprognostic (2.43e-2)" "unprognostic (4.49e-3)" "unprognostic (2.30e-1)" "unprognostic (1.48e-1)" "unprognostic (6.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.31e-2)" "unprognostic (4.97e-3)" 14.4 5.8 7.4 17.3 7.7 11.5 14.6 17.7 10.1 15.7 14.1 5.4 16.8 12.4 15.6 12.2 18.2 11.3 12.8 48.4 5.9 5.2 9.6 6.6 10.3 6.9 7.4 5.3 12.4 8.3 7.3 11.2 7.4 14.6 11.8 14.8 9.4 14.6 18.4 19.0 15.0 10.9 16.7 10.8 8.6 10.6 11.2 6.6 11.8 8.7 11.7 8.7 19.1 14.8 2.2 3.2 3.7 2.9 0.9 3.8 1.5 18.1 12.9 14.1 4.9 18.4 24.5 11.6 27.6 24.9 18.2 18.5 9.2 13.4 11.9 11.8 27.5 25.7 12.3 12.3 13.0 22.0 6.1 7.3 13.9 12.6 8.5 22.4 4.8 10.4 18.8 15.8 16.5 13.8 11.1 15.3 12.0 14.6 9.4 20.6 4.8 18.7 8.4 6.9 14.1 6.9 7.3 16.4 4.4 18.5 10.4 3.6 4.7 21.2 9.4 14.3 13.3 7.2 5.6 16.9 20.1 11.7 38.5 14.9 2.7 4.9 15.7 14.1 8.6 14.4 2.6 1.7 3.7 3.4 2.5 3.8 2.2 3.6 3.6 1.1 1.2 2.2 3.6 1.8 0.9 2.9 3.2 3.5 1.5 7.4 7.7 17.7 10.1 5.9 5.2 7.4 5.3 14.6 6.6 29.8 11.5 4.5 33.0 66.1 13.0 55.7 5.1 16.0 22.7 26.2 23.6 8.1 11.6 15.4 3.8 15.4 29.0 0.0 23.8 14.2 32.6 43.6 19.7 8.3 8.1 3.2 9.8 12.3 8.1 2.1 28.4 15.1 28.7 7.2 12.4 7.8 24.5 22.1 52.3 8.4 18.3 6.5 26.5 24.6 30.7 47.8 9.4 15.2 16.5 40.5 KDF1 "C1orf172, FLJ34633, RP11-344H11.3" ENSG00000175707 "Keratinocyte differentiation factor 1" Q8NAX2 1 26949562-26960406 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.6" "Group enriched" "Detected in many" 36 "B-cells: 3.7;T-cells: 8.6" "Cell line enhanced" "Detected in some" "A-431: 13.3;BEWO: 11.7;CAPAN-2: 12.5;HaCaT: 11.8;HBEC3-KT: 16.2;hTCEpi: 21.3;OE19: 20.5;SK-BR-3: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028639, HPA068312" Uncertain Supported "Nucleoplasm,Cell Junctions,Mitotic spindle" NA NA "Cell Junctions" "Nucleoplasm, Mitotic spindle" "HPA028639: AB_10599191, HPA068312: AB_2685972" "unprognostic (2.58e-1)" "unprognostic (1.23e-1)" "unprognostic (6.46e-2)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (8.45e-2)" "unprognostic (9.09e-2)" "unprognostic (9.01e-2)" "unprognostic (2.73e-1)" "unprognostic (3.91e-1)" "prognostic favorable (3.04e-13)" "unprognostic (1.38e-3)" "unprognostic (7.83e-2)" "unprognostic (8.03e-2)" "prognostic favorable (4.40e-4)" 0.2 1.1 0.6 3.8 0.7 0.0 7.9 1.5 3.6 2.9 11.9 0.4 13.6 9.3 1.0 17.3 16.1 5.5 4.2 0.5 0.8 0.1 7.9 3.5 7.5 6.7 0.2 0.6 1.0 23.8 6.6 9.0 12.4 0.8 6.0 5.1 2.0 14.3 11.5 0.2 13.3 12.5 0.2 0.2 1.0 7.7 5.8 0.5 1.6 14.5 7.2 8.6 5.2 6.0 3.7 0.1 0.0 0.0 0.0 8.6 2.4 13.3 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 6.6 12.5 0.0 0.5 0.0 0.0 11.8 0.0 16.2 0.0 0.0 0.2 0.0 0.0 2.3 0.1 0.0 0.0 0.0 21.3 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 7.9 0.0 0.0 0.9 20.5 0.1 0.0 0.0 1.9 2.9 6.3 8.2 0.0 0.1 13.9 0.0 1.5 9.0 0.2 0.1 0.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 4.5 3.5 5.9 4.2 0.1 3.7 8.6 5.1 0.0 0.0 0.0 0.0 0.3 2.4 0.6 0.7 1.5 3.6 0.8 0.1 0.2 0.6 0.8 0.5 11.9 9.1 0.5 10.7 0.0 0.4 0.3 12.7 9.4 4.5 14.0 0.0 28.2 21.6 24.5 0.3 0.1 17.1 0.0 20.6 20.1 0.8 11.8 0.0 2.9 2.4 0.0 7.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 14.1 1.0 18.2 22.9 0.0 7.3 2.1 0.0 0.2 5.8 7.0 0.0 24.8 1.5 17.2 16.2 KDM4A "JHDM3A, JMJD2, JMJD2A, KIAA0677, TDRD14A" ENSG00000066135 "Lysine demethylase 4A" O75164 1 43650158-43705515 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA007610 Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA007610: AB_1852006" "unprognostic (7.01e-2)" "unprognostic (1.50e-1)" "unprognostic (3.22e-2)" "unprognostic (6.18e-2)" "unprognostic (3.54e-2)" "unprognostic (5.40e-3)" "prognostic unfavorable (1.39e-5)" "unprognostic (4.88e-3)" "unprognostic (1.13e-1)" "unprognostic (5.47e-1)" "unprognostic (2.70e-1)" "unprognostic (7.95e-2)" "unprognostic (2.81e-1)" "unprognostic (2.32e-3)" "unprognostic (2.02e-1)" "unprognostic (1.92e-1)" "unprognostic (1.28e-1)" 12.8 29.5 12.7 15.4 19.7 11.2 14.5 23.4 22.3 17.5 18.8 20.7 17.6 29.0 18.2 14.6 19.1 19.7 15.4 10.7 11.9 11.5 13.9 18.5 15.3 14.8 14.8 16.3 22.1 15.1 22.3 22.4 13.8 19.1 15.3 20.0 21.6 17.9 12.9 13.2 23.4 23.3 16.1 13.8 18.6 15.2 6.9 14.1 29.7 18.5 11.3 22.3 17.2 15.5 6.7 5.9 12.8 7.2 6.2 7.7 4.6 10.6 9.9 16.0 28.4 15.8 15.0 11.4 10.1 11.6 15.5 15.4 11.3 9.6 14.0 10.5 10.1 11.8 11.2 19.8 12.0 16.1 9.8 16.3 19.8 14.9 9.1 15.1 14.2 16.0 16.3 19.5 15.2 19.2 11.9 16.1 12.2 9.8 20.1 11.2 8.4 11.1 12.1 26.7 9.2 10.0 14.9 18.8 9.9 11.0 21.4 14.4 13.0 22.1 15.3 27.8 24.9 8.9 48.2 12.3 9.3 15.0 8.3 13.7 9.2 11.0 12.6 9.7 12.0 17.5 11.1 6.8 12.8 6.9 5.6 7.7 6.7 6.7 5.6 5.9 5.1 4.6 4.0 4.5 6.2 7.2 5.3 7.1 4.6 12.7 19.7 23.4 22.3 11.9 11.5 14.8 16.3 19.1 14.1 8.9 21.1 2.2 4.2 8.1 20.8 6.8 7.6 26.8 4.5 1.8 35.3 7.1 5.0 7.9 9.2 7.1 13.8 0.0 5.9 4.7 8.3 4.8 12.7 8.6 7.5 30.2 11.5 9.8 6.4 4.4 11.5 7.7 1.7 10.0 19.3 10.6 8.9 10.5 13.8 5.7 23.4 6.5 6.2 0.7 1.0 4.1 6.8 5.7 14.0 5.0 KDM6A UTX ENSG00000147050 "Lysine demethylase 6A" O15550 X 44873177-45112602 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000568, HPA001165, HPA002111" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704" "unprognostic (1.73e-3)" "unprognostic (6.86e-3)" "unprognostic (1.45e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.65e-2)" "unprognostic (2.58e-3)" "unprognostic (8.22e-3)" "unprognostic (3.23e-1)" "unprognostic (2.44e-1)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-1)" "unprognostic (2.24e-2)" "unprognostic (5.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.16e-2)" 12.3 12.1 16.5 17.6 24.5 47.9 21.4 26.1 22.0 16.9 11.8 16.7 12.0 13.1 22.6 11.3 15.4 16.9 15.2 9.1 18.2 6.5 11.6 13.5 19.7 15.1 28.8 11.3 23.8 14.9 21.3 20.2 13.3 18.3 10.3 11.3 10.3 16.1 12.6 15.1 21.3 17.6 13.5 14.9 18.1 15.0 17.7 26.1 19.1 14.5 6.9 13.6 14.9 22.8 5.5 7.1 15.7 7.5 6.2 7.9 3.5 8.7 7.6 11.3 11.4 8.1 8.4 24.2 6.8 4.8 8.2 8.6 17.9 7.5 5.7 3.7 6.3 17.0 18.8 14.5 12.0 7.6 8.3 15.5 7.1 9.6 6.7 5.7 3.8 20.2 4.5 9.9 13.5 14.1 8.8 6.3 7.0 9.8 14.2 5.1 5.7 7.8 11.2 9.4 6.7 8.8 8.7 10.9 1.0 4.7 16.3 9.7 5.2 21.7 10.9 9.2 24.8 10.6 0.1 5.3 7.8 6.0 7.8 3.5 9.0 10.8 8.6 5.4 4.0 4.5 15.7 3.8 3.5 5.3 7.5 6.0 5.5 7.2 7.9 7.1 3.8 7.0 6.3 7.3 6.2 7.2 3.8 5.6 3.5 16.5 24.5 26.1 22.0 18.2 6.5 28.8 11.3 18.3 26.1 6.0 8.8 5.2 11.3 23.2 6.5 11.4 10.2 5.3 7.9 7.0 13.7 3.8 0.0 6.5 1.0 9.4 18.8 0.0 6.6 4.9 8.9 11.4 2.3 13.9 6.1 23.8 12.6 6.2 8.9 1.1 6.1 9.7 10.1 7.2 14.2 7.4 7.7 14.4 6.7 3.3 8.4 6.5 10.3 5.6 11.7 23.1 9.2 10.1 11.0 16.3 KEAP1 "INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454" ENSG00000079999 "Kelch like ECH associated protein 1" Q14145 19 10486120-10503741 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005558, CAB025337" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Centriolar satellite" Cytosol "CAB025337: , HPA005558: AB_1079175" "unprognostic (1.98e-1)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-2)" "unprognostic (2.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (5.22e-3)" "unprognostic (2.04e-1)" "unprognostic (9.99e-2)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.06e-1)" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" 16.0 13.7 13.5 10.4 14.3 9.1 12.4 13.2 15.1 13.1 15.7 15.4 13.8 13.6 11.0 12.7 26.3 15.1 12.7 19.7 13.9 13.7 13.2 22.0 10.8 15.5 16.7 7.4 11.8 14.3 11.1 10.2 11.5 14.3 13.9 8.8 11.8 11.3 13.9 63.9 16.8 13.8 11.6 16.5 11.3 10.6 12.2 13.8 13.1 14.5 29.1 16.1 14.5 11.2 14.6 23.7 21.3 19.8 21.0 30.8 19.6 17.3 31.8 8.8 11.7 18.2 15.5 9.4 14.8 11.0 15.2 13.6 22.6 17.5 24.7 39.0 16.4 11.3 15.6 17.5 11.5 7.5 23.9 19.2 37.3 9.5 26.7 17.6 19.5 20.3 16.0 15.6 17.1 8.0 12.7 14.4 7.4 22.8 45.8 13.2 24.0 14.1 53.6 25.7 16.6 26.8 25.7 11.0 28.9 9.8 20.8 24.3 12.7 20.6 13.8 12.8 8.1 11.9 26.1 17.7 24.5 13.2 27.4 17.9 26.7 33.4 24.2 18.9 23.3 17.9 16.1 19.8 21.3 30.8 17.0 29.3 14.6 21.5 28.3 23.7 5.7 13.5 19.1 10.9 21.0 16.6 16.3 25.4 19.6 13.5 14.3 13.2 12.8 13.9 13.7 16.7 7.4 14.3 13.8 26.8 17.3 19.6 22.6 19.5 21.5 20.3 20.4 13.4 17.0 10.4 7.9 22.5 11.6 29.0 22.3 24.1 31.5 0.0 31.3 21.0 19.7 21.7 11.5 28.8 25.7 25.4 25.8 27.0 14.8 34.6 27.0 14.9 10.1 57.7 20.6 39.6 26.7 21.0 24.4 19.1 11.1 12.9 15.6 19.5 17.3 19.3 22.4 22.4 27.9 21.7 KIAA1468 "FLJ33841, HsT3308, HsT885" ENSG00000134444 KIAA1468 Q9P260 18 62187255-62310217 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039708, HPA040038" Approved Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Centriolar satellite, Cytosol" "HPA039708: AB_10794753, HPA040038: AB_10793860" "unprognostic (1.33e-1)" "unprognostic (2.22e-1)" "unprognostic (3.98e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (4.03e-2)" "unprognostic (1.98e-3)" "unprognostic (2.44e-2)" "unprognostic (6.30e-2)" "unprognostic (3.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.36e-1)" "unprognostic (4.84e-3)" "unprognostic (2.47e-2)" "unprognostic (6.86e-2)" "unprognostic (3.54e-1)" "unprognostic (1.71e-2)" 11.7 13.3 14.8 15.7 31.6 18.3 17.8 25.7 25.9 14.3 16.5 14.3 16.6 13.8 13.9 18.3 36.5 11.8 13.9 10.3 12.5 14.4 14.8 11.5 11.8 15.8 13.7 16.0 12.8 12.6 20.2 20.0 11.9 22.8 18.5 21.7 13.5 18.8 14.1 11.8 29.6 15.5 11.1 11.4 17.1 18.0 8.0 16.8 18.3 14.4 16.6 22.0 15.5 21.7 3.7 3.5 6.0 3.5 4.0 4.7 1.9 7.7 7.1 8.7 8.3 9.3 11.0 9.3 14.0 11.7 12.6 14.0 3.7 7.3 5.4 7.3 12.3 8.3 16.3 12.4 8.4 15.5 4.9 7.7 4.5 8.0 8.3 8.3 8.6 6.3 8.0 10.3 10.7 6.6 10.4 8.6 5.2 3.4 5.5 13.2 4.5 5.3 7.4 5.1 5.3 6.1 6.6 11.0 6.3 14.4 15.7 12.4 6.6 8.4 12.4 7.2 11.8 6.4 9.4 10.9 13.5 4.2 5.9 6.9 16.1 3.0 5.3 9.5 9.3 10.7 5.0 3.5 4.1 4.1 3.0 3.3 3.0 3.8 3.9 3.5 3.7 4.1 4.7 6.0 4.0 2.5 2.4 4.4 1.9 14.8 31.6 25.7 25.9 12.5 14.4 13.7 16.0 22.8 16.8 14.9 16.3 7.5 6.2 7.6 23.5 8.1 5.1 8.1 14.8 0.0 9.8 5.5 0.0 5.8 0.4 8.3 12.9 23.3 7.4 3.4 5.4 9.4 7.0 7.8 6.3 20.6 12.1 7.4 15.3 0.0 6.9 14.5 10.1 7.2 16.0 5.2 7.1 5.8 7.4 5.0 13.9 6.5 4.7 9.9 4.9 18.7 5.5 9.5 14.3 9.7 KIAA1522 ENSG00000162522 KIAA1522 Q9P206 1 32741885-32774970 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 90.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.4;hTCEpi: 32.0;RT4: 35.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA032050, HPA032051, HPA064839" Approved Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366" "unprognostic (7.98e-2)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.29e-7)" "unprognostic (1.58e-1)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "prognostic unfavorable (8.25e-5)" "unprognostic (4.55e-2)" "prognostic favorable (1.29e-5)" "unprognostic (1.35e-2)" "unprognostic (1.35e-1)" "unprognostic (3.98e-1)" "unprognostic (2.12e-1)" 3.7 39.4 12.1 8.6 8.7 0.7 14.1 1.6 15.8 8.7 25.9 2.7 27.8 28.1 5.4 8.7 33.8 13.5 28.8 2.3 6.4 4.5 23.1 5.9 13.4 0.8 2.4 6.6 18.0 32.8 21.7 4.8 19.3 7.3 18.5 17.4 10.0 36.9 44.6 1.8 33.4 36.0 6.8 1.6 1.1 25.5 2.9 3.0 3.1 19.2 17.9 20.3 15.0 22.3 0.0 2.1 0.0 1.0 0.0 0.4 0.2 19.4 10.2 1.6 2.8 0.7 1.5 7.6 2.4 4.7 2.8 2.7 11.1 38.4 0.0 10.1 3.5 8.2 29.0 3.1 20.6 1.4 0.0 4.1 4.0 14.5 9.0 1.2 0.0 10.4 0.5 32.0 7.3 8.8 12.5 5.7 0.8 5.8 0.1 1.3 16.1 0.1 0.1 3.4 16.8 6.4 2.6 2.1 4.9 26.5 35.5 1.4 1.4 15.0 21.6 2.9 10.9 23.0 1.3 5.3 4.6 12.6 4.2 5.1 0.2 0.1 0.1 4.7 0.7 5.3 0.0 0.6 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 12.1 8.7 1.6 15.8 6.4 4.5 2.4 6.6 7.3 3.0 11.9 49.9 0.5 31.7 65.7 0.5 3.3 76.5 20.1 23.9 26.2 2.0 12.1 8.3 38.3 3.6 6.7 90.1 0.0 57.6 3.7 5.6 56.0 26.6 8.6 2.5 0.0 27.9 1.3 0.3 3.6 8.1 2.5 6.8 3.6 55.5 0.8 52.7 49.1 4.6 12.5 0.0 6.5 5.0 1.8 2.5 72.6 6.6 1.9 54.5 60.9 KIAA2026 FLJ20375 ENSG00000183354 KIAA2026 Q5HYC2 9 5881596-6007901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 22.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002109 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No "Vesicles, Cytosol" Nucleoplasm "HPA002109: AB_1078071" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (8.74e-2)" "unprognostic (6.86e-2)" "unprognostic (9.19e-2)" "unprognostic (8.41e-3)" "unprognostic (6.49e-2)" "unprognostic (1.52e-1)" "prognostic favorable (8.34e-4)" "unprognostic (2.41e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" 7.0 6.3 10.3 13.7 11.1 6.6 6.7 21.4 12.4 10.2 7.5 8.6 5.7 5.5 9.7 7.0 7.2 6.7 7.4 6.2 11.7 9.0 7.5 5.4 6.4 7.0 16.7 7.1 13.0 6.0 13.9 14.5 8.1 9.9 8.0 5.9 5.9 12.8 15.6 15.3 9.4 6.7 7.7 11.2 9.1 7.8 13.3 12.9 11.0 10.3 3.7 7.5 8.0 17.8 7.0 4.1 9.4 5.9 7.0 7.5 1.2 5.9 2.9 6.0 3.9 4.6 7.4 2.9 4.1 5.7 3.7 3.5 1.9 3.3 7.5 1.5 4.9 4.6 3.0 3.5 3.1 5.6 17.2 2.9 22.4 6.5 2.9 3.6 7.9 10.4 4.5 4.2 3.2 5.4 7.0 5.8 4.7 2.4 13.4 4.7 1.7 4.2 13.6 3.4 3.3 2.5 4.7 3.9 3.8 4.0 3.8 8.3 4.9 3.8 3.3 3.1 4.3 3.4 10.1 6.8 7.1 4.3 3.6 4.4 10.4 8.2 7.5 3.6 3.7 2.0 5.2 3.4 9.4 6.4 2.6 7.3 7.0 6.2 5.7 1.3 6.1 6.8 7.5 8.8 7.0 5.9 4.1 3.6 1.2 10.3 11.1 21.4 12.4 11.7 9.0 16.7 7.1 9.9 12.9 41.7 31.3 33.5 27.5 39.6 86.1 47.2 25.5 16.0 17.0 36.6 74.6 12.9 6.6 15.8 25.2 35.7 26.7 23.3 11.7 8.8 23.6 29.1 18.6 14.5 14.8 42.9 37.0 29.4 26.4 11.5 65.3 26.1 21.9 29.7 28.8 49.5 15.0 30.8 71.8 8.6 74.2 45.3 32.0 129.1 110.7 45.8 25.1 37.4 25.6 35.9 KIF20A RAB6KIFL ENSG00000112984 "Kinesin family member 20A" O95235 5 138178719-138187715 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.7;testis: 18.2" "Cell type enhanced" "Detected in some" 23 "Erythroid cells: 46.7;Extravillous trophoblasts: 10.5;Spermatocytes: 17.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "NK-cell: 10.0;T-reg: 3.2" "Group enriched" "Detected in many" 64 "NK-cells: 10.0;T-cells: 3.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036909, HPA036910" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Cleavage furrow" Yes Yes "Nucleoplasm, Cleavage furrow" "Cytokinetic bridge" "HPA036909: AB_10670245, HPA036910: AB_10671716" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (1.39e-3)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (2.60e-2)" "prognostic unfavorable (2.14e-12)" "prognostic unfavorable (6.79e-4)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.73e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.05e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-1)" "unprognostic (3.16e-1)" 2.3 1.7 0.3 3.6 0.4 10.4 0.7 0.3 0.7 1.7 2.7 0.4 0.3 2.7 1.6 2.2 10.7 0.3 0.3 0.8 0.3 0.3 1.2 1.2 2.3 6.7 0.6 0.4 0.8 0.5 0.0 0.3 6.6 0.5 1.0 4.2 0.4 2.0 0.3 0.5 3.5 2.7 4.4 0.5 3.8 2.1 18.2 0.3 47.7 0.5 6.1 11.7 1.8 3.0 0.1 0.0 0.0 0.0 10.0 3.2 0.4 22.2 15.0 33.2 22.0 1.7 3.3 14.3 19.3 17.7 42.1 31.8 28.2 20.8 9.6 10.4 24.3 15.8 22.1 31.1 36.1 42.2 14.0 14.7 14.2 26.8 17.9 0.1 6.9 6.6 1.2 0.6 22.4 12.9 7.1 27.2 13.7 5.9 18.4 29.1 20.4 11.6 6.8 21.0 13.1 16.4 12.8 33.3 9.9 11.5 11.0 9.9 9.8 36.5 12.4 8.5 44.5 15.8 7.2 12.9 11.0 16.4 9.9 32.2 9.5 9.1 10.7 7.1 20.5 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 3.2 0.4 0.3 0.4 0.3 0.7 0.3 0.3 0.6 0.4 0.5 0.3 0.0 1.7 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.4 46.7 0.0 10.5 0.4 0.1 4.6 0.0 4.9 0.0 0.0 3.7 1.0 1.0 0.3 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 17.9 4.6 0.4 0.8 0.0 1.6 0.0 KIF23 "KNSL5, MKLP-1, MKLP1" ENSG00000137807 "Kinesin family member 23" Q02241 15 69414246-69448427 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.8;testis: 20.4" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 31.4;Spermatocytes: 47.9;Spermatogonia: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 7.7" "Group enriched" "Detected in many" 12 "granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010414, HPA045208, HPA068831" Uncertain Enhanced "Nucleoplasm,Midbody ring,Mitotic spindle" Yes Yes Nucleoplasm "Midbody ring, Mitotic spindle" "CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045" "unprognostic (1.29e-1)" "unprognostic (2.40e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.86e-1)" "unprognostic (7.99e-3)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.43e-3)" "unprognostic (4.25e-3)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (5.85e-3)" "unprognostic (0.00e+0)" "unprognostic (1.15e-2)" "unprognostic (2.59e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" 1.8 2.6 1.8 12.7 1.3 16.3 3.2 0.3 0.9 2.2 3.3 0.3 1.4 3.5 3.3 1.2 8.8 1.8 2.4 2.2 0.7 0.5 4.9 0.8 2.5 6.7 0.9 0.5 1.6 0.9 0.0 0.3 10.8 1.3 1.9 4.3 0.6 2.1 0.9 0.3 3.0 3.9 3.4 1.4 4.5 3.1 20.4 0.2 41.8 0.6 6.3 8.8 1.8 3.3 0.3 0.1 7.7 2.2 0.1 2.1 0.6 25.2 22.0 16.3 15.6 1.0 1.9 9.9 27.7 15.0 40.2 31.3 13.3 19.8 14.8 8.4 14.3 21.4 29.2 33.6 10.3 40.9 13.7 15.7 13.9 20.6 8.2 0.6 14.3 12.9 0.9 1.1 19.2 16.2 5.1 13.6 12.0 9.2 18.5 25.2 11.1 8.0 7.7 20.2 9.4 8.8 9.1 36.3 8.2 10.6 13.1 8.3 6.9 32.2 14.2 12.1 21.4 13.5 6.5 8.8 24.3 32.4 16.8 40.7 7.2 19.5 13.3 8.6 19.3 21.4 0.0 2.2 7.7 0.0 1.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 1.0 0.1 2.1 0.6 1.8 1.3 0.3 0.9 0.7 0.5 0.9 0.5 1.3 0.2 0.0 0.3 0.0 2.6 1.6 0.2 0.8 7.6 1.4 6.8 7.0 2.0 5.9 3.3 1.8 6.3 0.1 1.1 0.0 0.0 31.4 3.1 0.5 2.3 0.0 6.8 0.0 1.7 6.2 3.2 3.2 0.9 2.9 0.0 10.0 2.2 0.1 0.4 0.0 1.8 0.5 0.0 6.5 2.3 47.9 18.3 0.9 2.1 0.8 2.3 1.0 KIF26A "DKFZP434N178, KIAA1236" ENSG00000066735 "Kinesin family member 26A" Q9ULI4 14 104138723-104180894 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Horizontal cells: 17.5;Intestinal endocrine cells: 7.5;Ito cells: 11.1;Spermatogonia: 7.5" "Group enriched" "Detected in many" 5 "stomach cancer: 3.8;testis cancer: 14.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 17.2;MCF7: 14.6;NTERA-2: 12.8;REH: 11.1;SCLC-21H: 11.9;SH-SY5Y: 24.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046882, HPA060346" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA046882: AB_2679856, HPA060346: AB_2684259" "unprognostic (3.01e-1)" "unprognostic (3.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.77e-2)" "unprognostic (2.79e-1)" "unprognostic (1.12e-1)" "unprognostic (5.49e-3)" "unprognostic (1.69e-1)" "unprognostic (1.21e-2)" "unprognostic (3.31e-3)" "unprognostic (5.24e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (7.78e-4)" "unprognostic (7.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.12e-2)" "unprognostic (4.68e-3)" 12.0 6.8 1.8 4.9 2.1 5.0 15.9 1.3 3.9 8.9 3.3 1.5 4.9 1.7 5.9 3.9 2.1 3.7 4.9 10.1 1.6 2.6 3.4 2.5 8.5 2.5 1.9 2.8 23.5 9.4 1.6 4.4 6.8 2.0 2.5 1.6 6.9 2.5 4.0 9.1 3.9 2.5 2.3 1.0 9.3 2.5 4.1 0.9 1.9 2.3 5.6 0.9 2.6 8.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 2.4 0.0 0.0 4.1 0.2 0.0 0.0 0.0 1.9 0.0 0.0 3.3 0.0 0.4 1.5 1.9 0.0 0.0 0.0 3.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 14.6 0.0 0.0 12.8 0.1 1.2 11.1 4.9 1.2 0.0 0.0 11.9 24.3 2.6 0.4 0.0 1.6 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 1.3 3.5 1.6 2.6 1.9 2.8 2.0 0.9 0.0 0.0 0.0 0.0 1.0 1.2 2.2 0.0 0.0 0.0 1.8 0.0 0.8 1.7 0.8 0.2 5.4 0.0 0.0 0.2 0.8 3.1 0.1 0.0 0.0 1.9 17.5 7.5 11.1 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.2 0.1 7.5 1.5 0.3 0.0 3.3 0.0 KIF2A "HK2, KIF2" ENSG00000068796 "Kinesin family member 2A" O00139 5 62306162-62537249 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Motor protein" "Cancer-related genes, Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004715, HPA004716" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome Yes No 2100000 "Nucleoplasm, Nucleoli, Centrosome" "HPA004715: AB_2667215, HPA004716: AB_1079211" "unprognostic (2.40e-2)" "unprognostic (3.43e-1)" "prognostic favorable (1.70e-4)" "unprognostic (2.74e-2)" "unprognostic (1.43e-1)" "prognostic favorable (5.45e-4)" "prognostic unfavorable (3.17e-6)" "unprognostic (8.77e-3)" "unprognostic (4.69e-2)" "unprognostic (9.10e-2)" "unprognostic (1.85e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (3.81e-5)" "unprognostic (3.53e-2)" "unprognostic (2.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" 11.3 9.3 25.4 21.9 26.4 12.4 15.5 15.4 40.1 19.7 13.5 19.4 8.0 10.3 12.9 7.6 14.3 17.5 13.7 7.2 26.2 24.1 8.2 5.8 10.6 29.4 24.9 24.6 13.0 12.3 15.2 14.3 27.8 37.0 10.2 14.5 6.8 10.7 11.9 7.4 7.9 15.8 13.5 34.3 17.4 9.6 39.2 26.4 28.7 13.0 5.6 26.7 17.4 14.8 9.0 8.4 7.1 3.0 15.8 25.4 9.7 17.3 17.4 29.1 25.8 11.0 15.5 23.8 18.6 15.4 20.3 25.8 18.7 19.1 43.1 20.6 16.4 24.0 11.0 22.0 14.9 27.1 43.2 15.4 43.2 16.3 10.2 13.0 23.5 16.5 12.8 9.9 19.7 17.9 11.9 18.5 24.9 30.6 26.3 16.9 13.1 39.4 11.7 16.9 4.2 11.0 29.0 23.0 23.8 9.1 21.1 26.1 21.7 25.3 10.6 13.1 22.5 13.9 13.3 16.0 12.1 20.0 14.0 18.5 24.9 35.9 45.5 14.0 28.4 14.8 7.1 3.0 3.4 20.2 2.6 22.8 9.0 20.3 20.6 4.0 7.8 17.9 18.4 5.3 15.8 1.8 8.4 25.4 9.7 25.4 26.4 15.4 31.2 26.2 24.1 24.9 24.6 37.0 26.4 14.9 13.1 22.3 22.3 14.9 41.8 7.0 7.6 71.0 25.0 19.2 98.2 16.2 11.6 30.0 88.3 17.5 11.4 0.0 27.0 18.7 10.4 29.9 16.3 3.4 13.1 49.3 20.2 14.7 10.2 90.3 12.0 18.7 11.8 152.3 5.1 22.4 23.3 7.4 12.4 13.5 88.2 25.8 13.3 80.2 42.1 8.3 36.7 39.6 9.5 40.0 KIF2C "CT139, KNSL6, MCAK" ENSG00000142945 "Kinesin family member 2C" Q99661 1 44739818-44767767 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.9;testis: 61.4" "Group enriched" "Detected in many" 18 "Early spermatids: 430.2;Late spermatids: 1559.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA006219, HPA079172" Enhanced Supported Nucleoplasm,Midbody,Centrosome Yes Yes "Nucleoplasm, Centrosome" Midbody "HPA006219: AB_2667540, HPA079172: " "unprognostic (3.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.77e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.07e-7)" "unprognostic (7.49e-3)" "unprognostic (3.33e-3)" "unprognostic (3.66e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (4.27e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.33e-3)" "unprognostic (1.49e-1)" "unprognostic (1.86e-2)" "unprognostic (2.41e-1)" 1.1 0.7 0.4 8.7 0.4 12.7 0.8 0.5 0.5 1.2 2.4 0.4 0.2 2.1 1.3 1.4 4.6 0.6 0.7 0.9 0.6 0.5 0.7 0.6 1.6 6.7 0.4 0.2 0.7 0.4 0.3 0.6 2.2 0.6 0.6 3.2 0.4 1.1 0.2 0.4 2.3 2.2 1.1 0.4 3.3 1.4 61.4 0.2 39.9 0.8 4.7 12.0 0.9 1.7 1.3 1.5 0.0 0.2 3.9 5.8 1.0 29.0 11.3 25.3 20.2 1.4 2.9 17.0 21.8 15.6 44.7 39.0 19.1 21.1 33.5 10.5 10.7 30.9 13.9 25.7 14.7 40.9 21.6 11.1 39.6 20.0 15.9 0.1 29.2 18.4 0.7 1.4 31.8 15.6 4.1 14.4 23.8 31.2 28.8 28.2 11.3 30.7 17.7 24.7 14.3 14.2 24.7 38.2 21.0 7.5 10.6 17.4 12.4 29.0 20.7 18.3 19.1 11.9 22.2 8.5 16.2 32.3 17.6 38.2 15.2 15.5 48.3 10.4 28.5 31.2 0.0 0.0 0.0 1.9 0.0 0.1 1.3 3.4 2.6 0.3 0.2 0.7 0.5 0.0 3.9 0.2 1.5 5.8 1.0 0.4 0.4 0.5 0.5 0.6 0.5 0.4 0.2 0.6 0.2 0.0 0.3 0.8 0.5 1.5 1.0 0.8 0.0 0.0 2.3 1.8 2.0 1.1 1.7 0.3 430.2 0.1 0.0 23.3 0.3 20.1 0.7 0.6 0.0 0.0 7.4 0.0 0.0 4.3 1.0 1559.3 8.6 1.3 0.0 7.2 0.9 0.3 0.1 0.0 6.3 0.0 0.2 6.5 0.3 55.1 28.0 0.4 3.1 0.7 1.6 0.4 KIF3A "FLA10, KLP-20" ENSG00000131437 "Kinesin family member 3A" Q9Y496 5 132692628-132737638 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.5" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 131.2;Cone photoreceptor cells: 117.8;Horizontal cells: 174.8;Spermatocytes: 129.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 27.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 27.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037085 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Intermediate filaments, Cytosol" "CAB037085: AB_477147" "unprognostic (8.22e-3)" "unprognostic (2.58e-1)" "unprognostic (2.29e-3)" "unprognostic (3.59e-2)" "unprognostic (2.51e-1)" "unprognostic (3.80e-1)" "unprognostic (8.21e-4)" "unprognostic (1.30e-1)" "unprognostic (4.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" "unprognostic (7.64e-2)" "unprognostic (6.08e-3)" "unprognostic (8.62e-2)" "unprognostic (1.92e-1)" "unprognostic (1.17e-1)" "unprognostic (1.23e-1)" 3.4 9.9 19.6 5.0 21.0 2.5 6.6 23.8 54.5 6.2 3.6 8.1 3.2 3.5 6.5 7.1 4.5 8.7 5.3 7.0 28.0 22.9 7.6 2.5 5.7 4.8 18.7 25.5 6.9 4.0 15.8 18.5 4.3 37.7 6.6 3.8 3.8 3.8 6.6 3.5 5.1 3.0 5.7 15.0 3.8 4.9 23.9 11.1 3.5 6.9 0.1 4.7 5.3 3.5 3.4 0.7 27.1 1.1 2.4 4.3 1.1 7.0 8.8 7.8 14.1 5.2 5.2 6.2 5.9 4.6 5.6 7.9 8.5 5.7 19.3 8.2 6.8 16.8 4.6 6.1 11.7 11.7 5.7 7.1 2.8 4.4 3.2 5.2 3.6 7.6 4.0 6.0 8.1 9.1 7.6 7.0 12.4 2.9 11.2 6.8 5.1 22.7 2.7 3.8 2.6 3.3 6.4 6.2 2.3 5.6 6.0 24.2 7.6 8.9 2.9 8.9 13.2 8.9 1.1 7.3 7.0 12.3 5.1 7.1 8.1 11.8 11.1 8.6 2.9 7.7 27.1 0.4 1.1 3.9 0.8 4.1 3.4 4.0 3.6 0.7 2.1 3.9 4.3 0.3 2.4 1.1 0.7 3.0 1.1 19.6 21.0 23.8 32.3 28.0 22.9 18.7 25.5 37.7 11.1 50.6 33.1 5.4 13.8 12.0 70.6 23.3 7.6 131.2 38.7 36.6 117.8 13.0 24.9 16.7 49.7 8.5 0.9 0.0 11.3 9.8 12.6 8.0 12.8 2.4 5.5 174.8 19.0 9.2 3.3 16.3 15.3 5.0 40.5 6.4 3.4 51.3 11.4 2.3 23.0 7.3 94.7 12.9 10.8 129.4 94.9 13.9 8.2 16.0 1.7 6.0 KIF3B "FLA8, KIAA0359, KLP-11" ENSG00000101350 "Kinesin family member 3B" O15066 20 32277664-32335011 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007119 Approved Uncertain "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA007119: AB_1852498" "unprognostic (1.74e-2)" "unprognostic (2.25e-1)" "unprognostic (5.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.73e-1)" "unprognostic (2.89e-1)" "unprognostic (1.49e-2)" "unprognostic (2.14e-1)" "unprognostic (9.01e-3)" "unprognostic (9.30e-2)" "unprognostic (1.41e-1)" "unprognostic (1.18e-1)" "prognostic favorable (1.44e-12)" "unprognostic (2.41e-2)" "unprognostic (2.68e-1)" "unprognostic (5.11e-2)" "unprognostic (4.42e-2)" 8.4 11.0 22.9 7.7 30.2 5.5 9.1 17.6 24.6 11.6 13.4 13.3 7.7 14.3 8.8 13.5 5.8 15.4 11.0 6.2 19.9 15.1 26.4 17.8 9.3 7.7 15.1 18.7 10.5 16.9 38.5 18.1 6.4 13.2 9.0 14.2 11.8 8.4 8.6 5.3 5.8 17.1 9.0 16.0 6.8 12.7 15.3 13.7 4.3 14.3 4.1 8.4 8.5 6.5 6.5 3.1 3.7 5.9 2.6 6.6 1.8 22.9 15.6 10.9 13.9 14.5 23.1 11.1 11.4 16.0 13.9 10.9 26.5 12.7 12.4 13.8 21.5 19.8 14.9 13.9 16.9 17.7 5.8 6.3 10.7 12.5 13.0 9.2 9.0 8.2 14.1 12.2 23.9 9.5 11.4 11.2 5.0 6.6 4.9 11.1 10.5 4.1 4.1 5.8 12.3 13.7 3.8 17.9 4.5 14.2 17.0 17.9 15.1 29.8 8.0 11.4 9.5 17.6 7.0 13.6 26.1 17.8 15.1 14.1 8.3 11.9 6.4 25.9 15.8 10.5 1.3 3.1 3.7 6.6 4.2 5.5 6.1 5.0 6.1 1.7 6.5 3.1 4.6 3.2 2.6 5.9 3.1 3.9 1.8 22.9 30.2 17.6 24.6 19.9 15.1 15.1 18.7 13.2 13.7 20.8 25.5 9.3 7.3 6.0 31.6 7.0 35.7 53.5 14.8 12.2 100.1 6.5 3.3 29.6 52.5 12.5 61.3 0.0 33.7 5.2 11.0 13.5 8.1 20.4 7.0 30.2 37.8 13.5 7.3 61.7 12.4 5.9 0.0 4.6 25.9 20.6 28.0 33.1 19.1 19.9 58.5 0.0 6.2 30.1 6.9 4.4 5.5 8.6 21.8 7.8 KIF5A "D12S1889, MY050, NKHC, SPG10" ENSG00000155980 "Kinesin family member 5A" Q12840 12 57549998-57586632 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 138.6" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 36.9;Horizontal cells: 25.4;Late spermatids: 11.4;Spermatogonia: 9.3" "Cancer enriched" "Detected in some" 5 "glioma: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "HDLM-2: 20.4;K-562: 8.6;NTERA-2: 10.6;SCLC-21H: 21.8;U-87 MG: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004469, HPA073448" Enhanced Approved "Nucleoplasm,Mitotic spindle,Cytosol" Yes No "Nucleoplasm, Cytosol" "Mitotic spindle" "HPA004469: AB_1079212, HPA073448: AB_2686601" "unprognostic (7.94e-2)" "unprognostic (4.95e-3)" "unprognostic (3.87e-1)" "unprognostic (3.34e-3)" "unprognostic (7.12e-2)" "unprognostic (4.22e-2)" "unprognostic (3.22e-5)" "unprognostic (2.82e-1)" "unprognostic (2.01e-1)" "unprognostic (1.52e-2)" "prognostic favorable (5.23e-4)" "unprognostic (7.61e-2)" "unprognostic (2.26e-4)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" 1.8 7.6 85.4 3.0 47.6 1.9 1.9 15.2 138.6 2.1 2.8 4.0 0.0 2.4 3.4 2.1 1.9 2.0 1.9 1.7 52.4 18.3 2.0 1.7 1.8 1.8 12.9 43.6 1.8 2.3 6.0 2.5 1.7 21.6 1.9 2.8 0.6 2.0 2.0 1.7 1.7 3.0 2.8 9.0 1.8 2.1 4.4 12.9 0.0 2.8 0.0 1.8 1.8 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.8 3.3 0.0 0.0 0.1 0.2 0.7 1.3 1.7 0.0 0.0 1.6 0.0 0.7 0.6 0.1 2.0 0.0 1.0 20.4 1.5 0.1 0.1 1.6 0.6 0.0 0.1 0.2 0.1 1.0 0.0 0.0 0.2 1.8 8.6 4.5 0.0 0.0 0.3 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 21.8 4.9 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.0 2.4 0.0 0.9 2.9 3.5 0.3 8.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.4 0.8 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.3 0.0 85.4 47.6 15.2 112.0 52.4 18.3 12.9 43.6 21.6 12.9 0.0 0.0 0.0 0.1 0.0 36.9 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 25.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 5.8 0.2 0.0 0.4 0.0 8.7 0.0 0.9 2.3 9.3 0.1 0.0 0.0 0.0 0.0 KLC1 "hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A" ENSG00000126214 "Kinesin light chain 1" Q07866 14 103561896-103714249 "Predicted intracellular proteins" "Host-virus interaction" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 117.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB009798, HPA044617, HPA052450" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (6.93e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (7.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-3)" "unprognostic (2.67e-2)" "unprognostic (9.21e-2)" "unprognostic (5.62e-2)" "prognostic favorable (6.75e-4)" "unprognostic (6.84e-3)" "prognostic unfavorable (7.17e-4)" "unprognostic (6.58e-2)" "unprognostic (8.69e-2)" "unprognostic (4.05e-1)" "unprognostic (1.49e-1)" 19.5 20.4 61.3 15.7 45.6 17.6 16.6 103.0 117.9 15.2 14.8 22.4 11.5 10.5 21.1 18.7 19.7 16.0 15.7 27.1 61.0 65.1 8.6 8.9 20.0 15.9 66.2 47.9 19.8 14.8 25.2 17.0 17.9 50.7 16.3 14.1 14.1 16.9 19.7 28.2 22.4 12.8 23.1 56.0 18.3 13.8 14.3 23.2 7.9 13.8 13.0 18.1 15.7 14.9 7.3 10.4 12.4 8.6 4.1 10.9 3.1 16.4 22.1 42.7 23.3 28.9 31.6 19.7 38.8 31.9 36.5 24.9 18.9 18.0 21.8 20.2 41.8 16.2 27.5 26.0 20.5 34.6 26.3 13.1 12.2 26.1 19.1 32.9 23.9 24.3 22.9 33.3 27.5 33.5 38.9 31.3 15.5 18.2 25.1 31.7 27.7 16.0 21.1 13.7 26.3 40.9 15.4 18.0 10.7 22.7 36.5 50.4 28.2 31.5 16.0 25.6 27.6 14.1 11.8 45.5 27.1 13.4 37.1 21.5 20.1 14.0 24.2 31.0 13.8 29.0 7.6 5.8 12.4 10.3 6.0 9.5 6.4 9.3 10.9 6.8 7.3 7.9 7.2 7.0 4.1 8.6 10.4 8.4 3.1 61.3 45.6 103.0 90.3 61.0 65.1 66.2 47.9 50.7 23.2 41.7 27.5 24.9 39.0 23.1 133.1 34.0 22.9 16.0 14.8 19.2 49.1 19.5 8.3 42.1 4.2 42.8 13.0 0.0 26.7 27.4 32.1 34.5 32.4 15.6 26.3 130.3 43.0 31.9 18.1 11.4 35.6 24.1 37.1 46.9 20.2 42.5 49.1 14.4 45.3 3.4 89.3 25.8 40.6 36.8 78.0 15.4 35.2 28.9 14.7 31.8 KLC3 "KLC2L, KLCt, KNS2B" ENSG00000104892 "Kinesin light chain 3" Q6P597 19 45333434-45351520 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 39.5;tongue: 25.3" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 126.0;Ductal cells: 38.6;Suprabasal keratinocytes: 160.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 25.8;HaCaT: 12.0;HBEC3-KT: 7.7;hTCEpi: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052797, HPA056508" Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Actin filaments" "Nucleoplasm, Cytosol" "HPA052797: AB_2681954, HPA056508: AB_2683159" "unprognostic (4.11e-2)" "unprognostic (3.71e-1)" "unprognostic (3.07e-4)" "prognostic unfavorable (1.46e-4)" "unprognostic (3.47e-3)" "unprognostic (1.13e-1)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.53e-1)" "unprognostic (1.75e-2)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (4.79e-3)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (4.14e-1)" "unprognostic (2.37e-1)" 0.1 0.2 0.0 0.2 1.2 1.9 1.9 0.0 0.5 4.0 0.1 0.0 0.0 0.1 0.6 2.9 10.6 0.1 0.2 0.1 0.2 0.0 1.9 0.1 0.7 0.2 0.0 0.0 0.3 4.5 1.5 1.1 0.9 0.5 1.7 0.2 4.0 7.8 2.2 0.6 39.5 0.3 0.0 0.0 0.2 0.2 2.8 0.2 0.3 1.1 25.3 9.2 0.2 7.9 1.5 1.0 3.3 0.9 1.0 1.3 0.6 25.8 0.2 0.1 0.3 0.1 0.1 2.1 0.2 0.0 0.0 0.1 2.6 4.8 0.2 2.1 0.0 2.8 12.0 1.7 7.7 0.1 0.6 3.9 0.1 0.7 0.5 0.0 0.2 1.7 0.0 9.8 0.1 1.9 0.3 0.0 0.4 0.4 0.3 0.1 3.4 0.1 0.4 0.6 0.4 0.8 4.0 0.0 0.2 0.2 0.9 3.4 0.6 0.2 5.5 0.7 0.3 4.8 0.1 0.0 0.3 2.8 0.2 0.3 0.6 0.5 0.2 0.1 0.1 0.3 3.3 0.7 0.6 0.8 0.5 0.7 0.9 1.0 0.9 0.3 1.5 1.0 1.3 2.6 1.0 0.9 1.0 0.8 0.6 0.0 1.2 0.0 0.5 0.2 0.0 0.0 0.0 0.5 0.2 0.0 3.7 0.0 35.4 126.0 0.9 0.4 2.5 2.7 2.3 1.8 0.0 0.2 8.3 38.6 3.0 0.0 0.0 0.0 2.6 0.4 1.2 9.3 0.0 0.0 0.3 1.6 0.0 0.6 0.0 8.5 1.7 1.4 13.5 1.0 0.0 0.8 11.5 0.0 0.4 1.4 1.9 0.0 4.1 0.5 8.3 160.2 0.6 0.0 0.0 19.7 KLF15 KKLF ENSG00000163884 "Kruppel like factor 15" Q9UIH9 3 126342635-126357442 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 25.6;Distal tubular cells: 24.9;Erythroid cells: 23.3;Hepatocytes: 54.2;Peritubular cells: 18.7;Proximal tubular cells: 19.2" "Cancer enhanced" "Detected in many" "liver cancer: 30.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 33.4;HHSteC: 20.3;RPMI-8226: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003286, HPA028866" Uncertain Supported "Nucleoplasm,Nuclear speckles,Vesicles" NA NA "Nucleoplasm, Nuclear speckles" Vesicles "HPA003286: , HPA028866: AB_10600819" "unprognostic (3.77e-3)" "unprognostic (1.08e-1)" "unprognostic (1.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.72e-3)" "unprognostic (2.11e-1)" "unprognostic (4.63e-2)" "unprognostic (1.09e-2)" "unprognostic (2.91e-1)" "unprognostic (1.32e-1)" "unprognostic (3.58e-2)" "unprognostic (1.10e-1)" "prognostic favorable (3.27e-7)" "unprognostic (6.75e-2)" "unprognostic (7.65e-2)" "unprognostic (1.91e-2)" "unprognostic (5.58e-3)" 35.0 7.7 11.8 2.3 19.8 1.5 13.8 10.0 14.2 6.1 6.2 11.6 4.4 2.8 7.4 6.0 7.3 10.4 5.1 16.9 15.7 6.0 20.1 32.5 7.1 2.9 24.8 7.0 40.6 46.3 3.2 6.1 3.2 14.6 9.3 2.4 7.0 23.1 7.5 41.0 3.7 3.6 5.8 10.5 4.0 11.1 4.7 22.3 0.0 8.6 4.5 2.3 11.9 22.0 12.2 9.4 18.6 10.4 13.9 12.0 9.1 0.4 0.0 1.2 5.2 33.4 0.6 5.7 0.3 0.8 0.4 0.7 0.6 0.0 1.8 0.5 0.0 1.0 0.0 3.0 0.1 0.1 0.1 1.2 0.1 0.4 4.2 20.3 0.0 0.1 3.1 0.2 0.0 0.7 0.0 0.3 2.5 2.3 4.1 0.1 0.4 0.0 0.7 3.7 0.7 0.1 2.6 0.1 10.9 0.1 0.4 0.4 4.4 0.1 0.2 5.4 1.9 0.3 2.5 0.1 0.1 0.2 0.2 0.1 2.7 0.3 0.4 0.1 0.8 0.7 18.6 7.4 10.2 7.7 10.4 9.3 12.2 8.2 8.1 8.4 11.8 10.7 12.0 17.9 13.9 9.1 9.4 10.7 9.1 11.8 19.8 10.0 14.2 15.7 6.0 24.8 7.0 14.6 22.3 6.0 2.9 1.9 2.3 0.0 1.6 25.6 10.2 1.4 1.2 0.0 0.0 0.1 24.9 0.0 0.1 1.1 0.0 23.3 0.0 0.2 0.9 3.9 0.0 54.2 0.1 0.0 0.0 5.5 2.2 0.6 11.2 0.0 1.7 0.0 0.0 11.0 0.6 0.0 18.7 19.2 3.2 0.0 0.9 0.0 0.1 0.0 0.2 0.0 0.0 1.4 KLF5 "BTEB2, CKLF, IKLF" ENSG00000102554 "Kruppel like factor 5" Q13887 13 73054976-73077542 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 88.1" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 1017.1;Suprabasal keratinocytes: 599.6;Urothelial cells: 1225.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 22.2" "Cell type enriched" "Detected in single" 18 "basophil: 16.3" "Lineage enriched" "Detected in single" 106 "granulocytes: 16.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.5;HaCaT: 31.5;HBEC3-KT: 27.5;hTCEpi: 39.3;OE19: 59.4;RT4: 33.2;SiHa: 28.0" "Group enriched" "Detected in many" 4 "amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3" "Low region specificity" "Detected in some" HPA040398 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA040398: AB_10673267" "unprognostic (7.90e-3)" "unprognostic (5.11e-2)" "unprognostic (2.03e-2)" "unprognostic (1.56e-1)" "unprognostic (4.69e-2)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (3.97e-2)" "unprognostic (5.82e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (4.43e-2)" "unprognostic (1.42e-3)" "unprognostic (3.56e-3)" "unprognostic (3.98e-1)" "unprognostic (5.09e-2)" "unprognostic (1.54e-2)" 2.3 1.5 4.1 24.3 22.2 12.9 8.1 0.7 1.2 19.6 74.4 0.4 4.3 28.7 4.8 3.7 88.4 8.3 48.4 1.3 1.4 1.2 3.9 1.2 12.8 0.1 0.9 1.1 5.0 3.5 0.0 7.3 22.8 4.3 17.6 32.9 1.8 26.4 5.4 10.0 59.4 88.1 4.1 2.4 0.8 17.9 12.2 1.4 3.0 20.7 64.4 61.8 23.4 34.1 0.0 0.0 16.3 0.0 0.0 0.1 0.0 5.3 7.4 0.0 0.1 0.2 0.4 8.5 3.1 7.3 1.4 1.7 6.9 27.5 0.1 16.7 2.7 0.5 31.5 9.6 27.5 2.2 0.2 2.5 0.1 15.7 0.6 2.0 2.5 0.4 2.0 39.3 0.4 15.4 1.4 0.0 0.9 0.3 0.5 6.3 1.8 0.5 0.1 0.3 59.4 10.6 0.4 7.0 0.6 21.8 33.2 0.7 0.3 28.0 4.5 1.9 3.6 0.6 0.6 0.0 1.9 5.7 0.0 1.3 0.9 0.4 0.9 2.7 0.5 2.3 16.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 4.1 22.2 0.7 1.2 1.4 1.2 0.9 1.1 4.3 1.4 151.8 97.6 0.5 1017.1 460.9 0.4 5.6 79.0 128.5 151.2 34.9 2.0 57.7 18.3 30.8 305.6 1.1 308.2 0.0 40.2 87.3 46.1 522.9 3.5 2.9 5.4 9.5 195.2 0.6 0.0 162.5 6.1 6.1 55.6 5.4 327.8 0.0 63.9 284.0 1.4 2.6 0.0 0.0 28.8 7.2 25.9 599.6 48.5 0.7 397.9 1225.4 KLF9 BTEB1 ENSG00000119138 "Kruppel like factor 9" Q13886 9 70384597-70414624 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 22.7;ASC TERT1: 31.6;HHSteC: 40.6;HSkMC: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029308 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA029308: AB_10601923" "unprognostic (2.12e-2)" "unprognostic (2.56e-1)" "unprognostic (3.12e-1)" "unprognostic (2.69e-2)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (3.64e-3)" "unprognostic (4.34e-1)" "unprognostic (5.55e-1)" "unprognostic (9.47e-2)" "unprognostic (7.86e-2)" "unprognostic (3.44e-1)" "prognostic favorable (6.59e-6)" "unprognostic (1.43e-3)" "unprognostic (1.75e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" 35.9 15.3 6.8 8.8 25.8 6.1 25.7 42.6 21.4 10.2 20.0 9.7 16.1 6.0 19.6 13.2 17.0 22.2 17.8 18.2 8.4 4.0 26.2 36.7 22.6 5.1 26.3 8.0 22.1 21.3 13.0 8.6 3.9 14.7 12.4 11.0 20.4 31.4 10.7 38.9 12.6 17.6 25.0 12.0 8.6 16.7 5.5 25.2 1.9 24.0 20.3 5.4 15.4 11.9 2.8 1.7 2.8 0.7 0.7 2.8 0.6 0.1 0.2 0.0 2.8 22.7 31.6 0.3 1.4 9.8 0.5 1.1 0.0 1.3 0.0 1.1 2.6 0.7 0.0 4.3 6.6 1.0 0.0 3.4 1.5 4.8 0.8 40.6 0.7 4.0 27.0 6.8 0.4 9.6 13.7 8.7 0.6 2.9 6.0 3.7 0.4 0.1 2.1 0.2 0.4 1.4 0.0 1.3 3.7 1.8 0.0 0.4 1.9 13.4 7.8 15.4 0.9 2.6 2.3 11.8 2.6 1.9 3.0 0.7 4.3 4.6 0.2 2.3 2.3 13.0 2.8 0.5 0.3 1.6 0.3 2.3 2.8 2.1 1.6 1.2 2.5 2.8 1.6 0.0 0.7 0.7 1.7 2.2 0.6 6.8 25.8 42.6 21.4 8.4 4.0 26.3 8.0 14.7 25.2 38.7 21.0 13.2 56.7 42.7 40.6 62.7 48.4 18.7 28.4 14.0 19.6 0.1 26.6 7.4 17.2 139.1 35.5 0.0 11.6 0.2 78.1 86.9 7.0 140.6 3.5 76.3 13.3 97.6 59.8 11.6 84.0 36.1 37.1 4.6 29.3 151.3 10.9 28.5 79.9 29.8 8.8 77.6 214.2 1.0 3.9 29.9 0.0 24.5 27.3 22.8 KLHDC2 "HCLP-1, LCP" ENSG00000165516 "Kelch domain containing 2" Q9Y2U9 14 49767608-49786385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000628 Approved Supported "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA "Nucleoplasm, Nuclear membrane" "Nuclear bodies" "HPA000628: AB_2666051" "unprognostic (2.65e-1)" "unprognostic (8.29e-2)" "unprognostic (1.30e-2)" "unprognostic (9.01e-2)" "unprognostic (2.57e-2)" "unprognostic (5.52e-3)" "unprognostic (4.54e-2)" "unprognostic (9.72e-3)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-3)" "unprognostic (6.77e-3)" "prognostic favorable (2.75e-10)" "unprognostic (2.20e-2)" "unprognostic (2.08e-1)" "unprognostic (1.32e-2)" "unprognostic (9.34e-2)" 17.0 20.2 18.2 9.6 18.0 7.6 20.7 21.0 22.3 15.4 22.0 10.8 16.2 15.9 18.4 14.3 13.6 13.4 15.2 47.1 16.0 14.3 29.7 41.7 12.6 13.1 17.6 16.8 22.9 43.2 16.2 15.5 11.1 17.6 16.9 16.1 18.5 16.2 18.8 40.7 14.9 22.5 20.7 13.5 10.2 20.3 21.7 18.3 15.0 24.8 13.1 9.5 23.9 13.0 13.1 7.0 15.0 7.0 12.5 19.9 8.7 8.5 7.2 13.6 6.6 19.6 17.2 14.3 9.0 17.2 11.4 11.6 4.2 11.7 17.2 12.7 16.1 6.6 7.7 8.3 8.2 9.7 11.8 9.4 5.3 5.4 9.8 14.3 11.3 4.7 17.7 14.2 5.2 10.3 14.1 10.4 14.6 6.8 12.9 9.0 10.1 11.6 4.9 10.0 9.9 21.2 9.2 14.6 10.3 5.2 18.3 16.9 13.4 15.1 28.0 9.8 10.9 10.7 4.3 8.8 10.6 8.4 8.3 4.6 17.7 11.4 10.1 5.9 5.9 5.5 8.8 7.0 15.0 9.2 4.5 11.5 13.0 14.0 14.5 7.0 13.1 19.9 13.3 6.8 12.5 4.4 5.4 13.3 8.7 18.2 18.0 21.0 22.3 16.0 14.3 17.6 16.8 17.6 18.3 38.7 44.9 30.4 46.5 43.5 61.9 8.0 63.7 8.1 29.6 45.4 47.1 79.2 91.2 47.8 50.9 38.7 75.6 0.0 75.6 56.4 54.1 49.6 30.0 84.4 29.0 62.0 54.9 39.9 21.1 13.6 75.4 27.9 37.1 35.1 73.9 61.3 50.5 92.2 72.9 135.2 91.2 64.7 53.4 224.0 88.8 58.1 68.9 41.5 79.2 42.7 KLHL35 FLJ33790 ENSG00000149243 "Kelch like family member 35" Q6PF15 11 75422394-75430629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;testis: 11.2" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 33.0;Early spermatids: 21.7;Late spermatids: 21.4;Spermatogonia: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.4" "Group enriched" "Detected in many" 4 "granulocytes: 5.4;T-cells: 2.1" "Cell line enhanced" "Detected in some" "CACO-2: 14.2;HMC-1: 9.5;PC-3: 8.2;SiHa: 16.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039864, HPA070736" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Centrosome" NA NA "Nucleoplasm, Centrosome" "Nucleoli fibrillar center" "HPA039864: AB_10794204, HPA070736: " "unprognostic (3.53e-2)" "prognostic favorable (4.63e-4)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "unprognostic (6.88e-2)" "unprognostic (4.15e-3)" "unprognostic (4.98e-2)" "unprognostic (3.92e-2)" "unprognostic (6.52e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (4.39e-2)" "unprognostic (8.68e-3)" "unprognostic (1.59e-1)" "unprognostic (1.05e-1)" "unprognostic (3.11e-2)" "unprognostic (1.28e-1)" 1.1 3.4 4.5 0.7 14.1 0.7 3.5 1.8 8.2 3.2 1.0 3.0 0.2 0.7 0.5 1.0 1.0 2.0 1.1 1.1 3.7 6.2 0.6 0.6 2.7 0.7 3.1 3.3 0.5 4.5 0.5 0.8 0.8 6.2 0.7 0.6 0.7 1.3 1.0 0.9 1.2 0.5 1.1 4.3 1.0 2.3 11.2 2.4 0.0 1.4 0.0 0.7 0.7 0.2 0.2 0.8 5.4 0.3 0.0 2.1 1.2 0.0 0.3 0.1 0.0 0.2 1.3 0.0 0.8 0.0 0.8 0.1 14.2 1.2 0.0 4.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.8 3.6 9.5 0.2 0.2 0.0 0.0 0.1 0.4 2.5 0.0 0.0 1.0 0.6 0.3 0.1 0.1 2.8 8.2 0.0 0.0 0.8 0.7 0.1 1.1 0.9 16.7 3.1 0.0 0.0 3.2 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 2.1 0.0 0.5 0.0 1.2 0.7 0.8 0.2 0.3 0.5 0.1 0.0 0.3 0.0 0.0 1.2 4.5 14.1 1.8 7.1 3.7 6.2 3.1 3.3 6.2 2.4 8.9 4.3 0.0 1.5 1.1 33.0 0.8 0.0 2.7 4.5 3.5 7.9 1.3 3.3 1.7 21.7 1.0 0.2 0.0 2.7 1.4 2.5 0.9 4.6 0.0 1.1 1.6 4.1 3.7 0.0 21.4 2.6 2.1 1.7 2.8 1.0 2.0 2.6 0.0 1.1 0.1 11.0 6.5 1.4 7.5 37.1 1.9 2.1 0.0 0.6 0.7 KLHL41 "KBTBD10, Krp1, SARCOSIN" ENSG00000239474 "Kelch like family member 41" O60662 2 169509702-169526262 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "skeletal muscle: 564.4;tongue: 157.3" "Cell type enriched" "Detected in some" 12 "Cardiomyocytes: 97.4" "Group enriched" "Detected in some" 9 "head and neck cancer: 10.8;prostate cancer: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HSkMC: 12.8;LHCN-M2: 20.3;RH-30: 32.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA021165, HPA021753, HPA021760" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091" "unprognostic (2.44e-2)" "unprognostic (6.12e-2)" "unprognostic (9.01e-2)" "unprognostic (2.94e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" "unprognostic (2.05e-1)" "unprognostic (5.46e-3)" "unprognostic (1.88e-1)" "unprognostic (5.38e-2)" "unprognostic (6.65e-4)" "unprognostic (9.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-2)" "unprognostic (1.52e-1)" 12.0 0.1 0.2 0.1 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.1 0.1 17.8 9.8 0.2 0.6 10.2 0.2 0.3 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.5 0.1 0.0 3.9 0.1 0.0 6.6 0.1 564.4 0.2 0.1 2.3 0.2 0.1 0.2 0.5 0.0 0.0 2.0 157.3 5.0 2.1 0.1 0.2 0.5 0.0 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.2 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.0 12.8 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 2.2 97.4 0.0 4.0 3.4 0.0 7.9 0.0 0.0 0.4 3.7 0.0 0.0 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.2 0.0 1.2 0.6 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.7 0.7 0.0 1.1 0.2 5.7 0.0 0.6 3.3 0.5 0.0 0.0 0.0 0.0 0.0 KLHL7 "KLHL6, RP42, SBBI26" ENSG00000122550 "Kelch like family member 7" Q8IXQ5 7 23105758-23177914 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 452.0;Late spermatids: 236.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029491, HPA029492" Uncertain Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029491: AB_10599605, HPA029492: AB_10600881" "unprognostic (1.24e-2)" "unprognostic (4.45e-1)" "unprognostic (1.77e-1)" "unprognostic (4.55e-2)" "unprognostic (1.29e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (3.78e-1)" "unprognostic (6.10e-2)" "unprognostic (6.41e-3)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "prognostic favorable (8.98e-5)" "unprognostic (2.46e-2)" "unprognostic (3.55e-3)" "unprognostic (3.23e-2)" "unprognostic (2.27e-2)" 7.5 14.6 9.2 5.6 13.0 8.2 10.3 12.6 15.1 8.8 5.7 7.9 4.7 5.9 9.1 9.9 7.7 7.4 7.6 37.1 8.1 8.7 9.2 7.7 6.4 5.8 8.3 9.7 9.6 5.9 7.1 6.1 6.5 15.9 8.1 6.3 8.6 7.2 6.8 7.4 8.6 5.8 8.1 10.6 5.8 5.2 40.7 6.2 9.6 7.2 5.1 6.7 6.9 7.1 5.5 5.5 32.0 8.7 4.2 8.0 6.0 10.9 9.4 25.9 30.6 12.7 11.1 9.5 9.7 14.4 14.3 16.7 11.4 8.0 10.8 7.9 11.8 23.7 11.9 9.9 6.8 12.1 2.8 7.1 7.1 8.1 14.6 9.5 14.3 5.6 9.8 8.9 16.4 13.5 11.4 18.2 13.4 12.4 11.8 23.3 12.6 11.9 22.8 35.7 7.5 11.2 10.6 14.5 9.8 13.4 9.5 15.6 15.3 21.1 10.5 9.9 16.6 8.7 7.5 7.7 12.1 12.6 26.5 11.5 18.6 15.2 25.7 8.0 15.2 14.4 18.7 7.8 32.0 6.8 8.7 7.1 4.5 7.3 6.4 5.5 5.5 5.5 5.4 7.4 4.2 7.5 4.0 8.0 6.0 9.2 13.0 12.6 15.1 8.1 8.7 8.3 9.7 15.9 6.2 20.8 5.6 13.3 15.2 20.9 19.9 85.8 5.1 16.0 9.1 8.7 27.5 18.6 10.0 15.7 452.0 14.1 4.9 0.0 15.3 24.1 17.0 11.5 20.8 5.9 16.7 35.0 10.4 14.1 15.3 236.4 15.5 14.1 11.8 12.6 7.6 23.5 14.7 0.0 19.4 9.8 15.0 6.5 19.1 94.0 10.6 29.5 19.8 15.2 6.4 22.7 KLK6 "Bssp, Klk7, neurosin, PRSS18, PRSS9" ENSG00000167755 "Kallikrein related peptidase 6" Q92876 19 50958631-50969673 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6;esophagus: 48.9" "Cell type enhanced" "Detected in some" 22 "Collecting duct cells: 10.4;Early spermatids: 2.0;Late spermatids: 2.1;Pancreatic endocrine cells: 4.6;Urothelial cells: 2.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 131.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 70.0;CAPAN-2: 167.5" "Region enhanced" "Detected in many" "pons and medulla: 175.6" "Group enriched" "Detected in many" 8 "midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4" HPA051837 Supported "Nucleoplasm,Nuclear membrane,Cytokinetic bridge" "Secreted in other tissues" Yes No 6800000 Nucleoplasm "Nuclear membrane, Cytokinetic bridge" "HPA051837: " "unprognostic (7.30e-2)" "unprognostic (3.32e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.10e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.85e-4)" "unprognostic (3.02e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (4.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (1.27e-4)" 0.9 0.9 9.7 0.9 23.5 0.9 6.5 3.3 42.2 10.0 1.0 82.0 0.0 1.1 2.0 1.2 48.9 24.6 3.8 0.9 20.1 11.8 9.0 0.9 0.9 0.9 46.1 14.9 0.9 0.9 0.9 0.2 0.9 44.3 1.0 0.9 0.0 5.9 2.8 0.9 2.9 0.9 1.0 97.6 5.1 1.0 1.5 32.6 0.0 0.9 15.7 28.1 0.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.3 167.5 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 15.4 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.1 0.2 0.0 0.1 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 23.5 3.3 23.1 20.1 11.8 46.1 14.9 44.3 32.6 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 2.7 KMT2D "ALR, CAGL114, MLL2, MLL4, TNRC21" ENSG00000167548 "Lysine methyltransferase 2D" O14686 12 49018975-49059774 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035977 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Yes No "Plasma membrane, Cytosol" Nucleoplasm "HPA035977: AB_10670673" "unprognostic (8.33e-2)" "unprognostic (1.49e-1)" "unprognostic (9.14e-2)" "unprognostic (2.52e-1)" "unprognostic (8.07e-2)" "unprognostic (6.91e-3)" "unprognostic (7.35e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (5.14e-2)" "unprognostic (7.23e-2)" "unprognostic (3.07e-1)" "unprognostic (1.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.87e-1)" "unprognostic (3.20e-2)" "unprognostic (7.60e-2)" 12.1 7.6 4.9 6.7 10.8 26.1 6.8 11.7 10.5 9.5 6.5 5.8 13.0 5.5 15.7 7.4 8.8 8.9 5.8 9.1 6.1 3.5 6.2 6.5 22.9 9.6 6.7 3.3 9.7 11.6 13.3 9.2 12.9 13.7 6.7 6.6 9.8 7.6 8.0 16.1 13.6 9.4 7.1 9.1 13.6 8.3 7.3 5.7 6.2 11.0 6.1 7.6 7.0 6.3 2.0 2.2 5.9 0.5 1.5 0.8 0.6 17.1 16.3 16.5 13.3 17.1 11.5 17.7 9.1 9.5 11.8 6.3 28.6 7.3 17.8 11.8 12.7 8.5 11.6 21.7 10.0 9.8 10.4 17.4 22.6 17.1 15.3 11.7 26.8 22.7 9.7 14.4 16.5 17.1 14.1 17.5 18.5 28.3 9.9 13.3 18.9 13.3 25.0 15.6 23.7 14.1 20.0 10.2 6.4 9.9 19.0 13.8 11.7 14.0 13.8 9.5 15.0 13.7 23.5 23.3 9.3 16.6 8.1 15.2 14.1 9.1 17.3 10.7 13.9 6.9 0.6 0.5 3.0 0.8 0.2 0.4 0.3 0.3 0.5 0.3 2.0 0.3 0.8 5.9 1.5 0.1 2.2 0.0 0.6 4.9 10.8 11.7 10.5 6.1 3.5 6.7 3.3 13.7 5.7 8.9 18.4 11.1 6.5 12.5 25.2 4.7 12.7 5.3 9.1 17.4 49.1 6.6 1.7 5.8 2.5 12.6 11.1 0.0 5.2 4.6 8.5 8.3 8.1 12.3 8.3 20.6 12.6 17.2 19.7 1.1 8.9 9.6 10.1 4.6 10.5 5.2 7.2 8.6 10.3 4.3 38.9 6.5 3.3 3.7 3.2 15.4 9.5 10.4 10.1 8.4 KPNB1 "IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97" ENSG00000108424 "Karyopherin subunit beta 1" Q14974 17 47649476-47685505 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 28.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029878, CAB034449, HPA050302" Supported Enhanced "Nucleoplasm,Nuclear membrane,Cytosol" Yes No 5500000 "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079" "unprognostic (2.57e-1)" "unprognostic (1.15e-1)" "unprognostic (4.33e-3)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (8.15e-2)" "prognostic unfavorable (2.55e-7)" "unprognostic (7.18e-3)" "unprognostic (9.52e-2)" "unprognostic (5.47e-3)" "unprognostic (4.37e-2)" "unprognostic (8.41e-3)" "prognostic unfavorable (8.43e-6)" "unprognostic (1.34e-2)" "unprognostic (1.20e-1)" "unprognostic (1.41e-2)" "unprognostic (3.44e-2)" 38.0 42.1 31.9 46.1 30.7 22.1 33.3 32.9 33.5 37.6 37.9 29.7 39.9 24.5 39.3 35.4 51.2 33.1 35.0 43.5 28.1 30.5 33.8 48.8 35.8 50.5 31.6 35.3 47.2 32.3 42.3 29.4 34.6 34.9 36.1 39.3 23.7 35.2 45.9 74.6 31.7 32.1 40.7 36.6 50.3 35.7 62.4 34.8 47.6 37.0 34.3 62.8 50.8 47.5 5.4 4.0 28.2 3.9 3.7 6.3 2.8 43.7 74.6 47.5 43.1 23.0 40.0 47.7 52.2 46.8 68.5 53.9 130.2 26.1 56.5 35.7 48.7 48.3 31.0 85.7 48.1 104.1 34.7 52.3 62.4 60.2 40.7 23.7 70.6 41.1 32.4 21.2 78.6 77.1 29.2 45.1 31.5 70.5 38.7 52.9 47.6 65.4 21.2 45.2 29.9 47.2 40.6 84.0 32.9 28.1 62.7 41.8 38.8 35.7 19.2 30.2 59.2 41.5 27.3 37.5 74.9 46.5 38.9 63.2 47.4 54.7 81.0 31.9 34.2 54.9 4.3 3.5 7.1 4.9 3.6 6.3 5.4 5.5 5.5 2.1 5.1 5.2 4.9 28.2 3.7 3.9 4.0 4.0 2.8 31.9 30.7 32.9 33.3 28.1 30.5 31.6 35.3 34.9 34.8 119.1 66.6 108.8 81.6 111.6 93.4 119.7 66.2 52.2 73.9 41.8 64.8 98.4 34.9 106.8 32.0 100.4 53.1 46.7 102.8 118.0 87.0 86.2 75.0 80.5 109.7 76.3 118.8 122.8 99.2 31.1 89.8 89.3 57.3 151.5 71.7 76.6 115.8 60.4 114.2 42.9 82.7 97.0 78.3 276.1 166.5 125.5 132.3 92.4 98.1 114.9 KPTN 2E4 ENSG00000118162 "Kaptin, actin binding protein" Q9Y664 19 47475144-47484268 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 18.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041710, HPA041796" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles" "HPA041710: AB_10961904, HPA041796: AB_10962832" "unprognostic (4.80e-3)" "unprognostic (2.22e-1)" "unprognostic (7.24e-2)" "unprognostic (1.53e-1)" "unprognostic (5.54e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (7.91e-6)" "unprognostic (9.30e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-2)" "unprognostic (5.51e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (7.82e-4)" "unprognostic (1.40e-1)" "unprognostic (8.72e-2)" "unprognostic (2.04e-1)" "unprognostic (2.34e-1)" 6.0 5.8 7.1 5.3 15.6 8.9 6.2 17.2 11.0 4.6 5.4 5.7 3.4 6.0 4.5 3.0 7.3 3.6 4.4 6.5 9.5 7.1 5.8 6.8 4.5 5.5 13.0 6.3 2.7 5.5 9.2 8.9 6.3 8.9 6.5 4.2 3.7 17.6 3.9 8.7 5.4 5.1 4.8 8.5 5.0 3.9 3.9 9.6 12.5 4.8 6.2 3.9 5.1 4.7 1.4 18.5 2.6 3.8 0.9 1.3 1.7 6.3 11.1 8.7 5.4 9.0 7.1 6.1 3.5 6.7 19.4 12.2 8.0 7.6 7.6 2.7 6.3 7.0 7.3 7.4 12.8 5.4 7.1 11.5 3.2 7.5 7.1 8.1 6.4 9.3 8.1 8.3 6.4 6.0 4.9 7.4 10.3 6.4 7.4 5.6 4.9 11.4 27.5 7.8 6.9 6.8 8.3 4.4 3.2 6.0 9.5 18.7 14.4 5.9 6.8 4.4 4.5 5.6 9.4 4.2 4.6 5.3 2.5 7.9 1.9 2.9 3.3 4.2 4.2 6.9 0.0 3.0 1.2 1.2 2.5 0.4 1.3 0.8 1.0 3.6 1.4 1.1 0.9 2.6 0.9 3.8 18.5 1.3 1.7 7.1 15.6 17.2 11.0 9.5 7.1 13.0 6.3 8.9 9.6 3.0 2.4 5.6 6.1 2.5 5.6 2.8 7.6 0.0 5.7 5.2 5.9 12.8 8.3 8.7 0.6 2.3 3.5 0.0 3.5 10.6 4.1 5.5 2.3 5.5 7.5 9.5 2.9 3.7 5.1 1.9 1.1 5.3 1.7 1.8 1.5 6.5 5.3 1.9 0.7 5.8 4.1 0.0 2.1 3.2 18.5 2.8 12.8 2.5 2.8 5.8 KREMEN1 "KREMEN, KRM1" ENSG00000183762 "Kringle containing transmembrane protein 1" Q96MU8 22 29073078-29168333 "Disease related genes, Predicted membrane proteins" "Wnt signaling pathway" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "RH-30: 18.3;U-2197: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058513 Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No 400000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA058513: AB_2683739" 5.2 11.8 7.1 6.8 17.8 2.7 5.8 5.0 6.9 9.6 9.6 7.6 25.7 4.9 6.0 13.2 27.8 8.6 5.0 16.8 8.3 3.6 10.5 3.2 8.3 9.1 5.2 4.3 17.4 3.4 16.3 8.0 7.2 4.2 7.1 8.5 21.2 35.4 20.6 18.9 26.5 8.1 4.7 3.0 13.9 6.4 14.5 6.8 19.0 17.1 33.4 20.0 5.9 10.0 0.7 1.2 9.0 0.6 0.8 0.4 0.2 2.6 1.8 6.2 3.2 2.1 6.4 5.3 0.7 6.2 2.0 3.0 8.4 1.2 0.1 2.4 2.9 5.1 12.8 12.8 5.1 2.2 3.1 8.1 0.7 0.9 7.9 2.2 0.1 0.7 6.2 10.4 2.2 1.2 0.9 0.3 5.2 2.7 0.2 2.5 2.2 0.0 0.8 0.3 17.3 1.4 0.4 18.3 0.2 2.2 4.9 12.5 7.0 7.3 2.6 9.6 2.1 9.7 0.4 0.2 8.4 2.6 31.2 0.9 0.6 0.2 0.2 5.3 1.1 9.7 2.1 0.6 0.3 0.3 0.5 0.3 0.3 0.3 0.2 0.1 0.7 0.4 0.4 9.0 0.8 0.4 1.2 0.2 0.2 7.1 17.8 5.0 6.9 8.3 3.6 5.2 4.3 4.2 6.8 14.9 20.2 0.0 11.3 13.6 3.3 19.9 7.6 16.0 26.1 7.0 0.0 11.2 1.7 4.8 2.5 4.1 2.6 0.0 3.6 1.2 9.9 8.7 18.5 2.4 2.3 0.0 0.0 6.7 17.9 7.7 16.4 3.9 0.0 2.8 16.3 29.9 3.3 5.5 9.9 4.4 2.7 12.9 4.2 7.7 6.4 16.9 4.5 2.2 7.3 8.9 KRT79 "K6L, KRT6L" ENSG00000185640 "Keratin 79" Q5XKE5 12 52821410-52834295 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 11.3;skin 1: 34.3" "Group enriched" "Detected in some" 5 "granulocytes: 4.6;Melanocytes: 3.3" "Group enriched" "Detected in some" 5 "breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "HMC-1: 99.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA059347 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA 950000000 "Nucleoplasm, Nuclear membrane, Cytosol" "HPA059347: AB_2683986" "unprognostic (5.19e-3)" "unprognostic (1.56e-3)" "unprognostic (5.24e-2)" "unprognostic (2.38e-2)" "unprognostic (6.85e-2)" "unprognostic (6.36e-2)" "unprognostic (3.17e-1)" "unprognostic (7.92e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-2)" "unprognostic (1.32e-1)" "unprognostic (2.72e-1)" "unprognostic (3.99e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 4.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 34.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 11.3 0.1 0.1 0.2 0.1 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 99.9 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 L3MBTL3 KIAA1798 ENSG00000198945 "L3MBTL3, histone methyl-lysine binding protein" Q96JM7 6 130013699-130141451 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 31.5;HUVEC TERT2: 30.6;TIME: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044382, HPA053035" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" Yes No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044382: AB_2678920, HPA053035: AB_2682021" "unprognostic (2.33e-1)" "unprognostic (9.92e-2)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (4.22e-3)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.48e-2)" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (7.56e-3)" "unprognostic (1.07e-1)" "unprognostic (8.44e-2)" "unprognostic (3.94e-3)" "unprognostic (2.88e-1)" "unprognostic (2.45e-2)" "unprognostic (1.60e-2)" 8.8 16.7 5.2 16.4 8.2 7.5 7.5 2.4 7.7 17.1 5.6 3.6 9.3 3.1 17.5 14.1 5.7 7.4 6.0 4.1 5.4 5.8 6.1 6.4 7.4 11.4 5.2 5.9 12.1 3.8 8.1 17.0 6.5 5.7 10.3 5.7 4.8 5.8 7.5 5.3 4.3 7.6 9.9 5.4 18.5 4.6 7.5 3.9 25.5 10.2 4.3 12.8 10.4 11.6 10.7 10.8 3.9 14.1 1.7 4.2 0.6 0.8 3.2 7.4 1.1 5.1 6.9 1.5 3.7 7.7 1.5 2.7 3.8 4.0 1.3 5.4 4.8 4.6 3.2 4.2 6.6 2.3 2.9 4.3 8.6 1.6 1.0 2.6 5.1 31.5 4.3 4.8 1.7 5.1 7.6 30.6 4.1 6.2 3.5 3.8 0.3 10.8 0.9 3.5 0.7 1.6 4.0 2.1 0.0 4.9 1.2 0.2 1.0 1.4 0.3 3.0 9.5 7.8 4.5 20.9 2.5 3.5 0.4 2.4 0.6 0.0 2.3 1.2 2.1 2.5 3.9 3.5 3.5 2.7 4.0 2.7 7.6 2.7 3.8 1.3 10.7 2.4 3.0 3.7 1.7 14.1 10.8 4.2 0.6 5.2 8.2 2.4 7.7 5.4 5.8 5.2 5.9 5.7 3.9 3.0 9.2 7.5 4.8 4.5 2.9 2.9 2.5 5.3 3.4 8.7 2.0 10.2 1.7 4.3 18.5 5.6 0.7 0.0 4.9 6.0 6.7 4.2 38.3 4.9 3.3 0.0 3.5 7.4 8.2 1.6 8.9 3.6 1.7 4.6 7.2 5.6 7.5 3.5 5.6 4.3 0.7 6.5 5.1 5.4 6.1 3.9 5.1 10.0 4.1 5.2 LACTB2 CGI-83 ENSG00000147592 "Lactamase beta 2" Q53H82 8 70635318-70669174 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 70.1;liver: 58.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 194.5;Proximal tubular cells: 262.2;Spermatocytes: 198.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 99.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044391, HPA053040" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 24000 Cytosol "Nucleoplasm, Golgi apparatus" "HPA044391: AB_10965168, HPA053040: AB_2682022" "unprognostic (6.33e-3)" "unprognostic (3.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.23e-2)" "unprognostic (1.82e-1)" "unprognostic (4.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.34e-1)" "unprognostic (8.10e-2)" "unprognostic (3.95e-1)" "unprognostic (7.73e-3)" "unprognostic (1.96e-1)" "prognostic favorable (5.60e-4)" "unprognostic (3.70e-1)" "unprognostic (7.49e-2)" "unprognostic (2.93e-1)" "unprognostic (5.93e-2)" 9.3 31.4 6.8 6.7 10.0 1.2 8.9 2.0 7.1 5.5 13.5 9.0 5.3 17.8 5.7 8.3 7.6 5.2 14.6 19.3 7.2 7.2 70.1 58.8 9.7 8.9 11.5 7.5 5.5 10.6 6.2 12.6 6.3 10.1 7.5 10.0 6.2 7.8 8.6 12.0 6.1 19.1 7.2 11.6 8.0 7.7 45.7 11.7 6.0 9.8 10.9 5.9 8.2 7.4 14.0 18.2 13.4 17.3 11.0 13.8 6.4 14.3 15.0 4.7 1.9 8.3 12.7 2.9 8.0 4.7 8.7 6.6 7.1 16.2 0.0 3.3 3.9 17.5 10.3 5.7 8.5 6.9 8.6 6.4 6.7 2.0 3.9 17.4 6.5 5.8 15.3 10.4 4.3 6.5 4.1 2.2 5.3 11.6 13.6 11.4 4.3 3.7 1.2 5.1 19.4 14.2 3.3 2.8 3.0 33.2 7.6 6.8 2.4 17.9 99.3 8.9 6.4 16.6 8.8 3.6 0.6 4.8 15.4 6.5 11.1 8.3 0.0 4.9 11.2 6.4 11.1 15.2 13.4 9.9 17.3 12.5 14.0 10.4 9.7 18.2 13.2 10.1 10.6 6.4 11.0 16.4 12.8 13.8 6.4 6.8 10.0 2.0 7.1 7.2 7.2 11.5 7.5 10.1 11.7 53.6 33.1 13.5 17.8 14.5 13.8 31.9 25.5 20.1 30.7 17.4 7.9 19.6 64.6 43.6 194.5 15.3 25.3 0.0 101.8 11.7 10.3 12.0 9.2 70.0 40.7 7.9 11.6 22.1 31.8 14.1 19.0 23.7 15.1 11.8 21.3 33.2 68.2 19.2 14.2 262.2 14.8 6.5 11.3 198.5 24.5 14.6 16.2 23.0 26.4 8.1 LAP3 "LAP, LAPEP, PEPS" ENSG00000002549 "Leucine aminopeptidase 3" P28838 4 17577192-17607972 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 227.4;monocytes: 251.5;Proximal tubular cells: 217.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029606, HPA029607" Enhanced Supported Nucleoplasm,Midbody,Cytosol Yes No 4100000 Cytosol "Nucleoplasm, Midbody" "HPA029606: AB_10599288, HPA029607: AB_10611381" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (2.87e-1)" "unprognostic (2.16e-1)" "unprognostic (1.55e-1)" "unprognostic (5.33e-2)" "unprognostic (1.44e-3)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (4.29e-3)" "unprognostic (1.73e-1)" "unprognostic (3.28e-2)" "unprognostic (3.06e-1)" "unprognostic (8.79e-2)" 42.5 29.7 23.2 43.9 38.5 18.1 30.7 8.5 23.5 13.3 21.0 23.5 12.3 27.5 17.2 20.8 19.3 18.7 24.3 25.4 24.4 17.0 71.7 70.3 39.4 54.2 33.7 16.1 13.5 14.7 23.5 13.2 25.0 34.9 15.3 22.7 15.0 23.0 12.1 33.3 20.9 30.6 26.9 35.0 54.9 20.8 19.3 30.7 19.9 29.4 21.7 32.1 24.4 23.7 7.5 45.7 9.5 46.1 11.8 12.9 25.3 10.9 9.6 9.2 8.7 18.3 22.3 0.1 17.3 19.5 62.9 76.5 17.5 20.9 43.2 11.5 13.3 37.5 6.8 34.5 12.2 24.0 16.4 9.9 23.9 10.6 22.8 21.3 21.5 15.4 22.7 7.8 20.6 10.9 7.2 21.8 11.4 23.1 30.9 14.8 11.8 19.1 29.5 19.2 20.6 18.4 29.7 8.8 21.8 16.4 12.9 13.6 11.2 15.8 9.8 33.8 13.3 8.3 8.3 14.1 16.0 10.8 16.8 30.0 28.4 43.4 37.3 21.6 35.9 15.4 8.4 43.4 9.5 8.0 46.1 7.4 7.5 7.5 8.5 45.7 5.2 6.5 6.8 6.2 11.8 31.9 25.9 12.9 25.3 23.2 38.5 8.5 23.5 24.4 17.0 33.7 16.1 34.9 30.7 26.8 44.7 44.2 21.0 19.6 8.0 43.2 10.2 46.8 26.1 26.2 2.0 31.2 99.5 46.8 71.4 104.1 38.5 0.0 96.6 44.5 25.9 23.1 63.4 92.3 227.4 6.4 15.6 68.2 96.6 22.8 21.3 135.7 40.5 251.5 30.0 93.7 42.5 30.2 32.9 217.2 12.6 32.3 24.7 46.4 13.2 19.9 46.6 30.5 39.9 21.7 LARP1 "KIAA0731, LARP, MGC19556" ENSG00000155506 "La ribonucleoprotein domain family member 1" Q6PKG0 5 154712902-154817607 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015222, HPA051397, HPA054819" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Endoplasmic reticulum, Cytosol" "CAB015222: , HPA051397: AB_2681467, HPA054819: AB_2682612" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (7.69e-2)" "unprognostic (1.76e-3)" "unprognostic (3.95e-2)" "unprognostic (3.08e-3)" "unprognostic (2.72e-2)" "unprognostic (3.34e-3)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.83e-2)" "unprognostic (2.07e-1)" "unprognostic (2.20e-1)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.83e-1)" 24.9 30.1 30.5 21.9 31.9 18.9 20.3 25.7 46.5 21.3 20.4 27.3 23.2 21.0 26.5 23.0 29.2 25.4 18.5 28.5 27.8 29.1 25.6 22.6 19.9 23.1 26.8 29.7 28.4 81.2 55.9 23.6 25.1 29.2 18.2 21.3 18.9 38.8 21.4 41.7 24.7 22.3 23.8 22.2 21.5 24.4 27.8 27.4 26.1 33.5 16.4 25.8 22.1 28.7 5.2 6.4 2.8 7.9 10.1 5.8 2.5 26.2 36.7 28.7 32.9 25.0 20.3 31.8 26.7 27.3 31.3 30.6 57.7 31.6 69.3 37.9 33.3 45.8 26.4 52.3 49.1 36.2 22.9 29.5 50.1 38.2 26.6 31.8 67.0 23.3 25.1 28.5 38.9 49.7 17.8 27.5 31.3 41.1 48.1 29.0 25.9 39.6 26.2 30.5 22.8 18.5 44.4 27.3 33.0 19.2 32.7 52.1 28.0 36.2 58.2 32.1 30.8 34.6 31.7 36.4 39.4 24.7 29.7 47.8 43.0 30.9 59.1 26.1 37.1 27.5 2.8 4.0 1.1 4.5 4.9 5.8 4.3 5.4 5.3 4.0 5.2 4.3 4.7 2.4 10.1 7.9 6.4 3.4 2.5 30.5 31.9 25.7 46.5 27.8 29.1 26.8 29.7 29.2 27.4 41.7 26.0 38.9 30.3 69.5 60.5 94.4 40.8 37.5 26.1 38.4 35.3 37.5 24.9 38.5 9.8 50.1 45.7 23.3 70.6 28.5 46.8 41.1 17.3 58.2 49.0 82.6 42.2 50.3 51.5 7.7 64.5 38.5 35.4 31.5 52.6 32.3 54.8 28.1 75.3 40.9 38.4 12.9 41.1 37.6 41.4 73.9 20.0 24.9 61.7 53.6 LAS1L FLJ12525 ENSG00000001497 "LAS1 like, ribosome biogenesis factor" Q9Y4W2 X 65512582-65534775 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044431, HPA061463" Supported Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA044431: AB_10965695, HPA061463: AB_2684530" "unprognostic (9.71e-2)" "unprognostic (1.62e-3)" "unprognostic (1.57e-1)" "unprognostic (1.47e-1)" "unprognostic (3.39e-2)" "unprognostic (2.38e-1)" "unprognostic (7.15e-3)" "unprognostic (2.83e-2)" "unprognostic (3.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.14e-1)" "unprognostic (5.06e-2)" "unprognostic (6.00e-3)" "unprognostic (1.26e-1)" "unprognostic (1.17e-3)" "unprognostic (2.00e-3)" "unprognostic (1.53e-1)" 16.4 14.7 22.6 17.8 26.4 27.9 21.4 38.3 26.1 18.0 17.9 30.1 14.1 11.1 21.9 17.4 17.1 23.8 14.2 14.0 24.2 22.0 15.7 24.4 15.5 23.2 26.4 23.4 26.2 19.8 29.0 13.8 16.3 26.0 17.8 17.2 19.7 19.5 22.5 20.4 23.9 13.4 20.4 29.7 17.8 14.6 23.7 25.7 26.7 16.4 15.4 26.7 15.3 16.2 20.7 22.0 12.4 20.8 17.8 22.5 17.3 20.3 33.8 16.1 13.4 7.0 9.0 15.7 12.3 7.9 19.2 17.0 16.5 15.2 31.8 17.7 9.2 14.2 14.5 32.4 21.6 21.7 12.1 26.5 14.3 29.6 16.2 8.5 36.6 13.0 9.2 12.8 19.2 13.7 8.4 12.7 19.8 33.5 33.2 11.3 24.2 27.8 28.1 23.8 24.0 31.3 24.0 22.5 35.2 13.2 9.2 12.8 14.7 19.6 14.4 8.9 14.3 10.8 19.5 9.1 11.9 23.6 36.2 18.5 12.1 14.2 35.0 11.6 38.8 6.3 12.4 15.7 7.8 18.8 20.8 20.8 20.2 17.6 22.3 22.0 20.7 22.5 18.5 1.7 17.8 15.0 16.4 17.6 17.3 22.6 26.4 38.3 26.1 24.2 22.0 26.4 23.4 26.0 25.7 11.9 18.2 15.2 17.8 16.3 32.6 8.3 15.3 32.1 28.4 3.5 27.5 27.9 13.3 18.3 44.1 14.8 7.4 0.0 23.0 25.7 15.1 11.9 17.4 12.9 14.3 42.9 16.0 11.6 7.1 108.3 16.1 12.3 10.1 20.8 7.9 15.2 17.5 7.0 14.5 12.9 33.2 12.9 20.2 20.5 20.0 16.3 14.9 11.8 12.8 14.4 LDB2 "CLIM1, LDB1" ENSG00000169744 "LIM domain binding 2" O43679 4 16501541-16898809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 21 "Endothelial cells: 120.7;Ito cells: 249.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "amygdala: 14.5;basal ganglia: 30.3;cerebral cortex: 45.3;hippocampal formation: 16.6;olfactory region: 21.7" "Cell type enriched" "Detected in single" 13 "NK-cell: 5.1" "Lineage enriched" "Detected in single" 13 "NK-cells: 5.1" "Cell line enhanced" "Detected in some" "AF22: 9.7;ASC TERT1: 9.3;fHDF/TERT166: 9.8;HAP1: 18.0;HUVEC TERT2: 34.0;U-138 MG: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017544, HPA068634" Supported Supported "Nucleoplasm,Nucleoli,Plasma membrane" No NA "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB017544: AB_2137013, HPA068634: AB_2686012" "unprognostic (3.43e-1)" "unprognostic (2.77e-1)" "unprognostic (9.10e-2)" "unprognostic (4.37e-1)" "unprognostic (7.25e-2)" "unprognostic (4.62e-3)" "unprognostic (2.10e-3)" "unprognostic (1.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.96e-2)" "unprognostic (2.05e-3)" "unprognostic (1.26e-3)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "unprognostic (7.10e-3)" 27.9 9.5 14.5 4.6 30.3 0.4 26.8 1.1 45.3 27.1 6.8 2.7 8.0 4.0 54.9 14.4 9.5 15.6 18.3 18.5 16.6 4.8 14.9 15.0 31.3 6.9 5.5 21.7 11.9 4.6 15.2 5.6 33.7 3.4 10.4 5.4 15.4 6.1 8.6 7.5 5.4 6.8 32.8 4.2 32.9 6.7 6.4 3.4 0.7 17.8 7.5 3.0 14.7 13.3 0.2 0.0 0.3 0.0 5.1 0.0 0.6 0.0 0.0 9.7 0.0 5.6 9.3 0.0 5.3 4.1 0.6 1.5 0.0 0.0 0.0 0.0 9.8 0.0 0.0 18.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 5.2 0.0 6.7 0.0 1.4 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 2.8 0.0 0.0 8.9 13.7 0.0 0.7 0.0 4.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.6 14.5 30.3 1.1 45.3 16.6 4.8 5.5 21.7 3.4 3.4 0.0 8.5 1.9 0.2 7.7 21.5 9.2 5.1 1.4 0.0 0.0 0.0 0.2 0.0 1.7 1.1 120.7 0.0 0.0 0.2 0.2 22.0 0.3 5.7 1.3 0.3 0.0 0.0 249.8 20.4 1.5 35.4 2.3 8.5 0.0 0.0 9.8 0.3 0.0 47.4 0.0 1.7 6.5 13.4 0.0 0.6 5.9 0.1 5.4 0.0 0.1 LDB3 "CMD1C, KIAA0613, PDLIM6, ZASP" ENSG00000122367 "LIM domain binding 3" O75112 10 86668449-86736068 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3" "Cell type enriched" "Detected in some" 41 "Cardiomyocytes: 1579.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HSkMC: 5.9;hTERT-RPE1: 5.8;SCLC-21H: 9.6;SK-MEL-30: 4.6" "Low region specificity" "Detected in all" HPA048955 Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 450000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA048955: AB_2680568" "unprognostic (1.60e-1)" "unprognostic (9.01e-2)" "unprognostic (4.87e-2)" "unprognostic (6.92e-2)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (2.57e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-2)" "unprognostic (7.61e-2)" "unprognostic (2.54e-3)" "unprognostic (3.55e-2)" "unprognostic (4.72e-4)" "unprognostic (3.07e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-2)" "unprognostic (3.16e-1)" 6.4 0.4 0.9 1.3 1.6 0.2 0.5 0.1 1.3 2.8 2.3 0.0 4.9 0.4 4.2 9.9 9.9 1.3 1.0 213.9 1.7 1.0 0.3 0.2 0.4 0.2 2.6 0.0 1.5 0.3 0.3 0.1 0.5 0.0 4.4 0.8 4.7 7.6 3.1 329.7 0.3 1.2 3.6 6.7 0.2 0.7 0.5 0.0 0.0 2.8 110.3 10.2 1.9 0.9 0.9 0.6 1.8 0.4 0.6 0.6 0.0 0.3 0.2 0.4 3.1 0.4 0.1 0.3 0.4 0.3 0.1 0.2 0.3 0.3 0.2 0.6 0.0 0.7 0.4 0.2 0.0 0.1 0.9 0.7 0.7 0.9 0.1 0.1 0.1 1.6 5.9 0.5 0.1 0.0 5.8 0.0 0.7 0.2 1.8 0.3 1.5 0.4 0.2 0.4 0.4 0.3 0.0 2.0 0.1 0.0 1.1 9.6 1.8 0.3 0.2 4.6 1.4 0.3 0.2 0.0 0.3 0.5 0.4 0.1 0.2 0.6 0.4 0.7 0.3 0.5 1.8 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.9 0.5 0.6 1.4 0.6 0.4 0.6 0.3 0.0 0.9 1.6 0.1 0.6 1.7 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.7 1579.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 18.3 0.7 0.0 0.0 1.0 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.2 10.3 0.4 1.7 0.0 0.0 1.0 0.1 0.0 6.3 0.0 3.4 38.8 33.0 0.6 1.0 0.0 0.0 0.0 0.0 0.1 LEO1 ENSG00000166477 "LEO1 homolog, Paf1/RNA polymerase II complex component" Q8WVC0 15 51938025-51971806 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "granulocytes: 262.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040741, HPA040941" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Centrosome" No No "Nucleoplasm, Nucleoli fibrillar center" Centrosome "HPA040741: AB_10794859, HPA040941: AB_10805832" "unprognostic (2.76e-2)" "unprognostic (2.14e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-3)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (2.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-1)" 10.7 15.2 15.0 15.3 27.9 8.3 17.0 42.6 24.4 13.4 17.8 14.1 9.7 13.9 12.6 11.2 24.4 9.7 14.2 10.6 14.0 14.0 21.4 27.8 10.2 17.2 14.8 14.9 10.6 10.3 25.2 22.4 12.7 22.7 13.8 21.0 9.1 21.2 12.5 13.5 21.8 19.8 12.6 15.3 14.3 13.9 9.8 18.5 23.4 12.0 9.4 18.2 16.9 15.7 12.3 15.3 9.6 15.3 18.9 19.7 10.0 9.6 22.6 14.6 11.7 15.1 13.1 10.5 15.8 13.1 13.6 12.4 15.6 6.4 19.6 9.3 16.2 15.1 19.0 19.4 14.1 13.1 13.0 8.8 30.9 18.4 27.3 11.9 27.8 43.2 14.0 11.1 10.6 13.8 12.9 13.2 16.6 18.7 10.8 16.1 41.2 14.7 21.1 6.3 28.9 9.7 16.5 25.3 20.5 11.9 27.2 10.4 15.9 12.0 18.5 12.3 16.7 15.4 25.4 15.7 13.5 9.3 12.4 18.8 8.5 26.5 18.1 11.8 39.9 14.3 5.4 9.4 9.6 18.7 14.6 17.5 12.3 18.7 15.2 15.3 10.1 19.5 17.5 2.3 18.9 15.3 11.5 19.7 10.0 15.0 27.9 42.6 24.4 14.0 14.0 14.8 14.9 22.7 18.5 32.8 27.7 10.4 12.9 23.2 35.2 17.1 20.4 45.5 39.8 7.0 9.8 21.3 13.3 21.4 1.6 15.0 19.3 0.0 21.0 22.3 16.2 9.1 262.5 12.3 16.9 25.4 7.5 8.6 12.3 2.1 7.5 7.8 3.3 14.4 16.3 20.9 17.2 14.0 12.7 17.9 20.8 6.5 9.2 15.6 9.0 21.7 14.8 15.4 13.9 20.1 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.8;testis: 28.6" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 41.6;Late spermatids: 34.7;Pancreatic endocrine cells: 29.9;Spermatocytes: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.8;hTERT-HME1: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 50.6" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 2.3 1.3 3.3 1.7 7.9 6.8 1.5 9.9 6.6 2.6 1.3 2.9 0.5 1.5 2.1 2.1 2.1 2.1 2.0 1.4 4.3 4.1 3.5 1.4 3.2 1.7 3.1 4.2 2.6 1.4 3.6 5.5 6.7 3.3 1.9 1.5 3.0 1.4 1.4 0.8 1.8 1.1 1.2 3.2 2.3 4.1 28.6 1.6 3.8 1.6 1.0 2.2 3.1 1.7 1.4 1.3 16.8 3.8 1.2 4.0 1.2 13.8 2.5 1.9 1.8 1.5 4.3 1.4 4.7 5.6 6.7 4.1 1.0 5.5 1.7 11.1 1.0 2.0 1.5 3.8 16.8 7.0 0.8 1.6 2.0 1.9 2.5 1.9 0.3 1.9 1.2 4.7 7.1 15.3 3.6 7.0 2.2 1.7 2.7 5.9 2.9 5.0 1.2 0.4 1.0 11.8 1.7 3.1 1.0 11.0 0.6 1.6 1.6 1.6 0.3 0.5 1.3 1.6 0.8 12.1 2.1 14.8 3.8 1.1 1.8 1.0 1.3 3.3 2.2 1.6 0.9 3.4 0.5 0.9 1.3 1.5 1.4 0.8 1.3 1.3 1.4 1.6 1.5 16.8 1.2 3.8 0.6 4.0 1.2 3.3 7.9 9.9 6.6 4.3 4.1 3.1 4.2 3.3 1.6 3.0 5.4 0.5 11.6 0.5 7.0 1.6 5.1 4.0 2.3 5.2 5.9 1.4 1.7 3.5 41.6 2.6 0.2 0.0 17.9 4.8 2.2 2.1 9.2 0.0 1.3 6.4 0.0 1.3 1.5 34.7 2.0 2.5 1.7 1.0 1.4 3.5 29.9 0.0 1.4 2.2 8.2 0.0 2.8 24.4 1.5 0.6 6.8 3.8 1.0 4.4 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: AB_2686682" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favorable (3.16e-4)" 25.7 27.5 23.0 18.1 31.2 17.1 27.1 23.1 37.5 18.6 26.8 18.8 21.5 31.9 22.9 22.4 16.2 30.0 23.5 16.4 21.2 19.0 29.3 35.1 16.6 18.5 20.6 21.3 34.3 38.6 28.5 20.2 12.3 21.6 19.1 26.1 22.6 28.2 24.0 23.8 18.5 28.5 18.7 21.4 17.5 22.6 15.5 14.3 19.9 34.1 10.7 20.1 20.3 14.8 11.3 7.2 2.9 11.6 8.6 17.1 9.3 7.4 6.7 5.0 13.5 22.8 37.4 5.1 7.7 12.8 8.1 9.2 16.2 15.4 19.7 9.6 8.3 5.9 13.9 10.3 10.4 9.4 7.1 12.9 14.1 9.3 12.7 15.1 12.7 10.3 31.5 33.7 9.6 22.8 24.8 8.2 19.1 14.6 14.3 11.1 11.6 8.9 12.3 3.4 9.3 18.3 7.6 6.1 10.7 10.2 11.4 15.0 6.9 5.8 13.1 17.6 5.3 20.7 11.6 6.2 5.1 5.5 8.4 4.4 13.0 20.2 8.4 9.5 8.3 3.6 2.5 7.3 2.9 8.6 7.8 12.5 11.3 14.2 10.6 7.2 8.1 17.1 15.5 2.4 8.6 11.6 6.4 12.6 9.3 23.0 31.2 23.1 37.5 21.2 19.0 20.6 21.3 21.6 14.3 20.8 22.7 30.4 41.1 44.1 20.2 12.5 22.9 25.4 11.4 22.7 9.8 40.0 77.9 12.6 6.3 19.6 22.0 23.3 28.4 18.9 32.4 29.0 25.3 16.3 26.2 17.5 26.7 20.3 41.0 11.9 30.2 21.2 37.1 17.2 34.4 24.4 16.0 28.1 28.7 31.5 16.5 25.8 38.1 20.6 19.4 38.8 23.3 42.4 49.8 24.8 LGALS3 "GALIG, LGALS2, MAC-2" ENSG00000131981 "Galectin 3" P17931 14 55124110-55145413 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing" "IgE-binding protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 3145.4;Paneth cells: 2942.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 67.4;intermediate monocyte: 55.4;myeloid DC: 41.7;non-classical monocyte: 44.2;T-reg: 25.9" "Group enriched" "Detected in all" 12 "dendritic cells: 41.7;monocytes: 67.4;T-cells: 25.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 90.9;CAPAN-2: 72.2;OE19: 119.2;SK-MEL-30: 169.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA003162, CAB005191" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 2300000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005191: AB_2136784, HPA003162: AB_1078937" "unprognostic (1.42e-1)" "unprognostic (9.79e-2)" "unprognostic (1.14e-1)" "unprognostic (3.15e-1)" "unprognostic (2.46e-2)" "unprognostic (3.34e-2)" "unprognostic (1.73e-3)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.28e-1)" "unprognostic (1.08e-3)" "unprognostic (5.97e-2)" "unprognostic (8.52e-2)" "unprognostic (1.44e-1)" "unprognostic (2.96e-2)" "unprognostic (2.65e-3)" "unprognostic (7.60e-3)" 95.7 11.0 10.4 50.9 13.6 29.8 53.2 6.5 11.7 54.1 127.1 6.1 42.4 75.7 50.3 30.7 76.1 26.1 83.9 42.3 8.4 5.7 19.9 3.9 65.5 16.6 8.5 9.4 58.9 24.2 0.5 11.0 78.7 5.5 51.7 93.7 25.7 78.3 51.7 31.3 76.1 182.4 48.2 8.7 11.1 36.9 20.4 5.7 5.5 18.0 65.7 41.7 41.1 44.4 1.3 41.7 3.6 67.4 2.5 25.9 37.2 21.7 6.9 0.2 0.1 45.3 90.9 26.5 17.4 36.7 4.8 8.6 15.0 72.2 0.0 9.2 20.3 8.8 21.8 0.4 18.2 2.7 25.7 0.3 0.0 7.7 6.9 34.4 0.0 0.0 28.3 27.8 5.6 11.7 11.0 7.5 0.0 0.0 21.0 10.9 14.7 0.0 5.3 0.3 119.2 19.6 0.0 0.9 1.5 45.3 29.1 0.6 1.7 40.7 0.0 169.5 1.2 17.9 2.4 13.7 23.0 3.2 8.5 0.3 11.7 37.1 0.1 33.0 1.4 2.4 1.7 67.4 3.4 1.8 55.4 11.4 1.3 6.8 5.1 41.7 0.4 0.3 1.0 3.6 2.5 44.2 1.1 25.9 37.2 10.4 13.6 6.5 11.7 8.4 5.7 8.5 9.4 5.5 5.7 670.0 300.6 39.7 543.1 560.7 2.0 183.5 254.8 1263.4 586.9 113.4 0.0 565.8 570.3 541.1 17.4 423.0 3145.4 116.8 951.7 754.6 506.8 590.1 552.4 0.9 1164.5 1.6 166.8 50.3 236.1 23.5 514.6 722.3 804.8 642.0 1587.7 215.8 859.9 2942.3 361.0 42.5 11.3 142.3 241.1 7.7 3.6 697.2 404.6 52.2 1480.8 936.7 LHX1 "LIM-1, LIM1" ENSG00000273706 "LIM homeobox 1" P48742 17 36936785-36944612 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 15.0;kidney: 5.7;seminal vesicle: 7.1" "Cell type enriched" "Detected in some" 9 "Horizontal cells: 341.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 8.1" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Cell line enhanced" "Detected in some" "HAP1: 6.3;HMC-1: 2.7;WM-115: 11.7" "Region enhanced" "Detected in many" "cerebellum: 21.5" "Region enriched" "Detected in many" 4 "cerebellum: 20.4" "HPA044307, HPA073521, HPA074382" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA044307: , HPA073521: AB_2732226, HPA074382: " "unprognostic (3.86e-5)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.85e-2)" "unprognostic (1.06e-4)" "unprognostic (2.67e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (4.20e-3)" "unprognostic (1.74e-5)" "unprognostic (1.33e-1)" "unprognostic (8.62e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 15.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.2 0.0 6.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.1 0.0 2.0 0.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 1.9 0.0 1.5 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 40.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 341.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.2 1.7 0.0 0.0 0.9 1.2 0.0 0.3 0.0 0.0 0.0 LHX5 ENSG00000089116 "LIM homeobox 5" Q9H2C1 12 113462034-113472280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0;stomach 1: 2.1;testis: 2.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 5 "cerebellum: 4.8;hypothalamus: 6.7;pons and medulla: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;HMC-1: 4.6;K-562: 1.2;SiHa: 3.3;U-2 OS: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053908 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear bodies" "HPA053908: AB_2682304" "unprognostic (5.20e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.21e-1)" "unprognostic (2.19e-2)" "unprognostic (1.06e-2)" "unprognostic (1.95e-1)" "unprognostic (4.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (5.10e-2)" "unprognostic (7.54e-3)" 0.0 0.1 0.0 0.0 0.3 0.0 0.0 4.8 4.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 2.1 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 6.7 1.2 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 LHX8 Lhx7 ENSG00000162624 "LIM homeobox 8" Q68G74 1 75128434-75161533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9" "Cell type enhanced" "Detected in single" 26 "Spermatogonia: 2.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 9.5;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 23.8;U-266/70: 8.0" "Region enhanced" "Detected in some" "basal ganglia: 9.9" "Group enriched" "Detected in some" 32 "basal ganglia: 15.3;hypothalamus: 4.4" HPA071806 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA071806: AB_2686449" "unprognostic (2.28e-2)" "unprognostic (6.23e-2)" "unprognostic (3.85e-3)" "unprognostic (1.52e-9)" "unprognostic (1.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.0 3.9 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.3 0.0 0.5 4.9 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.2 0.0 0.0 8.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.5 0.0 1.1 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 LIG1 ENSG00000105486 "DNA ligase 1" P18858 19 48115445-48170603 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037015, HPA041431, HPA048071" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Yes No Nucleoplasm "Golgi apparatus, Vesicles" "CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248" "unprognostic (1.83e-1)" "unprognostic (1.48e-3)" "unprognostic (6.45e-2)" "unprognostic (9.76e-2)" "unprognostic (9.47e-2)" "unprognostic (9.24e-3)" "unprognostic (1.17e-3)" "unprognostic (2.28e-1)" "unprognostic (6.03e-3)" "unprognostic (4.26e-1)" "unprognostic (1.78e-2)" "unprognostic (1.10e-3)" "prognostic unfavorable (5.75e-5)" "unprognostic (3.59e-2)" "unprognostic (4.09e-2)" "unprognostic (1.59e-2)" "unprognostic (1.55e-2)" 4.1 5.6 8.1 25.2 10.4 37.8 6.4 17.2 10.6 6.5 9.2 6.5 8.7 12.0 6.8 6.1 11.0 7.8 6.9 2.6 6.3 5.3 6.0 6.2 5.9 18.6 7.7 7.4 10.8 10.3 9.1 9.7 11.7 8.1 7.5 6.0 4.6 7.2 7.9 6.1 12.5 12.8 3.6 7.1 11.2 6.7 15.1 11.5 34.7 10.7 12.1 16.9 6.6 8.6 10.4 1.3 2.0 5.6 10.9 11.5 4.8 15.8 20.4 21.9 14.1 0.9 1.1 15.8 9.2 6.8 14.8 16.4 11.5 15.6 28.7 5.7 3.9 4.1 10.7 9.0 9.0 6.4 15.4 15.5 17.7 14.4 14.9 0.3 22.0 14.7 2.0 0.7 7.9 1.2 1.9 7.9 17.5 15.0 10.8 7.5 12.7 35.1 32.7 12.4 17.1 4.7 30.3 17.1 14.1 4.6 24.2 13.8 13.8 11.1 13.0 3.1 5.2 8.4 16.9 7.8 11.8 20.0 9.9 14.3 10.7 16.8 29.2 4.8 12.4 13.1 0.0 1.4 2.0 7.6 5.6 6.8 10.3 8.4 7.6 1.3 10.4 11.5 8.0 1.1 10.9 2.7 1.2 8.9 4.8 8.1 10.4 17.2 10.6 6.3 5.3 7.7 7.4 8.1 11.5 3.0 9.9 14.6 6.7 7.3 17.6 3.9 2.5 25.4 12.5 3.5 9.8 16.2 6.6 5.1 17.7 5.5 4.5 0.0 4.5 29.3 5.0 2.8 5.8 3.9 13.9 7.9 0.0 4.3 5.2 6.4 2.0 5.8 3.3 10.8 6.8 11.9 3.5 5.8 1.8 3.7 11.6 12.9 4.9 9.8 28.5 8.0 8.4 11.4 8.1 5.5 LIN28B "CSDD2, FLJ16517" ENSG00000187772 "Lin-28 homolog B" Q6ZN17 6 104936616-105083332 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 51.9" "Cell type enhanced" "Detected in some" 13 "Cytotrophoblasts: 66.0;Extravillous trophoblasts: 67.8;Syncytiotrophoblasts: 46.7" "Cancer enriched" "Detected in single" 25 "testis cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 14.1;BEWO: 73.1;Hep G2: 12.2;K-562: 23.6;NTERA-2: 12.9;SuSa: 13.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036630, HPA061745" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA036630: AB_10669911, HPA061745: AB_2684601" "unprognostic (2.00e-4)" "unprognostic (6.75e-2)" "unprognostic (2.02e-1)" "unprognostic (2.57e-2)" "unprognostic (1.59e-2)" "unprognostic (4.10e-2)" 0.1 0.1 1.2 0.0 0.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.1 0.1 0.1 0.5 0.8 0.0 0.0 0.0 1.0 51.9 1.2 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 5.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.7 2.1 0.4 0.2 0.5 0.3 0.0 0.9 14.1 2.8 0.0 0.0 73.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.8 0.0 8.8 0.0 0.0 0.0 6.8 10.1 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.3 0.0 0.0 1.5 1.7 12.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 1.1 13.5 0.0 2.9 0.3 0.0 1.5 0.0 0.0 4.3 6.0 0.0 0.0 0.0 0.0 1.6 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.1 0.2 2.1 0.2 0.4 0.7 0.2 0.3 1.2 0.8 0.1 1.3 0.9 1.3 0.5 0.8 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 5.9 66.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 67.8 0.0 0.0 0.0 0.0 8.0 1.6 0.0 0.0 0.0 17.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 6.5 0.0 5.8 9.2 0.0 46.7 0.0 0.0 0.0 LITAF "FLJ38636, PIG7, SIMPLE, TP53I7" ENSG00000189067 "Lipopolysaccharide induced TNF factor" Q99732 16 11547722-11636381 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 202.5" "Cell type enhanced" "Detected in many" 5 "monocytes: 551.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 202.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 202.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006960 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA006960: AB_1079254" "unprognostic (2.26e-1)" "unprognostic (4.96e-2)" "unprognostic (2.32e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (4.07e-2)" "unprognostic (8.75e-3)" "unprognostic (3.60e-1)" "unprognostic (6.15e-3)" "unprognostic (1.04e-1)" "unprognostic (4.61e-2)" "unprognostic (5.01e-1)" "unprognostic (1.85e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (3.57e-2)" "unprognostic (1.60e-1)" 55.0 14.1 18.0 49.2 42.4 53.3 65.7 5.0 18.5 50.4 36.4 45.2 20.2 13.9 42.7 28.8 19.6 34.0 35.3 31.5 20.7 15.7 48.9 66.3 73.0 80.6 28.6 13.2 43.1 26.3 15.9 17.1 46.2 42.8 36.2 36.7 26.0 57.3 32.2 18.6 28.5 24.1 41.6 52.1 57.9 26.3 11.0 19.0 18.7 53.3 18.8 36.4 47.4 41.6 14.1 16.9 202.5 10.3 20.2 37.6 35.6 13.9 26.1 16.5 7.9 2.5 1.9 16.7 18.2 56.1 17.4 25.9 10.8 37.7 7.0 23.3 15.3 20.2 17.3 6.9 30.5 16.6 53.6 7.2 0.5 22.7 54.7 38.7 2.1 2.4 5.8 59.3 14.2 38.9 15.6 0.0 0.4 4.3 27.3 0.2 13.3 0.3 32.3 26.8 18.6 0.1 2.1 3.6 40.3 14.5 19.8 4.1 12.4 31.5 40.3 32.4 26.6 22.5 11.9 0.1 7.2 12.2 4.2 4.2 10.7 23.5 18.0 8.3 17.1 41.3 32.2 10.3 20.8 37.6 9.8 22.8 14.1 23.5 33.5 13.6 13.9 26.8 31.7 202.5 20.2 5.7 16.9 26.2 35.6 18.0 42.4 5.0 18.5 20.7 15.7 28.6 13.2 42.8 19.0 41.7 81.4 104.3 281.2 139.8 1.8 51.2 129.9 133.8 114.9 155.3 0.0 57.9 411.1 191.6 1.7 48.8 46.4 0.0 64.4 335.4 125.8 223.3 202.9 35.5 219.5 0.0 16.8 61.4 140.8 7.9 52.0 294.8 148.5 551.0 130.0 207.3 91.3 203.2 64.3 66.5 3.5 51.8 174.1 0.0 4.7 115.6 31.0 220.6 89.7 303.0 LMX1A "LMX1, LMX1.1" ENSG00000162761 "LIM homeobox transcription factor 1 alpha" Q8TE12 1 165201867-165356715 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3;pituitary gland: 8.0" "Group enriched" "Detected in some" 33 "Early spermatids: 29.1;Intestinal endocrine cells: 40.3;Late spermatids: 14.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "SCLC-21H: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA028051, HPA030088" Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA028051: AB_10599731, HPA030088: AB_10601106" "unprognostic (1.73e-1)" "unprognostic (9.57e-2)" "unprognostic (7.58e-2)" "unprognostic (1.59e-1)" "unprognostic (2.17e-1)" "unprognostic (2.82e-1)" "unprognostic (2.63e-1)" "unprognostic (3.22e-2)" "unprognostic (2.10e-3)" "unprognostic (1.51e-1)" "unprognostic (9.82e-3)" 2.2 0.0 0.0 2.0 0.0 0.0 1.2 2.6 0.5 0.5 1.7 3.4 3.1 4.0 0.1 1.3 1.1 0.5 0.2 0.2 0.9 1.5 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.1 8.0 0.0 7.3 0.2 2.1 0.5 1.5 0.3 1.4 0.3 2.2 0.9 0.1 0.0 0.2 4.3 0.3 0.0 0.3 3.5 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.9 1.5 2.2 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 LRCH4 "LRN, LRRN1" ENSG00000077454 "Leucine rich repeats and calponin homology domain containing 4" O75427 7 100574011-100586153 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 153.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 45.7;NB-4: 70.7" "Low region specificity" "Detected in all" "HPA037667, HPA037668" Enhanced Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA037667: AB_10671882, HPA037668: AB_10672910" "unprognostic (2.41e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.61e-7)" "unprognostic (8.32e-3)" "unprognostic (2.76e-2)" "unprognostic (3.96e-3)" "unprognostic (8.98e-3)" "unprognostic (3.72e-2)" "unprognostic (2.52e-1)" "unprognostic (5.51e-2)" "unprognostic (2.63e-3)" "unprognostic (7.81e-2)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (7.96e-2)" "unprognostic (1.26e-2)" 11.4 15.2 14.5 32.0 25.7 52.7 13.8 19.7 22.2 12.0 14.0 16.4 11.8 22.0 12.3 9.6 14.4 14.0 15.9 10.2 16.2 9.1 16.1 12.2 20.8 39.1 25.8 13.1 23.7 17.3 8.9 22.8 26.4 19.2 14.6 7.2 18.3 23.5 13.0 15.8 15.0 27.8 8.1 25.7 54.5 14.9 43.3 23.1 31.1 20.0 6.8 25.2 9.9 12.0 5.9 6.2 24.2 8.4 1.4 7.3 2.9 7.9 4.5 4.5 4.0 2.7 2.1 8.6 7.7 3.5 4.5 3.7 7.5 11.7 5.8 8.7 2.3 4.8 6.9 2.2 3.2 1.3 5.7 6.0 6.6 5.3 3.5 8.6 11.4 45.7 3.5 3.5 3.8 2.1 2.9 4.6 15.2 8.2 11.9 3.2 15.0 13.1 70.7 4.7 7.4 5.3 14.6 3.7 7.1 3.5 2.8 5.9 8.8 3.7 11.8 9.0 6.1 7.9 24.9 7.2 6.2 11.3 8.6 4.6 12.1 5.7 5.2 4.8 28.3 10.6 12.6 8.4 11.9 5.2 6.8 4.7 4.7 5.1 5.9 6.2 5.9 7.3 5.9 24.2 1.4 4.7 5.9 5.2 2.9 14.5 25.7 19.7 22.2 16.2 9.1 25.8 13.1 19.2 23.1 8.9 16.7 24.7 13.8 10.6 13.6 0.7 25.5 6.7 6.8 21.0 39.3 33.4 13.3 27.1 153.1 9.5 22.2 0.0 21.3 11.2 9.5 12.1 18.5 11.3 30.3 12.7 5.8 15.4 53.4 19.7 23.0 33.3 13.5 52.3 12.9 15.5 23.1 14.0 9.6 6.2 29.9 19.4 12.2 42.6 28.7 10.0 86.4 42.9 11.0 14.2 LRIT3 "CSNB1F, FIGLER4, FLJ44691" ENSG00000183423 "Leucine rich repeat, Ig-like and transmembrane domains 3" Q3SXY7 4 109848202-109872315 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 17.1" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 31.4;Muller glia cells: 15.4;Rod photoreceptor cells: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013454 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA013454: AB_1853277" "unprognostic (5.41e-2)" "unprognostic (6.82e-2)" "unprognostic (4.20e-2)" "unprognostic (6.50e-2)" "unprognostic (3.42e-1)" "unprognostic (7.67e-3)" "unprognostic (1.54e-1)" "unprognostic (5.25e-2)" "unprognostic (3.16e-2)" "unprognostic (4.49e-2)" "unprognostic (6.92e-3)" "unprognostic (3.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.14e-2)" 0.6 0.6 0.7 0.6 1.2 0.4 1.7 2.0 1.3 1.2 0.6 0.6 0.6 0.3 0.7 1.8 0.6 1.0 0.6 0.6 0.8 0.7 4.4 0.7 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.6 0.6 0.6 0.9 0.5 17.1 0.8 0.6 1.6 3.2 0.6 0.6 0.6 0.8 0.2 1.3 0.6 0.6 0.8 0.6 0.6 0.6 0.6 0.1 0.3 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.0 0.6 0.6 0.0 0.0 0.1 1.3 0.1 0.2 0.3 1.6 0.3 0.4 0.2 0.1 1.3 0.0 0.0 2.0 0.1 0.3 0.2 0.1 1.3 0.3 0.6 0.0 0.0 0.9 1.0 0.2 0.8 0.2 0.6 0.0 0.2 1.0 0.3 0.5 0.0 0.0 0.4 0.0 0.3 0.1 1.2 0.0 0.3 0.3 0.6 0.3 0.6 1.0 0.0 0.3 0.9 0.3 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 1.2 2.0 1.3 0.8 0.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 31.4 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 LRMP JAW1 ENSG00000118308 "Lymphoid restricted membrane protein" Q12912 12 25004342-25108334 "Predicted intracellular proteins, Predicted membrane proteins" "Fertilization, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;lymphoid tissue: 69.5" "Cell type enhanced" "Detected in many" 9 "B-cells: 52.5;granulocytes: 24.4;Kupffer cells: 29.4;T-cells: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Daudi: 96.3;REH: 33.5;U-698: 110.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA002967, HPA018505" Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA002967: AB_1079161, HPA018505: AB_1851988" "unprognostic (3.78e-2)" "unprognostic (2.59e-3)" "unprognostic (7.54e-2)" "unprognostic (7.08e-3)" "unprognostic (2.36e-1)" "unprognostic (1.48e-3)" "unprognostic (7.98e-2)" "unprognostic (4.08e-2)" "unprognostic (7.32e-2)" "unprognostic (1.15e-1)" "unprognostic (3.59e-2)" "unprognostic (7.97e-2)" "unprognostic (7.25e-3)" "unprognostic (7.72e-2)" "unprognostic (9.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.59e-2)" 5.5 1.4 15.1 51.7 2.9 19.2 4.6 0.4 5.6 1.9 3.6 2.1 0.9 3.2 1.4 1.8 3.9 2.3 3.0 1.7 8.1 1.8 5.5 2.3 5.6 57.8 3.5 4.7 2.3 15.1 0.4 2.1 1.7 7.4 2.8 3.5 1.3 4.1 2.1 0.8 2.7 13.2 1.8 5.3 27.6 3.6 0.7 2.8 67.0 3.6 1.7 69.5 10.4 5.7 17.4 5.7 51.8 12.2 12.0 7.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 5.7 0.0 0.0 0.0 7.4 8.5 0.0 0.0 0.1 0.0 0.0 0.0 4.9 1.1 6.4 0.0 0.0 8.1 13.7 0.0 0.0 0.0 33.5 0.0 9.5 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.2 0.0 0.0 6.3 1.1 110.1 0.0 3.3 0.0 17.0 5.4 51.8 6.5 10.5 5.4 17.4 4.1 6.6 5.7 13.3 7.1 6.9 39.3 12.0 12.2 5.4 0.7 4.7 15.1 2.9 0.4 5.6 8.1 1.8 3.5 4.7 7.4 2.8 0.0 7.4 52.5 2.5 0.8 0.2 0.4 0.0 9.4 15.9 0.0 0.0 0.1 0.0 0.2 1.5 2.1 0.0 0.0 7.5 0.1 0.5 0.2 24.4 1.0 11.5 0.0 8.5 4.9 29.4 0.4 0.9 20.0 5.0 1.8 0.0 0.0 1.6 3.5 4.6 13.0 0.2 0.0 0.2 0.2 0.0 4.8 0.1 40.3 0.2 14.4 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856868-46918642 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;skin 1: 33.0" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 17.0;SuSa: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 1.2 1.9 16.0 1.3 20.3 0.5 2.1 7.3 23.7 3.0 5.4 11.6 0.6 3.9 2.1 1.3 2.4 2.0 2.5 7.2 20.4 5.8 1.2 0.7 3.4 0.5 9.6 12.6 5.4 2.7 9.3 3.3 3.1 14.5 2.7 4.1 1.3 2.1 3.0 4.4 33.0 5.3 2.0 9.7 4.2 9.6 1.6 19.0 0.0 2.9 1.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 17.0 5.2 10.6 2.9 3.9 0.7 1.5 2.3 2.5 2.2 0.0 0.0 1.1 8.7 2.4 3.0 9.5 5.8 1.8 0.0 7.9 0.8 3.0 5.2 2.2 0.1 1.5 3.6 3.4 3.5 0.9 2.0 1.9 2.1 0.7 0.0 1.3 0.6 0.1 0.2 9.2 0.0 0.7 1.2 5.8 0.0 0.2 2.2 0.0 11.2 0.9 0.0 2.8 13.6 0.2 0.4 0.1 4.6 2.9 5.2 1.6 0.0 0.0 0.3 3.4 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 20.3 7.3 17.3 20.4 5.8 9.6 12.6 14.5 19.0 0.0 3.4 0.0 2.5 7.2 0.4 4.8 0.0 0.0 2.3 1.8 39.3 1.8 1.7 0.0 0.4 0.7 6.3 0.0 0.3 0.4 4.3 0.3 4.7 0.0 0.2 0.0 0.0 1.3 0.0 0.0 1.7 0.0 1.7 1.0 2.2 8.7 0.5 2.3 1.1 0.2 2.6 0.0 1.2 0.1 0.7 9.5 1.1 0.0 1.8 0.7 LRR1 "LRR-1, MGC20689, PPIL5" ENSG00000165501 "Leucine rich repeat protein 1" Q96L50 14 49598697-49614672 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 43.9" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 77.7;Erythroid cells: 70.0;Spermatocytes: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA065703, HPA069364" Approved Approved "Nucleoplasm,Nuclear membrane,Vesicles" No No "Nucleoplasm, Nuclear membrane" Vesicles "HPA065703: AB_2685537, HPA069364: AB_2686129" "unprognostic (2.73e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-2)" "unprognostic (2.26e-2)" "unprognostic (2.85e-2)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (7.34e-2)" "unprognostic (2.50e-2)" "unprognostic (8.30e-2)" "unprognostic (4.64e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.90e-7)" "unprognostic (6.86e-2)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" "unprognostic (4.04e-2)" 5.7 6.0 1.7 7.8 2.5 14.2 5.0 2.4 2.8 3.2 8.5 2.5 2.6 7.8 4.2 2.8 7.2 3.7 4.6 6.9 1.5 1.1 4.3 5.6 4.5 9.6 2.5 1.6 3.1 6.5 1.3 1.6 4.8 2.3 3.3 6.2 4.3 6.0 5.5 7.5 4.8 7.9 3.5 3.3 8.1 4.9 43.9 2.0 28.0 3.8 7.7 9.2 4.7 4.6 12.5 14.6 20.3 18.8 7.3 12.7 8.5 22.3 16.0 12.8 12.7 2.9 2.1 14.8 12.1 11.1 27.6 24.9 14.3 18.8 20.3 8.4 7.2 8.0 14.6 15.3 11.0 19.4 20.7 12.1 9.8 11.6 9.1 2.3 23.2 12.9 2.2 3.8 12.3 5.6 1.9 13.0 17.5 9.9 13.7 13.6 20.1 27.0 19.4 7.7 10.7 20.9 19.1 21.6 14.6 9.3 9.2 12.8 7.2 11.6 13.9 8.3 3.4 17.9 15.1 5.0 19.1 31.7 8.4 14.9 7.5 10.7 22.2 9.8 16.3 14.3 16.9 12.3 20.3 9.3 18.8 11.8 12.5 11.9 12.6 12.7 9.2 9.5 10.7 6.6 7.3 13.1 14.6 12.7 8.5 1.7 2.5 2.4 2.8 1.5 1.1 2.5 1.6 2.3 2.0 3.0 6.2 3.0 4.9 13.9 3.6 2.8 10.2 2.7 7.9 3.5 2.0 8.3 1.7 11.3 77.7 8.4 10.5 70.0 19.7 27.5 7.5 7.5 13.9 5.6 18.9 1.6 4.6 6.2 11.1 26.3 6.9 12.4 10.1 14.4 8.4 4.5 10.8 0.0 3.2 6.2 5.0 6.5 7.1 63.9 10.0 13.0 6.4 6.4 12.4 5.9 LRRC2 ENSG00000163827 "Leucine rich repeat containing 2" Q9BYS8 3 46515423-46580099 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0" "Cell type enriched" "Detected in many" 17 "Cardiomyocytes: 175.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 5.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.8;HEL: 6.2;LHCN-M2: 6.2;TIME: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA039138, HPA064844" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA039138: AB_10795461, HPA064844: " "unprognostic (1.32e-4)" "unprognostic (3.44e-3)" "unprognostic (2.29e-2)" "unprognostic (3.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.44e-1)" "unprognostic (7.38e-3)" "unprognostic (1.61e-1)" "unprognostic (7.42e-2)" "unprognostic (1.45e-1)" "unprognostic (3.72e-3)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (1.09e-1)" "unprognostic (2.53e-1)" "unprognostic (1.96e-2)" "unprognostic (1.24e-1)" 1.8 0.5 1.9 0.4 1.4 0.4 1.0 1.4 3.0 2.6 1.1 0.2 0.0 0.4 3.9 1.4 1.1 1.1 1.4 53.9 1.3 0.4 2.2 2.5 0.6 0.3 0.5 2.3 2.8 0.7 0.1 2.2 0.5 1.0 1.2 0.8 0.4 1.4 0.2 70.3 1.2 0.6 2.3 0.4 1.3 1.0 0.4 0.0 1.4 10.1 20.0 1.2 1.7 1.8 1.2 0.8 2.6 0.7 1.1 2.5 0.3 0.2 0.1 0.2 0.3 1.0 2.3 0.1 0.8 1.5 0.6 0.8 0.0 0.2 0.3 0.2 10.8 0.1 0.2 3.8 0.0 1.4 0.5 0.1 6.2 0.4 0.2 0.3 0.2 0.1 0.2 0.1 4.3 0.0 3.6 0.2 0.8 0.1 0.4 6.2 0.1 0.8 0.1 1.5 0.5 0.2 0.1 0.1 0.3 0.1 0.3 0.5 1.2 0.8 0.2 1.6 1.3 0.2 0.8 4.9 0.3 0.6 2.5 1.6 0.4 0.3 2.9 0.2 0.1 1.4 2.2 0.7 0.6 0.6 0.4 0.4 0.7 1.6 0.3 0.2 1.2 0.8 0.6 2.6 1.1 0.5 0.8 2.5 0.3 1.9 1.4 1.4 3.0 1.3 0.4 0.5 2.3 1.0 0.0 8.9 0.6 0.0 0.8 1.6 0.0 175.7 2.5 1.4 0.0 1.8 0.0 0.1 8.3 0.2 2.0 1.5 0.0 0.0 0.8 0.0 4.3 0.4 10.3 8.9 1.5 0.0 2.9 5.5 0.0 1.7 0.6 1.1 10.1 0.0 1.5 0.3 1.5 0.0 0.0 0.5 0.1 0.0 3.9 0.6 0.2 2.0 0.1 0.7 1.7 0.4 LRRC28 "FLJ34269, FLJ45242, MGC24976" ENSG00000168904 "Leucine rich repeat containing 28" Q86X40 15 99251362-99390729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 131.5;Late spermatids: 330.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039378, HPA040784, HPA066130" Approved Approved "Nucleoplasm,Golgi apparatus,Mitochondria" No No Nucleoplasm "Golgi apparatus, Mitochondria" "HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623" "unprognostic (4.84e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.82e-3)" "unprognostic (9.86e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "prognostic favorable (9.97e-5)" "unprognostic (2.62e-1)" "unprognostic (1.21e-1)" "unprognostic (5.89e-2)" "unprognostic (8.37e-2)" "unprognostic (3.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.41e-1)" 9.1 9.5 7.5 5.3 12.7 7.4 7.3 12.7 15.4 7.7 10.4 8.1 6.1 15.8 6.9 7.6 9.9 5.0 8.8 10.8 7.5 6.5 17.7 42.3 6.2 6.3 6.9 8.4 5.8 18.1 9.1 10.8 5.9 9.8 6.3 9.5 9.3 8.6 6.9 18.0 12.1 18.2 7.8 6.7 6.3 9.1 24.1 5.2 17.7 7.4 8.2 8.6 7.9 7.3 4.8 6.0 21.8 6.9 3.4 7.0 4.2 2.9 7.1 7.1 9.1 10.2 14.4 3.0 3.1 8.7 5.3 6.3 5.5 6.3 5.9 5.7 7.3 6.6 6.5 5.1 9.8 7.8 3.6 7.5 4.0 3.3 5.5 9.0 3.9 6.5 8.5 13.6 5.0 10.0 12.0 16.7 9.5 3.5 5.9 11.0 5.6 10.6 6.5 2.9 22.4 2.5 6.5 6.0 5.3 11.3 9.3 3.2 4.1 7.3 4.0 11.4 11.2 6.2 7.4 6.0 5.2 3.6 4.0 6.0 12.1 16.7 3.6 6.7 3.8 9.7 15.6 6.9 21.8 5.5 5.5 4.3 4.8 5.2 5.7 6.0 4.1 4.8 4.1 3.6 3.4 5.3 5.0 7.0 4.2 7.5 12.7 12.7 15.4 7.5 6.5 6.9 8.4 9.8 5.2 14.9 2.6 9.7 11.4 12.2 20.0 13.3 10.2 10.7 6.8 10.4 21.6 15.0 23.2 11.2 131.5 10.5 25.7 23.3 25.7 18.2 9.3 9.5 2.3 32.1 16.9 20.6 8.7 11.1 19.8 330.3 11.8 8.6 13.5 17.2 15.4 14.3 13.6 20.1 8.1 54.9 19.0 0.0 12.0 42.3 35.8 13.8 10.9 15.0 13.6 11.9 LRRC75A "C17orf76, FAM211A, FLJ35696" ENSG00000181350 "Leucine rich repeat containing 75A" Q8NAA5 17 16441577-16492153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 42.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 12.0;HUVEC TERT2: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028528, HPA065840" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA028528: AB_10600755, HPA065840: " "unprognostic (1.09e-1)" "unprognostic (5.60e-2)" "unprognostic (5.79e-2)" "unprognostic (3.85e-5)" "unprognostic (3.93e-2)" "unprognostic (3.23e-2)" "unprognostic (3.44e-1)" "unprognostic (7.66e-3)" "unprognostic (7.74e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.46e-5)" "unprognostic (8.36e-2)" "unprognostic (4.28e-3)" "unprognostic (8.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-3)" "unprognostic (2.06e-1)" 1.0 8.9 5.2 2.8 3.7 1.7 0.6 0.7 6.3 2.2 26.3 1.5 1.4 15.0 1.9 0.5 0.4 0.9 0.5 0.4 4.1 2.4 0.8 0.2 1.6 1.9 1.6 3.2 1.8 1.6 3.7 4.1 1.5 2.1 1.1 10.4 1.9 0.3 1.7 0.4 0.4 42.3 3.0 0.8 6.4 1.3 8.5 0.4 0.5 1.2 0.0 1.9 1.3 0.7 0.8 0.0 0.3 0.6 0.3 0.6 0.2 1.2 1.0 1.2 0.8 0.3 0.5 0.1 0.3 0.8 2.8 2.3 1.1 0.3 0.0 0.8 0.1 0.5 0.4 0.3 0.2 0.1 0.4 0.9 12.0 0.6 0.0 0.4 0.2 0.9 0.0 0.0 0.6 0.0 0.4 3.9 1.3 0.5 0.2 0.0 2.0 1.9 0.8 0.2 2.8 0.1 0.7 0.7 0.1 0.6 0.2 2.3 0.6 0.0 0.2 2.8 0.5 0.2 0.1 0.0 0.3 1.4 0.9 1.5 1.5 0.3 0.2 0.1 0.7 1.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.6 0.3 0.3 0.6 0.0 0.0 0.2 5.2 3.7 0.7 6.3 4.1 2.4 1.6 3.2 2.1 0.4 38.7 51.3 11.9 7.2 0.0 8.7 0.3 7.6 16.0 36.4 1.8 5.9 13.7 16.6 3.8 5.3 6.0 49.1 23.3 6.1 16.9 3.9 6.4 27.8 8.1 10.5 3.2 23.7 9.2 10.7 5.9 15.3 6.7 0.0 1.8 44.8 16.7 5.7 23.0 10.6 15.2 16.4 12.9 2.3 3.8 6.7 0.0 14.0 8.9 47.2 6.2 LSG1 FLJ11301 ENSG00000041802 "Large 60S subunit nuclear export GTPase 1" Q9H089 3 194640788-194672477 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037704, HPA037705" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies, Cytosol" Nucleoplasm "HPA037704: AB_10672912, HPA037705: AB_2675621" "unprognostic (5.72e-3)" "unprognostic (9.38e-3)" "unprognostic (2.63e-1)" "unprognostic (1.23e-2)" "unprognostic (3.74e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.21e-7)" "unprognostic (4.63e-2)" "unprognostic (1.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.60e-2)" "unprognostic (4.86e-3)" "unprognostic (1.42e-1)" "unprognostic (3.00e-2)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.07e-1)" 20.4 17.8 14.2 17.9 20.7 28.8 21.8 14.5 18.9 17.7 18.5 19.2 16.6 20.4 21.6 24.8 22.5 18.3 15.3 17.8 13.3 15.1 20.4 30.6 18.2 20.2 19.9 13.3 21.9 25.6 20.6 24.4 24.2 23.8 21.0 22.3 15.9 19.8 22.2 30.1 26.0 20.0 18.0 16.3 22.2 18.5 18.6 15.9 25.0 23.5 15.8 28.1 18.7 20.3 13.2 14.0 10.7 10.6 17.0 14.9 8.2 20.3 13.5 8.2 13.8 12.9 7.0 16.7 12.2 11.8 16.8 14.9 17.8 9.4 16.1 36.8 11.2 29.4 14.9 25.9 13.9 20.5 20.8 12.5 17.2 14.0 10.1 9.2 18.9 16.7 6.8 12.1 17.4 16.2 6.2 18.2 11.4 14.3 17.9 13.8 28.3 17.0 11.3 22.4 27.5 24.9 20.7 13.5 18.2 9.0 17.7 15.6 10.8 15.9 14.6 14.9 16.2 34.3 12.4 13.9 12.8 14.6 18.0 25.0 19.7 25.9 38.2 10.3 24.4 19.8 2.8 8.1 10.7 13.5 10.6 14.9 13.2 11.0 11.9 14.0 11.0 12.9 11.5 1.1 17.0 7.1 7.4 12.2 8.2 14.2 20.7 14.5 18.9 13.3 15.1 19.9 13.3 23.8 15.9 17.9 26.4 14.6 12.3 14.3 17.0 13.4 25.5 49.5 39.8 8.7 11.8 20.5 5.0 16.5 8.6 13.5 11.5 23.3 19.4 16.2 10.6 9.4 51.0 12.4 11.2 14.3 7.5 9.8 4.5 6.5 14.4 13.1 11.8 10.8 11.2 18.2 16.1 9.9 13.8 10.2 17.4 19.4 9.8 18.1 33.3 14.1 23.8 13.8 14.5 7.1 LTC4S MGC33147 ENSG00000213316 "Leukotriene C4 synthase" Q16873 5 179793980-179796647 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism" "Lyase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.3" "Cell type enriched" "Detected in many" 6 "granulocytes: 332.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 8.5;eosinophil: 31.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 31.3" "Cell line enriched" "Detected in some" 10 "HMC-1: 52.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044688 Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA Nucleoplasm "Endoplasmic reticulum, Cytosol" "HPA044688: " "unprognostic (8.94e-2)" "unprognostic (2.40e-2)" "unprognostic (9.35e-3)" "unprognostic (3.57e-2)" "unprognostic (1.24e-2)" "unprognostic (9.40e-2)" "unprognostic (4.53e-5)" "unprognostic (2.27e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (2.65e-1)" "unprognostic (1.98e-2)" "unprognostic (4.62e-1)" 9.0 6.7 3.5 2.8 3.5 8.6 4.6 1.7 5.0 6.9 5.0 9.4 5.4 3.6 8.7 10.4 4.2 13.0 15.7 11.3 3.9 3.1 6.2 2.3 28.3 8.0 6.8 4.2 5.8 2.4 2.0 3.2 2.9 4.3 5.6 1.9 3.3 7.4 11.6 2.7 3.5 5.7 4.5 6.3 6.7 5.0 3.3 3.9 0.8 5.3 5.6 3.2 3.6 3.9 0.1 4.5 31.3 0.3 2.2 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 5.3 0.0 0.2 0.2 0.3 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 8.5 0.2 31.3 0.5 0.3 1.7 0.1 1.2 0.8 4.5 0.1 0.2 0.5 0.1 2.2 0.0 0.2 0.1 0.3 3.5 3.5 1.7 5.0 3.9 3.1 6.8 4.2 4.3 3.9 0.0 5.6 2.2 7.5 8.9 0.2 0.0 12.7 4.0 3.4 14.0 0.0 6.9 1.7 4.1 0.3 11.3 0.4 0.0 2.1 1.5 4.7 3.1 332.3 0.8 33.8 0.0 2.9 53.4 8.9 0.0 15.3 23.5 1.7 1.0 1.6 0.0 2.1 0.0 44.6 40.2 0.3 0.0 0.9 0.0 0.7 6.0 2.5 5.0 2.6 5.0 LUZP2 ENSG00000187398 "Leucine zipper protein 2" Q86TE4 11 24496970-25082631 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.1;brain: 32.7" "Group enriched" "Detected in some" 4 "Early spermatids: 18.8;Paneth cells: 21.8" "Group enriched" "Detected in some" 7 "glioma: 3.5;prostate cancer: 4.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 14.2;HAP1: 7.1;HeLa: 2.5;hTERT-RPE1: 6.1" "Low region specificity" "Detected in all" "HPA039007, HPA046161" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in brain" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039007: AB_2676307, HPA046161: AB_2679564" "unprognostic (4.49e-2)" "unprognostic (2.74e-2)" "unprognostic (8.63e-2)" "unprognostic (3.50e-1)" "unprognostic (5.22e-3)" "unprognostic (3.38e-1)" "unprognostic (4.88e-2)" "unprognostic (5.67e-4)" "unprognostic (2.40e-1)" "unprognostic (5.66e-2)" "unprognostic (6.16e-3)" "unprognostic (4.09e-2)" "unprognostic (5.18e-3)" "unprognostic (9.41e-3)" "unprognostic (4.18e-2)" "unprognostic (2.17e-1)" "unprognostic (9.64e-2)" 1.2 11.1 14.5 0.9 10.8 0.9 1.6 2.6 32.7 0.9 2.1 5.9 0.0 0.9 1.0 0.8 0.9 0.8 1.0 1.0 10.3 13.8 1.0 2.3 1.1 0.8 13.7 5.6 0.8 0.8 0.7 1.9 0.8 26.7 4.5 1.7 0.0 1.0 0.9 0.8 0.9 1.1 1.2 30.0 0.9 0.9 1.6 14.5 0.0 0.8 0.9 0.8 1.6 0.3 0.5 0.4 1.9 0.3 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.2 7.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.2 0.2 0.0 1.5 0.1 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.5 0.3 0.4 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.5 0.3 0.2 1.9 0.3 0.2 0.4 0.1 0.0 14.5 10.8 2.6 9.3 10.3 13.8 13.7 5.6 26.7 14.5 0.0 0.0 0.0 0.1 0.6 2.3 0.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.6 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 1.8 0.2 0.1 21.8 0.0 0.6 0.6 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.9 0.7 LYAR "ZC2HC2, ZLYAR" ENSG00000145220 "Ly1 antibody reactive" Q9NX58 4 4267701-4290169 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 435.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035880, HPA035881" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA035880: , HPA035881: AB_10669980" "unprognostic (2.81e-1)" "unprognostic (3.79e-1)" "unprognostic (2.64e-2)" "unprognostic (6.22e-3)" "unprognostic (1.44e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (1.08e-3)" "unprognostic (2.92e-2)" "prognostic favorable (8.82e-4)" "unprognostic (5.05e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.94e-2)" "unprognostic (1.61e-1)" "unprognostic (5.90e-2)" "unprognostic (2.72e-1)" 11.1 5.7 6.8 11.9 10.1 10.9 8.2 7.3 8.0 6.6 6.9 4.3 4.1 5.7 6.9 5.5 11.2 7.1 5.4 10.1 7.0 4.6 5.0 9.9 7.7 13.8 10.9 4.5 11.1 6.3 4.4 15.6 7.1 8.4 7.8 6.8 3.7 5.4 6.4 15.1 5.9 6.2 9.1 7.9 18.2 5.8 60.2 12.0 10.0 6.3 11.9 10.9 10.1 10.4 7.3 7.1 8.9 12.9 10.7 32.8 10.3 13.3 7.0 6.3 9.2 5.5 6.3 10.8 12.2 4.2 12.7 8.8 22.0 17.6 35.9 8.8 5.2 20.5 8.5 23.5 12.7 16.7 6.4 17.3 36.0 6.7 24.6 9.4 41.5 9.8 4.9 8.1 14.6 24.9 3.3 10.9 20.5 48.1 12.0 8.8 13.5 14.1 53.5 31.3 14.2 23.0 21.7 11.5 17.3 5.7 9.3 15.0 6.4 6.6 7.3 12.4 8.4 7.5 12.4 10.2 12.7 10.1 16.5 38.4 8.5 12.8 57.4 8.6 35.1 10.2 8.9 9.7 8.5 28.6 9.6 32.8 7.3 18.9 30.8 7.1 5.7 8.9 19.0 2.8 10.7 12.9 5.3 8.8 10.3 6.8 10.1 7.3 8.0 7.0 4.6 10.9 4.5 8.4 12.0 14.9 30.0 19.7 34.4 106.7 9.4 21.6 12.7 26.8 36.4 1.8 7.9 43.0 8.3 15.1 74.2 29.5 2.8 0.0 17.0 43.6 29.4 25.4 20.8 10.6 32.5 14.3 10.3 8.6 30.8 61.9 31.7 32.1 20.3 19.0 16.0 9.6 22.6 13.9 25.1 5.1 28.7 38.8 35.0 435.9 39.2 101.3 16.9 130.7 24.0 62.3 LYPD1 "LYPDC1, MGC29643" ENSG00000150551 "LY6/PLAUR domain containing 1" Q8N2G4 2 132644853-132671579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;fallopian tube: 74.6" "Group enriched" "Detected in many" 5 "Ductal cells: 49.4;Exocrine glandular cells: 65.7;monocytes: 108.2;Pancreatic endocrine cells: 67.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 57.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 10.9" "Lineage enriched" "Detected in single" 36 "granulocytes: 10.9" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 17.4;HUVEC TERT2: 14.8;SK-MEL-30: 15.2;SuSa: 13.7;U-251 MG: 31.7;WM-115: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068333 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA068333: " "unprognostic (9.25e-2)" "unprognostic (7.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.07e-2)" "unprognostic (6.40e-3)" "unprognostic (5.60e-2)" "unprognostic (8.36e-3)" "unprognostic (1.05e-2)" "unprognostic (6.70e-2)" "unprognostic (2.86e-2)" "unprognostic (1.51e-2)" "unprognostic (1.43e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" 1.5 2.5 16.4 1.7 27.8 1.2 1.4 3.8 16.8 1.3 2.5 4.6 0.0 1.4 2.5 1.8 1.4 74.6 3.6 1.8 18.9 19.0 3.2 1.6 1.4 3.5 16.9 5.4 8.4 3.5 2.0 12.4 1.2 11.8 1.4 1.4 5.4 21.7 1.4 1.2 1.5 1.4 1.8 7.0 1.3 1.4 1.5 3.4 1.2 1.3 1.1 2.5 1.4 0.0 0.3 0.0 10.9 0.0 0.0 0.0 0.0 0.2 4.8 5.4 0.0 0.0 0.0 0.0 1.1 0.6 2.4 0.5 0.4 0.6 0.0 10.1 2.0 1.6 5.2 0.0 0.0 1.2 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 1.0 14.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.3 0.1 2.1 0.0 0.0 0.0 7.1 0.1 0.7 1.3 0.6 0.0 15.2 13.7 0.0 0.1 0.7 0.3 7.6 3.2 31.7 0.0 0.0 0.0 6.2 0.0 63.9 1.3 0.0 10.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 27.8 3.8 11.0 18.9 19.0 16.9 5.4 11.8 3.4 0.0 0.0 0.0 0.0 0.1 0.8 0.2 5.1 0.0 0.0 5.2 0.0 0.0 1.7 49.4 4.4 0.0 0.0 0.0 65.7 0.0 0.1 0.1 0.0 0.0 0.1 14.3 1.7 0.6 0.3 6.3 3.7 0.0 0.0 108.2 0.0 1.5 67.6 0.0 0.0 2.2 0.8 0.0 5.3 1.1 1.8 0.0 0.0 0.0 0.0 0.0 LYST "CHS, CHS1" ENSG00000143669 "Lysosomal trafficking regulator" Q99698 1 235661041-235883640 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.8" "Cell type enhanced" "Detected in many" 6 "monocytes: 236.3;Rod photoreceptor cells: 167.4" "Cancer enhanced" "Detected in all" "melanoma: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Group enriched" "Detected in all" 5 "granulocytes: 13.0;monocytes: 5.9" "Cell line enhanced" "Detected in many" "HDLM-2: 13.7;SK-MEL-30: 12.7;THP-1: 44.9;U-937: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053366, HPA055725" Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" Yes No Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA053366: AB_2682129, HPA055725: AB_2682898" "unprognostic (1.56e-2)" "unprognostic (1.54e-1)" "unprognostic (9.92e-2)" "unprognostic (8.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.32e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" "unprognostic (6.29e-2)" "unprognostic (1.99e-1)" 10.3 5.2 6.4 9.0 8.8 31.3 10.6 10.5 7.1 8.8 5.3 3.8 3.4 3.4 6.8 4.3 6.6 5.6 5.8 4.7 4.3 2.4 5.0 6.1 10.9 7.8 4.2 6.0 6.2 5.0 9.1 12.6 5.5 5.3 6.0 5.0 9.6 8.2 4.8 3.9 11.7 6.3 9.8 9.2 11.3 8.4 6.4 6.3 38.8 8.5 4.0 7.6 9.3 10.6 1.6 1.7 13.0 5.9 1.7 1.0 0.7 3.8 0.9 0.4 0.9 6.0 6.9 0.6 1.4 5.7 1.5 1.4 0.0 1.0 0.5 0.6 3.1 3.6 1.8 0.5 0.7 1.3 13.7 1.2 1.2 0.8 0.3 1.1 1.8 1.7 2.3 3.6 1.9 4.7 2.2 1.2 0.6 0.1 0.8 1.2 0.2 2.3 3.9 0.1 0.7 0.4 0.1 0.5 0.0 4.4 4.2 2.5 0.5 1.5 0.0 12.7 0.5 0.5 44.9 2.6 1.1 0.5 1.3 1.2 0.9 0.0 0.0 1.9 17.2 3.2 0.4 3.1 5.7 0.6 3.5 1.0 1.1 0.3 0.7 1.7 1.6 0.2 0.5 13.0 1.7 5.9 0.2 0.2 0.7 6.4 8.8 10.5 7.1 4.3 2.4 4.2 6.0 5.3 6.3 17.9 50.4 48.0 71.9 63.1 61.8 9.2 10.2 24.1 39.8 10.4 88.4 5.4 10.0 5.6 9.9 41.7 11.5 0.0 10.7 4.0 23.9 49.0 106.6 14.5 28.2 49.3 9.2 15.4 73.1 13.4 25.9 70.4 114.7 236.3 11.3 23.7 24.4 14.2 20.5 9.0 167.4 12.9 28.6 79.6 22.6 57.0 7.3 65.4 6.3 82.9 LYZ ENSG00000090382 Lysozyme P61626 12 69348341-69354234 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase" "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 490.0;salivary gland: 1017.8" "Cell type enhanced" "Detected in many" 16 "Kupffer cells: 3040.5;Macrophages: 4386.3;Pancreatic endocrine cells: 1930.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 490.0;myeloid DC: 308.1" "Group enriched" "Detected in all" 18 "dendritic cells: 308.1;monocytes: 490.0" "Cell line enriched" "Detected in some" 13 "OE19: 521.4" "Not detected" "Not detected" "CAB000055, HPA048284, HPA066182" Enhanced Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Secreted to blood" NA NA 1500000000 2600000000 "Golgi apparatus, Actin filaments" Nucleoplasm "CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741" "unprognostic (8.52e-2)" "unprognostic (6.12e-3)" "unprognostic (2.83e-1)" "unprognostic (7.29e-2)" "unprognostic (7.91e-2)" "prognostic favorable (7.45e-4)" "unprognostic (1.21e-1)" "unprognostic (7.40e-2)" "unprognostic (1.41e-1)" "unprognostic (2.08e-2)" "unprognostic (1.44e-1)" "unprognostic (3.13e-1)" "unprognostic (2.50e-1)" "unprognostic (2.37e-1)" "unprognostic (3.65e-2)" "unprognostic (5.78e-2)" "unprognostic (3.62e-2)" 19.1 2.4 1.7 42.1 1.8 187.0 2.9 1.6 1.6 2.9 52.5 2.0 0.1 72.4 2.3 6.9 3.9 3.4 105.0 15.4 1.8 1.8 4.8 4.8 81.0 57.2 2.1 0.0 4.5 5.0 0.0 1.8 8.3 0.9 2.4 5.0 2.7 1017.8 2.8 1.8 2.1 95.0 1.8 2.5 34.2 212.1 1.6 0.5 24.5 2.4 207.7 75.7 6.6 2.4 1.6 308.1 21.9 490.0 2.3 1.1 407.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 39.8 0.0 4.6 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 4.5 0.1 521.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 22.3 0.0 7.5 490.0 5.9 0.7 102.3 1.1 1.6 0.4 0.5 308.1 0.4 0.4 0.4 21.9 2.3 17.6 6.5 0.6 407.9 1.7 1.8 1.6 1.6 1.8 1.8 2.1 0.0 0.9 0.5 80.4 424.7 79.8 2.3 50.8 0.1 0.0 815.3 52.2 87.6 26.2 0.0 4.1 0.0 46.7 1.4 10.8 19.6 0.0 484.8 7.4 19.7 4.1 113.9 7.3 924.7 0.0 12.0 37.4 3040.5 3.7 3.7 4386.3 50.6 757.4 61.5 0.0 1930.3 401.2 2.1 5.0 1.1 38.8 3.9 0.6 2.3 33.4 7.1 13.8 38.3 2.2 LZTR1 "BTBD29, LZTR-1" ENSG00000099949 "Leucine zipper like transcription regulator 1" Q8N653 22 20982013-20999038 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067852, HPA068772, HPA071248" Approved Approved Nucleoplasm,Centrosome,Cytosol No No Nucleoplasm "Centrosome, Cytosol" "HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372" "unprognostic (1.88e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (5.15e-4)" "unprognostic (9.81e-2)" "unprognostic (3.55e-1)" "unprognostic (3.78e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.16e-3)" "unprognostic (4.29e-2)" "unprognostic (1.65e-1)" "unprognostic (6.25e-2)" "unprognostic (1.25e-2)" 21.2 16.9 17.3 15.6 17.4 10.3 17.9 20.7 24.7 18.5 18.3 25.3 20.6 18.9 24.9 14.0 16.5 18.3 21.2 15.8 15.4 10.9 17.2 13.1 16.2 12.8 19.6 16.5 21.7 16.2 24.9 26.0 18.8 19.0 16.9 12.9 18.9 17.5 18.0 17.2 15.0 15.7 21.9 14.0 19.3 14.5 10.8 19.2 10.8 19.6 12.6 12.5 18.5 16.4 1.6 2.2 0.2 3.4 1.8 3.0 1.5 6.3 5.2 7.8 9.4 17.9 12.4 6.3 13.0 9.1 7.4 10.2 3.0 2.6 6.7 4.8 14.5 6.9 8.6 5.8 10.6 3.0 12.5 13.6 7.2 6.8 4.5 9.6 3.9 9.6 11.4 5.4 9.4 6.8 11.8 14.4 6.3 30.0 11.7 8.4 3.8 6.9 3.7 2.4 7.7 5.7 8.2 11.3 2.6 5.9 8.6 7.7 11.4 7.1 12.3 7.6 4.9 5.7 7.2 12.8 17.4 8.9 7.8 7.0 5.1 4.4 2.0 7.8 3.8 8.4 0.0 2.5 0.2 3.0 3.1 1.6 1.6 1.5 2.8 2.2 1.0 2.1 1.5 0.1 1.8 3.4 1.2 0.5 1.5 17.3 17.4 20.7 24.7 15.4 10.9 19.6 16.5 19.0 19.2 11.9 10.4 9.7 1.4 1.9 8.1 11.2 2.5 6.7 5.7 8.7 5.9 3.6 1.7 6.6 0.8 9.5 7.8 0.0 4.3 3.2 5.4 2.0 5.7 6.2 6.9 3.2 8.7 12.3 11.6 1.3 8.1 4.9 6.8 4.6 9.1 6.6 5.7 5.9 9.2 6.1 9.3 0.0 7.2 2.6 1.7 3.1 3.0 6.9 5.8 0.9 MAD2L1BP "CMT2, dJ261G23.1, KIAA0110" ENSG00000124688 "MAD2L1 binding protein" Q15013 6 43629540-43640952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028729 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No Nucleoplasm "Nuclear membrane, Nucleoli" "HPA028729: AB_2672752" "unprognostic (2.60e-1)" "unprognostic (2.06e-1)" "unprognostic (3.92e-2)" "unprognostic (6.97e-2)" "unprognostic (6.91e-2)" "unprognostic (6.92e-2)" "unprognostic (5.74e-3)" "unprognostic (2.67e-3)" "unprognostic (3.60e-1)" "unprognostic (7.18e-2)" "unprognostic (1.71e-1)" "unprognostic (6.64e-2)" "unprognostic (4.61e-2)" "unprognostic (1.18e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-1)" "unprognostic (3.25e-3)" 12.1 16.6 11.0 13.3 14.4 35.7 13.8 16.5 24.4 12.2 21.3 10.1 6.3 18.1 12.9 14.1 17.0 13.4 13.2 19.2 11.9 12.1 18.3 18.9 11.4 18.2 11.0 12.6 11.3 18.5 11.5 12.8 12.6 14.0 12.6 22.0 13.6 24.2 11.3 25.1 11.9 22.0 12.4 9.8 17.5 16.8 17.6 7.9 29.0 18.9 13.9 19.9 14.3 13.2 27.9 27.6 39.7 22.2 26.8 39.8 21.4 15.9 7.4 11.7 13.0 10.2 11.1 7.1 9.6 15.6 21.4 20.1 15.1 6.5 12.5 5.5 11.3 19.5 10.5 18.2 13.4 16.5 11.4 14.1 15.4 8.2 13.0 11.0 9.0 9.3 11.2 16.5 15.9 9.7 10.8 16.0 10.1 19.7 6.7 14.8 15.0 8.0 16.8 7.2 66.4 9.6 9.3 9.1 11.8 15.2 12.8 14.0 14.2 6.9 10.7 45.4 9.3 12.5 24.2 8.7 11.5 9.6 7.5 15.3 8.7 7.4 29.3 10.4 15.3 12.6 39.7 22.2 25.0 25.7 22.1 25.8 27.9 30.8 28.4 27.6 25.6 32.3 29.0 18.6 26.8 19.9 18.3 39.8 21.4 11.0 14.4 16.5 24.4 11.9 12.1 11.0 12.6 14.0 7.9 23.8 10.1 16.1 16.9 12.8 12.1 10.4 10.2 21.4 21.6 3.5 11.8 18.1 23.2 24.8 36.4 11.3 26.9 23.3 18.5 17.9 15.3 9.1 30.1 11.3 15.5 9.5 16.7 14.7 10.8 27.8 11.2 13.0 27.0 20.8 15.1 12.4 20.4 25.9 11.3 16.5 12.0 25.8 12.2 18.4 18.8 8.4 5.1 15.4 19.2 21.6 MAF1 DKFZp586G1123 ENSG00000179632 "MAF1 homolog, negative regulator of RNA polymerase III" Q9H063 8 144104499-144107611 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024821, HPA058548" Uncertain Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA024821: AB_2671696, HPA058548: AB_2683751" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.71e-2)" "unprognostic (2.21e-1)" "unprognostic (8.51e-2)" "unprognostic (9.67e-2)" "prognostic unfavorable (7.09e-4)" "unprognostic (6.12e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (9.40e-3)" "unprognostic (9.02e-2)" "unprognostic (2.59e-1)" "unprognostic (2.38e-1)" "unprognostic (3.99e-2)" 26.8 23.2 17.5 18.4 17.5 43.6 35.7 20.5 26.3 27.3 47.2 23.7 22.8 19.5 33.0 22.5 34.4 26.1 33.6 72.5 17.3 15.5 24.1 21.4 21.2 28.2 19.7 18.6 36.3 39.8 25.2 20.8 23.8 14.9 36.8 18.9 23.8 28.7 32.3 114.3 18.7 29.8 50.9 17.2 27.7 28.9 30.2 16.2 35.5 40.4 38.7 22.8 35.2 46.7 48.0 39.9 45.1 34.5 33.2 46.2 32.6 24.2 39.1 18.1 18.1 49.6 24.8 14.7 19.1 31.6 29.9 30.6 14.3 27.1 27.0 32.6 31.9 16.6 15.0 24.6 27.0 22.1 23.8 29.8 29.5 26.9 22.3 33.5 12.5 20.3 21.8 31.7 23.9 45.3 33.5 32.2 19.8 22.7 18.4 17.8 57.9 46.6 23.0 13.6 44.2 105.0 18.7 25.4 28.7 18.7 18.3 26.5 22.1 25.4 33.1 30.9 17.7 22.5 19.2 19.3 14.0 31.9 24.6 24.0 22.3 16.9 12.6 23.2 23.4 9.2 15.8 34.5 45.1 28.5 26.8 32.3 40.1 41.0 46.2 39.9 48.0 44.2 41.4 19.9 33.2 27.0 29.8 29.2 32.6 17.5 17.5 20.5 26.3 17.3 15.5 19.7 18.6 14.9 16.2 14.9 17.0 89.7 75.9 82.5 41.2 46.4 7.6 4.0 3.4 41.8 13.7 87.2 89.5 88.1 49.3 67.4 88.9 70.0 94.2 87.3 63.4 114.9 33.3 25.2 87.3 35.0 89.6 44.8 58.6 27.8 81.7 78.7 74.2 166.9 77.1 55.4 88.3 79.3 87.7 90.2 29.0 97.0 72.8 85.0 43.7 78.4 120.7 94.5 78.4 80.6 MAGEA11 "CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511" ENSG00000185247 "MAGE family member A11" P43364 X 149688228-149717266 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 36.5;testis: 9.3" "Cell type enhanced" "Detected in some" 22 "Spermatocytes: 9.3;Spermatogonia: 14.3;Syncytiotrophoblasts: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-2 OS: 23.4" HPA052687 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA052687: AB_2681915" "unprognostic (4.06e-3)" "unprognostic (2.05e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-2)" "unprognostic (9.64e-2)" "unprognostic (1.32e-1)" "unprognostic (6.13e-2)" "unprognostic (1.16e-1)" "unprognostic (6.67e-4)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 36.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 23.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 14.3 0.0 4.9 0.0 0.0 0.0 MAGED2 "11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386" ENSG00000102316 "MAGE family member D2" Q9UNF1 X 54807599-54816012 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Bartter syndrome, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 301.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031572, HPA031573" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA031572: AB_10599819, HPA031573: AB_10602181" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.32e-1)" "unprognostic (1.69e-3)" "unprognostic (4.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.41e-3)" "unprognostic (1.39e-1)" "unprognostic (2.97e-1)" "prognostic favorable (2.88e-4)" "prognostic favorable (2.82e-4)" "unprognostic (6.34e-2)" "unprognostic (3.55e-3)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" "unprognostic (3.58e-1)" 22.1 38.4 26.9 14.8 26.5 8.2 50.2 24.4 43.0 55.7 27.3 27.8 21.4 16.2 41.1 31.8 21.9 45.9 28.5 40.7 23.8 38.2 42.7 17.3 24.0 13.5 30.3 36.0 79.7 23.5 34.5 57.6 58.6 57.1 63.9 16.4 43.1 32.0 53.7 25.6 16.5 17.6 41.6 24.7 17.5 22.5 21.8 18.3 23.4 45.1 17.3 22.0 31.9 29.2 17.1 11.7 43.1 37.0 28.5 35.5 32.5 5.4 10.0 60.2 18.3 28.7 39.1 11.1 22.5 40.2 17.9 31.8 10.0 13.9 7.6 59.1 45.3 14.7 7.4 17.1 17.0 12.9 13.5 14.2 15.7 11.9 19.5 24.6 4.0 12.1 51.1 7.1 18.1 9.2 36.9 33.9 8.9 3.8 9.3 34.1 15.0 8.9 6.7 22.2 9.5 12.0 5.9 21.6 10.8 24.5 4.1 9.5 24.5 8.9 10.4 52.0 73.5 42.9 6.8 29.2 15.3 23.8 22.7 6.3 6.0 5.0 5.4 22.3 10.6 77.7 43.1 9.1 35.5 35.5 22.4 27.3 16.3 29.4 33.1 11.7 17.1 29.7 34.1 3.4 28.5 37.0 7.2 29.2 32.5 26.9 26.5 24.4 43.0 23.8 38.2 30.3 36.0 57.1 18.3 41.7 33.9 29.8 80.0 37.7 72.3 51.6 53.5 66.9 30.7 73.3 27.5 185.2 208.9 88.2 2.4 76.6 14.7 0.0 47.8 117.1 94.0 95.1 100.4 13.2 60.7 130.3 56.0 66.9 12.9 8.5 216.0 36.3 150.1 64.9 42.6 178.6 48.5 32.3 301.2 111.7 49.9 155.2 150.8 13.5 12.4 30.6 141.5 45.4 24.9 55.9 MAML2 "KIAA1819, MAM3" ENSG00000184384 "Mastermind like transcriptional coactivator 2" Q8IZL2 11 95976598-96343180 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 86.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.9" "Low region specificity" "Detected in all" HPA035223 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA035223: AB_10671101" "unprognostic (8.11e-2)" "unprognostic (2.51e-1)" "unprognostic (7.08e-2)" "unprognostic (9.07e-2)" "unprognostic (3.57e-3)" "unprognostic (3.32e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (8.05e-2)" "prognostic unfavorable (3.89e-4)" "unprognostic (9.11e-2)" "prognostic favorable (1.90e-4)" "unprognostic (9.76e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-1)" "unprognostic (7.19e-2)" 26.3 5.5 10.2 16.1 8.1 4.2 19.7 27.8 13.4 15.8 9.2 10.4 8.4 4.3 11.2 8.5 9.3 11.7 10.8 8.9 10.5 6.9 13.8 3.5 15.0 10.9 6.9 3.4 11.7 8.2 13.3 15.2 18.8 9.3 12.3 8.9 10.8 16.6 12.3 4.4 14.2 8.9 10.2 14.4 16.8 6.5 4.3 10.6 21.2 11.8 4.8 13.6 16.0 15.3 2.1 1.2 4.7 1.1 4.2 6.4 2.0 5.6 1.1 9.8 2.6 10.2 11.8 2.1 6.5 9.8 4.3 4.5 0.7 12.0 1.2 15.5 15.1 2.3 5.2 2.0 6.3 6.0 27.9 0.7 0.7 2.0 2.1 6.0 0.0 0.0 17.2 0.6 7.7 4.5 8.0 2.4 0.1 3.1 1.8 7.6 0.4 0.1 1.5 1.0 2.9 1.8 1.9 1.8 6.5 6.4 8.0 0.1 0.9 2.4 1.0 2.7 3.3 0.9 0.3 10.6 7.6 1.8 2.6 4.1 1.2 0.2 1.8 3.6 1.1 13.9 0.1 1.1 0.0 1.5 0.6 2.6 1.9 3.2 4.1 1.2 2.1 6.4 4.3 4.7 4.2 0.7 0.9 1.2 2.0 10.2 8.1 27.8 7.0 10.5 6.9 6.9 3.4 9.3 10.6 14.9 7.5 12.1 17.3 17.3 40.8 4.1 12.7 18.7 19.4 12.2 86.4 10.3 10.0 14.8 1.1 20.5 18.4 0.0 0.4 20.6 19.5 17.4 1.1 0.2 16.3 0.0 6.4 6.7 12.6 1.4 8.1 15.7 11.8 16.2 6.2 24.7 9.5 14.4 8.1 11.8 21.9 32.3 17.3 0.5 0.6 11.8 10.9 16.0 11.8 13.1 MAP3K10 "MEKK10, MLK2, MST" ENSG00000130758 "Mitogen-activated protein kinase kinase kinase 10" Q02779 19 40191744-40215575 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 13.9;Horizontal cells: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007039 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Actin filaments, Cytosol" "HPA007039: AB_1079357" "unprognostic (2.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-3)" "unprognostic (2.03e-2)" "unprognostic (2.04e-1)" "prognostic favorable (8.69e-4)" "unprognostic (4.50e-3)" "unprognostic (1.80e-1)" "unprognostic (3.94e-2)" "unprognostic (6.13e-2)" "unprognostic (1.34e-3)" "unprognostic (4.62e-3)" "unprognostic (6.88e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-2)" "unprognostic (4.77e-3)" "prognostic favorable (2.13e-4)" 7.7 7.0 29.6 4.7 22.8 3.7 2.2 14.3 32.0 3.3 3.4 5.3 1.8 4.4 4.5 1.8 3.7 3.1 4.0 8.2 28.2 11.2 4.7 2.1 4.2 4.6 11.5 9.4 4.3 8.1 4.7 5.2 3.7 9.0 4.6 2.0 2.4 6.9 4.8 22.9 5.6 5.0 4.0 5.3 6.7 6.2 6.6 7.1 2.3 3.3 2.6 2.4 3.8 5.4 0.8 0.0 0.0 0.2 0.0 0.9 0.0 6.3 7.6 2.4 5.6 2.2 1.3 6.5 4.4 2.2 2.0 2.1 1.7 1.8 5.8 4.6 1.5 5.1 2.1 0.9 2.3 0.3 11.0 7.2 1.5 3.2 1.7 4.2 1.3 3.7 1.2 5.5 2.2 1.5 2.3 1.9 8.2 5.5 9.9 0.6 3.8 4.8 2.3 2.8 2.1 5.0 5.9 2.5 3.4 1.8 4.0 7.9 11.4 5.1 1.9 10.4 1.5 2.5 2.3 3.1 5.4 5.2 7.8 8.5 13.1 7.5 2.6 6.2 2.4 7.8 0.0 0.1 0.0 0.4 0.2 0.0 0.8 0.2 0.9 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 29.6 22.8 14.3 28.7 28.2 11.2 11.5 9.4 9.0 7.1 0.0 0.0 2.2 1.5 1.3 13.9 2.4 0.0 0.0 0.0 7.0 7.9 0.6 0.0 2.3 2.6 2.3 2.6 0.0 3.6 0.7 1.9 2.0 0.0 2.6 2.2 22.3 4.1 3.7 2.2 6.5 2.8 1.1 1.7 1.0 1.9 5.2 3.4 1.9 4.6 3.7 7.3 6.5 2.6 2.6 1.7 2.4 1.1 1.9 2.1 1.7 MAP3K13 "LZK, MEKK13" ENSG00000073803 "Mitogen-activated protein kinase kinase kinase 13" O43283 3 185282941-185489097 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 456.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016497, HPA036691, HPA036692" Uncertain Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845" "unprognostic (8.95e-2)" "unprognostic (6.72e-3)" "unprognostic (9.46e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (5.16e-2)" "unprognostic (2.81e-1)" "unprognostic (2.61e-1)" "unprognostic (1.23e-2)" "unprognostic (9.04e-2)" "prognostic favorable (1.11e-4)" "prognostic unfavorable (7.27e-5)" "unprognostic (2.70e-3)" "unprognostic (1.54e-2)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (6.64e-2)" "unprognostic (9.31e-3)" 9.8 24.8 21.7 8.7 22.2 9.5 15.1 16.4 26.1 12.9 16.9 18.4 10.5 16.8 12.9 42.1 15.2 14.6 13.1 8.1 19.2 18.6 21.9 20.7 15.2 7.4 23.2 17.1 16.5 24.9 20.9 24.5 9.1 21.8 14.5 18.9 18.6 26.2 11.4 3.3 9.8 23.4 12.1 26.4 8.7 16.4 12.9 15.8 4.4 18.6 8.3 10.3 12.5 11.5 23.7 21.5 21.1 13.2 11.5 17.4 7.8 29.1 5.8 11.3 0.3 10.3 12.7 6.7 6.7 4.6 10.9 13.2 11.2 11.0 0.2 23.0 12.2 18.2 16.7 0.3 15.5 19.4 32.5 15.0 0.1 7.9 9.2 11.2 15.3 8.4 11.5 13.6 9.3 11.7 11.3 12.1 0.3 0.3 23.7 9.7 9.1 1.8 7.2 13.0 22.5 13.7 0.2 13.5 16.0 19.2 7.6 18.6 12.4 11.3 17.1 23.2 12.9 25.8 8.6 8.0 9.0 11.7 16.2 14.5 12.1 15.6 9.6 13.2 7.8 14.7 6.4 13.2 5.1 10.3 12.2 15.8 23.7 12.4 12.8 21.5 19.0 17.4 16.8 21.1 11.5 8.6 9.4 4.8 7.8 21.7 22.2 16.4 26.1 19.2 18.6 23.2 17.1 21.8 15.8 50.6 76.2 44.7 172.9 125.7 111.5 22.1 104.4 64.3 84.2 75.0 86.4 120.9 243.7 92.5 109.7 52.6 82.0 0.0 111.2 29.4 48.3 249.1 28.9 83.1 55.4 42.9 102.2 83.4 50.4 168.4 40.0 59.4 81.0 456.3 109.9 93.7 112.0 96.2 50.9 224.8 81.3 45.3 74.0 119.3 28.8 127.2 170.1 31.2 98.7 249.0 MAPK15 "ERK7, ERK8" ENSG00000181085 "Mitogen-activated protein kinase 15" Q8TD08 8 143716259-143722458 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;epididymis: 27.6;fallopian tube: 29.5" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 85.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;HaCaT: 5.4;HeLa: 14.3;MCF7: 13.9;T-47d: 12.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002704 Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA002704: AB_1079307" "unprognostic (9.11e-2)" "unprognostic (1.38e-1)" "unprognostic (8.04e-3)" "unprognostic (2.94e-1)" "unprognostic (2.54e-2)" "unprognostic (1.14e-2)" "unprognostic (1.22e-1)" "unprognostic (6.09e-2)" "unprognostic (2.59e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-1)" "unprognostic (9.51e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (5.78e-1)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" 0.6 0.1 3.6 0.3 8.1 0.1 1.1 0.2 2.1 4.5 0.4 8.7 5.2 0.5 2.2 27.6 1.3 29.5 0.4 1.1 5.4 4.6 3.9 0.2 7.4 0.5 0.2 1.5 4.7 2.0 9.1 4.2 0.6 26.9 0.9 0.4 1.6 3.0 2.4 0.2 4.9 0.7 0.5 0.4 0.5 0.9 7.3 2.4 0.1 8.4 0.5 0.4 0.5 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.7 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.2 7.2 0.0 1.3 0.0 0.0 5.4 0.1 0.2 0.0 1.1 1.6 0.0 14.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.3 2.7 0.0 0.0 13.9 0.0 0.0 2.0 1.2 1.1 0.0 3.0 0.4 0.9 1.3 4.0 4.0 0.0 2.8 0.0 0.2 12.5 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.1 0.2 2.1 5.4 4.6 0.2 1.5 26.9 2.4 0.0 8.3 0.0 0.2 0.3 0.0 0.8 0.0 85.6 13.6 0.0 0.0 0.0 0.0 0.6 12.6 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 2.7 0.7 0.3 0.1 0.0 0.1 0.0 MAPK4 "Erk3-related, Erk4, PRKM4" ENSG00000141639 "Mitogen-activated protein kinase 4" P31152 18 50560078-50731824 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 20.1;Early spermatids: 20.2;Late spermatids: 42.4;Muller glia cells: 55.0" "Group enriched" "Detected in many" 5 "glioma: 15.2;melanoma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.0;HeLa: 4.5;NTERA-2: 3.0;SCLC-21H: 15.7;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007461 Approved "Nucleoplasm,Golgi apparatus,Midbody" NA NA "Nucleoplasm, Golgi apparatus" Midbody "HPA007461: AB_1079308" "unprognostic (4.12e-2)" "unprognostic (3.24e-2)" "unprognostic (3.60e-1)" "unprognostic (1.42e-3)" "unprognostic (5.17e-2)" "unprognostic (1.84e-2)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.24e-2)" "unprognostic (1.61e-1)" "unprognostic (4.38e-3)" "unprognostic (2.16e-1)" "unprognostic (3.44e-7)" "unprognostic (1.96e-4)" "unprognostic (5.99e-4)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" 1.9 26.4 16.9 1.1 33.4 0.9 1.8 15.9 23.9 1.4 2.6 9.5 3.8 1.6 1.8 4.5 3.5 1.5 3.0 16.9 13.0 14.3 4.5 7.0 3.5 0.9 17.1 9.1 4.2 2.5 43.5 8.3 3.7 20.5 5.3 1.8 4.1 1.8 12.4 1.7 1.0 1.9 5.2 11.8 1.1 1.3 3.5 12.4 1.7 7.8 0.0 0.9 2.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.5 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.9 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 15.7 3.8 0.1 1.1 2.6 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 33.4 15.9 14.5 13.0 14.3 17.1 9.1 20.5 12.4 8.9 0.0 0.0 0.1 0.0 11.0 20.1 2.5 0.0 0.0 0.0 0.0 3.6 5.0 1.0 20.2 0.0 0.0 0.0 0.0 0.3 0.4 0.8 0.0 0.8 0.3 4.8 0.0 0.0 0.0 42.4 0.9 0.0 0.0 0.0 0.0 55.0 0.5 0.0 1.4 0.0 0.6 0.0 1.0 0.6 0.6 0.0 1.5 0.0 0.0 0.0 MAPKBP1 KIAA0596 ENSG00000137802 "Mitogen-activated protein kinase binding protein 1" O60336 15 41774434-41827855 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.1" "Cell type enhanced" "Detected in many" 18 "Basal keratinocytes: 48.5;Cone photoreceptor cells: 192.4;Suprabasal keratinocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030832, HPA030833" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA030832: AB_10601869, HPA030833: AB_2673628" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (6.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (9.84e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.80e-4)" "unprognostic (1.08e-3)" "unprognostic (6.03e-3)" "unprognostic (7.94e-2)" "unprognostic (1.68e-1)" "unprognostic (8.98e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" 4.7 6.0 10.6 5.0 13.8 4.4 5.7 48.1 13.9 6.1 5.7 8.8 4.4 10.6 9.3 5.4 12.5 8.0 5.3 4.2 8.6 6.7 3.9 2.3 4.7 4.0 8.6 9.2 15.4 4.3 5.8 9.5 6.1 9.3 5.9 4.3 7.0 5.1 7.1 4.9 26.3 10.5 10.2 6.8 5.7 5.4 19.5 10.7 4.4 8.7 5.2 7.4 8.4 6.6 1.9 1.9 4.3 2.1 2.2 3.3 1.6 4.9 2.6 7.1 6.7 7.9 7.8 4.8 7.1 17.7 6.4 4.7 5.2 1.8 1.2 5.8 5.7 8.9 12.0 6.8 19.7 4.6 4.5 2.0 5.0 8.1 1.7 3.4 3.2 10.3 4.0 15.8 10.2 18.5 10.6 9.4 8.3 3.1 2.3 9.0 1.0 2.6 2.8 0.8 2.9 5.4 2.9 5.1 0.5 3.7 5.6 8.0 4.6 4.1 4.1 3.1 7.6 4.9 2.5 7.4 9.2 4.5 8.9 6.9 5.2 8.5 2.9 6.2 4.3 7.7 4.3 1.3 1.1 3.3 0.7 2.4 1.9 1.9 1.4 1.9 1.8 2.4 2.0 0.7 2.2 2.1 0.7 0.8 1.6 10.6 13.8 48.1 13.9 8.6 6.7 8.6 9.2 9.3 10.7 6.0 13.0 2.2 7.6 48.5 11.4 2.8 2.5 10.7 9.1 3.5 192.4 5.0 0.0 2.7 11.7 7.0 4.0 0.0 3.0 3.5 5.5 3.6 1.1 1.8 3.3 14.3 4.6 4.9 2.1 19.1 6.6 4.6 8.5 4.6 1.4 6.1 3.3 1.5 7.4 0.3 8.2 12.9 3.9 8.1 4.1 46.9 4.5 4.4 2.0 12.1 MARCKSL1 "F52, MacMARCKS, MLP, MLP1" ENSG00000175130 "MARCKS like 1" P49006 1 32333832-32336379 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 166.5" "Cell type enhanced" "Detected in many" 9 "monocytes: 1596.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "eosinophil: 54.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 54.9" "Cell line enhanced" "Detected in many" "AF22: 108.3;NTERA-2: 104.4" "Low region specificity" "Detected in all" "CAB020787, HPA030528" Enhanced Supported "Nucleoplasm,Actin filaments,Cytosol" NA Yes 120000 Cytosol "Nucleoplasm, Actin filaments" "CAB020787: , HPA030528: AB_2673514" "unprognostic (8.08e-2)" "unprognostic (1.28e-1)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (3.16e-3)" "prognostic unfavorable (1.78e-6)" "unprognostic (3.65e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-3)" "unprognostic (2.91e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.50e-1)" "unprognostic (8.16e-3)" "unprognostic (1.08e-1)" "unprognostic (3.22e-2)" 9.9 12.7 59.9 22.1 45.4 10.9 27.7 22.0 58.0 22.3 27.5 126.3 5.3 15.9 25.8 42.3 3.6 15.9 24.9 10.7 64.2 47.2 6.4 9.7 9.0 41.5 83.6 35.4 74.1 4.8 1.3 4.9 11.0 56.6 22.5 30.7 5.2 19.9 14.2 2.0 5.3 13.9 11.3 166.5 12.5 34.8 30.3 52.3 41.4 29.0 2.2 49.2 17.0 5.5 6.4 2.2 54.9 6.7 0.2 3.9 1.2 8.4 7.6 108.3 44.2 2.4 0.9 19.2 3.5 2.2 10.6 7.0 18.0 6.2 19.0 13.3 2.4 0.0 4.5 34.9 0.4 7.8 0.4 25.8 1.0 2.9 39.7 7.5 4.9 0.1 12.4 1.4 7.9 0.2 16.5 30.9 32.8 29.1 0.2 14.2 20.0 61.7 20.9 104.4 27.4 17.6 77.1 11.6 9.0 15.9 16.8 67.2 63.9 18.6 20.6 58.5 46.0 14.3 8.8 9.1 4.5 26.3 0.4 6.7 2.9 0.2 49.9 0.5 7.5 23.7 0.7 1.0 54.9 0.9 5.4 0.3 4.6 1.9 1.2 1.5 6.4 3.9 1.6 4.4 0.2 6.7 2.2 1.0 1.2 59.9 45.4 22.0 54.9 64.2 47.2 83.6 35.4 56.6 52.3 0.0 2.2 147.6 95.4 83.2 17.7 7.3 163.1 2.7 4.5 57.6 5.9 9.9 69.6 353.9 21.7 181.6 54.0 0.0 269.1 98.8 68.7 341.5 23.0 3.8 20.1 9.5 716.9 486.2 57.0 35.8 567.8 77.4 285.1 1596.0 443.0 406.9 517.8 228.0 602.9 1.2 12.4 129.4 72.9 6.2 129.4 72.6 11.2 47.2 387.2 506.2 MAS1L "dJ994E9.2, MAS-L, MRG" ENSG00000204687 "MAS1 proto-oncogene like, G protein-coupled receptor" P35410 6 29486697-29487956 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 7.5;epididymis: 4.0" "Cell type enriched" "Detected in single" 58 "granulocytes: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 40 "HEL: 3.9" HPA017983 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA017983: AB_1849332" "unprognostic (3.66e-2)" "unprognostic (2.51e-1)" "unprognostic (2.30e-2)" "unprognostic (5.22e-2)" "unprognostic (1.65e-1)" 2.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 7.5 1.3 0.4 1.2 4.0 2.1 0.2 1.2 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 1.5 0.3 0.2 1.7 1.5 1.1 0.0 0.0 0.5 0.3 0.0 0.5 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAX "bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8" ENSG00000125952 "MYC associated factor X" P61244 14 65006174-65102695 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 94.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000328, HPA003474" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "CAB000328: AB_2281783, HPA003474: AB_1079317" "unprognostic (4.50e-3)" "unprognostic (1.51e-3)" "unprognostic (4.08e-2)" "unprognostic (2.87e-1)" "unprognostic (8.37e-2)" "unprognostic (2.42e-2)" "unprognostic (1.13e-3)" "unprognostic (1.30e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-3)" "unprognostic (7.19e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (2.99e-1)" "unprognostic (4.68e-2)" "prognostic favorable (2.12e-4)" "unprognostic (6.03e-2)" 33.4 25.5 31.3 31.5 38.6 68.7 25.8 59.0 38.2 34.6 29.4 37.2 26.3 31.5 34.3 24.0 47.6 38.2 27.9 30.1 29.9 28.4 26.3 21.8 31.4 43.4 37.1 21.6 39.7 20.0 17.4 23.7 30.2 32.7 31.9 25.0 26.8 33.6 37.7 27.8 32.1 40.2 30.7 34.8 42.9 24.8 15.7 40.9 41.3 30.2 22.5 40.7 35.1 40.7 18.7 19.1 87.5 23.6 19.2 30.0 44.8 28.9 11.3 7.0 11.3 18.4 14.4 9.1 10.2 15.6 12.7 15.7 7.2 20.4 24.1 8.6 12.2 11.3 14.5 17.5 14.2 9.6 24.3 10.6 37.5 7.5 7.9 21.6 14.1 94.4 17.2 10.1 11.7 13.0 16.6 14.1 16.3 17.6 9.8 12.9 16.0 32.6 48.6 9.3 17.1 18.6 18.5 11.0 10.8 11.8 9.7 15.1 9.8 13.4 14.3 13.1 6.5 14.0 18.0 17.6 11.7 14.2 10.8 8.1 12.1 10.2 15.3 14.6 13.6 11.7 87.5 23.6 80.6 21.7 20.1 23.7 18.7 25.4 22.1 19.1 17.6 26.6 22.3 49.5 19.2 17.4 18.3 30.0 44.8 31.3 38.6 59.0 38.2 29.9 28.4 37.1 21.6 32.7 40.9 26.8 27.2 50.6 55.5 151.2 22.4 25.5 22.9 21.4 27.3 17.4 19.6 34.8 44.7 33.9 34.8 46.7 63.2 0.0 27.8 36.5 43.0 52.7 62.2 19.1 53.4 44.5 42.5 68.2 78.5 71.7 72.2 46.3 54.0 34.3 40.5 43.3 45.6 87.7 56.6 49.1 15.0 135.8 55.6 40.5 26.6 157.8 45.2 59.0 24.2 65.0 MBIP ENSG00000151332 "MAP3K12 binding inhibitory protein 1" Q9NS73 14 36298558-36320676 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.2" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 218.5;Club cells: 169.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003388 Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA003388: AB_1079322" "unprognostic (8.79e-2)" "unprognostic (9.92e-2)" "unprognostic (5.07e-2)" "unprognostic (8.66e-2)" "unprognostic (9.85e-2)" "unprognostic (4.71e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.52e-4)" "unprognostic (5.24e-2)" "prognostic favorable (1.14e-4)" "unprognostic (4.65e-1)" "unprognostic (9.27e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-3)" "unprognostic (1.09e-1)" 10.4 11.7 11.4 5.7 17.0 15.4 12.9 16.4 14.9 15.4 12.2 11.5 3.6 8.6 14.0 11.3 14.0 9.1 8.6 7.2 10.7 13.0 19.5 15.0 46.2 8.1 9.9 8.9 20.0 9.0 10.4 25.1 9.8 13.3 13.8 11.7 10.1 7.7 8.9 6.0 14.3 13.2 11.0 13.6 9.8 19.0 8.8 11.8 14.4 61.2 4.0 7.9 12.4 9.3 12.0 10.4 5.1 9.3 8.3 17.9 9.6 16.6 8.7 18.7 18.8 18.8 18.2 14.1 14.3 17.8 19.0 20.0 17.8 16.8 15.8 21.9 18.4 10.0 12.8 19.6 13.2 23.4 22.8 14.7 9.2 8.7 30.3 20.5 18.8 10.3 18.6 20.4 12.4 16.1 19.7 11.8 22.2 15.8 19.8 14.0 16.0 18.0 15.3 15.8 14.3 26.0 8.7 16.3 11.0 21.4 12.9 28.0 11.1 11.8 11.4 18.9 16.7 18.6 12.3 9.2 21.2 13.8 15.5 14.7 16.4 18.9 24.8 8.1 9.7 14.6 1.4 9.3 2.0 11.2 6.8 14.1 12.0 13.7 13.8 9.2 8.7 17.9 14.5 5.1 8.3 5.3 10.4 16.1 9.6 11.4 17.0 16.4 14.9 10.7 13.0 9.9 8.9 13.3 11.8 202.5 218.5 10.4 31.7 80.1 24.3 9.4 2.5 50.9 169.5 24.4 2.0 20.7 49.7 17.7 2.7 17.7 14.6 0.0 16.6 17.7 24.9 20.7 12.7 21.2 15.9 87.4 30.2 15.4 9.9 2.5 29.7 14.5 20.3 9.0 12.1 23.6 16.8 17.5 25.5 38.3 22.5 12.9 21.2 42.9 36.4 57.2 16.6 14.9 17.7 12.9 MBTPS2 "KFSD, S2P" ENSG00000012174 "Membrane bound transcription factor peptidase, site 2" O43462 X 21839636-21885424 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005494, CAB009486" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "CAB009486: AB_2140370, HPA005494: AB_1079329" "unprognostic (7.97e-3)" "unprognostic (9.12e-2)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (7.22e-2)" "unprognostic (3.32e-1)" "unprognostic (9.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (8.38e-2)" "unprognostic (7.76e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (3.05e-2)" 12.0 17.4 9.3 7.2 13.9 2.5 12.7 20.8 18.5 11.8 9.3 13.4 6.9 7.6 14.7 9.1 9.3 10.9 10.1 11.6 9.9 10.7 13.9 26.0 8.6 6.6 10.6 13.0 18.7 12.2 17.9 15.6 22.3 17.4 15.7 9.1 12.4 14.1 13.1 14.5 8.2 8.1 14.6 14.6 7.5 9.1 6.9 7.0 7.1 13.1 7.4 6.7 11.4 9.1 3.9 6.9 1.5 4.8 4.6 5.9 3.3 8.9 18.6 8.9 9.1 11.3 14.0 4.3 13.3 13.6 12.7 11.1 7.4 12.3 7.8 6.9 14.2 24.8 8.4 12.3 7.6 15.7 5.8 9.8 3.8 11.8 6.1 15.5 8.2 3.8 13.2 8.3 19.1 14.1 12.9 9.7 4.6 10.6 8.7 14.4 5.6 3.3 4.3 8.3 4.7 13.8 4.2 16.6 8.7 8.8 4.6 2.2 18.3 18.7 11.9 16.4 12.4 15.9 7.1 11.5 16.0 3.7 23.2 9.9 10.7 13.5 3.8 17.8 3.4 15.3 0.1 4.3 1.5 4.5 4.8 4.2 3.9 3.5 4.1 6.9 3.8 4.7 5.6 0.5 4.6 4.8 4.8 5.9 3.3 9.3 13.9 20.8 18.5 9.9 10.7 10.6 13.0 17.4 7.0 8.9 7.8 3.0 3.4 4.8 11.7 12.0 7.6 10.7 6.8 7.0 17.7 5.6 0.0 5.1 0.3 4.6 3.3 0.0 7.7 5.4 8.9 6.6 10.4 16.1 8.0 28.6 2.4 10.4 9.5 0.9 9.8 4.4 10.1 3.6 3.3 7.7 5.3 3.1 12.4 7.5 14.0 0.0 6.9 2.8 1.7 2.4 4.0 4.3 4.2 4.1 MCC ENSG00000171444 "Mutated in colorectal cancers" P23508 5 113022099-113488830 "Predicted intracellular proteins" "Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 49.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 97.8;Cone photoreceptor cells: 53.0;Hepatocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.2;hTCEpi: 19.0;RT4: 17.6" "Low region specificity" "Detected in all" "HPA037390, HPA037391" Approved Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytosol" "Cytoplasmic bodies" "HPA037390: AB_2675451, HPA037391: AB_10671248" "unprognostic (6.60e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.23e-1)" "unprognostic (8.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.20e-1)" "unprognostic (5.21e-2)" "unprognostic (9.59e-2)" "unprognostic (8.02e-3)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favorable (6.19e-4)" "unprognostic (1.70e-3)" "unprognostic (3.34e-1)" "unprognostic (2.47e-2)" "unprognostic (2.90e-1)" 7.1 2.3 6.9 3.2 6.1 0.5 7.8 11.4 8.1 11.8 3.2 3.4 5.9 1.7 12.5 4.7 9.1 7.4 4.4 8.4 9.2 5.0 3.9 12.7 4.6 3.0 7.6 5.1 49.4 4.5 28.9 5.2 7.1 7.8 7.7 2.4 15.1 6.7 9.5 5.0 13.9 2.6 9.1 5.8 3.4 3.6 6.5 5.2 1.3 3.2 6.1 4.3 9.3 11.8 0.2 6.3 1.3 0.2 0.1 1.6 0.1 0.4 0.1 7.2 0.7 6.2 5.8 7.9 1.2 3.2 1.3 1.6 0.2 6.5 0.0 7.6 0.5 3.6 8.7 4.3 28.2 0.6 2.3 2.7 0.0 2.5 1.9 1.8 0.3 0.1 7.7 19.0 3.5 13.4 7.2 8.4 0.9 0.0 10.7 2.9 0.6 0.1 0.1 3.9 0.0 0.5 0.1 6.3 1.9 0.1 17.6 3.1 6.8 5.8 0.0 15.4 2.6 2.3 0.0 10.0 4.9 4.6 7.6 2.2 3.1 0.0 0.0 13.1 0.0 5.1 0.0 0.2 0.1 0.5 0.2 1.6 0.2 0.5 0.6 0.0 0.2 0.4 0.5 1.3 0.1 0.1 6.3 1.5 0.1 6.9 6.1 11.4 8.1 9.2 5.0 7.6 5.1 7.8 5.2 0.0 0.6 0.5 24.4 33.4 97.8 13.9 7.6 0.0 3.4 3.5 53.0 0.7 0.0 2.9 10.6 23.9 0.0 0.0 1.2 1.7 27.7 5.4 0.0 50.6 2.0 35.0 4.6 25.2 4.0 24.2 19.5 0.5 15.1 5.4 0.2 7.4 3.0 0.2 25.5 1.4 8.2 0.0 10.3 8.2 8.5 41.3 1.0 2.9 0.0 14.9 MCM3AP "GANP, KIAA0572, Map80, SAC3" ENSG00000160294 "Minichromosome maintenance complex component 3 associated protein" O60318 21 46235126-46286297 "Predicted intracellular proteins, Transporters" "Immunity, mRNA transport, Protein transport, Translocation, Transport" "Acyltransferase, Transferase" "Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021527, HPA032103" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" Nucleoplasm "HPA021527: AB_1853626, HPA032103: AB_2674152" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (2.20e-1)" "unprognostic (1.72e-1)" "unprognostic (6.31e-3)" "unprognostic (1.48e-2)" "unprognostic (2.06e-1)" "unprognostic (4.17e-2)" "unprognostic (4.76e-3)" "prognostic favorable (2.05e-4)" "unprognostic (1.96e-1)" "unprognostic (2.81e-3)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (2.28e-1)" 19.4 16.7 14.2 21.5 25.3 19.5 19.0 26.6 29.2 18.3 17.2 27.7 19.3 15.4 24.8 18.0 18.1 21.1 16.3 17.9 14.4 13.2 15.5 13.3 18.2 21.9 16.5 14.6 23.7 17.5 25.7 20.6 18.2 18.2 17.7 17.6 21.3 22.1 21.4 52.9 18.2 19.9 19.5 15.1 20.7 18.7 15.7 15.7 31.8 19.6 15.7 26.0 21.1 16.4 4.8 4.8 3.8 4.9 3.0 6.9 4.1 16.0 15.8 18.6 20.0 15.2 19.0 16.9 17.7 21.7 16.8 13.7 14.4 9.6 22.9 14.6 18.7 18.1 9.6 24.5 14.9 14.8 23.5 22.2 37.5 15.1 11.2 13.7 17.0 21.2 14.8 13.0 22.9 15.9 11.5 17.8 13.9 44.7 17.5 19.3 9.2 18.2 11.5 31.9 17.5 13.2 23.8 11.7 20.7 8.2 14.9 15.7 16.7 22.6 15.0 17.3 14.7 20.4 17.8 22.5 17.6 13.4 14.6 13.2 31.9 35.3 14.2 15.9 16.5 22.8 1.5 4.7 3.8 6.1 4.9 6.5 2.9 3.7 6.9 4.8 4.8 3.3 3.4 2.9 3.0 2.7 4.2 4.4 4.1 14.2 25.3 26.6 29.2 14.4 13.2 16.5 14.6 18.2 15.7 8.9 17.6 16.7 6.1 6.3 21.7 3.6 15.3 10.7 12.5 10.4 19.6 9.8 1.7 9.7 2.5 7.8 12.3 0.0 12.4 9.8 8.9 11.6 8.1 15.3 13.5 15.9 11.5 13.5 20.6 3.6 17.0 12.4 10.1 21.6 18.4 8.9 12.8 7.0 13.4 5.2 21.0 19.4 6.6 18.9 13.4 9.2 7.8 8.5 14.5 5.5 MCMBP "C10orf119, FLJ13081, MCM-BP" ENSG00000197771 "Minichromosome maintenance complex binding protein" Q9BTE3 10 119829404-119892556 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013792, HPA038481" Uncertain Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "CAB013792: , HPA038481: AB_10794620" "unprognostic (1.26e-1)" "unprognostic (7.92e-2)" "unprognostic (4.62e-2)" "unprognostic (2.31e-2)" "unprognostic (1.72e-2)" "unprognostic (4.64e-2)" "unprognostic (1.31e-3)" "unprognostic (5.61e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (7.32e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (2.23e-2)" "unprognostic (8.24e-2)" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" 33.6 15.3 11.7 23.2 13.8 14.6 35.5 17.2 13.8 27.0 26.3 16.9 11.4 15.5 28.0 14.9 26.4 23.0 18.7 26.3 12.0 10.2 18.7 23.7 28.5 38.6 17.4 8.5 29.2 18.2 23.2 17.6 35.4 14.2 22.5 21.4 15.7 21.0 17.4 30.1 23.8 20.7 26.0 16.8 26.0 20.7 15.4 15.5 38.0 24.5 28.2 24.7 32.5 28.6 4.5 6.9 12.1 9.7 4.1 5.1 2.4 31.0 22.1 31.0 21.4 15.7 19.3 18.2 28.8 31.6 36.7 38.0 28.8 25.5 36.2 13.3 23.0 16.7 29.0 37.0 29.0 43.0 26.5 27.3 18.6 17.6 22.0 24.4 34.3 45.0 15.8 16.4 33.2 43.8 20.2 25.1 23.7 17.1 27.3 24.0 23.0 43.0 20.7 15.6 23.1 16.0 27.2 60.0 18.4 15.7 21.4 13.4 17.2 21.0 17.5 24.0 24.3 11.9 24.5 19.4 18.1 17.8 18.3 34.3 19.7 21.9 40.1 21.6 23.1 11.1 12.1 5.3 3.6 4.2 9.7 5.1 4.5 3.9 4.4 6.9 1.8 4.2 3.8 6.4 4.1 6.1 3.5 3.9 2.4 11.7 13.8 17.2 13.8 12.0 10.2 17.4 8.5 14.2 15.5 14.9 13.9 20.1 27.2 38.0 10.0 16.2 12.7 10.7 18.2 19.2 3.9 30.7 11.6 9.6 3.3 32.4 15.1 0.0 11.5 42.5 26.3 18.7 17.4 23.1 33.4 30.2 10.4 30.1 35.7 4.9 27.9 31.3 21.9 8.2 18.5 16.9 12.8 7.0 21.2 17.5 17.1 19.4 29.9 27.6 61.5 37.4 33.2 27.4 26.9 24.5 MCOLN1 "ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1" ENSG00000090674 "Mucolipin 1" Q9GZU1 19 7522626-7534009 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Ion channel" "Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hofbauer cells: 91.8;Kupffer cells: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 30.9;monocytes: 28.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031763, CAB032637, HPA069495" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: " "unprognostic (5.51e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-2)" "unprognostic (3.30e-2)" "unprognostic (2.66e-1)" "unprognostic (4.07e-2)" "unprognostic (8.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.79e-2)" "unprognostic (1.47e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.36e-1)" "prognostic favorable (5.67e-4)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" 18.9 27.5 10.1 10.3 11.9 10.0 10.3 8.2 19.7 7.7 9.6 11.2 7.2 9.6 8.8 9.5 11.2 8.4 11.7 11.7 9.0 9.2 11.5 20.6 17.9 20.6 10.6 10.0 7.8 10.5 9.8 26.0 17.9 13.6 8.8 6.9 9.7 9.2 8.0 14.2 13.9 8.0 9.5 10.4 38.3 8.9 6.5 9.4 7.0 6.2 7.6 5.1 12.5 8.7 1.3 6.2 30.9 28.9 2.8 2.7 4.4 6.4 6.6 3.2 11.0 18.9 6.1 9.3 12.0 9.7 14.6 12.6 5.0 5.7 3.6 14.8 8.1 12.9 3.0 5.4 4.1 4.3 7.0 12.0 3.2 6.5 4.0 16.6 3.6 14.2 8.6 9.7 13.9 2.4 4.6 6.1 8.1 5.9 16.1 8.4 2.1 4.9 3.6 7.2 3.4 14.2 6.9 5.4 7.7 5.5 5.6 8.4 10.3 5.1 9.1 15.2 3.7 5.5 6.4 7.6 7.0 4.0 28.1 8.9 12.4 19.0 2.5 11.2 5.1 10.4 30.9 13.7 29.7 2.3 27.5 2.0 1.1 2.0 1.9 5.6 1.3 1.9 2.0 12.2 2.8 28.9 6.2 2.7 4.4 10.1 11.9 8.2 19.7 9.0 9.2 10.6 10.0 13.6 9.4 3.0 1.6 10.4 6.1 11.8 26.9 2.0 17.8 4.0 1.2 29.6 21.6 10.4 1.7 20.9 4.9 11.9 19.5 46.7 19.9 15.2 17.9 4.5 1.1 12.4 91.8 55.6 16.1 11.1 81.2 10.8 15.3 42.0 20.3 5.4 8.6 23.6 17.7 20.1 14.9 9.2 37.0 6.5 9.2 10.2 11.9 15.2 24.7 10.2 8.6 4.1 MCUB "CCDC109B, FLJ20647" ENSG00000005059 "Mitochondrial calcium uniporter dominant negative beta subunit" Q9NWR8 4 109560205-109688726 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 39.3;lymphoid tissue: 45.3" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 107.3;Exocrine glandular cells: 99.3;Extravillous trophoblasts: 82.0;Hofbauer cells: 95.7;Pancreatic endocrine cells: 50.6;Syncytiotrophoblasts: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048776 Enhanced Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Vesicles, Mitochondria" "HPA048776: AB_2680518" "unprognostic (6.12e-3)" "unprognostic (1.70e-2)" "unprognostic (3.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.42e-1)" "unprognostic (1.70e-1)" "unprognostic (1.70e-2)" "unprognostic (3.06e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-3)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.35e-6)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" 11.6 2.2 4.1 21.0 3.2 8.3 16.6 0.4 3.7 8.2 4.9 4.6 1.4 3.5 12.3 5.5 9.2 6.3 7.3 14.9 4.5 4.7 3.9 2.1 7.8 44.2 3.5 2.6 7.5 2.1 2.3 5.1 9.9 6.5 5.4 6.1 4.1 6.5 2.2 4.3 7.6 8.8 8.4 8.5 13.8 4.2 3.6 1.9 45.3 4.7 9.5 24.8 7.3 9.0 14.0 15.7 1.1 16.0 20.0 39.3 25.7 10.4 4.5 2.5 12.8 2.8 7.4 9.7 9.0 5.5 9.9 8.9 0.2 8.5 36.7 1.9 7.7 5.5 3.0 9.4 5.5 8.8 23.3 7.4 4.4 5.0 0.6 4.9 8.9 0.1 4.7 1.5 6.0 5.1 7.0 13.2 13.6 1.3 23.4 7.5 12.8 20.4 0.1 11.6 1.8 6.5 7.8 19.4 4.1 11.6 4.6 10.3 4.5 9.7 28.9 3.0 2.1 3.6 0.4 9.4 3.9 5.1 20.6 15.6 9.1 6.3 8.9 12.0 1.9 2.7 0.0 16.0 0.2 6.3 9.7 9.0 13.5 26.7 19.0 15.7 14.0 39.3 22.2 1.1 20.0 7.2 11.0 22.4 25.7 4.1 3.2 0.4 3.7 4.5 4.7 3.5 2.6 6.5 1.9 8.9 6.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 5.2 0.0 107.3 0.0 22.4 0.0 0.0 0.0 0.0 99.3 82.0 0.0 0.0 1.1 0.0 95.7 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 25.2 0.0 0.0 50.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 61.4 0.0 0.0 0.0 ME1 ENSG00000065833 "Malic enzyme 1" P48163 6 83210389-83431071 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Kupffer cells: 57.7;Muller glia cells: 93.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "MAIT T-cell: 15.6" "Lineage enriched" "Detected in many" 11 "T-cells: 15.6" "Cell line enhanced" "Detected in many" "CACO-2: 42.9;OE19: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006493 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3800000 "Nucleoplasm, Plasma membrane" Cytosol "HPA006493: AB_1078272" "unprognostic (7.21e-2)" "unprognostic (3.99e-2)" "unprognostic (2.24e-1)" "unprognostic (3.12e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (7.98e-3)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.24e-1)" "unprognostic (4.44e-3)" "unprognostic (1.41e-3)" "unprognostic (7.10e-3)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.81e-7)" "unprognostic (4.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.85e-2)" "unprognostic (4.51e-2)" 30.7 35.3 16.3 4.6 17.7 0.8 27.1 5.5 13.1 5.9 6.7 5.4 39.2 18.1 3.8 7.4 24.5 4.2 13.5 21.3 10.5 14.0 3.6 12.4 7.7 6.0 16.8 11.8 10.0 3.3 30.0 11.1 2.9 16.3 7.9 10.1 9.3 7.8 30.2 25.7 10.1 8.7 18.7 17.2 6.3 20.0 13.4 7.2 1.4 6.3 20.9 4.5 13.7 14.9 0.0 0.0 0.0 1.4 0.0 15.6 0.5 8.8 18.3 0.4 0.0 15.6 14.6 0.0 5.7 14.7 6.1 11.9 42.9 7.8 0.0 15.0 13.4 12.2 9.3 13.6 5.1 6.7 0.0 7.6 0.0 11.7 0.0 20.0 4.3 16.1 15.9 10.3 12.3 8.4 10.3 9.5 0.0 6.1 0.0 8.3 9.9 0.0 4.9 0.0 48.5 7.2 0.0 15.4 8.5 18.1 4.2 1.8 4.7 9.7 14.4 0.3 8.3 0.0 10.6 10.0 3.8 4.6 1.2 0.0 3.4 3.9 0.0 0.0 0.0 11.2 0.0 1.4 0.0 0.8 0.3 15.6 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 16.3 17.7 5.5 13.1 10.5 14.0 16.8 11.8 16.3 7.2 17.9 8.9 0.0 4.2 1.6 16.7 35.8 5.1 1.4 6.8 5.2 2.0 0.5 1.7 10.0 4.4 1.9 8.0 0.0 8.4 0.6 7.1 5.6 0.0 12.4 6.8 12.7 0.0 4.9 57.7 4.2 23.9 9.5 0.0 5.4 4.0 93.9 12.7 5.8 35.0 2.6 6.4 0.0 3.3 4.9 1.5 3.0 0.7 0.9 5.5 1.8 MED21 "SRB7, SURB7" ENSG00000152944 "Mediator complex subunit 21" Q13503 12 27022546-27066343 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017177 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA017177: AB_1857665" "unprognostic (3.02e-1)" "unprognostic (7.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.10e-1)" "unprognostic (7.18e-3)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" "unprognostic (7.32e-2)" "unprognostic (1.03e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.74e-8)" "unprognostic (3.18e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-2)" "unprognostic (1.42e-2)" 20.7 31.5 20.7 13.3 32.4 31.9 23.9 25.9 31.9 24.8 21.9 18.0 18.8 14.9 25.9 21.7 30.4 20.8 19.6 31.3 19.5 21.9 34.1 18.8 20.8 15.7 21.1 26.2 30.8 17.1 30.3 26.0 19.8 23.6 27.6 20.6 18.3 25.3 24.5 30.7 19.3 17.4 27.3 20.2 16.0 19.6 28.9 22.1 22.1 28.2 28.7 19.9 31.6 27.2 20.1 15.8 35.5 18.6 12.8 28.0 19.1 16.6 17.6 9.3 14.8 20.8 21.0 15.4 19.0 14.3 16.1 21.0 18.4 19.0 11.0 12.1 14.5 23.4 13.8 19.8 17.6 27.8 9.6 17.7 15.8 18.2 11.3 11.6 19.3 11.4 14.8 25.8 19.9 23.9 26.1 23.3 14.9 12.8 14.7 18.1 12.5 16.9 35.6 28.5 21.2 23.3 14.6 59.7 12.4 16.7 19.1 7.1 10.4 23.2 10.0 15.0 37.3 17.7 12.9 16.8 18.0 14.0 22.3 19.2 4.5 9.3 18.1 17.1 21.6 12.1 35.5 17.5 23.9 20.4 18.6 20.8 20.1 24.6 23.9 15.8 16.6 28.0 25.3 14.0 12.8 16.5 12.9 23.8 19.1 20.7 32.4 25.9 31.9 19.5 21.9 21.1 26.2 23.6 22.1 14.9 16.5 22.6 105.7 87.8 9.2 30.8 7.6 12.0 29.6 50.6 0.0 52.6 79.6 36.3 190.1 33.7 16.5 23.3 33.3 49.3 57.0 71.3 18.4 20.0 27.5 12.7 17.1 22.1 17.5 59.3 44.8 27.0 67.4 36.9 17.6 15.1 29.2 17.3 44.6 72.5 13.1 19.4 58.7 92.2 54.3 88.5 51.0 27.7 17.2 125.9 MED26 "CRSP7, CRSP70" ENSG00000105085 "Mediator complex subunit 26" O95402 19 16574907-16629062 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 45.5;Late spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA057997, HPA071835" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No Nucleoplasm "Vesicles, Cytosol" "HPA057997: AB_2732618, HPA071835: AB_2686455" "unprognostic (2.02e-2)" "prognostic favorable (2.46e-4)" "unprognostic (2.47e-2)" "unprognostic (2.57e-3)" "unprognostic (1.42e-1)" "unprognostic (3.60e-3)" "unprognostic (5.03e-2)" "unprognostic (3.77e-2)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.99e-3)" "unprognostic (2.60e-2)" "prognostic unfavorable (5.50e-5)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.98e-3)" 5.5 4.6 5.9 8.3 6.2 14.0 7.3 8.7 6.2 6.0 5.1 4.2 5.2 4.0 5.7 6.0 6.2 4.3 4.4 4.0 5.1 4.5 3.7 5.9 9.0 7.6 4.8 4.5 6.2 6.8 6.8 5.4 7.9 4.9 5.4 3.3 3.8 7.2 7.9 9.9 7.1 4.8 4.2 4.5 6.8 5.1 34.7 4.6 8.5 5.0 6.0 6.9 4.8 5.7 2.6 4.4 2.3 1.0 1.2 2.3 0.4 9.1 3.6 3.3 7.1 4.3 3.4 9.7 5.4 3.8 5.8 5.3 5.3 5.5 14.7 5.7 3.4 1.9 6.9 5.1 5.4 4.0 10.8 10.5 5.8 3.3 4.2 4.2 6.5 5.5 4.1 5.3 4.9 5.2 3.5 3.1 7.8 9.4 17.8 3.6 9.1 6.9 6.2 7.8 4.4 11.5 7.2 5.0 16.0 3.4 3.6 8.8 4.6 4.7 4.6 5.3 2.4 3.4 8.6 3.7 7.4 5.9 9.0 7.1 12.4 10.0 11.8 5.2 8.7 4.3 2.3 0.4 0.4 1.6 1.0 0.3 1.4 0.2 0.7 0.8 2.6 1.0 0.2 1.2 1.2 0.4 4.4 2.3 0.4 5.9 6.2 8.7 6.2 5.1 4.5 4.8 4.5 4.9 4.6 3.0 10.1 12.7 3.9 12.6 3.9 0.7 2.5 1.4 1.2 5.2 9.8 5.8 3.3 3.7 45.5 4.7 4.3 0.0 3.4 8.8 6.2 4.9 1.1 4.0 4.3 4.8 2.4 3.7 9.4 52.0 6.1 4.7 1.7 2.8 4.3 5.2 5.1 3.5 3.5 1.9 5.7 0.0 6.4 21.0 16.9 9.4 14.1 4.9 5.0 7.6 MED27 "CRSP34, CRSP8, MED3, TRAP37" ENSG00000160563 "Mediator complex subunit 27" Q6P2C8 9 131860107-132079908 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007002 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA007002: AB_1078574" "unprognostic (8.81e-2)" "prognostic favorable (1.59e-4)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" "unprognostic (9.57e-2)" "unprognostic (1.32e-2)" "unprognostic (1.55e-2)" "unprognostic (6.07e-2)" "unprognostic (6.63e-3)" "unprognostic (1.63e-1)" "unprognostic (8.59e-3)" "unprognostic (5.93e-2)" "unprognostic (7.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (4.60e-2)" 11.1 12.1 18.0 9.5 18.1 15.5 11.5 14.0 21.4 10.9 11.7 19.5 10.1 7.8 18.6 23.5 15.5 13.9 9.5 17.5 17.5 11.2 10.4 7.5 10.9 13.5 18.6 19.1 12.7 7.9 10.6 17.8 12.7 17.4 12.7 10.7 16.0 17.7 14.4 15.2 15.7 8.6 16.3 16.1 11.7 10.2 14.7 14.0 17.9 13.2 9.6 15.8 12.3 10.5 12.9 19.8 13.4 18.6 18.0 19.7 11.8 16.1 15.9 18.4 14.6 13.2 12.2 15.5 16.8 22.4 33.8 26.5 23.8 13.1 16.0 11.4 17.5 22.6 29.4 25.4 23.9 22.2 17.2 15.0 12.0 16.7 14.1 19.8 21.5 15.2 13.4 16.5 26.6 27.3 10.7 17.6 23.5 17.5 13.4 24.6 25.7 23.1 12.5 18.7 15.9 27.1 20.4 26.0 19.6 13.6 9.0 34.4 13.9 21.7 11.2 11.2 12.3 17.8 10.1 14.7 34.4 15.1 25.4 25.3 5.4 16.6 28.4 19.1 15.0 23.4 3.5 12.2 13.4 18.9 18.6 15.3 11.6 14.8 18.5 19.2 12.9 12.7 15.5 4.8 18.0 16.0 19.8 19.7 11.8 18.0 18.1 14.0 21.4 17.5 11.2 18.6 19.1 17.4 14.0 14.9 8.5 3.0 11.2 5.4 24.5 5.9 5.1 6.7 10.3 12.2 17.7 28.2 11.6 13.9 12.9 10.6 2.1 0.0 14.5 17.3 8.9 5.1 10.4 4.9 15.2 20.6 5.1 5.5 3.7 5.4 13.3 8.8 6.8 11.8 4.2 23.3 12.9 0.0 15.9 6.0 17.8 6.5 8.3 20.7 22.2 4.4 45.8 10.2 4.7 10.7 MEF2B RSRFR2 ENSG00000213999 "Myocyte enhancer factor 2B" Q02080 19 19145568-19170289 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "lymphoid tissue: 81.2" "Cell type enriched" "Detected in single" 16 "Sertoli cells: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "Daudi: 50.9;U-266/70: 51.2;U-698: 67.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004734 Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (7.31e-3)" "unprognostic (4.06e-2)" "unprognostic (9.44e-5)" "unprognostic (5.07e-2)" "unprognostic (2.01e-1)" "unprognostic (7.19e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-1)" "unprognostic (2.76e-1)" "unprognostic (1.98e-2)" "unprognostic (8.66e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-11)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (8.98e-3)" 2.0 1.0 0.8 81.2 1.2 1.4 1.9 0.6 1.4 2.7 3.0 0.9 0.6 1.5 2.2 1.1 1.5 2.3 2.2 1.9 1.0 0.6 1.8 2.9 2.0 32.3 1.1 0.9 3.7 0.8 0.8 2.1 0.8 1.0 3.7 1.0 1.8 3.5 1.1 1.4 2.3 3.1 1.1 1.2 6.7 1.7 1.7 0.8 1.6 3.0 3.5 58.7 1.9 2.9 0.1 0.2 1.1 0.9 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 50.9 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.4 0.1 0.5 0.0 0.2 0.3 0.3 0.0 0.0 0.9 0.4 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.4 0.5 0.1 51.2 4.7 67.3 0.1 0.3 0.0 0.0 0.9 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.6 1.4 1.0 0.6 1.1 0.9 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MEOX1 MOX1 ENSG00000005102 "Mesenchyme homeobox 1" P50221 17 43640388-43661954 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 25 "Basal keratinocytes: 3.7;Endothelial cells: 15.5;Melanocytes: 5.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 17.9" "Lineage enriched" "Detected in single" 66 "T-cells: 17.9" "Cell line enriched" "Detected in some" 13 "HeLa: 24.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA045214, HPA063788" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA045214: AB_10959299, HPA063788: " "unprognostic (1.36e-3)" "unprognostic (2.15e-4)" "unprognostic (1.25e-1)" "unprognostic (2.58e-3)" "unprognostic (2.01e-2)" "unprognostic (5.65e-3)" "unprognostic (1.25e-1)" "unprognostic (4.55e-3)" "unprognostic (6.71e-2)" "unprognostic (2.64e-1)" "unprognostic (1.46e-1)" "unprognostic (9.36e-2)" "unprognostic (3.44e-6)" "unprognostic (2.40e-2)" "unprognostic (2.66e-1)" "unprognostic (1.82e-1)" "unprognostic (7.47e-3)" 24.3 0.3 0.1 7.4 0.1 0.0 17.3 0.1 0.1 12.4 3.2 0.1 2.3 1.2 11.6 5.7 10.9 6.7 6.5 17.8 0.1 0.1 0.2 0.3 1.2 5.4 0.1 0.1 4.8 1.2 1.5 0.5 0.3 0.1 8.2 1.9 0.8 5.8 2.0 19.8 4.6 3.5 8.6 0.1 8.9 2.4 3.5 0.1 3.2 1.7 15.4 7.1 6.1 16.7 0.0 0.0 0.0 0.0 0.2 17.9 0.9 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 1.7 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.1 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 4.6 3.0 0.0 0.0 1.8 0.5 0.0 0.2 0.0 0.0 17.9 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 1.6 0.1 0.0 0.0 0.0 METAP1 "KIAA0094, MAP1A, MetAP1A" ENSG00000164024 "Methionyl aminopeptidase 1" P53582 4 98995620-99062813 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 345.0;Late spermatids: 1171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025485, HPA037997, HPA037998" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 11000 Cytosol "Nucleoplasm, Plasma membrane" "CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778" "unprognostic (1.79e-1)" "unprognostic (3.39e-1)" "prognostic favorable (7.22e-4)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (3.08e-5)" "unprognostic (1.09e-1)" "unprognostic (1.51e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.28e-5)" "unprognostic (2.00e-1)" "prognostic favorable (1.72e-4)" "unprognostic (5.50e-2)" "unprognostic (8.51e-2)" "unprognostic (1.15e-3)" "prognostic favorable (9.31e-4)" 12.1 8.3 10.0 16.0 10.1 11.8 18.6 9.2 13.8 16.0 17.9 7.0 22.9 13.4 24.1 25.9 37.2 14.0 12.3 27.9 9.5 7.1 14.3 13.7 10.7 12.6 7.9 9.8 11.3 13.0 7.8 14.4 9.2 9.9 19.1 19.3 7.5 19.0 21.5 27.2 16.4 15.2 27.8 10.1 13.9 11.6 46.8 8.1 27.0 10.8 21.8 19.1 36.6 22.6 12.7 11.7 10.4 11.1 12.5 19.2 10.8 21.7 21.5 18.9 20.3 15.0 24.1 21.0 31.2 20.1 26.7 25.5 24.1 32.5 32.3 12.5 25.2 16.0 21.9 33.1 31.2 37.1 22.5 15.8 28.8 15.7 25.9 16.3 38.9 24.2 17.3 22.8 22.7 24.1 20.8 21.9 18.3 22.5 19.5 28.5 16.6 34.1 18.6 23.2 37.1 17.5 22.4 29.5 17.2 42.9 28.2 25.9 15.3 10.4 32.4 12.3 22.1 12.4 14.9 17.8 21.6 27.5 19.8 27.2 14.2 19.9 25.5 18.6 20.0 21.4 10.4 9.4 4.2 14.9 11.1 19.2 12.7 15.4 14.5 11.7 10.1 15.1 13.5 2.3 12.5 10.7 5.8 13.4 10.8 10.0 10.1 9.2 13.8 9.5 7.1 7.9 9.8 9.9 8.1 38.7 10.5 13.7 44.1 37.7 4.6 49.8 20.4 18.7 17.0 14.0 2.0 22.0 11.6 26.9 345.0 13.5 29.0 0.0 25.4 55.9 12.3 21.8 3.5 16.4 15.6 3.2 7.5 16.5 19.6 1171.9 17.8 14.6 15.1 6.4 25.2 8.3 22.3 34.2 21.2 22.9 3.5 25.8 22.1 15.1 46.4 33.9 6.4 15.2 32.6 39.6 METRN "C16orf23, MGC2601" ENSG00000103260 "Meteorin, glial cell differentiation regulator" Q9UJH8 16 715115-719655 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.9" "Cell type enriched" "Detected in many" 8 "Muller glia cells: 554.6" "Cancer enhanced" "Detected in all" "glioma: 69.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 53.4;PC-3: 41.3" "Region enriched" "Detected in all" 5 "cerebellum: 549.1" "Low region specificity" "Detected in all" HPA051164 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted in brain" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA051164: AB_2681369" "unprognostic (1.60e-2)" "unprognostic (3.49e-1)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (7.49e-2)" "unprognostic (1.82e-1)" "unprognostic (2.59e-1)" "unprognostic (8.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.12e-2)" "unprognostic (3.32e-1)" "unprognostic (5.03e-3)" "unprognostic (3.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.09e-1)" "unprognostic (2.17e-2)" 7.7 14.9 44.7 5.1 58.9 2.6 4.6 14.2 45.4 4.1 7.0 24.1 19.8 5.6 5.3 7.8 3.1 27.4 6.4 12.4 39.6 31.6 10.5 8.5 6.0 4.2 45.7 15.1 2.7 43.1 5.2 15.1 5.3 15.3 7.4 2.5 9.2 27.3 16.8 21.5 3.9 5.9 4.4 39.5 5.4 8.3 4.6 19.0 2.5 6.6 3.4 3.0 3.9 5.0 3.2 0.9 0.8 1.0 1.7 2.9 0.5 2.6 22.5 4.4 22.5 7.9 4.4 7.2 5.3 2.7 2.1 1.4 3.3 6.6 0.4 12.5 3.7 8.2 9.9 0.6 5.2 0.3 1.4 9.9 0.9 4.1 17.0 4.8 1.9 2.9 10.7 5.7 0.6 1.3 6.7 0.7 6.3 1.5 0.5 1.6 53.4 0.7 6.5 1.6 2.9 41.3 7.3 5.1 7.3 5.5 0.7 7.0 8.9 2.1 5.9 27.4 0.5 8.9 3.8 2.4 6.1 11.7 7.1 4.6 3.4 0.9 0.4 9.6 1.4 14.4 0.0 0.3 0.8 2.9 1.0 1.7 3.2 1.5 2.7 0.2 0.5 0.9 1.9 0.0 1.7 1.0 0.9 2.8 0.5 44.7 58.9 14.2 27.4 39.6 31.6 45.7 15.1 15.3 19.0 0.0 2.1 4.2 14.7 3.4 38.6 14.0 50.9 2.7 0.0 15.7 13.7 0.6 43.1 6.3 6.5 12.6 15.0 0.0 4.2 1.8 8.7 28.3 0.0 27.2 5.2 66.7 26.2 19.0 5.1 14.5 10.3 4.8 10.1 0.0 8.1 554.6 5.4 14.7 8.9 43.5 29.1 25.8 15.3 3.9 11.3 2.6 0.3 6.4 8.6 14.2 METTL9 DREV1 ENSG00000197006 "Methyltransferase like 9" Q9H1A3 16 21597218-21657473 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 326.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053588, HPA056347" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA053588: AB_2682203, HPA056347: " "unprognostic (1.55e-1)" "unprognostic (2.18e-2)" "unprognostic (1.98e-3)" "unprognostic (5.43e-2)" "unprognostic (5.81e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (8.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.11e-2)" "unprognostic (7.57e-3)" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.49e-3)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (5.17e-2)" "unprognostic (1.65e-1)" 24.0 45.5 29.6 18.8 34.9 50.0 45.1 12.2 31.9 34.2 19.1 18.7 15.5 14.9 23.4 35.6 30.2 23.8 19.4 32.0 22.2 20.0 61.0 8.7 24.0 38.8 26.8 8.4 22.8 28.8 37.2 25.0 25.4 17.7 23.8 20.3 32.5 22.1 19.3 30.6 21.5 20.6 21.1 25.0 29.6 18.8 10.8 18.1 39.8 37.8 20.0 25.9 24.9 24.6 4.9 14.1 30.5 24.5 5.6 7.3 7.6 13.6 10.4 26.4 22.8 27.3 49.5 9.5 21.9 31.4 17.3 21.0 7.5 24.9 24.0 18.7 38.3 16.7 8.6 17.5 19.6 23.7 18.2 14.3 10.4 10.5 27.9 19.6 8.1 21.6 29.1 20.9 17.9 23.4 32.6 33.1 26.9 15.3 19.8 34.2 15.1 21.1 13.6 23.7 17.0 10.8 30.8 20.5 21.8 28.5 13.4 15.3 27.6 18.6 12.9 46.7 20.7 13.1 4.2 18.7 28.8 12.6 17.6 13.4 16.8 27.0 19.3 28.3 20.2 20.3 30.5 24.5 10.7 4.0 4.5 4.8 4.6 6.8 7.3 14.1 4.9 7.3 5.4 12.5 5.6 3.9 4.4 5.4 7.6 29.6 34.9 12.2 31.9 22.2 20.0 26.8 8.4 17.7 18.1 17.9 25.0 67.7 73.4 63.7 38.7 50.8 28.1 17.4 25.0 82.0 43.2 62.9 238.8 101.7 6.4 91.1 45.1 0.0 107.0 99.3 82.6 115.4 48.3 10.4 80.8 42.9 81.5 80.4 211.5 4.5 58.7 86.5 99.5 101.8 76.5 49.9 98.9 45.6 61.2 326.8 37.5 64.7 68.4 13.2 20.0 67.2 116.4 146.0 75.0 107.4 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B" Q3V5L5 17 76868456-76950393 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 28.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 5.1;Early spermatids: 6.3;Extravillous trophoblasts: 2.8;Late spermatids: 6.8" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 21.8;SCLC-21H: 11.2;U-138 MG: 13.2;U-2 OS: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes No "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: AB_2668423" "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 1.1 1.2 9.3 1.1 13.4 1.0 0.9 4.4 28.1 1.0 0.9 1.1 0.0 0.8 1.1 0.7 0.9 1.0 0.9 0.8 5.5 2.8 0.9 0.7 1.0 0.9 2.3 8.1 1.2 0.8 1.0 0.6 1.1 2.6 0.8 0.8 1.1 0.8 0.8 0.7 0.9 0.9 0.8 0.7 1.4 1.0 2.3 1.7 0.0 0.8 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 21.8 4.4 2.2 0.0 0.0 2.3 0.3 0.9 8.0 4.7 0.0 0.5 0.0 1.7 1.0 9.4 0.1 1.0 0.2 2.1 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.3 3.6 1.4 0.4 0.1 0.0 0.0 1.0 0.0 0.0 1.2 0.5 2.3 3.0 3.9 4.5 6.2 0.0 11.2 4.3 3.8 1.7 3.4 0.2 0.1 0.1 4.0 13.2 14.3 0.2 4.1 0.0 0.0 0.5 0.4 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 13.4 4.4 27.4 5.5 2.8 2.3 8.1 2.6 1.7 0.0 0.0 0.0 0.1 0.1 5.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 6.8 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 2.1 0.0 0.2 0.9 2.2 0.0 0.1 0.0 0.0 0.0 MICB PERB11.2 ENSG00000204516 "MHC class I polypeptide-related sequence B" Q29980 6 31494881-31511124 "Disease related genes, Predicted membrane proteins" "Adaptive immunity, Cytolysis, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 26.5" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 23.3;Hofbauer cells: 9.9;Kupffer cells: 12.9;monocytes: 10.0;T-cells: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 11.6;U-266/84: 26.5" HPA064618 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA064618: AB_2685301" "unprognostic (3.63e-3)" "unprognostic (8.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.51e-2)" "unprognostic (8.44e-2)" "unprognostic (5.94e-2)" "prognostic unfavorable (7.04e-5)" "unprognostic (2.05e-1)" "unprognostic (2.61e-1)" "unprognostic (1.67e-3)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (4.94e-9)" "unprognostic (1.91e-3)" "unprognostic (2.80e-2)" "unprognostic (9.72e-2)" "unprognostic (1.21e-2)" 3.3 1.2 0.8 9.1 0.8 6.1 3.5 3.0 1.0 1.8 1.6 0.9 0.0 1.0 2.1 1.3 2.1 1.1 1.7 2.2 1.0 0.6 2.9 1.3 6.9 7.8 1.2 0.8 1.3 2.9 0.2 0.6 0.8 1.2 1.1 1.9 1.1 1.9 0.7 0.8 1.0 5.0 1.7 1.5 11.7 1.4 2.3 1.1 8.1 2.4 0.7 8.1 3.2 26.5 2.2 2.1 4.1 4.8 1.9 4.4 1.9 2.4 0.8 0.0 0.0 1.5 2.5 0.0 1.7 1.7 2.2 2.9 0.0 0.3 2.8 6.2 3.2 7.1 0.6 0.7 2.9 0.8 2.4 2.6 3.2 0.5 1.1 0.5 1.0 2.7 3.1 0.6 3.8 2.2 2.3 1.4 4.4 3.3 5.9 2.6 0.0 0.9 4.2 0.3 0.0 0.4 3.4 0.0 5.9 2.6 0.1 0.0 0.0 1.1 0.0 0.5 0.9 1.5 1.2 1.4 1.7 0.0 1.5 0.0 11.6 26.5 6.2 0.4 8.7 3.7 4.1 3.1 4.0 2.9 3.6 3.6 2.2 2.9 3.9 2.1 2.0 1.6 3.1 3.1 1.9 4.8 1.3 4.4 1.9 0.8 0.8 3.0 1.0 1.0 0.6 1.2 0.8 1.2 1.1 3.0 1.0 5.1 0.6 2.6 0.0 0.3 2.5 0.0 1.2 0.0 0.0 0.1 1.7 1.2 0.0 1.9 0.3 23.3 0.6 0.2 3.3 1.7 0.0 0.0 9.9 0.0 0.0 3.1 12.9 0.0 0.3 8.1 1.7 10.0 0.7 0.0 1.5 2.0 0.4 0.3 0.0 0.0 3.9 0.7 1.5 1.0 0.1 10.0 1.7 1.1 MKI67 "MIB-, PPP1R105" ENSG00000148773 "Marker of proliferation Ki-67" P46013 10 128096659-128126385 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.2;lymphoid tissue: 81.5" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 163.5;Extravillous trophoblasts: 71.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.4;T-reg: 1.3" "Group enriched" "Detected in many" 13 "NK-cells: 1.1;T-cells: 1.4" "Low cell line specificity" "Detected in many" "CAB000058, HPA000451, HPA001164, CAB068198" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" "unprognostic (3.37e-1)" "unprognostic (9.92e-3)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.61e-6)" "unprognostic (7.16e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (9.47e-5)" "unprognostic (2.45e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (4.61e-1)" 1.8 1.2 0.2 9.9 0.5 25.2 1.8 0.3 0.5 1.5 5.0 0.6 0.2 3.6 0.7 1.4 13.4 0.3 1.2 1.3 0.2 0.2 1.2 1.0 1.9 8.8 0.2 0.2 0.5 0.4 0.0 0.4 2.9 0.5 0.7 5.8 0.5 2.2 0.6 0.5 3.9 6.2 1.3 0.8 6.5 3.5 2.5 0.2 81.5 0.4 5.2 10.0 1.3 3.5 0.0 0.0 0.0 0.0 1.1 1.4 0.4 48.1 24.5 25.5 18.0 1.0 2.2 7.9 18.3 13.5 17.4 15.6 20.0 20.0 36.3 5.3 12.5 11.5 29.4 26.7 13.7 26.2 38.2 12.9 31.1 18.1 12.5 0.0 43.6 16.9 0.5 0.6 17.8 18.3 4.3 17.0 16.9 14.2 34.9 17.2 19.1 26.0 13.3 10.1 12.5 11.2 19.4 33.4 4.8 6.3 13.5 8.9 9.6 25.9 9.3 4.4 8.8 7.7 9.3 15.7 9.2 18.5 13.0 49.4 15.9 12.6 44.0 7.7 20.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.4 1.0 0.0 1.1 0.0 0.0 1.3 0.4 0.2 0.5 0.3 0.5 0.2 0.2 0.2 0.2 0.5 0.2 0.0 4.8 10.7 0.5 5.7 0.0 1.2 2.5 2.7 7.9 0.0 0.0 2.7 0.0 0.4 2.5 0.0 2.7 163.5 0.0 71.7 3.4 1.4 1.1 1.0 34.1 0.0 6.4 3.7 8.0 0.5 0.3 12.7 3.3 0.0 4.8 0.0 0.1 2.9 0.4 0.0 0.0 0.0 0.4 8.8 14.6 2.6 6.5 13.4 20.7 4.1 MKRN3 "D15S9, MGC88288, RNF63, ZFP127, ZNF127" ENSG00000179455 "Makorin ring finger protein 3" Q13064 15 23565678-23630075 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 12.6;Cone photoreceptor cells: 23.6;Horizontal cells: 6.4;Rod photoreceptor cells: 6.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.7" "Lineage enriched" "Detected in many" 4 "T-cells: 5.7" "Cell line enhanced" "Detected in many" "JURKAT: 16.0;K-562: 17.1" "Low region specificity" "Detected in many" HPA029494 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA029494: AB_10603873" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (4.26e-1)" "unprognostic (1.86e-3)" "unprognostic (1.04e-3)" "unprognostic (1.15e-2)" "unprognostic (6.27e-4)" "unprognostic (1.51e-1)" "unprognostic (8.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.97e-3)" "unprognostic (2.86e-1)" "unprognostic (1.05e-4)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (8.91e-2)" "unprognostic (9.78e-2)" 1.0 0.7 5.1 1.2 10.4 4.0 1.2 1.0 11.1 0.5 1.1 8.4 0.0 1.3 1.3 3.2 5.6 0.9 0.8 0.8 6.4 3.4 1.1 0.7 1.0 1.9 14.4 3.0 1.2 1.7 0.5 3.8 8.5 5.1 1.2 0.8 3.1 5.2 1.0 1.4 1.2 1.9 0.8 8.2 1.5 0.9 5.7 13.3 5.0 0.9 1.1 1.7 0.7 0.6 1.0 0.9 1.3 0.5 0.4 5.7 0.7 4.6 3.3 3.0 3.1 0.0 0.0 7.0 0.3 0.0 2.8 1.9 8.3 0.0 0.2 0.1 0.0 6.2 8.0 1.3 0.0 0.7 0.0 0.3 6.7 8.9 0.3 0.1 7.8 6.0 0.1 0.0 5.8 0.0 1.2 0.0 16.0 17.1 7.3 0.8 0.0 8.2 3.4 0.0 4.4 10.1 5.9 1.1 4.1 0.0 0.1 0.7 2.4 0.0 3.4 0.0 0.2 2.6 2.3 0.0 7.8 6.6 0.4 5.5 9.2 11.3 5.5 4.5 0.1 0.1 1.3 0.5 0.4 1.8 0.2 1.0 1.0 0.6 1.4 0.2 0.9 2.0 5.7 1.3 0.4 0.3 0.9 0.4 0.7 5.1 10.4 1.0 6.8 6.4 3.4 14.4 3.0 5.1 13.3 0.0 0.0 0.0 1.1 0.5 12.6 0.4 0.0 0.0 0.0 0.0 23.6 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.9 0.3 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 3.4 0.0 0.0 0.4 0.0 6.4 0.0 1.2 2.4 1.0 0.0 0.5 0.0 0.0 0.4 MLF2 NTN4 ENSG00000089693 "Myeloid leukemia factor 2" Q15773 12 6747996-6767475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010811, HPA010859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA010811: AB_1079389, HPA010859: AB_1079388" "unprognostic (1.65e-1)" "unprognostic (6.55e-2)" "unprognostic (4.42e-1)" "unprognostic (9.88e-3)" "unprognostic (1.76e-1)" "unprognostic (4.19e-2)" "unprognostic (1.52e-1)" "unprognostic (4.15e-2)" "unprognostic (1.31e-1)" "unprognostic (9.11e-2)" "unprognostic (3.37e-1)" "unprognostic (6.23e-2)" "unprognostic (1.38e-1)" "unprognostic (5.83e-2)" "unprognostic (4.72e-1)" "unprognostic (8.44e-2)" "unprognostic (3.63e-1)" 31.4 45.6 55.8 23.3 65.4 36.9 24.9 50.5 100.5 28.6 30.9 44.0 23.9 36.5 32.1 30.5 39.3 31.7 28.6 44.1 54.4 47.2 37.9 77.4 24.8 21.5 40.2 42.5 28.3 33.4 43.3 31.1 32.5 44.8 38.4 27.6 28.2 43.1 36.7 45.3 33.6 35.1 35.9 33.7 21.8 27.7 21.0 30.7 26.0 36.3 28.9 29.4 29.3 23.6 17.0 38.9 86.7 20.1 11.8 14.8 16.9 39.1 64.9 33.4 58.7 31.3 31.9 51.3 38.6 46.4 66.4 58.3 62.7 38.9 28.3 10.2 50.2 43.4 32.9 41.0 55.8 41.3 44.5 38.0 20.0 34.4 35.9 34.6 21.2 27.6 29.8 45.6 51.3 39.3 48.8 27.0 27.0 25.1 11.8 46.2 55.6 29.1 32.8 107.8 42.5 22.4 18.6 30.7 25.1 55.4 49.5 21.3 42.2 34.8 61.6 37.3 73.7 17.9 35.1 26.6 39.6 52.8 41.8 56.3 14.4 16.3 37.6 52.9 18.5 46.6 35.4 20.1 73.9 14.8 18.0 14.3 15.3 11.5 13.9 22.6 17.0 12.2 13.5 86.7 11.8 19.5 38.9 11.2 16.9 55.8 65.4 50.5 100.5 54.4 47.2 40.2 42.5 44.8 30.7 35.7 25.7 57.9 127.1 121.2 102.4 55.8 104.4 45.5 36.4 104.7 39.3 229.6 237.1 156.1 7.9 68.0 134.5 0.0 110.6 175.2 95.0 155.3 83.1 146.5 129.4 76.3 96.6 62.0 41.9 7.0 105.6 62.0 97.8 201.0 116.3 120.9 125.1 111.0 100.8 262.4 48.7 51.8 117.9 51.9 90.7 109.8 357.4 59.8 120.9 152.3 MLST8 "GbetaL, GBL, Lst8, Pop3" ENSG00000167965 "MTOR associated protein, LST8 homolog" Q9BVC4 16 2204248-2209416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019935, HPA041841" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" NA NA Nucleoplasm "Golgi apparatus, Cell Junctions" "CAB019935: AB_561447, HPA041841: AB_2677701" "unprognostic (2.19e-1)" "unprognostic (7.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (3.35e-3)" "unprognostic (1.74e-1)" "unprognostic (8.17e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" "unprognostic (5.70e-3)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.60e-4)" "unprognostic (8.74e-2)" "unprognostic (1.20e-1)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" 12.4 18.6 24.0 11.9 22.8 15.7 10.4 23.1 39.1 11.6 14.4 15.7 12.5 16.6 9.9 14.0 15.9 17.4 12.6 18.4 23.9 18.5 15.5 17.9 9.1 13.3 20.7 20.0 16.0 32.3 11.1 12.6 15.5 16.1 14.4 6.8 17.3 25.5 13.0 36.6 13.5 13.9 8.7 14.1 10.5 15.6 25.5 13.3 13.4 20.8 13.9 11.8 13.2 9.0 8.5 14.8 2.5 18.6 7.4 9.6 11.5 7.2 20.7 8.6 21.9 11.3 8.0 14.2 5.9 8.1 10.4 9.6 28.0 10.1 18.6 15.0 7.1 4.3 8.8 8.7 18.0 1.2 14.1 39.7 12.6 20.5 18.0 16.4 19.3 17.8 11.4 12.9 12.1 15.7 8.5 11.1 25.8 18.1 12.9 5.5 30.3 18.3 25.8 16.6 6.2 19.3 19.2 8.6 32.6 7.8 4.3 27.2 13.9 9.8 22.2 15.8 3.3 13.1 18.9 7.8 12.2 13.8 9.8 8.0 14.8 8.9 20.3 6.0 17.1 10.2 0.0 15.2 2.5 8.5 18.6 6.6 8.5 7.5 9.6 14.8 7.2 9.0 9.0 1.7 7.4 16.9 8.2 7.2 11.5 24.0 22.8 23.1 39.1 23.9 18.5 20.7 20.0 16.1 13.3 6.0 13.6 23.8 14.5 13.1 30.3 3.0 10.2 10.7 6.8 15.7 19.6 58.4 29.9 30.2 39.4 11.9 36.0 23.3 37.0 37.8 20.1 13.3 8.1 14.5 41.0 28.6 27.6 19.6 22.1 78.3 13.8 14.5 16.9 34.3 26.7 26.0 26.7 37.4 14.2 30.7 24.7 19.4 15.5 24.7 25.4 13.6 44.1 18.7 37.1 11.1 MLX "bHLHd13, MAD7, MXD7, TCFL4" ENSG00000108788 "MLX, MAX dimerization protein" Q9UH92 17 42567068-42573239 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025329, HPA052766, HPA064438" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "CAB025329: , HPA052766: AB_2681940, HPA064438: AB_2685265" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.19e-3)" "unprognostic (1.21e-3)" "unprognostic (3.88e-1)" "unprognostic (2.46e-2)" "unprognostic (8.55e-3)" "unprognostic (2.49e-1)" "unprognostic (4.87e-2)" "unprognostic (8.66e-2)" "unprognostic (9.66e-2)" "unprognostic (2.89e-1)" "unprognostic (1.61e-2)" "unprognostic (7.43e-2)" "unprognostic (4.67e-2)" "unprognostic (2.05e-1)" "unprognostic (3.25e-1)" 21.3 19.2 10.4 12.6 11.9 8.3 22.5 10.3 14.3 12.3 32.2 10.8 15.4 27.5 11.0 15.1 18.8 10.5 19.2 38.1 9.8 9.8 23.5 34.7 19.0 18.6 11.3 6.6 10.4 36.8 8.5 13.0 13.7 9.4 13.4 23.1 11.6 18.5 14.8 43.3 15.6 42.5 12.1 10.2 18.7 20.6 7.4 8.9 20.3 23.5 24.9 19.7 16.5 13.1 14.6 26.3 34.7 33.5 12.8 18.2 23.0 15.8 18.3 14.4 14.6 22.0 25.4 10.0 23.8 21.1 25.7 23.3 16.5 16.5 19.1 16.8 20.2 23.4 24.0 26.2 15.4 22.6 15.1 24.6 19.7 13.2 18.3 25.9 26.4 28.5 22.0 17.2 20.6 18.9 17.4 18.9 23.1 21.5 17.1 29.3 21.0 37.0 13.0 10.2 39.3 16.6 16.8 29.9 20.4 20.8 19.6 22.5 11.2 10.6 13.7 26.7 20.0 28.1 31.3 13.4 22.9 14.8 25.0 35.1 17.4 19.7 18.0 25.7 16.9 26.9 14.2 25.0 34.7 14.3 30.8 15.8 14.6 14.8 14.3 26.3 11.8 13.1 13.1 32.3 12.8 33.5 14.1 18.2 23.0 10.4 11.9 10.3 14.3 9.8 9.8 11.3 6.6 9.4 8.9 62.5 76.9 37.4 23.4 37.3 27.5 22.9 40.8 30.8 50.0 26.2 23.6 33.1 51.4 35.7 17.8 23.2 101.9 0.0 60.3 38.8 28.7 21.1 44.1 46.0 60.8 23.8 24.8 23.4 50.2 21.2 32.5 61.4 30.4 50.5 40.2 12.3 61.7 61.4 29.4 44.4 24.5 51.8 33.9 8.4 38.4 43.5 36.8 35.8 48.8 32.5 MMACHC "cblC, DKFZP564I122" ENSG00000132763 "Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria" Q9Y4U1 1 45500053-45513382 "Disease related genes, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.1" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027394, HPA027399, HPA027402" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255" "unprognostic (3.34e-1)" "unprognostic (1.63e-1)" "unprognostic (7.03e-3)" "unprognostic (3.14e-2)" "unprognostic (4.05e-1)" "unprognostic (1.16e-2)" "unprognostic (9.04e-2)" "unprognostic (1.03e-2)" "unprognostic (1.90e-1)" "unprognostic (1.05e-2)" "unprognostic (3.88e-2)" "unprognostic (6.81e-2)" "unprognostic (2.61e-3)" "unprognostic (2.08e-3)" "unprognostic (8.83e-2)" "unprognostic (2.50e-2)" "unprognostic (2.58e-2)" 3.5 7.4 5.8 3.3 10.2 2.2 6.1 3.6 12.2 5.4 6.3 11.8 3.2 5.6 4.1 5.6 4.0 6.2 2.9 11.1 6.2 5.1 7.6 30.1 2.7 3.1 7.3 6.9 6.4 9.8 9.5 5.4 2.9 8.5 3.9 7.6 4.0 11.9 7.5 14.7 3.8 4.1 4.2 6.7 3.6 4.5 7.3 5.7 4.1 4.4 3.7 3.6 3.9 3.1 2.1 3.6 5.0 6.1 2.6 3.9 1.1 6.8 3.5 6.1 9.2 5.8 3.5 7.6 5.3 3.5 9.7 8.8 7.3 4.2 10.7 6.9 4.4 1.8 5.7 11.2 12.7 8.9 2.9 10.2 8.3 5.9 8.2 5.5 11.8 3.0 5.0 7.2 10.7 11.8 3.5 4.6 11.3 9.4 6.1 7.4 7.3 7.9 3.8 10.0 7.8 8.3 9.8 2.5 11.9 5.6 5.4 9.8 5.0 8.0 13.3 17.3 4.8 7.6 4.3 2.1 6.8 9.3 7.6 2.8 9.2 7.4 6.2 4.9 5.7 6.3 5.0 1.6 1.6 1.7 2.4 2.8 2.0 2.0 1.4 1.7 2.1 3.9 2.0 3.5 2.6 6.1 3.6 1.4 1.1 5.8 10.2 3.6 12.2 6.2 5.1 7.3 6.9 8.5 5.7 3.0 5.6 1.5 1.7 0.1 0.9 8.7 2.5 1.4 3.4 1.8 0.0 3.1 5.0 1.1 0.6 0.7 1.6 0.0 1.2 3.7 1.8 1.3 2.3 21.9 2.9 3.2 4.1 2.5 3.1 0.0 1.7 0.9 0.0 0.0 2.6 1.0 1.8 0.0 1.4 3.2 4.4 0.0 1.7 8.1 2.0 0.1 2.3 1.3 6.0 1.6 MMP15 "MT2-MMP, MTMMP2, SMCP-2" ENSG00000102996 "Matrix metallopeptidase 15" P51511 16 58025566-58046901 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.2" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 56.0;Enterocytes: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 2.9" "Lineage enriched" "Detected in single" 30 "dendritic cells: 2.9" "Cell line enhanced" "Detected in many" "BEWO: 37.1;Hep G2: 19.3;SK-BR-3: 18.6;WM-115: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002611, HPA040390" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB002611: , HPA040390: AB_2676956" "unprognostic (1.76e-2)" "unprognostic (7.32e-2)" "unprognostic (2.69e-1)" "unprognostic (6.85e-2)" "unprognostic (3.09e-1)" "unprognostic (1.68e-1)" "unprognostic (6.88e-3)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (1.24e-2)" "unprognostic (4.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (8.54e-8)" "unprognostic (3.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "prognostic favorable (3.08e-4)" 5.9 2.3 2.0 5.5 3.0 0.1 7.7 3.7 7.2 3.3 19.5 4.2 16.3 22.6 2.9 1.7 2.5 3.6 15.9 17.6 2.3 3.7 8.4 26.4 6.1 2.0 2.5 2.2 2.1 10.3 7.3 5.2 28.5 10.4 3.6 8.2 9.5 4.7 14.7 3.4 2.3 43.2 3.4 3.4 5.2 14.7 28.0 2.1 1.1 26.8 2.5 2.2 3.3 4.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 5.7 4.4 2.3 11.9 2.4 0.1 37.1 0.5 0.3 2.1 0.5 3.5 14.9 0.0 7.0 0.6 1.6 8.1 2.0 1.7 0.6 0.0 3.9 0.0 1.9 19.3 3.1 0.1 7.7 1.2 3.1 0.3 0.9 3.3 1.4 3.3 4.8 0.0 0.7 2.9 0.2 0.9 6.8 17.0 1.2 2.9 0.3 3.1 6.5 2.1 0.6 4.1 7.7 18.6 3.5 5.5 2.0 3.1 1.3 0.1 3.7 1.4 0.5 0.0 0.0 0.1 0.7 0.9 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 3.0 3.7 7.2 2.3 3.7 2.5 2.2 10.4 2.1 17.9 11.8 0.9 1.0 2.3 1.9 19.3 56.0 5.3 9.1 17.4 15.7 33.4 1.7 33.5 2.2 6.0 81.1 0.0 10.5 19.6 2.8 1.6 0.0 29.0 10.2 1.6 10.9 19.6 3.5 4.8 0.9 0.1 1.7 0.0 31.8 1.7 13.5 40.7 3.2 5.4 1.4 0.0 0.8 0.9 4.9 1.9 40.5 1.5 28.3 1.4 MNX1 "HB9, HLXB9, HOXHB9, SCRA1" ENSG00000130675 "Motor neuron and pancreas homeobox 1" P50219 7 156994051-157010651 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 43.3" "Cell type enhanced" "Detected in some" 15 "Intestinal endocrine cells: 24.1;Mucus-secreting cells: 18.0;Paneth cells: 9.0;Undifferentiated cells: 12.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 11.8;BEWO: 8.8;EFO-21: 11.3;HEK 293: 9.0;RPMI-8226: 24.7;SCLC-21H: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA071717 Approved Nucleoplasm,Nucleoli,Cytosol No NA Nucleoplasm "Nucleoli, Cytosol" "HPA071717: AB_2686437" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.87e-2)" "unprognostic (3.72e-3)" "unprognostic (8.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.07e-1)" "unprognostic (4.07e-2)" "unprognostic (5.06e-2)" "unprognostic (8.62e-4)" "unprognostic (1.00e-2)" "unprognostic (3.35e-2)" "unprognostic (2.23e-5)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.1 6.0 0.2 0.1 9.0 0.1 0.1 0.3 0.0 7.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 43.3 0.0 3.2 0.1 0.2 0.8 3.7 0.1 1.9 0.1 0.1 0.1 7.3 0.1 0.2 0.1 2.7 1.0 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 3.9 0.0 11.8 0.0 0.0 8.8 0.0 0.0 0.1 0.0 5.1 1.7 0.9 11.3 0.0 0.3 0.2 2.0 1.6 0.9 1.4 9.0 0.0 0.8 2.3 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 4.1 3.7 1.9 0.0 6.6 0.6 0.1 0.0 1.1 0.7 0.0 1.7 24.7 4.4 0.4 13.3 0.0 1.7 1.5 0.2 0.1 3.7 2.9 0.0 0.0 0.0 0.0 0.0 3.7 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.7 0.0 4.3 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 24.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 18.0 0.0 2.5 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.4 0.0 MOB1A "C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B" ENSG00000114978 "MOB kinase activator 1A" Q9H8S9 2 74152528-74178898 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 381.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (5.32e-2)" "unprognostic (2.45e-1)" "unprognostic (5.38e-2)" "unprognostic (2.62e-1)" "unprognostic (2.19e-1)" "unprognostic (8.19e-2)" "prognostic unfavorable (3.34e-4)" "unprognostic (9.36e-2)" "unprognostic (3.91e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-3)" "unprognostic (1.04e-1)" "unprognostic (2.20e-3)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.11e-3)" 32.2 18.0 12.2 41.5 16.3 36.6 36.2 10.8 11.3 24.5 21.5 12.6 16.1 19.7 27.1 19.8 28.9 22.0 19.9 20.9 11.0 10.4 34.7 21.4 28.4 65.1 14.7 6.9 28.4 12.6 13.8 11.5 20.9 15.9 21.0 20.7 14.3 18.1 18.8 12.8 22.9 30.2 31.6 21.8 51.1 18.7 17.9 12.8 57.0 25.4 16.9 42.4 29.2 24.6 22.3 22.2 32.3 42.8 20.6 15.9 25.2 21.0 12.1 15.2 16.4 25.1 27.5 18.0 17.0 22.9 22.2 21.9 16.5 15.4 43.3 14.6 21.3 16.5 17.7 19.4 19.4 33.7 30.4 11.6 39.1 8.4 17.4 20.1 33.8 63.2 23.2 19.0 17.7 15.0 16.7 23.2 16.8 16.7 16.1 21.5 11.4 42.4 28.8 14.1 18.1 9.9 29.3 52.4 23.0 19.1 26.4 7.7 10.1 24.1 17.9 15.5 12.0 14.3 16.1 22.0 28.9 15.2 20.2 26.9 12.0 10.6 33.3 19.4 28.9 15.4 30.8 24.0 32.3 14.8 39.0 15.9 22.3 13.3 15.7 22.2 17.2 12.3 14.6 24.0 20.6 42.8 15.5 13.4 25.2 12.2 16.3 10.8 11.3 11.0 10.4 14.7 6.9 15.9 12.8 47.6 54.3 138.1 70.9 121.6 12.3 37.0 43.3 80.3 58.0 78.5 5.9 57.5 77.9 53.0 5.0 60.8 83.6 46.7 46.0 83.4 58.3 90.4 109.5 38.0 153.8 25.4 36.1 63.3 177.0 8.5 57.8 185.9 64.1 381.5 63.9 22.4 63.0 74.8 64.3 137.3 13.0 71.1 74.1 87.4 46.2 115.4 55.5 96.5 62.4 139.8 MOB1B "MOB4A, MOBKL1A" ENSG00000173542 "MOB kinase activator 1B" Q7L9L4 4 70902326-71022449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 70.0;monocytes: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 34.3" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (1.05e-1)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (2.94e-1)" "unprognostic (1.36e-1)" "unprognostic (3.45e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.09e-3)" "unprognostic (2.70e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-3)" 9.8 10.1 15.7 17.8 13.0 30.9 11.1 10.4 20.0 10.5 9.7 17.3 4.8 6.1 13.9 8.6 9.9 11.8 9.1 11.1 19.8 10.6 29.3 8.3 20.6 13.4 15.5 18.6 13.8 11.0 18.0 10.9 11.2 12.8 12.7 8.5 8.0 11.1 8.6 10.8 11.2 8.4 14.1 17.4 10.6 10.1 7.6 15.4 52.3 14.4 8.2 12.8 10.8 9.8 0.6 5.3 2.5 3.1 0.7 1.4 1.2 3.9 3.2 12.2 9.9 6.6 8.4 10.0 11.9 6.5 6.7 5.9 4.2 7.6 22.0 5.7 10.5 4.5 2.8 7.5 10.0 16.2 11.6 2.6 34.3 3.6 3.3 6.6 7.5 6.9 6.9 5.5 7.5 6.1 7.5 7.9 11.4 21.0 7.2 10.5 4.2 23.2 4.6 4.0 2.6 4.2 7.5 11.8 3.0 11.1 6.9 4.2 8.1 5.1 2.3 15.9 6.8 5.4 4.8 9.4 18.6 9.5 8.4 4.8 4.6 1.5 9.4 6.5 5.5 8.5 0.8 3.1 2.5 1.3 1.6 1.1 0.5 0.6 0.6 4.0 0.6 0.8 0.7 0.4 0.7 0.9 5.3 1.4 1.2 15.7 13.0 10.4 20.0 19.8 10.6 15.5 18.6 12.8 15.4 23.8 15.5 2.2 5.2 15.9 2.0 14.7 7.6 21.4 12.5 41.8 17.7 4.6 8.3 4.9 0.4 9.5 0.9 70.0 4.0 4.9 11.2 9.8 10.4 6.4 9.9 6.4 36.4 9.8 34.3 1.4 4.0 21.6 10.1 52.3 8.4 6.0 8.0 0.0 8.1 15.9 4.3 25.8 21.7 7.2 9.8 14.9 4.8 5.4 5.6 8.4 MOB2 HCCA2 ENSG00000182208 "MOB kinase activator 2" Q70IA6 11 1469457-1501247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 57.3;urinary bladder: 51.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046313 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA046313: AB_10959882" "unprognostic (5.02e-1)" "unprognostic (5.71e-2)" "unprognostic (6.24e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.30e-2)" "unprognostic (1.06e-3)" "unprognostic (3.06e-2)" "unprognostic (1.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.30e-2)" "unprognostic (2.87e-1)" "prognostic favorable (2.02e-4)" "unprognostic (2.67e-1)" "unprognostic (8.56e-2)" "unprognostic (9.78e-2)" "unprognostic (1.15e-1)" 9.2 4.2 2.4 17.0 2.5 3.0 12.1 2.5 3.2 14.9 30.9 1.8 6.7 2.5 12.5 8.7 17.3 13.8 26.8 8.1 2.8 1.9 3.2 3.0 4.1 8.2 2.1 2.1 8.6 5.8 6.8 1.8 4.2 2.9 21.2 6.7 4.3 12.9 20.1 7.1 9.4 10.6 57.3 2.5 3.7 9.9 4.2 2.0 2.0 4.3 3.2 4.4 51.8 21.2 10.6 10.8 11.2 12.5 11.6 17.3 9.0 13.9 15.2 9.4 7.6 23.5 16.6 8.7 11.0 16.1 21.2 16.8 9.7 19.2 10.3 8.5 25.9 13.2 17.1 14.5 24.7 13.0 13.8 21.7 7.8 5.5 12.3 15.9 10.2 12.3 13.4 29.8 11.3 13.3 17.1 22.5 13.4 12.6 10.7 10.7 9.9 13.2 17.4 11.6 26.7 14.2 9.6 9.6 10.7 17.7 13.3 17.6 18.7 13.7 17.1 13.2 12.5 7.9 10.2 18.5 13.0 6.6 4.2 6.9 10.6 10.3 10.7 9.0 9.9 9.9 8.2 8.6 11.2 17.3 8.7 14.6 8.2 14.9 13.8 10.8 10.6 12.5 10.5 7.1 11.6 12.5 6.9 12.8 9.0 2.4 2.5 2.5 2.5 2.8 1.9 2.1 2.1 2.9 2.0 6.0 7.7 13.7 25.1 73.0 17.7 11.3 12.7 6.7 5.7 7.0 11.8 26.7 23.2 29.5 22.2 55.0 43.9 70.0 33.6 25.8 27.0 36.5 25.3 7.4 23.5 41.3 20.1 25.8 15.2 9.0 22.2 20.7 54.0 32.5 29.1 18.0 31.2 63.1 48.1 18.3 17.2 84.1 54.6 22.2 39.4 71.6 49.7 45.0 24.3 28.6 MOCS2 MOCO1 ENSG00000164172 "Molybdenum cofactor synthesis 2" "O96007, O96033" 5 53095679-53110063 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Distal tubular cells: 485.7;Proximal tubular cells: 194.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037679, HPA037680" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear speckles" "HPA037679: AB_2675604, HPA037680: AB_10673635" "unprognostic (3.27e-1)" "unprognostic (3.11e-2)" "unprognostic (2.82e-1)" "unprognostic (8.37e-3)" "unprognostic (2.12e-1)" "unprognostic (3.48e-2)" "unprognostic (1.60e-2)" "unprognostic (1.33e-1)" "unprognostic (6.66e-2)" "unprognostic (7.59e-2)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" "prognostic favorable (3.68e-6)" "unprognostic (1.04e-1)" "unprognostic (1.04e-2)" "unprognostic (2.04e-1)" "unprognostic (5.86e-2)" 18.1 34.6 41.5 9.8 38.0 4.0 19.6 21.7 41.8 16.0 17.1 20.7 10.4 17.6 14.8 28.2 17.0 12.9 15.9 39.9 36.7 32.1 49.7 52.0 13.1 11.4 30.0 22.4 21.2 18.4 30.4 23.3 16.2 28.7 18.6 14.9 17.2 21.2 20.8 38.3 8.9 17.6 16.1 27.1 10.7 16.6 11.0 20.0 8.2 31.5 19.4 11.2 16.9 15.4 16.9 12.5 6.3 10.9 17.3 25.8 12.9 20.2 16.6 12.0 28.7 24.6 22.7 15.2 24.9 26.2 22.2 26.4 22.6 15.2 20.7 37.5 19.6 34.4 12.3 24.0 25.5 35.0 5.2 23.4 15.9 16.3 20.4 25.3 17.2 12.0 18.1 12.8 25.2 22.5 22.0 23.8 26.7 15.4 11.3 37.0 30.0 18.5 9.8 10.6 8.7 34.6 9.4 25.8 18.8 38.4 15.4 8.9 10.3 18.1 14.8 18.6 15.9 28.6 4.4 15.2 21.3 22.1 18.9 32.0 13.3 19.7 23.4 30.5 4.9 32.9 5.2 9.2 6.3 16.9 10.9 20.2 16.5 19.0 19.2 12.5 16.9 25.8 22.2 1.7 17.3 9.8 11.4 18.3 12.9 41.5 38.0 21.7 41.8 36.7 32.1 30.0 22.4 28.7 20.0 50.6 20.6 25.2 32.7 11.8 27.0 111.0 66.2 36.1 19.4 66.3 25.5 82.4 485.7 34.6 5.6 32.8 17.8 0.0 38.2 28.9 48.8 44.5 9.3 99.9 36.5 6.4 25.3 19.0 25.0 10.1 46.9 27.4 21.9 7.2 17.9 36.8 23.4 19.3 64.7 194.9 18.1 32.3 50.3 40.7 54.7 13.7 27.0 26.1 22.9 30.2 MPHOSPH8 "HSMPP8, mpp8" ENSG00000196199 "M-phase phosphoprotein 8" Q99549 13 19633681-19673459 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039701, HPA040035" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA039701: AB_10805484, HPA040035: AB_10794207" "unprognostic (4.22e-1)" "unprognostic (5.58e-2)" "unprognostic (2.66e-1)" "unprognostic (4.01e-3)" "unprognostic (3.05e-2)" "unprognostic (1.86e-1)" "unprognostic (2.81e-3)" "unprognostic (4.90e-2)" "unprognostic (4.55e-2)" "unprognostic (1.59e-1)" "unprognostic (3.52e-3)" "unprognostic (3.40e-2)" "unprognostic (6.49e-2)" "unprognostic (3.86e-2)" "unprognostic (4.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.02e-1)" 20.6 27.1 37.7 33.4 37.1 19.2 21.4 48.9 45.0 32.0 26.6 13.2 31.7 17.8 29.4 26.7 19.1 22.3 18.8 27.9 31.0 27.2 18.9 16.5 22.9 28.4 28.8 32.8 43.6 22.0 20.9 44.3 20.0 28.4 26.1 20.1 11.9 24.5 38.8 25.7 26.6 23.9 31.3 37.1 30.0 22.5 16.6 33.5 16.5 26.8 11.7 20.4 31.3 37.9 21.7 13.8 39.4 9.9 11.5 17.6 3.6 12.9 8.3 12.5 20.2 16.2 20.6 22.1 19.5 14.2 12.3 10.6 12.7 22.9 20.5 15.6 11.8 19.2 21.7 22.9 13.6 15.9 25.5 11.7 33.0 13.7 15.4 14.4 23.7 26.9 12.1 17.7 9.7 13.7 18.8 16.2 16.7 15.9 13.2 11.4 12.6 18.1 19.9 12.2 24.1 9.3 14.6 28.8 16.2 21.4 10.1 17.1 10.5 18.2 16.8 17.7 21.8 10.2 19.7 19.0 9.6 8.6 18.1 9.8 9.0 9.3 20.4 7.3 22.0 14.8 39.4 9.5 15.4 13.0 6.9 11.5 21.5 14.6 12.5 4.3 21.7 17.6 14.4 27.5 11.5 9.9 13.8 11.3 3.6 37.7 37.1 48.9 45.0 31.0 27.2 28.8 32.8 28.4 33.5 86.4 100.8 102.7 102.3 61.2 189.0 78.6 81.5 60.2 84.2 97.7 78.5 107.7 41.4 45.8 58.1 101.2 89.2 23.3 47.7 70.1 98.0 73.8 137.8 68.9 64.6 198.6 56.6 106.2 53.3 25.9 166.0 79.7 64.1 91.0 71.4 105.7 42.2 94.7 147.8 48.2 208.1 174.6 116.5 181.6 204.0 64.6 49.1 124.6 63.9 55.3 MPHOSPH9 MPP9 ENSG00000051825 "M-phase phosphoprotein 9" Q99550 12 123152320-123244014 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 48.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037485 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA037485: AB_10672792" "unprognostic (2.98e-2)" "unprognostic (5.00e-1)" "unprognostic (4.36e-3)" "unprognostic (1.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.81e-1)" "unprognostic (5.81e-3)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.53e-3)" "unprognostic (1.31e-2)" "unprognostic (2.75e-1)" "unprognostic (5.14e-3)" "unprognostic (1.17e-1)" 5.3 9.8 11.0 10.5 14.6 24.8 5.6 21.6 14.9 5.5 6.7 7.7 4.9 7.9 6.4 12.8 5.9 6.1 4.0 8.8 8.8 6.0 7.1 12.7 6.1 12.0 7.1 8.0 6.9 6.3 9.9 20.4 5.7 9.9 5.8 7.6 7.7 5.9 5.2 7.2 5.4 8.0 5.9 9.1 10.2 5.9 14.4 11.0 48.9 6.2 3.2 10.8 5.5 5.0 6.2 4.9 8.3 3.7 8.5 12.1 3.0 8.5 9.1 14.6 16.4 6.5 6.1 5.5 8.8 4.5 11.1 8.9 8.6 4.2 16.8 6.5 5.8 10.6 6.1 18.8 7.2 15.5 10.7 12.2 17.1 10.1 8.4 5.0 15.9 14.9 6.6 2.7 10.5 10.5 9.8 11.3 25.6 11.8 7.4 10.1 7.2 18.1 25.2 10.0 5.6 9.9 16.2 14.7 10.9 8.6 8.4 18.7 8.8 13.7 5.5 8.6 15.3 10.3 12.0 6.4 9.1 13.1 10.5 12.5 11.6 18.7 14.0 7.3 15.3 18.8 8.3 3.7 5.1 10.9 3.6 7.7 5.6 8.6 9.8 3.5 6.2 12.1 11.8 0.7 8.5 3.1 4.9 7.4 3.0 11.0 14.6 21.6 14.9 8.8 6.0 7.1 8.0 9.9 11.0 8.9 7.4 13.8 3.9 3.9 36.9 12.6 10.2 14.7 9.1 7.0 108.0 8.9 5.0 4.1 46.8 4.5 3.3 0.0 1.6 5.6 8.1 2.8 2.3 27.6 7.3 50.9 13.7 5.5 12.0 48.4 6.6 7.2 3.3 14.4 5.1 17.7 1.6 0.0 10.6 7.1 64.2 0.0 4.1 30.0 19.6 1.9 1.4 22.3 7.5 2.4 MPLKIP "C7orf11, ORF20, TTDN1" ENSG00000168303 "M-phase specific PLK1 interacting protein" Q8TAP9 7 40126023-40134652 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA058457, HPA065463" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA058457: AB_2683724, HPA065463: AB_2685493" "unprognostic (5.59e-2)" "unprognostic (1.74e-1)" "unprognostic (9.40e-2)" "unprognostic (2.39e-2)" "unprognostic (5.55e-2)" "unprognostic (1.34e-3)" "unprognostic (2.73e-1)" "unprognostic (3.40e-2)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (3.16e-3)" "unprognostic (8.89e-2)" "unprognostic (1.61e-2)" "unprognostic (8.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-2)" "unprognostic (6.08e-2)" 13.7 15.2 11.6 9.3 12.7 8.7 14.8 13.9 12.1 12.7 14.5 12.6 9.5 11.9 11.0 13.6 12.9 10.0 9.3 9.3 11.8 11.4 20.5 52.1 8.7 13.3 15.0 8.8 12.0 17.3 10.1 16.1 13.8 10.4 11.5 11.6 11.1 14.4 10.5 10.1 11.3 13.4 9.2 11.9 12.7 10.8 11.0 12.0 25.5 19.2 7.9 12.8 11.3 12.6 53.8 41.9 52.9 38.0 30.7 45.0 40.9 24.1 7.1 13.3 16.7 13.4 15.8 14.7 8.7 10.3 13.9 14.1 9.7 11.8 19.7 12.9 9.0 26.5 29.7 8.0 16.3 17.4 15.1 29.0 15.0 10.5 20.4 16.1 17.8 14.4 14.8 22.6 9.9 12.9 13.9 16.7 21.6 39.3 15.1 14.1 12.4 18.0 60.4 18.4 20.2 24.2 26.4 9.2 25.9 15.4 5.7 19.4 24.1 14.3 13.6 20.9 19.5 17.5 26.7 15.1 7.5 22.7 9.1 13.5 24.6 29.1 33.4 12.8 30.6 22.1 43.4 38.0 52.9 28.0 34.3 31.3 53.8 35.9 32.8 39.4 47.0 40.0 35.1 20.4 30.7 31.5 41.9 45.0 40.9 11.6 12.7 13.9 12.1 11.8 11.4 15.0 8.8 10.4 12.0 47.6 34.6 54.8 74.2 97.8 44.2 15.9 53.5 53.5 39.8 55.8 23.6 94.3 99.5 60.1 107.2 61.3 51.0 0.0 47.7 63.7 58.5 51.4 49.7 109.9 60.4 50.9 46.7 45.4 55.0 29.2 70.2 56.9 55.6 52.3 57.8 42.0 52.6 70.6 51.9 148.0 42.4 51.8 48.1 54.9 49.5 117.2 80.0 48.0 77.3 91.3 MPP5 "FLJ12615, PALS1" ENSG00000072415 "Membrane palmitoylated protein 5" Q8N3R9 14 67241109-67335819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000993, HPA063890" Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA000993: AB_1079407, HPA063890: AB_2732707" "unprognostic (3.65e-1)" "unprognostic (3.82e-3)" "unprognostic (4.56e-2)" "unprognostic (9.20e-2)" "unprognostic (9.86e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.93e-3)" "unprognostic (9.89e-3)" "prognostic favorable (1.71e-12)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (6.90e-2)" "unprognostic (6.87e-2)" 7.1 9.2 14.8 6.8 29.2 7.0 10.1 9.4 18.0 9.0 12.5 15.9 13.7 18.5 6.9 20.8 14.4 7.2 9.0 7.3 16.4 17.0 28.8 17.2 11.5 4.5 30.6 10.2 6.4 8.6 22.9 11.4 27.9 20.5 15.8 11.6 7.6 15.9 18.6 14.6 8.6 18.7 11.9 23.3 6.2 9.7 8.2 25.4 6.8 24.1 6.9 5.8 9.1 9.1 3.6 2.4 3.7 2.8 6.7 4.4 1.2 54.9 8.8 8.9 7.2 5.2 4.7 7.9 16.8 8.8 12.3 8.3 8.7 16.9 4.7 8.0 13.6 4.3 11.5 5.1 9.7 18.9 2.2 3.5 4.3 9.3 6.0 6.0 1.6 3.3 5.0 3.7 7.1 9.1 8.9 6.8 5.4 4.5 2.1 19.6 7.4 5.2 2.0 3.0 8.0 6.0 4.7 14.2 5.6 11.2 13.7 5.0 3.6 10.4 10.2 5.8 8.2 10.5 3.3 10.6 15.7 33.4 5.5 7.3 3.2 2.9 7.2 10.5 3.7 5.4 0.4 2.2 3.7 1.7 2.8 1.4 3.6 2.0 1.9 2.4 1.9 4.4 2.4 0.8 6.7 2.3 2.4 1.1 1.2 14.8 29.2 9.4 18.0 16.4 17.0 30.6 10.2 20.5 25.4 59.6 21.6 6.0 21.7 18.7 9.4 22.4 12.7 9.4 17.0 21.0 41.2 18.5 11.6 19.2 4.4 14.3 41.0 0.0 23.5 8.9 16.6 25.6 4.7 16.8 14.2 3.2 5.2 16.5 9.6 3.9 7.5 7.2 3.3 7.2 18.4 24.1 20.2 31.6 10.6 28.4 34.5 6.5 19.6 8.3 33.8 15.2 14.6 4.4 19.5 31.5 MRI1 "MGC3207, MRDI, mtnA, Ypr118w" ENSG00000037757 "Methylthioribose-1-phosphate isomerase 1" Q9BV20 19 13764532-13774282 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042744, CAB045988" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No 2600000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "CAB045988: AB_2145566, HPA042744: AB_2678141" "unprognostic (1.16e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-3)" "unprognostic (1.61e-1)" "unprognostic (8.98e-2)" "unprognostic (1.50e-3)" "unprognostic (1.75e-2)" "unprognostic (1.18e-2)" "unprognostic (1.67e-1)" "unprognostic (1.77e-1)" "unprognostic (1.28e-1)" 14.5 18.5 12.5 21.8 18.3 16.6 16.8 24.5 21.8 21.5 17.2 23.6 23.5 19.0 24.2 21.3 20.7 19.9 17.6 13.5 14.6 12.1 24.4 20.1 15.4 19.5 16.5 14.3 24.0 20.5 21.3 17.3 24.2 17.2 17.8 13.4 18.5 23.4 21.6 13.0 28.6 18.5 13.3 16.6 22.0 19.8 5.0 16.7 20.0 21.8 10.5 18.2 18.1 20.6 5.7 8.9 6.9 5.8 5.0 6.6 3.6 10.7 8.0 4.0 9.6 4.4 8.2 9.8 12.8 7.4 11.6 10.6 8.4 8.6 5.8 5.1 4.7 5.5 18.1 18.6 13.2 7.1 10.1 32.2 4.6 12.7 9.0 3.9 13.9 10.8 8.2 7.3 5.9 4.7 10.5 10.7 5.7 8.8 0.3 5.0 15.8 15.4 8.9 6.6 3.9 22.9 14.5 5.4 13.1 5.9 8.4 8.0 7.2 4.6 10.5 10.0 5.6 8.2 5.1 6.5 6.0 5.5 21.2 6.2 7.9 8.3 1.7 5.1 16.1 7.1 6.9 5.5 1.9 6.2 5.8 6.0 5.0 5.3 6.6 4.7 5.7 4.3 3.3 4.1 5.0 3.2 8.9 4.8 3.6 12.5 18.3 24.5 21.8 14.6 12.1 16.5 14.3 17.2 16.7 8.9 16.6 10.8 9.0 9.8 3.1 0.8 5.1 20.1 14.8 15.7 7.9 10.1 5.0 8.2 0.6 6.0 9.1 0.0 11.0 7.7 8.5 6.0 12.7 9.0 6.3 1.6 8.7 12.3 8.9 1.4 16.1 8.5 1.7 6.4 9.4 3.3 5.8 11.0 14.2 8.1 6.3 25.8 5.5 0.4 3.9 9.9 4.5 14.4 9.1 8.0 MRPL46 "C15orf4, LIECG2, P2ECSL" ENSG00000259494 "Mitochondrial ribosomal protein L46" Q9H2W6 15 88459476-88467419 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050166 Uncertain Supported "Nucleoplasm,Cell Junctions,Mitochondria" NA NA Mitochondria "Nucleoplasm, Cell Junctions" "HPA050166: AB_2681039" "unprognostic (1.42e-1)" "unprognostic (6.94e-3)" "unprognostic (1.02e-1)" "unprognostic (1.21e-2)" "unprognostic (3.28e-2)" "unprognostic (5.16e-2)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.79e-1)" "unprognostic (4.64e-3)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "prognostic favorable (2.09e-6)" "unprognostic (7.73e-2)" "unprognostic (9.18e-2)" "unprognostic (6.96e-3)" "unprognostic (1.63e-1)" 11.0 28.3 14.2 11.9 14.7 5.4 13.2 15.8 15.6 7.3 12.4 8.5 10.0 11.1 9.6 11.5 13.3 10.5 8.3 40.8 11.8 11.3 19.3 38.7 7.4 10.4 13.2 13.0 11.4 8.9 8.1 9.2 13.7 13.8 9.0 13.8 7.8 9.3 9.5 57.0 8.2 9.3 11.1 11.4 9.7 12.0 13.7 11.7 12.2 10.0 17.9 11.0 11.1 13.4 31.8 24.6 13.2 24.5 24.3 31.9 25.1 10.0 32.2 10.6 11.3 15.2 11.1 19.6 14.4 13.5 21.8 19.5 39.6 22.2 23.9 14.8 13.0 19.5 24.6 40.7 17.7 17.6 9.7 32.4 19.9 23.2 41.3 9.5 19.4 15.5 12.8 21.6 16.4 11.4 11.0 18.8 23.7 21.8 10.2 15.8 21.5 16.3 24.6 16.4 18.6 19.6 18.8 14.6 18.1 16.9 32.3 16.1 10.5 13.7 21.6 29.5 18.6 24.3 24.2 11.6 17.0 16.1 9.0 20.7 9.5 19.6 19.4 18.7 21.4 12.8 9.9 19.6 13.2 26.8 24.5 30.5 31.8 28.7 26.1 24.6 28.4 31.9 28.4 3.5 24.3 17.6 20.9 26.9 25.1 14.2 14.7 15.8 15.6 11.8 11.3 13.2 13.0 13.8 11.7 0.0 6.4 19.3 18.4 12.2 20.3 64.9 30.6 16.0 10.3 34.9 25.5 77.8 101.2 30.3 48.5 15.4 23.1 0.0 32.9 37.0 13.4 13.1 21.9 82.5 31.2 14.3 27.2 17.2 12.6 6.8 13.3 9.2 6.8 63.1 17.9 17.8 28.5 17.5 17.7 80.1 22.7 25.8 10.5 30.3 24.5 20.5 67.5 22.7 28.6 26.5 MRTO4 "C1orf33, dJ657E11.4, MRT4" ENSG00000053372 "MRT4 homolog, ribosome maturation factor" Q9UKD2 1 19251539-19260128 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026446 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No "Nucleoplasm, Nuclear membrane" Nucleoli "HPA026446: AB_10601441" "unprognostic (3.99e-1)" "unprognostic (1.75e-1)" "unprognostic (2.18e-2)" "unprognostic (2.94e-1)" "unprognostic (4.12e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (1.56e-8)" "unprognostic (7.46e-2)" "unprognostic (5.58e-2)" "unprognostic (2.61e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.11e-8)" "unprognostic (5.87e-2)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (3.23e-2)" 17.2 16.5 20.4 16.9 18.5 12.0 21.6 10.7 21.7 12.1 13.8 12.4 10.2 17.5 15.6 15.2 21.6 18.8 11.8 11.7 19.1 15.9 13.6 23.7 10.5 23.0 16.1 19.1 18.7 41.2 10.2 8.8 12.5 15.1 12.2 17.6 10.6 13.2 11.9 22.8 15.3 19.3 17.3 10.0 14.5 13.7 21.6 11.6 14.5 12.9 29.3 22.7 11.4 12.4 14.7 12.8 1.0 8.2 10.6 15.7 7.2 24.3 17.3 14.4 18.8 7.0 11.2 12.7 19.1 10.8 32.7 21.6 24.9 25.3 36.0 16.0 15.8 14.3 19.4 39.7 28.8 33.0 12.8 30.3 26.6 15.5 21.4 8.8 35.1 11.2 9.8 19.1 36.9 19.2 8.7 18.3 16.4 40.2 11.6 19.3 17.8 28.5 25.4 18.4 25.6 26.4 26.8 17.5 27.8 17.8 8.3 23.1 17.0 14.6 20.1 20.1 10.7 14.3 20.7 12.0 17.9 22.2 27.4 32.4 9.5 16.5 47.4 17.4 45.1 28.5 0.7 7.5 0.7 7.9 8.2 15.7 14.7 9.6 10.8 11.4 13.1 13.0 11.6 1.0 10.6 6.2 12.8 6.7 7.2 20.4 18.5 10.7 21.7 19.1 15.9 16.1 19.1 15.1 11.6 6.0 12.6 26.1 38.7 33.2 19.2 9.0 35.7 17.4 23.9 7.0 9.8 42.2 34.9 44.9 14.5 23.3 5.4 0.0 47.2 51.2 28.2 15.4 25.4 14.4 42.9 14.3 20.7 11.6 12.1 27.6 21.3 21.7 18.6 39.7 19.8 19.2 44.4 14.0 19.1 30.1 13.8 19.4 28.8 37.0 43.7 29.4 21.7 14.6 31.2 31.2 MSH6 GTBP ENSG00000116062 "MutS homolog 6" P52701 2 47695530-47810101 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" DNA-binding "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009091, HPA028376, HPA028446, CAB070870" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA Yes Nucleoplasm "Golgi apparatus, Vesicles" "CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182" "unprognostic (5.10e-2)" "unprognostic (5.87e-3)" "unprognostic (3.29e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.98e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (1.79e-1)" "unprognostic (2.35e-3)" "unprognostic (1.01e-1)" "unprognostic (1.74e-3)" "unprognostic (8.99e-2)" "prognostic unfavorable (1.06e-7)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (9.68e-2)" "unprognostic (3.48e-2)" 13.0 20.5 9.7 13.1 18.8 13.6 13.0 20.5 13.1 17.9 13.3 17.6 10.7 6.1 28.2 11.0 12.4 18.3 8.4 8.6 11.4 8.8 9.5 14.6 11.0 21.7 23.9 9.6 43.2 27.6 16.2 17.3 14.9 15.0 14.6 10.3 8.7 12.0 13.2 10.4 10.3 10.5 22.1 14.9 11.6 11.1 25.1 22.0 40.4 13.4 10.4 25.8 14.2 16.4 8.4 8.4 7.6 9.8 9.7 15.1 5.7 27.5 20.6 38.3 9.1 11.6 12.2 17.3 15.3 13.5 15.9 16.7 15.1 9.6 45.5 23.0 16.6 21.9 11.6 34.5 19.5 20.8 19.8 17.2 29.1 16.3 15.3 7.1 29.2 10.7 9.9 6.2 16.2 10.8 14.9 9.9 1.1 25.3 16.7 15.5 19.9 31.1 13.8 33.6 18.6 9.5 73.8 50.2 20.5 9.7 17.9 21.5 23.3 21.3 10.2 9.3 35.1 12.2 10.3 6.0 18.5 22.6 14.0 19.8 15.7 21.2 76.2 15.6 18.7 11.3 7.6 5.8 4.9 8.4 9.8 10.4 8.4 9.5 8.3 8.4 8.1 15.1 7.6 3.9 9.7 9.3 4.2 9.5 5.7 9.7 18.8 20.5 13.1 11.4 8.8 23.9 9.6 15.0 22.0 26.8 18.4 9.7 20.1 22.3 26.4 6.9 0.0 28.1 31.8 7.0 33.4 24.9 3.3 12.8 25.7 15.3 2.6 0.0 8.4 16.9 17.4 11.4 17.3 8.5 11.1 14.3 4.6 12.3 5.1 11.5 23.6 12.1 3.3 7.2 7.9 27.0 8.8 3.5 21.2 5.3 29.7 6.5 17.2 40.0 40.2 15.3 8.0 13.3 9.3 10.7 MTMR10 FLJ20313 ENSG00000166912 "Myotubularin related protein 10" Q9NXD2 15 30938941-30991607 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006081 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nucleoplasm, Nuclear bodies" Cytosol "HPA006081: AB_2667508" "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (7.36e-2)" "unprognostic (4.43e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" "unprognostic (6.43e-2)" "unprognostic (2.54e-1)" "prognostic favorable (7.77e-12)" "unprognostic (9.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-1)" 13.9 7.3 19.9 7.8 22.8 12.0 16.3 8.4 19.3 10.0 8.4 32.9 4.2 9.6 7.4 8.1 17.1 6.4 7.5 10.2 22.5 13.3 25.9 19.2 10.6 9.6 30.9 11.9 9.5 9.8 14.8 4.3 32.7 29.4 9.2 8.5 9.5 11.1 10.0 24.3 7.6 8.9 8.3 84.0 10.7 10.0 6.6 24.9 8.9 11.7 6.0 8.3 9.5 7.2 3.4 3.8 14.1 6.9 1.4 1.6 1.6 5.5 6.3 5.8 3.1 12.9 7.0 4.2 8.0 16.8 6.8 6.7 4.0 1.9 2.3 11.0 10.7 6.7 8.2 4.5 4.8 6.4 8.3 1.2 2.9 4.1 5.9 7.5 5.5 5.9 9.4 3.8 4.3 4.8 8.0 16.7 6.8 3.1 6.5 6.1 1.6 5.8 1.6 2.9 6.9 2.6 4.4 5.0 13.1 25.3 8.8 2.1 5.4 3.8 4.6 1.6 8.4 2.9 10.4 7.9 7.9 5.0 4.1 4.9 5.9 5.0 6.0 4.6 2.0 8.8 3.3 3.2 3.0 0.8 4.2 0.8 2.1 0.9 0.6 3.2 3.4 1.6 1.3 14.1 1.4 6.9 3.8 1.3 1.6 19.9 22.8 8.4 19.3 22.5 13.3 30.9 11.9 29.4 24.9 23.8 14.6 5.9 3.7 7.9 0.0 20.2 5.1 4.0 7.9 31.4 0.0 14.7 1.7 2.9 11.5 11.7 10.0 0.0 3.2 2.6 7.6 7.4 16.2 28.7 10.3 0.0 5.8 10.4 21.9 17.8 9.8 17.2 8.5 2.8 9.0 0.0 4.2 8.6 7.1 13.3 0.0 0.0 5.3 12.1 6.6 9.7 32.2 5.7 6.8 5.2 MTRR cblE ENSG00000124275 "5-methyltetrahydrofolate-homocysteine methyltransferase reductase" Q9UBK8 5 7851186-7906025 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 57.4;Late spermatids: 61.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038113 Supported Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA038113: AB_10671520" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (5.32e-2)" "unprognostic (1.17e-2)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (6.60e-4)" "unprognostic (2.56e-2)" "unprognostic (5.82e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (9.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" 12.2 12.3 11.2 10.5 13.8 5.4 9.7 15.6 14.3 10.8 10.4 24.1 11.5 10.3 17.3 15.9 10.5 11.3 13.3 15.8 14.2 12.9 22.0 23.9 14.9 11.4 18.1 9.6 13.6 13.6 9.4 13.1 11.6 16.6 10.8 11.9 13.6 11.3 7.4 34.6 10.5 11.5 14.2 22.1 9.3 9.2 8.4 12.5 8.1 14.7 9.9 13.5 13.6 8.8 4.6 4.8 4.6 6.8 3.4 11.4 4.2 9.4 8.9 4.7 10.5 18.2 5.9 13.5 14.7 8.7 7.3 8.4 13.4 7.6 15.9 14.1 11.8 14.0 6.1 7.3 7.2 13.9 10.1 8.2 7.6 31.0 7.1 11.1 11.6 3.3 9.5 6.6 12.4 9.1 10.4 4.7 4.1 9.9 12.1 4.3 1.8 7.4 5.9 3.6 14.0 9.9 6.1 5.1 6.7 7.9 7.4 7.4 1.0 25.8 18.8 16.2 9.7 5.8 9.0 7.3 17.1 10.8 13.1 11.5 18.0 5.9 13.1 12.4 25.6 9.1 4.6 5.1 4.1 5.5 6.8 9.5 4.6 9.2 7.9 4.8 4.1 5.4 5.1 0.1 3.4 5.4 2.7 11.4 4.2 11.2 13.8 15.6 14.3 14.2 12.9 18.1 9.6 16.6 12.5 14.9 57.4 8.2 7.5 14.4 0.0 10.1 2.5 9.4 11.4 8.7 0.0 8.3 18.3 8.0 40.0 7.0 8.5 0.0 4.9 7.5 10.2 9.9 10.3 16.6 6.7 0.0 9.2 10.4 12.5 61.7 9.8 8.7 1.7 5.4 9.6 0.0 5.8 7.0 11.0 23.3 0.0 6.5 13.3 16.9 11.9 18.1 9.4 12.9 8.9 7.0 MUC20 "FLJ14408, KIAA1359" ENSG00000176945 "Mucin 20, cell surface associated" Q8N307 3 195720882-195741123 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 50.6" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 60.2;Urothelial cells: 102.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 25.3" HPA042249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 11000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042249: " "unprognostic (1.85e-1)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.83e-3)" "unprognostic (2.12e-1)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.41e-1)" "unprognostic (3.99e-4)" "unprognostic (7.66e-2)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.57e-4)" "unprognostic (2.05e-1)" "unprognostic (2.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.17e-1)" 1.7 1.2 1.1 3.4 2.1 1.2 1.8 2.5 1.2 6.3 15.2 1.1 4.7 3.2 1.5 5.2 15.9 5.7 8.7 1.1 1.1 0.7 50.6 4.8 6.4 1.1 1.1 1.1 4.6 7.6 1.0 4.6 13.3 1.1 4.9 7.6 1.2 10.6 1.8 2.5 2.1 4.1 2.0 1.1 1.6 2.3 1.8 1.1 3.0 3.9 1.9 14.9 10.6 26.6 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 3.0 0.1 0.5 0.0 0.2 1.3 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.5 3.4 0.1 0.8 0.1 0.8 0.0 1.9 1.0 0.3 0.0 25.3 0.2 0.4 0.1 0.0 0.0 0.2 0.7 0.9 0.1 1.1 1.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 2.5 1.2 1.1 0.7 1.1 1.1 1.1 1.1 32.8 14.7 0.0 8.8 1.5 20.2 0.5 10.2 60.2 37.5 21.0 33.4 0.0 1.7 32.3 0.0 1.3 15.6 0.0 8.7 0.1 1.5 12.8 1.1 6.4 0.4 11.1 13.3 1.8 0.6 0.0 4.9 0.9 3.3 0.0 7.2 5.6 13.7 18.6 6.0 1.4 22.0 0.0 1.6 1.1 0.7 1.6 0.0 0.5 13.5 102.7 MUL1 "C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218" ENSG00000090432 "Mitochondrial E3 ubiquitin protein ligase 1" Q969V5 1 20499448-20508161 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026827 Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA026827: AB_10601137" "unprognostic (1.39e-1)" "unprognostic (2.73e-2)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (6.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.31e-2)" "unprognostic (5.86e-3)" "unprognostic (4.05e-1)" "unprognostic (9.10e-2)" "prognostic favorable (6.15e-14)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" 13.3 15.9 10.3 12.9 12.3 20.6 20.4 9.2 22.2 13.1 15.8 19.0 8.0 11.6 18.2 10.7 17.2 17.0 18.5 26.2 11.7 12.5 20.5 20.1 16.3 12.1 16.8 9.5 17.5 26.8 21.9 13.0 21.6 17.6 13.9 13.3 14.3 15.3 18.1 26.7 17.4 19.5 17.0 11.7 13.6 15.2 14.1 11.6 18.5 15.1 14.6 14.0 16.3 13.6 23.2 26.0 31.9 30.4 25.2 32.1 27.5 17.1 16.6 9.6 19.8 20.8 11.7 10.4 17.0 20.4 21.2 20.5 10.2 28.5 12.9 19.1 24.0 16.1 26.1 17.2 24.6 15.5 12.8 13.6 9.9 11.2 14.8 24.5 13.5 17.0 19.1 32.5 21.7 22.6 12.5 13.8 11.7 12.9 15.8 23.0 8.7 8.1 9.1 9.8 14.3 15.9 8.0 12.1 16.7 25.0 9.6 9.8 14.5 15.3 16.4 20.9 8.1 11.5 13.0 15.6 20.7 11.9 18.0 15.2 18.5 16.1 13.9 16.2 18.4 19.1 26.3 26.5 31.9 30.9 30.4 32.1 23.2 23.6 31.4 26.0 21.5 27.1 26.3 24.0 25.2 25.4 20.1 32.1 27.5 10.3 12.3 9.2 22.2 11.7 12.5 16.8 9.5 17.6 11.6 20.8 9.3 11.7 7.8 4.6 12.5 14.6 12.7 9.4 6.8 17.4 5.9 33.7 10.0 21.4 1.6 9.7 12.0 0.0 20.3 20.8 12.1 8.1 3.5 11.9 19.7 12.7 8.2 10.4 11.4 2.8 12.0 7.7 18.6 21.6 11.8 15.6 19.7 11.5 14.5 8.7 10.5 19.4 8.5 10.6 13.4 6.1 31.5 10.8 10.1 9.0 MXD1 "bHLHc58, MAD, MAD1" ENSG00000059728 "MAX dimerization protein 1" Q05195 2 69897688-69942945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.1;bone marrow: 72.8;esophagus: 64.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 81.1" "Lineage enriched" "Detected in many" 49 "granulocytes: 81.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001599 Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA001599: AB_1079434" "unprognostic (1.59e-1)" "unprognostic (5.11e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (8.14e-6)" "unprognostic (1.49e-1)" "unprognostic (1.76e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-3)" "unprognostic (3.39e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (8.50e-4)" "unprognostic (8.72e-2)" "unprognostic (3.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.56e-3)" "unprognostic (1.77e-2)" 6.9 2.2 2.7 18.7 3.8 72.8 3.7 5.7 4.1 15.8 19.6 4.7 0.9 13.6 2.9 2.6 64.8 3.8 4.9 10.8 3.0 2.9 3.0 5.5 17.0 14.3 5.9 2.4 3.3 2.5 3.6 4.0 15.8 3.1 3.3 14.0 5.1 8.8 1.4 3.1 5.9 50.2 4.6 4.3 15.8 8.2 3.6 3.7 9.4 4.0 20.8 34.0 6.3 21.6 0.2 0.8 81.1 1.6 0.4 0.4 0.6 3.5 1.5 2.2 1.6 5.0 2.5 8.4 3.9 2.2 1.9 1.3 4.9 2.8 2.0 2.0 1.5 1.9 12.6 4.2 7.8 2.0 1.1 5.1 4.2 4.5 4.9 16.8 5.0 4.2 2.8 13.3 4.4 20.4 2.4 2.4 2.1 7.3 8.1 1.2 2.8 2.4 10.1 0.6 5.2 2.5 1.1 2.3 5.0 2.5 4.2 7.3 3.1 5.2 7.0 2.7 2.7 1.0 3.0 9.6 2.8 0.8 3.0 3.7 5.5 9.3 0.8 2.9 8.9 1.0 17.0 1.6 16.8 0.3 1.0 0.4 0.1 0.2 0.2 0.8 0.2 0.2 0.3 81.1 0.4 0.8 0.2 0.2 0.6 2.7 3.8 5.7 4.1 3.0 2.9 5.9 2.4 3.1 3.7 35.7 30.8 18.2 23.9 22.9 27.8 4.8 7.6 10.7 11.4 1.8 51.1 7.9 6.6 10.8 12.4 9.0 212.1 0.0 14.8 5.1 13.6 61.3 26.5 6.7 26.9 9.5 93.4 6.2 48.3 15.3 4.4 71.5 15.1 20.8 115.5 40.4 44.4 91.2 2.5 5.1 17.8 0.0 28.7 8.1 2.0 49.3 88.6 20.8 26.6 110.0 MYBPH ENSG00000133055 "Myosin binding protein H" Q13203 1 203167811-203175813 "Predicted intracellular proteins" "Cell adhesion" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 53.8" "Cell type enhanced" "Detected in single" 33 "Alveolar cells type 2: 2.2" "Group enriched" "Detected in many" 7 "glioma: 4.9;head and neck cancer: 20.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 6.1" "Group enriched" "Detected in some" 5 "CACO-2: 17.6;HSkMC: 34.5;THP-1: 8.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA061383 Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA061383: AB_2684497" "unprognostic (2.26e-4)" "unprognostic (2.04e-1)" "unprognostic (3.50e-1)" "unprognostic (1.06e-1)" "unprognostic (3.82e-2)" "unprognostic (1.32e-3)" "unprognostic (3.42e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (1.75e-1)" "unprognostic (7.62e-4)" "unprognostic (1.51e-1)" "unprognostic (3.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.74e-1)" 0.8 0.1 1.1 0.8 0.8 0.3 0.4 0.4 0.6 0.1 0.1 0.0 0.0 0.1 0.4 4.4 3.9 0.2 0.1 0.2 0.4 0.3 1.1 1.5 0.2 0.3 1.3 0.0 0.1 0.2 0.1 0.6 0.3 1.0 4.2 0.1 0.0 8.8 0.1 53.8 0.2 0.1 0.1 0.4 0.4 0.1 0.2 2.1 0.9 3.9 12.7 2.0 0.3 0.8 0.0 6.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 34.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 6.1 0.0 0.1 1.1 0.8 0.4 0.6 0.4 0.3 1.3 0.0 1.0 2.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYO1E "HuncM-IC, MGC104638, MYO1C" ENSG00000157483 "Myosin IE" Q12965 15 59132434-59372900 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 16.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 51.5;HaCaT: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003003, HPA023886" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA003003: , HPA023886: AB_1854253" "unprognostic (7.90e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-1)" "prognostic favorable (4.19e-4)" "unprognostic (1.49e-1)" "unprognostic (3.59e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (1.89e-1)" "unprognostic (5.38e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (2.41e-1)" "unprognostic (7.92e-2)" "unprognostic (7.31e-2)" "unprognostic (9.71e-2)" "unprognostic (1.15e-1)" "unprognostic (5.62e-2)" 25.9 4.6 7.9 18.4 19.0 0.7 13.3 2.3 12.6 13.6 28.5 40.6 26.5 13.6 18.1 17.0 22.1 10.0 21.5 6.8 12.6 7.6 22.4 33.4 11.6 18.9 27.2 7.6 6.8 8.8 23.7 6.6 18.7 17.2 15.6 19.4 13.0 12.4 43.5 7.2 28.8 25.9 12.3 25.5 11.4 17.1 4.7 22.4 2.6 9.9 10.6 21.7 15.6 16.2 7.0 16.9 0.4 3.4 2.5 0.4 1.6 29.6 51.5 2.8 1.9 22.1 18.1 14.6 12.1 5.9 6.7 7.9 12.7 11.6 11.8 8.7 9.4 27.7 47.8 4.3 18.7 9.0 5.4 2.4 0.1 43.0 11.2 20.5 0.0 1.6 24.7 11.5 8.6 25.4 21.4 11.0 0.2 0.0 0.1 11.4 2.7 0.1 0.2 6.8 4.8 11.5 0.0 12.5 7.2 36.4 14.0 1.5 5.1 26.9 5.6 10.4 8.9 3.7 1.3 13.3 13.6 3.9 41.3 11.8 0.0 0.7 0.2 24.9 0.1 12.2 0.0 3.1 0.0 0.1 3.4 0.0 6.6 0.0 0.0 11.0 7.0 0.0 0.0 0.4 2.5 1.2 16.9 0.4 1.6 7.9 19.0 2.3 12.6 12.6 7.6 27.2 7.6 17.2 22.4 6.0 7.7 0.0 21.2 22.0 0.0 3.2 20.4 34.8 6.8 24.4 0.0 3.3 3.3 39.7 3.4 16.1 46.1 0.0 15.8 17.7 9.9 27.4 4.6 9.4 29.8 0.0 18.9 4.3 3.3 5.2 8.6 16.2 18.6 7.2 21.7 11.7 42.3 31.6 11.3 3.0 0.9 12.9 23.0 1.0 3.8 21.0 10.8 1.0 19.6 34.4 MYPN MYOP ENSG00000138347 Myopalladin Q86TC9 10 68106117-68212017 "Disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 94.6" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 0.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 3.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "BJ: 16.6;fHDF/TERT166: 46.6;GAMG: 9.2;HBF TERT88: 11.0;LHCN-M2: 20.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA036299, HPA061494" Enhanced Approved Nucleoplasm,Vesicles,Cytosol No No "Nucleoplasm, Vesicles" Cytosol "HPA036299: , HPA061494: AB_2684539" "unprognostic (4.75e-2)" "unprognostic (2.20e-1)" "unprognostic (8.14e-3)" "unprognostic (8.62e-3)" "unprognostic (3.91e-1)" "unprognostic (3.36e-3)" "unprognostic (4.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "unprognostic (2.26e-3)" "unprognostic (3.94e-3)" "unprognostic (3.10e-1)" "unprognostic (2.88e-8)" "unprognostic (4.63e-5)" "unprognostic (9.94e-2)" "unprognostic (2.01e-1)" "unprognostic (3.47e-1)" 4.5 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.1 0.0 0.0 23.6 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.5 0.0 0.1 2.1 0.0 114.9 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.9 46.3 3.4 0.0 0.0 0.3 0.1 3.8 0.1 0.2 0.1 0.0 1.2 0.5 0.0 0.0 0.3 1.8 0.0 16.6 8.3 6.3 2.3 0.0 0.0 0.0 0.0 46.6 9.2 0.3 0.0 0.1 11.0 0.1 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.8 0.0 3.3 0.4 1.5 0.1 0.0 0.0 0.1 20.1 3.5 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.3 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.0 0.0 0.0 2.0 0.0 1.8 3.8 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.1 0.9 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.5 94.6 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MYRIP "DKFZp586F1018, exophilin-8, MyRIP, SLAC2-C, SLAC2C" ENSG00000170011 "Myosin VIIA and Rab interacting protein" Q8NFW9 3 39808914-40260321 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0;retina: 36.3" "Cell type enhanced" "Detected in many" 17 "Hepatocytes: 14.7;Ito cells: 44.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.5;HUVEC TERT2: 17.0;REH: 3.9;SCLC-21H: 3.6;SH-SY5Y: 10.5;T-47d: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006433 Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "HPA006433: AB_10603023" "unprognostic (1.87e-2)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.89e-2)" "unprognostic (2.36e-1)" "unprognostic (6.03e-2)" "unprognostic (2.57e-3)" "unprognostic (1.34e-3)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (1.91e-1)" "prognostic favorable (3.96e-8)" "unprognostic (7.12e-2)" "unprognostic (2.40e-1)" "unprognostic (8.92e-2)" "unprognostic (6.16e-2)" 4.8 2.0 31.0 2.2 7.8 0.5 3.4 23.7 19.4 9.0 4.2 3.9 1.3 2.9 6.0 3.8 2.4 3.3 4.3 2.8 13.9 9.6 2.7 16.7 1.7 2.6 8.5 11.0 5.3 13.1 2.1 8.4 0.6 10.8 3.4 4.4 36.3 16.0 1.8 2.7 1.8 2.8 3.9 5.5 10.2 7.7 1.7 4.2 0.0 2.1 1.6 2.9 2.8 2.7 0.8 0.1 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.3 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 1.1 0.0 0.1 3.9 0.0 0.0 0.4 2.2 3.6 10.5 0.0 0.0 0.0 0.0 4.2 0.0 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 31.0 7.8 23.7 18.4 13.9 9.6 8.5 11.0 10.8 4.2 0.0 5.6 0.0 0.1 0.7 2.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 9.9 0.0 0.0 2.3 0.0 0.2 1.7 2.3 14.7 0.0 4.8 0.0 44.8 4.3 3.6 0.9 0.0 0.0 0.0 9.6 6.3 1.0 0.0 0.0 0.8 4.3 0.0 0.5 2.7 0.2 0.5 0.0 0.0 0.6 0.0 N4BP2 B3BP ENSG00000078177 "NEDD4 binding protein 2" Q86UW6 4 40056826-40158252 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 35.6" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036770, HPA042607, HPA072549" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: " "unprognostic (5.03e-2)" "unprognostic (3.42e-1)" "unprognostic (7.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-3)" "unprognostic (2.88e-1)" "unprognostic (1.01e-1)" "unprognostic (3.66e-2)" "unprognostic (2.65e-2)" "unprognostic (9.55e-3)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (6.85e-3)" "unprognostic (1.45e-1)" 3.5 3.1 3.4 7.4 5.1 7.0 5.8 6.1 3.2 5.5 4.3 1.2 7.1 4.7 7.0 6.6 5.2 4.8 3.8 3.5 2.5 3.6 3.2 11.3 7.5 9.2 1.9 1.6 7.0 13.1 2.5 14.3 11.9 2.8 4.9 4.5 4.3 10.7 11.0 2.9 5.4 5.3 3.2 3.1 4.3 3.8 3.5 2.1 35.6 7.2 3.5 7.8 5.6 5.2 2.4 8.1 5.7 1.2 10.6 4.5 1.2 1.5 1.6 9.4 1.5 0.6 3.1 7.7 1.8 1.9 1.0 2.2 3.0 3.1 8.3 3.5 1.7 1.7 1.2 6.0 1.9 2.5 2.6 1.9 3.7 1.4 1.4 1.6 10.0 8.9 3.5 2.7 1.7 3.7 0.3 2.7 7.9 8.2 3.6 2.0 1.5 20.2 4.3 4.7 1.2 1.3 11.8 11.1 1.9 0.8 3.7 3.8 6.7 1.6 1.3 1.5 6.3 1.1 2.7 3.7 1.1 5.9 0.7 1.3 5.9 6.0 5.7 1.2 3.6 2.3 5.7 1.1 0.5 2.3 1.2 2.4 1.7 3.0 1.7 1.7 2.4 4.5 2.5 0.3 10.6 1.0 8.1 1.3 1.2 3.4 5.1 6.1 3.2 2.5 3.6 1.9 1.6 2.8 2.1 20.8 19.5 2.9 12.0 10.6 30.6 12.3 12.7 6.7 18.2 21.0 25.5 34.4 0.0 5.4 2.6 6.6 6.0 23.3 10.7 11.4 12.3 12.2 4.7 15.5 10.4 68.3 18.6 4.9 16.3 2.7 9.2 17.8 6.8 9.0 15.0 11.8 9.7 8.6 3.5 3.1 20.2 12.9 5.7 13.6 27.0 11.4 22.5 13.8 8.0 8.4 NAA35 "bA379P1.1, FLJ21613, FLJ22643, MAK10" ENSG00000135040 "N(alpha)-acetyltransferase 35, NatC auxiliary subunit" Q5VZE5 9 85941146-86022298 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021547 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA021547: AB_1853505" "unprognostic (5.87e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-3)" "unprognostic (9.25e-3)" "unprognostic (2.37e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.16e-7)" "unprognostic (1.86e-1)" "unprognostic (5.22e-3)" "unprognostic (1.56e-1)" "unprognostic (8.30e-2)" "unprognostic (1.09e-1)" "unprognostic (2.36e-3)" "unprognostic (1.88e-1)" "unprognostic (4.34e-2)" "unprognostic (9.18e-2)" "unprognostic (1.07e-2)" 11.3 19.5 15.2 16.4 14.6 9.7 17.1 20.1 17.6 13.4 16.5 12.5 22.9 14.9 20.5 21.0 16.8 13.5 14.4 14.2 16.6 14.0 16.0 14.3 10.8 10.2 14.6 16.2 16.2 16.4 19.1 25.5 16.9 14.4 17.4 19.5 13.0 16.3 20.0 28.7 13.4 17.4 16.4 14.1 10.3 13.4 25.7 15.1 10.0 19.8 15.8 12.7 14.4 13.5 12.2 5.8 8.9 4.7 5.9 9.6 4.4 22.9 16.0 16.0 12.5 9.4 11.3 25.1 14.5 14.2 16.3 13.8 11.0 15.9 7.8 8.5 14.7 13.7 32.2 14.6 17.0 17.5 19.5 10.5 17.2 17.4 15.0 17.5 26.3 15.6 11.7 14.8 17.4 25.8 11.4 15.3 16.2 21.0 15.3 15.4 15.8 14.7 15.3 16.1 27.7 16.4 12.6 22.7 12.1 17.8 20.9 14.6 13.0 16.5 14.6 12.8 17.3 11.7 11.1 12.1 10.5 13.2 17.5 13.4 20.5 25.1 5.3 13.4 11.4 10.7 2.0 4.6 8.9 7.0 4.7 9.3 12.2 7.7 6.5 5.8 12.2 9.6 7.7 2.1 5.9 3.2 3.8 6.4 4.4 15.2 14.6 20.1 17.6 16.6 14.0 14.6 16.2 14.4 15.1 3.0 13.1 12.0 17.1 14.4 24.0 19.6 10.2 32.1 21.6 10.4 21.6 18.4 1.7 16.5 5.9 11.9 11.1 0.0 22.5 15.1 13.4 18.4 11.5 8.9 10.6 20.6 20.1 8.6 9.5 3.6 8.6 12.9 13.5 11.8 15.0 22.0 15.4 14.0 11.0 7.1 32.7 12.9 16.5 58.6 33.7 14.4 26.0 12.8 14.6 17.4 NAA40 "FLJ13848, NAT11" ENSG00000110583 "N(alpha)-acetyltransferase 40, NatD catalytic subunit" Q86UY6 11 63938959-63957328 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 96.9;Late spermatids: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037816, HPA056142" Uncertain Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA037816: AB_10672289, HPA056142: " "unprognostic (3.52e-1)" "unprognostic (4.12e-1)" "unprognostic (1.40e-1)" "unprognostic (6.88e-3)" "unprognostic (1.50e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (1.43e-7)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (1.58e-1)" "unprognostic (7.01e-3)" "unprognostic (6.29e-3)" "unprognostic (3.42e-2)" "unprognostic (6.43e-3)" "unprognostic (2.49e-1)" "unprognostic (1.55e-1)" "unprognostic (5.25e-2)" 4.9 12.4 9.8 10.0 11.6 4.1 7.6 16.7 13.5 7.1 7.3 12.2 10.8 9.2 5.0 7.7 9.2 11.2 7.6 13.8 9.8 10.0 10.0 5.1 6.1 10.7 8.3 8.6 4.2 8.9 28.0 22.7 10.5 8.9 6.0 7.9 12.2 9.7 11.3 7.5 4.5 9.8 5.4 7.6 12.5 6.3 19.2 8.9 10.1 10.1 4.1 11.7 8.1 4.9 4.1 5.0 3.5 0.8 6.7 10.1 2.8 10.7 12.6 15.7 8.4 4.4 4.3 10.0 8.0 8.6 19.9 14.0 10.4 13.7 6.6 10.0 7.2 13.9 9.7 13.1 5.8 14.8 8.7 8.1 9.1 8.0 11.7 5.9 14.3 7.8 4.5 5.3 12.3 3.4 7.8 12.8 11.6 15.3 5.0 9.2 8.1 15.2 11.3 14.6 10.0 8.5 15.1 14.2 8.4 13.3 8.3 20.9 11.1 12.5 11.0 6.5 11.9 18.0 6.4 8.2 11.1 13.5 6.4 6.5 6.0 3.8 11.7 6.6 6.2 8.5 3.3 0.8 3.5 10.1 0.6 3.6 4.1 2.7 4.8 3.6 3.9 1.7 4.1 0.3 6.7 0.3 5.0 0.8 2.8 9.8 11.6 16.7 13.5 9.8 10.0 8.3 8.6 8.9 8.9 3.0 3.7 5.1 1.9 2.5 27.2 12.8 7.6 22.7 12.5 17.4 31.4 8.4 0.0 5.2 38.5 7.1 10.5 0.0 4.7 10.2 4.6 1.9 1.1 4.5 7.8 96.9 16.8 10.4 9.4 100.4 4.4 8.4 1.7 3.6 6.5 9.4 4.8 3.5 6.7 3.0 24.2 0.0 3.1 19.1 16.8 2.5 3.4 8.2 6.8 1.0 NAB1 ENSG00000138386 "NGFI-A binding protein 1" Q13506 2 190646746-190692766 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 90.6;Suprabasal keratinocytes: 121.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002738 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "Golgi apparatus" "HPA002738: AB_1079447" "unprognostic (1.44e-1)" "unprognostic (2.65e-2)" "unprognostic (6.02e-3)" "unprognostic (4.04e-3)" "unprognostic (9.05e-2)" "unprognostic (9.45e-2)" "unprognostic (7.12e-3)" "unprognostic (6.41e-2)" "unprognostic (2.13e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.52e-1)" "unprognostic (7.23e-3)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (3.85e-2)" 19.1 10.3 12.1 12.5 13.7 7.6 28.3 28.2 15.7 18.5 19.9 10.4 7.2 7.4 16.2 26.4 32.3 14.1 13.9 21.2 12.1 9.7 10.6 18.6 12.5 13.8 14.5 12.0 15.7 9.3 16.4 20.2 12.8 12.4 16.3 12.9 19.8 15.9 17.5 6.9 33.2 10.9 13.3 14.3 9.3 18.4 12.3 12.4 13.6 19.0 15.7 13.0 13.0 25.8 1.4 1.7 5.4 6.1 4.6 6.0 1.4 12.2 9.1 23.2 8.1 9.1 15.8 40.2 12.5 19.7 9.4 10.8 22.1 13.6 13.7 14.7 9.8 17.6 31.4 13.2 16.1 18.8 43.7 11.2 16.1 32.5 10.5 5.9 6.7 8.1 9.1 25.8 20.0 6.2 13.5 14.6 8.4 15.7 11.8 14.5 6.0 9.7 7.0 8.2 13.2 12.6 12.0 16.7 5.4 7.2 12.0 21.0 17.0 14.7 5.0 13.1 31.0 4.0 10.6 10.1 19.9 15.8 11.2 7.4 9.4 10.1 10.2 21.0 6.2 15.5 0.0 2.6 1.1 2.7 2.0 4.0 1.4 2.8 3.5 1.7 0.9 2.9 3.1 5.4 4.6 6.1 1.6 6.0 1.4 12.1 13.7 28.2 15.7 12.1 9.7 14.5 12.0 12.4 12.4 6.0 23.4 2.2 21.8 90.6 15.9 15.7 17.8 21.4 31.8 12.2 11.8 3.8 3.3 8.7 1.1 28.6 7.3 0.0 6.9 8.3 21.6 24.1 19.7 23.7 6.0 6.4 13.8 35.0 19.5 3.2 12.4 18.1 37.1 6.4 15.0 11.5 7.4 28.8 13.8 3.6 14.1 45.3 59.7 1.4 36.3 121.5 1.0 12.8 13.6 26.5 NAE1 "APP-BP1, APPBP1, ula-1" ENSG00000159593 "NEDD8 activating enzyme E1 subunit 1" Q13564 16 66802875-66873256 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatogonia: 205.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041178, HPA042041" Enhanced Approved Nucleoplasm,Microtubules,Centrosome NA NA 53000 Nucleoplasm "Microtubules, Centrosome" "HPA041178: AB_10964773, HPA042041: AB_10964772" "unprognostic (3.22e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-2)" "unprognostic (1.13e-1)" "unprognostic (2.00e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (3.92e-8)" "unprognostic (2.31e-1)" "unprognostic (5.58e-2)" "unprognostic (3.12e-3)" "unprognostic (5.34e-2)" "unprognostic (3.85e-2)" "unprognostic (7.09e-3)" "unprognostic (2.50e-1)" "unprognostic (1.84e-1)" "prognostic favorable (9.44e-5)" "unprognostic (1.97e-1)" 23.6 27.4 25.3 20.2 31.8 27.2 27.3 36.7 41.7 26.0 25.8 24.4 23.7 26.2 27.9 31.0 27.5 23.9 20.2 23.6 25.4 29.0 24.3 25.9 18.3 27.0 27.7 31.9 31.0 26.6 38.8 42.2 26.4 34.9 24.9 30.0 22.1 24.3 23.5 33.2 26.9 27.6 25.4 25.3 18.4 22.2 36.9 25.9 28.9 27.9 28.0 24.9 24.7 22.4 9.4 6.4 6.7 3.2 8.6 19.4 9.4 23.0 17.8 31.8 31.2 12.7 18.1 26.4 17.6 17.9 26.1 31.8 21.6 18.0 25.6 20.2 13.2 16.9 23.4 23.9 21.2 37.1 9.4 27.2 18.1 12.3 33.5 14.6 33.7 22.8 14.7 15.7 20.8 18.3 13.9 18.2 31.2 42.9 9.0 20.1 8.1 35.2 38.6 44.0 18.1 32.2 37.8 37.8 34.1 20.1 20.3 34.2 25.1 52.7 11.3 20.3 20.4 12.1 22.8 14.2 18.3 18.3 19.0 20.3 17.1 26.4 92.1 16.5 22.4 22.1 1.3 3.1 6.7 15.4 3.0 19.4 9.4 16.4 16.6 4.2 7.9 17.8 17.7 1.4 8.6 3.2 6.4 14.0 9.4 25.3 31.8 36.7 41.7 25.4 29.0 27.7 31.9 34.9 25.9 29.8 25.1 24.4 55.4 29.3 47.7 26.2 15.3 37.5 40.9 29.6 11.8 87.4 33.2 58.5 2.8 22.8 26.7 23.3 52.6 55.3 37.2 37.1 33.6 18.8 25.1 47.7 22.0 20.9 11.6 10.1 45.1 15.5 47.2 33.3 27.8 58.9 51.8 82.6 50.9 40.7 33.6 19.4 49.5 120.6 205.2 28.1 43.8 31.6 33.7 41.4 NAIF1 "bA379C10.2, C9orf90, DKFZp762G199" ENSG00000171169 "Nuclear apoptosis inducing factor 1" Q69YI7 9 128061233-128068206 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054898, HPA064931" Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA054898: AB_2682633, HPA064931: AB_2732725" "unprognostic (7.09e-2)" "unprognostic (5.92e-2)" "unprognostic (1.20e-2)" "unprognostic (5.56e-3)" "unprognostic (1.58e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.60e-1)" "unprognostic (6.15e-2)" "unprognostic (9.41e-2)" "prognostic favorable (1.02e-5)" "unprognostic (3.08e-1)" "prognostic favorable (8.30e-5)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (6.67e-2)" "unprognostic (3.92e-2)" 7.1 7.2 4.5 5.1 4.5 11.3 10.3 5.6 5.5 6.0 4.5 2.4 10.9 6.0 6.3 5.1 7.1 5.4 6.6 7.4 5.5 3.4 5.2 8.3 9.3 8.3 3.8 4.2 5.4 7.3 3.4 4.5 7.3 5.3 6.0 3.7 5.5 6.5 9.5 7.1 5.5 6.2 5.2 4.8 9.0 5.5 15.6 2.9 12.5 6.2 6.1 7.8 5.5 16.3 3.4 2.2 4.5 3.0 1.6 3.4 1.5 4.8 4.2 2.7 6.9 2.5 2.3 6.1 3.7 2.2 3.2 2.6 3.3 3.9 5.9 3.3 2.3 4.5 3.6 2.8 2.8 2.6 18.0 3.7 4.4 5.0 1.9 4.2 6.0 12.4 2.1 3.4 2.4 4.0 2.5 2.9 6.7 10.3 3.8 2.9 5.6 5.8 7.3 2.9 6.6 7.2 5.6 4.3 5.3 2.4 3.0 3.9 4.5 3.6 5.1 3.8 2.0 3.9 6.0 1.9 3.8 11.9 3.1 4.2 6.2 12.9 3.9 3.6 3.9 5.0 0.0 2.2 3.3 1.7 2.0 1.4 1.1 3.4 2.5 2.2 3.4 2.6 2.2 4.5 1.6 3.0 1.7 0.9 1.5 4.5 4.5 5.6 5.5 5.5 3.4 3.8 4.2 5.3 2.9 0.0 4.0 8.8 4.0 4.2 3.3 3.9 5.1 0.0 2.3 5.2 0.0 5.0 3.3 3.1 5.9 4.7 5.1 0.0 5.8 5.0 3.3 3.0 8.1 2.4 4.8 9.5 5.2 5.5 4.7 9.2 5.8 4.4 0.0 4.6 2.5 4.1 3.4 4.0 2.8 3.4 5.0 0.0 3.3 10.8 7.6 3.3 3.9 7.2 3.1 2.0 NAPRT "NAPRT1, PP3856" ENSG00000147813 "Nicotinate phosphoribosyltransferase" Q6XQN6 8 143574785-143578649 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Ligase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 22.3;SK-BR-3: 23.9;U-937: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023739, HPA024017, CAB068206, CAB068207" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 2000000 "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB068206: AB_2665644, CAB068207: AB_2665681, HPA023739: AB_1854308, HPA024017: AB_1854309" "unprognostic (7.08e-2)" "unprognostic (1.55e-1)" "unprognostic (5.76e-3)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.30e-1)" "unprognostic (7.65e-2)" "unprognostic (2.19e-1)" "unprognostic (2.84e-1)" "unprognostic (1.08e-2)" "unprognostic (1.75e-1)" "unprognostic (4.13e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.02e-2)" "unprognostic (3.97e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-2)" 9.7 6.4 4.9 9.7 6.2 21.1 13.2 10.7 5.4 6.7 25.2 2.3 9.9 33.0 4.7 4.7 16.4 4.8 15.5 4.9 3.9 2.1 10.7 28.3 8.3 12.1 3.7 0.1 5.9 6.5 2.4 2.8 8.6 4.1 6.9 3.8 5.2 12.8 3.8 7.1 12.4 34.4 5.2 2.2 9.8 11.8 5.5 4.0 3.0 6.8 8.9 9.5 7.6 8.1 0.8 4.7 4.6 8.4 0.5 1.6 2.4 3.4 4.0 0.4 0.8 0.3 1.2 2.6 0.8 0.4 1.3 0.8 3.3 22.3 0.9 6.3 0.2 0.0 7.7 0.2 6.3 0.0 4.1 6.4 5.3 10.5 0.9 2.8 1.3 2.8 0.1 2.2 0.1 0.0 0.0 1.4 4.4 4.9 4.1 0.1 4.3 2.6 2.7 1.0 4.7 2.5 4.6 0.1 11.0 0.9 1.3 1.8 0.4 10.0 23.9 3.0 0.1 0.9 3.1 4.2 0.7 6.4 4.7 1.7 0.5 0.2 1.1 1.1 18.5 3.3 0.0 4.4 4.6 1.6 8.4 0.5 0.8 0.7 1.5 4.7 0.2 0.8 0.7 2.7 0.5 8.4 1.5 0.2 2.4 4.9 6.2 10.7 5.4 3.9 2.1 3.7 0.1 4.1 4.0 32.8 29.7 8.2 53.6 0.0 11.6 7.8 50.9 2.7 17.0 71.5 17.7 41.1 58.0 56.8 30.9 28.6 149.9 23.3 48.4 46.0 12.4 35.0 7.0 99.2 70.9 15.9 10.5 37.4 86.2 46.4 29.7 44.6 0.0 92.0 73.3 27.1 82.3 117.4 20.5 160.6 12.5 12.9 11.5 15.6 17.6 0.0 47.0 17.5 111.6 67.7 NARS2 "DFNB94, FLJ23441, SLM5" ENSG00000137513 "Asparaginyl-tRNA synthetase 2, mitochondrial" Q96I59 11 78435961-78574874 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026793 Supported Approved Nucleoplasm,Mitochondria,Cytosol No No "Nucleoplasm, Mitochondria" Cytosol "HPA026793: AB_1848833" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (5.73e-3)" "unprognostic (1.79e-3)" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (5.62e-2)" "unprognostic (4.62e-3)" "prognostic favorable (1.39e-5)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.22e-6)" "unprognostic (8.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" 10.9 16.0 11.8 9.3 11.2 6.4 13.4 19.4 11.8 11.6 13.0 13.1 13.5 12.0 17.6 13.9 10.8 12.0 9.9 12.7 11.3 12.2 22.3 26.8 9.0 10.2 13.4 8.4 15.9 20.0 14.0 17.3 9.4 13.8 13.3 13.3 23.2 12.7 13.2 24.4 9.1 11.1 10.6 10.8 12.6 11.3 11.8 10.3 17.3 16.0 7.7 14.1 9.7 10.7 14.6 13.5 6.7 9.4 16.2 16.6 8.7 7.3 10.3 10.8 7.1 7.6 6.4 9.0 6.1 6.0 9.5 7.9 17.7 7.9 18.2 15.9 3.9 9.2 9.7 18.2 11.9 13.3 11.9 9.8 12.8 8.0 15.0 6.3 13.7 4.8 4.5 7.7 8.4 15.0 8.6 8.1 15.4 19.3 5.0 10.6 8.6 14.2 22.2 11.8 30.0 12.5 14.9 17.7 24.6 12.7 10.4 12.9 8.1 9.1 11.7 15.7 12.2 11.0 5.5 4.9 13.0 15.3 14.8 10.3 8.4 14.1 40.1 2.5 12.4 8.8 6.7 7.9 3.5 9.8 8.3 12.0 14.6 11.3 10.8 13.5 12.6 16.6 14.8 1.7 16.2 9.4 10.3 8.2 8.7 11.8 11.2 19.4 11.8 11.3 12.2 13.4 8.4 13.8 10.3 17.9 17.1 9.0 12.7 11.9 5.3 8.3 2.5 10.7 7.9 5.2 2.0 17.3 24.9 8.2 11.0 6.3 5.0 0.0 6.5 20.2 10.4 14.0 8.1 16.3 10.6 0.0 11.5 2.5 6.5 3.9 7.2 6.1 16.9 1.0 7.7 5.7 6.1 13.3 4.6 22.1 8.7 6.5 8.3 7.4 18.1 12.0 12.8 5.1 13.7 7.5 NAXE "AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1" ENSG00000163382 "NAD(P)HX epimerase" Q8NCW5 1 156591762-156594299 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Lipid transport, Transport" Isomerase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 120.4;Distal tubular cells: 170.8;Proximal tubular cells: 189.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043766, HPA048164" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 3300000 Nucleoplasm "Vesicles, Cytosol" "HPA043766: AB_2678660, HPA048164: AB_2680294" "unprognostic (1.27e-1)" "unprognostic (2.34e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (7.38e-2)" "unprognostic (5.32e-2)" "unprognostic (2.46e-3)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.08e-3)" "unprognostic (3.23e-2)" "unprognostic (3.14e-2)" "unprognostic (2.15e-2)" "unprognostic (8.05e-2)" "unprognostic (7.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-1)" 19.1 29.9 31.6 14.4 28.5 12.1 22.6 17.6 42.5 23.0 30.0 31.0 17.4 28.4 28.5 57.9 23.4 29.4 25.8 46.3 28.5 25.0 41.6 41.0 17.2 16.9 33.2 29.3 29.3 37.3 36.3 29.0 21.8 28.8 27.9 26.6 23.0 29.5 36.3 30.9 20.2 25.9 25.0 29.1 17.4 25.0 29.5 22.2 17.7 32.4 19.5 20.4 20.8 18.3 52.4 53.8 12.4 26.5 31.6 32.5 40.6 31.6 42.0 13.4 24.0 17.9 12.3 16.0 10.9 16.7 18.7 19.8 34.9 21.3 21.5 33.2 13.9 16.2 30.9 13.4 26.1 13.3 22.7 29.3 17.8 24.0 23.1 20.5 22.3 18.3 12.3 33.8 23.8 22.2 15.0 25.4 29.0 18.1 19.6 19.1 56.3 24.5 27.2 16.6 43.8 32.8 24.7 12.6 56.8 25.3 26.3 32.5 31.0 26.2 50.1 38.5 19.8 48.6 32.9 14.8 13.5 21.1 19.1 23.8 50.8 30.7 20.5 18.6 13.3 20.8 4.9 24.1 12.4 31.6 26.5 31.3 52.4 29.2 32.2 21.7 41.7 32.5 30.9 2.9 31.6 20.6 53.8 25.5 40.6 31.6 28.5 17.6 42.5 28.5 25.0 33.2 29.3 28.8 22.2 38.7 23.3 0.0 0.0 0.0 0.0 0.0 0.0 21.4 43.3 64.6 0.0 120.4 170.8 89.3 0.0 0.0 0.0 0.0 87.1 28.1 0.0 0.0 4.7 0.0 80.7 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 71.3 0.0 0.0 83.0 0.0 0.0 189.4 0.0 0.0 0.0 0.0 0.0 0.0 68.0 0.0 0.0 0.0 NBR1 "1A1-3B, CA125, KIAA0049, M17S2" ENSG00000188554 "NBR1, autophagy cargo receptor" Q14596 17 43170481-43211689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 246.4;Late spermatids: 675.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022944, HPA022999, HPA023999" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Vesicles "Nucleoplasm, Nuclear bodies" "HPA022944: AB_2671001, HPA022999: AB_1859532, HPA023999: AB_1859533" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (3.26e-2)" "unprognostic (3.28e-2)" "unprognostic (3.27e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (2.98e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "prognostic favorable (2.00e-5)" "unprognostic (1.65e-1)" "unprognostic (4.88e-2)" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" 26.3 29.5 27.1 17.2 27.3 7.7 28.0 27.3 29.4 25.6 32.9 33.3 29.0 31.0 28.4 25.5 23.1 25.6 20.7 29.8 26.0 22.0 38.3 39.6 21.1 25.4 27.2 21.8 34.1 26.5 55.8 25.0 31.2 22.8 30.1 32.1 20.7 25.5 29.5 62.9 23.9 37.7 24.2 34.2 23.3 23.2 57.0 31.7 29.8 32.1 24.5 19.8 32.5 23.7 9.6 12.6 25.2 21.5 15.5 17.1 14.4 12.6 15.4 13.2 14.0 30.1 31.3 12.7 23.8 47.3 19.8 16.4 8.0 20.1 6.7 24.8 33.1 19.7 13.9 15.0 30.8 28.8 21.0 16.0 8.0 19.6 17.2 28.8 6.7 12.4 35.5 34.9 21.7 42.8 40.4 30.8 15.6 17.1 18.1 26.2 7.1 14.4 4.9 4.2 14.7 10.0 4.8 20.8 22.0 25.1 14.3 8.0 14.2 16.4 8.1 23.8 23.2 22.1 11.1 25.5 29.1 10.9 13.3 9.4 21.7 17.6 8.8 19.7 9.3 20.0 23.5 16.1 25.2 14.2 15.3 14.6 9.6 12.9 13.7 12.6 6.7 12.4 11.9 23.1 15.5 21.5 8.0 17.1 14.4 27.1 27.3 27.3 29.4 26.0 22.0 27.2 21.8 22.8 31.7 38.7 36.1 13.0 29.2 21.2 32.9 75.1 40.8 54.9 43.3 34.9 37.3 22.6 16.6 20.6 246.4 37.9 79.4 0.0 19.1 15.5 24.6 46.9 24.4 55.7 18.8 19.1 38.7 46.1 53.8 675.8 54.4 30.1 25.3 7.2 58.7 45.6 24.4 63.7 41.8 46.8 51.6 38.8 23.9 41.7 27.0 23.8 13.2 29.6 48.7 29.1 NCAPD2 "CAP-D2, CNAP1, hCAP-D2, KIAA0159" ENSG00000010292 "Non-SMC condensin I complex subunit D2" Q15021 12 6493356-6531955 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 84.1" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012423, HPA036947, HPA037363" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-2)" "unprognostic (1.03e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (1.79e-8)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (5.00e-2)" "unprognostic (5.41e-3)" "unprognostic (4.53e-1)" "prognostic unfavorable (1.13e-7)" "unprognostic (4.80e-3)" "unprognostic (1.18e-1)" "unprognostic (4.53e-1)" "unprognostic (8.75e-2)" 6.8 8.8 6.5 24.6 12.7 16.7 7.7 7.7 9.0 8.0 11.3 16.2 7.0 10.6 11.5 8.8 17.7 8.1 6.5 6.2 7.5 5.4 7.0 5.1 7.7 20.4 16.5 6.2 7.7 7.2 9.6 6.3 13.9 8.7 8.2 12.4 8.1 10.5 8.3 7.0 14.8 13.0 8.2 12.7 16.4 9.9 17.2 11.4 84.1 11.4 12.4 24.3 10.9 9.5 5.0 4.8 7.2 2.8 7.8 7.4 3.2 22.1 20.5 22.1 16.0 5.8 6.0 25.8 15.3 12.3 24.8 20.1 18.5 23.6 23.3 4.6 10.0 21.0 19.6 36.4 17.9 47.4 42.2 20.4 21.3 23.5 10.5 2.4 26.4 15.4 3.8 6.7 19.3 19.8 11.4 16.3 15.0 13.5 9.5 21.9 11.0 29.9 17.4 34.5 20.9 16.0 25.6 50.3 12.4 8.3 12.4 9.1 9.6 22.8 10.8 8.1 36.0 4.7 16.6 10.2 16.3 26.8 11.0 29.7 7.4 10.0 33.2 9.6 15.3 20.2 7.2 2.0 3.6 6.3 2.8 5.6 5.0 6.2 7.3 3.0 3.8 7.4 7.2 1.9 7.8 1.9 4.8 7.2 3.2 6.5 12.7 7.7 9.0 7.5 5.4 16.5 6.2 8.7 11.4 6.0 6.1 13.0 3.2 3.2 3.6 2.9 7.6 5.3 3.4 1.8 7.9 6.8 0.0 4.1 14.9 2.6 5.2 46.7 3.3 16.2 3.1 2.8 3.5 2.6 8.6 4.8 1.2 9.2 10.8 20.4 5.5 5.4 0.0 5.4 6.3 10.0 4.5 5.7 5.6 2.0 7.6 0.0 3.6 17.7 10.0 3.0 5.3 6.9 8.0 3.0 NCOA1 "bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1" ENSG00000084676 "Nuclear receptor coactivator 1" Q15788 2 24491914-24770702 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019402, HPA070213, HPA070520" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No Nucleoplasm "Plasma membrane, Cytosol" "CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276" "unprognostic (2.73e-1)" "unprognostic (5.82e-2)" "unprognostic (2.46e-2)" "unprognostic (9.89e-3)" "unprognostic (7.60e-2)" "unprognostic (2.36e-2)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (1.72e-1)" "unprognostic (2.93e-3)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.15e-2)" "unprognostic (3.08e-1)" "unprognostic (1.29e-1)" "unprognostic (2.92e-2)" 9.8 10.0 15.3 7.3 18.0 8.9 10.5 15.9 17.1 13.7 8.9 13.5 4.9 12.5 13.0 11.5 10.8 10.0 8.3 8.8 20.8 12.2 11.9 8.8 9.4 8.2 10.8 9.9 17.2 10.3 23.9 16.0 10.1 14.2 9.6 10.1 19.9 10.6 13.0 42.5 9.3 10.9 11.6 9.7 9.6 7.6 11.4 10.7 8.5 7.0 12.2 9.3 9.7 10.8 2.5 5.5 14.2 3.5 3.4 4.1 1.8 6.7 5.0 8.9 4.6 9.8 9.0 13.6 3.6 7.3 4.6 4.1 4.7 2.9 4.9 1.5 6.6 8.8 1.6 5.3 3.1 5.0 23.3 7.7 17.6 2.0 1.9 6.2 8.0 14.7 14.3 4.7 4.4 3.6 5.7 4.6 6.4 10.7 8.2 6.9 4.5 7.1 2.9 4.2 4.0 3.4 5.7 41.0 2.5 5.0 9.2 8.1 6.4 8.4 5.1 3.7 4.9 6.1 4.1 5.0 7.7 6.1 5.2 3.6 9.5 8.2 8.6 4.4 5.1 3.8 11.0 3.5 6.9 3.8 2.7 4.1 1.8 3.4 4.1 2.6 2.5 3.3 4.0 14.2 3.4 2.8 5.5 3.7 1.8 15.3 18.0 15.9 17.1 20.8 12.2 10.8 9.9 14.2 10.7 35.7 29.8 13.6 10.7 27.1 97.2 33.1 15.3 20.1 31.8 14.0 49.1 11.2 6.6 12.0 13.1 29.2 24.6 23.3 23.0 14.9 31.2 14.1 18.6 20.3 15.3 58.8 24.2 33.2 25.2 3.8 43.7 26.2 18.6 10.0 22.7 63.8 17.7 35.1 40.7 11.4 67.4 38.8 35.4 32.1 36.8 27.0 4.5 25.4 23.0 14.6 NCOA7 "dJ187J11.3, ERAP140, TLDC4" ENSG00000111912 "Nuclear receptor coactivator 7" Q8NI08 6 125781161-125932030 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 348.4;Ciliated cells: 413.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030289, HPA030290, HPA030291, HPA030292" Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" No No "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834" "unprognostic (1.01e-2)" "unprognostic (3.21e-2)" "unprognostic (7.32e-3)" "unprognostic (7.27e-3)" "unprognostic (1.54e-1)" "unprognostic (4.67e-2)" "unprognostic (1.26e-1)" "unprognostic (6.27e-2)" "unprognostic (2.73e-1)" "unprognostic (2.14e-1)" "unprognostic (6.08e-2)" "unprognostic (4.37e-2)" "prognostic favorable (1.78e-6)" "unprognostic (2.10e-1)" "unprognostic (2.58e-1)" "unprognostic (1.14e-1)" "unprognostic (8.10e-2)" 32.0 37.6 24.8 26.6 33.7 23.1 20.4 39.7 32.6 19.2 18.0 17.9 3.9 19.8 13.9 6.4 22.7 11.3 28.9 12.3 23.2 24.1 33.7 21.5 30.8 19.0 35.7 25.6 12.5 11.8 7.4 49.3 8.0 39.5 12.2 18.4 7.6 31.6 8.5 6.3 8.7 23.1 17.1 30.9 16.2 18.7 4.9 35.4 4.7 15.6 12.0 16.6 44.1 20.8 12.8 22.6 10.5 8.8 9.1 17.5 3.5 4.3 11.9 0.7 5.3 26.6 15.8 7.8 5.9 23.5 7.3 10.1 11.0 4.1 17.4 31.9 3.2 36.1 25.8 4.0 4.0 4.5 37.0 4.6 8.9 15.2 4.1 15.1 5.0 8.5 11.2 9.8 7.0 5.4 13.1 15.2 5.7 12.5 10.4 4.5 4.9 4.9 5.3 0.9 10.8 2.4 3.7 1.8 3.2 13.0 29.9 12.2 10.6 30.2 8.2 13.2 2.3 2.0 6.6 8.7 1.7 3.7 8.6 4.4 12.8 10.4 9.1 3.7 7.1 5.8 10.5 8.1 2.8 14.1 6.3 17.5 12.8 13.4 11.2 6.5 7.5 7.4 7.2 5.0 9.1 8.8 22.6 5.2 3.5 24.8 33.7 39.7 32.0 23.2 24.1 35.7 25.6 39.5 35.4 291.8 348.4 26.9 190.5 87.1 48.0 8.5 68.8 413.6 277.5 59.3 41.2 6.8 68.0 215.9 0.7 103.4 38.3 0.0 123.8 8.9 57.0 95.1 35.9 21.9 11.7 35.0 34.3 88.4 26.4 3.2 39.1 30.8 49.0 32.5 25.4 86.2 116.6 101.7 27.6 77.2 48.8 12.9 29.8 8.4 33.0 51.8 3.2 39.2 37.9 172.9 NDOR1 "bA350O14.9, NR1" ENSG00000188566 "NADPH dependent diflavin oxidoreductase 1" Q9UHB4 9 137205685-137217009 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024504 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Intermediate filaments" "HPA024504: AB_1854338" "unprognostic (1.67e-1)" "unprognostic (1.44e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (5.89e-3)" "unprognostic (5.99e-2)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (2.61e-3)" "unprognostic (1.14e-1)" "unprognostic (1.07e-1)" "unprognostic (4.69e-3)" "unprognostic (2.05e-1)" "unprognostic (4.30e-2)" "unprognostic (6.74e-3)" 9.6 11.4 10.6 18.4 17.4 29.2 10.0 15.0 16.2 9.4 10.4 18.7 7.4 19.1 11.4 10.5 11.2 11.0 10.4 7.4 11.6 7.7 12.1 9.4 11.6 20.5 18.6 8.6 10.2 14.7 9.7 12.2 9.2 13.5 13.0 6.8 12.5 17.3 16.1 6.5 18.5 16.5 8.7 14.2 19.9 13.9 22.2 14.2 20.6 14.4 4.9 15.8 9.7 9.4 2.7 3.7 6.6 4.8 1.6 4.0 3.0 7.2 10.9 7.5 11.4 3.2 3.2 22.5 10.6 4.9 10.4 7.2 10.9 8.6 10.1 8.4 4.1 8.3 27.1 5.4 7.5 2.1 13.0 8.4 9.0 26.2 5.8 5.3 10.1 19.3 4.3 5.3 11.6 4.3 2.8 4.8 13.7 14.5 10.8 3.7 13.0 10.4 17.9 11.9 6.7 13.6 19.2 8.8 14.4 3.3 6.3 9.4 9.3 8.8 8.9 5.5 3.4 14.4 11.7 6.2 19.1 12.5 22.0 11.8 6.7 13.2 10.5 8.3 9.2 10.8 1.7 4.4 6.3 3.2 4.8 2.7 1.3 2.8 2.7 3.7 2.7 1.6 1.4 6.6 1.6 3.8 2.4 4.0 3.0 10.6 17.4 15.0 16.2 11.6 7.7 18.6 8.6 13.5 14.2 0.0 1.6 0.8 0.6 0.5 0.2 1.1 0.0 0.0 2.3 3.5 0.0 4.2 1.7 0.9 0.6 1.5 2.2 0.0 1.0 2.8 0.6 0.5 1.1 0.6 2.3 0.0 2.4 1.8 3.7 0.8 0.6 1.6 1.7 4.6 1.4 0.1 1.5 0.8 0.4 1.1 1.0 0.0 0.8 1.9 1.1 0.3 3.1 0.0 1.7 0.7 NDP "EVR2, norrin" ENSG00000124479 "NDP, norrin cystine knot growth factor" Q00604 X 43948776-43973504 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Vision, Wnt signaling pathway" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 40.4" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 100.6" "Cancer enhanced" "Detected in many" "glioma: 25.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 14 "T-cells: 1.7" "Cell line enriched" "Detected in some" 17 "U-87 MG: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003095 Supported Nucleoplasm,Nucleoli,Vesicles "Secreted to extracellular matrix" NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA003095: AB_1079457" "unprognostic (1.12e-1)" "unprognostic (7.12e-2)" "unprognostic (2.27e-2)" "unprognostic (2.55e-3)" "unprognostic (6.84e-3)" "unprognostic (1.51e-1)" "unprognostic (9.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" 0.9 0.6 17.3 0.6 18.6 0.5 3.6 14.6 15.0 19.1 0.7 12.6 0.2 0.6 13.6 19.9 0.6 18.0 0.9 1.4 14.0 7.8 0.7 0.5 0.6 0.7 11.0 10.9 40.4 0.6 0.8 0.2 5.3 13.1 6.8 0.7 1.4 0.6 12.4 1.5 1.1 0.6 10.7 7.5 0.6 0.7 1.4 12.2 0.0 1.2 0.0 0.7 1.0 1.7 0.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.1 1.1 0.7 0.0 0.0 1.1 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 41.2 0.4 2.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.3 18.6 14.6 15.0 14.0 7.8 11.0 10.9 13.1 12.2 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 12.4 0.0 0.0 0.0 0.0 100.6 0.7 0.0 9.2 0.0 3.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 NDRG2 "KIAA1248, SYLD" ENSG00000165795 "NDRG family member 2" Q9UN36 14 21016763-21070872 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 310.5;skeletal muscle: 253.0" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 411.1;Leydig cells: 322.7;Muller glia cells: 402.9;Sertoli cells: 588.6" "Cancer enhanced" "Detected in all" "glioma: 78.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "myeloid DC: 54.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 54.5" "Cell line enhanced" "Detected in many" "Hep G2: 27.9;HMC-1: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002896, HPA003590, CAB017491" Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 150000 "Centriolar satellite" "Nucleoplasm, Cytosol" "CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458" "unprognostic (9.27e-3)" "unprognostic (2.97e-3)" "unprognostic (1.26e-2)" "unprognostic (5.09e-3)" "unprognostic (2.00e-2)" "unprognostic (2.92e-2)" "prognostic favorable (6.71e-4)" "unprognostic (1.85e-3)" "unprognostic (5.57e-2)" "unprognostic (3.46e-2)" "unprognostic (1.69e-1)" "unprognostic (5.10e-2)" "prognostic favorable (1.43e-12)" "unprognostic (1.46e-1)" "unprognostic (5.56e-2)" "unprognostic (6.11e-2)" "unprognostic (4.19e-2)" 19.3 45.3 140.2 4.8 135.1 1.4 50.3 93.5 110.0 35.5 21.0 89.6 23.8 12.2 30.7 44.4 37.3 29.5 21.5 45.2 103.6 86.1 24.3 84.8 13.7 7.7 128.9 73.5 79.7 15.5 35.6 6.0 8.1 95.4 23.7 18.8 8.9 310.5 37.3 253.0 18.9 12.0 22.0 73.0 21.1 11.2 5.2 71.2 0.4 13.6 53.4 16.1 13.9 19.3 1.8 54.5 0.4 1.8 0.7 5.4 4.0 5.3 1.1 3.4 6.4 0.5 0.0 0.5 0.1 2.2 2.0 1.1 7.4 10.0 0.3 2.0 0.1 3.2 8.8 15.3 3.1 2.7 0.0 5.5 6.9 1.2 27.9 0.7 0.6 20.0 6.1 6.7 0.4 0.9 3.2 0.0 6.3 13.9 0.6 0.3 4.5 2.4 1.9 9.1 17.3 0.4 7.1 0.3 1.6 3.8 13.6 0.0 9.9 1.5 1.7 7.0 9.3 13.5 4.0 0.0 0.6 10.9 0.2 0.2 3.1 2.2 0.1 0.9 0.1 2.3 0.0 1.8 0.2 2.4 0.4 3.2 1.8 3.6 3.3 54.5 1.3 5.4 4.0 0.4 0.7 0.0 1.9 2.4 4.0 140.2 135.1 93.5 110.0 103.6 86.1 128.9 73.5 95.4 71.2 0.0 14.8 8.5 70.8 25.4 6.7 160.9 140.1 20.1 13.6 38.4 9.8 8.0 411.1 69.3 4.7 52.6 25.5 0.0 18.9 0.6 20.1 71.2 47.4 183.0 19.8 3.2 32.1 116.6 25.7 5.9 322.7 43.4 305.4 6.4 71.2 402.9 14.6 28.8 156.3 32.0 12.8 588.6 188.5 1.1 3.4 26.6 18.1 10.1 86.6 132.0 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596309-120602500 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 1416.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051739, HPA064441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Mitochondria" No No Mitochondria "Nucleoplasm, Nuclear membrane" "HPA051739: AB_2681585, HPA064441: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favorable (1.79e-4)" 25.5 68.2 37.6 20.1 37.7 22.4 59.4 40.7 51.6 25.6 37.2 19.1 25.6 33.6 23.2 32.2 30.2 24.3 27.8 130.2 32.5 30.8 53.3 46.9 25.4 42.0 37.3 29.4 25.8 36.5 34.1 32.8 18.5 36.7 26.8 34.8 24.6 33.9 29.5 195.7 27.3 30.6 37.6 32.4 22.6 28.7 26.6 25.6 31.1 25.9 64.8 25.4 32.3 29.1 64.5 73.4 52.1 60.5 39.1 79.7 49.0 51.3 37.5 44.9 44.9 28.3 33.8 36.5 28.9 38.4 37.6 41.6 36.4 39.5 26.1 58.7 32.3 47.2 49.8 34.6 36.8 28.4 40.0 39.8 40.3 39.4 36.6 17.2 35.4 47.8 30.5 49.1 18.3 24.1 45.6 46.9 49.7 23.8 40.2 40.3 40.3 70.0 51.3 35.7 84.6 102.8 40.6 25.6 57.4 60.9 32.1 50.6 51.8 33.9 38.0 61.5 31.3 64.0 56.5 36.0 33.3 43.9 14.1 40.2 49.6 44.7 78.9 52.6 49.9 45.1 46.2 46.2 52.1 45.5 60.5 47.4 64.5 63.5 51.3 58.4 47.2 54.8 53.4 28.1 39.1 60.5 73.4 79.7 49.0 37.6 37.7 40.7 51.6 32.5 30.8 37.3 29.4 36.7 25.6 151.8 116.9 147.4 227.4 197.5 114.3 1416.5 333.7 208.8 175.1 303.6 55.0 310.4 1039.5 474.7 797.6 248.2 436.8 93.5 541.7 349.0 180.0 247.2 169.9 411.5 288.6 79.4 286.7 153.4 221.7 73.1 254.9 235.4 411.7 399.5 378.0 175.1 503.3 436.8 260.6 758.9 123.5 252.2 270.2 329.1 90.3 219.8 294.7 162.0 391.3 307.0 NDUFV2 CI-24k ENSG00000178127 "NADH:ubiquinone oxidoreductase core subunit V2" P19404 18 9102630-9134345 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003404, HPA077896" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "HPA003404: AB_1079466, HPA077896: AB_2686866" "unprognostic (1.18e-1)" "unprognostic (3.89e-2)" "unprognostic (2.89e-1)" "unprognostic (8.22e-2)" "unprognostic (1.32e-2)" "unprognostic (6.72e-3)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "unprognostic (6.72e-3)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (1.31e-1)" "unprognostic (6.56e-2)" "unprognostic (1.95e-3)" 20.0 34.5 25.2 18.0 23.7 31.1 25.6 20.6 37.3 15.6 26.1 13.1 20.3 23.1 14.7 21.5 27.5 13.9 17.6 82.6 22.7 23.8 40.7 89.1 17.2 29.9 26.7 19.4 11.2 36.3 14.9 14.9 21.6 26.2 20.8 27.8 17.8 20.1 20.2 122.6 17.4 24.4 23.5 20.8 19.3 25.2 19.0 12.7 20.5 20.5 59.5 22.7 20.4 14.1 55.6 74.7 49.3 45.1 27.0 53.5 48.1 18.6 19.6 22.7 21.1 16.8 24.0 19.2 23.5 37.4 31.1 29.6 36.6 15.4 28.8 21.6 22.0 28.7 9.5 22.0 24.4 29.8 14.5 19.4 18.4 20.2 49.3 19.4 51.2 22.9 20.1 20.5 19.2 20.8 22.5 33.5 26.0 29.3 91.0 28.5 23.4 35.7 44.9 18.9 103.3 24.4 17.0 16.8 109.2 49.6 30.3 23.8 17.7 23.2 26.5 29.5 16.9 24.8 39.0 20.5 39.7 28.2 28.4 30.5 26.3 39.0 32.2 28.3 22.7 25.6 49.3 39.9 44.1 30.2 45.1 37.6 55.6 45.5 35.7 56.6 43.6 40.0 36.9 18.0 27.0 41.6 74.7 53.5 48.1 25.2 23.7 20.6 37.3 22.7 23.8 26.7 19.4 26.2 12.7 74.5 120.4 122.8 254.8 131.4 96.8 61.3 175.8 207.5 127.4 143.1 82.5 309.8 742.8 337.2 214.8 108.5 232.3 46.7 461.4 265.4 107.6 372.3 115.7 324.6 267.7 89.0 102.4 92.7 98.1 135.7 113.1 187.8 219.4 393.1 177.0 104.6 465.3 175.4 95.8 576.3 143.4 103.5 138.2 182.6 170.4 129.0 242.0 118.9 207.0 348.6 NEDD1 "GCP-WD, TUBGCP7" ENSG00000139350 "Neural precursor cell expressed, developmentally down-regulated 1" Q8NHV4 12 96907223-96953777 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 165.2;Late spermatids: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038591 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Centrosome" "Plasma membrane" "HPA038591: AB_10674688" "unprognostic (7.93e-2)" "unprognostic (3.18e-1)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (2.21e-1)" "unprognostic (5.92e-2)" "prognostic unfavorable (1.94e-4)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.81e-2)" "unprognostic (9.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.56e-1)" "unprognostic (2.46e-3)" "unprognostic (7.29e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-1)" "unprognostic (5.59e-2)" 10.7 6.2 5.7 10.0 6.6 9.8 9.8 2.5 7.1 10.8 9.3 7.1 1.7 4.9 13.5 8.3 11.6 10.0 5.5 8.3 6.0 4.4 12.6 5.4 9.4 10.3 7.0 3.7 13.3 7.7 14.9 13.5 7.9 6.5 11.9 7.2 6.3 8.5 6.3 25.5 7.8 10.3 15.4 8.4 14.5 7.2 17.8 8.3 30.6 11.9 24.3 10.7 15.1 9.6 9.4 5.9 19.9 11.1 15.6 14.0 7.3 13.7 9.1 15.8 9.6 7.8 7.1 11.2 47.8 17.0 22.1 19.1 6.0 5.1 8.5 4.6 38.2 10.3 12.4 10.6 11.0 29.8 16.3 9.1 10.6 6.0 5.3 6.5 14.4 9.6 5.2 9.1 13.4 10.4 14.6 10.8 14.7 6.1 6.3 15.8 5.6 26.2 6.6 8.7 7.2 29.2 13.9 16.0 8.4 9.0 9.0 4.9 8.7 13.4 7.6 8.3 12.9 10.2 5.1 7.7 13.9 10.7 9.9 11.2 6.2 7.5 11.4 4.3 7.3 16.8 10.0 6.9 19.9 12.1 11.1 13.7 9.4 13.4 12.9 5.9 8.1 14.0 10.9 5.4 15.6 7.8 4.6 14.0 7.3 5.7 6.6 2.5 7.1 6.0 4.4 7.0 3.7 6.5 8.3 8.9 8.6 11.3 24.7 17.2 8.1 8.9 7.6 25.4 15.9 15.7 0.0 7.5 8.3 8.1 165.2 9.1 5.3 0.0 7.0 11.4 8.4 20.9 16.1 4.9 7.5 17.5 5.8 12.3 4.3 65.3 11.5 9.3 6.8 3.6 7.0 12.9 6.8 7.0 9.6 10.5 8.4 19.4 8.2 26.7 24.6 12.3 3.3 18.1 6.6 16.3 NEDD9 "CAS-L, CASS2, HEF1" ENSG00000111859 "Neural precursor cell expressed, developmentally down-regulated 9" Q14511 6 11183298-11382348 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 72.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 437.7;Basal glandular cells: 247.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 49.8;HSkMC: 24.9" "Low region specificity" "Detected in all" "HPA009689, CAB009720, HPA038768, HPA039270, HPA072955" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: " "unprognostic (2.83e-3)" "unprognostic (2.33e-2)" "unprognostic (1.08e-2)" "unprognostic (6.93e-2)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "unprognostic (3.05e-2)" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.64e-1)" "unprognostic (5.59e-3)" "unprognostic (2.25e-2)" "unprognostic (2.37e-1)" "unprognostic (2.41e-1)" "unprognostic (1.05e-1)" 72.8 4.7 4.5 14.9 5.6 3.3 35.7 2.2 5.9 14.0 16.6 5.1 14.2 7.1 17.3 21.7 10.3 11.5 15.3 17.3 4.6 4.1 34.6 9.5 58.4 15.0 4.9 3.9 11.1 7.9 4.2 6.1 32.6 6.6 13.4 14.7 12.8 15.4 15.4 22.4 12.3 17.9 12.4 5.3 25.7 10.9 12.2 4.3 18.8 15.8 6.8 18.6 17.6 9.9 5.8 6.0 34.8 19.8 5.1 8.3 6.3 1.5 10.2 9.5 0.1 6.5 0.8 10.0 2.3 2.9 4.4 8.1 3.2 0.6 3.2 49.8 5.1 0.5 4.4 12.7 4.7 5.7 1.4 0.3 0.3 1.5 21.4 3.0 3.4 0.2 24.9 1.4 2.8 0.5 1.6 7.4 0.2 0.0 2.7 9.8 0.4 1.9 1.3 1.4 11.9 1.0 0.5 0.2 1.8 2.2 13.9 0.2 1.7 0.4 11.2 19.3 11.0 0.8 2.6 18.8 3.0 5.3 0.3 5.7 2.8 11.5 3.9 0.0 2.7 12.9 9.1 5.5 15.4 8.3 12.2 6.8 5.0 5.6 8.0 6.0 5.8 3.0 4.7 34.8 5.1 19.8 3.7 5.0 6.3 4.5 5.6 2.2 5.9 4.6 4.1 4.9 3.9 6.6 4.3 437.7 110.8 20.8 247.6 53.8 4.8 7.3 53.5 97.7 139.9 41.8 23.6 41.8 8.3 54.6 6.0 101.8 77.5 0.0 17.3 34.2 31.7 54.5 61.4 16.3 13.3 9.5 103.9 91.4 24.8 2.9 6.9 22.9 23.6 1.8 90.0 104.5 46.5 35.1 27.3 20.3 12.2 25.8 25.0 1.1 0.5 18.1 35.8 41.5 37.6 69.7 NEFL "CMT1F, CMT2E, NF68, NFL, PPP1R110" ENSG00000277586 "Neurofilament light" P07196 8 24950955-24957110 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.1" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 32.2;Distal tubular cells: 87.9;Horizontal cells: 28.6;Intestinal endocrine cells: 32.1;Muller glia cells: 29.9;Rod photoreceptor cells: 73.4" "Cancer enhanced" "Detected in many" "renal cancer: 24.0" "Cell type enriched" "Detected in some" 5 "memory CD4 T-cell: 13.7" "Lineage enriched" "Detected in single" 138 "T-cells: 13.7" "Group enriched" "Detected in some" 5 "HEK 293: 114.9;PC-3: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014850, HPA015021" Enhanced Supported Approved "Nucleoplasm,Intermediate filaments,Midbody" NA NA "Nucleoplasm, Intermediate filaments" Midbody "HPA014850: AB_1854397, HPA015021: AB_2669135" "unprognostic (7.63e-2)" "unprognostic (1.36e-2)" "unprognostic (9.53e-2)" "unprognostic (6.81e-2)" "unprognostic (2.82e-2)" "unprognostic (6.69e-2)" "unprognostic (3.69e-2)" "unprognostic (3.78e-3)" "unprognostic (3.06e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.91e-4)" "unprognostic (5.76e-3)" "unprognostic (7.88e-2)" "unprognostic (3.97e-3)" "unprognostic (3.17e-3)" 0.7 12.0 10.3 1.4 20.1 0.6 0.6 2.3 92.1 1.8 1.8 3.0 0.0 1.0 0.7 0.8 3.8 0.7 0.6 0.6 14.1 3.5 0.6 0.6 0.7 0.0 23.8 0.7 0.7 0.6 0.0 0.6 95.1 1.6 1.5 5.0 0.6 9.5 0.6 0.7 1.7 1.2 18.0 0.7 1.1 1.6 2.1 0.0 1.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 13.7 2.1 0.0 0.1 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.1 0.0 0.0 114.9 0.0 0.0 0.0 5.1 0.0 0.1 1.9 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.9 0.0 30.8 0.0 0.0 0.0 7.1 1.0 6.4 6.5 2.6 0.0 0.4 0.5 0.0 0.0 0.0 0.6 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 1.5 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 32.2 0.4 0.0 0.0 0.0 0.0 7.9 0.0 87.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 8.9 0.0 73.4 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 NEK1 "KIAA1901, NY-REN-55" ENSG00000137601 "NIMA related kinase 1" Q96PY6 4 169392857-169612629 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 85.6;Early spermatids: 83.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020873, HPA040413" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Cytosol "Nucleoplasm, Centriolar satellite" "HPA020873: AB_10671583, HPA040413: AB_10671169" "unprognostic (4.10e-2)" "unprognostic (2.97e-1)" "unprognostic (1.59e-2)" "unprognostic (1.97e-1)" "unprognostic (6.98e-2)" "unprognostic (3.10e-1)" "unprognostic (3.95e-1)" "unprognostic (3.29e-1)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "unprognostic (4.06e-3)" "unprognostic (2.21e-1)" "prognostic favorable (1.42e-4)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (2.10e-2)" "unprognostic (3.46e-1)" 9.6 10.5 13.5 9.2 15.8 6.0 8.7 20.7 14.5 13.6 8.4 12.5 7.1 5.4 12.4 9.1 7.9 15.7 10.2 11.4 13.7 13.2 10.2 6.9 7.7 8.0 15.9 11.3 16.3 6.6 15.3 16.5 7.2 16.0 11.6 7.7 8.9 6.4 10.6 7.1 4.7 5.7 11.1 18.2 8.0 8.1 18.3 14.8 14.7 13.3 6.4 7.4 10.0 8.2 4.5 3.3 6.7 3.3 2.2 5.3 1.3 4.2 1.8 7.8 8.4 12.1 13.5 2.5 8.9 8.0 7.2 6.8 2.4 5.0 11.3 1.7 7.8 6.9 1.4 7.3 7.6 8.2 12.4 5.0 7.6 7.7 2.9 7.1 7.6 6.1 10.8 4.3 7.3 12.8 14.7 7.0 10.9 13.4 21.5 9.2 2.7 9.8 3.4 2.5 2.7 4.5 6.1 5.1 3.6 7.6 5.0 8.5 9.7 6.5 3.2 6.0 6.2 4.0 3.4 8.4 4.6 4.2 4.7 6.0 8.7 13.3 8.6 7.6 3.8 8.0 6.7 2.1 1.8 4.4 3.3 4.8 4.4 3.4 2.7 1.5 4.5 5.1 5.3 1.1 2.2 1.6 3.3 3.2 1.3 13.5 15.8 20.7 12.9 13.7 13.2 15.9 11.3 16.0 14.8 11.9 13.1 13.3 12.5 8.5 20.5 31.9 0.0 85.6 22.7 17.4 27.5 17.5 14.9 8.5 83.6 9.0 5.4 23.3 5.5 6.7 16.2 7.0 17.4 6.6 9.1 17.5 6.9 8.6 6.9 39.7 21.9 8.9 5.0 2.8 5.0 23.4 6.9 4.2 29.7 8.1 24.4 12.9 18.6 59.1 27.4 5.5 24.7 8.6 6.8 9.5 NEK6 SID6-1512 ENSG00000119408 "NIMA related kinase 6" Q9HC98 9 124257606-124353307 "Enzymes, Predicted intracellular proteins, Transporters" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 103.8;Hofbauer cells: 99.7;monocytes: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045993, HPA056828" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Cytosol" "Centriolar satellite" "CAB045993: AB_2150651, HPA056828: AB_2683250" "unprognostic (6.27e-2)" "unprognostic (1.02e-2)" "unprognostic (4.15e-2)" "unprognostic (1.65e-2)" "unprognostic (5.22e-2)" "unprognostic (2.47e-2)" "unprognostic (3.13e-3)" "unprognostic (2.13e-2)" "unprognostic (2.38e-1)" "unprognostic (3.30e-2)" "unprognostic (1.38e-3)" "unprognostic (6.53e-2)" "unprognostic (5.03e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (7.66e-4)" "unprognostic (5.27e-2)" "unprognostic (4.77e-3)" 14.8 5.3 26.1 22.2 29.1 12.8 18.8 7.2 21.2 20.5 15.6 13.4 4.3 12.5 9.2 7.5 6.8 8.5 18.4 7.0 17.1 16.6 12.9 51.9 17.0 18.1 19.4 13.3 11.2 20.5 1.6 6.4 21.4 14.7 14.8 16.6 18.5 16.9 13.2 5.5 5.1 18.2 23.4 13.0 11.3 19.0 5.8 12.9 4.0 6.3 1.9 22.0 17.7 10.1 21.9 11.5 29.0 18.8 8.3 3.8 7.6 7.4 12.3 11.9 4.6 22.5 29.4 14.8 9.4 15.1 14.6 12.2 11.6 14.0 9.1 15.1 18.1 33.4 1.4 6.1 27.3 9.9 10.0 5.4 24.9 10.4 20.4 26.9 4.5 62.6 39.1 4.4 13.8 14.3 38.4 15.9 4.3 4.4 0.4 26.0 7.8 0.2 4.9 3.0 39.4 11.2 9.6 8.9 4.6 15.6 2.7 5.3 1.8 3.0 5.8 13.3 12.6 12.7 18.4 31.0 10.7 10.8 7.3 6.4 2.0 2.5 5.2 13.4 10.2 14.1 10.2 18.8 29.0 3.8 12.3 2.4 21.9 2.3 3.2 11.5 9.0 0.4 1.6 23.4 8.3 14.7 10.6 2.8 7.6 26.1 29.1 7.2 21.2 17.1 16.6 19.4 13.3 14.7 12.9 8.9 6.6 9.8 11.0 2.2 0.7 2.5 17.8 1.4 4.5 3.5 0.0 33.9 1.7 35.3 14.7 5.5 12.9 23.3 20.0 103.8 9.9 17.8 21.9 33.3 99.7 0.0 5.8 4.3 10.7 12.3 4.6 30.4 6.8 90.2 15.5 28.1 24.3 15.2 3.5 29.9 1.8 0.0 5.3 1.2 10.6 1.0 30.2 0.0 18.6 8.9 NEMF "FLJ10051, NY-CO-1, SDCCAG1" ENSG00000165525 "Nuclear export mediator factor" O60524 14 49782083-49853203 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004160 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA004160: AB_1079884" "unprognostic (9.92e-2)" "unprognostic (6.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.65e-1)" "unprognostic (9.15e-3)" "unprognostic (7.62e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.50e-1)" "unprognostic (1.12e-1)" "prognostic favorable (2.85e-4)" "unprognostic (3.61e-1)" "unprognostic (2.36e-1)" "unprognostic (8.98e-2)" "unprognostic (1.81e-2)" 13.6 12.2 15.0 14.8 20.9 30.9 12.5 28.0 22.1 15.0 14.4 14.6 14.4 8.1 14.3 12.2 18.2 11.6 11.2 15.0 16.9 15.0 14.6 11.2 11.6 13.4 21.1 17.2 15.2 13.1 26.4 30.9 15.5 27.9 13.9 12.4 10.7 14.8 14.8 17.4 11.5 15.1 13.9 24.8 14.7 13.7 8.4 23.2 17.0 15.7 9.8 14.5 13.5 13.4 36.1 33.0 28.4 21.9 20.3 26.8 7.8 18.8 21.1 20.2 13.4 22.9 18.5 18.1 23.8 15.8 15.7 15.5 10.8 20.3 5.2 18.3 19.6 12.3 27.0 19.0 14.9 25.4 21.0 10.9 20.9 20.1 16.3 13.4 27.3 19.2 16.4 11.0 16.6 15.5 21.3 22.4 12.1 25.8 19.8 21.5 17.3 16.2 9.0 12.1 15.1 21.3 16.8 20.0 11.9 18.6 25.0 13.4 12.5 22.1 23.8 22.1 22.8 20.5 17.8 26.4 23.1 20.3 15.0 16.3 14.1 25.1 22.4 8.6 12.9 20.6 27.6 18.2 20.1 20.5 16.3 19.5 32.8 21.0 19.2 15.2 36.1 24.8 26.8 28.4 20.3 21.9 33.0 17.9 7.8 15.0 20.9 28.0 22.1 16.9 15.0 21.1 17.2 27.9 23.2 38.7 66.5 52.5 59.9 30.6 90.1 88.4 30.6 92.3 58.0 41.8 94.2 66.4 31.5 48.3 7.7 60.9 51.0 23.3 34.1 50.5 56.0 46.7 86.6 27.6 51.0 123.9 51.9 44.2 43.5 8.9 60.9 57.0 23.6 64.1 43.0 55.4 40.2 57.5 63.3 24.8 92.1 71.1 53.6 79.2 54.9 29.7 90.6 62.3 45.2 79.7 NEO1 "HsT17534, IGDCC2, NGN, NTN1R2" ENSG00000067141 "Neogenin 1" Q92859 15 73051710-73305206 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 57.8;Peritubular cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009320, HPA027804, HPA027805, HPA027806" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 280000000 "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006" "unprognostic (1.90e-1)" "unprognostic (2.38e-2)" "unprognostic (7.60e-3)" "unprognostic (3.76e-2)" "unprognostic (5.44e-1)" "unprognostic (3.83e-2)" "unprognostic (8.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.22e-1)" "unprognostic (3.30e-2)" "unprognostic (5.51e-2)" "unprognostic (8.05e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-2)" "unprognostic (3.75e-1)" 7.3 5.8 19.2 6.2 22.4 1.2 11.4 12.7 23.9 13.4 30.0 44.5 14.8 17.9 14.2 7.2 8.0 15.4 13.4 6.8 20.1 14.1 16.2 5.9 10.7 2.7 27.1 15.7 17.5 11.5 44.4 6.9 1.5 19.3 23.1 36.9 16.0 11.5 25.5 17.9 24.6 19.0 16.0 22.3 3.6 15.1 9.0 22.5 2.1 12.5 3.8 4.7 10.1 9.5 0.0 0.3 1.4 0.3 0.8 3.1 0.3 3.7 18.3 21.9 14.4 13.3 3.9 5.5 1.4 1.8 3.6 0.7 2.7 18.5 1.0 2.2 4.0 13.6 0.8 15.3 8.4 1.5 6.6 11.3 12.3 0.2 2.5 3.8 0.3 0.4 9.6 15.6 0.7 7.2 4.2 0.0 9.6 0.0 23.5 0.8 11.2 4.3 0.2 20.9 2.8 1.5 10.0 11.7 2.4 7.0 10.1 10.0 14.1 17.2 7.7 9.1 18.4 8.1 2.2 0.0 16.9 9.0 5.4 3.9 10.1 18.6 2.6 3.6 3.5 4.7 0.0 0.3 0.4 1.8 0.0 3.1 0.0 1.1 1.4 0.0 0.0 0.6 0.5 1.4 0.8 0.0 0.3 0.0 0.3 19.2 22.4 12.7 23.9 20.1 14.1 27.1 15.7 19.3 22.5 8.9 7.2 1.7 6.9 12.6 14.6 4.2 22.9 4.0 6.8 21.0 13.7 0.5 1.7 8.7 3.0 2.9 34.1 0.0 5.5 0.6 7.9 14.5 0.0 5.9 0.7 9.5 57.8 8.0 0.3 4.1 29.4 0.5 10.1 0.0 37.7 10.4 9.4 38.6 59.1 14.3 21.5 6.5 8.6 5.7 18.1 22.2 0.2 4.5 47.7 6.1 NF2 "ACN, BANF, merlin, SCH" ENSG00000186575 "Neurofibromin 2" P35240 22 29603556-29698598 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 61.9;Late spermatids: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003097, CAB005385" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB005385: AB_2298548, HPA003097: AB_1079473" "unprognostic (3.27e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.14e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.61e-1)" "unprognostic (3.67e-2)" "unprognostic (2.16e-2)" "unprognostic (2.01e-3)" "unprognostic (4.66e-1)" "prognostic favorable (2.89e-5)" "unprognostic (7.73e-3)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (9.62e-2)" 11.8 12.4 23.6 11.1 20.1 10.0 15.4 20.8 28.1 10.8 9.7 9.0 11.8 7.8 10.5 11.3 14.2 11.3 8.0 19.7 26.6 16.4 13.5 11.1 11.9 24.1 18.0 13.5 11.0 12.9 46.8 8.6 6.9 11.4 10.2 8.7 9.5 9.3 15.4 25.7 12.1 8.5 11.9 10.7 10.4 8.8 21.6 10.1 14.9 15.6 11.5 9.9 10.6 10.2 8.5 13.6 6.6 17.3 11.6 15.0 9.8 26.6 10.8 3.8 24.6 7.4 7.4 3.6 21.7 12.2 23.8 20.6 10.6 6.6 7.1 18.0 22.3 16.5 9.5 7.8 12.6 21.3 10.3 6.1 8.4 8.1 7.6 7.9 12.0 10.0 6.8 5.7 16.9 20.6 8.1 16.7 4.6 4.1 6.6 23.1 11.2 7.3 4.8 2.8 6.3 10.2 7.6 20.3 6.8 24.2 12.5 5.8 4.0 12.4 8.4 4.9 4.0 5.4 4.8 31.0 35.5 40.5 15.4 36.6 10.3 8.2 8.5 9.4 4.7 22.6 6.6 9.5 3.6 15.0 13.5 12.8 8.2 11.3 10.1 13.6 8.5 9.8 9.2 2.3 11.6 17.3 9.3 9.4 9.8 23.6 20.1 20.8 28.1 26.6 16.4 18.0 13.5 11.4 10.1 6.0 16.1 9.0 9.6 12.6 16.5 19.9 17.8 6.7 7.9 14.0 9.8 9.9 18.3 42.9 61.9 9.8 8.4 0.0 21.5 6.3 12.6 9.5 23.0 12.5 12.4 28.6 12.6 10.4 10.0 86.8 6.6 7.2 8.5 6.4 7.5 17.3 28.7 15.6 11.7 16.2 8.5 6.5 14.9 21.4 7.2 12.5 3.2 10.9 9.8 8.6 NFE2L2 NRF2 ENSG00000116044 "Nuclear factor, erythroid 2 like 2" Q16236 2 177227595-177392697 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002990, CAB020317, HPA043438" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB020317: , HPA002990: AB_1079476, HPA043438: AB_2678482" "unprognostic (2.11e-1)" "unprognostic (3.12e-2)" "unprognostic (5.22e-2)" "unprognostic (1.41e-1)" "unprognostic (5.95e-2)" "unprognostic (3.90e-1)" "unprognostic (5.27e-2)" "unprognostic (9.58e-2)" "unprognostic (3.48e-2)" "unprognostic (9.86e-2)" "unprognostic (4.86e-2)" "unprognostic (1.83e-1)" "prognostic favorable (2.26e-4)" "unprognostic (1.97e-2)" "unprognostic (1.61e-1)" "unprognostic (1.26e-1)" "unprognostic (9.77e-3)" 30.9 24.4 25.4 19.3 34.7 15.0 24.6 36.4 29.7 31.7 28.3 25.8 22.2 28.1 27.7 30.9 82.5 27.0 28.9 32.3 28.0 16.9 44.8 49.3 29.0 19.7 49.0 18.7 53.1 16.3 21.7 52.5 29.4 33.5 39.0 25.4 21.7 34.7 28.1 25.9 48.1 29.2 42.1 42.7 26.8 45.9 21.9 41.6 21.1 49.5 35.8 25.5 43.7 47.1 23.5 41.1 42.4 35.6 25.8 43.2 22.6 10.6 12.3 11.2 12.0 37.8 40.8 12.8 18.2 25.3 16.6 18.8 16.2 20.4 10.5 19.8 20.6 31.6 19.8 13.1 27.7 23.3 8.1 8.0 13.5 21.6 31.6 48.4 8.0 12.8 28.1 65.2 23.6 35.1 39.4 16.4 8.3 14.0 20.6 22.8 10.6 8.1 21.1 12.2 55.2 11.6 6.7 9.8 10.6 25.4 40.1 14.6 9.5 41.2 13.3 43.1 33.7 10.3 21.6 24.7 17.2 11.5 19.1 11.1 14.5 8.7 8.8 17.2 8.9 33.0 42.4 35.6 21.4 23.0 34.1 26.6 23.5 26.9 23.6 41.1 19.9 43.2 28.2 39.9 25.8 31.9 15.5 25.0 22.6 25.4 34.7 36.4 29.7 28.0 16.9 49.0 18.7 33.5 41.6 145.9 85.8 49.5 216.1 262.7 59.6 57.4 96.8 143.2 127.4 146.5 15.7 88.4 333.2 126.2 58.6 116.1 96.6 0.0 147.7 27.7 204.6 118.5 212.0 76.9 78.0 54.0 72.6 97.6 100.1 19.8 266.3 164.9 91.1 213.8 57.7 176.6 122.9 89.2 201.2 56.4 47.1 38.8 169.0 50.5 33.8 275.8 155.7 62.3 90.2 201.5 NFKBIB "IKBB, TRIP9" ENSG00000104825 "NFKB inhibitor beta" Q15653 19 38899700-38908893 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.2" "Group enriched" "Detected in all" 13 "Early spermatids: 932.5;Late spermatids: 859.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063734 Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA063734: AB_2685107" "unprognostic (2.73e-1)" "unprognostic (3.24e-1)" "unprognostic (2.14e-1)" "unprognostic (9.16e-2)" "unprognostic (1.42e-1)" "unprognostic (4.35e-2)" "unprognostic (1.72e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-1)" "unprognostic (8.84e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.19e-2)" "unprognostic (4.35e-1)" "unprognostic (2.08e-1)" "unprognostic (3.50e-3)" 7.9 7.1 7.0 12.5 9.8 22.0 6.8 2.9 7.3 3.9 7.6 8.1 7.6 10.8 5.8 5.7 8.6 5.1 7.6 7.1 7.3 5.8 7.9 14.6 6.7 8.7 11.2 5.2 4.3 9.7 4.0 3.9 7.2 7.2 5.0 3.6 5.1 8.6 6.6 13.9 8.0 11.7 5.1 9.9 9.2 12.4 80.2 9.3 6.0 6.6 8.7 8.7 6.6 5.1 3.8 5.4 12.4 5.8 8.7 7.2 2.9 8.1 10.2 1.5 3.6 1.5 0.9 4.8 5.5 2.2 3.0 3.4 7.2 4.4 9.0 6.2 1.2 2.8 4.5 3.8 2.7 0.9 27.5 4.9 6.0 1.9 4.1 5.3 6.9 12.8 1.2 3.0 3.3 4.2 0.8 1.6 6.7 7.0 8.3 1.1 5.3 8.5 6.8 5.1 6.9 4.2 12.0 6.3 8.2 1.4 3.2 8.9 5.3 3.5 5.1 3.9 0.9 3.0 5.9 3.9 5.1 6.5 8.7 8.4 17.3 15.3 19.2 3.3 7.2 6.2 1.5 4.3 12.4 5.3 5.8 4.1 3.6 3.1 4.5 3.8 3.8 2.3 3.4 9.0 8.7 4.7 5.4 7.2 2.9 7.0 9.8 2.9 7.3 7.3 5.8 11.2 5.2 7.2 9.3 8.9 22.4 22.8 35.7 28.0 10.9 6.5 10.2 4.0 11.4 12.2 3.9 24.4 6.6 26.6 932.5 20.4 53.1 23.3 27.0 21.6 13.5 31.8 66.8 18.7 21.9 23.8 21.2 8.0 14.6 859.8 12.7 18.6 16.9 37.9 17.0 13.0 38.2 17.5 14.2 19.2 11.5 19.4 18.9 20.1 14.9 21.1 49.4 29.9 18.2 31.5 NFKBIE IKBE ENSG00000146232 "NFKB inhibitor epsilon" O00221 6 44258166-44265788 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 85.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002692, HPA005941, CAB010272" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478" "prognostic favorable (1.72e-5)" "unprognostic (1.43e-1)" "unprognostic (1.39e-2)" "unprognostic (2.37e-2)" "unprognostic (6.32e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (4.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.43e-2)" "unprognostic (3.36e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (1.37e-6)" "unprognostic (2.61e-2)" "unprognostic (8.83e-2)" "unprognostic (1.37e-2)" "prognostic favorable (8.07e-4)" 5.8 5.2 7.6 24.6 5.4 24.0 5.2 9.4 7.8 3.7 8.0 4.2 3.2 6.7 4.7 5.5 6.9 3.0 9.8 4.6 7.9 5.5 11.5 8.7 15.9 17.1 6.0 4.1 6.1 7.1 3.5 4.1 6.0 4.8 7.1 5.9 3.6 7.7 4.1 3.7 7.4 9.5 3.6 5.0 29.6 6.3 7.9 3.7 14.5 5.5 4.6 22.7 6.7 6.7 8.1 8.2 7.1 10.2 0.8 3.5 1.6 13.9 3.5 4.9 7.7 1.9 1.4 2.6 2.5 12.2 7.7 8.1 7.5 6.6 7.5 8.9 2.5 20.7 3.0 5.2 7.8 8.7 12.9 2.9 3.9 1.5 8.4 6.0 12.8 11.8 3.7 3.4 7.1 4.4 6.5 5.2 3.6 3.6 20.2 1.9 7.1 2.5 26.1 2.6 22.0 1.9 4.7 4.4 6.9 17.7 15.2 3.1 4.0 1.7 6.4 10.1 4.3 4.4 15.0 9.1 4.4 5.1 2.7 7.7 12.9 5.4 13.9 3.9 14.2 8.2 7.1 8.1 3.8 1.8 9.4 3.5 8.1 2.4 1.6 6.8 7.3 1.1 1.7 3.2 0.8 10.2 8.2 3.0 1.6 7.6 5.4 9.4 7.8 7.9 5.5 6.0 4.1 4.8 3.7 0.0 11.9 25.1 19.3 34.0 3.3 3.4 15.3 0.0 3.4 3.5 2.0 4.3 14.9 42.8 13.7 8.7 11.0 0.0 18.4 6.2 6.8 25.5 33.3 1.6 52.3 3.2 14.3 4.9 17.8 25.0 1.7 66.3 45.5 85.6 7.0 2.6 39.6 24.6 2.5 10.3 4.0 6.5 16.9 21.4 8.7 34.4 4.5 9.6 6.6 32.1 NGDN "C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD" ENSG00000129460 Neuroguidin Q8NEJ9 14 23469688-23509862 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000944 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA000944: AB_1079483" "unprognostic (2.63e-3)" "unprognostic (7.65e-2)" "unprognostic (2.84e-1)" "unprognostic (4.16e-3)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (8.87e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (3.87e-3)" "unprognostic (7.10e-2)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (9.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.58e-1)" "unprognostic (1.70e-1)" 20.1 17.6 17.2 19.3 23.6 35.7 26.9 28.9 25.8 17.8 17.8 21.2 18.7 15.0 29.1 22.3 17.4 21.7 12.1 14.8 17.6 15.7 20.6 21.0 15.5 20.4 23.5 17.4 27.2 16.6 20.9 20.7 19.7 19.1 19.7 19.4 17.4 24.0 19.9 32.8 22.7 17.9 21.0 21.6 19.7 17.5 19.0 25.2 19.6 23.7 17.2 22.8 17.3 19.7 42.0 26.7 18.9 23.4 35.2 44.6 28.2 11.0 21.9 16.8 15.7 16.3 11.8 22.2 14.6 15.3 31.3 25.4 21.6 20.2 27.4 10.8 13.3 22.2 19.2 33.2 18.1 36.9 18.2 17.5 24.5 13.3 66.7 22.2 32.4 17.5 14.7 23.1 24.6 29.4 12.4 15.8 21.2 27.1 19.6 15.2 26.2 24.1 24.5 21.2 25.4 29.5 19.7 20.1 14.0 20.0 21.0 17.2 19.4 17.3 20.8 23.9 17.8 12.9 20.8 11.9 14.8 17.6 13.9 21.2 24.5 42.5 39.8 6.4 16.6 15.8 17.5 21.5 18.9 31.6 23.4 33.5 42.0 34.3 32.1 25.3 36.6 44.6 35.1 6.6 35.2 22.4 26.7 37.4 28.2 17.2 23.6 28.9 25.8 17.6 15.7 23.5 17.4 19.1 25.2 32.8 26.9 41.2 49.3 62.7 21.0 17.7 17.8 28.1 29.6 26.2 15.7 50.7 28.2 31.1 4.1 34.3 17.4 23.3 31.3 36.0 37.0 25.4 43.9 18.1 26.5 23.8 23.6 16.0 16.4 4.5 32.5 29.5 30.4 36.1 18.8 20.7 28.1 19.9 26.5 27.0 24.7 19.4 38.7 57.2 69.0 59.1 47.8 41.5 22.0 44.2 NGRN DSC92 ENSG00000182768 "Neugrin, neurite outgrowth associated" Q9NPE2 15 90265659-90278141 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 103.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041367, HPA076267" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitochondria" "Intracellular and membrane" Yes No Mitochondria "Nucleoplasm, Cytokinetic bridge" "HPA041367: AB_10796668, HPA076267: " "unprognostic (2.82e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-3)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (3.19e-2)" "unprognostic (2.94e-2)" "unprognostic (5.00e-2)" "unprognostic (7.78e-2)" "unprognostic (1.93e-2)" "unprognostic (5.22e-2)" "unprognostic (7.22e-2)" "unprognostic (3.31e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.68e-3)" "unprognostic (3.21e-1)" 13.3 21.3 49.2 11.0 43.2 19.4 18.7 27.6 61.5 18.5 15.6 13.8 8.4 9.3 18.9 21.0 13.1 15.2 14.1 19.1 38.9 42.2 11.2 13.3 15.3 11.9 38.9 37.7 19.4 18.9 21.1 17.1 12.3 30.9 15.5 12.1 11.4 14.4 14.5 47.6 17.7 11.3 12.4 25.7 14.0 13.9 13.8 14.0 3.8 23.3 15.4 11.4 12.7 15.4 5.2 2.4 6.0 3.1 4.2 4.8 2.5 2.9 7.4 9.8 15.4 8.6 3.7 1.2 4.2 3.3 4.0 2.9 3.5 1.7 4.7 2.8 5.0 3.4 4.9 9.5 2.4 5.8 1.9 8.8 4.5 4.5 5.4 5.5 5.2 3.4 5.1 8.7 3.7 4.8 3.8 3.6 4.8 5.6 5.8 2.4 3.5 4.9 2.2 4.6 3.6 4.4 7.5 5.5 2.3 4.2 13.1 9.8 12.3 8.1 6.5 3.5 7.0 2.6 7.4 5.8 9.6 4.1 6.2 7.5 3.8 20.0 5.0 4.2 5.4 7.8 6.0 2.3 3.6 3.2 3.1 4.0 3.5 3.1 2.7 1.2 5.2 3.7 4.4 5.0 4.2 1.9 2.4 4.8 2.5 49.2 43.2 27.6 61.5 38.9 42.2 38.9 37.7 30.9 14.0 17.9 20.6 6.7 10.6 6.4 10.7 7.8 2.5 103.1 36.4 5.2 9.8 5.1 5.0 27.1 1.5 8.4 7.3 0.0 20.6 3.7 5.0 7.7 19.7 3.4 3.7 15.9 25.4 5.5 4.0 2.2 8.3 5.9 8.5 17.2 15.6 13.3 25.7 17.5 8.1 6.7 10.4 12.9 8.6 4.8 3.6 4.4 5.6 8.5 15.7 6.4 NIPBL "DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2" ENSG00000164190 "NIPBL, cohesin loading factor" Q6KC79 5 36876759-37066413 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040834, HPA058239" Approved Supported Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA040834: AB_10796562, HPA058239: AB_2683650" "unprognostic (4.92e-2)" "unprognostic (9.77e-2)" "unprognostic (5.28e-2)" "unprognostic (8.10e-2)" "unprognostic (9.38e-2)" "unprognostic (6.02e-2)" "unprognostic (7.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.85e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (6.39e-2)" "unprognostic (6.59e-2)" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (1.04e-1)" "unprognostic (3.40e-2)" 16.8 13.9 13.3 21.9 15.7 22.7 15.8 22.9 15.9 17.3 19.2 10.8 20.1 10.4 18.7 16.5 16.6 14.3 15.9 12.4 13.5 7.1 12.6 13.2 16.0 16.0 17.2 11.1 21.2 14.6 30.0 20.9 17.4 13.5 15.1 13.2 8.5 17.1 24.7 18.9 18.2 18.4 13.2 11.9 18.5 14.7 14.1 19.0 42.5 18.1 14.0 16.9 17.6 29.2 4.8 4.6 11.1 4.3 3.8 4.9 1.9 10.3 6.1 16.0 7.5 10.2 11.2 11.8 8.3 9.3 9.2 7.7 8.6 10.7 15.7 5.4 10.3 10.6 9.1 13.6 7.7 13.3 12.9 7.1 19.1 27.2 6.3 7.0 22.3 12.8 8.2 9.5 10.3 13.6 8.8 11.5 9.9 18.1 11.8 8.6 5.0 15.2 8.5 7.6 6.1 5.3 13.0 25.2 6.0 6.5 14.8 11.9 8.4 40.3 10.8 8.5 13.2 11.0 13.0 12.5 12.2 13.3 10.3 6.2 8.6 11.4 18.6 6.7 15.3 9.1 10.0 4.1 5.7 4.8 3.2 4.4 4.0 3.9 4.2 3.3 4.8 4.3 4.9 11.1 3.8 4.3 4.6 2.9 1.9 13.3 15.7 22.9 15.9 13.5 7.1 17.2 11.1 13.5 19.0 122.1 90.0 21.9 65.0 42.9 59.8 76.5 43.3 84.3 83.0 31.4 72.6 34.3 5.0 46.3 10.9 63.8 39.1 70.0 40.4 27.0 34.9 58.3 78.9 22.9 32.7 38.1 39.9 33.7 44.3 10.2 61.5 61.2 23.6 64.9 38.5 49.5 45.0 45.6 53.0 10.2 67.9 51.8 44.3 162.2 75.4 41.0 63.5 61.8 38.0 88.6 NKTR p104 ENSG00000114857 "Natural killer cell triggering receptor" P30414 3 42600614-42648741 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022120, HPA051576" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Plasma membrane, Cytosol" "HPA022120: AB_1854513, HPA051576: AB_2681540" "unprognostic (2.73e-3)" "unprognostic (3.11e-1)" "unprognostic (2.33e-1)" "unprognostic (2.06e-1)" "unprognostic (5.27e-3)" "prognostic favorable (1.26e-4)" "unprognostic (4.62e-2)" "unprognostic (5.65e-2)" "unprognostic (4.02e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (6.01e-4)" "prognostic unfavorable (5.02e-4)" "unprognostic (3.82e-1)" "unprognostic (4.57e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.05e-5)" 12.9 14.4 9.8 18.8 22.2 16.3 15.9 42.0 12.3 18.8 10.4 18.5 15.4 11.8 27.2 17.4 11.0 12.0 13.1 11.2 10.9 10.5 9.5 9.7 14.6 15.5 14.5 11.3 22.7 18.4 19.2 26.9 11.1 14.1 12.9 11.1 20.4 13.2 19.5 12.0 20.0 13.3 19.4 15.0 18.5 10.1 17.8 13.8 20.6 14.9 10.9 19.4 12.9 13.9 9.3 8.5 11.7 10.0 11.1 10.2 3.6 8.9 5.2 17.2 7.0 10.3 12.6 9.7 14.6 3.7 6.1 8.3 9.0 7.2 14.2 7.0 4.4 6.0 7.9 10.1 3.7 12.5 7.1 8.5 18.2 16.3 14.6 4.4 14.0 12.0 5.1 7.2 12.0 4.6 11.1 10.7 3.4 18.3 11.0 11.5 3.7 9.5 13.7 14.8 4.8 7.6 10.1 7.7 5.8 8.5 6.9 6.1 3.6 15.7 6.5 2.4 8.0 9.6 10.2 17.1 10.9 8.0 11.9 14.0 9.5 13.3 9.9 5.8 17.2 6.7 9.2 6.2 11.7 10.2 7.7 9.4 8.9 9.8 8.5 4.7 9.3 10.0 8.7 9.1 11.1 10.0 8.5 8.3 3.6 9.8 22.2 42.0 12.3 10.9 10.5 14.5 11.3 14.1 13.8 101.3 122.0 67.1 53.1 52.4 190.3 63.1 50.9 45.5 75.1 83.7 231.7 56.8 14.9 39.7 13.6 120.9 75.7 23.3 34.0 42.2 62.5 58.7 92.6 44.7 39.4 125.5 69.0 103.2 49.9 13.7 155.3 72.2 49.0 62.3 51.5 160.2 38.7 44.6 126.2 9.7 283.7 90.5 58.5 210.1 183.7 50.1 26.2 126.8 54.0 42.1 NLK ENSG00000087095 "Nemo like kinase" Q9UBE8 17 28041737-28196381 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 93.3;Cone photoreceptor cells: 145.3;Early spermatids: 243.8;Late spermatids: 250.1;Rod photoreceptor cells: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 32 "basophil: 17.6" "Lineage enriched" "Detected in single" 32 "granulocytes: 17.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018192, HPA056511" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA Nucleoplasm "Nucleoli, Cell Junctions" "HPA018192: AB_1854525, HPA056511: AB_2683160" "unprognostic (7.19e-2)" "unprognostic (1.98e-1)" "unprognostic (5.54e-2)" "unprognostic (5.64e-3)" "unprognostic (2.11e-1)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (2.59e-3)" "unprognostic (2.72e-2)" "unprognostic (4.23e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (5.29e-2)" "unprognostic (1.66e-1)" "unprognostic (3.92e-1)" "unprognostic (5.27e-2)" "unprognostic (6.57e-2)" 6.4 30.5 19.4 10.9 14.1 7.4 7.5 7.5 38.2 6.2 6.7 8.3 14.4 8.3 5.7 8.8 4.5 5.1 8.2 8.5 18.2 12.0 13.0 8.2 7.1 11.7 15.2 23.6 4.6 11.5 20.8 9.4 9.1 7.0 6.7 7.1 12.7 5.8 17.4 4.9 4.5 8.3 4.6 15.3 10.1 7.0 17.4 7.5 10.9 13.2 3.7 11.0 7.2 4.4 0.5 0.3 17.6 0.3 0.1 0.5 0.2 4.6 5.4 13.0 4.5 2.8 3.6 5.8 4.7 4.8 7.8 6.0 27.1 4.2 6.3 7.1 3.8 9.9 4.4 9.2 8.5 9.0 14.6 5.8 24.8 5.0 4.6 4.7 5.2 25.6 4.7 5.3 5.1 6.2 7.6 9.1 18.0 9.5 7.7 7.1 5.5 13.4 6.0 5.0 9.1 2.7 11.2 8.4 4.6 14.2 5.7 9.5 3.6 7.1 6.8 29.1 16.4 10.6 8.3 9.3 5.6 7.6 4.6 9.4 9.0 8.6 6.1 5.5 5.7 6.1 17.6 0.2 0.2 0.3 0.3 0.1 0.5 0.4 0.4 0.2 0.3 0.2 0.5 0.1 0.1 0.3 0.3 0.4 0.2 19.4 14.1 7.5 38.2 18.2 12.0 15.2 23.6 7.0 7.5 20.8 5.9 4.7 3.5 4.7 93.3 23.0 10.2 6.7 4.5 31.4 145.3 2.5 1.7 3.3 243.8 10.6 5.9 0.0 5.5 3.0 3.7 5.4 24.2 8.9 7.2 35.0 27.1 10.4 14.2 250.1 5.2 5.0 15.1 4.6 9.4 9.4 5.7 7.0 2.5 6.3 92.4 12.9 3.9 25.8 9.5 4.3 5.4 5.1 8.3 5.8 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 37.2;brain: 28.5;breast: 59.9" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 91.4" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 28.0" "Region enriched" "Detected in many" 16 "olfactory region: 206.6" "Group enriched" "Detected in many" 6 "olfactory region: 80.6;pons and medulla: 17.5" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favorable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 37.2 8.0 4.6 2.8 7.5 3.3 59.9 2.4 28.5 4.0 6.5 13.7 1.0 2.3 3.1 3.2 2.5 5.0 4.5 7.0 7.0 12.2 4.4 1.9 3.8 3.6 6.6 3.5 3.4 3.3 2.7 4.2 1.4 5.6 1.9 2.1 2.6 4.6 1.8 2.0 1.8 1.4 2.9 9.9 2.0 2.5 6.4 4.8 2.2 8.9 4.9 1.9 4.7 8.5 7.0 10.4 5.9 0.8 1.3 6.4 2.6 28.0 10.7 2.0 0.4 5.5 2.5 0.2 1.7 3.3 3.8 5.2 3.7 7.7 1.2 4.5 4.4 0.0 5.0 10.7 2.2 2.2 10.5 13.5 4.3 4.2 17.4 1.4 2.9 4.7 2.5 0.9 5.9 2.3 2.5 5.5 7.7 0.0 0.4 2.1 16.4 2.7 9.5 7.9 5.9 3.1 8.4 0.0 12.4 3.6 2.2 1.1 12.2 2.8 1.6 12.7 2.1 1.9 11.2 1.4 0.7 3.7 3.5 2.7 0.2 3.0 2.6 8.7 16.2 4.5 0.0 0.8 5.9 6.3 0.6 2.3 4.9 5.0 6.4 3.5 7.0 4.8 3.6 1.2 1.3 0.3 10.4 5.6 2.6 4.6 7.5 2.4 8.5 7.0 12.2 6.6 3.5 5.6 4.8 3.0 2.4 14.3 22.9 13.9 1.6 2.2 7.6 10.7 7.9 29.6 0.0 1.7 11.6 91.4 24.0 11.3 1.7 0.0 50.2 7.5 17.3 30.7 5.7 2.9 30.9 4.8 17.9 4.9 4.8 7.5 4.0 28.4 32.1 29.7 4.9 7.0 39.2 7.0 3.5 22.5 2.3 12.9 29.9 11.1 21.2 11.2 2.6 11.4 8.0 39.6 NME1 "NDPKA, NM23, NM23-H1" ENSG00000239672 "NME/NM23 nucleoside diphosphate kinase 1" P15531 17 51153536-51162428 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008467, CAB040571, HPA041113" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 28000000 Cytosol "Nucleoplasm, Plasma membrane" "CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305" "unprognostic (2.24e-1)" "unprognostic (2.01e-1)" "unprognostic (3.48e-3)" "unprognostic (5.96e-2)" "unprognostic (9.71e-2)" "unprognostic (2.33e-3)" "prognostic unfavorable (2.60e-5)" "unprognostic (4.54e-2)" "unprognostic (3.35e-1)" "unprognostic (2.33e-3)" "unprognostic (2.90e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.07e-9)" "unprognostic (9.01e-2)" "unprognostic (1.51e-1)" "unprognostic (1.83e-1)" "unprognostic (9.46e-2)" 25.0 29.5 38.0 28.1 30.1 27.9 29.0 19.6 41.9 16.4 25.4 13.1 10.1 15.1 17.3 22.5 30.1 22.2 13.4 14.1 41.7 39.4 19.6 56.0 14.2 28.5 34.2 34.2 15.6 43.6 13.7 17.3 16.9 38.9 14.5 36.8 14.9 34.3 14.7 14.8 22.4 12.4 29.6 20.5 22.4 13.4 11.6 11.3 19.0 18.8 32.7 41.4 22.8 15.2 24.9 36.2 0.6 19.5 17.2 20.3 18.4 46.6 93.2 32.2 44.9 13.5 21.6 54.1 36.4 25.3 75.5 57.3 73.3 28.3 82.1 38.0 33.6 30.0 25.1 61.5 61.9 64.6 39.8 82.8 53.8 72.4 101.8 27.4 59.0 24.7 20.5 39.0 56.8 53.2 13.3 45.5 26.4 79.4 27.3 44.7 79.0 70.1 67.8 38.6 103.3 85.0 43.0 63.6 75.6 57.9 32.6 44.7 51.5 19.1 52.3 33.9 28.8 54.4 39.9 28.6 48.7 44.2 30.3 74.7 35.2 81.2 96.7 29.5 50.1 37.0 0.2 15.2 0.6 13.4 19.5 20.3 24.9 14.4 14.6 36.2 17.3 16.4 17.8 0.4 17.2 11.5 20.7 12.1 18.4 38.0 30.1 19.6 41.9 41.7 39.4 34.2 34.2 38.9 11.3 29.8 22.5 33.5 67.6 117.7 287.4 27.7 63.7 36.1 59.1 68.0 269.0 166.3 127.6 180.3 23.8 58.6 14.6 46.7 172.7 210.0 82.7 60.4 46.0 102.6 183.6 38.1 86.1 27.0 26.9 65.0 56.7 62.9 123.2 55.9 70.8 61.6 165.1 38.6 55.2 140.8 268.7 12.9 66.0 19.8 83.3 116.3 74.0 40.6 110.8 81.0 NMRK1 "bA235O14.2, C9orf95, FLJ20559, NRK1" ENSG00000106733 "Nicotinamide riboside kinase 1" Q9NWW6 9 75060573-75088217 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 102.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 29.9;Karpas-707: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049795 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA049795: AB_2680886" "unprognostic (1.12e-1)" "unprognostic (4.13e-2)" "unprognostic (3.58e-2)" "prognostic favorable (3.70e-6)" "unprognostic (3.56e-2)" "unprognostic (2.35e-1)" "unprognostic (5.20e-3)" "unprognostic (2.21e-2)" "unprognostic (3.27e-2)" "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (1.78e-1)" "prognostic favorable (5.60e-4)" "unprognostic (9.25e-2)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "unprognostic (5.64e-2)" 15.5 7.7 11.1 15.9 10.7 6.9 14.3 21.5 14.6 13.2 15.2 5.8 20.1 12.2 8.1 15.6 24.6 9.4 10.9 9.4 10.2 9.7 22.1 40.3 15.4 19.9 10.8 9.7 15.2 30.6 45.8 18.1 19.7 10.2 15.9 10.3 10.9 29.5 17.7 15.0 15.6 26.6 8.3 8.7 18.8 13.6 6.7 8.9 14.4 31.6 11.2 22.0 12.6 14.8 6.7 8.8 7.3 6.7 8.2 24.2 10.1 5.1 1.1 1.5 3.5 12.2 16.5 8.3 7.5 11.8 1.9 3.1 0.0 13.6 3.0 4.5 7.2 3.6 9.0 1.7 5.0 6.0 29.9 1.8 2.1 2.4 2.6 10.9 2.0 0.4 11.4 12.9 3.1 6.4 11.4 13.0 5.2 0.2 36.8 13.2 3.8 1.9 1.8 1.9 19.4 4.7 0.6 13.5 19.3 15.3 9.2 1.0 0.2 3.2 3.3 4.2 10.3 8.5 2.2 8.9 6.5 1.2 5.9 2.0 16.3 13.0 1.8 10.6 2.2 6.6 7.3 2.7 4.5 13.9 2.5 16.7 6.7 24.2 16.0 3.1 3.9 22.1 16.7 5.2 8.2 6.7 8.8 15.4 10.1 11.1 10.7 21.5 14.6 10.2 9.7 10.8 9.7 10.2 8.9 35.7 17.1 17.1 33.3 18.7 8.5 15.1 15.3 20.1 22.7 22.7 7.9 52.7 44.7 25.5 14.0 20.7 33.3 0.0 31.3 65.3 17.5 21.3 1.1 34.4 51.6 11.1 4.1 39.3 19.7 24.5 21.9 10.5 25.3 102.8 28.0 9.6 23.2 24.6 11.7 75.6 7.6 12.9 15.2 6.6 3.8 23.6 38.1 29.9 22.4 26.0 NOC3L "AD24, C10orf117, FAD24, FLJ12820" ENSG00000173145 "NOC3 like DNA replication regulator" Q8WTT2 10 94333226-94362959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 70.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063958, HPA067638, HPA070981" Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331" "unprognostic (1.29e-1)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.49e-1)" "unprognostic (1.27e-3)" "unprognostic (4.58e-2)" "unprognostic (6.49e-3)" "unprognostic (3.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.34e-1)" "unprognostic (9.93e-2)" "unprognostic (5.50e-2)" "unprognostic (1.47e-2)" "unprognostic (3.24e-2)" "unprognostic (2.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.30e-1)" 16.7 13.2 9.2 11.2 14.5 3.7 14.4 10.8 12.7 13.5 8.9 6.0 8.4 6.7 14.1 8.5 14.3 12.1 7.3 8.8 9.3 6.6 11.0 15.0 9.7 14.9 16.4 7.7 15.4 7.8 12.5 18.2 11.0 14.5 12.5 8.2 6.3 9.7 8.9 18.8 11.6 8.4 9.8 16.6 19.8 8.1 14.1 13.1 12.8 15.7 13.6 16.0 16.1 10.6 13.7 4.3 0.5 4.1 7.5 5.8 3.1 17.9 9.8 6.7 21.5 7.0 11.4 7.9 14.4 11.4 19.8 23.0 16.7 12.7 19.5 10.6 7.2 10.2 13.0 19.0 8.6 32.1 13.3 14.2 13.2 8.2 10.7 14.0 20.9 6.0 6.5 8.5 20.8 21.0 12.9 8.8 7.3 20.5 9.9 19.4 6.0 13.1 15.6 14.1 10.5 10.9 5.9 15.3 10.7 11.7 5.6 4.8 11.9 10.3 5.2 15.9 7.8 13.4 8.1 8.5 12.7 12.8 11.5 24.1 9.4 18.8 27.1 11.6 20.3 9.4 0.0 2.4 0.5 4.3 3.9 5.4 13.7 4.4 5.4 4.3 12.6 5.8 5.1 0.1 7.5 4.1 3.8 4.0 3.1 9.2 14.5 10.8 12.7 9.3 6.6 16.4 7.7 14.5 13.1 17.9 10.7 18.7 20.6 21.1 20.3 20.0 10.2 28.1 47.8 21.0 7.9 18.3 21.6 16.6 2.2 24.1 2.0 0.0 11.8 11.5 13.4 12.0 28.8 9.2 11.3 12.7 5.2 13.5 14.5 3.6 17.0 13.1 11.8 25.2 6.0 21.0 12.3 2.9 23.3 18.0 20.6 12.9 21.8 59.0 70.2 19.1 12.7 13.8 8.6 13.5 NOCT "Ccr4c, CCR4L, CCRN4L, NOC" ENSG00000151014 Nocturnin Q9UK39 4 139015789-139045939 "Enzymes, Predicted intracellular proteins" "Biological rhythms" "Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.7" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 8.9;Cone photoreceptor cells: 13.7;Extravillous trophoblasts: 7.7;Syncytiotrophoblasts: 10.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012287, HPA053714" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA012287: AB_2668640, HPA053714: AB_2682238" "unprognostic (2.16e-1)" "unprognostic (2.16e-3)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-3)" "unprognostic (2.00e-3)" "unprognostic (3.24e-1)" "prognostic unfavorable (5.28e-5)" "unprognostic (1.86e-1)" "unprognostic (5.64e-3)" "unprognostic (4.63e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (3.52e-4)" "prognostic unfavorable (6.23e-4)" 17.5 3.9 3.3 4.9 8.0 38.7 7.4 3.2 7.3 2.7 3.1 2.7 0.0 2.2 2.8 1.5 4.0 2.5 7.9 5.4 4.9 3.7 6.9 25.8 5.1 3.1 3.0 3.1 1.7 4.4 4.0 4.7 9.3 3.7 2.0 2.8 1.8 10.8 1.4 12.0 3.9 10.5 4.5 2.3 3.2 3.0 4.9 2.6 3.7 2.9 11.8 3.9 3.7 4.6 1.9 1.5 6.3 3.1 1.4 2.4 0.2 4.7 5.5 2.2 4.1 5.0 2.1 13.5 7.1 5.1 10.1 7.3 7.3 2.0 15.8 5.7 5.3 14.3 3.4 11.4 6.2 9.6 7.0 4.6 7.3 3.3 6.4 4.5 10.7 4.3 2.4 3.1 11.2 7.6 2.0 4.4 3.2 13.1 5.2 4.5 5.4 7.3 5.6 7.0 2.1 5.9 6.0 6.4 5.6 6.8 3.1 8.2 5.5 4.5 5.1 4.0 8.9 3.7 8.3 6.6 5.5 7.1 5.2 8.4 4.3 4.0 10.0 5.1 21.2 6.9 1.5 1.4 0.8 2.4 1.5 1.4 1.1 1.1 1.3 0.6 1.9 0.8 1.6 6.3 1.4 3.1 1.5 0.7 0.2 3.3 8.0 3.2 7.3 4.9 3.7 3.0 3.1 3.7 2.6 8.9 0.6 0.0 2.6 0.0 4.7 0.0 2.5 1.4 1.2 0.0 13.7 4.3 1.7 1.9 0.6 0.0 0.3 0.0 0.2 7.7 0.5 2.0 2.3 1.5 1.4 1.6 0.0 0.6 2.2 0.0 0.9 0.7 0.0 0.0 0.1 0.3 1.8 0.0 0.0 3.1 4.6 0.0 0.0 0.9 3.2 0.0 10.1 0.0 0.0 1.7 NONO "NMT55, NRB54, P54, P54NRB, PPP1R114" ENSG00000147140 "Non-POU domain containing octamer binding" Q15233 X 71283192-71301168 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022069, HPA054094, HPA054559" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles" NA NA 150000 Nucleoplasm "Nucleoli fibrillar center, Nuclear speckles" "CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522" "unprognostic (2.39e-3)" "unprognostic (2.22e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (8.87e-2)" "unprognostic (5.54e-2)" "unprognostic (1.02e-3)" "unprognostic (9.34e-2)" "unprognostic (2.32e-2)" "unprognostic (1.41e-2)" "unprognostic (3.12e-1)" "unprognostic (2.07e-1)" "unprognostic (7.29e-3)" "unprognostic (6.79e-2)" "unprognostic (5.73e-3)" "unprognostic (2.76e-2)" "unprognostic (3.04e-2)" 37.2 55.9 30.2 37.7 30.8 51.2 37.2 54.8 38.6 45.4 33.4 36.0 38.4 29.9 52.4 40.5 41.0 40.5 37.2 30.5 27.5 29.0 40.1 43.3 37.3 45.7 28.8 31.7 69.2 61.0 39.4 48.2 42.4 27.5 40.8 37.5 42.5 39.8 41.4 37.2 38.4 35.2 40.5 38.3 45.9 40.3 34.4 29.0 98.4 51.0 39.1 57.4 43.6 36.8 44.1 47.3 35.3 51.8 45.4 51.8 58.9 59.7 66.1 91.5 50.2 37.3 38.6 50.1 49.0 45.6 66.3 58.6 52.4 44.4 68.0 54.6 45.1 45.8 44.7 136.6 42.6 73.1 51.7 91.2 55.8 69.4 52.2 31.7 78.1 49.0 40.8 30.4 67.1 45.0 55.0 54.5 49.3 71.1 71.3 61.2 53.0 101.1 71.2 114.0 60.3 53.7 90.9 96.0 58.3 50.9 52.9 63.5 78.9 63.5 41.5 56.3 55.5 39.0 50.6 50.0 42.9 64.5 60.0 56.7 41.2 77.9 77.4 32.1 90.9 61.4 35.3 44.8 34.9 45.8 47.6 51.8 43.7 46.6 44.9 47.3 44.1 50.8 50.2 20.8 45.4 51.8 41.2 50.1 58.9 30.2 30.8 54.8 38.6 27.5 29.0 28.8 31.7 27.5 29.0 71.5 74.4 79.8 78.6 112.2 63.2 53.3 94.3 53.5 84.2 41.8 39.3 104.8 48.0 113.5 9.9 89.5 55.4 70.0 96.7 148.6 89.4 78.5 84.5 108.5 99.0 50.9 134.1 70.0 136.1 12.1 98.7 83.7 54.0 104.6 95.9 77.6 111.2 84.2 120.2 93.8 45.1 64.7 107.2 22.8 62.3 107.0 108.8 84.7 122.4 84.4 NOP9 C14orf21 ENSG00000196943 "NOP9 nucleolar protein" Q86U38 14 24299862-24309124 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000850 Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA000850: AB_1078287" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (4.57e-3)" "unprognostic (1.85e-1)" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.69e-2)" "unprognostic (9.37e-2)" "unprognostic (7.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "prognostic favorable (9.39e-6)" "unprognostic (7.03e-3)" "unprognostic (3.80e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" 12.0 12.9 11.3 11.4 11.4 14.4 10.0 13.3 17.5 11.3 14.4 16.8 9.6 16.5 11.1 10.1 16.6 10.3 13.8 19.4 10.9 10.6 9.7 14.2 9.5 15.1 13.7 10.0 13.3 13.3 20.1 8.9 11.6 10.9 10.8 12.3 13.0 12.5 11.5 29.7 13.5 12.4 12.3 12.3 18.8 10.9 13.0 10.7 11.8 11.2 18.3 14.9 12.1 9.4 1.6 2.1 1.8 5.2 0.4 1.6 1.4 5.0 10.1 8.2 10.3 7.2 6.1 8.2 9.1 6.8 10.7 8.4 7.6 9.0 13.0 5.1 8.2 8.7 13.2 16.3 11.3 11.2 8.2 6.2 9.5 14.0 17.3 5.8 21.8 11.0 6.1 8.8 7.9 7.4 5.8 9.9 7.6 8.1 6.5 7.4 8.7 10.1 8.3 3.7 17.8 13.0 12.7 5.0 8.3 6.6 11.6 8.3 6.4 12.7 14.9 2.8 6.2 6.3 5.8 10.1 7.3 6.0 5.9 8.5 9.1 8.0 9.8 3.9 10.0 5.7 1.4 2.3 1.8 1.5 2.4 1.6 1.2 1.4 0.7 2.1 1.6 1.0 1.0 0.5 0.4 5.2 1.1 1.2 1.4 11.3 11.4 13.3 17.5 10.9 10.6 13.7 10.0 10.9 10.7 3.0 3.5 3.7 3.0 11.1 8.2 0.8 5.1 5.3 9.1 8.7 7.9 5.4 0.0 6.6 2.4 4.1 11.3 23.3 8.7 4.6 4.7 4.7 1.1 16.3 6.5 6.4 10.3 3.7 9.7 0.5 6.1 4.7 0.0 2.8 8.1 3.9 9.7 9.9 4.2 6.5 7.4 6.5 3.1 3.5 6.0 11.8 5.4 3.2 12.1 3.9 NOTCH3 "CADASIL, CASIL" ENSG00000074181 "Notch 3" Q9UM47 19 15159038-15200981 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Sertoli cells: 407.4;Smooth muscle cells: 286.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 10 "dendritic cells: 2.4;granulocytes: 1.0" "Cell line enhanced" "Detected in many" "AF22: 28.4;MCF7: 28.0;U-87 MG: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005393, HPA044392" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA 18000000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB005393: AB_2151246, HPA044392: AB_2678926" "unprognostic (4.97e-2)" "unprognostic (3.89e-2)" "unprognostic (7.06e-3)" "prognostic unfavorable (5.92e-4)" "unprognostic (9.20e-2)" "unprognostic (1.73e-2)" "unprognostic (2.72e-1)" "unprognostic (9.04e-2)" "unprognostic (3.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (3.13e-1)" "prognostic unfavorable (2.53e-7)" "unprognostic (3.35e-2)" "unprognostic (8.34e-3)" "unprognostic (4.40e-2)" "unprognostic (2.00e-3)" 35.9 3.7 4.7 6.4 6.4 0.5 53.7 2.7 7.5 25.9 7.3 6.2 9.2 3.7 22.9 23.1 33.8 14.6 22.7 25.0 4.6 3.6 9.2 1.6 16.2 11.7 5.0 6.4 14.1 6.9 10.1 4.9 37.3 6.4 13.4 3.0 8.3 11.4 11.4 16.6 48.3 6.2 11.0 2.8 11.8 5.5 10.1 3.9 44.4 14.9 36.7 10.3 14.9 24.6 0.1 2.4 1.0 0.1 0.1 0.1 0.0 5.3 3.4 28.4 12.9 4.0 3.2 12.8 4.3 0.2 0.2 0.1 6.5 5.6 0.1 3.3 7.9 0.1 6.4 5.1 0.1 0.2 0.0 1.3 0.1 5.3 1.4 2.0 0.0 0.5 3.7 3.1 6.6 0.7 0.2 0.3 1.9 0.2 0.2 0.5 28.0 6.4 0.0 16.6 4.6 0.0 0.0 1.6 0.1 0.0 17.2 0.8 9.2 0.0 16.2 0.0 8.8 17.2 0.0 0.0 0.8 9.3 0.1 0.1 0.0 0.3 0.0 19.9 0.1 0.4 1.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.0 2.4 0.0 0.0 4.7 6.4 2.7 7.5 4.6 3.6 5.0 6.4 6.4 3.9 8.9 1.0 0.0 6.5 21.4 0.3 21.8 0.0 0.0 9.1 15.7 0.0 16.8 5.0 12.3 0.3 7.4 0.0 0.0 0.0 3.2 12.6 12.2 0.0 0.0 2.5 0.0 0.0 3.1 9.7 0.0 8.3 3.7 16.9 1.0 0.3 0.5 1.2 0.0 11.0 0.0 0.6 407.4 286.6 0.7 1.1 63.1 26.3 0.0 0.0 30.2 NOVA2 "ANOVA, NOVA3" ENSG00000104967 "NOVA alternative splicing regulator 2" Q9UNW9 19 45933734-45973546 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.5" "Group enriched" "Detected in some" 11 "Bipolar cells: 50.9;Endothelial cells: 25.9;Horizontal cells: 20.6;Ito cells: 35.6" "Cancer enhanced" "Detected in many" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.3;HDLM-2: 8.8;HUVEC TERT2: 14.2;SH-SY5Y: 4.8;TIME: 21.2;U-2 OS: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045607 Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" No No "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "HPA045607: AB_10962628" "unprognostic (9.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.68e-2)" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (3.04e-3)" "unprognostic (1.46e-1)" "unprognostic (6.21e-2)" "unprognostic (2.36e-1)" "unprognostic (3.02e-3)" "unprognostic (6.42e-5)" "unprognostic (1.16e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (5.05e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-1)" "unprognostic (8.31e-2)" 11.8 4.5 23.9 2.7 22.7 1.3 5.7 13.0 33.5 3.9 2.5 7.2 0.0 2.5 5.6 2.7 2.4 3.6 4.2 5.8 17.1 10.9 3.2 2.7 9.4 2.2 7.1 17.3 2.0 2.5 3.3 5.7 9.7 11.1 2.6 2.4 2.5 2.4 3.1 5.5 2.7 2.0 5.7 5.5 2.4 2.5 4.3 8.7 0.0 4.5 0.4 1.8 3.9 3.5 0.0 0.0 0.4 0.1 0.4 0.1 0.0 0.0 0.1 8.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 1.1 0.0 0.0 8.8 0.3 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 4.8 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 5.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 23.9 22.7 13.0 29.3 17.1 10.9 7.1 17.3 11.1 8.7 0.0 0.0 0.0 0.1 0.6 50.9 3.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.3 25.9 0.0 0.0 0.2 0.0 0.4 0.2 0.0 0.4 0.1 20.6 0.0 35.6 2.6 2.4 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.4 0.0 3.1 0.0 0.0 2.3 1.9 0.1 0.0 0.0 0.0 0.3 NPNT "EGFL6L, POEM" ENSG00000168743 Nephronectin Q6UXI9 4 105894775-106004027 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 125.3" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 172.7;Alveolar cells type 2: 69.4;Club cells: 97.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 104.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 15.2;CAPAN-2: 9.9;HeLa: 17.2;Hep G2: 13.7;MCF7: 12.2;RPTEC TERT1: 20.0;T-47d: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003711, HPA050203" Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cell Junctions, Cytosol" "HPA003711: AB_1854591, HPA050203: AB_2681050" "unprognostic (1.24e-1)" "unprognostic (7.93e-2)" "unprognostic (1.59e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-1)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (7.85e-3)" "unprognostic (4.78e-4)" "unprognostic (1.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "prognostic favorable (8.28e-8)" "unprognostic (4.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (2.31e-2)" 5.4 1.6 3.4 2.4 4.4 0.0 8.3 0.7 2.5 13.3 11.0 1.9 4.2 16.4 8.7 11.4 5.7 5.9 19.0 2.5 2.5 2.7 22.7 1.3 34.9 0.9 7.5 2.4 4.1 11.6 0.0 14.6 3.0 2.2 26.3 7.6 16.9 2.8 5.7 2.6 2.1 37.7 4.0 0.9 4.4 4.0 3.0 2.8 3.4 125.3 3.7 2.3 3.7 6.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 15.2 0.1 0.0 0.0 0.0 7.6 9.9 0.1 0.4 0.1 0.0 0.9 3.8 0.0 0.0 0.0 3.9 0.4 17.2 13.7 0.0 0.0 0.1 1.7 1.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 12.2 0.2 0.7 0.1 0.0 6.2 0.0 0.0 0.1 20.0 0.8 0.9 0.3 0.9 7.4 0.0 2.3 26.8 0.6 0.0 0.3 0.2 0.2 0.6 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 0.7 2.5 2.5 2.7 7.5 2.4 2.2 2.8 172.7 69.4 0.0 4.6 1.6 0.2 2.0 33.1 10.7 97.8 31.4 0.0 2.2 1.7 19.0 11.6 8.0 8.0 0.0 2.1 0.1 0.9 29.6 0.0 0.0 0.3 0.0 15.0 3.1 0.0 11.8 2.3 1.3 5.0 0.0 9.2 0.0 6.3 3.1 0.0 3.0 0.1 0.0 33.5 0.5 1.5 1.0 1.3 0.0 6.9 2.8 NPR1 "ANPa, ANPRA, GUCY2A, NPRA" ENSG00000169418 "Natriuretic peptide receptor 1" P16066 1 153678637-153693992 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "cGMP biosynthesis" "Lyase, Receptor, Vasoactive" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 98.4" "Cell type enriched" "Detected in many" 10 "Ito cells: 136.2" "Cancer enhanced" "Detected in all" "ovarian cancer: 39.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "ASC diff: 60.5" "Region enriched" "Detected in many" 5 "olfactory region: 23.0" "Region enhanced" "Detected in single" "olfactory region: 11.1" HPA031087 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Plasma membrane" "HPA031087: AB_10601975" "unprognostic (2.54e-1)" "unprognostic (3.03e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.55e-1)" "unprognostic (6.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.03e-1)" "unprognostic (2.46e-1)" "unprognostic (3.27e-2)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (6.69e-2)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" "unprognostic (4.06e-1)" "unprognostic (1.74e-2)" 41.1 4.3 0.5 5.9 0.9 0.1 98.4 0.5 0.8 8.1 8.2 0.3 7.3 1.2 16.8 11.1 8.7 25.0 9.3 19.6 0.9 0.5 28.7 3.7 34.8 8.6 0.7 0.0 19.5 4.2 7.8 4.5 11.8 2.5 4.9 1.5 2.0 2.0 9.0 6.9 3.4 4.6 15.6 2.2 1.2 5.0 6.4 0.2 0.8 7.6 5.1 1.1 11.6 26.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 60.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.0 0.0 7.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.5 0.8 0.9 0.5 0.7 0.0 2.5 0.2 0.0 5.8 0.0 0.4 1.3 0.0 4.8 5.1 0.0 0.0 14.0 0.0 0.1 0.0 0.6 8.0 14.2 0.0 0.0 0.0 0.9 3.9 0.4 0.0 1.5 0.2 0.0 0.0 136.2 6.0 7.9 9.5 0.0 0.0 9.0 0.0 0.0 0.7 0.0 3.9 2.8 0.0 0.0 0.9 0.2 0.1 0.9 0.6 0.0 0.0 0.0 NPTXR ENSG00000221890 "Neuronal pentraxin receptor" O95502 22 38818452-38843982 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 73.6" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "GAMG: 11.4;SCLC-21H: 15.0;SiHa: 11.2;U-87 MG: 43.1" "Low region specificity" "Detected in all" HPA001079 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 280000 "Plasma membrane, Cytosol" Nucleoplasm "HPA001079: AB_1078414" "unprognostic (6.29e-2)" "prognostic favorable (3.93e-4)" "unprognostic (6.82e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.55e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (1.52e-3)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.49e-2)" "unprognostic (9.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.77e-2)" 2.3 3.8 39.1 1.8 17.5 0.8 1.9 16.2 73.6 5.8 2.6 4.3 0.5 1.5 5.6 3.3 2.7 6.1 2.0 10.5 57.4 15.2 1.3 0.8 1.7 1.6 5.6 20.7 6.2 3.6 5.9 2.0 0.9 4.5 6.2 1.7 1.0 3.2 5.6 0.9 1.2 1.4 5.7 3.3 2.1 2.0 1.6 4.0 0.0 2.5 0.0 1.6 2.5 1.9 0.3 0.2 0.6 0.2 0.6 2.3 0.4 0.4 2.9 0.1 0.8 6.0 0.6 0.0 1.9 0.4 3.8 1.3 2.9 0.6 0.0 3.5 0.5 11.4 0.4 0.8 0.1 1.3 0.2 1.0 0.0 0.1 4.5 0.6 0.0 0.1 1.9 0.1 3.5 0.0 5.6 0.1 0.0 3.6 0.1 0.1 4.5 0.0 0.2 3.5 1.4 1.0 0.7 0.0 7.0 1.0 8.1 15.0 0.9 11.2 0.0 0.3 0.8 4.8 1.1 0.2 6.9 4.2 0.0 0.3 1.0 0.0 0.0 43.1 8.7 3.5 0.5 0.2 0.1 1.8 0.0 1.3 0.1 1.0 2.3 0.0 0.3 1.5 1.2 0.6 0.6 0.1 0.2 0.0 0.4 39.1 17.5 16.2 49.0 57.4 15.2 5.6 20.7 4.5 4.0 0.0 0.0 0.0 1.9 1.0 5.4 14.2 5.1 2.7 3.4 3.5 2.0 0.0 0.0 5.7 1.6 4.2 0.0 0.0 3.3 0.0 0.8 4.6 0.0 0.2 0.2 0.0 1.7 5.5 0.3 0.4 1.7 0.3 1.7 0.0 0.0 6.5 3.1 0.0 2.1 0.5 3.1 0.0 2.6 0.0 0.8 0.9 0.0 0.0 0.0 3.3 NR2C1 "TR2, TR2-11" ENSG00000120798 "Nuclear receptor subfamily 2 group C member 1" P13056 12 95020229-95073703 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035040, HPA035041, HPA067767" Supported Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898" "unprognostic (2.44e-1)" "unprognostic (8.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.51e-1)" "unprognostic (3.56e-3)" "unprognostic (3.01e-2)" "prognostic unfavorable (5.18e-5)" "unprognostic (1.30e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-1)" "unprognostic (3.83e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (2.31e-1)" "unprognostic (1.42e-1)" "unprognostic (2.16e-1)" "prognostic favorable (5.62e-5)" 11.6 15.8 15.9 11.8 14.7 15.5 12.4 38.3 23.9 12.5 11.2 12.5 12.9 11.2 17.6 20.2 8.3 15.5 11.1 14.8 14.6 9.3 10.3 14.0 14.2 9.9 11.7 15.2 16.3 12.5 16.4 15.4 11.2 13.7 10.7 12.7 14.6 8.0 17.4 19.6 11.0 11.2 15.7 14.2 14.3 10.5 22.2 14.9 12.3 18.0 9.0 10.2 12.3 10.7 4.5 6.2 3.5 4.2 3.5 9.0 3.9 8.1 10.1 16.1 7.6 3.7 6.7 22.9 8.0 5.8 8.0 7.5 8.9 4.6 9.9 2.9 5.3 5.1 8.7 7.9 6.2 6.1 4.3 16.8 12.0 8.2 10.6 8.5 8.0 5.2 7.7 5.1 5.5 6.8 8.9 8.5 12.4 9.1 3.9 9.3 5.4 8.7 18.6 10.9 6.6 17.8 8.4 11.3 5.9 9.0 9.4 8.3 6.6 12.8 5.5 5.9 9.3 9.6 5.1 8.0 6.5 6.4 7.9 4.5 5.7 9.3 9.5 1.6 9.4 3.0 0.5 4.1 3.5 7.1 4.2 9.0 3.7 5.7 6.0 6.2 4.5 7.2 5.0 2.6 3.5 3.7 6.2 3.7 3.9 15.9 14.7 38.3 23.9 14.6 9.3 11.7 15.2 13.7 14.9 32.8 12.5 7.0 12.2 7.3 39.9 16.1 10.2 22.7 1.2 10.4 17.7 12.6 3.3 10.1 14.3 14.6 8.5 0.0 8.2 10.9 11.3 8.0 9.3 10.6 8.3 23.8 6.9 12.9 10.5 3.8 40.6 10.2 13.5 10.8 10.9 14.6 14.3 11.5 28.3 6.8 50.7 6.5 9.8 54.9 23.8 6.5 6.5 10.9 10.9 17.1 NR3C1 "GR, GRL" ENSG00000113580 "Nuclear receptor subfamily 3 group C member 1" P04150 5 143277931-143435512 "Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Receptor, RNA-binding" "Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004248, CAB010435" Supported Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "CAB010435: AB_2155784, HPA004248: AB_1078976" "unprognostic (1.38e-1)" "unprognostic (1.93e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.43e-2)" "unprognostic (2.74e-1)" "unprognostic (4.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.15e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.72e-6)" "unprognostic (9.06e-3)" "unprognostic (1.02e-1)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" 27.7 8.6 13.5 26.1 14.9 29.6 23.5 30.1 19.2 14.9 14.2 17.0 10.5 13.0 14.7 12.9 18.2 13.7 14.7 17.4 13.4 14.1 13.5 27.3 22.0 16.1 18.3 12.8 15.5 12.5 21.9 18.9 31.9 13.6 14.3 10.3 14.2 12.0 15.2 40.4 18.3 14.8 16.8 17.2 17.5 13.4 7.3 18.2 37.1 18.0 15.1 18.2 14.8 32.2 11.1 13.6 33.7 11.8 10.9 9.6 7.3 10.1 20.7 1.5 0.0 13.6 15.2 1.8 15.9 19.1 13.8 15.9 1.5 13.6 9.0 7.3 23.3 16.1 9.6 0.1 12.5 17.1 5.0 7.1 2.3 28.0 4.5 12.8 9.3 7.2 11.0 16.2 22.6 22.1 17.2 5.1 4.1 3.3 34.3 12.1 3.6 5.4 6.6 4.1 1.7 4.4 1.9 14.4 19.1 4.0 0.7 2.7 2.1 27.8 4.0 6.6 1.8 1.8 13.4 12.2 33.4 6.6 15.9 12.0 6.9 6.3 14.1 17.5 9.6 11.6 25.4 9.8 17.9 9.3 11.8 7.7 7.6 9.6 8.9 13.6 11.1 9.2 8.9 33.7 10.9 10.5 12.4 5.8 7.3 13.5 14.9 30.1 19.2 13.4 14.1 18.3 12.8 13.6 18.2 62.5 66.3 52.2 35.5 52.2 11.3 38.3 43.3 45.5 46.6 24.4 15.7 34.4 14.9 27.4 129.9 67.3 15.8 0.0 28.6 30.5 63.9 36.5 86.6 160.0 47.2 35.0 27.0 55.3 56.4 113.7 58.4 78.4 50.6 53.3 2.3 41.2 29.3 21.0 67.1 50.1 55.0 148.8 81.5 18.0 35.6 49.2 30.6 85.5 12.0 12.3 NR4A1 "GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3" ENSG00000123358 "Nuclear receptor subfamily 4 group A member 1" P22736 12 52022832-52059507 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 1121.0;granulocytes: 643.7;Smooth muscle cells: 682.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "intermediate monocyte: 18.2;non-classical monocyte: 24.4" "Lineage enriched" "Detected in many" 13 "monocytes: 24.4" "Cell line enhanced" "Detected in many" "HeLa: 25.8;MCF7: 29.4;SK-BR-3: 28.0;SK-MEL-30: 48.6" "Group enriched" "Detected in many" 5 "amygdala: 35.3;basal ganglia: 43.1;cerebral cortex: 77.4;hippocampal formation: 65.3;olfactory region: 79.3" "Low region specificity" "Detected in all" "HPA059742, HPA070142" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA059742: AB_2684119, HPA070142: AB_2732149" "unprognostic (2.40e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (1.74e-1)" "unprognostic (1.65e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-2)" "unprognostic (2.22e-3)" "unprognostic (1.90e-1)" "unprognostic (1.16e-1)" "prognostic favorable (6.99e-4)" "unprognostic (3.41e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-2)" "unprognostic (8.89e-3)" 69.1 111.3 4.0 58.1 12.9 5.7 25.0 5.4 10.9 32.3 23.3 21.1 46.0 5.6 49.8 33.9 28.1 63.3 99.9 76.7 4.8 5.0 17.9 12.1 50.1 8.3 7.5 5.9 177.3 16.1 28.9 51.8 7.6 13.1 88.3 13.8 43.7 66.8 203.2 32.3 23.4 24.3 98.4 6.8 5.1 32.8 11.8 6.4 11.9 34.7 35.8 14.9 71.4 54.5 0.4 1.8 0.2 24.4 0.1 0.2 0.7 1.9 9.7 1.9 3.4 1.4 0.4 7.4 1.8 3.6 1.5 2.1 9.5 1.8 2.0 0.8 3.2 1.4 1.0 5.8 0.8 0.8 0.1 2.0 2.7 25.8 2.6 1.4 1.0 9.1 0.3 1.1 1.4 0.1 1.0 0.4 2.1 2.6 0.5 0.1 29.4 0.7 2.8 5.3 3.0 1.0 0.9 0.3 4.8 0.0 0.7 1.6 4.8 6.0 28.0 48.6 1.3 1.7 3.0 0.0 1.4 4.7 0.9 1.5 16.5 7.8 4.2 1.0 0.8 8.1 0.1 0.6 0.0 0.1 18.2 0.1 0.4 0.0 0.0 1.8 0.4 0.2 0.0 0.2 0.1 24.4 0.1 0.1 0.7 4.0 12.9 5.4 10.9 4.8 5.0 7.5 5.9 13.1 6.4 223.4 1121.0 24.4 132.4 396.0 36.6 7.8 15.3 111.1 143.3 82.0 117.8 62.1 5.0 12.1 16.2 91.9 82.8 0.0 11.1 32.1 293.0 212.1 643.7 7.4 47.6 15.9 331.5 135.7 50.1 4.5 28.1 257.6 352.6 8.2 251.3 24.1 5.1 265.7 22.3 0.7 70.9 122.9 682.6 1.5 12.4 413.3 92.5 20.2 184.5 44.7 NR6A1 "CT150, GCNF, GCNF1, RTR" ENSG00000148200 "Nuclear receptor subfamily 6 group A member 1" Q15406 9 124517275-124771310 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.2" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 112.0;Spermatocytes: 68.9;Spermatogonia: 111.8" "Cancer enriched" "Detected in many" 16 "testis cancer: 27.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.6" "Cell line enhanced" "Detected in many" "BEWO: 47.8;CACO-2: 11.0;Hep G2: 10.7;K-562: 14.1;NTERA-2: 17.0;U-266/84: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031461, HPA045145" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA031461: AB_2673894, HPA045145: AB_2679233" "unprognostic (1.73e-1)" "unprognostic (6.66e-2)" "unprognostic (4.53e-1)" "unprognostic (1.34e-6)" "unprognostic (4.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.52e-5)" "unprognostic (6.31e-2)" "unprognostic (8.01e-3)" "unprognostic (2.71e-2)" "unprognostic (1.58e-2)" "unprognostic (1.63e-1)" "unprognostic (7.26e-2)" "unprognostic (7.20e-3)" "unprognostic (1.71e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-1)" 0.6 1.0 2.9 1.4 3.4 5.5 1.8 5.8 3.5 0.8 7.9 1.2 1.3 2.5 0.9 1.4 2.2 1.0 0.9 1.0 3.3 1.3 1.9 2.8 1.8 0.7 2.1 2.4 0.6 3.3 1.5 2.2 4.2 2.2 1.7 2.3 1.7 1.5 1.4 1.9 2.6 5.3 0.8 2.3 1.1 0.7 28.2 2.8 0.0 7.3 0.8 1.1 1.3 1.4 0.3 1.0 8.6 1.2 0.1 0.0 0.1 0.5 1.2 6.3 0.8 0.1 0.1 47.8 0.1 0.4 0.3 0.5 11.0 1.2 2.1 0.4 0.0 1.6 1.1 0.6 0.5 0.7 0.5 2.0 1.7 1.8 10.7 0.0 1.0 3.1 0.0 0.6 0.5 0.7 0.1 0.1 0.5 14.1 0.3 0.2 0.2 0.0 1.3 17.0 0.5 0.5 0.5 0.6 0.9 0.2 0.8 0.9 0.3 0.0 0.3 0.4 9.8 1.1 0.5 0.0 0.6 1.3 0.4 0.3 1.4 10.3 1.9 0.3 1.0 0.3 0.1 1.2 2.0 0.0 0.9 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 8.6 0.1 0.6 0.2 0.0 0.1 2.9 3.4 5.8 3.5 3.3 1.3 2.1 2.4 2.2 2.8 0.0 7.7 0.0 15.1 33.2 2.8 1.4 10.2 4.0 4.5 5.2 27.5 30.8 1.7 7.9 43.0 2.7 13.2 0.0 3.1 112.0 3.0 14.2 1.1 5.5 7.1 1.6 4.6 1.3 1.8 22.4 1.1 4.6 8.5 5.4 6.7 8.0 2.3 7.0 1.8 1.9 10.5 0.0 2.1 68.9 111.8 34.8 25.6 0.0 13.0 11.9 NRCAM "Bravo, KIAA0343" ENSG00000091129 "Neuronal cell adhesion molecule" Q92823 7 108147623-108456717 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.0" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 66.8;Cone photoreceptor cells: 96.2;Muller glia cells: 46.7" "Cancer enriched" "Detected in all" 7 "glioma: 57.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD8 T-cell: 5.5" "Lineage enriched" "Detected in single" 15 "T-cells: 5.5" "Cell line enhanced" "Detected in some" "A549: 26.4;AF22: 25.7;EFO-21: 47.9;HMC-1: 51.2;SH-SY5Y: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012606 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 70000000 Nucleoplasm "Vesicles, Plasma membrane" "HPA012606: AB_1854636" "unprognostic (2.66e-1)" "unprognostic (2.65e-1)" "unprognostic (2.52e-3)" "unprognostic (2.18e-2)" "unprognostic (4.08e-3)" "unprognostic (1.01e-2)" "unprognostic (4.47e-3)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "unprognostic (4.81e-2)" "unprognostic (9.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.22e-2)" "unprognostic (9.70e-3)" "unprognostic (6.42e-2)" "unprognostic (6.51e-3)" "unprognostic (3.28e-2)" 2.5 28.7 24.5 2.3 23.7 1.2 1.6 16.6 82.0 5.0 1.6 10.5 9.5 1.5 2.6 26.6 1.5 3.7 6.3 1.1 19.1 15.9 5.8 1.3 2.7 1.6 11.8 21.2 2.1 21.5 1.2 14.6 6.4 21.7 1.6 1.6 0.7 2.4 12.1 1.0 1.6 1.5 1.6 10.8 4.2 2.3 2.2 9.9 0.0 4.0 0.0 2.9 1.5 0.8 0.1 0.0 0.3 0.0 0.0 5.5 0.6 0.0 26.4 25.7 0.0 3.1 0.6 0.5 0.1 0.1 0.2 0.4 10.6 0.0 0.0 47.9 0.2 0.4 0.1 0.6 0.4 0.2 0.0 3.4 0.0 0.2 0.2 0.0 0.2 51.2 4.3 0.0 0.0 0.1 0.0 16.5 0.0 0.0 0.2 0.4 9.9 0.1 0.0 3.5 15.7 0.0 0.0 7.5 8.6 5.9 0.0 5.0 31.5 0.3 0.0 0.5 0.9 0.0 0.0 17.5 1.1 0.2 0.0 4.3 0.0 0.1 0.2 0.2 0.0 14.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.6 24.5 23.7 16.6 34.7 19.1 15.9 11.8 21.2 21.7 9.9 0.0 0.0 0.0 0.0 0.3 66.8 0.5 2.5 0.0 0.0 5.2 96.2 2.1 3.3 1.3 25.4 0.9 0.0 0.0 10.2 0.2 0.9 0.7 22.0 0.0 0.7 12.7 0.0 2.5 1.5 4.7 0.9 0.0 3.3 1.0 0.0 46.7 5.7 0.0 0.4 2.1 7.9 0.0 0.9 1.0 1.1 0.1 3.7 0.0 0.0 0.0 NRIP1 RIP140 ENSG00000180530 "Nuclear receptor interacting protein 1" P48552 21 14961235-15065936 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029785, HPA046571, HPA060036" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193" "unprognostic (5.60e-2)" "unprognostic (1.87e-1)" "unprognostic (5.20e-3)" "unprognostic (4.64e-3)" "unprognostic (7.98e-2)" "unprognostic (2.59e-2)" "unprognostic (2.74e-1)" "unprognostic (2.75e-3)" "unprognostic (8.94e-3)" "unprognostic (1.55e-1)" "unprognostic (2.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-2)" "unprognostic (6.53e-2)" "unprognostic (1.07e-1)" "unprognostic (2.72e-1)" "unprognostic (2.80e-1)" 29.0 15.0 10.8 12.6 7.5 19.6 18.4 20.8 10.5 23.1 21.2 6.7 8.5 14.5 16.6 13.4 13.1 18.8 9.0 11.8 9.3 5.8 16.0 22.7 9.3 8.9 5.9 7.3 14.4 15.8 8.3 11.2 16.8 7.2 13.9 15.8 12.7 10.3 7.7 36.5 7.6 30.3 17.3 12.9 17.0 8.4 6.8 7.7 22.1 7.3 12.4 5.9 13.0 14.9 2.6 1.7 0.5 1.4 1.2 5.6 0.7 9.7 20.7 16.3 0.0 8.2 5.3 5.8 11.6 5.2 7.8 5.9 3.8 7.7 0.0 6.6 11.0 3.6 5.1 1.0 6.9 15.7 0.0 4.5 14.7 7.2 11.9 4.9 7.4 3.2 6.5 9.7 8.0 9.4 8.1 5.7 2.2 10.4 8.1 5.1 5.5 3.4 0.0 6.6 3.9 6.2 41.5 12.8 0.3 4.5 16.9 1.4 0.0 9.6 5.1 3.9 13.3 12.4 5.6 9.8 6.3 4.2 9.8 4.7 3.9 0.0 0.0 13.8 0.0 3.2 0.0 1.4 0.5 1.0 0.8 5.6 0.9 1.0 1.1 1.7 2.6 1.7 0.6 0.3 1.2 1.4 1.7 0.5 0.7 10.8 7.5 20.8 10.5 9.3 5.8 5.9 7.3 7.2 7.7 44.7 32.8 11.5 54.8 16.6 33.5 15.3 17.8 18.7 61.4 27.9 47.1 13.0 8.3 20.2 11.9 25.5 34.2 0.0 23.8 109.4 21.7 35.8 29.1 42.3 36.7 20.6 36.1 28.3 37.6 14.4 34.8 26.2 8.5 33.3 38.8 58.9 25.8 40.3 25.5 33.6 60.2 32.3 17.0 9.3 2.3 16.4 11.8 7.7 42.0 78.2 NRIP2 DKFZP761G1913 ENSG00000053702 "Nuclear receptor interacting protein 2" Q9BQI9 12 2825348-2835544 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 48.5" "Cell type enhanced" "Detected in some" 16 "Rod photoreceptor cells: 9.2;Sertoli cells: 25.8;Smooth muscle cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039197, HPA039860" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039197: AB_10673416, HPA039860: AB_10794203" "unprognostic (3.28e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (8.05e-4)" "unprognostic (2.10e-2)" "unprognostic (8.11e-2)" "unprognostic (4.26e-3)" "unprognostic (5.66e-2)" "unprognostic (4.42e-3)" "unprognostic (2.89e-1)" "unprognostic (4.39e-2)" "prognostic favorable (8.69e-5)" "unprognostic (7.15e-2)" "unprognostic (2.82e-2)" "unprognostic (7.55e-2)" "unprognostic (5.23e-2)" "unprognostic (1.00e-1)" "unprognostic (8.97e-2)" 5.4 5.1 5.8 3.9 20.1 4.3 3.9 48.5 20.9 6.0 4.2 13.5 1.1 2.9 9.8 9.9 3.0 5.9 7.4 6.2 9.7 7.3 9.2 1.6 2.0 4.6 27.6 5.6 11.7 2.5 0.5 2.6 3.3 11.9 3.2 3.8 4.6 4.3 6.6 5.4 3.2 4.1 6.4 7.2 8.0 3.3 2.6 27.7 0.7 5.9 3.0 3.0 3.8 6.3 2.1 0.8 5.9 1.1 1.1 2.3 0.3 0.8 1.7 2.9 1.7 0.0 0.0 3.6 2.1 0.0 0.0 0.0 4.3 2.1 2.3 0.6 0.0 0.7 1.6 0.0 0.0 0.0 1.6 2.5 3.6 4.5 0.5 0.0 4.4 2.7 0.1 0.0 0.0 0.0 4.4 0.0 2.5 2.0 5.3 0.0 1.8 2.7 2.3 2.9 1.7 0.8 1.7 3.1 1.4 0.0 2.9 2.3 3.3 1.6 2.4 0.5 5.4 1.6 0.8 2.3 1.2 1.5 1.7 3.0 0.9 0.2 3.4 2.9 2.1 1.5 5.9 1.1 0.4 1.7 0.7 0.9 2.1 1.3 1.5 0.7 2.0 2.3 1.0 0.5 1.1 0.4 0.8 0.5 0.3 5.8 20.1 48.5 20.9 9.7 7.3 27.6 5.6 11.9 27.7 0.0 0.6 0.0 0.5 0.1 4.0 1.4 0.0 0.0 0.0 1.8 5.9 0.2 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 4.9 0.0 9.2 25.8 17.6 0.1 0.2 0.1 0.0 0.0 0.0 0.0 NRP2 VEGF165R2 ENSG00000118257 "Neuropilin 2" O60462 2 205681990-205798133 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Ito cells: 162.7;monocytes: 389.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;naive B-cell: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.5;HUVEC TERT2: 30.2;TIME: 28.8;U-251 MG: 58.9;U-87 MG: 27.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039980, HPA054974" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted in other tissues" NA NA 15000000 "Vesicles, Plasma membrane" Nucleoplasm "HPA039980: AB_10795517, HPA054974: AB_2682657" "unprognostic (4.28e-2)" "unprognostic (1.17e-1)" "unprognostic (8.12e-3)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (1.57e-2)" "unprognostic (9.36e-2)" "unprognostic (3.70e-1)" "unprognostic (2.15e-3)" "unprognostic (2.90e-2)" "unprognostic (2.56e-3)" "unprognostic (4.17e-1)" "prognostic unfavorable (7.68e-7)" "unprognostic (2.22e-3)" "unprognostic (5.45e-2)" "unprognostic (6.41e-3)" "prognostic unfavorable (7.80e-5)" 24.3 14.5 8.7 11.4 7.4 2.6 7.8 1.2 7.0 34.4 35.4 3.9 8.4 3.5 33.7 4.6 24.8 13.1 25.8 4.4 11.5 8.3 3.4 6.2 15.8 4.9 8.9 3.9 33.0 1.4 2.5 6.6 29.9 9.0 18.6 7.0 27.7 2.6 21.0 2.5 3.3 8.2 44.7 8.6 4.7 17.1 3.4 5.2 2.6 7.3 6.0 3.0 39.3 24.6 1.4 0.5 0.0 1.8 0.0 0.0 0.5 0.7 14.2 9.1 0.0 8.2 2.6 2.7 2.2 4.3 2.8 2.7 13.4 34.5 0.0 3.4 7.1 5.6 5.5 0.4 4.4 4.7 0.0 1.9 0.1 0.6 0.1 22.4 0.0 0.5 19.7 3.4 3.9 3.5 17.4 30.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 11.4 0.0 2.5 0.0 0.5 3.1 5.7 0.0 8.2 0.3 0.3 0.0 20.3 24.3 0.0 0.1 28.8 12.5 0.1 3.2 58.9 0.0 0.0 0.8 27.8 0.0 26.1 0.0 1.8 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.7 7.4 1.2 3.8 11.5 8.3 8.9 3.9 9.0 5.2 83.4 48.1 3.9 13.9 17.2 25.2 4.8 7.6 64.3 72.8 1.8 0.0 68.2 0.0 2.1 5.6 84.5 0.0 0.0 3.3 4.0 46.3 4.7 3.5 0.9 113.5 0.0 1.2 162.7 27.7 10.2 2.6 22.5 18.6 389.5 0.1 4.3 31.6 0.0 4.6 0.6 2.4 0.0 10.3 1.7 0.7 11.0 21.5 0.7 0.0 44.5 NRSN2 "C20orf98, dJ1103G7.6" ENSG00000125841 "Neurensin 2" Q9GZP1 20 346782-359660 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.9" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015967 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA015967: AB_1854647" "unprognostic (5.67e-2)" "unprognostic (3.47e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (4.05e-2)" "unprognostic (4.48e-2)" "unprognostic (1.48e-1)" "unprognostic (4.96e-2)" "unprognostic (5.92e-2)" "prognostic favorable (1.61e-4)" "unprognostic (6.96e-2)" "unprognostic (1.96e-3)" "unprognostic (2.94e-2)" "unprognostic (1.96e-1)" "unprognostic (7.85e-3)" "unprognostic (1.73e-3)" 8.4 18.6 34.3 6.0 39.3 0.9 7.2 22.7 70.9 12.8 6.6 11.0 4.9 3.5 12.5 16.0 6.1 13.4 9.3 13.5 31.1 24.9 10.1 1.8 8.7 4.1 17.1 28.5 18.3 10.5 26.5 16.3 10.1 27.8 12.2 6.1 12.8 13.3 16.5 1.4 5.0 3.8 16.3 8.7 5.7 5.3 12.8 6.8 1.3 14.9 2.5 4.2 9.4 4.8 9.4 4.8 1.5 1.1 3.4 3.9 1.5 18.9 23.0 13.9 13.1 18.4 20.6 5.4 12.6 24.3 22.9 23.0 12.6 0.4 0.0 4.4 23.3 16.8 8.3 11.2 1.9 14.6 0.1 11.3 6.8 11.0 24.0 18.6 0.2 1.1 23.3 1.5 16.3 2.7 18.7 15.7 0.1 13.5 12.3 20.0 3.3 0.3 5.8 10.7 0.2 11.9 10.8 7.8 0.9 22.8 0.1 28.4 20.4 15.0 4.4 21.5 9.5 18.4 7.1 10.4 24.5 13.0 0.9 15.3 2.3 0.4 5.1 3.2 0.2 12.9 0.0 1.1 1.5 3.8 0.3 1.1 7.2 1.1 3.9 2.1 9.4 1.6 2.7 0.0 3.4 0.4 4.8 0.9 1.5 34.3 39.3 22.7 70.9 31.1 24.9 17.1 28.5 27.8 6.8 0.0 1.9 0.0 3.1 2.9 24.5 4.0 0.0 2.7 7.9 12.2 2.0 6.1 1.7 11.0 5.5 4.5 1.3 0.0 1.4 5.3 10.8 2.5 4.7 0.4 2.7 15.9 28.3 4.3 1.2 10.0 12.0 1.2 3.3 3.6 2.7 12.3 3.8 1.9 9.9 5.7 12.7 19.4 9.2 21.3 6.6 1.9 3.7 1.0 2.0 2.7 NSFL1C "dJ776F14.1, p47, UBX1, UBXD10, UBXN2C" ENSG00000088833 "NSFL1 cofactor" Q9UNZ2 20 1442162-1473842 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047108, HPA050628" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No 920000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA047108: AB_2679935, HPA050628: AB_2681194" "unprognostic (7.55e-2)" "unprognostic (5.26e-2)" "unprognostic (2.51e-2)" "unprognostic (2.47e-1)" "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.10e-2)" "unprognostic (1.59e-1)" "unprognostic (4.67e-2)" "unprognostic (2.58e-1)" "unprognostic (4.97e-2)" "unprognostic (6.90e-2)" "unprognostic (5.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.44e-2)" "unprognostic (7.50e-3)" 15.7 22.7 20.2 10.2 23.5 15.8 15.3 18.2 26.5 16.6 14.7 17.1 9.3 11.1 17.4 21.2 19.8 19.9 12.2 21.9 16.7 18.2 14.8 19.8 12.7 9.6 17.1 22.4 22.7 10.8 12.4 9.9 21.5 24.2 16.8 13.9 20.1 13.6 21.8 49.7 25.6 12.4 18.9 15.8 12.2 12.6 11.1 15.3 12.8 13.1 14.8 12.4 15.9 13.7 14.5 12.0 32.4 10.9 5.9 11.0 9.4 21.3 24.8 15.9 15.1 14.4 13.4 11.8 10.0 18.0 24.5 18.2 20.9 17.4 11.9 8.1 18.1 23.3 20.3 9.7 26.2 18.9 4.4 10.6 12.0 4.4 24.0 15.2 11.6 7.3 11.4 9.6 25.5 8.5 14.2 17.4 8.6 15.5 10.7 17.1 10.2 12.1 22.2 17.1 16.5 27.5 5.8 19.8 11.6 28.5 15.0 9.2 11.3 12.1 24.1 10.9 9.7 14.7 8.0 16.1 19.0 14.0 11.0 16.3 8.6 15.3 9.9 14.1 16.3 13.4 10.7 8.9 32.4 8.5 10.6 8.5 13.9 9.2 8.3 12.0 14.5 10.5 9.2 29.1 5.9 10.9 9.5 11.0 9.4 20.2 23.5 18.2 26.5 16.7 18.2 17.1 22.4 24.2 15.3 20.8 21.0 25.3 52.2 79.2 58.7 30.5 20.4 25.4 30.7 29.6 21.6 128.5 48.0 77.9 14.8 36.0 52.0 0.0 82.5 121.5 43.5 44.6 39.3 35.8 71.3 66.7 41.9 25.2 37.6 26.4 36.2 39.7 40.5 47.7 29.3 44.2 95.4 52.6 43.5 54.7 37.5 77.6 53.6 80.7 105.4 66.1 126.8 34.5 37.5 81.7 NT5E "CALJA, CD73, eN, eNT, NT5" ENSG00000135318 "5'-nucleotidase ecto" P21589 6 85449584-85495791 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3" "Group enriched" "Detected in many" 47 "B-cells: 19.9;T-cells: 17.3" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017357 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1600000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017357: AB_1846330" "unprognostic (1.92e-2)" "unprognostic (4.44e-3)" "unprognostic (1.54e-1)" "unprognostic (1.57e-3)" "unprognostic (9.33e-2)" "unprognostic (1.82e-3)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.49e-2)" "unprognostic (2.26e-1)" "unprognostic (2.78e-1)" 12.2 3.2 9.3 7.7 11.6 0.5 16.6 1.1 6.9 58.8 13.9 3.6 8.1 18.6 33.3 14.8 7.6 12.2 15.4 6.1 5.7 5.5 8.8 26.0 3.4 6.8 6.3 6.6 25.4 1.4 1.6 9.3 42.2 5.3 16.4 15.6 15.3 4.6 17.8 5.7 4.5 14.9 35.3 6.3 7.0 6.0 12.4 4.2 1.6 26.5 7.3 7.1 16.6 20.2 19.9 0.0 0.2 0.0 0.4 17.3 3.9 5.3 2.8 4.9 0.1 11.2 35.7 0.0 34.5 37.8 17.0 32.0 0.0 53.0 0.0 12.4 30.1 43.8 2.7 0.0 34.7 40.6 0.0 0.0 0.0 0.8 0.6 5.6 0.0 0.0 9.1 0.4 34.7 22.1 93.4 14.1 0.0 0.0 0.1 105.7 0.9 0.0 0.0 0.1 0.9 3.8 0.1 1.1 0.1 36.8 2.4 0.0 0.6 0.4 2.1 11.7 0.2 0.0 0.9 61.2 13.9 0.1 17.5 56.1 2.6 1.6 0.0 95.4 0.0 43.5 0.0 0.0 0.2 2.0 0.0 3.5 13.4 2.3 6.6 0.0 19.9 2.4 17.3 0.2 0.4 0.0 0.0 0.8 3.9 9.3 11.6 1.1 6.9 5.7 5.5 6.3 6.6 5.3 4.2 0.0 4.3 15.6 1.0 4.6 4.6 0.8 20.4 6.7 6.8 1.8 9.8 0.4 3.3 3.7 0.5 13.5 10.3 0.0 3.7 1.5 16.9 0.9 0.0 29.0 1.3 0.0 0.0 45.4 5.3 0.9 12.0 2.5 6.8 0.0 33.2 5.6 72.9 31.7 24.1 20.6 77.4 0.0 8.0 0.0 0.2 4.3 12.7 2.2 13.8 5.9 NUAK1 "ARK5, KIAA0537, NuaK1" ENSG00000074590 "NUAK family kinase 1" O60285 12 106063340-106140033 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.3;parathyroid gland: 18.6" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 46.0;Endothelial cells: 46.6;Ito cells: 119.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "AF22: 23.1;EFO-21: 23.1;RH-30: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057143 Approved "Nucleoplasm,Nucleoli fibrillar center,Microtubules" Yes No "Nucleoli fibrillar center" "Nucleoplasm, Microtubules" "HPA057143: AB_2683349" "unprognostic (4.20e-2)" "unprognostic (8.42e-2)" "unprognostic (3.71e-2)" "prognostic unfavorable (9.83e-4)" "unprognostic (4.13e-2)" "unprognostic (2.34e-1)" "unprognostic (1.43e-1)" "unprognostic (4.80e-2)" "unprognostic (9.91e-2)" "unprognostic (4.06e-3)" "unprognostic (3.29e-1)" "unprognostic (1.31e-1)" "unprognostic (1.93e-3)" "prognostic unfavorable (4.27e-4)" "unprognostic (2.31e-1)" "unprognostic (8.70e-2)" "unprognostic (4.47e-2)" 8.2 1.8 4.2 2.0 13.0 0.0 5.5 9.9 20.1 4.6 1.7 24.3 1.1 1.0 5.8 1.6 1.9 3.6 2.7 11.3 5.1 3.3 2.5 2.4 4.9 1.5 8.7 8.4 3.2 1.2 18.6 1.9 2.5 7.6 3.6 2.2 2.3 1.8 3.7 9.4 11.6 1.5 6.3 5.5 1.1 1.5 1.3 9.3 1.1 1.8 1.1 1.4 3.4 3.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 5.0 3.4 23.1 0.2 9.3 1.0 10.7 5.7 3.9 4.4 3.3 1.7 0.8 0.0 23.1 10.4 1.9 4.8 4.8 4.6 2.1 0.0 1.3 0.0 3.7 1.8 1.9 0.0 0.0 4.8 3.1 2.5 0.8 7.6 8.4 0.0 0.0 16.8 3.1 0.5 0.1 0.2 4.5 0.0 1.4 0.0 33.2 4.0 2.5 5.9 2.7 0.1 2.6 0.8 0.2 15.9 1.2 0.1 6.2 3.8 12.9 1.4 6.8 0.0 0.0 0.3 1.1 0.0 3.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.0 9.9 17.5 5.1 3.3 8.7 8.4 7.6 9.3 0.0 3.7 0.0 32.0 11.9 30.8 46.0 2.5 0.0 5.7 7.0 0.0 0.4 3.3 5.0 0.3 46.6 0.0 23.3 8.3 4.1 9.2 4.4 0.0 10.5 6.1 38.1 0.0 119.1 9.7 1.7 3.7 1.3 10.1 1.0 2.0 1.7 11.7 0.0 2.8 1.4 2.6 0.0 14.4 0.7 5.5 13.9 0.2 0.9 0.9 3.7 NUDCD3 "KIAA1068, NudCL" ENSG00000015676 "NudC domain containing 3" Q8IVD9 7 44379121-44490880 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019136, HPA019528, HPA019529" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374" "unprognostic (3.72e-2)" "unprognostic (9.28e-3)" "unprognostic (2.33e-2)" "unprognostic (2.05e-3)" "unprognostic (2.18e-3)" "unprognostic (2.05e-2)" "unprognostic (4.73e-2)" "unprognostic (2.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "unprognostic (5.62e-2)" "prognostic favorable (9.16e-4)" "unprognostic (3.51e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-1)" "unprognostic (6.50e-2)" 8.3 6.3 15.3 5.4 20.8 7.3 7.2 10.9 26.0 7.8 5.8 7.7 6.4 4.0 6.9 7.3 8.0 10.3 6.7 19.5 15.2 13.0 6.0 5.8 7.2 6.2 12.5 16.8 9.3 6.8 12.8 4.7 5.3 10.1 8.4 5.7 6.1 7.1 9.9 18.3 7.0 5.0 8.8 10.1 5.8 5.9 9.9 7.1 4.1 8.1 4.8 6.6 6.3 5.3 4.7 2.8 3.2 3.1 2.5 4.7 3.5 3.1 5.9 4.3 7.8 5.4 4.5 1.7 5.2 5.0 6.0 6.3 4.0 2.2 10.1 3.9 6.7 8.4 3.7 5.9 6.8 3.5 5.8 6.3 2.9 3.6 2.9 5.0 4.8 1.8 4.0 4.6 4.5 5.2 3.6 7.3 3.4 7.2 3.3 4.4 2.8 2.1 4.5 5.5 3.1 7.9 3.3 4.7 3.7 3.4 4.9 4.7 13.5 3.0 5.6 2.3 4.5 4.3 6.9 7.1 4.3 4.4 2.7 4.1 9.2 9.6 5.1 4.5 5.8 7.4 2.0 2.8 3.2 4.6 2.7 4.7 3.5 4.4 3.8 2.6 4.7 4.6 4.0 1.8 2.5 3.1 2.8 4.4 3.5 15.3 20.8 10.9 26.0 15.2 13.0 12.5 16.8 10.1 7.1 11.9 19.2 17.2 11.6 10.1 37.9 38.9 12.7 21.4 13.6 36.6 51.1 17.0 19.9 27.0 56.9 21.1 21.5 0.0 18.7 15.8 15.0 14.2 9.2 28.8 15.6 46.1 16.7 21.5 19.8 67.6 28.1 11.6 15.1 19.8 21.4 25.5 23.6 21.2 26.5 21.3 40.2 32.3 15.5 52.1 13.7 14.2 12.0 15.8 25.0 10.8 NUDT19 RP2 ENSG00000213965 "Nudix hydrolase 19" A8MXV4 19 32691961-32713796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042761 Uncertain Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA042761: " "unprognostic (1.20e-1)" "unprognostic (2.90e-1)" "unprognostic (2.35e-3)" "unprognostic (6.61e-3)" "unprognostic (2.62e-2)" "unprognostic (2.44e-1)" "unprognostic (6.18e-3)" "unprognostic (1.97e-1)" "unprognostic (3.14e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (2.81e-1)" "unprognostic (1.23e-1)" "prognostic favorable (1.35e-4)" 9.9 18.7 7.2 11.1 7.0 10.8 10.7 7.4 7.6 5.6 12.8 6.1 8.4 10.2 6.6 8.8 16.9 6.3 7.6 19.3 6.1 6.5 10.5 16.4 15.9 9.2 6.2 5.5 8.5 18.9 9.5 9.3 6.6 6.1 11.2 10.7 9.4 14.7 11.8 29.5 13.2 12.9 6.9 5.6 8.9 11.3 6.8 6.6 6.8 5.9 13.1 13.0 9.9 8.4 8.4 11.9 9.0 23.6 18.7 14.8 6.5 13.7 16.0 1.8 15.9 5.5 7.2 0.3 7.8 2.9 5.8 5.5 9.0 7.6 0.2 9.4 9.0 4.5 9.0 11.0 9.1 7.7 15.8 6.6 17.8 6.4 3.3 7.6 13.3 5.5 5.8 12.1 4.9 12.0 6.8 8.5 2.8 13.7 10.2 10.4 9.1 0.1 12.3 1.9 3.8 7.6 0.1 3.5 7.7 9.6 10.3 7.2 10.3 13.9 11.9 9.8 3.3 6.5 16.3 6.8 8.1 5.2 8.0 13.9 12.0 10.1 4.5 9.7 12.8 7.4 6.6 17.3 9.0 11.9 21.7 12.8 8.4 12.5 14.8 11.9 5.9 10.0 13.8 3.3 18.7 23.6 9.5 13.8 6.5 7.2 7.0 7.4 7.6 6.1 6.5 6.2 5.5 6.1 6.6 11.9 12.6 8.2 6.5 19.5 12.8 18.7 5.1 4.0 4.5 7.0 11.8 9.8 23.2 2.6 7.7 4.5 9.7 0.0 9.9 9.4 9.4 8.5 1.1 9.3 12.6 3.2 11.6 12.3 12.1 3.1 3.7 10.8 11.8 7.2 13.0 5.5 9.5 14.0 8.9 14.8 26.4 0.0 6.6 1.4 1.9 27.6 6.5 13.3 15.8 7.9 NUDT5 "hYSAH1, YSA1H" ENSG00000165609 "Nudix hydrolase 5" Q9UKK9 10 12165325-12196144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019827 Approved Approved Nucleoplasm,Vesicles,Centrosome NA NA 660000 Vesicles "Nucleoplasm, Centrosome" "HPA019827: AB_1854704" "unprognostic (2.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (3.77e-3)" "unprognostic (4.91e-2)" "unprognostic (2.54e-2)" "unprognostic (4.60e-2)" "unprognostic (1.32e-1)" "unprognostic (6.39e-3)" "unprognostic (2.06e-1)" "unprognostic (9.97e-2)" "prognostic unfavorable (7.14e-12)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (3.68e-2)" 19.6 22.0 17.4 18.6 21.2 13.5 20.2 15.4 21.4 16.7 20.4 16.1 15.2 17.3 10.0 16.5 25.8 16.3 12.1 10.0 16.2 14.3 26.0 57.1 16.8 22.7 21.7 12.8 12.5 16.9 19.1 35.7 19.9 18.5 13.4 24.2 13.2 16.7 19.7 5.1 20.6 15.9 11.6 17.9 22.4 14.1 8.0 21.5 28.2 19.1 16.5 29.5 16.2 18.6 22.4 45.9 50.1 19.5 16.2 37.0 20.4 35.6 26.3 31.5 29.3 30.5 30.2 27.9 26.4 16.9 31.1 33.4 37.7 34.1 35.7 23.0 21.4 19.5 35.9 43.9 40.9 28.7 29.2 42.9 29.7 32.3 55.4 31.8 19.7 20.9 31.7 24.5 33.9 17.3 24.1 39.7 57.2 39.7 24.4 28.3 32.7 36.8 23.1 27.4 57.3 16.4 33.7 11.4 41.4 29.1 12.3 15.2 22.8 32.0 24.7 36.7 38.5 42.3 20.3 24.8 13.3 25.5 37.0 32.3 20.6 36.2 48.0 27.9 25.7 9.8 8.1 19.1 33.5 22.8 19.5 26.2 22.4 24.6 26.8 27.0 18.3 17.0 23.0 50.1 16.2 14.8 45.9 37.0 20.4 17.4 21.2 15.4 21.4 16.2 14.3 21.7 12.8 18.5 21.5 23.8 37.8 33.5 51.1 38.1 19.2 2.8 25.5 60.2 39.8 22.7 15.7 73.5 63.0 74.1 27.1 31.4 34.2 23.3 72.2 127.8 35.8 30.5 31.1 116.5 105.0 20.6 36.8 40.5 41.3 6.6 36.5 39.3 28.7 110.0 34.5 32.9 64.5 28.1 27.3 95.7 22.5 32.3 25.6 20.2 27.5 52.9 48.6 51.7 51.0 40.6 NUF2 "CDCA1, CT106, NUF2R" ENSG00000143228 "NUF2, NDC80 kinetochore complex component" Q9BZD4 1 163266576-163355764 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 38.6;testis: 29.0" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 232.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059692, HPA076604" Supported Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA059692: AB_2684103, HPA076604: " "unprognostic (9.41e-2)" "unprognostic (2.61e-1)" "unprognostic (2.56e-1)" "unprognostic (5.32e-3)" "unprognostic (6.20e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.04e-5)" "prognostic unfavorable (9.16e-4)" "prognostic unfavorable (4.83e-4)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.75e-4)" "unprognostic (3.70e-2)" "unprognostic (0.00e+0)" "unprognostic (9.79e-2)" "unprognostic (7.88e-2)" "unprognostic (2.69e-1)" "unprognostic (5.96e-2)" 1.3 0.9 0.8 9.8 0.9 14.1 0.6 0.5 0.9 1.4 2.5 0.6 0.9 2.3 0.6 2.1 6.1 0.5 0.7 1.5 0.8 0.6 0.7 0.6 1.9 9.9 0.8 0.6 0.7 0.4 0.3 0.4 3.6 0.7 0.6 2.9 0.8 1.3 0.0 0.5 2.2 3.2 1.0 1.4 4.4 1.6 29.0 0.3 38.6 0.5 5.1 9.2 1.5 1.8 1.4 0.6 2.6 0.2 3.0 7.7 1.0 26.3 9.2 24.5 10.2 0.7 2.5 13.3 16.7 11.8 27.2 23.9 7.0 23.3 22.7 14.0 6.7 11.3 15.5 14.9 6.3 34.5 23.7 10.7 8.9 10.6 10.0 0.0 15.3 18.4 0.3 0.6 13.7 9.7 5.1 12.3 22.3 16.7 31.5 25.7 5.1 27.9 20.6 13.3 19.4 14.2 19.0 21.4 20.1 7.7 3.6 18.3 21.1 8.9 9.7 9.2 15.9 14.9 32.1 8.7 20.3 22.8 15.2 33.6 22.6 31.8 43.3 6.7 12.6 22.4 2.6 0.2 2.5 2.4 0.1 1.0 1.2 3.6 2.4 0.5 1.4 2.5 2.1 0.9 3.0 0.2 0.6 7.7 1.0 0.8 0.9 0.5 0.9 0.8 0.6 0.8 0.6 0.7 0.3 0.0 0.3 3.7 1.8 5.3 1.0 0.8 0.0 0.0 4.5 0.0 0.0 2.7 0.0 0.7 15.8 0.1 0.8 46.7 0.2 23.9 1.8 0.4 4.6 0.2 11.3 0.0 0.0 1.8 3.7 10.7 2.3 2.5 0.0 1.0 0.9 2.5 0.2 0.0 2.1 0.0 2.0 6.5 0.5 232.2 40.5 2.0 3.3 3.8 2.2 1.4 NUFIP2 "182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1" ENSG00000108256 "NUFIP2, FMR1 interacting protein 2" Q7Z417 17 29255836-29294118 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067443 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA067443: AB_2685841" "unprognostic (6.51e-2)" "unprognostic (6.96e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-2)" "unprognostic (3.38e-1)" "unprognostic (2.12e-1)" "unprognostic (4.94e-3)" "unprognostic (1.40e-1)" "unprognostic (3.79e-2)" "unprognostic (9.42e-3)" "unprognostic (1.60e-3)" "unprognostic (5.24e-2)" "unprognostic (1.28e-3)" "unprognostic (3.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.18e-2)" "unprognostic (6.04e-3)" 21.6 20.6 25.0 25.4 28.6 83.5 25.1 38.8 39.0 17.3 18.0 15.5 17.4 19.6 17.8 15.9 27.1 17.0 17.7 21.8 24.1 15.6 16.9 28.9 31.5 22.2 24.2 15.5 20.0 19.8 26.2 40.8 44.4 28.9 18.4 16.6 13.9 25.4 27.5 43.7 17.9 20.3 13.3 30.5 24.6 22.0 17.0 27.2 18.3 20.2 15.6 22.9 19.0 42.6 6.9 9.8 21.2 6.9 4.1 6.1 1.6 15.2 24.9 14.6 10.1 12.6 14.8 24.5 15.2 9.2 11.7 10.8 27.4 8.4 24.8 22.8 10.4 10.5 21.6 11.6 10.6 15.0 26.5 20.8 18.7 22.7 7.1 11.7 23.8 20.3 12.7 13.1 12.9 14.0 13.6 8.6 9.2 30.5 18.5 12.0 12.6 25.0 10.8 15.0 11.7 9.2 20.6 25.1 10.6 9.9 25.1 14.0 8.9 27.2 51.2 16.6 20.4 17.6 16.1 14.1 22.5 22.5 13.1 25.9 25.9 23.8 28.8 14.9 12.7 19.1 8.8 5.2 6.2 4.9 5.0 3.7 6.8 4.7 5.2 4.1 6.9 6.1 5.0 21.2 4.1 6.9 9.8 2.4 1.6 25.0 28.6 38.8 39.0 24.1 15.6 24.2 15.5 28.9 27.2 74.5 64.2 22.8 72.9 88.5 53.5 62.1 45.9 93.7 81.9 29.6 90.3 51.9 13.3 28.1 31.3 71.7 45.3 0.0 24.0 25.9 79.0 66.2 44.0 49.9 37.9 54.0 46.3 54.0 64.2 19.1 32.8 71.6 38.8 19.8 49.9 42.9 31.3 40.1 32.9 24.5 57.0 19.4 63.4 26.4 24.5 85.4 152.2 34.6 41.7 98.3 NUP107 NUP84 ENSG00000111581 "Nucleoporin 107" P57740 12 68686734-68745809 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031679 Uncertain "Nucleoplasm,Nuclear membrane,Centrosome" NA NA Nucleoplasm "Nuclear membrane, Centrosome" "HPA031679: AB_2673992" "unprognostic (2.89e-1)" "unprognostic (3.32e-1)" "unprognostic (4.10e-1)" "unprognostic (5.43e-2)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "prognostic unfavorable (3.12e-9)" "unprognostic (4.03e-2)" "unprognostic (1.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.17e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.43e-2)" "unprognostic (2.05e-1)" "unprognostic (1.00e-1)" "unprognostic (1.96e-1)" 18.3 12.6 10.2 16.5 13.2 18.7 17.4 20.7 15.2 19.0 12.2 12.1 12.2 9.2 18.6 18.0 14.0 16.6 8.5 12.1 12.2 6.6 12.1 11.1 12.5 21.4 13.2 10.2 19.8 12.5 14.2 16.2 23.5 12.2 12.6 15.3 11.3 13.0 11.8 13.9 14.8 15.8 13.7 12.5 19.7 12.0 20.5 15.9 40.6 12.5 13.1 22.5 17.8 13.1 13.6 7.0 9.5 14.2 20.6 17.0 8.0 17.1 22.1 26.4 19.1 7.8 10.0 28.6 18.8 10.9 28.3 23.7 22.2 14.6 31.5 18.4 9.0 12.6 19.8 29.6 13.9 37.9 29.5 22.0 35.9 15.9 18.7 4.9 31.6 12.2 5.3 6.6 22.6 14.8 9.9 16.9 18.3 42.8 22.7 17.7 20.8 26.0 27.6 29.0 6.6 21.7 26.6 31.8 18.9 12.2 18.3 15.6 16.0 20.8 15.7 11.3 21.5 23.5 15.3 10.3 15.5 15.8 18.0 22.9 9.9 19.8 38.2 11.9 23.1 18.2 6.3 6.5 9.5 13.1 8.5 17.0 13.5 13.0 14.0 7.0 13.6 16.2 14.5 1.7 20.6 14.2 5.5 13.4 8.0 10.2 13.2 20.7 15.2 12.2 6.6 13.2 10.2 12.2 15.9 11.9 15.3 27.4 14.6 15.3 20.5 11.3 12.7 20.1 14.8 8.7 17.7 24.8 10.0 15.4 26.7 16.1 8.4 0.0 15.4 25.3 16.3 13.0 15.1 6.7 15.5 12.7 8.2 17.8 11.1 7.1 35.9 19.8 18.6 27.9 11.3 22.6 17.1 7.0 20.5 5.8 31.5 12.9 14.6 52.6 42.8 15.4 11.8 25.9 13.0 10.0 NUP188 KIAA0169 ENSG00000095319 "Nucleoporin 188" Q5SRE5 9 128947699-129007096 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.3" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Spermatocytes: 41.6;Spermatogonia: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061750, HPA063942" Approved Uncertain Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA061750: AB_2684602, HPA063942: AB_2685156" "unprognostic (4.64e-1)" "unprognostic (6.91e-3)" "unprognostic (2.36e-1)" "prognostic favorable (5.20e-5)" "unprognostic (9.50e-2)" "unprognostic (4.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.91e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (7.78e-2)" "unprognostic (4.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.68e-2)" "unprognostic (2.87e-1)" "unprognostic (2.81e-3)" "unprognostic (3.53e-3)" 10.2 11.1 7.6 12.6 9.2 14.3 14.0 13.3 8.7 9.2 9.3 10.1 9.6 5.8 9.8 6.7 16.6 8.3 7.6 9.2 5.6 6.3 8.1 9.6 13.1 16.6 6.5 6.7 10.8 13.3 12.6 13.6 9.1 7.3 9.5 9.3 11.2 9.9 8.3 10.9 16.4 9.0 11.0 7.7 12.2 9.5 60.3 7.3 26.5 9.2 11.3 17.3 8.5 10.5 6.1 7.9 6.3 10.7 6.0 12.0 7.0 10.9 21.0 17.4 23.7 13.2 13.1 15.6 15.4 12.2 28.3 18.9 25.3 8.8 19.2 5.8 16.9 18.3 32.6 39.0 19.1 21.2 15.4 18.8 17.1 39.2 19.9 8.4 29.2 17.3 9.1 9.0 29.7 15.2 8.3 16.2 25.0 37.5 13.7 19.9 27.8 24.9 11.9 23.3 21.1 20.2 22.9 37.7 19.6 8.7 12.4 24.5 11.8 39.9 15.2 5.9 13.4 16.7 10.8 13.1 23.5 16.7 23.6 27.5 11.7 21.6 26.0 13.7 18.7 17.3 6.3 5.3 1.9 9.3 10.7 12.0 6.1 7.9 9.0 7.9 5.9 8.1 8.6 0.8 6.0 5.9 3.3 9.5 7.0 7.6 9.2 13.3 8.7 5.6 6.3 6.5 6.7 7.3 7.3 0.0 13.0 7.5 5.2 5.8 14.9 2.7 7.6 4.0 2.3 5.2 43.2 6.4 1.7 5.5 10.1 6.8 3.2 0.0 5.6 5.9 6.9 7.5 5.8 3.8 7.4 19.1 8.7 12.9 4.9 3.1 8.9 7.2 1.7 4.6 6.7 7.5 7.5 0.0 11.0 1.9 25.0 25.8 4.2 41.6 37.7 9.8 7.2 7.0 6.0 7.2 NUP214 "CAIN, CAN, D9S46E, N214" ENSG00000126883 "Nucleoporin 214" P35658 9 131125561-131234670 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 131.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 225.7;Kupffer cells: 255.0;Late spermatids: 282.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 43.7;neutrophil: 131.5" "Group enriched" "Detected in many" 5 "granulocytes: 131.5;monocytes: 43.7" "Cell line enhanced" "Detected in all" "K-562: 73.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048789 Approved "Nucleoplasm,Vesicles,Focal adhesion sites" NA NA 100000 Nucleoplasm "Vesicles, Focal adhesion sites" "HPA048789: AB_2680521" "unprognostic (1.30e-1)" "unprognostic (9.51e-3)" "unprognostic (9.92e-3)" "unprognostic (1.15e-1)" "unprognostic (7.42e-2)" "unprognostic (8.31e-2)" "unprognostic (1.07e-3)" "unprognostic (2.10e-2)" "unprognostic (3.35e-1)" "unprognostic (4.95e-1)" "unprognostic (6.60e-3)" "unprognostic (1.08e-1)" "prognostic favorable (2.39e-5)" "unprognostic (5.49e-2)" "unprognostic (6.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" 16.9 10.3 11.5 13.8 13.9 29.4 12.9 13.0 14.4 10.2 11.4 19.8 10.4 9.0 15.0 13.7 16.1 12.1 10.2 9.7 9.5 8.1 19.0 15.1 11.7 13.3 13.2 8.8 14.2 17.0 16.7 16.9 13.0 11.3 11.1 10.8 15.3 13.0 11.1 15.5 17.5 11.7 11.1 14.3 35.8 12.3 63.7 13.3 27.4 11.8 7.6 16.8 10.7 11.2 1.2 16.8 131.5 43.7 1.2 0.8 17.9 6.8 9.8 8.4 5.0 6.8 6.6 8.8 6.1 6.3 8.0 6.5 8.0 5.0 11.1 4.9 8.4 8.3 15.7 11.3 8.0 7.8 8.0 5.5 6.9 14.0 15.6 6.0 10.8 7.5 7.1 7.4 10.2 8.3 5.1 8.1 7.4 73.0 6.4 8.2 12.8 14.2 16.4 9.1 9.9 8.6 5.0 10.6 11.1 9.2 6.3 7.1 7.4 10.2 9.4 5.3 6.3 12.4 27.0 7.0 14.1 7.9 9.2 9.9 5.6 10.9 10.8 6.9 6.5 8.5 3.5 43.7 17.3 0.7 18.4 0.8 1.2 0.7 0.6 16.8 1.1 0.7 0.7 131.5 1.2 15.0 1.5 0.4 17.9 11.5 13.9 13.0 14.4 9.5 8.1 13.2 8.8 11.3 13.3 17.9 19.9 15.2 9.5 7.7 29.6 24.0 15.3 16.0 15.9 22.7 43.2 10.9 8.3 9.1 225.7 14.6 13.6 0.0 13.1 9.3 11.4 11.4 8.1 11.9 75.5 15.9 19.5 18.4 255.0 282.5 21.6 77.0 10.1 15.4 14.3 14.8 12.0 5.8 19.1 6.7 31.6 6.5 8.1 90.1 44.5 9.5 9.2 11.8 16.3 9.3 NUP35 MP44 ENSG00000163002 "Nucleoporin 35" Q8NFH5 2 183117513-183161680 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 6 "Early spermatids: 131.7;Late spermatids: 308.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018401, HPA018410, HPA018441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" No No "Nucleoplasm, Nuclear membrane" "Plasma membrane" "HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720" "unprognostic (6.18e-3)" "unprognostic (3.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.58e-3)" "unprognostic (1.37e-1)" "unprognostic (9.91e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (3.95e-1)" "unprognostic (6.21e-3)" "prognostic favorable (3.45e-4)" "unprognostic (2.32e-2)" "unprognostic (1.61e-3)" "unprognostic (1.78e-3)" "unprognostic (6.78e-2)" "unprognostic (3.47e-2)" "unprognostic (1.24e-1)" "unprognostic (3.96e-2)" 8.8 10.9 9.1 13.7 21.4 4.1 15.3 18.9 12.6 9.2 8.6 5.6 5.8 7.3 9.6 9.0 11.7 10.6 9.1 7.9 11.1 6.8 11.9 16.4 9.5 9.3 11.5 5.1 13.1 17.2 8.9 13.1 9.0 8.8 9.3 10.7 7.3 9.7 9.6 9.1 10.9 7.1 10.5 7.6 7.8 9.3 25.8 9.7 19.1 10.3 12.6 12.7 8.0 10.2 8.9 3.8 1.7 6.8 5.9 10.5 5.0 10.0 10.8 16.8 9.9 6.1 5.9 12.2 12.1 9.8 18.3 17.6 19.8 12.2 17.1 11.4 6.4 21.7 8.7 23.1 13.4 29.7 15.3 15.3 16.1 9.0 21.0 4.6 11.6 10.9 4.3 7.1 15.6 14.9 4.1 10.7 10.3 14.5 12.7 13.9 11.7 13.4 13.9 28.6 15.8 33.4 16.5 13.3 12.1 16.9 12.3 14.9 10.4 11.2 13.1 12.7 13.0 8.5 8.1 5.7 14.4 10.2 11.6 13.5 8.5 18.4 18.2 9.8 8.5 19.3 0.0 4.8 1.7 6.1 6.3 10.5 8.9 7.8 7.5 3.8 7.9 9.6 8.4 0.1 5.9 6.8 3.6 7.7 5.0 9.1 21.4 18.9 12.6 11.1 6.8 11.5 5.1 8.8 9.7 8.9 5.0 11.1 14.4 23.1 10.8 4.1 10.2 8.1 14.8 15.7 17.7 18.4 10.0 10.8 131.7 9.3 3.1 23.3 11.1 17.4 12.4 7.0 8.1 11.9 7.4 6.4 3.5 11.6 6.2 308.3 8.9 3.7 20.3 4.6 6.6 10.8 9.6 7.0 7.8 10.1 17.1 12.9 13.2 34.7 19.4 24.0 7.9 8.9 7.4 9.7 NUP43 "bA350J20.1, FLJ13287" ENSG00000120253 "Nucleoporin 43" Q8NFH3 6 149724315-149749665 "Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027126, HPA027291, HPA028500" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287" "prognostic unfavorable (2.08e-4)" "unprognostic (3.02e-1)" "unprognostic (3.86e-2)" "unprognostic (1.45e-3)" "unprognostic (2.29e-1)" "unprognostic (8.19e-3)" "prognostic unfavorable (7.13e-7)" "unprognostic (5.14e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-2)" "unprognostic (6.25e-3)" "unprognostic (2.02e-1)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" 16.9 14.2 12.7 15.2 13.8 7.6 19.6 15.6 13.5 20.1 13.1 17.9 18.3 12.4 18.4 11.5 17.4 13.1 9.1 14.7 10.9 10.0 15.7 13.7 12.6 20.3 15.2 9.2 15.7 22.6 14.1 13.2 18.8 12.9 16.6 14.1 17.7 14.2 14.2 20.0 18.7 16.6 16.2 12.1 22.7 14.4 13.8 16.4 28.6 18.9 12.1 24.2 18.4 14.2 10.6 8.1 5.1 8.6 6.1 9.7 3.3 9.0 15.8 13.9 21.8 8.9 11.2 21.8 15.7 9.0 15.4 19.5 22.6 8.5 26.1 16.8 8.6 14.4 14.5 23.8 13.8 26.2 12.2 16.7 29.9 16.8 21.0 6.1 30.6 19.5 6.8 7.3 22.4 14.3 5.8 12.1 15.1 30.5 14.6 12.8 9.7 22.0 12.7 12.2 10.3 9.4 21.6 19.2 8.7 10.1 12.6 5.7 9.6 18.7 11.9 6.1 12.0 12.7 13.0 9.4 12.6 13.7 17.9 23.9 9.0 18.3 28.0 11.2 21.3 17.6 4.4 8.3 5.1 6.3 8.6 6.6 7.3 7.4 6.2 4.2 10.6 7.8 9.7 3.3 6.1 7.2 8.1 7.9 3.3 12.7 13.8 15.6 13.5 10.9 10.0 15.2 9.2 12.9 16.4 3.0 5.6 6.2 4.5 7.0 11.7 12.6 10.2 2.7 4.5 3.5 5.9 9.5 3.3 7.6 27.2 5.3 3.4 0.0 6.7 10.5 4.7 5.3 0.0 3.2 6.7 6.4 9.8 6.2 10.3 58.0 9.5 6.0 8.5 10.0 5.8 11.1 5.5 0.0 9.9 3.8 9.5 12.9 8.2 4.9 10.0 7.4 5.5 6.9 7.6 5.6 NYNRIN "CGIN1, FLJ11811, KIAA1305" ENSG00000205978 "NYN domain and retroviral integrase containing" Q9P2P1 14 24398786-24419288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 45.9" "Cell type enhanced" "Detected in many" 5 "Club cells: 12.5;Ito cells: 16.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 26.6" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Lineage enhanced" "Detected in single" "dendritic cells: 1.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 9.1;HEL: 9.1;HUVEC TERT2: 22.7;RT4: 18.7;TIME: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018945 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA018945: AB_1859538" "unprognostic (9.41e-3)" "unprognostic (3.96e-2)" "unprognostic (2.02e-1)" "unprognostic (4.49e-3)" "unprognostic (5.08e-2)" "unprognostic (1.14e-2)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.44e-3)" "unprognostic (4.21e-1)" "unprognostic (1.01e-1)" "unprognostic (4.51e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (3.39e-1)" "unprognostic (2.43e-1)" 8.1 2.8 2.1 4.3 2.2 0.2 6.8 26.6 2.6 16.7 7.6 2.5 29.6 2.9 14.6 45.9 11.6 13.4 14.5 5.1 2.2 4.2 6.1 3.6 7.5 2.0 1.8 1.8 28.0 2.9 4.5 4.9 10.5 2.4 9.8 4.1 9.1 5.5 20.2 2.5 9.1 4.5 8.0 1.5 5.2 4.5 7.3 1.4 3.5 7.5 8.5 6.5 8.6 10.2 0.0 1.7 0.0 0.1 0.5 0.1 0.0 0.1 0.0 3.0 0.0 4.1 8.7 0.2 1.4 1.4 0.9 1.1 2.1 9.1 0.2 0.4 5.4 0.1 0.0 4.8 0.1 1.0 0.0 0.5 9.1 1.2 0.2 3.1 0.0 0.0 8.8 0.4 0.6 0.0 1.6 22.7 0.1 1.4 0.0 0.1 0.4 0.0 0.4 1.7 0.6 0.0 1.2 0.0 0.0 0.0 18.7 0.4 6.5 0.0 0.8 0.1 7.6 1.6 1.3 10.9 0.1 5.5 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 2.1 2.2 26.6 2.6 2.2 4.2 1.8 1.8 2.4 1.4 3.0 1.7 0.0 3.9 4.0 0.4 1.7 7.6 1.4 12.5 8.7 0.0 0.9 0.0 3.3 0.7 7.1 1.3 0.0 2.7 0.9 6.6 0.8 0.0 1.8 8.5 0.0 5.2 16.0 5.1 0.0 2.3 0.8 3.3 1.0 8.5 5.3 3.7 3.5 0.4 0.1 0.3 0.0 4.7 0.0 1.1 3.3 0.9 0.0 8.3 3.1 OAS3 ENSG00000111331 "2'-5'-oligoadenylate synthetase 3" Q9Y6K5 12 112938352-112973249 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 64.2;BJ hTERT+ SV40 Large T+ RasG12V: 70.2;GAMG: 31.4" "Not detected" "Not detected" "HPA041253, HPA041372" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" Yes No 21000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041253: AB_10794990, HPA041372: AB_10795590" "unprognostic (8.47e-2)" "unprognostic (9.13e-2)" "unprognostic (1.27e-2)" "unprognostic (4.39e-3)" "unprognostic (2.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.14e-3)" "unprognostic (8.06e-3)" "unprognostic (3.19e-1)" "unprognostic (1.73e-2)" "unprognostic (2.29e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.23e-5)" "unprognostic (4.25e-2)" "unprognostic (1.37e-2)" "unprognostic (3.29e-2)" "unprognostic (2.93e-2)" 36.9 4.9 5.1 11.2 5.4 18.3 7.0 2.9 5.5 10.5 6.8 5.5 3.2 7.3 10.0 11.8 17.9 4.2 9.4 6.7 4.5 5.3 10.3 7.1 19.9 13.3 5.1 5.1 6.1 3.2 3.3 4.6 19.3 8.7 5.6 6.9 8.9 24.7 3.4 3.3 6.0 9.3 8.3 6.2 22.0 9.5 3.0 3.3 21.3 9.9 6.7 13.5 9.9 8.2 2.6 4.8 10.1 14.7 5.0 3.8 3.9 6.3 9.5 0.0 1.5 0.3 1.4 0.8 1.2 8.3 64.2 70.2 7.2 5.8 0.4 2.3 2.9 31.4 5.5 1.2 7.8 5.4 4.7 0.3 4.9 4.4 2.3 1.2 1.7 2.7 0.5 2.5 9.1 0.5 1.1 3.3 1.3 0.1 1.0 0.8 4.1 2.7 0.9 0.5 11.7 5.6 3.9 3.4 0.1 3.0 17.6 0.2 0.0 5.8 2.2 5.7 0.0 7.6 0.5 2.2 1.7 1.2 1.5 2.6 0.5 19.2 0.1 1.4 4.8 5.2 0.9 7.9 1.6 2.0 8.6 2.5 2.6 3.0 3.0 4.8 1.3 2.2 2.6 10.1 5.0 14.7 0.2 3.8 3.9 5.1 5.4 2.9 5.5 4.5 5.3 5.1 5.1 8.7 3.3 3.0 4.6 2.4 4.8 3.1 0.4 1.7 0.0 0.0 2.3 3.5 0.0 4.0 3.3 10.8 6.1 13.4 4.1 0.0 8.6 15.8 5.4 6.5 1.1 1.5 16.5 0.0 1.7 9.2 4.7 5.9 9.5 6.6 1.7 6.4 6.3 4.4 14.5 4.0 14.2 2.1 0.2 0.0 3.1 0.5 0.2 4.1 1.6 4.6 3.7 25.3 ODF3L2 "C19orf19, FLJ40059" ENSG00000181781 "Outer dense fiber of sperm tails 3 like 2" Q3SX64 19 463346-474983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "skeletal muscle: 12.5;testis: 16.7" "Cell type enriched" "Detected in some" 5 "Late spermatids: 894.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.5;BEWO: 2.2;EFO-21: 3.1;HMC-1: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA067065, HPA067973" Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA067065: , HPA067973: AB_2685937" "unprognostic (3.75e-4)" "unprognostic (1.79e-2)" "unprognostic (1.83e-3)" "unprognostic (9.69e-3)" "unprognostic (5.88e-2)" "unprognostic (5.65e-2)" "unprognostic (9.32e-2)" "unprognostic (1.35e-1)" "unprognostic (2.34e-2)" "unprognostic (1.77e-2)" "unprognostic (2.13e-2)" "unprognostic (4.06e-2)" "unprognostic (2.02e-5)" "unprognostic (3.13e-3)" "unprognostic (8.99e-2)" "unprognostic (3.05e-1)" "unprognostic (1.99e-1)" 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.3 0.5 0.0 16.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 2.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 3.1 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.3 0.0 0.2 1.1 0.0 0.0 0.6 0.1 0.6 1.0 0.1 0.0 0.8 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 187.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 894.9 7.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.7 0.0 0.1 6.4 5.2 0.0 0.0 0.0 0.0 0.0 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121179 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 159.5" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 41.2;Horizontal cells: 36.5;Ito cells: 74.3;Leydig cells: 41.1" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 38 "classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 51 "dendritic cells: 5.1;monocytes: 5.0" "Cell line enhanced" "Detected in some" "HeLa: 25.5;MCF7: 21.5;NTERA-2: 28.6;OE19: 20.3;SCLC-21H: 41.3;SiHa: 34.2;T-47d: 53.0;U-2197: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" NA NA 130000000 Nucleoli "Nucleoplasm, Cytosol" "HPA057444: AB_2683443" "unprognostic (6.77e-2)" "prognostic favorable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 7.7 10.0 80.5 5.0 41.5 0.9 4.7 30.9 159.5 7.4 5.4 4.6 0.7 2.5 6.9 26.4 5.0 4.4 3.8 3.9 77.2 19.1 3.4 2.4 4.7 5.2 18.8 36.5 6.2 5.1 3.6 9.9 1.1 13.5 4.8 5.7 0.9 2.6 7.5 6.1 4.5 3.5 6.9 6.1 5.8 3.9 2.8 2.8 0.3 2.7 0.8 7.1 4.1 6.2 0.0 5.1 0.0 5.0 0.0 0.0 0.6 0.0 1.6 3.2 0.0 0.4 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.3 13.1 0.6 0.6 0.0 0.0 3.6 0.2 0.0 25.5 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 21.5 0.1 0.0 28.6 20.3 0.0 0.0 0.0 12.0 0.0 0.0 41.3 5.5 34.2 0.1 2.1 2.2 53.0 0.0 0.0 2.0 4.6 23.1 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 3.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 80.5 41.5 30.9 119.7 77.2 19.1 18.8 36.5 13.5 2.8 0.0 9.3 0.0 2.8 8.7 20.7 5.8 7.6 0.0 3.4 0.0 41.2 0.0 0.0 7.4 5.8 26.1 0.0 0.0 2.3 0.0 8.2 6.1 2.3 0.5 0.3 36.5 2.4 74.3 4.5 8.9 41.1 2.8 20.3 0.0 1.7 32.6 3.6 2.9 27.6 0.0 12.0 0.0 11.7 0.6 3.4 5.5 0.0 0.0 5.5 0.9 OLR1 "CLEC8A, LOX-1, SCARE1" ENSG00000173391 "Oxidized low density lipoprotein receptor 1" P78380 12 10158301-10172138 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;lung: 46.8;placenta: 53.4" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 386.0;Hofbauer cells: 209.3;Macrophages: 102.1;Syncytiotrophoblasts: 387.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 32.7;HaCaT: 17.2;HHSteC: 34.6;hTCEpi: 15.9;SiHa: 65.9;SK-BR-3: 26.2" "Low region specificity" "Detected in all" HPA050798 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1060000 "Nucleoplasm, Plasma membrane" Vesicles "HPA050798: AB_2756318" "unprognostic (2.30e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "prognostic unfavorable (8.24e-5)" "unprognostic (6.34e-2)" "unprognostic (6.07e-3)" "unprognostic (5.40e-2)" "unprognostic (2.64e-1)" "unprognostic (1.97e-2)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (4.94e-3)" "unprognostic (3.47e-2)" "unprognostic (1.48e-2)" "unprognostic (1.42e-1)" 2.0 1.9 6.0 14.1 10.3 10.6 2.0 1.3 10.2 1.9 0.5 21.3 0.0 0.8 1.0 0.9 0.5 1.2 3.9 1.1 8.5 6.7 6.9 1.8 46.8 0.5 16.4 4.4 0.4 1.6 2.8 1.9 53.4 12.3 1.4 0.7 0.2 2.0 0.7 0.4 0.5 0.8 1.2 28.5 0.6 1.4 2.8 10.5 0.0 1.5 0.0 0.6 4.3 0.4 0.5 5.9 3.3 1.5 0.3 0.3 1.1 1.8 0.1 0.0 0.1 0.0 0.0 4.5 3.1 0.5 2.0 0.7 32.7 0.0 0.4 0.0 4.2 0.1 17.2 0.0 0.1 1.3 0.0 0.0 0.0 1.6 0.0 34.6 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 65.9 26.2 0.0 4.9 7.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 1.5 2.7 0.2 0.2 0.3 0.3 0.3 0.2 5.9 0.5 0.3 0.3 3.3 0.3 0.4 0.8 0.2 1.1 6.0 10.3 1.3 7.4 8.5 6.7 16.4 4.4 12.3 10.5 26.8 30.9 0.0 0.2 1.3 0.4 0.0 2.5 12.0 7.9 0.0 0.0 386.0 0.0 0.0 9.4 1.2 0.0 0.0 0.0 8.5 1.3 0.0 14.0 0.8 209.3 0.0 0.0 0.0 21.9 7.6 0.3 102.1 0.0 36.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 387.3 0.0 0.0 0.0 OPRK1 "KOR, OPRK" ENSG00000082556 "Opioid receptor kappa 1" P41145 8 53225716-53251697 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.0;prostate: 6.7" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 7.3;Leydig cells: 4.4" "Cancer enhanced" "Detected in some" "prostate cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067549 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA067549: AB_2732770" "unprognostic (1.01e-1)" "unprognostic (1.17e-2)" "unprognostic (8.70e-3)" "unprognostic (3.73e-2)" "unprognostic (6.74e-2)" "unprognostic (2.22e-3)" "unprognostic (8.09e-2)" "unprognostic (9.71e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" "unprognostic (3.35e-2)" "unprognostic (9.54e-4)" "unprognostic (1.61e-1)" 0.7 0.7 15.9 0.3 18.0 0.4 0.3 2.2 8.8 0.4 0.4 0.3 0.0 0.4 0.4 0.6 0.5 0.7 0.4 0.8 4.5 6.2 0.3 0.5 0.8 0.4 1.7 5.8 0.4 0.3 0.4 0.8 2.8 3.1 6.7 0.4 0.0 0.3 0.4 3.8 0.4 0.5 0.5 0.5 0.6 0.3 2.8 1.6 0.2 0.9 0.0 0.3 0.3 0.1 0.2 0.8 1.2 0.2 0.1 0.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 22.1 0.1 1.2 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.0 15.9 18.0 2.2 8.8 4.5 6.2 1.7 5.8 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 OR1N2 ENSG00000171501 "Olfactory receptor family 1 subfamily N member 2" Q8NGR9 9 122553112-122554214 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" 33 "Cardiomyocytes: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "RT4: 1.1" "Not detected" "Not detected" HPA060968 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" Nucleoplasm "HPA060968: " 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OSBP OSBP1 ENSG00000110048 "Oxysterol binding protein" P22059 11 59574398-59616144 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039227, HPA043625" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039227: AB_2676401, HPA043625: AB_2678587" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "prognostic favorable (2.08e-5)" "unprognostic (7.80e-3)" "unprognostic (7.32e-2)" "unprognostic (2.79e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (7.42e-2)" "unprognostic (1.42e-3)" "unprognostic (1.22e-1)" "prognostic favorable (3.08e-7)" "unprognostic (1.25e-1)" "unprognostic (9.00e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" 15.6 36.6 12.3 10.6 16.3 13.8 16.5 14.7 18.0 16.1 18.8 13.7 35.4 17.3 15.9 19.9 15.9 13.8 19.5 14.7 10.3 11.6 26.3 54.8 12.9 9.7 12.4 12.7 16.6 30.2 31.4 14.7 29.4 17.9 16.1 17.3 12.6 27.7 26.2 32.5 20.9 22.3 15.1 9.5 12.5 19.1 11.3 12.1 18.8 19.6 12.5 13.8 16.7 13.7 4.6 7.9 3.5 3.1 4.0 6.1 2.1 17.7 14.9 11.1 14.9 26.2 24.6 12.2 14.5 18.9 17.5 15.8 16.8 18.1 18.0 19.5 16.7 21.5 18.7 20.4 19.3 19.8 17.3 9.4 12.1 11.6 11.3 28.1 15.4 24.0 18.8 24.1 16.4 43.4 18.3 18.7 16.9 20.7 16.8 15.5 8.2 14.5 11.4 12.6 26.1 14.7 14.1 17.8 12.4 20.8 20.7 13.1 9.3 17.2 21.6 19.8 16.0 30.2 9.9 20.2 15.0 10.5 22.4 9.7 23.5 19.0 18.3 16.9 11.2 12.0 3.5 3.1 2.8 5.9 2.9 5.5 4.6 6.1 4.6 3.2 3.4 5.6 4.7 3.0 4.0 2.5 7.9 2.6 2.1 12.3 16.3 14.7 18.0 10.3 11.6 12.4 12.7 17.9 12.1 23.8 7.0 11.2 14.5 35.1 21.6 29.9 33.1 20.1 17.0 26.2 21.6 11.7 6.6 12.1 7.6 17.2 30.7 0.0 16.0 10.9 16.4 26.0 27.6 56.3 13.4 25.4 28.8 10.4 12.9 10.6 14.7 12.1 13.5 3.6 35.0 16.7 18.6 22.9 18.7 17.9 19.4 6.5 13.7 21.8 13.2 41.4 25.7 10.2 25.1 19.0 OSBPL7 "MGC71150, ORP7" ENSG00000006025 "Oxysterol binding protein like 7" Q9BZF2 17 47807372-47821834 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 37.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 25.9;Mucus-secreting cells: 23.6;Paneth cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036076, HPA053083, HPA073967" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036076: AB_10601042, HPA053083: AB_2682038, HPA073967: " "unprognostic (3.88e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.55e-3)" "unprognostic (2.05e-3)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.08e-1)" "prognostic favorable (1.19e-5)" 4.1 3.4 9.0 9.6 13.4 7.3 3.9 10.7 11.9 6.8 16.8 12.0 7.5 24.6 6.7 3.7 2.8 6.1 10.5 4.6 9.7 7.3 7.2 1.4 6.3 7.9 13.9 9.8 7.4 11.4 5.3 7.8 3.2 10.3 10.1 10.3 7.7 8.8 10.1 20.2 1.9 32.2 6.2 6.6 12.3 37.9 1.4 16.4 7.9 8.4 2.9 8.1 6.8 5.2 2.6 2.9 1.7 1.4 1.1 5.5 2.1 3.8 4.6 2.0 2.3 2.2 3.2 1.7 1.5 2.1 2.5 2.9 4.6 11.8 3.9 5.8 2.1 0.9 28.9 1.1 3.1 0.8 13.1 1.6 2.9 8.6 3.0 2.0 6.0 0.1 5.0 0.6 1.6 1.1 7.9 5.1 6.9 2.8 5.4 3.9 5.0 6.0 6.4 1.2 15.5 5.8 5.6 3.1 5.4 3.4 3.0 2.0 4.8 2.4 0.8 2.2 2.6 4.2 3.9 5.9 3.9 3.4 0.0 1.2 9.9 3.6 3.8 4.2 5.1 1.4 0.0 1.4 1.7 5.5 1.0 2.3 2.6 2.2 3.1 1.7 1.4 1.6 2.3 0.9 1.1 0.0 2.9 2.7 2.1 9.0 13.4 10.7 11.9 9.7 7.3 13.9 9.8 10.3 16.4 0.0 3.8 4.5 1.0 0.1 5.7 2.8 2.5 1.4 7.9 3.5 5.9 0.2 0.0 2.4 0.0 3.7 25.9 0.0 13.3 0.1 1.5 2.4 2.3 0.4 2.3 11.1 5.8 5.5 2.8 0.0 2.6 0.8 1.7 1.0 23.6 7.7 6.3 26.8 2.5 0.8 7.7 0.0 1.0 0.0 0.2 0.1 0.5 7.2 13.6 0.5 OSCAR ENSG00000170909 "Osteoclast associated, immunoglobulin-like receptor" Q8IYS5 19 54094668-54102692 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2" "Group enriched" "Detected in some" 5 "Hofbauer cells: 36.7;Kupffer cells: 33.7;Macrophages: 28.2;monocytes: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 34 "classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2" "Group enriched" "Detected in many" 75 "dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6" "Cell line enhanced" "Detected in some" "EFO-21: 13.6;HHSteC: 9.3;hTERT-HME1: 4.9;NB-4: 5.4;U-937: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073996 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 72000000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA073996: " "unprognostic (9.09e-2)" "unprognostic (6.79e-3)" "unprognostic (8.47e-3)" "unprognostic (2.14e-1)" "unprognostic (2.12e-2)" "unprognostic (9.04e-2)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.05e-2)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.71e-5)" "unprognostic (1.84e-1)" "unprognostic (2.88e-2)" "unprognostic (9.69e-2)" "unprognostic (4.28e-2)" 4.5 1.0 1.4 3.8 2.8 18.9 1.4 0.4 1.5 1.3 0.9 3.5 0.0 0.4 0.7 1.3 1.2 2.2 2.3 1.1 3.8 1.9 1.0 1.7 40.4 4.7 3.5 0.4 1.2 0.7 0.3 0.5 2.2 4.0 0.8 0.7 1.0 1.3 0.8 0.7 1.9 1.0 2.8 5.6 20.2 1.3 0.6 2.4 1.7 1.0 0.0 1.2 1.7 3.1 0.0 9.4 18.3 20.6 0.0 0.2 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.4 0.0 13.6 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 9.3 0.7 0.0 0.0 0.2 0.6 4.9 0.8 0.0 0.1 0.0 0.4 0.1 0.1 0.0 5.4 0.3 0.2 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.6 0.5 16.8 0.0 0.0 20.6 11.7 0.1 12.8 0.0 0.0 0.1 0.2 9.4 0.0 0.0 0.0 18.3 0.0 11.2 0.4 0.1 7.0 1.4 2.8 0.4 1.4 3.8 1.9 3.5 0.4 4.0 2.4 3.0 5.1 0.0 0.5 0.7 0.0 0.3 2.5 6.7 3.4 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.2 1.1 0.0 36.7 0.0 0.0 0.0 33.7 0.0 0.0 28.2 0.0 39.7 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.6 0.1 0.2 0.0 0.0 0.3 OSCP1 "C1orf102, NOR1" ENSG00000116885 "Organic solute carrier partner 1" Q8WVF1 1 36415827-36450451 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 35.8;testis: 49.9" "Group enriched" "Detected in many" 5 "Ciliated cells: 144.6;Early spermatids: 336.5;Spermatocytes: 91.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028436, HPA052655" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA028436: AB_10600885, HPA052655: " "unprognostic (3.46e-3)" "unprognostic (7.57e-2)" "unprognostic (4.67e-2)" "prognostic favorable (6.88e-4)" "unprognostic (1.28e-2)" "unprognostic (4.81e-2)" "unprognostic (3.38e-2)" "unprognostic (4.52e-2)" "unprognostic (5.52e-2)" "unprognostic (8.80e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (1.02e-2)" "unprognostic (4.20e-2)" 3.9 5.3 6.2 1.5 14.0 1.2 6.0 3.6 12.7 6.2 3.6 6.5 7.5 1.8 6.3 14.1 3.2 35.8 5.5 4.7 6.5 8.9 11.9 1.8 6.7 1.3 4.9 5.3 5.9 6.2 15.7 15.7 8.9 7.8 6.4 2.5 6.7 5.3 6.8 2.4 3.4 1.3 5.0 3.2 0.9 3.5 49.9 3.2 1.3 11.1 3.5 2.4 3.2 2.6 0.8 3.8 0.3 1.7 0.3 3.1 0.8 5.2 5.0 6.2 7.1 7.4 7.2 1.1 3.2 7.8 7.9 5.4 0.1 4.6 1.1 6.0 5.7 5.8 4.1 0.2 6.0 5.1 0.9 4.7 0.0 3.3 0.5 9.1 0.6 0.9 8.1 9.8 11.1 4.9 11.5 5.4 5.0 0.1 1.3 6.2 3.7 2.7 1.9 6.3 2.0 2.1 2.9 2.5 0.9 12.9 1.8 16.6 7.3 5.9 2.8 4.1 6.1 6.1 0.9 4.6 5.7 2.1 10.3 5.3 2.3 2.3 0.5 11.0 0.1 3.8 0.0 0.7 0.0 0.9 1.7 0.0 0.4 0.9 0.7 1.8 0.8 2.2 3.1 0.3 0.3 0.2 3.8 2.2 0.8 6.2 14.0 3.6 12.7 6.5 8.9 4.9 5.3 7.8 3.2 8.9 7.5 0.5 6.7 1.3 5.3 4.7 5.1 144.6 19.4 12.2 15.7 9.8 19.9 11.2 336.5 2.4 0.7 0.0 8.1 2.6 4.1 4.3 0.0 1.9 3.8 4.8 4.7 2.5 0.6 35.1 11.5 1.2 3.3 0.0 2.6 12.3 7.9 4.0 8.5 18.1 18.9 0.0 3.3 91.2 18.9 2.8 16.8 0.7 2.6 3.3 OSTM1 "GL, HSPC019" ENSG00000081087 "Osteopetrosis associated transmembrane protein 1" Q86WC4 6 108041409-108165854 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Osteopetrosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Melanocytes: 143.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010851 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No 130000 Cytosol "Nucleoplasm, Vesicles" "HPA010851: AB_1079533" "prognostic unfavorable (4.36e-4)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (1.72e-3)" "prognostic unfavorable (4.26e-4)" "unprognostic (9.40e-2)" "unprognostic (2.56e-1)" "unprognostic (2.25e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.34e-6)" "prognostic unfavorable (1.20e-4)" "unprognostic (2.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" 26.3 21.9 9.0 18.1 13.5 5.5 16.7 13.7 17.2 14.4 17.8 12.8 9.9 8.4 21.8 10.3 14.1 15.0 13.5 23.2 10.4 16.5 22.0 15.9 17.0 17.2 11.0 10.5 15.6 9.7 11.8 26.0 24.7 20.0 15.4 12.4 29.7 10.8 19.0 18.0 10.4 12.9 24.7 13.1 21.7 14.3 11.1 10.7 13.6 12.4 8.1 13.9 21.0 19.4 10.8 12.4 20.9 28.1 14.5 16.4 16.9 2.1 6.4 7.6 11.1 23.0 7.5 10.9 16.0 16.1 11.7 19.5 3.8 3.6 5.0 13.2 11.1 31.6 4.1 7.5 5.4 18.1 11.5 5.9 10.6 4.1 4.7 17.8 11.6 24.7 10.9 13.6 14.4 11.5 10.8 5.9 5.7 8.3 18.5 18.9 3.0 2.5 2.6 3.0 2.6 4.9 4.1 11.1 2.7 8.4 5.8 0.8 4.5 12.9 3.3 28.5 10.6 3.7 16.9 7.2 10.3 3.8 22.7 22.6 7.1 12.1 4.4 30.4 7.9 22.6 16.8 13.9 15.2 15.0 19.9 16.0 10.8 12.8 16.4 12.4 6.2 12.0 15.0 20.9 14.5 28.1 8.9 15.4 16.9 9.0 13.5 13.7 17.2 10.4 16.5 11.0 10.5 20.0 10.7 8.9 21.3 25.4 14.7 41.4 29.2 18.5 12.7 5.3 6.8 12.2 9.8 18.7 1.7 10.8 3.4 18.0 10.3 0.0 19.8 29.3 16.9 16.3 24.2 12.4 46.3 27.0 4.1 28.8 46.6 2.7 13.3 33.0 143.4 10.8 4.2 24.0 15.6 12.9 26.9 21.0 15.7 25.8 33.9 19.8 19.5 27.1 51.1 27.7 2.9 14.0 OTP ENSG00000171540 "Orthopedia homeobox" Q5XKR4 5 77628712-77639688 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 16.2" "Group enriched" "Detected in some" 8 "Sertoli cells: 6.5;Spermatocytes: 2.6" "Cancer enriched" "Detected in single" 6 "glioma: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.3;SCLC-21H: 1.6;THP-1: 1.5" "Region enriched" "Detected in some" 7 "hypothalamus: 23.4" "Region enhanced" "Detected in some" "hypothalamus: 24.0" HPA059342 Enhanced Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies" NA NA Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies" "HPA059342: AB_2732635" "unprognostic (1.00e-1)" "unprognostic (2.40e-2)" "unprognostic (6.25e-2)" "unprognostic (8.06e-3)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (7.77e-2)" "unprognostic (2.39e-2)" "unprognostic (9.66e-2)" "unprognostic (4.64e-2)" "unprognostic (7.76e-14)" "unprognostic (3.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.49e-3)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.2 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 OTUD1 "DUBA7, OTDC1" ENSG00000165312 "OTU deubiquitinase 1" Q5VV17 10 23439458-23442390 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.8;tongue: 61.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 124.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.3;HaCaT: 23.8;SiHa: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038503, HPA038504" Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA038503: AB_2676049, HPA038504: AB_10672712" "unprognostic (1.84e-1)" "unprognostic (2.80e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.56e-1)" "unprognostic (1.29e-2)" "unprognostic (3.18e-3)" "unprognostic (2.41e-1)" "unprognostic (7.77e-2)" "unprognostic (4.10e-2)" "unprognostic (1.80e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.61e-7)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-2)" 11.6 9.2 5.9 8.5 6.9 39.3 14.7 9.7 9.5 13.8 8.8 9.3 6.9 4.9 9.8 10.0 8.2 9.0 9.9 25.9 6.0 5.9 14.7 7.3 26.6 11.0 6.2 6.7 10.9 6.5 12.8 7.8 11.5 5.4 8.0 5.8 9.8 6.4 6.2 60.8 17.5 7.9 7.3 6.5 13.1 16.9 9.9 5.8 8.1 14.9 61.1 12.3 12.7 10.5 3.5 1.0 5.1 4.0 0.2 3.5 0.5 3.0 1.5 1.6 0.7 6.4 3.2 2.1 1.2 2.7 3.0 2.7 0.6 25.3 1.4 2.7 1.6 1.0 23.8 1.7 3.0 2.0 10.7 4.6 0.0 3.7 0.9 5.6 0.2 2.1 3.3 13.2 0.9 4.2 2.6 1.0 1.5 0.3 10.1 1.6 1.5 0.9 0.9 1.2 1.7 0.8 1.5 7.3 1.4 3.9 2.6 0.7 1.7 15.4 2.7 7.0 4.4 1.1 2.2 1.8 1.7 2.4 4.6 0.5 5.0 9.2 0.7 2.6 1.0 0.7 5.1 1.6 2.6 0.8 1.7 1.0 1.9 1.5 0.8 1.0 3.5 1.2 1.7 3.6 0.2 4.0 0.6 3.5 0.5 5.9 6.9 9.7 9.5 6.0 5.9 6.2 6.7 5.4 5.8 62.5 14.4 35.3 7.1 28.4 17.9 124.4 10.2 8.1 4.5 5.2 2.0 2.2 10.0 5.5 7.1 15.7 28.0 0.0 6.1 2.7 16.0 9.2 5.7 7.2 41.9 50.9 5.8 16.5 44.2 4.7 6.1 61.4 32.1 1.8 19.7 27.9 10.6 14.4 12.4 18.8 24.4 6.5 18.9 6.7 2.8 26.7 6.6 10.1 12.6 5.9 OTUD3 "DUBA4, KIAA0459" ENSG00000169914 "OTU deubiquitinase 3" Q5T2D3 1 19882513-19912945 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028543, HPA028544" Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Intermediate filaments" "HPA028543: AB_10599302, HPA028544: AB_10602277" "unprognostic (6.45e-3)" "unprognostic (9.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.95e-1)" "unprognostic (1.41e-1)" "unprognostic (3.16e-3)" "unprognostic (1.70e-3)" "unprognostic (3.15e-3)" "unprognostic (4.99e-2)" "unprognostic (1.09e-1)" "unprognostic (8.81e-2)" "unprognostic (4.68e-2)" "unprognostic (1.08e-1)" "unprognostic (9.83e-2)" "unprognostic (1.94e-1)" "unprognostic (7.28e-2)" "unprognostic (2.21e-2)" 6.5 11.0 15.0 6.9 19.2 11.4 10.0 19.3 23.2 10.6 8.9 6.6 6.4 10.2 14.2 13.0 6.1 8.2 7.2 5.2 12.6 7.3 7.1 4.8 8.5 7.0 9.9 12.5 11.2 7.2 9.3 20.2 5.4 9.0 9.8 8.3 6.9 6.2 9.2 9.2 13.0 9.6 11.9 8.1 7.7 7.3 28.4 9.7 6.0 6.9 2.9 6.3 7.0 7.6 1.7 0.6 0.8 0.4 0.6 2.2 0.3 5.1 1.9 8.7 10.4 3.8 3.3 8.6 5.5 3.2 2.8 2.8 9.1 4.9 8.1 4.5 12.1 2.0 5.0 8.1 3.2 5.5 5.3 10.8 7.8 10.4 6.3 2.1 5.7 7.2 2.7 3.2 4.4 5.7 6.0 3.7 8.3 5.5 3.5 4.8 2.8 4.3 5.7 4.1 4.1 5.1 10.1 22.3 3.0 4.7 5.6 7.7 5.5 3.9 3.2 4.2 8.9 4.8 4.2 4.5 6.8 8.7 7.5 4.7 4.0 3.4 5.0 4.8 7.6 3.1 0.8 0.4 0.1 1.5 0.3 1.4 1.7 1.7 1.4 0.3 1.3 2.2 1.8 0.7 0.6 0.1 0.6 0.9 0.3 15.0 19.2 19.3 23.2 12.6 7.3 9.9 12.5 9.0 9.7 14.9 6.9 3.0 5.2 12.6 13.5 3.6 0.0 10.7 1.2 8.7 15.7 2.3 0.0 4.5 9.9 4.5 3.8 0.0 4.0 4.7 4.2 8.8 1.1 2.1 1.6 25.4 11.5 9.2 1.6 11.5 5.2 3.3 5.0 2.8 6.7 10.2 3.9 5.9 5.6 3.4 16.0 6.5 3.5 19.1 21.2 7.8 2.1 4.4 5.9 3.0 OTUD5 "DKFZp761A052, DUBA" ENSG00000068308 "OTU deubiquitinase 5" Q96G74 X 48922028-48958386 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "U-266/70: 187.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017375 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoplasm, Nucleoli fibrillar center" "HPA017375: AB_1854844" "unprognostic (9.73e-2)" "prognostic favorable (9.57e-4)" "unprognostic (2.67e-2)" "unprognostic (7.25e-2)" "unprognostic (1.08e-1)" "unprognostic (6.65e-2)" "unprognostic (2.33e-3)" "prognostic favorable (1.48e-4)" "unprognostic (1.11e-1)" "unprognostic (1.14e-1)" "prognostic favorable (8.20e-4)" "unprognostic (1.32e-1)" "unprognostic (3.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-2)" "unprognostic (5.05e-3)" 23.5 27.5 32.4 26.8 40.9 38.4 21.9 35.0 52.4 21.3 22.9 28.2 23.4 30.5 25.5 26.8 20.5 25.1 20.9 16.6 29.8 31.3 22.6 24.5 25.2 30.8 25.4 29.8 30.0 25.4 29.6 26.8 23.1 29.4 24.0 17.8 20.4 26.9 27.4 24.4 24.5 29.1 27.1 21.4 34.5 22.3 12.7 24.0 34.8 24.5 14.4 27.2 22.1 22.7 7.8 6.3 8.6 5.1 18.6 7.5 3.5 6.2 9.5 4.4 11.0 7.5 6.8 5.2 5.5 6.5 7.0 7.6 4.7 7.0 7.0 3.6 6.9 6.1 7.7 6.7 5.6 6.5 8.2 8.1 5.3 9.6 5.4 6.4 5.0 5.9 7.5 5.2 7.2 4.9 7.7 5.5 5.8 6.7 11.1 4.9 6.3 7.9 10.9 8.0 2.3 7.5 6.3 6.5 9.1 4.9 5.6 4.3 7.6 7.3 4.7 7.3 10.8 6.3 4.6 7.8 4.6 5.8 12.0 4.5 187.1 46.7 6.7 7.0 7.1 3.1 5.2 3.4 7.0 7.0 5.1 5.8 7.8 5.5 6.0 4.8 6.0 5.2 7.5 8.6 18.6 4.7 6.3 7.0 3.5 32.4 40.9 35.0 52.4 29.8 31.3 25.4 29.8 29.4 24.0 8.9 21.1 23.0 19.4 19.7 31.7 8.5 10.2 17.4 17.0 26.2 25.5 11.3 8.3 13.0 1.5 18.5 26.4 0.0 15.9 12.0 16.5 23.0 6.9 22.9 14.5 27.0 46.2 18.4 24.7 1.5 19.2 19.5 25.3 21.6 26.6 16.0 17.8 15.8 22.3 20.3 25.0 12.9 13.3 5.9 10.9 22.3 25.7 30.9 17.4 22.8 OTUD6B "CGI-77, DUBA5" ENSG00000155100 "OTU domain containing 6B" Q8N6M0 8 91070196-91087095 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024046, HPA024503, HPA024772" Approved Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846" "prognostic unfavorable (7.50e-4)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "unprognostic (4.78e-3)" "unprognostic (4.91e-2)" "unprognostic (1.49e-1)" "unprognostic (1.52e-2)" "unprognostic (1.16e-3)" "unprognostic (2.17e-1)" "unprognostic (5.51e-2)" "unprognostic (1.27e-2)" "unprognostic (8.61e-3)" "unprognostic (1.87e-2)" "unprognostic (1.96e-1)" "unprognostic (4.53e-1)" "unprognostic (8.78e-2)" "unprognostic (5.71e-2)" 11.4 11.3 14.6 14.1 18.2 8.9 13.2 13.8 19.6 12.3 11.3 9.9 10.3 9.2 12.1 9.0 13.2 9.1 8.6 14.0 14.9 13.7 11.0 10.5 10.0 13.8 18.5 15.5 12.5 9.9 11.2 14.4 14.9 16.2 11.6 11.3 6.0 9.5 14.8 35.3 11.2 9.1 12.4 19.9 11.3 8.8 11.9 17.4 13.9 11.8 11.0 11.9 11.9 14.0 7.2 12.9 8.8 7.8 7.8 6.8 2.9 16.3 9.4 8.5 6.3 3.8 2.9 8.8 13.0 4.9 12.1 7.9 8.1 10.3 17.3 6.3 6.8 4.9 5.6 17.5 10.6 18.8 13.9 10.7 23.6 9.8 6.1 8.2 12.0 12.5 4.8 5.1 9.7 23.1 7.2 9.8 13.7 23.6 10.9 10.3 8.9 20.1 7.9 4.5 12.5 18.7 9.1 8.1 15.5 9.4 11.8 2.0 7.6 1.2 28.8 12.5 11.5 14.7 5.8 10.0 7.2 10.9 11.0 12.3 10.9 20.7 25.5 10.6 15.1 13.8 8.8 6.5 4.3 5.9 7.8 6.8 7.2 4.8 5.7 8.1 6.8 6.7 5.9 0.9 7.8 5.8 12.9 3.6 2.9 14.6 18.2 13.8 19.6 14.9 13.7 18.5 15.5 16.2 17.4 8.9 9.9 12.4 5.2 20.6 13.1 14.0 10.2 9.4 13.6 1.8 31.4 9.3 8.3 4.7 0.4 7.5 3.1 0.0 4.3 8.3 5.1 4.0 18.4 9.2 7.0 11.1 10.4 9.2 7.5 0.9 8.9 9.4 3.3 8.2 4.2 13.4 5.3 4.2 3.9 6.2 16.7 0.0 7.2 1.9 6.6 15.8 5.6 7.9 5.6 4.7 PAGE1 "CT16.3, GAGE-9, GAGEB1, PAGE-1" ENSG00000068985 "PAGE family member 1" O75459 X 49687450-49695993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 126 "testis: 18.2" "Cell type enhanced" "Detected in some" 30 "Sertoli cells: 32.3;Spermatocytes: 65.7;Spermatogonia: 164.4" "Cancer enhanced" "Detected in many" "liver cancer: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 49.0;Karpas-707: 37.8;U-266/84: 58.3" HPA003473 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Mitochondria" "HPA003473: AB_1079558" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 37.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.7 58.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 5.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 32.3 0.0 65.7 164.4 0.0 0.0 0.0 0.0 0.0 PAK6 PAK5 ENSG00000137843 "P21 (RAC1) activated kinase 6" Q9NQU5 15 40238759-40277487 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 22.2" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 38.8;Suprabasal keratinocytes: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 14.8;HaCaT: 23.0;hTCEpi: 14.1;SK-BR-3: 7.8" HPA031124 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.85e-3)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (7.79e-3)" "unprognostic (7.08e-3)" "unprognostic (9.57e-2)" "unprognostic (2.71e-1)" "unprognostic (7.73e-2)" "unprognostic (1.34e-2)" "unprognostic (7.13e-3)" "unprognostic (4.04e-2)" "unprognostic (8.87e-3)" "unprognostic (1.72e-1)" "unprognostic (1.79e-1)" "unprognostic (7.37e-3)" "unprognostic (3.34e-2)" 0.3 5.3 14.7 0.8 18.4 0.8 2.3 11.3 20.1 3.0 1.3 1.6 2.5 1.4 1.0 1.1 15.8 4.3 1.4 7.9 11.6 5.2 3.4 0.4 2.6 1.0 3.0 10.9 0.6 7.4 12.9 6.4 8.1 2.1 3.6 1.2 0.3 3.4 7.5 3.5 22.2 1.4 0.8 1.2 1.0 3.6 12.8 2.2 0.0 7.4 8.5 5.1 3.0 5.1 1.4 0.7 2.9 0.7 2.0 5.5 1.2 2.7 0.0 0.2 0.1 0.0 0.0 4.4 0.0 0.1 0.6 0.4 14.8 2.0 0.1 2.4 0.0 0.9 23.0 3.3 4.9 0.2 0.1 0.7 0.0 1.9 0.1 0.0 0.1 0.3 0.0 14.1 0.2 3.3 0.2 0.0 3.9 1.1 0.2 0.0 3.2 0.0 0.3 0.4 2.7 2.0 0.2 0.1 1.8 1.1 6.0 5.4 1.3 1.9 7.8 0.2 1.3 0.9 7.2 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.0 0.5 0.4 0.1 2.1 0.7 2.9 5.5 0.3 2.1 1.4 0.5 4.2 0.7 0.5 0.3 1.2 1.3 2.0 0.2 0.5 0.1 1.2 14.7 18.4 11.3 20.1 11.6 5.2 3.0 10.9 2.1 2.2 0.0 3.4 0.0 6.8 8.8 3.9 0.0 7.6 4.0 4.5 5.2 0.0 38.8 11.6 4.0 5.9 0.0 0.0 0.0 3.7 1.2 0.6 4.0 0.0 0.0 3.5 0.0 4.7 0.0 0.3 4.5 1.7 0.3 1.7 0.0 0.8 1.4 2.7 0.0 1.8 0.0 0.0 0.0 0.1 1.6 1.5 16.7 7.6 1.3 1.9 6.8 PALM2-AKAP2 ENSG00000157654 "PALM2-AKAP2 readthrough" 9 109780309-110172512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 41.0;heart muscle: 26.8" "Group enriched" "Detected in some" 14 "Alveolar cells type 1: 125.0;granulocytes: 32.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 15.7;hTEC/SVTERT24-B: 15.1;RH-30: 29.7;U-251 MG: 13.2;WM-115: 17.3" "HPA058905, HPA074153, HPA076866" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: " "unprognostic (7.12e-2)" "unprognostic (1.64e-6)" "unprognostic (7.90e-2)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" "unprognostic (3.19e-1)" "unprognostic (9.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.37e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-3)" "unprognostic (7.77e-2)" "unprognostic (1.98e-4)" "unprognostic (3.36e-5)" 41.0 2.8 1.6 3.3 1.6 0.1 19.6 0.7 4.7 4.8 2.3 1.5 2.1 1.1 15.2 4.7 2.1 2.5 5.0 26.8 1.8 2.4 2.4 24.8 9.7 1.2 1.9 0.5 5.9 1.1 1.6 1.1 9.2 3.0 3.2 0.6 1.1 2.0 3.6 4.5 1.8 1.0 7.8 1.4 0.5 1.1 1.4 0.9 0.0 3.8 2.5 0.3 5.2 8.9 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 3.3 0.0 15.7 5.6 1.3 5.5 5.4 1.6 3.7 0.0 0.1 0.0 0.5 5.7 6.5 2.0 0.0 1.3 4.6 0.2 1.6 0.0 5.1 0.1 0.1 0.0 0.0 7.1 0.1 15.1 2.4 4.8 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 4.4 0.0 1.4 0.0 29.7 0.0 4.1 0.0 1.8 0.0 2.1 0.2 7.5 4.6 0.6 0.0 0.1 3.4 8.6 0.3 13.2 0.0 0.2 0.0 4.3 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.6 1.6 0.7 3.0 1.8 2.4 1.9 0.5 3.0 0.9 125.0 5.8 0.0 0.0 0.0 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PALM3 ENSG00000187867 "Paralemmin 3" A6NDB9 19 14053365-14059159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 26.5;testis: 19.7" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 36.3;Cholangiocytes: 17.8;Club cells: 18.2;Collecting duct cells: 36.6;Exocrine glandular cells: 24.3;Hepatocytes: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 22.1;CACO-2: 23.7;HAP1: 19.8;NTERA-2: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052794, HPA056119" Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA052794: AB_2681952, HPA056119: AB_2683042" "unprognostic (3.67e-2)" "unprognostic (9.08e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (7.87e-4)" "unprognostic (2.14e-2)" "unprognostic (1.47e-1)" "unprognostic (4.66e-2)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" "unprognostic (3.91e-1)" "unprognostic (3.93e-2)" "unprognostic (3.88e-2)" "unprognostic (2.09e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (1.10e-2)" "unprognostic (1.72e-3)" 0.2 0.2 4.3 0.9 1.9 0.0 2.1 3.7 3.6 2.9 0.5 3.2 0.2 2.7 0.4 11.1 0.2 1.5 1.6 0.2 4.2 2.8 12.9 26.5 2.4 0.2 1.7 4.3 0.4 11.7 1.8 0.2 0.7 10.1 1.8 0.2 1.1 6.9 8.0 0.2 0.2 0.8 0.9 2.7 0.2 13.0 19.7 4.9 0.2 6.8 0.2 1.0 3.9 1.9 0.9 0.2 0.0 0.3 0.0 1.8 0.0 1.6 1.5 3.7 22.1 0.3 0.1 4.5 0.4 0.1 1.3 0.6 23.7 0.5 0.0 0.2 0.4 7.0 0.1 19.8 0.0 0.3 0.0 1.3 0.1 0.5 2.6 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.6 0.1 0.0 4.6 0.0 0.0 3.7 0.2 0.1 14.2 1.8 1.3 0.0 0.0 0.0 0.0 1.9 2.7 3.6 0.1 0.0 0.0 4.0 1.4 0.0 0.2 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.9 0.8 0.3 0.0 0.1 0.9 1.8 1.8 0.0 0.0 0.1 0.2 0.5 0.0 4.3 1.9 3.7 3.6 4.2 2.8 1.7 4.3 10.1 4.9 53.6 36.3 0.0 0.6 0.0 0.8 0.3 17.8 2.7 18.2 36.6 0.0 0.2 1.7 6.7 0.0 0.0 0.9 0.0 24.3 2.0 1.0 1.4 1.1 31.8 0.1 0.0 1.2 1.3 1.3 0.0 0.9 0.1 1.7 1.8 1.9 0.4 3.8 0.6 2.5 6.8 0.5 0.0 0.0 0.0 6.8 0.0 1.8 0.0 0.6 0.2 PAM16 "Magmas, Tim16, TIMM16" ENSG00000217930 "Presequence translocase associated motor 16" Q9Y3D7 16 4331549-4355607 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 36.3" HPA062721 Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA062721: AB_2684849" "unprognostic (2.69e-2)" "unprognostic (1.64e-1)" "unprognostic (4.06e-1)" "unprognostic (6.81e-2)" "unprognostic (6.98e-2)" "unprognostic (9.68e-2)" "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-1)" "unprognostic (4.79e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (5.73e-5)" "unprognostic (7.25e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "prognostic favorable (1.33e-4)" 10.9 15.2 12.9 8.4 14.1 17.0 10.0 9.3 15.1 7.0 9.5 5.6 8.2 14.0 7.8 11.8 11.2 7.5 7.5 19.9 11.1 10.7 9.2 33.7 9.8 10.9 9.8 11.3 8.5 26.1 7.1 10.3 8.0 9.2 8.8 8.0 7.8 13.2 11.0 54.5 12.6 10.1 8.2 8.3 9.5 10.1 16.2 7.3 7.3 12.0 17.8 9.6 8.4 9.9 16.0 19.8 11.2 15.3 11.5 14.3 12.3 3.9 7.7 4.2 10.3 2.8 3.9 10.9 9.5 2.3 3.6 2.9 5.4 5.8 11.5 10.6 2.8 3.7 8.1 3.9 4.2 1.7 11.2 25.4 12.0 7.2 3.8 4.6 8.4 9.0 5.8 5.4 4.3 4.7 3.2 2.8 8.1 14.1 5.5 3.0 10.6 7.6 14.7 6.8 2.5 17.2 14.5 3.5 11.1 3.7 3.8 16.0 12.4 8.2 7.0 9.7 3.3 9.2 10.2 3.5 7.2 9.3 36.3 10.4 8.2 8.8 14.3 2.6 8.2 6.8 0.2 15.3 2.3 12.3 9.5 10.5 16.0 11.2 11.3 10.7 15.5 14.3 13.7 11.2 11.5 10.2 19.8 12.7 12.3 12.9 14.1 9.3 15.1 11.1 10.7 9.8 11.3 9.2 7.3 3.0 4.5 2.2 0.9 3.5 0.5 0.4 10.2 6.7 5.7 0.0 0.0 1.9 6.6 3.1 2.6 0.7 2.1 0.0 2.6 2.3 2.7 1.0 1.1 10.9 1.5 1.6 0.0 4.3 7.8 0.8 4.6 1.1 1.7 7.2 2.1 0.3 5.2 3.4 3.5 3.0 0.6 6.5 1.4 8.9 12.9 5.1 1.0 1.7 3.4 1.0 PAPD7 "LAK-1, POLK, POLS, TRF4, TRF4-1" ENSG00000112941 "Poly(A) RNA polymerase D7, non-canonical" Q5XG87 5 6713007-6757048 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045487, HPA046742" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA045487: AB_2679346, HPA046742: AB_2679781" "unprognostic (1.45e-1)" "unprognostic (2.96e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-3)" "unprognostic (7.57e-2)" "unprognostic (1.30e-2)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.62e-1)" "unprognostic (9.78e-2)" "unprognostic (3.10e-3)" "unprognostic (3.73e-2)" "prognostic unfavorable (7.99e-5)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.60e-2)" "prognostic favorable (8.55e-4)" 13.5 7.9 9.6 13.9 11.1 25.8 16.3 22.7 12.3 15.1 16.6 10.6 14.8 9.5 13.2 8.0 12.2 11.3 11.4 8.6 10.7 7.3 9.7 19.9 13.2 14.1 14.8 5.8 18.5 13.3 13.2 12.2 10.0 9.0 11.6 8.3 10.2 17.0 10.6 10.4 16.7 13.1 13.9 7.9 14.8 10.1 11.1 11.7 25.4 11.3 11.3 11.6 12.5 34.9 1.9 3.8 0.7 0.7 0.5 2.3 0.8 16.5 11.2 13.8 17.0 10.0 9.0 19.9 11.3 14.1 14.1 16.0 11.6 9.3 12.1 8.7 13.8 15.8 12.3 11.3 8.7 13.0 13.6 7.2 6.2 35.5 6.3 6.2 9.3 9.4 6.1 7.6 15.7 10.1 10.4 8.2 9.1 8.3 16.1 11.4 9.1 12.6 12.2 7.5 5.1 8.8 11.5 11.8 3.1 5.6 9.5 13.8 10.5 26.9 13.1 7.7 7.8 7.9 5.1 7.2 16.9 17.8 14.7 15.7 15.4 6.3 10.7 11.0 8.7 10.4 0.0 0.7 0.7 2.1 0.4 2.3 1.9 1.7 1.6 1.2 1.5 1.9 1.7 0.4 0.5 0.6 3.8 1.8 0.8 9.6 11.1 22.7 12.3 10.7 7.3 14.8 5.8 9.0 11.7 6.0 20.8 6.7 8.4 29.1 16.5 0.0 7.6 4.0 9.1 0.0 35.3 4.5 0.0 0.0 9.6 8.2 7.3 0.0 0.0 3.5 14.1 9.6 4.7 13.2 5.8 14.3 4.7 16.0 5.7 2.8 6.1 7.6 3.3 0.0 8.1 7.8 0.0 6.2 8.5 0.0 24.9 0.0 14.7 6.3 4.9 22.6 4.7 6.9 7.6 8.7 PAPSS1 "ATPSK1, PAPSS" ENSG00000138801 "3'-phosphoadenosine 5'-phosphosulfate synthase 1" O43252 4 107590276-107720452 "Enzymes, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 113.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 50.3;eosinophil: 62.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 62.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049781 Approved Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA049781: AB_2680879" "unprognostic (1.36e-2)" "unprognostic (5.03e-2)" "prognostic favorable (9.14e-4)" "prognostic favorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.70e-5)" "unprognostic (1.58e-2)" "unprognostic (1.05e-1)" "unprognostic (8.92e-2)" "unprognostic (1.42e-1)" "unprognostic (5.76e-2)" "unprognostic (6.23e-3)" "unprognostic (1.29e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-2)" "unprognostic (1.38e-1)" 13.5 7.4 24.3 14.4 28.5 11.1 25.2 16.4 32.2 26.6 10.0 45.0 9.4 7.9 25.1 22.8 18.3 24.9 13.3 7.7 31.3 23.9 16.7 5.1 22.0 14.7 29.7 21.9 15.6 24.6 15.6 15.5 8.5 38.2 21.7 12.7 9.5 32.2 14.0 3.3 24.5 8.5 17.0 59.9 9.6 30.4 8.1 25.5 14.7 10.3 11.0 24.6 16.5 13.7 8.5 9.2 62.2 10.2 4.6 6.8 5.8 10.5 9.7 16.4 20.4 20.2 25.5 13.1 13.5 25.4 13.2 17.8 14.8 15.3 16.5 8.6 24.7 10.2 13.3 15.5 26.7 17.1 38.8 11.7 19.3 21.0 33.0 11.1 29.2 33.4 21.1 13.8 15.2 12.5 32.2 29.3 21.1 4.2 32.2 37.0 16.2 23.5 9.0 17.5 11.4 10.8 19.8 25.9 4.7 19.9 14.7 18.6 26.9 14.0 21.1 16.5 21.8 12.5 4.5 17.3 16.6 17.1 11.1 11.3 25.9 17.2 15.4 20.1 22.4 26.0 50.3 8.9 62.2 3.0 9.6 3.5 8.5 4.0 3.4 9.2 4.1 2.5 2.9 9.4 4.6 10.2 1.8 6.8 5.8 24.3 28.5 16.4 32.2 31.3 23.9 29.7 21.9 38.2 25.5 89.3 19.8 21.5 31.5 28.4 13.4 6.5 30.6 113.8 69.4 54.1 9.8 17.1 14.9 29.3 5.2 17.4 7.0 0.0 40.0 37.0 49.8 27.9 41.5 8.1 53.6 28.6 22.5 20.3 50.0 3.7 16.7 46.3 57.3 35.1 18.0 37.3 29.6 7.0 24.1 21.2 13.7 25.8 22.7 16.5 14.3 35.8 7.4 11.8 15.1 20.1 PARG ENSG00000227345 "Poly(ADP-ribose) glycohydrolase" Q86W56 10 49818279-49970203 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021819, HPA053007" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA021819: AB_1854974, HPA053007: AB_2682014" "unprognostic (5.77e-3)" "unprognostic (6.74e-2)" "unprognostic (3.06e-2)" "unprognostic (9.90e-2)" "unprognostic (1.22e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.57e-5)" "unprognostic (1.21e-1)" "unprognostic (3.97e-1)" "unprognostic (8.34e-2)" "unprognostic (1.47e-1)" "unprognostic (4.06e-2)" "unprognostic (5.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (8.54e-2)" "unprognostic (1.13e-1)" 4.0 5.6 4.3 4.2 5.4 1.4 5.3 7.8 6.3 4.8 5.1 6.7 4.9 3.0 6.2 4.3 3.6 6.6 4.6 5.9 9.2 5.2 3.5 5.8 4.5 4.7 3.5 8.1 4.7 5.8 4.9 6.1 4.7 5.1 8.1 6.7 5.1 4.7 4.0 5.9 4.7 5.8 4.9 6.9 4.4 4.8 6.9 7.0 12.5 7.7 8.3 9.4 5.5 12.7 10.6 18.6 13.7 9.0 11.2 13.7 12.7 14.0 14.8 14.2 8.5 11.9 9.6 8.3 10.7 6.6 14.4 15.7 8.0 15.9 14.7 14.6 9.8 8.7 9.3 10.2 14.1 8.2 7.2 15.5 12.4 20.5 10.1 9.0 12.7 16.6 8.5 11.1 7.1 15.5 12.7 18.4 7.8 24.3 18.6 21.2 11.1 11.9 8.2 12.9 16.3 10.3 16.4 13.3 18.8 18.8 7.9 9.1 9.2 11.3 9.6 14.2 9.4 14.0 20.5 15.9 15.0 6.7 12.5 6.2 3.0 5.2 5.5 7.9 6.9 7.1 6.7 7.0 6.9 9.4 9.1 3.0 8.3 7.7 5.4 5.5 5.5 8.9 11.7 8.3 4.6 5.5 13.2 23.8 12.7 29.4 12.5 12.2 25.5 6.5 8.3 6.3 3.5 8.3 8.5 23.3 5.6 5.2 6.7 4.0 13.9 9.6 8.2 4.8 6.3 7.4 13.2 3.3 6.9 7.0 3.3 9.0 8.1 8.9 6.7 2.9 7.8 27.7 20.8 0.0 5.5 15.7 12.1 5.3 3.9 7.5 9.7 3.8 PARM1 "Cipar1, DKFZP564O0823, WSC4" ENSG00000169116 "Prostate androgen-regulated mucin-like protein 1" Q6UWI2 4 74933095-75050115 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 143.3;Mucus-secreting cells: 90.2;Paneth cells: 120.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 10.1;myeloid DC: 4.6;naive B-cell: 6.4" "Group enriched" "Detected in many" 15 "B-cells: 10.1;dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "ASC diff: 24.5;Karpas-707: 23.9;U-266/70: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038236 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA038236: AB_10675789" "unprognostic (2.57e-2)" "unprognostic (5.20e-2)" "unprognostic (1.26e-3)" "unprognostic (8.61e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-3)" "unprognostic (3.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.73e-1)" "unprognostic (9.74e-2)" "unprognostic (9.44e-2)" "unprognostic (3.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.23e-1)" 23.1 21.5 5.7 25.0 15.2 0.3 16.4 1.3 29.4 18.7 36.0 1.2 28.5 2.8 20.3 18.0 5.8 12.2 11.5 39.8 6.9 13.0 27.5 1.1 15.1 10.2 3.3 10.3 11.9 29.2 23.2 32.1 16.1 4.8 35.0 45.8 70.2 25.6 27.6 7.4 6.2 8.3 29.3 2.4 9.7 5.5 11.2 1.2 6.3 79.8 3.7 8.0 24.9 19.7 10.1 4.6 0.1 0.5 0.0 0.0 0.7 0.5 1.0 0.9 0.0 24.5 0.1 0.1 0.0 0.1 0.0 0.0 2.0 0.2 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 4.1 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 23.9 0.4 0.2 2.6 0.1 2.3 0.0 1.4 0.0 2.2 6.0 0.1 4.9 1.5 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 1.4 1.6 0.1 2.1 26.8 2.5 6.8 2.5 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 10.1 0.0 0.0 4.6 6.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.7 5.7 15.2 1.3 29.4 6.9 13.0 3.3 10.3 4.8 1.2 14.9 63.1 13.4 17.1 2.9 7.9 143.3 30.6 1.4 11.4 0.0 0.0 0.3 3.3 0.1 6.8 3.8 80.6 23.3 43.2 0.6 15.4 43.3 1.1 0.0 1.4 0.0 19.1 3.1 0.0 20.6 33.9 7.2 8.5 1.0 90.2 0.0 26.9 120.2 70.0 27.6 1.0 45.3 52.3 1.7 3.3 1.6 0.7 1.5 46.2 8.4 PARP11 C12orf6 ENSG00000111224 "Poly(ADP-ribose) polymerase family member 11" Q9NR21 12 3791047-3873448 "Enzymes, Predicted intracellular proteins" "Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026895 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026895: AB_1854980" "unprognostic (9.58e-2)" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (3.58e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (2.11e-1)" "unprognostic (7.52e-2)" "unprognostic (3.81e-2)" "unprognostic (2.87e-2)" 7.1 14.5 11.2 8.6 9.2 3.7 8.3 11.0 9.1 6.4 5.4 5.6 4.8 4.9 10.2 7.5 5.0 6.3 5.6 5.1 6.1 5.7 5.7 5.7 6.3 12.8 5.0 5.7 13.1 6.6 10.0 10.4 4.1 7.6 12.0 5.7 7.2 6.6 6.0 4.1 3.9 6.5 7.2 6.1 9.2 4.2 12.8 5.6 16.9 12.3 2.7 12.1 8.3 5.8 10.7 10.2 18.3 10.2 8.2 12.5 7.1 2.3 1.9 12.8 2.0 4.1 6.5 3.6 2.8 4.8 5.0 5.0 7.3 1.8 7.0 1.8 6.2 6.3 2.0 4.2 4.2 8.1 14.1 4.2 10.0 0.0 5.4 4.6 6.7 3.8 5.2 3.3 3.9 11.1 0.0 3.7 13.7 2.6 5.7 7.0 3.3 3.5 2.6 4.7 2.4 0.3 7.1 8.7 1.6 2.3 5.3 0.8 2.9 2.8 2.4 3.6 14.6 0.4 6.1 7.2 4.3 4.3 6.6 3.8 2.7 5.9 9.8 4.1 3.7 1.1 18.3 10.2 10.2 9.2 8.5 12.5 10.7 10.2 6.7 10.2 10.1 11.7 9.4 10.2 8.2 6.4 8.9 4.3 7.1 11.2 9.2 11.0 9.1 6.1 5.7 5.0 5.7 7.6 5.6 8.9 7.4 11.8 4.3 1.6 11.1 3.2 2.5 6.7 2.3 1.8 2.0 3.0 0.0 3.1 60.8 4.5 2.1 0.0 2.6 1.5 4.6 8.0 14.9 3.4 6.2 3.2 3.5 8.0 9.1 25.5 9.8 6.9 1.7 3.6 3.7 6.2 2.9 4.2 8.1 3.3 6.9 6.5 5.1 7.5 8.7 1.6 2.2 10.2 4.3 3.4 PARP8 "FLJ21308, pART16" ENSG00000151883 "Poly(ADP-ribose) polymerase family member 8" Q8N3A8 5 50665899-50846522 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "T-cells: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049183 Approved Approved "Nucleoplasm,Midbody ring,Cytosol" Yes No Nucleoplasm "Midbody ring, Cytosol" "HPA049183: AB_2680667" "unprognostic (1.22e-2)" "unprognostic (2.53e-1)" "unprognostic (1.77e-1)" "unprognostic (1.05e-1)" "unprognostic (2.12e-1)" "unprognostic (6.33e-2)" "unprognostic (8.86e-3)" "unprognostic (7.27e-2)" "unprognostic (1.86e-2)" "unprognostic (8.96e-2)" "unprognostic (2.85e-1)" "unprognostic (6.81e-2)" "unprognostic (9.63e-2)" "unprognostic (2.84e-2)" "unprognostic (4.42e-2)" "unprognostic (4.23e-2)" "prognostic favorable (1.12e-4)" 6.2 7.8 8.8 17.1 9.5 33.5 5.3 2.4 18.7 5.6 5.5 3.3 0.6 6.8 5.2 5.4 5.2 7.4 12.3 3.6 12.8 8.0 5.8 4.2 10.9 18.2 4.9 11.0 5.9 7.1 9.8 14.4 5.6 5.4 6.1 4.3 4.1 7.6 4.2 1.7 4.2 14.2 5.4 7.0 20.1 10.2 6.4 2.8 9.9 21.9 1.1 12.3 8.8 7.0 7.1 3.9 13.1 5.9 15.5 32.0 9.5 11.6 0.0 5.4 8.6 1.5 2.6 8.6 1.9 7.0 1.9 5.5 0.3 15.4 6.9 8.2 0.2 19.8 5.8 0.9 5.8 4.5 9.7 7.4 5.1 4.7 0.4 2.8 11.9 0.1 3.3 4.9 3.8 2.7 11.6 0.1 10.9 0.7 4.2 2.6 3.8 14.2 15.0 5.8 0.2 2.8 7.2 11.4 7.9 3.5 5.8 6.0 9.3 6.2 10.2 1.6 8.3 0.4 42.0 0.0 0.4 7.3 0.5 5.7 3.1 0.1 13.4 6.5 3.3 7.9 10.3 5.9 13.1 20.6 1.6 32.0 6.0 16.1 23.0 3.9 7.1 10.0 16.7 12.3 15.5 1.1 1.8 9.5 9.5 8.8 9.5 2.4 18.7 12.8 8.0 4.9 11.0 5.4 2.8 29.8 22.6 12.3 4.8 7.1 13.4 4.5 12.7 21.4 21.6 21.0 0.0 17.5 6.6 11.2 19.7 4.5 6.9 0.0 8.8 5.9 9.1 8.6 13.9 3.6 12.9 6.4 14.5 8.6 28.5 11.4 1.1 17.1 8.5 13.6 3.6 0.5 14.3 7.6 2.8 3.7 2.1 6.5 6.9 5.1 5.5 3.4 20.7 90.6 6.5 13.5 PARP9 "BAL, BAL1" ENSG00000138496 "Poly(ADP-ribose) polymerase family member 9" Q8IXQ6 3 122527924-122564577 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 35.1;BJ hTERT+ SV40 Large T+ RasG12V: 41.9;SK-MEL-30: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066708 Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA066708: AB_2685707" "unprognostic (3.06e-2)" "unprognostic (4.80e-2)" "unprognostic (1.55e-3)" "unprognostic (6.70e-3)" "unprognostic (1.11e-1)" "unprognostic (6.38e-2)" "unprognostic (4.73e-3)" "unprognostic (3.39e-3)" "unprognostic (1.31e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.00e-3)" "unprognostic (5.63e-3)" "unprognostic (1.56e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-2)" "unprognostic (9.65e-3)" "unprognostic (1.56e-2)" 27.1 20.2 8.7 17.2 12.4 9.1 13.8 2.9 13.9 13.1 13.1 9.9 7.4 10.4 23.3 10.1 15.6 12.3 14.9 8.5 7.4 6.0 17.8 38.6 18.9 17.5 8.5 6.0 12.1 14.4 16.0 20.3 11.9 10.3 15.1 10.1 11.5 19.1 6.6 8.6 5.7 21.2 14.8 16.3 27.3 11.1 5.4 10.3 21.8 17.5 9.0 19.1 13.7 9.8 7.3 11.9 38.2 18.0 13.0 10.6 9.1 8.0 2.7 1.0 0.7 6.3 13.0 0.9 2.7 14.7 35.1 41.9 4.2 8.9 1.8 6.0 5.4 22.1 8.9 2.3 4.8 7.3 14.0 1.6 8.7 2.8 2.2 6.7 2.8 5.8 10.6 4.7 5.0 1.2 7.0 7.5 5.6 0.8 7.5 1.4 3.5 8.9 3.5 0.4 1.6 7.6 9.5 9.9 0.6 13.4 4.6 0.6 2.4 7.2 1.2 32.4 0.5 3.8 3.1 4.5 1.5 4.4 0.3 1.6 4.7 2.4 3.3 5.2 3.1 2.7 14.4 12.7 15.3 9.2 17.7 8.6 7.3 9.8 10.3 11.9 5.0 7.5 9.1 38.2 13.0 18.0 1.4 10.6 9.1 8.7 12.4 2.9 13.9 7.4 6.0 8.5 6.0 10.3 10.3 38.7 36.9 16.7 9.4 6.4 0.8 5.2 10.2 61.6 44.3 19.2 0.0 4.3 1.7 24.9 1.3 19.0 15.3 0.0 34.9 16.2 11.4 10.4 9.3 43.1 36.1 0.0 10.3 21.5 31.3 2.6 17.0 29.4 6.8 32.5 9.7 14.7 28.4 7.2 22.6 18.9 0.8 19.4 9.6 1.0 0.9 5.8 1.4 12.7 6.6 15.5 PAX5 BSAP ENSG00000196092 "Paired box 5" Q02548 9 36833275-37034185 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 21.6;lymphoid tissue: 33.4" "Cell type enriched" "Detected in some" 27 "B-cells: 57.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "midbrain: 1.6" "Group enriched" "Detected in some" 209 "memory B-cell: 20.1;naive B-cell: 21.6" "Lineage enriched" "Detected in single" 216 "B-cells: 21.6" "Group enriched" "Detected in some" 8 "Daudi: 21.5;REH: 62.5;U-698: 28.2" "Region enriched" "Detected in single" 11 "midbrain: 4.7" "Group enriched" "Detected in some" 6 "hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2" "CAB026269, CAB026869, HPA056394, HPA068498" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997" "unprognostic (4.69e-4)" "unprognostic (3.83e-1)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.46e-2)" "unprognostic (1.11e-3)" "unprognostic (3.15e-1)" "unprognostic (8.96e-2)" "unprognostic (6.03e-2)" "unprognostic (1.01e-1)" 0.4 0.2 0.2 33.4 0.2 5.5 0.2 0.2 0.2 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.4 0.2 0.2 0.3 0.5 0.3 0.3 23.2 1.6 0.0 0.2 0.2 0.0 0.5 0.1 0.2 0.3 0.3 0.4 2.5 0.0 0.6 0.2 8.7 0.0 0.3 16.5 0.7 0.9 0.0 2.3 0.4 0.2 30.1 1.3 0.2 21.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.1 62.5 0.1 0.1 0.0 0.0 4.4 1.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 1.6 0.0 0.2 0.0 0.0 0.0 57.6 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 PBDC1 "CXorf26, MGC874" ENSG00000102390 "Polysaccharide biosynthesis domain containing 1" Q9BVG4 X 76172936-76178204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003155 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA 88000 Nucleoplasm "Nucleoli, Cytosol" "HPA003155: AB_1078592" "unprognostic (6.95e-2)" "unprognostic (9.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.78e-2)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (2.47e-3)" "unprognostic (7.23e-2)" "unprognostic (1.78e-1)" "unprognostic (1.56e-3)" "unprognostic (8.82e-3)" "unprognostic (3.64e-1)" "unprognostic (1.39e-2)" "unprognostic (1.05e-1)" "unprognostic (4.98e-2)" "prognostic favorable (8.57e-4)" "unprognostic (1.62e-1)" 24.9 25.4 12.7 15.1 14.3 28.9 17.1 15.3 14.9 21.3 31.5 10.0 14.8 28.5 21.3 18.4 26.9 15.1 14.2 14.7 12.5 12.5 36.3 39.1 16.6 17.0 17.6 8.8 23.1 16.1 15.2 22.8 21.9 15.0 22.3 20.9 10.3 18.0 14.3 19.2 19.5 48.9 22.3 22.7 23.8 17.8 8.4 14.6 21.1 22.5 21.2 18.2 20.8 17.6 28.1 24.0 17.0 27.8 27.1 30.6 17.1 12.1 17.7 15.2 10.4 19.5 19.5 13.1 21.6 18.5 19.9 17.2 16.9 16.8 16.6 14.6 21.8 24.8 17.5 25.3 24.2 26.0 12.3 16.0 12.3 9.9 25.3 30.7 36.1 18.1 15.5 19.9 27.2 23.3 12.1 25.3 6.0 17.4 8.3 24.3 14.2 17.0 26.5 42.2 30.2 27.8 14.6 16.0 2.1 29.1 22.5 8.9 11.5 9.5 15.9 0.1 20.5 9.7 13.6 21.7 14.9 14.9 17.7 19.7 14.6 25.8 9.9 16.5 12.7 11.7 6.7 17.6 17.0 30.6 25.6 22.2 28.1 27.5 29.7 22.5 23.7 28.2 26.9 3.3 27.1 27.8 24.0 22.5 17.1 12.7 14.3 15.3 14.9 12.5 12.5 17.6 8.8 15.0 14.6 32.8 23.2 24.8 69.4 47.1 21.4 36.9 33.1 33.5 30.7 38.4 13.7 48.2 41.4 60.7 1.0 28.6 58.6 0.0 54.4 49.7 36.0 52.4 50.7 46.4 62.6 7.9 26.5 19.6 30.5 1.1 44.3 40.9 43.9 80.2 37.2 21.5 53.5 34.8 36.4 66.3 19.3 51.8 41.1 2.3 16.4 61.6 46.0 44.5 46.0 68.1 PBX1 ENSG00000185630 "PBX homeobox 1" P40424 1 164555584-164899296 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.9" "Cell line enhanced" "Detected in many" "HEL: 30.9;NTERA-2: 30.3;SK-BR-3: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003505, HPA003881, CAB018768" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020" "unprognostic (2.26e-2)" "unprognostic (1.95e-1)" "unprognostic (9.09e-2)" "unprognostic (2.14e-2)" "unprognostic (5.21e-3)" "unprognostic (6.94e-3)" "unprognostic (5.95e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "unprognostic (2.24e-3)" "unprognostic (2.30e-1)" "unprognostic (8.81e-2)" "unprognostic (1.34e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 13.2 17.3 14.9 8.3 15.0 1.4 16.4 14.1 17.4 73.4 26.3 11.2 15.9 13.6 67.2 15.3 20.8 35.1 25.8 12.6 10.9 9.7 15.4 4.2 10.4 2.3 11.6 14.6 35.2 29.4 21.3 12.4 9.6 8.1 27.6 9.3 10.2 19.6 25.1 16.8 6.0 14.6 56.8 8.0 5.1 13.9 9.7 8.7 2.7 17.4 8.5 6.6 32.2 24.7 0.0 0.1 2.9 0.0 0.3 0.2 2.5 1.1 22.6 22.3 6.0 15.1 7.3 1.3 9.5 6.1 2.6 1.8 4.3 4.0 0.0 2.0 12.9 1.4 7.9 8.8 2.5 1.0 1.1 9.4 30.9 18.2 0.0 10.0 0.0 7.9 7.2 0.0 1.6 0.7 5.6 0.1 0.0 0.0 0.0 0.7 14.9 0.0 0.1 30.3 1.3 1.1 0.0 7.4 9.0 1.8 13.5 0.8 13.2 10.9 62.4 0.0 21.3 23.7 0.0 0.1 1.3 3.1 8.8 2.7 2.8 21.3 0.0 0.1 0.0 0.1 2.9 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.1 0.0 2.5 14.9 15.0 14.1 17.4 10.9 9.7 11.6 14.6 8.1 8.7 20.8 15.2 0.9 91.3 20.3 27.6 44.2 91.7 25.4 21.6 31.4 104.1 89.0 28.2 41.5 72.1 39.2 28.0 0.0 58.9 4.5 75.2 44.0 71.4 17.3 8.6 4.8 87.2 60.8 1.6 78.2 59.0 6.8 15.1 1.8 35.4 34.9 31.8 59.6 97.6 49.4 28.8 38.8 62.7 0.9 11.5 24.6 87.5 3.2 39.4 82.1 PBX3 ENSG00000167081 "PBX homeobox 3" P40426 9 125747345-125967377 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.7" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 52.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 16.1" "Lineage enriched" "Detected in all" 4 "dendritic cells: 16.1" "Cell line enhanced" "Detected in many" "THP-1: 36.5" "Region enhanced" "Detected in all" "olfactory region: 205.0" "Region enriched" "Detected in all" 4 "olfactory region: 287.4" HPA003881 Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA003881: AB_1855020" "unprognostic (1.97e-2)" "unprognostic (3.78e-2)" "unprognostic (1.15e-1)" "unprognostic (1.93e-2)" "unprognostic (1.27e-1)" "unprognostic (2.35e-1)" "unprognostic (2.20e-1)" "unprognostic (3.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.88e-1)" "unprognostic (2.42e-3)" "unprognostic (7.02e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (8.03e-2)" "unprognostic (6.29e-2)" 8.0 25.0 4.4 16.2 11.6 3.0 10.4 6.6 3.4 16.6 18.9 3.7 6.5 3.1 10.7 10.9 9.1 5.9 22.8 16.1 2.9 6.3 3.4 7.6 9.4 6.1 9.5 3.4 35.0 12.9 86.7 6.8 3.1 13.0 18.8 6.1 7.1 10.5 12.3 3.6 8.2 6.0 21.2 17.6 5.5 10.0 5.1 6.2 6.8 14.7 5.5 3.8 13.3 12.0 1.8 16.1 2.9 1.8 3.8 2.1 1.0 4.7 4.6 20.8 19.2 5.8 9.5 3.7 12.4 7.1 8.7 6.2 5.9 9.4 4.7 1.5 9.9 8.9 3.6 11.7 5.0 17.2 5.0 8.3 4.0 3.5 2.3 7.4 4.4 7.3 4.8 5.7 6.8 4.4 19.2 9.7 3.2 0.2 4.5 17.9 2.5 4.1 2.1 15.3 5.7 3.1 7.7 31.0 0.6 6.6 2.8 11.2 19.4 8.6 1.6 3.8 8.2 7.1 36.5 11.7 17.6 4.8 10.3 23.2 3.2 5.0 4.9 8.4 6.2 9.0 2.9 1.8 2.3 0.9 1.6 1.2 1.4 1.2 1.0 2.1 1.8 2.1 1.0 1.7 3.8 1.3 16.1 1.8 1.0 4.4 11.6 6.6 3.4 2.9 6.3 9.5 3.4 13.0 6.2 8.9 14.7 3.2 9.5 20.1 6.8 52.9 2.5 9.4 13.6 12.2 35.3 0.3 6.6 9.5 11.1 10.8 0.9 0.0 2.2 0.8 11.1 16.7 16.1 9.6 14.6 39.7 11.1 11.1 29.5 8.8 18.4 15.9 6.8 9.0 6.2 8.0 2.8 15.9 10.6 1.5 38.9 0.0 12.0 12.2 7.9 23.1 0.3 7.2 2.3 7.6 PCBP3 "FLJ44028, PCBP3-OT1, PCBP3OT" ENSG00000183570 "Poly(rC) binding protein 3" P57721 21 45643694-45942454 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 151.7;Cone photoreceptor cells: 47.1;Horizontal cells: 109.7;Late spermatids: 60.8;Rod photoreceptor cells: 75.1" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "cerebellum: 47.4;pons and medulla: 23.0" "Cell type enhanced" "Detected in many" "eosinophil: 5.9" "Group enriched" "Detected in many" 6 "B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.9;HDLM-2: 27.2;HSkMC: 20.9;SH-SY5Y: 23.6;U-87 MG: 12.6;U-937: 15.1" "Region enriched" "Detected in all" 5 "olfactory region: 280.8" "Region enhanced" "Detected in all" "olfactory region: 184.8" "HPA030247, HPA073145" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA030247: AB_10601244, HPA073145: " "unprognostic (3.88e-2)" "unprognostic (1.19e-1)" "unprognostic (2.01e-4)" "unprognostic (9.89e-4)" "unprognostic (2.74e-1)" "unprognostic (1.40e-1)" "unprognostic (4.10e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-2)" "unprognostic (1.64e-3)" "unprognostic (1.12e-3)" "unprognostic (1.97e-2)" "unprognostic (1.96e-6)" "unprognostic (8.67e-2)" "unprognostic (2.32e-2)" "unprognostic (8.04e-2)" "unprognostic (1.97e-2)" 6.5 11.7 6.0 11.2 6.7 12.3 6.3 47.4 12.6 3.8 7.9 7.0 2.2 3.1 9.3 12.4 1.4 3.2 4.4 2.7 6.5 7.3 2.2 1.1 1.8 5.0 6.9 3.7 3.4 3.5 0.6 14.8 2.3 23.0 1.5 3.0 20.2 1.7 1.9 1.1 1.6 4.8 12.3 7.3 11.6 3.4 20.5 6.1 22.6 0.8 0.0 4.6 2.3 1.8 2.9 0.0 5.9 0.4 0.6 1.6 0.5 0.0 0.0 0.2 0.0 6.9 14.9 0.0 0.8 0.2 1.6 0.7 0.0 0.0 0.0 0.3 4.0 1.9 0.0 0.8 0.0 0.2 27.2 0.1 0.0 0.0 0.0 7.0 0.0 0.0 20.9 0.1 0.2 0.4 0.0 0.0 1.0 0.0 0.1 0.9 0.3 7.7 1.6 0.4 0.0 1.3 0.0 0.0 1.1 0.0 0.0 2.6 23.6 0.5 0.0 0.0 0.7 0.0 4.2 0.0 0.0 0.0 6.1 0.0 0.3 1.5 0.0 12.6 15.1 0.5 4.4 0.4 5.9 1.6 0.3 0.3 2.9 0.9 0.0 0.0 1.9 1.5 0.2 1.4 0.6 0.2 0.0 0.8 0.5 6.0 6.7 47.4 6.0 6.5 7.3 6.9 3.7 23.0 6.1 0.0 0.0 1.4 0.1 0.2 151.7 2.8 0.0 0.0 1.2 1.8 47.1 0.0 0.0 0.1 29.4 0.5 0.0 0.0 0.2 0.1 1.3 0.9 0.0 0.0 0.4 109.7 2.9 2.5 0.0 60.8 7.8 0.2 3.3 0.0 0.0 29.6 1.4 0.0 12.0 0.0 75.1 0.0 5.3 25.0 12.0 0.0 0.0 0.0 0.0 0.3 PCDH1 pc42 ENSG00000156453 "Protocadherin 1" Q08174 5 141853111-141879246 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 37.9;Exocrine glandular cells: 40.1;Pancreatic endocrine cells: 44.8;Urothelial cells: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.5;HaCaT: 36.8;HUVEC TERT2: 19.3;OE19: 26.1;RT4: 25.2;TIME: 25.1;WM-115: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047720, HPA050538" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA 270000 "Nucleoplasm, Cell Junctions" Nucleoli "HPA047720: AB_2680130, HPA050538: AB_2681162" "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (5.30e-2)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (4.16e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (1.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.43e-1)" "prognostic favorable (7.55e-5)" "unprognostic (2.05e-1)" "unprognostic (4.16e-2)" "unprognostic (3.13e-2)" "unprognostic (1.91e-1)" 22.4 4.5 14.8 7.4 17.6 1.4 19.0 16.1 25.6 8.3 22.2 7.3 11.4 20.6 7.0 7.0 26.9 9.7 6.8 8.9 11.6 7.4 14.9 13.0 18.9 3.4 8.8 16.9 2.5 11.0 1.3 5.2 32.5 9.2 11.1 14.4 6.0 23.7 12.3 7.4 17.3 15.8 7.5 7.5 1.6 22.8 1.5 9.8 0.0 9.1 3.9 8.8 8.6 11.7 0.0 0.0 0.3 0.0 0.0 2.2 0.5 6.2 0.3 2.6 2.9 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.5 29.5 0.0 15.2 0.2 0.3 36.8 3.4 2.7 0.0 0.0 0.1 0.0 0.1 0.0 2.4 0.0 0.1 0.0 6.2 0.0 0.4 6.3 19.3 0.0 0.0 3.1 0.0 5.0 0.1 0.0 11.2 26.1 5.0 0.1 0.0 4.2 2.1 25.2 0.3 0.6 0.1 8.1 6.5 7.9 6.5 0.1 25.1 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.2 0.0 17.8 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.5 14.8 17.6 16.1 25.6 11.6 7.4 8.8 16.9 9.2 9.8 0.0 4.0 0.0 10.2 0.9 9.1 2.2 22.9 4.0 2.3 12.2 0.0 0.6 3.3 13.6 0.3 21.8 37.9 0.0 40.1 0.2 1.6 22.4 0.0 26.0 0.2 25.4 7.5 6.2 1.9 0.8 0.6 0.5 0.0 0.0 17.6 4.0 44.8 19.3 0.4 5.1 0.4 12.9 15.1 0.2 0.2 2.3 16.8 0.0 14.7 43.0 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149315-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0;placenta: 31.1;seminal vesicle: 23.6" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 16.2;Muller glia cells: 8.7;Smooth muscle cells: 4.7" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 6.9;HUVEC TERT2: 16.1;MOLT-4: 13.4;TIME: 32.0;U-138 MG: 8.6;U-251 MG: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: AB_2686605" "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 1.9 7.6 17.9 1.5 35.5 1.2 1.3 1.7 48.0 3.3 1.5 23.2 4.5 1.3 3.1 1.9 1.6 2.6 1.9 1.8 17.5 12.6 3.7 1.3 2.0 1.2 13.2 16.3 4.1 1.4 1.2 1.7 31.1 13.6 14.7 1.5 1.3 1.8 23.6 1.2 1.3 1.7 2.0 6.8 1.2 1.3 2.9 19.2 0.9 1.5 0.0 1.2 3.6 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 5.2 0.0 0.1 0.0 0.0 5.0 2.7 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 16.1 0.0 0.2 0.0 2.4 0.0 13.4 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 32.0 8.6 0.0 0.0 7.3 0.0 0.0 0.0 0.6 0.0 4.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.9 35.5 1.7 27.7 17.5 12.6 13.2 16.3 13.6 19.2 0.0 1.1 0.0 0.2 0.1 16.2 2.0 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.0 3.3 1.0 0.0 0.0 0.0 0.7 1.6 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.4 0.0 2.3 0.0 4.7 1.8 0.7 0.3 2.4 0.0 0.0 0.4 PCDHA4 "CNR1, CNRN1, CRNR1, PCDH-ALPHA4" ENSG00000204967 "Protocadherin alpha 4" Q9UN74 5 140806929-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Ciliated cells: 5.3;granulocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 9.1;AF22: 8.9;EFO-21: 7.7;T-47d: 7.7" "Low region specificity" "Detected in all" "HPA043180, HPA073478" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA043180: AB_10806381, HPA073478: AB_2686608" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (2.85e-1)" "unprognostic (5.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.14e-2)" "unprognostic (2.56e-1)" "unprognostic (7.90e-3)" "unprognostic (7.14e-3)" "unprognostic (7.00e-2)" "unprognostic (5.06e-3)" "unprognostic (6.94e-5)" "unprognostic (5.01e-3)" "unprognostic (6.21e-2)" "unprognostic (3.98e-1)" "unprognostic (6.29e-3)" "unprognostic (4.79e-2)" 0.9 0.8 5.1 0.9 6.5 3.2 1.7 12.1 8.7 2.1 1.1 1.6 0.4 0.9 2.3 2.0 0.6 1.6 5.1 1.2 4.5 3.2 2.0 0.6 1.7 1.5 1.9 2.1 1.1 4.1 1.0 1.4 0.7 3.9 1.8 1.1 0.4 1.1 1.3 1.1 2.0 0.9 1.1 3.0 1.1 1.0 1.4 2.4 0.0 1.3 0.1 0.7 1.3 0.8 1.5 1.3 2.0 0.7 0.8 1.1 0.0 0.2 9.1 8.9 0.4 0.1 0.3 0.3 0.2 0.1 0.1 0.1 0.2 1.8 0.3 7.7 0.2 0.4 0.3 0.0 0.1 0.2 0.2 0.2 0.4 0.6 0.3 0.1 0.3 0.5 0.4 2.4 0.2 0.4 0.6 0.5 0.4 0.2 1.2 0.3 0.2 0.2 0.3 2.5 1.9 1.3 0.2 0.2 0.3 0.3 0.4 0.4 3.8 0.1 2.0 0.8 1.6 7.7 0.3 0.9 2.0 1.3 0.7 0.2 0.5 0.2 0.2 0.3 0.4 0.8 1.8 0.7 0.7 1.1 0.4 0.8 0.8 0.8 0.7 0.3 1.5 0.8 1.1 2.0 0.8 0.7 1.3 0.6 0.0 5.1 6.5 12.1 6.6 4.5 3.2 1.9 2.1 3.9 2.4 3.0 1.3 0.0 0.5 0.0 0.9 0.8 0.0 5.3 1.2 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.7 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.3 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell type enhanced" "Detected in some" 27 "Alveolar cells type 1: 6.0;Bipolar cells: 1.7;Ciliated cells: 1.4;Rod photoreceptor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.7;EFO-21: 3.7;hTCEpi: 11.3;PC-3: 6.4;SCLC-21H: 5.0" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles No No "Nucleoplasm, Nucleoli" Vesicles "HPA052775: AB_2681942" "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.7 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 1.1 0.0 0.3 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 6.4 0.0 0.0 0.0 0.5 0.4 5.0 2.4 0.0 0.7 0.0 1.2 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 6.0 0.3 0.0 0.0 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCIF1 "bA465L10.1, C20orf67, PPP1R121" ENSG00000100982 "PDX1 C-terminal inhibiting factor 1" Q9H4Z3 20 45934628-45948023 "Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049517 Enhanced Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No Nucleoplasm "Microtubules, Cytokinetic bridge" "HPA049517: AB_2680801" "unprognostic (5.42e-3)" "unprognostic (7.76e-2)" "unprognostic (7.69e-2)" "prognostic unfavorable (8.86e-4)" "unprognostic (1.39e-2)" "unprognostic (4.20e-2)" "unprognostic (1.89e-2)" "unprognostic (2.11e-1)" "unprognostic (1.90e-1)" "unprognostic (1.72e-1)" "unprognostic (7.57e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.50e-6)" "unprognostic (1.01e-1)" "unprognostic (4.44e-2)" "unprognostic (9.14e-3)" "unprognostic (1.24e-1)" 18.5 15.7 12.7 18.4 17.8 26.2 19.2 33.7 27.9 26.0 19.4 26.7 15.9 14.7 29.8 17.0 19.4 28.8 16.9 23.7 12.9 12.4 16.3 13.2 18.9 23.9 17.7 13.6 37.5 23.5 21.5 18.9 18.7 14.4 20.0 10.8 23.9 20.6 20.8 27.1 24.2 17.1 19.6 16.1 22.8 16.3 17.6 16.2 36.0 24.8 15.3 22.2 18.7 20.4 31.8 28.1 42.4 26.4 38.3 32.7 31.9 11.4 15.9 12.4 15.3 8.7 10.7 13.8 4.7 14.1 14.2 13.8 27.1 15.5 12.4 15.7 12.4 16.4 13.0 8.8 16.1 6.1 7.6 6.3 15.9 12.8 18.1 16.5 14.2 16.1 14.7 16.9 8.7 14.0 12.7 11.8 20.7 11.1 17.4 10.1 24.1 28.0 26.7 4.4 13.9 14.0 17.5 11.5 15.2 11.5 12.1 17.0 17.1 17.6 16.6 8.9 6.9 17.5 16.7 10.1 17.5 14.0 15.4 9.2 20.2 11.6 11.4 22.0 13.2 10.1 37.2 26.4 42.4 32.7 25.7 25.6 30.2 28.3 29.5 28.1 31.8 29.8 25.9 42.3 38.3 24.8 22.6 29.1 31.9 12.7 17.8 33.7 27.9 12.9 12.4 17.7 13.6 14.4 16.2 3.0 13.9 23.9 22.3 7.7 9.2 19.8 15.3 14.7 5.7 10.4 2.0 16.0 13.3 16.7 7.6 13.9 10.8 0.0 33.3 18.9 12.0 21.3 13.9 9.7 15.1 12.7 25.5 9.2 13.9 6.4 10.6 17.3 16.9 24.4 15.0 10.3 21.8 14.0 12.0 18.2 9.5 0.0 13.9 12.6 10.4 9.4 23.2 27.3 11.9 32.3 PDE9A ENSG00000160191 "Phosphodiesterase 9A" O76083 21 42653636-42775509 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 168.7;Paneth cells: 77.2" "Cancer enhanced" "Detected in all" "prostate cancer: 31.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.8" "Group enriched" "Detected in many" 4 "NK-cells: 1.7;T-cells: 6.8" "Cell line enhanced" "Detected in many" "AF22: 16.3;EFO-21: 16.5;MCF7: 12.2;NB-4: 18.2;NTERA-2: 22.5;SCLC-21H: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011380, HPA011978" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA011380: AB_1855132, HPA011978: " "unprognostic (5.75e-2)" "unprognostic (9.92e-3)" "unprognostic (3.50e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (5.06e-2)" "unprognostic (3.99e-2)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-2)" "unprognostic (5.01e-2)" "unprognostic (1.90e-2)" "unprognostic (4.01e-3)" "unprognostic (1.97e-1)" "unprognostic (6.55e-2)" "unprognostic (1.79e-1)" 6.1 6.6 9.9 6.8 15.2 0.8 9.4 13.7 9.0 3.7 37.1 11.9 14.0 3.0 5.7 18.8 6.1 10.3 7.7 3.5 6.2 7.7 13.2 2.5 4.7 4.6 10.0 4.9 4.1 4.0 4.7 6.0 9.6 6.9 33.2 15.8 9.7 8.8 15.9 2.3 3.8 26.1 22.3 8.0 15.9 8.4 1.5 8.9 4.9 5.2 2.1 4.1 12.6 4.0 0.5 0.9 1.0 0.1 1.7 6.8 0.5 0.0 1.5 16.3 2.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.8 9.8 0.0 16.5 0.0 1.1 0.0 1.4 5.3 0.0 0.0 5.6 0.0 0.0 3.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 12.2 0.8 18.2 22.5 8.0 0.0 0.0 0.0 0.6 11.2 4.5 12.5 7.4 2.8 0.0 0.2 4.0 0.1 10.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.1 0.6 0.2 0.5 6.8 1.7 1.0 1.7 0.1 0.9 2.2 0.5 9.9 15.2 13.7 6.7 6.2 7.7 10.0 4.9 6.9 8.9 3.0 5.3 0.0 8.5 0.9 21.0 1.4 5.1 1.4 0.0 17.4 0.0 0.0 24.9 6.2 0.3 6.7 168.7 0.0 2.1 0.1 3.1 27.6 1.1 0.8 5.6 33.4 12.6 3.7 0.6 1.7 10.9 1.0 27.0 1.8 19.3 9.4 5.1 77.2 5.6 7.6 2.7 12.9 5.9 0.4 0.7 0.5 0.3 2.1 22.2 13.1 PDGFRA "CD140a, GAS9, PDGFR2" ENSG00000134853 "Platelet derived growth factor receptor alpha" P16234 4 54229097-54298247 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 81.5" "Group enriched" "Detected in many" 9 "Fibroblasts: 171.4;Leydig cells: 416.6;Peritubular cells: 384.4" "Cancer enhanced" "Detected in all" "glioma: 30.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 82.8;ASC TERT1: 38.8;BJ hTERT+: 48.0;fHDF/TERT166: 33.4;HHSteC: 28.0;HSkMC: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004947, CAB018143" Supported Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 150000 "Nucleoplasm, Plasma membrane, Cell Junctions" "CAB018143: AB_2162351, HPA004947: AB_2732399" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "unprognostic (4.59e-3)" "unprognostic (1.60e-1)" "unprognostic (8.92e-2)" "prognostic favorable (9.33e-4)" "unprognostic (1.24e-1)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (2.18e-2)" "unprognostic (2.18e-1)" "unprognostic (7.01e-2)" "prognostic unfavorable (9.79e-6)" "unprognostic (9.58e-3)" "unprognostic (9.87e-2)" "unprognostic (2.16e-2)" "unprognostic (1.72e-3)" 35.0 12.4 12.6 16.1 7.6 0.9 17.2 2.4 20.1 33.2 19.1 9.2 6.4 9.6 27.6 14.6 21.9 22.5 16.2 15.3 8.9 7.4 22.8 8.4 24.1 26.9 9.2 4.0 81.5 6.8 1.6 2.1 25.1 7.2 18.6 15.2 19.2 8.5 8.3 11.9 7.0 17.4 19.7 8.8 51.6 13.6 19.0 9.3 0.5 11.3 12.8 4.3 35.9 24.6 0.9 0.4 2.5 0.4 0.3 0.8 0.3 0.0 0.0 0.2 0.1 82.8 38.8 0.1 4.3 48.0 0.0 0.1 11.5 0.0 0.1 0.1 33.4 0.1 0.1 3.3 0.0 0.0 0.4 0.1 0.1 0.1 0.2 28.0 0.0 0.0 70.4 0.0 5.5 0.0 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 6.7 0.0 0.1 0.0 0.3 0.1 0.0 0.1 15.2 0.5 16.6 0.0 0.0 0.0 0.1 0.4 0.0 0.3 2.5 0.4 0.2 0.5 0.2 0.2 0.6 0.8 0.4 0.0 0.9 0.7 0.4 2.3 0.3 0.3 0.4 0.2 0.3 12.6 7.6 2.4 7.3 8.9 7.4 9.2 4.0 7.2 9.3 0.0 0.3 0.9 0.3 15.1 0.7 4.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 2.9 1.6 3.3 0.0 0.0 5.8 1.2 171.4 0.4 0.0 0.8 2.8 0.0 0.0 38.1 0.6 3.7 416.6 1.6 21.9 8.2 0.0 18.3 12.2 0.0 384.4 0.0 0.4 0.0 13.2 1.1 3.5 13.8 1.1 0.0 0.0 0.8 PDGFRL PRLTS ENSG00000104213 "Platelet derived growth factor receptor like" Q15198 8 17576433-17644071 "Disease related genes, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 14.3" "Cell type enhanced" "Detected in many" 11 "Fibroblasts: 36.0;Leydig cells: 69.0;Peritubular cells: 66.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "AN3-CA: 49.5;BJ hTERT+: 40.1;HSkMC: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052801 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted - unknown location" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA052801: AB_2681956" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (5.10e-2)" "unprognostic (1.59e-2)" "unprognostic (7.39e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (6.54e-2)" "unprognostic (3.86e-1)" "unprognostic (7.46e-2)" "unprognostic (1.63e-1)" "unprognostic (6.72e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.58e-3)" "unprognostic (1.26e-1)" "unprognostic (4.47e-3)" "unprognostic (6.00e-3)" 7.7 0.4 0.5 0.1 0.9 0.0 14.3 0.6 0.5 8.0 1.3 0.0 3.6 2.0 0.3 5.8 2.6 1.2 0.3 0.4 0.4 0.3 0.7 0.0 0.4 11.6 1.6 2.3 2.0 1.5 0.9 0.0 1.4 1.1 3.3 1.8 0.6 6.3 0.5 0.2 1.0 0.9 8.3 0.0 0.9 2.0 0.0 0.9 1.4 1.4 0.0 0.0 0.1 0.0 4.5 0.2 49.5 1.5 0.6 3.2 0.9 40.1 1.8 8.0 0.2 0.0 0.0 0.2 0.6 6.0 0.0 2.7 0.2 1.0 0.0 3.0 0.0 1.4 1.0 3.8 0.0 0.0 21.9 0.0 2.2 0.0 0.0 3.3 0.4 0.0 0.6 0.2 3.2 0.0 0.1 2.4 0.2 0.7 0.0 0.0 0.1 0.2 2.9 0.1 0.3 0.3 0.3 0.8 3.0 0.1 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.4 11.7 0.4 2.2 0.0 0.0 3.4 0.0 0.0 14.1 0.0 2.5 19.2 2.7 0.1 0.0 6.4 17.2 36.0 1.7 0.0 0.0 2.7 0.0 1.2 2.5 0.0 3.1 69.0 0.3 10.1 2.8 1.0 1.3 4.9 0.0 66.4 0.0 0.4 0.0 6.1 0.5 1.0 8.7 8.1 0.0 0.2 0.3 PDHX "DLDBP, E3BP, OPDX, PDX1, proX" ENSG00000110435 "Pyruvate dehydrogenase complex component X" O00330 11 34915829-35020591 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.5" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 117.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038484, HPA038485" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Nucleoplasm, Plasma membrane" Mitochondria "HPA038484: AB_10669645, HPA038485: AB_10669540" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (8.34e-3)" "unprognostic (3.56e-3)" "unprognostic (1.94e-1)" "unprognostic (2.14e-1)" "unprognostic (5.41e-2)" "unprognostic (2.60e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.83e-5)" "unprognostic (2.24e-1)" "unprognostic (8.28e-2)" "unprognostic (9.53e-2)" "unprognostic (2.82e-1)" 13.5 14.9 13.4 8.6 17.2 4.2 10.4 13.9 23.3 9.2 13.3 10.6 9.3 12.2 8.9 8.6 10.9 6.7 7.7 46.1 14.4 12.8 15.0 25.7 7.8 6.8 14.7 14.1 7.7 13.1 14.6 14.7 15.8 22.1 12.0 12.7 8.9 12.4 14.1 70.5 8.8 12.3 11.5 12.0 6.6 13.7 15.7 9.0 5.9 9.1 19.0 8.7 13.0 10.7 12.8 19.5 12.1 21.7 15.0 14.9 9.8 9.1 24.0 13.9 5.5 10.2 12.1 13.6 17.1 14.0 19.4 18.9 31.0 8.5 12.6 11.2 14.4 22.7 17.8 26.9 14.4 19.3 11.3 22.5 11.8 25.3 35.6 22.2 22.3 14.0 12.3 17.9 10.6 14.5 11.2 14.0 10.8 25.3 11.6 15.2 15.6 13.8 13.8 11.3 25.2 14.4 12.1 24.9 10.9 29.0 24.1 14.7 10.7 15.1 22.9 23.4 14.5 25.7 13.8 9.7 14.4 16.2 14.8 18.9 11.1 22.0 15.6 11.3 11.0 14.5 8.6 13.6 12.1 11.5 15.0 10.8 12.8 10.9 9.4 19.5 11.7 13.3 9.6 2.8 15.0 21.7 5.2 14.9 9.8 13.4 17.2 13.9 23.3 14.4 12.8 14.7 14.1 22.1 9.0 32.8 21.1 9.0 18.1 23.1 25.5 117.0 20.4 18.7 19.4 5.2 27.5 53.6 54.7 18.3 35.0 10.9 12.8 23.3 12.6 28.3 19.4 19.1 5.7 22.1 23.1 19.1 8.6 9.8 15.0 31.1 10.0 15.5 20.3 28.9 16.0 18.1 13.9 14.4 12.7 22.7 23.2 0.0 20.9 40.9 33.4 22.2 69.5 10.4 19.0 16.9 PDIA5 "FLJ30401, PDIR" ENSG00000065485 "Protein disulfide isomerase family A member 5" Q14554 3 123067062-123225227 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.0" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 119.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 12.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA030353, HPA030355" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" NA NA 2900000 "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA030353: AB_10599734, HPA030355: AB_10602200" "unprognostic (8.81e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-2)" "prognostic favorable (4.55e-4)" "unprognostic (4.34e-2)" "unprognostic (2.10e-2)" "unprognostic (7.38e-2)" "unprognostic (2.41e-1)" "unprognostic (3.21e-2)" "unprognostic (4.02e-2)" "unprognostic (1.55e-1)" "unprognostic (2.26e-3)" "prognostic unfavorable (8.09e-11)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-2)" "unprognostic (4.06e-3)" 11.6 17.1 2.6 11.2 3.1 6.3 9.3 1.0 4.0 10.0 11.0 2.4 10.9 5.6 12.2 17.1 6.7 9.1 22.2 7.2 2.5 1.2 11.0 66.0 14.4 7.1 2.2 1.8 11.4 18.3 5.2 12.1 29.1 1.9 14.3 10.8 12.7 10.8 7.6 8.1 6.1 8.2 9.5 2.3 8.6 17.6 18.0 2.5 3.2 18.2 5.5 7.9 7.8 6.9 3.2 12.8 0.3 9.0 0.5 2.4 2.3 8.2 5.1 6.4 7.7 29.4 26.7 34.1 15.8 26.5 8.8 24.4 16.3 7.6 0.0 20.6 24.4 5.7 4.4 2.8 9.6 9.4 0.2 3.1 3.6 1.5 19.4 12.2 9.1 0.6 22.8 14.5 6.0 12.6 9.5 29.8 3.5 4.6 21.6 6.0 10.1 2.4 10.6 4.7 18.9 5.3 2.3 4.6 22.8 7.4 4.8 6.9 4.2 7.7 8.6 13.5 10.9 7.5 11.1 16.6 2.3 7.3 10.6 4.2 6.4 1.7 3.7 7.3 7.2 7.7 0.0 9.0 0.3 1.4 2.2 2.4 3.2 1.0 0.9 5.4 0.8 0.6 0.6 0.2 0.5 0.4 12.8 0.0 2.3 2.6 3.1 1.0 4.0 2.5 1.2 2.2 1.8 1.9 2.5 17.9 27.8 1.5 3.6 4.4 9.3 2.0 25.5 8.1 13.6 5.2 37.3 39.8 0.0 28.0 1.1 21.8 3.3 0.0 25.3 119.9 23.6 13.9 3.5 42.3 10.8 0.0 8.1 37.4 8.4 1.5 22.5 4.5 8.5 1.8 26.1 2.0 13.8 3.5 20.8 4.9 29.6 12.9 7.3 1.2 1.5 3.6 42.0 2.2 16.3 4.3 PDLIM5 "Enh, LIM" ENSG00000163110 "PDZ and LIM domain 5" Q96HC4 4 94451857-94668227 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 129.6;skeletal muscle: 173.0" "Cell type enriched" "Detected in all" 8 "Cardiomyocytes: 1784.7" "Cancer enriched" "Detected in all" 8 "prostate cancer: 132.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 51.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 51.1" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013511, HPA016740, HPA020026" Enhanced Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA 2200000 "Nucleoplasm, Plasma membrane, Focal adhesion sites" "CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154" "unprognostic (6.20e-2)" "unprognostic (1.94e-1)" "unprognostic (2.81e-2)" "unprognostic (1.08e-2)" "unprognostic (6.61e-2)" "unprognostic (2.24e-1)" "unprognostic (1.33e-1)" "unprognostic (2.46e-2)" "unprognostic (7.60e-2)" "unprognostic (2.65e-1)" "unprognostic (1.18e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (2.11e-2)" "unprognostic (3.15e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" 11.6 4.8 6.2 4.2 6.1 8.7 9.8 3.4 5.8 12.7 11.0 3.7 7.1 5.6 37.5 12.9 14.0 10.2 11.0 129.6 5.3 5.2 12.9 13.9 5.6 5.3 5.4 4.5 10.3 8.1 3.4 6.8 18.9 10.2 15.3 5.4 12.6 15.3 12.5 173.0 5.6 15.8 22.1 4.9 7.0 5.6 5.5 3.7 1.0 5.3 52.9 9.5 17.7 7.1 3.2 5.6 51.1 12.2 2.7 3.9 3.8 8.2 24.4 9.5 3.7 21.0 14.4 3.7 20.1 16.7 11.5 9.3 22.5 18.3 3.3 20.6 20.1 5.9 8.5 12.9 18.8 19.3 5.8 5.4 12.0 15.9 8.5 30.3 3.9 10.8 19.3 16.6 27.6 21.5 51.4 25.9 3.4 5.1 3.6 24.5 8.1 4.0 1.3 3.2 18.1 10.2 1.9 7.0 2.9 12.9 26.4 4.7 6.3 11.0 25.1 5.6 8.0 2.9 1.2 32.4 30.1 4.8 13.0 12.2 2.5 3.2 3.3 16.4 2.8 7.0 51.1 6.8 5.9 3.8 11.8 3.1 3.2 3.7 3.9 5.6 2.5 2.5 3.2 6.8 2.7 12.2 1.9 3.4 3.8 6.2 6.1 3.4 3.9 5.3 5.2 5.4 4.5 10.2 3.7 41.7 23.4 12.7 232.1 172.6 4.3 1784.7 58.6 30.8 37.5 47.1 29.5 9.2 11.6 82.1 14.6 128.1 146.3 23.3 81.9 91.7 90.4 234.4 50.8 159.4 34.4 1.6 105.0 135.1 57.1 6.8 38.3 60.2 59.1 29.7 89.1 79.1 115.5 83.5 62.6 63.8 35.6 77.6 141.3 13.2 30.2 137.1 19.9 15.0 51.0 185.7 PDP1 "PDH, PDP, PPM2A, PPM2C" ENSG00000164951 "Pyruvate dehyrogenase phosphatase catalytic subunit 1" Q9P0J1 8 93857807-93926066 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 71.4;Early spermatids: 99.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 39.5;hTERT-RPE1: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018483, HPA019081, HPA021152" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol Yes No "Nucleoplasm, Mitochondria, Cytosol" "HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635" "prognostic unfavorable (8.61e-5)" "unprognostic (4.62e-1)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.46e-2)" "unprognostic (1.38e-1)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (3.25e-1)" "prognostic favorable (8.42e-9)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (5.04e-2)" "unprognostic (1.67e-1)" 5.1 32.3 11.0 4.6 38.9 5.9 7.9 7.5 62.2 7.5 4.3 4.7 1.6 3.3 7.7 8.6 8.0 6.1 9.6 22.9 10.1 8.0 6.3 2.2 6.0 5.6 5.1 32.5 9.7 9.3 20.6 4.2 6.6 4.4 5.2 6.2 4.4 6.6 4.7 31.8 3.2 5.5 5.5 3.4 5.8 5.5 12.9 4.8 4.1 9.3 7.0 5.8 7.7 5.1 11.0 12.7 7.8 21.5 2.8 19.5 8.8 7.9 3.9 8.6 3.6 7.1 13.1 2.8 6.3 7.0 7.4 8.7 4.1 29.6 4.4 21.2 10.0 39.5 17.7 3.6 5.3 11.0 0.4 1.8 2.1 4.9 1.4 8.2 1.0 3.0 8.4 10.5 12.6 20.2 39.3 16.7 4.0 0.7 7.3 9.0 1.9 6.2 3.2 3.9 8.6 5.1 1.5 5.1 0.8 5.1 5.5 0.8 3.7 4.1 0.4 19.3 7.3 1.3 1.2 29.6 9.0 5.8 21.0 7.4 4.1 1.7 3.7 11.5 3.7 7.9 3.1 15.4 7.8 5.6 14.3 5.3 9.3 9.1 7.2 12.7 11.0 5.5 4.8 1.8 2.8 21.5 2.1 19.5 8.8 11.0 38.9 7.5 62.2 10.1 8.0 5.1 32.5 4.4 4.8 11.9 5.6 13.4 11.2 11.6 34.7 71.4 22.9 22.7 17.0 15.7 7.9 3.5 5.0 24.3 99.2 14.7 6.0 0.0 11.9 3.2 11.6 13.3 5.8 2.5 5.7 9.5 9.8 14.1 20.8 22.0 10.6 16.2 10.1 2.8 5.2 19.0 22.2 7.0 12.7 8.6 10.6 6.5 12.7 7.2 9.7 9.5 3.7 10.1 8.9 17.0 PDZK1 "NHERF3, PDZD1" ENSG00000174827 "PDZ domain containing 1" Q5T2W1 1 145670852-145708148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 49.2;kidney: 124.3" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 758.4" "Group enriched" "Detected in many" 12 "breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3" "Region enriched" "Detected in single" 17 "cerebellum: 10.0" "Cell type enriched" "Detected in many" 4 "NK-cell: 7.6" "Lineage enriched" "Detected in many" 4 "NK-cells: 7.6" "Group enriched" "Detected in some" 4 "RPTEC TERT1: 43.1;T-47d: 112.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005755, HPA006155, CAB008971" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163" "unprognostic (4.56e-3)" "unprognostic (3.07e-1)" "unprognostic (8.79e-2)" "unprognostic (4.41e-2)" "unprognostic (9.15e-2)" "unprognostic (2.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.42e-1)" "unprognostic (2.08e-1)" "unprognostic (3.27e-1)" "unprognostic (2.34e-2)" "unprognostic (9.87e-3)" "prognostic favorable (2.54e-7)" "unprognostic (9.90e-2)" "unprognostic (3.02e-1)" "unprognostic (1.00e-3)" "unprognostic (8.87e-2)" 0.1 0.6 0.2 0.2 0.3 0.0 5.8 10.0 0.2 0.3 16.5 0.2 0.8 13.2 0.3 6.7 0.1 0.1 10.6 0.1 0.2 0.2 124.3 25.7 0.4 0.1 0.3 0.2 0.2 4.2 0.0 0.1 0.9 0.5 0.1 1.3 1.2 0.1 0.1 0.1 0.7 49.2 0.1 0.4 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 1.0 1.1 0.5 0.2 7.6 1.8 0.5 1.3 0.2 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 18.9 0.1 0.1 0.2 1.1 0.0 0.6 0.0 0.1 0.1 1.8 0.3 0.1 0.4 7.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 1.1 0.1 0.2 0.2 0.2 0.5 0.0 1.3 0.2 43.1 0.0 0.1 1.2 0.3 0.3 0.0 1.2 112.0 0.1 0.1 0.2 0.2 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.1 1.5 0.2 0.6 1.0 0.4 1.8 0.2 1.0 0.4 0.7 0.4 7.6 0.1 1.1 0.1 0.5 0.2 0.3 10.0 0.2 0.2 0.2 0.3 0.2 0.5 0.1 0.0 0.0 0.9 0.0 0.1 0.4 0.4 61.1 0.0 0.0 54.1 0.0 0.0 117.7 1.7 8.9 0.0 18.0 0.0 1.6 0.1 0.2 0.1 0.0 45.6 0.2 0.0 6.3 1.8 1.2 5.2 0.0 0.0 0.0 0.0 0.5 0.0 1.8 2.9 0.0 758.4 0.3 0.0 0.3 0.2 0.2 0.0 0.1 0.0 1.0 0.0 PEAR1 "FLJ00193, JEDI, MEGF12" ENSG00000187800 "Platelet endothelial aggregation receptor 1" Q5VY43 1 156893698-156916434 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 26.3;Erythroid cells: 23.3;Ito cells: 34.4;Leydig cells: 41.1;Peritubular cells: 33.6;Sertoli cells: 25.8;Smooth muscle cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.1;HBEC3-KT: 13.8;HHSteC: 10.4;HUVEC TERT2: 24.4;TIME: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035217 Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA 35000000 "Nucleoplasm, Cell Junctions" Centrosome "HPA035217: AB_10669902" "unprognostic (1.02e-1)" "unprognostic (1.84e-5)" "unprognostic (4.77e-2)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.48e-1)" "unprognostic (5.62e-2)" "unprognostic (5.93e-2)" "unprognostic (1.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.17e-1)" "unprognostic (5.04e-1)" "prognostic unfavorable (4.31e-4)" "unprognostic (1.20e-2)" "unprognostic (3.37e-3)" "unprognostic (8.51e-2)" "unprognostic (2.64e-2)" 18.5 7.1 1.8 3.0 5.1 2.8 29.2 1.2 2.9 16.5 5.8 2.7 6.3 2.3 15.9 10.5 6.6 8.9 10.3 11.1 2.7 1.8 6.8 3.8 12.0 10.1 3.2 2.1 10.6 3.2 1.7 3.9 15.5 3.7 9.6 1.4 15.5 4.1 5.5 11.4 4.4 4.1 9.6 3.1 12.2 4.1 8.1 1.5 0.6 10.5 5.8 2.1 6.7 11.5 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.2 1.3 0.4 0.0 0.0 1.8 0.0 5.4 9.1 2.2 1.3 0.1 0.2 0.0 0.2 4.0 0.2 0.1 0.0 13.8 0.6 0.0 0.0 6.7 0.2 0.3 10.4 0.0 0.0 5.4 0.0 3.1 0.7 0.5 24.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.0 0.0 39.2 0.0 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 1.8 5.1 1.2 2.9 2.7 1.8 3.2 2.1 3.7 1.5 0.0 5.6 0.0 0.0 0.8 1.3 5.6 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.1 26.3 0.0 23.3 0.3 0.1 5.1 0.1 1.1 0.0 0.4 0.0 1.7 34.4 1.3 1.9 41.1 0.4 5.0 0.0 1.0 0.3 0.9 0.0 33.6 0.0 0.2 25.8 14.6 0.7 1.1 1.0 0.2 0.0 0.0 0.1 PEF1 PEF1A ENSG00000162517 "Penta-EF-hand domain containing 1" Q9UBV8 1 31629862-31644896 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061608 Approved Nucleoplasm,Vesicles,Cytosol NA NA 660000 "Nucleoplasm, Cytosol" Vesicles "HPA061608: AB_2684567" "unprognostic (2.92e-2)" "prognostic favorable (3.95e-4)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-1)" "unprognostic (8.40e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (5.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.79e-2)" "unprognostic (1.60e-2)" "unprognostic (2.12e-1)" "unprognostic (1.35e-1)" "unprognostic (8.85e-3)" "unprognostic (2.38e-1)" "unprognostic (1.60e-1)" "unprognostic (2.89e-3)" 34.0 27.0 26.9 15.3 28.7 17.0 27.1 22.5 40.8 26.6 23.4 25.9 21.1 16.2 27.1 46.5 29.7 29.0 26.1 26.4 24.3 23.8 28.3 38.7 24.9 20.8 25.0 17.3 31.1 20.8 31.6 21.6 44.2 28.6 29.8 24.2 25.7 24.8 33.4 25.5 32.5 20.7 31.9 22.4 23.6 20.5 17.8 16.5 27.4 85.9 20.3 30.7 23.7 21.9 39.1 40.4 60.9 39.5 42.0 49.2 48.7 17.7 20.8 17.4 13.4 20.6 21.6 16.7 16.9 29.1 41.0 36.2 12.2 26.9 19.0 23.7 37.7 21.1 18.7 33.6 43.2 33.3 23.8 36.4 15.7 16.8 24.6 36.3 15.3 14.9 22.2 50.0 40.0 37.6 26.2 39.6 23.5 16.2 19.7 29.3 20.9 23.3 14.9 24.1 22.0 23.7 22.7 16.9 20.7 32.0 19.3 24.9 14.4 19.3 18.2 25.2 28.6 16.2 11.2 20.9 17.8 15.3 30.2 22.3 12.7 12.8 20.4 22.4 22.6 21.3 60.9 39.5 46.2 49.2 35.3 47.5 37.8 42.1 44.6 40.4 39.1 39.9 40.0 40.1 42.0 32.7 37.4 41.9 48.7 26.9 28.7 22.5 40.8 24.3 23.8 25.0 17.3 28.6 16.5 38.7 33.6 34.3 57.8 32.2 37.2 14.6 20.4 20.1 21.6 66.3 11.8 131.6 96.2 58.8 67.1 60.4 35.8 0.0 54.4 80.4 36.6 45.7 71.5 20.5 54.6 50.9 42.5 31.9 17.0 60.2 41.7 26.1 47.2 124.4 29.6 55.3 47.2 34.8 55.2 41.2 20.3 19.4 42.2 34.5 41.5 44.9 152.9 34.6 33.2 48.8 PELI1 ENSG00000197329 "Pellino E3 ubiquitin protein ligase 1" Q96FA3 2 64092652-64144454 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.7" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 199.1;Suprabasal keratinocytes: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.9" "Group enriched" "Detected in all" 4 "granulocytes: 33.9;monocytes: 9.2" "Cell line enhanced" "Detected in many" "CACO-2: 21.8;U-698: 54.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.33e-2)" "unprognostic (3.43e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (3.12e-3)" "unprognostic (6.73e-3)" "unprognostic (8.01e-3)" "unprognostic (4.16e-2)" "unprognostic (3.52e-3)" "unprognostic (5.99e-3)" "unprognostic (3.33e-1)" "prognostic unfavorable (5.67e-6)" "unprognostic (6.72e-2)" "unprognostic (6.22e-2)" "unprognostic (8.88e-2)" "unprognostic (1.03e-1)" 15.7 5.1 10.0 15.1 20.5 105.7 22.3 15.1 8.9 9.9 14.5 11.0 3.3 9.9 14.5 7.1 26.4 8.0 14.9 11.6 11.3 6.8 6.7 8.6 20.1 16.8 15.6 5.2 4.8 6.2 11.0 14.8 13.7 10.8 7.6 11.8 6.0 12.3 8.5 4.5 17.5 17.3 8.4 15.0 17.8 10.2 7.8 12.8 19.9 6.3 10.2 19.3 14.1 14.8 3.9 2.3 33.9 9.2 1.3 5.0 2.5 1.3 1.0 14.0 9.3 1.6 1.2 3.2 1.8 2.0 1.6 2.6 21.8 1.5 17.9 4.4 0.6 0.6 2.1 4.2 3.9 3.3 4.4 3.3 1.6 0.7 3.5 4.9 1.7 3.2 1.6 3.1 2.4 8.4 1.7 9.2 6.9 1.0 4.5 1.4 0.1 3.8 2.5 9.1 4.1 0.6 4.8 4.8 10.2 6.7 4.0 6.4 9.0 1.3 2.1 4.8 4.5 1.1 1.2 6.5 1.5 2.2 1.5 2.6 10.4 1.0 54.2 0.8 1.6 4.1 5.1 6.5 6.3 0.4 6.1 0.7 3.9 2.2 0.9 2.3 2.4 2.7 1.1 33.9 1.3 9.2 0.2 5.0 2.5 10.0 20.5 15.1 8.8 11.3 6.8 15.6 5.2 10.8 12.8 26.8 45.1 22.4 65.1 199.1 0.9 5.1 10.2 30.8 55.7 5.2 0.0 1.4 1.7 4.5 8.5 42.7 37.0 0.0 23.1 6.5 25.9 43.3 14.0 6.8 19.1 3.2 24.6 36.2 52.6 7.8 1.4 57.1 106.3 13.6 22.2 4.5 18.2 28.1 1.8 7.7 1.8 0.0 48.4 6.1 7.8 190.1 3.3 11.5 27.3 104.0 PELI2 ENSG00000139946 "Pellino E3 ubiquitin protein ligase family member 2" Q9HAT8 14 56117814-56301526 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 21.4" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 19.3;JURKAT: 24.9;MOLT-4: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.26e-1)" "unprognostic (2.25e-1)" "unprognostic (9.21e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (2.53e-2)" "unprognostic (3.36e-3)" "unprognostic (1.81e-1)" "unprognostic (2.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.14e-1)" "prognostic favorable (1.53e-6)" "unprognostic (3.64e-1)" "unprognostic (2.15e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" 12.3 3.3 5.2 5.6 4.6 16.5 8.7 21.4 6.5 7.5 9.4 5.4 9.7 11.1 9.3 7.1 4.7 5.9 11.5 3.4 4.6 4.5 9.7 3.1 7.3 4.8 5.2 3.9 16.0 38.9 1.7 5.5 3.3 4.4 8.2 4.2 9.2 7.6 12.4 3.8 6.5 12.6 17.7 5.8 6.6 14.1 10.0 4.2 38.2 4.9 3.4 2.6 13.3 14.9 0.9 2.0 9.0 3.0 0.5 0.8 1.1 0.0 1.8 5.1 0.0 2.8 4.2 0.1 0.7 2.4 0.5 0.0 0.1 0.4 0.1 2.4 1.4 0.0 0.5 3.9 0.0 0.2 1.2 1.4 4.4 7.9 0.0 2.4 0.6 19.3 2.7 0.2 0.0 0.0 2.8 0.9 24.9 3.2 0.0 0.5 0.0 21.6 0.2 8.3 0.0 0.7 10.6 0.3 0.9 2.1 8.7 10.2 0.0 0.4 0.0 5.7 3.3 0.0 3.5 0.3 1.5 2.6 0.4 2.5 0.4 0.0 0.5 2.7 3.0 1.5 1.4 3.0 3.5 0.5 1.6 0.8 0.2 0.6 0.3 2.0 0.9 0.4 0.3 9.0 0.5 1.2 0.5 0.0 1.1 5.2 4.6 21.4 4.4 4.6 4.5 5.2 3.9 4.4 4.2 0.0 7.7 2.7 11.0 12.7 30.0 1.9 7.6 14.7 10.3 12.2 27.5 0.0 3.3 4.4 2.3 10.9 8.4 0.0 12.2 0.1 5.6 7.0 5.7 0.8 1.1 20.6 6.9 11.1 16.5 4.1 15.8 11.1 16.9 2.8 7.4 10.0 8.6 3.7 17.0 8.8 18.5 12.9 22.1 1.4 27.2 15.9 0.1 3.5 3.0 9.7 PELI3 MGC35521 ENSG00000174516 "Pellino E3 ubiquitin protein ligase family member 3" Q8N2H9 11 66466327-66477337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 20.6;Intestinal endocrine cells: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033750, HPA038875, HPA062281" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Vesicles" Nucleoli "CAB033750: AB_2161361, HPA038875: AB_2676249, HPA062281: AB_2684735" "unprognostic (1.15e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (1.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.19e-3)" "unprognostic (7.91e-3)" "prognostic favorable (8.19e-4)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.01e-2)" 6.7 9.5 14.5 3.8 17.0 1.8 7.4 19.6 33.1 7.4 8.3 6.7 6.4 4.8 10.3 9.1 10.6 8.2 10.1 7.7 17.4 13.5 4.6 3.2 7.1 4.3 13.0 12.5 15.3 9.9 21.5 8.3 3.8 15.8 11.5 2.9 6.4 10.4 22.3 10.8 11.2 4.7 11.3 6.2 5.0 5.8 6.2 7.8 0.3 8.5 2.7 3.4 9.0 11.8 3.3 3.3 1.3 6.8 1.2 3.1 1.4 15.5 6.6 5.4 4.2 8.6 3.4 4.3 5.0 6.5 4.8 4.1 9.6 3.5 3.9 5.0 5.4 8.6 8.4 3.5 6.3 2.0 7.6 3.1 1.0 5.4 2.8 5.4 0.8 7.6 3.2 7.1 4.9 1.7 7.0 1.0 5.2 1.8 6.1 2.0 9.5 3.2 2.4 3.4 8.2 6.8 10.8 3.9 4.1 2.6 5.0 6.5 3.6 2.5 7.2 17.0 2.4 8.4 4.2 2.7 4.2 6.5 18.3 4.1 5.6 3.2 2.1 8.9 2.5 3.5 1.3 2.5 0.4 2.5 1.8 2.0 2.8 2.1 3.1 3.3 3.3 2.2 1.8 0.1 1.2 6.8 1.0 2.4 1.4 14.5 17.0 19.6 33.1 17.4 13.5 13.0 12.5 15.8 7.8 6.0 1.3 0.0 3.4 1.4 12.1 6.2 2.5 0.0 0.0 0.0 9.8 1.9 1.7 2.7 3.7 2.5 0.0 0.0 2.1 1.7 3.1 2.0 0.0 2.4 2.9 20.6 25.4 1.8 0.6 5.6 6.9 3.2 0.0 2.8 0.5 5.5 1.9 0.8 9.2 2.2 8.5 6.5 4.8 1.9 3.2 0.3 0.2 0.0 0.6 1.6 PEX6 "PAF-2, PXAAA1" ENSG00000124587 "Peroxisomal biogenesis factor 6" Q13608 6 42963870-42979220 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis" "Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 73.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025924, HPA074179" Supported Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA025924: AB_1855230, HPA074179: " "unprognostic (7.32e-3)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (9.16e-2)" "unprognostic (9.18e-2)" "unprognostic (3.27e-1)" "unprognostic (8.88e-2)" "unprognostic (5.92e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "unprognostic (7.24e-3)" "unprognostic (5.31e-2)" "unprognostic (3.79e-3)" "unprognostic (1.86e-1)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (1.55e-1)" 13.0 14.9 12.1 11.5 18.9 9.0 11.5 21.7 19.0 14.7 16.9 14.6 15.3 9.8 11.9 8.8 18.2 23.4 13.0 10.4 12.9 12.1 11.3 18.8 7.4 17.6 17.3 9.1 20.0 73.2 21.3 18.2 10.6 16.0 17.8 8.5 10.8 15.0 12.8 15.2 14.2 24.6 10.5 9.9 12.8 10.6 10.6 17.2 22.3 21.5 6.9 10.9 11.2 12.4 4.3 4.3 4.8 3.2 4.0 6.1 2.5 15.9 7.7 3.9 14.5 14.5 14.0 4.0 2.8 4.4 2.3 4.8 4.8 4.7 6.5 3.9 6.7 9.8 15.1 13.5 14.6 2.4 12.6 7.2 2.1 10.9 2.8 9.8 2.2 4.5 17.4 16.9 9.5 2.6 18.8 11.7 8.9 11.3 6.7 5.0 1.8 5.7 7.2 4.8 36.3 6.7 12.3 6.8 2.6 5.9 4.6 12.2 5.3 2.6 10.4 14.7 6.6 20.5 9.8 6.5 7.4 1.4 3.6 6.4 10.1 8.8 8.9 2.5 11.3 5.9 2.1 3.2 4.8 3.0 2.4 5.4 2.6 4.4 6.1 4.3 4.3 5.5 5.1 2.0 4.0 1.5 2.5 2.1 2.5 12.1 18.9 21.7 19.0 12.9 12.1 17.3 9.1 16.0 17.2 6.0 1.6 2.7 8.8 4.4 14.5 4.5 5.1 5.3 3.4 7.0 2.0 7.7 11.6 2.4 2.2 4.0 12.4 0.0 1.3 5.7 6.4 6.2 0.0 10.5 4.9 20.6 5.2 9.8 6.7 2.2 13.6 2.8 8.5 1.0 7.4 10.6 1.7 7.0 8.9 9.8 6.4 0.0 5.2 7.7 2.8 4.8 6.2 4.4 8.0 5.5 PFDN6 "H2-KE2, HKE2, KE-2, PFD6" ENSG00000204220 "Prefoldin subunit 6" O15212 6 33289302-33298401 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043032, HPA048123" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 110000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA043032: AB_2678278, HPA048123: AB_2680273" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (7.66e-2)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (1.35e-2)" "unprognostic (8.29e-2)" "unprognostic (3.36e-1)" "unprognostic (1.55e-1)" "prognostic favorable (1.01e-4)" "unprognostic (6.93e-2)" "unprognostic (6.67e-2)" "prognostic unfavorable (8.97e-4)" "unprognostic (1.79e-1)" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.68e-3)" 12.5 19.1 29.2 15.4 27.8 15.0 15.6 13.2 33.9 12.0 17.7 12.9 13.1 13.8 14.4 22.4 15.1 12.5 11.4 16.2 31.6 24.8 19.1 23.2 10.8 15.7 27.0 31.9 14.5 21.3 15.3 14.6 14.0 20.7 12.5 16.2 8.2 15.8 16.0 43.6 10.8 13.7 13.4 20.7 11.3 12.2 33.1 17.5 10.7 12.2 22.5 18.9 11.8 9.8 6.8 5.0 3.4 7.1 3.9 7.5 4.3 15.0 10.1 7.0 14.5 7.9 6.7 11.5 11.6 5.9 10.1 9.7 9.5 7.5 22.2 14.1 6.5 19.4 11.0 11.5 13.3 15.3 14.9 12.2 19.9 11.2 15.8 8.8 15.2 13.0 6.0 15.3 14.3 10.2 8.0 9.9 13.1 24.2 9.6 10.9 10.3 18.2 16.1 11.7 10.0 8.8 15.7 10.3 22.4 16.4 7.2 16.3 19.7 10.1 26.4 16.7 7.4 15.2 22.0 8.3 7.2 10.7 8.9 19.1 19.3 52.6 24.8 7.0 20.2 10.3 3.2 5.1 3.4 4.1 6.5 4.2 5.9 5.6 7.5 4.9 6.8 3.3 4.6 2.7 3.9 7.1 5.0 5.3 4.3 29.2 27.8 13.2 33.9 31.6 24.8 27.0 31.9 20.7 17.5 23.8 8.3 51.5 39.3 49.5 21.5 17.7 71.4 17.4 17.0 52.4 9.8 107.5 102.8 74.2 74.3 28.8 70.3 0.0 89.2 103.2 41.2 43.0 62.1 64.4 70.1 17.5 48.4 19.0 26.8 30.2 57.2 47.3 67.4 83.0 47.0 38.4 78.6 71.9 46.3 154.1 21.2 38.8 32.0 200.4 54.7 55.8 92.7 37.6 54.6 43.9 PGAM2 PGAM-M ENSG00000164708 "Phosphoglycerate mutase 2" P15259 7 44062727-44065587 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0" "Group enriched" "Detected in many" 13 "Early spermatids: 421.0;Late spermatids: 1332.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 39.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA043801, HPA050314, HPA060173" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA 60000000 Nucleoplasm "Nucleoli, Cytosol" "HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215" 1.4 0.8 2.0 0.4 2.2 0.4 0.5 6.9 2.1 0.5 0.5 3.6 0.0 0.6 0.5 9.1 6.1 0.6 0.7 111.6 2.1 3.2 0.8 0.4 0.4 0.4 4.2 1.6 0.5 0.6 0.6 1.3 0.4 2.0 1.9 0.4 2.3 7.6 0.5 379.1 0.4 0.4 0.4 3.2 0.5 0.5 16.7 1.1 4.8 1.5 119.0 4.8 0.4 0.0 0.3 1.3 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 4.3 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 1.3 1.7 0.2 2.0 2.2 6.9 2.1 2.1 3.2 4.2 1.6 2.0 1.1 0.0 0.0 0.5 0.2 1.0 4.3 0.0 0.0 0.0 0.0 0.0 9.8 0.0 68.0 0.0 421.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 22.0 0.0 0.3 1332.7 7.2 0.4 1.7 0.0 0.0 3.8 0.2 0.2 5.6 1.9 4.2 25.8 3.1 30.5 5.6 0.5 0.0 0.0 0.2 0.4 PGF "D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760" ENSG00000119630 "Placental growth factor" P49763 14 74941834-74955784 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 177.3" "Group enriched" "Detected in many" 16 "Extravillous trophoblasts: 1478.5;Syncytiotrophoblasts: 1775.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "BEWO: 93.4;HUVEC TERT2: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041624 Approved Nucleoplasm,Mitochondria,Cytosol "Secreted to blood" No No 20800 Nucleoplasm "Mitochondria, Cytosol" "HPA041624: AB_10794522" "unprognostic (1.67e-2)" "unprognostic (4.62e-2)" "unprognostic (9.25e-3)" "unprognostic (1.34e-3)" "unprognostic (8.67e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (4.45e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-3)" "prognostic unfavorable (1.33e-6)" "unprognostic (2.52e-3)" "unprognostic (1.20e-1)" "unprognostic (3.49e-2)" "unprognostic (1.14e-1)" 4.3 2.7 1.9 4.4 2.4 0.0 4.3 1.6 3.5 13.1 2.3 2.3 4.0 1.3 2.9 6.3 3.9 9.2 3.4 5.1 2.4 4.1 3.1 2.6 3.6 4.9 2.9 2.0 3.8 1.9 5.4 2.0 177.3 4.6 7.5 1.1 3.5 3.8 6.7 3.3 6.0 4.3 4.6 1.7 1.2 1.7 3.3 2.0 1.4 24.2 4.4 2.9 5.1 5.9 0.7 0.7 1.1 1.0 0.0 2.4 0.2 0.3 0.3 0.3 0.3 0.4 0.0 93.4 0.8 0.8 0.4 0.5 2.2 0.1 0.0 2.0 0.6 0.0 0.1 0.4 4.2 0.3 0.0 0.5 0.0 0.0 2.2 0.3 0.0 2.4 1.1 1.0 1.7 0.4 0.1 44.0 0.0 0.0 0.0 12.4 0.1 0.0 0.1 0.4 0.0 0.7 0.0 11.6 0.0 0.1 0.2 7.0 3.8 0.0 0.1 1.6 5.9 0.0 0.1 8.9 0.0 2.3 0.0 3.7 0.0 0.0 0.1 1.4 0.1 0.1 0.0 0.2 1.1 2.4 1.0 0.0 0.7 0.3 0.7 0.3 0.3 0.6 1.0 0.0 0.0 0.8 0.7 0.5 0.2 1.9 2.4 1.6 2.2 2.4 4.1 2.9 2.0 4.6 2.0 8.9 5.8 0.8 13.0 21.9 0.8 2.8 0.0 1.4 7.9 0.0 13.7 75.1 0.0 0.9 0.1 15.8 0.5 0.0 0.4 1478.5 42.9 3.3 5.8 0.0 33.1 0.0 6.8 7.4 0.3 0.6 12.0 4.5 20.3 0.0 1.1 1.9 0.6 0.2 18.4 0.4 7.5 103.5 62.6 0.2 3.4 17.1 1775.1 0.9 1.7 4.7 PGGT1B "BGGI, GGTI" ENSG00000164219 "Protein geranylgeranyltransferase type I subunit beta" P53609 5 115204012-115262872 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 111.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030646 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Endoplasmic reticulum" Cytosol "HPA030646: AB_10602019" "unprognostic (2.73e-2)" "unprognostic (1.67e-1)" "unprognostic (3.92e-2)" "unprognostic (7.34e-2)" "unprognostic (5.57e-2)" "unprognostic (7.56e-3)" "unprognostic (1.34e-1)" "unprognostic (1.75e-1)" "unprognostic (3.25e-2)" "unprognostic (1.33e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-1)" "unprognostic (4.38e-2)" "unprognostic (1.58e-1)" "unprognostic (3.75e-1)" "unprognostic (5.93e-3)" "unprognostic (1.15e-2)" 10.5 12.4 7.3 13.3 10.1 10.9 13.9 8.8 22.1 10.8 13.8 7.7 7.9 12.3 9.2 4.6 14.9 7.3 7.0 13.5 9.5 5.9 8.2 13.7 22.2 22.2 10.2 10.0 9.6 10.1 12.0 13.4 7.8 8.2 8.4 15.1 5.7 10.6 8.4 10.2 9.9 10.4 9.5 6.9 10.4 11.0 5.1 10.5 10.2 8.8 9.9 10.1 9.6 10.5 8.0 11.5 21.8 16.7 6.7 6.3 6.4 10.2 11.2 12.8 16.5 7.5 6.3 6.3 12.7 7.5 10.6 11.0 12.2 11.0 20.9 17.3 8.8 11.0 8.0 16.8 16.7 15.9 23.0 9.3 12.0 14.6 9.7 10.0 16.5 17.8 9.4 10.3 10.4 10.9 6.8 10.6 12.4 9.7 8.9 12.1 16.0 14.4 5.5 9.5 11.6 8.7 15.8 17.1 21.2 11.1 19.4 12.5 9.5 15.1 11.5 12.1 8.0 15.4 12.4 12.1 10.9 10.3 7.5 14.8 15.0 16.7 11.0 7.9 17.2 15.1 8.3 12.8 21.8 5.0 16.6 5.6 6.8 5.7 6.3 11.5 8.0 5.4 5.0 13.1 6.7 16.7 10.3 4.9 6.4 7.3 10.1 8.8 22.1 9.5 5.9 10.2 10.0 8.2 10.5 11.9 14.4 20.7 10.2 8.9 22.7 15.7 5.1 25.4 18.2 15.7 45.2 12.3 23.2 17.0 28.4 16.1 17.8 0.0 18.9 11.6 11.7 13.7 23.1 24.5 19.5 22.3 28.9 20.3 18.3 8.1 12.4 23.0 10.1 12.6 23.0 25.4 17.9 21.0 14.5 18.3 111.9 12.9 14.1 11.4 15.6 10.8 11.3 19.1 23.3 17.8 PGLYRP1 "PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L" ENSG00000008438 "Peptidoglycan recognition protein 1" O75594 19 46019153-46023065 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 73.7;bone marrow: 130.1" "Cell type enhanced" "Detected in single" 35 "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 190 "eosinophil: 63.0;neutrophil: 73.7" "Lineage enriched" "Detected in single" 205 "granulocytes: 73.7" "Cell line enhanced" "Detected in some" "A549: 7.3;HEK 293: 4.1;HeLa: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045702, HPA070227" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 47000000 Vesicles "Nucleoplasm, Cytosol" "HPA045702: AB_10960204, HPA070227: " "unprognostic (2.87e-2)" "unprognostic (4.26e-1)" "unprognostic (1.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.58e-1)" "unprognostic (4.93e-3)" "unprognostic (2.20e-1)" "unprognostic (6.46e-2)" "unprognostic (7.77e-2)" "unprognostic (2.61e-2)" "unprognostic (8.51e-3)" "unprognostic (7.18e-2)" "unprognostic (2.04e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (1.73e-1)" "unprognostic (4.37e-3)" 0.7 0.1 0.2 0.5 0.4 130.1 0.2 0.4 0.2 0.1 0.3 0.3 0.0 0.2 0.1 0.1 0.2 0.4 0.1 10.9 0.2 0.2 0.2 1.5 10.9 1.0 0.2 0.0 0.7 0.2 0.1 1.4 4.1 0.1 0.1 0.1 0.5 0.7 0.1 1.3 0.3 0.2 0.1 0.1 26.9 0.2 0.9 0.0 7.5 1.3 0.0 0.5 0.1 5.5 0.0 0.0 73.7 0.3 0.0 0.0 0.4 0.6 7.3 1.2 0.8 0.0 0.0 2.0 0.6 0.0 0.0 0.0 1.2 0.6 2.0 0.2 0.0 0.6 2.7 0.0 0.0 0.0 1.9 4.1 0.8 3.5 0.3 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.7 0.6 0.0 0.5 0.4 2.2 0.4 0.0 2.7 1.6 0.2 0.2 0.0 2.6 0.8 0.2 0.5 0.1 0.0 0.6 0.3 0.1 0.0 0.1 0.3 0.7 1.1 1.6 1.3 0.8 1.1 1.7 0.1 0.0 0.0 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.7 0.0 0.3 0.0 0.0 0.4 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PHF14 KIAA0783 ENSG00000106443 "PHD finger protein 14" O94880 7 10973336-11169630 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000538, HPA017376" Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA000538: AB_1079604, HPA017376: AB_2732420" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "unprognostic (3.73e-3)" "unprognostic (7.38e-3)" "unprognostic (8.05e-2)" "unprognostic (3.38e-1)" "unprognostic (4.66e-3)" "unprognostic (1.80e-1)" "unprognostic (5.32e-3)" "unprognostic (6.76e-2)" "unprognostic (2.94e-2)" "unprognostic (3.10e-1)" "unprognostic (4.84e-3)" "unprognostic (1.24e-1)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" "unprognostic (2.33e-1)" 12.5 10.9 25.0 12.4 20.4 6.4 18.4 21.4 23.8 14.0 12.7 10.7 7.2 10.3 17.9 11.0 10.6 12.4 12.6 7.7 24.7 22.1 12.2 14.8 11.3 12.0 18.5 15.5 20.2 9.8 18.4 21.4 11.0 20.0 13.9 14.3 7.1 10.0 11.5 9.3 11.3 10.1 14.9 16.2 12.9 13.3 12.0 14.9 31.5 12.7 7.6 12.9 11.9 10.6 3.9 5.8 1.6 2.0 3.4 4.6 0.8 6.7 14.1 20.7 21.4 7.3 7.1 9.9 5.3 4.5 6.5 7.1 12.5 12.2 26.4 9.8 5.0 14.3 9.5 18.4 6.3 7.1 9.5 7.0 13.0 12.5 16.3 6.7 28.8 12.4 6.4 6.8 7.5 13.8 9.0 9.3 10.4 17.2 9.4 7.7 8.7 11.4 12.8 17.3 28.2 10.1 19.3 13.3 8.3 6.7 13.2 18.5 26.0 8.2 28.0 8.9 15.4 14.9 21.2 8.5 9.0 12.0 5.7 10.3 12.1 20.9 18.5 6.3 24.5 21.1 1.6 2.0 1.2 2.9 1.8 2.3 3.9 3.2 3.7 1.2 3.4 4.6 3.8 0.1 3.4 1.6 5.8 4.1 0.8 25.0 20.4 21.4 23.8 24.7 22.1 18.5 15.5 20.0 14.9 38.7 34.5 48.8 62.8 51.1 77.9 19.4 30.6 36.1 53.4 31.4 55.0 57.8 23.2 78.4 17.7 69.7 43.4 0.0 73.0 66.3 61.3 43.8 56.4 39.4 36.4 74.7 88.5 58.9 35.9 9.5 95.3 36.0 35.4 30.7 59.7 49.5 75.4 42.1 110.0 27.0 64.0 51.8 48.4 133.9 124.4 45.8 33.3 30.5 59.7 46.9 PHF20 "C20orf104, dJ1121G12.1, TDRD20A" ENSG00000025293 "PHD finger protein 20" Q9BVI0 20 35771974-35950381 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 349.5;Late spermatids: 510.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029619, HPA029620, HPA029621" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201" "unprognostic (1.21e-3)" "unprognostic (7.30e-2)" "unprognostic (3.20e-2)" "unprognostic (2.35e-3)" "unprognostic (1.36e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.76e-1)" "unprognostic (2.17e-1)" "unprognostic (2.64e-2)" "unprognostic (4.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (7.23e-2)" "unprognostic (1.01e-2)" 19.1 11.6 14.0 16.8 19.0 14.1 17.2 25.1 19.2 15.9 15.9 16.1 8.1 8.1 19.1 11.6 16.5 14.2 14.8 15.2 14.1 13.8 11.2 11.1 16.5 17.3 14.9 13.0 18.9 9.4 17.9 20.0 15.6 15.0 14.7 11.7 14.7 15.3 15.7 46.6 12.9 12.3 17.2 18.9 20.8 12.7 17.4 15.2 19.4 14.2 14.5 20.8 18.7 21.8 12.0 8.2 23.6 11.9 13.0 12.4 6.5 9.7 7.8 13.7 20.3 10.0 11.5 12.8 11.2 10.7 11.3 9.9 22.8 7.4 16.4 10.2 14.9 13.9 6.1 12.6 15.6 13.8 7.4 5.4 30.5 15.0 8.4 10.0 14.6 11.9 9.0 22.0 11.9 18.4 13.4 12.3 11.7 12.5 10.6 12.9 5.8 14.7 8.5 6.8 6.5 9.8 10.8 20.3 9.7 9.0 6.8 12.5 10.2 20.0 23.2 10.2 13.0 18.3 10.9 17.2 25.1 5.7 13.0 11.4 9.8 11.6 12.0 18.5 10.7 12.8 11.9 8.6 23.6 10.6 9.0 11.3 12.0 10.5 11.9 8.2 9.8 12.0 12.4 20.5 13.0 11.9 7.7 5.5 6.5 14.0 19.0 25.1 19.0 14.1 13.8 14.9 13.0 15.0 15.2 35.7 39.9 77.0 65.2 30.9 75.5 47.0 30.6 57.6 40.9 36.6 92.3 85.9 31.5 25.8 349.5 40.9 11.8 0.0 17.4 39.0 36.8 47.3 136.5 15.3 46.9 108.1 34.5 39.3 53.1 510.4 33.1 60.9 37.1 31.5 24.9 44.2 20.8 25.7 50.2 19.5 75.2 19.4 39.6 55.4 46.4 24.7 18.7 82.0 29.0 53.3 PHF21B "BHC80L, FLJ34161, PHF4" ENSG00000056487 "PHD finger protein 21B" Q96EK2 22 44881162-45009999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 12.5;Cone photoreceptor cells: 21.6;Early spermatids: 12.7;Horizontal cells: 27.0;Late spermatids: 30.5;Rod photoreceptor cells: 25.4" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.2;AN3-CA: 7.3;JURKAT: 6.4;NTERA-2: 5.2;SCLC-21H: 6.4;SH-SY5Y: 28.4;U-2 OS: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053834, HPA074665" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA053834: AB_2682276, HPA074665: " "unprognostic (1.04e-1)" "unprognostic (7.76e-2)" "unprognostic (2.00e-1)" "unprognostic (7.44e-2)" "unprognostic (1.37e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.55e-1)" "unprognostic (3.83e-3)" "unprognostic (1.86e-3)" "unprognostic (2.02e-1)" "unprognostic (9.35e-2)" "unprognostic (2.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.22e-1)" 0.7 3.5 8.4 0.8 7.4 0.5 0.8 3.7 10.9 10.1 0.7 3.6 0.9 0.7 8.6 1.7 1.6 2.3 0.8 1.3 7.8 3.4 2.2 0.5 0.6 0.6 4.7 3.2 5.6 1.8 2.0 17.9 0.6 4.2 4.8 0.6 6.5 0.8 2.1 0.7 0.5 0.7 2.3 4.4 0.6 1.0 8.5 7.3 0.0 3.0 0.0 0.6 0.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.3 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 1.5 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.2 0.4 0.0 0.0 6.4 0.0 0.0 0.1 0.6 0.9 0.0 5.2 0.0 0.3 0.0 1.9 0.1 0.0 0.1 6.4 28.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.1 6.4 0.0 0.2 0.3 0.0 3.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 7.4 3.7 7.3 7.8 3.4 4.7 3.2 4.2 7.3 0.0 0.0 0.0 0.8 0.1 12.5 1.3 0.0 1.4 0.0 0.0 21.6 0.0 1.7 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 27.0 0.0 0.0 0.0 30.5 0.6 0.0 0.0 0.0 0.0 4.6 0.1 0.0 1.8 0.0 25.4 0.0 0.0 0.7 3.4 0.0 0.0 0.0 0.0 0.1 PHGDH "PDG, PGDH, SERA" ENSG00000092621 "Phosphoglycerate dehydrogenase" O43175 1 119648411-119744226 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 16.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 99.3" "Low region specificity" "Detected in all" "CAB003681, HPA021241, HPA024031, CAB068216" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No 9000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300" "unprognostic (2.30e-1)" "unprognostic (2.16e-1)" "unprognostic (1.80e-2)" "prognostic unfavorable (1.48e-4)" "prognostic favorable (1.62e-4)" "unprognostic (9.80e-2)" "unprognostic (1.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.24e-2)" "unprognostic (4.45e-3)" "unprognostic (8.80e-3)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (1.78e-3)" 18.8 1.9 33.3 4.4 32.1 4.4 13.8 7.8 27.2 11.9 5.8 49.7 9.4 4.2 6.1 41.0 16.7 24.5 3.9 5.3 26.7 20.5 14.0 53.2 4.3 5.7 42.0 20.7 17.3 58.2 67.5 5.7 6.4 23.3 24.5 4.7 8.7 62.9 16.4 1.7 35.9 3.0 8.1 28.3 1.9 9.0 8.6 38.1 9.9 15.8 7.3 7.3 7.9 14.1 6.7 3.2 2.9 0.7 1.2 16.5 3.2 13.6 5.6 14.6 35.0 8.4 11.0 27.2 12.3 22.3 17.7 29.3 28.8 2.4 0.0 5.4 33.0 1.9 18.4 27.0 25.7 12.5 0.1 24.6 4.3 19.6 19.9 17.3 27.5 0.1 15.8 43.0 16.9 20.0 9.9 12.7 48.8 7.9 32.6 7.8 53.5 18.4 8.4 36.4 10.6 42.5 16.2 25.3 2.3 1.2 16.2 15.7 14.4 9.0 6.1 99.3 13.9 12.3 47.0 0.1 2.9 15.3 17.9 13.8 26.9 6.7 27.5 35.8 38.5 22.7 2.9 0.7 0.2 2.9 0.2 0.2 6.7 1.8 4.9 3.2 2.7 9.1 16.5 2.0 1.2 0.2 1.8 2.4 3.2 33.3 32.1 7.8 27.2 26.7 20.5 42.0 20.7 23.3 38.1 3.0 9.3 9.7 92.1 46.0 0.8 2.0 84.1 21.4 7.9 19.2 2.0 32.1 114.4 48.9 40.9 3.3 0.2 0.0 120.7 43.3 25.5 86.4 5.7 90.0 8.0 0.0 1.7 2.5 1.3 81.6 62.7 4.8 54.0 19.0 1.1 79.1 39.9 2.5 120.2 80.4 2.9 12.9 16.0 5.2 3.4 67.4 21.2 5.0 1.5 39.9 PHLDA1 "DT1P1B11, PHRIP, TDAG51" ENSG00000139289 "Pleckstrin homology like domain family A member 1" Q8WV24 12 76025447-76033932 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 142.4" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 1037.1;Smooth muscle cells: 353.3;Urothelial cells: 680.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1" "Group enriched" "Detected in many" 7 "monocytes: 2.5;T-cells: 4.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 65.6;RPTEC TERT1: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016160, HPA019000, HPA063520" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028" "unprognostic (9.09e-2)" "unprognostic (2.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.51e-3)" "unprognostic (2.33e-1)" "unprognostic (2.60e-3)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.21e-3)" "unprognostic (5.03e-2)" "unprognostic (1.21e-1)" "unprognostic (3.34e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-1)" "unprognostic (4.55e-3)" 13.2 15.9 9.4 8.4 12.1 9.0 13.5 6.4 15.7 11.5 4.5 11.1 4.8 3.4 7.1 3.1 33.3 5.1 20.0 9.6 8.2 7.9 13.8 33.2 14.2 3.0 8.4 5.6 10.8 8.8 2.6 6.0 7.1 10.0 4.8 5.5 24.9 142.4 6.5 3.3 6.3 7.0 7.6 9.7 14.6 10.8 2.3 10.1 2.5 18.0 13.2 19.9 17.0 17.8 0.3 0.1 0.4 2.5 0.3 4.1 0.6 12.7 15.3 12.0 6.6 5.6 11.7 0.8 10.8 29.2 4.9 6.8 8.4 15.6 0.0 3.2 4.5 16.3 6.5 0.3 18.1 10.6 1.9 0.2 0.3 0.7 14.3 8.2 0.3 3.3 3.6 13.3 20.4 40.6 65.6 11.8 0.0 1.0 0.3 25.1 1.6 0.0 1.6 4.4 7.7 23.6 0.0 3.1 0.3 51.5 28.9 0.8 2.3 1.8 0.1 35.1 15.6 7.7 0.1 10.9 16.8 1.6 19.5 10.6 0.1 0.0 0.0 28.4 0.1 20.9 0.3 0.1 0.2 2.4 0.2 3.9 0.3 2.5 2.5 0.0 0.2 0.5 0.6 0.4 0.3 2.5 0.1 4.1 0.6 9.4 12.1 6.4 7.7 8.2 7.9 8.4 5.6 10.0 10.1 11.9 17.2 2.7 1037.1 173.4 1.5 29.5 10.2 6.7 22.7 29.6 2.0 4.8 71.3 68.6 1.0 95.1 0.7 0.0 35.8 6.3 85.4 57.9 80.5 117.3 97.6 1.6 112.7 23.9 10.8 1.3 8.6 53.3 271.7 41.5 10.3 90.9 162.8 3.5 14.5 32.7 4.0 265.1 353.3 0.5 0.4 66.0 6.2 23.0 8.0 680.5 PIGQ "GPI1, hGPI1" ENSG00000007541 "Phosphatidylinositol glycan anchor biosynthesis class Q" Q9BRB3 16 566995-584136 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039105, HPA039828, HPA061414" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: AB_2684508" "unprognostic (1.23e-2)" "unprognostic (6.12e-3)" "unprognostic (2.81e-1)" "unprognostic (2.65e-2)" "unprognostic (1.09e-2)" "unprognostic (2.42e-1)" "unprognostic (9.58e-2)" "unprognostic (8.05e-2)" "unprognostic (2.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (8.98e-2)" "prognostic favorable (2.53e-6)" "unprognostic (2.73e-1)" "unprognostic (2.60e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" 13.9 15.7 12.8 8.7 13.9 48.4 8.4 12.8 20.6 8.4 9.7 11.4 16.7 15.4 10.9 23.3 7.2 10.0 13.6 7.4 10.5 11.1 18.9 12.5 13.0 6.2 9.1 13.2 10.4 29.3 18.1 15.3 8.4 9.4 11.2 4.1 15.4 15.5 17.6 12.4 12.8 8.1 5.5 7.2 10.3 13.6 15.3 8.2 11.8 18.4 4.2 7.9 9.8 6.7 5.6 10.5 5.9 6.0 5.5 5.3 3.9 8.6 13.0 4.6 6.5 3.0 1.8 8.7 9.0 3.5 3.9 4.3 9.1 8.0 4.5 11.8 2.0 3.5 13.8 2.1 4.0 0.8 13.1 19.0 6.9 14.1 6.4 5.8 6.0 6.5 3.3 6.0 6.5 1.3 2.6 3.6 8.5 15.5 2.6 1.3 11.2 11.1 6.9 6.3 1.8 13.4 21.6 3.9 10.5 3.5 3.5 8.4 13.2 10.3 4.7 6.6 1.5 10.7 4.2 8.7 6.6 8.4 7.5 6.3 10.0 2.9 3.6 2.2 3.3 6.5 1.2 4.8 3.0 5.3 5.6 4.6 4.4 4.6 5.1 4.9 5.6 5.1 3.1 5.9 5.5 6.0 10.5 4.2 3.9 12.8 13.9 12.8 20.6 10.5 11.1 9.1 13.2 9.4 8.2 14.9 20.7 3.0 6.7 4.2 12.5 7.3 0.0 17.4 9.1 38.4 3.9 8.9 3.3 16.0 23.2 7.0 20.0 46.7 15.1 7.4 9.1 8.5 8.1 14.3 8.2 9.5 19.4 5.5 7.3 44.6 6.9 7.4 15.1 5.4 11.8 17.5 12.5 9.9 6.7 11.5 12.9 0.0 9.5 27.2 12.6 4.3 4.9 6.9 11.0 3.5 PIGX FLJ20522 ENSG00000163964 "Phosphatidylinositol glycan anchor biosynthesis class X" Q8TBF5 3 196639775-196736007 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 34.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029409, HPA073301" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029409: AB_10610280, HPA073301: " "unprognostic (8.83e-2)" "prognostic favorable (2.12e-4)" "unprognostic (2.14e-1)" "unprognostic (2.42e-3)" "unprognostic (9.25e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.45e-5)" "unprognostic (1.91e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.02e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.53e-1)" "unprognostic (1.46e-1)" "unprognostic (2.01e-1)" 19.1 13.7 25.1 12.7 25.5 9.3 19.2 16.9 25.8 13.1 15.5 13.1 7.8 12.3 15.2 18.5 16.6 12.6 12.7 13.9 23.2 25.4 18.1 12.5 15.6 27.0 24.8 13.4 10.9 16.0 28.1 18.2 17.7 14.5 18.6 17.1 16.3 12.9 18.5 18.6 12.3 11.8 17.1 21.7 18.4 10.6 9.0 14.2 24.6 15.5 10.6 14.7 13.6 10.7 1.7 3.2 34.5 4.4 3.6 2.1 1.5 22.3 10.2 13.4 9.4 14.2 10.8 7.6 10.1 12.2 12.4 12.9 9.8 14.6 11.0 33.9 10.1 15.4 12.3 11.4 9.6 15.4 10.0 10.6 9.1 7.1 6.6 13.1 10.2 17.0 8.1 15.0 10.0 9.5 9.9 6.7 18.0 6.2 22.1 11.3 20.3 26.3 13.3 6.0 17.8 11.6 14.3 15.8 15.9 12.8 7.5 13.0 14.4 17.0 11.7 13.9 10.5 40.5 9.5 3.5 11.9 5.2 13.0 15.5 27.9 32.1 20.8 10.8 12.6 12.3 15.5 3.0 34.5 1.5 4.4 1.3 1.7 1.4 2.1 3.2 1.7 1.6 1.4 8.6 3.6 4.4 1.4 1.7 1.5 25.1 25.5 16.9 25.8 23.2 25.4 24.8 13.4 14.5 14.2 17.9 21.8 19.9 24.6 15.1 31.0 10.7 20.4 9.4 11.4 27.9 45.2 17.1 29.9 6.9 19.9 15.7 18.7 0.0 4.9 17.4 22.4 27.9 11.5 14.4 17.0 31.8 15.1 17.8 18.3 17.2 25.9 19.4 20.3 10.8 17.7 33.8 5.4 14.4 32.9 29.9 34.6 25.8 19.4 21.4 33.5 13.9 9.7 17.8 26.3 16.3 PIK3AP1 "BCAP, FLJ35564" ENSG00000155629 "Phosphoinositide-3-kinase adaptor protein 1" Q6ZUJ8 10 96593312-96720514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 66.5;Kupffer cells: 114.3;Macrophages: 53.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9" "Group enriched" "Detected in all" 6 "B-cells: 17.5;monocytes: 38.9" "Cell line enhanced" "Detected in some" "Daudi: 24.7;NB-4: 17.8;REH: 52.8;THP-1: 26.9;U-698: 33.7;U-937: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026136, HPA038452" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" No No Cytosol "Nucleoplasm, Plasma membrane" "CAB026136: , HPA038452: AB_2676019" "unprognostic (2.83e-2)" "unprognostic (4.61e-3)" "unprognostic (7.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.79e-1)" "unprognostic (1.49e-1)" "unprognostic (4.60e-2)" "unprognostic (1.10e-1)" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" "unprognostic (2.10e-1)" "unprognostic (5.11e-2)" "unprognostic (1.28e-1)" "unprognostic (4.69e-2)" "unprognostic (5.45e-1)" "unprognostic (1.13e-1)" 5.8 2.2 2.9 16.8 7.1 14.7 4.8 1.0 3.0 1.4 2.2 3.2 0.0 1.9 1.3 2.3 1.3 2.0 8.5 3.3 3.1 2.4 6.2 38.4 6.0 19.5 5.3 0.5 3.3 16.1 0.3 3.0 10.9 5.1 1.8 2.7 1.6 29.7 0.8 1.1 1.5 6.6 2.4 7.3 32.0 1.9 1.7 4.3 2.0 2.4 0.6 19.2 4.1 2.2 17.5 4.4 4.7 38.9 4.5 4.8 4.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.4 24.7 2.5 0.0 0.4 0.0 5.2 0.0 0.2 13.7 0.9 3.7 0.0 0.4 0.0 10.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.3 17.8 0.2 7.0 0.3 52.8 1.2 5.8 0.0 0.0 1.1 0.6 0.0 0.0 0.3 0.1 0.0 26.9 0.0 0.0 0.8 0.0 0.2 0.2 0.0 33.7 0.0 27.7 0.0 1.7 5.4 3.3 4.8 15.5 1.7 17.5 0.1 1.5 4.4 16.2 0.0 1.2 4.7 4.5 38.9 3.9 0.1 4.2 2.9 7.1 1.0 3.0 3.1 2.4 5.3 0.5 5.1 4.3 3.0 3.8 29.6 0.0 1.3 0.2 2.2 28.1 1.4 3.4 1.8 2.0 0.4 1.7 26.1 3.3 1.4 2.6 0.0 25.2 0.7 1.0 0.5 13.9 66.5 41.2 0.0 1.7 8.0 114.3 0.4 1.1 53.7 5.0 2.8 2.5 0.2 22.8 18.4 2.1 12.8 3.3 0.0 1.7 0.2 0.2 1.0 1.9 27.7 2.9 0.1 PIK3C2A PI3K-C2alpha ENSG00000011405 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha" O00443 11 17077730-17207983 "Enzymes, Predicted intracellular proteins" "Endocytosis, Exocytosis" "Kinase, Transferase" "Cataract, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037641, HPA037642" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA037641: AB_10671878, HPA037642: AB_10697081" "unprognostic (2.35e-1)" "unprognostic (2.16e-2)" "unprognostic (3.71e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-1)" "unprognostic (6.63e-2)" "unprognostic (2.47e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-2)" "unprognostic (1.86e-2)" "unprognostic (4.74e-2)" "unprognostic (1.84e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.20e-2)" "unprognostic (1.51e-1)" "unprognostic (1.18e-1)" "unprognostic (1.37e-1)" 22.3 16.8 17.6 17.2 26.3 9.2 20.0 22.6 17.2 22.1 17.2 13.9 22.2 15.6 20.3 19.2 16.8 18.2 20.2 16.3 14.5 11.6 25.7 16.3 22.2 11.3 17.6 16.1 17.6 14.2 62.9 23.0 23.5 28.5 18.7 14.3 15.2 15.6 27.5 15.4 13.1 17.9 19.5 31.8 17.5 18.3 19.4 18.0 11.4 32.2 9.3 11.5 23.1 20.5 4.4 5.2 6.0 7.2 4.2 4.8 1.6 23.1 10.6 17.8 11.1 12.9 13.2 16.0 14.7 15.9 10.8 15.1 25.8 2.6 6.8 7.3 12.6 17.7 15.4 14.2 11.2 19.2 5.8 12.3 4.2 12.9 10.1 14.1 5.2 6.7 10.2 7.9 10.6 20.9 10.1 25.6 4.3 9.9 6.6 8.3 7.1 2.8 3.3 10.1 13.0 8.2 2.9 18.5 4.7 13.4 20.6 10.5 9.3 22.3 9.6 10.3 15.6 5.7 5.3 31.9 8.7 12.6 22.5 8.9 2.7 5.9 5.6 10.4 4.9 10.0 4.1 4.1 2.9 4.6 2.5 3.0 3.6 3.7 3.6 5.2 4.4 4.8 2.8 6.0 4.2 7.2 3.7 2.3 1.6 17.6 26.3 22.6 17.2 14.5 11.6 17.6 16.1 28.5 18.0 71.5 56.0 17.6 19.9 31.4 47.8 22.4 22.9 29.4 39.8 34.9 66.8 25.6 16.6 15.8 21.3 80.2 17.1 0.0 21.6 14.0 19.7 34.1 30.2 28.6 16.4 33.4 27.5 108.1 38.5 12.0 23.9 23.8 18.6 11.8 20.1 82.7 22.6 11.5 29.4 17.0 41.1 38.8 29.8 36.4 15.5 29.6 120.0 19.2 17.2 27.3 PIN4 "EPVH, PAR14, PAR17" ENSG00000102309 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 4" Q9Y237 X 72181353-72302926 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 68.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054483, HPA064504" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA054483: AB_2682503, HPA064504: AB_2685274" "unprognostic (2.47e-1)" "unprognostic (6.97e-3)" "unprognostic (1.65e-1)" "unprognostic (3.77e-2)" "unprognostic (8.42e-2)" "unprognostic (1.30e-2)" "unprognostic (1.14e-2)" "prognostic favorable (6.37e-4)" "unprognostic (1.56e-1)" "unprognostic (2.13e-2)" "unprognostic (2.49e-1)" "unprognostic (9.54e-2)" "unprognostic (2.09e-3)" "unprognostic (1.92e-1)" "prognostic favorable (2.58e-4)" "unprognostic (3.34e-3)" "prognostic favorable (2.66e-4)" 14.4 11.3 15.0 8.0 14.7 6.1 18.8 10.7 16.2 9.7 9.7 8.4 6.7 9.5 11.6 19.3 8.9 8.7 30.7 11.2 15.2 12.2 15.6 23.2 7.9 7.9 12.9 11.0 12.7 8.1 8.0 9.2 9.8 10.0 10.4 11.1 6.6 30.7 37.1 68.7 7.3 9.6 9.2 12.4 16.7 9.3 4.7 6.9 9.7 12.9 40.1 9.1 7.8 9.2 28.9 26.8 23.4 23.6 22.4 33.4 22.7 15.4 18.1 19.0 12.9 13.0 10.9 10.1 10.6 12.2 13.0 13.4 9.1 11.5 4.6 31.0 10.9 17.6 11.0 16.8 18.6 16.1 11.7 37.8 7.9 21.6 23.9 7.2 12.5 6.7 7.3 10.3 14.2 4.9 14.7 13.2 14.2 13.3 20.6 9.7 18.7 10.9 21.1 13.5 17.6 16.4 10.9 15.1 13.7 16.5 10.8 12.2 21.7 12.4 5.8 10.9 14.6 9.0 11.5 13.2 5.9 9.1 16.2 7.7 7.1 7.6 7.7 17.0 12.6 6.4 21.9 23.3 23.4 26.8 23.6 26.4 28.9 28.3 25.5 22.8 26.4 29.3 29.4 9.7 22.4 21.8 26.8 33.4 22.7 15.0 14.7 10.7 16.2 15.2 12.2 12.9 11.0 10.0 6.9 62.5 35.0 52.8 54.1 38.4 26.9 74.7 81.5 84.3 51.2 113.4 7.9 137.4 154.2 102.6 10.6 70.5 117.6 23.3 102.2 92.0 70.9 50.1 55.5 238.7 95.4 27.0 88.9 80.4 73.2 6.2 69.0 61.7 57.3 68.5 76.9 55.6 124.5 101.7 76.4 218.0 33.7 84.1 78.3 14.4 39.1 40.9 100.9 62.3 82.1 54.0 PINX1 "FLJ20565, Gno1, LPTL, LPTS, MGC8850, PinX1, Pxr1" ENSG00000254093 "PIN2/TERF1 interacting telomerase inhibitor 1" Q96BK5 8 10764963-10839884 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023139, HPA023146" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoli "Nucleoplasm, Mitochondria" "HPA023139: AB_1855384, HPA023146: " "unprognostic (4.01e-1)" "prognostic favorable (2.45e-5)" "unprognostic (7.80e-3)" "unprognostic (3.35e-2)" "unprognostic (4.10e-1)" "unprognostic (4.61e-2)" "unprognostic (1.83e-2)" "unprognostic (3.40e-2)" "unprognostic (9.73e-3)" "unprognostic (2.49e-1)" "unprognostic (1.40e-1)" "unprognostic (4.37e-1)" "unprognostic (2.59e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" 14.3 14.4 9.9 16.0 13.9 14.8 13.8 14.5 16.5 12.6 14.2 12.6 7.1 11.5 15.7 8.9 19.3 10.7 9.3 11.7 10.6 10.1 13.1 19.4 11.2 19.2 13.2 10.9 16.1 17.2 7.6 10.7 13.3 17.6 11.4 12.0 15.6 14.9 8.5 21.2 19.0 11.3 15.9 11.1 14.8 11.7 24.0 9.7 18.7 12.4 17.8 19.6 11.5 14.3 9.8 8.8 4.4 8.4 8.9 16.0 8.4 6.4 8.7 9.4 8.9 8.0 6.5 10.8 9.9 4.5 10.9 7.4 9.1 5.7 17.4 3.5 5.3 13.4 13.1 23.8 18.3 14.1 7.0 7.1 7.3 6.1 9.8 9.0 7.8 4.6 5.4 11.7 8.6 16.1 3.9 15.1 11.9 23.1 10.8 10.7 7.7 25.5 9.8 21.6 28.3 9.7 20.9 11.5 15.9 8.1 8.0 7.8 8.1 6.6 7.9 21.7 12.0 8.4 9.7 9.1 6.6 14.3 8.4 12.7 4.9 12.7 31.7 6.8 14.8 14.9 1.5 6.8 4.4 12.5 8.4 16.0 9.7 10.9 13.1 8.8 9.8 15.0 11.6 0.4 8.9 7.3 6.8 12.3 8.4 9.9 13.9 14.5 16.5 10.6 10.1 13.2 10.9 17.6 9.7 3.0 4.1 9.9 14.8 23.7 5.2 3.3 7.6 10.7 9.1 3.5 11.8 14.9 10.0 0.0 29.6 11.4 4.0 0.0 0.0 9.6 8.0 5.2 13.9 6.6 14.3 3.2 8.1 11.6 4.0 22.3 8.6 9.6 6.8 0.0 3.9 6.2 0.0 4.8 6.0 8.2 21.5 0.0 6.2 24.9 25.1 25.0 40.3 11.7 7.7 8.0 PIP4K2C "FLJ22055, PIP5K2C" ENSG00000166908 "Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma" Q8TBX8 12 57591174-57603418 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 112.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028658 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028658: AB_10601245" "unprognostic (7.84e-3)" "unprognostic (1.51e-1)" "unprognostic (2.42e-1)" "unprognostic (2.77e-2)" "unprognostic (2.49e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (7.98e-4)" "unprognostic (3.17e-2)" "unprognostic (6.00e-2)" "unprognostic (5.51e-2)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "prognostic favorable (2.06e-6)" "unprognostic (1.87e-1)" "unprognostic (2.16e-1)" "unprognostic (3.27e-1)" "unprognostic (3.42e-1)" 9.3 13.3 13.9 9.2 25.9 16.7 15.0 18.9 45.5 12.5 17.5 14.6 15.8 11.6 14.2 62.0 20.0 20.0 12.1 10.8 15.4 10.9 26.9 14.4 14.4 9.2 14.3 21.2 12.3 14.9 29.6 13.7 11.1 18.8 16.7 19.4 17.4 18.6 14.6 9.4 18.4 13.3 11.9 12.7 10.7 27.6 25.6 12.1 5.9 17.9 8.5 13.1 14.6 14.1 6.8 5.4 29.7 8.4 9.4 16.1 6.5 19.1 13.5 5.5 6.6 0.0 0.0 17.8 8.0 15.0 14.5 13.5 17.2 27.7 4.1 17.6 9.3 17.9 17.5 9.0 15.7 11.7 6.2 10.1 7.5 6.5 12.1 12.8 6.9 13.5 5.0 26.7 5.5 10.3 17.8 7.3 4.6 9.6 12.6 7.5 18.9 6.2 6.0 10.5 11.7 11.8 0.1 49.9 6.2 15.2 32.8 9.3 11.5 17.2 11.5 10.9 19.4 31.6 6.4 1.6 7.3 10.1 10.7 8.4 9.7 11.3 9.3 14.4 5.9 12.1 29.7 5.2 15.3 16.1 6.2 10.7 5.9 9.9 12.0 5.4 6.8 9.6 11.5 10.2 9.4 8.4 2.3 12.1 6.5 13.9 25.9 18.9 45.5 15.4 10.9 14.3 21.2 18.8 12.1 8.9 7.5 3.0 5.7 11.0 13.1 112.2 15.3 13.4 9.1 33.2 17.7 9.3 18.3 16.2 23.8 3.5 18.0 0.0 17.1 13.6 4.9 9.9 3.5 11.6 7.9 7.9 21.4 9.8 2.9 35.3 6.4 4.1 11.8 8.2 16.1 6.5 28.1 13.6 4.9 10.1 8.3 19.4 6.4 11.9 7.1 11.2 14.5 8.7 8.6 7.1 PIP5K1A ENSG00000143398 "Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha" Q99755 1 151197949-151249536 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029366 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA029366: AB_10602116" "unprognostic (1.05e-1)" "unprognostic (2.36e-2)" "unprognostic (8.64e-2)" "unprognostic (7.94e-3)" "unprognostic (1.17e-1)" "unprognostic (3.28e-2)" "unprognostic (1.26e-2)" "unprognostic (3.01e-1)" "unprognostic (8.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.16e-7)" "unprognostic (1.44e-1)" "unprognostic (8.14e-2)" "unprognostic (2.93e-1)" "unprognostic (1.59e-1)" 18.1 19.5 15.7 15.4 21.0 9.6 20.2 22.6 27.6 19.8 18.0 20.3 14.7 16.4 24.8 22.6 20.7 19.4 20.7 18.9 17.3 13.4 17.8 18.3 21.7 17.1 12.7 17.5 20.4 16.6 21.8 25.3 44.6 14.6 17.3 15.6 29.5 17.8 15.2 26.1 20.4 20.4 27.2 16.1 20.1 16.8 42.1 14.0 19.3 20.1 13.9 22.3 16.2 17.7 9.1 8.7 11.7 6.2 4.7 5.9 6.3 17.7 13.8 21.4 24.7 14.1 15.0 21.1 23.5 33.0 43.9 39.4 25.1 17.2 16.2 25.0 25.0 19.8 15.1 27.7 16.1 38.5 24.3 19.8 12.8 18.3 12.0 26.7 22.9 16.2 19.9 15.0 27.3 34.6 19.4 17.8 25.8 12.5 13.8 22.0 24.9 22.8 11.4 31.7 13.6 21.5 22.1 18.7 12.0 22.5 10.3 14.4 19.0 31.7 24.4 20.6 37.4 25.6 21.7 17.1 17.5 24.4 16.1 28.2 19.3 32.1 36.5 17.0 6.7 20.8 0.1 5.5 7.3 5.3 6.2 4.1 9.1 5.0 5.9 8.4 4.6 5.4 4.2 11.7 4.7 4.8 8.7 3.9 6.3 15.7 21.0 22.6 27.6 17.3 13.4 12.7 17.5 14.6 14.0 29.8 13.5 19.0 21.3 58.7 33.2 17.3 12.7 12.0 11.4 29.6 92.3 21.0 8.3 11.8 2.8 13.2 15.9 0.0 7.5 24.0 19.1 15.9 11.5 11.6 11.1 25.4 5.8 17.8 10.1 3.6 12.4 11.5 11.8 10.0 8.4 13.8 13.3 8.4 10.3 7.9 43.5 12.9 19.6 46.5 22.4 43.7 53.1 8.7 9.5 32.5 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4" "Group enriched" "Detected in many" 6 "Extravillous trophoblasts: 39.8;Spermatocytes: 108.0;Spermatogonia: 40.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 4.4" "Lineage enriched" "Detected in single" 5 "T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" NA Yes "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: AB_2686050" "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.33e-4)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 0.9 0.7 0.7 9.4 0.6 19.5 1.3 2.6 0.8 1.3 2.9 0.3 0.5 1.9 0.8 1.5 7.2 0.2 1.5 1.4 0.7 0.7 0.8 1.0 1.3 6.2 0.8 0.2 0.3 1.3 0.0 0.7 4.3 0.4 0.6 0.8 0.3 1.3 0.2 1.6 3.4 3.2 0.6 1.0 4.4 2.7 61.4 0.2 42.8 0.3 9.2 12.7 0.7 2.0 0.8 0.4 0.3 0.5 0.4 4.4 1.0 24.9 17.5 6.8 9.8 0.1 0.3 18.6 19.4 4.6 12.3 11.8 13.6 14.8 15.6 8.7 2.1 7.3 32.1 4.8 6.2 2.2 20.0 15.7 7.9 15.8 11.9 0.0 8.8 22.5 0.2 0.5 7.3 2.0 1.5 2.5 17.3 22.7 27.7 4.0 37.4 24.6 24.5 11.2 11.7 9.3 26.9 15.3 30.2 2.3 5.5 13.0 13.8 9.4 24.5 7.3 3.9 14.0 17.6 2.3 16.6 21.0 24.2 20.3 21.0 15.6 26.8 6.3 11.8 19.2 0.0 0.4 0.3 0.3 0.3 0.0 0.8 0.5 0.5 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.1 4.4 1.0 0.7 0.6 2.6 0.8 0.7 0.7 0.8 0.2 0.4 0.2 0.0 1.4 0.0 0.8 2.3 0.1 0.4 2.5 0.0 2.3 1.8 5.9 3.0 0.0 1.1 11.2 0.3 0.2 0.0 0.5 39.8 0.4 0.5 0.0 0.2 10.2 0.0 1.7 0.0 1.3 7.5 0.3 1.3 0.0 1.0 1.2 0.3 0.3 0.0 0.4 0.0 6.7 0.0 0.0 108.0 40.5 0.5 6.2 0.7 3.5 0.4 PLA1A ps-PLA1 ENSG00000144837 "Phospholipase A1 member A" Q53H76 3 119597842-119629811 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 14.0;Hepatocytes: 21.7;Peritubular cells: 13.4" "Group enriched" "Detected in many" 5 "liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "T-reg: 1.9" "Lineage enriched" "Detected in single" 5 "T-cells: 1.9" "Cell line enriched" "Detected in some" 18 "SK-MEL-30: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059740 Approved "Nucleoplasm,Nuclear speckles,Cytoplasmic bodies" "Secreted in other tissues" NA NA "Nuclear speckles, Cytoplasmic bodies" Nucleoplasm "HPA059740: AB_2684118" "unprognostic (1.35e-1)" "prognostic favorable (2.81e-7)" "unprognostic (2.24e-2)" "unprognostic (3.46e-2)" "unprognostic (3.18e-2)" "unprognostic (1.94e-2)" "unprognostic (1.11e-2)" "unprognostic (2.43e-1)" "unprognostic (3.87e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" "unprognostic (9.09e-2)" "unprognostic (1.55e-3)" "unprognostic (9.53e-3)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" "unprognostic (2.67e-1)" 2.5 0.4 3.8 1.5 4.7 0.2 1.8 1.4 2.5 2.5 1.3 1.7 47.8 0.6 3.2 63.1 0.8 2.7 1.3 5.0 3.6 4.3 9.3 17.2 13.7 6.1 6.0 1.0 0.5 1.8 11.4 1.0 4.4 7.0 6.0 1.2 10.7 1.5 123.8 10.3 0.3 1.9 4.2 7.4 0.5 2.2 2.0 2.5 0.4 5.0 0.4 3.7 2.1 1.3 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.7 0.3 0.5 0.1 0.0 0.2 0.0 0.0 23.9 0.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 3.8 4.7 1.4 2.5 3.6 4.3 6.0 1.0 7.0 2.5 0.0 1.7 0.0 0.3 0.6 0.0 1.2 2.5 2.7 1.2 14.0 0.0 0.1 1.7 2.7 5.2 8.7 0.0 0.0 1.9 0.0 0.6 0.3 1.1 21.7 1.6 0.0 1.7 4.9 0.3 2.2 0.3 5.3 1.7 7.2 0.0 0.0 2.2 0.0 13.4 4.9 0.0 0.0 0.3 0.0 0.2 0.5 1.6 0.0 0.0 0.3 PLAA "DOA1, FLJ11281, FLJ12699, PLA2P, PLAP" ENSG00000137055 "Phospholipase A2 activating protein" Q9Y263 9 26904083-26947463 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005035, HPA020994, HPA020996" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 5300 "Plasma membrane, Cytosol" Nucleoplasm "CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" "unprognostic (4.00e-3)" "unprognostic (5.00e-1)" "unprognostic (1.61e-1)" "unprognostic (4.06e-2)" "unprognostic (4.50e-3)" "unprognostic (2.48e-1)" "unprognostic (5.54e-2)" "prognostic favorable (7.87e-4)" "unprognostic (3.24e-2)" "unprognostic (1.44e-1)" "unprognostic (9.29e-3)" "unprognostic (1.86e-2)" "unprognostic (6.68e-2)" "unprognostic (1.39e-2)" "unprognostic (5.10e-1)" 13.6 20.1 9.4 12.4 13.1 29.6 11.9 12.9 18.0 13.4 12.3 11.1 13.5 10.5 15.6 12.8 16.2 10.8 13.6 26.2 10.1 10.2 15.0 19.6 14.4 16.4 9.6 10.9 12.3 12.9 15.0 10.0 17.4 13.4 12.1 13.1 9.5 13.4 11.6 52.6 13.5 12.3 16.1 10.0 16.1 12.0 15.7 7.9 27.0 13.0 18.2 14.6 14.9 12.7 13.2 12.2 19.2 17.9 13.5 16.5 8.6 27.8 16.5 20.9 21.1 14.2 18.1 15.8 26.2 15.0 20.1 19.7 5.8 13.4 25.2 21.9 20.0 14.0 11.2 20.7 20.7 22.2 33.1 8.7 15.6 27.2 11.1 14.5 12.5 21.4 16.1 12.5 24.5 17.9 15.2 20.0 18.9 9.5 25.6 21.6 11.6 24.2 12.2 30.3 14.4 14.4 17.3 13.1 14.9 15.6 16.7 13.4 23.0 14.0 16.6 8.2 21.4 11.5 9.7 24.2 0.0 24.9 13.0 21.2 8.4 18.3 26.2 14.2 17.9 10.4 19.2 11.9 18.7 11.2 16.8 12.5 13.2 11.6 11.3 12.2 11.5 10.7 12.2 11.2 13.5 17.9 6.3 16.5 8.6 9.4 13.1 12.9 18.0 10.1 10.2 9.6 10.9 13.4 7.9 14.9 9.1 11.2 9.4 9.7 8.3 21.0 2.5 12.0 13.6 8.7 0.0 21.0 8.3 14.9 21.7 15.3 9.5 0.0 14.0 21.7 10.4 9.6 40.3 9.0 18.5 4.8 9.2 12.9 13.3 3.6 8.1 9.9 1.7 10.8 7.3 8.5 12.8 8.7 7.8 7.9 6.1 19.4 17.8 24.7 22.0 8.3 41.2 13.8 11.4 10.2 PLCG2 ENSG00000197943 "Phospholipase C gamma 2" P16885 16 81739097-81962693 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.8" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 211.5;Muller glia cells: 142.4;Rod photoreceptor cells: 205.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 40.5;HMC-1: 19.4;REH: 16.5;U-698: 90.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004280, HPA020099, HPA020100" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 21000 "Vesicles, Cytosol" Nucleoplasm "CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325" "unprognostic (2.86e-2)" "unprognostic (1.34e-1)" "unprognostic (1.09e-3)" "unprognostic (1.10e-1)" "unprognostic (1.58e-1)" "prognostic favorable (6.71e-4)" "unprognostic (6.23e-2)" "unprognostic (5.01e-2)" "unprognostic (2.22e-1)" "unprognostic (4.58e-2)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" "prognostic favorable (4.88e-4)" "unprognostic (1.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-1)" "unprognostic (3.40e-3)" 8.4 3.8 3.3 55.8 4.9 14.1 10.7 1.0 2.4 5.6 10.3 5.3 3.1 8.7 11.2 12.2 6.0 4.7 10.1 4.4 3.3 2.8 20.6 8.8 10.7 35.5 5.2 1.8 2.0 3.6 1.0 1.8 4.1 4.5 4.3 3.6 4.6 8.8 2.8 2.0 4.1 17.6 4.6 8.6 33.6 4.2 2.3 4.2 6.3 5.3 2.6 44.6 7.5 7.7 18.8 3.9 26.8 12.2 14.0 1.1 2.3 0.3 0.7 0.1 0.6 0.0 0.0 0.9 0.0 0.1 0.5 0.2 0.2 1.8 40.5 6.9 0.0 1.7 0.9 0.9 0.1 0.3 0.3 0.4 4.8 0.0 0.0 0.3 4.8 19.4 0.0 0.4 0.3 0.2 0.0 0.9 1.8 0.5 3.4 0.1 1.2 0.5 12.1 0.7 0.5 0.2 16.5 0.0 5.2 0.1 0.8 0.3 0.1 1.1 0.3 0.3 0.9 0.7 15.0 0.2 0.0 0.7 0.1 0.1 8.1 13.2 90.0 0.0 6.7 0.3 2.8 4.4 26.8 0.7 5.7 0.3 18.8 0.2 1.1 3.9 17.3 0.3 0.8 24.8 14.0 12.2 2.6 0.1 2.3 3.3 4.9 1.0 2.4 3.3 2.8 5.2 1.8 4.5 4.2 11.9 81.1 49.9 1.4 2.6 211.5 5.2 40.8 10.7 21.6 15.7 98.2 11.2 11.6 2.3 17.0 11.7 1.0 70.0 0.0 1.8 5.8 2.7 38.3 37.2 23.7 95.3 20.6 36.2 45.8 26.9 10.3 15.6 8.5 7.2 0.4 142.4 0.1 5.8 4.6 4.5 205.4 6.5 2.3 4.4 2.9 1.9 9.3 26.2 1.2 4.8 PLD3 HU-K4 ENSG00000105223 "Phospholipase D family member 3" Q8IV08 19 40348456-40380439 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 638.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 149.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 149.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012800, CAB020812" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA 490000 "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB020812: , HPA012800: AB_1855330" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.64e-3)" "unprognostic (2.56e-3)" "unprognostic (2.06e-3)" "unprognostic (2.68e-1)" "unprognostic (4.52e-2)" "unprognostic (3.89e-2)" "unprognostic (1.09e-1)" "unprognostic (4.60e-2)" "prognostic favorable (6.44e-4)" "unprognostic (4.34e-2)" "prognostic favorable (2.21e-4)" "unprognostic (3.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (6.42e-2)" 45.7 57.5 44.6 23.1 79.0 12.8 21.9 35.5 126.1 31.2 23.5 25.4 17.1 22.6 26.3 35.0 18.3 30.0 30.8 33.0 46.4 73.4 22.1 25.6 49.7 25.2 44.7 53.9 44.8 42.5 32.9 122.1 38.9 62.2 29.6 16.1 31.6 35.3 37.2 27.4 24.2 23.5 25.6 28.6 48.9 23.0 17.0 19.3 11.9 20.6 11.2 12.9 27.3 20.7 3.6 23.0 149.2 24.6 9.7 7.8 16.8 14.1 43.7 28.3 44.5 78.9 37.6 21.6 35.1 35.8 25.5 29.2 8.3 16.0 6.1 36.9 30.5 8.3 6.6 6.8 13.8 11.2 22.9 24.9 6.6 15.0 10.4 53.9 2.7 75.9 71.5 28.9 19.4 13.4 42.8 21.4 10.1 23.3 24.9 18.3 18.5 4.8 13.1 18.5 23.2 9.0 6.1 21.6 25.2 13.1 10.6 20.3 33.8 16.8 10.4 18.8 30.9 14.3 47.6 37.6 21.5 10.3 18.2 7.8 26.0 27.7 6.3 34.6 11.0 13.3 149.2 24.6 35.3 7.8 12.8 6.4 3.6 6.2 6.9 23.0 3.1 6.5 6.5 2.5 9.7 5.7 3.3 6.1 16.8 44.6 79.0 35.5 126.1 46.4 73.4 44.7 53.9 62.2 19.3 29.8 62.9 34.4 70.6 31.5 98.5 18.5 25.5 12.0 28.4 54.1 31.4 137.8 18.3 50.7 5.8 46.8 52.7 0.0 51.3 94.8 142.4 49.1 59.9 35.8 638.2 114.4 69.9 90.9 219.8 8.6 140.4 84.2 87.7 44.1 36.8 99.5 49.7 41.2 135.1 30.0 39.3 19.4 53.1 13.9 57.5 29.2 163.8 35.4 34.5 52.0 PLEKHA2 TAPP2 ENSG00000169499 "Pleckstrin homology domain containing A2" 8 38901235-38973909 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004706 Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA004706: AB_1079633" "unprognostic (2.78e-1)" "unprognostic (8.80e-3)" "unprognostic (4.15e-3)" "unprognostic (3.03e-1)" "unprognostic (8.61e-2)" "unprognostic (9.07e-3)" "unprognostic (6.16e-3)" "unprognostic (1.45e-1)" "unprognostic (1.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-2)" "unprognostic (6.59e-2)" "prognostic unfavorable (1.95e-6)" "unprognostic (2.39e-2)" "unprognostic (1.00e-1)" "unprognostic (4.55e-2)" "unprognostic (9.60e-3)" 7.7 9.7 8.8 19.1 6.6 14.2 6.4 3.4 6.9 8.6 8.2 4.8 11.8 3.7 9.0 11.5 6.7 6.9 8.9 17.7 7.0 4.7 7.3 4.0 9.7 29.9 6.6 6.9 10.5 4.5 15.3 6.9 6.9 4.8 9.0 5.0 16.7 5.9 10.3 5.4 5.4 8.8 9.9 8.0 16.3 6.4 5.0 5.7 5.2 7.8 3.2 26.2 12.8 8.6 14.2 5.3 7.5 2.0 3.8 2.7 0.9 9.5 2.2 1.4 3.4 3.6 7.2 1.5 11.6 9.2 8.9 7.6 1.2 6.6 53.5 13.9 10.7 8.0 6.0 3.7 7.4 13.5 13.5 0.3 27.3 19.0 1.3 13.2 8.7 11.2 16.4 5.1 4.6 8.3 21.0 1.5 8.9 2.7 15.5 8.3 1.2 17.8 4.1 1.3 7.7 3.4 4.6 7.4 11.3 10.9 8.3 0.1 2.1 13.6 2.5 9.3 2.2 5.7 4.3 2.1 6.5 5.1 1.1 9.2 4.9 4.5 24.9 10.3 9.5 1.4 5.2 1.5 7.5 2.0 2.0 2.1 8.9 2.3 2.3 1.8 14.2 1.5 2.7 3.4 3.8 2.0 5.3 1.9 0.9 8.8 6.6 3.4 6.9 7.0 4.7 6.6 6.9 4.8 5.7 3.0 22.7 61.4 10.3 7.8 1.4 36.3 12.7 16.0 7.9 38.4 0.0 6.5 1.7 7.0 0.6 10.3 9.7 0.0 4.7 13.6 10.8 9.2 35.8 10.2 42.5 55.6 12.6 26.4 69.1 0.9 21.0 38.7 15.1 13.6 10.4 15.1 16.5 3.5 23.7 11.5 1.4 12.9 14.1 0.5 6.1 5.8 3.8 36.2 12.1 26.6 PLEKHA7 DKFZp686M22243 ENSG00000166689 "Pleckstrin homology domain containing A7" Q6IQ23 11 16777317-17014443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 6.8;MAIT T-cell: 4.5" "Group enriched" "Detected in many" 6 "granulocytes: 6.8;T-cells: 4.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.4;HaCaT: 28.7;OE19: 23.8;RT4: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038610, HPA066103" Approved Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA038610: AB_10671746, HPA066103: AB_2732738" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (4.30e-2)" "unprognostic (2.51e-2)" "unprognostic (6.95e-3)" "unprognostic (2.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.65e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-3)" "unprognostic (3.13e-2)" "prognostic favorable (1.89e-15)" "unprognostic (9.74e-2)" "unprognostic (1.17e-2)" "unprognostic (4.81e-1)" "unprognostic (2.65e-2)" 6.8 1.2 5.3 6.6 8.0 0.1 10.7 2.9 4.9 7.7 18.1 10.9 10.0 17.7 4.7 6.0 30.6 6.0 15.1 13.6 7.5 4.2 18.1 9.0 6.4 1.2 7.2 4.6 8.1 18.9 19.1 3.2 18.7 14.5 6.0 11.5 18.2 15.0 16.3 2.7 8.9 32.0 2.7 8.1 1.7 15.2 7.4 7.9 1.4 7.2 1.9 5.5 10.7 12.4 0.5 0.9 6.8 0.3 0.2 4.5 0.3 5.1 4.6 4.9 2.2 0.2 0.0 8.1 0.0 0.1 1.7 3.2 7.9 43.4 0.0 2.0 0.6 0.2 28.7 6.5 0.0 1.2 1.5 6.3 13.3 3.7 5.4 0.1 0.0 0.1 0.2 2.5 0.0 0.1 4.0 0.0 5.6 0.5 0.1 0.7 3.3 3.0 0.1 2.7 23.8 4.5 4.1 0.0 1.0 4.2 39.3 3.1 0.3 5.9 16.9 0.2 9.3 4.3 1.5 1.1 0.0 1.6 1.2 1.0 2.9 0.9 5.8 0.0 0.2 0.0 0.2 0.3 6.8 0.6 0.1 4.5 0.5 0.8 0.6 0.3 0.2 0.2 0.4 0.6 0.2 0.1 0.9 0.1 0.3 5.3 8.0 2.9 4.9 7.5 4.2 7.2 4.6 14.5 7.9 3.0 13.4 0.0 1.2 0.6 1.2 8.7 5.1 6.7 12.5 10.4 23.6 5.4 3.3 4.7 11.7 2.3 8.4 0.0 5.3 0.8 0.6 0.8 2.3 2.4 1.7 0.0 0.0 0.6 1.0 4.5 0.6 2.4 0.0 1.0 4.6 3.9 7.6 3.5 0.4 8.1 10.6 0.0 0.3 0.2 0.5 0.4 5.0 0.5 2.6 4.6 PLEKHO2 "DKFZp761K2312, PLEKHQ1, PP1628, pp9099" ENSG00000241839 "Pleckstrin homology domain containing O2" Q8TD55 15 64841883-64868007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.9" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 56.4;Ito cells: 42.4;Kupffer cells: 40.1;Muller glia cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 10.4;granulocytes: 30.2;monocytes: 26.6" "Cell line enhanced" "Detected in many" "ASC diff: 31.3" HPA040055 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 450000 "Plasma membrane, Cytosol" Nucleoplasm "HPA040055: AB_10793954" "unprognostic (4.32e-2)" "unprognostic (7.32e-3)" "unprognostic (8.60e-2)" "unprognostic (9.10e-2)" "unprognostic (1.11e-1)" "unprognostic (2.90e-2)" "unprognostic (3.05e-2)" "unprognostic (2.80e-1)" "unprognostic (7.70e-2)" "unprognostic (2.05e-2)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.08e-3)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (1.78e-1)" "unprognostic (5.85e-3)" 22.1 17.4 12.9 19.9 16.6 29.4 12.4 6.2 9.9 10.3 12.2 11.5 5.2 6.8 11.9 13.3 10.7 13.0 17.4 9.3 13.3 8.0 8.1 8.2 22.4 19.6 10.1 8.7 10.4 5.7 5.1 6.4 22.6 17.2 10.5 5.6 17.0 6.1 10.2 5.9 6.0 9.4 16.9 14.5 57.9 10.2 7.0 11.3 5.1 18.6 6.6 13.8 17.1 14.1 4.0 10.4 30.2 26.6 2.7 5.4 10.3 2.7 1.8 3.5 3.4 31.3 18.0 8.3 8.1 12.2 8.7 8.9 2.2 1.7 7.4 4.3 16.5 8.8 1.0 4.0 3.3 5.1 11.4 1.2 7.4 0.8 2.5 24.1 8.3 11.1 13.0 2.9 10.8 3.5 7.5 12.0 1.5 2.2 26.5 11.5 0.8 1.7 9.0 6.7 1.4 1.7 6.4 8.5 5.3 1.4 1.9 0.3 3.0 3.4 1.2 11.1 6.0 1.2 11.3 15.5 6.7 6.2 6.3 3.3 9.9 15.5 2.5 7.2 10.8 3.9 7.0 14.3 9.2 5.4 20.4 5.0 4.0 3.1 5.0 10.4 2.6 1.3 2.7 30.2 2.7 26.6 1.2 4.1 10.3 12.9 16.6 6.2 9.9 13.3 8.0 10.1 8.7 17.2 11.3 0.0 9.3 8.6 2.1 4.9 0.7 2.6 2.5 1.4 2.3 8.7 0.0 3.3 3.3 2.2 3.2 18.3 0.0 0.0 1.3 4.0 9.3 2.4 18.4 0.8 56.4 0.0 0.0 42.4 40.1 1.8 17.0 30.6 13.5 6.4 0.1 62.2 2.1 0.0 24.1 2.1 3.2 12.9 8.0 0.9 1.9 3.9 5.0 11.5 0.2 3.1 PLK2 SNK ENSG00000145632 "Polo like kinase 2" Q9NYY3 5 58453982-58460260 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 180.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 147.8;T-47d: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009624, HPA069329" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "CAB009624: AB_2167745, HPA069329: " "unprognostic (4.82e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (7.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (2.44e-2)" "unprognostic (1.06e-2)" "unprognostic (1.01e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" "unprognostic (3.46e-1)" "unprognostic (1.95e-3)" 11.4 3.7 19.6 4.0 40.2 4.4 23.4 1.3 39.4 20.6 5.7 3.7 5.0 5.1 19.2 7.1 17.7 9.5 18.2 28.1 18.8 5.1 6.9 17.6 17.7 3.8 4.2 20.6 11.8 12.6 3.8 3.3 25.9 8.7 8.7 8.7 12.6 22.1 6.2 8.7 20.9 6.1 15.4 2.7 54.7 4.7 19.8 7.4 1.0 8.9 16.6 7.5 14.2 15.5 1.2 2.9 3.0 1.6 10.4 1.2 0.6 16.4 14.9 5.2 0.4 2.7 4.5 2.0 3.5 5.9 11.7 6.8 1.1 14.6 0.0 23.2 12.6 28.5 20.7 0.2 8.1 10.7 0.0 0.4 0.0 6.7 1.2 14.8 0.0 0.4 2.6 11.3 4.5 12.7 147.8 23.5 0.0 0.0 0.5 23.1 6.0 0.0 0.0 0.9 1.6 2.4 0.8 14.3 0.0 30.8 3.3 0.3 0.7 10.8 2.1 9.5 9.7 51.9 0.2 30.0 3.2 8.7 1.4 28.1 0.0 0.0 0.0 2.5 0.0 14.4 3.0 0.7 2.3 0.1 1.6 0.0 1.2 0.7 0.0 2.9 0.9 1.2 0.6 1.9 10.4 0.6 2.0 0.5 0.6 19.6 40.2 1.3 39.4 18.8 5.1 4.2 20.6 8.7 7.4 17.9 18.6 2.7 128.0 125.8 2.8 105.2 22.9 18.7 68.2 17.4 3.9 55.6 8.3 96.4 5.7 109.7 37.3 0.0 69.2 180.6 32.4 45.1 9.2 6.0 13.5 0.0 80.9 51.5 8.9 2.3 11.8 11.2 23.6 5.4 25.3 3.5 71.6 40.7 10.3 2.5 2.7 0.0 79.3 72.4 10.4 90.5 108.6 6.4 24.3 54.0 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 12.7;Distal tubular cells: 6.6;Early spermatids: 7.1;Late spermatids: 7.9;Leydig cells: 17.8;Peritubular cells: 7.4;Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 62.8;U-251 MG: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA045188: AB_2679246" "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.8 1.7 1.0 0.0 1.0 0.0 0.0 8.0 6.3 0.1 0.7 0.1 0.9 1.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.0 62.8 6.5 0.0 0.7 1.6 0.7 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.0 3.3 0.0 0.6 0.1 0.5 0.0 0.5 3.5 1.4 0.0 9.0 7.2 4.0 0.3 34.8 0.0 0.0 0.0 6.6 0.0 1.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 12.7 0.0 0.0 3.5 0.0 0.0 6.6 0.0 7.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 2.5 0.0 7.9 17.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 7.4 7.6 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.3 PLPP6 "FLJ46512, FLJ90191, PDP1, PPAPDC2" ENSG00000205808 "Phospholipid phosphatase 6" Q8IY26 9 4662315-4665258 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 74.5;Late spermatids: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HDLM-2: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018096 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA018096: AB_1855609" "unprognostic (2.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.03e-1)" "unprognostic (4.36e-3)" "unprognostic (1.17e-1)" "unprognostic (4.38e-2)" "unprognostic (6.95e-3)" "unprognostic (1.33e-1)" "unprognostic (5.26e-2)" "unprognostic (9.06e-2)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.99e-4)" "unprognostic (2.56e-1)" "unprognostic (2.28e-2)" "unprognostic (2.87e-2)" "unprognostic (5.88e-2)" 4.0 8.3 4.4 7.2 6.8 1.1 7.3 11.9 9.7 5.7 9.4 6.2 4.2 10.2 4.9 13.2 9.2 4.1 9.7 3.0 4.9 4.8 6.3 20.0 4.7 8.3 8.6 6.3 4.2 19.2 8.7 5.5 13.1 9.4 16.9 10.0 4.7 10.4 8.5 2.2 8.6 15.4 3.3 4.9 7.1 10.7 8.4 3.4 16.2 7.2 6.9 9.6 7.4 5.5 4.3 5.1 8.5 5.1 4.7 13.0 5.1 3.9 4.1 4.4 5.4 3.6 4.0 4.4 2.7 3.5 2.2 2.5 1.0 2.6 3.8 1.1 2.6 5.5 4.9 3.1 3.8 2.3 47.7 2.9 7.6 3.9 5.4 3.2 2.7 5.7 4.4 3.1 1.7 3.8 2.9 3.3 4.3 1.3 4.0 2.8 4.2 2.5 7.2 4.0 4.0 1.4 2.5 0.0 2.9 3.8 4.5 11.1 5.6 3.2 2.9 1.6 5.7 4.1 6.1 3.8 2.0 1.7 2.6 1.7 0.8 3.0 1.0 3.1 1.9 1.8 8.5 5.1 4.1 4.2 4.4 4.6 3.5 7.4 6.3 5.1 4.3 13.0 9.2 2.1 4.7 4.9 3.9 10.0 5.1 4.4 6.8 11.9 9.7 4.9 4.8 8.6 6.3 9.4 3.4 6.0 2.4 3.4 2.0 0.0 6.8 0.0 5.1 0.0 2.3 1.8 2.0 14.4 1.7 10.9 74.5 1.4 8.5 0.0 12.1 2.1 0.0 7.1 0.0 13.2 5.4 3.2 10.5 4.3 5.3 33.5 2.6 2.2 0.0 1.8 8.4 3.8 8.7 7.4 4.6 2.6 4.3 0.0 0.0 0.6 1.0 0.0 8.7 1.5 6.4 2.6 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821977 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6" "Cell type enhanced" "Detected in single" 21 "Horizontal cells: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Group enriched" "Detected in some" 6 "NB-4: 24.1;THP-1: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: AB_2681787, HPA057034: AB_2683316" "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.7 0.7 20.5 1.2 30.0 18.2 2.1 0.1 21.3 0.9 0.7 0.7 0.0 0.7 1.3 0.7 0.7 12.6 1.1 0.7 14.4 13.1 0.7 0.7 2.6 0.9 3.9 14.9 1.0 0.7 0.7 0.1 0.8 4.7 0.9 0.7 0.1 0.7 0.8 0.9 0.8 1.0 0.7 1.1 0.9 0.9 3.0 3.1 0.0 0.7 0.0 0.7 0.8 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 5.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.0 0.1 0.9 0.0 0.0 0.0 2.1 0.0 0.6 0.0 0.2 1.7 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.4 0.0 24.1 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.1 0.0 0.0 2.7 2.2 51.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 3.9 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.0 0.1 21.3 14.4 13.1 3.9 14.9 4.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 PLSCR1 MMTRA1B ENSG00000188313 "Phospholipid scramblase 1" O15162 3 146515180-146544864 "Predicted intracellular proteins, Transporters" "Antiviral defense" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 55.1;BJ hTERT+ SV40 Large T+ RasG12V: 73.3;HHSteC: 50.5;SK-MEL-30: 91.2" "HPA068923, CAB070421" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA Yes "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB070421: AB_11153452, HPA068923: AB_2686059" "unprognostic (7.88e-2)" "unprognostic (1.10e-1)" "unprognostic (5.34e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (3.35e-1)" "unprognostic (5.22e-2)" "unprognostic (7.73e-3)" "unprognostic (9.19e-3)" "unprognostic (6.93e-3)" "unprognostic (3.07e-3)" "unprognostic (1.10e-1)" "unprognostic (1.09e-3)" "unprognostic (5.26e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-1)" "unprognostic (1.63e-1)" 60.9 14.9 11.9 39.7 21.4 27.0 31.1 5.7 19.0 20.9 29.6 7.2 22.1 18.4 19.6 25.7 25.4 19.5 30.8 22.7 16.1 12.7 32.0 36.5 33.8 38.6 17.6 4.9 40.0 26.1 10.3 18.4 25.7 22.1 25.0 28.0 12.6 32.3 34.2 16.4 9.9 24.6 19.4 29.8 46.0 20.5 15.4 14.8 16.4 27.5 14.9 19.5 27.5 48.0 6.5 27.5 26.2 41.2 14.3 8.1 17.6 17.2 6.9 4.4 2.0 6.6 11.2 6.8 5.4 14.8 55.1 73.3 5.5 14.4 1.3 12.9 3.4 43.1 14.2 3.5 5.1 9.3 5.3 3.5 11.1 2.2 4.1 50.5 6.3 5.8 17.8 8.7 6.1 31.1 8.8 8.0 3.2 7.1 17.2 11.2 6.7 4.9 2.4 4.2 11.7 6.2 4.4 4.9 0.4 15.5 4.7 2.7 0.0 6.9 3.4 91.2 6.3 3.4 7.7 4.8 4.4 3.8 9.9 9.0 13.2 2.4 0.0 4.5 4.6 3.8 8.2 41.2 11.0 5.6 40.4 8.1 6.5 3.7 5.0 27.5 4.9 2.6 3.8 26.2 14.3 22.7 7.3 2.1 17.6 11.9 21.4 5.7 19.0 16.1 12.7 17.6 4.9 22.1 14.8 32.8 47.9 22.6 70.0 32.7 0.4 4.0 86.6 81.7 60.3 90.7 0.0 46.8 63.0 225.1 1.5 110.1 67.7 0.0 192.6 100.1 54.5 74.2 26.7 25.9 121.5 0.0 31.9 91.4 84.8 2.2 106.4 157.8 45.5 24.4 60.9 52.6 150.7 102.1 43.2 33.8 1.3 38.8 58.7 0.3 2.2 25.0 37.2 21.3 51.4 160.1 PLSCR2 ENSG00000163746 "Phospholipid scramblase 2" Q9NRY7 3 146391421-146495991 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 8.1;testis: 16.8" "Group enriched" "Detected in some" 25 "Early spermatids: 161.5;Late spermatids: 194.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.9;EFO-21: 2.3;GAMG: 3.7;Karpas-707: 2.5;U-266/70: 2.1" HPA051352 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA051352: " "unprognostic (1.11e-1)" "unprognostic (9.83e-2)" "unprognostic (8.94e-3)" "unprognostic (7.53e-3)" "unprognostic (3.81e-2)" "unprognostic (1.51e-2)" "unprognostic (3.67e-2)" "unprognostic (1.84e-2)" "unprognostic (4.11e-1)" "unprognostic (5.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.16e-1)" "unprognostic (1.88e-4)" "unprognostic (4.06e-1)" "unprognostic (9.71e-2)" "unprognostic (3.02e-1)" "unprognostic (1.23e-2)" 0.3 0.3 0.3 1.7 0.3 1.3 0.4 1.0 0.4 0.4 1.5 0.0 1.3 0.2 0.3 8.1 0.6 0.9 1.4 0.3 1.1 0.3 1.4 0.3 1.0 1.8 0.3 0.4 1.0 1.2 0.3 3.2 0.5 1.6 0.4 0.5 0.6 1.4 3.0 0.3 0.3 0.4 0.2 0.8 0.3 0.5 16.8 0.0 0.1 2.5 0.7 0.1 0.3 2.2 0.6 0.5 1.7 1.1 1.3 1.6 0.6 0.0 0.3 0.0 0.0 0.0 1.4 0.2 0.0 0.4 0.6 0.8 0.2 1.9 0.0 2.3 0.0 3.7 0.2 0.3 0.0 0.4 0.1 0.4 0.6 0.8 0.2 0.8 0.0 0.7 0.5 0.5 0.2 0.9 0.6 0.0 0.2 0.3 2.5 0.1 0.0 0.0 0.0 0.5 0.0 1.5 0.2 0.0 0.0 1.5 0.0 0.6 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.6 0.6 1.3 0.6 0.9 1.4 0.5 0.3 1.4 1.6 1.7 1.3 0.0 0.4 0.0 0.6 0.3 0.3 1.0 0.4 1.1 0.3 0.3 0.4 1.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.5 1.4 0.0 7.0 0.0 0.1 1.7 0.8 161.5 0.0 0.0 0.0 0.5 0.1 0.3 0.3 0.0 0.0 0.1 0.0 1.7 0.6 0.0 194.1 1.7 0.3 0.0 0.0 0.0 1.0 0.7 0.0 1.4 1.1 0.3 0.0 0.1 4.8 2.3 0.1 0.0 0.0 0.6 0.1 PLXNA3 "6.3, Plxn3, PLXN4, SEX, XAP-6" ENSG00000130827 "Plexin A3" P51805 X 154458281-154477779 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058989 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA 58000 "Vesicles, Plasma membrane" Nucleoplasm "HPA058989: AB_2683872" "unprognostic (2.79e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-3)" "unprognostic (8.04e-3)" "unprognostic (1.63e-1)" "unprognostic (9.05e-3)" "unprognostic (1.06e-2)" "unprognostic (2.25e-1)" "unprognostic (2.42e-1)" "unprognostic (6.26e-2)" "unprognostic (1.05e-1)" "unprognostic (4.10e-2)" "unprognostic (1.38e-3)" "unprognostic (2.30e-1)" "unprognostic (3.00e-1)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" 6.9 7.6 9.8 6.6 9.3 3.5 13.3 25.9 7.4 8.1 6.2 13.8 7.3 7.2 8.6 9.2 5.3 8.3 7.9 6.6 10.5 8.0 5.1 2.5 7.2 7.1 8.7 3.6 16.4 9.9 5.1 35.2 7.4 8.2 9.2 4.8 6.1 13.8 7.5 2.9 19.5 7.2 8.2 8.4 7.0 10.0 5.8 9.8 4.6 9.3 1.8 7.2 6.3 16.4 1.8 0.5 2.7 0.5 2.1 1.0 0.3 8.2 1.6 4.9 12.4 5.2 6.6 6.6 11.8 2.5 2.8 3.8 6.2 3.5 1.5 6.4 12.7 6.6 7.3 4.9 5.7 1.0 0.7 3.7 1.5 19.3 3.4 4.1 0.8 6.9 8.9 4.2 4.1 0.3 9.7 3.1 2.4 3.8 1.3 4.3 10.2 1.4 6.3 1.6 2.6 3.7 5.3 0.4 0.5 3.7 5.5 10.3 5.3 4.4 7.9 2.0 3.6 4.8 1.8 7.8 6.1 5.6 0.6 5.0 0.9 0.1 2.2 11.4 1.1 1.6 2.7 0.5 0.8 0.8 0.4 0.6 1.8 1.0 0.8 0.1 1.2 0.6 0.8 1.4 2.1 0.3 0.5 0.7 0.3 9.8 9.3 25.9 7.4 10.5 8.0 8.7 3.6 8.2 9.8 11.9 11.4 0.9 8.3 7.7 18.3 4.5 2.5 10.7 5.7 10.4 11.8 2.9 0.0 11.1 0.0 3.7 8.0 0.0 5.0 4.9 9.1 8.5 8.1 0.9 7.4 4.8 6.9 3.7 4.3 0.4 10.6 6.4 13.5 7.2 11.4 5.2 13.0 10.5 8.1 0.7 8.9 12.9 6.2 0.2 2.2 6.5 7.8 6.4 7.1 6.5 PNMA1 MA1 ENSG00000176903 "PNMA family member 1" Q8ND90 14 73711783-73714372 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003817, HPA015007" Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA Cytosol "Nucleoplasm, Focal adhesion sites" "HPA003817: AB_1079646, HPA015007: AB_1855502" "unprognostic (2.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (7.49e-5)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.90e-1)" "unprognostic (5.35e-2)" "unprognostic (3.63e-1)" "unprognostic (5.58e-2)" "unprognostic (4.58e-2)" "unprognostic (1.67e-3)" "unprognostic (2.04e-3)" "unprognostic (4.17e-2)" "unprognostic (2.23e-3)" "prognostic unfavorable (4.51e-5)" 19.6 18.0 39.1 11.1 42.4 4.7 17.4 30.4 68.2 16.0 19.3 11.2 15.8 8.2 20.5 32.4 13.9 20.9 14.3 13.1 29.6 33.5 16.4 3.1 8.4 12.5 25.8 39.4 31.8 5.7 6.7 20.9 12.3 27.0 29.0 10.1 8.9 4.6 53.4 5.8 4.5 9.1 29.5 19.8 10.1 10.9 38.1 17.3 6.0 11.0 2.5 7.3 14.8 21.2 3.3 3.6 4.0 4.6 4.8 12.8 6.4 15.0 13.7 23.7 17.6 17.9 19.0 9.8 16.0 9.0 14.7 10.8 12.9 9.4 0.3 11.2 19.4 14.0 10.1 18.2 9.5 15.2 14.3 11.2 8.6 11.5 9.6 19.2 4.7 13.7 16.7 11.5 17.5 11.1 29.0 22.1 9.3 7.4 9.6 19.9 37.0 9.4 11.6 7.1 7.8 48.5 14.9 14.8 0.3 19.3 0.4 28.2 21.6 28.2 6.5 12.6 15.0 31.6 8.1 21.3 29.7 23.9 18.0 12.9 8.5 13.1 4.5 29.3 6.8 9.8 2.6 1.7 4.0 8.4 3.3 5.6 2.9 10.8 8.5 3.6 3.3 10.6 9.7 1.6 4.8 4.6 0.6 12.8 6.4 39.1 42.4 30.4 59.9 29.6 33.5 25.8 39.4 27.0 17.3 6.0 4.0 2.4 6.5 3.4 46.6 16.9 0.0 17.4 3.4 14.0 11.8 6.4 13.3 8.4 68.4 12.6 3.1 0.0 5.9 9.3 17.3 7.4 16.1 0.9 13.5 55.6 18.0 22.1 5.4 42.0 30.2 13.2 18.6 19.8 3.7 60.0 19.1 0.0 79.5 17.9 44.9 71.1 44.2 97.4 36.5 3.3 5.0 13.8 1.7 3.1 PNMA8A "FLJ10781, KIAA1183L, PNMAL1" ENSG00000182013 "PNMA family member 8A" Q86V59 19 46466491-46471563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.0" "Group enriched" "Detected in some" 4 "Ciliated cells: 20.1;Collecting duct cells: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 17.9;K-562: 18.9;LHCN-M2: 19.6;SH-SY5Y: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012956, HPA077702" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA012956: AB_1844328, HPA077702: " "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.98e-2)" "unprognostic (9.35e-3)" "unprognostic (1.01e-1)" "unprognostic (6.90e-3)" "unprognostic (1.76e-3)" "unprognostic (9.56e-2)" "unprognostic (1.78e-2)" "unprognostic (2.85e-2)" "unprognostic (1.82e-1)" "unprognostic (6.48e-3)" 1.2 17.4 18.6 1.2 26.4 1.1 3.9 24.8 61.0 2.9 1.6 5.1 1.2 1.2 9.7 12.7 1.5 16.7 4.3 10.7 16.6 29.9 7.2 0.9 1.8 0.8 14.1 25.7 13.5 5.0 3.8 14.5 2.4 19.5 7.1 1.1 5.4 4.4 8.1 1.2 1.5 1.3 5.9 8.9 0.9 1.4 16.1 4.4 4.3 11.7 0.0 1.0 1.9 0.7 1.1 1.1 3.0 0.5 0.8 2.6 0.3 0.0 7.4 10.8 10.7 3.2 7.2 2.0 0.7 0.1 1.3 0.7 0.1 0.8 0.0 10.1 0.5 3.8 0.1 17.9 2.9 0.9 0.0 6.7 0.0 0.2 0.2 5.3 0.1 0.1 1.8 3.6 4.5 0.0 1.0 1.0 6.4 18.9 0.1 19.6 0.0 0.1 0.1 9.1 0.0 0.0 0.0 11.9 0.0 4.5 0.0 8.8 17.4 0.0 0.2 0.0 10.4 0.1 0.2 0.6 0.0 0.1 0.1 3.6 0.0 0.0 0.1 0.1 0.0 1.2 3.0 0.5 0.3 0.3 0.3 0.2 1.1 0.3 0.9 0.1 0.7 0.4 2.6 1.3 0.8 0.1 1.1 0.2 0.3 18.6 26.4 24.8 37.2 16.6 29.9 14.1 25.7 19.5 4.4 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 20.1 3.4 10.4 0.0 0.7 3.3 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PNPLA8 "IPLA2-2, IPLA2G, iPLA2gamma" ENSG00000135241 "Patatin like phospholipase domain containing 8" Q9NP80 7 108470422-108569666 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020083 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA020083: AB_1851849" "unprognostic (4.48e-2)" "unprognostic (3.37e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (4.61e-1)" "unprognostic (2.73e-2)" "unprognostic (3.48e-2)" "unprognostic (3.32e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (2.49e-1)" "prognostic favorable (1.86e-6)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (4.28e-3)" "unprognostic (1.24e-1)" 21.5 35.7 29.3 12.4 28.9 51.5 15.0 15.6 27.2 15.4 13.4 9.5 9.3 8.6 13.4 13.7 18.3 9.7 15.9 17.9 23.0 22.1 23.1 24.6 16.7 12.0 20.7 17.5 15.6 10.1 20.7 33.4 25.2 23.2 14.4 11.4 6.0 11.4 13.9 29.8 11.4 10.8 15.3 20.3 19.5 11.1 10.8 21.1 16.1 22.6 13.0 15.3 22.5 12.8 20.0 19.3 16.7 26.8 14.6 12.5 13.7 14.1 6.4 11.3 10.1 25.2 17.4 16.7 13.5 23.8 11.1 18.6 6.1 8.1 7.9 17.1 13.2 22.4 5.4 19.1 8.6 16.9 11.8 5.3 5.4 10.5 4.5 18.4 3.7 11.2 15.7 16.3 14.9 13.8 12.2 15.0 8.9 6.3 22.7 13.8 9.3 8.7 8.9 5.0 8.9 9.1 3.2 11.9 16.7 13.3 18.0 9.4 13.2 12.9 14.0 16.2 14.9 5.9 6.4 12.1 18.3 8.2 27.2 7.4 19.3 19.5 11.7 17.4 5.7 11.8 14.1 19.7 16.7 10.5 21.8 12.5 20.0 10.3 10.3 19.3 18.7 11.2 10.7 16.5 14.6 26.8 7.6 12.5 13.7 29.3 28.9 15.6 27.2 23.0 22.1 20.7 17.5 23.2 21.1 38.7 43.0 28.7 103.5 82.5 61.7 43.5 10.2 81.7 58.0 22.7 17.7 46.4 79.6 26.9 49.7 39.4 25.7 0.0 33.2 30.6 50.6 71.1 70.4 40.3 28.4 30.2 54.7 19.6 49.4 40.1 29.7 48.1 52.3 17.2 16.2 37.9 25.2 14.1 37.1 33.7 29.7 19.4 38.2 17.7 27.4 118.6 108.9 23.5 13.6 109.8 POLE2 DPE2 ENSG00000100479 "DNA polymerase epsilon 2, accessory subunit" P56282 14 49643555-49688422 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA replication" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.6;lymphoid tissue: 17.6" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 23.3;Spermatogonia: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027555 Uncertain Supported "Nucleoplasm,Nuclear bodies,Vesicles" No No "Nucleoplasm, Nuclear bodies" Vesicles "HPA027555: AB_10610282" "unprognostic (1.42e-1)" "unprognostic (6.57e-3)" "unprognostic (3.53e-2)" "unprognostic (7.44e-2)" "unprognostic (2.04e-2)" "unprognostic (4.99e-3)" "unprognostic (7.60e-3)" "unprognostic (2.32e-3)" "unprognostic (1.10e-3)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (1.37e-3)" "unprognostic (5.13e-11)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.50e-3)" 3.3 2.2 1.5 11.6 2.8 17.6 3.4 1.7 1.6 4.4 4.2 1.1 1.5 2.6 2.8 3.5 9.0 2.4 2.3 1.6 1.0 1.2 2.5 5.1 2.2 5.3 1.1 0.3 2.7 5.0 1.4 2.5 4.1 1.4 2.1 5.2 2.6 2.6 0.7 1.1 3.7 7.7 2.9 2.7 5.4 3.0 5.3 2.4 17.6 1.6 10.3 8.4 2.1 4.2 1.2 0.9 0.7 0.0 3.2 2.7 0.5 17.3 8.9 16.9 7.8 0.8 5.0 8.6 9.9 5.0 15.8 18.3 8.9 13.6 10.8 5.6 5.5 8.5 10.7 16.9 6.1 18.7 12.6 9.3 16.1 9.8 11.0 0.4 19.2 7.0 1.4 0.4 8.6 1.4 2.0 9.1 14.5 14.1 6.9 15.8 15.2 19.5 12.5 9.9 14.2 20.8 16.6 15.5 9.8 5.7 9.8 12.2 7.0 10.0 5.9 3.1 8.5 11.8 6.8 3.2 2.5 18.8 10.5 7.8 5.1 10.3 25.0 4.8 14.2 10.2 0.0 0.0 0.7 0.9 0.0 0.7 1.2 0.9 1.7 0.6 1.2 0.1 0.8 0.0 3.2 0.0 0.9 2.7 0.5 1.5 2.8 1.7 1.6 1.0 1.2 1.1 0.3 1.4 2.4 3.0 0.3 0.8 1.6 4.2 0.8 0.8 0.0 1.4 1.2 0.0 0.0 5.3 0.0 1.2 0.9 0.8 0.8 23.3 1.3 8.5 2.6 1.2 0.0 3.2 4.7 0.0 1.2 6.7 3.7 0.2 1.4 1.2 1.7 1.0 2.0 2.1 0.6 0.0 2.8 0.8 3.3 0.0 1.9 3.0 22.2 3.1 2.9 0.9 2.9 0.8 POLQ POLH ENSG00000051341 "DNA polymerase theta" O75417 3 121431427-121546641 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.5;lymphoid tissue: 21.4" "Cell type enhanced" "Detected in some" 10 "Club cells: 3.4;Extravillous trophoblasts: 2.8;Spermatocytes: 7.0;Spermatogonia: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 5.2" HPA053359 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes Nucleoplasm "Golgi apparatus, Cytosol" "HPA053359: " "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (2.70e-1)" "unprognostic (6.23e-3)" "unprognostic (3.09e-5)" "unprognostic (8.55e-3)" "unprognostic (1.09e-4)" "unprognostic (2.86e-1)" "unprognostic (5.59e-5)" "unprognostic (2.06e-3)" "unprognostic (0.00e+0)" "prognostic favorable (1.04e-4)" "unprognostic (1.76e-1)" "unprognostic (6.01e-2)" "unprognostic (5.76e-2)" 0.5 0.8 0.2 8.2 0.7 9.5 0.6 0.6 0.4 0.9 3.5 0.2 0.8 2.0 0.9 0.6 6.0 0.3 0.4 0.8 0.3 0.2 0.4 0.6 0.9 4.7 0.3 0.0 0.4 0.4 0.0 0.2 2.8 0.3 0.4 3.7 0.1 1.1 0.8 1.2 2.4 3.9 0.5 0.4 2.6 1.1 5.8 0.6 21.4 0.3 5.6 7.5 0.6 1.7 0.5 1.1 1.6 0.4 0.0 0.4 0.0 13.5 9.2 7.9 5.6 0.7 0.9 7.2 6.4 2.5 7.6 10.2 7.3 5.0 16.1 2.9 3.5 9.2 10.7 9.3 4.1 12.9 4.7 5.1 10.3 5.7 4.5 0.0 11.1 9.5 0.1 0.3 6.9 4.3 1.3 3.7 6.0 6.8 12.3 7.9 5.2 10.0 6.5 7.5 4.1 4.5 8.5 9.5 5.7 2.4 7.8 4.3 3.9 7.4 4.0 2.6 7.2 3.7 11.1 2.9 6.7 8.8 2.6 8.3 6.2 5.0 16.7 3.2 8.3 4.9 1.6 0.2 0.0 0.3 0.2 0.0 0.3 0.4 0.3 0.4 0.5 0.0 0.2 0.0 0.0 0.4 1.1 0.1 0.0 0.2 0.7 0.6 0.4 0.3 0.2 0.3 0.0 0.3 0.6 0.0 0.3 0.0 0.4 0.8 0.3 1.4 0.0 1.4 3.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.4 0.0 0.0 2.8 0.7 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.2 0.3 1.5 0.0 1.0 0.4 0.5 0.3 0.3 0.0 0.1 0.1 0.0 0.5 7.0 3.3 0.1 0.2 0.9 0.9 0.9 POLR1A "DKFZP586M0122, FLJ21915, RPA1, RPO1-4" ENSG00000068654 "RNA polymerase I subunit A" O95602 2 86020216-86106155 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010145, HPA031513, HPA049700" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" No No "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "unprognostic (1.32e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (3.70e-9)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.31e-2)" "unprognostic (4.56e-2)" "unprognostic (3.27e-1)" "unprognostic (2.20e-3)" "unprognostic (1.94e-1)" "prognostic unfavorable (8.41e-4)" "unprognostic (7.20e-2)" 14.3 12.9 10.1 12.4 16.5 9.7 10.3 12.2 20.3 11.1 11.0 17.4 8.3 9.4 19.5 7.4 13.5 12.3 11.7 12.7 9.0 9.2 11.5 15.1 9.4 9.6 9.0 9.4 12.6 14.3 18.2 15.9 11.4 13.8 10.7 11.8 13.9 11.2 12.5 22.5 12.3 8.6 16.0 8.0 11.2 10.4 14.9 10.9 14.0 10.3 11.4 14.2 10.9 9.6 2.6 2.6 1.8 2.5 2.0 3.8 1.2 9.4 21.6 9.6 18.5 9.5 7.6 14.0 8.7 5.8 12.6 7.8 27.0 7.5 21.7 9.3 8.9 12.2 11.0 24.7 12.9 11.2 9.0 12.8 18.7 9.2 18.1 6.7 17.7 10.1 5.8 8.1 18.6 14.5 4.8 9.7 10.1 24.7 5.5 8.6 8.4 13.1 7.5 17.5 12.7 14.3 15.8 21.1 10.2 5.6 15.5 15.0 7.8 9.6 12.8 6.9 6.9 7.5 6.2 15.4 15.3 12.1 13.0 17.5 7.8 7.5 19.0 7.9 15.3 13.4 1.8 1.5 0.2 3.0 2.5 3.8 2.0 1.5 2.5 1.8 2.6 1.4 1.8 0.7 2.0 1.9 2.6 0.7 1.2 10.1 16.5 12.2 20.3 9.0 9.2 9.0 9.4 13.8 10.9 3.0 7.8 6.1 2.9 3.8 11.5 7.8 15.3 6.7 3.4 8.7 15.7 5.7 3.3 5.9 2.4 5.7 4.2 0.0 4.0 4.4 3.8 4.3 5.8 7.2 10.2 11.1 9.2 4.9 2.8 1.5 5.8 3.1 5.0 1.8 6.1 2.9 5.0 0.0 4.9 3.0 10.1 0.0 4.7 4.2 7.5 2.4 3.2 4.4 9.0 3.7 POLR3G "RPC32, RPC7" ENSG00000113356 "RNA polymerase III subunit G" O15318 5 90471748-90514553 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.2" "Cell type enhanced" "Detected in many" 10 "Spermatogonia: 27.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010109, HPA052658, HPA074330" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: " "unprognostic (4.31e-1)" "unprognostic (5.35e-2)" "unprognostic (2.62e-2)" "unprognostic (3.55e-3)" "unprognostic (1.18e-1)" "unprognostic (3.42e-2)" "unprognostic (4.19e-6)" "unprognostic (2.17e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-2)" "unprognostic (3.52e-2)" "unprognostic (9.71e-2)" "unprognostic (1.21e-14)" "unprognostic (3.86e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-2)" "unprognostic (8.17e-5)" 2.7 1.6 7.1 3.6 10.2 4.4 3.8 7.2 7.2 3.7 2.6 6.7 1.4 2.8 2.7 8.4 7.3 2.7 2.4 2.7 7.7 7.7 1.7 4.0 2.9 8.1 10.3 6.1 4.1 4.1 11.1 3.9 3.1 20.2 2.9 3.1 2.6 4.2 1.5 4.4 7.4 2.3 4.2 16.0 3.3 2.1 8.0 8.1 1.0 5.9 8.5 3.2 4.4 4.7 3.9 2.1 6.8 2.8 5.4 3.2 0.8 10.7 6.2 7.4 1.9 2.3 4.1 3.4 5.4 1.7 8.6 7.0 3.6 8.0 29.4 1.8 2.2 8.5 4.5 9.2 8.6 30.8 13.5 8.2 10.8 2.9 5.5 3.9 7.5 2.7 2.7 4.0 14.3 10.9 1.7 10.6 11.7 15.3 2.7 3.1 5.2 7.9 4.7 34.9 1.5 27.7 7.0 3.2 16.6 2.5 1.0 9.4 2.5 2.2 4.1 14.9 3.4 2.2 2.1 12.7 4.7 9.0 6.6 20.3 6.8 17.4 21.7 10.4 10.0 37.3 6.8 0.6 0.3 3.2 0.8 1.6 3.9 1.1 2.0 0.9 2.4 2.4 2.6 1.6 5.4 2.8 2.1 0.5 0.8 7.1 10.2 7.2 7.2 7.7 7.7 10.3 6.1 20.2 8.1 6.0 2.1 0.8 1.2 3.2 2.7 3.4 0.0 2.7 0.0 1.8 7.9 0.7 3.3 2.6 3.0 1.4 0.5 0.0 3.9 5.2 1.5 3.0 6.9 2.4 1.5 3.2 6.4 3.7 0.3 1.0 0.3 0.6 1.7 0.0 1.3 0.6 2.9 2.0 1.1 1.3 0.8 0.0 1.4 7.7 27.4 7.4 0.7 0.0 1.6 0.6 POLR3H "KIAA1665, RPC8" ENSG00000100413 "RNA polymerase III subunit H" Q9Y535 22 41525804-41544606 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046787 Approved Supported Nucleoplasm,Vesicles,Centrosome NA NA Nucleoplasm "Vesicles, Centrosome" "HPA046787: AB_2679806" "unprognostic (1.55e-1)" "unprognostic (6.74e-2)" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (9.57e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.05e-2)" "unprognostic (1.33e-2)" "unprognostic (5.43e-2)" "prognostic favorable (5.41e-4)" "unprognostic (6.40e-2)" "unprognostic (1.54e-1)" "unprognostic (2.94e-2)" "unprognostic (1.49e-1)" "unprognostic (4.00e-2)" "unprognostic (1.70e-1)" 16.8 14.0 30.0 9.1 28.8 5.5 13.5 21.0 27.4 12.1 7.5 15.8 12.6 6.1 10.5 11.7 17.0 19.0 10.3 14.8 24.0 20.5 10.0 18.9 14.7 10.9 22.2 17.6 22.4 13.7 13.1 11.5 7.9 17.2 11.0 6.8 12.1 12.2 14.2 7.7 14.6 6.2 14.4 14.2 7.2 7.9 14.2 16.5 7.0 15.4 8.2 9.3 8.1 9.1 11.6 11.2 0.6 13.8 3.9 10.2 7.5 16.3 11.0 10.2 14.9 11.2 10.2 6.8 13.7 12.8 23.4 18.9 22.2 5.4 13.9 10.8 23.0 13.2 7.5 18.6 22.4 14.7 12.7 23.0 8.3 17.5 10.6 11.6 34.4 14.2 12.7 14.6 30.8 8.3 8.9 11.4 13.9 17.4 8.9 13.0 15.5 8.8 9.4 7.2 21.7 14.3 13.5 8.0 14.5 10.9 9.6 9.8 5.9 17.9 18.2 8.7 6.6 7.2 9.8 10.2 14.0 15.2 24.3 18.1 6.8 12.6 21.0 24.4 12.3 13.3 0.0 10.0 0.1 7.3 13.8 10.2 11.6 7.1 8.6 11.2 10.1 10.0 8.1 0.6 3.9 12.7 10.8 4.4 7.5 30.0 28.8 21.0 26.9 24.0 20.5 22.2 17.6 17.2 16.5 0.0 23.5 18.2 9.8 15.8 16.9 5.1 12.7 9.4 21.6 15.7 15.7 29.8 39.7 26.3 30.8 8.2 2.9 23.3 25.7 23.4 15.5 13.0 11.5 29.7 27.4 20.6 13.7 9.2 6.9 113.5 15.5 10.0 23.6 22.6 4.1 18.5 23.5 7.0 19.1 28.8 20.6 0.0 10.5 44.7 55.2 22.3 15.0 10.2 8.5 11.3 POMT2 LGMD2N ENSG00000009830 "Protein O-mannosyltransferase 2" Q9UKY4 14 77274956-77320884 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003663 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003663: AB_1079655" "unprognostic (2.15e-1)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (7.10e-3)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-3)" "unprognostic (1.94e-3)" "unprognostic (8.50e-3)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.75e-3)" "unprognostic (3.46e-2)" 6.7 10.8 10.4 6.8 11.4 3.8 7.7 12.5 13.3 6.8 6.3 18.0 9.8 4.6 6.9 17.1 5.7 8.7 6.9 7.7 9.3 7.7 8.1 8.3 6.2 3.0 11.7 6.2 7.6 10.6 14.7 16.1 11.4 9.7 7.3 5.8 8.2 10.1 12.3 17.0 4.3 4.6 7.8 8.4 5.2 5.6 30.9 14.4 2.5 11.5 4.9 3.8 5.7 5.0 1.4 1.9 0.8 1.9 0.0 1.7 0.4 10.4 13.4 13.0 14.7 9.3 7.5 10.4 9.2 7.6 13.8 11.8 6.6 9.4 3.1 7.5 8.6 19.1 11.7 6.1 9.2 9.6 4.6 8.3 1.9 6.6 5.4 11.4 2.1 6.3 7.6 9.8 12.9 12.6 9.6 8.0 3.1 4.9 7.3 9.0 20.6 3.6 10.1 3.7 14.5 11.3 3.5 12.7 2.8 14.3 7.7 11.0 10.8 6.0 10.2 7.7 8.9 10.5 4.4 6.6 10.4 16.4 12.0 8.0 4.8 9.4 1.4 5.3 3.2 9.1 0.0 0.4 0.0 1.7 1.9 0.4 1.4 0.0 0.3 0.9 0.2 0.1 0.0 0.8 0.0 0.8 1.9 0.0 0.4 10.4 11.4 12.5 13.3 9.3 7.7 11.7 6.2 9.7 14.4 6.0 3.2 2.2 2.3 2.7 6.5 4.0 5.1 0.0 0.0 1.8 15.7 5.0 0.0 6.6 8.0 2.8 3.9 0.0 6.4 8.6 6.0 3.5 2.3 4.4 4.8 7.9 17.2 3.1 2.4 12.1 1.7 2.2 1.7 3.6 3.0 8.2 5.8 1.9 3.9 3.0 15.0 0.0 3.9 9.8 8.5 1.6 4.8 0.0 2.6 1.4 POR "CYPOR, FLJ26468" ENSG00000127948 "Cytochrome p450 oxidoreductase" P16435 7 75899200-75986855 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 443.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 74.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004372, HPA010136" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB004372: AB_627391, HPA010136: AB_1079657" "unprognostic (1.89e-1)" "unprognostic (1.53e-1)" "unprognostic (2.81e-3)" "unprognostic (8.67e-2)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (4.32e-2)" "unprognostic (1.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (9.31e-2)" "unprognostic (1.71e-1)" "unprognostic (3.94e-2)" "unprognostic (9.89e-2)" 12.8 48.2 7.4 7.5 10.8 3.6 15.0 5.3 16.4 11.0 20.8 9.6 32.1 24.9 9.0 8.2 13.4 12.8 9.9 8.4 7.1 7.2 12.0 78.4 13.7 9.9 5.2 10.1 14.4 12.8 12.1 18.5 18.6 7.1 9.3 5.3 10.8 7.8 58.7 13.1 10.0 24.3 7.0 5.2 11.7 9.8 22.4 5.0 8.2 33.3 9.9 8.6 9.8 10.2 5.7 20.6 26.7 18.4 11.2 9.9 13.9 12.8 28.2 12.9 24.0 48.9 18.6 21.6 5.4 17.7 10.2 14.3 21.1 57.3 12.3 5.0 11.7 34.8 6.3 16.9 8.5 4.4 10.5 12.5 5.7 8.3 39.0 34.0 5.7 10.2 38.1 10.7 13.4 9.8 8.2 9.4 6.1 17.0 5.3 9.1 18.9 6.1 10.2 16.1 20.2 16.0 8.8 8.5 13.2 11.5 15.6 13.5 12.9 14.5 74.1 19.5 7.6 21.2 9.6 8.5 9.6 10.6 14.4 10.6 5.2 8.0 8.4 13.6 8.7 12.3 26.7 18.4 25.3 9.9 17.7 8.3 5.4 8.4 9.2 20.6 5.7 8.4 7.1 24.3 11.2 13.0 5.8 8.7 13.9 7.4 10.8 5.3 16.4 7.1 7.2 5.2 10.1 7.1 5.0 35.7 31.2 12.6 24.7 15.1 30.1 9.3 56.0 78.9 37.5 69.8 11.8 88.1 1.7 55.5 13.2 25.3 144.8 0.0 25.7 71.6 24.8 20.8 24.3 443.8 58.9 14.3 19.0 27.6 38.6 6.1 70.2 40.5 11.8 16.2 29.0 33.2 24.3 119.3 105.7 27.5 21.8 64.7 30.9 14.7 32.6 12.8 161.6 20.0 36.8 40.7 POU2F1 "OCT1, OTF1" ENSG00000143190 "POU class 2 homeobox 1" P14859 1 167220829-167427345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 106.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002608, HPA058559, HPA064323" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" No No "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB002608: , HPA058559: AB_2683756, HPA064323: AB_2685245" "unprognostic (1.74e-1)" "unprognostic (9.33e-2)" "unprognostic (1.28e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-3)" "unprognostic (4.26e-2)" "unprognostic (5.67e-6)" "unprognostic (4.47e-2)" "unprognostic (5.14e-1)" "unprognostic (7.94e-3)" "unprognostic (1.95e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.98e-5)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.17e-2)" 6.9 5.7 15.5 7.3 11.9 12.6 7.2 36.4 13.8 7.7 6.6 9.5 5.2 4.1 7.5 8.4 5.3 6.5 4.3 5.1 14.5 6.7 7.0 5.8 6.6 8.2 7.7 10.8 8.1 6.1 15.5 8.3 9.6 7.1 6.7 6.8 12.0 5.5 6.5 10.5 8.8 6.6 5.5 6.3 9.3 6.1 10.1 10.9 7.4 6.9 4.9 9.7 7.6 6.2 7.5 5.9 8.6 5.9 1.4 4.4 2.2 6.4 5.2 13.5 4.1 1.6 1.6 5.5 0.8 1.4 1.6 1.6 7.5 3.7 7.3 3.5 1.3 1.5 5.0 8.2 2.5 2.4 2.9 3.1 5.1 3.6 6.1 1.0 5.6 3.4 1.1 1.4 1.8 3.3 2.0 2.1 5.1 5.4 4.2 2.1 3.4 5.1 3.6 15.7 3.5 2.1 7.5 4.9 3.2 2.8 3.6 8.2 6.2 5.0 3.7 3.3 7.1 4.1 6.9 3.4 3.1 4.9 1.9 3.1 4.0 1.8 16.9 1.4 3.4 3.9 8.6 2.3 2.8 4.4 2.7 3.3 7.5 2.3 2.0 2.5 6.8 3.2 2.4 3.3 1.4 5.9 5.9 2.1 2.2 15.5 11.9 36.4 13.8 14.5 6.7 7.7 10.8 7.1 10.9 11.9 12.1 21.9 10.4 11.8 54.9 13.2 12.7 6.7 10.3 19.2 96.2 15.4 5.0 8.8 23.3 16.6 8.5 0.0 10.1 15.3 13.4 14.9 19.6 11.6 11.2 44.5 23.2 11.1 35.6 28.6 23.9 14.6 6.8 23.4 14.3 47.2 12.6 7.0 19.4 6.9 106.3 25.8 11.9 18.5 40.0 9.7 43.3 13.8 13.0 9.7 PPDPF "C20orf149, dJ697K14.9, exdpf" ENSG00000125534 "Pancreatic progenitor cell differentiation and proliferation factor" Q9H3Y8 20 63520724-63522206 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 2540.0;Paneth cells: 2816.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 18.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040929 Approved Nucleoplasm,Nucleoli,Microtubules Yes No "Nucleoplasm, Microtubules" Nucleoli "HPA040929: AB_10794155" "unprognostic (3.75e-2)" "unprognostic (5.39e-2)" "unprognostic (4.37e-2)" "unprognostic (9.03e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-2)" "unprognostic (1.91e-1)" "unprognostic (2.00e-1)" "unprognostic (4.20e-1)" "prognostic favorable (3.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-1)" "unprognostic (2.09e-2)" 63.9 19.9 42.2 46.0 43.0 36.5 38.8 22.3 55.1 54.3 78.6 61.5 43.5 41.3 39.9 46.0 112.6 44.7 67.3 53.2 32.9 31.0 72.1 28.4 56.5 42.8 44.5 34.9 45.6 69.5 15.4 35.0 22.2 48.7 75.3 32.2 58.8 143.7 54.1 116.1 86.2 48.5 61.8 72.0 40.0 120.2 49.0 21.6 28.7 48.0 73.3 87.9 68.6 65.2 5.8 3.4 18.9 4.5 2.4 5.2 3.4 44.6 13.9 9.5 19.2 10.8 18.2 30.7 27.5 8.9 36.0 14.2 25.4 26.9 9.6 37.1 18.3 13.7 47.3 4.8 31.4 5.8 17.1 9.5 3.9 13.0 4.8 29.7 0.0 20.6 17.9 63.4 9.1 12.7 11.9 14.1 12.2 16.1 22.7 13.1 60.8 45.7 0.4 10.3 35.8 80.8 20.9 21.5 19.4 25.7 18.4 32.6 24.9 27.3 44.1 18.9 6.6 63.0 26.2 23.2 30.4 34.6 40.2 22.7 18.1 14.2 6.5 21.5 11.3 19.8 1.9 2.4 18.9 5.2 3.1 4.3 4.6 4.6 4.8 2.9 5.8 4.1 4.5 1.1 2.4 4.5 3.4 5.0 3.4 42.2 43.0 22.3 55.1 32.9 31.0 44.5 34.9 48.7 21.6 291.8 201.0 276.1 613.6 510.4 42.1 61.0 749.1 294.5 174.0 910.7 11.8 432.7 2540.0 793.9 185.5 235.8 2093.0 327.1 669.9 547.6 555.3 988.2 330.2 190.7 548.2 47.7 765.2 266.4 322.1 856.1 344.3 360.7 1130.3 1110.9 1414.5 95.8 744.2 2816.1 271.2 1340.7 49.4 194.1 670.9 133.9 288.9 814.8 346.3 385.8 996.5 1073.4 PPIL6 "bA425D10.6, dJ919F19.1, MGC41939, RSPH12" ENSG00000185250 "Peptidylprolyl isomerase like 6" Q8IXY8 6 109390215-109441171 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 36.5" "Group enriched" "Detected in many" 4 "Ciliated cells: 187.4;Early spermatids: 262.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 6.5;ASC diff: 10.4;ASC TERT1: 12.9;hTERT-RPE1: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036717, HPA058165" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA036717: AB_10671969, HPA058165: " "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (5.68e-2)" "unprognostic (2.68e-2)" "unprognostic (3.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (5.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.03e-2)" "unprognostic (1.42e-3)" "unprognostic (2.51e-2)" "unprognostic (4.71e-2)" "unprognostic (1.95e-1)" "unprognostic (3.29e-2)" "unprognostic (5.86e-2)" "unprognostic (2.32e-1)" 1.5 1.4 5.5 1.1 8.6 0.7 3.6 5.0 4.8 4.6 1.7 7.2 7.4 1.9 3.8 12.7 2.0 36.5 1.7 2.6 6.0 5.4 4.9 1.2 8.9 1.1 3.4 3.2 6.3 4.3 6.6 7.6 1.6 18.3 1.8 1.6 2.6 2.8 5.0 3.9 1.7 1.1 5.4 3.2 1.3 2.3 20.4 5.3 0.0 17.2 1.4 1.1 2.9 2.0 5.1 1.7 2.0 1.3 1.7 1.3 1.1 1.8 1.0 1.2 6.5 10.4 12.9 1.1 0.0 2.3 0.5 0.2 0.1 1.8 0.0 0.5 0.6 0.9 1.2 1.0 0.0 0.3 0.5 0.9 0.5 0.1 0.0 5.2 0.6 0.3 2.7 6.2 0.2 3.9 9.3 0.8 1.4 0.9 0.3 0.4 0.6 0.1 0.6 0.2 4.2 1.3 0.8 0.0 0.6 5.0 0.1 1.5 2.5 0.2 0.3 4.3 0.3 0.5 1.0 0.4 0.1 0.2 1.1 0.2 0.3 0.1 0.1 2.1 0.1 0.4 2.0 1.2 1.2 0.9 1.3 0.9 5.1 1.2 1.1 1.7 3.2 1.1 1.0 1.6 1.7 1.1 1.7 1.3 1.1 5.5 8.6 5.0 4.8 6.0 5.4 3.4 3.2 18.3 5.3 6.0 5.8 0.0 3.5 1.9 2.1 3.3 5.1 187.4 22.7 3.5 2.0 0.5 21.6 1.6 262.5 1.5 0.7 0.0 1.0 0.7 1.7 2.9 0.0 0.0 0.3 1.6 2.9 0.6 0.0 40.8 4.9 0.5 3.3 1.0 1.8 4.9 0.7 0.0 4.9 8.0 11.5 0.0 1.2 52.6 22.0 2.6 0.6 0.5 1.7 1.1 PPL ENSG00000118898 Periplakin O60437 16 4882507-4960741 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 68.5;Collecting duct cells: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.2;HaCaT: 57.0;MCF7: 20.8;SiHa: 30.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA042550, HPA059859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 310000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA042550: AB_2678048, HPA059859: AB_2684145" "unprognostic (2.12e-2)" "unprognostic (1.78e-1)" "unprognostic (1.16e-1)" "unprognostic (3.90e-2)" "unprognostic (2.84e-2)" "unprognostic (1.40e-1)" "unprognostic (3.70e-3)" "unprognostic (5.58e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (2.41e-2)" "unprognostic (1.31e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" 10.8 0.7 2.2 1.4 0.7 0.2 6.8 0.6 3.0 23.5 2.9 0.2 4.1 1.7 2.6 5.1 126.9 2.9 5.8 1.8 1.8 0.2 3.0 3.3 4.7 0.2 0.0 0.9 1.7 2.8 1.6 2.8 2.9 0.5 4.6 1.0 0.7 24.3 3.3 3.2 30.7 2.0 5.0 0.0 0.2 2.1 1.5 0.0 0.5 7.2 57.8 60.9 5.0 39.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 6.9 2.5 0.0 0.0 18.7 27.2 9.0 0.0 0.4 0.0 0.1 11.6 17.8 0.1 4.1 0.3 1.0 57.0 0.3 6.8 0.0 0.0 0.4 0.0 13.8 2.0 1.2 0.0 0.0 1.3 6.3 0.0 2.2 1.4 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 1.8 9.2 5.4 0.0 0.0 8.7 13.6 11.1 9.4 0.1 30.5 10.2 0.1 2.8 5.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 3.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.6 3.0 1.8 0.2 0.0 0.9 0.5 0.0 68.5 23.2 0.5 33.9 31.1 7.7 3.5 30.6 12.0 30.7 54.1 5.9 1.6 1.7 15.3 0.6 6.4 4.5 0.0 4.0 1.2 11.0 30.6 0.0 10.9 0.6 1.6 37.8 4.3 0.8 0.2 51.2 1.8 16.9 1.8 3.9 5.3 16.8 5.8 3.9 0.8 11.2 0.0 5.6 3.9 2.9 44.8 1.1 0.7 5.0 47.5 PPP1CA "PP-1A, PP1A, PP1alpha, PPP1A" ENSG00000172531 "Protein phosphatase 1 catalytic subunit alpha" P62136 11 67398183-67421183 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 177.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004545, HPA046833" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 8100000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB004545: AB_628177, HPA046833: AB_2679829" "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.09e-1)" "unprognostic (1.51e-2)" "unprognostic (3.15e-3)" "unprognostic (3.93e-2)" "unprognostic (2.07e-1)" "unprognostic (3.89e-2)" "unprognostic (5.05e-3)" "unprognostic (8.00e-2)" "unprognostic (1.66e-1)" "unprognostic (9.96e-2)" "unprognostic (7.69e-2)" "prognostic favorable (1.17e-4)" "unprognostic (7.60e-2)" 28.4 35.4 24.2 42.0 32.3 42.1 25.1 19.6 33.4 23.9 39.6 22.1 29.9 33.9 19.6 25.8 59.7 22.8 28.6 33.0 21.8 17.1 43.7 55.0 27.6 49.3 19.9 19.9 20.1 53.3 23.1 21.6 44.0 19.3 27.2 33.2 23.2 49.7 31.1 39.0 34.4 47.3 20.5 21.3 53.7 35.1 15.7 19.4 77.7 38.5 40.5 63.9 25.5 25.7 78.8 76.6 126.2 118.0 68.2 113.9 177.2 45.3 52.4 31.1 45.8 15.5 19.0 31.7 22.5 26.4 45.4 34.5 74.9 54.8 39.1 38.4 34.1 33.8 39.8 35.9 46.8 27.9 41.1 24.4 37.5 24.7 39.2 33.9 47.6 48.5 21.4 31.0 38.6 22.8 21.6 45.5 38.3 34.8 32.4 36.7 103.5 60.3 93.6 51.6 86.5 41.5 42.9 43.0 33.8 44.6 37.6 24.3 40.4 26.1 46.9 69.4 24.3 56.1 33.0 32.4 35.1 35.9 41.3 29.1 32.5 30.1 44.4 42.0 32.7 36.9 81.4 80.1 126.2 88.6 100.5 69.3 78.8 79.8 90.5 76.6 77.0 49.1 69.2 93.3 68.2 118.0 54.4 113.9 177.2 24.2 32.3 19.6 33.4 21.8 17.1 19.9 19.9 19.3 19.4 71.5 93.0 166.0 108.0 88.8 35.0 7.9 117.2 41.5 46.6 82.0 9.8 320.7 180.8 238.7 1.8 77.3 292.4 23.3 272.4 398.0 69.2 127.9 107.3 102.4 338.5 41.3 93.0 87.2 194.1 5.3 45.5 157.2 129.9 390.5 160.1 42.9 250.4 210.5 26.9 236.5 23.6 97.0 60.9 13.0 106.5 106.3 357.3 222.6 164.6 168.4 PPP1CB "PP-1B, PP1B, PP1beta" ENSG00000213639 "Protein phosphatase 1 catalytic subunit beta" P62140 2 28751640-28802940 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022558, HPA065425, CAB069426" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 7700000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022558: , CAB069426: , HPA065425: AB_2685489" "unprognostic (2.90e-1)" "unprognostic (5.03e-2)" "unprognostic (5.49e-2)" "unprognostic (2.00e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (6.52e-6)" "unprognostic (3.47e-2)" "unprognostic (2.44e-1)" "unprognostic (3.15e-2)" "unprognostic (1.54e-3)" "unprognostic (3.95e-1)" "unprognostic (1.68e-1)" "unprognostic (3.66e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-1)" "unprognostic (2.26e-2)" 28.5 22.6 30.0 20.5 37.6 29.5 32.4 19.1 29.8 51.1 39.3 21.1 30.7 24.4 58.0 31.8 86.0 37.0 33.3 67.1 27.8 27.9 32.0 20.0 35.3 22.3 27.4 24.4 39.7 21.9 48.9 28.7 42.3 22.0 46.4 27.7 25.2 36.5 38.6 99.6 25.1 30.0 100.8 27.5 25.2 31.4 25.5 21.4 28.1 27.5 32.9 25.3 82.1 50.5 15.6 25.4 41.5 42.7 23.5 28.3 17.9 37.1 23.4 81.7 25.2 28.0 26.1 47.6 20.0 22.8 19.5 19.3 20.7 22.0 29.7 25.1 20.6 21.6 23.0 23.2 26.7 23.2 47.1 12.0 22.5 28.8 22.4 61.0 25.4 10.6 20.0 38.0 21.0 44.0 20.5 23.5 15.8 20.4 29.5 25.5 18.6 26.9 22.0 26.8 28.6 18.6 26.4 72.4 22.6 63.3 44.9 22.4 27.7 31.0 34.6 27.1 24.4 16.7 14.2 28.1 26.1 28.7 18.6 24.0 21.1 33.1 60.9 27.7 27.4 19.3 22.5 24.8 32.1 16.8 37.8 21.3 15.6 25.5 19.6 25.4 13.4 22.7 25.5 41.5 23.5 42.7 19.6 28.3 17.9 30.0 37.6 19.1 29.8 27.8 27.9 27.4 24.4 22.0 21.4 86.4 80.7 105.5 134.5 437.2 53.8 298.4 104.4 129.8 72.8 294.8 25.5 104.9 207.2 242.7 375.6 106.2 128.9 163.5 183.3 167.5 182.4 291.0 146.3 81.8 104.3 154.1 271.6 108.6 144.9 304.1 182.1 233.4 318.9 92.8 133.9 100.9 238.2 181.4 283.9 113.6 53.2 620.9 265.8 57.5 61.8 400.4 328.6 110.8 99.3 394.6 PPP1R1C Inhibitor-1-like ENSG00000150722 "Protein phosphatase 1 regulatory inhibitor subunit 1C" Q8WVI7 2 181954241-182131398 "Predicted intracellular proteins" "Cell cycle, Cell division" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.5;heart muscle: 27.8" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 106.6;Late spermatids: 139.1;Spermatocytes: 41.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;HAP1: 1.2;JURKAT: 1.1;MOLT-4: 2.1;SiHa: 1.3;SuSa: 1.2;U-266/70: 1.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA055043 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA055043: AB_2797251" "unprognostic (1.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.54e-3)" "unprognostic (1.08e-2)" "unprognostic (1.36e-1)" "unprognostic (1.01e-1)" "unprognostic (2.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.57e-2)" "unprognostic (6.59e-3)" "unprognostic (1.13e-1)" "unprognostic (7.98e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-3)" "unprognostic (7.68e-2)" "unprognostic (3.07e-2)" "unprognostic (9.75e-3)" 0.2 0.1 0.7 0.1 3.5 0.1 0.2 3.5 1.8 0.1 0.2 3.0 0.0 0.2 0.2 0.1 0.3 0.2 0.5 27.8 1.5 1.1 0.2 1.2 0.3 0.2 0.8 0.6 0.1 0.6 0.1 0.4 0.2 7.5 1.4 0.2 0.5 0.5 0.2 4.3 0.2 0.7 0.1 2.5 0.2 0.4 0.6 1.3 0.0 0.2 3.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.4 2.1 0.0 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.3 0.2 0.3 1.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.9 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.5 3.5 1.8 1.5 1.1 0.8 0.6 7.5 1.3 11.9 5.4 0.0 0.5 0.2 0.8 34.2 10.2 1.4 11.4 3.5 0.0 2.7 1.7 2.3 106.6 0.0 0.0 0.0 9.8 5.6 0.7 0.1 0.0 17.9 0.5 0.0 5.8 0.0 0.3 139.1 5.5 0.0 3.3 6.4 0.3 6.0 14.6 0.0 0.7 0.5 1.9 0.0 0.5 41.8 2.0 0.3 2.1 0.0 0.7 0.9 PPP2R3C "C14orf10, FLJ20644, G4-1, G5PR" ENSG00000092020 "Protein phosphatase 2 regulatory subunit B''gamma" Q969Q6 14 35085467-35122517 "Predicted intracellular proteins" "Cone-rod dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 382.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040835, HPA058834" Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No Nucleoplasm "Golgi apparatus, Cytosol" "HPA040835: AB_10794152, HPA058834: AB_2683831" "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (7.32e-3)" "unprognostic (5.33e-2)" "unprognostic (9.73e-2)" "unprognostic (1.10e-3)" "unprognostic (3.05e-1)" "unprognostic (7.85e-2)" "unprognostic (9.48e-3)" "unprognostic (1.17e-2)" "unprognostic (1.91e-1)" "unprognostic (2.18e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-3)" "unprognostic (8.55e-2)" "unprognostic (8.29e-2)" 14.5 12.5 19.1 15.5 23.8 26.4 12.2 17.9 22.1 12.9 13.8 11.4 9.5 14.1 10.9 11.0 8.9 10.0 12.5 14.8 17.9 11.4 10.1 10.5 12.1 18.9 28.4 17.2 12.6 9.5 11.3 30.8 12.7 20.6 11.8 14.7 6.8 10.2 9.7 20.0 6.5 15.3 14.5 22.8 21.5 13.1 46.8 24.1 18.9 8.7 7.5 16.4 14.7 10.4 12.2 12.7 32.1 19.2 13.9 14.7 11.4 15.6 8.6 14.9 13.3 9.8 19.8 11.2 12.6 10.7 14.9 18.3 6.8 11.3 16.8 5.0 12.0 6.1 6.7 6.7 4.8 22.2 18.4 7.8 9.4 4.6 24.9 14.4 17.4 18.5 15.2 4.5 11.2 6.9 8.0 20.2 9.9 9.9 17.1 21.4 11.3 18.3 16.3 13.5 9.2 10.0 18.2 11.5 13.8 5.2 9.1 16.1 14.0 15.5 11.2 20.3 7.1 7.4 20.8 17.1 16.3 7.0 13.7 14.4 15.3 20.1 34.2 8.3 16.7 18.5 20.0 15.0 32.1 10.7 19.2 11.7 12.2 10.8 13.8 12.7 11.0 9.6 11.7 28.1 13.9 16.4 8.1 14.7 11.4 19.1 23.8 17.9 22.1 17.9 11.4 28.4 17.2 20.6 24.1 14.9 24.8 50.1 18.1 10.2 15.8 23.0 25.5 22.7 12.5 19.2 3.9 16.4 28.2 26.6 382.3 29.2 28.5 23.3 31.4 21.7 23.5 24.4 33.4 19.2 53.2 7.9 30.0 26.4 42.9 134.4 26.2 49.9 27.0 72.1 21.2 18.8 38.8 20.3 28.7 31.1 19.1 32.3 31.1 103.4 61.7 11.8 29.1 39.5 20.2 26.5 PPP2R5C "B56G, B56gamma, PR61G" ENSG00000078304 "Protein phosphatase 2 regulatory subunit B'gamma" Q13362 14 101761798-101927989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "T-cells: 251.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027553 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA027553: AB_10602081" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (1.23e-1)" "unprognostic (1.99e-1)" "unprognostic (1.31e-3)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.72e-1)" 25.5 29.4 52.6 37.7 45.3 48.1 27.4 25.7 38.9 27.8 31.1 25.6 30.1 22.4 24.0 29.2 32.7 22.3 25.4 48.4 49.3 35.6 25.5 38.1 34.5 53.8 44.7 32.4 28.4 25.6 27.6 35.3 19.5 27.5 23.1 33.3 26.6 28.9 27.8 30.5 28.9 31.7 27.7 45.5 36.8 25.4 27.6 29.5 51.4 29.6 28.3 52.1 33.2 21.9 20.1 24.9 35.3 25.3 16.8 60.5 20.9 21.0 14.5 24.6 23.7 22.3 31.5 23.8 19.9 26.4 25.0 24.0 14.5 36.8 57.7 19.3 25.8 17.6 22.2 22.4 21.1 32.6 25.9 10.6 16.7 17.2 14.1 16.5 25.6 35.9 20.7 27.4 17.2 16.0 22.3 22.4 31.5 34.7 24.4 23.8 32.1 25.7 28.3 14.3 42.5 24.2 21.8 27.7 14.2 24.0 24.0 19.3 36.1 27.0 17.9 33.7 18.0 32.8 19.7 22.1 15.8 15.1 60.7 19.7 34.1 51.0 96.2 23.7 19.0 17.5 20.1 19.8 18.2 60.5 24.3 38.9 20.1 39.7 47.5 16.9 17.8 28.6 44.1 35.3 16.8 25.3 24.9 39.7 20.9 52.6 45.3 25.7 38.9 49.3 35.6 44.7 32.4 27.5 29.5 77.4 85.3 74.9 37.2 52.1 31.6 113.5 48.4 68.3 52.4 34.9 55.0 41.1 39.7 33.2 55.5 45.2 45.9 46.7 40.7 39.2 41.8 41.7 66.0 70.6 61.7 25.4 45.5 59.5 108.0 50.8 48.6 71.4 81.0 136.1 71.3 33.5 39.8 66.8 42.8 53.6 38.0 38.8 46.4 23.7 25.4 61.5 43.8 251.6 58.7 59.3 PPP4C "PP4, PPX" ENSG00000149923 "Protein phosphatase 4 catalytic subunit" P60510 16 30075978-30085377 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043837 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA043837: AB_2678695" "unprognostic (1.20e-1)" "unprognostic (1.33e-2)" "unprognostic (2.68e-1)" "unprognostic (4.74e-2)" "unprognostic (2.16e-1)" "unprognostic (5.79e-3)" "unprognostic (3.28e-3)" "unprognostic (2.60e-3)" "unprognostic (3.82e-1)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (9.36e-2)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" 24.7 26.6 13.5 26.1 14.1 26.7 18.6 16.0 15.9 19.2 28.4 14.5 20.5 22.5 19.2 28.4 39.1 17.7 31.9 28.5 12.6 12.1 28.9 52.3 27.4 25.3 12.5 12.8 22.5 26.3 23.9 16.2 51.6 11.9 18.3 17.4 18.8 22.0 14.9 26.0 26.1 38.8 15.9 11.9 36.2 22.6 39.0 9.5 59.7 27.1 26.5 37.9 22.2 21.1 19.5 30.3 57.3 28.2 12.4 23.6 12.0 30.8 34.6 23.1 32.2 21.9 18.5 36.0 27.5 30.7 36.2 40.2 30.4 40.3 24.0 35.4 32.4 23.6 25.2 28.6 34.1 21.4 30.1 51.2 16.3 21.5 67.2 33.3 22.9 30.9 26.8 30.2 33.0 21.0 21.7 42.0 31.3 31.8 22.0 27.6 88.9 39.9 41.8 44.0 24.5 18.4 44.7 24.0 41.8 34.2 31.8 22.5 33.3 13.5 40.8 23.5 20.2 37.6 39.0 26.7 21.2 22.3 17.1 21.1 37.8 41.5 28.1 30.2 29.6 25.6 21.4 26.9 57.3 18.3 28.2 13.1 17.0 19.2 20.6 30.3 19.5 17.2 15.2 56.9 12.4 24.5 23.5 23.6 12.0 13.5 14.1 16.0 15.9 12.6 12.1 12.5 12.8 11.9 9.5 47.6 33.1 81.7 96.8 130.7 20.0 9.3 89.2 54.9 23.9 73.3 27.5 268.8 134.3 208.0 127.6 84.2 174.4 0.0 169.7 278.1 71.4 111.6 69.1 85.6 210.3 33.4 120.5 58.9 91.3 98.3 58.1 124.3 75.9 252.5 114.3 41.8 254.7 168.4 49.1 156.3 25.7 71.1 65.1 231.9 141.6 150.8 352.1 111.4 129.3 192.9 PPP4R3A "FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1" ENSG00000100796 "Protein phosphatase 4 regulatory subunit 3A" Q6IN85 14 91457611-91510554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002568, HPA063917" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA002568: AB_1079207, HPA063917: AB_2685153" "unprognostic (5.51e-2)" "unprognostic (2.93e-2)" "unprognostic (3.26e-1)" "unprognostic (1.40e-1)" "unprognostic (4.40e-2)" "unprognostic (9.95e-3)" "unprognostic (4.10e-2)" "unprognostic (5.71e-3)" "unprognostic (1.05e-1)" "unprognostic (8.34e-3)" "unprognostic (1.33e-1)" "unprognostic (3.85e-2)" "unprognostic (3.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.57e-1)" "unprognostic (4.53e-2)" 19.0 14.2 22.1 25.7 19.7 48.5 20.1 33.2 22.6 20.6 22.7 15.0 22.0 19.8 22.0 17.7 22.7 21.0 23.4 15.7 19.4 14.2 20.7 27.8 21.4 29.0 20.8 16.8 23.4 21.7 25.6 24.0 25.1 16.3 21.6 20.9 14.7 20.5 29.1 34.8 25.4 27.1 19.9 18.0 29.1 21.2 25.3 18.3 44.6 19.6 20.3 27.5 19.9 25.6 9.0 7.4 8.5 4.7 12.1 10.0 3.6 14.8 17.8 22.4 15.7 12.3 12.2 30.6 12.8 12.5 14.5 14.4 15.4 19.5 33.4 16.4 11.3 9.9 16.1 21.8 16.5 22.8 27.2 8.9 17.2 12.5 12.6 13.9 33.6 18.8 8.5 25.6 11.3 17.1 12.2 14.7 18.0 15.5 24.8 16.1 23.9 25.2 16.3 16.4 24.0 12.6 29.3 24.2 14.3 14.6 24.1 26.2 14.4 19.0 46.4 16.1 20.1 24.3 19.4 14.5 12.9 11.6 13.3 16.2 19.1 28.6 38.5 15.5 15.8 20.1 8.5 3.1 3.6 7.2 3.5 10.0 7.1 7.3 6.5 2.9 9.0 9.0 7.3 3.4 12.1 4.7 7.4 9.3 3.6 22.1 19.7 33.2 22.6 19.4 14.2 20.8 16.8 16.3 18.3 29.8 38.7 24.8 38.8 0.0 25.4 0.0 28.1 30.8 55.7 43.6 19.6 27.8 24.9 17.8 7.1 24.8 26.2 0.0 21.5 23.8 19.2 43.0 18.6 43.3 22.6 30.2 12.9 29.4 42.3 4.7 34.8 35.8 0.0 19.0 36.6 23.0 22.0 35.1 40.0 19.2 27.4 25.8 0.0 69.4 52.6 0.0 37.1 40.5 33.2 68.0 PPP4R3B "FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2" ENSG00000275052 "Protein phosphatase 4 regulatory subunit 3B" Q5MIZ7 2 55547292-55618880 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001233, CAB017185" Approved Supported "Nucleoplasm,Nuclear speckles,Centrosome" NA NA "Nucleoplasm, Nuclear speckles" Centrosome "CAB017185: , HPA001233: AB_1080033" "unprognostic (9.60e-2)" "unprognostic (2.47e-2)" "unprognostic (5.77e-2)" "unprognostic (1.87e-2)" "unprognostic (6.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (3.27e-2)" "unprognostic (8.27e-3)" "unprognostic (7.62e-2)" "unprognostic (1.07e-2)" "unprognostic (3.69e-1)" "prognostic unfavorable (6.03e-4)" "unprognostic (9.73e-2)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" 11.9 10.4 12.1 10.6 13.1 8.1 10.9 17.5 13.1 11.2 11.4 8.6 7.4 11.5 8.8 7.8 12.0 12.5 9.1 5.3 12.8 12.7 18.1 8.3 13.0 13.3 7.9 10.8 13.6 10.7 11.7 11.1 11.4 9.5 10.6 7.8 9.6 9.1 6.0 11.0 14.4 10.3 11.1 10.8 11.0 8.0 12.3 18.7 12.6 6.2 14.3 11.3 10.0 17.6 16.9 23.9 19.6 20.0 25.3 21.6 19.8 15.5 17.2 14.5 18.4 19.4 23.6 16.1 17.6 13.9 12.0 18.3 19.3 27.1 32.7 15.9 22.1 17.3 19.5 13.2 20.9 38.9 8.1 27.0 14.6 24.4 29.8 30.7 22.4 15.0 32.0 17.0 29.3 17.9 21.8 15.0 25.5 27.4 18.3 23.3 19.7 20.2 16.9 26.1 12.3 18.5 26.0 20.4 19.1 20.9 21.3 13.0 17.5 24.2 26.0 12.0 15.3 24.9 17.1 21.3 27.4 10.4 22.1 28.4 21.3 10.4 20.0 29.3 22.7 21.2 15.6 23.9 20.4 19.6 23.0 17.6 21.5 21.2 16.9 16.9 25.3 22.0 18.1 20.0 19.3 9.2 21.5 21.6 41.7 35.8 11.1 36.9 0.0 44.1 0.0 17.8 115.1 53.4 15.7 31.4 25.9 33.2 27.6 4.8 23.3 28.5 0.0 35.4 23.5 13.4 47.5 27.9 46.9 23.3 50.9 17.5 23.9 37.1 5.9 25.9 31.9 0.0 36.9 39.3 48.7 31.4 28.1 33.9 42.6 36.0 6.5 0.0 36.3 23.1 0.0 39.9 35.5 36.7 53.1 PPP6R3 "C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3" ENSG00000110075 "Protein phosphatase 6 regulatory subunit 3" Q5H9R7 11 68460731-68615334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017183, HPA038467, HPA038468" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB017183: , HPA038467: AB_2676029, HPA038468: AB_2676030" "unprognostic (9.46e-3)" "unprognostic (1.45e-1)" "unprognostic (4.62e-2)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (6.19e-2)" "unprognostic (1.97e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (3.33e-2)" "unprognostic (1.02e-1)" "unprognostic (2.38e-2)" "unprognostic (2.20e-3)" "unprognostic (3.29e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (1.54e-2)" "unprognostic (6.43e-2)" 33.0 29.8 16.7 25.7 24.1 36.5 26.8 35.7 25.8 33.2 29.6 27.9 24.9 21.5 43.8 24.3 29.9 26.6 24.6 27.5 17.3 16.5 28.8 28.2 27.9 26.8 25.0 18.5 36.4 23.8 49.0 48.1 40.0 23.7 28.3 27.5 28.2 28.2 29.2 46.4 25.8 31.5 35.5 24.3 31.1 27.7 28.2 24.0 45.5 39.2 34.8 31.8 34.3 26.9 14.8 15.0 16.9 16.7 11.7 17.7 7.1 24.4 29.0 30.1 21.0 16.1 16.4 23.3 21.5 20.9 25.0 23.0 50.3 24.9 28.2 21.2 20.0 26.4 23.2 33.0 24.3 33.2 27.3 13.9 32.6 29.5 16.9 15.4 30.9 29.2 16.2 16.4 25.7 27.9 14.1 22.8 22.7 27.5 21.1 17.8 32.8 31.0 23.9 15.0 48.5 17.2 29.2 41.0 27.4 16.7 35.6 17.0 20.3 30.5 24.2 44.3 26.2 35.9 16.6 22.6 24.7 23.4 26.2 18.2 16.7 23.2 37.1 17.9 13.7 26.2 14.6 11.5 14.4 14.7 15.2 14.0 14.1 15.6 14.4 7.4 14.8 17.7 16.1 16.9 11.7 16.7 15.0 15.0 7.1 16.7 24.1 35.7 25.8 17.3 16.5 25.0 18.5 23.7 24.0 41.7 36.5 27.5 21.7 29.5 48.6 33.5 28.1 24.1 38.7 26.2 53.0 16.9 13.3 13.4 59.6 29.4 28.0 23.3 14.3 14.1 23.1 34.0 26.6 21.2 15.0 25.4 29.2 29.4 18.4 17.8 28.7 25.2 20.3 10.8 26.5 31.9 19.2 28.3 29.7 13.5 49.0 19.4 28.1 27.7 29.7 31.0 27.5 26.6 23.4 35.3 PRDM10 "KIAA1231, MGC131802, PFM7" ENSG00000170325 "PR/SET domain 10" Q9NQV6 11 129899706-130002835 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026997, HPA061749" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA Nucleoplasm "Nucleoli fibrillar center, Vesicles" "HPA026997: AB_1855681, HPA061749: " "unprognostic (4.40e-2)" "unprognostic (2.17e-1)" "unprognostic (5.32e-3)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (1.52e-3)" "unprognostic (2.19e-2)" "unprognostic (2.48e-1)" "unprognostic (1.87e-3)" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (5.69e-2)" "unprognostic (4.88e-1)" "unprognostic (6.23e-2)" "unprognostic (1.51e-1)" 5.8 5.4 7.6 7.2 8.9 14.2 8.5 20.3 10.4 7.4 7.8 6.4 5.8 6.6 8.2 6.8 8.4 5.4 5.5 4.6 7.7 6.2 5.0 7.3 6.3 6.9 6.6 6.5 7.3 6.2 9.7 11.2 8.3 6.4 7.1 8.0 5.5 6.7 5.4 12.9 12.1 7.0 6.1 6.3 6.7 7.8 5.6 6.3 14.4 6.5 4.7 9.9 6.2 7.0 8.8 3.3 9.4 3.8 7.1 5.0 1.8 3.0 4.1 5.1 3.4 2.3 2.8 3.4 2.5 3.3 2.1 2.8 4.2 3.3 12.2 3.1 2.9 2.9 4.1 4.3 2.1 3.5 4.7 4.2 8.0 5.0 3.2 1.5 7.2 33.3 2.0 4.8 3.2 2.1 3.3 3.8 3.3 4.4 4.7 3.1 3.6 4.8 3.6 3.9 4.1 3.0 4.5 3.2 1.8 3.1 5.6 5.6 2.9 3.7 4.3 1.2 3.0 3.0 3.0 3.7 5.0 2.3 2.5 3.3 1.2 2.0 16.9 2.2 3.9 4.5 3.9 3.4 8.5 4.5 3.4 4.1 8.8 3.5 3.5 3.3 6.0 5.0 2.4 9.4 7.1 3.8 3.2 4.1 1.8 7.6 8.9 20.3 10.4 7.7 6.2 6.6 6.5 6.4 6.3 3.0 2.4 0.0 1.9 5.5 3.2 2.4 2.5 1.4 1.2 0.0 0.0 1.2 0.0 1.0 2.9 0.6 3.5 0.0 1.0 1.1 2.0 3.2 1.1 1.5 1.3 1.6 1.7 1.3 2.8 2.9 2.3 1.8 0.0 1.0 2.8 0.8 0.8 2.6 1.8 0.7 2.2 0.0 1.4 0.3 0.6 4.4 0.5 1.8 2.3 2.7 PRDM5 PFM2 ENSG00000138738 "PR/SET domain 5" Q9NQX1 4 120684919-120922870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 57.4;Late spermatids: 22.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "eosinophil: 9.1;neutrophil: 6.7" "Lineage enriched" "Detected in single" 29 "granulocytes: 9.1" "Cell line enhanced" "Detected in many" "U-266/84: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051406 Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "HPA051406: AB_2681472" "unprognostic (7.74e-2)" "unprognostic (8.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.09e-1)" "unprognostic (7.20e-2)" "unprognostic (9.30e-2)" "unprognostic (3.28e-2)" "unprognostic (4.52e-2)" "unprognostic (5.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.13e-1)" "unprognostic (3.00e-2)" "unprognostic (4.91e-4)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (5.56e-3)" 5.0 5.9 3.5 3.6 3.9 4.6 5.4 1.9 5.4 9.3 5.2 2.7 6.3 1.9 8.6 7.0 3.3 7.7 6.1 5.0 3.2 3.1 3.1 0.8 7.4 2.7 3.4 4.2 15.2 10.3 19.3 12.5 5.0 6.1 7.7 4.4 9.4 3.3 6.8 2.2 2.7 3.2 9.5 6.2 3.3 4.1 5.0 3.3 0.5 8.4 5.1 2.3 5.8 14.1 0.0 0.0 9.1 0.0 0.0 0.3 0.0 1.8 2.9 6.6 0.1 4.0 8.3 7.8 3.9 8.6 4.0 3.5 3.7 1.1 0.4 1.1 5.2 3.8 0.0 0.0 0.8 5.3 0.0 1.1 2.4 2.6 0.2 4.3 8.1 0.1 5.8 2.6 2.8 3.6 3.7 2.9 1.0 0.0 12.1 4.9 0.3 1.2 0.0 4.9 0.6 2.2 0.0 7.7 5.0 1.4 0.0 1.2 5.3 0.0 0.1 0.8 3.6 5.5 3.4 1.1 0.2 2.4 4.1 3.8 11.2 15.6 0.0 3.0 0.0 3.0 0.1 0.0 9.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 6.7 0.0 0.0 0.0 0.0 0.0 3.5 3.9 1.9 5.4 3.2 3.1 3.4 4.2 6.1 3.3 11.9 3.5 0.5 2.5 1.4 9.5 7.3 0.0 2.7 5.7 1.8 7.9 0.8 1.7 1.8 57.4 4.9 0.0 0.0 2.1 2.1 4.4 2.0 2.3 0.0 0.7 0.0 3.5 3.7 0.3 22.0 8.1 0.8 1.7 0.0 2.7 8.2 1.9 0.0 8.9 0.0 8.0 6.5 3.6 5.0 3.3 1.5 0.5 0.0 2.4 0.6 PRIM1 ENSG00000198056 "DNA primase subunit 1" P49642 12 56731596-56752373 "Predicted intracellular proteins" "DNA replication, Transcription" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 38.6;Spermatogonia: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040010 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA Yes "Nucleoplasm, Golgi apparatus, Vesicles" "HPA040010: AB_10805599" "unprognostic (3.04e-3)" "unprognostic (1.67e-2)" "unprognostic (2.12e-2)" "unprognostic (1.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.61e-2)" "prognostic unfavorable (2.40e-8)" "unprognostic (4.68e-2)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (1.82e-1)" "unprognostic (1.98e-3)" "unprognostic (3.94e-1)" "unprognostic (2.16e-1)" "unprognostic (5.35e-2)" "unprognostic (6.53e-2)" 5.7 5.2 6.7 9.8 9.3 26.0 10.1 16.0 10.6 6.0 8.2 6.7 5.5 4.5 6.2 4.9 9.6 6.2 3.1 4.0 7.6 4.6 4.5 8.2 5.4 11.1 9.2 4.6 9.7 10.7 7.9 12.3 5.0 7.9 5.2 11.1 5.3 7.0 4.3 6.3 7.9 8.3 6.1 11.8 10.2 6.3 17.0 10.8 28.3 5.1 6.8 13.2 5.6 6.9 8.6 6.3 3.5 6.2 5.3 12.7 4.6 12.2 10.6 14.7 9.0 1.7 2.6 17.3 10.4 8.5 18.5 17.3 11.4 15.8 24.1 8.7 4.8 7.4 12.4 17.7 11.3 20.4 12.0 11.0 31.8 6.8 10.9 0.5 38.9 13.5 1.1 2.1 16.4 7.1 2.8 6.6 28.1 29.9 38.1 10.7 9.1 22.2 14.8 16.3 8.8 13.3 25.0 25.8 20.8 4.4 9.3 15.0 13.3 12.4 6.0 5.6 11.2 19.4 14.9 3.0 9.6 22.8 10.0 13.1 13.9 27.7 13.6 6.0 16.5 12.7 1.4 1.4 3.5 7.8 3.4 9.0 8.6 10.5 7.5 3.4 8.2 12.7 10.0 0.0 5.3 6.2 6.3 9.1 4.6 6.7 9.3 16.0 10.6 7.6 4.6 9.2 4.6 7.9 10.8 6.0 5.0 11.5 11.9 3.4 4.2 2.4 2.5 8.1 6.8 7.0 5.9 7.0 0.0 4.4 5.0 5.8 1.3 70.0 6.4 22.0 3.3 2.7 3.5 4.3 10.3 19.1 1.2 3.7 7.3 2.5 6.6 7.2 3.3 9.0 2.9 5.6 3.4 0.0 4.6 1.6 11.8 12.9 3.9 38.6 82.6 3.4 3.8 10.5 8.5 2.0 PRMT9 "FLJ46629, PRMT10" ENSG00000164169 "Protein arginine methyltransferase 9" Q6P2P2 4 147637785-147684230 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 79.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036844, HPA042537" Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Microtubules "Nucleoplasm, Cytosol" "HPA036844: AB_10672341, HPA042537: AB_2678043" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" "unprognostic (4.65e-3)" "unprognostic (2.35e-1)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (4.14e-2)" "unprognostic (7.29e-2)" "unprognostic (2.11e-2)" "unprognostic (2.33e-1)" "prognostic favorable (3.58e-7)" "unprognostic (1.72e-1)" "unprognostic (4.52e-2)" "unprognostic (1.54e-2)" "unprognostic (1.30e-2)" 6.0 17.2 6.0 5.2 8.6 12.4 6.9 8.0 8.9 5.6 4.5 4.2 7.9 2.5 8.6 7.6 5.0 7.5 8.4 6.5 5.6 5.0 7.5 5.8 7.6 5.3 5.8 5.3 22.6 7.2 16.3 10.0 5.0 7.1 6.0 4.5 9.8 5.8 11.3 6.7 5.6 4.3 6.1 4.6 4.5 5.9 11.2 3.9 11.6 15.8 2.8 5.4 5.5 5.2 9.6 6.0 10.8 6.1 5.1 10.4 2.7 3.5 2.3 5.7 4.3 4.4 7.6 5.0 3.9 6.3 6.0 6.4 1.8 4.0 12.3 1.8 3.4 3.1 2.5 6.7 3.4 8.3 4.4 3.9 6.8 4.5 3.0 3.3 9.8 3.8 5.2 3.5 3.7 3.3 4.9 5.0 6.2 6.7 7.2 5.1 2.0 8.3 3.9 2.9 3.4 4.3 5.6 4.8 4.5 4.9 2.8 3.5 5.4 6.3 5.0 3.2 3.9 2.1 2.2 4.2 3.9 3.1 4.3 4.3 8.2 6.5 8.1 4.3 6.1 2.8 7.4 6.0 10.8 6.7 6.1 6.5 9.5 8.1 8.2 4.0 9.6 10.4 9.0 4.2 5.1 4.4 6.0 6.8 2.7 6.0 8.6 8.0 8.9 5.6 5.0 5.8 5.3 7.1 3.9 0.0 7.7 61.1 2.9 0.0 54.5 5.5 7.6 2.7 1.2 33.2 106.0 12.1 5.0 5.9 58.8 4.3 5.9 0.0 5.8 8.6 8.5 4.1 34.5 5.7 15.3 47.7 16.7 12.3 31.0 9.5 16.7 14.9 0.0 9.0 4.8 26.9 5.9 3.6 15.9 3.3 79.2 12.9 4.6 29.1 14.0 0.0 12.7 30.5 4.7 1.4 PRODH "HSPOX2, PIG6, PRODH1, PRODH2, TP53I6" ENSG00000100033 "Proline dehydrogenase 1" O43272 22 18912777-18936553 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 24.6;Melanocytes: 20.3;Suprabasal keratinocytes: 13.2" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "OE19: 39.9;RPTEC TERT1: 19.8" HPA020361 Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA Mitochondria "Nucleoplasm, Vesicles" "HPA020361: AB_10963116" "unprognostic (2.46e-2)" "prognostic favorable (1.54e-4)" "unprognostic (1.40e-1)" "unprognostic (3.70e-2)" "unprognostic (3.80e-2)" "unprognostic (1.20e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-2)" "unprognostic (2.49e-2)" "unprognostic (6.56e-2)" "unprognostic (3.12e-2)" "unprognostic (1.61e-2)" "unprognostic (7.44e-2)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.34e-2)" "unprognostic (3.94e-2)" 3.8 2.3 20.8 2.8 19.3 2.0 3.3 9.8 21.3 2.0 3.5 16.2 0.1 13.8 2.3 2.2 8.8 2.4 2.2 4.6 22.2 10.8 9.9 6.6 8.6 2.3 14.9 21.8 2.4 2.2 1.9 1.5 2.4 13.5 2.6 2.6 7.4 2.1 2.4 15.5 13.0 48.9 1.9 12.6 2.2 2.1 3.5 9.8 0.1 4.3 4.1 3.7 2.1 2.3 0.4 0.4 0.0 0.0 1.0 0.3 0.0 0.0 0.4 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.4 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.4 39.9 0.0 0.0 0.0 0.2 19.8 0.4 0.0 0.1 0.4 0.6 0.1 2.9 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 20.8 19.3 9.8 21.3 22.2 10.8 14.9 21.8 13.5 9.8 14.9 24.6 0.0 0.2 4.5 0.0 1.6 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.5 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.0 0.3 13.2 0.0 0.0 0.4 0.1 PROM2 ENSG00000155066 "Prominin 2" Q8N271 2 95274453-95291308 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 45.9;Collecting duct cells: 31.4;Urothelial cells: 37.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 23.8;CAPAN-2: 42.0;HaCaT: 22.6;hTCEpi: 24.6;MCF7: 18.6;RT4: 25.6;SK-BR-3: 36.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB046005, HPA063728" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB046005: AB_2284371, HPA063728: AB_2685104" "prognostic unfavorable (2.16e-4)" "unprognostic (1.60e-1)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.55e-6)" "unprognostic (1.46e-2)" "unprognostic (4.59e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-2)" 0.3 0.2 0.5 2.9 0.6 0.0 9.3 1.1 0.5 11.4 5.2 0.3 22.2 4.4 1.4 22.5 42.6 2.2 37.2 0.5 0.6 0.5 18.8 0.4 1.3 0.3 0.6 0.3 1.5 8.6 8.1 1.5 12.5 0.3 11.6 4.2 0.3 35.6 20.0 1.3 26.7 2.6 2.7 0.7 0.4 11.5 1.8 0.3 1.7 5.7 21.6 22.2 20.0 14.8 0.0 0.2 0.6 0.0 0.0 0.3 0.0 23.8 0.0 0.0 0.2 0.1 0.0 12.1 0.0 0.0 0.1 0.1 0.2 42.0 0.0 0.0 0.0 0.0 22.6 0.0 13.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 24.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 18.6 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 25.6 0.2 0.0 0.0 36.7 0.0 0.3 11.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.2 0.0 0.5 0.6 1.1 0.5 0.6 0.5 0.6 0.3 0.3 0.3 3.0 3.4 0.0 20.8 6.0 0.2 1.4 45.9 6.7 11.4 31.4 3.9 15.3 10.0 12.0 0.4 0.0 2.6 0.0 9.6 2.3 0.8 11.1 0.0 0.0 2.0 0.0 3.5 0.0 0.0 1.1 0.3 0.0 6.8 1.0 10.5 0.0 12.7 7.0 0.7 0.0 0.9 0.0 1.0 0.7 0.0 11.2 9.4 0.0 12.4 37.6 PRR16 DSC54 ENSG00000184838 "Proline rich 16" Q569H4 5 120464278-120687332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 13.7;Early spermatids: 13.9;Fibroblasts: 10.5;Horizontal cells: 14.3;Smooth muscle cells: 8.3" "Cancer enriched" "Detected in many" 5 "prostate cancer: 13.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 24.5;BJ hTERT+: 25.5;fHDF/TERT166: 30.7;HSkMC: 19.7;hTERT-RPE1: 32.1;LHCN-M2: 29.7;U-138 MG: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049254 Approved Approved Nucleoplasm,Midbody,Cytosol Yes No Nucleoplasm "Midbody, Cytosol" "HPA049254: AB_2680693" "unprognostic (1.71e-1)" "unprognostic (3.87e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-1)" "unprognostic (6.61e-2)" "unprognostic (7.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.42e-2)" "unprognostic (8.33e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-2)" "unprognostic (2.06e-1)" "unprognostic (2.54e-8)" "unprognostic (3.05e-2)" "unprognostic (9.13e-2)" "unprognostic (2.65e-1)" "unprognostic (2.38e-3)" 11.6 4.4 4.7 7.0 4.9 0.9 11.3 21.1 7.6 20.3 5.2 2.2 1.8 2.9 15.7 4.6 4.1 5.8 8.2 16.9 4.7 3.8 3.6 1.5 10.0 3.1 2.3 4.9 6.9 2.4 1.8 2.5 12.8 9.6 10.9 6.7 1.4 3.2 3.9 30.4 4.4 4.9 11.6 3.0 4.3 4.3 3.2 1.6 0.0 4.9 14.2 1.8 8.7 23.2 0.5 1.4 0.7 3.2 0.2 0.2 1.0 1.0 0.0 2.5 0.0 7.0 24.5 0.0 11.1 25.5 15.9 12.2 0.0 0.0 0.0 0.0 30.7 2.8 0.0 2.4 0.2 16.8 0.0 0.6 0.0 0.3 0.0 6.7 0.0 0.0 19.7 2.7 4.7 15.0 32.1 0.5 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 1.9 0.0 1.3 0.0 0.0 4.9 0.0 0.0 0.3 2.0 0.0 0.0 0.1 36.7 4.2 1.1 5.7 0.1 0.0 0.0 2.1 0.0 1.2 0.5 3.2 0.2 0.1 1.8 0.1 0.2 0.1 0.0 1.4 0.5 0.1 0.2 0.7 0.2 1.1 0.5 0.1 1.0 4.7 4.9 21.1 7.6 4.7 3.8 2.3 4.9 9.6 1.6 0.0 0.0 0.0 6.4 1.1 2.0 2.5 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.1 13.9 0.1 0.0 0.0 0.0 0.0 10.5 6.0 0.0 0.0 0.5 14.3 0.0 0.6 1.2 7.4 2.6 1.2 1.7 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.5 0.0 8.3 0.6 1.5 0.5 0.5 0.0 0.0 0.5 PRR22 MGC24975 ENSG00000212123 "Proline rich 22" Q8IZ63 19 5782960-5784765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 82.5" "Group enriched" "Detected in many" 13 "Early spermatids: 151.0;Late spermatids: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 16.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044157 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA044157: AB_10960694" "unprognostic (8.09e-2)" "unprognostic (1.53e-3)" "unprognostic (5.19e-3)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-1)" "unprognostic (3.20e-2)" "unprognostic (2.89e-2)" "unprognostic (1.20e-1)" "unprognostic (3.77e-2)" "unprognostic (3.42e-3)" "unprognostic (9.37e-3)" "unprognostic (4.18e-2)" "unprognostic (9.93e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-1)" "unprognostic (2.79e-3)" 1.1 1.0 1.1 1.7 1.5 2.0 1.1 1.1 1.7 1.1 1.3 1.2 1.1 3.1 1.1 1.1 1.6 2.5 1.1 1.1 1.1 0.7 2.4 4.4 1.1 1.5 1.1 1.1 1.1 2.7 1.0 1.2 1.1 1.1 2.7 0.3 1.1 3.2 1.1 1.1 5.4 3.3 1.1 1.1 2.7 2.4 82.5 1.1 1.1 2.3 1.1 1.1 1.1 1.1 0.2 0.0 0.0 0.2 0.0 0.9 0.1 1.8 3.2 1.4 6.6 0.0 0.2 6.6 1.3 0.6 1.0 1.6 3.2 1.8 2.9 3.7 0.2 0.7 2.4 1.0 1.3 0.2 4.5 10.3 1.4 1.4 1.1 0.6 3.1 16.1 0.8 1.1 1.4 0.4 0.1 0.2 3.6 7.2 0.0 0.8 6.9 3.6 3.8 8.3 0.3 3.3 3.5 1.2 4.6 0.3 2.1 1.8 3.3 0.3 2.4 3.7 0.3 2.8 2.5 1.0 2.5 6.8 8.7 1.6 9.4 7.3 5.6 0.2 6.2 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.4 0.0 0.0 0.2 0.0 0.0 0.1 1.1 1.5 1.1 1.1 1.1 0.7 1.1 1.1 1.1 1.1 3.0 0.3 0.8 0.4 0.2 5.3 0.3 2.5 0.0 2.3 3.5 0.0 1.9 0.0 0.7 151.0 0.4 2.6 0.0 0.6 0.7 0.8 1.1 0.0 2.1 0.9 4.8 2.4 0.6 1.0 60.2 2.0 0.0 0.0 0.0 2.6 2.2 0.7 1.5 0.4 1.0 5.3 6.5 0.0 8.3 6.6 1.0 1.5 0.0 2.7 0.5 PRR36 ENSG00000183248 "Proline rich 36" Q9H6K5 19 7868719-7874379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.5;pituitary gland: 6.5" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 12.4;Cone photoreceptor cells: 11.8;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 22.3;SCLC-21H: 6.5;SH-SY5Y: 14.6;T-47d: 7.3" "Low region specificity" "Detected in all" HPA062741 Uncertain Approved "Nucleoplasm,Nuclear speckles,Golgi apparatus" Yes No "Golgi apparatus" "Nucleoplasm, Nuclear speckles" "HPA062741: AB_2684860" "unprognostic (3.15e-2)" "unprognostic (1.02e-1)" "unprognostic (6.23e-2)" "unprognostic (5.61e-2)" "unprognostic (1.72e-1)" "unprognostic (1.20e-2)" "unprognostic (9.62e-2)" "unprognostic (3.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.15e-3)" "unprognostic (1.75e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-3)" "unprognostic (7.89e-2)" "prognostic favorable (7.74e-4)" "unprognostic (3.56e-1)" "unprognostic (8.52e-3)" 0.4 2.0 11.8 0.5 11.4 0.3 1.5 12.0 20.5 0.7 0.4 0.8 0.0 0.8 1.2 0.8 0.3 1.1 0.5 0.3 8.0 1.1 0.4 1.3 0.4 0.0 10.6 0.9 3.2 1.6 6.5 0.3 5.5 2.5 0.4 0.5 3.0 1.0 0.3 0.8 0.4 0.4 0.7 0.4 1.4 0.7 1.2 0.0 1.0 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.7 5.3 4.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 2.3 0.0 1.5 0.0 0.5 0.1 4.1 0.0 0.0 0.0 5.2 0.0 0.2 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 2.6 0.1 0.1 0.0 2.3 0.2 0.2 2.0 0.3 0.4 22.3 0.0 0.2 3.0 4.3 6.5 14.6 0.0 0.2 0.0 0.4 7.3 0.0 0.0 0.0 2.7 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 12.4 0.8 2.5 0.0 0.0 5.2 11.8 0.2 5.0 2.7 5.2 0.0 0.0 0.0 0.8 0.2 0.0 1.8 0.0 0.2 0.1 9.5 3.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 4.2 0.7 0.0 0.0 1.0 4.3 0.0 0.3 0.2 0.7 0.0 0.2 0.0 0.4 1.0 PRR7 MGC10772 ENSG00000131188 "Proline rich 7, synaptic" Q8TB68 5 177446445-177456286 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 41.2;Suprabasal keratinocytes: 58.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 17.4;SK-MEL-30: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046636 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA046636: AB_2679730" "unprognostic (3.69e-1)" "unprognostic (9.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (4.08e-2)" "unprognostic (7.94e-3)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (4.75e-2)" "unprognostic (5.86e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (8.84e-3)" "unprognostic (2.22e-1)" "unprognostic (3.76e-2)" "unprognostic (1.69e-1)" 1.9 2.4 12.5 3.2 22.0 15.1 1.7 4.1 28.5 1.1 2.9 9.8 0.0 2.9 1.7 1.3 1.9 3.2 1.9 1.1 14.1 7.6 1.5 2.2 2.0 3.6 4.8 8.4 1.2 4.0 2.6 6.2 1.3 6.2 2.0 1.4 4.7 5.2 1.5 1.7 8.8 2.6 1.2 4.4 4.9 4.6 3.2 4.6 1.2 1.2 0.8 2.3 1.5 0.9 3.2 3.0 10.8 0.6 2.0 7.3 1.5 7.2 2.8 0.8 5.7 0.0 0.4 2.5 3.4 0.6 1.0 1.3 0.6 3.9 7.0 9.0 0.5 2.9 6.1 0.4 3.1 0.4 6.1 9.0 2.1 2.7 2.1 0.6 4.2 5.1 0.6 1.3 0.4 0.2 0.9 0.4 2.7 1.1 5.0 0.9 9.7 3.5 10.7 1.4 1.1 17.4 9.9 2.6 7.0 1.2 0.6 14.1 10.1 1.3 3.4 16.1 0.0 3.0 0.6 2.6 5.7 9.7 5.1 8.2 2.7 1.5 3.4 5.6 6.8 4.1 2.4 0.1 10.8 3.0 0.5 7.3 2.1 3.4 5.1 0.1 3.2 3.2 4.1 4.8 2.0 0.6 3.0 2.5 1.5 12.5 22.0 4.1 28.5 14.1 7.6 4.8 8.4 6.2 4.6 3.0 0.0 13.7 25.0 38.5 12.6 1.2 10.2 0.0 1.2 7.0 0.0 0.9 8.3 10.1 10.8 4.5 7.1 0.0 9.4 0.7 3.9 23.6 27.5 2.8 1.4 6.4 41.2 1.8 2.2 9.7 0.9 2.9 27.0 1.0 9.4 15.2 9.0 7.8 2.1 9.8 13.1 0.0 9.8 3.3 11.7 58.5 1.1 25.5 9.1 15.4 PRR9 ENSG00000203783 "Proline rich 9" Q5T870 1 153217584-153219317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 33.1;tongue: 13.0" "Group enriched" "Detected in some" 16 "Early spermatids: 3.6;Late spermatids: 8.1;Syncytiotrophoblasts: 7.4" "Group enriched" "Detected in many" 6 "cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SuSa: 20.7" "Not detected" "Not detected" HPA027714 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA027714: AB_10602194" "unprognostic (1.45e-1)" "unprognostic (1.46e-1)" "unprognostic (4.17e-1)" "unprognostic (3.48e-1)" "unprognostic (7.02e-2)" "unprognostic (8.27e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-2)" 1.0 0.0 0.0 0.0 0.0 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.6 0.3 13.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 20.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 PRRC2A "BAT2, D6S51E, G2" ENSG00000204469 "Proline rich coiled-coil 2A" P48634 6 31620720-31637771 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 26.4;HEK 293: 48.2;U-266/70: 24.8;U-266/84: 26.3;U-698: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026383, HPA046791, HPA066501" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "CAB026383: , HPA046791: AB_2679809, HPA066501: AB_2732747" "unprognostic (2.07e-1)" "unprognostic (6.84e-2)" "unprognostic (3.82e-1)" "unprognostic (2.25e-3)" "unprognostic (5.04e-2)" "unprognostic (4.63e-1)" "unprognostic (2.42e-3)" "unprognostic (2.09e-1)" "unprognostic (3.07e-1)" "unprognostic (1.14e-1)" "unprognostic (8.29e-3)" "unprognostic (2.38e-1)" "unprognostic (2.75e-1)" "unprognostic (1.01e-1)" "unprognostic (1.57e-1)" "unprognostic (5.40e-2)" "unprognostic (3.10e-1)" 10.9 18.4 20.7 28.9 22.1 5.0 12.2 25.2 29.1 15.0 24.6 18.4 11.9 4.8 19.7 51.5 47.2 32.3 13.8 24.2 18.4 13.2 16.0 10.2 41.7 14.9 14.3 20.4 29.3 12.2 4.8 18.5 8.6 15.9 30.9 7.1 15.0 12.3 15.9 35.1 28.8 23.0 12.8 11.5 43.5 34.6 46.3 16.7 27.1 16.8 10.4 14.4 16.0 13.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 0.0 11.9 11.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.5 13.4 0.0 0.0 0.0 26.4 0.0 0.0 48.2 0.1 0.1 0.0 0.0 0.1 0.0 5.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 24.8 26.3 25.1 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 22.1 25.2 29.1 18.4 13.2 14.3 20.4 15.9 16.7 0.0 5.6 32.9 25.1 29.2 36.4 5.9 22.9 4.0 3.4 38.4 56.9 23.5 5.0 21.7 40.5 23.2 27.9 0.0 22.0 18.4 28.7 31.4 10.4 23.6 28.8 35.0 37.4 33.2 22.9 13.8 45.5 23.5 18.6 25.2 37.1 21.4 27.4 37.9 42.1 12.2 34.7 19.4 30.3 66.6 44.4 24.8 15.3 26.2 41.7 23.6 PRRG1 PRGP1 ENSG00000130962 "Proline rich and Gla domain 1" O14668 X 37349275-37457295 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.4" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078129 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA078129: AB_2686878" "unprognostic (8.82e-2)" "prognostic unfavorable (4.65e-4)" "unprognostic (8.34e-2)" "unprognostic (2.08e-3)" "unprognostic (1.92e-1)" "unprognostic (5.11e-3)" "unprognostic (2.24e-2)" "unprognostic (7.23e-3)" "unprognostic (1.01e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (8.21e-2)" "prognostic favorable (2.05e-7)" "unprognostic (1.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.48e-1)" 11.6 5.5 12.0 3.1 22.0 0.7 5.8 2.6 18.7 6.7 5.7 35.9 4.6 4.1 6.2 2.5 5.9 4.0 12.4 8.5 17.9 10.7 14.9 10.7 6.3 2.5 31.0 9.9 6.2 2.6 1.2 2.3 10.6 21.3 5.1 6.0 3.0 3.9 11.6 19.3 3.1 4.3 7.5 43.4 4.0 3.4 2.4 23.7 0.0 11.6 2.9 1.6 5.9 4.5 0.6 0.2 2.6 1.7 0.2 0.4 0.1 15.0 3.4 2.8 2.8 9.4 7.6 1.2 6.4 8.6 2.3 4.0 8.2 9.7 0.0 11.1 5.0 4.3 4.9 7.6 4.8 4.0 0.0 2.4 2.7 3.6 2.8 11.5 0.0 3.5 11.8 4.0 4.5 3.8 4.6 11.9 0.0 1.2 0.0 8.0 1.1 0.0 0.0 3.3 2.4 7.2 0.0 6.2 0.0 39.4 0.7 0.0 0.0 4.7 7.5 2.8 7.7 0.0 1.6 8.5 3.6 2.2 7.0 1.9 0.0 0.0 0.0 3.6 0.0 3.3 2.6 1.7 0.1 0.2 0.5 0.2 0.6 0.1 0.3 0.1 0.4 0.2 0.4 0.8 0.2 0.2 0.2 0.2 0.1 12.0 22.0 2.6 13.9 17.9 10.7 31.0 9.9 21.3 23.7 6.0 3.4 0.0 4.2 10.1 1.8 7.6 12.7 0.0 0.0 31.4 0.0 5.5 6.6 5.9 0.6 16.5 5.6 0.0 2.7 11.7 8.7 5.9 1.1 15.3 3.8 17.5 2.9 14.7 5.1 0.0 4.4 1.4 3.3 1.0 4.8 1.9 12.9 8.0 2.5 7.3 0.2 6.5 5.6 0.9 3.6 5.5 8.7 0.0 4.1 7.4 PRRG2 PRGP2 ENSG00000126460 "Proline rich and Gla domain 2" O14669 19 49580646-49591015 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 38.8;Paneth cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.7;OE19: 13.8;RT4: 9.0;SK-BR-3: 10.5;T-47d: 11.4;U-266/84: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010702 Approved Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Nucleoli" Cytosol "HPA010702: AB_1079693" "unprognostic (2.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (1.04e-2)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (5.60e-1)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.67e-1)" "prognostic favorable (3.82e-9)" "unprognostic (4.89e-2)" "unprognostic (1.46e-1)" "unprognostic (6.58e-3)" "unprognostic (3.68e-2)" 0.9 0.4 0.5 1.1 0.6 0.0 4.8 1.1 1.3 4.0 14.3 0.4 17.5 8.3 1.9 9.6 13.7 3.3 9.8 0.7 0.5 0.4 15.0 12.1 5.2 0.4 0.7 0.4 1.9 13.4 13.8 16.1 8.6 0.7 5.4 5.3 0.7 24.9 14.6 1.2 10.1 23.2 1.4 0.5 1.0 7.1 1.7 0.4 2.1 21.9 9.8 7.8 4.2 4.2 1.2 4.2 2.1 0.9 0.0 1.4 0.4 8.4 0.3 0.2 0.7 1.0 0.0 3.6 0.2 0.0 0.3 0.3 1.7 11.7 0.5 1.3 0.1 0.2 6.8 0.2 6.6 0.3 0.8 0.9 0.4 0.5 0.6 0.7 0.3 0.9 0.7 5.8 0.2 0.2 0.6 2.6 0.7 0.2 0.6 0.0 1.8 0.1 0.7 0.5 13.8 1.1 0.2 0.3 6.6 5.2 9.0 1.9 0.2 1.0 10.5 0.1 0.9 11.4 0.1 0.4 0.7 0.5 0.3 0.1 4.1 13.7 0.4 0.1 0.2 0.3 0.0 0.9 0.4 1.4 0.1 0.7 1.2 0.6 0.6 0.1 0.7 0.8 0.7 2.1 0.0 0.7 4.2 0.6 0.4 0.5 0.6 1.1 1.3 0.5 0.4 0.7 0.4 0.7 0.4 6.0 12.0 1.3 12.1 3.7 1.9 0.8 10.2 4.0 9.1 12.2 2.0 11.6 3.3 27.3 0.7 6.2 38.8 0.0 29.0 5.4 0.8 11.8 2.3 4.9 2.1 4.8 15.5 0.6 3.2 0.0 0.3 2.3 1.7 12.6 13.9 0.8 24.3 31.6 0.0 12.1 3.7 0.0 1.8 0.5 1.5 4.1 10.6 0.8 14.2 12.8 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 49.0" "Cell type enriched" "Detected in some" 8 "Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 72.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: AB_2679642, HPA052681: AB_2681912" "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 12.1 1.9 2.0 5.9 11.3 49.0 6.8 6.5 3.1 1.6 2.7 0.6 0.0 0.6 0.7 0.5 1.9 1.0 1.1 2.4 1.7 6.2 0.5 0.7 0.8 0.6 1.6 2.4 1.0 0.6 0.8 0.0 0.6 2.9 0.8 0.7 3.4 1.9 1.3 4.2 1.5 0.8 1.0 2.8 1.3 1.6 0.7 1.5 0.7 0.7 1.7 1.0 2.0 3.2 0.0 0.4 0.4 0.4 0.0 1.5 0.4 0.0 0.0 0.1 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.3 0.7 14.1 0.3 0.0 0.0 3.9 0.2 0.3 0.0 0.0 0.1 72.0 0.1 0.0 0.1 0.5 0.0 1.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.5 0.7 0.4 0.0 0.0 0.4 0.0 0.4 2.0 11.3 6.5 3.1 1.7 6.2 1.6 2.4 2.9 1.5 0.0 0.0 0.0 0.0 0.6 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.3 0.2 0.0 0.0 0.0 PRTFDC1 HHGP ENSG00000099256 "Phosphoribosyl transferase domain containing 1" Q9NRG1 10 24848607-24952604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "NK-cell: 7.9" "Lineage enriched" "Detected in many" 7 "NK-cells: 7.9" "Cell line enhanced" "Detected in many" "CACO-2: 30.1;CAPAN-2: 38.0;HEL: 22.1" HPA021458 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA021458: AB_1855793" "unprognostic (2.61e-1)" "unprognostic (3.47e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (9.49e-3)" "unprognostic (2.03e-1)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (2.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (7.66e-3)" "unprognostic (1.94e-2)" 4.1 18.3 18.1 3.3 18.2 0.6 6.1 6.1 24.0 8.1 7.7 29.0 2.4 13.9 12.9 6.1 4.5 5.9 11.8 8.6 16.8 13.0 4.0 2.2 3.4 2.8 18.1 12.6 17.1 3.6 10.2 11.0 2.3 16.2 6.5 9.2 6.0 7.2 6.9 0.9 1.4 13.2 8.0 22.5 2.3 13.8 1.7 20.7 2.3 3.7 1.1 2.4 6.0 4.6 0.0 0.3 0.1 0.0 7.9 1.1 1.7 7.6 16.5 12.3 5.0 2.0 10.3 0.0 8.1 6.1 5.8 8.0 30.1 38.0 0.0 1.3 9.4 0.4 4.3 14.0 0.0 9.1 0.0 0.6 22.1 3.0 0.0 6.1 0.0 0.0 3.0 0.1 3.1 0.0 5.5 9.1 0.9 7.2 4.2 2.7 0.2 3.4 0.0 8.5 1.3 0.3 3.8 0.0 0.0 5.2 0.2 8.8 0.4 7.7 0.0 0.0 0.3 0.4 1.7 4.9 2.6 6.5 9.4 4.8 0.4 0.0 0.0 6.9 0.0 0.3 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.4 0.5 0.3 0.0 0.1 0.3 0.1 7.9 0.0 0.2 0.0 1.7 18.1 18.2 6.1 15.8 16.8 13.0 18.1 12.6 16.2 20.7 0.0 0.3 0.0 3.7 2.4 10.4 6.9 5.1 1.4 4.5 3.5 2.0 0.5 5.0 4.6 1.0 1.6 4.1 0.0 0.5 4.3 14.2 0.7 0.0 0.0 5.4 6.4 5.2 9.2 1.6 0.8 11.2 0.3 3.3 1.8 4.2 32.0 2.4 2.6 9.2 0.0 15.3 0.0 9.5 2.3 4.1 2.5 0.7 0.0 14.3 0.9 PRY "PRY1, PTPN13LY" ENSG00000169789 "PTPN13-like, Y-linked" O14603 Y 22490397-22514637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 1.9;epididymis: 2.3;testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "memory CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "A549: 3.1;HDLM-2: 2.3;SK-MEL-30: 1.5" "HPA046366, HPA059887" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA046366: AB_2679639, HPA059887: " 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRY2 PTPN13LY2 ENSG00000169807 "PTPN13-like, Y-linked 2" O14603 Y 22071756-22096007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.4;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.4;naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in single" "SK-MEL-30: 3.6" "HPA046366, HPA059887" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA046366: AB_2679639, HPA059887: " 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSD "EFA6, EFA6A, KIAA2011, PSD1, TYL" ENSG00000059915 "Pleckstrin and Sec7 domain containing" A5PKW4 10 102402617-102421539 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 51.6;Cone photoreceptor cells: 90.3;Rod photoreceptor cells: 65.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 10.3;MOLT-4: 5.5;SCLC-21H: 9.7;SH-SY5Y: 8.5;U-2 OS: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059237 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA059237: AB_2683954" "unprognostic (2.43e-1)" "unprognostic (1.74e-1)" "unprognostic (5.62e-3)" "unprognostic (1.53e-1)" "unprognostic (3.16e-2)" "unprognostic (2.90e-2)" "unprognostic (7.73e-3)" "unprognostic (1.75e-1)" "unprognostic (9.59e-2)" "unprognostic (7.59e-2)" "unprognostic (2.24e-3)" "unprognostic (4.71e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (8.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" 1.2 9.8 48.7 4.3 59.4 1.6 1.5 8.0 66.8 6.7 21.5 1.7 0.0 6.7 23.9 2.4 3.2 11.1 9.4 1.9 48.7 12.2 1.5 1.4 1.7 1.8 7.6 26.7 5.6 4.7 2.5 13.6 1.8 4.2 6.2 4.4 3.7 1.5 2.2 1.2 2.1 5.8 20.7 1.8 1.5 4.8 4.6 7.0 0.0 1.2 0.0 1.5 11.7 3.0 0.8 0.0 1.1 0.2 0.9 1.3 0.0 0.3 0.1 3.9 3.5 1.4 0.8 0.3 0.3 0.0 0.1 0.0 2.7 0.4 0.3 2.5 0.1 0.3 0.2 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.1 2.2 0.0 0.1 10.3 0.3 0.6 0.1 1.7 0.0 1.4 0.6 0.9 0.0 2.1 5.5 0.3 0.5 0.3 0.0 1.5 0.0 0.1 0.0 0.2 9.7 8.5 0.1 0.1 0.2 0.3 0.6 0.5 0.0 2.9 4.7 0.2 0.0 2.5 0.3 0.1 0.3 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.2 0.2 0.3 0.0 0.8 0.3 1.3 1.1 0.9 0.0 0.0 0.0 0.0 48.7 59.4 8.0 41.2 48.7 12.2 7.6 26.7 4.2 7.0 3.0 0.3 0.0 0.2 0.6 51.6 1.2 5.1 0.0 2.3 0.0 90.3 0.2 1.7 0.1 4.1 0.3 0.8 0.0 1.7 0.1 1.7 0.3 0.0 0.5 0.6 12.7 17.2 0.0 0.0 2.0 3.4 0.0 0.0 0.0 0.6 8.6 0.7 0.6 3.9 0.7 65.1 0.0 0.3 3.7 3.4 0.1 0.6 0.0 0.8 0.1 PSD3 "DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942" ENSG00000156011 "Pleckstrin and Sec7 domain containing 3" Q9NYI0 8 18527301-19084730 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.6" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 598.4;Late spermatids: 164.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.2;hTERT-RPE1: 22.8;LHCN-M2: 22.0;U-87 MG: 23.6" "Low region specificity" "Detected in all" HPA002455 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No "Nucleoplasm, Vesicles" Cytosol "HPA002455: AB_2666597" "unprognostic (3.87e-2)" "unprognostic (2.52e-2)" "prognostic favorable (7.55e-4)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.56e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.84e-2)" "unprognostic (7.27e-2)" "unprognostic (3.39e-1)" "unprognostic (2.50e-3)" "unprognostic (2.13e-1)" "unprognostic (7.18e-3)" "unprognostic (3.71e-2)" "unprognostic (8.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.45e-1)" 2.3 15.5 18.3 2.7 40.5 1.3 5.2 51.6 50.7 11.3 5.7 13.4 2.5 4.2 7.8 3.6 4.8 2.6 6.5 21.8 23.2 9.3 2.1 15.6 4.1 2.2 10.0 27.6 16.0 8.3 9.5 9.6 5.6 10.7 3.7 6.5 5.4 3.2 5.5 1.3 3.9 4.3 5.2 7.4 8.4 8.0 12.7 11.4 0.0 5.4 1.4 3.1 6.1 3.3 3.1 0.6 2.3 1.3 1.9 2.0 0.7 4.9 2.6 11.7 0.0 4.2 26.2 0.6 2.6 4.1 2.4 5.0 1.5 2.0 2.9 1.7 10.7 10.6 0.4 3.4 4.7 4.6 0.0 3.0 0.2 2.0 0.2 7.7 0.0 0.1 6.8 2.9 13.3 2.3 22.8 3.1 0.7 0.3 2.3 22.0 1.7 0.0 0.5 2.3 4.3 6.8 2.3 10.2 1.3 6.1 6.4 5.0 5.6 1.1 0.5 1.8 2.6 0.0 1.1 12.9 7.5 5.2 17.6 2.3 0.2 0.3 6.7 23.6 1.2 2.5 2.3 1.3 1.3 1.0 0.8 1.3 1.6 1.0 0.6 0.5 3.1 0.5 0.6 1.5 1.9 1.1 0.6 2.0 0.7 18.3 40.5 51.6 50.7 23.2 9.3 10.0 27.6 10.7 11.4 3.0 2.4 0.5 11.9 19.5 56.4 111.0 5.1 32.1 13.6 8.7 111.9 2.6 1.7 13.2 598.4 4.9 21.3 0.0 7.4 1.2 30.9 8.6 0.0 36.1 11.0 17.5 5.8 6.2 9.7 164.8 30.8 10.6 1.7 103.6 15.1 80.8 19.5 14.4 50.5 0.2 50.2 12.9 11.5 10.0 15.8 8.7 0.9 0.0 13.0 24.0 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes No "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853" "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favorable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 16.3 15.3 21.0 13.4 34.9 19.2 15.7 15.5 24.7 16.5 26.2 66.1 9.5 26.6 14.2 15.4 19.0 12.6 17.1 9.9 28.6 18.2 19.7 16.9 16.9 10.8 42.1 20.7 13.5 15.0 21.8 9.2 22.7 31.8 13.6 25.6 15.0 16.8 13.4 13.0 24.7 27.9 14.6 61.9 14.6 16.3 16.8 39.7 15.4 19.7 8.7 15.9 17.2 13.5 9.0 24.4 38.1 34.0 11.7 10.5 17.1 14.4 22.2 20.8 8.3 29.1 20.8 18.9 21.3 24.5 21.9 27.6 27.6 36.2 9.4 14.1 20.2 17.9 38.5 17.5 16.1 23.9 21.5 10.8 10.8 15.1 13.4 26.9 10.8 21.1 21.3 29.4 18.1 22.4 20.0 17.5 10.6 12.0 19.2 20.4 28.7 8.2 14.1 9.0 25.7 16.5 10.5 17.7 12.0 30.4 30.7 11.6 15.5 23.2 21.8 18.9 19.7 27.0 24.3 18.5 22.3 18.4 18.1 10.0 12.6 18.4 9.6 18.7 13.2 13.5 29.2 27.1 27.1 7.2 30.8 7.0 7.2 7.0 5.9 24.4 9.0 6.6 6.4 38.1 11.7 34.0 12.8 10.5 17.1 21.0 34.9 15.5 24.7 28.6 18.2 42.1 20.7 31.8 39.7 26.8 35.7 14.6 21.9 25.3 16.5 10.1 20.4 22.7 26.1 22.7 37.3 22.8 5.0 24.3 8.6 20.3 63.6 0.0 23.2 24.7 22.1 24.7 17.4 18.6 27.3 12.7 15.5 13.5 47.8 10.0 15.3 43.2 15.1 33.3 34.1 13.6 29.5 51.8 14.5 13.3 27.4 25.8 18.4 21.6 13.7 28.9 41.8 20.3 36.6 44.4 PSKH2 ENSG00000147613 "Protein serine kinase H2" Q96QS6 8 86048373-86088621 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "kidney: 1.9;placenta: 1.2;testis: 2.0" "Cell type enhanced" "Detected in single" 35 "Rod photoreceptor cells: 1.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "HEL: 14.3" "HPA015095, HPA056839" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA015095: AB_1855815, HPA056839: " "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSMA4 "HC9, HsT17706" ENSG00000041357 "Proteasome subunit alpha 4" P25789 15 78540405-78552419 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004973, HPA055466, HPA060613" Supported Supported Nucleoplasm,Vesicles,Cytosol No No 12000000 "Nucleoplasm, Cytosol" Vesicles "CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332" "unprognostic (1.80e-1)" "unprognostic (7.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-1)" "unprognostic (4.71e-2)" "unprognostic (5.35e-2)" "unprognostic (6.26e-3)" "unprognostic (1.09e-1)" "unprognostic (3.28e-2)" "unprognostic (2.08e-3)" "unprognostic (2.75e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (6.74e-10)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.78e-3)" "unprognostic (6.32e-3)" 41.2 38.8 24.9 36.7 25.8 33.4 33.0 25.3 37.5 32.4 38.0 17.9 23.7 39.4 35.3 32.5 49.9 27.1 24.4 37.7 29.8 27.6 55.7 76.3 37.4 45.1 25.5 26.9 31.2 24.4 20.2 25.9 55.4 33.8 35.3 41.3 19.1 26.0 25.0 60.3 26.3 49.1 36.6 28.1 45.5 31.5 36.5 21.4 61.6 42.6 75.0 44.8 41.3 28.3 29.4 61.9 31.4 75.6 37.7 40.0 61.4 40.8 59.2 51.2 45.1 32.4 30.6 40.2 38.4 30.9 47.4 50.8 61.4 59.6 89.1 56.8 35.3 53.1 55.9 103.3 41.6 45.8 36.5 72.0 74.8 44.3 49.5 52.5 76.0 46.2 24.7 26.1 39.8 39.7 29.2 51.0 49.1 80.2 35.0 38.6 58.7 51.2 71.4 48.2 47.5 34.8 44.6 67.8 29.8 47.9 71.5 45.2 33.0 61.6 45.0 46.8 66.1 41.6 62.6 40.6 35.4 47.2 38.9 65.3 32.0 75.4 84.0 33.2 114.3 39.0 18.8 47.4 31.4 27.8 75.6 28.5 29.4 29.2 29.0 61.9 22.9 23.3 28.3 21.7 37.7 69.7 35.3 40.0 61.4 24.9 25.8 25.3 37.5 29.8 27.6 25.5 26.9 33.8 21.4 119.1 93.9 158.5 221.9 205.7 52.1 151.9 114.7 164.6 121.7 115.1 9.8 396.5 263.6 267.2 515.0 152.3 149.0 93.5 255.0 368.3 172.3 213.0 169.8 170.4 287.4 68.3 140.2 108.6 138.2 238.7 139.8 214.9 126.5 342.7 139.0 49.5 230.5 135.3 138.6 288.5 32.6 148.8 177.5 257.9 168.3 185.9 373.9 156.9 171.4 236.4 PSMB7 ENSG00000136930 "Proteasome subunit beta 7" Q99436 9 124353466-124415444 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052408, HPA054902" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No No 2700000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA052408: AB_2681820, HPA054902: AB_2682635" "unprognostic (7.75e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (3.64e-3)" "unprognostic (2.83e-1)" "unprognostic (1.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.24e-3)" "unprognostic (9.03e-2)" "unprognostic (3.60e-1)" "unprognostic (2.99e-1)" "unprognostic (1.78e-1)" "unprognostic (1.26e-2)" "unprognostic (1.67e-1)" "unprognostic (3.45e-1)" "unprognostic (1.93e-3)" "unprognostic (3.98e-2)" 36.9 56.9 51.0 32.8 55.1 53.4 41.9 33.7 52.7 26.6 33.3 34.0 27.9 32.5 33.6 52.1 41.9 32.6 29.2 59.6 44.5 41.3 53.7 87.1 27.0 33.6 43.6 46.9 32.7 67.1 38.5 24.1 53.2 47.3 28.8 37.1 31.1 48.2 26.9 76.7 48.7 32.2 31.4 39.9 28.6 33.1 50.3 36.5 48.2 32.7 67.7 39.5 32.3 30.8 53.4 67.9 45.2 62.7 53.6 66.2 69.0 52.6 64.4 44.1 53.3 31.2 37.2 63.6 51.3 70.8 74.4 51.4 84.6 51.6 60.1 41.5 48.0 73.5 75.4 54.9 54.3 68.4 57.8 47.4 37.7 102.4 70.2 70.5 74.7 37.6 44.5 48.0 77.5 77.7 57.5 62.4 54.6 76.8 42.8 57.4 91.7 53.5 50.2 65.2 80.2 92.2 47.4 65.8 70.2 52.6 34.5 52.1 42.3 48.8 62.5 76.0 45.2 72.1 32.9 49.4 48.2 38.9 61.4 76.8 46.5 130.1 60.7 80.6 46.1 67.6 40.4 61.7 45.2 41.8 62.7 45.0 53.4 48.1 46.1 67.9 47.5 46.3 44.9 27.3 53.6 58.4 57.8 66.2 69.0 51.0 55.1 33.7 52.7 44.5 41.3 43.6 46.9 47.3 36.5 71.5 73.0 111.6 140.8 172.4 37.7 121.6 112.1 101.7 62.6 66.3 21.6 382.0 280.2 281.6 279.3 121.5 147.6 46.7 340.4 299.5 140.7 127.9 102.7 222.4 205.6 31.8 135.5 87.8 123.1 322.3 128.9 128.4 189.0 172.3 121.7 86.0 308.8 129.0 117.8 341.8 43.4 84.1 126.0 246.2 184.2 191.3 408.7 106.6 146.6 177.4 PSMC3 "TBP-1, TBP1" ENSG00000165916 "Proteasome 26S subunit, ATPase 3" P17980 11 47418769-47426473 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 134.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006065 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 180000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA006065: AB_1079706" "unprognostic (2.01e-2)" "unprognostic (5.08e-3)" "unprognostic (9.43e-2)" "unprognostic (8.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.71e-2)" "unprognostic (8.99e-3)" "unprognostic (1.63e-1)" "unprognostic (9.95e-2)" "unprognostic (1.27e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" 27.9 25.9 37.3 24.1 49.3 31.8 26.2 25.6 39.7 25.1 28.2 24.9 21.1 20.3 27.2 26.0 29.4 25.0 21.8 45.7 32.8 28.0 30.7 60.2 21.5 22.8 36.1 27.3 21.0 25.2 31.0 16.8 39.8 28.2 22.6 24.0 21.3 32.1 29.8 134.7 34.8 20.9 30.8 24.3 25.7 24.9 24.0 22.9 33.5 27.1 38.3 28.8 25.5 25.3 39.2 45.1 32.6 54.7 45.0 51.1 61.3 39.2 44.7 43.0 31.6 20.7 22.3 41.9 32.8 48.8 82.5 58.6 39.8 23.0 31.9 20.4 41.2 36.3 39.5 37.6 42.9 37.3 47.4 48.7 30.6 54.7 38.4 26.8 35.6 32.8 24.8 23.2 33.4 37.8 18.3 46.3 33.2 43.3 30.1 50.2 87.5 44.9 45.4 42.1 49.9 54.0 47.6 84.6 27.9 38.4 29.6 31.5 27.2 26.8 37.8 20.6 19.0 46.8 37.2 32.6 47.3 59.9 66.9 83.9 32.7 37.7 36.9 48.9 35.8 59.1 24.4 43.5 32.6 47.9 53.1 43.7 39.2 40.4 43.8 45.1 32.8 35.6 36.2 9.8 45.0 54.7 45.1 51.1 61.3 37.3 49.3 25.6 39.7 32.8 28.0 36.1 27.3 28.2 22.9 53.6 40.7 50.7 95.5 76.6 41.9 207.9 76.5 49.5 45.5 64.6 15.7 229.8 129.3 164.4 108.0 86.3 137.8 116.8 176.4 216.8 106.9 72.7 72.8 141.0 139.1 35.0 61.9 63.8 58.5 158.2 82.0 66.5 94.5 170.5 67.3 81.7 174.0 108.7 94.0 148.2 36.4 116.4 134.6 87.3 61.8 67.5 295.1 69.6 93.3 88.7 PSMC6 p42 ENSG00000100519 "Proteasome 26S subunit, ATPase 6" P62333 14 52707172-52728587 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042823 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No 190000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042823: AB_2678188" "unprognostic (2.38e-2)" "unprognostic (2.72e-2)" "unprognostic (9.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-2)" "unprognostic (4.26e-3)" "unprognostic (3.14e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (2.79e-2)" "unprognostic (3.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.52e-2)" "unprognostic (5.00e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (4.67e-1)" 30.4 31.1 29.1 23.0 36.8 19.9 30.7 30.1 40.9 26.4 26.4 19.7 29.8 25.6 27.8 27.0 38.0 26.1 19.3 39.7 30.6 28.3 36.1 45.7 21.6 25.7 29.9 35.0 27.8 25.2 26.5 34.7 37.1 44.0 25.5 28.8 14.7 23.4 25.3 73.3 23.0 26.4 29.5 30.1 28.2 24.9 15.5 31.1 30.0 28.6 44.9 32.9 31.6 24.5 37.6 43.1 37.0 40.9 29.8 48.5 40.6 47.1 30.6 36.8 27.3 25.8 27.0 39.8 37.2 35.8 60.4 45.5 38.3 38.8 41.1 46.6 32.2 30.5 36.0 46.8 32.6 63.6 39.4 20.4 30.1 25.2 40.8 31.2 42.6 29.3 20.0 32.6 30.5 30.9 33.0 37.9 20.7 44.7 17.8 44.0 43.2 33.2 29.6 29.7 44.7 42.1 28.4 64.7 18.3 39.8 48.1 26.5 19.7 33.1 20.7 31.7 34.6 42.6 31.2 29.0 33.7 47.3 26.1 38.1 12.6 32.1 46.0 21.8 29.3 30.5 35.8 36.5 37.0 32.1 40.9 37.1 37.6 39.6 34.9 43.1 34.2 38.2 37.3 30.6 29.8 39.9 22.4 48.5 40.6 29.1 36.8 30.1 40.9 30.6 28.3 29.9 35.0 44.0 31.1 65.5 57.0 70.1 126.5 76.5 60.1 71.1 58.6 97.7 95.5 54.1 64.8 139.1 114.4 111.7 19.5 70.0 62.6 46.7 92.7 114.5 84.1 71.0 64.8 74.2 82.7 58.8 67.5 44.2 77.8 18.3 62.2 71.9 75.9 72.1 50.7 62.8 96.7 45.6 61.5 108.8 98.3 71.1 100.0 39.9 74.1 63.0 198.6 69.5 59.8 107.7 PSMD12 "p55, Rpn5" ENSG00000197170 "Proteasome 26S subunit, non-ATPase 12" O00232 17 67337916-67366627 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023119 Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA 44000 Microtubules "Nucleoplasm, Cytosol" "HPA023119: AB_1855845" "unprognostic (6.06e-2)" "unprognostic (3.16e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.35e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.28e-2)" "unprognostic (3.72e-2)" "prognostic favorable (6.32e-4)" "unprognostic (2.63e-1)" "unprognostic (7.32e-3)" "prognostic unfavorable (4.73e-6)" "unprognostic (1.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" 16.4 18.0 16.0 12.3 16.0 11.8 14.1 19.5 26.7 11.7 11.8 8.8 11.5 9.4 12.5 13.3 16.4 9.9 11.4 14.9 17.0 19.7 17.1 31.4 10.8 11.3 23.6 15.3 12.6 17.6 15.7 12.9 13.7 32.5 12.8 13.8 8.1 12.5 11.0 42.3 11.6 10.8 15.7 13.4 12.0 12.4 15.5 11.3 12.7 12.2 18.9 16.7 17.2 19.6 8.8 10.8 12.1 18.1 11.4 14.0 8.9 28.4 17.4 13.8 15.1 10.6 12.9 18.9 20.3 13.0 22.6 20.1 18.0 12.7 16.4 13.1 16.5 17.8 16.9 23.9 20.8 34.0 7.9 17.8 19.1 14.5 18.5 13.8 19.8 11.8 14.2 13.9 21.4 16.9 10.1 22.2 12.7 25.4 9.8 21.2 19.5 18.1 19.2 16.6 13.7 23.1 9.3 35.5 14.7 16.8 23.8 13.2 19.1 15.0 29.4 19.6 17.0 21.0 16.8 22.8 24.1 16.2 18.0 36.6 10.0 15.3 13.9 28.4 21.0 13.8 12.1 10.6 8.8 9.9 17.4 14.0 8.6 13.0 11.1 10.8 8.8 11.7 12.3 7.6 11.4 18.1 7.0 12.1 8.9 16.0 16.0 19.5 26.7 17.0 19.7 23.6 15.3 32.5 11.3 44.7 50.4 33.7 90.9 99.7 41.1 95.7 28.1 60.2 102.4 43.6 23.6 81.6 59.7 68.1 139.8 67.3 22.6 23.3 68.5 68.6 54.6 70.8 48.6 75.5 49.5 87.4 31.6 41.1 43.5 155.9 42.8 55.9 45.5 62.3 25.6 57.8 66.4 21.0 41.4 62.2 40.5 25.8 111.2 105.1 101.1 82.8 102.9 48.5 28.3 110.7 PSMG1 "c21-LRP, DSCR2, LRPC21, PAC1" ENSG00000183527 "Proteasome assembly chaperone 1" O95456 21 39174769-39183851 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 67.3" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 408.1;Spermatocytes: 226.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057193, HPA070225" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No "Nucleoplasm, Golgi apparatus, Cytosol" "HPA057193: AB_2683363, HPA070225: AB_2686236" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.10e-1)" "unprognostic (9.38e-2)" "unprognostic (5.06e-3)" "unprognostic (2.02e-1)" "unprognostic (1.66e-2)" "unprognostic (5.09e-2)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.84e-1)" "unprognostic (8.98e-2)" "unprognostic (1.32e-2)" "unprognostic (4.17e-3)" 7.0 11.0 8.2 8.7 8.0 15.1 6.9 7.7 13.1 7.0 10.2 4.7 5.2 9.2 8.2 9.2 12.5 6.9 9.4 7.6 7.5 8.9 11.7 21.4 6.1 8.1 6.9 10.2 7.9 21.5 5.1 10.0 7.5 8.5 5.7 10.0 7.3 8.0 5.2 13.0 7.0 8.4 8.3 7.1 7.0 7.1 67.3 4.6 7.8 10.6 10.4 7.6 6.7 7.4 11.4 11.5 7.3 7.9 6.7 14.9 7.9 27.1 8.9 6.5 8.9 3.2 3.7 17.3 15.0 6.6 11.8 7.6 16.3 7.1 29.4 8.0 4.2 10.5 7.8 10.2 8.0 7.7 12.6 16.1 55.6 13.8 21.1 5.8 26.4 11.1 5.1 6.0 12.5 12.6 2.6 6.2 12.8 40.9 16.9 7.0 14.4 16.2 14.3 22.4 10.4 13.9 26.5 8.1 29.9 4.9 8.1 20.7 6.1 18.9 10.7 14.9 1.2 10.1 13.3 7.0 13.6 4.7 18.2 21.2 13.0 20.5 25.5 11.5 44.7 10.4 7.3 6.4 3.5 10.6 7.8 12.2 11.4 14.9 12.2 11.5 9.0 11.9 10.4 0.5 6.7 7.9 10.5 12.6 7.9 8.2 8.0 7.7 13.1 7.5 8.9 6.9 10.2 8.5 4.6 6.0 18.3 19.9 34.3 120.8 14.8 21.8 22.9 12.0 29.6 19.2 3.9 93.4 56.3 35.1 408.1 22.4 14.4 0.0 43.3 92.9 37.1 22.6 34.7 28.1 51.9 7.9 28.7 19.6 18.1 33.7 29.4 26.6 43.9 26.2 40.2 9.4 31.9 21.0 31.1 76.3 16.1 25.8 31.9 226.4 91.0 85.4 45.5 20.3 50.8 26.7 PSTPIP2 ENSG00000152229 "Proline-serine-threonine phosphatase interacting protein 2" Q9H939 18 45983536-46072272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7" "Cell type enhanced" "Detected in many" 5 "granulocytes: 41.7;Kupffer cells: 40.3;Macrophages: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 38.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 37.7;HMC-1: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040923, HPA040944" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" No No 7100000 "Plasma membrane, Mitochondria" Nucleoplasm "HPA040923: AB_10794429, HPA040944: AB_10795485" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-2)" "unprognostic (4.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (5.83e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (2.39e-7)" "unprognostic (5.21e-2)" "unprognostic (3.55e-1)" "unprognostic (1.61e-1)" "unprognostic (1.93e-1)" 4.6 3.3 1.8 6.1 3.1 36.9 4.9 0.6 2.1 3.4 3.4 0.9 2.7 2.0 2.7 2.8 4.4 2.9 4.4 4.0 4.5 1.2 3.3 8.6 7.4 11.5 3.4 0.4 3.1 3.9 2.2 3.9 11.6 3.5 5.8 3.0 3.5 4.5 8.8 16.6 5.9 3.1 4.1 4.6 46.7 4.3 1.9 3.2 3.0 1.8 6.5 5.6 4.6 3.0 0.0 8.9 38.1 12.4 0.9 3.9 6.3 1.0 0.0 1.4 0.0 0.3 2.6 7.9 5.6 2.8 2.0 1.7 4.3 1.5 0.0 0.3 1.8 0.0 13.7 7.7 10.6 2.5 0.0 1.2 37.7 1.9 0.0 2.3 2.2 41.9 1.9 13.2 1.9 6.3 1.8 4.0 0.0 9.0 0.0 8.8 1.3 0.3 0.0 0.9 0.0 0.0 0.0 2.9 1.8 4.2 13.8 0.1 0.8 0.9 3.9 0.1 11.4 12.4 4.4 2.9 0.2 3.2 0.3 0.0 0.0 0.1 0.0 0.5 0.0 0.1 20.7 9.0 38.1 3.9 12.4 1.3 0.0 2.3 2.8 8.9 0.0 2.8 3.3 4.9 0.9 11.9 0.3 1.4 6.3 1.8 3.1 0.6 2.1 4.5 1.2 3.4 0.4 3.5 3.2 11.9 15.2 6.9 15.7 12.2 0.6 2.8 2.5 2.7 13.6 0.0 0.0 21.1 3.3 8.8 1.9 2.2 0.4 0.0 3.3 2.5 3.8 21.9 41.7 16.3 12.6 0.0 1.2 10.4 40.3 5.0 2.6 35.6 6.8 6.4 2.6 9.5 20.5 0.0 2.1 2.9 0.2 6.5 6.2 0.5 1.1 8.9 7.3 12.5 2.2 17.0 PTAFR ENSG00000169403 "Platelet activating factor receptor" P25105 1 28147166-28193936 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 98.3" "Group enriched" "Detected in many" 7 "granulocytes: 73.9;Hofbauer cells: 62.8;Kupffer cells: 70.6;Macrophages: 55.7;Pancreatic endocrine cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7" "Group enriched" "Detected in many" 5 "granulocytes: 98.3;monocytes: 28.2" "Group enriched" "Detected in some" 4 "HBEC3-KT: 14.7;HMC-1: 53.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027543 Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA027543: AB_10610287" "unprognostic (2.22e-2)" "unprognostic (2.59e-2)" "unprognostic (6.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.75e-1)" "unprognostic (3.74e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.23e-1)" "unprognostic (2.39e-1)" "unprognostic (1.60e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.59e-2)" "unprognostic (5.48e-2)" "unprognostic (1.38e-2)" 5.6 2.3 2.4 16.2 1.9 20.3 2.4 0.6 2.0 6.9 3.4 1.6 3.5 1.8 2.8 1.4 16.8 2.8 7.5 3.5 2.1 2.3 6.4 1.8 9.2 6.1 4.1 1.0 1.5 2.7 0.9 0.7 3.5 1.8 2.6 3.4 0.6 3.4 2.6 1.1 2.8 5.0 3.8 5.1 15.4 2.3 2.2 1.1 2.3 1.4 22.2 21.7 5.9 3.6 1.5 13.2 98.3 28.2 0.0 0.1 10.1 7.7 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 2.2 0.5 0.0 0.0 0.1 5.3 0.2 14.7 0.3 0.1 0.2 2.9 0.0 0.3 0.0 0.7 53.6 0.0 2.4 0.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 7.2 0.2 0.2 0.1 0.1 0.0 0.0 3.6 0.8 0.1 0.0 0.0 7.3 0.0 0.2 0.1 2.0 0.0 0.1 0.3 0.0 0.0 0.5 0.4 2.1 0.0 0.9 0.2 5.9 28.2 98.3 0.0 8.9 0.1 1.5 0.0 0.0 13.2 0.7 0.0 0.0 85.7 0.0 3.5 0.1 0.1 10.1 2.4 1.9 0.6 2.0 2.1 2.3 4.1 1.0 1.8 1.1 6.0 7.9 4.3 1.5 5.8 1.2 2.0 2.5 6.7 2.3 1.8 2.0 0.5 0.0 8.8 0.0 5.9 0.2 0.0 4.6 0.4 2.2 0.4 73.9 0.8 62.8 0.0 0.0 1.8 70.6 0.0 0.6 55.7 0.0 4.6 0.0 0.2 55.1 0.0 0.0 0.0 0.8 0.0 0.9 2.1 0.5 2.5 1.3 1.0 0.0 8.6 PTHLH "HHM, PLP, PTHR, PTHRP" ENSG00000087494 "Parathyroid hormone like hormone" P12272 12 27958084-27972705 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 45.6" "Cell type enhanced" "Detected in some" 15 "Exocrine glandular cells: 7.9;Melanocytes: 21.9;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 64.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "T-reg: 3.0" "Lineage enriched" "Detected in single" 30 "T-cells: 3.0" "Group enriched" "Detected in some" 4 "HaCaT: 64.7;HBEC3-KT: 80.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035982 Approved Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA035982: AB_10794631" "unprognostic (1.67e-1)" "unprognostic (5.26e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.60e-2)" "unprognostic (1.18e-1)" "unprognostic (5.16e-2)" "unprognostic (4.09e-3)" "unprognostic (3.84e-1)" "prognostic unfavorable (1.82e-9)" "unprognostic (2.01e-2)" "unprognostic (1.34e-1)" "unprognostic (5.23e-3)" "unprognostic (7.87e-3)" 2.9 1.0 6.5 3.5 5.3 0.0 20.2 1.4 8.7 11.0 2.3 1.4 2.1 2.4 11.2 2.0 17.0 1.2 45.6 4.0 4.3 3.5 0.4 0.2 1.3 1.1 1.4 4.3 2.6 1.7 0.7 2.3 3.6 3.1 5.5 1.8 2.4 5.3 2.6 0.7 1.5 1.6 13.4 0.8 3.6 1.9 1.3 1.0 0.1 1.4 15.8 3.4 8.0 12.3 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.3 2.2 0.0 0.0 0.6 0.6 0.0 0.0 0.2 0.1 0.2 0.0 1.7 0.0 0.1 0.5 2.1 64.7 0.2 80.0 0.0 1.6 0.3 0.1 0.4 0.0 0.2 0.0 0.1 0.0 4.4 2.0 7.9 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.7 0.0 0.3 0.1 7.7 0.0 0.0 0.0 3.6 0.0 0.4 2.7 0.1 0.0 1.2 0.3 2.0 1.1 17.0 1.0 0.0 2.6 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 6.5 5.3 1.4 6.2 4.3 3.5 1.4 4.3 3.1 1.0 0.0 0.0 0.0 1.1 4.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.0 4.2 1.3 0.0 0.0 7.9 0.0 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.9 0.2 21.9 1.0 0.0 2.2 5.5 0.0 0.0 0.0 0.3 6.5 2.8 0.4 0.1 1.3 0.0 0.0 0.0 0.1 PTMS ParaT ENSG00000159335 Parathymosin P20962 12 6765516-6770952 "Predicted intracellular proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 12.9;eosinophil: 3.3;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 6 "dendritic cells: 4.2;granulocytes: 12.9" "Cell line enhanced" "Detected in many" "HDLM-2: 84.1" HPA038186 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" No No 31000 "Nucleoli, Nucleoli rim" Nucleoplasm "HPA038186: AB_10673042" "unprognostic (3.11e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (3.57e-2)" "unprognostic (1.09e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (2.47e-1)" "unprognostic (4.16e-1)" "unprognostic (1.01e-1)" "unprognostic (8.69e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (6.18e-5)" "unprognostic (1.02e-1)" "unprognostic (3.21e-1)" "unprognostic (2.35e-3)" "unprognostic (1.55e-2)" 47.0 24.7 45.4 23.5 54.9 7.5 79.3 54.0 40.3 46.0 58.1 7.9 32.4 17.8 71.3 24.9 43.7 36.5 30.8 21.8 31.7 20.0 43.4 155.3 50.7 19.4 11.1 28.6 72.9 18.3 45.8 21.0 26.3 17.9 58.7 19.1 26.6 22.7 58.1 22.6 29.9 24.4 62.5 17.7 20.8 28.3 16.1 15.3 9.5 28.3 29.8 13.0 44.4 81.6 0.1 4.2 12.9 0.3 0.2 1.3 0.3 6.1 27.1 46.7 43.7 25.2 21.2 16.9 26.7 30.0 24.4 21.0 17.2 25.2 2.3 20.1 48.6 20.5 12.9 27.1 24.9 9.7 84.1 36.8 3.0 16.0 5.9 28.6 0.7 7.2 20.1 10.1 17.5 36.2 37.4 27.3 1.2 21.3 6.2 22.2 15.4 1.1 4.9 44.5 13.1 29.4 0.5 12.2 5.1 19.2 1.2 14.3 46.5 29.3 11.0 22.9 34.4 10.0 3.1 37.0 33.6 46.8 4.6 24.4 5.4 2.6 3.2 26.1 2.0 24.5 12.9 0.3 3.3 1.3 0.1 0.6 0.1 0.1 1.2 0.3 0.0 0.0 0.2 1.0 0.2 0.0 4.2 0.5 0.3 45.4 54.9 54.0 40.3 31.7 20.0 11.1 28.6 17.9 15.3 0.0 19.7 44.0 264.1 257.1 332.2 6.9 79.0 10.7 12.5 146.5 188.5 124.4 198.9 34.5 5.5 262.5 134.0 116.8 29.5 354.7 255.9 393.3 54.0 544.5 395.5 109.7 492.9 234.5 56.9 9.0 453.3 138.5 215.9 116.4 209.5 249.7 32.6 106.6 650.6 469.2 250.9 588.6 361.9 5.8 34.1 217.8 136.5 54.3 187.5 139.3 PTPN13 "PTP-BAS, PTP-BL, PTP1E, PTPL1" ENSG00000163629 "Protein tyrosine phosphatase, non-receptor type 13" Q12923 4 86594315-86815171 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 152.9;Basal keratinocytes: 97.1;Rod photoreceptor cells: 171.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 3.0;MAIT T-cell: 2.3;memory CD4 T-cell: 2.2;non-classical monocyte: 4.9" "Group enriched" "Detected in many" 7 "monocytes: 4.9;T-cells: 2.3" "Cell line enhanced" "Detected in many" "AF22: 45.2;RT4: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002213, HPA063119" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "CAB002213: AB_564089, HPA063119: " "unprognostic (5.36e-2)" "unprognostic (4.46e-1)" "unprognostic (1.11e-1)" "unprognostic (2.54e-3)" "unprognostic (4.02e-1)" "unprognostic (9.03e-3)" "unprognostic (4.43e-2)" "unprognostic (4.38e-2)" "unprognostic (2.46e-1)" "unprognostic (7.05e-2)" "unprognostic (3.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-3)" "unprognostic (3.95e-3)" "unprognostic (2.26e-1)" "unprognostic (2.66e-1)" "unprognostic (2.85e-2)" 10.3 5.9 10.8 2.7 16.9 0.7 9.9 5.7 11.6 15.9 4.1 13.0 7.6 1.2 10.8 21.2 18.7 11.4 6.5 5.3 10.4 5.7 22.1 1.6 18.0 4.3 16.9 7.9 24.1 4.3 26.6 38.3 3.0 14.2 12.0 2.4 39.0 5.9 9.4 1.0 43.0 2.3 8.7 10.3 3.5 3.6 12.2 17.6 1.9 16.9 12.4 11.8 15.7 17.6 0.0 0.5 0.1 4.9 0.1 2.3 0.1 5.1 2.6 45.2 4.4 19.1 16.7 0.0 9.5 19.4 3.6 4.6 0.0 2.6 0.0 2.1 10.5 1.3 17.0 7.8 14.3 7.0 0.1 5.8 4.3 5.6 0.0 2.3 7.5 0.0 10.7 4.6 2.6 8.7 7.6 0.0 0.0 0.0 7.4 0.0 2.3 0.6 2.7 10.3 0.0 1.9 1.5 0.0 0.0 13.8 21.5 2.6 3.8 2.8 6.3 5.2 7.6 3.7 0.2 0.0 3.5 2.7 0.0 1.2 7.7 0.0 0.0 3.7 0.0 1.5 0.0 0.2 0.0 0.2 3.0 2.3 0.0 2.2 0.3 0.5 0.0 0.0 0.0 0.1 0.1 4.9 0.0 0.1 0.1 10.8 16.9 5.7 11.6 10.4 5.7 16.9 7.9 14.2 17.6 44.7 152.9 0.0 21.0 97.1 9.8 1.7 10.2 32.1 75.1 45.4 86.4 0.2 3.3 4.3 20.2 2.2 0.0 0.0 3.0 0.1 20.2 12.1 4.7 0.0 0.2 1.6 4.6 1.8 2.2 14.8 42.3 5.7 18.6 0.0 0.5 14.1 4.3 3.5 30.8 9.2 171.6 12.9 12.5 24.4 21.6 86.9 0.2 4.4 0.2 45.5 PTPN22 "Lyp, Lyp1, Lyp2, PTPN8" ENSG00000134242 "Protein tyrosine phosphatase, non-receptor type 22" Q9Y2R2 1 113813811-113871759 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Immunity" "Hydrolase, Protein phosphatase" "Diabetes mellitus, Disease mutation, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.6;lymphoid tissue: 46.0" "Cell type enhanced" "Detected in many" 15 "B-cells: 29.6;granulocytes: 26.6;Kupffer cells: 19.2;Macrophages: 20.5;T-cells: 65.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 33.5;HL-60: 13.3;U-266/70: 14.4;U-698: 18.0;U-937: 13.6" "Region enriched" "Detected in single" 10 "cerebellum: 5.9" "Not detected" "Not detected" "HPA004912, CAB012209, HPA013350" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570" "unprognostic (2.25e-2)" "unprognostic (5.31e-3)" "unprognostic (3.48e-1)" "unprognostic (3.33e-4)" "unprognostic (9.14e-2)" "unprognostic (2.47e-3)" "unprognostic (9.60e-2)" "unprognostic (8.14e-2)" "unprognostic (3.71e-1)" "unprognostic (1.82e-1)" "unprognostic (1.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.75e-6)" "unprognostic (3.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-2)" 4.2 1.4 0.5 17.1 0.8 23.6 1.9 1.0 0.5 2.4 3.3 0.3 1.0 4.1 2.0 2.2 2.0 1.7 3.2 2.5 0.6 0.7 3.4 1.8 9.0 14.9 0.7 0.4 1.5 2.4 0.0 0.9 0.9 1.0 1.7 2.8 1.3 2.7 3.0 0.6 1.0 9.9 0.9 2.1 19.0 3.1 1.1 0.4 46.0 1.5 2.4 12.8 4.8 1.7 7.2 6.2 17.2 3.5 7.5 14.9 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.3 0.0 0.2 33.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 3.1 0.0 4.7 0.0 0.0 0.1 13.3 10.5 3.0 0.0 1.4 0.1 2.7 5.2 8.4 0.0 7.7 5.1 0.1 9.4 7.5 0.0 0.0 0.0 0.5 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 2.4 8.0 0.1 0.1 0.2 14.4 3.0 18.0 5.5 13.6 0.0 10.2 3.5 17.2 12.8 0.9 14.9 7.2 6.5 10.1 6.2 4.7 3.9 9.4 1.7 7.5 0.4 3.7 10.0 4.6 0.5 0.8 1.0 0.5 0.6 0.7 0.7 0.4 1.0 0.4 0.0 9.2 29.6 0.2 2.3 0.4 0.5 0.0 4.0 0.0 1.8 2.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.5 0.2 0.9 0.2 26.6 0.6 7.1 0.0 0.0 0.6 19.2 0.6 0.0 20.5 3.3 1.8 1.0 0.0 0.6 0.0 0.0 0.0 0.4 12.9 0.9 0.3 0.2 2.4 0.1 65.4 1.7 0.2 PTPN23 "DKFZP564F0923, HD-PTP, KIAA1471" ENSG00000076201 "Protein tyrosine phosphatase, non-receptor type 23" Q9H3S7 3 47381011-47413441 "Enzymes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016845 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Nuclear bodies" Vesicles "HPA016845: AB_1855926" "unprognostic (1.17e-3)" "unprognostic (8.68e-2)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (6.24e-2)" "unprognostic (1.07e-3)" "unprognostic (2.07e-2)" "unprognostic (9.55e-2)" "unprognostic (7.12e-2)" "unprognostic (5.67e-2)" "unprognostic (4.34e-2)" "prognostic favorable (1.82e-4)" "unprognostic (3.05e-2)" "unprognostic (4.40e-1)" "unprognostic (9.53e-2)" "unprognostic (4.68e-2)" 15.9 18.5 23.1 17.4 22.3 19.2 21.6 22.8 25.0 18.1 12.5 21.4 14.6 20.7 20.0 15.1 17.2 17.2 12.8 13.2 17.9 11.7 16.4 13.0 16.8 17.8 24.6 23.7 23.4 19.4 53.4 29.9 17.1 20.5 16.9 10.4 15.2 20.8 19.0 25.7 25.9 16.0 16.0 20.3 19.2 17.9 17.8 22.7 9.7 24.8 9.7 11.1 17.7 18.1 1.4 1.1 3.7 1.2 0.9 1.5 0.8 13.0 18.6 10.4 13.4 13.6 10.5 10.0 11.9 11.9 11.2 9.5 15.7 12.9 9.3 11.0 13.5 19.9 11.7 8.9 12.9 5.4 8.6 9.6 12.8 13.6 14.6 15.0 7.5 17.4 13.9 13.3 14.5 14.9 7.9 13.7 7.9 9.5 12.8 11.9 18.3 7.1 6.3 11.1 9.1 13.1 4.4 5.0 11.2 8.4 25.3 5.5 13.0 10.5 22.4 8.7 6.6 12.8 7.2 13.7 17.1 14.5 23.7 16.8 18.4 12.0 5.4 18.6 7.1 12.1 3.7 1.2 0.0 0.8 0.5 0.6 1.4 0.6 1.3 0.4 0.7 0.6 0.8 1.4 0.9 0.5 1.1 1.5 0.8 23.1 22.3 22.8 25.0 17.9 11.7 24.6 23.7 20.5 22.7 8.9 6.5 1.5 4.4 7.1 11.3 6.2 10.2 10.7 7.9 5.2 13.7 8.5 1.7 9.1 1.4 11.1 14.2 0.0 7.6 6.5 6.1 7.9 2.3 9.6 11.6 15.9 7.0 12.3 11.1 2.1 17.8 7.8 11.8 9.0 15.6 9.2 11.8 8.6 12.7 8.2 13.8 6.5 6.2 7.4 10.9 9.5 7.8 4.3 11.5 6.3 PTPN4 PTPMEG ENSG00000088179 "Protein tyrosine phosphatase, non-receptor type 4" P29074 2 119759631-119983818 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 53.9;Cone photoreceptor cells: 98.2;Horizontal cells: 152.6;Rod photoreceptor cells: 80.5;T-cells: 90.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "NK-cells: 12.2;T-cells: 19.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019351 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA019351: AB_1855928" "unprognostic (1.45e-1)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-2)" "unprognostic (9.00e-2)" "unprognostic (9.57e-2)" "unprognostic (2.34e-1)" "prognostic favorable (5.16e-4)" "unprognostic (3.31e-2)" "unprognostic (3.34e-3)" "unprognostic (3.13e-1)" "unprognostic (1.10e-1)" "unprognostic (3.34e-2)" "unprognostic (1.74e-1)" "unprognostic (1.87e-1)" "unprognostic (4.08e-2)" "unprognostic (1.81e-1)" 6.8 6.9 10.0 5.9 12.2 7.3 7.2 37.4 16.9 9.6 5.5 7.2 5.2 8.1 7.2 6.6 6.9 8.9 6.3 8.9 10.2 8.4 12.0 6.6 8.0 7.9 7.3 13.1 8.9 6.3 11.6 16.3 4.1 8.3 6.2 4.0 7.1 7.9 6.6 11.2 5.8 5.5 4.7 7.3 9.2 8.9 7.7 6.5 18.9 22.5 6.8 6.5 5.3 5.8 0.5 0.3 0.9 0.4 12.2 19.3 4.7 7.4 4.4 5.8 7.7 5.2 5.4 9.9 3.4 9.6 1.9 5.3 6.6 11.6 5.4 8.2 3.8 5.8 6.6 4.5 5.3 5.2 12.6 3.8 3.7 4.2 6.2 3.5 3.8 2.8 4.9 10.0 9.0 4.1 6.6 8.5 5.5 6.4 5.5 5.1 5.7 5.2 4.4 7.6 4.2 7.2 3.6 10.0 7.6 7.0 10.2 7.6 9.4 4.7 6.0 3.9 5.1 2.9 2.4 10.6 0.3 6.7 2.3 4.1 9.5 13.2 6.8 5.1 0.2 3.2 0.2 0.2 0.9 19.3 0.3 15.6 0.5 9.6 15.1 0.3 0.5 3.2 11.0 0.7 12.2 0.4 0.3 5.6 4.7 10.0 12.2 37.4 16.9 10.2 8.4 7.3 13.1 8.3 6.5 3.0 10.5 14.0 12.8 7.2 53.9 13.9 10.2 6.7 6.8 15.7 98.2 8.5 6.6 6.1 3.8 12.8 8.1 0.0 6.3 9.0 7.6 8.7 11.5 9.0 3.6 152.6 8.7 13.5 5.6 7.1 16.1 5.3 8.5 7.2 7.8 23.6 5.5 10.1 13.4 10.4 80.5 0.0 5.0 21.2 20.6 5.8 3.1 90.0 10.6 7.8 PURG "PURG-A, PURG-B" ENSG00000172733 "Purine rich element binding protein G" Q9UJV8 8 30995802-31033715 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7" "Group enriched" "Detected in some" 7 "Bipolar cells: 11.8;Early spermatids: 11.1;Horizontal cells: 19.1;Late spermatids: 16.8;Muller glia cells: 11.3" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.7;JURKAT: 6.1;NTERA-2: 6.8;SH-SY5Y: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047746 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Nucleoli "HPA047746: AB_2680145" "unprognostic (3.37e-1)" "unprognostic (2.15e-1)" "unprognostic (6.69e-2)" "unprognostic (7.33e-3)" "unprognostic (3.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.51e-3)" "unprognostic (1.10e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (4.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.27e-1)" "unprognostic (1.83e-2)" "unprognostic (5.30e-2)" 1.3 1.9 11.0 1.2 10.3 0.6 0.9 14.7 13.5 2.4 1.0 2.4 0.5 1.0 5.6 2.6 1.5 1.6 3.0 1.6 9.4 6.2 1.7 0.7 1.4 1.3 4.9 7.3 1.6 0.7 0.6 3.9 1.5 6.2 1.9 1.1 1.7 1.6 2.6 1.0 0.9 1.0 5.0 4.5 2.5 1.3 8.1 6.4 0.0 0.8 0.0 1.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.1 0.0 0.0 0.2 0.4 0.7 1.8 0.0 0.0 0.2 0.0 0.0 3.0 0.0 2.9 0.0 1.0 0.0 4.4 1.6 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.3 0.0 1.0 4.3 6.1 0.4 0.5 0.2 0.0 0.9 0.0 6.8 0.0 0.3 2.2 1.2 0.0 0.0 0.0 1.2 8.2 0.0 0.0 0.0 3.3 0.0 0.0 2.6 2.9 3.7 0.0 0.4 0.3 0.0 0.2 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.3 14.7 8.9 9.4 6.2 4.9 7.3 6.2 6.4 0.0 0.0 0.0 0.0 0.0 11.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 11.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 11.3 0.0 0.0 1.4 0.0 1.8 0.0 0.3 1.7 1.1 0.0 0.0 0.0 0.0 0.0 PUS10 "CCDC139, FLJ32312" ENSG00000162927 "Pseudouridylate synthase 10" Q3MIT2 2 60940222-61018259 "Enzymes, Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044736, HPA049582" Approved Approved "Nucleoplasm,Nuclear bodies,Mitochondria" No No "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA044736: AB_2679066, HPA049582: AB_2680824" "unprognostic (1.90e-3)" "unprognostic (1.35e-1)" "unprognostic (3.49e-2)" "unprognostic (2.44e-4)" "unprognostic (1.77e-1)" "unprognostic (1.86e-2)" "unprognostic (1.25e-1)" "unprognostic (1.72e-2)" "unprognostic (2.90e-2)" "unprognostic (8.21e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-1)" "unprognostic (1.16e-4)" "unprognostic (1.07e-1)" "unprognostic (6.60e-2)" "unprognostic (9.45e-2)" "unprognostic (1.15e-3)" 7.0 8.7 7.4 5.0 7.3 3.9 7.3 6.8 7.9 4.8 10.0 5.1 3.0 9.2 7.7 9.1 5.0 5.4 6.4 4.6 6.5 6.9 8.5 17.6 6.3 6.5 8.5 4.6 6.8 7.2 6.3 10.3 4.2 5.9 6.6 6.0 6.7 6.2 3.9 6.7 4.3 19.8 3.6 7.1 5.9 4.2 7.8 8.0 9.1 10.4 4.1 8.3 4.4 4.4 5.2 4.9 9.8 6.9 4.8 4.3 1.8 2.7 1.6 4.5 7.7 4.0 4.4 5.2 5.7 5.3 5.6 5.3 4.3 3.9 8.7 5.9 3.2 5.2 3.0 5.1 4.6 6.8 8.8 2.5 7.9 2.1 13.4 7.1 8.7 5.0 5.2 5.4 3.9 9.5 6.9 7.0 8.7 8.1 6.1 3.8 2.5 6.9 7.0 4.1 2.1 3.0 6.8 6.0 4.4 3.2 5.3 2.6 3.6 4.5 8.0 9.1 3.2 3.1 5.6 5.3 5.4 4.2 3.5 4.1 7.4 3.2 18.6 4.6 5.2 6.0 9.8 1.9 2.0 3.9 2.2 4.3 5.2 2.5 2.6 1.6 3.2 3.0 3.4 4.1 4.8 6.9 4.9 1.5 1.8 7.4 7.3 6.8 7.9 6.5 6.9 8.5 4.6 5.9 8.0 0.0 11.0 1.9 2.2 2.2 6.8 4.2 0.0 10.7 3.4 3.5 0.0 5.2 6.6 2.6 1.5 3.9 16.5 0.0 4.4 3.8 2.8 2.9 0.0 11.6 5.3 1.6 1.2 6.2 5.1 1.1 2.8 3.2 1.7 10.8 2.0 6.5 4.3 2.9 1.4 5.1 6.3 6.5 2.1 7.1 10.9 1.9 10.4 5.7 3.3 4.3 PVALB D22S749 ENSG00000100362 Parvalbumin P20472 22 36800684-36819479 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 125.0;parathyroid gland: 137.5" "Group enriched" "Detected in some" 10 "Distal tubular cells: 543.8;Horizontal cells: 1442.9" "Group enriched" "Detected in many" 10 "breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3" "Region enhanced" "Detected in all" "cerebellum: 125.0" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.4" "Cell line enriched" "Detected in single" 198 "RPMI-8226: 134.1" "Region enriched" "Detected in many" 5 "cerebellum: 2377.5" "Low region specificity" "Detected in all" "CAB002515, HPA048536" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" No NA Nucleoplasm "Nucleoli, Cell Junctions" "CAB002515: AB_563948, HPA048536: AB_2680433" "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "unprognostic (9.75e-2)" "unprognostic (1.79e-3)" "unprognostic (7.80e-2)" "unprognostic (2.49e-2)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (2.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-1)" "unprognostic (5.21e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-1)" "unprognostic (1.65e-2)" "unprognostic (8.99e-3)" 0.9 0.8 1.2 0.9 3.9 0.8 4.3 125.0 47.2 0.8 0.8 6.6 0.0 0.8 1.1 0.9 0.8 0.8 0.9 0.8 4.5 9.4 16.7 1.8 1.2 1.2 28.6 2.5 0.8 0.8 137.5 0.2 1.2 22.9 0.9 0.9 27.3 1.2 1.0 5.0 0.8 0.8 0.9 12.6 1.2 0.9 1.1 1.2 0.0 0.9 0.0 1.4 1.2 1.0 0.0 0.5 3.4 0.4 0.0 0.3 12.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 134.1 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.3 12.2 1.2 3.9 125.0 47.2 4.5 9.4 28.6 2.5 22.9 1.2 0.0 0.0 0.0 0.0 0.0 39.1 0.2 0.0 0.0 0.0 36.6 9.8 0.2 543.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.5 0.0 40.7 1442.9 0.0 40.5 3.7 0.0 0.6 0.9 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.8 104.1 0.0 0.0 0.0 0.6 0.0 0.3 1.0 0.0 0.0 PVR "CD155, HVED, Necl-5, NECL5, PVS, Tage4" ENSG00000073008 "Poliovirus receptor" P15151 19 44643798-44663583 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 65.6" "Cell type enhanced" "Detected in many" 5 "Pancreatic endocrine cells: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 5 "dendritic cells: 5.6;monocytes: 8.1" "Cell line enhanced" "Detected in many" "TIME: 53.4" "HPA012568, HPA064739" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Secreted - unknown location" NA NA 940000000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA012568: AB_1846248, HPA064739: " "unprognostic (2.90e-3)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.36e-1)" "unprognostic (2.34e-1)" "unprognostic (7.89e-2)" "unprognostic (2.45e-3)" "unprognostic (3.06e-2)" "prognostic unfavorable (9.30e-4)" "unprognostic (9.05e-3)" "unprognostic (1.69e-1)" "unprognostic (2.09e-3)" "unprognostic (2.64e-3)" "unprognostic (1.69e-1)" "unprognostic (4.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-3)" "prognostic unfavorable (2.75e-4)" 10.0 13.9 7.4 7.5 8.1 4.7 9.2 11.0 11.0 6.5 10.6 6.5 4.1 13.7 11.3 5.7 6.6 8.8 9.2 23.5 5.8 10.0 10.6 65.6 14.8 2.4 6.0 6.5 10.4 15.9 9.9 20.7 15.5 9.7 10.4 7.7 6.6 8.5 6.9 19.8 5.5 13.0 11.1 7.0 4.8 12.3 6.0 7.2 2.3 8.5 10.8 3.7 8.3 6.7 0.0 5.6 1.2 8.1 0.6 0.4 2.2 21.8 15.3 1.5 6.1 1.9 2.3 2.6 36.9 10.3 12.1 13.9 8.9 9.3 0.0 21.2 10.7 21.2 14.4 5.2 14.0 8.1 2.6 10.1 3.9 9.6 6.0 12.9 1.5 8.4 2.9 6.9 10.7 21.0 12.1 13.1 2.3 1.8 0.0 5.6 1.9 1.3 1.3 3.4 7.4 11.3 0.0 7.0 2.0 26.0 6.7 6.6 7.7 23.4 14.7 5.2 1.7 8.3 3.7 53.4 14.7 18.1 10.8 28.8 0.0 2.1 0.0 11.7 7.5 8.3 0.0 6.4 0.0 0.2 6.6 0.0 0.0 0.0 0.4 5.6 0.0 0.2 0.1 1.2 0.6 8.1 0.5 0.0 2.2 7.4 8.1 11.0 11.0 5.8 10.0 6.0 6.5 9.7 7.2 14.9 28.0 4.5 12.8 3.2 6.9 11.2 20.4 2.7 18.2 1.8 2.0 2.4 3.3 43.0 8.5 13.5 11.9 0.0 30.3 30.1 5.4 11.3 1.1 36.5 7.4 1.6 12.6 7.4 9.2 10.2 5.2 7.8 1.7 25.2 9.7 1.3 48.8 14.4 14.9 2.8 3.3 0.0 17.8 3.4 1.5 4.8 0.8 0.0 10.6 6.5 PYCARD "ASC, CARD5, TMS-1" ENSG00000103490 "PYD and CARD domain containing" Q9ULZ3 16 31201485-31203450 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 130.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 312.0;Hofbauer cells: 375.8;Kupffer cells: 516.6;Macrophages: 364.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0" "Group enriched" "Detected in all" 6 "dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4" "Cell line enhanced" "Detected in many" "MCF7: 34.5;NB-4: 54.4;THP-1: 40.1;U-937: 24.9" "CAB006853, CAB015948, HPA049074, HPA054496" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA 1100000 Nucleoplasm "Nucleoli, Cytosol" "CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506" "unprognostic (1.00e-3)" "unprognostic (2.62e-2)" "unprognostic (2.40e-1)" "unprognostic (4.67e-3)" "unprognostic (3.34e-1)" "unprognostic (1.87e-1)" "unprognostic (5.29e-2)" "unprognostic (2.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.33e-1)" "unprognostic (6.52e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (6.09e-7)" "unprognostic (4.45e-3)" "unprognostic (2.51e-1)" "unprognostic (3.61e-2)" "unprognostic (6.97e-2)" 11.6 4.4 3.6 16.7 4.6 22.4 8.6 3.6 3.3 8.2 26.8 6.8 4.1 38.7 5.4 7.9 20.7 6.8 8.5 6.6 2.4 2.6 5.6 6.8 15.0 32.8 6.4 1.8 6.6 6.1 1.3 3.2 6.6 4.0 9.7 4.4 4.7 9.6 5.6 3.5 31.2 29.9 3.5 6.4 34.1 13.3 3.7 3.3 20.6 5.5 22.3 26.3 7.9 11.8 17.1 66.8 130.8 90.4 16.0 16.0 53.1 5.7 13.5 0.1 0.0 1.3 3.0 0.1 2.8 4.0 1.8 1.2 0.0 7.2 2.4 0.0 2.7 0.0 16.0 0.7 10.7 0.0 17.3 0.0 2.2 1.6 4.4 4.6 20.1 16.0 4.0 5.6 0.8 0.1 0.0 3.9 0.0 9.9 3.7 0.5 34.5 0.0 54.4 3.7 2.3 0.0 17.5 0.0 7.6 0.1 5.6 0.1 0.0 2.4 0.0 2.7 0.0 3.3 40.1 2.6 0.1 0.2 2.4 0.0 0.1 0.0 0.0 1.4 24.9 0.0 37.8 90.4 71.4 15.1 87.5 9.5 17.1 12.7 15.5 66.8 15.2 8.9 12.3 130.8 16.0 85.0 61.0 16.0 53.1 3.6 4.6 3.6 3.3 2.4 2.6 6.4 1.8 4.0 3.3 20.8 28.2 73.7 67.5 65.8 0.1 2.8 28.1 36.1 29.6 24.4 0.0 46.3 5.0 83.5 0.3 38.6 312.0 23.3 50.3 8.9 26.7 26.8 108.5 3.0 375.8 0.0 56.6 41.7 516.6 1.5 43.7 364.0 92.8 16.2 110.6 0.0 56.2 271.9 21.2 1.4 0.6 25.8 23.3 0.3 1.1 143.2 14.9 75.0 247.3 42.2 QRICH2 DKFZP434P0316 ENSG00000129646 "Glutamine rich 2" Q9H0J4 17 76274049-76307998 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 27.4" "Cell type enhanced" "Detected in some" 21 "Cholangiocytes: 7.6;Early spermatids: 25.8;Late spermatids: 5.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA052219 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nucleoplasm, Nuclear membrane, Vesicles" "HPA052219: AB_2681766" "unprognostic (3.11e-2)" "unprognostic (2.44e-3)" "unprognostic (9.11e-3)" "unprognostic (4.42e-3)" "unprognostic (1.35e-1)" "unprognostic (1.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.83e-1)" "unprognostic (2.61e-1)" "unprognostic (8.82e-4)" "unprognostic (3.64e-1)" "unprognostic (1.39e-1)" "unprognostic (6.97e-2)" "unprognostic (7.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.71e-3)" 0.9 0.8 1.2 0.9 2.2 1.9 0.9 5.7 2.0 0.9 0.9 0.9 0.9 0.3 0.9 1.0 1.0 1.2 0.9 0.9 1.4 2.0 0.9 1.1 1.1 0.9 1.4 0.9 0.9 1.3 0.6 0.9 1.4 0.9 0.9 0.8 0.9 5.6 0.9 1.4 1.7 0.9 0.9 1.2 0.9 0.3 27.4 0.9 0.9 3.0 0.9 0.9 0.9 0.9 0.9 0.0 0.0 0.1 0.3 0.4 0.3 1.2 2.5 4.8 5.4 2.6 2.4 2.2 2.2 0.5 1.7 0.5 1.3 0.5 6.5 0.9 1.4 1.3 0.5 6.3 1.1 2.1 1.8 3.8 0.6 1.7 5.8 1.4 0.9 3.0 2.1 1.0 1.9 0.1 3.3 2.1 2.0 3.5 1.3 0.6 3.8 3.4 0.8 1.9 1.6 5.2 7.6 3.9 0.2 0.9 2.3 4.4 4.4 1.1 0.6 2.6 4.9 2.0 2.7 2.1 1.4 5.1 6.8 2.6 1.8 1.7 0.6 1.5 3.8 1.6 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.2 2.2 5.7 2.0 1.4 2.0 1.4 0.9 0.9 0.9 0.0 0.0 0.0 0.3 0.1 0.5 1.6 7.6 0.0 0.0 1.8 0.0 0.6 0.0 0.7 25.8 0.6 0.3 0.0 0.0 0.9 0.2 0.3 0.0 0.8 0.2 1.6 0.0 0.0 0.3 5.8 0.9 0.0 1.7 1.0 0.5 1.5 0.5 0.0 0.7 0.4 1.8 0.0 0.6 2.1 1.1 0.3 0.3 0.0 0.4 0.3 RAB3A ENSG00000105649 "RAB3A, member RAS oncogene family" P20336 19 18196784-18204074 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 114.7" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 94.1;Distal tubular cells: 33.2;Horizontal cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 13.8;SCLC-21H: 25.3;SH-SY5Y: 12.1;U-2197: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003160, CAB009949, CAB078998" Enhanced Supported Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731" "unprognostic (1.82e-1)" "unprognostic (2.22e-1)" "unprognostic (6.80e-3)" "prognostic unfavorable (3.17e-4)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (1.36e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (1.13e-1)" "prognostic favorable (6.14e-7)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (6.14e-2)" 2.3 13.0 32.3 2.6 50.5 2.0 2.0 39.1 114.7 2.8 3.1 6.3 0.0 3.6 2.7 2.6 2.4 3.2 2.8 17.0 40.8 32.7 4.1 2.2 2.5 2.4 31.5 35.6 8.0 2.3 5.0 7.5 2.4 38.2 3.8 2.8 5.8 4.2 4.4 7.5 2.5 3.0 2.9 7.0 2.5 2.5 2.2 4.8 0.0 2.9 0.1 2.1 2.9 0.7 4.6 6.0 5.1 3.0 0.7 4.2 2.6 0.9 1.0 2.4 3.2 3.8 1.0 1.4 2.1 1.2 1.4 1.9 0.9 0.6 3.4 2.3 1.7 1.3 2.7 11.0 1.3 0.7 0.7 3.5 1.3 4.0 3.8 1.0 2.3 4.2 3.2 1.3 0.8 0.4 2.8 0.4 4.2 0.7 1.2 1.3 3.2 5.1 0.6 1.9 2.8 13.8 3.6 0.2 2.8 1.5 0.5 25.3 12.1 1.0 4.4 2.4 1.0 0.9 0.4 0.4 1.3 0.9 17.5 1.2 2.1 4.6 0.8 3.3 1.7 1.1 0.0 3.0 3.8 3.0 2.2 4.0 4.6 3.2 3.0 6.0 2.2 4.1 4.2 5.1 0.7 2.7 5.5 1.8 2.6 32.3 50.5 39.1 95.0 40.8 32.7 31.5 35.6 38.2 4.8 0.0 0.0 0.9 2.1 2.9 94.1 1.1 2.5 0.0 0.0 15.7 7.9 1.4 33.2 2.1 2.4 1.4 1.4 0.0 0.8 3.6 3.9 1.4 0.0 1.5 4.3 87.4 9.2 3.1 1.6 0.0 4.0 4.3 10.1 2.8 2.3 11.3 0.8 2.0 5.3 6.3 28.8 0.0 8.6 0.3 2.8 4.3 1.5 2.2 3.7 1.4 RAC1 "p21-Rac1, Rac-1, TC-25" ENSG00000136238 "Rac family small GTPase 1" P63000 7 6374523-6403977 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035994, HPA047820" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 44000000 "Nucleoplasm, Cytosol" Nucleoli "CAB035994: , HPA047820: AB_2680167" "unprognostic (8.66e-3)" "unprognostic (2.47e-1)" "unprognostic (4.00e-1)" "unprognostic (2.40e-2)" "unprognostic (1.88e-3)" "unprognostic (4.06e-2)" "prognostic unfavorable (1.74e-5)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.63e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.95e-1)" "unprognostic (2.11e-2)" "unprognostic (4.13e-2)" "unprognostic (8.72e-3)" 45.2 35.0 71.0 28.4 64.0 24.4 46.5 42.1 93.0 48.7 58.9 75.5 22.5 51.6 48.7 49.5 93.4 47.2 40.0 48.4 73.8 59.8 47.8 42.9 45.6 38.3 76.7 60.9 45.1 29.2 51.0 25.2 55.8 54.9 40.5 64.0 37.2 43.3 48.9 57.4 58.6 49.8 57.3 88.2 35.0 49.7 28.1 47.1 41.3 40.9 42.8 50.7 52.2 54.0 11.0 32.0 49.1 31.9 7.3 11.8 10.7 75.1 34.1 35.3 38.3 41.9 53.5 21.1 42.4 52.1 56.6 57.7 33.5 71.1 21.2 27.5 59.1 58.6 53.6 37.6 51.4 72.5 9.9 31.2 21.3 27.6 24.1 50.4 19.2 17.4 35.6 46.0 40.7 45.7 43.1 49.8 21.0 38.0 16.8 60.9 54.8 10.5 45.2 63.2 38.3 40.9 18.7 35.9 31.1 72.7 47.7 26.8 45.1 29.9 109.6 34.0 42.1 61.8 57.8 52.2 37.2 56.0 45.5 48.9 12.8 14.0 20.0 34.3 36.7 70.4 7.6 31.9 16.4 7.2 22.2 4.5 11.0 8.1 9.2 32.0 11.0 9.8 6.5 49.1 7.3 22.1 18.2 11.8 10.7 71.0 64.0 42.1 93.0 73.8 59.8 76.7 60.9 54.9 47.1 137.0 112.5 192.8 745.4 829.8 84.3 183.1 481.6 92.3 104.6 338.5 23.6 691.3 454.3 121.1 58.5 522.9 706.2 303.7 149.3 914.8 466.9 1152.5 132.3 288.4 738.1 138.2 323.2 535.2 736.9 43.7 441.0 745.3 435.3 408.4 531.5 280.9 231.2 471.0 444.5 611.5 54.4 472.1 495.6 210.1 328.6 1004.1 707.0 194.1 436.1 1582.5 RAI14 "DKFZp564G013, KIAA1334, NORPEG, RAI13" ENSG00000039560 "Retinoic acid induced 14" Q9P0K7 5 34656237-34832627 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 64.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 166.4;Early spermatids: 198.0;Late spermatids: 250.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 59.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036949, HPA036950" Supported Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA Nucleoplasm "Actin filaments, Cytosol" "HPA036949: AB_10670568, HPA036950: AB_10669721" "unprognostic (7.63e-2)" "unprognostic (9.86e-2)" "unprognostic (4.87e-2)" "unprognostic (1.40e-1)" "unprognostic (3.38e-2)" "unprognostic (4.75e-2)" "unprognostic (5.49e-2)" "unprognostic (6.18e-2)" "unprognostic (6.28e-2)" "unprognostic (2.62e-1)" "unprognostic (8.18e-2)" "unprognostic (4.58e-2)" "prognostic unfavorable (9.75e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.33e-1)" "unprognostic (4.81e-2)" "unprognostic (4.34e-2)" 5.6 4.5 3.9 8.3 5.9 0.5 5.1 4.4 3.2 23.3 9.1 5.5 14.1 2.5 29.2 8.2 8.8 6.8 8.8 3.6 4.4 3.5 7.7 11.2 10.4 5.1 6.9 1.5 9.5 4.8 6.4 2.7 64.4 5.6 10.4 4.0 8.2 8.4 10.8 2.0 7.6 3.6 34.7 17.0 21.2 6.0 26.6 5.7 2.1 6.7 2.7 3.8 22.5 14.9 0.8 0.6 2.5 0.8 2.5 3.3 0.3 2.7 10.8 12.5 8.3 6.7 23.5 16.0 32.7 26.4 18.9 19.0 8.2 3.5 0.6 13.1 16.0 20.7 1.8 14.2 24.1 41.1 0.0 6.8 4.5 10.2 5.0 20.8 0.1 0.4 21.9 7.6 33.9 27.1 31.2 59.9 1.0 6.3 0.2 24.6 2.2 0.4 0.1 9.7 1.6 10.5 3.9 19.1 0.1 22.0 15.6 3.3 1.8 19.3 2.9 8.8 19.1 3.3 0.5 38.5 30.8 16.5 7.5 14.2 0.7 0.0 0.0 26.0 0.0 11.9 2.5 0.8 0.3 3.3 0.3 0.4 0.5 1.0 0.2 0.2 0.8 0.3 0.6 1.6 2.5 0.1 0.6 0.1 0.3 3.9 5.9 4.4 3.2 4.4 3.5 6.9 1.5 5.6 5.7 98.3 166.4 1.7 20.2 10.6 1.9 3.3 5.1 24.1 95.5 33.2 64.8 23.9 6.6 30.0 198.0 51.8 3.2 0.0 24.7 59.3 26.2 11.8 3.5 21.9 6.5 14.3 1.7 16.5 2.4 250.8 66.7 4.2 5.0 1.8 0.8 18.5 39.1 1.9 29.7 18.0 4.7 0.0 17.3 8.1 12.4 13.8 130.6 2.5 2.3 63.1 RANBP2 "ADANE, ANE1, NUP358" ENSG00000153201 "RAN binding protein 2" P49792 2 108719481-108785811 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway" "RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564" Supported Supported "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane" "Nucleoplasm, Vesicles" "CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.22e-1)" "unprognostic (4.37e-2)" "unprognostic (1.28e-2)" "unprognostic (9.30e-2)" "unprognostic (5.47e-2)" "unprognostic (2.91e-1)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (4.23e-1)" "unprognostic (5.23e-2)" "unprognostic (1.62e-2)" "unprognostic (8.74e-2)" "unprognostic (3.08e-1)" "unprognostic (3.40e-2)" "unprognostic (2.53e-1)" 20.5 24.3 14.4 17.0 18.6 35.5 24.4 23.1 22.2 19.8 17.1 12.8 25.5 13.3 19.9 21.5 17.0 19.1 14.8 20.2 12.9 12.5 18.9 19.5 17.7 19.2 15.1 17.0 32.4 24.1 48.5 37.5 18.8 16.5 21.8 15.8 14.3 20.0 31.6 37.5 17.3 17.4 23.2 17.8 16.3 20.9 20.6 15.9 26.6 28.7 18.0 17.5 20.5 19.7 5.6 5.1 8.3 6.3 4.2 8.7 2.3 18.4 11.3 16.3 14.7 19.0 17.0 15.8 16.6 13.2 13.8 12.1 28.1 8.9 29.1 12.9 17.3 17.0 15.6 27.8 17.3 20.1 17.7 13.5 30.3 14.0 19.8 11.1 35.3 10.2 14.3 13.2 21.5 16.8 13.6 21.0 12.7 32.4 16.1 18.2 10.2 15.6 14.4 20.5 9.3 13.6 14.8 25.0 14.0 12.2 23.1 23.7 10.9 14.7 12.7 16.1 10.2 8.1 16.3 25.0 14.4 19.1 10.1 18.5 13.4 19.8 26.4 11.2 16.0 11.1 8.3 5.3 5.1 7.6 3.4 8.7 5.5 6.3 6.9 4.2 5.6 6.2 6.7 8.3 4.2 6.3 5.1 5.1 2.3 14.4 18.6 23.1 22.2 12.9 12.5 15.1 17.0 16.5 15.9 71.5 71.1 34.9 25.8 49.5 43.3 85.9 33.1 57.6 70.5 55.8 68.7 22.7 1.7 31.3 59.8 43.8 25.7 0.0 44.1 15.0 32.3 38.2 83.1 49.9 41.1 30.2 102.2 27.0 44.0 22.0 35.6 64.2 45.5 49.5 50.9 18.7 36.5 25.9 52.6 15.4 37.7 45.3 62.9 74.1 59.2 59.2 34.0 44.5 31.5 31.5 RAPGEFL1 Link-GEFII ENSG00000108352 "Rap guanine nucleotide exchange factor like 1" Q9UHV5 17 40177010-40195656 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.7;skin 1: 87.1" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 40.4;Enterocytes: 66.1;Paneth cells: 46.5;Suprabasal keratinocytes: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 39.0;hTCEpi: 19.5;T-47d: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022895 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Nucleoplasm, Microtubules" "Cytokinetic bridge" "HPA022895: AB_1856071" "prognostic favorable (8.43e-4)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.13e-2)" "unprognostic (4.64e-3)" "unprognostic (3.48e-2)" "unprognostic (5.92e-2)" "unprognostic (1.80e-1)" "unprognostic (3.64e-2)" "unprognostic (2.67e-1)" "unprognostic (7.46e-3)" "unprognostic (8.84e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.23e-2)" "unprognostic (1.50e-1)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" 1.5 1.3 15.9 2.7 17.2 1.8 4.1 8.2 22.7 8.9 19.5 1.8 0.9 18.8 1.6 4.3 37.7 2.9 5.9 1.1 11.2 6.2 0.6 1.7 1.6 1.1 2.8 20.2 0.8 1.6 0.8 2.7 1.2 5.5 3.4 17.7 1.3 5.7 3.2 4.6 87.1 15.5 2.0 1.9 1.4 12.6 2.4 2.9 0.2 0.9 13.3 10.7 6.5 19.4 0.1 0.9 2.9 0.4 0.0 0.6 0.0 2.1 1.1 5.8 4.3 0.6 1.4 2.8 0.8 0.6 1.1 1.3 2.4 3.1 1.7 0.8 1.1 1.0 39.0 1.1 1.3 1.6 3.1 2.9 1.0 1.3 2.4 0.7 2.1 3.6 1.6 19.5 1.2 0.5 1.7 1.7 5.8 0.7 1.2 0.8 6.0 1.9 2.5 1.8 10.7 1.1 3.6 0.7 1.0 0.7 11.4 11.2 2.3 1.3 13.2 0.5 5.1 34.1 1.6 3.3 1.4 2.9 1.5 1.3 1.9 1.8 1.4 3.3 1.3 1.7 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.4 0.4 0.9 0.0 0.1 0.2 2.9 0.0 0.4 0.2 0.0 0.0 15.9 17.2 8.2 22.7 11.2 6.2 2.8 20.2 5.5 2.9 0.0 0.6 0.8 9.6 40.4 2.1 1.6 20.4 0.0 1.2 1.8 5.9 0.1 0.0 0.5 2.4 1.6 66.1 0.0 0.7 0.2 1.0 5.0 5.7 3.8 0.5 1.6 4.7 4.9 0.8 1.4 3.1 1.6 5.0 1.8 32.6 2.8 1.2 46.5 3.5 0.0 4.6 0.0 1.4 11.5 10.4 84.8 0.6 0.0 32.3 31.9 RASGRP4 ENSG00000171777 "RAS guanyl releasing protein 4" Q8TDF6 19 38409051-38426305 "Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 10.9;granulocytes: 26.5;Hofbauer cells: 12.0;Kupffer cells: 34.4;Macrophages: 11.0" "Cancer enhanced" "Detected in many" "testis cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 22.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEL: 19.4;HMC-1: 19.4;U-937: 5.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041929 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041929: AB_10961405" "unprognostic (1.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (1.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.00e-1)" "unprognostic (5.23e-4)" "unprognostic (6.54e-2)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (2.19e-2)" "unprognostic (1.05e-1)" "unprognostic (4.56e-1)" "unprognostic (2.66e-2)" 4.5 1.8 2.4 8.0 3.3 23.3 5.4 0.7 1.8 1.8 1.7 2.8 0.1 1.4 1.6 2.9 1.6 2.6 3.4 6.2 2.0 1.3 1.5 1.8 11.8 23.1 3.4 0.2 1.1 1.6 0.5 0.9 3.0 1.8 1.7 1.2 1.7 1.6 0.8 1.5 1.4 2.4 2.7 4.2 19.2 1.9 0.8 2.4 0.5 1.0 0.2 1.0 2.6 3.1 0.1 5.2 22.4 9.5 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 19.4 0.0 0.0 0.0 0.1 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 6.0 7.1 10.6 0.0 8.5 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.0 22.4 0.0 9.5 0.4 0.7 2.1 2.4 3.3 0.7 1.8 2.0 1.3 3.4 0.2 1.8 2.4 0.0 1.1 0.0 0.0 0.7 0.0 10.9 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 0.0 26.5 0.0 12.0 0.0 0.0 1.8 34.4 0.0 0.0 11.0 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 RBM18 MGC2734 ENSG00000119446 "RNA binding motif protein 18" Q96H35 9 122237624-122264839 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057281, HPA077955" Uncertain Enhanced "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA057281: AB_2683394, HPA077955: " "unprognostic (1.75e-2)" "unprognostic (7.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (2.52e-3)" "unprognostic (1.08e-1)" "unprognostic (9.39e-3)" "unprognostic (7.27e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "prognostic favorable (8.00e-7)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 12.8 14.8 16.5 9.1 16.5 15.1 24.6 18.1 20.3 14.4 13.4 10.5 13.7 10.4 13.6 16.2 11.8 11.6 11.7 27.2 16.7 18.6 17.3 12.2 10.7 10.9 17.8 13.2 15.1 13.7 16.0 18.2 16.2 16.3 17.2 12.6 8.2 12.6 13.9 29.4 10.1 10.8 13.2 16.0 12.4 12.3 7.6 15.0 11.9 15.3 13.5 11.1 13.0 14.4 8.7 9.5 16.0 13.0 7.7 10.0 8.2 5.8 6.1 8.4 9.2 12.4 15.4 7.3 13.3 10.9 9.1 8.5 7.0 5.8 10.2 5.8 8.6 10.1 13.7 13.1 13.8 11.5 10.4 5.9 7.6 10.2 5.9 14.0 15.1 10.5 13.1 15.7 9.6 19.6 9.2 13.1 8.3 10.4 8.0 13.6 6.3 7.8 9.3 6.5 19.8 10.2 7.0 17.4 13.8 12.7 6.6 17.6 9.3 10.0 14.1 15.0 6.9 8.2 8.6 7.2 8.6 4.9 13.7 13.0 11.7 21.5 8.5 14.1 9.4 10.2 6.8 9.2 16.0 10.0 10.5 9.6 8.7 8.9 9.7 9.5 6.0 9.3 9.7 9.7 7.7 13.0 6.9 9.1 8.2 16.5 16.5 18.1 20.3 16.7 18.6 17.8 13.2 16.3 15.0 29.8 10.9 16.7 9.8 19.3 11.8 46.6 7.6 17.4 13.6 24.4 2.0 28.1 23.2 20.9 61.1 24.8 12.3 0.0 14.0 35.6 16.0 18.9 17.3 13.7 24.5 3.2 18.9 13.5 21.4 54.6 12.4 16.2 18.6 10.0 16.7 15.8 18.5 13.9 15.9 18.9 11.6 19.4 23.1 10.1 19.4 22.6 47.6 17.3 13.6 14.1 RBM20 ENSG00000203867 "RNA binding motif protein 20" Q5T481 10 110644397-110839469 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 45.9;skeletal muscle: 20.9" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 137.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HEL: 4.8;K-562: 4.6;RH-30: 15.7;SH-SY5Y: 14.6;SuSa: 5.0;T-47d: 8.8" "Region enhanced" "Detected in some" "olfactory region: 4.6" "Not detected" "Not detected" "HPA035806, HPA070358" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Yes No "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA035806: AB_10672097, HPA070358: " "unprognostic (2.43e-1)" "unprognostic (8.24e-3)" "unprognostic (5.81e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (2.75e-2)" "unprognostic (5.47e-3)" "unprognostic (1.33e-1)" "unprognostic (2.78e-2)" "unprognostic (4.14e-3)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "unprognostic (3.34e-1)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (6.46e-2)" 1.7 0.1 0.4 0.6 1.9 0.1 2.2 0.5 1.5 0.9 2.6 1.3 0.0 0.2 2.5 7.5 3.6 1.9 2.3 45.9 0.6 0.2 1.1 0.1 0.5 0.1 0.3 1.3 2.4 13.7 0.9 1.2 1.4 1.4 1.0 0.5 4.3 6.3 0.7 20.9 0.7 1.0 2.1 0.6 0.1 0.6 0.9 1.4 0.0 0.7 3.4 0.5 1.8 3.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.0 2.3 5.7 4.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 15.7 0.0 0.0 0.0 0.1 14.6 0.1 0.0 0.6 5.0 8.8 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.9 0.5 1.5 0.6 0.2 0.3 1.3 1.4 1.4 0.0 0.0 0.0 0.2 0.1 1.3 137.1 0.0 17.4 0.0 0.0 2.0 1.0 1.7 0.0 0.7 0.6 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.4 4.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.7 1.4 2.3 6.5 1.9 0.0 0.5 0.0 2.6 0.0 0.0 0.1 RBM34 KIAA0117 ENSG00000188739 "RNA binding motif protein 34" P42696 1 235131183-235161457 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028606 Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No Nucleoli "Nucleoplasm, Mitotic chromosome" "HPA028606: AB_10601494" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (7.30e-2)" "unprognostic (3.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (6.57e-4)" "unprognostic (2.98e-2)" "unprognostic (5.65e-3)" "unprognostic (2.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-8)" "unprognostic (8.50e-2)" "unprognostic (1.85e-1)" "unprognostic (8.73e-2)" "unprognostic (7.09e-4)" 15.8 10.5 17.2 16.4 18.1 30.6 14.8 15.5 22.3 11.0 13.5 10.6 7.0 16.7 10.9 15.2 15.4 9.9 11.3 15.2 13.4 11.6 19.4 14.2 11.5 20.0 16.9 9.9 13.9 13.5 6.6 24.9 14.7 20.9 13.5 12.6 7.6 18.3 11.2 22.2 17.9 17.6 10.9 17.9 14.6 13.1 28.8 17.3 17.5 14.7 10.9 17.1 14.1 16.0 34.2 27.2 38.0 19.2 25.3 35.5 22.7 12.0 9.1 9.5 12.1 7.2 13.0 23.6 12.8 8.9 11.5 11.1 12.3 13.8 20.8 13.9 7.7 9.2 18.1 11.3 11.7 11.1 18.8 18.4 15.6 6.5 8.5 14.4 24.6 15.3 11.4 13.5 10.7 7.4 10.6 9.2 20.8 22.1 10.7 14.5 6.9 21.4 21.2 27.6 16.6 6.5 20.1 10.5 24.0 11.9 9.2 11.8 21.5 17.7 11.3 28.9 6.9 24.6 26.8 9.6 11.7 10.2 16.1 25.6 13.0 21.0 22.0 13.7 16.5 18.2 38.0 16.9 20.4 23.7 19.2 28.2 34.2 27.3 30.4 17.2 26.3 26.0 29.9 8.2 25.3 19.1 27.2 35.5 22.7 17.2 18.1 15.5 22.3 13.4 11.6 16.9 9.9 20.9 17.3 17.9 10.9 5.1 5.4 2.9 3.3 2.6 5.1 16.0 11.4 3.5 9.8 5.2 5.0 5.6 5.6 3.5 3.6 0.0 5.4 3.7 3.5 4.5 22.0 3.0 2.9 0.0 7.5 5.5 6.8 4.4 3.7 4.3 3.3 9.0 2.6 4.1 7.1 2.9 5.3 7.9 4.9 0.0 5.2 6.1 5.3 3.3 5.1 11.4 3.7 5.7 RBM46 "CT68, MGC27016" ENSG00000151962 "RNA binding motif protein 46" Q8TBY0 4 154781213-154828813 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 34.5" "Group enriched" "Detected in some" 13 "Spermatocytes: 74.4;Spermatogonia: 75.5" "Cancer enriched" "Detected in single" 15 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 2.7;SuSa: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079488 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA079488: " "unprognostic (4.79e-1)" "unprognostic (1.14e-2)" "unprognostic (3.23e-1)" "unprognostic (1.59e-2)" "unprognostic (3.33e-3)" "unprognostic (1.13e-1)" "unprognostic (8.11e-2)" "unprognostic (2.24e-2)" "unprognostic (2.99e-7)" "unprognostic (4.86e-2)" "unprognostic (7.31e-2)" "unprognostic (4.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 5.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 74.4 75.5 0.0 0.0 0.0 0.0 0.0 RBMS2 SCR3 ENSG00000076067 "RNA binding motif single stranded interacting protein 2" Q15434 12 56521929-56596196 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039225, HPA058784" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA039225: AB_10963056, HPA058784: AB_2683819" "unprognostic (1.35e-1)" "unprognostic (5.31e-2)" "unprognostic (2.61e-1)" "unprognostic (5.29e-2)" "unprognostic (9.09e-2)" "unprognostic (3.19e-3)" "unprognostic (4.78e-2)" "unprognostic (1.89e-2)" "unprognostic (7.01e-2)" "unprognostic (2.80e-1)" "unprognostic (2.86e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.22e-4)" "unprognostic (2.67e-2)" "unprognostic (4.73e-2)" "unprognostic (4.06e-3)" "unprognostic (2.63e-2)" 24.5 7.2 5.7 5.8 10.0 3.6 31.3 8.5 8.7 12.2 9.9 6.0 6.1 4.7 17.5 11.9 9.3 10.4 10.4 19.3 8.6 5.1 12.4 4.4 53.1 8.0 7.5 5.2 12.6 7.5 11.5 12.1 24.8 11.4 9.6 9.6 14.3 10.3 9.8 9.3 7.5 7.5 12.9 19.2 13.2 8.0 4.8 7.4 2.7 16.5 8.1 5.3 11.7 19.2 1.1 4.9 3.0 8.3 2.1 2.3 1.5 11.7 9.8 4.2 6.1 10.4 10.0 4.3 14.9 15.4 11.5 10.1 7.7 20.9 0.2 17.8 15.1 4.5 8.5 3.9 23.7 12.9 3.9 3.1 1.4 7.6 2.3 6.7 1.7 2.8 8.9 6.0 11.9 14.1 13.4 21.1 2.5 0.7 2.9 19.4 1.5 1.6 1.9 2.5 0.0 3.6 0.9 4.7 0.2 14.2 2.8 0.4 3.2 17.3 6.3 2.1 9.9 6.7 3.1 32.2 7.2 15.3 3.9 3.5 2.6 1.1 0.8 2.6 0.4 10.0 1.0 8.3 2.6 1.6 2.6 1.7 0.6 0.7 2.3 4.9 1.1 1.8 1.2 3.0 2.1 0.6 1.3 0.9 1.5 5.7 10.0 8.5 8.7 8.6 5.1 7.5 5.2 11.4 7.4 38.7 15.6 0.0 8.0 3.3 4.1 6.7 15.3 6.7 17.0 12.2 9.8 17.8 1.7 19.9 9.7 41.2 4.1 0.0 14.6 31.2 7.2 11.1 8.1 1.0 9.3 7.9 5.2 47.9 21.6 17.0 16.1 7.3 0.0 2.8 6.9 6.1 28.5 11.2 23.3 9.1 1.6 25.8 8.3 0.7 1.1 1.8 19.8 0.9 6.6 11.5 RCHY1 "ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363" ENSG00000163743 "Ring finger and CHY zinc finger domain containing 1" Q96PM5 4 75479037-75514764 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030338, HPA030339" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA030338: , HPA030339: AB_10603232" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "prognostic favorable (9.09e-4)" "unprognostic (1.90e-1)" "unprognostic (3.45e-3)" "unprognostic (1.19e-2)" "unprognostic (7.87e-3)" "unprognostic (5.82e-2)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" "unprognostic (7.45e-3)" "unprognostic (4.60e-2)" "prognostic favorable (3.62e-5)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "unprognostic (1.83e-1)" "prognostic favorable (7.89e-5)" 8.8 12.1 15.7 9.9 20.1 15.6 17.8 20.7 16.8 10.2 12.7 9.8 8.7 9.0 11.0 7.5 8.4 12.9 7.2 17.6 14.1 16.2 17.1 12.5 10.4 12.2 15.9 15.7 16.2 10.6 14.9 13.0 10.5 17.1 12.0 14.2 7.7 12.3 11.3 29.7 5.9 9.2 12.4 16.7 12.2 10.3 13.4 15.4 14.9 20.3 8.0 12.7 9.7 12.1 4.4 7.4 18.9 8.8 4.6 7.4 4.3 6.1 3.2 9.5 8.9 10.0 8.8 5.4 4.1 9.7 8.6 10.2 8.7 7.6 10.2 7.9 5.9 8.5 3.7 24.1 7.3 13.1 8.3 7.9 13.2 6.0 11.1 8.6 17.8 7.3 8.1 9.2 9.9 9.3 10.4 17.3 13.3 12.2 10.4 20.0 9.9 16.3 7.2 15.8 16.8 5.6 8.8 22.4 8.7 13.4 10.5 14.7 8.1 6.8 16.0 17.7 10.9 9.0 8.1 6.8 5.7 5.6 5.0 6.9 11.1 7.9 14.5 6.9 12.7 8.9 18.9 8.8 8.5 4.3 5.2 7.4 4.4 5.3 5.0 7.4 2.2 3.9 5.5 3.7 4.6 4.7 3.8 5.2 4.3 15.7 20.1 20.7 16.8 14.1 16.2 15.9 15.7 17.1 15.4 17.9 6.4 18.7 28.1 36.1 36.0 49.4 12.7 6.7 7.9 22.7 19.6 28.8 58.0 26.3 26.2 18.6 15.4 0.0 19.8 19.5 23.5 31.2 4.7 21.3 16.6 22.3 13.3 23.9 33.0 39.2 20.8 22.4 27.0 14.4 23.7 22.1 21.3 24.6 23.7 44.0 19.0 32.3 22.7 60.0 42.9 27.0 28.3 34.8 27.1 23.7 RCOR2 ENSG00000167771 "REST corepressor 2" Q8IZ40 11 63911221-63916844 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.6" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 18.1;NTERA-2: 23.4;SCLC-21H: 36.7;SH-SY5Y: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021638 Uncertain Approved Nucleoplasm,Vesicles,Midbody Yes NA Nucleoplasm "Vesicles, Midbody" "HPA021638: AB_10960885" "unprognostic (1.96e-2)" "unprognostic (1.15e-1)" "unprognostic (4.10e-2)" "unprognostic (1.98e-3)" "unprognostic (3.10e-2)" "unprognostic (5.86e-2)" "unprognostic (2.33e-4)" "unprognostic (8.64e-2)" "unprognostic (1.46e-1)" "unprognostic (4.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-3)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.51e-1)" "unprognostic (9.93e-2)" "unprognostic (6.06e-3)" 0.8 1.4 3.3 0.7 8.0 0.3 0.7 9.3 16.6 3.0 1.4 3.4 0.0 2.0 3.5 2.6 1.2 3.7 1.6 5.9 4.0 2.6 0.7 0.4 1.0 0.3 2.4 3.8 5.2 1.4 3.2 5.0 1.8 1.8 1.7 1.7 3.3 2.3 1.7 3.1 0.6 1.6 2.5 2.2 0.5 1.2 7.0 2.5 4.1 0.6 0.6 0.3 2.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.1 1.2 0.3 1.5 5.4 0.1 0.3 0.2 0.6 0.7 0.1 0.1 0.2 0.4 0.3 0.2 7.9 0.0 0.2 0.2 1.0 0.2 0.1 5.8 3.0 0.0 0.1 1.8 0.0 0.3 0.0 0.0 0.1 2.4 0.9 0.0 0.0 1.6 1.6 6.4 23.4 2.3 0.0 5.8 1.0 0.5 0.0 0.0 36.7 24.4 0.1 1.6 0.9 4.6 1.3 2.2 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 8.0 9.3 11.0 4.0 2.6 2.4 3.8 1.8 2.5 0.0 0.0 0.0 0.0 0.0 15.7 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.2 3.7 0.5 0.0 0.0 0.0 0.2 3.2 1.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.9 0.3 0.0 0.4 0.0 2.1 0.0 0.2 0.7 2.6 0.3 0.7 0.0 1.1 0.0 RDH8 "PRRDH, SDR28C2" ENSG00000080511 "Retinol dehydrogenase 8 (all-trans)" 19 10013249-10022279 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "retina: 29.4" "Cell type enhanced" "Detected in some" 28 "Bipolar cells: 33.9;Cone photoreceptor cells: 51.1;Early spermatids: 58.4;Rod photoreceptor cells: 203.6" "Group enriched" "Detected in some" 8 "melanoma: 2.2;stomach cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.9;SK-MEL-30: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA064473 Approved "Nucleoplasm,Midbody ring,Cytosol" NA NA Nucleoplasm "Midbody ring, Cytosol" "HPA064473: " "unprognostic (4.12e-1)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (9.98e-3)" "unprognostic (4.58e-3)" "unprognostic (2.66e-1)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (3.86e-1)" "unprognostic (2.63e-1)" 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 2.9 0.8 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 0.3 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.0 58.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.4 0.0 203.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 RERG MGC15754 ENSG00000134533 "RAS like estrogen regulated growth inhibitor" Q96A58 12 15107783-15348675 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 73.6" "Cell type enhanced" "Detected in many" 10 "Sertoli cells: 90.5;Smooth muscle cells: 84.3" "Cancer enhanced" "Detected in all" "breast cancer: 19.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "myeloid DC: 1.5" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "AN3-CA: 8.2;BEWO: 18.8;T-47d: 36.0;U-2 OS: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041387 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA041387: AB_10796669" "unprognostic (5.33e-2)" "unprognostic (1.05e-1)" "unprognostic (7.72e-2)" "prognostic unfavorable (7.56e-4)" "unprognostic (8.72e-2)" "unprognostic (9.42e-3)" "unprognostic (2.47e-1)" "unprognostic (2.38e-2)" "unprognostic (1.85e-3)" "unprognostic (2.76e-2)" "unprognostic (5.07e-2)" "unprognostic (2.69e-1)" "unprognostic (7.16e-3)" "unprognostic (2.61e-3)" "unprognostic (3.30e-2)" "unprognostic (3.50e-1)" "unprognostic (2.58e-2)" 12.6 21.9 3.5 8.2 23.9 0.2 22.8 0.8 9.3 31.9 14.5 0.8 24.6 2.0 73.6 43.2 7.3 29.0 6.7 6.0 4.2 4.8 19.5 1.3 7.8 2.0 4.3 4.1 23.6 5.1 0.9 0.9 15.4 17.6 12.6 4.6 2.9 6.0 38.9 3.5 4.2 7.4 40.3 2.3 15.2 9.8 11.7 3.5 0.0 2.6 2.8 1.8 15.7 10.6 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.1 8.2 3.4 0.2 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.3 0.0 3.3 0.0 2.6 0.0 1.1 0.4 0.5 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.7 0.3 0.1 0.1 0.9 0.0 0.5 0.0 0.0 0.1 3.2 0.1 0.0 1.2 1.3 1.4 0.0 0.6 36.0 0.0 0.0 0.5 12.1 0.2 0.1 0.1 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 23.9 0.8 9.3 4.2 4.8 4.3 4.1 17.6 3.5 0.0 2.1 0.0 7.7 3.4 1.0 0.7 5.1 0.0 5.7 7.0 0.0 10.8 13.3 6.3 15.0 2.2 0.0 0.0 9.0 11.7 23.8 2.4 0.0 0.0 1.8 3.2 1.7 1.8 0.0 13.1 20.4 2.3 6.8 0.0 0.0 6.0 1.6 0.0 30.1 20.9 0.6 90.5 84.3 7.9 14.5 4.8 11.7 0.0 0.0 4.2 RETREG3 "DKFZp686B1036, FAM134C, FLJ33806" ENSG00000141699 "Reticulophagy regulator family member 3" Q86VR2 17 42579513-42610623 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 28.0;Collecting duct cells: 29.6;Exocrine glandular cells: 21.8;Pancreatic endocrine cells: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016492 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA016492: AB_1853027" "unprognostic (6.79e-2)" "unprognostic (1.29e-2)" "unprognostic (2.78e-1)" "prognostic favorable (1.61e-4)" "unprognostic (5.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.53e-2)" "unprognostic (2.21e-1)" "unprognostic (2.61e-1)" "unprognostic (2.58e-2)" "unprognostic (1.00e-2)" "unprognostic (2.51e-1)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.24e-1)" "unprognostic (5.68e-1)" "unprognostic (9.64e-3)" "unprognostic (5.43e-2)" 23.2 17.4 11.9 15.8 15.6 5.8 16.3 23.1 21.9 17.0 18.8 13.2 15.5 13.1 25.4 20.9 21.6 15.0 20.8 10.0 11.2 12.3 16.0 28.7 16.2 19.0 11.3 9.8 17.4 43.2 19.6 16.5 29.4 13.7 19.4 16.1 32.5 24.6 14.1 18.5 31.1 17.5 15.7 7.8 24.0 17.1 27.2 8.5 29.9 17.8 16.7 26.3 14.8 17.1 14.1 7.8 22.6 11.4 13.7 27.8 16.6 6.6 20.6 9.0 14.7 23.3 13.0 13.0 9.5 12.9 11.3 13.3 9.7 14.3 14.6 13.4 15.4 11.6 26.0 11.6 14.2 11.0 15.6 11.1 5.9 12.6 17.2 16.0 10.1 15.3 19.8 19.6 12.4 12.6 12.6 12.1 10.8 12.1 14.5 8.9 11.5 14.8 14.8 5.7 12.5 5.1 8.1 14.1 14.9 12.9 21.4 16.3 11.2 10.2 8.3 14.4 17.4 23.7 7.9 15.3 12.3 7.6 12.1 9.0 25.1 29.8 13.0 11.2 6.5 9.3 22.6 8.0 17.7 24.2 10.0 21.2 13.0 20.0 23.0 7.8 14.1 19.8 22.2 7.2 13.7 11.4 7.7 27.8 16.6 11.9 15.6 23.1 21.9 11.2 12.3 11.3 9.8 13.7 8.5 23.8 28.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 11.4 29.6 0.0 17.6 6.6 15.5 0.0 0.0 0.0 0.0 21.8 13.6 0.0 0.0 7.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 12.6 0.0 0.0 25.9 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 RFX2 FLJ14226 ENSG00000087903 "Regulatory factor X2" P48378 19 5993164-6199572 "Predicted intracellular proteins, Transcription factors" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 51.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 120.5;Early spermatids: 120.3;Late spermatids: 146.0;Spermatocytes: 95.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "neutrophil: 18.3" "Lineage enriched" "Detected in many" 9 "granulocytes: 18.3" "Cell line enhanced" "Detected in many" "HMC-1: 16.3;SCLC-21H: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048969 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA048969: AB_2680577" "unprognostic (1.31e-1)" "prognostic favorable (2.80e-4)" "unprognostic (6.72e-2)" "prognostic favorable (2.67e-4)" "unprognostic (1.37e-1)" "unprognostic (4.15e-2)" "unprognostic (1.22e-2)" "unprognostic (1.12e-3)" "unprognostic (1.86e-2)" "unprognostic (3.84e-2)" "prognostic favorable (7.36e-4)" "unprognostic (3.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" 6.7 2.0 8.4 5.3 9.4 8.6 6.4 8.3 7.0 6.9 11.3 7.2 0.7 4.1 15.7 7.0 9.0 22.0 6.4 5.4 9.5 3.6 1.9 2.5 10.0 2.1 4.4 4.0 7.2 5.3 2.9 12.9 2.2 9.9 4.1 2.6 3.1 2.4 3.3 2.5 6.6 5.7 14.8 9.0 2.1 5.9 51.5 7.5 4.1 3.0 12.1 3.1 8.7 5.3 0.3 1.6 18.3 2.0 0.5 0.5 0.6 4.0 3.3 5.3 10.3 2.8 1.6 3.1 2.6 3.6 2.2 3.5 1.4 5.1 4.6 2.8 3.4 4.8 6.4 1.3 5.2 3.0 1.1 0.8 7.2 3.3 1.4 3.2 3.1 16.3 1.9 4.5 4.9 2.6 2.7 3.3 6.4 4.6 0.2 2.2 2.0 6.2 4.3 1.4 5.6 2.0 1.7 3.2 0.5 2.8 7.9 20.1 2.5 2.5 2.0 1.4 0.6 3.4 3.5 4.8 0.9 4.6 3.6 2.6 6.7 2.2 2.6 2.8 11.6 1.9 0.0 2.0 0.8 0.1 0.4 0.0 0.3 0.4 0.3 1.6 0.1 0.4 0.5 18.3 0.5 1.1 0.0 0.0 0.6 8.4 9.4 8.3 7.0 9.5 3.6 4.4 4.0 9.9 7.5 23.8 40.1 2.2 23.8 23.5 3.3 7.2 15.3 120.5 40.9 3.5 2.0 5.2 3.3 3.9 120.3 9.9 3.0 0.0 1.5 5.4 9.7 5.5 44.0 2.0 7.0 0.0 13.2 6.7 8.7 146.0 7.5 13.6 6.8 5.4 4.4 5.5 2.3 1.5 3.9 1.5 3.6 25.8 14.6 95.0 13.0 19.3 4.7 4.9 5.2 17.3 RGL1 RGL ENSG00000143344 "Ral guanine nucleotide dissociation stimulator like 1" Q9NZL6 1 183636085-183928531 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ito cells: 46.1;Kupffer cells: 85.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 5.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 18.6;HSkMC: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019788 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA019788: AB_1856215" "unprognostic (3.08e-1)" "unprognostic (5.25e-3)" "unprognostic (8.73e-2)" "unprognostic (1.24e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.49e-5)" "prognostic favorable (4.32e-4)" "unprognostic (1.12e-1)" "unprognostic (6.34e-2)" "unprognostic (5.77e-3)" "unprognostic (4.59e-2)" "unprognostic (2.63e-3)" "unprognostic (4.87e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (2.88e-2)" 22.1 15.7 22.1 16.9 24.8 1.5 19.7 14.2 23.2 18.1 9.9 25.5 8.8 7.9 17.4 11.5 9.9 14.4 20.3 15.0 21.5 15.0 25.7 14.3 18.4 17.4 18.2 16.3 18.7 6.3 10.5 9.7 14.2 19.1 12.5 11.9 21.0 7.8 11.1 3.0 8.4 9.4 19.8 19.6 37.5 7.6 13.0 20.4 1.7 9.1 2.9 8.9 18.1 12.6 0.0 2.4 0.2 5.2 0.0 1.1 1.2 0.1 0.7 13.7 2.1 18.6 8.6 13.9 6.3 10.6 2.9 3.6 6.1 0.4 0.1 5.9 4.4 2.2 0.3 0.9 1.6 2.8 0.2 1.0 0.1 1.4 6.2 5.0 0.2 0.7 29.2 0.3 7.3 1.7 13.7 10.6 1.4 0.0 10.1 6.0 0.0 1.4 0.1 4.9 0.4 0.4 11.8 0.9 12.0 0.8 3.8 1.7 4.1 1.9 2.1 1.0 4.6 0.1 0.1 7.7 4.1 1.6 12.8 3.4 1.0 0.2 0.0 4.3 0.1 11.3 0.0 2.1 0.0 0.2 5.2 0.4 0.0 0.8 0.0 2.4 0.0 1.1 0.6 0.2 0.0 1.8 0.0 0.6 1.2 22.1 24.8 14.2 21.9 21.5 15.0 18.2 16.3 19.1 20.4 8.9 10.5 2.2 2.1 7.2 2.4 7.5 5.1 16.0 11.4 5.2 0.0 3.9 5.0 2.6 10.2 13.6 2.1 0.0 0.8 1.7 10.8 3.3 3.5 2.1 33.6 7.9 0.0 46.1 85.8 11.8 12.0 15.6 5.0 1.0 0.8 26.6 0.8 0.0 19.4 23.7 1.9 25.8 4.7 1.6 2.7 4.1 4.3 0.5 0.4 1.4 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 118.6;Suprabasal keratinocytes: 96.1;Urothelial cells: 169.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA054646: AB_2682555, HPA067421: AB_2685836" "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 4.7 4.4 20.7 4.1 22.0 2.3 4.4 10.2 37.2 5.4 2.9 10.2 1.5 5.3 6.4 5.6 13.5 7.5 4.4 4.7 13.4 5.6 4.4 6.7 6.5 3.4 12.3 16.3 8.9 3.1 3.1 6.1 4.1 9.4 6.8 2.2 3.1 6.5 5.7 6.8 20.6 4.6 3.0 18.9 4.1 3.2 5.5 9.9 4.3 3.8 3.4 3.6 5.5 7.9 1.0 1.5 1.6 3.9 0.4 1.3 0.7 4.0 5.1 10.3 7.4 3.5 2.7 4.3 4.3 3.5 4.5 3.3 4.1 2.4 1.0 2.7 3.8 6.6 3.9 2.0 13.9 1.5 0.1 1.6 0.4 2.9 10.0 3.1 0.3 5.7 2.3 9.5 2.3 3.2 4.1 9.9 3.6 4.7 0.2 4.1 3.4 0.7 10.8 4.9 2.3 4.9 10.2 4.0 3.3 2.3 12.0 11.7 12.0 2.7 1.9 9.1 2.6 4.7 6.9 7.4 8.8 5.8 1.8 4.6 5.1 4.0 2.3 5.1 6.0 6.2 1.0 1.2 0.3 0.9 3.9 0.3 0.2 0.8 0.5 1.5 1.0 1.3 0.5 1.6 0.4 3.7 0.8 0.6 0.7 20.7 22.0 10.2 37.2 13.4 5.6 12.3 16.3 9.4 9.9 6.0 8.3 0.5 118.6 75.0 19.0 7.5 15.3 29.4 20.5 5.2 27.5 5.3 3.3 9.0 3.8 21.1 5.1 0.0 9.2 1.0 10.0 34.2 13.9 22.7 19.8 9.5 14.3 25.8 6.1 4.2 13.8 19.0 16.9 5.4 9.9 38.9 11.1 0.0 7.4 18.1 18.7 0.0 8.8 20.2 14.9 96.1 5.6 4.5 8.0 169.4 RGS6 ENSG00000182732 "Regulator of G protein signaling 6" P49758 14 71932439-72566529 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8" "Group enriched" "Detected in some" 9 "Early spermatids: 155.9;Late spermatids: 221.8" "Group enriched" "Detected in some" 7 "glioma: 3.1;thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.6;T-reg: 1.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HEL: 8.3;Karpas-707: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003067 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA003067: AB_1079807" "unprognostic (7.18e-2)" "unprognostic (7.78e-2)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (5.61e-2)" "unprognostic (3.80e-2)" "unprognostic (1.24e-4)" "unprognostic (7.83e-2)" "unprognostic (2.03e-1)" "unprognostic (8.17e-2)" "unprognostic (1.30e-1)" "unprognostic (2.06e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-2)" "unprognostic (8.06e-3)" "unprognostic (2.10e-1)" "unprognostic (3.68e-2)" 6.9 0.8 8.6 1.1 11.1 2.0 4.9 4.0 18.0 7.9 1.8 2.8 0.3 0.8 2.7 4.2 1.0 3.6 1.9 15.7 3.7 7.5 3.3 0.6 1.7 0.5 15.4 9.3 2.3 0.6 10.9 2.6 4.6 20.8 0.7 1.8 1.3 1.3 2.5 1.7 1.4 1.4 2.2 5.2 1.5 0.8 13.9 2.4 0.0 8.5 0.3 1.0 1.1 1.3 0.5 0.4 1.6 0.2 0.6 1.2 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 30.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.6 0.0 0.4 1.2 4.1 8.6 11.1 4.0 18.0 3.7 7.5 15.4 9.3 20.8 2.4 0.0 0.0 0.0 0.0 0.2 1.4 19.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 155.9 0.7 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 221.8 1.7 0.0 0.0 8.2 0.0 0.0 0.0 0.0 7.1 0.1 0.4 12.9 20.2 1.2 1.0 0.1 0.7 0.0 0.0 0.4 RHOJ "ARHJ, FLJ14445, RASL7B, TCL" ENSG00000126785 "Ras homolog family member J" Q9H4E5 14 63204114-63293219 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 18 "Endothelial cells: 65.7;Ito cells: 34.4;Peritubular cells: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.6;HUVEC TERT2: 90.5;TIME: 24.0;WM-115: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003050 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA003050: AB_1079812" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (4.37e-2)" "unprognostic (2.42e-1)" "unprognostic (6.71e-2)" "unprognostic (1.77e-2)" "unprognostic (2.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.19e-1)" "unprognostic (3.04e-3)" "unprognostic (1.42e-2)" "unprognostic (7.07e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (3.50e-3)" "unprognostic (4.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.06e-3)" 17.0 2.9 11.4 6.4 12.0 0.2 14.3 7.3 15.8 15.1 12.0 3.4 7.9 5.8 22.8 14.7 12.4 15.6 20.0 13.0 11.3 4.6 7.3 4.0 18.6 7.0 8.0 9.8 11.9 3.6 3.3 6.5 7.3 6.8 15.9 8.8 14.8 7.2 11.8 5.8 6.0 8.4 25.3 5.4 9.4 9.4 4.7 8.5 0.0 13.1 13.9 3.9 16.9 9.2 1.2 0.9 2.6 0.8 1.4 0.6 0.1 0.0 0.0 15.6 0.0 0.0 0.0 0.0 2.5 10.5 0.9 1.5 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 8.9 90.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.2 0.0 0.0 24.0 0.0 0.2 0.2 1.4 0.0 0.0 0.0 0.0 0.0 26.0 1.0 0.8 0.6 0.5 0.4 0.3 0.7 0.4 0.4 0.2 1.2 0.6 0.6 2.6 1.4 0.2 0.9 0.2 0.1 11.4 12.0 7.3 15.8 11.3 4.6 8.0 9.8 6.8 8.5 0.0 2.2 0.0 0.2 5.3 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.4 0.4 65.7 0.0 0.0 0.7 0.0 11.6 0.5 0.0 0.0 0.1 0.0 0.0 34.4 1.0 0.5 10.9 1.7 3.3 0.0 0.0 9.1 0.1 0.0 15.2 0.0 0.2 6.5 8.0 0.1 0.4 4.3 0.1 0.0 0.0 0.5 RIF1 "FLJ10599, FLJ12870" ENSG00000080345 "Replication timing regulatory factor 1" Q5UIP0 2 151409883-151508013 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036887, HPA036888" Supported Uncertain "Nucleoplasm,Nuclear bodies,Plasma membrane" No No "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA036887: AB_2675361, HPA036888: AB_2675362" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.71e-1)" "unprognostic (4.71e-3)" "unprognostic (5.87e-2)" "unprognostic (1.79e-2)" "unprognostic (3.73e-2)" "unprognostic (1.86e-1)" "unprognostic (2.51e-2)" "unprognostic (2.84e-2)" "unprognostic (1.80e-3)" "unprognostic (4.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.41e-2)" 13.7 9.0 12.1 11.7 18.2 31.1 16.6 23.6 17.1 12.7 10.9 12.4 8.7 7.2 15.5 7.3 10.2 11.5 9.8 8.5 11.7 8.5 9.8 11.2 10.9 13.0 15.7 11.6 19.4 12.1 16.3 17.3 13.4 13.6 10.8 10.6 9.6 12.0 9.3 18.3 13.9 10.4 13.5 11.6 10.2 10.1 17.8 15.9 18.4 15.5 9.4 12.9 11.6 11.9 6.2 2.6 7.9 4.7 10.7 7.8 2.3 9.9 8.5 13.3 10.1 5.5 7.0 12.8 12.1 9.0 11.0 13.2 13.9 8.2 19.1 11.0 8.5 9.1 10.4 20.4 8.6 18.7 13.4 9.7 30.4 10.4 9.9 5.8 30.5 10.2 5.3 5.6 19.7 15.0 6.1 10.6 11.8 24.5 16.2 11.2 6.7 18.0 10.6 21.3 5.3 11.6 18.5 21.1 12.5 5.7 12.4 12.1 9.3 15.8 7.3 8.2 9.8 6.4 11.1 13.2 16.7 11.7 10.1 12.8 8.0 13.9 27.9 7.6 12.3 11.0 7.9 3.6 4.3 6.8 2.5 7.8 6.2 5.8 4.9 2.6 5.2 7.7 5.9 4.2 10.7 4.7 2.4 4.0 2.3 12.1 18.2 23.6 17.1 11.7 8.5 15.7 11.6 13.6 15.9 89.3 38.8 22.7 37.6 43.8 43.2 30.5 30.6 22.7 51.2 14.0 29.5 33.1 1.7 31.1 9.9 38.7 14.2 0.0 18.7 32.2 38.4 39.1 32.4 17.1 19.6 44.5 24.0 27.6 27.0 9.9 40.6 34.9 28.7 29.7 28.7 37.8 25.0 23.5 32.2 9.5 42.4 84.1 40.1 87.8 126.0 36.4 34.2 27.4 28.4 37.2 RILPL1 FLJ39378 ENSG00000188026 "Rab interacting lysosomal protein like 1" Q5EBL4 12 123470054-123533718 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041314 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041314: AB_10795587" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (3.71e-2)" "unprognostic (5.36e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-3)" "unprognostic (1.94e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (2.30e-2)" "unprognostic (8.30e-2)" "unprognostic (4.25e-2)" "unprognostic (2.98e-1)" "unprognostic (2.32e-1)" "unprognostic (6.07e-3)" "unprognostic (2.81e-1)" 6.1 5.7 9.9 3.5 12.3 3.0 3.7 5.2 11.3 4.8 4.7 12.6 4.4 2.1 6.6 5.0 4.8 5.0 4.3 43.8 9.6 7.5 3.8 3.0 5.5 2.3 21.1 5.8 7.2 3.2 5.7 3.6 7.1 11.1 6.2 2.2 4.9 8.0 7.8 66.2 6.2 2.7 9.8 14.4 3.8 3.0 2.9 15.1 0.3 8.2 9.7 1.9 4.7 5.3 1.6 1.2 4.6 1.2 1.2 2.0 0.7 5.9 8.4 7.6 5.9 8.6 8.1 8.0 10.8 6.1 5.9 5.3 5.2 1.4 0.3 5.4 10.5 4.3 6.5 5.6 5.2 2.4 6.1 10.3 0.8 5.4 7.6 15.1 0.3 2.3 9.2 10.3 6.6 9.6 14.8 6.0 1.1 4.7 0.4 5.9 9.9 0.6 1.9 5.6 1.7 8.9 1.0 4.2 0.3 4.2 6.3 1.2 7.1 5.8 5.1 12.9 4.4 6.7 0.2 11.8 7.8 3.9 11.2 6.8 1.3 0.6 0.2 8.0 0.1 4.8 1.4 1.0 0.7 0.9 0.5 0.8 0.9 1.0 0.8 0.3 1.6 2.0 1.6 4.6 1.2 1.2 1.2 0.9 0.7 9.9 12.3 5.2 9.9 9.6 7.5 21.1 5.8 11.1 15.1 35.7 13.2 0.0 4.3 4.0 13.4 9.2 5.1 5.3 11.4 10.4 5.9 7.9 1.7 1.8 1.3 4.6 0.0 0.0 1.8 5.2 5.6 3.2 1.1 1.3 4.4 22.3 0.0 10.4 1.3 0.9 14.4 1.0 5.0 1.0 1.0 20.0 2.1 0.0 7.8 1.8 6.2 6.5 6.1 0.9 2.3 3.3 7.8 1.3 0.5 2.6 RIMBP2 "KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2" ENSG00000060709 "RIMS binding protein 2" O15034 12 130396137-130716281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;parathyroid gland: 49.1;pituitary gland: 42.7" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 19.7;Cone photoreceptor cells: 29.5;Intestinal endocrine cells: 72.5;Rod photoreceptor cells: 13.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive B-cell: 2.7" "Lineage enriched" "Detected in single" 28 "B-cells: 2.7" "Group enriched" "Detected in some" 6 "SCLC-21H: 17.6;SH-SY5Y: 34.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041494, HPA044114" Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA041494: , HPA044114: AB_2678815" "unprognostic (4.15e-4)" "unprognostic (9.77e-3)" "unprognostic (1.20e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-3)" "unprognostic (3.63e-1)" "unprognostic (1.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (6.82e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.86e-1)" "unprognostic (6.41e-3)" "unprognostic (5.27e-2)" "unprognostic (2.07e-1)" "unprognostic (1.03e-1)" "unprognostic (4.73e-2)" 0.9 11.9 14.1 1.1 13.0 0.6 0.6 1.1 24.7 6.1 1.5 1.6 0.0 2.5 2.5 2.4 0.8 6.6 1.1 0.4 15.3 11.0 2.8 0.6 0.7 0.5 5.6 12.9 2.1 2.3 49.1 42.7 0.4 4.9 1.3 1.8 4.1 0.6 1.4 0.5 2.4 2.3 2.3 5.6 1.1 5.2 2.3 1.6 0.0 0.9 0.0 0.5 0.8 0.7 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.2 4.2 0.0 0.0 17.6 34.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 13.0 1.1 24.7 15.3 11.0 5.6 12.9 4.9 1.6 0.0 0.0 0.0 0.0 1.8 19.7 0.8 0.0 1.4 0.0 0.0 29.5 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 9.5 72.5 0.0 0.0 1.7 0.9 0.0 0.0 0.0 1.2 3.1 0.1 0.0 0.7 0.0 13.7 0.0 0.0 1.1 1.2 0.5 0.0 0.0 0.6 0.0 RIMS3 "NIM3, RIM3" ENSG00000117016 "Regulating synaptic membrane exocytosis 3" Q9UJD0 1 40620679-40665657 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.7" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 10.7;Late spermatids: 23.5;Muller glia cells: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 1.8;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 9 "dendritic cells: 4.6;T-cells: 1.8" "Cell line enhanced" "Detected in many" "Daudi: 37.3;JURKAT: 13.2;SH-SY5Y: 17.7;U-87 MG: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055285 Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA055285: AB_2682771" "unprognostic (3.51e-3)" "unprognostic (7.18e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-4)" "unprognostic (3.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.44e-5)" "unprognostic (2.41e-1)" "unprognostic (1.53e-1)" "unprognostic (2.87e-1)" "unprognostic (2.54e-1)" "unprognostic (7.93e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.25e-2)" "unprognostic (3.11e-2)" "unprognostic (2.19e-2)" 1.3 7.2 13.6 2.2 19.2 3.7 3.1 21.5 47.7 1.4 3.4 3.4 0.0 1.1 3.0 2.2 2.9 2.1 1.3 1.5 7.8 17.4 1.4 0.7 3.1 2.0 7.4 22.3 2.5 1.1 4.0 0.5 3.8 4.9 3.2 3.8 2.0 2.0 4.1 0.6 2.7 1.7 4.8 3.4 1.7 2.5 3.1 4.4 0.7 2.8 0.0 2.8 1.7 1.0 0.1 4.6 0.1 0.3 0.1 1.8 0.1 1.9 0.7 2.9 3.1 0.1 0.0 0.4 0.0 0.0 0.5 0.6 0.3 0.6 37.3 0.0 0.0 1.4 0.3 1.9 0.3 0.3 6.4 0.9 2.1 0.2 1.0 0.1 0.3 1.7 0.0 1.5 0.1 0.1 0.1 0.1 13.2 1.8 1.4 0.0 3.4 5.5 0.2 1.8 0.3 0.2 2.5 2.6 6.9 0.5 0.5 10.0 17.7 0.4 1.8 1.2 4.0 0.4 10.4 0.0 0.3 3.0 0.0 0.5 0.3 2.7 8.2 16.3 0.6 0.3 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.3 4.6 0.4 0.1 13.6 19.2 21.5 47.7 7.8 17.4 7.4 22.3 4.9 4.4 6.0 0.0 0.0 0.2 0.5 6.3 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 10.7 0.1 1.7 0.0 1.3 0.1 0.3 0.4 1.1 0.0 2.4 4.8 0.0 0.0 2.1 23.5 0.0 1.1 0.0 1.0 1.9 12.8 2.3 0.8 0.7 0.3 0.6 0.0 2.2 3.3 1.1 0.1 0.2 0.0 0.6 0.1 RLBP1 CRALBP ENSG00000140522 "Retinaldehyde binding protein 1" P12271 15 89209869-89221751 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Transport, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "retina: 164.1" "Cell type enriched" "Detected in some" 43 "Muller glia cells: 2424.2" "Group enriched" "Detected in some" 30 "glioma: 3.7;melanoma: 7.4" "Group enriched" "Detected in many" 4 "amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7" "Group enriched" "Detected in some" 7 "basophil: 3.3;neutrophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Cell line enriched" "Detected in single" 48 "SK-MEL-30: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042051, HPA044083" Enhanced Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042051: AB_2732495, HPA044083: AB_2678802" "unprognostic (3.19e-2)" "unprognostic (2.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (5.21e-2)" "unprognostic (3.17e-1)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.78e-1)" "unprognostic (1.13e-1)" "unprognostic (8.42e-2)" 0.2 0.7 6.9 0.6 10.6 0.6 0.2 0.6 11.5 0.2 0.8 0.3 0.1 0.9 0.2 1.0 0.3 0.2 0.3 0.2 3.7 1.3 0.2 0.2 0.3 0.3 1.6 0.6 0.2 0.2 0.2 1.7 0.3 0.4 0.2 0.8 164.1 0.2 0.2 0.5 0.3 0.6 0.5 0.5 0.3 0.2 1.1 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.0 3.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 6.9 10.6 0.6 7.0 3.7 1.3 1.6 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 17.2 0.3 0.0 0.0 0.0 0.0 37.3 3.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 2424.2 0.0 0.0 0.0 0.0 56.9 0.0 0.0 0.1 0.0 0.0 16.7 0.0 0.0 0.0 RNF121 FLJ11099 ENSG00000137522 "Ring finger protein 121" Q9H920 11 71928701-71997597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046041 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA046041: AB_10965850" "unprognostic (1.36e-2)" "unprognostic (8.84e-2)" "unprognostic (9.72e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.38e-2)" "unprognostic (1.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (6.54e-2)" "unprognostic (1.85e-2)" "unprognostic (1.90e-1)" "prognostic favorable (2.72e-6)" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (2.57e-2)" "unprognostic (1.70e-1)" 9.8 14.1 18.5 14.0 14.9 6.5 14.1 18.5 16.6 12.6 13.0 12.4 22.4 18.5 17.9 26.3 10.6 14.3 10.8 13.1 11.7 11.7 20.2 16.9 9.4 8.9 12.4 13.4 15.0 15.6 24.1 19.4 18.9 12.1 13.5 13.1 15.7 18.0 19.5 19.2 11.8 18.7 14.1 10.1 10.1 12.8 16.3 13.6 8.9 15.6 8.1 15.3 11.9 10.4 5.9 6.9 8.8 5.5 5.6 7.0 5.1 4.9 10.8 11.1 8.2 10.8 8.5 7.8 9.2 9.9 14.6 15.4 21.0 11.0 4.6 8.1 10.3 14.2 11.7 12.2 11.1 15.8 6.6 7.1 7.7 10.5 10.3 8.0 6.7 6.6 8.0 9.9 15.8 9.5 15.8 26.0 7.3 11.6 4.9 12.8 11.2 4.5 7.7 7.7 22.5 11.0 5.8 23.5 4.3 16.5 9.7 7.9 8.5 11.9 10.2 16.7 12.3 11.8 4.9 16.1 10.4 9.8 6.9 7.7 6.0 5.4 5.2 9.0 4.4 9.1 8.8 4.1 4.0 5.6 5.5 7.0 5.9 4.7 4.5 3.9 2.2 5.3 5.9 2.1 5.6 3.9 6.9 3.9 5.1 18.5 14.9 18.5 16.6 11.7 11.7 12.4 13.4 12.1 13.6 6.0 14.0 12.6 8.9 7.8 15.3 7.9 12.7 6.7 4.5 19.2 19.6 28.1 6.6 23.5 3.1 4.9 16.2 23.3 28.0 22.0 10.8 9.4 6.9 12.1 12.5 9.5 9.2 8.0 5.7 2.0 12.0 10.2 10.1 17.2 10.4 17.5 24.0 9.9 11.7 16.5 17.5 19.4 9.0 21.6 17.7 5.1 26.0 12.8 8.3 8.2 RNF13 RZF ENSG00000082996 "Ring finger protein 13" O43567 3 149812708-149962139 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 72.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064784 Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA064784: AB_2685350" "unprognostic (1.27e-1)" "unprognostic (2.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (8.49e-2)" "unprognostic (4.36e-3)" "unprognostic (1.72e-1)" "unprognostic (1.25e-1)" "unprognostic (6.94e-3)" "unprognostic (1.13e-1)" "prognostic favorable (2.00e-8)" "unprognostic (2.95e-1)" "unprognostic (4.11e-2)" "unprognostic (2.17e-1)" "unprognostic (1.79e-1)" 24.0 21.3 30.6 19.0 39.4 9.8 28.5 19.9 30.4 19.0 17.7 39.9 16.2 14.3 16.8 33.7 16.8 15.9 20.4 16.4 40.5 29.7 35.8 39.2 31.7 19.6 60.9 26.8 18.1 19.6 23.5 14.9 32.4 40.7 25.5 20.3 19.5 36.1 20.9 18.0 18.4 16.3 20.4 102.2 25.5 17.0 12.5 51.2 13.3 32.1 18.8 15.9 21.4 16.5 8.8 15.7 72.4 31.5 7.8 8.5 14.6 19.7 12.3 8.3 9.5 32.8 20.1 13.9 10.9 28.2 10.6 15.8 10.8 28.4 8.2 16.0 13.4 19.5 18.8 11.1 14.0 14.9 10.0 8.1 9.9 5.7 10.5 21.8 10.6 14.1 21.2 26.6 8.9 24.2 12.8 11.7 7.9 3.1 16.7 9.4 11.1 7.6 7.0 5.5 19.1 9.6 5.5 8.9 34.8 20.5 9.2 4.4 12.7 9.0 13.6 35.2 6.8 25.9 11.2 12.2 14.4 5.8 15.2 7.0 28.4 18.7 16.9 12.1 9.9 7.7 12.9 20.3 16.6 6.8 25.2 8.5 8.8 7.6 7.6 15.7 8.3 7.3 7.5 72.4 7.8 31.5 11.2 8.3 14.6 30.6 39.4 19.9 29.2 40.5 29.7 60.9 26.8 40.7 51.2 101.3 59.5 39.3 61.2 65.4 43.7 25.6 38.2 34.8 61.4 45.4 27.5 86.4 36.5 54.3 2.2 62.6 27.6 0.0 62.0 65.2 68.3 63.5 58.9 46.6 172.6 20.6 19.4 77.3 168.9 4.7 70.5 155.4 97.8 42.3 26.4 85.9 48.5 29.6 82.7 59.8 32.2 90.5 50.9 19.7 29.6 63.2 43.8 51.0 24.3 45.5 RNF145 FLJ31951 ENSG00000145860 "Ring finger protein 145" Q96MT1 5 159157409-159210053 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036562 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA036562: AB_10696657" "unprognostic (1.57e-1)" "unprognostic (9.02e-3)" "unprognostic (4.11e-2)" "unprognostic (3.88e-2)" "unprognostic (3.24e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (1.64e-6)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.54e-1)" "unprognostic (3.53e-1)" "unprognostic (1.67e-1)" "unprognostic (8.92e-3)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" 13.3 20.1 23.9 15.6 23.0 7.1 24.1 30.2 27.3 11.3 11.7 5.7 5.3 4.7 12.6 13.6 26.7 11.4 20.8 16.8 22.0 8.4 8.2 6.1 30.7 36.3 17.5 9.7 14.1 6.0 26.9 29.0 21.9 18.5 11.8 12.6 10.2 17.8 14.8 5.5 14.9 11.0 13.8 12.4 12.7 11.2 7.9 18.0 12.4 14.3 8.0 19.6 19.3 15.7 8.9 2.7 14.4 2.6 2.1 6.2 1.3 20.3 20.1 31.0 37.2 32.8 14.6 6.0 16.3 28.5 15.1 24.6 6.9 16.9 7.0 29.4 14.3 28.8 26.7 24.4 21.5 26.7 28.8 8.7 14.7 22.9 5.7 14.1 9.7 14.1 9.0 38.9 14.1 20.7 21.2 14.8 17.1 14.6 27.1 14.2 0.5 11.0 3.0 13.4 6.4 10.3 14.7 13.5 14.0 20.2 7.0 11.3 20.9 16.5 17.7 26.8 22.1 12.4 8.9 15.8 17.0 15.6 13.6 28.9 6.0 8.3 6.5 19.8 12.1 36.3 2.8 2.6 14.4 3.2 2.5 3.7 8.9 4.7 3.8 1.9 4.4 6.2 4.3 9.7 2.1 2.2 2.7 5.7 1.3 23.9 23.0 30.2 27.3 22.0 8.4 17.5 9.7 18.5 18.0 104.2 213.5 76.8 93.4 109.1 103.7 10.0 79.0 48.2 106.9 34.9 55.0 2.7 16.6 63.7 22.1 50.7 48.5 46.7 99.7 20.5 58.0 100.6 68.1 16.3 39.0 108.1 52.0 127.7 90.9 29.9 42.8 54.8 62.4 223.6 41.8 63.1 90.1 51.8 48.8 8.4 48.6 45.3 49.5 14.9 33.0 86.9 9.2 73.0 57.2 150.2 RNF146 "dactylidin, dJ351K20.1, DKFZp434O1427" ENSG00000118518 "Ring finger protein 146" Q9NTX7 6 127266610-127288567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027158, HPA027209" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" Nucleoplasm "HPA027158: AB_10600772, HPA027209: AB_10602312" "unprognostic (8.22e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-1)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.37e-1)" "unprognostic (5.47e-3)" "unprognostic (1.87e-1)" "unprognostic (6.74e-2)" "prognostic favorable (5.26e-5)" "unprognostic (2.65e-2)" "prognostic favorable (7.32e-4)" "unprognostic (4.04e-2)" "unprognostic (1.29e-1)" "unprognostic (6.13e-2)" "unprognostic (2.15e-2)" 27.3 20.9 28.5 16.6 29.1 5.1 23.9 63.7 34.5 22.7 18.6 29.2 10.5 11.8 32.0 35.2 14.2 17.9 21.3 25.2 26.3 21.7 20.9 16.8 21.0 17.3 30.0 27.7 28.5 12.6 26.5 27.4 27.8 31.3 18.6 17.6 17.5 16.7 20.3 55.9 16.0 15.2 26.1 28.7 24.6 15.5 16.3 27.7 9.2 26.7 15.5 17.6 19.2 18.7 11.7 14.2 22.8 22.8 11.5 10.3 9.1 5.5 7.0 26.7 23.5 24.8 24.9 9.7 18.9 30.3 10.1 14.6 9.1 8.4 10.0 13.4 15.4 15.9 7.1 7.9 8.9 14.8 11.5 6.9 12.7 8.4 12.7 24.6 7.5 9.1 21.7 18.7 11.4 22.8 23.4 17.7 10.0 13.7 9.9 22.3 10.6 7.4 13.6 9.7 3.4 7.3 9.4 6.9 5.0 14.4 6.1 16.0 16.2 7.4 10.5 11.6 16.5 7.1 26.1 20.8 17.9 5.9 18.5 13.3 14.3 8.8 6.6 13.7 13.2 16.8 16.8 18.9 16.1 9.3 20.0 9.7 11.1 8.0 10.3 14.2 11.7 7.3 10.2 22.8 11.5 22.8 7.1 8.6 9.1 28.5 29.1 63.7 34.5 26.3 21.7 30.0 27.7 31.3 27.7 32.8 24.8 20.8 11.4 15.8 34.0 33.0 38.2 20.1 7.9 8.7 3.9 25.1 34.9 24.3 40.1 34.9 12.8 0.0 14.1 22.7 38.1 21.4 21.9 25.2 22.8 28.6 19.7 28.3 67.8 33.7 64.5 25.0 43.9 24.4 11.5 36.1 15.1 13.9 62.6 42.1 18.1 32.3 33.5 44.7 12.2 17.6 32.2 28.7 10.9 14.1 RNF166 "MGC14381, MGC2647" ENSG00000158717 "Ring finger protein 166" Q96A37 16 88696495-88706421 "Predicted intracellular proteins" "Autophagy, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.9" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 37.7;Macrophages: 37.5;T-cells: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042970 Approved "Nucleoplasm,Plasma membrane,Cytosol" No No Nucleoplasm "Plasma membrane, Cytosol" "HPA042970: AB_10796682" "unprognostic (3.01e-2)" "unprognostic (6.98e-3)" "unprognostic (3.96e-2)" "unprognostic (5.36e-3)" "unprognostic (1.23e-1)" "unprognostic (2.71e-2)" "unprognostic (6.52e-2)" "unprognostic (5.86e-2)" "unprognostic (4.88e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.04e-4)" "unprognostic (3.22e-2)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.54e-1)" "unprognostic (3.91e-2)" "unprognostic (1.28e-1)" "unprognostic (2.69e-2)" 9.2 8.1 9.2 22.8 8.9 63.9 10.5 13.7 15.3 6.7 7.2 11.2 3.7 12.0 8.1 8.3 6.4 9.1 12.3 10.0 8.6 7.3 9.6 9.7 20.8 30.5 8.9 6.5 9.7 11.4 5.3 8.5 7.5 8.4 8.9 4.9 11.0 12.1 6.0 14.8 8.2 16.0 8.3 11.1 47.2 10.9 9.2 9.1 21.6 8.8 7.8 23.8 9.7 6.7 2.0 11.8 28.7 12.5 5.5 17.1 9.7 4.2 6.8 5.3 8.4 2.6 2.2 10.1 4.3 2.8 5.1 2.3 4.6 2.7 5.1 5.6 2.5 2.9 4.7 3.1 2.8 2.0 2.6 9.2 6.9 5.0 7.7 6.9 6.8 8.8 2.6 2.7 4.0 3.3 2.8 5.3 8.7 11.5 3.8 2.1 8.3 15.9 44.6 8.7 1.8 9.1 14.9 3.3 13.2 2.3 1.9 4.9 5.5 9.8 2.0 5.3 2.7 5.8 23.3 7.3 3.8 5.7 5.7 5.1 8.6 5.0 12.4 3.4 25.9 5.3 3.0 12.5 28.7 17.1 9.1 14.8 2.0 10.4 14.8 11.8 1.9 8.7 12.5 20.4 5.5 10.5 7.3 10.5 9.7 9.2 8.9 13.7 15.3 8.6 7.3 8.9 6.5 8.4 9.1 8.9 5.1 15.7 4.7 4.2 10.1 2.4 7.6 1.4 3.4 7.0 5.9 7.4 8.3 5.2 1.1 8.0 2.0 0.0 8.0 7.5 8.2 3.6 20.7 4.0 34.7 7.9 4.7 10.4 37.7 1.8 8.6 37.5 10.1 11.8 2.7 8.9 4.6 0.0 7.4 5.6 8.6 6.5 7.1 9.4 8.6 5.1 3.1 66.8 4.1 1.3 RNF182 MGC33993 ENSG00000180537 "Ring finger protein 182" Q8N6D2 6 13924446-13980302 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.9;brain: 17.6" "Group enriched" "Detected in some" 4 "Bipolar cells: 16.5;Horizontal cells: 14.3;Muller glia cells: 15.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 37.0;RPTEC TERT1: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012309 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA012309: AB_1856349" "unprognostic (1.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.66e-5)" "unprognostic (6.16e-2)" "unprognostic (2.08e-1)" "unprognostic (9.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.71e-2)" "unprognostic (4.21e-1)" "unprognostic (6.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (9.33e-5)" "unprognostic (6.66e-3)" "unprognostic (1.33e-3)" "unprognostic (1.26e-1)" 1.2 0.7 7.6 0.6 6.2 12.9 1.2 16.6 17.6 1.2 0.7 7.5 2.0 0.8 1.6 2.5 1.0 2.7 0.9 1.0 11.0 7.3 2.6 0.5 5.7 0.8 6.8 8.5 1.1 3.6 0.5 2.0 2.9 14.3 0.9 0.6 2.2 1.9 4.7 0.9 0.8 1.1 1.0 5.1 0.5 0.6 7.0 2.9 0.0 3.0 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.8 5.3 0.0 1.8 2.3 0.3 2.7 3.7 7.5 7.3 0.1 0.0 0.0 0.0 2.9 8.2 0.0 6.2 0.0 13.8 0.0 2.0 0.1 37.0 0.0 0.0 0.0 0.0 1.2 0.0 11.6 0.1 8.7 0.1 1.5 0.2 0.0 5.2 0.0 0.0 0.9 3.0 0.0 10.3 1.5 1.3 0.4 29.7 0.0 6.4 6.1 0.2 0.0 10.4 2.0 0.0 1.0 2.8 9.2 2.0 0.1 6.1 0.0 0.0 0.0 6.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.2 16.6 12.1 11.0 7.3 6.8 8.5 14.3 2.9 0.0 0.0 0.0 0.0 0.2 16.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 14.3 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 15.3 0.1 0.0 0.0 0.5 1.2 6.5 0.8 3.0 1.9 0.0 0.2 0.0 0.0 0.0 RNF219 "C13orf7, FLJ13449" ENSG00000152193 "Ring finger protein 219" Q5W0B1 13 78614291-78659179 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034785, HPA034786" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA034785: AB_10601496, HPA034786: AB_2674331" "unprognostic (2.99e-1)" "unprognostic (1.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.60e-1)" "unprognostic (7.88e-2)" "unprognostic (1.34e-2)" "unprognostic (2.83e-3)" "unprognostic (1.50e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.84e-2)" "unprognostic (4.26e-3)" "prognostic unfavorable (4.99e-6)" "unprognostic (6.87e-2)" "unprognostic (2.01e-1)" "unprognostic (6.91e-2)" "unprognostic (2.53e-2)" 17.6 7.7 10.7 8.9 15.5 3.4 10.6 24.2 16.3 11.9 8.0 4.7 7.3 7.4 11.3 7.8 8.7 9.1 7.1 10.6 10.7 10.3 7.6 6.7 8.0 13.9 11.9 12.1 12.3 6.6 5.0 11.5 12.2 12.7 10.2 8.5 4.0 7.1 10.1 8.7 8.5 8.7 12.7 13.4 13.6 6.8 21.7 13.4 21.8 9.5 8.5 16.7 12.8 9.2 10.5 7.0 8.2 10.6 12.3 13.3 7.8 11.2 4.4 19.4 11.3 6.8 6.6 8.8 9.4 7.1 9.3 11.7 8.7 8.4 19.0 4.6 5.9 6.1 11.2 15.2 7.4 16.4 11.8 11.1 29.0 5.7 7.7 5.7 28.0 9.1 6.3 8.3 7.7 8.4 5.3 7.6 9.7 7.5 2.6 12.1 3.1 17.0 9.5 0.0 12.0 4.9 19.9 15.9 7.3 6.3 6.0 14.1 7.9 6.5 8.3 7.0 11.5 4.2 22.6 6.2 8.1 7.4 5.3 7.8 2.7 3.1 18.3 13.0 17.1 8.7 4.8 6.0 8.2 9.5 9.7 11.3 10.5 10.7 11.6 7.0 10.1 13.3 11.9 2.0 12.3 10.6 5.9 10.4 7.8 10.7 15.5 24.2 16.3 10.7 10.3 11.9 12.1 12.7 13.4 14.9 3.0 8.0 7.0 7.4 10.5 18.7 10.2 12.0 10.3 8.7 5.9 13.2 5.0 9.1 22.1 14.3 2.7 0.0 3.9 10.1 8.0 5.7 9.3 5.7 8.1 9.5 4.7 12.3 10.6 11.0 13.6 12.8 11.8 7.2 4.7 9.6 7.1 2.9 9.9 7.6 8.0 0.0 5.2 23.9 51.1 10.0 4.2 9.5 7.1 5.8 RNF25 "AO7, FLJ13906" ENSG00000163481 "Ring finger protein 25" Q96BH1 2 218663864-218672411 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036420, HPA036421" Uncertain Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Actin filaments" "HPA036420: AB_2675114, HPA036421: AB_10669604" "unprognostic (3.22e-2)" "unprognostic (7.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (3.46e-1)" "unprognostic (2.04e-3)" "unprognostic (8.82e-2)" "unprognostic (1.26e-3)" "unprognostic (2.50e-1)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.69e-2)" 13.4 12.7 13.9 11.1 16.1 6.2 13.7 13.4 27.6 17.3 13.3 17.1 9.8 4.3 16.6 16.2 12.2 16.8 11.8 17.2 13.1 16.5 13.7 15.6 11.9 12.1 12.1 11.6 17.8 13.0 19.3 14.8 17.7 15.4 14.7 9.0 15.3 13.6 17.9 16.9 15.7 10.3 16.0 10.0 12.9 11.8 18.4 9.1 15.3 16.8 12.7 16.8 14.0 11.8 13.3 8.2 23.3 11.2 14.8 15.0 13.9 5.9 7.6 6.9 8.0 10.6 6.5 7.5 6.8 17.1 23.4 21.8 12.7 4.0 4.0 5.4 14.3 12.9 5.4 8.0 13.3 10.2 4.3 10.9 5.4 5.6 12.0 13.0 4.8 5.9 14.3 12.4 21.2 14.3 6.5 12.7 15.4 9.1 6.2 15.0 17.0 5.4 5.9 11.0 4.9 8.7 7.6 4.4 5.8 14.3 6.4 7.0 7.9 5.2 5.9 10.1 5.0 7.0 8.8 7.3 13.3 6.3 5.2 9.6 5.4 4.2 6.7 11.2 6.0 8.0 23.3 10.6 14.9 13.9 10.3 12.6 11.9 13.7 13.6 8.2 13.3 15.0 11.7 8.9 14.8 11.2 7.4 11.5 13.9 13.9 16.1 13.4 27.6 13.1 16.5 12.1 11.6 15.4 9.1 0.0 0.3 4.7 4.6 5.6 7.4 3.1 5.1 5.3 2.3 1.8 7.9 11.1 13.3 10.5 10.3 5.9 6.4 0.0 11.4 8.1 7.2 3.0 6.9 6.4 11.3 4.8 1.2 9.2 5.9 3.4 6.6 4.6 8.5 10.0 4.9 7.0 10.2 8.6 12.0 11.5 4.5 25.8 6.1 14.4 11.9 5.9 8.4 10.1 4.8 3.9 RNF26 MGC2642 ENSG00000173456 "Ring finger protein 26" Q9BY78 11 119334527-119337313 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027620 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA Yes Nucleoplasm "Vesicles, Cytosol" "HPA027620: AB_1856356" "unprognostic (9.23e-3)" "unprognostic (3.54e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (3.40e-1)" "unprognostic (1.07e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (2.14e-2)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (7.24e-3)" "unprognostic (6.22e-2)" "prognostic favorable (3.45e-6)" "unprognostic (9.61e-2)" "unprognostic (3.50e-2)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.73e-4)" 19.0 21.5 13.6 15.4 21.6 25.6 16.9 18.4 38.9 19.8 22.0 17.6 14.5 20.3 31.2 15.6 26.0 24.4 19.8 15.1 17.1 13.8 22.3 28.7 17.3 17.5 15.0 16.6 25.6 18.5 31.4 14.3 27.5 27.2 19.2 18.2 20.2 20.0 28.5 17.6 19.8 21.4 27.0 14.3 19.8 24.3 27.6 13.0 26.7 20.6 14.0 21.1 25.8 18.1 13.8 14.2 7.1 15.5 9.8 16.7 16.2 15.7 17.5 16.4 19.3 16.2 12.8 17.4 17.2 18.6 20.1 15.9 29.5 33.2 14.0 23.8 20.4 30.5 28.8 23.2 25.9 12.6 16.6 12.8 36.8 8.2 24.3 12.4 15.4 15.3 13.3 13.3 25.0 22.6 13.2 15.2 21.7 17.8 22.0 13.8 34.5 14.1 16.0 16.4 18.3 22.4 14.7 16.8 11.1 12.3 11.5 11.7 11.3 13.9 17.6 4.6 16.5 39.9 12.9 10.0 24.3 16.2 12.7 15.6 5.3 8.6 0.1 8.1 26.1 18.9 7.1 15.5 3.9 16.7 14.5 11.0 9.0 12.7 14.5 14.2 13.8 14.5 12.4 1.1 9.8 14.1 8.1 6.6 16.2 13.6 21.6 18.4 38.9 17.1 13.8 15.0 16.6 27.2 13.0 3.0 6.5 9.0 12.0 6.2 9.1 0.5 28.1 2.7 7.9 10.4 2.0 31.3 5.0 17.7 3.4 7.5 10.0 0.0 15.0 54.3 13.5 11.2 7.0 19.8 18.0 4.8 13.2 8.6 9.9 4.9 13.0 8.8 1.7 12.6 10.2 9.7 11.8 10.2 16.6 10.3 7.6 6.5 10.3 12.2 8.3 7.4 20.4 9.6 14.5 8.6 RNF4 "RES4-26, SLX5, SNURF" ENSG00000063978 "Ring finger protein 4" P78317 4 2462220-2625320 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022047, HPA049356" Approved Supported "Nucleoplasm,Nuclear bodies,Microtubule ends" NA NA "Nucleoplasm, Nuclear bodies" "Microtubule ends" "HPA022047: , HPA049356: AB_2680726" "unprognostic (8.38e-3)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (9.31e-3)" "unprognostic (9.03e-3)" "prognostic unfavorable (6.38e-4)" "unprognostic (1.34e-1)" "unprognostic (6.79e-2)" "unprognostic (2.58e-1)" "unprognostic (5.64e-2)" "unprognostic (1.93e-2)" "unprognostic (6.40e-2)" "unprognostic (4.70e-2)" "unprognostic (8.67e-2)" "unprognostic (1.54e-1)" 28.6 29.1 25.4 32.2 39.4 36.4 28.6 35.9 50.3 28.2 25.1 34.8 28.4 27.0 32.2 28.0 30.3 27.8 27.1 24.6 22.7 22.8 32.3 25.6 27.4 41.9 23.5 23.4 32.1 31.0 31.2 30.0 29.4 36.7 28.5 26.7 29.2 36.1 28.5 26.0 28.5 29.3 31.8 23.1 41.9 28.9 36.8 23.7 50.4 29.3 19.1 51.5 27.7 26.3 36.9 35.3 41.8 39.9 39.7 43.7 45.8 20.1 19.1 20.0 13.9 17.5 18.2 22.4 24.6 27.7 26.2 23.8 21.6 19.0 25.5 14.7 24.8 34.7 13.2 21.2 19.3 25.0 12.0 12.8 30.9 19.7 20.7 26.2 21.7 27.1 21.1 23.4 24.3 20.3 18.4 24.2 21.7 16.3 35.3 26.7 13.8 34.7 30.3 30.8 16.9 24.0 25.4 19.1 13.2 17.8 25.7 18.6 17.6 17.3 13.4 17.2 22.5 21.3 16.4 20.1 22.9 11.2 21.5 37.7 45.7 60.8 28.3 22.3 23.7 23.7 14.6 29.6 41.8 43.7 39.3 43.7 36.9 37.5 43.0 35.3 27.2 36.2 36.3 32.9 39.7 39.9 23.6 39.9 45.8 25.4 39.4 35.9 50.3 22.7 22.8 23.5 23.4 36.7 23.7 20.8 20.3 25.1 14.7 24.5 12.4 15.7 17.8 13.4 21.6 21.0 15.7 18.0 18.3 19.5 11.0 20.2 14.8 0.0 20.4 27.8 17.2 19.5 13.9 17.8 17.4 12.7 11.6 15.4 34.2 17.3 15.8 20.0 6.8 27.9 14.2 9.2 25.2 14.0 19.4 17.7 16.5 25.8 21.7 26.7 47.3 28.1 18.2 33.1 15.6 29.1 RNF41 "NRDP1, SBBI03" ENSG00000181852 "Ring finger protein 41" Q9H4P4 12 56202175-56221933 "Enzymes, Predicted intracellular proteins" "Apoptosis, Autophagy, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016812 Approved Approved "Nucleoplasm,Nuclear bodies,Midbody ring" NA NA "Nucleoplasm, Nuclear bodies" "Midbody ring" "HPA016812: AB_1856370" "unprognostic (1.14e-2)" "unprognostic (6.30e-2)" "unprognostic (4.04e-2)" "unprognostic (6.86e-2)" "unprognostic (9.59e-2)" "unprognostic (8.22e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (6.93e-2)" "unprognostic (4.18e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.90e-2)" "prognostic favorable (2.52e-5)" "unprognostic (1.64e-1)" "unprognostic (1.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" 22.2 17.6 18.6 11.8 30.2 12.0 14.3 30.9 47.1 16.2 15.0 16.9 12.3 8.5 16.4 9.7 16.5 17.7 18.0 22.6 17.3 22.4 14.1 10.5 16.5 14.8 15.3 18.2 17.0 16.0 17.9 16.7 14.6 25.3 25.2 13.6 14.6 10.5 15.6 21.2 10.1 10.8 20.3 11.8 13.5 12.2 10.1 12.1 11.3 20.5 10.1 17.0 16.2 11.5 24.6 13.1 41.1 11.5 13.4 12.5 12.3 7.5 11.6 12.6 20.0 26.5 19.3 9.4 25.3 25.1 22.8 18.6 14.2 9.9 14.6 13.5 21.4 7.6 8.7 17.0 12.2 16.6 15.3 9.3 19.6 8.3 8.1 55.6 21.4 21.4 24.6 28.7 19.0 33.6 30.1 22.1 12.4 13.9 15.0 12.6 12.2 12.2 9.6 15.2 7.6 13.6 13.3 9.1 8.8 12.1 11.1 23.1 14.0 22.1 12.7 20.0 13.2 17.8 25.2 13.3 11.5 12.3 14.8 9.8 10.8 12.4 13.3 13.7 12.9 13.7 21.0 11.5 41.1 12.5 11.4 11.2 22.7 10.6 10.9 13.1 24.6 11.0 11.2 15.8 13.4 11.2 10.2 12.1 12.3 18.6 30.2 30.9 47.1 17.3 22.4 15.3 18.2 25.3 12.1 41.7 26.4 27.0 18.8 10.6 26.2 20.1 25.5 24.1 25.0 15.7 21.6 13.2 14.9 14.3 78.7 16.4 9.3 23.3 18.6 14.4 14.9 30.9 24.4 14.9 17.6 27.0 19.5 22.1 29.2 38.0 21.3 21.9 6.8 21.6 13.2 23.9 17.8 16.1 24.4 15.8 16.9 25.8 21.4 9.9 12.2 14.4 14.1 15.0 13.6 16.9 RP2 "NM23-H10, NME10, TBCCD2" ENSG00000102218 "RP2, ARL3 GTPase activating protein" O75695 X 46836940-46882358 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000234, HPA000909" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA 77000 "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA000234: AB_1079831, HPA000909: AB_2666140" "unprognostic (2.26e-1)" "unprognostic (6.01e-3)" "unprognostic (2.79e-2)" "unprognostic (2.98e-1)" "unprognostic (1.69e-1)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.97e-4)" "unprognostic (2.58e-2)" "unprognostic (9.76e-3)" "unprognostic (3.10e-2)" "unprognostic (3.79e-3)" "unprognostic (9.75e-2)" "unprognostic (6.15e-3)" "unprognostic (2.96e-2)" "unprognostic (9.66e-2)" "unprognostic (1.61e-1)" "unprognostic (4.28e-3)" 17.2 10.6 5.0 10.7 6.6 31.4 8.2 5.6 4.3 6.3 10.1 5.5 3.5 7.4 8.4 7.1 17.2 5.8 9.3 5.9 5.7 4.8 10.2 17.1 14.0 18.1 8.1 2.8 6.9 4.7 5.6 4.1 28.0 8.5 6.9 7.7 4.9 8.3 6.1 2.9 5.0 18.6 6.3 10.6 24.3 6.4 5.7 6.7 12.1 5.9 8.7 11.7 7.0 8.7 5.0 10.7 23.0 15.9 3.4 3.3 5.3 11.3 5.4 11.0 6.0 8.7 10.8 26.2 14.6 11.5 12.9 13.1 23.4 9.8 13.5 5.9 15.4 11.0 7.5 10.6 10.6 17.6 5.9 6.1 7.2 6.9 5.6 10.0 15.0 25.3 8.4 7.0 10.2 5.5 7.3 16.3 6.1 3.2 7.1 14.5 1.0 9.3 13.8 6.8 7.7 10.5 11.9 15.1 7.2 8.3 11.6 4.1 5.5 12.9 8.1 6.6 20.6 9.0 14.2 14.4 10.0 7.5 15.8 5.1 2.7 3.5 8.0 5.2 10.8 10.4 23.0 10.6 16.6 3.2 14.4 2.6 5.0 2.6 2.7 10.7 4.6 3.3 3.0 20.9 3.4 15.9 3.8 2.8 5.3 5.0 6.6 5.6 4.3 5.7 4.8 8.1 2.8 8.5 6.7 8.9 6.1 9.3 2.7 14.1 1.7 1.2 10.2 13.4 3.4 8.7 2.0 20.8 0.0 4.1 1.0 6.7 17.1 0.0 4.6 5.1 11.3 5.8 11.5 18.8 21.5 0.0 3.5 11.6 61.8 1.9 5.2 29.1 20.3 10.8 8.8 3.2 9.2 11.6 5.3 3.1 4.8 6.5 6.0 6.0 4.6 13.0 31.9 6.5 8.0 11.8 RP9 PAP-1 ENSG00000164610 "RP9, pre-mRNA splicing factor" Q8TA86 7 33094797-33109401 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031523, HPA050778" Uncertain Enhanced Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA031523: AB_10603235, HPA050778: AB_2681233" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (1.07e-2)" "unprognostic (1.82e-1)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (2.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.22e-2)" "unprognostic (7.53e-2)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.65e-5)" "unprognostic (4.19e-2)" "unprognostic (2.63e-2)" "unprognostic (2.70e-1)" "unprognostic (1.61e-1)" 10.1 13.8 11.7 9.4 16.0 20.7 14.9 17.1 16.0 10.9 12.2 13.0 7.0 10.3 14.6 18.8 8.1 10.0 10.7 19.2 11.1 10.1 11.4 11.5 9.7 19.4 17.4 8.6 14.2 16.9 10.4 14.2 11.7 11.0 14.0 11.8 12.8 15.0 14.4 34.7 10.7 12.5 15.7 11.8 17.2 10.5 15.2 12.6 13.6 15.6 9.0 18.2 13.4 16.0 34.1 11.7 8.1 5.0 5.9 8.4 3.3 9.9 14.3 15.1 17.2 9.6 9.0 7.2 12.7 10.9 14.7 11.8 12.7 7.3 12.6 8.4 10.5 18.1 10.0 18.3 10.9 19.0 5.7 11.4 9.2 11.3 11.8 16.9 12.3 6.5 9.0 10.3 16.7 33.1 12.0 12.0 13.5 16.5 11.6 14.7 20.6 13.2 33.8 12.7 13.3 10.3 13.3 13.1 8.4 10.6 9.6 14.6 20.0 8.9 20.0 21.7 18.7 10.5 17.1 9.6 14.6 20.5 12.9 20.6 18.9 17.1 25.1 10.3 17.6 28.2 6.4 5.0 8.1 6.6 3.6 6.1 22.0 7.0 7.4 5.3 34.1 8.4 7.8 0.9 5.9 4.6 11.7 5.9 3.3 11.7 16.0 17.1 16.0 11.1 10.1 17.4 8.6 11.0 12.6 11.9 8.5 17.4 13.8 18.7 16.3 32.5 12.7 10.7 11.4 14.0 13.7 16.9 18.3 14.1 3.5 21.7 10.5 0.0 13.7 16.3 19.4 11.5 3.5 15.1 16.0 7.9 9.8 14.7 7.6 2.7 16.7 9.9 21.9 9.0 16.4 15.8 13.4 5.8 15.2 13.5 12.9 25.8 20.2 33.0 48.0 15.7 8.7 11.8 18.0 10.7 RPE ENSG00000197713 Ribulose-5-phosphate-3-epimerase Q96AT9 2 210002565-210022259 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (5.07e-2)" "unprognostic (8.15e-2)" "unprognostic (3.06e-1)" "unprognostic (2.34e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.42e-6)" "unprognostic (1.59e-3)" "unprognostic (1.69e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.00e-6)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "unprognostic (5.84e-2)" 19.4 26.9 20.6 16.7 28.0 14.6 22.6 26.4 27.7 18.7 19.7 23.3 20.7 17.4 27.8 21.5 24.0 17.6 17.3 17.2 21.1 21.0 26.7 23.3 19.4 21.6 21.7 21.7 22.9 14.1 14.8 41.9 24.4 18.6 20.5 26.6 18.9 18.3 27.9 12.3 17.2 16.0 27.1 25.8 15.6 19.8 11.9 19.7 23.5 25.2 14.5 23.2 24.1 20.2 8.6 28.9 8.0 20.5 30.5 10.7 11.3 20.6 26.8 17.4 17.5 28.3 27.4 29.9 27.2 21.8 25.9 34.8 38.5 31.7 13.9 17.9 21.0 35.1 20.3 25.6 29.0 39.6 16.7 18.1 25.8 39.3 35.9 38.6 27.3 19.9 19.2 28.9 29.7 38.7 23.6 33.7 13.9 25.9 19.4 21.2 32.9 14.8 23.8 25.5 41.7 19.6 18.7 20.8 19.9 29.9 30.9 20.9 12.0 23.0 22.5 18.2 32.8 19.4 31.4 27.6 34.8 23.2 16.9 25.1 11.7 14.8 29.9 25.2 27.0 22.5 6.9 17.3 8.0 10.2 20.5 8.9 8.6 8.0 9.6 28.9 8.4 10.7 9.6 1.7 30.5 13.7 10.6 10.7 11.3 20.6 28.0 26.4 27.7 21.1 21.0 21.7 21.7 18.6 19.7 6.0 6.9 14.7 13.5 14.7 12.5 5.3 7.6 13.4 19.4 17.4 19.6 32.4 26.6 20.5 8.8 11.9 12.3 23.3 15.1 36.8 15.5 12.1 5.8 15.5 33.1 9.5 9.8 17.2 17.6 9.3 10.3 20.4 13.5 16.2 14.2 8.2 17.4 14.0 13.8 37.0 12.9 6.5 14.1 16.4 16.1 17.8 21.4 11.4 18.9 12.0 RPEL1 ENSG00000235376 "Ribulose-5-phosphate-3-epimerase like 1" Q2QD12 10 103245887-103248016 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;brain: 1.2;pituitary gland: 1.2" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 2.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 2.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.1;NB-4: 1.1" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (7.52e-2)" "unprognostic (1.69e-1)" "unprognostic (4.78e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.83e-1)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.91e-2)" "unprognostic (6.59e-2)" "unprognostic (4.34e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (1.62e-1)" "unprognostic (6.72e-2)" "unprognostic (5.06e-2)" 0.0 0.1 0.1 1.0 0.3 0.1 0.1 1.2 0.2 0.0 0.0 0.3 0.4 0.4 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.8 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.4 1.0 0.3 0.7 1.4 0.6 0.2 0.5 0.5 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.4 0.7 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.3 1.1 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.2 1.1 0.7 0.2 0.0 0.0 0.1 0.3 0.5 0.2 0.3 0.1 0.3 0.4 0.2 0.1 0.1 0.4 0.0 0.1 0.9 0.1 0.2 0.3 0.1 0.3 0.7 0.4 0.1 0.3 0.7 0.2 0.5 0.7 0.5 0.4 0.4 0.3 1.0 0.4 0.5 0.6 0.0 1.4 0.4 0.3 0.4 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.5 0.0 0.0 1.2 0.0 7.9 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.2 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.2 0.3 0.3 0.0 0.7 0.0 RPIA ENSG00000153574 "Ribose 5-phosphate isomerase A" P49247 2 88691644-88750935 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cytotrophoblasts: 210.0;Syncytiotrophoblasts: 188.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042620, HPA057954" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA 4100000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA042620: AB_10793980, HPA057954: AB_2683563" "unprognostic (3.35e-2)" "unprognostic (1.35e-2)" "unprognostic (6.96e-2)" "unprognostic (9.24e-2)" "unprognostic (4.31e-1)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.46e-5)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (8.70e-2)" "unprognostic (8.82e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (8.53e-6)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (8.79e-3)" 12.9 8.8 6.6 15.6 7.0 43.0 12.1 11.1 6.4 8.1 12.7 6.1 11.0 12.4 11.1 7.3 18.3 8.5 14.0 10.9 5.0 4.9 6.8 6.2 9.0 16.2 7.2 3.8 11.7 26.5 3.6 11.4 26.1 6.5 8.8 13.4 6.0 12.6 8.5 17.6 9.2 12.7 7.7 5.1 15.4 10.4 8.9 7.6 30.7 9.6 10.5 19.3 8.1 11.8 18.5 14.1 21.4 12.5 13.3 22.4 11.6 8.5 5.0 10.2 8.1 7.2 7.4 22.4 4.8 4.5 7.9 5.4 17.8 11.4 43.7 10.4 5.5 10.9 5.2 12.7 4.0 12.5 20.7 16.5 17.5 3.2 17.6 7.3 32.0 12.9 6.8 3.4 7.0 11.0 3.9 11.1 23.4 18.7 7.6 7.4 13.4 35.1 28.1 9.2 28.4 8.3 18.4 12.1 10.7 6.5 13.8 7.3 8.3 5.7 7.4 11.0 5.8 4.0 13.2 6.3 4.7 12.4 15.4 13.6 5.9 4.8 43.8 4.8 29.1 6.7 5.5 9.7 21.4 11.1 9.8 14.2 18.5 15.5 16.4 14.1 15.4 22.4 18.4 2.3 13.3 12.5 6.8 12.6 11.6 6.6 7.0 11.1 6.4 5.0 4.9 7.2 3.8 6.5 7.6 11.9 10.4 45.3 15.3 33.2 8.7 11.4 15.3 2.7 3.4 19.2 2.0 210.0 8.3 13.5 6.8 26.6 15.2 70.0 30.1 69.7 29.7 21.6 21.8 5.9 38.8 12.7 18.4 17.8 15.5 2.6 18.4 22.5 38.8 25.2 24.7 4.3 21.4 28.1 17.7 12.9 5.1 19.4 18.0 25.3 32.5 35.8 188.7 37.3 56.2 35.5 RPL22L1 ENSG00000163584 "Ribosomal protein L22 like 1" Q6P5R6 3 170864875-170870483 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 101.9" "Low region specificity" "Detected in all" "HPA048060, HPA056207, HPA068294" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA048060: AB_2732544, HPA056207: AB_2683065, HPA068294: AB_2732781" "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.59e-1)" "unprognostic (1.45e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-3)" "unprognostic (1.01e-2)" "unprognostic (9.50e-2)" "unprognostic (1.97e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "prognostic unfavorable (5.13e-12)" "unprognostic (5.12e-2)" "unprognostic (3.55e-1)" "unprognostic (1.23e-1)" "unprognostic (6.96e-2)" 17.2 14.6 8.9 28.1 9.5 36.0 21.5 6.0 9.3 14.3 15.7 5.3 6.6 8.4 12.2 12.3 33.6 15.3 11.8 11.3 7.4 8.5 11.4 64.3 18.8 31.4 10.1 5.7 18.6 71.6 1.9 12.1 10.5 10.7 14.7 15.7 6.4 15.7 14.0 17.7 19.4 13.7 12.2 11.5 37.5 17.4 9.7 8.9 17.9 15.2 32.5 27.8 18.9 15.9 24.1 24.2 1.9 7.6 13.1 13.8 3.5 15.8 17.9 5.8 67.6 17.3 101.9 17.8 16.1 37.2 13.1 8.5 7.6 3.7 49.0 3.7 15.0 41.1 4.1 14.4 41.1 7.3 2.9 2.6 4.4 2.2 17.1 70.0 9.0 6.5 74.0 84.0 4.1 44.6 20.5 44.5 27.2 3.1 3.1 71.8 20.1 65.7 5.1 90.9 6.1 3.2 88.2 2.1 7.5 32.5 35.3 0.9 4.9 1.6 8.1 7.0 3.3 11.3 8.0 20.6 2.5 19.3 5.0 22.4 5.0 3.5 7.8 45.9 5.5 52.1 1.0 4.8 1.9 6.8 5.7 13.8 24.1 10.0 9.0 5.1 17.9 6.7 7.4 1.0 13.1 7.6 24.2 6.3 3.5 8.9 9.5 6.0 8.1 7.4 8.5 10.1 5.7 10.7 8.9 8.9 36.6 274.9 201.6 175.5 13.0 14.5 53.5 57.6 92.1 19.2 3.9 84.0 56.3 132.5 30.8 89.5 76.2 23.3 199.7 252.2 105.2 161.6 105.0 90.9 170.2 7.9 138.8 87.8 140.5 29.1 129.2 89.6 74.2 57.7 130.6 34.1 350.4 115.2 83.8 69.0 18.4 45.3 94.8 47.6 26.2 216.6 82.3 126.9 150.6 274.6 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 32.8 38.8 38.9 29.5 30.6 36.9 47.5 24.2 34.7 26.4 28.0 19.2 40.6 31.4 18.8 25.2 24.1 18.0 25.0 30.5 38.9 28.4 30.8 40.7 22.5 29.4 40.3 27.0 23.4 45.0 15.4 18.8 21.9 31.9 31.6 14.4 19.2 65.2 35.4 55.0 19.8 30.9 28.5 31.1 27.1 32.6 28.8 24.6 16.3 40.8 28.0 23.7 24.3 54.5 64.2 73.5 67.3 57.7 42.8 60.3 50.5 20.9 25.9 12.5 17.6 14.1 9.2 26.3 24.1 19.6 21.1 16.8 28.7 13.9 26.2 25.2 14.2 17.2 17.0 19.6 24.7 7.3 37.7 62.7 25.2 22.0 25.3 20.6 36.8 32.9 13.8 18.7 18.1 22.2 11.4 14.3 19.9 28.1 19.0 13.3 23.2 17.6 36.7 21.7 46.7 49.7 28.1 16.3 39.4 22.1 20.8 27.9 15.6 19.5 31.1 43.3 8.0 22.4 29.8 16.9 17.6 40.2 19.6 31.4 33.1 30.4 40.7 23.9 25.6 41.1 42.1 57.7 67.3 53.4 52.1 49.2 62.0 54.4 55.2 46.3 64.2 53.2 54.1 63.4 42.8 42.0 73.5 60.3 50.5 38.9 30.6 24.2 34.7 38.9 28.4 40.3 27.0 31.9 24.6 41.7 44.3 107.2 91.0 121.8 95.6 68.3 109.5 34.8 36.4 92.5 49.1 134.1 184.1 166.7 17.8 129.5 196.8 46.7 167.0 202.1 94.9 166.3 69.2 175.1 185.7 33.4 136.9 111.1 105.7 22.2 126.8 125.3 102.9 172.3 137.0 80.8 187.2 164.9 118.5 232.2 81.9 77.6 104.0 59.0 146.0 129.4 110.1 136.4 130.8 112.7 RPS6KA3 "CLS, HU-3, MRX19, RSK, RSK2" ENSG00000177189 "Ribosomal protein S6 kinase A3" P51812 X 20149911-20267519 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 69.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003221, CAB003853, CAB013520" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.80e-2)" "unprognostic (4.26e-2)" "unprognostic (3.53e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (1.61e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (5.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (4.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-1)" 19.7 12.5 9.9 23.0 12.5 8.2 16.5 15.2 12.1 11.4 23.2 4.4 22.1 13.7 12.4 10.1 13.6 12.7 15.7 21.3 9.7 8.8 14.1 25.8 21.6 34.0 9.9 10.0 12.7 14.0 36.6 9.8 11.0 10.2 14.5 18.8 7.7 14.3 11.3 45.2 11.7 23.7 16.1 11.7 25.8 11.8 4.8 9.7 29.4 13.5 15.0 18.2 20.3 19.0 4.2 8.6 12.5 6.9 8.3 11.3 2.7 12.9 22.7 8.6 4.4 8.4 14.8 2.6 11.2 17.1 8.4 11.6 25.7 16.7 8.5 3.9 11.8 12.3 9.2 9.8 9.5 15.7 7.1 7.8 10.0 14.3 69.0 8.6 19.5 10.4 9.4 7.6 13.2 16.7 7.4 30.4 9.0 6.6 24.4 8.8 6.1 12.6 6.0 6.2 16.9 13.7 6.7 18.2 9.8 7.3 10.9 4.0 3.9 15.1 4.6 16.4 11.2 0.0 5.8 16.9 9.2 6.4 29.1 6.3 19.5 11.9 9.5 17.4 9.7 21.7 12.5 4.7 9.5 6.3 6.9 11.3 2.9 7.3 6.9 7.0 4.2 5.0 6.0 7.5 8.3 6.9 8.6 3.5 2.7 9.9 12.5 15.2 12.1 9.7 8.8 9.9 10.0 10.2 9.7 41.7 68.2 18.2 31.8 48.3 33.6 19.4 38.2 21.4 51.2 15.7 21.6 3.3 3.3 23.3 0.1 48.1 43.4 0.0 26.0 5.7 28.8 47.0 42.8 61.1 20.6 12.7 24.0 29.4 46.1 1.1 12.0 60.4 35.4 20.8 53.4 26.6 30.0 46.0 19.8 23.7 8.7 19.4 35.0 3.3 7.7 48.6 3.0 56.7 46.1 54.2 RPS6KA6 RSK4 ENSG00000072133 "Ribosomal protein S6 kinase A6" Q9UK32 X 84058346-84187907 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 19.9;Collecting duct cells: 17.4;Cone photoreceptor cells: 23.6;Intestinal endocrine cells: 24.0;Rod photoreceptor cells: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 11.0;PC-3: 11.9;RH-30: 14.6;SH-SY5Y: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002852, HPA003904" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA002852: AB_1079854, HPA003904: AB_1079853" "unprognostic (1.17e-1)" "unprognostic (1.02e-2)" "unprognostic (3.44e-1)" "unprognostic (4.93e-4)" "unprognostic (1.71e-1)" "unprognostic (3.04e-3)" "unprognostic (2.09e-2)" "unprognostic (2.50e-1)" "unprognostic (2.86e-1)" "unprognostic (4.88e-2)" "unprognostic (3.38e-3)" "unprognostic (2.88e-1)" "unprognostic (2.12e-9)" "unprognostic (4.44e-3)" "unprognostic (1.30e-2)" "unprognostic (2.34e-2)" "unprognostic (8.49e-3)" 0.7 2.9 5.9 1.0 12.2 0.0 2.3 4.7 5.1 3.1 4.5 1.1 20.7 1.7 2.7 4.0 1.5 4.0 1.9 1.2 5.1 2.9 9.2 0.9 0.8 0.2 1.5 3.3 4.9 3.4 13.5 9.1 0.5 4.4 4.3 3.7 1.5 3.0 15.0 1.4 2.3 2.0 1.7 1.0 0.6 2.4 2.6 2.7 0.8 14.5 0.9 0.6 3.3 2.3 1.2 0.8 2.4 0.5 0.7 2.8 0.1 0.0 3.7 3.6 0.0 3.4 3.4 0.0 7.7 4.1 3.4 2.9 2.8 3.0 0.0 0.0 4.1 0.0 0.1 9.1 6.1 8.1 0.0 4.6 0.0 0.1 0.0 3.1 0.0 0.0 1.9 0.0 0.0 3.8 3.8 0.8 0.0 0.0 0.2 2.7 0.0 1.3 0.1 11.0 0.0 11.9 0.0 14.6 0.0 0.6 8.5 0.0 11.7 0.0 4.2 0.0 5.2 2.0 0.0 0.0 0.1 4.4 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 2.4 0.4 0.5 0.5 0.3 0.4 1.2 0.4 0.7 0.8 0.6 0.4 0.4 1.1 0.7 0.5 0.4 2.8 0.1 5.9 12.2 4.7 5.1 5.1 2.9 1.5 3.3 4.4 2.7 8.9 2.4 2.0 4.4 0.2 19.9 2.0 12.7 6.7 3.4 17.4 23.6 2.1 1.7 0.4 0.4 0.6 3.4 0.0 1.1 0.6 0.3 7.4 0.0 1.5 0.2 1.6 24.0 1.3 0.0 0.0 4.0 0.0 0.0 0.0 5.0 2.8 1.3 2.9 5.6 3.3 18.2 0.0 0.6 3.7 6.3 0.4 1.9 0.0 5.3 4.2 RRAD "RAD, REM3" ENSG00000166592 "RRAD, Ras related glycolysis inhibitor and calcium channel regulator" P55042 16 66921679-66925644 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 246.0" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 183.7;Cardiomyocytes: 231.4;Sertoli cells: 109.9;Smooth muscle cells: 182.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HDLM-2: 62.2;U-87 MG: 18.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA041755 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA041755: AB_2677655" "unprognostic (1.40e-2)" "unprognostic (2.78e-2)" "unprognostic (9.77e-2)" "unprognostic (3.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-3)" "unprognostic (3.46e-2)" "unprognostic (3.33e-2)" "unprognostic (2.04e-2)" "unprognostic (4.80e-3)" 7.3 2.1 0.4 2.4 2.7 1.3 5.0 1.2 1.7 4.7 2.0 3.2 1.8 1.2 3.3 8.5 20.4 6.3 4.1 61.2 0.7 0.6 5.6 0.8 6.3 1.3 1.5 0.8 4.7 0.7 1.0 2.0 10.7 4.6 4.2 0.4 3.9 4.3 1.4 246.0 2.2 1.2 5.7 1.7 0.8 1.7 2.3 1.2 0.3 3.9 14.7 4.3 4.5 5.7 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 2.8 0.0 0.0 0.0 0.3 0.1 1.6 0.1 0.2 1.4 0.7 1.9 0.0 1.6 0.1 0.5 0.1 0.0 0.1 0.2 62.2 0.1 0.0 0.0 0.7 2.8 0.0 0.2 0.8 0.3 5.0 0.0 1.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.2 1.5 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.0 0.1 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 2.7 1.2 1.0 0.7 0.6 1.5 0.8 4.6 1.2 65.5 183.7 3.5 1.9 8.4 12.5 231.4 0.0 83.0 19.4 64.6 9.8 1.0 19.9 33.7 1.5 14.0 4.9 0.0 2.7 2.7 26.9 9.8 33.5 0.0 1.3 1.6 10.2 1.3 1.5 0.4 0.6 14.2 21.9 1.0 2.7 1.5 34.5 1.7 4.9 5.8 3.0 109.9 182.3 1.7 1.9 8.8 4.7 2.2 3.0 2.6 RRAGD "bA11D8.2.1, DKFZP761H171" ENSG00000025039 "Ras related GTP binding D" Q9NQL2 6 89364636-89412270 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.0" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 118.0;Distal tubular cells: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.3" "Group enriched" "Detected in many" 7 "granulocytes: 6.3;monocytes: 3.9" "Cell line enhanced" "Detected in many" "Karpas-707: 28.2;SCLC-21H: 14.8;U-266/70: 35.7;U-266/84: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068664 Approved Approved Nucleoplasm,Vesicles,Centrosome NA NA Nucleoplasm "Vesicles, Centrosome" "HPA068664: AB_2686016" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.53e-3)" "unprognostic (1.09e-1)" "unprognostic (2.03e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (7.80e-4)" "unprognostic (3.75e-2)" "unprognostic (1.66e-2)" "unprognostic (4.33e-2)" "unprognostic (1.11e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.47e-8)" "unprognostic (8.41e-3)" "unprognostic (1.23e-1)" "unprognostic (9.46e-2)" "unprognostic (4.40e-2)" 8.1 8.4 9.2 2.6 12.8 8.9 8.8 22.4 16.3 8.7 3.3 7.9 3.1 2.2 2.1 6.6 12.8 11.9 3.7 29.9 8.6 7.4 21.8 5.0 6.4 2.8 8.5 7.9 2.2 6.4 16.0 11.5 3.4 10.7 5.9 2.4 12.8 38.7 4.2 60.0 5.5 2.1 7.5 12.6 4.4 2.3 6.1 9.2 4.1 23.3 13.9 5.2 9.2 9.3 0.1 0.7 6.3 3.9 0.1 0.6 0.3 0.0 0.7 1.9 1.4 0.2 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.7 0.0 10.0 0.0 10.7 0.0 0.0 0.0 5.3 2.4 0.0 0.0 0.8 7.1 8.5 0.2 0.6 0.0 0.0 0.0 0.0 7.4 0.2 28.2 0.0 0.7 3.4 3.5 1.6 0.0 0.7 7.1 10.3 0.1 2.6 0.2 14.8 0.8 0.2 1.0 12.0 0.6 0.3 5.6 0.0 0.8 1.2 5.1 1.3 35.7 16.5 0.0 2.7 5.4 0.8 3.9 1.2 2.6 0.0 1.1 0.1 0.1 0.4 0.0 0.7 0.0 0.3 0.6 6.3 0.1 3.9 0.6 0.0 0.3 9.2 12.8 22.4 9.1 8.6 7.4 8.5 7.9 10.7 9.2 8.9 11.8 7.5 12.1 14.3 18.0 118.0 15.3 13.4 5.7 14.0 29.5 0.4 99.5 14.2 15.2 3.6 0.0 0.0 14.9 1.2 6.0 29.7 4.6 8.6 46.1 44.5 1.2 3.1 19.9 10.4 2.8 8.5 37.1 5.4 0.3 18.0 12.3 0.0 3.9 15.6 14.2 0.0 6.6 8.4 25.7 19.7 0.6 1.5 0.0 25.7 RRP7A "CGI-96, Rrp7" ENSG00000189306 "Ribosomal RNA processing 7 homolog A" Q9Y3A4 22 42509968-42519802 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001586, HPA046768" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA001586: AB_1078506, HPA046768: AB_2679796" "unprognostic (8.46e-2)" "unprognostic (3.30e-3)" "unprognostic (5.96e-2)" "unprognostic (3.21e-3)" "unprognostic (9.71e-3)" "unprognostic (2.92e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (6.73e-2)" "unprognostic (3.00e-1)" "unprognostic (2.28e-1)" "unprognostic (2.41e-1)" "unprognostic (3.22e-2)" "unprognostic (9.53e-3)" "unprognostic (8.02e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" 10.4 12.9 19.9 15.4 26.6 16.5 13.5 18.5 20.9 12.8 12.2 15.1 9.4 10.2 12.0 47.3 15.1 18.9 12.0 11.1 17.5 14.8 14.0 18.1 11.3 21.5 14.8 9.3 21.2 12.0 16.6 10.3 17.7 17.4 17.8 10.8 12.6 15.2 14.6 13.5 14.9 13.3 11.9 11.7 15.6 12.0 11.2 18.6 17.4 11.6 8.7 16.4 10.7 11.0 26.2 30.5 17.4 27.5 15.2 18.4 20.3 13.0 18.4 10.1 11.9 6.5 4.3 20.5 11.1 6.7 14.4 12.2 23.4 7.5 21.8 5.7 7.9 8.0 14.5 11.6 15.5 6.2 5.5 23.7 11.8 12.8 12.6 6.2 28.3 10.2 5.5 7.8 19.5 9.9 5.2 8.7 11.7 16.6 6.3 8.5 26.5 27.2 11.6 8.4 10.4 13.4 47.4 10.4 9.6 7.5 16.0 5.5 3.9 8.2 23.6 10.8 5.4 9.6 12.8 6.5 11.0 14.2 8.4 11.3 9.7 7.2 25.6 9.2 10.9 15.8 10.0 23.5 17.4 18.4 26.4 17.7 20.5 16.1 16.8 18.1 26.2 17.7 16.5 4.7 15.2 27.5 30.5 13.5 20.3 19.9 26.6 18.5 20.9 17.5 14.8 14.8 9.3 17.4 18.6 20.8 35.8 52.9 72.3 38.9 26.5 14.2 25.5 34.8 33.0 21.0 15.7 80.7 14.9 65.2 48.5 37.9 36.0 23.3 23.4 117.3 32.9 62.0 46.2 29.2 83.7 25.4 25.3 31.3 37.8 94.1 20.4 49.8 32.1 146.1 29.9 22.2 58.6 42.1 17.3 34.2 28.7 6.5 26.9 30.9 22.8 33.1 100.7 41.5 40.0 87.7 RRP8 "KIAA0409, NML" ENSG00000132275 "Ribosomal RNA processing 8" O43159 11 6595075-6603620 "Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038487, HPA057562" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA038487: AB_10672518, HPA057562: AB_2683468" "unprognostic (9.01e-2)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.10e-7)" "unprognostic (4.64e-2)" "unprognostic (2.48e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.23e-2)" "unprognostic (3.81e-3)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.87e-2)" 13.8 11.9 13.9 15.8 14.8 32.1 17.9 18.1 15.3 15.9 24.9 16.1 10.5 14.0 15.5 21.3 13.8 11.9 15.4 16.2 16.0 10.3 13.3 24.7 14.3 16.0 18.4 13.6 12.4 12.7 12.0 12.3 12.8 14.2 19.8 14.4 11.8 10.9 19.7 18.6 15.5 12.8 19.5 11.0 17.7 15.1 12.3 18.6 11.8 14.2 9.7 16.6 20.2 13.9 13.3 14.4 20.3 12.0 14.4 13.8 10.2 10.1 10.2 4.1 5.2 8.5 7.4 5.8 5.2 6.6 12.2 11.5 10.4 12.0 14.3 5.2 5.0 9.0 10.3 11.6 9.3 13.0 6.8 16.6 6.7 12.2 11.8 9.8 12.2 9.4 6.3 12.1 5.8 10.6 8.1 12.5 6.7 13.3 8.4 9.6 12.6 11.8 18.2 10.0 17.9 9.2 10.6 3.3 3.2 11.4 8.2 6.3 7.4 7.5 15.4 8.6 7.0 8.4 10.7 6.4 11.6 5.3 11.2 10.1 9.4 8.4 13.6 9.8 12.3 7.4 20.3 11.0 10.7 13.7 11.8 13.2 10.9 13.5 12.6 14.4 13.3 13.3 13.8 4.4 14.4 12.0 11.0 12.6 10.2 13.9 14.8 18.1 15.3 16.0 10.3 18.4 13.6 14.2 18.6 20.8 12.9 13.7 14.7 20.6 17.1 18.3 7.6 10.7 15.9 8.7 13.7 19.6 10.0 15.6 5.3 16.6 10.9 23.3 13.9 17.0 14.6 9.7 17.3 19.1 16.3 3.2 6.9 9.8 8.4 10.4 12.0 12.0 8.5 19.8 12.8 13.3 18.6 13.3 9.2 16.5 27.4 0.0 20.9 21.2 17.2 23.7 16.7 14.9 15.9 12.2 RSBN1 "FLJ11220, ROSBIN" ENSG00000081019 "Round spermatid basic protein 1" Q5VWQ0 1 113761832-113812476 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042124, HPA049484" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA042124: AB_10794644, HPA049484: AB_2680787" "unprognostic (3.26e-2)" "unprognostic (1.32e-1)" "unprognostic (1.15e-3)" "unprognostic (2.13e-1)" "unprognostic (3.66e-2)" "unprognostic (2.30e-2)" "unprognostic (5.06e-2)" "unprognostic (6.60e-2)" "unprognostic (1.06e-1)" "unprognostic (1.97e-2)" "unprognostic (1.56e-1)" "unprognostic (3.96e-1)" "unprognostic (1.51e-2)" "unprognostic (4.67e-2)" "unprognostic (1.43e-1)" "unprognostic (1.24e-1)" "unprognostic (1.15e-3)" 10.4 8.4 8.6 9.4 14.6 35.8 10.3 23.9 12.0 17.0 14.4 6.9 8.1 7.7 13.4 8.6 9.7 10.9 8.4 8.1 8.9 9.1 10.4 7.9 11.5 11.8 8.1 7.3 18.3 13.3 17.6 15.1 8.2 8.4 11.5 10.9 9.6 10.1 10.7 17.1 10.7 10.9 11.5 7.2 12.8 8.8 12.4 10.0 22.6 11.8 5.7 12.7 16.6 10.7 20.7 16.4 25.7 9.2 14.3 20.8 7.3 11.9 3.4 11.8 7.0 7.0 8.1 5.7 4.2 9.2 8.7 9.1 4.0 3.6 10.5 6.8 5.2 4.0 5.3 8.3 5.2 14.2 10.1 6.0 7.9 3.7 4.6 5.3 14.8 8.5 6.1 5.7 7.4 7.1 7.4 6.8 11.8 11.9 6.6 6.3 12.2 11.8 8.8 9.9 3.8 5.9 21.6 11.5 5.4 5.2 5.2 11.9 9.5 8.1 8.0 7.2 6.2 3.9 10.0 8.1 7.8 8.5 11.6 6.9 8.8 6.6 13.3 8.1 9.1 13.0 25.7 9.2 14.6 18.6 6.9 18.8 18.3 20.1 17.1 7.6 20.7 20.8 16.9 17.9 14.3 7.5 16.4 17.4 7.3 8.6 14.6 23.9 12.0 8.9 9.1 8.1 7.3 8.4 10.0 32.8 16.1 30.8 35.7 66.3 83.2 16.9 15.3 29.4 29.6 24.4 62.8 21.1 16.6 17.4 15.1 40.5 36.7 23.3 22.6 20.3 33.4 36.6 34.7 17.0 17.1 92.2 47.3 27.0 20.5 4.0 46.6 26.3 38.8 34.3 43.1 59.4 19.0 44.2 46.7 12.8 100.8 38.8 50.9 94.3 33.0 57.0 26.3 58.9 38.5 36.5 RSL24D1 "C15orf15, HRP-L30-iso, L30, RPL24, RPL24L" ENSG00000137876 "Ribosomal L24 domain containing 1" Q9UHA3 15 55180806-55197067 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062724, HPA063392" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA062724: AB_2684850, HPA063392: AB_2685002" "unprognostic (3.40e-2)" "unprognostic (3.00e-1)" "unprognostic (3.83e-1)" "unprognostic (7.28e-2)" "unprognostic (3.80e-2)" "unprognostic (1.07e-3)" "unprognostic (6.71e-3)" "unprognostic (1.15e-1)" "unprognostic (6.56e-3)" "unprognostic (1.34e-1)" "unprognostic (6.19e-3)" "unprognostic (7.22e-2)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (4.54e-2)" "unprognostic (4.95e-1)" "unprognostic (2.41e-1)" 27.7 24.3 26.7 23.4 28.8 76.1 47.8 35.7 29.9 40.6 32.2 10.0 25.6 18.1 34.5 26.6 34.2 26.4 21.4 25.3 25.1 25.3 24.3 26.7 27.0 35.8 25.4 25.8 54.7 37.8 15.0 23.2 22.4 24.1 44.3 20.5 11.2 25.8 21.3 47.2 19.3 21.1 50.4 27.5 28.6 28.8 24.2 20.6 39.5 43.1 36.9 27.4 61.9 49.6 29.1 27.0 11.4 24.1 22.7 45.1 47.7 16.1 16.4 18.1 23.7 14.2 26.8 14.7 17.1 19.2 14.4 18.4 15.7 9.9 50.4 15.5 12.3 14.1 19.8 23.8 19.8 19.4 24.5 14.8 25.8 13.2 19.5 32.8 48.5 16.9 22.7 42.0 14.4 41.9 23.3 17.8 37.9 48.6 36.6 16.7 16.5 26.5 42.8 22.3 33.1 14.8 21.2 22.7 75.9 21.6 15.0 25.7 30.8 7.9 22.3 55.4 15.0 21.4 71.8 12.4 11.9 13.9 13.8 24.4 35.3 53.9 50.1 18.5 48.1 19.9 11.4 23.8 11.4 19.6 23.4 31.1 29.1 29.5 24.3 27.0 22.5 45.1 34.0 6.0 22.7 24.1 21.1 32.4 47.7 26.7 28.8 35.7 29.9 25.1 25.3 25.4 25.8 24.1 20.6 92.3 65.6 256.3 349.8 515.7 83.5 63.5 89.2 77.6 80.8 80.3 21.6 138.6 242.1 170.0 67.8 119.6 46.1 70.0 234.1 222.4 198.3 186.8 150.0 57.1 128.0 14.3 134.4 79.8 196.0 28.6 188.4 183.5 269.9 194.8 102.0 68.6 201.1 134.0 140.4 191.4 51.1 155.2 258.6 71.0 148.8 456.4 145.9 187.5 118.2 292.9 RTCB "C22orf28, FAAP, HSPC117" ENSG00000100220 "RNA 2',3'-cyclic phosphate and 5'-OH ligase" Q9Y3I0 22 32387582-32412255 "Enzymes, Predicted intracellular proteins" "tRNA processing" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000535, HPA001103" Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA 43000 Nucleoplasm "Vesicles, Cytosol" "HPA000535: AB_2666021, HPA001103: AB_1078351" "unprognostic (1.84e-1)" "unprognostic (6.48e-2)" "unprognostic (1.07e-2)" "unprognostic (2.71e-3)" "unprognostic (7.21e-3)" "unprognostic (1.43e-2)" "unprognostic (1.75e-3)" "unprognostic (1.49e-1)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (2.40e-2)" "unprognostic (5.07e-2)" "prognostic favorable (4.25e-5)" "unprognostic (6.91e-2)" "unprognostic (5.35e-2)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" 26.4 30.1 20.1 20.4 29.7 15.1 29.2 22.9 34.5 25.7 35.6 35.2 32.7 51.6 29.7 25.8 30.8 26.9 22.9 26.4 19.6 24.6 42.4 55.1 23.1 22.7 29.1 26.2 29.0 29.4 38.4 29.9 33.7 36.7 27.0 42.3 27.1 29.9 28.6 40.9 46.6 61.7 31.8 24.4 29.3 29.7 30.8 25.5 32.0 32.7 30.1 46.6 26.5 24.2 44.6 51.5 29.0 47.7 37.0 40.5 44.0 32.2 29.0 36.4 27.3 31.9 23.8 29.0 28.3 34.1 45.3 43.1 37.6 13.2 8.0 19.0 33.0 27.9 22.0 41.6 41.1 58.7 40.4 41.8 22.8 24.6 34.1 22.0 53.3 20.9 23.4 27.3 44.8 43.6 25.0 40.7 22.6 27.0 22.8 33.0 26.9 22.6 18.5 20.8 37.5 26.6 35.2 39.3 41.2 31.1 28.1 37.6 20.8 30.7 19.9 35.9 40.0 21.8 20.7 30.6 25.0 36.9 21.7 27.1 15.9 12.7 28.9 25.9 24.2 32.6 29.0 43.5 27.4 31.7 47.7 35.5 44.6 33.3 33.0 51.5 43.6 39.9 34.6 4.3 37.0 35.5 28.9 40.5 44.0 20.1 29.7 22.9 34.5 19.6 24.6 29.1 26.2 36.7 25.5 29.8 30.2 40.2 48.9 53.8 50.9 32.3 48.4 37.5 22.7 33.2 19.6 98.9 56.3 89.0 3.8 37.9 93.2 0.0 84.1 74.7 40.4 51.2 42.6 54.7 75.2 49.3 44.9 35.0 41.7 7.0 32.5 40.0 28.7 107.4 50.3 61.1 82.4 59.7 44.9 108.7 48.0 25.8 37.2 57.2 58.8 66.5 81.8 30.9 51.3 61.4 RTL3 "FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5" ENSG00000179300 "Retrotransposon Gag like 3" Q8N8U3 X 78656069-78659328 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;GAMG: 3.2;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4" "HPA051991, HPA053174, HPA075136" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA Nucleoplasm "Golgi apparatus, Plasma membrane" "HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737" "unprognostic (3.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (1.23e-1)" "unprognostic (1.69e-2)" "unprognostic (2.85e-1)" "unprognostic (4.00e-6)" "unprognostic (1.53e-2)" "unprognostic (3.64e-1)" "unprognostic (2.49e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 2.6 0.2 2.5 0.2 0.5 0.4 0.5 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.5 0.7 0.0 0.1 0.3 1.1 2.7 0.0 0.0 3.2 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 2.4 2.6 0.0 0.0 0.0 0.1 4.0 3.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.6 0.0 0.6 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.1 1.4 0.2 3.4 0.2 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL4 "FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16" ENSG00000187823 "Retrotransposon Gag like 4" Q6ZR62 X 112454500-112457112 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "kidney: 3.5;liver: 4.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "testis cancer: 1.4;thyroid cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;SuSa: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003272 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003272: AB_2257414" "unprognostic (9.86e-2)" "unprognostic (2.04e-4)" "unprognostic (6.35e-2)" "unprognostic (5.33e-3)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.5 4.7 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RUNX3 "AML2, CBFA3, PEBP2A3" ENSG00000020633 "Runt related transcription factor 3" Q13761 1 24899511-24965121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.5;lymphoid tissue: 47.6" "Cell type enhanced" "Detected in many" 17 "B-cells: 38.9;granulocytes: 46.0;Macrophages: 35.5;Melanocytes: 43.9;monocytes: 68.5;T-cells: 144.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 39.5;Karpas-707: 53.2;SK-MEL-30: 29.5;U-266/70: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004195, CAB025416, HPA059006" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB025416: , HPA004195: , HPA059006: AB_2683877" "unprognostic (7.75e-3)" "unprognostic (6.51e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.42e-1)" "unprognostic (7.60e-2)" "unprognostic (1.81e-2)" "unprognostic (6.51e-2)" "unprognostic (6.95e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "prognostic unfavorable (5.59e-5)" "unprognostic (1.10e-1)" "unprognostic (4.42e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" 3.0 1.1 0.9 25.4 1.1 31.5 3.4 0.5 1.0 11.9 8.0 1.2 0.3 2.5 1.7 1.4 3.5 1.7 6.2 1.3 0.9 1.1 2.2 2.3 11.7 28.8 2.8 0.7 1.3 1.0 0.0 1.0 1.3 1.8 2.3 2.3 2.8 6.5 2.2 2.2 9.5 13.7 1.3 1.8 30.6 2.7 2.1 0.8 14.2 1.8 3.1 47.6 8.9 2.2 4.5 1.0 4.3 4.6 18.1 15.1 3.1 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 6.3 6.2 5.4 0.0 0.1 3.7 0.0 0.2 39.5 0.6 0.1 0.6 0.0 0.0 1.4 13.7 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 53.2 0.0 0.0 0.4 12.2 0.2 0.0 1.0 0.0 0.0 7.4 0.0 0.1 1.2 0.0 2.4 0.0 29.5 1.0 0.0 8.5 0.0 0.0 0.6 0.0 0.1 18.4 12.8 6.0 0.0 13.8 1.5 0.4 0.7 4.3 15.1 3.0 8.1 4.5 5.7 13.2 0.9 3.8 2.8 10.3 0.9 18.1 4.6 1.0 5.7 3.1 0.9 1.1 0.5 1.0 0.9 1.1 2.8 0.7 1.8 0.8 0.0 5.1 38.9 0.7 6.8 0.0 2.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.2 0.1 1.2 0.7 46.0 0.8 4.9 0.0 0.0 1.8 17.0 0.8 0.0 35.5 43.9 68.5 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 4.7 0.2 2.7 5.1 0.2 144.9 0.0 0.4 RUVBL2 "ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b" ENSG00000183207 "RuvB like AAA ATPase 2" Q9Y230 19 48993448-49015995 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.0" "Group enriched" "Detected in all" 4 "Ciliated cells: 184.7;Early spermatids: 493.7;Late spermatids: 663.3;Spermatocytes: 292.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012432, HPA042880, HPA067966" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933" "unprognostic (1.71e-1)" "unprognostic (9.06e-3)" "unprognostic (3.51e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (7.06e-3)" "unprognostic (6.25e-2)" "unprognostic (3.28e-1)" "unprognostic (8.13e-2)" "unprognostic (7.58e-2)" "unprognostic (2.81e-2)" "unprognostic (2.21e-2)" "unprognostic (7.61e-3)" "unprognostic (1.61e-1)" "unprognostic (2.58e-1)" 6.9 5.3 6.7 7.5 7.1 13.4 4.8 8.2 10.4 4.8 9.9 7.6 6.3 11.2 8.3 5.5 16.1 5.5 7.2 9.1 6.9 6.0 7.6 10.3 5.5 8.2 7.7 8.1 6.5 8.7 1.6 6.4 5.5 6.7 6.0 3.2 6.5 10.0 6.6 27.8 7.7 10.0 3.7 7.1 6.9 10.7 59.0 5.8 14.6 8.8 9.4 8.1 6.4 12.9 12.6 16.4 5.6 14.3 11.0 12.5 15.2 28.9 29.8 3.5 20.0 1.5 2.7 9.4 15.7 6.8 18.0 11.8 15.4 12.6 27.2 12.1 3.1 5.1 15.4 2.2 10.3 2.1 16.5 12.2 17.7 9.0 7.8 5.0 34.8 12.4 3.1 2.1 4.0 2.1 3.3 6.6 23.0 30.7 11.6 1.6 5.9 30.7 4.1 10.8 6.0 4.4 25.5 16.1 17.5 3.2 11.2 14.3 20.6 15.8 13.2 5.6 1.1 11.6 13.4 9.7 11.4 16.8 7.5 38.7 23.5 26.8 28.1 8.4 17.1 16.3 5.6 14.3 4.2 11.1 11.1 11.2 10.9 11.1 9.1 16.4 12.6 12.2 8.0 1.0 11.0 10.8 12.5 12.5 15.2 6.7 7.1 8.2 10.4 6.9 6.0 7.7 8.1 6.7 5.8 11.9 20.2 23.7 40.9 24.6 15.0 38.6 28.1 184.7 36.4 31.4 31.4 91.2 39.7 59.0 493.7 24.1 23.6 23.3 61.9 63.4 32.5 34.0 12.7 31.1 44.6 17.5 16.8 27.6 18.3 663.3 33.4 26.7 25.3 43.3 33.6 23.6 48.7 31.6 40.3 61.6 24.1 19.4 37.1 292.2 46.3 24.1 96.9 25.3 49.4 33.5 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042205-237833988 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 106.6" "Cell type enriched" "Detected in many" 30 "Cardiomyocytes: 1960.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.8;HEK 293: 10.7;K-562: 3.3;NB-4: 2.7;NTERA-2: 4.0;U-937: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 1.1 0.9 6.2 0.9 18.7 0.5 1.1 14.8 10.5 1.3 1.2 0.0 1.2 0.7 1.1 0.7 1.8 1.0 1.8 106.6 5.7 1.1 0.9 0.9 1.4 0.6 1.0 7.3 2.2 4.2 0.5 2.0 1.1 1.6 2.0 0.8 0.2 0.9 1.4 0.9 1.0 1.0 4.6 1.0 1.0 1.2 1.1 3.0 0.0 2.7 0.0 0.6 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.3 0.0 0.0 0.3 0.6 0.0 0.0 7.8 10.7 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 2.7 4.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 18.7 14.8 10.5 5.7 1.1 1.0 7.3 1.6 3.0 0.0 0.3 0.0 0.0 0.3 65.2 1960.0 0.0 1.4 2.3 1.8 9.8 0.0 0.0 0.0 15.8 1.5 0.0 0.0 2.5 0.0 2.1 0.0 0.0 0.0 0.1 1.6 3.4 1.3 0.0 10.2 1.1 0.0 8.5 0.0 0.0 1.5 0.3 0.0 0.0 0.0 4.7 0.0 18.6 3.2 0.9 0.0 0.0 0.0 0.0 0.0 S100A1 "S100-alpha, S100A" ENSG00000160678 "S100 calcium binding protein A1" P23297 1 153627926-153632039 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 465.5;skeletal muscle: 423.5" "Cell type enhanced" "Detected in many" 22 "Collecting duct cells: 146.5;Distal tubular cells: 137.6;Hofbauer cells: 149.3;Melanocytes: 323.9;Proximal tubular cells: 712.0" "Group enriched" "Detected in all" 5 "melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Hep G2: 43.7;SK-MEL-30: 149.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002599, HPA006462" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 240000 Cytosol "Nucleoplasm, Golgi apparatus" "CAB002599: AB_2315307, HPA006462: AB_1079857" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (5.96e-5)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.19e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (2.34e-3)" "unprognostic (6.83e-3)" "unprognostic (5.22e-1)" "unprognostic (5.04e-3)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.68e-1)" "unprognostic (4.56e-2)" "unprognostic (2.70e-3)" "unprognostic (9.74e-4)" 27.7 3.2 70.0 2.8 67.3 2.2 14.3 4.1 42.5 2.0 2.4 47.3 0.0 3.5 2.6 8.5 14.1 8.8 2.6 465.5 44.9 42.9 20.0 2.6 2.4 2.5 85.0 30.7 2.2 4.5 2.0 4.3 4.5 31.4 6.3 2.1 4.3 99.3 3.7 423.5 4.0 2.9 2.1 87.7 2.4 3.3 2.8 31.8 0.0 29.0 57.6 4.7 2.9 0.1 0.6 0.6 2.1 1.0 0.3 0.5 0.5 0.7 0.3 0.5 4.6 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.9 0.4 0.5 19.6 0.0 0.2 1.1 0.0 0.0 0.0 0.5 0.4 1.0 0.6 43.7 0.0 0.3 0.3 0.1 0.0 0.0 0.0 1.0 0.0 0.1 3.5 0.5 0.0 1.2 0.1 0.5 0.2 0.5 0.4 3.1 0.4 1.1 0.8 1.7 0.7 0.2 0.3 1.4 149.9 1.4 4.5 2.3 0.4 0.4 0.3 0.3 0.4 0.7 0.7 0.7 0.3 0.8 0.2 2.1 0.3 0.0 0.1 0.3 0.1 0.0 0.2 0.5 0.0 0.6 0.3 0.0 0.0 0.3 1.0 0.6 0.0 0.5 70.0 67.3 4.1 42.5 44.9 42.9 85.0 30.7 31.4 31.8 0.0 0.0 0.0 1.1 8.7 0.6 57.3 5.1 0.0 0.0 146.5 2.0 0.9 137.6 0.7 0.5 2.1 0.9 0.0 3.4 0.8 2.3 1.2 0.0 3.2 149.3 0.0 1.7 13.5 0.6 1.5 6.1 1.3 323.9 0.0 2.2 60.1 1.1 0.0 8.5 712.0 2.2 0.0 2.1 0.9 0.7 1.9 2.9 0.0 1.5 0.6 S100A9 "60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14" ENSG00000163220 "S100 calcium binding protein A9" P06702 1 153357854-153361027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Antioxidant" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6" "Cell type enriched" "Detected in many" 7 "Kupffer cells: 11072.0" "Cancer enhanced" "Detected in all" "cervical cancer: 5468.0;head and neck cancer: 6692.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 381.5;neutrophil: 638.3" "Group enriched" "Detected in many" 6 "granulocytes: 638.3;monocytes: 381.5" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 233.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA004193, CAB009441" Enhanced Supported "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA 10600000 1400000000 "Nucleoplasm, Cell Junctions, Cytosol" "CAB009441: AB_2184420, HPA004193: AB_1856537" "unprognostic (1.72e-1)" "unprognostic (3.33e-2)" "unprognostic (2.40e-1)" "unprognostic (3.94e-3)" "unprognostic (1.36e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (1.13e-6)" "unprognostic (1.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.48e-1)" "unprognostic (7.52e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-2)" 19.5 2.1 1.3 41.9 4.2 820.1 4.1 0.9 2.1 143.6 4.4 0.7 0.4 0.7 4.9 4.0 642.6 9.9 4.4 51.2 2.5 0.4 2.8 4.8 29.2 169.0 5.3 0.6 3.4 4.4 0.1 0.9 10.4 5.2 2.2 0.7 2.0 109.6 0.5 3.4 7.5 1.4 13.1 2.1 103.2 3.5 2.9 1.4 3.8 6.7 477.6 228.0 24.3 237.0 0.5 87.5 638.3 381.5 0.3 1.0 323.2 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.8 36.6 0.0 0.0 2.2 0.0 15.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 12.7 0.0 0.8 0.0 0.0 0.0 0.7 0.3 0.0 2.9 0.0 0.3 0.0 0.2 0.0 0.0 0.5 7.7 0.0 9.5 0.1 0.0 0.3 233.1 0.1 0.1 3.6 29.6 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 6.7 0.0 5.3 381.5 46.4 0.5 31.6 1.0 0.4 0.4 0.3 87.5 0.5 0.3 0.3 638.3 0.3 15.0 2.9 0.5 323.2 1.3 4.2 0.9 2.1 2.5 0.4 5.3 0.6 5.2 1.4 214.4 574.2 57.1 52.5 17.7 0.0 2.5 66.2 112.4 185.4 34.9 0.0 111.0 5.0 49.4 1.3 7.0 0.5 23.3 32.9 44.2 7.1 19.6 151.1 16.4 1627.6 0.0 0.0 71.2 11072.0 2.2 5.5 1162.8 0.0 4.6 2.1 0.0 10.3 0.8 0.0 16.3 0.2 0.0 2.5 0.3 1.3 29.1 1033.7 24.9 1.9 291.7 S100B S100beta ENSG00000160307 "S100 calcium binding protein B" P04271 21 46598962-46605208 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 342.0" "Cell type enhanced" "Detected in some" 16 "Kupffer cells: 25.7;Macrophages: 53.7;Melanocytes: 94.5;monocytes: 55.9" "Group enriched" "Detected in all" 58 "glioma: 463.5;melanoma: 495.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 78.0" "Lineage enriched" "Detected in many" 7 "T-cells: 78.0" "Group enriched" "Detected in some" 7 "SK-MEL-30: 82.9;WM-115: 163.0" "Low region specificity" "Detected in all" "CAB000073, HPA015768, CAB078196" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA 120000 "Nucleoplasm, Cytosol" Vesicles "CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538" "unprognostic (5.67e-3)" "unprognostic (6.39e-3)" "unprognostic (2.08e-3)" "unprognostic (2.08e-2)" "unprognostic (4.54e-3)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.57e-3)" "unprognostic (6.70e-2)" "unprognostic (4.41e-7)" "unprognostic (3.55e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" 67.7 14.0 60.9 5.6 51.0 2.0 13.2 39.4 151.2 5.2 9.1 101.0 3.0 4.7 1.5 7.6 8.6 2.1 8.3 6.6 74.6 65.4 1.5 1.6 2.9 9.8 152.0 36.5 2.4 3.0 1.1 3.1 1.4 90.3 3.0 8.3 7.4 10.1 15.3 1.3 5.7 7.5 4.3 342.0 5.7 4.3 1.5 46.4 0.0 1.3 1.8 10.8 8.2 1.6 0.1 3.4 0.7 1.9 11.0 78.0 10.6 0.1 0.0 18.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 82.9 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 1.0 163.0 0.0 0.1 0.0 78.0 1.8 22.4 0.0 0.2 14.5 3.4 0.1 0.6 33.3 0.7 11.0 1.9 0.8 0.0 10.6 60.9 51.0 39.4 37.6 74.6 65.4 152.0 36.5 90.3 46.4 3.0 7.4 0.9 0.2 14.9 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.2 7.6 0.0 0.0 4.9 25.7 0.4 5.2 53.7 94.5 55.9 0.0 9.7 0.1 0.0 0.0 0.0 4.0 0.0 2.1 0.0 0.1 11.0 0.1 0.5 0.0 0.1 SAFB2 KIAA0138 ENSG00000130254 "Scaffold attachment factor B2" Q14151 19 5586999-5624046 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050894 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA050894: AB_2681266" "unprognostic (7.46e-2)" "unprognostic (3.09e-1)" "unprognostic (7.69e-3)" "prognostic favorable (7.10e-4)" "unprognostic (7.95e-2)" "unprognostic (6.76e-3)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.11e-1)" "unprognostic (5.14e-2)" "prognostic favorable (2.53e-4)" "unprognostic (2.23e-2)" "unprognostic (2.82e-3)" "unprognostic (1.17e-2)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "prognostic favorable (2.12e-4)" 25.7 29.6 31.0 29.6 33.7 35.4 17.4 50.8 46.2 27.4 21.6 28.4 23.1 25.8 30.2 27.4 15.7 26.8 19.4 21.0 30.3 24.6 32.2 20.0 18.2 26.8 30.5 26.5 42.8 24.2 31.0 38.4 17.3 28.6 28.4 20.9 21.3 23.6 34.8 38.1 18.9 25.7 24.8 43.4 29.4 20.1 23.4 34.3 23.5 26.9 11.1 25.2 24.1 32.7 11.4 9.3 24.3 9.5 6.4 13.3 5.6 17.8 23.3 17.0 12.5 16.7 10.8 19.8 17.0 9.3 10.7 10.1 29.7 13.0 34.2 15.6 8.5 8.7 16.5 20.7 10.6 17.7 23.7 22.1 26.0 23.7 23.0 9.7 21.7 24.5 10.7 11.3 15.6 12.1 10.6 10.4 12.4 24.9 17.3 12.6 20.0 25.9 20.7 29.0 14.0 24.7 32.9 14.7 19.0 12.0 30.6 16.0 14.9 22.6 10.4 13.7 11.4 15.4 13.4 16.4 13.2 13.8 16.5 23.2 23.0 20.5 24.8 13.6 18.9 21.6 24.3 9.5 15.8 11.9 8.2 13.3 10.3 10.5 9.2 8.3 11.4 11.7 9.1 18.3 6.4 8.5 9.3 9.5 5.6 31.0 33.7 50.8 46.2 30.3 24.6 30.5 26.5 28.6 34.3 38.7 42.6 34.8 47.8 41.4 64.3 26.8 12.7 65.6 37.5 31.4 70.7 37.5 19.9 41.3 5.9 42.1 42.8 23.3 38.9 37.8 33.4 47.8 39.5 21.3 27.2 41.3 41.2 22.7 23.2 5.1 67.0 39.7 25.3 49.5 33.1 83.1 36.3 42.1 61.9 50.7 79.7 45.3 49.5 61.2 74.7 36.6 27.0 50.7 37.9 44.8 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 29.1;testis: 22.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 65.6;Cone photoreceptor cells: 58.9;Early spermatids: 61.5;Late spermatids: 75.0;Rod photoreceptor cells: 75.7;Spermatocytes: 45.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 10.8" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.8 1.3 5.3 0.5 6.7 0.9 1.5 0.8 3.3 1.2 0.7 2.2 3.1 0.6 1.5 7.5 0.7 6.2 1.5 0.6 3.7 2.9 6.0 0.6 1.8 1.9 1.4 3.1 3.2 2.7 5.2 29.1 0.5 7.9 1.3 0.5 4.4 0.8 1.1 0.5 0.8 0.6 0.6 1.5 0.7 0.7 22.1 2.3 0.1 6.9 0.0 1.8 1.9 0.7 0.6 0.2 2.3 0.5 0.6 0.4 0.1 3.6 4.9 1.9 4.1 0.5 2.1 1.8 1.5 1.3 4.0 3.6 3.5 3.3 4.0 1.6 1.5 3.5 3.5 1.4 2.0 5.5 0.3 0.7 0.6 1.4 0.9 0.2 0.7 4.3 2.0 1.3 3.4 0.4 1.7 2.7 2.0 0.4 1.2 1.6 10.8 0.9 0.4 0.8 0.9 1.6 1.7 1.9 0.2 6.9 2.0 4.3 2.7 5.1 0.8 0.7 0.8 6.4 1.2 1.0 3.7 2.2 3.9 1.9 0.7 3.3 2.6 4.7 0.2 1.9 0.7 0.5 1.2 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.6 0.3 0.4 2.3 0.6 0.5 0.1 0.4 0.1 5.3 6.7 0.8 3.3 3.7 2.9 1.4 3.1 7.9 2.3 0.0 0.0 0.0 0.4 0.2 9.7 0.8 2.5 65.6 2.3 0.0 58.9 0.2 1.7 2.4 61.5 0.3 0.0 0.0 0.6 0.2 0.6 0.5 0.0 0.0 0.1 3.2 3.5 0.0 0.0 75.0 1.4 0.0 0.0 0.0 0.0 4.8 1.0 0.0 0.0 3.4 75.7 0.0 0.3 45.6 6.0 0.0 0.2 0.0 0.0 0.1 SAP18 "2HOR0202, MGC27131, SAP18p" ENSG00000150459 "Sin3A associated protein 18" O00422 13 21140514-21149084 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011352, CAB012273" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB012273: , HPA011352: AB_1856563" "unprognostic (5.08e-2)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-3)" "unprognostic (2.84e-1)" "unprognostic (5.21e-2)" "unprognostic (3.02e-1)" "unprognostic (3.18e-1)" "unprognostic (8.15e-2)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (4.14e-2)" "unprognostic (2.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.70e-2)" "unprognostic (3.70e-3)" "unprognostic (2.78e-2)" 35.3 67.0 55.2 45.3 57.4 81.0 38.0 35.2 49.1 30.0 44.8 43.9 37.6 53.1 37.5 40.3 59.5 32.4 33.0 66.3 68.4 61.3 63.2 47.5 34.8 41.7 64.9 50.2 37.3 52.3 16.2 38.8 43.1 54.9 34.4 23.8 26.4 50.1 34.5 121.6 31.4 48.6 48.1 73.5 31.6 41.6 79.2 49.3 34.0 34.9 51.0 24.4 37.3 48.6 90.1 107.4 97.9 96.4 70.0 94.1 143.8 29.7 16.8 27.3 29.4 29.6 24.9 42.3 38.1 28.4 35.4 26.2 30.3 57.8 30.9 47.1 31.5 38.5 31.3 33.5 23.9 40.0 47.1 17.0 44.0 22.2 50.2 33.7 59.7 35.7 25.0 27.3 27.0 32.4 27.4 26.5 37.6 20.8 17.7 31.9 38.1 67.4 98.2 34.2 83.3 18.5 42.8 43.1 30.7 49.6 26.8 31.8 27.8 24.5 36.5 47.1 31.8 35.2 87.7 32.2 21.8 24.3 39.4 44.3 27.5 38.1 85.1 21.2 35.6 39.9 69.6 82.9 97.9 70.0 89.0 70.6 90.1 86.2 82.4 81.2 77.6 84.2 83.2 83.4 70.0 96.4 107.4 94.1 143.8 55.2 57.4 35.2 49.1 68.4 61.3 64.9 50.2 54.9 49.3 125.0 120.4 256.8 291.2 407.4 98.9 565.8 201.2 230.2 162.7 221.6 39.3 478.6 643.2 319.3 984.2 273.5 352.1 93.5 320.2 439.3 341.9 285.9 252.8 227.3 346.1 112.8 225.1 143.1 173.7 111.6 316.9 273.6 386.3 458.1 262.9 223.0 331.8 354.2 285.3 790.7 102.1 200.5 388.3 329.4 303.0 369.1 759.6 214.2 268.2 375.5 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062124-137070588 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.8;Mucus-secreting cells: 6.4;Paneth cells: 4.9;Undifferentiated cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavorable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 1.0 0.4 11.5 10.5 7.0 3.3 2.6 1.4 14.4 2.5 6.2 10.1 0.0 7.6 1.0 0.4 7.8 0.8 5.4 0.4 9.6 7.5 1.2 0.4 2.7 4.7 8.0 3.8 0.3 0.8 0.3 0.4 1.8 5.4 5.4 3.5 0.0 7.3 0.4 0.4 5.4 7.7 1.0 7.0 2.7 4.6 1.5 2.7 9.2 0.6 3.5 10.0 1.0 1.9 0.5 0.8 0.5 1.7 0.0 0.4 0.4 16.0 8.7 3.4 10.2 0.1 0.2 18.5 2.6 1.8 2.8 1.3 16.4 7.4 16.8 8.6 1.3 2.6 22.8 10.8 3.0 0.6 11.5 12.4 7.3 9.6 18.3 0.0 8.3 12.7 0.0 0.5 1.0 1.8 0.7 4.6 8.6 10.1 7.6 0.8 37.7 2.4 22.4 6.4 37.2 19.8 25.6 13.1 18.6 3.5 4.6 17.9 10.6 10.2 28.6 3.9 0.8 23.1 15.8 2.9 2.6 8.8 7.7 13.0 2.6 7.6 8.1 6.0 9.9 8.1 0.2 1.7 0.0 0.0 0.5 0.4 0.5 0.3 0.0 0.8 0.2 0.1 0.0 0.5 0.0 0.8 0.2 0.3 0.4 11.5 7.0 1.4 6.1 9.6 7.5 8.0 3.8 5.4 2.7 0.0 0.0 0.0 0.6 3.8 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.3 0.0 0.0 0.4 0.0 0.0 2.7 0.6 2.1 0.0 0.0 2.5 0.0 0.0 0.6 3.0 0.0 0.0 1.8 0.0 0.0 6.4 0.6 0.3 4.9 0.0 0.0 0.5 0.0 0.3 0.0 1.2 2.4 0.5 1.0 4.5 0.5 SARS2 "FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS" ENSG00000104835 "Seryl-tRNA synthetase 2, mitochondrial" Q9NP81 19 38915266-38930896 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 34.4;Late spermatids: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA052730, HPA056957" Approved Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (3.20e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.88e-3)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.57e-2)" "unprognostic (8.62e-3)" "unprognostic (8.36e-2)" "unprognostic (1.67e-1)" "unprognostic (5.62e-3)" "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.69e-2)" 5.8 16.5 9.9 7.2 12.8 11.1 7.4 10.7 20.4 8.0 9.2 11.3 11.4 12.3 9.0 9.4 12.9 11.5 8.2 12.3 8.3 8.6 13.4 20.6 6.3 11.0 10.9 7.8 9.5 14.4 11.2 11.4 10.7 15.0 11.0 8.5 11.8 13.6 9.9 15.5 15.6 9.9 8.1 7.2 11.3 11.1 8.8 11.5 11.4 13.8 9.5 12.6 11.0 8.3 6.3 12.7 0.4 7.2 6.5 8.0 4.3 5.7 17.4 7.0 4.1 2.9 6.0 9.6 4.0 5.5 9.5 7.5 14.2 7.1 6.5 5.8 5.7 3.8 5.4 7.3 11.4 2.4 5.5 9.4 12.9 7.5 12.2 6.9 11.0 12.9 9.1 6.2 6.2 4.3 4.7 6.7 10.5 11.1 6.4 4.8 12.2 8.3 10.0 7.1 9.0 3.5 12.0 6.3 7.1 10.1 13.9 12.0 7.6 5.4 14.5 3.6 2.7 7.4 7.4 4.3 5.9 6.8 4.6 3.9 4.7 2.7 5.1 3.8 7.7 4.9 0.0 4.1 0.4 8.0 7.2 6.4 6.3 5.9 8.0 12.7 5.7 4.3 4.9 0.3 6.5 6.4 5.0 6.6 4.3 9.9 12.8 10.7 20.4 8.3 8.6 10.9 7.8 15.0 11.5 6.0 6.4 9.5 3.4 3.8 7.2 8.1 10.2 4.0 4.5 5.2 7.9 34.4 13.3 13.2 10.2 3.2 5.1 0.0 11.2 19.0 5.1 2.3 5.7 8.1 11.2 4.8 10.9 6.2 6.2 42.6 4.4 3.5 3.3 6.4 7.1 2.9 7.8 3.5 4.6 5.6 13.4 0.0 2.1 1.5 7.2 3.6 24.4 6.9 16.6 2.6 SASH3 "753P9, CXorf9, HACS2, SH3D6C, SLY" ENSG00000122122 "SAM and SH3 domain containing 3" O75995 X 129779979-129795201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.8;bone marrow: 33.2;lymphoid tissue: 85.3" "Cell type enhanced" "Detected in some" 12 "B-cells: 45.6;Hofbauer cells: 45.7;Kupffer cells: 59.2;T-cells: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 43.6;JURKAT: 31.2;MOLT-4: 31.1;NB-4: 23.7;REH: 23.3;U-698: 39.8;U-937: 30.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001085 Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA001085: AB_2184289" "unprognostic (1.88e-2)" "unprognostic (5.82e-3)" "unprognostic (1.49e-3)" "prognostic favorable (3.15e-4)" "unprognostic (1.12e-1)" "unprognostic (1.19e-3)" "unprognostic (1.67e-1)" "unprognostic (3.23e-3)" "unprognostic (7.92e-3)" "unprognostic (3.45e-1)" "unprognostic (8.75e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.51e-5)" "unprognostic (3.30e-1)" "unprognostic (3.56e-2)" "unprognostic (3.17e-2)" "unprognostic (1.53e-1)" 7.8 3.4 2.8 34.6 5.2 33.2 2.7 0.7 2.2 2.0 3.3 4.0 0.2 3.9 1.9 2.1 2.9 3.4 3.6 2.0 3.3 2.4 3.3 3.0 10.6 38.2 5.2 1.1 1.3 1.8 0.2 1.8 2.5 4.2 2.7 3.5 1.6 7.8 0.8 0.9 1.1 18.8 2.4 6.2 55.7 4.2 0.8 4.0 85.3 2.5 2.0 38.6 7.0 2.0 22.0 27.6 53.7 44.2 33.4 46.9 61.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.2 0.0 3.7 0.0 0.0 31.1 23.7 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.1 0.0 0.0 0.0 8.8 39.8 0.0 30.9 0.0 7.9 29.4 53.7 46.9 44.1 38.7 19.1 26.7 43.1 27.6 22.0 19.3 30.0 29.1 33.4 44.2 12.7 32.3 61.8 2.8 5.2 0.7 2.2 3.3 2.4 5.2 1.1 4.2 4.0 0.0 5.1 45.6 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 23.3 0.0 0.5 0.4 0.0 21.9 0.9 45.7 0.0 0.0 3.7 59.2 0.0 0.3 20.3 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.5 75.2 0.0 0.0 SBF2 "CMT4B2, DENND7B, KIAA1766, MTMR13" ENSG00000133812 "SET binding factor 2" Q86WG5 11 9778667-10294207 "Disease related genes, Predicted intracellular proteins" Autophagy "Guanine-nucleotide releasing factor" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050933 Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Intermediate filaments, Cytosol" "HPA050933: AB_2681280" "unprognostic (2.26e-1)" "unprognostic (1.45e-2)" "unprognostic (1.91e-2)" "unprognostic (1.00e-1)" "unprognostic (2.28e-1)" "unprognostic (5.36e-2)" "unprognostic (5.55e-2)" "unprognostic (6.44e-3)" "unprognostic (2.84e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-3)" "unprognostic (2.43e-1)" "prognostic favorable (3.66e-5)" "unprognostic (3.72e-2)" "unprognostic (8.77e-2)" "unprognostic (3.43e-1)" "unprognostic (4.11e-2)" 26.2 12.7 19.8 8.9 22.5 6.1 17.9 26.7 17.4 23.6 15.6 18.4 13.2 9.8 19.1 14.2 16.9 15.3 14.9 13.7 16.3 12.3 20.8 13.8 13.8 8.7 14.6 12.0 26.8 8.0 33.9 23.2 20.5 13.7 16.8 15.3 15.6 14.7 17.7 8.8 13.2 11.1 22.0 16.1 12.4 13.3 15.3 19.1 7.8 24.0 9.1 9.2 20.2 25.5 0.6 1.0 3.9 3.9 0.9 0.6 0.5 6.7 6.1 9.6 6.8 12.9 17.2 49.3 5.3 9.6 6.3 8.9 4.0 8.3 2.6 2.8 9.3 9.2 4.5 5.7 4.3 11.0 2.7 4.1 1.0 4.4 5.4 5.2 2.4 3.6 8.7 5.8 3.3 12.3 9.6 10.2 5.6 2.2 2.5 7.4 2.0 3.5 0.7 4.1 6.1 6.1 3.3 6.7 3.4 5.6 6.1 3.2 7.1 7.3 10.2 4.5 5.2 3.0 1.7 11.1 11.3 5.6 11.2 4.3 0.9 1.9 3.7 8.4 1.2 7.9 0.0 1.9 0.1 0.2 1.8 0.6 0.3 0.2 0.4 1.0 0.6 0.3 0.1 3.9 0.9 3.9 0.4 0.2 0.5 19.8 22.5 26.7 17.4 16.3 12.3 14.6 12.0 13.7 19.1 41.7 103.3 8.8 32.8 22.7 31.5 23.8 15.3 38.8 31.8 15.7 70.7 11.6 3.3 11.0 12.7 38.3 13.8 0.0 7.5 10.5 31.5 47.0 19.8 14.7 16.3 35.0 42.1 51.0 51.2 6.2 47.2 31.9 28.7 15.4 17.1 13.0 10.9 21.8 25.5 9.8 76.6 25.8 28.8 16.8 16.8 26.8 11.6 34.6 17.2 43.4 SCAMP1 SCAMP37 ENSG00000085365 "Secretory carrier membrane protein 1" O15126 5 78360583-78479071 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044753, CAB079009" Supported Approved "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Nucleoplasm, Vesicles, Cell Junctions" "CAB079009: , HPA044753: " "unprognostic (8.25e-2)" "unprognostic (3.65e-2)" "unprognostic (1.40e-3)" "unprognostic (5.34e-3)" "unprognostic (2.60e-1)" "unprognostic (2.57e-3)" "unprognostic (5.51e-2)" "unprognostic (3.43e-2)" "unprognostic (1.31e-1)" "unprognostic (8.23e-3)" "unprognostic (2.35e-2)" "unprognostic (2.56e-1)" "prognostic favorable (1.92e-4)" "unprognostic (8.44e-3)" "unprognostic (7.56e-2)" "unprognostic (3.12e-2)" "unprognostic (4.99e-2)" 7.5 8.3 9.2 4.0 19.3 2.4 10.0 12.8 19.5 8.4 6.4 5.4 9.9 5.3 8.7 9.3 8.6 10.7 6.4 8.0 15.8 10.4 6.2 5.9 3.9 6.5 15.8 8.8 8.8 17.5 14.6 7.6 14.6 12.2 7.3 7.6 10.6 11.0 4.7 5.8 5.3 9.1 9.0 3.9 9.6 4.5 7.1 4.1 14.2 3.8 3.7 8.8 6.3 7.9 14.9 15.3 15.8 10.0 9.9 7.4 12.5 9.9 9.9 30.6 13.7 17.7 15.6 11.6 16.9 9.6 21.9 3.7 23.5 18.5 13.1 16.9 27.5 10.2 14.0 21.8 17.2 6.5 13.3 8.5 7.9 7.6 8.8 5.4 6.6 11.6 20.2 10.9 17.3 24.2 14.6 10.4 3.2 13.3 18.2 14.7 9.3 11.5 8.0 5.4 10.2 11.4 16.3 21.1 17.5 14.9 28.1 17.1 10.7 15.2 10.9 10.5 21.1 9.8 14.9 10.6 7.9 11.7 9.7 9.3 11.2 11.5 20.7 20.3 8.8 15.3 11.4 12.8 8.2 12.6 9.9 7.9 9.4 9.8 14.9 6.6 7.8 6.8 7.0 10.0 15.8 4.6 9.1 7.4 23.8 19.0 6.7 28.6 34.8 72.3 33.0 20.4 71.0 26.1 38.4 66.8 10.4 11.6 22.7 31.3 27.8 11.7 23.3 26.3 21.3 31.0 36.1 11.5 13.9 16.8 30.2 34.0 22.1 30.5 12.1 18.7 22.7 28.7 6.4 33.6 43.2 26.4 11.5 26.9 20.5 63.0 12.9 25.0 17.0 20.4 39.5 8.8 13.8 17.0 25.0 SCAPER "Zfp291, ZNF291" ENSG00000140386 "S-phase cyclin A associated protein in the ER" Q9BY12 15 76347904-76905444 "Predicted intracellular proteins" "Disease mutation, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 237.6;Rod photoreceptor cells: 661.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046253, HPA048077" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA No "Nucleoplasm, Nuclear speckles" Cytosol "HPA046253: AB_2679600, HPA048077: " "unprognostic (3.67e-1)" "unprognostic (8.60e-2)" "unprognostic (6.08e-2)" "unprognostic (8.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (4.94e-2)" "unprognostic (3.74e-2)" "unprognostic (5.40e-2)" "unprognostic (1.02e-1)" "prognostic favorable (2.69e-9)" "unprognostic (2.14e-1)" "unprognostic (3.79e-1)" "unprognostic (1.86e-1)" "unprognostic (2.89e-3)" 9.0 10.9 17.0 9.3 15.6 8.8 9.4 26.0 20.7 10.3 8.3 10.7 9.8 8.9 10.0 10.8 12.1 9.0 7.5 17.8 15.9 17.2 12.6 9.9 8.4 7.1 17.3 13.2 16.8 10.9 24.1 36.3 24.6 15.6 9.9 6.3 7.7 9.7 9.5 17.9 9.8 8.3 10.4 20.6 7.5 7.9 25.7 14.7 12.6 16.3 8.7 7.7 9.4 9.5 13.2 6.6 20.4 4.6 12.0 14.3 2.8 5.0 4.7 6.6 3.8 3.3 6.2 5.5 7.0 4.9 3.2 4.6 5.0 4.1 5.1 6.1 2.3 8.6 5.5 15.5 2.9 4.8 11.9 7.6 2.7 5.7 2.4 4.3 7.2 6.4 5.1 5.2 3.8 6.2 7.0 4.3 10.5 3.8 14.6 5.5 2.1 7.0 2.2 2.0 4.7 2.8 6.4 10.5 1.8 2.9 5.2 15.7 7.6 9.2 3.2 7.5 8.4 4.8 6.0 5.2 7.4 6.9 3.5 6.0 8.9 18.6 7.6 4.3 9.1 4.9 20.4 4.6 11.5 8.6 2.5 9.8 11.0 8.7 7.6 2.5 13.2 14.3 9.1 7.7 12.0 2.9 6.6 6.6 2.8 17.0 15.6 26.0 17.1 15.9 17.2 17.3 13.2 15.6 14.7 92.3 52.8 16.4 22.9 18.3 84.2 167.4 15.3 16.0 40.9 12.2 237.6 23.7 1.7 11.6 45.9 22.0 20.2 0.0 5.1 9.4 13.4 12.1 20.9 7.9 11.7 73.1 15.5 19.0 11.0 17.8 19.0 10.3 10.1 3.6 7.7 46.4 5.9 11.6 18.0 5.7 661.5 19.4 11.7 121.4 69.5 16.4 43.5 21.2 12.4 19.7 SCARF2 "HUMZD58C02, SREC-II, SREC2" ENSG00000244486 "Scavenger receptor class F member 2" Q96GP6 22 20424815-20437826 "Disease related genes, Predicted membrane proteins" "Cell adhesion" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 28.8;Fibroblasts: 17.0;Leydig cells: 12.4;Peritubular cells: 16.6;Sertoli cells: 12.9;Smooth muscle cells: 14.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 14.2;SH-SY5Y: 15.8;SK-MEL-30: 15.7;U-138 MG: 21.8;U-2 OS: 22.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035079 Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 360000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA035079: AB_10670287" "unprognostic (2.12e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-3)" "unprognostic (2.29e-1)" "unprognostic (2.92e-1)" "unprognostic (7.68e-2)" "unprognostic (7.87e-2)" "unprognostic (8.27e-2)" "unprognostic (2.18e-2)" "unprognostic (1.68e-1)" "unprognostic (2.94e-1)" "prognostic unfavorable (2.78e-5)" "unprognostic (4.38e-3)" "unprognostic (3.18e-2)" "unprognostic (3.00e-3)" "prognostic unfavorable (4.28e-4)" 6.5 2.4 0.0 4.1 0.3 0.1 9.2 0.0 1.2 10.6 3.2 0.4 2.9 1.4 8.1 6.6 1.8 2.6 11.3 3.4 0.6 3.2 1.1 5.9 5.1 0.8 0.4 12.6 1.6 0.0 0.6 5.6 0.9 5.5 0.0 9.2 1.1 6.8 1.8 2.2 1.9 9.9 0.5 5.3 1.4 2.5 0.0 0.0 5.4 3.3 1.4 7.1 10.9 0.1 0.1 0.9 0.0 0.0 1.8 0.0 0.4 0.2 3.2 5.5 1.9 2.7 1.3 14.2 5.9 3.4 1.8 0.0 0.0 0.2 8.3 6.8 0.2 0.1 1.8 0.0 0.4 0.4 11.9 1.1 0.2 2.5 11.8 0.0 0.6 4.6 0.0 1.7 0.8 1.6 1.7 0.0 0.1 0.1 1.2 0.6 0.0 0.2 4.3 0.0 1.8 0.3 9.0 0.0 0.0 0.0 1.4 15.8 0.1 0.0 15.7 0.6 0.5 0.0 2.1 21.8 22.9 0.5 3.2 0.6 0.2 0.2 0.1 0.3 10.8 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 1.7 2.5 3.0 28.8 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.2 3.3 0.0 0.0 0.0 1.2 17.0 2.2 0.0 0.0 0.5 0.0 0.0 2.5 0.6 0.0 12.4 0.6 3.3 0.0 0.0 0.5 0.0 0.0 16.6 0.0 0.4 12.9 14.4 0.5 0.2 2.4 0.3 0.0 0.0 0.5 SCEL "FLJ21667, MGC22531" ENSG00000136155 Sciellin O95171 13 77535674-77645263 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 145.6;skin 1: 70.8;tongue: 62.2" "Cell type enriched" "Detected in many" 13 "Alveolar cells type 1: 631.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.4;HaCaT: 23.3;HBEC3-KT: 11.1;OE19: 31.1;RPTEC TERT1: 45.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA039737, HPA040154" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Plasma membrane" "Nucleoplasm, Cytosol" "HPA039737: AB_10805485, HPA040154: AB_10795359" "unprognostic (1.18e-1)" "unprognostic (1.17e-1)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.07e-4)" "unprognostic (5.91e-2)" "unprognostic (4.54e-2)" "unprognostic (6.62e-2)" "unprognostic (3.51e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (1.24e-4)" "unprognostic (4.57e-2)" "prognostic favorable (6.87e-4)" "unprognostic (1.81e-1)" "unprognostic (2.82e-1)" "unprognostic (1.75e-3)" "prognostic unfavorable (1.73e-5)" 0.4 0.0 0.1 0.2 0.4 0.0 4.9 0.1 0.2 15.2 0.2 0.2 0.1 0.0 0.8 0.2 145.6 0.0 0.3 0.1 0.1 0.0 0.4 0.1 27.8 0.1 0.1 0.1 0.2 0.1 0.0 0.1 3.7 0.2 0.1 0.4 0.1 11.8 0.1 0.3 70.8 0.2 0.1 0.2 0.1 0.0 0.5 0.1 0.4 0.5 62.2 35.1 0.4 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.7 0.0 0.0 23.3 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 6.3 0.0 0.0 0.0 45.3 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 631.3 30.6 0.0 0.0 9.5 0.0 0.2 0.0 6.7 42.1 0.0 0.0 0.3 0.0 4.1 5.8 0.0 0.0 0.0 0.2 0.0 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.6 1.7 0.0 4.3 1.5 26.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.7 48.8 0.1 0.0 0.0 2.6 SCMH1 Scml3 ENSG00000010803 "Scm polycomb group protein homolog 1" Q96GD3 1 41027200-41242154 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048898, HPA053292" Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No Nucleoplasm "Nuclear bodies, Cytosol" "HPA048898: , HPA053292: AB_2797246" "unprognostic (6.02e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.82e-4)" "unprognostic (1.98e-2)" "unprognostic (8.77e-2)" "unprognostic (8.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.40e-1)" "unprognostic (7.38e-2)" "unprognostic (9.47e-2)" "unprognostic (1.63e-1)" "unprognostic (8.08e-2)" "prognostic favorable (5.80e-4)" 12.5 13.1 14.7 18.2 15.3 11.2 21.3 15.9 13.9 15.8 27.9 6.7 23.4 9.0 21.4 16.7 11.1 16.5 17.2 27.2 12.6 8.8 14.8 9.5 11.4 10.5 7.6 12.5 24.8 30.2 26.5 23.0 7.8 10.7 22.7 12.6 16.8 19.2 23.8 28.4 8.4 12.7 36.9 7.4 8.7 18.5 26.6 6.7 11.3 14.3 11.1 8.3 22.7 25.7 4.3 7.6 2.2 2.2 2.9 4.2 1.7 9.0 6.1 14.5 13.3 6.7 12.7 0.0 7.3 12.8 12.3 12.8 5.8 11.7 16.6 5.6 13.2 10.3 2.3 11.2 9.8 10.6 11.4 8.5 7.7 8.2 14.4 29.0 16.5 12.8 13.8 10.0 8.1 19.8 14.9 12.3 20.7 7.2 12.9 12.0 4.9 16.5 14.3 13.3 7.7 6.5 18.3 15.2 9.8 9.8 11.4 10.2 11.0 12.7 10.2 10.5 10.3 9.0 42.5 9.0 12.9 10.1 7.9 13.3 13.2 7.4 18.1 8.1 14.8 11.7 1.3 1.2 2.2 3.3 2.2 4.2 4.3 3.9 3.1 3.7 2.1 2.9 2.4 0.0 2.9 0.5 7.6 2.7 1.7 14.7 15.3 15.9 13.9 12.6 8.8 7.6 12.5 10.7 6.7 8.9 6.7 8.0 23.8 6.0 13.8 13.5 10.2 4.0 7.9 12.2 15.7 6.7 1.7 8.8 7.2 6.8 7.8 0.0 18.3 2.6 8.0 20.7 4.7 4.7 5.2 7.9 8.1 6.7 4.8 9.4 15.3 3.1 8.5 2.8 6.2 6.0 11.3 3.5 17.0 11.5 13.5 19.4 8.0 50.0 28.6 3.1 4.0 4.8 11.7 11.9 SCN1A "FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI" ENSG00000144285 "Sodium voltage-gated channel alpha subunit 1" P35498 2 165984641-166149214 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 33.9" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 26.9;Bipolar cells: 33.9" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC TERT1: 11.6;Hep G2: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078664 Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA078664: AB_2686888" "unprognostic (9.25e-2)" "unprognostic (3.97e-2)" "unprognostic (6.88e-2)" "unprognostic (7.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "unprognostic (4.70e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-1)" "unprognostic (9.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.03e-9)" "unprognostic (6.92e-2)" "unprognostic (3.69e-2)" "unprognostic (5.06e-3)" "unprognostic (6.93e-1)" 1.1 1.3 5.2 1.1 13.6 1.0 1.1 10.3 26.6 1.1 1.1 2.3 0.0 1.0 1.1 1.1 1.0 6.8 1.0 1.1 6.9 8.3 1.1 1.1 5.6 1.0 5.7 9.7 1.0 1.0 1.1 2.9 1.2 33.9 1.1 1.1 0.3 1.0 1.0 1.2 1.1 1.1 1.1 3.6 1.1 1.1 1.4 4.2 0.0 1.1 0.0 1.0 1.1 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 11.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.2 13.6 10.3 26.6 6.9 8.3 5.7 9.7 33.9 4.2 6.0 26.9 0.0 0.0 0.0 33.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649673 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 67.3" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 66.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "LHCN-M2: 22.0;RH-30: 18.3" "Group enriched" "Detected in some" 5 "amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0" "Low region specificity" "Detected in many" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.3 0.2 1.3 0.2 0.3 0.4 0.6 0.1 2.3 2.0 0.4 0.0 0.4 0.3 0.9 0.8 0.2 0.4 0.3 67.3 0.5 0.7 0.1 0.1 0.2 0.1 0.1 0.3 0.6 0.2 0.1 0.8 0.3 0.0 1.3 0.2 1.2 0.3 1.6 5.5 0.2 0.3 0.4 0.1 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.1 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.8 0.4 0.0 0.1 0.3 2.7 0.0 0.0 0.0 0.9 0.9 2.7 0.0 0.4 0.0 1.2 0.7 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.5 0.0 1.7 3.6 0.4 0.0 0.0 22.0 1.1 0.0 0.0 2.0 0.0 0.0 0.0 18.3 0.0 0.0 2.4 0.3 2.4 0.0 0.0 0.0 0.7 0.0 0.0 4.4 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 2.3 0.5 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 3.1 66.1 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.3 0.9 0.0 0.0 0.0 0.0 1.0 SDCBP "MDA-9, SYCL" ENSG00000137575 "Syndecan binding protein" O00560 8 58552924-58582860 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Melanocytes: 843.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 166.5" "Group enriched" "Detected in all" 5 "granulocytes: 166.5;monocytes: 44.8" "Cell line enhanced" "Detected in many" "HHSteC: 100.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012245, HPA023840" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA 1500000 "Nucleoplasm, Cytosol" "Nuclear membrane" "CAB012245: , HPA023840: AB_1857712" "unprognostic (2.39e-2)" "unprognostic (3.34e-2)" "unprognostic (1.84e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (2.60e-3)" "unprognostic (7.14e-2)" "unprognostic (1.04e-3)" "unprognostic (1.11e-1)" "unprognostic (5.68e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.02e-2)" "unprognostic (2.82e-2)" "unprognostic (2.92e-1)" 106.2 32.0 28.5 37.6 45.2 51.5 67.4 20.9 29.0 42.7 28.4 18.8 22.2 19.7 38.4 28.2 37.8 28.0 47.9 36.9 32.1 25.8 41.4 41.7 73.1 49.7 33.4 16.9 35.5 20.1 36.4 16.4 68.5 47.6 35.5 33.6 53.0 41.5 20.7 22.5 24.7 34.3 37.9 39.0 70.1 31.0 25.4 22.2 34.3 44.4 23.4 21.4 50.0 44.2 5.9 21.7 166.5 44.8 3.4 9.8 29.7 14.5 22.6 24.1 12.5 90.5 78.0 10.6 15.0 53.8 21.9 28.8 9.0 30.7 0.0 24.2 20.1 40.3 6.1 13.0 17.3 27.1 2.6 11.1 22.0 20.1 7.2 100.5 5.6 35.8 53.2 23.4 22.0 66.1 34.2 52.4 15.3 10.8 12.9 49.6 3.8 12.3 6.6 15.1 57.5 6.5 6.0 7.3 2.8 34.8 15.3 10.6 19.1 16.0 6.9 73.8 27.9 6.3 15.3 45.0 21.1 9.1 24.9 9.6 3.9 5.2 8.8 53.8 0.0 18.9 52.9 44.8 43.7 5.7 30.0 7.1 5.9 7.6 6.0 21.7 5.4 9.8 7.4 166.5 3.4 26.4 6.0 8.5 29.7 28.5 45.2 20.9 29.0 32.1 25.8 33.4 16.9 47.6 22.2 196.5 114.3 99.6 291.9 300.9 9.9 48.4 58.6 61.6 77.3 195.4 15.7 224.5 190.6 334.0 5.9 318.0 108.1 46.7 256.7 631.9 182.6 258.8 390.0 80.9 683.1 14.3 107.7 330.8 517.6 7.7 216.6 535.9 843.5 212.0 105.0 74.6 227.0 96.2 150.3 153.5 9.7 97.0 282.9 12.5 6.5 151.4 403.9 126.8 84.4 372.9 SDCBP2 "SITAC18, ST-2" ENSG00000125775 "Syndecan binding protein 2" Q9H190 20 1309909-1329239 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 104.7" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 454.6;Pancreatic endocrine cells: 472.7;Paneth cells: 448.9;Urothelial cells: 654.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.2;OE19: 33.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005804, HPA064490" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA005804: , HPA064490: AB_2732713" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (2.37e-1)" "unprognostic (5.85e-2)" "unprognostic (2.54e-1)" "unprognostic (2.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (1.01e-1)" "unprognostic (3.78e-3)" "prognostic unfavorable (3.07e-4)" "unprognostic (3.17e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.37e-4)" 1.7 0.4 5.2 10.6 6.7 0.2 1.5 1.5 4.9 6.6 59.4 1.2 0.9 46.1 1.5 9.1 32.4 0.9 35.1 1.3 3.5 3.6 2.5 3.8 3.7 0.9 2.8 1.0 1.2 4.4 0.2 1.4 1.9 1.4 3.7 19.0 1.0 6.4 1.9 1.1 13.4 104.7 2.5 1.1 1.1 34.0 1.5 1.6 1.0 4.0 12.5 24.3 17.0 9.8 1.2 2.6 4.4 2.0 2.1 5.3 1.8 6.3 0.3 0.9 0.3 3.7 3.3 0.6 1.9 3.9 1.8 1.7 1.3 11.2 0.7 1.3 0.7 1.2 5.0 0.3 9.3 0.9 0.2 0.6 0.5 0.4 0.9 3.7 0.6 0.7 1.1 6.6 1.4 1.4 3.8 6.1 1.2 0.9 0.5 0.7 1.5 1.0 1.8 0.9 33.8 0.4 1.0 0.4 1.2 0.7 8.7 1.5 1.2 1.0 5.7 2.1 0.4 0.3 0.5 4.1 0.9 0.4 1.8 0.7 1.7 1.6 0.6 0.4 2.5 0.5 0.4 2.0 4.4 2.4 0.7 1.8 0.6 3.2 2.5 2.6 1.2 2.7 4.7 2.2 2.1 1.3 1.7 5.3 1.8 5.2 6.7 1.5 4.9 3.5 3.6 2.8 1.0 1.4 1.6 14.9 6.2 5.0 56.0 49.5 0.7 0.7 81.5 4.0 6.8 15.7 0.0 1.3 23.2 94.6 12.4 13.0 454.6 0.0 187.2 0.8 4.4 102.5 9.2 4.9 0.9 1.6 34.4 4.9 1.6 1.1 1.4 2.2 8.5 3.6 127.5 1.0 472.7 448.9 0.0 1.3 1.0 0.0 4.2 1.7 6.6 83.6 1.4 2.5 60.5 654.3 SDHB "SDH, SDH1" ENSG00000117118 "Succinate dehydrogenase complex iron sulfur subunit B" P21912 1 17018722-17054170 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 395.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002868, CAB009822, CAB068233, CAB068234, CAB068235" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" "Intracellular and membrane" NA NA Mitochondria "Nucleoplasm, Plasma membrane" "CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889" "unprognostic (1.06e-1)" "unprognostic (2.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (8.45e-2)" "unprognostic (5.51e-2)" "unprognostic (3.93e-2)" "prognostic favorable (2.93e-7)" "unprognostic (1.46e-1)" "unprognostic (2.75e-1)" "unprognostic (7.82e-2)" "unprognostic (3.82e-2)" 17.8 25.6 19.8 16.6 21.7 17.0 26.4 18.0 29.1 13.9 30.8 12.3 15.1 34.0 14.2 15.7 19.8 13.6 15.1 86.9 18.2 16.4 51.0 75.1 16.8 24.6 20.1 18.9 10.5 30.7 20.0 11.3 15.6 16.7 13.0 31.5 11.7 15.9 19.5 96.2 13.2 31.4 21.3 16.5 17.2 21.7 18.7 15.7 14.2 15.5 52.2 18.0 15.4 17.1 22.2 45.9 48.5 48.7 18.9 26.7 25.0 26.0 25.8 14.7 18.8 28.7 28.5 16.8 22.8 29.3 52.3 47.2 36.3 31.3 35.7 28.5 30.7 33.8 30.7 58.7 45.4 59.0 20.9 48.1 32.1 26.9 27.8 35.1 50.2 23.9 29.3 30.0 45.2 76.6 27.8 36.9 31.4 26.8 41.4 36.3 21.5 33.3 28.7 12.2 41.9 51.9 24.0 28.4 44.2 48.1 14.8 27.8 15.2 30.9 38.7 64.9 16.3 22.7 28.4 18.3 20.1 22.7 36.9 30.0 17.3 21.3 36.5 30.8 76.6 22.2 16.6 38.4 37.4 18.3 48.7 18.3 22.2 21.2 19.5 45.9 18.3 19.3 19.5 48.5 18.9 42.2 21.5 26.7 25.0 19.8 21.7 18.0 29.1 18.2 16.4 20.1 18.9 16.7 15.7 59.6 39.6 77.3 79.1 46.2 28.1 395.8 109.5 78.9 40.9 45.4 13.7 93.2 300.1 104.4 146.0 54.0 212.4 116.8 130.5 121.6 58.6 70.1 65.7 198.8 162.9 35.0 46.7 41.7 81.2 13.8 53.5 90.6 60.8 125.4 89.5 52.1 97.2 192.9 63.6 355.3 35.5 38.8 60.4 85.9 68.4 47.7 101.8 52.3 135.8 97.0 SEC31B "DKFZP434M183, SEC31B-1, SEC31L2" ENSG00000075826 "SEC31 homolog B, COPII coat complex component" Q9NQW1 10 100486642-100519864 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Bipolar cells: 34.2;Collecting duct cells: 10.4;Cone photoreceptor cells: 37.3;Horizontal cells: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.4;JURKAT: 12.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035882, HPA040819, HPA060052" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: " "unprognostic (1.23e-1)" "unprognostic (3.13e-3)" "unprognostic (3.39e-3)" "unprognostic (1.03e-2)" "unprognostic (4.85e-2)" "unprognostic (1.42e-3)" "unprognostic (1.97e-3)" "unprognostic (6.63e-2)" "unprognostic (2.22e-1)" "unprognostic (2.25e-2)" "unprognostic (1.10e-4)" "unprognostic (8.23e-3)" "prognostic unfavorable (6.41e-7)" "unprognostic (2.31e-2)" "unprognostic (2.54e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-4)" 2.8 2.4 3.3 3.2 5.0 6.4 2.6 12.1 11.8 2.7 2.8 5.4 4.3 1.9 3.0 3.5 1.4 2.9 2.6 5.6 3.1 3.6 2.7 3.4 2.4 4.3 3.3 5.6 3.9 0.8 3.9 5.0 2.4 6.3 2.9 2.7 6.1 2.8 2.5 13.6 2.4 2.9 3.2 3.4 4.9 1.9 16.2 3.4 0.0 2.6 5.2 3.6 2.3 1.9 0.9 0.0 0.1 0.2 0.0 2.1 0.1 0.2 0.2 2.8 0.9 0.9 1.6 0.3 0.5 1.3 0.2 0.9 0.3 0.4 0.6 0.8 0.0 0.1 0.3 1.5 0.4 0.8 3.5 0.8 1.4 1.8 0.3 1.2 1.0 1.2 2.4 1.4 0.2 1.7 12.4 0.5 12.5 0.3 1.7 0.0 0.0 1.8 3.1 0.0 0.2 0.6 2.7 0.1 1.1 0.9 0.0 0.2 0.9 0.3 0.0 0.6 2.1 0.7 0.3 0.0 0.4 0.4 0.3 0.2 1.3 0.6 0.8 0.1 3.4 0.4 0.0 0.1 0.0 0.5 0.2 2.1 0.0 0.0 0.4 0.0 0.9 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 3.3 5.0 12.1 11.8 3.1 3.6 3.3 5.6 6.3 3.4 6.0 5.0 0.0 0.8 1.0 34.2 6.5 5.1 2.7 2.3 10.4 37.3 1.0 0.0 0.4 0.9 2.1 2.1 0.0 0.2 0.3 1.9 1.8 1.1 6.4 1.9 38.1 5.2 3.1 4.3 0.8 3.1 1.8 1.7 3.6 3.9 4.3 0.3 0.0 3.9 0.6 6.7 0.0 1.2 7.5 3.2 1.0 0.7 2.6 4.0 0.9 SEMA4B "KIAA1745, MGC131831, SEMAC, SemC" ENSG00000185033 "Semaphorin 4B" 15 90160604-90229679 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 14.7;naive B-cell: 11.8;neutrophil: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 14.7;granulocytes: 4.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 52.8;RPTEC TERT1: 32.7;RT4: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013372 Approved Approved "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Vesicles" "HPA013372: AB_1856670" "unprognostic (3.33e-2)" "unprognostic (5.96e-2)" "unprognostic (2.23e-2)" "unprognostic (2.50e-2)" "unprognostic (7.78e-2)" "unprognostic (4.48e-2)" "unprognostic (6.34e-3)" "prognostic unfavorable (1.25e-4)" "unprognostic (2.04e-1)" "unprognostic (9.31e-2)" "unprognostic (1.58e-3)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (3.57e-2)" "unprognostic (7.09e-2)" 7.0 19.8 13.1 13.7 16.7 7.1 13.6 9.1 13.1 16.2 21.7 9.4 18.2 24.0 9.0 12.3 56.7 16.3 20.3 13.8 13.3 7.6 18.6 32.1 11.6 10.0 13.4 11.1 17.0 19.8 9.4 10.8 14.6 15.4 18.1 10.0 15.4 21.3 15.7 4.0 29.0 22.2 13.5 18.8 16.3 22.4 8.3 14.8 12.8 32.7 15.5 27.2 31.6 24.6 14.7 0.9 4.0 2.0 0.3 0.7 1.0 5.9 16.2 1.2 3.8 1.1 0.8 8.9 1.8 4.0 2.3 2.4 1.9 52.8 4.2 20.4 1.3 13.3 28.3 1.0 26.3 1.9 24.0 3.4 5.5 4.0 2.6 4.5 0.6 2.5 3.2 11.5 2.5 5.2 9.6 2.5 1.2 2.6 6.7 1.2 4.4 1.5 2.3 5.5 13.2 14.9 1.8 0.9 9.2 32.7 35.5 3.9 3.9 6.4 10.4 2.4 2.8 7.2 1.7 5.7 1.8 3.4 3.8 4.1 9.7 11.8 2.1 17.4 4.5 1.8 0.0 2.0 0.3 0.7 1.2 0.5 14.7 0.5 0.4 0.9 11.8 0.4 0.5 4.0 0.3 2.0 0.1 0.1 1.0 13.1 16.7 9.1 13.1 13.3 7.6 13.4 11.1 15.4 14.8 14.9 22.7 19.3 32.9 57.8 2.9 5.5 10.2 17.4 40.9 15.7 23.6 11.3 3.3 21.9 0.9 4.5 26.4 0.0 31.3 69.5 4.8 31.7 0.0 11.5 10.7 15.9 4.1 4.3 5.1 0.7 12.0 6.0 5.0 1.0 13.0 31.5 34.3 19.0 11.3 3.3 45.7 19.4 15.5 0.3 3.2 49.9 10.4 4.4 14.9 45.4 SEMA4F "SEMAM, SEMAW" ENSG00000135622 "Ssemaphorin 4F" O95754 2 74654228-74683853 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 11.8;Horizontal cells: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064095, HPA065969" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA Nucleoplasm "Plasma membrane, Centrosome" "HPA064095: AB_2732710, HPA065969: AB_2685590" "unprognostic (9.69e-2)" "unprognostic (8.88e-3)" "unprognostic (1.58e-2)" "prognostic unfavorable (5.94e-5)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.23e-2)" "unprognostic (1.61e-3)" "unprognostic (6.95e-2)" "unprognostic (9.01e-3)" "unprognostic (6.53e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.74e-6)" "unprognostic (2.60e-2)" "unprognostic (8.08e-2)" "prognostic favorable (6.94e-4)" "unprognostic (4.69e-2)" 8.1 5.1 15.5 3.5 15.5 1.3 5.7 12.9 21.3 5.2 3.8 3.3 2.3 1.9 6.6 6.7 2.7 5.6 3.5 4.9 17.2 12.2 4.8 2.1 8.1 5.1 5.3 16.5 9.1 4.6 13.7 10.2 3.5 7.8 5.2 4.2 3.6 5.0 5.7 3.0 4.9 3.0 7.0 5.7 4.7 4.3 7.2 3.8 2.9 4.7 1.3 4.9 3.5 4.7 2.8 0.2 1.4 0.4 2.5 5.6 2.1 6.5 4.4 4.8 6.8 7.8 4.4 3.0 4.5 9.4 8.2 7.6 1.8 3.8 2.2 4.9 7.2 19.8 1.9 7.0 7.7 9.1 5.7 5.9 3.8 1.8 3.6 2.8 0.8 6.1 4.0 6.7 5.5 2.9 18.7 3.5 5.0 0.2 0.1 4.8 1.9 3.5 0.7 2.6 3.7 4.3 0.0 6.2 0.0 6.4 3.0 3.0 7.2 6.6 2.7 8.2 6.0 3.2 0.5 3.8 14.1 6.8 3.4 8.2 5.3 5.2 0.3 17.2 0.3 7.5 0.5 0.2 1.4 5.6 0.1 3.2 2.8 3.0 4.9 0.2 2.1 3.3 3.9 0.8 2.5 0.4 0.1 2.2 2.1 15.5 15.5 12.9 21.3 17.2 12.2 5.3 16.5 7.8 3.8 0.0 6.2 0.0 1.5 0.3 8.8 1.4 10.2 1.4 7.9 5.2 11.8 0.7 1.7 2.0 3.1 1.6 0.4 0.0 1.4 2.0 1.2 1.5 2.3 0.6 0.7 11.1 6.9 2.5 0.0 2.4 0.9 0.7 0.0 1.8 0.7 4.1 2.7 0.9 1.4 0.2 5.7 6.5 0.4 3.1 9.8 0.4 0.3 2.5 1.0 1.1 SEMA6A "HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ" ENSG00000092421 "Semaphorin 6A" Q9H2E6 5 116443616-116574934 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.2" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 93.0;Horizontal cells: 130.3;Ito cells: 160.2;Syncytiotrophoblasts: 291.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 12.9;HAP1: 15.1;NTERA-2: 33.8;SuSa: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031264, HPA031265, HPA031267" Approved Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" NA NA 180000 Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA031264: , HPA031265: AB_10610423, HPA031267: " "unprognostic (3.79e-2)" "unprognostic (3.91e-1)" "unprognostic (1.82e-2)" "unprognostic (6.81e-2)" "unprognostic (2.69e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.39e-4)" "unprognostic (1.64e-1)" "unprognostic (4.71e-2)" "unprognostic (5.82e-2)" "unprognostic (1.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.62e-3)" "unprognostic (1.92e-1)" "unprognostic (6.21e-3)" "unprognostic (7.32e-3)" 12.7 37.4 12.6 4.9 34.7 3.6 10.6 18.7 26.5 6.9 19.6 31.2 0.8 19.2 6.1 3.4 3.9 6.2 12.8 5.0 17.2 12.9 6.1 6.0 17.8 4.5 35.9 13.9 13.1 10.3 2.2 4.4 30.2 32.2 6.6 17.5 2.6 15.1 3.2 7.6 5.6 24.0 6.3 48.2 8.2 5.4 6.6 31.4 0.5 6.7 1.6 2.7 4.6 5.9 1.6 0.7 0.1 0.4 0.0 1.3 0.0 0.1 0.0 10.9 12.9 0.0 0.0 11.3 0.2 0.1 0.0 0.0 0.6 0.4 0.4 0.5 0.1 0.2 0.1 15.1 0.0 0.0 0.4 2.2 0.2 0.2 3.6 0.1 0.1 0.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 1.1 33.8 0.0 0.1 1.9 7.1 0.5 5.6 9.7 3.0 1.1 0.0 0.2 5.8 68.7 4.2 0.7 0.2 1.0 0.9 0.1 0.4 0.2 0.1 0.2 0.1 0.5 4.0 0.0 0.4 0.0 1.2 0.0 0.1 1.6 1.3 0.0 0.3 1.2 0.4 0.5 0.1 0.0 0.2 0.7 0.1 0.0 12.6 34.7 18.7 24.0 17.2 12.9 35.9 13.9 32.2 31.4 0.0 1.1 0.8 0.7 5.8 8.1 6.7 48.4 0.0 0.0 14.0 2.0 93.0 0.0 26.5 9.7 56.5 45.5 0.0 1.1 3.7 16.0 1.5 0.0 0.6 10.8 130.3 26.9 160.2 15.5 1.4 6.1 1.3 23.6 0.0 31.1 5.1 2.5 42.1 1.8 3.7 3.2 0.0 6.2 0.5 1.4 3.6 291.1 1.3 32.4 0.5 SEPT3 SEP3 ENSG00000100167 "Septin 3" Q9UH03 22 41969475-41998221 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.6" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 17.5;Early spermatids: 10.9;Extravillous trophoblasts: 21.5;Horizontal cells: 14.3;Late spermatids: 20.4" "Cancer enhanced" "Detected in many" "glioma: 24.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 1.2;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "AF22: 13.8;SCLC-21H: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003548, CAB017633" Supported Supported Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Nucleoplasm, Plasma membrane" "Actin filaments" "CAB017633: AB_2301476, HPA003548: AB_1079908" "unprognostic (2.10e-1)" "unprognostic (4.67e-2)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.78e-4)" "unprognostic (4.56e-2)" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (2.37e-1)" "unprognostic (2.67e-3)" "unprognostic (3.09e-2)" "unprognostic (1.30e-2)" "unprognostic (6.30e-2)" "unprognostic (2.51e-2)" "unprognostic (9.15e-2)" "unprognostic (6.68e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" 1.3 4.4 31.3 1.4 26.9 1.3 2.0 35.9 101.6 1.4 1.5 5.6 0.0 1.4 1.4 2.2 1.3 1.2 1.5 1.2 28.9 17.2 1.4 1.2 1.7 1.5 13.2 24.3 1.2 2.0 10.7 1.0 4.9 13.4 2.1 1.5 1.0 1.3 1.2 1.2 2.2 1.4 1.4 7.3 1.3 1.5 2.4 5.3 0.0 1.7 0.0 1.5 1.4 0.1 0.3 1.2 2.1 0.0 0.1 0.2 0.0 0.7 0.8 13.8 10.3 0.1 0.0 6.9 0.1 0.1 0.9 0.4 0.2 1.6 11.1 0.4 0.1 5.9 0.0 7.2 0.0 0.3 4.6 2.3 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.5 0.0 0.0 0.0 0.0 6.2 0.0 1.7 0.0 1.2 1.8 0.1 9.4 0.1 0.3 8.9 0.0 0.6 0.0 1.3 37.2 7.7 5.5 0.0 9.1 1.4 1.3 3.3 0.0 0.0 4.9 0.4 0.5 7.3 6.4 0.1 0.1 4.5 1.4 2.1 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.2 0.0 31.3 26.9 35.9 42.1 28.9 17.2 13.2 24.3 13.4 5.3 0.0 0.0 0.0 0.0 0.3 17.5 0.4 0.0 0.0 2.3 0.0 3.9 1.5 0.0 0.0 10.9 0.0 0.0 0.0 0.0 21.5 0.1 0.0 0.0 0.0 1.4 14.3 1.2 0.0 0.0 20.4 0.3 0.3 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 1.6 0.3 4.6 0.0 0.0 0.0 SEPT5 "H5, HCDCREL-1, PNUTL1" ENSG00000184702 "Septin 5" Q99719 22 19714464-19724224 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.2;parathyroid gland: 86.4" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 9.2;Late spermatids: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "eosinophil: 11.9;neutrophil: 4.4" "Lineage enriched" "Detected in single" 46 "granulocytes: 11.9" "Cell line enhanced" "Detected in many" "K-562: 67.2;THP-1: 21.5" "CAB016120, HPA029095, HPA063885" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA 1600000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB016120: AB_628240, HPA029095: AB_2672904, HPA063885: AB_2685141" "unprognostic (4.07e-2)" "unprognostic (1.47e-1)" "unprognostic (6.78e-3)" "unprognostic (1.39e-2)" "unprognostic (3.92e-1)" "unprognostic (1.86e-1)" "unprognostic (2.50e-2)" "unprognostic (3.77e-1)" "unprognostic (5.66e-2)" "unprognostic (6.19e-2)" "unprognostic (1.88e-3)" "unprognostic (4.34e-1)" "prognostic unfavorable (6.87e-6)" "unprognostic (3.39e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (3.30e-2)" 4.2 6.4 60.7 2.3 62.9 12.5 5.1 31.2 86.2 12.2 3.0 5.5 1.1 2.2 7.4 17.0 15.0 14.1 5.5 50.9 52.9 14.6 2.0 1.1 3.7 3.0 12.4 38.7 9.0 5.5 86.4 11.1 4.4 14.9 4.3 2.7 5.3 3.6 4.0 2.8 42.9 2.5 6.4 3.6 2.2 3.4 6.2 9.5 1.9 6.7 4.1 3.1 3.5 5.6 0.0 0.2 11.9 0.1 0.0 0.2 6.3 0.1 3.1 12.2 18.9 1.2 4.0 0.1 4.7 5.9 5.3 3.1 0.2 1.6 0.4 1.8 10.4 7.8 1.7 8.9 1.7 2.7 3.2 1.1 0.2 0.6 0.0 4.9 0.2 13.0 5.3 2.2 1.7 0.7 1.5 2.2 6.7 67.2 0.2 8.3 1.2 1.3 7.5 1.6 0.3 3.3 13.6 0.4 2.1 0.3 0.4 19.6 16.0 0.7 1.0 0.8 3.2 4.9 21.5 0.8 14.0 18.8 0.6 0.9 1.3 0.0 0.1 1.7 0.6 4.5 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 4.4 0.0 0.0 0.2 0.0 6.3 60.7 62.9 31.2 86.2 52.9 14.6 12.4 38.7 14.9 9.5 0.0 3.4 0.0 0.0 0.8 4.8 3.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 9.2 0.5 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.1 3.2 5.1 1.3 0.0 35.9 2.6 0.0 3.3 0.0 0.0 1.9 0.0 0.0 3.2 0.0 0.3 0.0 7.2 2.3 2.7 7.0 0.0 0.0 0.0 0.0 SETBP1 "KIAA0437, SEB" ENSG00000152217 "SET binding protein 1" Q9Y6X0 18 44680173-45068510 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 58.1;Peritubular cells: 37.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.9;naive B-cell: 7.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "AF22: 9.5;Karpas-707: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049022, HPA057259" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA049022: AB_2680602, HPA057259: AB_2683384" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.11e-1)" "unprognostic (1.97e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "unprognostic (1.91e-1)" "unprognostic (3.57e-2)" "unprognostic (3.49e-1)" "unprognostic (2.01e-2)" "unprognostic (2.71e-3)" "unprognostic (6.52e-2)" "prognostic favorable (6.34e-8)" "unprognostic (2.18e-2)" "unprognostic (2.29e-1)" "unprognostic (6.06e-2)" "unprognostic (7.81e-5)" 10.6 2.9 3.8 13.2 8.7 2.1 9.8 16.0 12.6 16.9 14.6 4.2 19.9 2.5 14.0 17.5 6.6 11.0 7.9 6.8 3.6 3.5 15.0 7.2 9.8 7.0 2.9 7.4 12.8 8.2 9.1 5.1 10.2 3.2 12.2 5.3 14.0 6.9 21.3 14.5 6.6 6.9 19.9 3.7 5.9 9.1 5.5 1.2 3.4 8.4 8.7 8.8 11.9 13.3 7.5 4.3 0.2 1.6 0.0 0.6 0.2 0.0 1.7 9.5 0.0 2.7 0.7 0.6 0.8 1.7 0.9 0.7 0.1 0.0 0.5 0.3 1.0 0.5 2.8 1.0 3.0 0.6 0.8 0.5 0.0 1.0 0.6 0.0 0.0 0.0 2.3 1.1 0.0 1.8 1.6 0.3 0.0 0.0 37.9 0.2 0.5 0.0 0.0 1.3 0.0 0.6 3.1 0.0 3.3 3.2 2.2 4.8 2.5 0.0 0.0 0.5 4.5 1.3 0.0 0.0 5.6 2.1 0.0 4.4 5.0 0.3 0.0 3.4 0.1 3.2 0.2 0.0 0.0 0.6 1.1 0.0 4.9 0.1 0.5 0.1 7.5 0.0 0.2 0.0 0.0 1.6 4.3 0.0 0.2 3.8 8.7 16.0 12.6 3.6 3.5 2.9 7.4 3.2 1.2 0.0 2.6 26.0 8.5 13.7 11.5 3.6 10.2 2.7 3.4 15.7 17.7 1.3 3.3 4.1 0.9 9.5 0.4 0.0 2.9 1.2 27.4 6.4 0.0 13.5 1.6 3.2 11.5 12.3 1.6 1.8 58.1 2.7 3.3 0.0 2.5 9.1 3.3 8.4 37.4 6.8 19.3 6.5 30.7 0.0 0.1 13.2 0.7 4.9 4.6 1.0 SF3B3 "KIAA0017, RSE1, SAP130, SF3b130" ENSG00000189091 "Splicing factor 3b subunit 3" Q15393 16 70523788-70577670 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041134, HPA042986" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA041134: AB_2677317, HPA042986: AB_10960386" "unprognostic (3.39e-2)" "unprognostic (1.53e-1)" "unprognostic (7.47e-2)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (1.06e-2)" "unprognostic (7.67e-2)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (6.97e-2)" "unprognostic (2.29e-1)" "unprognostic (3.28e-2)" "unprognostic (1.60e-1)" "unprognostic (8.76e-2)" "unprognostic (7.91e-2)" "unprognostic (1.73e-1)" 23.8 21.1 11.8 22.1 23.2 24.7 22.4 24.9 26.9 23.4 20.6 20.9 15.6 17.1 27.5 13.9 31.8 22.1 15.6 20.1 14.0 12.8 17.0 19.0 18.4 28.5 16.9 15.0 33.3 22.5 34.0 26.8 19.9 16.5 18.4 16.4 20.2 22.6 17.3 30.9 28.9 18.8 20.1 15.4 21.0 17.9 15.5 15.9 47.7 25.1 17.2 31.9 23.7 25.0 23.2 21.4 16.4 18.8 21.0 25.9 19.7 18.7 19.7 25.6 17.9 12.7 11.8 19.3 17.8 15.3 23.3 18.9 20.1 15.1 25.2 14.4 13.9 13.9 22.1 27.0 15.2 37.7 8.1 18.9 19.6 16.2 21.3 8.6 27.6 23.2 11.2 11.1 26.0 19.2 14.9 13.9 14.8 26.7 9.0 18.5 23.2 24.2 13.6 23.5 11.9 11.3 42.8 19.9 28.3 7.5 25.9 22.3 16.5 58.0 9.2 9.0 11.2 19.9 13.7 14.2 17.3 19.0 13.3 18.7 10.2 22.3 67.6 11.5 17.7 16.1 11.5 15.8 16.4 23.1 18.8 25.4 18.6 21.8 24.2 21.4 23.2 25.9 22.0 5.4 21.0 17.9 12.0 24.0 19.7 11.8 23.2 24.9 26.9 14.0 12.8 16.9 15.0 16.5 15.9 23.8 22.6 29.8 20.4 19.9 34.7 26.8 15.3 13.4 17.0 22.7 13.7 28.1 6.6 18.9 6.0 22.6 16.5 0.0 19.7 29.6 17.4 18.3 17.3 20.2 20.4 38.1 20.3 17.8 20.0 7.9 31.4 16.3 16.9 15.4 20.5 20.0 21.1 14.0 31.1 13.9 24.9 6.5 14.4 21.8 37.3 22.8 21.3 22.0 26.4 23.0 SFSWAP "SFRS8, SWAP" ENSG00000061936 "Splicing factor SWAP" Q12872 12 131711081-131799737 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039362, HPA040063" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA039362: AB_10794089, HPA040063: AB_10795413" "unprognostic (1.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.39e-3)" "unprognostic (2.04e-1)" "unprognostic (4.45e-2)" "unprognostic (2.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.44e-1)" "unprognostic (1.50e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (7.50e-2)" "unprognostic (2.93e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" 20.2 15.0 17.7 23.2 24.0 47.1 17.9 31.1 23.8 16.6 15.7 31.1 11.6 20.4 25.7 15.1 15.7 15.7 16.5 11.9 20.5 15.9 15.7 12.3 16.4 20.7 27.0 17.2 21.4 19.8 19.5 18.0 16.6 16.6 14.7 9.9 16.9 22.1 15.5 27.4 30.0 19.0 17.3 21.1 23.7 18.4 17.5 26.4 21.9 17.1 15.9 16.8 16.7 20.5 6.6 11.0 8.5 6.4 8.4 5.5 2.6 13.8 12.5 8.9 9.4 7.1 5.9 20.0 10.8 7.5 12.8 8.8 12.2 6.7 17.1 10.1 8.0 6.6 13.0 12.5 9.9 7.5 5.2 19.7 15.5 6.8 14.2 7.6 19.9 15.3 6.7 11.4 11.5 14.0 10.2 7.9 13.3 21.4 6.8 5.7 17.4 16.7 30.3 23.2 7.5 20.9 19.6 9.0 13.4 7.3 10.2 14.0 15.8 10.2 8.6 12.8 7.3 12.4 15.6 10.1 10.6 14.0 8.2 12.0 19.5 21.2 17.2 10.5 13.7 14.2 3.0 6.4 2.6 5.2 4.4 5.0 3.5 4.6 4.2 4.5 6.6 4.9 5.5 8.5 8.4 5.0 11.0 3.8 2.6 17.7 24.0 31.1 23.8 20.5 15.9 27.0 17.2 16.6 26.4 68.5 35.6 23.8 31.0 34.6 46.7 18.0 30.6 41.5 52.4 14.0 62.8 26.1 0.0 18.1 18.1 30.8 17.4 0.0 22.9 26.0 25.5 26.3 36.9 13.9 19.7 39.7 20.7 21.5 25.9 9.6 27.9 25.3 21.9 30.7 20.8 35.2 22.5 16.7 28.0 9.9 59.1 45.3 25.8 31.1 42.7 40.9 36.5 37.1 19.3 46.4 SFT2D1 "C6orf83, MGC19825, pRGR1" ENSG00000198818 "SFT2 domain containing 1" Q8WV19 6 166319728-166342591 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014677 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA014677: AB_2238986" "unprognostic (8.45e-2)" "unprognostic (1.43e-3)" "unprognostic (2.29e-1)" "unprognostic (1.41e-2)" "unprognostic (6.77e-2)" "prognostic unfavorable (7.47e-4)" "prognostic unfavorable (2.19e-5)" "unprognostic (3.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.68e-1)" "unprognostic (6.53e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (4.20e-2)" "unprognostic (5.05e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.75e-2)" 21.1 24.6 33.6 21.7 31.8 16.4 24.5 15.6 25.0 20.2 27.9 43.4 23.4 23.5 14.7 37.0 19.6 18.8 18.6 15.6 34.9 26.2 27.6 12.5 27.2 23.9 43.9 18.6 18.3 32.6 13.4 11.8 25.9 27.8 27.3 26.8 15.0 38.0 19.4 11.2 12.5 24.9 16.0 61.2 24.6 27.6 18.3 32.8 20.6 24.9 15.3 23.7 17.1 16.1 25.5 57.6 50.1 30.1 14.9 21.7 24.2 13.3 13.0 10.7 22.4 19.6 17.5 16.8 20.8 17.9 14.7 22.3 27.1 27.5 11.8 15.9 17.0 25.7 16.3 15.6 17.1 22.5 16.3 28.5 13.9 11.0 38.2 17.7 35.2 28.3 16.4 20.4 16.9 14.8 21.2 7.8 19.6 25.7 11.9 22.6 21.5 10.3 60.1 10.5 39.9 12.8 7.3 12.3 27.5 36.0 13.9 2.0 9.3 14.2 23.2 18.5 12.6 12.6 63.7 7.3 9.2 17.7 24.3 21.5 11.4 8.2 12.9 19.5 22.2 22.4 29.5 28.5 34.7 18.1 28.1 11.3 25.5 14.7 15.1 30.4 21.2 15.9 15.9 50.1 14.9 30.1 57.6 21.7 24.2 33.6 31.8 15.6 25.0 34.9 26.2 43.9 18.6 27.8 32.8 38.7 55.2 94.6 100.0 76.8 8.2 23.0 58.6 44.2 44.3 102.9 0.0 131.5 76.3 136.4 33.1 53.4 86.8 23.3 110.4 203.9 98.4 175.7 146.5 20.8 187.8 14.3 27.6 63.3 172.6 14.5 78.9 142.4 94.5 228.2 114.9 23.5 133.8 128.7 44.6 126.0 8.4 84.1 53.6 137.2 79.4 89.8 109.7 82.0 105.5 178.5 SGK494 ENSG00000167524 "Uncharacterized serine/threonine-protein kinase SgK494" 17 28607964-28614200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 89.8;Rod photoreceptor cells: 106.4;Spermatocytes: 85.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: AB_2679710" "unprognostic (1.83e-1)" "unprognostic (9.42e-2)" "unprognostic (2.84e-2)" "unprognostic (2.30e-2)" "unprognostic (2.11e-1)" "unprognostic (2.06e-3)" "unprognostic (9.33e-3)" "unprognostic (2.63e-1)" "unprognostic (8.62e-4)" "unprognostic (2.09e-2)" "unprognostic (6.81e-2)" "unprognostic (3.45e-5)" "unprognostic (1.20e-7)" "unprognostic (2.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-3)" 1.6 4.7 10.3 3.5 25.3 10.6 2.3 17.8 25.8 1.9 1.8 0.9 0.4 0.7 2.0 4.5 1.3 2.4 0.8 2.1 8.6 3.7 5.6 1.6 3.2 3.3 2.5 10.7 3.7 1.3 2.0 5.6 3.1 11.2 2.3 4.0 6.3 1.9 3.2 3.8 6.3 2.3 1.9 2.9 3.4 1.3 8.5 4.1 0.1 2.5 0.1 3.5 1.9 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 5.1 6.1 5.7 1.9 2.5 4.4 0.8 0.3 2.1 1.9 6.1 0.7 7.0 0.9 2.8 3.1 3.1 4.5 2.4 2.7 3.9 6.7 7.3 4.0 3.6 0.2 9.8 5.2 1.2 7.3 7.4 4.2 1.7 2.3 9.7 7.0 0.6 1.3 7.1 2.4 6.5 6.1 3.2 0.9 7.1 8.7 4.6 1.2 6.7 3.7 3.5 4.3 2.4 3.6 8.6 3.6 5.5 3.0 4.1 3.5 4.1 5.0 3.8 3.6 8.5 3.0 7.1 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 25.3 17.8 25.8 8.6 3.7 2.5 10.7 11.2 4.1 0.0 1.3 5.2 5.5 0.0 89.8 0.3 10.2 0.0 1.2 5.2 21.6 5.6 0.0 2.0 10.6 2.9 4.2 0.0 1.3 2.0 1.0 5.8 0.0 5.8 3.6 33.4 1.2 8.6 5.7 2.2 2.0 3.2 0.0 3.6 2.7 6.8 1.9 7.0 1.8 1.4 106.4 0.0 0.3 85.6 14.7 0.0 20.7 5.0 3.2 3.4 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186292 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 40.1" "Cell type enhanced" "Detected in some" 27 "Cytotrophoblasts: 5.4;Extravillous trophoblasts: 33.5;Hofbauer cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Enhanced Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214" "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.6 0.6 0.4 9.1 0.4 8.9 1.0 0.4 1.5 0.9 3.4 0.3 0.6 2.7 0.8 0.5 4.0 0.3 1.7 0.4 0.3 0.4 0.8 1.0 0.9 6.9 0.4 0.1 0.5 0.5 0.0 0.4 3.7 0.2 0.6 3.5 0.1 1.0 0.1 0.3 1.1 3.4 0.8 0.4 4.9 1.5 8.6 0.2 40.1 0.5 2.4 7.4 1.2 1.5 9.0 4.5 8.3 0.2 0.3 2.7 0.6 9.5 10.9 14.9 9.1 0.7 1.3 10.1 10.3 5.3 15.0 16.5 7.7 11.8 14.6 5.2 4.2 10.6 5.6 14.0 5.7 19.0 18.6 9.3 16.6 7.5 6.1 0.1 15.1 14.3 0.1 0.4 16.5 7.0 2.1 8.9 17.4 14.2 26.2 12.4 9.4 23.7 8.5 15.8 10.2 8.3 15.2 19.1 8.5 3.8 7.0 7.4 7.8 11.4 14.1 6.8 11.6 9.1 10.6 2.4 11.4 13.7 10.2 20.5 11.3 26.2 17.0 6.2 15.3 17.1 8.3 0.1 1.5 0.3 0.2 0.1 8.6 0.7 0.8 0.4 9.0 0.2 0.4 1.6 0.3 0.2 4.5 2.7 0.6 0.4 0.4 0.4 1.5 0.3 0.4 0.4 0.1 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 5.4 0.0 1.1 0.0 0.0 0.0 0.0 1.6 33.5 0.0 0.0 1.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 SH2D3A NSP1 ENSG00000125731 "SH2 domain containing 3A" Q9BRG2 19 6752160-6767588 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 105.7;Urothelial cells: 79.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.8;HaCaT: 16.2;HBEC3-KT: 31.1;SK-BR-3: 15.7" "Not detected" "Not detected" "HPA035722, HPA064382" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" NA NA Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA035722: AB_10670024, HPA064382: AB_2685251" "unprognostic (3.32e-2)" "unprognostic (5.48e-2)" "unprognostic (1.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (3.96e-1)" "unprognostic (2.60e-3)" "unprognostic (3.63e-1)" "unprognostic (8.41e-2)" "unprognostic (6.48e-3)" "prognostic unfavorable (6.21e-4)" "prognostic favorable (1.42e-4)" "unprognostic (7.31e-2)" "unprognostic (1.74e-1)" "unprognostic (1.32e-3)" "unprognostic (1.81e-3)" 0.5 0.2 0.4 9.2 0.9 1.9 5.3 0.6 0.5 4.7 19.7 0.5 8.7 10.9 3.8 6.7 20.0 3.0 15.8 0.4 0.4 0.0 9.6 1.7 13.4 5.4 0.6 0.4 1.1 18.8 4.9 3.4 14.3 0.9 11.0 4.3 1.6 24.0 13.3 0.8 15.3 18.0 2.2 1.0 3.8 11.0 2.5 0.4 5.0 10.9 11.0 17.2 9.0 9.4 5.6 0.4 0.0 0.1 1.9 9.2 1.0 18.8 2.7 0.0 0.1 0.0 0.0 9.3 0.1 0.0 0.0 0.0 6.8 14.6 2.9 8.6 0.0 0.0 16.2 1.1 31.1 0.0 1.4 2.7 0.1 2.3 1.0 0.0 0.2 4.0 0.0 13.0 0.0 3.2 0.4 0.0 6.6 3.1 7.2 0.0 6.6 1.4 0.0 0.7 10.2 5.3 0.5 0.0 11.5 5.6 12.0 0.0 0.0 1.1 15.7 0.0 0.4 10.4 0.1 0.3 0.3 1.1 0.2 0.1 6.2 6.7 3.6 0.1 2.0 0.1 0.0 0.0 0.0 3.0 0.1 5.2 3.9 6.8 6.2 0.1 5.6 9.2 4.7 0.0 1.9 0.1 0.4 3.3 1.0 0.4 0.9 0.6 0.5 0.4 0.0 0.6 0.4 0.9 0.4 17.9 13.9 36.4 105.7 27.2 3.5 1.7 30.6 17.4 30.7 38.4 9.8 19.1 1.7 53.7 0.9 2.6 48.5 23.3 31.9 46.8 3.3 55.3 5.7 2.6 3.1 0.0 11.6 1.8 0.0 0.0 0.6 4.3 3.3 5.4 27.1 0.8 56.0 66.2 0.0 9.1 4.5 0.0 2.1 7.5 8.9 34.9 9.0 13.8 21.5 79.6 SH2D7 LOC646892 ENSG00000183476 "SH2 domain containing 7" A6NKC9 15 78077808-78104909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "testis: 37.1" "Group enriched" "Detected in some" 4 "Early spermatids: 17.9;Late spermatids: 23.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;AN3-CA: 2.8;BEWO: 2.6;HEK 293: 2.0;SCLC-21H: 2.4;SH-SY5Y: 4.4;SuSa: 2.3" "Low region specificity" "Detected in all" "HPA051320, HPA058382, HPA076728" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA051320: AB_2681439, HPA058382: , HPA076728: " "unprognostic (1.22e-2)" "unprognostic (4.31e-2)" "unprognostic (2.24e-1)" "unprognostic (1.24e-2)" "unprognostic (2.53e-1)" "unprognostic (1.42e-1)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-3)" "unprognostic (4.73e-2)" "unprognostic (2.92e-1)" "unprognostic (2.32e-3)" "unprognostic (5.15e-3)" "unprognostic (1.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 0.1 0.2 0.6 0.5 0.4 0.0 0.1 0.5 0.5 0.1 4.3 0.1 0.1 5.0 0.1 0.1 0.1 0.0 1.0 0.2 0.4 0.4 0.1 0.1 0.6 0.1 0.3 0.1 0.1 0.3 0.0 0.2 0.3 0.1 0.2 0.5 0.2 0.2 0.1 0.1 0.1 4.2 0.1 0.3 0.1 0.3 37.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 2.1 2.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 1.5 0.1 0.0 1.1 1.4 0.0 0.0 0.4 2.4 4.4 0.4 0.6 0.2 2.3 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.5 0.5 0.4 0.4 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 2.5 0.0 0.0 0.0 SH3BP5L KIAA1720 ENSG00000175137 "SH3 binding domain protein 5 like" Q7L8J4 1 248810446-248826633 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038067, HPA038068" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA038067: AB_2675814, HPA038068: AB_10670651" "unprognostic (2.48e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (4.41e-1)" "unprognostic (2.78e-1)" "unprognostic (2.27e-3)" "unprognostic (1.99e-3)" "unprognostic (5.84e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (1.50e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-2)" "unprognostic (1.55e-1)" "unprognostic (4.99e-2)" "unprognostic (4.66e-2)" 4.1 5.0 5.3 4.0 4.8 3.0 3.3 10.3 8.7 4.1 4.9 6.2 4.9 2.5 7.2 4.7 3.3 6.5 5.5 4.0 4.1 4.5 3.9 4.2 4.2 3.9 4.2 5.9 2.4 5.0 3.9 2.9 5.1 5.7 13.6 8.0 5.6 4.3 5.0 5.4 4.3 3.6 3.6 4.0 4.1 3.7 1.1 1.2 6.2 1.8 0.4 1.5 1.0 10.0 6.3 8.4 9.6 12.0 8.1 11.0 22.7 7.8 13.3 10.1 6.1 8.9 5.0 13.8 19.0 3.3 10.8 7.9 9.7 6.4 11.5 2.8 8.2 6.8 4.9 7.3 8.9 9.9 6.6 10.5 14.7 5.6 9.4 8.8 9.5 14.0 5.3 8.9 3.3 8.4 6.1 14.7 11.2 16.2 9.6 5.9 10.2 9.1 4.5 9.7 13.4 7.0 8.7 7.5 6.6 9.4 18.4 12.1 16.4 7.0 6.6 34.5 13.2 14.7 4.5 12.2 10.3 6.9 5.5 1.8 5.4 1.1 1.0 1.1 0.5 1.5 0.9 1.2 1.1 0.5 0.4 6.2 0.4 0.4 0.8 0.2 1.0 0.0 1.3 3.0 1.7 4.0 8.1 8.9 2.5 0.0 0.0 10.4 0.0 7.5 1.7 7.2 1.1 3.1 12.6 0.0 5.1 4.0 5.1 3.0 0.0 7.4 5.2 7.9 7.5 4.3 5.7 0.4 4.0 3.7 3.3 5.4 7.2 3.7 8.3 8.7 5.3 5.8 3.3 0.0 3.3 8.0 6.0 4.1 9.5 5.2 5.2 2.7 SHANK2 "CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3" ENSG00000162105 "SH3 and multiple ankyrin repeat domains 2" Q9UPX8 11 70467856-71252577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 38.7;Horizontal cells: 128.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.1" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.1" "Cell line enhanced" "Detected in many" "Karpas-707: 16.9;MCF7: 9.7;RT4: 15.6;T-47d: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008174, HPA017220" Approved Uncertain "Nucleoplasm,Nuclear speckles,Vesicles" NA NA Nucleoplasm "Nuclear speckles, Vesicles" "HPA008174: AB_1856822, HPA017220: " "unprognostic (3.08e-1)" "unprognostic (1.31e-3)" "unprognostic (1.79e-1)" "unprognostic (1.51e-2)" "unprognostic (1.51e-1)" "unprognostic (7.23e-5)" "unprognostic (1.24e-1)" "unprognostic (6.67e-2)" "unprognostic (1.83e-2)" "unprognostic (8.42e-2)" "unprognostic (4.87e-2)" "unprognostic (4.01e-1)" "prognostic favorable (1.94e-6)" "unprognostic (3.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.03e-2)" "unprognostic (4.80e-2)" 2.1 1.7 16.8 0.8 22.6 0.0 7.3 6.1 24.1 2.8 3.1 2.3 1.9 2.4 1.8 3.1 5.1 7.9 1.1 0.2 12.2 8.1 7.0 4.7 5.5 0.3 3.6 12.9 0.2 11.3 0.0 7.3 2.7 8.7 4.6 2.8 1.4 12.7 3.3 0.1 1.2 2.0 0.6 1.5 1.5 4.7 1.2 3.7 0.0 8.5 0.0 0.5 2.3 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 7.8 4.3 0.0 0.5 0.7 3.1 0.6 0.3 0.0 0.0 8.2 2.9 5.1 1.5 0.0 0.2 0.8 0.0 2.9 0.0 0.0 0.2 0.0 0.0 8.5 0.0 0.0 1.7 0.2 1.5 0.0 0.0 1.1 0.0 0.1 0.0 16.9 1.6 9.7 0.0 0.0 3.3 7.4 0.3 0.0 7.7 7.6 3.9 15.6 2.5 1.0 0.0 6.2 0.0 3.6 12.0 0.0 0.0 0.1 1.2 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.8 22.6 6.1 24.1 12.2 8.1 3.6 12.9 8.7 3.7 38.7 14.2 0.0 2.7 0.0 16.0 2.4 10.2 20.1 5.7 7.0 0.0 9.5 3.3 7.0 1.4 1.0 0.9 0.0 1.9 2.4 0.6 8.4 2.3 19.0 1.0 128.7 0.0 0.0 0.0 1.6 0.0 0.5 5.0 0.0 8.2 5.0 7.6 3.5 0.7 8.7 0.9 0.0 1.4 0.6 0.7 0.5 12.2 0.0 5.2 3.8 SHB ENSG00000107338 "SH2 domain containing adaptor protein B" Q15464 9 37919134-38069211 "Predicted intracellular proteins" "Angiogenesis, Apoptosis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 74.8;Urothelial cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 71 "basophil: 8.1" "Lineage enriched" "Detected in single" 71 "granulocytes: 8.1" "Cell line enhanced" "Detected in many" "OE19: 35.0" "CAB010161, HPA049911, HPA052108" Uncertain Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Cytosol "Nucleoplasm, Cytoplasmic bodies" "CAB010161: AB_2187742, HPA049911: AB_2680949, HPA052108: AB_2681730" "unprognostic (4.57e-2)" "unprognostic (1.13e-1)" "unprognostic (5.45e-2)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.42e-2)" "unprognostic (2.10e-1)" "unprognostic (3.38e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (5.96e-3)" "unprognostic (2.48e-2)" "unprognostic (3.31e-3)" "unprognostic (7.68e-3)" "unprognostic (1.01e-1)" "unprognostic (3.29e-1)" "unprognostic (1.10e-1)" 8.6 5.6 7.5 5.3 15.9 7.2 8.0 1.4 12.5 8.2 8.4 16.1 3.2 10.1 6.1 5.6 19.6 5.9 29.4 20.2 8.9 5.0 13.6 34.2 11.6 3.1 17.9 5.3 5.6 17.8 13.7 13.1 7.7 12.6 12.9 7.0 7.6 18.9 11.3 6.4 13.0 9.5 11.9 7.6 6.7 14.1 3.5 16.3 2.7 7.7 10.3 11.1 10.7 11.9 0.0 0.0 8.1 0.0 0.0 0.1 0.0 8.1 12.9 1.4 0.2 1.5 3.6 2.3 9.0 11.0 6.3 4.9 3.0 5.7 0.0 10.9 7.7 14.6 7.8 5.1 13.3 4.4 6.9 10.3 0.0 4.5 9.5 10.0 0.4 0.4 3.2 4.2 9.9 7.6 14.7 6.4 1.3 3.2 2.7 7.3 5.5 1.0 0.4 3.4 35.0 12.3 0.4 3.8 0.4 13.1 2.9 13.9 11.1 1.2 9.8 2.2 11.5 6.2 0.5 7.9 2.9 10.6 1.5 14.3 0.8 0.3 0.1 17.4 0.8 2.8 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 15.9 1.4 12.5 8.9 5.0 17.9 5.3 12.6 16.3 6.0 6.4 0.5 74.8 18.1 0.3 8.1 35.7 2.7 6.8 21.0 7.9 8.6 13.3 14.6 1.8 9.8 10.5 0.0 17.2 1.0 5.7 35.8 0.0 19.8 5.2 0.0 7.5 5.5 1.3 3.4 0.6 2.1 6.8 0.0 10.6 2.0 17.9 8.6 0.4 18.2 1.4 0.0 4.7 0.5 6.8 29.6 3.3 0.0 7.4 45.7 SHISA2 "bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166" ENSG00000180730 "Shisa family member 2" Q6UWI4 13 26044597-26051031 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 9.6;Basal glandular cells: 8.8;Urothelial cells: 18.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 18.9;JURKAT: 13.2;LHCN-M2: 13.2;NTERA-2: 9.6;RH-30: 30.7;U-2197: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA049752, HPA050172" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA049752: , HPA050172: AB_2681041" "unprognostic (2.08e-2)" "unprognostic (3.00e-1)" "unprognostic (2.41e-1)" "unprognostic (9.71e-2)" "unprognostic (6.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.30e-4)" "unprognostic (4.03e-2)" "unprognostic (3.10e-1)" "unprognostic (7.45e-2)" "unprognostic (2.17e-2)" "prognostic favorable (2.43e-4)" "unprognostic (5.56e-3)" "unprognostic (2.09e-1)" "unprognostic (3.46e-1)" "unprognostic (1.51e-2)" 0.3 0.0 0.7 0.0 2.0 0.0 12.9 0.0 0.5 1.5 0.0 0.4 0.0 7.9 0.0 0.0 0.3 0.0 2.0 0.6 3.0 0.0 3.7 0.1 1.1 0.0 0.0 0.0 1.7 0.0 0.4 0.0 1.9 0.0 10.2 1.0 0.3 0.0 3.5 0.0 1.6 0.9 20.8 0.3 0.0 0.0 0.8 0.6 2.2 1.1 1.0 5.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.2 2.5 1.0 0.0 0.0 1.2 18.9 0.7 13.2 0.0 0.0 13.2 0.7 1.3 0.3 9.6 5.5 4.8 0.0 30.7 0.1 1.2 4.3 0.3 0.0 0.2 0.0 3.4 2.0 0.4 0.1 1.0 0.0 0.5 19.2 4.2 0.0 0.0 0.0 0.0 0.0 2.6 2.2 0.4 1.7 0.6 0.7 1.0 0.6 1.7 0.7 0.3 0.8 3.9 5.6 1.6 1.0 1.1 0.6 0.7 0.4 0.0 9.6 0.0 8.8 4.7 0.0 0.4 0.0 1.4 0.0 3.5 0.0 0.2 0.0 4.0 1.5 1.2 0.0 0.0 0.2 0.3 0.7 2.4 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.7 0.0 0.2 1.7 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 1.2 0.3 3.6 1.5 0.1 0.0 0.0 18.2 SHPRH "bA545I5.2, FLJ90837, KIAA2023" ENSG00000146414 "SNF2 histone linker PHD RING helicase" Q149N8 6 145864245-145964423 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Helicase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 175.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034854, HPA044852" Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Cytosol" "HPA034854: AB_10964488, HPA044852: " "unprognostic (3.10e-2)" "unprognostic (4.46e-2)" "unprognostic (5.61e-3)" "unprognostic (1.53e-2)" "unprognostic (7.40e-3)" "unprognostic (2.20e-2)" "unprognostic (2.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (5.03e-1)" "unprognostic (7.90e-2)" "unprognostic (6.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" "unprognostic (3.01e-1)" 10.9 7.3 8.3 11.0 10.0 5.5 10.4 38.0 11.5 10.6 8.0 4.5 10.8 6.0 14.1 9.2 8.5 9.8 6.7 7.2 7.2 4.2 8.4 6.5 7.1 9.0 7.6 5.9 18.8 8.7 11.4 19.7 6.6 8.5 8.3 7.4 7.3 10.2 13.7 11.4 13.9 8.2 11.0 10.3 8.8 8.5 10.7 8.7 8.4 12.5 7.2 8.0 10.7 11.5 6.7 4.8 4.4 2.4 3.4 4.3 1.2 3.0 2.3 11.7 6.8 5.4 5.8 5.6 3.6 2.9 4.5 5.8 5.3 2.1 10.6 4.5 2.7 3.5 5.2 7.1 5.1 5.9 4.7 8.1 10.7 5.3 4.4 4.0 22.4 6.7 4.0 5.9 4.2 6.2 4.4 4.8 7.6 14.8 6.0 3.8 2.7 14.4 8.3 7.8 5.0 4.1 10.4 18.1 3.6 6.1 3.0 9.6 6.7 6.4 5.9 4.0 8.4 3.1 10.8 5.3 2.9 5.4 5.6 4.2 4.9 7.0 12.7 3.0 9.6 4.4 1.6 2.3 4.4 4.3 2.4 3.7 3.9 3.6 2.9 2.7 6.7 4.1 3.3 0.1 3.4 2.4 4.8 3.3 1.2 8.3 10.0 38.0 11.5 7.2 4.2 7.6 5.9 8.5 8.7 26.8 18.9 20.8 15.3 18.8 113.2 15.9 17.8 12.0 23.9 21.0 198.3 12.7 6.6 15.4 8.3 19.7 10.0 0.0 11.1 5.8 14.4 13.4 12.7 14.8 10.2 89.0 18.5 14.1 21.8 5.1 46.9 15.5 13.5 15.4 14.3 57.4 13.0 10.5 32.2 4.5 175.4 71.1 21.7 76.9 67.5 17.2 5.5 20.3 15.0 9.6 SHROOM4 KIAA1202 ENSG00000158352 "Shroom family member 4" Q9ULL8 X 50591647-50814302 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 27.3" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 15.2;Endothelial cells: 36.5;Ito cells: 31.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "basophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "EFO-21: 6.1;HUVEC TERT2: 23.3;RH-30: 4.5;RPTEC TERT1: 5.0;TIME: 8.7;WM-115: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010089, HPA010565" Uncertain Approved "Nucleoplasm,Vesicles,Focal adhesion sites" NA NA "Focal adhesion sites" "Nucleoplasm, Vesicles" "HPA010089: , HPA010565: AB_1079961" "unprognostic (2.55e-2)" "unprognostic (1.43e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (8.37e-4)" "unprognostic (1.34e-1)" "unprognostic (1.60e-2)" "unprognostic (4.30e-3)" "unprognostic (4.55e-2)" "unprognostic (2.13e-1)" "unprognostic (2.93e-1)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (7.30e-2)" "unprognostic (2.83e-1)" "unprognostic (1.74e-2)" "unprognostic (2.75e-1)" 13.1 3.5 5.9 3.6 12.1 2.4 10.1 1.9 7.7 6.4 2.9 27.3 1.6 2.4 6.8 3.6 5.2 4.3 5.7 8.5 8.3 4.8 9.7 1.9 21.4 1.9 15.9 6.5 2.5 1.9 3.6 3.7 15.3 13.0 3.6 3.0 4.8 3.5 3.7 6.0 3.2 2.6 7.4 19.7 2.1 2.4 1.5 15.8 0.0 6.3 6.7 2.1 4.8 4.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.5 0.1 0.0 6.1 0.8 0.0 0.6 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.5 0.0 5.0 2.2 0.1 0.0 0.0 0.8 1.3 3.3 0.0 0.1 8.7 0.0 0.0 0.0 0.6 0.4 0.0 0.0 1.2 0.2 4.5 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 12.1 1.9 7.7 8.3 4.8 15.9 6.5 13.0 15.8 23.8 15.2 0.0 1.7 3.2 0.1 2.5 0.0 2.7 2.3 5.2 0.0 0.4 3.3 0.6 0.0 36.5 0.3 0.0 0.2 2.3 1.9 0.8 3.5 1.0 0.5 0.0 2.9 31.3 3.8 0.0 1.1 1.5 0.0 0.0 2.3 2.8 1.3 0.0 1.1 2.6 0.3 0.0 1.4 0.0 0.9 2.8 0.2 0.0 2.6 1.4 SHTN1 "KIAA1598, shootin-1, shootin1" ENSG00000187164 "Shootin 1" A0MZ66 10 116881482-117126586 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 14.0;intermediate monocyte: 8.8;myeloid DC: 13.2;non-classical monocyte: 4.0;plasmacytoid DC: 8.9" "Group enriched" "Detected in many" 43 "dendritic cells: 13.2;monocytes: 14.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037942, HPA037943" Enhanced Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA037942: AB_2675748, HPA037943: AB_10671637" "unprognostic (1.00e-1)" "unprognostic (2.50e-2)" "unprognostic (6.77e-3)" "unprognostic (2.81e-1)" "unprognostic (7.85e-2)" "unprognostic (1.61e-1)" "unprognostic (2.42e-2)" "unprognostic (1.03e-1)" "unprognostic (2.56e-1)" "unprognostic (1.35e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.08e-6)" 3.5 6.5 51.5 6.8 50.1 1.6 8.7 9.8 34.1 5.5 7.0 42.3 0.3 6.7 4.4 8.4 5.4 5.2 6.5 2.6 58.9 37.0 7.8 12.1 9.8 4.5 67.8 22.7 6.8 10.9 18.6 20.4 5.4 36.3 7.3 8.6 2.0 9.9 3.0 0.9 9.6 7.8 3.8 67.4 7.0 9.0 9.9 54.5 0.4 11.9 1.4 4.1 4.0 2.4 0.0 13.2 0.3 14.0 0.0 0.2 3.5 15.8 8.9 0.9 1.9 0.0 0.0 8.9 1.3 3.5 2.7 5.2 10.0 10.5 0.0 2.7 4.9 8.1 8.2 7.1 6.0 2.8 0.0 7.4 0.0 9.4 6.2 1.2 2.8 2.5 0.4 5.3 2.7 5.2 7.2 6.6 4.3 4.3 0.0 1.9 6.3 0.0 0.1 3.4 3.0 6.0 0.0 12.0 3.5 7.4 2.2 9.9 3.9 10.7 15.6 9.7 10.9 12.5 2.5 11.3 0.9 6.7 0.0 7.8 1.7 0.0 0.0 4.9 0.0 4.9 0.0 14.0 0.1 0.0 8.8 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.3 0.0 4.0 8.9 0.2 3.5 51.5 50.1 9.8 30.2 58.9 37.0 67.8 22.7 36.3 54.5 71.5 33.1 2.4 13.5 0.0 78.9 3.4 28.1 33.5 43.3 22.7 58.9 35.1 18.3 40.5 5.8 1.3 14.6 0.0 45.7 25.7 3.1 31.7 2.3 42.7 35.4 46.1 16.4 3.1 79.2 9.0 10.3 62.9 0.0 91.0 20.8 13.1 41.7 50.9 4.9 44.5 55.6 12.9 3.5 17.4 41.4 0.0 16.7 0.0 17.7 11.9 SIPA1L3 KIAA0545 ENSG00000105738 "Signal induced proliferation associated 1 like 3" O60292 19 37907228-38208372 "Disease related genes, Predicted intracellular proteins" "GTPase activation" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A549: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042072, HPA045480, HPA074988" Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: " "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.86e-1)" "unprognostic (5.56e-2)" "unprognostic (9.99e-2)" "unprognostic (1.22e-2)" "unprognostic (1.31e-2)" "unprognostic (5.48e-2)" "unprognostic (3.11e-1)" "unprognostic (6.05e-2)" "unprognostic (3.15e-1)" "unprognostic (5.43e-2)" "unprognostic (9.26e-3)" "unprognostic (6.45e-2)" "unprognostic (4.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.96e-2)" 6.2 6.2 10.8 15.3 11.9 5.4 10.0 18.1 13.2 9.8 18.3 13.0 13.9 31.1 6.7 6.4 9.0 9.3 7.6 11.1 15.8 7.7 12.4 6.9 10.5 11.4 10.5 7.8 6.0 17.1 7.4 7.8 3.4 8.5 9.7 12.8 11.2 14.1 9.1 11.4 19.0 29.7 6.2 8.7 12.2 16.4 8.1 12.4 11.7 18.2 6.7 20.2 10.0 11.8 4.6 0.9 1.1 3.5 0.9 1.4 0.3 16.8 29.9 3.7 4.7 2.2 2.2 2.5 7.3 6.2 4.8 4.6 10.2 9.8 9.6 6.3 6.2 4.1 3.8 3.4 13.7 5.4 3.2 1.6 2.6 2.8 3.2 4.3 1.8 2.8 1.7 7.2 9.0 19.3 7.2 5.5 2.8 1.9 2.1 8.4 5.2 2.4 2.5 3.0 13.4 8.0 5.3 3.0 1.4 10.7 14.5 8.9 4.8 8.0 13.8 1.1 2.1 9.2 1.7 11.6 8.1 2.8 24.8 11.2 2.8 4.7 3.3 10.4 2.4 10.4 0.2 0.4 1.1 0.5 0.7 0.2 3.0 0.4 0.5 0.2 4.6 0.4 1.4 0.3 0.9 3.5 0.9 0.3 0.3 10.8 11.9 18.1 13.2 15.8 7.7 10.5 7.8 8.5 12.4 6.0 8.5 13.9 4.5 10.6 18.9 5.1 22.9 10.7 10.3 22.7 13.7 1.6 3.3 6.9 4.1 4.5 68.3 0.0 13.1 1.1 2.2 6.5 2.3 20.2 2.9 31.8 24.2 6.2 4.9 6.4 2.0 5.3 5.0 5.4 41.5 2.3 12.5 30.2 1.8 17.1 5.9 6.5 2.8 1.4 4.7 14.1 0.7 3.2 27.0 4.6 SIRT2 SIR2L ENSG00000068903 "Sirtuin 2" Q8IXJ6 19 38878555-38899862 "Cancer-related genes, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation" Transferase "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.6;skeletal muscle: 108.7" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 174.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004573, HPA011165" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "CAB004573: AB_2188600, HPA011165: AB_1856900" "unprognostic (2.15e-2)" "unprognostic (2.24e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (7.20e-7)" "unprognostic (3.75e-3)" "unprognostic (1.28e-2)" "unprognostic (2.85e-2)" "unprognostic (2.44e-3)" "unprognostic (2.73e-1)" "unprognostic (4.83e-2)" "unprognostic (2.97e-3)" "unprognostic (1.02e-1)" "unprognostic (1.90e-1)" "unprognostic (3.60e-2)" "unprognostic (1.19e-1)" "unprognostic (8.73e-2)" "unprognostic (1.70e-1)" 14.1 11.0 30.2 8.1 36.0 10.7 9.1 14.3 38.8 11.0 8.4 78.1 4.0 9.3 9.7 7.8 17.1 12.9 10.7 20.3 36.9 23.5 9.0 12.0 10.8 8.8 52.3 20.5 17.3 9.5 10.1 6.2 7.7 40.8 9.8 7.6 5.8 14.9 11.2 108.7 13.7 9.3 12.8 86.6 9.9 9.0 7.9 46.3 3.2 10.1 23.4 8.9 10.6 7.1 13.2 21.5 28.0 33.0 16.6 23.5 22.1 8.2 5.2 4.4 11.1 25.6 17.6 3.0 6.1 10.9 9.5 12.3 9.3 5.3 2.9 13.3 11.3 7.3 4.5 8.1 13.1 5.8 13.2 8.4 5.6 5.9 5.6 18.1 3.9 12.4 18.4 15.8 7.8 9.4 11.8 16.7 9.4 5.2 22.9 14.5 4.7 7.8 3.0 0.7 14.1 7.3 10.4 12.6 8.0 7.7 7.4 11.3 5.1 7.1 9.5 6.7 3.9 4.3 10.1 15.8 12.9 2.8 19.9 9.0 9.4 4.5 6.6 10.3 9.8 11.9 19.5 27.3 28.0 23.5 33.0 14.6 12.2 11.4 16.1 21.1 13.2 7.5 12.5 20.7 16.6 25.8 21.5 15.5 22.1 30.2 36.0 14.3 38.8 36.9 23.5 52.3 20.5 40.8 46.3 14.9 20.8 11.4 27.5 45.8 26.8 30.8 7.6 29.4 20.5 12.2 33.4 28.9 31.5 27.0 174.5 26.3 34.2 23.3 15.3 12.8 23.1 19.4 25.3 16.2 56.7 28.6 16.8 23.9 33.7 57.6 28.7 34.2 43.9 14.4 20.4 20.6 21.1 18.6 38.5 23.3 27.0 19.4 35.0 12.7 5.9 52.6 35.4 43.6 15.8 22.6 SKAP1 "SCAP1, SKAP55" ENSG00000141293 "Src kinase associated phosphoprotein 1" Q86WV1 17 48133440-48430275 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.9;lymphoid tissue: 52.1" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 48.5;granulocytes: 113.6;Late spermatids: 118.7;T-cells: 123.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 19.3;HDLM-2: 9.9;HMC-1: 8.5;JURKAT: 14.5;Karpas-707: 10.5;RPMI-8226: 12.4;RPTEC TERT1: 15.4;U-266/70: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002969, CAB025882, CAB055513" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB025882: , CAB055513: , HPA002969: AB_1079870" "prognostic favorable (5.07e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-2)" "unprognostic (1.80e-2)" "unprognostic (2.28e-2)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.57e-2)" "unprognostic (8.39e-2)" "unprognostic (1.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.71e-1)" "unprognostic (5.71e-2)" "unprognostic (6.20e-2)" "unprognostic (2.72e-1)" "unprognostic (1.94e-1)" "prognostic favorable (3.14e-4)" 1.9 9.4 0.5 28.0 0.6 2.9 4.5 0.4 0.6 5.9 3.8 0.6 10.9 1.1 2.2 10.6 2.1 8.0 6.2 2.1 1.3 1.1 12.9 2.0 5.2 20.0 0.7 0.4 2.4 2.8 11.6 17.5 0.7 1.2 3.0 2.4 1.6 10.2 7.4 0.5 1.2 6.1 1.2 1.9 11.7 2.2 7.8 0.6 52.1 1.8 1.3 27.7 5.1 4.3 11.9 0.1 2.1 0.2 22.3 50.9 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 19.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.2 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 10.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 15.4 0.0 0.0 0.0 1.0 0.0 0.1 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 9.6 6.8 0.0 0.0 0.0 0.0 2.1 0.1 0.3 35.9 0.0 30.1 2.8 29.6 32.2 0.1 11.9 26.1 28.9 0.7 22.3 0.2 0.1 50.9 22.3 0.5 0.6 0.4 0.6 1.3 1.1 0.7 0.4 1.2 0.6 3.0 14.6 10.4 0.1 1.8 0.0 0.6 0.0 2.7 5.7 8.7 0.0 0.1 39.7 0.2 48.5 1.6 0.3 0.0 1.6 0.1 1.3 0.3 113.6 25.1 0.2 0.0 1.2 6.2 3.7 118.7 1.4 1.7 1.7 0.0 0.6 2.0 1.5 0.0 0.7 1.1 0.3 6.5 0.3 34.8 4.1 1.1 0.2 123.7 0.1 0.4 SKIDA1 "C10orf140, FLJ45187" ENSG00000180592 "SKI/DACH domain containing 1" 10 21513478-21526368 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 9.6" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 13.7;Early spermatids: 13.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 23.1;AN3-CA: 5.9;BEWO: 10.7;SH-SY5Y: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039208, HPA040439" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA039208: AB_10795034, HPA040439: AB_10796122" "unprognostic (5.36e-2)" "unprognostic (1.84e-1)" "unprognostic (5.32e-3)" "unprognostic (6.45e-4)" "unprognostic (9.97e-2)" "unprognostic (3.23e-3)" "unprognostic (3.61e-2)" "unprognostic (1.12e-2)" "unprognostic (1.59e-2)" "unprognostic (4.23e-1)" "unprognostic (9.35e-3)" "unprognostic (5.93e-2)" "unprognostic (3.38e-6)" "unprognostic (8.13e-2)" "unprognostic (1.50e-1)" "unprognostic (8.20e-2)" "unprognostic (8.52e-3)" 0.9 1.9 1.9 0.4 3.3 1.7 2.2 3.1 5.9 1.3 1.7 0.0 0.0 0.3 1.0 1.0 0.9 1.7 0.6 5.5 2.5 1.8 4.1 4.3 1.0 0.3 1.4 3.4 4.2 1.5 7.3 1.8 2.5 3.0 1.1 0.6 4.1 2.6 2.0 0.5 2.9 0.5 1.0 1.2 0.4 0.6 4.6 0.3 0.9 9.6 0.7 0.3 1.1 1.1 0.6 0.5 1.5 0.6 0.5 0.3 0.1 0.4 1.0 23.1 5.9 0.5 0.2 10.7 0.5 0.3 0.0 0.0 2.1 0.1 0.2 0.9 0.3 0.1 1.4 2.1 0.4 0.0 0.0 2.6 0.1 1.0 0.2 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.7 0.2 0.4 0.1 0.2 0.1 0.9 0.7 0.1 1.4 0.0 0.0 0.3 0.7 0.0 0.4 0.6 2.5 5.3 0.8 4.0 0.1 2.0 0.4 4.6 0.3 0.2 0.7 0.2 0.5 0.1 0.0 0.3 1.4 0.0 0.2 1.5 0.3 0.5 0.2 0.3 0.3 0.3 0.2 0.2 0.3 0.6 0.3 0.3 1.3 0.5 0.6 0.5 0.2 0.1 1.9 3.3 3.1 5.9 2.5 1.8 1.4 3.4 3.0 0.3 0.0 1.0 0.0 0.8 1.3 13.7 5.2 5.1 0.0 2.3 1.8 0.0 4.6 6.6 0.1 13.5 3.5 0.0 0.0 0.6 3.1 1.7 0.6 1.1 8.9 2.4 1.6 0.0 3.1 1.5 6.6 1.4 0.0 0.0 0.0 0.0 6.8 0.5 0.0 2.1 5.1 4.0 6.5 0.6 4.8 3.2 1.6 2.9 0.0 0.0 0.2 SLA2 "C20orf156, FLJ21992, SLAP-2" ENSG00000101082 "Src like adaptor 2" Q9H6Q3 20 36612318-36646216 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.7;lymphoid tissue: 36.5" "Cell type enriched" "Detected in some" 8 "T-cells: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 6 "gdT-cell: 13.9;MAIT T-cell: 11.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 10.8;naive CD8 T-cell: 14.5;NK-cell: 16.5;plasmacytoid DC: 21.7;T-reg: 14.9" "Group enriched" "Detected in many" 8 "dendritic cells: 21.7;NK-cells: 16.5;T-cells: 14.9" "Group enriched" "Detected in some" 7 "HEL: 41.9;JURKAT: 24.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA053746, HPA058217" Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA053746: AB_2682246, HPA058217: AB_2683641" "unprognostic (4.16e-3)" "prognostic favorable (7.36e-4)" "unprognostic (4.52e-4)" "unprognostic (2.30e-6)" "unprognostic (3.37e-2)" "unprognostic (3.79e-3)" "unprognostic (2.15e-3)" "unprognostic (1.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.84e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.77e-8)" "unprognostic (8.48e-2)" "unprognostic (1.73e-1)" "unprognostic (1.98e-2)" "unprognostic (6.45e-3)" 2.3 0.8 0.7 15.1 0.8 11.3 1.3 1.5 0.5 1.5 3.9 0.2 2.3 2.8 2.0 1.1 1.7 1.4 4.8 1.6 0.7 0.7 1.5 1.9 6.9 17.1 0.7 0.0 1.6 0.8 0.0 1.1 1.6 0.8 1.5 1.8 1.8 6.3 0.4 0.9 0.7 7.5 1.5 1.1 15.9 2.5 1.0 0.3 36.5 1.5 1.1 18.4 3.8 1.3 0.2 21.7 2.3 0.3 16.5 14.9 11.6 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.9 0.2 1.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.1 0.0 0.1 4.9 3.5 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 3.5 0.0 0.8 0.2 1.6 13.9 0.3 11.7 0.2 11.5 12.9 0.1 0.1 10.8 14.5 2.3 16.5 0.0 21.7 14.9 11.6 0.7 0.8 1.5 0.5 0.7 0.7 0.7 0.0 0.8 0.3 0.0 3.8 0.0 0.1 0.3 0.2 0.3 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.1 0.0 0.2 0.0 0.0 1.3 1.5 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.1 0.1 0.1 31.9 0.1 0.3 SLBP HBP ENSG00000163950 "Stem-loop binding protein" Q14493 4 1692800-1712555 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Spermatocytes: 268.0;Spermatogonia: 323.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019254, HPA061670" Supported Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA019254: AB_1856951, HPA061670: AB_2684581" "unprognostic (1.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.05e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (2.29e-5)" "unprognostic (5.53e-2)" "unprognostic (1.94e-2)" "unprognostic (1.13e-2)" "unprognostic (9.81e-3)" "unprognostic (9.55e-3)" "unprognostic (4.58e-2)" "unprognostic (7.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.07e-2)" 19.8 18.1 26.9 30.4 28.0 60.7 27.5 23.8 30.0 19.3 19.3 14.2 20.7 16.3 20.4 21.9 25.0 19.0 15.8 17.9 25.1 26.5 23.7 21.2 18.7 43.9 19.9 24.0 23.1 17.8 13.0 19.5 27.7 16.0 20.0 21.3 17.9 24.7 21.2 15.1 24.7 17.0 20.5 17.1 26.1 18.2 50.6 12.4 52.4 24.9 17.7 42.8 23.7 26.6 24.4 24.1 45.3 29.8 19.8 36.1 30.4 29.4 12.1 17.5 18.4 15.5 17.7 18.2 25.9 22.2 31.5 31.9 25.0 34.4 38.9 15.5 21.4 37.2 18.1 35.1 23.5 37.0 15.9 19.0 48.8 15.1 25.1 19.2 45.1 23.8 12.2 18.9 23.9 15.9 18.3 17.9 26.1 34.9 38.5 38.5 10.6 69.4 41.1 21.8 31.1 21.6 52.3 28.6 24.6 30.3 22.4 19.9 15.3 22.0 14.3 15.3 24.7 23.7 29.8 15.1 26.5 15.2 27.9 40.3 22.4 40.7 93.0 24.8 38.7 26.0 9.3 29.8 21.8 23.6 22.3 21.4 24.4 30.8 33.2 24.1 18.0 26.5 25.1 45.3 19.8 19.8 19.1 36.1 30.4 26.9 28.0 23.8 30.0 25.1 26.5 19.9 24.0 16.0 12.4 14.9 16.8 53.9 86.5 93.4 17.7 7.1 25.5 8.1 7.9 34.9 23.6 121.4 91.2 43.6 64.1 31.8 21.2 23.3 27.3 39.1 59.3 64.3 23.1 26.1 70.1 23.8 34.4 29.4 34.0 32.9 40.9 44.4 62.4 61.3 27.5 27.6 30.6 23.0 41.4 37.4 11.4 12.9 49.1 268.0 323.2 92.5 37.4 59.9 37.5 71.2 SLC13A5 "INDY, NACT" ENSG00000141485 "Solute carrier family 13 member 5" Q86YT5 17 6684713-6713567 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 65 "liver: 150.4;salivary gland: 153.9" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 374.3" "Cancer enriched" "Detected in some" 15 "liver cancer: 27.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 61 "Hep G2: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044343 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044343: AB_10961771" "unprognostic (8.46e-3)" "unprognostic (3.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.75e-2)" "unprognostic (7.33e-2)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (8.79e-3)" "unprognostic (1.32e-1)" "unprognostic (3.23e-1)" "unprognostic (1.26e-3)" "unprognostic (1.30e-3)" "unprognostic (3.78e-11)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (2.05e-2)" "unprognostic (2.04e-1)" 0.2 0.8 1.0 0.1 1.9 0.1 0.2 0.6 2.3 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.9 0.1 0.1 0.9 0.7 0.4 150.4 0.1 0.2 0.8 1.2 0.3 0.2 0.1 0.2 0.1 0.6 0.1 0.1 0.0 153.9 0.1 0.1 0.1 0.1 0.1 0.2 0.9 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.9 0.6 2.3 0.9 0.7 0.8 1.2 0.6 0.0 0.0 0.0 7.0 0.6 0.5 0.2 0.6 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 23.3 0.4 0.1 0.0 0.3 0.0 374.3 0.0 0.0 0.0 15.4 21.0 0.0 0.6 0.3 0.0 0.0 0.0 7.4 9.8 0.0 0.0 0.0 1.4 0.0 0.0 0.9 1.5 0.4 0.1 0.0 0.0 0.2 SLC19A3 THTR2 ENSG00000135917 "Solute carrier family 19 member 3" Q9BZV2 2 227683763-227718031 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.2;breast: 78.2;placenta: 27.5" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 134.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 14.3;BEWO: 7.4;CACO-2: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038898 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA038898: AB_10673481" "unprognostic (3.37e-2)" "unprognostic (3.59e-5)" "unprognostic (1.95e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (4.67e-2)" "unprognostic (3.12e-3)" "unprognostic (7.28e-2)" "unprognostic (8.20e-2)" "unprognostic (1.68e-1)" "unprognostic (1.71e-2)" "unprognostic (7.01e-3)" 48.2 0.6 2.2 1.8 2.4 1.2 78.2 1.5 1.9 0.5 6.1 1.0 0.5 7.7 0.6 0.4 0.6 0.6 8.9 1.9 2.3 2.4 2.1 16.0 5.6 1.3 3.0 0.7 0.9 1.3 0.2 0.3 27.5 2.6 0.5 1.6 0.7 0.9 0.2 0.7 1.6 4.5 0.5 2.6 0.5 0.5 0.6 1.5 0.0 0.5 0.4 0.4 1.0 2.3 2.6 1.8 8.6 1.8 4.3 1.1 0.4 0.3 1.6 0.3 1.0 14.3 0.4 7.4 0.1 0.2 0.3 0.6 18.7 0.5 0.4 0.2 0.1 4.6 0.5 0.5 0.5 0.8 0.1 1.2 0.1 1.0 0.8 1.7 0.2 0.2 3.3 0.4 0.1 0.9 0.3 0.0 0.3 0.2 0.9 0.0 1.8 0.1 0.7 3.2 0.6 0.3 0.3 0.2 0.2 0.2 0.3 1.1 0.1 0.6 2.1 0.5 2.7 0.3 0.2 0.5 0.5 0.5 4.2 0.4 0.2 0.1 0.7 1.4 0.3 0.5 8.6 1.8 1.7 1.0 1.2 0.6 1.6 0.8 0.9 0.4 2.6 1.0 1.1 6.1 4.3 1.1 1.8 0.4 0.4 2.2 2.4 1.5 1.9 2.3 2.4 3.0 0.7 2.6 1.5 8.9 3.2 0.0 0.4 0.0 2.9 0.3 0.0 0.0 0.0 1.8 0.0 45.5 1.7 1.7 0.3 0.5 6.4 0.0 0.0 7.0 0.9 0.3 0.0 11.4 4.6 0.0 1.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.8 0.6 0.0 0.0 2.2 0.1 0.0 1.0 0.0 0.1 0.0 134.3 0.0 5.6 0.3 SLC22A23 "C6orf85, FLJ22174" ENSG00000137266 "Solute carrier family 22 member 23" A1A5C7 6 3268962-3457022 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 73.9;Late spermatids: 171.9;Mucus-secreting cells: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014697 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA014697: AB_1844371" "unprognostic (4.58e-2)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "prognostic favorable (6.57e-4)" "unprognostic (5.16e-3)" "unprognostic (3.25e-3)" "unprognostic (1.40e-1)" "unprognostic (4.53e-3)" "unprognostic (9.74e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (2.39e-4)" "unprognostic (8.91e-2)" "unprognostic (4.30e-1)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" 7.4 2.2 9.0 4.6 16.2 8.1 9.3 8.4 14.8 5.6 17.4 30.8 3.4 19.6 3.6 11.8 16.8 11.3 7.5 2.2 11.0 8.1 6.9 12.6 8.0 3.9 28.6 8.7 3.0 14.9 14.8 6.5 8.3 17.8 14.2 14.4 5.7 10.0 2.8 5.9 14.9 20.3 3.0 17.5 4.6 26.0 7.2 21.0 5.2 4.1 9.8 9.9 3.8 9.9 0.1 0.7 0.8 0.3 0.3 1.4 1.9 2.4 5.6 12.5 13.9 4.4 5.0 16.0 0.4 0.1 0.7 0.3 12.5 0.4 0.6 1.4 2.7 11.1 3.6 2.5 6.6 0.2 2.0 7.7 5.8 2.1 11.0 0.6 0.3 0.4 1.2 13.0 12.1 0.6 2.6 0.4 3.2 5.2 3.3 0.4 2.9 0.5 1.4 4.3 13.7 2.3 1.3 0.8 9.9 0.0 15.3 1.4 0.2 3.3 4.8 4.1 13.3 18.5 0.1 3.1 7.3 2.3 9.4 1.5 7.5 0.1 0.2 12.8 0.4 4.4 0.0 0.3 0.0 0.4 0.0 0.2 0.0 1.0 0.4 0.2 0.1 1.4 0.9 0.8 0.3 0.2 0.7 0.0 1.9 9.0 16.2 8.4 14.8 11.0 8.1 28.6 8.7 17.8 21.0 6.0 13.7 0.5 4.2 10.3 7.9 2.4 10.2 33.5 17.0 5.2 7.9 12.2 0.0 2.5 73.9 8.4 29.0 23.3 7.0 0.9 1.4 19.2 0.0 10.0 9.8 0.0 4.1 6.7 8.0 171.9 1.7 2.0 3.3 10.8 52.1 9.1 5.7 14.4 0.7 2.4 3.4 0.0 0.9 2.1 1.1 11.0 7.7 1.0 22.6 3.9 SLC25A36 "FLJ10618, PNC2" ENSG00000114120 "Solute carrier family 25 member 36" Q96CQ1 3 140941830-140979933 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027036 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoplasm "HPA027036: AB_1857048" "unprognostic (4.12e-2)" "unprognostic (9.98e-2)" "unprognostic (2.86e-1)" "unprognostic (1.37e-1)" "unprognostic (6.52e-2)" "unprognostic (3.46e-1)" "unprognostic (9.00e-2)" "unprognostic (1.71e-2)" "unprognostic (1.99e-2)" "unprognostic (2.47e-2)" "unprognostic (3.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.20e-1)" "unprognostic (2.34e-1)" "unprognostic (6.03e-2)" "prognostic favorable (1.55e-4)" 20.2 16.9 14.9 13.4 20.5 36.5 25.2 18.7 31.3 23.5 19.4 18.3 17.3 22.3 25.6 37.3 12.2 25.1 13.7 29.5 15.9 19.0 29.0 3.1 22.4 18.6 15.6 16.7 32.6 33.9 29.7 26.3 19.1 21.6 20.6 14.8 21.1 17.5 17.7 60.6 16.2 17.2 20.4 18.5 14.1 23.6 24.4 12.2 15.4 23.7 15.1 12.7 20.7 18.5 17.0 14.9 15.7 13.1 18.1 16.6 10.9 23.8 5.4 17.5 14.3 16.1 20.6 22.1 9.0 11.5 10.1 14.3 14.9 11.4 19.9 22.4 7.6 14.5 16.0 21.2 8.8 20.7 15.2 17.2 16.4 13.0 9.4 24.2 23.4 10.2 23.2 29.6 7.4 22.7 22.7 10.6 14.7 8.7 12.9 14.7 10.3 13.9 16.1 17.4 5.9 10.1 15.1 15.6 28.2 11.9 8.2 11.3 18.5 12.2 22.2 39.1 16.0 15.4 13.3 10.7 14.1 7.9 24.9 8.6 26.2 17.0 23.2 18.2 9.8 6.9 10.5 10.4 15.7 11.4 13.1 13.3 17.0 11.7 12.5 14.9 16.0 16.6 15.7 1.8 18.1 13.1 10.9 10.2 10.9 14.9 20.5 18.7 31.3 15.9 19.0 15.6 16.7 21.6 12.2 92.3 107.7 22.2 58.2 60.7 96.5 82.2 38.2 133.8 62.6 68.0 125.7 48.2 54.7 22.9 5.0 40.0 22.6 0.0 33.6 33.4 49.8 72.0 63.6 0.4 22.8 87.4 57.0 29.4 35.2 11.5 55.3 36.5 54.0 29.7 27.0 70.1 26.8 17.5 55.9 52.8 122.5 58.2 54.2 29.3 61.1 47.6 41.3 41.1 40.3 64.7 SLC26A11 ENSG00000181045 "Solute carrier family 26 member 11" Q86WA9 17 80219699-80253500 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 37.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029893 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA029893: AB_10600809" "unprognostic (5.86e-2)" "unprognostic (6.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (1.55e-5)" "unprognostic (3.80e-2)" "unprognostic (2.63e-3)" "prognostic unfavorable (1.82e-6)" "unprognostic (2.05e-2)" "unprognostic (3.54e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.43e-5)" "unprognostic (2.86e-1)" "unprognostic (3.50e-1)" "unprognostic (9.54e-3)" "unprognostic (8.40e-2)" "unprognostic (8.69e-2)" "unprognostic (7.32e-2)" 9.9 30.9 10.2 10.2 19.3 16.3 8.4 9.1 18.0 11.6 8.2 12.6 14.1 8.7 11.6 14.6 6.9 9.2 10.0 5.1 9.4 30.5 12.4 6.9 12.8 14.3 10.5 17.4 18.3 7.9 14.9 25.6 21.1 17.2 11.8 5.1 15.6 12.2 14.8 6.5 13.1 11.9 11.6 9.3 17.3 7.3 4.8 7.3 1.8 18.1 4.9 6.7 9.8 14.1 0.4 1.3 0.1 2.3 0.1 4.9 1.9 0.5 8.2 9.7 7.5 4.9 3.6 11.2 4.7 5.9 10.6 6.6 9.4 1.7 0.1 9.6 4.9 7.7 3.1 5.4 3.5 4.2 11.2 9.7 0.0 10.4 8.7 12.9 0.0 1.5 6.6 5.7 5.1 2.3 1.0 8.9 1.9 4.0 11.9 6.2 7.7 0.4 0.2 4.3 2.3 8.0 0.4 1.0 4.3 9.6 9.0 3.8 11.9 4.7 11.8 12.2 15.8 14.1 0.2 6.6 8.6 5.0 7.3 0.5 13.5 5.1 1.3 4.4 0.0 6.8 0.0 2.3 0.0 1.8 0.9 2.6 0.4 3.2 2.6 1.3 0.2 4.9 2.0 0.1 0.1 0.3 0.0 4.0 1.9 10.2 19.3 9.1 18.0 9.4 30.5 10.5 17.4 17.2 7.3 6.0 12.0 0.9 9.3 4.0 28.0 2.0 0.0 2.7 5.7 12.2 55.0 12.2 1.7 6.3 0.4 14.1 3.9 0.0 5.3 7.0 8.2 9.4 1.1 2.0 14.0 3.2 9.8 6.2 5.9 0.2 15.8 8.3 3.3 2.8 2.5 21.0 3.9 3.5 11.7 4.8 37.6 32.3 4.7 0.2 1.5 4.1 21.7 5.7 2.8 5.2 SLC34A2 NAPI-3B ENSG00000157765 "Solute carrier family 34 member 2" O95436 4 25648011-25678748 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lung: 259.9;seminal vesicle: 69.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 443.7;Alveolar cells type 2: 1050.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 585.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 81 "BEWO: 12.6;EFO-21: 47.7;RPTEC TERT1: 34.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037989, HPA066474" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA037989: AB_10670536, HPA066474: " "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.38e-1)" "unprognostic (4.25e-2)" "unprognostic (7.33e-2)" "unprognostic (9.83e-2)" "unprognostic (2.37e-2)" "unprognostic (6.60e-3)" "unprognostic (6.27e-2)" "unprognostic (1.89e-2)" "unprognostic (5.77e-2)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (3.25e-1)" "unprognostic (6.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.93e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 3.2 0.2 0.1 13.0 0.1 0.0 24.7 2.9 6.9 2.1 0.5 13.0 3.4 0.1 0.1 0.1 10.8 0.5 259.9 0.0 0.1 0.0 2.9 4.4 0.0 0.6 2.6 0.8 0.3 0.0 1.6 27.4 69.1 0.1 0.7 2.1 0.0 0.1 0.1 0.4 0.5 0.0 0.4 27.9 0.1 1.9 0.0 0.1 0.4 0.2 1.9 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.9 0.5 0.2 0.3 0.3 0.1 0.2 0.1 0.1 0.0 0.4 0.3 0.2 1.5 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.8 0.0 443.7 1050.6 0.0 0.1 0.0 0.0 0.6 40.8 125.8 178.6 19.2 0.0 1.6 5.0 57.7 3.5 0.0 0.0 0.0 7.1 0.0 0.0 3.5 26.7 0.0 0.2 0.0 0.0 0.0 0.0 14.0 1.1 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 2.9 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 SLC35B1 UGTREL1 ENSG00000121073 "Solute carrier family 35 member B1" P78383 17 49700943-49709014 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048655, HPA057418" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA048655: AB_2680481, HPA057418: AB_2683432" "unprognostic (1.35e-1)" "unprognostic (2.15e-2)" "unprognostic (1.09e-3)" "unprognostic (6.36e-2)" "unprognostic (8.31e-2)" "unprognostic (2.86e-3)" "unprognostic (6.17e-3)" "unprognostic (4.39e-2)" "unprognostic (2.47e-2)" "unprognostic (4.00e-3)" "unprognostic (3.37e-2)" "unprognostic (4.42e-2)" "prognostic unfavorable (5.69e-7)" "unprognostic (6.28e-2)" "unprognostic (7.88e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-2)" 8.5 8.3 8.4 7.4 11.8 8.0 10.7 8.2 14.0 9.3 13.0 9.3 9.2 13.7 7.6 26.5 9.4 9.9 7.3 15.8 8.6 9.2 16.0 46.7 10.1 16.0 9.8 7.9 7.5 22.3 13.5 13.2 12.4 9.9 7.4 13.1 8.4 22.4 12.7 33.7 9.2 27.3 8.0 8.1 10.2 9.3 9.1 7.1 6.5 19.7 13.8 10.8 9.9 6.7 6.6 25.0 8.1 15.1 7.0 9.5 7.9 13.6 22.9 17.2 27.0 15.8 9.9 19.5 14.5 23.6 30.9 24.8 47.3 16.0 9.5 34.0 20.1 18.6 10.2 27.1 17.3 33.9 11.6 19.8 12.0 15.1 27.7 27.6 22.5 11.4 10.1 19.0 22.2 27.8 7.9 19.0 15.6 11.7 27.4 21.2 27.8 16.5 14.6 7.6 25.6 25.9 11.1 18.6 25.7 15.1 14.5 14.9 19.1 8.5 6.8 9.9 19.3 21.8 15.4 8.1 23.6 10.5 25.2 19.0 14.5 23.8 14.2 15.4 17.1 20.6 8.1 15.1 5.0 9.5 13.5 6.9 6.6 6.5 8.9 16.7 3.6 6.6 6.0 6.7 7.0 9.1 25.0 7.4 7.9 8.4 11.8 8.2 14.0 8.6 9.2 9.8 7.9 9.9 7.1 14.9 27.2 30.7 36.3 19.8 25.8 35.5 20.4 30.8 31.8 26.2 33.4 49.1 29.9 55.6 40.4 35.0 41.9 0.0 89.2 91.8 36.1 53.6 41.5 49.5 66.9 20.6 48.6 22.7 21.3 11.3 27.9 37.0 35.4 45.9 30.5 41.4 64.2 27.5 19.4 37.9 30.4 12.9 15.3 44.2 33.8 22.0 67.3 35.2 36.0 37.4 SLC35F1 "C6orf169, dJ230I3.1" ENSG00000196376 "Solute carrier family 35 member F1" Q5T1Q4 6 117907526-118317676 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 41.9" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 11.0;Early spermatids: 10.7;Horizontal cells: 15.9;Late spermatids: 17.4;Melanocytes: 13.5;Muller glia cells: 27.9" "Group enriched" "Detected in some" 16 "glioma: 15.1;melanoma: 3.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 9 "AF22: 23.9;WM-115: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019576 Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA019576: AB_2190216" "unprognostic (1.46e-1)" "unprognostic (5.67e-2)" "unprognostic (7.08e-2)" "unprognostic (1.37e-3)" "unprognostic (3.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.39e-1)" "unprognostic (4.04e-1)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (4.44e-3)" "unprognostic (2.19e-1)" "unprognostic (8.83e-4)" "unprognostic (3.04e-3)" "unprognostic (6.03e-2)" "unprognostic (8.32e-2)" "unprognostic (2.02e-1)" 2.8 2.7 13.8 2.1 14.5 0.9 1.2 3.6 41.9 1.7 3.5 4.3 0.0 1.6 2.7 5.5 1.8 1.5 1.8 5.3 10.4 10.2 1.7 1.0 1.1 1.0 9.3 15.3 1.4 1.4 1.0 0.6 1.0 5.6 2.3 2.3 2.6 1.7 2.9 1.2 1.6 1.8 2.6 4.1 1.6 1.4 1.8 5.6 0.0 1.8 0.0 1.0 1.4 2.6 0.2 0.6 1.0 0.1 0.3 0.9 0.1 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.2 0.0 2.9 3.4 0.0 0.0 0.1 0.0 40.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.0 0.3 0.0 0.6 0.0 0.1 13.8 14.5 3.6 17.4 10.4 10.2 9.3 15.3 5.6 5.6 0.0 0.0 0.0 0.0 0.3 11.0 4.3 0.0 0.0 2.3 0.0 2.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.1 15.9 0.0 0.0 0.0 17.4 0.6 0.0 13.5 0.0 0.0 27.9 0.0 0.0 1.1 0.0 1.8 0.0 0.7 0.9 1.2 0.0 0.0 0.0 0.0 0.0 SLC35F6 "ANT2BP, C2orf18, FLJ20555, TANGO9" ENSG00000213699 "Solute carrier family 35 member F6" Q8N357 2 26764284-26781231 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 48.6;Karpas-707: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034655 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA034655: AB_10696359" "unprognostic (2.26e-1)" "unprognostic (7.45e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-1)" "unprognostic (7.71e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.11e-4)" "prognostic unfavorable (3.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.35e-1)" "unprognostic (3.24e-1)" "unprognostic (2.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.07e-2)" "unprognostic (9.95e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-2)" 37.3 24.1 9.7 10.5 11.7 6.5 42.2 8.3 15.6 17.9 14.5 16.0 12.4 10.4 14.1 14.0 25.2 12.5 14.4 15.0 10.4 11.6 37.4 25.4 15.3 22.0 12.3 9.3 20.4 12.6 13.1 12.2 26.6 11.9 15.3 9.0 13.8 16.7 14.2 16.7 30.9 14.7 15.4 11.4 14.8 16.3 11.7 9.1 10.5 24.1 20.4 15.5 13.8 18.2 3.1 7.1 7.8 19.0 8.6 8.8 5.9 8.3 14.7 4.5 11.4 15.5 7.0 6.9 4.7 7.3 6.1 5.6 9.2 16.0 2.2 8.0 6.6 15.1 10.4 6.4 9.5 4.3 3.8 3.1 2.5 5.6 7.7 48.6 2.7 12.8 11.1 9.8 6.9 23.2 2.8 7.1 3.4 4.7 42.8 6.1 13.5 3.4 2.4 2.5 6.0 3.9 3.0 12.9 3.5 16.2 6.7 3.4 4.5 8.0 13.1 8.5 3.9 4.9 2.8 6.4 8.0 8.5 10.9 5.2 8.3 10.4 4.3 8.6 4.6 7.2 7.0 12.0 5.3 8.8 16.5 5.0 3.1 6.1 8.0 7.1 2.5 4.2 6.0 7.8 8.6 19.0 5.5 3.8 5.9 9.7 11.7 8.3 15.6 10.4 11.6 12.3 9.3 11.9 9.1 11.9 8.0 6.7 11.8 15.0 17.3 11.2 25.5 5.3 7.9 31.4 5.9 22.1 6.6 29.6 1.5 19.2 18.8 0.0 33.5 20.1 22.4 12.8 1.1 19.2 46.2 14.3 8.7 28.8 43.7 1.1 17.0 26.4 27.0 10.8 8.7 18.9 38.9 9.1 11.3 49.9 9.7 25.8 29.9 3.7 6.5 22.5 31.8 13.8 9.7 10.6 SLC38A7 FLJ10815 ENSG00000103042 "Solute carrier family 38 member 7" Q9NVC3 16 58665109-58685104 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 273.8;Late spermatids: 600.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041777 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041777: AB_10796782" "unprognostic (2.16e-3)" "unprognostic (2.30e-2)" "unprognostic (6.23e-3)" "prognostic favorable (6.87e-4)" "unprognostic (3.49e-1)" "unprognostic (8.08e-3)" "unprognostic (9.76e-3)" "unprognostic (6.34e-3)" "unprognostic (1.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.77e-1)" "unprognostic (4.90e-2)" "prognostic favorable (2.87e-4)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (7.50e-2)" "unprognostic (4.93e-3)" 7.0 11.1 10.6 6.7 10.0 2.7 7.2 7.7 13.7 6.2 5.3 10.6 6.8 4.8 6.0 7.4 6.0 4.2 6.5 13.8 7.2 7.2 7.4 12.1 5.2 4.3 6.1 11.0 4.7 5.0 16.9 10.2 8.4 8.3 5.2 6.9 8.9 6.1 5.6 9.6 5.3 4.9 8.5 5.8 10.3 5.4 27.1 6.6 4.2 8.0 8.1 5.1 6.5 6.3 2.8 6.1 2.5 8.6 2.3 5.2 6.6 4.4 7.0 6.9 10.6 14.4 8.7 13.0 10.5 12.2 14.8 10.3 6.5 6.9 2.8 6.0 14.6 11.9 10.8 6.6 7.3 8.8 1.8 6.0 3.2 5.8 10.5 21.9 6.6 9.2 17.4 15.4 10.3 6.8 8.0 15.1 6.7 9.4 4.3 10.7 5.3 2.6 3.9 7.5 4.7 10.4 9.6 7.5 7.6 6.5 10.2 5.1 7.7 15.8 10.8 4.6 9.7 5.1 2.8 11.8 8.1 6.2 14.0 3.1 6.3 4.1 3.2 11.0 4.0 6.0 0.2 8.6 2.5 5.2 8.4 3.1 1.9 3.3 3.8 6.1 2.8 2.7 2.9 0.8 2.3 7.5 2.1 2.2 6.6 10.6 10.0 7.7 13.7 7.2 7.2 6.1 11.0 8.3 6.6 3.0 4.1 0.5 3.9 3.4 9.7 11.2 2.5 4.0 3.4 10.4 11.8 7.3 3.3 12.6 273.8 4.7 3.9 0.0 7.4 7.9 5.7 3.0 1.1 8.5 31.3 15.9 12.6 8.6 8.6 600.3 8.9 7.1 8.5 2.8 3.6 8.0 10.5 3.5 8.1 4.6 7.1 6.5 5.1 6.2 6.1 3.8 12.8 1.8 5.1 2.7 SLC39A10 "DKFZp564L2123, FLJ90515, KIAA1265" ENSG00000196950 "Solute carrier family 39 member 10" Q9ULF5 2 195575977-195737702 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.0;thyroid gland: 39.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036512, HPA036513, HPA066087" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 49000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (5.33e-2)" "unprognostic (1.33e-3)" "prognostic favorable (1.46e-5)" "unprognostic (7.40e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (2.10e-2)" "unprognostic (8.73e-2)" "unprognostic (2.84e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (8.46e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-2)" "unprognostic (3.68e-1)" "unprognostic (2.47e-2)" "unprognostic (6.89e-2)" 6.6 10.9 16.0 6.0 24.8 3.7 6.2 10.8 41.0 9.8 3.8 4.2 4.9 3.6 9.4 3.3 3.5 8.5 7.6 4.7 15.0 11.2 7.8 2.1 6.3 6.5 8.5 24.4 7.4 5.7 5.8 5.7 10.7 15.7 16.7 4.0 1.4 4.8 6.5 3.3 5.7 5.7 6.7 10.2 14.4 4.3 7.9 6.2 10.6 39.9 1.7 6.4 6.1 4.9 9.4 18.4 19.3 2.7 11.0 4.6 1.5 2.9 9.9 18.9 5.2 3.7 8.8 9.8 13.7 6.7 6.6 3.3 14.8 10.6 4.1 20.9 7.8 5.1 4.2 11.5 12.6 8.4 2.1 8.6 4.6 15.4 12.1 4.1 16.8 1.9 5.2 1.8 7.3 8.4 23.4 14.8 4.2 13.3 5.8 10.6 2.8 4.8 5.2 22.0 17.2 7.8 11.3 6.6 10.2 28.8 4.9 7.3 10.0 13.7 28.0 7.2 34.5 4.5 10.5 14.5 12.1 14.0 7.9 7.1 2.0 1.2 2.4 9.7 7.9 12.2 19.3 2.7 1.9 4.5 2.5 3.5 6.8 4.0 3.7 3.3 9.4 3.5 4.6 0.5 11.0 1.8 18.4 3.9 1.5 16.0 24.8 10.8 39.7 15.0 11.2 8.5 24.4 15.7 6.2 3.0 10.9 18.2 9.3 22.8 21.9 7.3 7.6 6.7 29.6 34.9 7.9 41.3 1.7 17.6 23.2 27.0 2.9 23.3 9.5 54.8 20.3 18.5 12.7 2.5 21.6 7.9 15.0 24.5 18.1 11.5 17.5 29.7 6.8 8.2 5.1 15.6 17.5 2.9 17.7 14.9 19.9 12.9 13.8 47.8 27.0 17.9 19.6 21.5 4.5 6.4 SLC39A6 LIV-1 ENSG00000141424 "Solute carrier family 39 member 6" Q13433 18 36108532-36129385 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 212.3" "Cancer enhanced" "Detected in all" "breast cancer: 361.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042377 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA042377: AB_2677968" "unprognostic (7.60e-2)" "unprognostic (2.27e-2)" "unprognostic (5.50e-3)" "unprognostic (2.58e-3)" "unprognostic (1.02e-1)" "unprognostic (4.87e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (1.18e-1)" "unprognostic (3.19e-1)" "unprognostic (4.50e-2)" "unprognostic (7.63e-3)" "unprognostic (2.16e-1)" "unprognostic (4.74e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" 11.1 12.6 14.3 8.6 13.4 4.3 63.5 19.4 14.7 15.7 8.7 16.0 68.7 4.1 24.7 24.5 9.8 27.7 10.3 8.2 14.2 17.5 12.3 7.7 7.9 8.2 18.3 8.7 30.5 15.5 32.1 23.9 52.5 16.0 55.2 5.9 25.1 15.5 51.5 7.7 22.6 5.7 12.7 21.7 11.2 8.1 9.9 13.5 8.0 15.7 10.7 11.3 23.8 20.2 12.6 25.2 22.2 14.6 12.9 15.6 9.7 10.4 13.2 31.7 18.6 33.5 24.8 8.3 28.5 33.8 19.1 22.5 7.3 11.6 11.3 14.4 27.4 13.3 25.5 27.6 26.7 29.1 25.1 10.0 4.9 18.6 10.6 21.3 16.5 12.4 22.6 59.1 29.0 25.3 17.6 2.8 9.4 2.5 22.8 26.8 16.0 16.2 3.7 7.6 5.7 7.5 16.8 18.1 14.8 21.3 35.2 33.4 29.4 35.1 10.3 48.1 13.6 14.0 7.8 4.6 46.7 7.8 8.8 14.3 21.5 20.8 8.6 16.1 11.7 24.5 19.5 9.8 22.2 13.0 14.6 15.6 12.6 11.1 11.5 12.2 12.3 9.8 14.2 7.5 12.9 13.7 25.2 12.2 9.7 14.3 13.4 19.4 12.4 14.2 17.5 18.3 8.7 16.0 13.5 35.7 16.0 13.7 44.4 40.8 40.2 16.6 10.2 42.8 60.3 40.1 31.4 5.4 1.7 46.8 16.8 10.8 2.8 0.0 32.7 50.5 40.3 212.3 23.1 7.9 18.4 22.3 24.5 7.4 15.6 14.6 34.5 25.1 64.1 24.4 6.7 35.8 34.0 0.0 44.9 13.9 25.8 38.8 37.6 43.4 22.9 65.1 19.9 16.0 4.1 55.4 SLC40A1 "FPN1, HFE4, IREG1, MTP1, SLC11A3" ENSG00000138449 "Solute carrier family 40 member 1" Q9NP59 2 189560579-189583758 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 126.4;lymphoid tissue: 170.2" "Group enriched" "Detected in many" 5 "Kupffer cells: 1044.2;Syncytiotrophoblasts: 2060.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 64.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 93.2;CACO-2: 21.3;HEL: 75.5;HMC-1: 19.9;T-47d: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065634 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA065634: AB_2685524" "unprognostic (1.28e-2)" "unprognostic (1.73e-2)" "unprognostic (9.41e-2)" "unprognostic (1.83e-2)" "unprognostic (8.00e-3)" "unprognostic (1.36e-2)" "unprognostic (1.66e-1)" "unprognostic (6.22e-2)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "unprognostic (6.43e-2)" "unprognostic (6.44e-2)" "prognostic favorable (8.55e-5)" "unprognostic (4.66e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.11e-2)" 18.2 126.4 3.9 10.1 5.5 3.9 47.4 1.8 3.5 20.0 25.7 3.7 13.9 34.4 24.7 24.3 6.3 25.9 25.2 37.1 4.1 4.3 14.4 42.1 45.9 170.2 5.1 1.9 50.9 24.0 4.6 9.8 51.3 6.4 18.4 15.8 11.6 10.2 16.6 12.3 4.9 44.7 13.6 5.8 76.4 11.3 16.2 3.5 17.0 20.8 6.4 8.8 11.1 20.4 0.1 22.7 64.7 20.8 0.8 17.3 20.1 0.0 1.3 0.1 0.0 93.2 0.6 4.5 0.0 1.1 0.3 0.5 21.3 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.3 75.5 0.3 7.8 0.3 0.2 19.9 6.5 0.0 0.2 0.0 2.1 2.2 2.9 7.7 0.2 1.1 0.0 3.1 4.9 0.2 16.0 0.3 0.0 0.8 0.4 0.9 3.1 0.1 0.9 0.1 6.2 0.0 7.4 36.8 1.1 0.0 0.1 2.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 20.8 32.9 0.4 4.7 0.6 0.0 11.3 1.0 22.7 0.1 17.3 3.7 64.7 0.8 0.4 3.7 1.0 20.1 3.9 5.5 1.8 3.5 4.1 4.3 5.1 1.9 6.4 3.5 116.1 32.3 28.1 45.3 8.1 3.7 37.5 142.7 53.5 39.8 31.4 3.9 335.3 41.4 23.9 6.9 30.8 119.4 70.0 64.9 10.7 46.3 32.2 9.2 223.5 72.3 6.4 17.9 211.8 1044.2 4.7 112.2 26.2 8.5 1.8 50.3 9.6 51.2 77.2 55.2 100.1 43.2 64.7 18.1 5.0 0.9 7.0 2060.1 8.4 30.8 19.7 SLC43A3 "DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1" ENSG00000134802 "Solute carrier family 43 member 3" Q8NBI5 11 57406954-57427580 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 149.9;thyroid gland: 69.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 63.7;Hofbauer cells: 71.5;Sertoli cells: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 71.0;HMC-1: 62.7;RPMI-8226: 80.1;WM-115: 76.4" "Region enriched" "Detected in many" 4 "olfactory region: 12.7" "Low region specificity" "Detected in all" "HPA030551, HPA077244" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA030551: AB_10604094, HPA077244: AB_2732335" "unprognostic (2.64e-1)" "unprognostic (7.63e-2)" "unprognostic (9.67e-3)" "unprognostic (7.41e-3)" "unprognostic (6.59e-3)" "unprognostic (5.30e-3)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.26e-1)" "unprognostic (5.73e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (3.97e-13)" "unprognostic (8.16e-2)" "unprognostic (1.77e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-1)" 32.3 6.3 2.5 12.4 4.3 18.8 16.8 2.2 3.0 11.9 9.6 3.6 2.4 2.7 10.1 6.5 12.6 8.9 11.4 12.5 3.1 1.5 4.2 149.9 16.5 8.8 4.0 1.8 16.0 7.2 1.2 1.8 5.1 3.4 11.6 4.2 9.4 12.2 3.1 15.4 11.0 6.2 10.3 4.7 11.6 6.9 6.8 2.3 10.4 69.0 11.5 13.8 20.3 15.4 2.7 23.6 6.1 36.8 1.1 7.8 14.0 40.0 0.0 2.3 0.0 7.8 11.5 0.1 3.1 13.3 4.6 7.9 0.0 8.8 23.1 1.4 7.3 2.4 23.1 6.7 4.1 9.3 0.1 0.0 36.0 13.7 0.0 15.9 71.0 62.7 34.5 0.1 44.6 0.5 3.3 12.9 10.7 41.1 22.4 17.8 0.0 14.9 45.6 3.5 0.0 0.7 30.9 0.4 80.1 11.0 0.0 5.5 0.0 8.8 0.2 37.4 0.2 3.4 10.8 6.8 0.2 12.0 30.4 8.7 0.0 0.1 5.8 27.5 25.8 76.4 3.2 28.8 6.1 5.7 34.5 6.5 2.7 4.0 7.8 23.6 2.0 3.1 3.2 2.5 1.1 36.8 23.6 6.9 14.0 2.5 4.3 2.2 3.0 3.1 1.5 4.0 1.8 3.4 2.3 14.9 41.4 4.5 6.7 41.6 0.5 2.8 30.6 5.3 34.2 1.8 0.0 0.5 0.0 47.0 1.0 23.3 0.0 0.0 5.5 2.2 20.2 3.4 63.7 53.8 71.5 0.0 0.0 11.6 17.3 1.4 9.2 55.1 28.7 0.0 0.5 0.9 10.9 0.0 11.7 0.0 0.0 64.7 18.4 1.0 0.2 15.4 0.7 15.0 0.6 2.5 SLC4A1AP "HLC3, kanadaptin" ENSG00000163798 "Solute carrier family 4 member 1 adaptor protein" Q9BWU0 2 27663471-27694976 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 127.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036679 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA036679: AB_2675244" "unprognostic (5.63e-2)" "unprognostic (1.01e-1)" "unprognostic (4.62e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (2.21e-1)" "unprognostic (7.89e-3)" "prognostic unfavorable (3.76e-7)" "unprognostic (1.32e-1)" "unprognostic (7.74e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-1)" "unprognostic (9.66e-2)" "unprognostic (9.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.42e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.79e-4)" 12.3 16.1 18.8 14.2 27.0 12.7 13.9 27.4 29.0 11.5 11.3 15.8 8.7 11.6 12.8 12.2 14.2 12.3 9.8 18.6 17.9 19.6 15.3 15.0 12.8 14.6 17.0 20.5 15.2 13.3 23.8 16.0 14.5 29.1 12.6 12.3 9.0 12.4 12.1 26.0 15.1 12.0 12.5 15.4 13.1 12.5 29.9 16.8 16.1 14.6 14.9 15.1 11.1 11.0 16.7 13.3 40.8 17.9 22.5 19.5 14.1 22.0 12.9 13.0 12.1 13.4 12.4 19.1 18.4 12.7 19.4 15.9 18.8 16.2 14.0 17.1 14.7 20.5 15.8 20.8 14.2 17.4 19.4 17.0 16.1 13.5 20.6 16.4 22.9 15.4 11.1 18.1 19.3 18.3 16.3 19.7 13.8 23.2 15.3 17.8 13.4 15.4 22.5 13.1 14.6 12.7 12.8 28.5 16.1 19.9 10.3 14.2 14.0 14.3 19.6 17.6 13.8 11.8 15.1 19.9 18.1 16.4 12.5 21.4 25.3 35.7 44.8 19.6 18.5 14.4 40.8 17.7 24.2 17.6 16.9 17.4 13.5 16.1 15.3 13.3 16.7 19.5 16.5 16.5 22.5 17.9 10.7 17.1 14.1 18.8 27.0 27.4 29.0 17.9 19.6 17.0 20.5 29.1 16.8 29.8 21.6 5.2 11.5 10.5 20.1 26.0 12.7 22.7 29.6 17.4 17.7 21.1 5.0 23.4 23.8 18.3 9.7 0.0 31.5 17.0 12.3 7.8 37.0 14.0 21.3 23.8 15.6 12.9 15.8 3.1 16.1 13.3 16.9 27.1 10.6 21.0 27.1 8.6 18.0 12.6 20.2 32.3 10.0 127.5 65.0 10.5 20.4 15.0 8.5 7.6 SLCO4C1 "OATP-H, OATP4C1, OATPX, SLC21A20" ENSG00000173930 "Solute carrier organic anion transporter family member 4C1" Q6ZQN7 5 102233986-102296549 "Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 55.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 38.8;Proximal tubular cells: 28.3" "Cancer enriched" "Detected in many" 5 "renal cancer: 22.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3" "Cell line enhanced" "Detected in some" "Karpas-707: 8.1;RPTEC TERT1: 45.9;U-937: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058249 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA058249: " "unprognostic (1.63e-2)" "unprognostic (2.47e-2)" "unprognostic (4.48e-4)" "unprognostic (5.70e-6)" "unprognostic (7.43e-2)" "unprognostic (7.71e-3)" "unprognostic (3.24e-3)" "unprognostic (2.05e-3)" "unprognostic (2.13e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-3)" "unprognostic (5.83e-2)" "prognostic favorable (1.12e-4)" "unprognostic (3.29e-2)" "unprognostic (1.07e-1)" "unprognostic (5.91e-2)" "unprognostic (8.22e-2)" 0.4 0.4 0.3 0.7 0.7 5.4 0.3 0.2 1.8 0.3 1.9 0.0 5.2 1.4 0.2 0.6 0.3 0.3 1.6 1.1 0.3 0.4 55.9 5.2 11.0 0.2 0.3 1.0 0.3 0.9 0.0 0.7 0.1 0.2 0.4 0.5 0.0 3.2 11.8 0.3 0.6 2.1 0.0 0.3 1.6 0.4 1.3 0.0 1.5 1.0 0.3 0.1 0.7 1.1 0.1 0.4 10.0 1.1 2.6 4.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.5 45.9 0.0 0.3 0.2 0.0 0.1 0.0 1.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 11.6 0.0 7.9 1.1 7.5 4.3 0.0 0.4 0.0 0.7 2.3 0.4 0.1 0.2 1.5 10.0 2.6 0.0 0.3 0.0 1.0 0.3 0.7 0.2 1.8 0.3 0.4 0.3 1.0 0.2 0.0 6.0 38.8 0.0 0.1 0.0 0.0 0.3 0.0 4.0 6.8 5.2 0.0 0.0 1.7 0.2 8.3 0.0 1.2 0.0 0.7 0.0 0.0 0.0 5.7 5.5 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 28.3 0.0 0.0 0.0 1.7 0.7 0.0 0.0 2.2 1.2 0.3 SLX4 "BTBD12, FANCP, KIAA1784, KIAA1987" ENSG00000188827 "SLX4 structure-specific endonuclease subunit" Q8IY92 16 3581181-3611598 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 19.9;testis: 25.0" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 10.9;Spermatocytes: 18.6;Spermatogonia: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049421, HPA066238" Approved Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA049421: AB_2680759, HPA066238: AB_2685642" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-2)" "unprognostic (4.62e-1)" "unprognostic (6.08e-3)" "unprognostic (8.28e-5)" "unprognostic (6.52e-2)" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.97e-2)" "unprognostic (1.50e-1)" "unprognostic (4.32e-2)" "unprognostic (8.39e-3)" "unprognostic (1.20e-1)" "unprognostic (1.43e-3)" "unprognostic (5.74e-2)" 2.9 3.1 5.3 6.1 8.5 6.0 2.4 19.9 11.8 2.5 2.9 9.8 2.5 4.9 6.5 3.3 3.4 3.0 2.8 2.2 7.4 4.3 2.9 2.7 3.0 8.6 3.8 8.1 2.7 3.1 3.7 8.6 2.6 7.4 3.3 2.2 5.4 3.0 2.6 5.5 4.2 4.0 3.1 3.3 4.8 3.7 25.0 3.2 5.8 2.6 1.0 6.5 3.1 2.7 0.6 0.2 3.0 1.1 0.6 0.6 0.7 3.0 9.3 6.1 7.5 2.3 2.4 6.3 4.8 2.4 5.6 6.2 4.6 3.7 10.9 4.8 2.4 4.3 6.7 4.1 3.4 3.3 9.1 5.1 7.5 6.7 2.9 2.0 7.2 10.6 1.8 2.5 5.2 2.9 1.4 4.0 6.2 7.1 6.0 4.4 5.1 4.4 6.3 5.0 1.8 3.5 8.9 10.0 3.0 2.2 2.1 5.2 4.6 4.2 3.0 1.5 3.3 7.3 5.7 4.7 6.5 9.0 5.5 5.6 5.4 4.2 12.8 2.1 7.4 6.3 3.0 0.4 0.0 0.6 0.5 0.4 0.3 0.3 0.3 0.2 0.6 0.3 0.5 0.5 0.6 1.1 0.2 0.3 0.7 5.3 8.5 19.9 11.8 7.4 4.3 3.8 8.1 7.4 3.2 0.0 2.9 4.5 0.8 0.7 7.7 1.4 2.5 2.7 4.5 0.0 2.0 1.3 0.0 1.4 3.5 1.1 1.5 0.0 2.1 1.5 1.5 0.4 0.0 0.9 2.3 0.0 0.0 1.8 1.6 1.6 2.0 3.2 0.0 1.0 2.2 1.7 1.6 0.0 1.8 0.4 10.9 0.0 1.8 18.6 10.0 0.5 0.8 3.5 1.7 0.5 SMAD2 "JV18-1, MADH2, MADR2" ENSG00000175387 "SMAD family member 2" Q15796 18 47808957-47931146 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 200.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025507, HPA067203, CAB073546" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "CAB025507: , CAB073546: , HPA067203: AB_2685803" "unprognostic (1.55e-1)" "unprognostic (2.49e-1)" "unprognostic (1.43e-2)" "unprognostic (9.82e-3)" "unprognostic (9.88e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.91e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-3)" "unprognostic (6.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.20e-3)" "unprognostic (2.68e-1)" "unprognostic (6.13e-2)" "unprognostic (3.20e-2)" "unprognostic (6.28e-2)" 38.5 39.2 29.0 26.2 25.9 19.6 31.4 19.5 28.9 28.8 34.2 29.4 28.9 21.5 26.6 26.3 33.5 28.8 25.7 31.1 26.1 27.1 26.4 20.9 28.3 23.8 30.9 24.3 36.6 28.1 25.7 24.4 34.8 28.6 27.8 29.8 31.7 29.7 28.7 33.9 28.0 26.4 34.6 35.4 34.1 26.3 29.2 26.2 60.7 46.1 23.6 31.5 35.1 35.7 12.0 21.8 28.9 24.7 24.5 25.9 19.7 22.2 32.0 19.5 18.9 31.2 38.2 22.3 24.3 29.2 25.4 29.7 12.2 21.4 34.6 17.5 30.8 35.6 24.6 21.9 27.1 34.1 37.6 11.2 29.4 48.3 19.8 36.4 40.8 30.1 28.2 35.0 21.7 50.3 29.6 28.0 28.2 13.6 29.0 31.2 14.5 28.0 19.6 9.6 1.1 7.6 20.5 28.5 23.6 57.0 38.4 18.1 21.2 29.2 20.1 23.8 19.9 15.2 27.2 31.3 37.7 21.8 10.2 17.6 28.5 27.3 30.2 26.1 27.9 27.5 28.9 22.6 25.0 16.9 24.7 21.2 12.0 23.1 20.9 21.8 9.4 25.8 19.8 22.7 24.5 20.8 15.5 25.9 19.7 29.0 25.9 19.5 28.9 26.1 27.1 30.9 24.3 28.6 26.2 41.7 29.7 22.0 39.2 48.3 44.4 40.0 40.8 30.8 45.5 73.3 200.3 37.8 33.2 31.7 53.8 44.7 32.0 46.7 38.2 33.2 34.3 51.4 20.8 22.6 38.9 33.4 49.0 57.7 52.1 97.0 38.6 38.2 49.0 44.1 42.5 37.9 37.5 24.6 50.2 32.1 82.1 32.3 35.9 26.3 39.6 54.1 58.1 38.1 35.7 55.8 SMAD4 "DPC4, MADH4" ENSG00000141646 "SMAD family member 4" Q13485 18 51028394-51085045 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019154 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA019154: AB_1853480" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (4.83e-2)" "unprognostic (1.17e-2)" "unprognostic (4.05e-1)" "unprognostic (7.29e-3)" "unprognostic (9.00e-2)" "unprognostic (4.01e-2)" "unprognostic (2.51e-2)" "unprognostic (1.03e-3)" "unprognostic (4.40e-2)" "prognostic favorable (1.92e-5)" "unprognostic (2.62e-2)" "unprognostic (4.23e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" 25.6 17.5 16.0 14.0 16.7 11.4 24.9 29.7 16.0 27.9 22.6 17.9 21.3 15.1 28.2 18.8 21.7 20.5 17.5 19.6 15.3 11.5 21.0 22.0 20.1 16.0 17.2 13.3 30.5 25.0 30.0 28.9 30.6 14.2 27.8 17.4 18.4 23.1 22.8 39.7 18.2 23.4 27.6 13.9 21.7 19.3 17.6 18.4 38.8 35.0 13.9 18.1 29.0 24.1 3.6 3.6 3.4 1.8 2.9 4.7 1.3 8.5 11.4 30.9 8.9 12.8 19.8 17.4 15.1 16.6 20.3 25.5 7.0 2.0 14.3 4.5 13.0 10.4 14.2 17.3 6.8 21.6 12.4 9.8 9.9 11.4 8.0 12.7 17.2 7.8 8.9 11.5 10.0 14.7 19.6 14.7 7.3 11.1 13.2 12.0 4.5 10.2 5.0 16.1 4.6 7.1 13.3 15.7 14.0 9.7 3.7 19.1 11.3 14.1 2.6 9.4 13.7 7.0 10.0 11.0 17.2 8.0 4.3 10.0 19.9 13.8 12.4 11.2 6.7 11.3 0.8 1.8 1.8 3.2 1.1 3.7 2.2 3.3 2.6 3.6 3.6 4.0 4.7 3.4 2.9 1.3 2.9 4.3 1.3 16.0 16.7 29.7 16.0 15.3 11.5 17.2 13.3 14.2 18.4 20.8 23.2 11.8 18.4 22.8 13.2 33.5 40.8 16.0 19.4 21.0 19.6 15.5 10.0 16.2 7.3 23.2 15.6 0.0 10.8 16.8 23.8 31.7 4.6 40.0 13.2 14.3 38.1 23.9 26.1 11.4 30.8 16.7 27.0 5.4 33.8 18.9 18.1 24.3 28.7 18.5 20.8 25.8 29.2 13.9 16.2 23.8 10.5 13.8 26.2 22.5 SMAD6 "HsT17432, MADH6, MADH7" ENSG00000137834 "SMAD family member 6" O43541 15 66702228-66782848 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.1" "Cell type enriched" "Detected in many" 6 "Ito cells: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 21.2;HaCaT: 12.6;HeLa: 17.4;U-2197: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061917 Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA061917: AB_2684637" "unprognostic (1.20e-1)" "unprognostic (7.43e-3)" "unprognostic (5.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.02e-1)" "unprognostic (3.50e-3)" "unprognostic (9.59e-2)" "unprognostic (4.50e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (1.10e-3)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (1.55e-3)" "unprognostic (4.30e-2)" "unprognostic (1.33e-1)" "prognostic favorable (5.45e-5)" 9.8 1.9 2.5 3.1 4.6 0.6 5.1 0.8 2.8 6.3 4.7 2.6 2.1 3.8 5.2 1.9 3.1 4.4 11.6 21.6 3.0 2.0 6.1 6.2 37.1 1.2 3.6 2.3 5.1 3.1 2.3 2.8 13.8 4.5 9.7 2.5 18.5 1.6 22.1 1.8 1.6 3.8 3.1 2.9 3.2 8.0 1.7 2.0 0.0 16.7 0.6 0.8 6.8 7.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.9 7.0 1.1 2.4 4.3 1.1 6.7 4.9 0.1 0.8 0.0 1.4 3.1 0.5 21.2 4.2 0.6 12.6 1.5 0.0 0.1 1.5 5.8 10.9 17.4 1.1 0.5 0.0 0.8 1.4 0.0 0.0 0.0 2.4 0.9 3.6 0.9 0.7 0.3 1.3 0.1 3.0 2.1 7.1 2.6 0.0 1.3 1.5 2.4 5.5 2.6 1.1 2.7 3.0 0.5 4.3 1.0 2.0 4.2 3.1 4.0 12.3 0.9 0.4 1.2 0.2 2.2 3.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.5 4.6 0.8 2.8 3.0 2.0 3.6 2.3 4.5 2.0 11.9 5.9 1.4 1.0 0.7 0.0 4.5 5.1 0.0 4.5 1.8 2.0 0.5 3.3 4.3 2.8 19.4 2.8 0.0 5.0 0.7 4.3 1.5 4.6 2.8 1.7 0.0 0.0 107.4 9.5 1.0 2.6 0.8 0.0 1.0 2.0 11.1 5.6 0.0 7.8 1.5 0.3 0.0 1.0 0.2 0.6 0.1 0.7 0.5 5.3 0.3 SMAGP "hSMAGP, MGC149453, MGC149454" ENSG00000170545 "Small cell adhesion glycoprotein" Q0VAQ4 12 51244558-51270890 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.4" "Group enriched" "Detected in many" 9 "Cytotrophoblasts: 1087.3;Syncytiotrophoblasts: 704.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 39.4;OE19: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039711 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA039711: AB_10674985" "unprognostic (2.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.96e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.01e-1)" "unprognostic (1.63e-3)" "unprognostic (6.26e-2)" "unprognostic (7.48e-2)" "unprognostic (9.11e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.46e-1)" "prognostic favorable (2.24e-4)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.99e-2)" "unprognostic (1.52e-1)" 7.5 6.9 0.9 11.3 1.7 0.9 26.3 1.1 1.3 13.1 22.6 0.9 5.3 6.9 8.0 13.6 53.4 3.2 21.8 6.0 1.0 1.0 10.9 4.3 17.6 14.2 1.5 0.4 5.2 14.9 4.6 1.9 50.0 3.0 4.8 24.3 2.6 10.2 6.9 3.6 12.6 8.5 3.4 4.3 11.5 14.1 4.8 0.7 1.2 4.2 28.7 33.1 7.9 24.6 22.5 2.6 8.6 3.7 12.3 9.5 3.5 23.3 7.2 0.8 0.8 3.2 12.7 39.4 18.0 18.1 9.2 5.7 14.2 24.6 0.2 3.2 11.1 3.4 8.3 5.1 6.9 12.9 1.1 4.1 3.1 0.9 4.7 8.9 0.7 3.0 8.2 5.3 19.9 18.0 21.1 22.1 6.0 2.4 1.3 14.8 20.6 3.8 2.8 3.6 47.5 27.9 0.2 0.3 0.8 13.3 5.4 0.9 1.1 3.9 15.8 2.8 9.9 13.6 1.2 7.7 10.3 9.8 0.5 10.9 0.4 0.6 0.4 15.1 7.7 5.5 1.9 3.7 6.4 9.5 2.4 6.1 22.5 4.2 6.9 2.6 17.6 3.9 7.0 8.6 12.3 2.6 1.5 2.7 3.5 0.9 1.7 1.1 1.3 1.0 1.0 1.5 0.4 3.0 0.7 0.0 18.8 28.2 46.4 19.3 1.2 1.1 53.5 8.1 12.5 15.7 0.0 1087.3 41.4 27.1 6.5 53.4 61.6 0.0 95.9 65.5 13.8 46.6 12.7 5.8 83.3 1.6 19.7 38.1 5.4 2.1 12.0 6.7 13.5 5.4 100.2 2.5 97.3 73.7 9.2 15.3 1.2 25.8 8.1 5.2 28.8 26.0 704.6 15.2 97.4 72.3 SMARCA2 "BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2" ENSG00000080503 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2" P51531 9 1980290-2193624 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Hypotrichosis, Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "HDLM-2: 180.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029981, CAB037276" Enhanced Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB037276: AB_477083, HPA029981: AB_10602406" "unprognostic (5.34e-2)" "unprognostic (1.99e-2)" "unprognostic (6.27e-2)" "unprognostic (6.53e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (2.62e-1)" "unprognostic (3.97e-1)" "unprognostic (3.60e-3)" "unprognostic (9.64e-2)" "prognostic favorable (1.26e-6)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (8.32e-3)" "unprognostic (8.50e-2)" 23.6 29.6 38.8 21.3 43.6 40.7 30.1 41.6 44.0 23.8 17.3 20.0 38.4 10.3 26.4 30.1 20.4 29.4 22.8 21.2 30.2 30.8 23.4 28.9 20.2 29.5 25.9 32.4 85.0 18.5 104.1 35.0 23.2 24.7 23.2 15.9 22.8 26.1 44.8 41.3 27.0 18.3 26.6 19.7 23.9 15.8 26.5 23.4 20.6 28.0 24.8 27.1 23.7 22.0 9.9 11.3 20.4 8.3 8.6 12.5 4.2 5.4 4.0 3.0 4.3 6.2 7.3 9.0 6.8 5.5 3.1 2.4 0.0 2.2 9.3 2.8 6.2 1.7 2.3 1.6 5.7 2.2 180.9 2.5 25.2 11.1 1.9 2.4 10.5 14.8 4.8 2.2 3.1 5.9 5.7 5.0 4.4 0.8 32.1 5.3 2.2 2.6 8.8 3.0 3.3 1.5 11.8 3.8 8.4 7.3 4.9 1.9 1.7 4.4 1.0 1.9 4.5 2.0 6.8 6.0 5.1 2.5 3.2 3.3 2.9 3.7 4.2 5.6 4.0 1.4 20.4 4.6 13.1 10.3 6.2 9.9 9.9 9.9 10.5 5.6 8.0 12.5 10.0 13.5 8.6 8.3 11.3 10.4 4.2 38.8 43.6 41.6 44.0 30.2 30.8 25.9 32.4 24.7 23.4 68.5 60.6 20.6 16.9 52.1 54.6 85.9 25.5 107.1 55.7 101.2 35.3 80.6 26.6 21.1 24.7 47.7 25.6 0.0 19.4 19.6 52.6 19.1 45.2 54.3 27.1 33.4 35.7 35.0 45.5 17.2 71.1 37.2 47.2 35.1 32.1 44.7 15.3 7.0 81.7 15.9 34.9 12.9 28.8 18.6 13.6 46.0 74.1 47.1 24.0 12.4 SMIM13 C6orf228 ENSG00000224531 "Small integral membrane protein 13" P0DJ93 6 11094033-11138733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 66.6;Syncytiotrophoblasts: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065706 Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA "Nucleoplasm, Nuclear membrane, Golgi apparatus" "HPA065706: AB_2685539" "unprognostic (6.89e-2)" "unprognostic (1.22e-1)" "unprognostic (1.58e-1)" "unprognostic (7.11e-3)" "unprognostic (4.01e-1)" "unprognostic (2.57e-1)" "unprognostic (3.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (6.66e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.04e-2)" "unprognostic (2.76e-1)" "unprognostic (9.22e-2)" "unprognostic (3.45e-2)" 5.7 4.2 7.5 2.8 13.0 2.0 4.5 13.3 26.4 4.3 3.2 7.7 1.1 3.1 4.6 3.2 8.5 3.0 3.7 5.7 6.5 2.8 3.9 8.7 5.2 2.3 9.5 8.3 3.8 3.2 7.6 2.8 11.4 14.3 4.3 3.3 2.8 5.3 4.6 9.1 13.7 3.9 4.7 4.9 5.1 3.4 9.4 8.1 1.7 3.9 2.1 2.6 3.3 4.9 0.5 2.4 1.3 0.4 1.2 1.0 0.4 5.7 5.0 7.8 6.5 8.1 9.2 8.1 16.2 7.0 8.4 9.4 6.6 1.9 7.3 22.1 5.2 8.3 5.1 16.1 5.7 15.1 4.0 11.7 7.5 5.6 5.2 10.8 13.9 1.8 11.0 15.9 8.6 11.3 6.6 8.8 6.6 10.6 3.0 15.8 3.2 5.9 8.1 3.6 3.9 4.4 7.9 14.3 10.1 5.1 4.6 18.1 10.0 3.4 11.2 18.9 11.3 2.7 5.8 12.5 12.7 9.2 5.2 10.8 5.6 18.7 10.4 3.0 5.9 19.4 1.3 0.3 0.3 1.0 0.4 0.8 0.5 0.4 0.5 0.6 0.3 0.1 0.9 0.1 1.2 0.3 2.4 0.6 0.4 7.5 13.0 13.3 19.6 6.5 2.8 9.5 8.3 14.3 8.1 11.9 1.0 11.2 14.5 66.6 17.0 10.5 5.1 1.4 2.3 10.4 19.6 24.9 3.3 4.9 6.3 10.5 4.0 0.0 6.5 30.2 12.4 11.5 10.4 20.8 12.3 28.6 3.5 7.4 5.3 3.8 2.6 9.5 15.1 4.6 6.9 7.1 7.9 3.5 3.9 6.6 13.9 0.0 10.3 11.3 17.0 34.5 54.5 6.9 7.4 14.0 SMIM20 "C4orf52, MITRAC7, PNX" ENSG00000250317 "Small integral membrane protein 20" Q8N5G0 4 25861830-25929874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016552 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA016552: AB_1859536" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" "unprognostic (1.78e-1)" "unprognostic (6.52e-3)" "unprognostic (1.55e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.02e-1)" "unprognostic (5.42e-2)" "unprognostic (2.86e-1)" "prognostic favorable (8.97e-5)" "unprognostic (5.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.53e-1)" "unprognostic (5.12e-3)" 14.9 20.5 21.8 15.6 26.7 7.1 25.0 11.4 28.0 12.9 16.4 8.3 12.8 24.1 13.7 46.4 11.9 15.1 22.5 33.7 17.9 16.2 27.1 22.7 18.5 26.0 19.2 14.3 19.5 50.0 8.7 10.0 9.5 22.8 13.6 16.1 11.3 20.4 15.7 51.3 6.9 23.8 24.0 22.6 12.7 18.8 17.7 13.5 9.3 21.3 15.3 14.5 14.5 15.9 27.1 21.4 13.3 20.3 18.1 31.1 18.2 12.9 10.9 14.6 14.1 16.2 35.4 19.6 12.7 15.4 10.9 14.0 9.6 23.1 21.4 22.1 14.0 22.7 3.8 17.0 16.2 15.3 12.1 13.5 12.3 7.9 18.3 27.6 14.6 8.2 25.0 32.6 13.9 21.2 21.4 8.4 14.5 19.7 7.0 13.4 8.3 15.8 24.9 27.6 17.3 16.3 13.1 19.1 13.7 24.3 9.5 18.9 17.6 8.1 5.7 27.9 16.8 11.8 20.9 13.9 11.9 14.1 13.3 16.1 13.8 11.3 22.4 18.0 15.6 15.0 13.3 18.2 8.4 15.7 20.3 20.5 27.1 22.7 19.7 20.5 26.8 31.1 24.7 9.2 18.1 15.2 21.4 23.2 18.2 21.8 26.7 11.4 28.0 17.9 16.2 19.2 14.3 22.8 13.5 8.9 35.3 39.7 30.7 19.5 7.0 54.2 58.6 29.4 35.2 34.9 7.9 53.4 111.0 55.9 8.3 17.8 60.0 0.0 54.3 51.6 39.2 34.0 10.4 52.1 61.7 1.6 18.6 19.0 49.0 18.9 34.8 47.0 42.2 36.1 53.7 55.6 48.1 35.1 45.3 134.2 16.1 71.1 36.2 42.9 40.5 16.9 36.6 25.9 63.5 25.3 SMPDL3A "ASM3A, ASML3a, FLJ20177, yR36GH4.1" ENSG00000172594 "Sphingomyelin phosphodiesterase acid like 3A" Q92484 6 122789049-122809720 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 208.6;Proximal tubular cells: 122.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "basophil: 31.2" "Lineage enriched" "Detected in many" 10 "granulocytes: 31.2" "Cell line enhanced" "Detected in many" "ASC diff: 22.3;hTCEpi: 18.3;OE19: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030148 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted to blood" No No 22000000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA030148: AB_10601591" "unprognostic (2.60e-1)" "unprognostic (1.22e-1)" "prognostic favorable (6.11e-4)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (8.30e-3)" "unprognostic (3.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.27e-2)" "unprognostic (3.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.8 15.9 4.0 8.3 5.4 8.1 24.9 9.7 9.9 35.3 46.7 3.8 8.0 19.2 10.0 9.8 9.6 5.1 8.5 11.9 4.5 4.1 20.1 36.9 13.0 29.1 4.7 5.6 6.2 24.6 16.1 7.0 23.2 6.5 19.6 28.5 7.6 9.5 13.7 56.1 32.1 63.6 10.9 4.9 37.7 13.1 3.8 3.2 3.3 7.2 18.0 7.6 18.7 24.3 0.1 0.4 31.2 3.2 0.0 0.0 0.5 0.1 1.2 3.0 1.4 22.3 10.1 9.6 5.0 13.5 1.5 3.3 1.6 1.3 0.0 0.7 3.1 4.1 2.4 0.8 2.5 1.3 0.0 2.6 1.1 5.1 4.2 14.3 0.0 0.0 12.3 18.3 1.4 2.7 6.0 2.7 0.0 1.8 0.0 6.2 4.4 0.0 0.1 0.5 28.0 3.9 0.0 5.3 0.1 7.4 2.0 2.2 0.0 0.7 9.1 12.7 2.0 1.5 0.7 5.2 3.0 1.7 0.3 3.2 0.0 0.0 0.0 4.3 2.3 6.7 31.2 1.7 0.4 0.0 1.9 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.5 4.0 5.4 9.7 9.9 4.5 4.1 4.7 5.6 6.5 3.2 3.0 16.2 2.2 20.4 47.7 2.8 3.6 22.9 5.3 3.4 5.2 3.9 117.9 48.0 19.1 0.1 5.8 208.6 0.0 22.5 35.4 27.9 13.5 9.3 67.1 54.3 3.2 46.8 24.5 86.5 1.1 14.4 9.9 33.7 1.0 51.3 11.4 17.1 87.7 13.4 122.4 5.9 12.9 8.3 0.9 3.9 66.5 96.2 4.3 33.0 12.8 SMUG1 "FDG, HMUDG, UNG3" ENSG00000123415 "Single-strand-selective monofunctional uracil-DNA glycosylase 1" Q53HV7 12 54121277-54189008 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026804, HPA065892" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA026804: , HPA065892: " "unprognostic (2.68e-1)" "unprognostic (2.86e-1)" "unprognostic (8.58e-2)" "unprognostic (7.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.30e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.82e-1)" "unprognostic (6.12e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.67e-3)" "unprognostic (3.35e-1)" "unprognostic (2.41e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (2.46e-1)" "unprognostic (1.73e-1)" 9.5 15.2 17.3 7.0 16.4 4.9 15.5 13.2 16.1 9.8 11.1 11.7 13.5 9.2 9.5 24.1 19.2 14.2 9.2 10.7 15.0 7.8 13.8 23.5 7.8 17.0 11.5 15.0 10.3 23.6 8.3 11.5 14.9 14.4 11.9 10.5 14.2 16.2 10.9 13.6 16.4 16.2 9.2 10.4 11.2 15.2 12.1 14.1 12.6 12.4 6.1 13.1 10.0 9.8 24.2 23.8 38.0 25.0 13.0 20.8 17.0 13.1 24.3 9.6 9.9 17.8 13.9 16.2 10.2 13.4 16.1 14.7 24.3 29.5 7.9 26.2 14.7 15.1 17.3 6.7 26.9 10.4 8.2 14.1 11.8 19.4 17.3 21.3 7.9 14.7 15.9 42.0 18.9 18.8 17.6 12.9 14.1 19.6 17.3 17.6 25.4 9.8 15.4 11.9 22.6 22.0 7.2 9.8 14.2 19.9 19.4 14.3 17.0 11.7 20.2 17.9 20.3 31.5 14.9 6.2 10.8 12.0 9.7 11.6 16.2 12.7 5.3 15.7 6.2 16.3 38.0 25.0 28.7 15.8 19.7 15.7 24.2 15.6 17.0 21.1 18.8 14.1 14.1 24.5 13.0 15.8 23.8 20.8 17.0 17.3 16.4 13.2 16.1 15.0 7.8 11.5 15.0 14.4 14.1 6.0 13.6 25.1 12.2 6.6 9.3 17.5 17.8 29.4 11.4 24.4 7.9 73.8 51.4 31.2 3.9 10.8 34.2 0.0 34.9 84.6 11.8 15.7 2.3 42.7 39.7 6.4 11.1 16.5 16.8 8.1 17.3 14.0 5.0 41.5 23.4 10.0 39.3 24.6 16.6 49.7 9.3 32.3 9.6 25.1 29.2 9.2 83.6 15.0 23.3 16.5 SNAPC2 "PTFdelta, SNAP45" ENSG00000104976 "Small nuclear RNA activating complex polypeptide 2" Q13487 19 7920316-7923250 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049843, HPA077597" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA049843: AB_2680910, HPA077597: AB_2732354" "unprognostic (4.56e-3)" "unprognostic (1.89e-1)" "unprognostic (7.98e-3)" "unprognostic (8.11e-3)" "unprognostic (2.03e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (4.89e-5)" "unprognostic (1.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.82e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.31e-1)" "unprognostic (1.57e-1)" "unprognostic (3.22e-1)" "unprognostic (5.30e-2)" "unprognostic (9.78e-2)" 12.5 15.1 11.0 14.2 17.1 20.3 12.0 19.3 19.8 30.8 20.0 13.2 11.9 14.2 32.4 11.8 20.3 21.8 12.1 12.1 11.7 11.6 15.6 11.1 12.3 12.4 10.6 13.6 24.2 15.1 12.0 16.5 13.6 12.2 24.8 6.0 10.8 18.0 27.0 8.1 16.4 11.3 22.8 9.1 14.8 11.9 28.7 12.3 18.3 17.5 10.4 11.4 29.9 16.1 11.5 20.1 14.7 20.9 17.7 15.5 10.4 9.1 10.7 5.1 19.7 7.0 15.1 4.6 9.7 10.5 9.7 8.8 4.9 8.0 7.9 12.2 11.4 7.7 11.3 3.5 7.3 2.8 10.1 9.0 11.0 4.7 6.9 12.8 6.8 18.3 12.3 11.3 11.4 7.0 7.9 11.0 8.4 10.8 13.3 5.9 8.1 8.7 19.5 6.4 4.7 23.8 10.4 5.0 7.8 8.9 3.2 6.0 13.4 5.0 5.5 21.8 2.3 8.9 7.5 14.1 32.8 11.6 30.6 12.1 12.7 20.8 4.8 20.5 14.3 10.3 4.5 16.4 14.7 13.7 20.9 13.7 11.5 11.7 11.8 20.1 11.0 12.2 12.2 2.4 17.7 20.7 13.3 15.5 10.4 11.0 17.1 19.3 19.8 11.7 11.6 10.6 13.6 12.2 12.3 3.0 3.0 13.5 18.0 21.6 7.9 2.6 7.6 0.0 3.4 10.4 0.0 10.4 14.9 20.2 1.4 15.7 11.6 0.0 21.1 18.3 26.1 27.3 18.4 4.7 26.0 22.3 11.5 11.6 20.4 5.2 12.7 24.4 18.6 41.5 10.5 5.7 22.2 3.5 13.4 12.9 5.4 12.9 30.3 8.6 21.2 21.2 8.2 21.9 12.0 19.5 SNAPC3 "MGC132011, MGC33124, PTFbeta, SNAP50" ENSG00000164975 "Small nuclear RNA activating complex polypeptide 3" Q92966 9 15422704-15465953 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 98.3;Late spermatids: 162.5;Spermatocytes: 125.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053145, HPA066031" Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "HPA053145: AB_2682055, HPA066031: AB_2685600" "unprognostic (2.62e-1)" "unprognostic (4.26e-1)" "unprognostic (5.42e-3)" "unprognostic (2.09e-1)" "unprognostic (4.93e-3)" "unprognostic (6.08e-2)" "unprognostic (5.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.12e-2)" "unprognostic (2.64e-2)" "unprognostic (1.36e-3)" "unprognostic (3.07e-1)" "unprognostic (2.63e-1)" "unprognostic (4.38e-2)" "unprognostic (2.09e-2)" 9.8 18.5 18.7 10.3 21.1 4.6 10.4 26.3 21.2 17.9 13.2 10.4 10.3 11.6 16.5 15.5 12.6 10.8 10.8 17.5 18.0 14.0 12.3 8.6 10.0 11.2 15.2 16.3 17.4 11.1 12.8 18.4 16.7 21.8 13.3 14.6 9.6 10.5 11.3 19.3 13.7 14.2 12.8 15.2 12.8 10.5 14.7 15.9 11.9 11.3 6.8 10.8 12.9 15.1 12.2 7.7 5.0 21.2 5.0 8.2 5.5 3.9 5.1 10.8 4.1 8.7 9.1 6.3 6.2 2.8 3.7 4.4 2.4 1.7 2.8 2.4 3.9 5.2 2.4 5.7 2.9 4.6 13.1 6.7 10.1 10.8 3.3 4.3 2.2 7.8 5.9 5.9 2.6 3.0 15.7 6.8 6.7 2.8 4.6 8.4 1.2 2.7 7.2 3.4 3.0 13.5 5.5 1.3 1.5 6.4 2.4 11.6 8.2 2.1 1.9 1.4 9.9 4.6 4.6 5.6 6.2 2.5 2.6 7.9 6.1 7.3 3.5 4.0 3.0 2.8 3.4 10.1 5.0 5.7 16.7 5.5 9.9 5.7 5.1 7.7 12.2 8.2 7.9 1.2 5.0 21.2 6.3 7.9 5.5 18.7 21.1 26.3 21.2 18.0 14.0 15.2 16.3 21.8 15.9 17.9 11.0 17.8 12.4 8.5 19.2 37.1 5.1 13.4 5.7 19.2 29.5 10.6 11.6 16.6 98.3 16.4 21.6 0.0 8.2 10.8 16.4 10.3 17.3 12.4 13.8 33.4 14.5 19.0 22.1 162.5 31.4 10.0 18.6 17.2 14.1 15.1 11.3 27.7 28.7 24.2 17.8 12.9 21.7 125.8 27.9 10.5 8.1 17.1 16.2 10.2 SNRNP25 "C16orf33, U11/U12-25K" ENSG00000161981 "Small nuclear ribonucleoprotein U11/U12 subunit 25" Q9BV90 16 53010-57669 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 56.9;skeletal muscle: 63.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 56.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041183, HPA044248" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041183: AB_2677353, HPA044248: AB_2678873" "unprognostic (7.87e-2)" "prognostic favorable (1.95e-4)" "unprognostic (6.04e-2)" "unprognostic (5.03e-2)" "unprognostic (2.04e-1)" "unprognostic (5.99e-2)" "unprognostic (1.17e-1)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (8.99e-2)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.16e-5)" "unprognostic (1.51e-1)" "unprognostic (1.52e-1)" "unprognostic (1.45e-1)" "unprognostic (6.03e-3)" 7.1 10.1 31.4 11.5 25.4 15.6 7.4 15.7 31.2 7.1 9.7 6.8 5.4 7.2 6.6 9.6 8.8 8.8 6.3 28.7 25.0 22.6 11.7 16.4 5.4 16.4 28.1 20.3 10.9 10.8 7.7 10.8 4.9 24.7 9.8 10.1 7.5 12.6 8.4 63.7 4.3 6.4 8.6 13.5 6.6 10.2 6.4 7.7 9.4 9.4 11.0 16.4 6.8 4.8 18.0 56.9 23.2 9.9 5.2 6.5 5.7 11.6 26.5 14.7 17.1 5.3 6.3 7.2 9.9 6.4 22.2 18.8 35.6 11.4 37.0 11.8 8.1 11.9 12.0 26.9 18.2 17.1 13.3 20.9 21.4 37.0 35.6 5.6 39.1 25.5 8.0 6.5 19.7 5.5 4.8 11.9 22.4 32.0 8.8 12.6 55.2 20.5 16.3 17.6 20.8 13.0 33.1 15.7 44.2 11.7 8.2 16.2 10.5 22.3 29.0 4.8 15.1 18.7 19.1 9.3 9.8 12.3 12.6 15.8 9.2 21.7 57.4 5.2 21.0 15.0 2.8 6.6 23.2 4.0 9.9 5.0 17.5 4.2 4.9 12.8 18.0 4.5 4.5 4.5 5.2 8.5 56.9 6.5 5.7 31.4 25.4 15.7 31.2 25.0 22.6 28.1 20.3 24.7 7.7 11.9 11.0 47.7 21.4 16.6 18.1 96.8 15.3 44.2 9.1 31.4 3.9 47.2 132.6 34.7 1.7 16.8 21.9 23.3 44.3 49.4 26.3 35.5 4.6 52.5 99.3 11.1 42.3 11.6 18.6 4.5 19.8 52.0 59.1 138.9 29.1 45.5 30.9 42.9 28.0 74.2 12.0 6.5 32.0 32.0 47.5 19.2 21.9 20.1 45.1 16.3 SNRPA1 Lea1 ENSG00000131876 "Small nuclear ribonucleoprotein polypeptide A'" P09661 15 101281510-101295282 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045622, HPA048499" Supported Supported "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA Nucleoplasm "Nuclear speckles, Nuclear bodies" "HPA045622: AB_2679394, HPA048499: AB_2680421" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.08e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (8.56e-5)" "unprognostic (5.80e-2)" "unprognostic (1.66e-3)" "prognostic favorable (8.83e-5)" "unprognostic (4.74e-2)" "unprognostic (6.77e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (2.84e-1)" "unprognostic (2.43e-1)" "unprognostic (1.37e-2)" 11.9 13.3 12.4 26.1 19.6 35.2 17.7 9.7 17.2 9.9 18.0 10.2 10.4 14.6 14.3 21.1 24.6 12.4 11.8 17.3 17.9 9.8 16.1 19.7 14.1 29.2 11.2 12.2 10.8 16.3 9.1 10.7 29.3 14.1 10.3 19.3 11.3 17.2 9.1 13.4 12.1 22.5 11.7 9.4 26.4 15.9 24.3 7.0 33.4 11.6 18.1 30.0 12.3 12.2 21.7 23.5 8.4 18.2 18.3 26.9 15.3 31.5 22.1 21.4 10.8 6.0 5.0 21.0 29.5 13.6 26.5 20.2 47.2 28.3 35.2 16.9 19.9 20.8 18.9 31.9 21.0 28.5 17.8 49.3 27.6 36.0 24.9 4.6 31.6 19.8 4.0 15.8 16.9 21.3 5.9 17.0 27.3 38.4 33.2 16.2 35.1 31.8 33.6 27.3 42.5 18.8 31.8 23.1 35.5 19.3 83.2 16.7 17.6 18.0 20.6 22.2 23.4 19.8 25.0 12.3 14.2 26.9 16.5 29.3 27.5 81.2 68.5 11.5 29.9 16.7 1.4 15.0 8.4 24.6 18.2 24.1 21.7 25.4 24.2 23.5 19.1 21.2 26.3 2.9 18.3 16.6 22.3 26.9 15.3 12.4 19.6 9.7 17.2 17.9 9.8 11.2 12.2 14.1 7.0 17.9 53.6 59.5 65.8 58.3 35.1 25.2 15.3 45.5 37.5 34.9 11.8 110.2 58.0 79.4 34.5 35.0 39.1 93.5 94.8 120.7 56.9 51.6 62.5 29.7 59.4 35.0 25.9 25.8 23.7 11.4 32.2 36.6 40.5 102.8 40.2 29.4 78.7 40.3 26.9 68.5 28.5 12.9 49.2 116.7 62.4 44.3 93.9 69.8 47.8 83.9 SNRPD3 "Sm-D3, SMD3" ENSG00000100028 "Small nuclear ribonucleoprotein D3 polypeptide" P62318 22 24555503-24609980 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001170 Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 360000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA001170: AB_1080042" "unprognostic (3.30e-1)" "unprognostic (1.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.28e-3)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (4.44e-2)" "unprognostic (1.13e-3)" "unprognostic (1.20e-2)" "unprognostic (3.52e-2)" "unprognostic (3.64e-2)" "unprognostic (2.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.87e-1)" "unprognostic (1.65e-2)" 23.7 31.8 23.8 28.9 23.3 29.7 29.5 27.1 27.4 29.3 38.3 24.7 29.8 27.9 31.6 30.6 41.8 30.8 27.1 31.6 21.8 24.2 38.5 61.6 26.5 36.4 24.3 26.8 33.9 34.0 27.8 31.8 33.3 22.6 27.8 33.1 27.9 42.9 27.3 59.0 26.7 35.5 29.6 25.5 32.3 27.8 22.4 23.1 46.8 39.2 61.0 42.7 27.1 30.2 42.5 39.0 38.1 34.9 36.6 33.2 29.8 40.8 14.0 44.0 15.9 16.5 14.3 16.6 39.9 18.3 39.8 37.1 20.0 15.8 36.4 18.9 24.9 22.5 30.9 55.9 48.9 40.5 27.8 57.1 39.2 28.3 30.0 18.0 96.5 24.6 16.3 22.7 43.1 22.6 20.0 28.9 36.6 26.8 18.5 16.2 20.8 41.1 24.1 24.3 59.9 20.3 39.6 46.1 18.9 35.4 31.7 20.7 23.0 25.5 16.7 21.2 41.6 25.1 26.3 30.5 33.2 33.3 16.6 29.5 19.1 36.9 67.0 16.4 33.3 22.4 12.2 31.4 38.1 28.2 34.9 31.3 42.5 30.7 30.6 39.0 36.3 29.4 33.2 15.7 36.6 34.7 37.1 28.9 29.8 23.8 23.3 27.1 27.4 21.8 24.2 24.3 26.8 22.6 23.1 89.3 66.8 98.3 99.5 96.5 53.8 84.4 107.0 99.0 103.5 123.9 33.4 200.2 247.1 146.4 83.4 72.8 133.3 46.7 100.1 182.6 81.8 90.9 84.3 175.2 153.4 36.5 106.7 63.8 76.9 64.2 107.6 83.1 64.1 146.1 105.1 109.1 116.0 112.2 111.4 223.0 50.7 64.7 75.6 104.2 134.4 99.4 150.8 87.3 125.1 101.6 SNTB2 "D16S2531E, EST25263, SNT2B2, SNT3, SNTL" ENSG00000168807 "Syntrophin beta 2" Q13425 16 69187129-69309052 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 187.1;Rod photoreceptor cells: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001394 Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA001394: AB_1080170" "unprognostic (4.86e-1)" "unprognostic (3.26e-2)" "unprognostic (2.77e-2)" "unprognostic (8.07e-3)" "unprognostic (6.46e-2)" "unprognostic (9.68e-2)" "unprognostic (1.89e-2)" "unprognostic (5.50e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-2)" "unprognostic (3.64e-2)" "unprognostic (5.77e-3)" "unprognostic (1.71e-2)" "unprognostic (7.43e-2)" "unprognostic (1.73e-2)" "unprognostic (1.88e-1)" 20.7 8.4 5.8 10.2 7.9 3.8 13.4 5.3 9.4 22.9 12.2 4.5 13.3 5.5 17.8 10.9 16.1 13.0 10.4 8.6 4.8 3.2 14.1 5.8 12.7 7.2 4.8 4.8 13.9 6.6 31.9 7.2 7.4 5.3 16.7 7.8 26.0 8.3 8.4 8.8 12.7 9.6 15.7 5.0 8.6 9.3 10.5 4.0 6.4 22.8 6.8 7.5 18.3 20.2 1.0 0.6 3.0 1.0 2.6 3.7 0.9 4.0 6.2 4.3 3.4 16.0 21.6 5.3 8.0 11.2 6.3 7.0 6.1 3.7 5.1 4.9 9.3 3.3 7.4 5.8 3.9 8.2 2.2 3.2 2.2 6.1 5.2 5.3 0.1 3.4 15.4 2.9 10.3 4.2 6.6 18.8 1.4 1.3 8.0 7.6 4.6 1.7 0.7 2.9 2.4 5.0 10.1 3.8 9.5 3.3 6.2 1.6 3.6 24.5 3.5 2.5 3.4 4.1 0.3 14.6 11.9 5.7 8.3 7.4 1.8 2.8 5.8 7.6 0.8 5.4 1.1 1.0 1.0 3.2 1.0 3.3 1.0 1.6 1.8 0.6 0.8 1.0 3.7 3.0 2.6 1.0 0.4 1.6 0.9 5.8 7.9 5.3 9.4 4.8 3.2 4.8 4.8 5.3 4.0 17.9 9.4 7.8 23.9 33.8 22.9 6.5 2.5 5.3 7.9 26.2 39.3 8.1 3.3 9.2 20.9 65.9 17.4 0.0 21.0 7.0 31.2 42.1 1.1 9.7 6.1 4.8 9.9 84.7 22.9 21.8 54.7 10.1 28.7 1.8 17.0 187.1 14.1 24.6 61.2 27.4 126.8 6.5 39.2 22.7 8.3 33.9 3.1 21.0 16.8 25.9 SNX10 ENSG00000086300 "Sorting nexin 10" Q9Y5X0 7 26291895-26374329 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;brain: 39.0;liver: 37.4" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 242.1;Hofbauer cells: 146.8;Kupffer cells: 156.1;Macrophages: 186.4;Muller glia cells: 262.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 67.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 27.2;U-937: 22.3;WM-115: 77.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015605, HPA064782" Approved Supported Nucleoplasm,Nucleoli,Microtubules NA NA "Nucleoplasm, Microtubules" Nucleoli "HPA015605: AB_1857342, HPA064782: AB_2685349" "unprognostic (6.42e-2)" "unprognostic (2.72e-3)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.92e-2)" "unprognostic (2.48e-3)" "unprognostic (4.51e-2)" "unprognostic (4.87e-1)" "unprognostic (9.36e-2)" "unprognostic (1.59e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (8.06e-5)" "unprognostic (1.12e-2)" "unprognostic (3.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.50e-1)" 17.7 8.7 20.2 18.6 17.9 20.9 6.7 13.2 39.0 2.9 3.3 2.1 0.1 2.5 5.4 0.8 1.8 1.9 5.2 1.3 22.2 32.7 21.3 37.4 22.4 18.0 27.8 20.8 1.0 5.0 0.6 3.0 8.9 36.2 2.2 3.9 1.8 1.4 1.5 0.9 1.0 3.6 5.4 15.4 22.1 2.3 3.0 2.1 3.8 1.9 0.1 13.6 6.3 1.8 16.3 20.1 67.6 30.9 9.0 5.6 11.6 13.9 1.3 0.0 2.6 0.0 0.0 15.2 0.0 1.0 0.0 0.0 0.1 4.7 6.1 11.0 0.0 9.6 0.4 3.5 0.9 0.0 8.4 3.3 0.6 0.1 9.2 0.0 13.0 2.3 0.1 1.4 0.0 1.1 0.0 0.2 7.9 0.3 0.0 0.0 2.4 5.4 13.7 4.0 0.1 1.3 0.0 0.0 0.3 27.2 3.0 6.0 1.8 3.0 2.2 15.8 5.0 4.0 18.6 0.0 0.0 3.3 0.0 3.4 4.7 3.7 4.1 0.1 22.3 77.5 8.2 29.2 0.7 4.0 30.9 3.8 16.3 2.8 3.4 20.1 14.5 1.5 2.6 67.6 9.0 30.1 7.4 5.6 11.6 20.2 17.9 13.2 39.0 22.2 32.7 27.8 20.8 36.2 2.1 3.0 17.1 49.9 1.0 4.7 17.7 1.6 20.4 1.4 7.9 22.7 2.0 11.6 242.1 51.3 0.9 5.6 2.6 23.3 23.5 64.7 3.6 2.8 31.1 90.6 146.8 33.4 9.1 2.5 156.1 0.7 1.1 186.4 8.5 49.5 2.5 262.3 22.1 0.0 0.0 123.2 20.4 0.0 3.3 1.6 28.0 2.6 24.0 38.8 9.7 0.9 SNX30 ATG24A ENSG00000148158 "Sorting nexin family member 30" Q5VWJ9 9 112750838-112881671 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 65.1;Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019346 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA019346: AB_2286395" "unprognostic (1.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.08e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-1)" "unprognostic (3.69e-1)" "unprognostic (8.05e-3)" "unprognostic (2.04e-3)" "unprognostic (4.48e-2)" "unprognostic (3.59e-3)" "unprognostic (3.39e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.01e-7)" "unprognostic (4.48e-3)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-2)" 4.9 4.4 12.2 7.7 12.6 8.3 7.7 18.1 18.5 10.9 11.1 25.6 3.6 7.9 6.4 4.1 5.3 3.8 5.4 3.4 14.2 12.0 23.7 5.2 23.4 8.8 14.8 12.8 6.9 5.2 6.9 6.3 5.1 14.7 4.1 11.7 4.9 7.1 4.3 2.6 5.7 8.9 7.5 20.3 7.4 4.7 12.7 11.8 2.3 3.1 2.6 8.7 5.4 4.6 0.7 4.2 1.5 5.1 0.8 1.7 1.6 6.0 3.8 6.6 5.2 8.3 7.6 5.5 5.2 10.9 4.4 4.2 13.5 1.4 10.1 4.4 13.4 7.9 7.2 7.9 3.1 6.9 3.2 3.7 3.1 3.4 5.4 6.0 3.1 5.6 6.2 4.3 6.8 5.1 11.2 3.8 2.6 4.8 5.8 5.9 4.2 2.0 3.6 7.2 9.8 4.0 4.3 15.4 2.6 8.6 10.6 9.8 3.1 6.8 9.4 13.0 7.0 7.0 5.6 4.2 6.6 7.0 19.3 4.4 15.1 13.9 4.8 8.5 2.9 12.8 0.0 5.1 1.5 0.8 2.0 1.7 0.0 0.8 1.0 4.2 0.7 0.7 0.6 0.7 0.8 2.1 0.7 1.6 1.6 12.2 12.6 18.1 18.5 14.2 12.0 14.8 12.8 14.7 11.8 6.0 65.1 0.0 1.9 7.2 5.7 3.8 5.1 1.4 9.1 5.2 9.8 0.4 5.0 2.1 5.3 3.0 12.4 46.7 2.8 1.6 5.7 3.1 6.9 5.9 11.9 7.9 4.6 12.3 19.7 6.3 5.2 12.5 20.3 1.0 9.7 2.6 3.4 17.3 7.4 33.2 2.7 0.0 1.4 5.5 10.5 9.7 0.3 3.8 8.6 5.4 SNX31 MGC39715 ENSG00000174226 "Sorting nexin 31" Q8N9S9 8 100572882-100663415 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0" "Cell type enriched" "Detected in some" 5 "Early spermatids: 73.9" "Cancer enriched" "Detected in many" 22 "urothelial cancer: 24.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 50 "RT4: 42.9" "Region enriched" "Detected in single" 5 "thalamus: 2.9" "Region enhanced" "Detected in single" "olfactory region: 3.1" "HPA024284, HPA053466" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA024284: AB_1853894, HPA053466: AB_2682161" "unprognostic (1.39e-1)" "unprognostic (3.83e-2)" "unprognostic (7.99e-2)" "unprognostic (1.52e-1)" "unprognostic (7.20e-5)" "unprognostic (1.04e-1)" "unprognostic (1.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-2)" "unprognostic (1.69e-1)" "unprognostic (7.79e-3)" "unprognostic (1.66e-1)" "prognostic favorable (1.47e-4)" "unprognostic (2.54e-1)" "unprognostic (4.05e-2)" 0.5 0.0 0.6 0.1 0.7 0.1 0.4 0.6 2.3 1.7 0.3 0.3 0.1 0.2 0.3 0.2 6.2 0.3 0.9 1.8 0.8 0.7 0.3 0.4 0.3 0.3 0.9 0.3 0.3 0.2 0.1 0.2 0.1 0.6 13.8 0.1 0.4 1.4 0.1 1.0 0.5 0.1 7.4 0.8 0.1 0.6 3.3 0.5 0.1 0.4 2.6 21.4 25.4 16.0 1.1 0.3 3.0 0.5 1.6 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 2.5 0.5 0.2 0.3 0.2 0.1 1.1 0.1 0.2 0.2 0.5 0.1 0.3 3.0 1.6 0.0 0.3 0.0 0.0 0.6 0.7 0.6 0.3 0.8 0.7 0.9 0.3 0.6 0.5 0.0 0.0 0.0 3.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 73.9 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.4 0.4 0.4 0.0 0.0 0.0 1.0 SOCS5 "CIS6, Cish5, CISH6, KIAA0671, SOCS-5" ENSG00000171150 "Suppressor of cytokine signaling 5" O75159 2 46698952-46763129 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 45.7;fHDF/TERT166: 44.5;U-138 MG: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020884, CAB025510" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No Cytosol "Nucleoplasm, Plasma membrane" "CAB025510: , HPA020884: AB_1857356" "unprognostic (1.69e-1)" "unprognostic (1.98e-2)" "unprognostic (5.71e-2)" "unprognostic (1.64e-2)" "unprognostic (2.20e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (7.28e-4)" "unprognostic (4.52e-2)" "unprognostic (9.13e-2)" "prognostic unfavorable (7.53e-4)" "unprognostic (2.10e-3)" "unprognostic (3.01e-1)" "unprognostic (1.47e-3)" "unprognostic (8.29e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" 12.2 10.1 16.9 5.6 24.9 6.2 21.3 26.4 14.9 13.6 9.4 6.3 7.6 4.8 14.0 8.8 8.2 9.6 11.2 11.2 11.9 8.1 9.1 6.3 10.1 9.9 9.1 10.8 23.8 6.0 14.8 9.0 6.9 11.8 9.9 6.5 5.8 9.3 13.0 8.8 6.9 6.8 13.6 10.8 8.1 7.2 9.5 8.8 10.9 9.8 5.0 6.1 9.4 9.0 4.8 1.3 6.3 3.7 2.3 3.3 1.6 5.2 4.0 3.5 5.1 11.2 16.2 4.3 24.7 45.7 12.1 7.1 3.8 2.6 2.7 4.8 44.5 3.7 2.6 3.8 3.9 15.4 2.6 3.5 4.2 3.7 4.5 7.0 2.4 4.7 12.8 5.9 10.3 4.1 13.5 4.1 1.1 3.6 2.9 7.7 1.8 2.1 3.9 3.9 5.5 3.3 2.8 5.9 3.4 4.9 4.0 2.7 7.5 6.0 4.0 4.6 3.5 1.6 3.5 4.6 30.2 6.8 10.0 4.8 3.7 2.2 2.3 13.8 4.8 9.3 1.2 1.1 6.3 2.4 1.0 3.0 4.5 1.5 1.6 1.2 4.8 2.7 3.3 1.1 2.3 3.7 1.3 2.5 1.6 16.9 24.9 26.4 14.9 11.9 8.1 9.1 10.8 11.8 8.8 3.0 6.7 6.0 6.3 14.7 12.1 13.6 15.3 5.3 9.1 3.5 21.6 3.1 5.0 6.3 8.5 22.4 6.3 0.0 5.9 1.9 12.1 8.8 16.2 6.4 4.0 17.5 10.4 20.3 6.3 5.1 16.1 7.2 6.8 6.4 7.6 8.9 5.5 7.0 15.9 6.3 5.3 12.9 17.9 11.9 15.6 12.7 2.3 4.4 6.0 4.8 SOD1 "ALS, ALS1, IPOA" ENSG00000142168 "Superoxide dismutase 1" P00441 21 31659622-31668931 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antioxidant, Oxidoreductase" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 282.6" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 2529.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001401, CAB008670" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 44900000 91000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB008670: AB_1623312, HPA001401: AB_1080132" "unprognostic (1.73e-1)" "unprognostic (1.18e-2)" "unprognostic (4.43e-1)" "unprognostic (6.19e-2)" "unprognostic (1.39e-1)" "unprognostic (9.59e-3)" "unprognostic (8.34e-2)" "unprognostic (2.30e-1)" "unprognostic (3.47e-1)" "unprognostic (5.28e-2)" "unprognostic (9.33e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-2)" "unprognostic (1.57e-1)" "unprognostic (3.26e-2)" 39.2 86.5 71.1 29.1 74.3 24.6 108.6 35.6 74.9 26.8 37.7 19.1 35.4 62.5 24.6 42.2 25.8 36.0 46.8 96.5 77.8 73.1 84.0 282.6 23.0 26.8 80.2 67.0 53.9 27.2 27.1 30.4 29.7 96.1 35.1 32.6 19.3 19.7 39.3 83.9 20.5 45.5 45.2 88.2 19.2 25.8 22.2 43.8 12.3 30.1 34.7 25.6 25.4 124.0 57.6 32.3 24.9 57.2 29.6 95.6 55.6 56.2 49.2 34.5 34.5 46.2 32.3 28.7 47.5 28.3 32.3 24.4 63.7 35.8 67.3 50.0 43.7 58.6 20.4 49.5 34.9 26.6 49.7 61.4 108.7 64.6 91.1 30.6 47.9 40.7 33.4 26.6 45.2 25.2 36.8 36.2 51.6 74.9 86.2 38.9 91.3 51.4 48.4 51.9 89.1 52.5 44.3 69.6 104.7 63.1 34.6 37.8 31.7 87.9 46.5 45.6 32.5 53.5 42.4 42.4 25.1 55.7 33.9 34.9 65.8 142.4 79.8 51.3 70.0 33.3 22.1 21.9 24.9 45.0 30.2 51.6 57.6 73.1 56.9 28.6 40.9 76.2 59.3 5.1 29.6 57.2 32.3 95.6 55.6 71.1 74.3 35.6 74.9 77.8 73.1 80.2 67.0 96.1 43.8 273.9 132.0 321.6 545.9 436.4 220.9 652.4 591.1 509.9 249.1 371.6 45.2 624.2 1382.7 369.6 242.1 264.2 846.2 327.1 713.9 544.4 341.5 540.9 215.8 2529.1 314.9 267.0 277.0 292.2 203.5 693.0 483.3 265.6 398.1 397.7 279.9 378.3 307.6 522.5 496.4 1894.8 157.7 433.4 418.2 79.3 538.3 305.8 607.1 266.4 526.4 451.3 SP6 "Epfn, KLF14" ENSG00000189120 "Sp6 transcription factor" Q3SY56 17 47844908-47855874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 82.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 1.3;pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 45.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024516, HPA044469" Supported "Nucleoplasm,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Mitotic spindle, Centrosome" "HPA024516: AB_10960551, HPA044469: AB_10966430" "unprognostic (3.06e-2)" "unprognostic (4.32e-2)" "unprognostic (1.07e-2)" "unprognostic (7.55e-3)" "unprognostic (6.79e-2)" "unprognostic (4.57e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.22e-1)" "unprognostic (8.72e-2)" "unprognostic (3.92e-3)" "unprognostic (1.63e-1)" "unprognostic (9.59e-3)" "prognostic favorable (6.39e-4)" "unprognostic (3.33e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.72e-4)" 0.9 1.0 0.1 0.5 0.0 0.0 3.8 1.3 0.2 1.7 1.8 0.1 33.7 1.5 0.4 4.1 5.8 1.1 0.4 0.4 0.1 0.1 0.9 0.1 3.6 0.5 0.1 0.0 3.6 0.4 2.0 0.2 24.7 1.1 6.9 0.7 0.2 1.0 26.2 0.1 14.9 5.3 0.3 0.3 0.9 0.3 0.4 0.0 0.8 1.3 5.6 3.6 5.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.4 0.0 0.0 0.0 0.0 45.4 0.2 0.2 0.9 0.2 9.5 0.9 0.0 0.3 0.0 0.6 1.3 0.0 1.6 0.2 0.1 0.3 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.1 0.1 0.1 2.2 0.0 0.0 0.8 0.0 0.0 0.0 3.9 0.8 0.0 0.0 0.0 0.2 5.7 1.4 0.0 0.0 5.8 0.0 8.7 2.3 0.0 3.0 0.2 1.3 0.0 0.2 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.3 0.2 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 45.5 0.0 0.7 0.0 0.3 6.9 0.0 0.7 1.6 0.3 1.6 0.0 0.0 3.6 0.0 1.7 1.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 1.3 2.9 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.6 82.6 0.0 2.7 5.1 SPATA12 ENSG00000186451 "Spermatogenesis associated 12" Q7Z6I5 3 57060441-57075432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 26.6" "Group enriched" "Detected in some" 125 "Early spermatids: 496.6;Late spermatids: 837.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.0" "Lineage enriched" "Detected in single" 10 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "GAMG: 5.4;HUVEC TERT2: 2.4;RH-30: 3.1" "HPA043323, HPA075578" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA043323: AB_10796792, HPA075578: " "unprognostic (2.31e-1)" "unprognostic (2.18e-4)" "unprognostic (3.47e-4)" "unprognostic (2.21e-2)" "unprognostic (2.66e-1)" "unprognostic (8.79e-3)" "unprognostic (1.69e-3)" "unprognostic (3.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.29e-1)" "unprognostic (6.80e-2)" "unprognostic (1.76e-2)" "unprognostic (4.71e-3)" "unprognostic (7.29e-2)" "unprognostic (1.62e-2)" "unprognostic (1.14e-1)" "unprognostic (2.44e-3)" 0.2 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.8 0.1 0.3 2.4 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 1.1 0.1 0.4 26.6 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.5 0.5 0.0 5.4 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.6 0.0 0.0 1.1 0.2 0.5 0.0 0.0 1.1 2.4 0.0 0.0 0.6 0.2 0.1 0.0 0.0 1.5 1.2 1.5 0.0 3.1 0.1 2.0 1.2 0.0 0.0 0.2 0.0 1.3 0.6 0.0 0.0 0.8 0.0 2.0 0.4 0.3 0.0 0.2 1.0 0.6 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 496.6 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.3 837.5 4.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 5.3 0.0 0.0 0.0 0.0 4.6 2.3 0.0 0.0 0.0 0.0 0.3 SPATA2L "C16orf76, MGC26885, tamo" ENSG00000158792 "Spermatogenesis associated 2 like" Q8IUW3 16 89696343-89701705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041182, HPA042453" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA041182: AB_2677352, HPA042453: AB_2678005" "unprognostic (1.22e-1)" "unprognostic (9.04e-2)" "unprognostic (5.23e-2)" "unprognostic (9.13e-3)" "unprognostic (2.21e-1)" "unprognostic (6.62e-2)" "unprognostic (2.72e-2)" "unprognostic (2.13e-1)" "unprognostic (4.86e-2)" "unprognostic (9.25e-2)" "unprognostic (1.40e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-3)" "unprognostic (8.86e-2)" "unprognostic (4.19e-2)" "unprognostic (5.84e-2)" "unprognostic (2.55e-1)" 6.8 5.3 6.3 5.4 10.3 8.8 3.7 6.8 14.1 4.1 6.9 1.6 4.9 12.3 4.7 7.2 3.9 4.6 7.7 2.8 7.2 4.9 7.5 11.4 6.3 3.6 3.4 7.6 5.4 17.0 5.1 12.9 6.5 2.8 4.2 2.2 4.9 6.1 3.4 1.8 5.0 10.7 3.3 2.0 5.6 7.7 4.6 2.6 6.7 5.6 0.7 5.4 4.0 2.2 5.8 5.9 16.5 7.8 2.4 7.3 4.7 5.3 4.2 1.5 7.0 1.2 1.2 8.2 3.7 1.7 1.7 1.1 8.0 4.5 1.8 5.0 1.2 2.3 9.3 1.3 2.0 0.3 1.7 15.1 1.2 1.5 10.8 3.9 1.0 3.7 1.2 2.6 2.8 0.8 2.0 1.9 2.1 5.5 1.3 1.2 24.2 3.1 5.7 4.3 5.4 5.7 6.8 0.7 5.2 2.5 1.9 8.3 5.4 3.9 4.0 4.5 0.7 10.3 4.1 4.8 1.7 6.4 0.3 1.7 3.2 1.9 1.6 5.3 3.0 3.2 3.3 4.9 6.0 7.3 7.8 5.1 4.8 5.2 5.3 5.3 5.8 4.6 4.9 16.5 2.4 5.8 5.9 3.9 4.7 6.3 10.3 6.8 14.1 7.2 4.9 3.4 7.6 2.8 2.6 3.0 0.3 1.4 16.6 14.0 6.6 0.4 5.1 0.0 0.0 10.4 0.0 7.5 1.7 11.7 4.4 4.9 29.5 0.0 11.8 4.1 5.7 10.1 4.6 5.0 6.8 3.2 22.8 5.5 7.5 1.0 2.6 7.2 8.5 3.6 6.8 5.1 10.5 17.3 2.1 8.4 7.4 0.0 9.2 1.0 2.5 17.3 20.8 5.0 6.2 11.6 SPATA6 "FLJ10007, SRF-1, SRF1" ENSG00000132122 "Spermatogenesis associated 6" Q9NWH7 1 48295372-48472208 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.8" "Group enriched" "Detected in many" 31 "Early spermatids: 1331.5;Late spermatids: 2941.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 10.5;ASC TERT1: 17.7;HSkMC: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028234 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA028234: AB_2672532" "unprognostic (1.36e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (2.87e-2)" "unprognostic (3.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.77e-2)" "unprognostic (4.69e-3)" "unprognostic (2.40e-2)" "unprognostic (2.61e-2)" "unprognostic (8.41e-2)" "unprognostic (6.50e-2)" "unprognostic (3.41e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-1)" "unprognostic (7.89e-2)" "unprognostic (5.71e-3)" 5.8 8.9 6.2 3.0 12.9 1.5 8.4 2.4 8.9 7.5 5.0 12.9 10.1 3.3 6.9 7.9 4.1 16.2 5.9 4.7 7.8 5.6 6.9 2.4 7.5 7.0 14.9 3.9 9.0 5.2 12.8 21.5 5.3 8.5 6.4 4.6 6.6 6.9 12.2 3.8 5.0 3.7 8.3 10.0 4.1 7.3 61.8 13.4 1.1 10.3 2.4 2.2 6.5 12.2 0.2 1.7 5.2 8.2 0.3 0.6 0.7 0.1 0.9 9.5 10.5 8.8 17.7 1.3 1.0 4.0 0.8 0.7 0.1 0.7 0.0 0.6 1.7 5.1 0.2 0.8 2.3 0.7 0.7 1.3 0.1 0.4 0.4 1.8 0.0 0.7 12.6 1.8 1.5 0.5 5.2 3.8 1.5 0.1 0.0 4.0 0.3 0.1 0.1 4.0 0.7 1.0 2.9 0.0 0.9 5.8 1.6 2.3 5.2 3.8 0.4 9.1 8.2 2.3 0.5 1.1 1.4 1.4 2.2 1.5 0.0 0.0 0.0 5.8 0.1 6.3 0.0 1.8 5.2 0.1 4.3 0.0 0.2 0.4 0.0 1.7 0.1 0.6 0.5 0.3 0.3 8.2 0.8 0.0 0.7 6.2 12.9 2.4 8.9 7.8 5.6 14.9 3.9 8.5 13.4 3.0 7.7 0.0 15.5 4.9 17.1 2.8 15.3 68.3 17.0 15.7 43.2 0.3 14.9 7.4 1331.5 8.1 2.1 0.0 9.1 0.6 10.3 7.2 16.1 2.1 4.2 30.2 9.2 9.2 17.5 2941.6 33.9 13.4 18.6 1.8 5.2 21.5 4.5 3.4 23.7 7.7 44.9 19.4 9.2 58.1 20.0 4.5 0.2 0.9 5.2 8.8 SPATA7 "HSD3, LCA3" ENSG00000042317 "Spermatogenesis associated 7" Q9P0W8 14 88384924-88470350 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.6" "Group enriched" "Detected in many" 24 "Early spermatids: 817.6;Late spermatids: 902.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038082, HPA038083" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA038082: AB_10671738, HPA038083: AB_10671519" "unprognostic (2.09e-2)" "unprognostic (6.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.50e-3)" "unprognostic (3.22e-2)" "unprognostic (6.75e-2)" "unprognostic (1.29e-3)" "unprognostic (4.70e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-3)" "prognostic favorable (4.16e-5)" "unprognostic (2.88e-1)" "prognostic favorable (2.50e-5)" "unprognostic (8.41e-2)" "unprognostic (1.29e-2)" "unprognostic (6.09e-2)" "unprognostic (2.81e-2)" 6.3 7.2 7.8 2.8 10.3 2.2 7.1 18.0 12.5 6.1 4.5 6.5 4.5 2.9 7.7 8.5 3.7 9.6 6.5 5.3 8.1 7.4 10.5 5.9 5.0 3.0 6.4 9.7 13.6 6.9 9.2 15.0 3.6 13.3 5.8 4.1 5.5 4.6 5.9 4.7 6.6 2.8 6.4 5.8 3.7 4.3 55.6 5.9 3.3 13.5 3.9 2.0 5.7 4.4 3.7 4.4 1.7 3.0 0.9 5.6 2.2 2.1 3.3 4.9 6.8 8.1 15.4 5.0 3.7 8.4 4.7 3.1 0.9 4.1 1.5 2.3 5.0 3.5 2.1 2.3 3.5 4.4 2.5 1.6 0.1 1.6 1.1 12.1 3.4 0.3 7.3 5.9 1.9 3.6 15.4 8.6 4.2 1.1 2.4 4.3 2.5 1.5 3.1 0.6 2.6 4.2 3.5 5.1 0.8 7.5 1.3 2.9 4.5 4.7 6.4 3.8 5.1 5.5 3.7 4.4 2.9 3.8 4.8 2.0 2.4 1.2 0.5 5.8 1.0 2.4 0.0 2.2 0.6 4.8 3.0 5.6 3.7 4.0 2.2 4.4 0.9 2.2 4.2 1.7 0.9 1.8 4.3 1.4 2.2 7.8 10.3 18.0 12.5 8.1 7.4 6.4 9.7 13.3 5.9 11.9 5.3 0.8 8.2 2.2 10.8 10.9 5.1 36.1 10.3 3.5 19.6 2.1 8.3 7.6 817.6 5.2 1.1 0.0 6.3 3.2 6.4 3.4 1.1 3.4 5.0 14.3 15.6 6.2 8.6 902.3 19.0 3.3 8.5 4.6 4.4 10.6 5.8 4.8 15.9 19.9 19.4 6.5 5.0 18.2 13.5 1.8 0.9 3.8 4.6 2.7 SPINK4 "MGC133107, PEC-60" ENSG00000122711 "Serine peptidase inhibitor, Kazal type 4" O60575 9 33218365-33248567 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 35.8;intestine: 120.9;lymphoid tissue: 24.3" "Cell type enriched" "Detected in some" 24 "Mucus-secreting cells: 2251.6" "Group enriched" "Detected in many" 20 "colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 5.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.1" "Group enriched" "Detected in some" 11 "HMC-1: 38.2;OE19: 100.1" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Not detected" "Not detected" HPA007286 Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Secreted to digestive system" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA007286: AB_1080083" "unprognostic (3.49e-2)" "unprognostic (2.32e-1)" "prognostic favorable (8.85e-5)" "unprognostic (3.09e-4)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (9.66e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-1)" "unprognostic (3.25e-1)" "unprognostic (2.42e-3)" 0.2 0.4 0.2 24.3 0.3 0.0 0.2 0.2 0.2 0.2 69.3 0.2 0.2 28.8 0.2 0.2 0.3 0.2 35.8 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.4 0.2 0.2 0.3 110.5 2.5 0.2 0.2 0.3 0.2 120.9 4.6 0.2 0.3 0.5 0.3 0.2 0.2 0.2 0.2 0.2 3.4 0.2 0.0 0.0 5.1 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 6.2 0.2 0.0 0.0 38.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.4 0.0 100.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 3.2 0.6 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.2 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 20.7 0.0 0.0 0.0 0.0 5.2 11.8 0.0 0.0 0.1 0.7 0.0 94.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 84.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2251.6 15.3 0.1 40.3 0.0 0.0 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.1 SPINT1 "HAI, MANSC2" ENSG00000166145 "Serine peptidase inhibitor, Kunitz type 1" O43278 15 40844018-40858207 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 121.0" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 913.5;Syncytiotrophoblasts: 1399.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 52.1;HaCaT: 59.5;hTCEpi: 42.4;RT4: 48.2;SK-BR-3: 89.3;T-47d: 42.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006903, HPA031178" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 3400000 "Plasma membrane, Cytosol" Nucleoplasm "HPA006903: AB_1079038, HPA031178: AB_2732463" "prognostic unfavorable (6.97e-4)" "unprognostic (1.00e-3)" "unprognostic (3.00e-3)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (3.19e-1)" "unprognostic (5.94e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-3)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.37e-7)" "unprognostic (5.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.45e-3)" "unprognostic (2.17e-2)" 2.2 0.5 0.9 11.6 1.2 0.0 12.6 2.9 0.8 12.9 64.4 1.2 38.6 31.9 3.6 25.5 71.1 6.4 30.7 0.8 0.8 0.7 27.9 1.5 18.5 3.7 0.9 0.6 3.4 25.0 28.8 9.7 85.5 1.3 17.5 17.9 3.2 50.8 24.0 0.6 39.1 121.0 2.3 1.0 3.1 17.6 1.9 0.7 4.8 15.4 26.9 44.3 12.8 21.5 5.1 19.0 15.3 10.9 3.6 1.8 3.8 19.0 0.1 0.0 0.1 0.0 0.0 52.1 0.3 0.4 0.6 0.3 30.4 32.0 0.0 22.8 0.0 0.5 59.5 4.9 28.6 0.4 0.1 1.6 0.8 0.5 1.6 0.3 3.3 15.1 0.0 42.4 0.6 2.7 0.5 2.3 1.9 0.4 0.1 0.0 14.8 0.1 2.5 5.9 32.2 2.8 1.9 0.0 3.7 28.8 48.2 12.8 0.6 1.4 89.3 2.3 9.6 42.7 2.5 0.0 0.0 0.3 0.1 0.0 0.1 3.6 0.1 0.1 2.5 0.1 0.0 10.9 7.9 0.3 9.3 0.5 5.1 1.8 0.8 19.0 3.9 0.7 0.2 15.3 3.6 9.6 2.3 0.2 3.8 0.9 1.2 2.9 0.8 0.8 0.7 0.9 0.6 1.3 0.7 53.6 17.1 2.7 86.0 67.5 0.0 0.4 109.5 4.0 18.2 127.4 0.0 913.5 21.6 354.0 0.5 0.7 428.8 0.0 224.2 67.1 7.5 132.0 10.3 0.4 125.6 0.0 141.5 0.0 13.6 0.8 3.4 17.8 13.5 101.8 147.7 0.0 241.9 199.9 0.0 40.0 0.1 0.0 5.2 0.6 5.2 76.9 1399.8 2.2 145.0 168.6 SPIRE2 "KIAA1832, spir-2" ENSG00000204991 "Spire type actin nucleation factor 2" Q8WWL2 16 89818179-89871319 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.6" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 40.0;Mucus-secreting cells: 37.2;Paneth cells: 34.2;Syncytiotrophoblasts: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 21.5;T-47d: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041413, HPA049415" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA Nucleoplasm "Vesicles, Intermediate filaments" "HPA041413: AB_2677464, HPA049415: AB_2680755" "unprognostic (2.92e-1)" "unprognostic (1.39e-1)" "unprognostic (6.07e-3)" "unprognostic (6.96e-2)" "unprognostic (7.40e-2)" "unprognostic (7.31e-2)" "prognostic unfavorable (9.77e-5)" "unprognostic (2.10e-1)" "unprognostic (7.75e-2)" "unprognostic (5.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.95e-3)" "unprognostic (7.21e-3)" "unprognostic (6.65e-2)" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.59e-2)" 1.5 2.1 7.2 3.9 9.3 2.2 1.7 19.5 11.2 2.1 14.8 2.1 5.9 10.9 2.5 3.2 2.5 9.1 7.6 0.8 6.2 7.8 1.9 4.0 3.2 1.0 5.5 6.1 1.6 3.0 8.4 18.4 40.6 7.4 3.5 11.7 2.7 2.2 5.0 1.2 2.0 12.6 1.9 2.5 1.5 20.2 3.8 1.4 0.0 5.0 0.9 1.3 6.4 4.9 2.1 1.6 5.5 1.4 1.7 1.2 0.6 0.2 6.2 3.9 3.3 1.1 0.7 13.2 2.1 1.2 2.9 1.2 2.4 6.6 4.1 0.9 0.6 3.1 6.6 1.7 0.2 0.9 1.6 7.6 0.8 5.1 6.3 1.0 0.2 1.4 1.4 1.5 0.9 0.8 0.3 0.1 0.3 6.3 1.2 0.8 9.2 0.1 1.4 4.3 21.5 3.8 3.1 1.4 0.9 1.5 6.3 10.3 5.3 8.6 3.8 3.7 3.4 14.2 2.2 0.3 1.7 3.7 2.4 1.8 0.5 2.6 0.4 2.6 1.5 3.5 4.6 1.4 0.9 1.1 0.7 0.8 1.2 0.9 0.7 0.3 2.1 1.2 1.2 5.5 1.7 1.3 1.6 0.5 0.6 7.2 9.3 19.5 11.2 6.2 7.8 5.5 6.1 7.4 1.4 6.0 3.7 0.8 3.6 0.8 11.1 2.0 7.6 5.3 1.2 12.2 3.9 11.0 3.3 1.2 2.4 0.5 40.0 0.0 0.3 2.8 1.3 4.5 0.0 1.8 2.2 22.3 15.1 0.0 1.8 1.7 0.9 1.1 0.0 0.0 37.2 2.4 1.0 34.2 1.8 0.8 10.1 0.0 1.0 4.6 8.4 0.5 58.9 0.8 30.5 25.1 SPOCD1 "FLJ25348, PPP1R146" ENSG00000134668 "SPOC domain containing 1" Q6ZMY3 1 31790422-31816051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.9;urinary bladder: 13.7" "Cell type enhanced" "Detected in some" 19 "Ductal cells: 9.9;Hofbauer cells: 13.9;Pancreatic endocrine cells: 18.9;Urothelial cells: 44.4" "Group enriched" "Detected in many" 7 "glioma: 13.9;urothelial cancer: 5.6" "Region enhanced" "Detected in many" "pons and medulla: 8.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.9;hTEC/SVTERT24-B: 19.7;RT4: 33.2;TIME: 17.3;U-87 MG: 32.7" "Low region specificity" "Detected in some" "HPA031713, HPA031714, HPA031715" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008" "unprognostic (7.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.85e-3)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (2.15e-3)" "unprognostic (2.60e-2)" "unprognostic (3.51e-1)" "unprognostic (2.18e-1)" "unprognostic (3.01e-2)" "unprognostic (3.00e-1)" "unprognostic (0.00e+0)" "unprognostic (1.97e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.05e-5)" 28.9 0.5 1.8 5.1 1.6 0.3 1.6 0.4 3.9 2.0 0.7 1.5 0.1 1.6 2.4 2.8 0.3 2.1 1.6 0.4 1.2 1.6 0.5 0.2 12.9 0.9 2.6 0.3 1.8 0.1 0.1 1.6 3.5 8.2 1.8 0.9 1.8 0.1 0.3 0.4 0.1 0.9 2.4 3.1 1.9 1.1 11.9 0.6 0.1 0.4 0.8 0.2 13.7 2.1 0.0 0.0 1.9 0.1 0.0 0.0 7.3 10.7 0.3 0.0 0.0 0.2 1.5 0.5 14.1 18.9 13.7 9.2 0.2 0.6 0.1 1.9 15.9 5.6 1.4 0.0 0.2 4.3 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.2 6.9 0.2 19.7 0.6 11.1 9.3 0.7 0.2 0.2 8.1 0.0 0.1 0.0 0.2 0.1 0.3 0.0 1.4 0.0 0.0 33.2 0.0 0.0 0.3 0.0 0.9 0.4 8.2 0.0 17.3 14.5 1.4 9.3 5.3 0.0 0.1 0.0 32.7 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 1.8 1.6 0.4 0.6 1.2 1.6 2.6 0.3 8.2 0.6 0.0 5.9 0.0 4.0 0.1 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 9.9 0.2 0.1 0.0 0.0 8.9 0.5 0.4 1.7 1.1 0.0 13.9 0.0 1.7 0.6 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.0 1.4 0.0 4.3 0.0 0.2 0.0 0.0 44.4 SPPL2B "IMP4, KIAA1532, PSL1" ENSG00000005206 "Signal peptide peptidase like 2B" Q8TCT7 19 2328615-2354806 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 82.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005592, HPA039292" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Plasma membrane" Centrosome "CAB005592: AB_325074, HPA039292: AB_2676429" "unprognostic (4.16e-2)" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "prognostic favorable (5.00e-5)" "unprognostic (2.34e-1)" "unprognostic (1.54e-3)" "unprognostic (1.74e-1)" "unprognostic (7.93e-3)" "unprognostic (3.00e-1)" "unprognostic (1.72e-1)" "prognostic favorable (1.33e-4)" "unprognostic (3.29e-3)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.26e-2)" "unprognostic (2.45e-1)" "unprognostic (3.02e-1)" "unprognostic (3.40e-2)" 5.4 4.6 5.0 11.7 5.4 11.7 4.0 6.9 6.9 3.4 9.0 7.9 9.6 19.3 4.7 10.0 3.2 5.2 9.8 3.3 5.6 4.2 3.9 3.5 10.3 7.1 4.7 3.4 13.8 6.3 11.0 6.8 7.1 4.7 3.9 6.0 10.5 8.7 7.5 8.7 16.2 5.0 7.0 8.1 13.8 20.1 6.4 9.3 3.0 3.7 5.7 2.3 2.0 14.4 17.4 9.3 7.7 6.2 8.2 5.9 8.3 13.4 5.8 10.2 4.8 4.9 14.8 11.0 3.2 4.0 4.3 9.4 9.6 8.0 10.4 5.1 3.8 11.3 1.9 3.8 1.2 9.3 8.4 5.3 21.0 12.5 9.0 9.3 7.0 7.1 4.3 3.8 2.7 6.3 5.6 16.8 8.6 20.5 2.4 9.3 10.1 11.9 10.8 7.5 5.5 16.9 3.0 22.1 4.4 21.1 10.3 9.8 11.0 6.7 8.4 3.9 11.2 15.7 12.5 7.4 5.3 18.6 8.6 27.1 9.7 8.4 9.2 10.9 12.8 9.3 7.7 7.0 6.6 7.5 4.8 9.0 6.0 6.5 9.4 14.4 7.8 8.2 3.4 6.2 5.1 17.4 5.9 5.9 3.0 15.0 22.0 6.2 0.0 23.4 5.1 28.1 20.1 9.1 24.4 45.2 44.0 1.7 13.7 36.9 9.0 59.3 0.0 10.0 18.3 4.6 7.2 6.9 10.6 10.4 30.2 39.1 14.7 9.5 82.4 13.8 5.3 0.0 5.4 51.1 13.7 10.1 30.8 14.9 6.2 39.6 0.0 8.1 41.9 12.4 0.0 35.8 4.5 38.9 4.3 SPRED3 ENSG00000188766 "Sprouty related EVH1 domain containing 3" Q2MJR0 19 38388421-38399587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.7" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 7.3;Intestinal endocrine cells: 10.4" "Cancer enhanced" "Detected in many" "glioma: 3.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.3;TIME: 14.7;U-87 MG: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071521 Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA071521: " "unprognostic (1.09e-1)" "unprognostic (1.88e-3)" "unprognostic (8.71e-3)" "unprognostic (3.35e-3)" "unprognostic (3.70e-2)" "unprognostic (2.00e-3)" "unprognostic (2.09e-3)" "unprognostic (7.77e-3)" "unprognostic (1.49e-1)" "unprognostic (9.22e-3)" "unprognostic (1.69e-2)" "unprognostic (3.09e-2)" "unprognostic (1.40e-11)" "unprognostic (6.21e-4)" "unprognostic (3.67e-1)" "unprognostic (1.04e-3)" "unprognostic (8.45e-3)" 2.0 1.2 4.3 2.7 10.1 0.9 1.2 2.8 10.7 0.9 0.6 1.7 0.0 4.7 1.2 1.2 0.9 0.7 2.0 1.1 5.0 4.7 1.2 0.4 0.9 0.5 2.8 4.6 0.5 2.9 4.5 5.8 0.8 4.7 1.2 0.8 0.9 0.8 1.1 0.9 2.3 3.7 2.3 1.7 0.5 1.3 1.7 0.9 0.0 1.8 0.0 0.6 0.9 0.8 0.8 0.7 2.2 0.6 0.9 0.5 0.3 0.2 1.1 3.8 3.1 0.6 1.8 2.1 7.5 5.0 2.5 2.3 0.4 0.8 0.2 2.7 2.5 2.0 0.1 0.6 0.9 2.3 0.7 1.4 0.0 0.2 0.4 1.3 2.0 0.1 1.3 0.9 5.9 1.7 12.3 7.8 0.6 0.6 1.4 7.6 0.4 0.0 0.1 1.7 0.5 3.8 0.9 1.3 0.1 5.4 0.6 0.2 2.9 0.1 0.2 0.3 1.7 0.6 0.1 14.7 2.8 8.6 2.3 4.1 0.6 0.2 0.5 9.4 0.3 4.7 1.6 0.6 0.4 0.4 0.2 0.3 0.3 0.5 0.3 0.1 0.8 0.4 0.3 2.2 0.9 0.5 0.7 0.2 0.3 4.3 10.1 2.8 9.8 5.0 4.7 2.8 4.6 4.7 0.9 0.0 0.0 0.0 1.1 0.0 7.3 1.0 0.0 0.0 0.0 1.8 2.0 0.4 0.0 0.8 0.3 0.1 0.7 0.0 0.5 0.2 0.0 1.1 0.0 0.0 0.1 1.6 10.4 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 2.5 2.2 0.0 0.0 0.0 0.2 0.0 1.0 0.9 0.6 0.1 0.7 0.0 0.6 0.6 SPRR4 ENSG00000184148 "Small proline rich protein 4" Q96PI1 1 152970666-152972574 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 51.9;tongue: 18.9" "Group enriched" "Detected in some" 27 "Early spermatids: 9.1;Late spermatids: 36.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 3.6;hTCEpi: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA055963 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA055963: AB_2682988" "unprognostic (4.40e-2)" "unprognostic (7.38e-3)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" 0.1 0.0 0.1 0.7 0.1 0.0 4.9 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.4 0.1 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 51.9 0.1 0.1 0.1 0.1 0.0 2.9 0.1 1.8 0.1 18.9 0.4 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SPRY1 hSPRY1 ENSG00000164056 "Sprouty RTK signaling antagonist 1" O43609 4 123396795-123403760 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 139.1" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 160.4;Leydig cells: 414.8;Muller glia cells: 173.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 29.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 30.2;AN3-CA: 61.1;ASC diff: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013538, HPA051369, HPA070554" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280" "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.06e-1)" "unprognostic (7.15e-2)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (1.36e-1)" "unprognostic (9.43e-2)" "unprognostic (6.99e-2)" "unprognostic (4.32e-1)" "unprognostic (4.06e-1)" "unprognostic (3.11e-2)" "unprognostic (8.77e-3)" "unprognostic (1.21e-3)" "unprognostic (4.48e-2)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" 139.1 12.6 3.3 14.7 4.3 5.8 69.0 4.9 3.5 28.5 24.8 1.9 18.0 4.5 18.6 28.0 38.1 19.1 27.1 34.1 2.6 1.7 10.2 6.4 23.1 9.1 3.3 2.8 32.2 9.8 17.0 9.5 15.6 2.9 25.0 8.8 11.8 14.6 16.5 48.1 25.5 8.1 20.7 2.8 7.1 11.6 28.4 1.5 13.0 29.6 16.3 8.6 60.8 39.9 29.9 0.7 2.8 0.1 6.1 15.5 0.9 1.9 0.5 30.2 61.1 24.8 16.9 2.0 0.1 1.5 0.1 0.6 1.8 3.2 0.0 13.6 0.9 0.1 0.3 0.8 1.4 0.2 0.0 3.1 0.6 0.0 9.4 7.0 4.2 0.0 6.8 0.8 0.2 0.6 3.3 2.5 0.7 0.5 0.5 1.4 0.2 4.9 10.5 7.2 6.9 10.0 2.1 3.2 0.0 4.1 4.4 4.6 3.9 0.0 6.1 5.8 3.3 0.6 0.0 6.2 0.4 0.0 0.1 0.9 0.3 0.0 0.0 0.4 0.8 1.0 0.0 0.1 2.8 0.5 0.0 15.5 9.6 1.8 4.2 0.0 29.9 2.7 2.9 0.1 6.1 0.0 0.7 0.0 0.9 3.3 4.3 4.9 3.5 2.6 1.7 3.3 2.8 2.9 1.5 26.8 27.0 15.2 13.8 44.1 75.2 10.9 35.7 13.4 27.3 26.2 31.4 10.0 68.0 3.5 1.7 160.4 6.3 0.0 9.4 1.5 42.7 12.9 9.2 4.4 8.2 6.4 25.4 120.9 11.6 4.0 414.8 9.7 43.9 1.0 13.1 173.3 8.4 3.5 54.5 12.6 80.4 148.8 86.8 1.9 1.5 37.9 2.6 25.5 14.1 12.5 SRA1 "SRA, STRAA1" ENSG00000213523 "Steroid receptor RNA activator 1" Q9HD15 5 140537340-140558252 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Activator, Receptor, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 26.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044598, HPA050153" Approved Supported Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA044598: AB_2679013, HPA050153: AB_2681033" "unprognostic (1.51e-1)" "unprognostic (1.04e-2)" "unprognostic (8.69e-2)" "prognostic favorable (8.01e-6)" "unprognostic (9.32e-2)" "unprognostic (2.56e-1)" "unprognostic (2.90e-1)" "unprognostic (2.43e-1)" "unprognostic (9.38e-2)" "unprognostic (7.41e-2)" "unprognostic (5.58e-3)" "unprognostic (2.61e-1)" "unprognostic (5.34e-2)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-1)" 4.8 9.9 2.5 4.8 3.0 5.6 2.7 13.3 3.5 2.5 3.3 3.1 3.0 4.1 2.5 2.6 3.5 4.3 2.7 3.0 3.5 14.4 4.4 3.5 2.2 4.9 2.7 4.5 7.7 3.7 3.7 3.0 5.5 4.4 4.4 3.9 3.4 3.4 2.1 5.7 4.6 6.8 4.1 3.1 2.3 2.3 9.0 15.6 26.9 16.4 7.5 11.3 14.2 6.2 15.0 8.0 8.3 3.9 5.3 11.2 10.7 6.1 7.0 7.4 27.4 3.9 5.3 7.9 4.1 3.7 4.2 1.4 7.9 2.8 8.2 9.3 4.7 16.3 10.4 8.3 8.4 6.4 10.2 4.1 3.7 1.9 6.2 3.2 9.2 4.7 8.2 4.6 19.1 6.8 13.2 2.4 3.4 12.1 7.6 6.8 5.1 3.6 7.5 5.7 6.6 6.2 5.7 7.2 2.9 7.0 9.6 5.0 6.7 3.5 5.7 8.6 10.3 6.8 5.6 8.2 11.0 4.3 8.1 16.4 12.0 7.0 14.3 6.5 9.0 6.8 6.7 15.6 7.4 5.6 6.4 26.9 7.5 13.3 9.3 11.3 14.2 6.0 53.3 35.8 43.2 46.5 23.0 70.0 68.8 34.8 30.7 31.4 7.9 84.2 96.2 79.1 75.5 39.4 72.4 0.0 128.7 102.6 52.4 64.7 66.9 57.8 81.7 14.3 36.9 43.6 67.7 108.8 23.3 67.0 64.1 111.0 51.7 47.0 131.8 77.2 28.0 111.7 19.5 25.8 48.6 45.0 29.2 40.1 149.7 55.1 40.7 117.5 SRCAP "DOMO1, EAF1, KIAA0309, SWR1" ENSG00000080603 "Snf2 related CREBBP activator protein" Q6ZRS2 16 30698209-30741409 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 21.9;Suprabasal keratinocytes: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA028929 Approved Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA028929: AB_10601265" "unprognostic (1.26e-1)" "unprognostic (1.35e-1)" "unprognostic (5.07e-1)" "unprognostic (6.57e-2)" "unprognostic (1.78e-1)" "unprognostic (6.95e-2)" "unprognostic (8.59e-2)" "unprognostic (2.34e-2)" "unprognostic (3.77e-1)" "unprognostic (6.45e-2)" "unprognostic (4.36e-2)" "unprognostic (8.57e-2)" "unprognostic (1.16e-2)" "unprognostic (2.09e-1)" "unprognostic (4.11e-2)" "unprognostic (7.71e-2)" "unprognostic (1.07e-1)" 13.5 15.5 15.4 17.1 15.6 23.6 13.6 24.8 18.1 14.8 16.3 20.4 14.0 14.1 23.6 12.0 13.0 15.1 16.0 11.9 11.5 9.3 10.5 9.3 11.6 13.9 18.2 10.8 17.2 17.8 31.2 18.2 16.3 13.0 14.1 10.3 17.5 17.2 13.4 23.5 14.8 18.0 13.4 12.6 16.0 15.9 22.4 14.0 20.5 17.4 10.1 15.1 21.4 12.7 3.2 2.3 6.2 3.2 1.7 2.4 1.5 13.8 27.4 16.5 16.8 13.0 9.3 17.8 10.5 9.7 12.1 9.7 13.0 10.2 28.8 14.5 13.3 8.3 13.9 17.1 13.1 10.0 18.6 39.3 18.3 24.0 11.1 5.8 21.2 22.2 9.7 6.5 18.1 14.9 6.2 12.3 9.7 28.1 16.3 8.8 17.1 18.1 8.4 17.2 5.8 12.3 25.3 13.0 16.5 3.8 16.0 16.0 16.6 11.7 15.3 4.5 5.8 17.3 12.0 19.8 17.2 12.6 9.7 14.0 18.6 15.7 21.2 13.8 11.2 13.1 0.7 1.8 6.2 2.4 3.2 1.9 1.8 1.3 2.4 1.3 3.2 1.3 1.1 5.4 1.7 0.8 2.3 2.1 1.5 15.4 15.6 24.8 18.1 11.5 9.3 18.2 10.8 13.0 14.0 3.0 3.0 1.9 1.7 21.9 7.6 1.4 2.5 0.0 2.3 1.8 7.9 2.0 0.0 1.0 0.8 1.7 4.7 0.0 2.7 1.1 1.7 2.4 2.3 2.9 2.0 7.9 10.9 1.8 0.3 0.5 2.6 1.7 10.1 2.8 2.8 2.9 1.5 1.7 1.1 0.5 5.5 0.0 3.9 4.7 5.1 50.8 2.1 4.3 2.7 2.5 SREBF1 "bHLHd1, SREBP-1c, SREBP1, SREBP1a" ENSG00000072310 "Sterol regulatory element binding transcription factor 1" P36956 17 17810399-17837002 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Group enriched" "Detected in many" 4 "granulocytes: 4.7;T-cells: 2.2" "Cell line enhanced" "Detected in many" "RPMI-8226: 50.5;SK-BR-3: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005406, HPA043343, HPA043878" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710" "unprognostic (9.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-2)" "prognostic favorable (2.66e-4)" "unprognostic (4.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (3.14e-2)" "unprognostic (9.02e-3)" "prognostic favorable (9.05e-4)" "unprognostic (3.12e-1)" "unprognostic (9.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (7.65e-2)" "unprognostic (2.36e-3)" 34.0 78.2 16.4 9.3 17.9 14.8 15.5 5.8 22.3 15.7 13.8 31.9 30.4 28.9 8.6 23.4 20.5 15.7 17.6 10.2 13.5 10.3 9.0 49.9 11.9 14.4 20.3 16.7 20.5 7.7 9.6 12.5 16.0 11.8 18.0 6.4 15.1 72.7 33.0 16.8 14.5 27.4 7.1 13.1 7.3 13.6 16.8 16.2 15.2 9.5 13.6 13.8 11.9 15.0 0.6 0.4 4.7 0.8 0.4 2.2 0.5 14.0 33.0 4.1 25.4 8.4 15.4 7.1 5.2 16.5 4.5 11.0 6.7 27.3 8.8 4.9 4.1 4.2 40.0 4.7 13.8 1.1 5.4 2.0 4.8 27.4 7.0 10.5 0.6 9.2 12.0 5.9 6.3 3.9 3.5 5.1 20.1 9.3 31.6 1.0 34.5 11.6 8.1 5.5 10.8 6.6 8.3 3.0 50.5 3.6 7.3 4.9 20.2 6.1 49.0 14.5 3.0 16.6 9.3 5.8 2.4 12.2 5.8 3.2 9.3 0.8 4.0 14.2 6.9 12.6 0.0 0.8 0.4 1.8 0.5 0.4 0.6 0.8 0.3 0.4 0.4 1.6 2.2 4.7 0.4 0.6 0.3 0.2 0.5 16.4 17.9 5.8 22.3 13.5 10.3 20.3 16.7 11.8 16.2 6.0 17.5 8.2 12.6 8.2 22.4 7.3 17.8 5.3 11.4 19.2 27.5 4.6 1.7 13.5 1.8 8.9 29.9 0.0 20.4 13.9 14.1 19.0 14.9 58.7 10.6 55.6 28.7 12.9 10.4 3.0 27.6 8.3 8.5 13.6 18.3 29.8 13.8 13.5 10.3 5.4 29.3 12.9 10.4 11.3 5.8 15.9 16.6 7.5 21.1 21.3 SREBF2 "bHLHd2, SREBP2" ENSG00000198911 "Sterol regulatory element binding transcription factor 2" Q12772 22 41833079-41907308 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031962, HPA031963" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "HPA031962: AB_10601266, HPA031963: AB_2674090" "unprognostic (6.53e-2)" "unprognostic (6.07e-2)" "unprognostic (1.75e-2)" "unprognostic (1.50e-3)" "unprognostic (3.41e-3)" "unprognostic (9.08e-2)" "unprognostic (5.04e-2)" "unprognostic (1.31e-1)" "unprognostic (4.78e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (9.85e-2)" "prognostic favorable (1.37e-4)" "unprognostic (4.68e-2)" "unprognostic (1.92e-2)" "unprognostic (3.22e-1)" "unprognostic (7.93e-3)" 13.9 45.2 42.9 19.6 41.7 18.2 16.3 51.9 66.5 16.5 27.7 32.7 22.3 26.1 19.4 41.5 42.4 18.9 28.7 33.9 37.3 33.6 18.9 20.4 27.9 21.1 21.7 38.4 22.7 29.7 34.2 17.4 15.8 34.2 22.8 20.9 25.4 29.0 20.0 17.2 32.9 22.3 19.8 24.7 16.0 30.2 13.5 21.0 15.6 14.3 20.5 26.1 17.1 19.0 9.6 8.4 2.0 5.5 1.8 6.4 4.9 18.4 13.2 35.2 32.7 20.7 27.7 19.7 6.2 20.8 7.3 15.1 15.5 24.5 33.0 8.8 15.1 27.1 31.8 20.1 41.0 5.2 9.2 21.9 16.5 23.3 15.4 34.6 24.0 11.2 25.9 23.3 19.2 24.1 16.9 14.4 18.7 16.9 39.9 7.7 23.5 17.4 18.2 22.3 23.1 10.2 20.2 20.1 52.9 30.5 19.5 14.3 10.7 14.2 26.2 26.3 21.5 16.4 42.9 15.3 9.9 18.6 4.6 7.3 29.2 14.8 26.3 9.7 18.3 15.1 0.0 5.5 2.0 6.4 4.9 4.4 9.6 3.5 4.6 6.6 7.3 3.2 3.6 1.0 1.8 4.0 8.4 2.1 4.9 42.9 41.7 51.9 66.5 37.3 33.6 21.7 38.4 34.2 21.0 41.7 33.4 16.0 10.9 14.4 35.6 26.3 38.2 21.4 18.2 55.8 9.8 22.2 3.3 17.6 15.3 9.8 40.6 0.0 37.7 17.9 14.6 18.9 12.7 20.4 12.4 54.0 47.2 6.7 13.8 5.3 29.1 8.0 6.8 21.6 38.3 18.8 30.8 24.6 25.8 4.5 16.2 19.4 18.4 7.7 15.8 24.6 30.6 13.1 31.8 20.2 SRPK1 SFRSK1 ENSG00000096063 "SRSF protein kinase 1" Q96SB4 6 35832966-35921342 "Enzymes, Predicted intracellular proteins" "Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 311.7;Late spermatids: 401.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016431, HPA056486" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA016431: AB_1857478, HPA056486: AB_2683148" "unprognostic (4.65e-3)" "unprognostic (6.82e-3)" "unprognostic (2.54e-3)" "unprognostic (1.01e-3)" "unprognostic (7.74e-2)" "unprognostic (3.31e-2)" "prognostic unfavorable (7.90e-6)" "unprognostic (1.23e-2)" "unprognostic (2.54e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (6.53e-5)" "unprognostic (7.28e-2)" "unprognostic (2.21e-3)" "unprognostic (9.24e-2)" "unprognostic (4.43e-1)" "unprognostic (1.01e-1)" "unprognostic (7.55e-3)" 13.5 7.1 8.1 15.4 11.7 32.1 11.7 22.5 17.8 12.8 23.8 7.8 10.8 20.3 15.2 7.9 24.9 8.9 10.8 8.7 8.9 7.8 17.8 18.9 14.9 14.6 8.0 8.3 9.5 26.0 11.7 17.7 27.9 9.6 10.5 28.7 12.4 17.6 9.4 19.9 26.2 25.7 11.3 7.9 19.0 13.9 32.7 7.6 21.0 8.5 17.0 19.8 15.2 15.7 4.3 2.8 24.6 3.4 5.0 6.7 2.9 29.9 11.4 16.8 25.0 9.4 12.3 21.2 18.4 17.8 17.2 18.3 32.0 10.1 40.0 15.6 11.3 20.0 15.4 32.8 21.9 31.0 27.3 23.6 21.0 13.4 27.7 8.3 31.1 10.4 7.9 12.0 19.8 26.0 13.7 21.6 22.9 44.5 17.0 14.4 10.6 32.0 24.2 13.7 18.3 12.5 22.5 20.1 24.7 17.3 50.4 35.8 13.1 18.9 18.0 12.7 17.8 10.1 20.7 15.6 16.2 12.7 11.0 23.1 10.0 22.1 37.6 6.4 36.1 14.4 24.5 2.1 13.7 4.3 2.5 6.1 4.3 5.7 5.7 2.8 3.3 4.8 5.2 24.6 5.0 3.4 1.6 6.7 2.9 8.1 11.7 22.5 17.8 8.9 7.8 8.0 8.3 9.6 7.6 8.9 26.3 24.4 65.1 37.5 33.6 21.8 12.7 32.1 38.7 21.0 35.3 43.2 24.9 50.7 311.7 24.1 38.6 23.3 58.8 43.3 21.3 68.6 7.0 40.0 19.1 9.5 44.4 11.1 17.1 401.7 20.4 16.9 15.1 36.1 44.8 13.4 78.7 42.1 23.3 44.4 84.4 6.5 23.1 154.9 90.6 36.5 33.2 34.8 87.4 132.9 SRSF5 "HRS, SFRS5, SRP40" ENSG00000100650 "Serine and arginine rich splicing factor 5" Q13243 14 69726900-69772005 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043484, HPA056523" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA043484: AB_10797143, HPA056523: AB_2683164" "unprognostic (2.08e-3)" "prognostic favorable (7.91e-4)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.30e-3)" "unprognostic (1.07e-3)" "unprognostic (2.37e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" 66.6 60.1 67.1 60.9 74.4 131.5 70.3 111.7 88.8 54.3 63.3 67.8 77.1 42.6 71.3 74.6 66.3 79.3 50.1 48.5 66.2 43.0 40.5 60.8 69.4 63.3 86.4 62.1 76.6 41.0 56.4 124.8 59.2 74.0 59.0 54.7 69.2 68.5 75.6 76.0 78.1 74.1 59.7 68.6 66.5 62.0 35.3 75.6 47.8 70.8 52.3 69.1 69.6 55.8 41.2 37.4 60.8 45.1 30.8 38.2 24.4 70.0 20.5 50.2 22.6 31.0 26.9 27.9 33.8 36.4 27.6 29.3 25.7 45.0 72.6 17.9 45.8 28.4 33.5 38.0 48.3 32.6 62.0 20.9 54.7 54.9 28.1 36.1 51.0 41.5 55.7 30.8 31.8 34.1 41.5 38.2 63.2 38.0 43.3 17.1 56.9 58.6 34.6 29.4 55.3 18.9 50.3 23.9 27.9 35.1 86.3 26.2 37.4 57.3 34.8 43.6 31.4 37.9 43.0 47.2 16.2 43.4 17.6 31.6 42.1 27.5 117.5 38.1 43.5 22.2 39.0 24.1 37.2 37.3 43.4 38.2 41.2 33.2 33.4 26.2 40.6 33.2 31.5 60.8 30.8 45.1 37.4 27.4 24.4 67.1 74.4 111.7 88.8 66.2 43.0 86.4 62.1 74.0 75.6 235.2 245.0 272.6 618.6 122.6 370.2 163.3 193.6 401.5 253.6 174.5 225.8 335.9 271.9 173.3 146.9 251.5 417.9 163.5 148.9 193.0 195.8 288.7 459.5 204.3 193.9 357.6 290.6 219.1 193.0 84.2 319.9 251.8 126.5 254.3 249.3 292.6 182.8 399.8 251.0 172.0 307.5 271.7 240.9 175.1 136.3 127.2 626.6 371.3 207.8 495.2 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42595114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: AB_2680020" "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favorable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 12.7 11.6 24.5 17.8 26.4 29.9 20.8 25.2 23.8 14.0 14.8 14.4 9.1 19.4 9.1 20.6 16.6 10.6 11.8 10.8 23.5 20.6 15.8 26.2 11.9 34.8 20.5 15.9 13.5 29.0 10.9 16.1 10.7 17.4 22.2 15.5 11.3 18.6 10.8 10.1 14.9 19.3 8.4 24.0 19.7 15.6 6.4 14.9 20.4 18.7 14.7 32.0 16.0 11.1 48.0 30.0 32.8 25.9 31.0 53.5 32.9 16.1 7.4 14.9 13.5 19.2 15.6 9.3 10.5 12.0 15.7 17.8 14.2 14.8 22.1 9.6 7.2 16.5 9.1 17.8 14.7 17.3 11.0 20.8 24.0 14.5 23.8 13.8 31.3 18.9 12.2 9.5 12.6 11.9 10.9 17.1 19.7 21.7 33.4 12.6 15.3 22.0 38.9 23.6 21.8 18.2 11.7 10.9 30.7 17.4 20.4 8.4 12.0 8.9 14.0 14.1 16.8 18.3 29.3 10.0 9.2 15.1 22.1 19.1 24.3 38.4 37.5 13.6 34.4 8.8 19.0 23.5 32.8 38.4 25.9 51.6 48.0 50.5 45.3 24.9 40.8 43.9 44.1 31.1 31.0 19.2 30.0 53.5 32.9 24.5 26.4 25.2 23.8 23.5 20.6 20.5 15.9 17.4 14.9 11.9 11.8 77.1 64.6 95.1 14.4 16.1 38.2 14.7 15.9 26.2 7.9 47.4 48.0 38.3 2.3 39.4 43.1 23.3 43.1 65.4 37.6 63.9 45.0 58.7 58.5 22.3 52.9 28.3 37.6 2.5 31.9 41.0 49.0 61.3 42.2 24.6 41.3 53.7 14.9 68.9 23.5 12.9 39.1 13.2 24.0 120.8 31.2 95.9 48.0 96.2 SSFA2 "CS-1, KIAA1927, KRAP, SPAG13" ENSG00000138434 "Sperm specific antigen 2" P28290 2 181891833-181930738 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 85.5" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 167.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034665, HPA039989" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA034665: AB_2674271, HPA039989: AB_2676788" "unprognostic (1.68e-1)" "unprognostic (3.27e-2)" "unprognostic (2.17e-2)" "unprognostic (4.70e-2)" "unprognostic (8.77e-2)" "unprognostic (8.87e-2)" "unprognostic (2.13e-1)" "unprognostic (4.74e-2)" "unprognostic (5.63e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (6.95e-2)" "prognostic favorable (2.91e-5)" "unprognostic (3.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (5.79e-5)" 14.2 10.1 23.3 11.8 27.0 16.1 21.6 25.8 22.5 17.7 24.4 26.2 9.4 17.5 13.0 8.9 12.0 10.7 18.7 13.6 23.7 19.1 22.8 36.0 23.0 11.2 31.3 17.7 7.2 85.5 10.5 10.2 40.9 24.8 18.1 24.1 22.3 29.2 10.0 16.6 50.6 19.5 14.2 27.8 14.7 26.0 16.7 23.8 9.3 19.6 12.2 7.9 14.3 23.5 1.2 3.8 8.1 6.4 1.0 1.4 1.8 16.4 8.2 24.0 4.0 21.0 17.4 6.8 29.2 28.4 10.3 13.7 8.5 19.1 0.4 9.5 20.5 12.7 14.3 5.8 14.0 19.9 7.5 6.6 16.6 35.3 6.8 15.5 8.5 15.6 10.3 20.7 17.7 24.1 24.4 53.7 8.0 7.4 9.2 28.6 8.3 7.5 11.9 1.6 15.3 19.4 5.6 9.7 5.7 29.0 5.0 4.2 3.7 17.1 6.1 26.1 9.5 4.4 18.6 21.3 24.4 11.8 8.7 15.1 6.3 2.7 6.6 11.4 5.1 18.2 8.1 3.9 5.7 1.4 3.9 0.9 0.6 1.0 0.9 3.8 1.2 1.3 1.1 6.6 1.0 6.4 3.1 0.6 1.8 23.3 27.0 25.8 22.5 23.7 19.1 31.3 17.7 24.8 23.8 134.0 40.6 11.2 36.2 97.1 18.5 23.0 35.7 33.5 35.2 31.4 35.3 19.9 14.9 15.8 9.0 52.6 132.6 0.0 62.2 21.0 25.9 46.7 22.0 89.3 18.4 25.4 105.7 36.8 47.5 13.4 17.5 29.8 55.6 15.4 57.0 17.2 54.1 41.9 16.3 36.3 33.6 38.8 24.5 22.3 25.4 167.2 27.9 12.9 39.3 84.6 SSH1 KIAA1298 ENSG00000084112 "Slingshot protein phosphatase 1" Q8WYL5 12 108778192-108857590 "Enzymes, Predicted intracellular proteins" "Actin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019845 Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA019845: AB_1857497" "unprognostic (1.18e-3)" "unprognostic (3.00e-1)" "unprognostic (2.49e-1)" "unprognostic (2.70e-2)" "unprognostic (9.40e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (5.80e-5)" "unprognostic (3.28e-2)" "unprognostic (3.69e-2)" "unprognostic (1.72e-3)" "unprognostic (7.12e-2)" "unprognostic (3.42e-1)" "unprognostic (1.71e-2)" "unprognostic (1.41e-1)" "unprognostic (8.66e-2)" "unprognostic (9.55e-2)" "unprognostic (6.22e-2)" 7.3 7.8 8.5 7.4 8.1 10.6 9.3 20.3 8.8 7.4 8.5 6.8 13.1 4.4 9.8 7.9 7.6 8.2 8.3 10.1 8.0 6.9 5.8 7.4 10.1 8.7 7.7 5.2 7.9 8.0 9.7 6.8 7.8 8.4 6.5 6.5 15.0 5.9 8.0 21.4 7.1 6.5 10.4 8.1 8.6 7.1 5.2 6.6 2.0 7.0 7.9 6.6 10.0 13.3 1.8 2.0 5.7 4.0 2.1 2.9 1.2 5.1 6.8 4.5 3.5 8.5 7.3 4.0 6.6 14.2 6.1 5.4 3.4 2.5 2.4 4.7 15.5 10.4 5.1 2.7 11.2 5.0 5.0 2.6 5.7 3.1 2.1 4.6 2.9 15.2 10.0 3.8 5.5 12.3 15.1 5.6 3.0 1.3 2.0 15.9 2.9 3.3 4.2 3.1 2.0 5.5 2.4 5.3 3.2 2.4 9.2 3.3 4.5 5.8 1.6 12.8 6.5 2.1 2.6 4.4 10.9 4.7 6.5 3.8 3.9 3.5 3.0 5.7 2.4 34.4 4.2 2.4 4.8 2.9 4.0 2.7 1.6 1.5 2.5 1.6 1.8 1.4 1.6 5.7 2.1 3.2 2.0 1.7 1.2 8.5 8.1 20.3 8.8 8.0 6.9 7.7 5.2 8.4 6.6 8.9 17.3 4.7 15.4 8.4 10.6 21.2 12.7 8.1 14.8 14.0 15.7 4.7 5.0 7.7 1.6 37.5 3.5 0.0 7.0 3.7 10.3 7.2 19.7 13.4 11.2 11.1 5.2 25.8 24.7 2.6 6.1 17.8 11.8 43.3 6.6 8.8 10.1 0.0 12.0 4.9 20.7 6.5 17.6 1.1 6.6 7.9 1.9 15.4 5.7 12.2 ST8SIA2 "HsT19690, SIAT8B, ST8SIA-II, STX" ENSG00000140557 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" Q92186 15 92393828-92468728 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.7;heart muscle: 10.0" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 4.5;Muller glia cells: 2.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "pons and medulla: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 22.2;LHCN-M2: 6.5;RH-30: 10.1;RPMI-8226: 7.3;SH-SY5Y: 4.3;WM-115: 6.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054518, HPA057819" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA054518: AB_2682514, HPA057819: " "unprognostic (4.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.26e-1)" "unprognostic (9.32e-3)" "unprognostic (1.03e-1)" "unprognostic (2.87e-2)" "unprognostic (2.32e-1)" "unprognostic (1.28e-5)" "unprognostic (3.91e-2)" "unprognostic (5.39e-3)" "unprognostic (1.59e-2)" "unprognostic (4.44e-3)" "unprognostic (4.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-1)" "unprognostic (3.00e-1)" 0.3 1.1 1.3 0.2 2.2 0.1 1.2 1.5 3.7 2.6 0.3 0.0 0.0 0.1 1.3 2.5 0.4 0.1 0.7 10.0 3.0 3.6 0.3 0.1 0.1 0.2 2.2 1.4 0.1 0.1 0.1 0.9 0.1 17.7 0.3 0.2 1.0 0.8 0.5 2.1 0.1 0.4 0.2 0.2 0.1 0.2 0.8 0.1 2.5 0.2 1.5 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.2 0.0 3.5 0.0 0.0 0.0 10.1 7.3 0.0 0.0 0.5 4.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.7 0.3 0.0 0.2 0.8 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.2 1.5 2.6 3.0 3.6 2.2 1.4 17.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 STAB1 "CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1" ENSG00000010327 "Stabilin 1" Q9NY15 3 52495338-52524495 "Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 90.8" "Cell type enriched" "Detected in many" 5 "Ito cells: 1114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 68 "classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8" "Group enriched" "Detected in many" 69 "dendritic cells: 2.8;monocytes: 10.8" "Group enriched" "Detected in some" 47 "HUVEC TERT2: 33.9;NB-4: 46.8;TIME: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005434 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 60000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA005434: AB_1080097" "unprognostic (1.18e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (3.63e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-2)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.38e-1)" "unprognostic (4.00e-3)" "unprognostic (2.66e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (3.88e-7)" "unprognostic (3.16e-2)" "unprognostic (9.40e-2)" "unprognostic (4.70e-2)" "unprognostic (1.08e-1)" 39.5 37.6 8.0 26.7 12.8 6.5 41.3 3.2 6.8 13.1 23.4 6.9 4.2 16.1 13.6 26.4 9.7 15.5 16.8 19.7 5.4 4.2 19.2 35.8 21.7 80.7 9.1 2.7 9.9 7.1 4.9 11.9 32.1 10.2 13.5 18.0 23.7 10.4 9.7 8.0 5.1 18.7 18.3 7.2 90.8 11.6 9.7 8.7 2.6 11.9 11.4 11.1 15.9 15.4 0.0 2.8 0.0 10.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 33.9 0.0 0.1 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 6.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 8.0 12.8 3.2 6.8 5.4 4.2 9.1 2.7 10.2 8.7 0.0 6.7 12.3 0.5 5.4 1.0 2.0 12.7 0.0 0.0 3.5 0.0 1.3 0.0 0.0 0.4 14.5 0.0 46.7 0.0 1.5 3.8 0.0 17.4 8.3 103.3 0.0 1.2 1114.7 238.9 1.9 4.0 46.3 11.8 0.0 0.0 0.5 0.0 0.0 19.1 0.3 0.0 19.4 1.5 0.7 1.1 4.3 1.8 4.3 0.0 0.2 STAM2 Hbp ENSG00000115145 "Signal transducing adaptor molecule 2" O75886 2 152116801-152175992 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 107.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035528, HPA035529" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA035528: AB_10601606, HPA035529: AB_10672868" "unprognostic (1.53e-1)" "unprognostic (1.79e-1)" "unprognostic (4.81e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (5.16e-2)" "unprognostic (2.76e-2)" "unprognostic (3.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-1)" "unprognostic (7.92e-2)" "unprognostic (1.11e-2)" "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" 17.8 19.1 17.2 12.4 19.9 4.9 21.3 16.1 19.5 19.6 16.7 17.6 17.2 15.1 18.5 16.0 17.8 21.6 15.6 16.1 15.3 15.4 24.6 17.8 17.6 13.0 19.9 14.4 20.6 20.5 23.1 34.0 16.7 20.4 22.1 18.4 14.5 19.5 19.3 14.3 17.6 19.6 19.8 20.0 14.0 18.8 24.3 21.2 16.0 23.8 13.2 14.7 19.5 16.6 2.3 3.3 14.0 6.5 2.5 2.2 1.7 5.4 5.3 5.0 6.0 13.1 15.7 5.3 11.4 13.2 7.4 9.5 5.2 5.2 7.2 9.2 16.2 6.5 5.6 5.5 10.5 12.0 8.8 4.4 5.1 3.7 7.9 15.0 7.5 10.1 11.9 10.2 13.8 18.7 10.8 7.9 4.9 3.3 5.1 15.1 5.4 4.0 5.9 3.1 4.1 7.7 3.2 6.1 3.9 11.6 9.5 2.6 4.1 6.3 5.7 9.4 5.8 7.6 7.0 10.4 16.6 5.3 13.0 6.9 4.3 4.3 4.6 12.5 6.1 9.0 14.0 3.5 4.4 1.9 4.7 1.8 1.7 2.0 2.0 2.7 2.3 1.7 2.1 8.8 2.5 6.5 3.3 2.2 1.7 17.2 19.9 16.1 19.5 15.3 15.4 19.9 14.4 20.4 21.2 23.8 24.4 5.2 9.3 12.2 10.1 27.1 7.6 68.3 35.2 15.7 15.7 6.6 19.9 12.8 107.8 9.8 14.8 0.0 12.2 11.8 13.1 14.9 25.5 13.5 14.5 1.6 7.9 20.3 24.5 38.6 14.7 14.8 13.5 17.2 16.2 13.6 17.2 17.3 14.5 11.4 12.0 25.8 11.3 26.5 19.2 11.5 16.9 6.9 11.9 13.1 STAMBP AMSH ENSG00000124356 "STAM binding protein" O95630 2 73828916-73873659 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "LHCN-M2: 162.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035800, HPA035801" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 11000 Nucleoplasm "Plasma membrane, Cytosol" "HPA035800: AB_10670591, HPA035801: AB_2732470" "unprognostic (1.86e-2)" "unprognostic (1.14e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (4.70e-5)" "unprognostic (6.13e-2)" "unprognostic (2.08e-3)" "unprognostic (3.73e-2)" "unprognostic (1.71e-1)" "unprognostic (6.58e-2)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (1.01e-1)" "unprognostic (2.29e-1)" "unprognostic (7.72e-2)" "unprognostic (2.63e-1)" "unprognostic (1.43e-1)" "unprognostic (2.89e-1)" 12.9 12.8 22.1 13.9 23.0 10.5 17.8 20.1 21.8 18.1 18.4 35.0 13.6 17.8 23.1 15.4 22.7 16.5 14.7 19.0 23.3 21.2 19.6 16.9 13.4 15.3 33.0 14.3 16.3 15.1 20.9 17.8 20.6 26.3 20.2 20.7 14.6 18.3 15.7 30.1 14.4 25.2 19.0 54.7 13.8 15.6 13.3 22.3 18.4 20.1 15.9 19.0 16.8 16.4 17.6 16.9 27.8 17.8 16.7 20.7 12.3 5.4 6.3 5.0 4.6 4.7 5.7 5.8 3.3 4.6 6.2 6.0 10.5 5.2 4.6 5.3 2.8 8.3 4.3 5.3 11.8 7.1 8.0 6.0 6.1 4.4 8.2 6.5 5.0 7.4 4.5 8.5 7.3 10.6 7.9 3.6 6.3 6.6 7.0 162.7 6.6 7.7 4.5 8.0 7.8 3.4 5.4 13.2 6.5 6.6 6.2 9.2 6.8 4.1 5.0 7.1 5.6 4.7 3.0 3.1 5.6 6.7 3.3 5.9 6.6 6.4 3.5 6.9 5.4 6.5 22.6 16.2 27.8 14.4 17.8 15.4 17.6 16.7 14.0 16.9 16.2 17.5 13.2 24.1 16.7 15.7 16.4 20.7 12.3 22.1 23.0 20.1 21.2 23.3 21.2 33.0 14.3 26.3 22.3 17.9 15.3 14.1 25.1 14.4 19.9 35.5 35.7 25.4 27.3 24.4 11.8 35.2 41.4 32.4 59.2 21.7 40.9 46.7 31.9 28.3 22.6 34.8 51.9 34.7 29.0 25.4 9.9 20.3 24.7 104.7 30.2 29.2 6.8 36.9 31.9 21.5 36.9 38.6 32.5 47.1 19.2 38.8 20.6 32.3 49.5 18.9 37.2 19.5 31.2 23.0 STARD3 "es64, MLN64" ENSG00000131748 "StAR related lipid transfer domain containing 3" Q14849 17 39637065-39663484 "Cancer-related genes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "SK-BR-3: 89.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017021, HPA024307, HPA073948" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB017021: , HPA024307: , HPA073948: " "unprognostic (1.11e-1)" "unprognostic (2.14e-2)" "unprognostic (6.35e-2)" "unprognostic (8.92e-3)" "unprognostic (2.09e-2)" "unprognostic (2.94e-1)" "prognostic unfavorable (3.60e-5)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (6.25e-3)" "unprognostic (5.88e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (1.33e-1)" "unprognostic (5.22e-2)" "unprognostic (8.51e-3)" "unprognostic (3.00e-2)" 22.2 34.8 23.3 27.5 28.0 33.5 22.8 27.7 30.1 17.1 23.7 38.1 21.7 26.6 20.6 20.7 22.4 25.6 27.7 17.8 21.0 16.8 18.2 24.0 27.0 31.5 28.5 25.7 21.5 32.7 21.9 23.7 26.9 25.7 19.0 9.7 17.9 21.4 26.7 20.8 24.5 34.2 15.8 27.8 32.3 25.3 26.7 26.1 33.0 21.1 15.1 24.8 28.8 18.7 15.3 23.2 35.3 21.2 21.4 25.3 17.4 7.9 12.6 5.7 10.1 6.9 8.4 8.5 6.5 8.5 8.5 7.8 7.4 13.1 7.1 14.2 5.9 10.5 15.2 3.4 7.7 1.9 9.6 12.9 4.8 5.5 8.6 9.7 9.7 10.8 9.1 6.3 9.6 4.6 6.5 8.2 9.9 11.1 9.2 7.8 7.0 9.1 9.2 6.3 5.4 6.9 7.2 9.8 10.5 5.8 9.0 7.2 7.7 4.9 89.9 16.1 4.0 10.6 11.6 7.7 12.0 8.3 13.1 12.2 8.8 10.8 5.7 10.7 10.5 12.3 12.5 21.2 29.3 25.3 19.6 18.5 11.9 18.3 19.0 23.2 15.3 18.4 16.9 35.3 21.4 15.6 10.8 20.4 17.4 23.3 28.0 27.7 30.1 21.0 16.8 28.5 25.7 25.7 26.1 3.0 9.8 21.7 11.2 14.7 13.5 3.0 20.4 5.3 3.4 10.4 35.3 24.1 8.3 20.7 2.3 23.3 21.4 0.0 30.9 31.1 16.0 17.5 18.5 10.6 45.2 17.5 26.4 42.4 36.6 4.1 15.8 20.8 5.0 17.2 11.7 17.0 30.5 15.8 12.4 8.7 13.2 12.9 9.5 8.4 13.9 14.8 33.4 34.8 12.4 16.9 STIP1 "HOP, STI1" ENSG00000168439 "Stress induced phosphoprotein 1" P31948 11 64185272-64204543 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 168.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017448, HPA039291, HPA044062" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3700000 "Nucleoplasm, Plasma membrane" Cytosol "CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795" "unprognostic (2.49e-3)" "unprognostic (6.04e-2)" "unprognostic (1.57e-1)" "unprognostic (4.65e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.23e-4)" "prognostic unfavorable (6.18e-8)" "unprognostic (2.16e-3)" "unprognostic (4.56e-2)" "unprognostic (1.12e-2)" "unprognostic (3.56e-2)" "unprognostic (3.04e-3)" "unprognostic (1.70e-1)" "unprognostic (6.72e-2)" "unprognostic (8.23e-2)" "unprognostic (7.16e-2)" "unprognostic (2.99e-2)" 27.3 49.7 32.2 32.0 40.5 25.8 41.5 45.3 41.9 28.3 25.5 29.2 20.6 19.2 30.1 25.2 31.5 36.2 21.6 34.4 32.2 42.8 24.7 27.8 25.4 31.9 47.7 22.5 34.1 24.1 39.1 38.3 37.0 40.7 30.1 28.5 20.3 22.6 29.5 51.9 27.6 20.7 33.2 39.7 26.5 24.4 56.4 49.0 29.8 46.1 23.4 41.2 26.0 168.2 32.2 26.8 20.9 39.6 39.5 35.9 39.5 49.3 77.1 48.7 40.5 27.1 18.1 43.8 44.9 24.2 65.2 38.0 56.4 42.4 59.1 52.9 35.5 77.2 52.5 122.1 44.9 71.8 46.4 49.8 83.2 51.8 51.9 23.6 43.9 52.6 18.4 28.3 54.0 40.7 26.6 45.9 44.1 82.2 34.0 37.4 72.3 66.0 59.9 58.6 47.6 65.2 65.0 46.4 59.8 45.5 43.8 39.7 35.3 51.2 54.2 41.7 53.4 57.6 30.4 41.1 41.5 51.3 54.1 60.4 31.0 66.9 62.4 53.7 44.2 59.6 19.0 25.3 20.9 35.9 36.2 35.7 32.2 27.2 32.0 26.8 26.0 30.5 33.8 7.7 39.5 39.6 22.2 24.0 39.5 32.2 40.5 45.3 41.9 32.2 42.8 47.7 22.5 40.7 49.0 41.7 29.9 44.0 125.4 71.4 35.5 38.9 30.6 104.4 56.9 19.2 39.3 105.5 41.4 70.8 21.1 33.5 27.4 23.3 47.8 125.3 57.5 60.1 78.4 24.1 80.9 60.4 64.5 15.4 15.0 52.9 25.3 54.0 59.1 71.3 20.5 32.1 57.8 21.6 37.4 29.8 29.8 25.8 88.2 82.3 133.5 63.0 176.4 42.1 24.4 89.5 STK16 "MPSK, PKL12" ENSG00000115661 "Serine/threonine kinase 16" O75716 2 219245455-219250337 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029450 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA029450: AB_10603118" "unprognostic (1.99e-1)" "unprognostic (2.08e-1)" "unprognostic (5.84e-2)" "prognostic favorable (6.09e-4)" "unprognostic (6.21e-2)" "unprognostic (5.55e-2)" "unprognostic (4.98e-3)" "unprognostic (4.25e-1)" "unprognostic (1.48e-1)" "unprognostic (4.22e-2)" "unprognostic (1.73e-2)" "unprognostic (3.17e-1)" "unprognostic (4.39e-3)" "unprognostic (1.76e-1)" "unprognostic (2.00e-1)" "unprognostic (2.68e-1)" "unprognostic (1.34e-1)" 10.2 19.0 15.7 12.8 20.3 13.3 14.6 8.8 21.0 11.5 16.2 15.2 20.5 17.2 11.4 22.1 16.0 18.3 15.5 13.0 14.5 11.9 19.5 30.1 11.4 24.6 14.2 13.2 13.2 24.5 16.5 15.1 14.0 13.3 14.3 13.7 12.8 19.0 16.3 9.9 12.2 14.2 11.5 12.3 15.9 16.8 18.9 12.7 27.2 19.8 12.8 17.0 12.9 10.3 7.9 7.8 5.8 7.6 14.5 11.2 9.7 7.4 9.8 8.6 7.3 21.5 21.0 9.9 9.6 13.3 8.2 8.2 11.4 16.6 4.3 13.5 16.0 13.1 7.7 10.0 16.0 4.4 10.5 11.5 9.7 8.9 9.8 19.5 9.2 11.4 22.4 25.7 11.3 29.9 16.2 9.9 10.1 12.1 11.8 14.0 13.7 10.0 20.1 8.0 13.5 6.0 9.5 9.7 12.6 17.1 8.6 6.9 8.8 3.4 13.7 19.7 6.5 14.3 19.5 7.6 11.2 7.9 9.1 9.2 14.6 6.2 10.3 12.4 9.8 9.8 2.0 7.6 5.8 6.0 4.2 6.8 7.8 7.5 11.2 7.8 7.9 7.8 10.0 5.2 14.5 3.6 6.7 8.4 9.7 15.7 20.3 8.8 21.0 14.5 11.9 14.2 13.2 13.3 12.7 6.0 6.4 22.9 15.0 8.8 7.4 7.8 28.1 5.3 5.7 7.0 15.7 20.2 58.0 33.5 69.7 11.7 27.6 0.0 51.6 21.3 17.4 15.1 8.1 39.4 25.1 12.7 24.8 11.6 19.1 56.4 14.1 15.7 20.3 43.3 36.3 18.3 30.3 42.9 12.7 72.1 18.4 0.0 12.2 38.1 6.9 9.8 10.8 30.5 35.9 14.0 STK32B "HSA250839, STK32, STKG6, YANK2" ENSG00000152953 "Serine/threonine kinase 32B" Q9NY57 4 5051442-5500998 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.6;lymphoid tissue: 33.6" "Cell type enhanced" "Detected in some" 25 "Distal tubular cells: 14.9;Early spermatids: 83.1;Late spermatids: 31.4;Proximal tubular cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive B-cell: 1.3;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.3;dendritic cells: 3.5" "Cell line enhanced" "Detected in some" "GAMG: 11.9;HUVEC TERT2: 11.7;REH: 10.3;U-2197: 18.7;WM-115: 47.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015820 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA015820: AB_1858913" "unprognostic (4.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.08e-2)" "unprognostic (1.35e-1)" "unprognostic (8.12e-3)" "unprognostic (9.96e-2)" "unprognostic (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.63e-8)" "unprognostic (8.10e-3)" "unprognostic (5.04e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-3)" 5.2 0.8 6.0 2.1 4.8 2.3 7.3 1.0 5.8 6.0 2.1 5.2 1.6 1.2 5.7 1.6 2.3 2.5 4.7 0.9 4.5 7.6 23.6 0.5 1.3 2.8 5.3 2.2 1.2 4.9 0.8 0.8 5.1 4.2 2.3 2.2 3.0 2.9 1.9 2.1 3.6 1.6 7.0 3.9 0.6 9.5 7.1 2.9 33.6 2.8 2.1 1.9 4.2 6.1 1.3 3.5 0.0 0.5 0.0 0.0 0.0 0.0 5.8 0.3 0.0 0.2 0.4 0.0 4.0 0.5 2.7 0.1 0.0 0.0 0.0 0.9 8.2 11.9 0.0 0.6 0.0 1.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.1 11.7 0.6 0.0 0.0 1.4 0.0 0.0 0.8 1.7 0.0 0.0 10.3 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 3.5 0.3 0.0 0.0 3.0 0.0 1.2 18.7 0.0 0.4 0.0 0.0 0.0 0.0 47.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.0 4.8 1.0 5.8 4.5 7.6 5.3 2.2 4.2 2.9 0.0 0.6 0.0 0.1 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.8 83.1 1.6 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 31.4 1.4 0.9 5.0 0.0 0.0 0.0 0.3 0.0 1.1 13.3 0.0 0.0 0.3 0.9 3.0 0.9 0.0 0.0 0.0 0.0 STK33 ENSG00000130413 "Serine/threonine kinase 33" Q9BYT3 11 8391868-8594289 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 245.0;Late spermatids: 113.1;Rod photoreceptor cells: 83.4;Spermatocytes: 126.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 7.1;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 5 "B-cells: 7.1" "Cell line enhanced" "Detected in many" "Daudi: 14.0;hTERT-RPE1: 14.2;Karpas-707: 13.1;SCLC-21H: 14.7;U-251 MG: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA015742, HPA056855" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA015742: AB_1857592, HPA056855: AB_2683257" "unprognostic (2.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (3.57e-1)" "unprognostic (1.40e-1)" "unprognostic (7.28e-2)" "unprognostic (3.85e-4)" "unprognostic (1.23e-1)" "unprognostic (8.06e-2)" "unprognostic (1.33e-3)" "unprognostic (9.46e-2)" "prognostic favorable (4.89e-6)" "unprognostic (2.39e-2)" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.90e-2)" 0.9 6.1 4.7 1.6 7.5 1.1 0.6 6.1 4.4 5.4 5.3 6.8 7.7 2.6 9.6 15.3 2.3 30.7 4.5 11.4 6.6 6.1 7.7 0.4 5.3 2.3 4.9 2.7 10.3 4.6 20.4 29.9 0.3 17.7 5.3 1.3 14.8 1.6 8.9 2.6 0.3 2.5 7.0 6.7 1.2 4.4 34.4 4.6 4.5 14.6 1.5 1.8 3.7 1.4 7.1 0.7 0.0 0.0 0.2 1.4 0.3 0.0 2.0 9.7 0.0 0.0 0.0 0.0 1.7 1.9 4.2 3.9 1.1 0.0 14.0 7.3 0.3 5.5 0.0 4.3 1.3 3.7 0.0 11.9 0.0 2.6 3.3 1.6 7.8 0.0 0.4 0.0 0.1 0.0 14.2 0.3 6.9 0.0 13.1 0.1 0.0 0.2 0.0 6.9 0.0 0.0 5.2 1.3 8.8 3.8 0.0 14.7 3.9 0.0 0.0 0.1 2.7 0.0 0.8 0.0 0.0 6.6 0.1 14.8 3.1 12.4 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.1 0.0 1.4 0.0 4.4 0.0 1.1 0.0 0.2 0.0 0.7 0.2 0.3 4.7 7.5 6.1 4.4 6.6 6.1 4.9 2.7 17.7 4.6 17.9 12.6 5.4 1.1 0.0 19.2 34.4 10.2 245.0 47.8 19.2 66.8 0.1 3.3 7.5 72.9 1.3 0.0 0.0 4.4 2.7 0.3 0.2 1.1 0.0 0.2 1.6 8.7 0.0 0.0 113.1 4.0 0.4 0.0 0.0 1.3 30.6 4.5 0.0 15.9 11.9 83.4 0.0 0.2 126.9 25.1 0.0 0.0 0.0 2.9 0.0 STK39 "DCHT, SPAK" ENSG00000198648 "Serine/threonine kinase 39" Q9UEW8 2 167954020-168248141 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 35.5" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 65.7;Urothelial cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046022, HPA061803, HPA062802" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870" "prognostic favorable (3.96e-4)" "unprognostic (2.97e-2)" "unprognostic (4.40e-2)" "unprognostic (4.22e-2)" "unprognostic (4.36e-1)" "unprognostic (6.14e-2)" "prognostic unfavorable (5.67e-5)" "unprognostic (3.04e-2)" "unprognostic (8.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.20e-2)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (9.45e-2)" "unprognostic (8.61e-3)" "unprognostic (1.14e-1)" "unprognostic (6.20e-3)" 6.2 2.1 8.4 4.6 11.0 1.3 3.5 9.3 14.1 4.3 9.1 8.3 1.7 10.5 2.3 4.7 14.1 1.9 5.9 7.6 9.8 7.4 2.9 0.8 2.4 7.3 12.3 9.7 3.2 9.9 5.0 8.2 1.2 14.2 9.9 11.7 7.1 22.8 3.8 2.2 3.4 6.1 4.3 19.0 2.5 11.2 35.5 5.5 7.2 2.2 1.8 8.0 5.6 5.3 0.7 1.0 0.0 0.7 1.9 3.4 0.5 6.7 4.1 15.5 4.9 9.5 14.1 1.5 17.0 12.5 11.4 10.6 0.0 22.0 18.7 4.7 11.0 9.9 17.7 9.9 12.4 14.3 5.9 6.1 7.7 4.5 13.8 17.8 10.4 0.8 9.7 17.7 13.5 14.1 13.8 7.7 14.7 0.1 0.0 23.9 3.9 18.1 3.7 10.7 14.0 8.6 25.8 6.1 1.5 8.6 16.8 22.9 9.7 5.9 0.9 6.9 7.7 3.1 7.6 7.3 13.8 4.3 9.7 11.1 0.0 0.0 15.0 10.5 9.3 9.3 0.0 0.7 0.0 2.5 0.4 1.3 0.7 1.9 3.4 1.0 0.7 0.4 2.0 0.0 1.9 0.3 0.3 3.3 0.5 8.4 11.0 9.3 14.1 9.8 7.4 12.3 9.7 14.2 5.5 3.0 12.3 0.8 21.2 3.4 13.8 25.8 22.9 6.7 7.9 5.2 15.7 0.1 18.3 9.7 21.3 3.5 23.2 0.0 19.9 0.0 7.3 65.7 0.0 0.0 3.5 19.1 21.9 3.1 5.1 13.5 9.5 5.2 16.9 1.0 13.9 26.9 26.4 17.3 10.6 3.8 25.3 6.5 7.2 19.9 7.7 3.9 0.2 15.2 20.4 55.5 STK4 "KRS2, MST1, YSK3" ENSG00000101109 "Serine/threonine kinase 4" Q13043 20 44966474-45079959 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "monocytes: 469.7;T-cells: 231.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004038, HPA015270" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB004038: AB_2144632, HPA015270: AB_1854150" "unprognostic (2.77e-1)" "unprognostic (1.10e-1)" "unprognostic (8.83e-2)" "unprognostic (8.49e-3)" "unprognostic (2.95e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.96e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.28e-1)" "unprognostic (5.70e-2)" "unprognostic (3.96e-1)" "unprognostic (1.18e-2)" 9.5 8.8 10.4 24.5 11.5 39.5 8.1 7.5 13.4 7.8 8.6 10.3 5.4 8.1 9.3 6.5 8.9 7.3 9.4 6.1 9.3 8.8 6.3 7.4 18.8 30.6 10.5 9.1 8.3 6.4 5.9 9.3 8.2 7.7 7.5 10.6 7.4 9.3 8.7 4.2 11.4 16.1 8.2 12.0 29.1 9.6 7.4 9.6 32.3 8.0 4.9 36.6 11.5 8.7 10.8 6.9 40.6 13.3 10.3 14.5 7.9 11.8 8.0 10.3 7.3 6.3 7.9 7.1 10.5 16.0 17.7 16.1 22.7 6.5 28.9 9.1 7.4 14.9 12.6 10.8 14.0 22.8 12.9 5.7 21.1 11.7 16.0 11.1 27.1 30.0 6.4 11.6 16.6 18.2 8.9 6.5 19.6 9.7 16.7 8.9 9.3 20.2 18.3 6.2 7.7 5.5 13.1 11.3 13.4 6.5 8.1 4.9 6.0 15.5 9.0 11.8 8.2 8.2 17.1 8.3 13.4 13.0 15.4 12.0 21.8 17.1 32.3 13.1 13.0 9.8 24.4 7.6 20.5 14.5 7.7 14.4 10.3 13.8 13.3 6.9 10.8 14.3 11.9 40.6 10.3 13.3 3.9 13.3 7.9 10.4 11.5 7.5 13.4 9.3 8.8 10.5 9.1 7.7 9.6 14.9 24.0 181.6 40.4 49.5 24.2 7.0 15.3 16.0 18.2 40.1 49.1 20.3 8.3 14.1 4.8 32.3 20.5 0.0 15.3 21.4 24.3 25.1 129.5 19.1 53.0 41.3 24.6 22.7 103.3 3.6 21.0 108.8 126.5 469.7 17.4 20.3 16.0 25.9 15.9 10.9 64.0 12.9 30.2 36.4 43.8 46.3 16.2 231.2 17.4 36.3 STOX1 "C10orf24, FLJ25162" ENSG00000165730 "Storkhead box 1" Q6ZVD7 10 68827541-68895432 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8;fallopian tube: 19.1" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 48.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;T-cells: 3.0" "Cell line enhanced" "Detected in many" "AN3-CA: 10.9;HAP1: 10.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037844, HPA037845" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Intracellular and membrane" No NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA037844: AB_2675700, HPA037845: AB_10671369" "prognostic favorable (3.37e-5)" "unprognostic (5.53e-3)" "unprognostic (6.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.63e-3)" "unprognostic (1.95e-2)" "unprognostic (2.24e-3)" "prognostic favorable (2.08e-4)" "unprognostic (1.52e-1)" "unprognostic (2.45e-3)" "unprognostic (5.33e-3)" "unprognostic (5.29e-2)" "unprognostic (3.87e-2)" "unprognostic (8.77e-2)" "unprognostic (3.06e-2)" "unprognostic (2.33e-1)" "unprognostic (3.46e-2)" 8.7 6.4 17.8 1.7 13.4 0.6 4.8 1.8 13.4 2.0 2.6 6.8 1.3 2.0 2.8 11.9 2.5 19.1 1.7 0.9 16.1 9.3 4.5 0.9 2.2 1.8 11.5 10.2 1.9 1.6 6.1 8.8 1.5 5.6 2.3 2.8 5.0 2.6 2.1 1.9 1.4 2.8 2.5 2.4 0.9 2.2 3.8 7.3 3.3 8.7 0.0 1.7 1.6 0.9 0.7 3.5 0.0 0.0 0.2 3.0 0.2 2.2 2.4 5.4 10.9 2.3 0.0 3.2 0.2 0.1 1.6 1.7 2.3 3.3 2.1 3.1 0.0 4.2 0.6 10.1 0.0 0.8 2.5 4.2 0.2 0.5 3.1 0.3 2.7 3.9 0.2 0.2 0.3 0.0 0.3 0.1 5.6 0.5 0.3 0.2 2.2 4.6 3.4 1.8 0.5 1.5 3.4 0.1 0.0 3.2 5.8 1.7 5.0 3.9 1.0 0.7 3.6 2.4 2.2 0.0 0.0 0.3 0.0 1.5 1.0 1.9 2.2 0.0 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.4 0.8 0.6 0.0 0.7 3.0 1.4 0.0 0.2 0.0 3.5 0.3 0.2 17.8 13.4 1.8 12.5 16.1 9.3 11.5 10.2 5.6 7.3 0.0 0.3 0.5 3.2 1.3 0.9 0.3 0.0 48.2 9.1 1.8 0.0 1.1 3.3 0.0 0.2 0.1 0.4 0.0 0.3 0.2 0.6 1.8 2.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 1.6 1.5 0.2 0.0 0.0 1.2 0.3 6.5 5.7 1.6 11.1 0.4 1.0 0.0 5.6 1.7 STOX2 DKFZp762K222 ENSG00000173320 "Storkhead box 2" Q9P2F5 4 183797692-184023526 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 30.6;Horizontal cells: 31.8;Ito cells: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.6;HeLa: 9.9;NTERA-2: 14.7;SH-SY5Y: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049776, HPA065002" Uncertain Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "HPA049776: AB_2680875, HPA065002: " "unprognostic (9.79e-3)" "unprognostic (3.46e-1)" "unprognostic (2.10e-1)" "unprognostic (6.57e-3)" "unprognostic (3.33e-1)" "unprognostic (6.41e-2)" "unprognostic (4.57e-4)" "unprognostic (8.97e-3)" "unprognostic (1.25e-1)" "unprognostic (1.86e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" "unprognostic (7.06e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-3)" "unprognostic (2.49e-1)" 3.0 2.8 12.0 1.2 12.6 8.4 3.1 20.3 17.5 3.9 2.1 18.2 1.6 1.6 3.2 5.9 8.2 4.7 4.5 4.9 9.6 8.3 3.4 4.0 3.5 1.1 16.2 18.0 5.8 10.6 12.0 8.1 2.4 11.8 4.1 1.7 2.5 11.0 4.2 3.2 6.2 1.8 3.2 9.2 6.2 3.7 1.6 16.4 0.8 9.6 0.8 1.9 4.3 3.4 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.7 3.7 11.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 1.5 0.0 2.3 0.0 2.4 0.2 6.4 1.0 0.0 0.0 5.1 0.0 9.9 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.0 1.5 0.0 0.5 0.0 0.1 14.7 0.0 0.5 0.1 4.3 0.0 2.8 3.5 6.0 14.0 2.7 0.0 0.0 4.4 0.2 0.3 0.0 0.0 2.5 0.0 0.1 0.1 3.2 1.8 0.6 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 12.0 12.6 20.3 16.6 9.6 8.3 16.2 18.0 11.8 16.4 11.9 16.6 0.0 5.8 3.8 30.6 19.3 5.1 20.1 12.5 7.0 0.0 2.3 3.3 3.9 0.8 18.3 0.0 0.0 2.7 1.7 1.5 4.2 0.0 4.9 0.9 31.8 1.7 22.1 2.6 2.2 0.6 0.2 1.7 0.0 0.0 15.1 2.4 0.0 4.2 1.9 3.4 0.0 1.0 0.5 2.4 2.9 0.6 0.0 0.0 2.6 STRN3 "PPP2R6B, S/G2NA, SG2NA" ENSG00000196792 "Striatin 3" Q13033 14 30893799-31026401 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003392, HPA004636, CAB069925" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA 15000 Cytosol "Nucleoplasm, Actin filaments" "CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940" "unprognostic (4.08e-1)" "unprognostic (8.66e-2)" "unprognostic (8.08e-2)" "unprognostic (4.22e-2)" "unprognostic (3.06e-2)" "unprognostic (7.74e-3)" "unprognostic (3.37e-2)" "unprognostic (2.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.53e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "prognostic favorable (9.66e-4)" "unprognostic (8.74e-2)" "unprognostic (7.85e-2)" "unprognostic (4.83e-2)" "unprognostic (1.01e-2)" 18.5 14.3 15.9 12.1 16.2 10.9 13.5 23.4 17.7 15.8 17.4 11.5 16.5 8.8 14.7 14.8 16.5 10.8 14.0 21.5 14.4 12.1 15.2 22.7 11.6 7.2 12.9 10.1 12.6 13.1 18.0 20.2 14.1 13.9 16.2 14.0 11.4 12.6 17.2 52.0 12.6 11.3 22.0 11.8 11.9 12.9 22.4 14.6 9.3 14.9 13.5 9.7 25.1 20.5 7.0 10.5 8.5 7.9 7.4 10.0 2.4 18.0 15.5 17.4 12.4 14.9 11.2 14.4 17.2 12.7 14.4 14.6 20.7 12.2 10.5 12.6 12.5 7.3 9.9 19.3 11.0 21.4 9.1 6.5 10.4 10.6 40.0 16.1 8.9 11.6 11.9 11.5 11.5 14.1 12.9 11.5 9.8 12.5 10.0 13.9 12.3 11.5 8.6 8.5 12.9 14.5 8.5 20.4 2.8 21.6 25.9 10.9 9.0 19.1 14.0 9.3 17.5 16.0 7.6 13.9 14.2 12.7 8.9 6.8 9.5 10.8 10.3 7.0 6.5 11.3 6.3 7.1 8.3 6.8 7.9 8.9 7.0 8.5 7.7 5.8 6.9 8.6 10.0 8.5 7.4 6.2 10.5 6.4 2.4 15.9 16.2 23.4 17.7 14.4 12.1 12.9 10.1 13.9 14.6 20.8 21.9 13.7 39.9 87.1 24.8 45.2 22.9 24.1 22.7 29.6 25.5 19.0 10.0 31.6 16.6 27.5 18.7 0.0 23.0 16.4 24.9 45.1 8.1 36.5 11.3 35.0 30.7 33.7 22.1 10.5 24.7 21.2 42.2 16.2 16.6 25.1 30.6 14.2 26.2 21.4 28.8 25.8 45.3 61.6 46.8 84.3 27.8 16.0 14.0 41.0 STT3A "ITM1, MGC9042, STT3-A, TMC" ENSG00000134910 "STT3A, catalytic subunit of the oligosaccharyltransferase complex" P46977 11 125591712-125625215 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 202.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030735 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA030735: AB_10603342" "unprognostic (8.25e-3)" "unprognostic (5.45e-2)" "unprognostic (3.02e-2)" "prognostic favorable (1.32e-4)" "unprognostic (5.10e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (3.57e-4)" "unprognostic (8.40e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-2)" "unprognostic (8.96e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.60e-2)" "unprognostic (6.38e-2)" "unprognostic (1.28e-1)" "unprognostic (1.82e-2)" 20.6 20.5 8.3 13.1 11.7 8.3 16.9 10.7 13.9 27.8 19.3 17.7 39.6 12.0 30.5 41.4 19.6 20.8 15.1 19.5 8.3 9.1 26.2 67.1 18.7 14.9 9.3 7.7 30.1 59.0 202.3 27.5 35.9 11.6 22.2 17.4 20.8 50.7 41.4 9.5 12.9 19.8 17.1 12.3 21.8 17.7 17.1 6.7 19.2 38.6 13.6 20.8 19.5 18.0 15.0 53.2 27.0 15.5 17.2 27.5 13.4 21.0 19.2 24.5 33.6 46.2 35.8 26.3 38.5 46.0 31.3 39.2 58.2 56.9 27.4 46.7 56.6 44.4 38.9 33.9 33.7 41.7 21.3 18.0 64.5 13.2 40.2 51.1 38.6 30.3 27.6 24.5 43.4 84.8 36.9 34.9 12.3 27.1 41.1 39.5 15.5 15.5 12.3 15.7 42.1 20.9 18.4 20.9 41.2 34.2 32.7 15.2 13.2 27.2 44.5 13.7 30.0 52.2 27.8 31.2 45.2 16.3 19.0 30.2 12.9 15.1 21.1 17.4 39.1 35.8 27.0 15.5 11.6 19.7 14.8 27.5 15.0 19.1 18.2 21.6 11.6 13.8 16.0 5.4 17.2 13.0 53.2 14.1 13.4 8.3 11.7 10.7 13.9 8.3 9.1 9.3 7.7 11.6 6.7 26.8 23.5 18.2 11.3 14.3 10.2 18.6 12.7 14.7 14.8 15.7 19.6 40.7 1.7 26.7 7.6 11.9 13.5 23.3 23.5 56.2 25.7 16.7 16.2 32.7 27.0 1.6 15.0 33.2 22.3 2.6 19.8 13.2 23.6 8.2 32.3 15.2 29.5 14.0 17.7 11.9 13.8 19.4 10.3 29.9 10.9 12.9 38.1 13.3 22.9 12.9 STX12 "STX13, STX14" ENSG00000117758 "Syntaxin 12" Q86Y82 1 27773183-27824452 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041038, HPA055300" Approved Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" No No "Nucleoplasm, Golgi apparatus, Vesicles" "HPA041038: AB_10794261, HPA055300: AB_2682778" "unprognostic (3.47e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-1)" "unprognostic (8.16e-3)" "unprognostic (2.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.26e-2)" "unprognostic (3.52e-1)" "unprognostic (1.14e-2)" "unprognostic (2.78e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-1)" "unprognostic (1.91e-2)" "unprognostic (8.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "unprognostic (2.24e-1)" 38.5 20.2 32.2 16.3 29.6 6.3 22.9 25.8 35.9 20.3 19.4 27.3 23.5 22.9 20.4 42.1 25.7 15.0 25.9 15.3 31.2 31.9 23.2 18.5 31.2 16.3 35.5 29.0 15.2 19.5 16.7 19.6 21.1 32.3 20.8 21.4 11.6 17.7 22.2 14.2 17.1 20.9 23.1 36.9 20.0 38.7 9.0 19.9 6.3 67.0 11.0 13.9 19.4 14.8 7.6 14.2 10.1 21.7 5.2 6.4 8.3 8.8 4.2 11.5 7.5 21.9 26.7 5.9 18.7 27.6 17.2 19.6 5.2 11.5 9.6 20.1 25.0 7.4 7.4 7.5 9.3 17.3 8.5 9.0 5.5 4.7 5.2 17.2 6.0 11.6 25.0 11.4 24.2 13.9 14.2 27.6 5.6 7.2 9.7 18.7 3.2 5.2 4.6 4.8 13.1 6.0 3.3 9.2 5.8 15.2 14.6 12.9 7.0 8.8 7.6 13.5 9.7 5.2 5.4 29.6 8.8 5.0 19.9 6.4 5.8 4.2 5.6 14.2 9.3 12.3 10.1 19.6 7.5 3.7 21.7 6.4 7.6 4.4 5.7 14.2 6.5 4.9 4.1 9.3 5.2 21.0 7.0 4.4 8.3 32.2 29.6 25.8 31.8 31.2 31.9 35.5 29.0 32.3 19.9 50.6 27.6 22.7 84.1 97.1 42.7 15.9 28.1 17.4 38.7 54.1 29.5 25.5 31.5 43.8 1.6 48.9 48.7 0.0 51.3 28.6 42.2 58.3 22.0 15.5 45.8 25.4 39.6 55.3 69.4 1.5 33.4 58.6 50.6 19.8 27.1 61.7 52.7 46.0 44.6 44.7 48.6 38.8 58.4 14.9 17.5 86.7 65.2 22.3 26.7 83.3 SUGT1 SGT1 ENSG00000165416 "SGT1 homolog, MIS12 kinetochore complex assembly cochaperone" Q9Y2Z0 13 52652709-52700909 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015942, HPA043949" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB015942: , HPA043949: AB_2678745" "unprognostic (3.66e-2)" "unprognostic (3.98e-2)" "unprognostic (3.57e-1)" "unprognostic (1.22e-1)" "unprognostic (3.77e-2)" "prognostic unfavorable (8.69e-4)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (3.76e-1)" "unprognostic (1.96e-3)" "unprognostic (9.51e-2)" "unprognostic (1.12e-1)" "unprognostic (6.83e-2)" "unprognostic (2.82e-3)" "unprognostic (9.05e-2)" "unprognostic (2.93e-2)" "unprognostic (1.56e-1)" 22.7 29.9 40.0 23.1 44.8 26.2 27.9 39.7 42.7 17.9 24.0 23.0 14.9 25.8 19.4 20.6 27.1 19.2 18.9 33.8 34.0 28.8 30.8 34.3 19.8 23.5 35.9 28.9 20.8 28.6 14.0 39.8 24.4 36.0 18.1 26.5 14.2 22.5 16.8 26.1 23.1 24.8 21.4 31.1 21.3 23.1 31.2 43.5 15.2 21.6 19.5 27.4 21.8 48.3 17.5 23.4 29.0 19.1 17.5 25.3 13.6 14.4 15.8 23.4 17.7 23.2 19.0 22.5 31.8 21.1 19.9 16.0 34.4 36.4 31.8 9.0 19.7 29.0 25.0 28.9 18.3 29.4 26.2 12.0 29.5 20.7 26.0 16.9 22.9 22.2 13.2 16.7 20.6 15.7 25.7 33.4 20.5 27.5 10.5 30.4 10.2 21.3 42.1 27.4 57.1 15.2 24.5 13.6 13.7 34.6 16.3 7.8 9.9 16.4 13.5 14.9 28.0 13.9 21.9 23.9 16.7 19.5 19.1 27.1 8.3 11.7 28.3 10.0 18.4 24.0 29.0 16.8 26.8 14.9 19.1 14.6 17.5 19.4 20.0 18.6 16.3 14.9 16.5 2.3 17.5 18.2 23.4 25.3 13.6 40.0 44.8 39.7 42.7 34.0 28.8 35.9 28.9 36.0 43.5 35.7 29.0 35.8 53.8 35.3 49.1 109.5 25.5 52.2 44.3 48.8 23.6 57.7 66.3 74.9 142.6 65.3 46.8 70.0 78.0 119.0 50.9 41.8 35.8 37.6 84.7 47.7 32.7 35.6 39.5 64.1 54.4 48.2 45.5 144.3 43.5 84.8 75.8 48.9 56.3 76.3 51.1 25.8 66.5 100.6 92.8 37.8 62.2 49.8 45.0 44.3 SUPT6H "KIAA0162, SPT6H" ENSG00000109111 "SPT6 homolog, histone chaperone" Q7KZ85 17 28662091-28702684 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012416, HPA036382" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB012416: , HPA036382: AB_2675094" "unprognostic (8.18e-2)" "unprognostic (2.27e-1)" "unprognostic (2.72e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-1)" "unprognostic (8.23e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (1.02e-1)" "unprognostic (2.18e-2)" "unprognostic (9.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "prognostic favorable (4.36e-5)" "unprognostic (4.75e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.06e-2)" 27.6 30.0 30.0 24.1 32.8 56.3 25.6 31.9 35.7 28.0 30.1 28.5 23.2 19.9 38.6 28.4 24.4 24.1 25.0 23.8 25.7 22.0 24.1 32.6 26.3 26.0 25.7 32.8 33.1 28.8 40.7 34.5 31.9 24.3 26.9 21.8 33.2 28.2 29.2 50.1 38.6 28.7 40.0 29.8 33.1 28.5 23.4 29.0 27.2 27.6 18.4 29.4 30.7 27.1 5.7 8.2 14.4 6.1 5.4 5.6 3.4 18.0 37.8 19.0 21.7 23.2 15.6 14.7 24.8 26.6 29.3 26.3 35.1 8.1 19.2 13.0 24.8 22.6 21.6 27.8 18.0 30.5 35.7 24.7 26.8 30.6 21.7 19.4 28.1 30.0 21.4 10.9 31.1 20.8 19.4 19.2 18.9 26.3 22.8 20.8 21.5 27.7 12.0 14.7 15.9 12.3 14.2 35.0 15.6 14.5 35.8 14.5 19.2 29.1 46.0 15.7 27.3 28.2 20.0 30.2 23.2 19.2 22.0 31.6 29.0 22.2 28.2 26.2 12.7 19.1 14.4 5.9 5.4 5.2 3.9 5.5 5.6 4.3 5.6 4.8 5.7 4.4 3.8 9.0 5.4 6.1 8.2 3.8 3.4 30.0 32.8 31.9 35.7 25.7 22.0 25.7 32.8 24.3 29.0 35.7 51.4 21.7 18.1 19.9 27.9 43.2 22.9 33.5 36.4 19.2 53.0 21.0 5.0 19.2 3.9 24.0 22.2 23.3 18.3 17.3 18.8 16.3 47.6 30.2 20.6 28.6 29.7 19.0 21.5 14.4 23.9 20.4 8.5 27.9 19.2 20.5 25.9 16.7 25.1 9.4 40.8 32.3 22.2 18.4 16.2 21.2 41.6 20.8 17.7 21.8 SURF2 ENSG00000148291 "Surfeit 2" Q15527 9 133356552-133361169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.1" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 358.5;Late spermatids: 675.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044340, HPA052213, HPA059710" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: " "unprognostic (1.53e-1)" "unprognostic (6.10e-3)" "unprognostic (1.24e-3)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (6.27e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (5.46e-3)" "unprognostic (8.28e-2)" "unprognostic (1.07e-3)" "unprognostic (1.09e-2)" "unprognostic (3.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" 8.3 9.2 15.8 9.0 13.2 8.2 10.7 13.1 14.5 5.7 8.8 7.4 10.8 13.2 6.4 12.0 11.0 10.7 11.2 8.9 13.4 11.0 14.3 12.0 6.5 12.1 13.1 8.7 9.0 17.5 7.1 11.3 5.9 10.3 7.7 5.7 7.7 14.2 8.8 11.5 14.8 11.4 6.9 9.4 8.6 9.3 50.1 6.6 10.6 10.1 14.9 9.8 6.5 8.3 17.5 15.6 13.1 16.2 13.2 26.9 14.1 7.2 12.5 5.3 6.5 3.8 3.0 11.1 3.7 3.3 5.9 3.1 17.1 6.0 7.2 5.4 2.4 5.1 19.9 8.3 9.0 2.7 6.9 11.5 5.7 14.3 6.3 7.7 9.3 4.3 3.6 10.7 8.4 12.4 2.1 2.7 8.9 9.0 5.0 4.0 43.6 9.6 6.2 16.6 17.4 24.2 10.7 7.9 16.9 5.0 8.3 19.7 9.9 8.2 13.8 11.0 3.4 14.7 4.4 5.1 9.0 9.1 9.2 13.1 6.2 12.3 7.8 5.7 5.6 9.0 13.1 16.2 12.0 17.8 16.2 23.1 15.6 21.9 20.2 13.8 17.5 20.8 19.7 7.1 13.2 11.6 15.6 26.9 14.1 15.8 13.2 13.1 14.5 13.4 11.0 13.1 8.7 10.3 6.6 11.9 7.8 21.6 25.7 74.8 17.9 12.4 45.9 48.2 17.0 21.0 2.0 33.0 89.5 56.4 358.5 19.4 48.7 0.0 70.1 21.0 22.4 21.1 9.2 21.5 25.8 12.7 35.1 20.3 25.9 675.3 24.2 22.4 40.5 27.9 17.1 13.2 50.2 28.1 23.0 64.0 18.9 64.7 32.0 140.5 86.5 77.0 21.4 26.1 23.8 17.8 SVBP "CCDC23, MGC45441" ENSG00000177868 "Small vasohibin binding protein" Q8N300 1 42807052-42817252 "Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 164.4;Spermatogonia: 149.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008507 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Secreted to blood" Yes No "Nucleoplasm, Nuclear bodies, Cytosol" "HPA008507: AB_2072066" "prognostic favorable (6.33e-4)" "unprognostic (2.68e-2)" "unprognostic (2.91e-1)" "unprognostic (4.60e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.15e-2)" "unprognostic (3.35e-3)" "unprognostic (1.59e-2)" "unprognostic (6.73e-3)" "unprognostic (2.16e-1)" "unprognostic (5.37e-3)" "unprognostic (1.17e-3)" "unprognostic (7.07e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" 20.1 14.1 25.6 11.1 18.9 32.3 20.1 24.0 20.4 16.2 15.7 17.6 10.4 9.7 20.5 23.9 13.0 20.1 15.5 19.6 21.8 19.7 16.0 15.9 13.8 17.8 23.5 22.3 34.4 9.1 10.7 20.0 23.5 20.4 16.8 14.5 13.6 11.6 14.5 21.1 10.1 11.8 17.1 26.9 14.3 11.5 38.2 18.7 29.2 15.5 16.1 19.4 16.2 15.1 24.5 16.0 30.2 16.8 14.3 44.8 9.7 10.2 4.9 32.3 11.6 13.1 20.9 15.7 8.8 7.3 12.0 12.4 9.0 8.2 11.1 9.7 11.8 9.4 7.1 5.7 9.4 16.2 19.7 9.8 22.3 4.9 17.9 10.6 16.7 14.6 13.1 15.1 6.7 6.9 13.0 12.1 22.4 17.3 6.0 15.3 4.8 16.7 20.0 17.7 9.8 6.0 12.2 24.6 7.8 12.7 11.2 19.3 17.3 10.5 6.1 12.6 35.9 4.8 47.3 9.2 10.6 12.0 8.5 14.2 5.8 7.1 8.0 6.8 11.4 10.0 20.8 16.6 30.2 11.4 15.9 10.3 22.1 20.4 14.0 16.0 24.5 19.2 16.4 29.3 14.3 16.8 13.4 44.8 9.7 25.6 18.9 24.0 20.4 21.8 19.7 23.5 22.3 20.4 18.7 8.9 4.6 32.1 27.2 0.0 5.5 0.0 28.1 13.4 17.0 19.2 2.0 47.5 46.4 41.3 113.1 20.3 12.5 93.5 21.4 53.4 17.5 19.3 10.5 31.8 64.1 6.4 17.5 31.3 40.5 49.2 39.7 28.7 0.0 64.1 23.7 13.2 34.6 28.5 50.5 34.8 13.5 58.2 0.0 164.4 149.9 0.0 51.5 20.0 30.2 25.4 SYAP1 "FLJ14495, PRO3113" ENSG00000169895 "Synapse associated protein 1" Q96A49 X 16719632-16765336 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000175, HPA000882, HPA048047" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA000175: AB_1080142, HPA000882: AB_2666128, HPA048047: AB_2680240" "unprognostic (4.66e-2)" "unprognostic (2.99e-2)" "unprognostic (1.25e-2)" "unprognostic (5.44e-2)" "unprognostic (1.89e-1)" "unprognostic (1.52e-2)" "unprognostic (9.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.82e-1)" "unprognostic (1.62e-2)" "unprognostic (1.95e-1)" "unprognostic (3.95e-3)" "unprognostic (1.14e-2)" "unprognostic (8.10e-2)" "unprognostic (5.28e-3)" 17.6 31.3 13.1 12.9 12.3 26.2 16.5 10.2 14.0 17.1 23.8 12.2 16.1 20.6 17.0 13.7 18.5 14.4 20.7 25.7 13.5 13.7 28.7 51.4 17.6 11.4 15.8 11.0 19.9 14.3 22.8 15.9 18.9 18.4 16.2 16.1 10.7 15.9 21.3 22.5 12.6 33.0 12.3 17.3 13.7 16.9 10.1 11.2 15.3 16.2 13.3 15.1 17.9 13.5 12.6 11.1 17.8 15.0 13.8 15.2 9.1 15.9 13.5 9.8 18.3 13.3 15.2 4.5 12.8 9.2 10.7 10.7 12.6 13.3 12.5 18.8 12.5 21.9 9.6 11.9 16.7 14.4 8.1 23.8 5.0 14.6 12.0 9.5 8.5 7.8 10.3 7.9 18.5 15.8 12.5 14.7 3.9 10.7 7.1 14.4 18.8 4.5 9.2 11.4 8.9 14.9 5.0 12.4 12.6 15.9 10.6 10.0 12.3 23.8 17.0 12.6 13.3 22.6 7.7 11.6 13.8 7.3 28.0 10.3 7.7 6.6 14.6 13.6 4.3 11.2 9.2 10.5 12.7 15.2 11.3 12.3 12.6 13.0 13.9 11.1 10.8 13.1 13.6 17.8 13.8 15.0 9.2 14.4 9.1 13.1 12.3 10.2 14.0 13.5 13.7 15.8 11.0 18.4 11.2 59.6 59.3 59.9 76.6 56.9 18.5 68.5 81.5 190.1 93.3 75.0 21.6 57.3 94.5 102.2 188.0 47.2 124.9 23.3 115.1 64.1 49.1 85.9 200.3 200.6 44.7 22.3 101.7 67.5 63.9 250.6 39.1 90.0 64.1 53.3 93.6 45.0 138.4 150.8 51.2 108.8 19.3 58.2 83.4 13.3 21.5 45.9 125.9 62.3 95.4 91.2 SYCE1 "bA108K14.6, C10orf94, CT76" ENSG00000171772 "Synaptonemal complex central element protein 1" Q8N0S2 10 133553901-133569835 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 75.4" "Group enriched" "Detected in some" 5 "Early spermatids: 103.1;Late spermatids: 85.3;Spermatocytes: 250.9;Spermatogonia: 112.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "K-562: 17.4;U-2 OS: 16.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040208 Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA040208: AB_10796450" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-2)" "unprognostic (1.61e-1)" "unprognostic (3.20e-1)" "unprognostic (5.75e-1)" "unprognostic (5.38e-2)" "unprognostic (3.36e-1)" "unprognostic (2.22e-2)" "unprognostic (7.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" 1.8 1.8 4.9 0.7 5.4 0.3 1.3 8.1 8.2 0.4 0.7 0.9 0.0 0.4 0.8 0.5 0.6 1.4 1.6 0.7 4.0 3.3 0.9 3.9 0.5 1.1 1.5 6.7 1.1 1.5 0.2 0.3 8.6 3.5 1.8 0.6 0.2 0.4 0.6 0.9 0.3 0.5 0.7 1.7 0.8 0.5 75.4 0.0 0.1 1.4 0.1 0.7 0.4 0.0 1.3 2.0 0.3 2.6 0.2 3.2 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.7 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.4 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.1 16.1 0.2 0.3 0.2 0.3 0.4 0.0 0.1 0.0 0.0 1.7 0.3 3.2 1.8 3.0 0.9 2.4 0.8 1.2 1.3 1.4 2.7 0.0 0.2 2.6 2.0 2.2 1.8 4.9 5.4 8.1 8.2 4.0 3.3 1.5 6.7 3.5 0.0 0.0 1.0 0.0 1.5 0.9 1.8 0.2 2.5 2.7 2.3 0.0 0.0 0.3 0.0 0.0 103.1 0.1 0.0 0.0 0.9 0.1 0.8 0.4 0.0 5.1 0.6 9.5 0.0 0.0 0.0 85.3 4.9 0.6 0.0 0.0 0.0 0.3 0.7 0.0 3.5 0.3 1.6 25.8 0.4 250.9 112.4 0.9 0.2 0.0 0.0 0.3 SYCE3 C22orf41 ENSG00000217442 "Synaptonemal complex central element protein 3" A1L190 22 50551112-50562905 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 61.5" "Group enriched" "Detected in many" 6 "Early spermatids: 349.3;Spermatocytes: 429.3;Spermatogonia: 109.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.8;Karpas-707: 7.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047813 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA047813: AB_2797234" "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-1)" "unprognostic (2.98e-3)" "unprognostic (1.68e-2)" "unprognostic (4.05e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.55e-2)" "unprognostic (5.20e-2)" 0.4 0.4 0.7 0.5 0.9 0.1 0.7 0.2 0.6 0.2 0.4 0.5 0.4 0.1 0.2 1.1 0.2 0.8 0.6 0.1 0.5 0.7 1.0 0.8 0.4 0.9 0.9 0.3 0.1 0.2 0.2 0.4 0.4 0.7 0.1 0.0 0.2 0.7 0.1 0.0 0.2 0.0 0.5 0.7 0.1 0.2 61.5 0.4 0.0 1.1 0.2 0.3 0.7 0.0 0.5 1.9 8.0 1.3 0.0 0.3 0.3 0.4 0.7 0.1 0.3 0.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 8.8 0.4 3.2 0.0 1.8 0.0 0.9 1.0 0.0 0.0 0.5 0.0 0.6 0.0 4.0 0.0 1.6 2.3 2.0 0.3 1.4 0.5 0.0 1.8 0.0 7.4 0.4 3.3 0.0 0.0 0.3 3.7 0.0 0.0 0.0 3.9 1.2 2.6 0.8 2.3 0.0 2.2 1.4 0.3 2.1 1.8 0.0 0.7 0.8 0.0 0.1 1.9 0.4 1.1 0.9 0.3 0.2 0.0 1.3 1.5 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 0.2 8.0 0.0 0.9 0.0 0.0 0.3 0.7 0.9 0.2 0.6 0.5 0.7 0.9 0.3 0.7 0.4 0.0 0.0 0.0 0.4 0.1 0.5 0.4 5.1 0.0 0.0 1.8 0.0 4.2 3.3 1.3 349.3 0.1 0.3 0.0 0.6 2.6 0.1 0.3 0.0 1.6 1.4 0.0 0.0 0.6 1.2 52.2 10.0 0.0 0.0 4.6 0.0 0.9 1.2 0.0 6.7 2.1 0.4 45.3 0.0 429.3 109.7 0.1 3.1 0.0 0.3 0.9 SYCP2 SCP2 ENSG00000196074 "Synaptonemal complex protein 2" Q9BX26 20 59863563-59933655 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 11.1;testis: 41.7" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 330.2" "Group enriched" "Detected in many" 6 "breast cancer: 6.7;cervical cancer: 11.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 19.1;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062401, HPA065613" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA062401: AB_2684752, HPA065613: AB_2685519" "unprognostic (8.10e-3)" "unprognostic (8.28e-3)" "unprognostic (1.62e-1)" "unprognostic (2.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.19e-3)" "unprognostic (2.50e-2)" "unprognostic (2.18e-1)" "unprognostic (4.11e-2)" "unprognostic (1.44e-1)" "unprognostic (3.74e-1)" "unprognostic (7.02e-3)" "unprognostic (4.84e-3)" "unprognostic (8.48e-2)" "unprognostic (2.46e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" 2.2 0.5 1.3 0.9 2.3 1.4 11.1 2.5 5.7 1.3 1.2 1.0 0.8 1.1 1.1 0.9 0.8 0.8 2.0 2.1 1.2 1.2 3.3 0.8 1.6 3.1 1.8 2.7 0.4 4.9 1.3 3.0 2.9 3.9 2.9 0.8 0.6 3.0 0.7 0.8 2.0 1.7 0.6 1.6 2.3 4.5 41.7 0.8 3.0 1.9 0.2 1.5 1.3 1.0 0.9 0.1 2.6 0.3 0.0 2.7 0.5 0.1 0.5 0.1 0.5 0.2 0.3 0.6 1.6 0.4 0.7 0.1 10.2 1.0 0.0 1.6 0.7 0.3 0.2 0.2 0.0 0.4 3.2 0.2 0.1 2.0 0.1 0.0 0.1 7.6 0.1 0.1 0.1 0.0 0.4 0.0 19.1 0.1 0.0 0.3 4.9 21.1 1.1 0.2 0.6 0.1 0.0 0.0 0.1 0.9 2.4 0.1 1.8 37.2 5.4 1.1 0.7 33.6 1.9 0.2 0.0 1.1 4.5 0.0 0.0 0.0 0.0 0.0 0.7 2.1 2.5 0.3 2.3 2.6 0.0 2.7 0.7 1.5 1.7 0.1 0.9 0.9 1.5 2.6 0.0 0.1 0.1 1.0 0.5 1.3 2.3 2.5 5.7 1.2 1.2 1.8 2.7 3.9 0.8 0.0 0.6 0.5 1.0 0.9 1.3 3.6 2.5 14.7 10.3 1.8 2.0 0.5 1.7 0.6 36.7 2.3 0.0 0.0 3.1 0.2 1.2 2.0 2.3 0.0 0.5 0.0 0.0 3.1 0.6 13.5 4.4 1.1 5.0 0.0 0.0 2.2 1.6 0.2 1.8 2.6 1.0 51.8 1.9 330.2 31.3 0.0 0.3 1.3 0.2 1.1 SYDE1 "7h3, FLJ13511, SYD1" ENSG00000105137 "Synapse defective Rho GTPase homolog 1" Q6ZW31 19 15107403-15114988 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.0" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 126.4;Sertoli cells: 84.1;Syncytiotrophoblasts: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-138 MG: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013328 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA013328: AB_1848705" "unprognostic (9.99e-2)" "unprognostic (3.73e-2)" "unprognostic (8.17e-3)" "unprognostic (1.65e-2)" "unprognostic (6.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.07e-2)" "unprognostic (2.46e-2)" "unprognostic (2.96e-1)" "unprognostic (5.01e-3)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (5.63e-7)" "unprognostic (1.82e-2)" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.27e-4)" 15.6 7.7 3.5 5.9 4.3 0.1 19.9 2.0 3.5 19.5 13.9 4.4 3.8 4.3 18.6 6.8 10.7 12.2 10.5 9.3 4.0 1.8 9.6 3.3 9.4 4.9 3.1 2.4 17.9 4.6 2.3 3.8 60.0 5.0 11.8 2.9 22.0 3.3 13.6 5.9 4.4 5.7 14.2 2.5 7.6 7.9 7.4 4.3 0.9 8.2 5.8 2.8 12.9 12.8 0.2 0.3 0.0 0.0 0.0 0.5 0.0 4.1 6.4 3.5 9.0 7.9 7.3 2.7 17.5 12.9 17.2 14.7 1.4 2.5 0.0 11.6 17.6 5.9 2.6 2.7 3.1 9.7 0.1 3.0 0.6 11.9 2.8 15.0 0.0 0.0 12.7 2.3 10.3 4.7 10.5 3.1 0.0 0.0 0.0 12.8 2.0 0.0 0.0 5.7 0.1 6.6 0.0 8.6 0.0 4.2 0.5 0.1 6.9 9.8 6.0 11.7 3.5 0.7 0.4 6.6 41.5 12.6 19.0 18.8 0.0 0.1 0.0 11.2 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 2.0 3.5 4.0 1.8 3.1 2.4 5.0 4.3 3.0 1.4 0.5 0.6 2.2 0.3 3.9 2.5 0.0 1.2 1.8 0.0 4.9 0.0 3.9 8.8 12.6 0.0 0.0 0.3 126.4 14.7 0.5 0.0 0.0 3.0 1.6 0.0 19.0 1.3 12.0 27.3 0.8 13.5 0.0 0.0 13.2 1.5 0.0 39.6 5.5 0.4 84.1 29.9 1.2 0.5 2.3 112.5 0.0 0.0 0.1 SYMPK "SPK, SYM" ENSG00000125755 Symplekin Q92797 19 45815410-45863290 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 114.2;Late spermatids: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041756, HPA042449" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA041756: AB_10963544, HPA042449: AB_2678003" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (2.59e-1)" "unprognostic (1.59e-2)" "unprognostic (3.11e-2)" "unprognostic (2.33e-3)" "unprognostic (9.93e-2)" "unprognostic (9.78e-2)" "unprognostic (1.23e-1)" "unprognostic (9.16e-3)" "unprognostic (1.67e-2)" "unprognostic (1.44e-1)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (2.58e-1)" "unprognostic (6.38e-2)" 14.7 15.9 15.3 23.7 24.2 20.7 15.2 25.1 32.2 17.1 18.2 25.3 20.3 18.6 22.6 18.9 17.4 19.3 17.6 14.6 17.3 18.0 15.0 21.6 15.6 27.2 19.3 16.8 21.6 16.3 20.5 24.0 34.8 19.9 17.4 12.2 16.1 21.5 17.5 33.4 21.1 18.0 13.9 18.7 23.0 19.4 38.0 22.0 28.5 20.5 11.6 23.4 16.8 16.7 7.9 9.2 6.5 7.1 4.2 5.2 2.7 19.5 34.6 14.2 10.7 13.9 17.8 23.9 15.6 11.0 16.0 18.3 15.3 18.0 34.5 10.7 17.6 9.1 16.1 19.0 17.0 14.4 26.7 21.3 19.9 23.7 16.1 16.0 21.8 23.4 12.9 10.4 17.2 19.6 11.0 16.5 18.3 26.2 22.6 13.9 18.3 20.2 23.1 12.1 17.1 8.0 21.7 16.5 21.4 11.4 35.4 16.2 20.5 19.1 12.5 12.6 14.9 17.1 30.2 18.2 13.3 21.3 10.2 22.7 29.9 56.5 28.0 15.2 14.7 21.8 2.1 5.1 2.2 3.4 3.8 3.2 4.7 3.0 5.2 4.2 7.9 2.6 2.4 6.5 4.2 7.1 9.2 2.3 2.7 15.3 24.2 25.1 32.2 17.3 18.0 19.3 16.8 19.9 22.0 0.0 7.7 30.4 14.0 18.5 20.9 5.9 22.9 5.3 5.7 24.4 33.4 28.3 46.4 19.9 114.2 15.7 30.0 0.0 14.8 27.8 19.9 17.1 12.7 31.6 15.8 20.6 34.9 31.3 25.6 108.4 17.8 20.1 13.5 41.5 31.6 9.8 17.3 23.0 19.8 10.3 28.0 19.4 14.2 22.9 39.6 18.6 47.9 13.8 27.0 18.6 SYNCRIP "dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1" ENSG00000135316 "Synaptotagmin binding cytoplasmic RNA interacting protein" O60506 6 85607785-85643792 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010895, HPA041275, HPA069241" Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA 77000 Nucleoplasm "Vesicles, Cytosol" "CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: " "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (1.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.49e-2)" "unprognostic (6.22e-2)" "prognostic unfavorable (6.28e-5)" "unprognostic (6.84e-2)" "unprognostic (6.48e-2)" "prognostic favorable (5.59e-4)" "unprognostic (1.58e-2)" "unprognostic (1.43e-1)" "unprognostic (4.86e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "unprognostic (4.11e-1)" 29.1 28.3 27.9 31.3 36.2 30.4 28.4 35.6 37.9 32.9 29.4 19.2 31.8 20.4 32.7 18.9 48.8 24.5 21.9 31.3 29.3 19.0 25.2 31.3 25.7 35.0 31.9 23.1 26.2 34.9 37.5 27.9 31.3 28.2 23.1 29.6 17.3 31.4 32.8 41.4 27.2 23.7 53.5 28.1 24.7 25.4 19.8 30.1 38.1 42.0 29.8 41.7 31.2 39.4 13.2 20.9 4.6 20.0 18.1 18.6 12.6 32.2 24.2 40.4 23.5 26.6 31.7 25.6 47.9 39.5 43.5 43.2 39.6 21.3 76.3 34.9 46.1 34.6 31.3 59.1 47.5 76.3 26.2 27.1 68.0 29.2 27.2 22.5 83.0 29.3 25.9 27.4 49.7 51.2 23.5 45.8 22.9 68.1 36.0 50.2 35.5 38.8 35.4 38.7 31.2 25.8 58.3 64.6 32.4 35.6 51.8 38.1 30.9 33.3 28.2 19.6 25.2 24.4 51.7 42.0 29.5 24.1 30.9 57.2 22.5 44.4 50.3 27.0 50.2 41.0 1.0 13.0 4.6 17.7 18.6 18.6 13.2 16.8 15.9 20.9 11.9 15.3 16.6 1.6 18.1 20.0 15.5 16.7 12.6 27.9 36.2 35.6 37.9 29.3 19.0 31.9 23.1 28.2 30.1 107.2 97.5 44.7 111.8 131.7 43.4 77.5 48.4 87.0 134.2 43.6 15.7 88.7 46.4 116.0 77.9 92.0 42.3 0.0 85.9 107.5 80.8 88.9 59.0 74.1 86.4 58.8 54.4 52.8 60.2 17.6 68.1 69.2 50.6 61.3 65.0 37.9 106.5 45.6 60.5 62.1 40.3 19.4 102.9 77.7 58.0 123.8 98.7 52.5 77.4 123.7 SYNJ1 "INPP5G, PARK20" ENSG00000159082 "Synaptojanin 1" O43426 21 32628759-32728048 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, RNA-binding" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011916 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA011916: AB_1857692" "unprognostic (6.84e-2)" "unprognostic (8.64e-2)" "unprognostic (5.76e-2)" "unprognostic (6.44e-2)" "unprognostic (1.27e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.45e-1)" "unprognostic (3.73e-3)" "unprognostic (1.63e-1)" "unprognostic (6.22e-3)" "unprognostic (1.84e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-1)" "unprognostic (6.36e-2)" "unprognostic (5.97e-2)" "unprognostic (1.79e-1)" "unprognostic (2.92e-1)" 5.5 6.8 13.6 5.0 25.9 20.6 4.2 19.5 39.0 4.8 4.8 6.5 0.8 3.9 4.6 5.3 3.9 4.0 5.2 5.2 18.3 18.2 7.4 5.5 6.5 5.7 16.6 18.4 4.6 4.5 10.6 10.9 9.3 33.5 3.6 5.5 7.0 3.8 4.0 4.4 5.0 4.6 5.0 7.3 6.0 4.2 9.0 5.7 3.2 6.8 1.5 4.8 4.7 3.3 0.4 3.1 11.5 6.0 0.5 3.0 1.1 5.6 2.8 5.2 5.7 9.1 7.3 10.6 11.7 6.7 7.2 6.0 6.4 2.6 2.1 3.9 7.0 9.6 5.3 9.3 6.8 8.6 6.7 8.9 14.1 9.2 3.5 4.9 5.8 12.5 4.1 5.1 12.4 6.3 5.9 11.2 7.5 10.5 12.1 9.2 5.7 5.4 4.8 3.7 6.2 6.5 5.9 11.3 7.4 7.6 4.1 5.9 4.6 14.4 9.2 5.6 7.4 7.9 7.5 12.3 11.1 5.5 8.9 6.4 6.3 7.3 4.4 8.4 11.0 8.8 3.7 3.4 7.9 1.6 6.0 2.7 0.2 2.4 2.6 3.1 0.4 2.9 2.8 11.5 0.5 5.3 1.6 3.0 1.1 13.6 25.9 19.5 28.7 18.3 18.2 16.6 18.4 33.5 5.7 6.0 4.8 2.9 2.0 4.2 21.5 7.3 5.1 4.0 2.3 1.8 43.2 13.3 5.0 1.6 14.8 7.9 4.9 0.0 1.2 7.9 3.7 2.2 3.5 3.6 8.6 9.5 2.9 8.6 19.0 8.6 2.6 7.5 1.7 1.0 2.7 19.5 2.1 3.5 4.2 5.0 40.7 6.5 3.4 16.4 10.9 2.9 31.8 6.9 4.0 4.1 SYNPO KIAA1029 ENSG00000171992 Synaptopodin Q8N3V7 5 150601080-150659220 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory B-cell: 2.9;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 27 "B-cells: 3.3" "Cell line enhanced" "Detected in many" "BEWO: 26.4;EFO-21: 21.8;HUVEC TERT2: 21.3;TIME: 51.7;U-87 MG: 45.9" "Group enriched" "Detected in many" 6 "amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1" "Low region specificity" "Detected in all" "CAB033265, HPA034631, CAB037325, HPA071347" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179" "unprognostic (2.09e-2)" "unprognostic (7.72e-3)" "unprognostic (3.95e-2)" "unprognostic (2.78e-3)" "unprognostic (3.07e-2)" "unprognostic (1.66e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.53e-6)" "unprognostic (1.23e-1)" "unprognostic (5.72e-2)" "unprognostic (2.21e-2)" "unprognostic (6.35e-2)" 17.3 14.6 17.7 4.4 18.9 0.6 5.7 1.4 24.9 4.3 5.5 2.4 0.8 6.6 5.1 4.8 6.7 4.4 6.8 66.1 16.6 4.0 15.8 7.8 11.7 2.4 4.5 5.6 23.3 6.8 2.5 2.8 63.4 3.7 7.6 4.1 16.4 2.6 6.7 222.7 1.8 7.6 8.2 4.8 14.5 4.7 17.4 3.9 0.5 4.0 5.7 2.6 6.2 17.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 7.0 0.0 0.1 1.0 0.9 26.4 4.0 5.5 1.4 1.1 6.2 2.8 0.0 21.8 5.7 8.7 2.6 0.0 3.9 0.5 0.0 0.0 0.0 10.6 1.3 6.0 0.0 0.2 1.1 6.3 1.5 1.1 8.2 21.3 0.0 0.0 0.0 1.3 0.4 0.0 0.2 0.8 2.6 3.4 0.1 0.2 0.0 1.0 0.5 2.5 11.7 5.8 6.4 0.2 9.7 0.4 1.9 51.7 5.2 16.3 0.1 1.0 0.2 0.0 0.3 45.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.7 18.9 1.4 24.9 16.6 4.0 4.5 5.6 3.7 3.9 32.8 13.5 0.9 2.8 4.0 1.3 219.1 35.7 5.3 14.8 7.0 2.0 9.9 0.0 44.4 1.6 40.9 50.6 0.0 30.5 5.8 12.3 1.6 0.0 38.0 1.9 0.0 13.3 42.4 6.7 1.9 2.6 1.1 5.0 41.5 9.9 6.1 29.3 25.9 26.2 3.3 0.6 45.3 32.0 0.7 0.4 1.9 21.6 1.3 9.1 3.0 SYTL2 "CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2" ENSG00000137501 "Synaptotagmin like 2" Q9HCH5 11 85694224-85811159 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 65.2" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 139.2;granulocytes: 122.9;Mucus-secreting cells: 160.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 10.5;MAIT T-cell: 17.9" "Lineage enriched" "Detected in many" 6 "T-cells: 17.9" "Cell line enhanced" "Detected in many" "MCF7: 25.3;OE19: 41.5;RH-30: 51.1;RPTEC TERT1: 36.5" "Low region specificity" "Detected in many" HPA039651 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane" "HPA039651: AB_10795153" "unprognostic (8.07e-3)" "unprognostic (6.72e-3)" "prognostic favorable (2.67e-4)" "unprognostic (9.34e-4)" "unprognostic (6.60e-3)" "unprognostic (2.19e-4)" "unprognostic (2.24e-2)" "unprognostic (5.37e-2)" "unprognostic (5.56e-2)" "unprognostic (5.45e-2)" "unprognostic (1.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.85e-2)" "unprognostic (4.03e-1)" "unprognostic (1.87e-2)" "unprognostic (9.72e-2)" "prognostic favorable (9.07e-4)" 12.8 5.5 27.6 11.8 13.9 1.8 9.7 6.8 32.0 6.5 26.3 6.8 2.1 11.4 7.6 11.8 9.6 6.3 15.0 5.7 13.8 9.0 14.5 3.9 8.1 5.7 8.4 21.5 3.7 2.5 7.2 5.5 9.8 12.4 9.9 39.8 5.7 8.4 5.8 3.7 4.6 17.7 7.8 12.8 5.4 65.2 3.2 5.1 5.8 4.2 5.0 3.8 17.2 11.3 0.1 0.7 0.0 0.0 3.0 17.9 1.7 0.9 2.2 3.5 0.3 0.8 4.6 0.0 8.6 11.3 7.6 17.4 9.7 1.3 0.2 3.2 6.0 11.1 6.3 0.2 0.7 10.1 0.6 0.0 0.0 0.0 0.1 0.5 0.7 0.1 5.8 1.1 16.5 0.2 1.8 0.0 0.2 0.1 0.1 9.6 25.3 0.0 0.2 5.9 41.5 3.9 0.3 51.1 0.0 36.5 13.2 0.1 0.1 1.9 1.5 0.8 3.1 0.1 0.1 0.0 12.0 4.6 7.5 0.4 0.0 0.0 4.5 12.3 0.1 7.3 0.0 0.0 0.0 10.5 0.0 17.9 0.0 2.1 6.3 0.0 0.1 1.7 3.1 0.0 3.0 0.0 0.7 0.8 1.7 27.6 13.9 6.8 32.0 13.8 9.0 8.4 21.5 12.4 5.1 20.8 30.4 1.4 10.2 3.2 8.3 1.6 10.2 139.2 38.7 64.6 7.9 0.7 0.0 8.4 1.1 3.6 40.7 0.0 14.7 0.2 9.3 37.7 122.9 0.4 0.5 1.6 18.5 7.4 4.7 0.4 1.7 3.9 10.1 1.0 160.5 13.4 13.2 34.8 28.3 7.7 8.1 32.3 29.7 3.3 2.1 5.0 0.3 30.0 35.7 46.4 SYTL5 ENSG00000147041 "Synaptotagmin like 5" Q8TDW5 X 38006582-38128819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.0" "Cell type enhanced" "Detected in some" 11 "Club cells: 5.7;Mucus-secreting cells: 10.5;Syncytiotrophoblasts: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 19 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 19 "monocytes: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 5.6;MCF7: 5.2;OE19: 7.5;SK-MEL-30: 13.4;SuSa: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026074 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA026074: AB_1857697" "unprognostic (3.60e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (6.68e-2)" "unprognostic (3.09e-3)" "unprognostic (3.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.10e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (5.21e-2)" "unprognostic (1.51e-1)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" 0.5 6.0 10.5 3.4 11.0 0.0 2.9 0.5 2.5 7.0 7.3 0.5 0.5 2.3 2.6 1.0 12.2 0.2 2.9 0.9 9.2 8.9 1.0 6.1 2.4 0.5 2.4 0.5 0.5 6.4 0.0 1.1 17.0 0.5 2.0 3.5 1.5 7.1 1.7 0.5 0.0 14.3 3.9 1.3 0.8 13.8 0.7 0.5 0.7 0.9 1.2 5.9 1.3 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 5.6 1.3 0.0 0.0 0.5 2.1 0.6 0.0 0.0 0.0 0.0 0.6 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.7 0.1 0.0 0.1 0.1 0.2 5.2 0.0 0.0 2.3 7.5 0.0 0.0 1.9 0.0 0.0 0.4 2.9 0.0 0.3 1.1 13.4 19.0 0.0 0.0 0.0 0.1 4.5 0.0 3.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.5 11.0 0.5 2.5 9.2 8.9 2.4 0.5 0.5 0.5 0.0 1.3 0.0 0.2 0.0 0.0 0.3 0.0 1.4 5.7 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.1 0.0 0.8 3.1 0.1 0.9 0.0 0.9 0.2 0.0 2.9 0.6 0.0 0.0 0.6 0.0 0.0 0.0 10.5 0.0 3.5 2.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.6 0.6 SYVN1 "DER3, HRD1" ENSG00000162298 "Synoviolin 1" Q86TM6 11 65121780-65134533 "Enzymes, Predicted membrane proteins" "Stress response, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 56.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005480, HPA024300, CAB037030" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum,Plasma membrane" NA NA Nucleoplasm "Endoplasmic reticulum, Plasma membrane" "CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.22e-1)" "unprognostic (2.17e-2)" "unprognostic (2.85e-2)" "prognostic favorable (6.88e-4)" "unprognostic (7.67e-2)" "unprognostic (2.50e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-2)" "unprognostic (1.56e-2)" "unprognostic (4.89e-1)" "unprognostic (3.85e-2)" "unprognostic (1.16e-1)" 13.8 20.8 11.0 33.0 15.3 13.8 14.9 13.3 19.3 15.1 14.2 21.0 20.2 13.2 16.0 21.1 14.4 16.1 15.3 12.9 11.3 10.0 16.4 78.0 14.2 28.9 18.2 8.7 17.1 68.1 24.4 21.0 20.9 14.4 15.0 15.4 13.3 48.9 22.6 16.7 14.4 19.6 13.6 12.8 27.1 18.3 14.4 14.9 10.3 23.5 8.0 42.2 13.3 12.6 17.5 13.0 11.6 5.4 2.2 5.5 3.8 8.6 11.1 6.7 9.0 17.1 9.8 6.7 9.0 9.3 11.5 8.2 6.0 15.2 49.0 12.3 11.5 15.2 13.5 7.3 9.1 9.5 7.6 5.5 7.7 12.9 13.4 20.8 11.5 14.0 12.4 16.5 10.1 23.0 10.3 7.4 5.2 9.6 25.1 6.7 12.9 5.0 8.3 7.2 9.1 7.7 8.5 5.7 19.7 7.2 8.6 4.4 9.0 8.3 20.7 14.5 6.2 15.4 7.6 7.1 8.0 5.3 14.3 6.0 50.2 34.7 56.6 10.8 5.9 8.9 11.6 5.4 9.3 5.5 3.3 5.0 15.4 3.9 5.1 3.1 17.5 2.9 3.0 5.2 2.2 3.2 13.0 3.6 3.8 11.0 15.3 13.3 19.3 11.3 10.0 18.2 8.7 14.4 14.9 14.9 21.3 22.2 6.0 15.7 10.2 3.4 33.1 9.4 20.5 10.4 31.4 11.5 1.7 10.5 4.3 8.3 15.8 23.3 16.3 12.6 12.1 13.4 1.1 60.4 13.6 12.7 8.1 14.1 14.8 3.5 19.0 11.6 11.8 6.4 25.0 10.8 17.1 12.4 12.4 7.2 17.1 12.9 7.5 21.0 10.9 14.1 35.8 10.2 14.5 11.6 SZT2 "C1orf84, FLJ10387, FLJ34502, KIAA0467, RP11-506B15.1, SZT2A, SZT2B" ENSG00000198198 "SZT2, KICSTOR complex subunit" Q5T011 1 43389882-43454247 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029012 Approved Approved "Nucleoplasm,Vesicles,Actin filaments" NA NA "Nucleoplasm, Vesicles, Actin filaments" "HPA029012: AB_10600817" "unprognostic (1.35e-1)" "unprognostic (2.55e-1)" "unprognostic (4.14e-1)" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.47e-7)" "prognostic unfavorable (2.53e-4)" "prognostic favorable (6.20e-4)" "unprognostic (1.54e-1)" "unprognostic (1.81e-2)" "unprognostic (5.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (1.84e-3)" "unprognostic (8.28e-2)" "unprognostic (7.19e-2)" "unprognostic (2.61e-2)" 10.0 8.4 9.0 15.9 12.8 13.5 10.3 16.1 12.9 10.2 10.2 21.7 12.8 8.8 13.7 8.3 9.4 11.3 8.2 8.6 8.7 6.8 7.9 6.1 10.3 11.1 12.4 9.1 14.9 10.8 23.6 16.1 8.1 10.9 10.9 8.9 13.5 11.4 11.6 10.9 17.4 11.6 12.1 9.9 11.0 10.0 12.2 11.1 13.9 16.3 5.9 12.6 12.3 9.6 1.8 3.0 4.9 1.8 1.3 3.0 1.2 6.3 5.9 6.0 5.3 15.4 9.2 8.4 4.9 7.0 6.8 6.7 2.0 7.8 5.9 6.5 8.6 4.4 7.7 5.0 9.0 5.2 7.5 5.0 10.7 11.4 3.7 6.1 8.5 8.8 8.2 7.2 11.2 10.3 8.0 7.4 7.0 4.7 9.3 5.1 3.2 5.8 3.0 4.9 4.3 6.4 7.4 6.5 7.9 4.3 8.0 5.8 5.4 9.8 9.0 6.7 7.7 5.4 13.1 9.6 7.4 9.3 10.3 8.5 9.7 3.8 4.7 7.7 5.9 5.4 3.8 1.8 4.9 1.5 1.5 3.0 1.4 0.8 0.8 1.5 1.8 1.7 1.3 3.7 1.3 1.7 3.0 1.7 1.2 9.0 12.8 16.1 12.9 8.7 6.8 12.4 9.1 10.9 11.1 23.8 20.0 9.3 3.1 1.6 15.1 4.4 5.1 6.7 7.9 5.2 58.9 5.4 0.0 5.2 11.0 6.0 8.5 0.0 5.7 4.3 5.1 3.8 13.9 9.5 4.8 12.7 3.5 9.8 7.8 11.5 8.6 6.9 5.0 9.0 5.7 7.8 5.7 3.5 5.6 7.1 22.6 19.4 4.3 7.0 6.6 1.6 4.6 12.8 6.4 3.2 TACC2 AZU-1 ENSG00000138162 "Transforming acidic coiled-coil containing protein 2" O95359 10 121989174-122254545 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 109.4" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 186.1;Syncytiotrophoblasts: 191.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 36.6" "Low region specificity" "Detected in all" "HPA031020, HPA031021, HPA061394" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 110000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA031020: AB_10669988, HPA031021: AB_2673701, HPA061394: AB_2684500" "unprognostic (3.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.75e-2)" "unprognostic (7.07e-2)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (9.15e-2)" "unprognostic (8.43e-3)" "unprognostic (1.14e-1)" "unprognostic (3.51e-1)" "unprognostic (2.13e-1)" "unprognostic (1.83e-2)" "prognostic favorable (2.50e-10)" "unprognostic (7.02e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (8.45e-4)" "unprognostic (1.61e-1)" 8.2 5.8 9.6 2.4 11.7 0.6 7.8 17.7 16.6 6.9 17.2 2.6 4.0 6.3 8.4 4.3 13.4 9.6 7.7 43.3 8.0 4.8 19.3 3.8 54.1 0.8 3.1 9.0 4.7 6.3 11.9 41.0 45.4 6.8 12.0 8.6 4.8 18.5 6.0 109.4 28.9 8.2 8.9 3.2 1.3 10.2 2.2 3.9 0.1 19.6 4.4 2.5 15.1 8.8 0.1 0.1 0.3 0.0 0.1 0.2 0.0 7.2 22.8 11.2 6.4 3.2 3.2 13.6 3.2 8.6 4.4 3.1 9.3 12.0 0.0 2.9 5.0 5.1 24.3 3.5 8.6 4.6 1.2 1.8 0.0 2.8 17.7 4.9 0.0 0.1 1.4 36.6 2.4 15.6 3.6 9.2 0.0 1.8 0.2 4.3 9.5 0.0 4.0 6.6 11.2 10.4 0.1 6.4 3.4 12.0 11.1 7.5 6.1 5.2 21.8 11.6 3.4 4.3 0.1 8.5 2.0 1.5 4.9 5.9 1.0 4.5 0.1 3.7 0.0 5.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 9.6 11.7 17.7 16.6 8.0 4.8 3.1 9.0 6.8 3.9 77.4 80.3 0.8 44.9 29.9 18.8 186.1 7.6 88.3 50.0 34.9 0.0 36.8 1.7 7.5 1.6 14.3 44.5 0.0 12.6 2.8 12.8 69.9 6.9 14.5 5.4 41.3 28.8 7.4 0.0 2.1 6.4 3.5 6.8 0.0 35.8 1.1 14.9 38.5 7.1 9.8 2.5 12.9 35.4 0.5 4.3 47.2 191.1 2.5 36.7 77.4 TADA1 "ADA1, hADA1, HFI1, STAF42, TADA1L" ENSG00000152382 "Transcriptional adaptor 1" Q96BN2 1 166856510-166876327 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028651 Approved Supported "Nucleoplasm,Focal adhesion sites,Cytosol" No No Nucleoplasm "Focal adhesion sites, Cytosol" "HPA028651: AB_10602476" "unprognostic (9.53e-3)" "unprognostic (2.31e-1)" "unprognostic (1.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (7.09e-2)" "unprognostic (5.99e-3)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.98e-2)" "unprognostic (3.64e-2)" "unprognostic (2.73e-2)" "unprognostic (6.35e-2)" "unprognostic (1.07e-1)" "unprognostic (1.26e-2)" 6.5 10.6 13.8 7.1 18.5 17.8 10.2 18.2 20.0 11.3 9.1 17.0 3.4 8.3 10.5 8.6 10.1 9.8 6.6 9.2 13.2 14.6 12.9 28.9 6.7 10.1 11.1 14.3 12.7 7.5 11.3 13.7 12.5 15.0 9.2 10.2 13.4 8.7 8.4 10.7 8.5 9.0 8.5 10.8 7.3 8.0 12.0 10.3 16.7 11.5 7.1 10.9 8.6 7.8 13.4 13.0 8.1 8.2 16.2 19.5 15.1 8.2 7.9 14.9 8.8 4.5 5.8 8.9 4.3 5.3 7.3 6.3 7.2 6.7 15.7 8.5 5.1 5.9 6.3 12.0 7.7 5.9 9.9 11.5 5.2 6.8 11.8 6.7 14.6 9.6 4.4 8.9 4.3 11.0 5.2 5.9 11.9 18.5 9.6 5.6 5.7 18.0 11.6 22.7 13.3 8.9 15.2 6.6 19.9 9.7 11.1 9.6 16.8 7.8 10.1 9.1 14.3 13.8 15.4 4.4 6.0 6.9 6.5 9.1 13.6 18.5 29.4 4.1 6.7 5.6 1.8 8.1 8.1 14.0 8.2 15.5 13.1 15.2 15.8 13.0 13.4 19.5 15.3 1.3 16.2 6.2 8.5 14.3 15.1 13.8 18.5 18.2 20.0 13.2 14.6 11.1 14.3 15.0 10.3 8.9 2.4 2.9 4.3 5.5 7.4 9.4 0.0 4.0 4.5 3.5 7.9 5.3 5.0 3.2 3.4 3.7 3.8 0.0 3.5 6.3 4.0 4.4 4.7 17.1 3.7 1.6 6.9 3.7 5.1 1.3 4.0 2.5 1.7 5.4 5.3 6.6 3.0 0.0 2.8 5.0 5.7 0.0 3.8 4.7 12.9 4.4 6.1 5.3 5.1 3.2 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973641-29992261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favorable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 27.8 24.1 26.2 15.1 26.7 12.3 17.7 29.2 30.6 13.5 13.6 21.5 11.8 18.5 16.8 13.0 12.4 14.1 15.1 17.6 25.0 18.2 13.9 10.4 23.0 14.4 22.1 22.7 15.8 16.3 26.2 18.7 22.5 20.7 13.6 9.6 15.0 17.1 15.9 22.8 20.0 19.3 14.8 14.9 26.3 16.0 21.2 20.2 14.0 15.9 9.8 11.5 12.8 18.0 2.6 3.3 4.8 2.8 2.0 3.2 2.0 11.2 21.5 11.8 18.6 13.9 9.3 18.1 20.7 11.1 14.0 13.1 17.2 15.1 12.2 17.6 14.9 9.4 17.6 10.7 10.4 7.6 18.9 22.7 13.1 21.7 17.2 10.1 12.9 25.3 10.9 9.1 14.9 6.0 9.8 23.4 11.7 11.8 12.4 13.3 20.8 15.0 18.3 11.4 8.4 14.5 27.7 17.1 11.3 8.8 10.6 13.9 11.2 11.8 15.8 6.2 7.9 19.8 14.6 32.6 24.2 11.2 17.1 11.9 18.1 11.6 11.5 14.8 14.8 17.6 1.3 2.8 1.5 2.9 2.7 3.1 2.0 2.9 2.6 1.8 2.6 1.6 1.4 4.8 2.0 1.4 3.3 3.2 2.0 26.2 26.7 29.2 30.6 25.0 18.2 22.1 22.7 20.7 20.2 8.9 11.5 2.2 4.2 9.5 13.3 8.1 5.1 4.0 7.9 8.7 37.3 6.7 1.7 7.6 3.1 27.6 23.3 0.0 10.2 4.8 9.3 5.8 3.5 9.7 8.4 9.5 12.6 44.2 12.4 2.1 11.5 5.5 6.8 4.6 14.9 8.7 12.7 14.2 12.0 6.4 19.2 6.5 7.6 21.1 17.2 8.4 10.1 9.2 13.3 5.7 TAS2R42 "hT2R55, T2R24, T2R55, TAS2R55" ENSG00000186136 "Taste 2 receptor member 42" Q7RTR8 12 11185993-11186937 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036149 Uncertain Approved "Nucleoplasm,Actin filaments,Focal adhesion sites" NA NA "Nucleoplasm, Actin filaments" "Focal adhesion sites" "HPA036149: AB_10672080" "unprognostic (2.45e-2)" "unprognostic (4.17e-2)" 0.0 0.7 0.2 0.2 0.4 0.0 0.0 1.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.7 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.7 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R5 T2R5 ENSG00000127366 "Taste 2 receptor member 5" Q9NYW4 7 141790217-141791367 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 8.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 10.6" HPA053742 Approved "Nucleoplasm,Nucleoli,Cytoplasmic bodies" NA NA "Nucleoplasm, Nucleoli" "Cytoplasmic bodies" "HPA053742: " "unprognostic (5.48e-3)" "unprognostic (3.90e-3)" "unprognostic (6.07e-2)" "unprognostic (8.00e-3)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.71e-1)" "unprognostic (2.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.13e-5)" "unprognostic (1.13e-2)" "unprognostic (8.29e-7)" "unprognostic (1.29e-1)" "unprognostic (3.28e-1)" "unprognostic (6.92e-2)" "unprognostic (1.39e-2)" 1.0 1.0 0.4 1.4 1.1 0.2 3.2 4.9 0.7 2.5 0.9 0.8 2.8 6.1 1.1 3.0 0.8 0.8 0.6 0.7 1.0 0.5 1.1 1.2 0.4 4.6 1.5 0.1 2.9 1.0 1.7 1.2 1.6 1.0 2.6 8.8 1.7 1.2 1.2 1.9 0.7 1.4 1.7 1.2 1.3 2.4 1.0 0.6 0.5 0.2 0.4 1.4 0.1 0.5 0.2 1.4 0.6 0.9 2.7 1.7 0.6 0.6 0.5 0.9 2.1 0.4 1.1 0.9 0.3 0.0 0.3 1.5 0.8 0.3 0.6 1.7 0.3 1.2 2.7 0.9 1.7 1.3 2.3 10.6 1.2 2.9 3.0 1.0 1.5 2.6 0.4 0.1 1.7 0.6 3.9 1.3 0.2 0.3 0.2 0.1 2.8 0.4 0.7 2.0 1.3 0.3 0.4 0.2 1.7 0.1 0.4 0.3 1.0 0.7 0.6 1.2 1.9 0.4 1.4 0.8 0.8 0.5 0.5 0.2 0.0 1.0 0.0 0.0 0.9 0.3 0.4 0.0 1.0 0.9 1.4 0.0 0.4 0.0 0.6 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TATDN3 ENSG00000203705 "TatD DNase domain containing 3" Q17R31 1 212791828-212816626 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032092 Approved Approved "Nucleoplasm,Golgi apparatus,Focal adhesion sites" NA NA Nucleoplasm "Golgi apparatus, Focal adhesion sites" "HPA032092: AB_10671086" "unprognostic (9.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.17e-1)" "unprognostic (1.46e-1)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.80e-1)" "unprognostic (3.88e-2)" "unprognostic (3.34e-3)" "unprognostic (5.02e-3)" "prognostic favorable (1.59e-4)" "unprognostic (1.93e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-3)" "unprognostic (2.96e-3)" 13.0 14.8 14.4 10.9 24.7 11.9 11.0 12.5 22.9 7.6 8.8 16.6 6.8 7.0 8.5 15.2 8.3 8.7 8.3 20.7 13.7 15.2 18.3 11.1 8.5 16.2 14.5 18.9 10.1 11.3 12.8 11.9 8.0 22.1 8.0 8.6 11.4 9.4 8.2 29.4 7.4 8.1 11.6 15.5 11.5 11.9 10.5 12.0 11.3 13.1 8.3 10.8 10.6 6.5 15.6 30.1 23.8 24.1 5.3 6.9 8.7 6.6 6.6 5.8 8.6 9.4 14.1 13.4 7.4 8.0 5.9 7.4 1.7 9.4 14.7 7.0 6.3 3.4 4.3 7.1 10.0 6.4 9.0 9.2 7.4 5.5 3.2 10.9 17.7 9.3 11.3 7.2 8.0 19.9 6.4 8.5 21.0 14.4 12.3 6.5 3.1 15.1 5.9 7.8 8.2 4.3 8.7 11.0 26.3 6.1 3.3 12.4 10.6 8.1 13.8 16.2 11.0 14.7 11.0 5.8 4.5 6.0 9.3 7.2 11.0 16.9 24.4 11.6 14.1 6.7 8.5 15.6 23.8 5.5 23.7 4.9 15.6 6.9 6.6 18.4 12.7 5.5 6.6 17.5 5.3 24.1 30.1 6.4 8.7 14.4 24.7 12.5 22.9 13.7 15.2 14.5 18.9 22.1 12.0 6.0 15.2 14.3 8.7 3.9 14.8 33.0 10.2 10.7 3.4 3.5 17.7 10.9 34.9 14.4 7.5 6.3 3.9 0.0 14.5 14.4 6.0 4.5 6.9 5.5 16.4 14.3 9.8 4.3 25.0 2.9 4.9 17.6 13.5 30.7 4.0 14.9 11.0 7.0 4.6 20.7 27.3 6.5 6.9 21.3 16.9 3.9 7.8 10.2 5.8 5.5 TBC1D14 KIAA1322 ENSG00000132405 "TBC1 domain family member 14" Q9P2M4 4 6909242-7033118 "Plasma proteins, Predicted intracellular proteins" Autophagy "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 64.3" "Low region specificity" "Detected in all" "HPA036930, HPA067398" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Yes No "Golgi apparatus, Vesicles" Nucleoplasm "HPA036930: AB_10670155, HPA067398: AB_2685833" "unprognostic (3.05e-2)" "unprognostic (7.48e-3)" "unprognostic (4.80e-3)" "unprognostic (8.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.78e-3)" "unprognostic (9.63e-2)" "unprognostic (5.25e-2)" "unprognostic (9.71e-2)" "unprognostic (7.65e-2)" "unprognostic (1.80e-1)" "unprognostic (2.90e-1)" "prognostic favorable (5.28e-10)" "unprognostic (1.56e-1)" "unprognostic (3.50e-1)" "unprognostic (5.13e-3)" "unprognostic (4.12e-2)" 20.0 31.2 31.9 24.4 33.8 10.6 22.0 18.1 32.8 16.0 20.2 22.5 17.0 17.3 16.2 21.9 24.3 18.8 15.0 22.9 28.6 27.5 32.1 21.6 20.7 48.4 28.8 20.5 23.3 19.3 23.6 20.7 18.0 29.0 19.6 20.7 26.1 23.2 16.7 35.1 37.3 20.0 17.8 37.3 26.2 35.8 22.4 29.3 24.0 14.9 17.9 19.9 16.7 15.4 5.3 7.5 26.4 8.2 5.5 8.9 6.0 10.5 11.5 13.0 14.5 10.8 9.1 7.9 8.5 9.3 8.0 6.8 11.9 22.1 17.0 5.0 10.1 20.3 7.7 21.8 19.5 9.8 4.7 7.1 28.5 7.6 12.4 7.5 12.8 64.3 7.0 27.7 7.5 12.4 10.2 7.5 16.2 26.9 6.1 9.6 6.9 19.7 13.0 17.6 12.7 13.0 24.8 17.1 18.4 11.9 7.5 19.9 14.2 7.0 7.7 26.1 10.6 10.6 12.3 7.4 8.8 6.7 7.7 12.5 11.8 27.4 17.5 8.3 16.6 8.4 1.7 8.2 3.5 5.9 5.3 8.9 5.2 6.4 6.3 6.9 5.3 4.9 4.5 26.4 5.5 2.4 7.5 7.5 6.0 31.9 33.8 18.1 28.0 28.6 27.5 28.8 20.5 29.0 29.3 6.0 15.3 5.2 6.6 8.0 8.4 3.4 10.2 5.3 11.4 14.0 13.7 10.5 16.6 9.8 45.7 4.7 10.4 0.0 8.7 6.1 5.1 11.2 7.0 21.7 20.9 23.8 6.3 7.4 37.2 22.1 6.6 13.2 18.6 6.4 15.6 10.6 9.0 14.0 8.1 19.2 6.3 0.0 5.2 15.8 18.9 10.5 13.7 15.0 16.6 9.1 TBC1D2 "Armus, PARIS1, TBC1D2A" ENSG00000095383 "TBC1 domain family member 2" Q9BYX2 9 98198999-98255721 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 53.6;Hofbauer cells: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 18.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 27.5;HaCaT: 36.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030871, HPA076521" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Nucleoplasm, Plasma membrane, Cytosol" "HPA030871: AB_10670046, HPA076521: " "unprognostic (2.32e-2)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.86e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (9.21e-3)" "unprognostic (6.40e-3)" "unprognostic (2.30e-1)" "unprognostic (6.07e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.30e-2)" "unprognostic (4.30e-1)" 13.1 4.1 6.6 7.0 15.6 14.5 7.6 7.7 7.6 7.8 12.0 17.8 6.0 15.5 4.4 4.3 25.3 4.4 5.3 2.2 9.5 7.4 4.6 12.6 27.4 4.5 15.2 5.3 4.3 3.0 4.5 3.1 11.9 9.0 8.1 5.9 6.2 10.1 8.8 3.3 18.8 15.2 5.7 14.3 6.7 5.1 3.1 12.2 4.7 7.1 14.7 16.8 14.7 11.6 0.9 7.0 8.1 18.4 0.7 3.9 6.4 27.5 4.0 0.2 0.9 3.1 6.1 9.1 12.2 6.8 8.9 7.4 2.6 12.1 0.4 9.3 7.1 1.9 36.4 0.2 13.6 3.1 0.9 0.5 0.2 14.1 2.0 14.6 0.6 1.1 8.4 22.5 8.9 22.3 15.8 3.1 0.7 0.8 0.3 7.0 3.5 0.1 1.6 0.6 2.7 2.3 0.4 1.8 0.0 13.6 17.2 0.3 0.5 4.1 9.1 1.2 0.6 3.0 0.9 19.0 10.9 3.3 1.8 4.9 0.6 0.5 0.2 11.1 1.0 1.2 1.1 18.4 5.5 1.9 10.8 1.3 0.9 2.8 1.6 7.0 0.6 1.2 1.4 8.1 0.7 8.0 0.9 3.9 6.4 6.6 15.6 7.7 7.6 9.5 7.4 15.2 5.3 9.0 12.2 53.6 12.2 1.9 11.4 7.3 2.4 0.6 7.6 5.3 20.5 3.5 0.0 18.5 3.3 3.7 1.5 3.1 15.0 0.0 2.8 9.4 2.1 3.8 0.0 4.7 31.3 1.6 7.5 0.6 19.8 1.0 1.7 9.3 3.3 3.6 11.1 2.9 8.7 7.0 0.7 2.5 2.2 0.0 2.0 1.6 2.8 9.5 14.5 1.9 4.2 11.1 TBC1D22A C22orf4 ENSG00000054611 "TBC1 domain family member 22A" Q8WUA7 22 46762617-47175699 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001173 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA001173: AB_1080212" "unprognostic (1.62e-1)" "unprognostic (5.90e-3)" "unprognostic (1.10e-1)" "unprognostic (4.79e-3)" "unprognostic (3.65e-2)" "unprognostic (7.07e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (5.95e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (1.69e-1)" "unprognostic (9.17e-2)" "unprognostic (4.68e-2)" "unprognostic (4.93e-2)" "unprognostic (4.14e-1)" "unprognostic (1.09e-1)" "unprognostic (2.39e-1)" 18.1 17.6 18.3 36.5 16.0 14.0 16.4 10.8 18.5 14.6 23.1 22.4 16.5 22.8 20.6 17.8 24.8 19.6 22.1 15.1 16.1 15.4 18.1 14.8 18.5 26.6 17.3 17.0 16.1 20.5 18.8 15.9 23.2 16.9 12.5 15.3 17.0 23.5 15.5 23.7 22.6 26.3 13.0 18.4 27.2 22.8 14.2 18.2 21.1 17.8 16.5 36.3 16.5 17.3 11.7 10.8 13.2 15.0 4.4 8.6 5.6 13.4 9.4 6.0 7.2 8.7 12.3 7.3 9.2 12.6 10.5 11.4 10.5 10.5 11.8 10.4 14.0 6.6 15.0 5.1 14.4 7.4 5.1 14.3 6.7 8.2 20.2 13.4 14.5 5.4 14.3 17.0 7.2 10.2 12.7 17.3 7.5 4.3 12.7 9.5 6.9 6.4 7.5 5.8 12.7 10.6 8.3 7.0 12.7 12.2 7.0 4.9 9.1 8.5 3.2 14.3 7.8 7.7 9.7 13.9 8.1 11.6 8.5 5.8 8.5 2.7 7.6 20.1 7.5 5.0 2.1 9.0 5.3 5.9 13.0 5.7 10.8 5.5 5.5 10.8 11.7 3.6 4.0 13.2 4.4 15.0 5.3 8.6 5.6 18.3 16.0 10.8 18.5 16.1 15.4 17.3 17.0 16.9 18.2 23.8 16.5 38.9 10.0 5.7 16.7 6.9 10.2 16.0 21.6 7.0 17.7 19.9 10.0 21.8 10.3 16.1 28.0 0.0 20.6 15.8 9.4 9.0 16.2 7.8 29.2 20.6 3.5 20.9 20.7 2.2 9.2 25.5 10.1 51.3 15.2 12.9 26.2 21.2 11.0 16.5 28.1 12.9 7.1 4.9 9.7 6.9 24.3 10.2 16.6 10.2 TBC1D9B "GRAMD9B, KIAA0676" ENSG00000197226 "TBC1 domain family member 9B" Q66K14 5 179862066-179907859 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038350 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli fibrillar center" "HPA038350: AB_10673170" "unprognostic (5.06e-2)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" "unprognostic (9.53e-2)" "unprognostic (9.45e-3)" "unprognostic (4.25e-1)" "unprognostic (1.06e-1)" "unprognostic (2.84e-1)" "unprognostic (1.10e-1)" "unprognostic (5.08e-2)" "unprognostic (2.01e-1)" "unprognostic (2.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (3.99e-4)" "unprognostic (8.22e-2)" 30.4 28.7 31.2 14.3 29.8 17.0 21.2 27.0 37.9 21.7 17.8 36.7 20.6 16.4 18.9 24.5 21.7 20.7 19.0 15.2 31.4 26.6 20.7 22.4 18.3 16.8 34.9 23.3 24.8 24.6 22.7 13.3 14.8 29.0 18.2 14.5 17.5 25.6 21.9 20.3 24.0 18.9 19.1 42.3 18.0 16.1 12.2 24.1 12.0 23.3 12.5 17.2 17.4 19.7 5.4 9.4 5.0 8.1 3.7 5.5 4.9 10.7 16.6 7.6 17.6 23.3 14.9 17.7 13.1 13.6 13.2 13.2 11.1 10.8 7.4 16.2 15.9 17.3 10.3 9.1 30.6 6.1 24.6 10.2 6.6 12.2 7.4 12.5 8.7 23.0 17.2 13.3 10.4 7.5 12.3 14.5 14.8 4.4 8.7 11.8 27.0 5.6 7.2 5.3 8.2 9.5 9.7 5.8 7.3 12.4 17.6 10.9 8.0 12.4 14.8 15.0 8.5 11.7 14.1 14.7 19.3 8.6 9.2 11.5 4.4 5.7 5.8 18.3 11.2 13.6 4.5 5.9 5.0 5.5 8.1 4.5 5.4 4.0 4.7 7.8 5.1 3.9 3.1 0.8 3.7 7.9 9.4 3.4 4.9 31.2 29.8 27.0 37.9 31.4 26.6 34.9 23.3 29.0 24.1 20.8 19.2 17.1 8.5 14.7 25.0 8.4 17.8 10.7 9.1 26.2 7.9 15.5 11.6 18.4 1.7 23.8 22.6 0.0 15.6 18.8 15.9 12.8 10.5 30.0 27.4 58.8 17.3 23.4 26.1 5.4 30.0 21.0 15.1 19.0 21.9 15.8 21.8 23.0 26.9 18.1 17.7 25.8 11.0 6.9 17.5 13.7 11.8 13.1 18.2 11.9 TCF7L2 "TCF-4, TCF4" ENSG00000148737 "Transcription factor 7 like 2" Q9NQB0 10 112950250-113167678 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 184.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 12.1;non-classical monocyte: 33.1" "Lineage enriched" "Detected in many" 13 "monocytes: 33.1" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in many" 8 "midbrain: 84.5;thalamus: 98.3" "Group enriched" "Detected in all" 5 "midbrain: 190.1;pons and medulla: 104.8;thalamus: 169.1" "CAB013535, HPA038800" Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "CAB013535: AB_2533167, HPA038800: " "unprognostic (1.79e-2)" "unprognostic (3.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (4.59e-3)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-2)" "unprognostic (5.09e-1)" "unprognostic (7.10e-2)" "unprognostic (6.10e-3)" "unprognostic (3.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (3.64e-1)" "unprognostic (7.36e-3)" 27.4 10.3 8.7 18.7 10.0 7.3 46.4 5.4 10.3 27.4 34.2 15.4 28.1 21.0 26.6 14.9 12.6 18.2 15.3 13.5 8.1 17.9 10.2 22.9 26.9 13.9 8.5 9.0 25.6 13.9 16.5 17.9 24.0 10.2 14.4 23.7 13.9 14.9 52.8 13.7 17.6 40.4 18.0 13.9 27.3 24.0 10.6 10.1 6.6 14.3 9.3 7.0 21.5 16.3 0.0 1.7 2.5 33.1 0.0 0.6 1.1 7.1 18.6 20.4 19.7 10.7 7.1 24.4 5.1 9.9 3.5 4.3 12.3 21.6 0.0 5.7 9.5 4.8 5.1 6.9 8.8 4.5 0.8 6.4 5.0 12.4 11.3 11.4 1.9 1.8 12.6 3.2 5.5 9.4 15.1 5.9 4.2 5.2 0.3 4.1 13.9 3.2 1.2 14.6 8.0 10.7 9.0 15.0 3.2 7.7 9.9 0.4 6.3 7.7 7.6 8.1 16.5 4.9 1.1 13.7 3.3 9.6 8.5 10.4 1.3 0.1 0.1 3.3 4.2 7.4 0.1 1.8 0.1 0.6 12.1 0.4 0.0 0.1 0.5 1.7 0.0 0.1 0.3 2.5 0.0 33.1 0.0 0.0 1.1 8.7 10.0 5.4 10.3 8.1 17.9 8.5 9.0 10.2 10.1 20.8 21.6 4.7 23.8 37.8 2.4 10.6 35.7 20.1 34.2 38.4 5.9 36.9 10.0 28.5 5.5 37.0 121.0 0.0 38.6 184.2 40.4 33.1 0.0 57.7 15.1 4.8 19.0 55.3 68.7 2.7 54.7 21.0 30.4 1.0 68.2 36.6 41.7 91.2 45.6 13.4 5.7 90.5 44.3 3.0 23.4 34.8 23.8 4.3 42.7 42.0 TCIM "C8orf4, hTC-1, TC-1, TC1" ENSG00000176907 "Transcriptional and immune response regulator" Q9NR00 8 40153455-40155308 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 21 "Alveolar cells type 2: 796.6;Collecting duct cells: 190.1;Distal tubular cells: 164.2;Ductal cells: 262.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 14.6;AF22: 41.5;BJ: 15.6;BJ hTERT+: 40.9;EFO-21: 27.2;HeLa: 26.1;RPTEC TERT1: 20.7;SuSa: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027188 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA027188: AB_10601150" "unprognostic (8.88e-2)" "unprognostic (2.76e-2)" "unprognostic (7.89e-3)" "unprognostic (7.95e-2)" "unprognostic (7.33e-3)" "unprognostic (1.87e-3)" "unprognostic (2.11e-1)" "unprognostic (2.32e-1)" "unprognostic (2.93e-2)" "unprognostic (8.15e-2)" "unprognostic (6.23e-2)" "unprognostic (8.19e-2)" "unprognostic (2.54e-2)" "unprognostic (5.32e-3)" "unprognostic (1.39e-1)" "unprognostic (9.13e-3)" "unprognostic (4.48e-2)" 23.5 5.9 1.8 23.2 4.5 0.0 16.0 0.6 5.9 32.1 24.1 1.0 15.6 6.0 14.3 20.3 22.2 4.3 22.1 38.3 2.0 1.7 44.5 54.7 96.5 5.0 2.7 4.3 11.9 24.4 28.9 6.2 50.2 2.3 29.6 15.2 7.9 89.9 16.3 20.2 4.0 21.2 72.4 4.3 26.7 10.7 4.9 1.4 1.3 15.8 14.4 4.8 35.8 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 41.5 0.0 0.0 0.0 0.1 15.6 40.9 0.0 0.2 0.2 0.0 0.0 27.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 26.1 6.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 1.4 0.0 16.3 0.0 0.0 13.1 0.0 0.4 0.1 0.2 0.3 0.4 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 4.5 0.6 5.9 2.0 1.7 2.7 4.3 2.3 1.4 92.3 796.6 0.0 0.0 0.0 0.0 0.0 0.0 16.0 142.1 190.1 0.0 1.4 164.2 262.6 0.0 0.0 0.0 0.0 95.4 11.4 0.0 0.0 24.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 8.2 0.0 0.0 112.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TCL1A TCL1 ENSG00000100721 "T cell leukemia/lymphoma 1A" P56279 14 95709967-95714196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "blood: 179.4;lymphoid tissue: 63.7" "Group enriched" "Detected in some" 5 "B-cells: 166.3;Spermatogonia: 48.5" "Cancer enriched" "Detected in many" 18 "testis cancer: 64.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 381 "memory B-cell: 45.6;naive B-cell: 179.4;plasmacytoid DC: 79.8" "Group enriched" "Detected in many" 487 "B-cells: 179.4;dendritic cells: 79.8" "Group enriched" "Detected in some" 157 "Daudi: 71.1;REH: 92.4;U-698: 94.4" "Not detected" "Not detected" "CAB004045, HPA016604" Enhanced Enhanced "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB004045: AB_2179419, HPA016604: AB_1857859" "unprognostic (1.27e-3)" "unprognostic (3.12e-4)" "unprognostic (2.61e-4)" "unprognostic (2.01e-2)" "unprognostic (1.27e-1)" "unprognostic (4.75e-4)" "unprognostic (7.70e-2)" "unprognostic (9.67e-3)" "unprognostic (1.03e-1)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-2)" "unprognostic (2.64e-2)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (4.55e-1)" 0.4 0.2 0.2 53.4 0.2 4.8 0.3 0.2 0.2 0.2 0.9 0.0 0.2 0.0 0.3 0.0 0.8 0.3 0.6 0.3 0.2 0.2 1.1 0.4 3.2 63.7 0.2 0.0 0.3 0.2 0.0 0.2 0.6 0.0 0.4 0.2 0.1 2.9 0.0 0.2 0.2 10.4 0.1 0.2 33.5 0.5 5.3 0.0 4.7 0.8 1.2 53.6 3.6 0.3 179.4 79.8 0.2 0.1 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.5 94.4 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 45.6 0.0 0.0 0.1 179.4 0.1 0.0 0.2 0.0 0.1 79.8 0.0 6.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 2.2 166.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 20.6 48.5 0.0 0.0 0.0 0.0 0.0 TDRD3 FLJ21007 ENSG00000083544 "Tudor domain containing 3" Q9H7E2 13 60396457-60573878 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "granulocytes: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034925, HPA067153" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB034925: AB_2240523, HPA067153: AB_2732759" "unprognostic (8.52e-2)" "unprognostic (3.19e-1)" "unprognostic (2.23e-1)" "prognostic favorable (2.77e-4)" "unprognostic (5.21e-2)" "unprognostic (2.62e-1)" "unprognostic (7.37e-2)" "unprognostic (5.79e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-1)" "unprognostic (6.18e-3)" "unprognostic (9.62e-2)" "unprognostic (9.95e-2)" "unprognostic (3.68e-2)" "unprognostic (4.40e-2)" "unprognostic (1.27e-3)" 13.7 12.0 13.0 10.3 14.7 6.9 16.9 13.8 14.2 16.7 17.2 11.7 14.2 12.9 15.2 14.2 16.5 14.4 12.7 16.7 12.9 10.6 16.2 13.5 16.9 11.3 13.5 14.8 20.6 21.3 15.3 15.4 12.4 17.7 15.5 15.5 11.1 12.5 14.8 42.4 15.2 16.7 19.0 16.8 12.9 14.8 15.9 15.0 18.7 16.9 18.6 12.1 19.0 15.4 3.8 7.2 2.3 3.5 3.0 6.9 2.1 4.4 4.9 10.9 25.4 4.4 9.5 6.5 5.1 5.8 6.0 3.9 3.2 7.4 10.9 2.1 7.5 5.1 6.3 8.9 7.5 6.5 8.2 6.8 20.3 9.4 6.2 8.5 14.2 10.6 6.4 10.7 3.5 10.6 12.5 8.1 9.0 4.5 6.7 6.5 4.8 12.7 7.4 8.3 16.1 3.8 6.8 5.3 7.2 8.2 5.9 9.7 11.6 7.4 9.0 18.5 7.8 4.6 6.2 6.8 3.8 3.9 4.3 5.6 13.3 11.5 9.4 3.6 7.4 11.7 0.5 2.3 2.3 5.5 3.5 3.8 3.8 6.2 6.2 3.3 2.7 5.2 6.4 0.1 3.0 2.5 7.2 6.9 2.1 13.0 14.7 13.8 14.2 12.9 10.6 13.5 14.8 17.7 15.0 20.8 28.8 13.4 9.0 7.0 29.0 40.4 5.1 33.5 25.0 10.4 51.1 7.3 18.3 11.5 16.8 12.8 9.3 0.0 15.4 8.8 8.3 6.1 143.8 7.2 6.3 19.1 16.7 8.0 9.4 17.0 17.5 11.6 18.6 8.2 13.8 13.4 9.6 15.3 17.3 9.9 28.8 6.5 7.5 33.9 15.5 5.8 5.6 13.8 13.8 6.3 TEDC1 C14orf80 ENSG00000185347 "Tubulin epsilon and delta complex 1" Q86SX3 14 105489855-105499575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Exocrine glandular cells: 11.1;Extravillous trophoblasts: 21.4;Hofbauer cells: 12.7;monocytes: 20.8;Pancreatic endocrine cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039049, HPA039050" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039049: AB_2676320, HPA039050: AB_10670918" "unprognostic (8.06e-2)" "unprognostic (1.06e-2)" "unprognostic (9.17e-2)" "unprognostic (1.65e-1)" "unprognostic (3.06e-1)" "unprognostic (1.57e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (5.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-3)" "unprognostic (8.73e-3)" "unprognostic (2.88e-1)" "unprognostic (1.17e-1)" "unprognostic (6.18e-3)" 5.1 2.0 10.5 8.5 13.6 10.8 5.2 5.1 10.3 3.3 7.6 10.7 2.0 9.4 5.5 5.0 5.2 4.0 5.5 3.4 10.3 7.4 2.9 4.0 6.2 8.8 7.9 4.6 2.7 6.4 2.5 4.5 7.9 7.1 3.7 3.2 3.9 5.8 4.6 3.9 10.1 8.3 2.1 7.4 5.9 10.6 9.1 9.5 16.0 5.1 7.1 11.8 6.1 3.5 0.8 5.7 1.4 2.2 0.1 3.7 0.7 7.9 18.5 4.4 6.6 0.4 0.7 12.0 6.4 2.5 7.7 7.4 6.6 15.1 12.1 13.4 1.0 3.0 21.3 1.5 6.8 1.5 14.3 7.6 3.2 10.2 6.5 0.3 6.1 8.9 0.1 2.3 5.2 1.6 1.0 3.0 11.3 5.0 15.2 1.2 30.8 12.7 13.9 5.7 6.8 19.6 10.4 6.8 8.4 2.1 6.8 12.6 7.4 6.6 7.8 4.6 1.0 12.4 6.1 3.8 5.4 9.2 16.4 10.5 8.9 3.7 7.3 6.9 7.0 8.7 0.0 1.2 1.4 1.5 2.2 1.0 0.3 2.2 3.7 1.7 0.8 1.4 0.4 0.4 0.1 2.0 5.7 1.6 0.7 10.5 13.6 5.1 10.3 10.3 7.4 7.9 4.6 7.1 9.5 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.2 1.8 0.0 3.9 3.3 8.1 0.0 0.0 0.0 0.0 11.1 21.4 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 20.8 0.0 0.0 10.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 TERT "EST2, hEST2, TCS1, TP2, TRT" ENSG00000164362 "Telomerase reverse transcriptase" O14746 5 1253147-1295069 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase" "Cancer-related genes, Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 1.2;Spermatogonia: 1.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 62.6;fHDF/TERT166: 59.4;HBEC3-KT: 120.8;hTEC/SVTERT24-B: 76.3;LHCN-M2: 34.4;TIME: 98.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA054641, HPA065897" Supported Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA054641: AB_2682554, HPA065897: AB_2685576" "unprognostic (1.21e-2)" "unprognostic (2.88e-2)" "unprognostic (1.24e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-3)" "unprognostic (6.42e-3)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "unprognostic (6.91e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (9.16e-4)" "unprognostic (8.84e-11)" "unprognostic (1.92e-1)" "unprognostic (2.15e-1)" "unprognostic (3.35e-1)" 0.0 0.0 0.0 7.1 0.9 3.4 0.0 0.0 0.2 0.1 1.1 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 1.0 0.4 5.0 0.0 12.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 31.3 62.6 0.5 0.0 23.8 4.3 8.0 0.1 0.1 0.7 0.0 59.4 0.0 0.0 0.2 120.8 5.1 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.3 0.0 3.1 76.3 0.8 0.1 0.2 0.5 0.6 0.1 34.4 0.0 0.2 1.7 0.4 0.0 0.2 0.9 0.0 0.8 3.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 98.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.2 0.0 TESMIN "CXCDC2, MTL5" ENSG00000132749 "Testis expressed metallothionein like protein" Q9Y4I5 11 68707440-68751564 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 81.0" "Cell type enhanced" "Detected in some" 9 "Distal tubular cells: 5.0;Ductal cells: 5.8;Exocrine glandular cells: 3.4;Extravillous trophoblasts: 3.7;Pancreatic endocrine cells: 5.1;Proximal tubular cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 10.7;T-47d: 21.2" "Not detected" "Not detected" HPA018539 Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA018539: " "unprognostic (1.99e-1)" "unprognostic (3.97e-3)" "unprognostic (1.34e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (3.22e-2)" "unprognostic (6.71e-2)" "unprognostic (1.76e-2)" "unprognostic (6.99e-3)" "unprognostic (2.54e-1)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (8.47e-2)" "unprognostic (5.27e-2)" "unprognostic (6.39e-2)" "unprognostic (2.99e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-1)" 0.3 0.5 0.3 1.6 1.4 4.8 3.3 0.1 0.6 0.6 1.9 0.0 3.8 1.0 0.5 1.2 1.3 1.3 1.0 0.4 0.2 0.9 3.2 0.3 0.4 0.9 0.6 0.4 0.8 2.6 2.6 1.9 0.4 1.8 1.7 2.2 0.6 2.5 5.2 0.1 0.5 1.2 0.3 0.7 1.2 0.6 81.0 0.1 5.5 1.5 0.9 2.0 0.5 0.7 0.4 0.1 2.8 1.1 0.0 1.1 0.4 6.2 2.7 1.2 0.0 0.0 0.0 3.2 1.4 0.7 2.0 0.9 0.8 6.3 2.5 1.4 0.2 0.0 3.0 0.9 1.2 1.6 2.6 2.2 1.8 0.9 0.0 0.0 1.3 10.7 0.0 3.4 0.1 2.0 2.7 0.6 3.0 3.8 4.8 0.3 4.1 0.7 3.6 6.5 2.9 2.8 1.6 0.3 0.7 2.3 0.1 4.0 4.3 0.0 1.3 0.0 3.5 21.2 8.7 2.3 0.2 0.4 0.1 0.1 1.9 1.7 2.4 0.1 3.7 1.7 0.0 1.0 1.0 0.3 0.4 0.6 0.0 1.1 0.2 0.1 0.4 0.4 0.3 2.8 0.0 1.1 0.1 0.8 0.4 0.3 1.4 0.1 0.6 0.2 0.9 0.6 0.4 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.7 5.0 5.8 0.0 0.0 0.0 0.0 3.4 3.7 0.0 0.0 2.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.1 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 TET3 "hCG_40738, MGC22014" ENSG00000187605 "Tet methylcytosine dioxygenase 3" O43151 2 73986404-74108176 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 44.0;Suprabasal keratinocytes: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050845 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA050845: AB_2681256" "unprognostic (1.07e-2)" "unprognostic (1.21e-2)" "unprognostic (3.08e-1)" "unprognostic (1.12e-2)" "unprognostic (4.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (9.83e-2)" "unprognostic (7.74e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.05e-1)" "unprognostic (5.30e-1)" "unprognostic (1.55e-2)" "unprognostic (1.10e-1)" 2.9 2.3 7.2 6.1 10.8 20.9 3.9 26.0 17.1 3.2 5.1 20.6 0.5 6.7 2.9 1.9 10.2 3.0 3.3 1.6 7.1 3.3 2.6 5.1 5.6 4.3 12.0 9.5 2.9 3.6 3.5 4.2 5.7 12.4 3.6 5.5 5.9 5.9 1.8 1.8 18.9 7.2 2.7 5.3 5.5 5.3 2.1 11.7 0.6 3.4 1.7 5.1 4.0 5.0 1.1 1.4 2.5 2.2 0.4 0.9 0.9 6.2 5.5 10.5 6.4 0.9 1.0 19.4 1.3 1.7 2.5 2.0 11.8 5.8 10.5 2.6 1.7 1.1 6.7 9.3 3.7 2.6 4.5 3.7 13.4 4.6 4.0 3.9 14.0 8.3 1.5 9.8 3.1 7.3 3.1 3.8 7.4 9.1 3.5 1.4 10.3 6.9 9.2 5.9 5.4 1.9 10.5 6.6 3.6 2.8 11.7 13.2 11.3 2.8 7.5 3.6 4.4 4.8 11.4 4.8 2.7 11.4 1.3 4.7 3.1 1.3 9.1 1.8 9.8 3.5 0.5 2.0 1.0 0.4 2.2 0.9 1.1 0.5 0.5 1.4 0.9 0.7 0.6 2.5 0.4 0.7 1.4 0.0 0.9 7.2 10.8 26.0 17.1 7.1 3.3 12.0 9.5 12.4 11.7 6.0 7.0 0.0 3.0 44.0 14.5 2.8 5.1 10.7 9.1 1.8 19.6 5.5 0.0 3.0 2.9 5.6 9.5 23.3 3.8 27.5 6.6 4.8 2.3 4.4 8.9 9.5 5.8 3.7 27.8 0.6 0.6 13.8 10.1 9.0 8.4 1.5 5.1 10.5 2.8 1.2 5.8 0.0 5.3 0.5 3.1 59.6 2.1 4.3 6.4 4.8 TFAP2D TFAP2BL1 ENSG00000008197 "Transcription factor AP-2 delta" Q7Z6R9 6 50713828-50772988 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 4.4" "Cell type enhanced" "Detected in single" 24 "Horizontal cells: 1.6" "Cancer enriched" "Detected in single" 10 "lung cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 5.2;U-2197: 1.6" "Region enriched" "Detected in many" 4 "midbrain: 14.1" "Region enriched" "Detected in many" 7 "midbrain: 16.3" HPA048962 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA048962: AB_2680573" 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFDP2 Dp-2 ENSG00000114126 "Transcription factor Dp-2" Q14188 3 141944428-142149544 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 140.3" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 731.6;Late spermatids: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 42.8;MOLT-4: 80.4;REH: 42.9;U-698: 70.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018396, HPA070399" Supported Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes No Nucleoplasm "Vesicles, Mitotic spindle" "CAB018396: AB_2287284, HPA070399: " "unprognostic (1.35e-2)" "prognostic favorable (6.32e-4)" "unprognostic (8.08e-3)" "unprognostic (2.90e-2)" "unprognostic (4.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-3)" "unprognostic (2.60e-3)" "unprognostic (5.42e-2)" "unprognostic (1.46e-1)" "unprognostic (5.04e-2)" "unprognostic (2.04e-1)" "prognostic favorable (9.84e-4)" "unprognostic (6.04e-2)" "unprognostic (3.91e-2)" "unprognostic (2.45e-1)" "unprognostic (1.08e-1)" 8.4 8.4 6.1 6.3 8.7 20.7 9.3 9.9 8.6 8.9 11.1 6.5 6.5 10.4 9.9 8.6 8.3 7.2 11.6 12.0 7.5 4.9 14.3 9.5 6.8 5.3 6.0 5.0 11.6 8.8 10.4 19.4 13.5 8.0 9.9 6.6 8.8 7.9 6.9 14.5 8.0 14.6 11.8 8.5 5.3 8.6 51.9 5.4 140.3 10.6 4.8 6.4 9.7 8.0 9.3 16.5 24.6 4.5 18.0 14.7 5.7 6.3 2.9 12.3 9.8 4.1 4.5 27.1 3.2 3.7 5.1 8.3 3.7 6.3 22.5 15.0 3.6 9.0 3.8 3.1 6.1 7.2 9.0 5.6 27.1 4.4 4.9 4.0 8.2 9.6 4.2 4.3 5.6 5.4 4.8 3.5 42.8 10.1 1.2 8.8 4.8 80.4 3.1 9.9 3.3 4.0 42.9 8.5 5.2 5.9 3.3 5.4 5.0 10.8 4.0 5.5 9.6 9.3 4.2 2.3 4.9 4.5 3.9 4.0 4.2 3.8 70.6 3.9 2.2 2.3 24.6 2.1 22.3 14.7 3.4 5.7 6.6 6.7 7.6 4.8 9.3 10.1 11.8 2.4 18.0 4.5 16.5 6.1 5.7 6.1 8.7 9.9 8.6 7.5 4.9 6.0 5.0 8.0 5.4 29.8 20.4 15.7 43.3 22.2 30.3 70.0 38.2 54.9 33.0 45.4 31.4 191.4 79.6 29.5 731.6 22.4 31.6 116.8 23.1 95.8 33.4 41.8 31.3 35.9 24.4 35.0 37.2 20.9 9.2 294.5 71.4 15.0 5.0 17.2 32.3 24.6 24.5 32.3 70.7 74.6 34.6 25.8 21.4 52.6 55.1 17.6 83.0 35.5 42.3 22.7 TGDS "SDR2E1, TDPGD" ENSG00000088451 "TDP-glucose 4,6-dehydratase" O95455 13 94574051-94596257 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039927, HPA040857" Approved Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA039927: AB_10795238, HPA040857: AB_10794867" "unprognostic (4.07e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (2.87e-1)" "unprognostic (9.99e-2)" "unprognostic (1.96e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (5.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-2)" "unprognostic (1.09e-1)" 11.1 12.2 7.9 11.4 11.8 5.8 13.4 8.0 7.8 11.9 9.0 9.0 13.4 11.1 13.7 13.2 10.3 10.5 8.7 7.7 7.0 7.0 11.8 31.9 7.8 12.5 11.8 6.8 13.9 14.1 6.2 24.3 10.8 10.1 10.5 10.6 15.4 12.5 12.7 7.6 7.9 11.1 10.3 12.6 11.9 9.8 7.2 12.6 27.1 15.8 8.9 12.5 10.9 9.2 9.9 8.0 10.5 7.0 10.4 17.4 6.7 7.4 3.1 5.2 4.7 7.7 6.2 6.5 6.8 6.5 6.4 6.2 8.5 7.3 11.4 6.9 4.7 4.2 4.7 9.2 5.3 6.6 9.0 3.6 9.2 3.6 7.9 9.8 31.4 6.3 7.2 4.2 3.6 10.3 5.1 5.9 8.4 9.0 4.0 5.8 4.5 8.6 16.2 6.9 12.0 4.0 7.3 5.3 6.7 8.1 3.3 7.4 4.1 5.1 10.8 19.0 9.1 4.8 17.1 5.5 2.6 6.8 3.9 5.6 9.1 4.9 42.1 7.0 11.7 7.0 10.5 5.3 9.6 9.6 6.2 14.5 9.9 11.3 10.5 8.0 7.3 17.4 12.4 1.5 10.4 7.0 7.1 12.5 6.7 7.9 11.8 8.0 7.8 7.0 7.0 11.8 6.8 10.1 12.6 11.9 5.0 15.6 9.5 2.2 4.5 4.7 0.0 10.7 10.3 7.0 2.0 12.9 8.3 9.8 1.1 6.3 5.5 0.0 8.0 15.4 12.0 9.9 10.5 19.8 10.0 1.6 5.2 9.2 7.6 0.4 13.3 9.6 8.5 12.6 8.1 6.3 8.2 7.0 7.8 13.3 4.0 25.8 6.4 12.0 10.4 3.1 8.7 8.7 8.0 8.7 THAP10 ENSG00000129028 "THAP domain containing 10" Q9P2Z0 15 70881342-70892785 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 17.0;Collecting duct cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.3" "Lineage enriched" "Detected in many" 6 "monocytes: 7.3" "Cell line enhanced" "Detected in many" "U-2197: 27.6" "HPA041416, HPA073220" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA041416: AB_10795592, HPA073220: " "unprognostic (1.00e-1)" "unprognostic (3.51e-1)" "unprognostic (5.42e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-1)" "unprognostic (6.15e-2)" "unprognostic (6.25e-2)" "unprognostic (2.16e-2)" "unprognostic (2.99e-2)" "unprognostic (6.47e-2)" "unprognostic (1.55e-3)" "unprognostic (3.71e-2)" "prognostic favorable (3.05e-5)" "unprognostic (1.25e-2)" "unprognostic (2.12e-2)" "unprognostic (7.46e-2)" "unprognostic (9.44e-3)" 3.3 4.6 7.5 2.5 10.9 0.3 3.9 13.4 16.0 4.8 4.1 9.9 0.8 4.3 4.2 4.0 3.9 6.3 3.0 9.4 7.8 10.3 5.8 3.7 3.6 1.8 9.5 6.5 7.8 3.7 8.7 4.6 3.6 11.7 5.7 3.8 7.0 3.7 6.5 3.8 2.4 2.4 4.1 11.6 1.8 5.1 6.2 7.6 0.2 7.0 1.8 1.6 5.5 3.8 0.6 1.1 0.0 7.3 0.8 0.4 0.2 4.7 8.2 5.3 6.8 2.7 3.2 0.1 9.2 4.0 7.9 9.4 1.2 6.5 0.0 5.8 2.4 9.9 7.3 11.2 2.1 7.0 0.0 5.8 1.7 4.7 0.5 1.4 0.4 3.5 1.1 3.5 4.4 4.2 5.6 3.8 0.0 0.5 0.0 5.2 3.6 0.0 1.6 7.8 3.5 3.2 0.0 6.7 0.2 3.1 3.9 5.7 6.1 6.3 2.7 3.9 5.5 3.2 3.8 3.0 5.6 3.8 27.6 6.4 2.3 2.7 0.0 3.3 0.6 7.8 0.0 0.6 0.0 0.1 0.9 0.1 0.6 0.4 0.0 1.1 0.3 0.0 0.3 0.0 0.8 7.3 0.0 0.3 0.2 7.5 10.9 13.4 16.0 7.8 10.3 9.5 6.5 11.7 7.6 0.0 0.3 0.0 3.6 1.5 17.0 5.5 0.0 4.0 1.2 10.4 0.0 0.1 8.3 2.5 6.1 2.2 0.8 0.0 1.0 0.2 2.2 1.8 0.0 1.0 1.2 1.6 2.9 0.6 0.3 4.7 2.3 0.9 0.0 0.0 1.3 4.7 0.7 2.9 4.6 4.8 4.1 0.0 2.0 9.9 1.9 1.3 0.1 0.0 2.9 3.7 THAP3 ENSG00000041988 "THAP domain containing 3" Q8WTV1 1 6624866-6635586 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067114 Approved Approved Nucleoplasm,Nucleoli,Mitochondria No No Nucleoplasm "Nucleoli, Mitochondria" "HPA067114: AB_2685782" "unprognostic (1.82e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.89e-2)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (2.14e-3)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (4.63e-2)" "unprognostic (3.50e-3)" "unprognostic (4.30e-2)" "unprognostic (1.11e-2)" "unprognostic (4.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.26e-3)" 14.2 17.2 16.4 11.4 16.8 12.9 31.4 21.5 20.3 16.5 16.6 13.8 11.8 12.0 15.2 13.6 11.8 16.3 11.9 19.0 16.0 14.5 17.2 17.3 10.8 15.5 18.1 14.1 23.7 28.8 12.1 14.2 11.4 17.6 17.0 7.2 11.5 24.8 16.7 20.9 14.2 11.4 12.7 13.0 15.3 12.0 11.9 16.3 11.6 22.6 9.0 12.9 17.2 21.6 22.2 18.0 10.6 14.7 17.0 22.0 15.0 9.9 9.4 8.6 12.4 14.3 12.9 8.3 9.0 11.8 24.0 15.0 12.6 6.3 8.8 12.2 9.9 8.9 7.9 13.6 8.0 8.4 15.1 22.3 10.1 12.6 11.2 17.9 7.1 10.5 12.0 10.3 15.1 13.3 14.7 10.3 15.5 10.2 11.4 8.8 6.9 12.4 16.2 7.4 11.7 16.0 11.9 10.5 12.7 10.7 2.4 11.4 12.9 11.0 15.2 20.8 7.5 9.7 12.9 9.3 12.8 7.7 8.7 14.0 12.9 13.7 11.6 10.8 15.4 7.2 10.2 14.7 10.6 20.1 11.7 20.2 17.1 19.7 20.8 18.0 22.2 22.0 18.5 9.0 17.0 9.1 16.4 19.3 15.0 16.4 16.8 21.5 20.3 16.0 14.5 18.1 14.1 17.6 16.3 0.0 6.9 9.8 10.6 12.5 10.9 5.6 7.6 14.7 3.4 8.7 5.9 12.9 16.6 9.6 5.3 14.0 11.6 23.3 9.0 15.6 14.6 13.0 5.7 10.0 13.4 4.8 7.5 10.4 13.2 2.3 17.3 8.3 10.1 22.6 7.7 9.8 9.8 8.4 21.9 15.1 6.9 12.9 20.6 8.1 16.0 12.9 13.7 9.2 11.5 13.7 THAP7 MGC10963 ENSG00000184436 "THAP domain containing 7" Q9BT49 22 20999104-21002196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003083 Approved Supported "Nucleoplasm,Nuclear membrane,Vesicles" NA NA Nucleoplasm "Nuclear membrane, Vesicles" "HPA003083: AB_1080264" "unprognostic (6.48e-2)" "unprognostic (2.13e-3)" "unprognostic (3.28e-1)" "unprognostic (4.89e-3)" "unprognostic (1.92e-2)" "unprognostic (1.82e-3)" "unprognostic (5.56e-2)" "unprognostic (1.40e-2)" "unprognostic (2.82e-1)" "unprognostic (2.74e-3)" "unprognostic (1.27e-3)" "unprognostic (2.23e-2)" "unprognostic (9.15e-2)" "unprognostic (2.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.72e-2)" "unprognostic (3.51e-3)" 11.2 17.1 12.0 10.5 11.5 9.7 11.5 14.8 24.1 16.6 15.0 14.0 19.8 15.6 14.3 11.7 11.6 13.6 16.6 12.5 11.3 11.4 13.1 22.5 11.1 14.8 12.0 11.5 20.2 20.5 11.7 26.8 12.4 11.4 18.8 5.8 18.7 30.2 19.8 44.5 15.0 14.4 12.2 8.9 16.2 15.3 28.6 11.7 12.3 22.1 14.6 14.2 13.0 12.0 23.9 15.7 4.3 11.6 11.0 24.7 12.4 10.6 12.0 3.2 5.5 2.9 3.6 7.2 6.1 5.4 7.4 7.0 6.1 6.2 9.0 5.8 3.4 4.0 7.3 2.8 5.6 1.1 8.4 17.7 10.5 9.1 7.1 8.9 10.0 6.6 3.4 7.0 6.5 6.0 3.3 3.9 6.0 49.9 9.2 4.0 13.6 10.7 6.7 4.7 7.2 12.1 8.9 6.5 4.8 3.9 5.5 7.3 6.1 7.0 9.0 9.5 1.5 10.4 6.8 2.5 12.2 9.6 7.2 6.1 13.4 7.6 6.8 13.1 6.4 10.4 1.0 11.5 4.3 14.3 11.6 19.0 23.9 17.6 14.8 10.7 18.4 24.7 19.7 1.0 11.0 11.4 15.7 14.5 12.4 12.0 11.5 14.8 24.1 11.3 11.4 12.0 11.5 11.4 11.7 14.9 22.6 29.8 17.2 16.9 31.2 10.0 38.2 18.7 10.3 24.4 13.7 26.0 54.7 21.0 23.7 22.4 23.1 0.0 33.0 27.5 22.8 23.6 20.8 30.8 24.2 12.7 21.4 15.4 10.5 35.5 38.6 16.3 38.8 28.9 19.4 37.0 21.8 17.6 30.4 35.1 21.3 38.8 25.9 123.0 55.1 14.3 24.7 22.4 21.5 10.6 THYN1 THY28 ENSG00000151500 "Thymocyte nuclear protein 1" Q9P016 11 134248279-134253370 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038732, HPA038733" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA038732: AB_10697397, HPA038733: AB_2676183" "unprognostic (5.91e-2)" "unprognostic (6.22e-3)" "unprognostic (4.54e-2)" "unprognostic (3.48e-3)" "unprognostic (2.32e-2)" "unprognostic (8.99e-2)" "unprognostic (2.12e-1)" "prognostic favorable (1.01e-5)" "unprognostic (3.32e-2)" "unprognostic (1.99e-2)" "unprognostic (1.02e-1)" "unprognostic (1.13e-1)" "unprognostic (2.37e-1)" "unprognostic (1.71e-1)" "unprognostic (6.92e-2)" "unprognostic (1.66e-2)" "unprognostic (2.61e-2)" 20.1 22.4 36.7 13.3 39.3 21.4 26.1 29.6 43.6 22.8 22.7 16.0 20.8 16.8 22.8 45.2 16.0 27.9 17.3 27.8 30.2 30.4 22.4 31.6 15.8 20.4 24.9 38.1 37.6 15.6 13.6 25.2 12.3 24.5 29.7 26.0 17.5 14.3 32.7 14.3 15.5 16.7 24.5 23.2 17.7 18.7 24.3 23.1 35.0 29.9 15.6 23.9 22.6 15.7 27.8 30.6 74.0 24.4 29.7 50.7 34.4 7.9 4.8 18.1 14.4 17.6 20.1 10.7 6.9 15.2 16.2 15.3 26.9 19.6 14.9 23.2 9.5 17.4 12.4 27.3 20.9 15.9 15.2 7.7 41.4 6.9 24.2 25.2 32.8 13.7 15.2 11.2 19.2 12.7 21.2 25.4 51.0 19.0 7.2 14.5 4.4 38.1 60.5 21.0 31.8 18.1 18.1 13.4 12.6 22.2 14.0 17.3 14.0 14.2 3.5 8.1 13.8 20.2 16.7 13.4 7.0 10.8 6.3 10.4 8.1 8.4 31.6 10.4 42.9 8.0 37.6 21.7 74.0 36.0 24.4 43.1 27.8 38.3 36.2 23.1 21.8 44.3 50.7 11.3 29.7 22.5 30.6 44.7 34.4 36.7 39.3 29.6 43.6 30.2 30.4 24.9 38.1 24.5 23.1 29.8 30.3 34.7 31.3 21.2 28.4 47.5 45.9 57.6 36.4 34.9 13.7 48.6 72.9 41.7 18.7 37.2 24.6 0.0 48.8 45.0 39.0 15.9 39.3 41.5 45.5 27.0 55.3 25.2 23.0 14.4 46.6 30.2 38.8 40.5 38.5 42.7 42.8 31.6 45.6 69.9 17.8 45.3 31.6 74.4 76.8 18.1 11.6 37.3 53.4 22.6 TIAM2 STEF ENSG00000146426 "T cell lymphoma invasion and metastasis 2" Q8IVF5 6 154832697-155257723 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 76.6;Early spermatids: 131.1;Late spermatids: 220.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.3" "Group enriched" "Detected in many" 4 "B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3" "Cell line enhanced" "Detected in many" "AF22: 35.1;HDLM-2: 15.0;RH-30: 22.9" "Group enriched" "Detected in many" 5 "amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6" "Low region specificity" "Detected in all" "HPA011134, HPA013903" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA011134: AB_1858005, HPA013903: AB_1858004" "unprognostic (9.14e-2)" "unprognostic (5.79e-2)" "unprognostic (1.44e-1)" "unprognostic (6.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (4.36e-2)" "unprognostic (1.89e-1)" "unprognostic (5.74e-2)" "unprognostic (1.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.38e-3)" "unprognostic (1.82e-1)" "unprognostic (8.13e-2)" "unprognostic (6.04e-2)" "unprognostic (1.05e-1)" 0.6 2.1 5.3 1.7 9.4 0.7 1.5 7.9 21.1 1.5 11.6 0.7 0.1 11.0 1.2 0.8 1.0 1.2 4.0 3.5 4.7 2.0 0.7 0.7 0.9 2.0 1.7 9.5 0.9 1.8 0.2 1.8 0.8 0.6 3.0 1.1 1.3 2.4 3.6 3.0 1.0 27.4 1.4 0.9 1.2 4.0 15.6 1.9 0.0 7.8 0.0 2.5 2.3 1.2 3.3 0.9 8.3 11.3 0.8 1.8 0.4 4.3 0.8 35.1 4.1 1.5 4.3 0.4 1.8 1.1 1.7 2.9 0.5 2.6 1.0 1.9 3.2 0.6 0.7 1.2 0.0 1.2 15.0 1.9 0.3 0.6 2.0 0.9 0.3 1.1 2.9 0.1 0.6 0.1 1.6 2.4 0.5 0.5 0.1 3.9 0.4 0.4 0.9 2.5 0.2 1.0 4.5 22.9 0.4 0.1 0.2 0.9 8.0 0.1 0.4 0.2 6.9 0.3 0.5 0.8 0.3 8.9 0.3 0.9 0.2 1.7 0.2 0.1 0.5 2.2 0.4 0.2 3.1 0.2 3.2 0.3 3.3 0.5 0.3 0.9 1.0 0.6 0.4 8.3 0.8 11.3 0.3 1.8 0.4 5.3 9.4 7.9 21.1 4.7 2.0 1.7 9.5 0.6 1.9 3.0 1.6 8.1 16.3 2.7 13.8 7.3 7.6 2.7 1.2 1.8 76.6 1.2 0.0 4.7 131.1 3.0 2.9 0.0 2.7 2.1 4.7 7.7 19.6 0.9 1.7 22.3 0.0 7.4 2.1 220.7 9.2 4.7 11.8 14.4 4.2 6.9 4.2 2.0 7.4 0.7 25.2 0.0 3.8 5.2 5.5 2.3 0.3 4.8 2.6 7.4 TICAM1 "MGC35334, PRVTIRB, TICAM-1, TRIF" ENSG00000127666 "Toll like receptor adaptor molecule 1" Q8IUC6 19 4815932-4831704 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Urothelial cells: 129.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042460 Uncertain Uncertain "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA042460: AB_10806240" "unprognostic (2.09e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "prognostic favorable (4.81e-4)" "unprognostic (3.52e-2)" "unprognostic (2.88e-2)" "unprognostic (7.60e-3)" "prognostic unfavorable (3.48e-4)" "unprognostic (9.86e-2)" "unprognostic (1.59e-1)" "unprognostic (6.16e-2)" "unprognostic (2.82e-1)" "unprognostic (4.43e-2)" "unprognostic (2.30e-2)" "unprognostic (5.02e-2)" "unprognostic (3.53e-2)" "unprognostic (6.48e-2)" 10.5 6.9 7.3 9.4 9.5 18.2 9.4 5.9 15.8 10.2 15.4 7.0 3.4 20.3 8.3 5.2 35.6 8.0 11.4 7.7 5.9 5.4 11.0 15.2 14.1 9.0 6.4 6.1 8.0 14.8 4.2 7.8 6.8 7.1 8.2 5.2 6.1 11.8 5.7 15.3 15.8 21.3 5.2 6.5 11.6 15.2 2.8 6.5 4.4 8.5 12.1 21.7 9.3 13.3 5.3 5.0 7.8 9.1 1.5 3.1 5.4 21.3 4.2 0.0 3.7 3.2 4.1 2.0 7.0 7.3 5.7 6.4 4.3 7.7 14.6 4.0 8.1 5.7 14.6 2.0 7.4 2.2 15.6 3.9 3.6 8.5 4.1 9.0 1.3 9.5 6.6 9.3 7.1 5.2 4.4 5.9 5.1 7.8 3.1 3.1 8.0 3.6 0.7 0.6 3.8 16.9 8.1 0.9 9.5 5.1 6.7 2.9 5.5 4.3 13.1 7.2 0.0 5.9 3.0 11.6 7.0 4.8 17.6 10.6 12.7 11.1 10.1 8.1 5.0 5.3 7.8 5.3 2.3 2.6 7.8 2.4 5.3 2.6 3.0 5.0 4.0 1.7 1.0 1.6 1.5 9.1 3.6 3.1 5.4 7.3 9.5 5.9 15.8 5.9 5.4 6.4 6.1 7.1 6.5 6.0 11.1 7.8 63.8 61.6 0.7 2.1 17.8 4.0 9.1 5.2 0.0 5.3 6.6 27.1 0.0 10.5 58.5 0.0 15.3 9.5 9.3 51.3 10.4 12.5 12.1 1.6 28.0 11.1 8.6 0.0 3.4 18.8 13.5 23.4 15.2 0.8 36.4 38.6 4.9 7.0 0.2 6.5 8.9 0.3 1.1 62.2 2.9 7.9 11.0 129.1 TIFA "MGC20791, T2BP, T6BP, TIFAA" ENSG00000145365 "TRAF interacting protein with forkhead associated domain" Q96CG3 4 112274542-112285903 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 46.1;U-266/70: 28.9;U-698: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045889 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoplasm, Nucleoli" Cytosol "HPA045889: AB_10963785" "unprognostic (2.41e-2)" "unprognostic (2.47e-2)" "unprognostic (4.13e-2)" "unprognostic (3.23e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-3)" "unprognostic (1.05e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (2.14e-2)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (6.44e-3)" "unprognostic (1.52e-1)" "unprognostic (2.56e-1)" "unprognostic (2.99e-1)" "unprognostic (8.49e-3)" 5.7 6.4 3.3 16.7 3.8 19.2 7.4 6.1 4.5 7.0 3.9 2.0 8.4 3.4 3.6 2.3 14.3 4.0 4.2 7.9 4.7 2.1 4.1 14.6 6.7 22.9 5.4 1.6 9.2 32.2 4.1 3.3 7.4 3.9 6.6 3.7 5.4 21.3 4.5 4.0 9.0 8.7 4.7 4.0 20.3 7.1 3.0 4.8 12.5 14.8 7.8 23.2 7.2 7.3 23.2 7.0 11.3 3.8 9.1 17.7 6.1 7.0 1.8 2.6 4.4 3.2 2.6 5.3 5.6 10.6 3.6 6.1 0.9 6.3 21.5 4.6 2.2 5.3 2.1 3.6 4.3 7.5 17.4 2.1 2.1 4.3 2.0 2.2 6.7 2.9 3.5 2.4 3.8 4.2 6.1 5.6 6.0 2.1 46.1 4.7 3.5 11.8 3.7 0.5 4.3 2.3 20.6 6.7 14.3 7.9 4.8 6.1 6.3 4.5 9.5 2.2 1.2 4.0 9.7 4.2 5.7 6.7 4.7 4.4 28.9 26.5 39.8 5.3 4.5 4.1 2.9 3.8 2.0 6.3 2.7 10.3 21.2 11.7 11.0 7.0 23.2 5.4 6.6 11.3 9.1 3.2 6.5 17.7 6.1 3.3 3.8 6.1 4.5 4.7 2.1 5.4 1.6 3.9 4.8 17.9 20.6 34.4 9.9 18.9 1.0 14.1 10.2 6.7 11.4 12.2 0.0 42.8 16.6 12.7 0.0 14.5 5.8 0.0 21.2 17.8 22.6 27.2 3.5 8.5 16.0 0.0 8.6 4.9 10.7 0.0 8.3 11.2 32.1 6.4 7.0 11.3 12.9 3.6 10.3 6.3 0.6 6.5 13.4 0.9 3.0 22.7 66.4 27.3 6.5 10.7 TIGD6 DKFZp761E2110 ENSG00000164296 "Tigger transposable element derived 6" Q17RP2 5 149993118-150001167 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044599 Uncertain Approved "Nucleoplasm,Vesicles,Actin filaments" NA NA Nucleoplasm "Vesicles, Actin filaments" "HPA044599: AB_10961286" "unprognostic (1.06e-1)" "unprognostic (3.25e-1)" "prognostic favorable (5.35e-4)" "unprognostic (1.94e-2)" "unprognostic (8.18e-2)" "unprognostic (3.00e-2)" "unprognostic (1.30e-3)" "unprognostic (7.48e-2)" "unprognostic (5.96e-2)" "unprognostic (3.85e-2)" "prognostic favorable (5.88e-4)" "unprognostic (1.94e-3)" "unprognostic (1.85e-3)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.33e-3)" "unprognostic (1.18e-1)" 6.9 10.5 5.9 3.9 10.7 2.8 9.9 9.3 9.4 5.8 6.1 10.0 8.9 4.7 6.5 11.1 5.0 6.9 5.1 4.5 6.4 4.7 7.7 7.0 5.3 3.9 7.3 7.1 8.6 6.8 28.0 10.5 5.5 7.1 8.8 5.7 6.4 8.1 12.6 3.8 7.2 5.2 5.9 7.6 5.8 6.1 9.8 8.0 6.1 6.5 3.6 4.3 6.2 6.1 3.5 3.3 2.1 4.0 6.3 8.0 2.6 2.3 6.4 4.3 9.2 12.4 10.2 6.7 6.7 7.1 5.3 5.3 4.1 4.2 1.1 6.0 7.9 6.4 4.2 3.8 4.9 6.3 5.0 3.2 2.0 3.3 2.2 11.0 2.8 5.0 10.5 9.4 6.8 8.9 6.2 4.1 4.6 2.7 5.4 6.5 5.5 3.7 1.3 1.8 3.0 5.4 4.2 4.9 3.0 5.0 3.4 3.3 4.3 4.7 7.6 9.5 5.5 8.5 4.9 5.4 4.3 3.3 4.7 4.9 4.0 1.5 3.0 6.8 3.1 6.6 0.2 4.0 2.1 2.8 3.9 2.5 2.7 3.8 2.8 3.3 3.5 8.0 5.1 0.0 6.3 2.2 2.2 3.7 2.6 5.9 10.7 9.3 9.4 6.4 4.7 7.3 7.1 7.1 8.0 11.9 2.4 0.0 5.8 1.9 4.8 4.6 2.5 2.7 4.5 3.5 0.0 4.6 6.6 4.3 1.1 2.3 2.5 0.0 4.2 2.2 2.5 6.1 3.5 1.3 3.7 3.2 2.9 3.1 1.2 1.9 4.0 2.2 3.3 7.2 2.5 6.1 3.4 2.3 3.2 6.7 5.6 0.0 3.9 16.4 5.5 1.0 3.0 0.9 2.3 3.8 TIRAP "Mal, wyatt" ENSG00000150455 "TIR domain containing adaptor protein" P58753 11 126283065-126298845 "Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054431 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA054431: AB_2682486" "unprognostic (9.30e-3)" "unprognostic (7.39e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.24e-4)" "unprognostic (2.73e-2)" "unprognostic (5.77e-2)" "unprognostic (1.27e-1)" "unprognostic (6.89e-2)" "unprognostic (2.40e-1)" "unprognostic (2.28e-1)" "unprognostic (4.65e-2)" "unprognostic (1.42e-1)" "unprognostic (3.34e-3)" "unprognostic (4.29e-3)" "unprognostic (3.62e-2)" "unprognostic (3.47e-1)" "unprognostic (2.57e-1)" 8.8 10.4 5.2 11.9 5.4 3.9 16.8 7.2 8.0 11.9 18.9 4.6 13.2 11.6 11.1 11.1 9.7 8.7 14.2 11.6 4.4 6.5 9.2 14.8 16.8 17.6 6.5 5.8 13.4 18.7 14.0 8.8 9.2 5.1 11.1 8.9 10.5 15.3 21.1 10.5 8.4 17.3 13.6 4.7 13.4 8.7 3.5 2.4 3.3 8.0 6.4 9.8 11.8 7.3 6.5 8.7 8.8 10.5 4.4 8.3 6.2 1.9 6.2 3.3 5.6 5.7 8.0 4.0 5.1 8.3 3.6 3.4 9.7 7.4 5.0 8.8 5.2 6.3 5.6 3.5 3.9 1.4 13.2 3.3 13.5 3.5 6.2 4.6 8.2 7.3 6.0 5.5 6.7 4.7 4.3 5.9 4.1 3.6 11.6 4.1 3.5 0.2 1.3 1.5 13.9 5.7 1.7 0.9 4.7 2.8 6.9 4.1 5.3 6.0 6.0 4.2 4.6 16.4 4.3 5.8 2.0 1.9 4.1 3.8 3.2 4.6 3.7 3.1 6.6 6.2 7.7 10.5 4.9 7.7 8.7 7.4 4.3 6.1 8.3 8.7 6.5 5.0 4.9 8.8 4.4 5.7 5.9 6.1 6.2 5.2 5.4 7.2 8.0 4.4 6.5 6.5 5.8 5.1 2.4 6.0 1.6 1.3 1.4 0.3 3.0 0.8 0.0 1.4 3.4 3.5 0.0 2.8 0.0 2.5 0.0 1.5 4.2 0.0 3.5 4.1 1.6 1.9 1.1 4.9 4.4 3.2 1.2 2.5 4.0 0.0 4.4 2.7 1.7 0.0 2.6 2.4 3.0 4.2 4.2 1.7 2.3 0.0 1.2 0.1 0.6 0.1 2.2 1.9 2.4 1.3 TJP2 "DFNA51, X104, ZO-2, ZO2" ENSG00000119139 "Tight junction protein 2" Q9UDY2 9 69121264-69255208 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 241.2;Rod photoreceptor cells: 273.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.0" "Lineage enriched" "Detected in single" 8 "monocytes: 4.0" "Cell line enhanced" "Detected in many" "A-431: 53.3" "HPA001813, CAB009228, HPA070714" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 790000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161" "unprognostic (1.30e-1)" "unprognostic (7.69e-2)" "unprognostic (1.23e-3)" "unprognostic (7.68e-2)" "unprognostic (2.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.94e-2)" "unprognostic (1.86e-1)" "unprognostic (4.82e-2)" "unprognostic (3.30e-2)" "unprognostic (2.93e-3)" "unprognostic (3.60e-1)" "prognostic favorable (1.78e-14)" "unprognostic (3.29e-2)" "unprognostic (6.42e-2)" "unprognostic (8.15e-3)" "unprognostic (5.85e-2)" 25.2 9.5 23.7 8.0 29.7 5.7 20.7 35.6 24.9 9.0 20.0 50.3 20.6 27.2 11.9 7.3 28.9 12.6 13.2 19.8 35.1 12.7 23.3 34.5 23.9 5.8 39.7 20.5 20.9 13.2 43.2 3.6 18.0 32.0 13.5 16.7 19.1 18.0 23.1 8.3 18.6 25.7 15.3 39.7 3.5 30.4 17.8 41.1 11.1 22.5 9.0 10.8 26.5 26.6 0.0 0.2 0.4 4.0 0.0 0.5 0.5 53.3 1.7 4.3 4.8 20.1 19.7 23.3 8.1 6.0 13.0 7.1 6.5 19.5 7.7 8.1 4.5 7.0 32.9 6.9 17.1 14.8 27.3 5.0 7.4 4.6 32.9 5.7 3.0 14.1 15.3 12.3 10.1 6.1 3.7 27.2 2.1 4.5 5.2 6.8 7.5 1.1 0.4 10.4 33.4 11.7 3.9 6.1 0.8 33.4 35.6 1.9 3.3 2.9 20.8 0.6 9.9 6.7 1.6 39.0 9.7 10.5 7.5 8.3 5.4 1.1 0.1 11.2 4.3 3.6 0.0 0.7 0.0 0.0 1.5 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.4 0.0 4.0 0.1 0.5 0.5 23.7 29.7 35.6 17.5 35.1 12.7 39.7 20.5 32.0 41.1 41.7 21.4 1.4 65.1 57.9 241.2 34.6 50.9 9.4 5.7 3.5 33.4 24.0 0.0 27.8 2.7 42.7 67.5 0.0 20.8 23.1 14.7 83.3 5.7 92.7 4.9 17.5 11.1 25.2 17.0 3.6 27.0 2.8 27.0 4.6 41.5 123.0 32.6 42.5 13.1 1.4 273.3 0.0 10.3 21.3 11.1 56.0 36.2 3.1 36.2 146.9 TLDC1 KIAA1609 ENSG00000140950 "TBC/LysM-associated domain containing 1" Q6P9B6 16 84476421-84554033 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 115.8;Rod photoreceptor cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041020 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041020: AB_10794184" "unprognostic (8.35e-3)" "unprognostic (4.27e-2)" "unprognostic (1.48e-1)" "unprognostic (5.45e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-3)" "unprognostic (5.97e-4)" "prognostic unfavorable (1.03e-5)" "unprognostic (3.94e-1)" "unprognostic (2.85e-2)" "prognostic unfavorable (7.05e-5)" "unprognostic (2.92e-2)" "unprognostic (6.78e-3)" "unprognostic (9.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-2)" 5.5 4.9 7.6 7.1 10.7 1.8 7.3 8.1 11.5 8.1 7.1 6.3 5.2 6.0 14.0 8.8 24.4 6.9 6.5 4.7 6.3 4.5 7.6 5.1 6.4 6.1 5.0 9.4 8.7 5.2 11.3 4.4 15.8 10.7 7.8 7.8 12.9 7.7 6.1 4.5 11.0 9.3 10.7 4.0 5.4 6.8 8.1 3.4 8.3 7.6 6.5 10.0 10.4 12.1 3.3 2.7 13.6 3.5 3.1 8.7 2.6 14.7 10.4 9.1 4.9 4.2 7.4 4.3 10.9 9.8 11.3 3.3 5.9 17.9 2.0 5.9 21.0 8.3 16.5 2.5 29.3 14.9 1.1 2.2 1.6 5.1 5.1 5.2 1.2 5.1 5.1 12.7 10.5 13.9 9.2 4.7 5.9 2.7 2.5 7.6 3.5 1.1 1.2 2.8 7.7 3.6 4.5 2.3 0.7 10.0 8.3 3.0 2.1 9.9 7.1 4.9 10.0 10.2 2.0 11.5 7.9 3.6 4.2 4.5 2.0 3.5 5.4 4.7 0.6 2.7 13.6 3.1 4.4 3.8 2.7 3.7 3.3 6.8 5.5 2.7 2.7 7.6 4.7 3.1 3.1 3.5 0.8 8.7 2.6 7.6 10.7 8.1 11.5 6.3 4.5 5.0 9.4 10.7 3.4 3.0 4.5 2.7 8.9 2.1 14.1 3.3 5.1 8.1 6.8 12.2 115.8 28.9 5.0 15.5 1.4 5.8 13.6 0.0 7.5 8.8 5.1 7.2 4.7 1.5 7.3 4.8 2.9 5.5 4.8 1.2 7.5 2.7 3.3 10.8 4.5 8.1 14.4 7.0 5.3 6.1 65.7 0.0 5.1 4.6 3.9 3.0 39.4 3.2 4.8 20.0 TLR5 "FLJ10052, MGC126430, MGC126431, SLEB1, TIL3" ENSG00000187554 "Toll like receptor 5" O60602 1 223109406-223143282 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 17.8;Collecting duct cells: 21.0;Kupffer cells: 23.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "classical monocyte: 17.0;intermediate monocyte: 15.7;myeloid DC: 12.8;neutrophil: 13.4;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 10 "dendritic cells: 12.8;granulocytes: 13.4;monocytes: 17.0" "Cell line enhanced" "Detected in some" "A-431: 4.4;HaCaT: 6.7;OE19: 3.9;SK-BR-3: 4.3;T-47d: 4.8" "Low region specificity" "Detected in many" CAB009013 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB009013: AB_2240732" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-2)" "unprognostic (3.81e-2)" "unprognostic (3.09e-2)" "unprognostic (6.83e-2)" "unprognostic (1.49e-2)" "unprognostic (2.71e-1)" "unprognostic (4.23e-3)" "unprognostic (1.46e-1)" "unprognostic (3.69e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (1.06e-3)" "unprognostic (5.60e-2)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" 3.8 2.4 5.3 4.8 7.3 0.4 9.7 0.8 5.3 7.1 2.7 3.4 1.7 1.7 2.4 6.2 9.0 5.6 4.8 5.8 5.0 2.6 4.6 2.2 6.5 12.5 7.0 0.8 22.5 5.3 6.6 6.3 3.5 6.8 6.2 2.3 3.2 12.6 2.9 1.4 3.7 2.3 3.7 12.8 6.7 4.5 2.3 8.1 1.2 4.3 3.5 5.7 5.9 7.8 0.1 12.8 13.4 17.0 0.2 1.4 5.7 4.4 0.4 0.7 0.4 0.3 0.0 0.6 0.2 0.0 0.1 0.1 0.0 1.3 0.0 0.9 0.4 0.1 6.7 0.1 0.5 0.4 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.1 1.9 0.5 0.2 1.7 0.9 0.0 0.0 0.6 1.0 0.3 2.5 3.9 0.0 0.1 0.0 0.2 2.1 0.8 1.8 0.4 1.3 4.3 0.1 1.0 4.8 0.0 0.0 0.1 0.1 0.0 1.2 0.2 0.0 0.2 0.0 0.7 0.5 0.0 17.0 0.2 0.1 15.7 0.2 0.1 0.9 0.2 12.8 0.0 1.4 0.4 13.4 0.2 6.3 0.2 0.6 5.7 5.3 7.3 0.8 5.3 5.0 2.6 7.0 0.8 6.8 8.1 3.0 10.5 0.0 5.9 0.5 0.0 1.7 17.8 8.1 15.9 21.0 2.0 1.2 3.3 3.0 3.3 1.0 0.0 0.0 3.4 0.3 5.0 3.3 2.3 0.6 15.6 0.0 1.2 0.6 23.7 4.0 8.6 11.1 3.3 0.0 0.3 1.1 2.0 0.0 8.1 0.0 0.1 0.0 1.4 4.3 4.5 1.4 0.7 0.0 1.2 6.5 TM2D2 BLP1 ENSG00000169490 "TM2 domain containing 2" Q9BX73 8 38988808-38996824 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047152, HPA050547" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles, Plasma membrane" "HPA047152: AB_2679957, HPA050547: AB_2681168" "prognostic unfavorable (7.49e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.71e-4)" "unprognostic (2.55e-2)" "unprognostic (7.02e-2)" "unprognostic (2.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-2)" "unprognostic (2.43e-3)" "unprognostic (4.58e-2)" "unprognostic (1.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-2)" "unprognostic (8.61e-2)" 21.6 26.2 19.9 14.9 24.3 11.3 24.5 18.8 29.6 21.0 15.3 18.4 25.4 17.5 20.1 27.6 17.2 17.9 22.9 19.4 18.7 20.4 32.6 29.0 21.1 18.1 20.5 17.3 23.3 26.8 25.9 17.5 32.6 25.7 22.8 16.6 22.9 18.8 23.4 14.6 18.5 20.7 17.7 16.4 24.3 19.2 26.1 13.9 11.1 39.7 14.9 14.9 16.7 19.5 14.4 33.5 27.2 18.8 17.4 22.8 19.2 14.0 22.7 10.6 14.6 24.8 16.7 14.6 29.9 18.4 22.7 20.6 17.3 12.2 4.9 23.6 22.1 25.5 15.3 11.2 18.1 24.8 5.9 8.6 11.3 13.3 18.6 22.0 3.3 14.7 20.3 17.8 17.8 8.7 16.6 29.1 8.4 12.4 14.7 30.2 8.7 8.2 11.4 13.4 21.2 9.0 7.0 13.7 8.3 25.9 11.2 3.5 6.9 11.4 8.0 14.7 19.6 19.6 7.1 26.1 18.4 13.8 26.8 15.0 10.3 22.7 8.7 14.0 7.7 12.8 27.2 16.2 14.5 18.0 18.8 19.6 14.3 21.2 19.6 17.0 14.4 20.2 19.6 4.5 17.4 15.6 33.5 22.8 19.2 19.9 24.3 18.8 29.6 18.7 20.4 20.5 17.3 25.7 13.9 11.9 14.3 17.6 48.8 31.1 21.6 15.1 30.6 20.1 20.5 48.8 19.6 78.2 24.9 57.6 44.6 26.6 11.9 0.0 33.5 82.1 36.1 49.2 21.9 33.7 172.6 22.3 9.9 66.3 32.3 35.5 33.4 33.8 25.3 106.4 10.7 40.2 58.6 15.2 23.3 48.2 29.3 0.0 18.1 33.0 59.4 13.6 66.8 22.0 14.9 50.4 TM4SF5 ENSG00000142484 "Transmembrane 4 L six family member 5" O14894 17 4771884-4783213 "Predicted membrane proteins" "Cell cycle" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "intestine: 80.9;liver: 69.8" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 55.9;Hepatocytes: 125.4;Intestinal endocrine cells: 110.5;Mucus-secreting cells: 76.1;Paneth cells: 190.0" "Cancer enriched" "Detected in many" 9 "liver cancer: 219.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 5 "monocytes: 1.1" "Group enriched" "Detected in some" 13 "CACO-2: 23.4;Hep G2: 40.5;OE19: 25.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA055674 Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA055674: " "unprognostic (1.81e-1)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (4.44e-2)" "unprognostic (9.33e-2)" "unprognostic (3.57e-2)" "unprognostic (1.95e-1)" "unprognostic (5.21e-3)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 45.1 0.1 0.1 50.5 0.1 0.2 0.1 0.1 7.0 0.1 0.1 0.1 3.1 69.8 0.1 0.1 0.1 0.1 0.1 0.9 4.1 0.1 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 80.9 0.1 0.1 0.1 8.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 23.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 40.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 25.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 25.5 0.0 0.0 1.8 0.0 0.0 5.0 1.1 1.5 0.0 55.9 0.0 8.1 1.2 0.0 0.0 4.6 125.4 0.1 0.0 110.5 6.2 3.2 1.3 0.0 0.0 0.0 0.0 76.1 0.0 4.9 190.0 0.0 47.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.9 34.5 0.0 TMEM107 MGC10744 ENSG00000179029 "Transmembrane protein 107" Q6UX40 17 8173237-8176399 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 171.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052555, HPA059653" Approved Approved "Nucleoplasm,Plasma membrane,Midbody ring" Yes No "Nucleoplasm, Plasma membrane" "Midbody ring" "HPA052555: AB_2681870, HPA059653: AB_2684096" "unprognostic (2.87e-2)" "unprognostic (2.67e-1)" "unprognostic (2.85e-2)" "prognostic favorable (9.39e-5)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (5.70e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (6.02e-3)" "unprognostic (1.83e-2)" "unprognostic (1.87e-1)" "unprognostic (2.66e-3)" "unprognostic (1.26e-1)" "unprognostic (4.99e-1)" "unprognostic (2.66e-1)" "unprognostic (1.49e-1)" 8.6 11.8 13.7 7.1 19.6 17.5 13.0 7.3 23.2 11.7 8.3 9.9 10.7 4.2 10.0 30.1 8.8 38.7 9.4 8.8 11.0 13.4 12.1 4.0 12.8 17.7 10.9 17.1 7.5 9.6 17.8 20.8 10.0 15.6 5.9 7.8 12.6 8.7 10.1 1.7 12.7 6.0 10.1 10.5 11.9 7.1 15.9 8.2 7.8 19.1 4.3 9.6 9.5 7.8 33.1 18.7 28.4 29.9 14.5 20.8 12.7 31.6 10.0 15.5 7.1 9.4 14.2 3.1 7.4 7.0 6.5 8.6 1.2 18.2 8.7 9.5 7.4 4.6 22.1 6.3 14.5 10.3 10.7 7.4 4.7 17.4 3.4 3.8 1.8 5.2 6.9 9.2 17.1 8.3 13.7 10.8 10.8 4.0 17.1 15.3 9.4 4.3 5.0 1.6 3.9 4.6 7.9 4.2 12.5 12.0 2.4 4.5 7.1 8.6 1.8 6.3 3.7 5.4 6.4 6.8 3.3 6.3 5.2 3.9 6.7 3.7 3.4 19.0 7.1 5.3 10.5 13.3 28.4 18.8 15.8 16.3 26.7 18.1 20.0 11.8 33.1 20.0 20.8 10.9 14.5 29.9 18.7 14.3 12.7 13.7 19.6 7.3 23.2 11.0 13.4 10.9 17.1 15.6 8.2 8.9 9.8 33.9 18.2 17.1 17.7 6.2 40.8 171.3 25.0 31.4 43.2 15.0 11.6 14.4 7.1 20.4 10.3 0.0 9.6 17.4 16.6 14.7 34.8 17.8 39.4 11.1 8.7 23.9 38.4 6.3 11.8 29.7 32.1 21.6 12.1 32.1 11.5 14.4 14.2 15.3 60.3 0.0 11.3 47.4 49.2 25.0 11.1 34.5 15.3 9.7 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116299-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 14.1" "Group enriched" "Detected in some" 8 "granulocytes: 1.1;Hofbauer cells: 2.2" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 7 "granulocytes: 4.3;monocytes: 3.2" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 15.0;THP-1: 12.1;U-937: 10.0" "Group enriched" "Detected in many" 8 "amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0" "Low region specificity" "Detected in many" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: AB_2686036" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 1.3 1.8 7.4 2.2 12.0 2.2 2.0 8.1 19.1 1.0 0.8 2.4 0.0 1.1 1.1 2.3 0.8 1.2 1.0 2.3 7.1 4.0 0.8 0.8 0.9 0.8 2.9 6.9 0.9 2.7 0.8 2.0 1.9 2.3 14.1 1.0 0.2 1.2 1.0 2.8 1.5 0.9 1.3 2.5 1.1 1.0 2.4 4.2 0.0 0.6 0.0 0.8 1.0 0.3 0.0 0.5 4.3 3.2 0.0 0.0 0.6 0.0 0.0 6.3 0.9 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.3 0.0 0.8 3.2 2.2 0.0 0.1 0.2 3.1 0.0 0.3 0.1 15.0 2.3 0.0 0.0 0.3 0.9 0.0 12.1 0.6 0.7 0.3 0.2 0.0 0.2 0.3 0.9 0.0 10.0 0.3 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.6 7.4 12.0 8.1 18.0 7.1 4.0 2.9 6.9 2.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM169 FLJ34263 ENSG00000163449 "Transmembrane protein 169" Q96HH4 2 216081866-216102783 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 14.3;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.4;LHCN-M2: 6.9;RPTEC TERT1: 12.5;SCLC-21H: 10.7;SH-SY5Y: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062462, HPA062797, HPA070657, HPA074877" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: " "unprognostic (5.15e-2)" "unprognostic (2.93e-1)" "unprognostic (7.87e-3)" "unprognostic (4.69e-7)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (1.97e-1)" "unprognostic (4.43e-1)" "unprognostic (7.16e-2)" "unprognostic (5.72e-2)" "unprognostic (1.00e-1)" "unprognostic (1.35e-1)" "unprognostic (2.79e-2)" "unprognostic (7.51e-3)" "unprognostic (4.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" 1.7 2.9 5.9 2.5 6.2 1.3 0.9 9.7 16.8 2.1 1.3 3.9 1.6 1.9 1.1 1.9 0.9 2.9 2.5 1.1 5.5 6.3 4.9 4.2 2.1 2.4 5.5 4.8 1.1 1.0 0.8 2.4 0.7 9.1 1.4 1.2 4.9 0.9 1.1 1.5 1.6 1.7 1.2 6.6 2.6 1.0 1.3 2.5 0.7 6.7 0.0 2.0 1.1 0.7 3.0 0.2 4.3 5.7 0.7 6.3 1.3 0.1 0.4 8.4 0.2 1.0 0.1 0.0 0.3 0.2 0.2 0.8 0.4 2.5 0.1 6.3 0.4 0.5 0.2 1.1 0.0 0.2 1.2 0.4 2.7 0.1 1.5 1.8 0.2 0.6 0.6 0.6 0.6 0.8 2.0 0.0 0.9 0.0 0.4 6.9 0.7 0.2 0.3 4.4 0.0 0.1 1.5 2.5 0.2 12.5 0.0 10.7 15.4 0.3 0.2 6.1 4.2 0.4 1.1 0.1 0.2 0.5 0.2 0.4 1.9 2.0 0.4 1.9 0.2 1.6 1.3 1.8 0.3 2.3 1.5 1.7 2.4 4.0 2.7 0.0 3.0 4.2 1.9 4.3 0.7 5.7 0.2 6.3 1.3 5.9 6.2 9.7 11.5 5.5 6.3 5.5 4.8 9.1 2.5 0.0 0.0 0.5 0.0 0.0 14.3 0.6 5.1 0.0 0.0 5.2 21.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 4.7 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.4 2.4 11.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 TMEM176B "LR8, MS4B2" ENSG00000106565 "Transmembrane protein 176B" Q3YBM2 7 150791285-150801360 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.3;liver: 247.9" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 572.0;Hepatocytes: 1056.4;monocytes: 841.4;Paneth cells: 725.5;Proximal tubular cells: 817.7" "Cancer enhanced" "Detected in all" "liver cancer: 537.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 92.3;intermediate monocyte: 68.0" "Lineage enriched" "Detected in many" 5 "monocytes: 92.3" "Group enriched" "Detected in some" 17 "HSkMC: 120.5;THP-1: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047509 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Nucleoplasm, Plasma membrane" "HPA047509: AB_2680072" "unprognostic (5.21e-2)" "unprognostic (7.86e-2)" "unprognostic (1.30e-2)" "unprognostic (8.27e-2)" "unprognostic (3.35e-2)" "unprognostic (6.96e-2)" "unprognostic (7.23e-2)" "unprognostic (2.74e-2)" "unprognostic (5.31e-2)" "unprognostic (1.47e-1)" "unprognostic (5.72e-3)" "unprognostic (7.50e-2)" "unprognostic (3.11e-3)" "unprognostic (5.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.53e-1)" "unprognostic (4.05e-2)" 13.9 5.5 7.8 19.8 10.7 1.1 11.7 2.1 6.3 8.6 27.6 5.7 2.0 18.3 3.8 15.2 9.6 9.0 50.2 26.8 7.6 5.2 62.9 247.9 11.2 22.9 10.5 3.3 20.3 6.8 0.3 3.2 12.5 8.4 6.1 27.9 22.0 5.1 3.2 2.5 4.2 53.1 10.7 13.2 23.5 10.6 5.2 8.7 4.3 4.9 7.0 10.5 14.7 11.6 0.2 20.0 5.7 92.3 0.0 0.4 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 120.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 38.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 92.3 5.7 0.2 68.0 0.4 0.2 0.0 0.0 20.0 0.0 0.0 0.0 1.1 0.0 36.2 0.9 0.0 42.0 7.8 10.7 2.1 6.3 7.6 5.2 10.5 3.3 8.4 8.7 3.0 12.4 33.9 0.5 11.2 135.3 52.1 175.8 12.0 19.4 355.9 2.0 0.8 140.9 63.8 13.3 17.2 572.0 0.0 29.9 1.1 82.5 3.5 52.1 1056.4 94.1 6.4 123.0 27.0 68.8 9.8 40.3 84.1 15.1 841.4 193.4 69.9 82.8 725.5 3.2 817.7 17.3 0.0 22.6 3.2 3.4 13.7 2.3 14.6 213.0 1.0 TMEM181 "GPR178, KIAA1423" ENSG00000146433 "Transmembrane protein 181" Q9P2C4 6 158536436-158635428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040189, HPA040228" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Vesicles "Nucleoplasm, Golgi apparatus" "HPA040189: AB_10793959, HPA040228: " "unprognostic (1.93e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (9.87e-2)" "unprognostic (6.51e-2)" "unprognostic (3.09e-1)" "unprognostic (1.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (4.07e-2)" "unprognostic (1.46e-1)" "unprognostic (1.93e-1)" "unprognostic (4.36e-1)" "unprognostic (3.26e-1)" 7.1 5.6 32.4 4.8 49.2 3.1 8.6 5.3 36.6 13.4 10.1 4.2 6.5 10.9 8.4 3.9 6.3 5.8 7.3 5.3 18.5 8.7 3.3 6.4 6.7 3.4 5.5 23.3 5.6 18.5 8.1 21.5 6.5 11.2 9.4 11.5 4.3 22.4 10.0 4.9 7.0 12.6 7.8 7.3 7.6 16.3 16.0 8.5 2.3 9.7 2.1 3.2 9.9 7.0 1.0 2.1 7.7 3.4 3.9 4.7 1.4 10.2 5.9 8.4 12.9 22.3 20.5 16.1 23.2 13.6 12.1 13.9 10.0 12.6 4.3 12.0 19.2 26.0 15.2 12.4 15.3 19.3 6.3 8.9 8.0 8.8 21.1 18.2 10.0 7.7 16.9 15.1 13.5 18.3 18.3 19.4 6.2 15.2 5.4 19.8 6.2 4.4 12.5 6.5 20.4 7.6 4.3 9.7 4.9 11.6 8.0 24.9 17.1 17.0 16.0 11.1 12.1 6.1 14.1 18.4 12.6 8.5 20.8 20.0 3.2 2.2 4.8 15.2 12.6 11.9 7.7 2.2 5.7 4.7 2.3 3.6 0.9 2.7 3.7 1.6 1.0 2.4 3.2 1.6 3.9 3.4 2.1 2.6 1.4 32.4 49.2 5.3 36.6 18.5 8.7 5.5 23.3 11.2 8.5 11.9 31.5 2.4 11.3 18.1 13.4 14.8 20.4 5.3 7.9 15.7 17.7 7.7 3.3 22.0 3.2 24.0 29.3 0.0 28.2 10.9 15.0 29.8 10.5 18.6 8.9 19.1 42.6 20.3 14.2 4.0 12.0 13.6 13.5 4.6 34.5 6.0 36.3 28.1 16.6 4.8 14.4 6.5 17.1 14.2 22.6 18.3 4.3 20.1 24.4 29.1 TMEM183A C1orf37 ENSG00000163444 "Transmembrane protein 183A" Q8IXX5 1 203007386-203024848 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072607 Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA072607: AB_2686539" "unprognostic (2.94e-3)" "unprognostic (1.60e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (6.46e-2)" "unprognostic (3.21e-2)" "unprognostic (4.82e-3)" "unprognostic (5.28e-2)" "unprognostic (7.84e-2)" "unprognostic (4.83e-2)" "unprognostic (6.01e-3)" "unprognostic (9.55e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" 12.2 12.6 22.4 13.5 20.8 50.1 17.2 31.9 30.4 14.4 21.1 12.4 6.7 20.0 13.6 15.2 19.3 12.0 15.0 11.5 19.8 21.0 16.0 21.1 13.4 20.2 19.3 14.8 15.0 29.9 12.0 8.2 10.9 20.8 15.0 23.6 11.1 22.2 13.6 8.8 16.1 18.8 17.6 12.4 14.5 15.8 27.7 12.3 23.3 20.5 14.8 17.7 15.3 20.7 17.4 27.2 35.6 24.4 26.4 23.7 24.3 12.7 12.4 15.9 26.1 21.1 15.9 26.3 12.8 12.7 14.9 13.1 15.0 13.5 31.9 9.3 16.5 6.0 16.2 21.3 18.0 12.4 10.3 25.9 15.7 14.5 16.5 15.3 28.1 13.9 15.6 20.1 12.2 24.8 15.1 18.7 25.8 32.2 11.6 13.8 28.4 22.9 28.9 43.8 17.3 19.8 17.7 27.2 25.6 23.0 12.5 20.5 25.7 19.2 32.1 18.4 26.5 22.9 22.2 13.8 10.1 14.1 17.2 14.0 11.8 18.9 24.7 11.1 21.9 10.6 21.1 24.4 35.6 18.1 20.4 17.9 16.6 20.5 20.5 27.2 17.4 23.7 19.3 21.3 26.4 18.5 19.5 21.2 24.3 22.4 20.8 31.9 30.4 19.8 21.0 19.3 14.8 20.8 12.3 14.9 15.6 44.9 49.0 65.3 20.7 10.9 48.4 28.1 28.4 33.2 9.8 46.3 59.7 71.4 117.2 35.8 68.3 23.3 66.2 74.0 37.9 74.7 17.3 45.7 54.3 17.5 50.6 32.5 53.2 96.3 25.0 47.0 37.1 59.5 68.9 18.9 55.2 56.1 27.6 74.5 26.2 19.4 47.6 72.3 76.8 71.8 43.1 44.7 83.1 77.4 TMEM184B "C22orf5, DKFZP586A1024, FM08, HS5O6A" ENSG00000198792 "Transmembrane protein 184B" Q9Y519 22 38219291-38273034 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 65.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 60.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024076 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "HPA024076: AB_1858106" "unprognostic (1.52e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-1)" "unprognostic (8.96e-2)" "unprognostic (3.82e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.94e-6)" "unprognostic (1.14e-2)" "unprognostic (5.18e-2)" "unprognostic (4.52e-2)" "unprognostic (9.20e-2)" "unprognostic (1.77e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.96e-1)" 21.8 16.5 23.9 14.7 24.1 6.0 27.5 26.4 40.0 22.4 14.4 31.2 12.2 18.5 12.1 9.5 11.0 14.2 16.1 17.8 25.8 21.5 13.0 7.4 20.5 8.6 26.1 22.2 10.8 18.0 27.3 21.9 41.2 23.8 12.3 12.5 20.1 16.8 17.3 19.0 10.9 16.5 15.7 41.2 14.1 19.3 5.8 20.9 3.9 16.7 10.6 9.2 20.0 15.4 1.6 7.3 12.4 3.1 6.2 5.8 2.6 17.3 15.2 9.0 7.1 17.9 14.4 20.8 18.8 26.8 15.5 13.8 11.1 8.1 3.3 14.8 28.0 14.0 21.6 8.1 18.5 10.5 11.8 14.5 6.6 11.1 9.2 18.9 5.1 9.2 12.0 16.5 18.2 20.4 16.0 19.3 5.1 4.1 11.7 13.4 9.9 3.2 4.3 7.3 13.0 14.0 5.6 8.1 3.3 11.5 19.3 19.5 3.4 14.1 20.7 10.0 10.9 11.4 3.8 28.4 15.8 16.2 13.8 11.4 24.3 60.1 2.7 22.9 3.8 13.5 12.4 3.1 4.6 5.8 2.4 5.3 1.6 3.3 4.3 4.7 1.2 2.3 2.7 11.2 6.2 1.6 7.3 1.0 2.6 23.9 24.1 26.4 35.4 25.8 21.5 26.1 22.2 23.8 20.9 6.0 15.0 1.5 15.0 11.0 17.0 14.6 10.2 4.0 9.1 14.0 2.0 27.6 3.3 15.0 4.9 26.7 7.5 0.0 19.1 38.8 21.0 27.4 2.3 3.4 13.3 14.3 24.9 16.0 7.5 1.7 10.9 10.2 13.5 16.2 16.0 40.7 22.7 7.0 12.7 4.2 8.1 19.4 23.4 2.3 6.6 8.4 65.6 10.1 9.4 30.1 TMEM192 FLJ38482 ENSG00000170088 "Transmembrane protein 192" Q8IY95 4 165070608-165208549 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014717, HPA024110" Enhanced Supported Nucleoplasm,Endosomes,Lysosomes NA NA "Endosomes, Lysosomes" Nucleoplasm "HPA014717: AB_1844373, HPA024110: AB_2204898" "prognostic unfavorable (9.52e-4)" "unprognostic (5.38e-3)" "unprognostic (9.16e-2)" "unprognostic (4.39e-2)" "unprognostic (2.60e-2)" "unprognostic (1.55e-2)" "unprognostic (2.91e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (3.10e-1)" "unprognostic (3.27e-2)" "unprognostic (5.06e-2)" "prognostic favorable (2.33e-14)" "unprognostic (2.09e-2)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (9.30e-2)" 12.6 14.4 11.3 7.4 13.6 5.3 12.1 12.0 11.9 11.6 9.7 10.5 6.2 8.3 9.7 10.0 7.8 10.1 8.9 10.4 9.9 9.4 40.7 37.7 9.1 8.5 13.0 10.6 21.8 21.3 20.3 14.2 9.3 13.1 19.4 11.7 24.7 11.3 7.8 19.0 7.4 8.2 8.6 13.3 10.8 10.5 8.6 11.3 3.1 22.9 5.2 6.6 12.1 7.3 18.2 12.0 3.4 12.5 13.4 12.8 7.7 6.3 9.6 3.5 8.8 9.1 3.2 8.1 9.7 14.3 10.1 11.3 5.6 10.5 14.0 5.8 6.2 16.5 5.7 13.0 9.9 11.7 9.0 6.7 7.8 7.2 6.3 23.3 19.1 10.5 11.7 21.2 9.1 18.6 8.8 8.2 7.6 13.2 23.6 12.4 13.8 3.3 5.6 7.3 13.3 8.3 7.5 3.0 12.7 8.2 9.4 7.5 7.8 15.1 24.1 15.3 5.4 11.7 8.8 6.1 4.5 5.5 14.0 10.9 23.2 30.6 19.5 10.7 10.6 17.8 2.0 12.5 3.4 9.7 10.9 12.8 18.2 7.5 9.9 11.6 15.2 8.3 10.0 1.4 13.4 5.8 12.0 6.0 7.7 11.3 13.6 12.0 11.9 9.9 9.4 13.0 10.6 13.1 11.3 29.8 33.4 17.1 16.9 8.7 34.9 28.7 48.4 12.0 22.7 52.4 15.7 23.8 10.0 18.4 13.5 19.6 13.2 0.0 22.3 16.3 19.5 28.7 38.3 68.1 32.6 35.0 20.8 27.0 24.1 7.5 36.8 24.0 27.0 9.0 15.9 31.7 12.7 14.0 31.5 49.7 25.3 6.5 13.2 13.1 11.9 11.3 28.1 19.8 22.9 12.3 TMEM205 "MBC3205, UNQ501" ENSG00000105518 "Transmembrane protein 205" Q6UW68 19 11342776-11346518 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 396.4;Hepatocytes: 417.5;Late spermatids: 488.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041504 Approved Approved "Nucleoplasm,Nuclear membrane,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nuclear membrane" "HPA041504: AB_10795595" "unprognostic (2.54e-2)" "unprognostic (2.60e-2)" "unprognostic (7.19e-2)" "unprognostic (1.57e-2)" "unprognostic (6.83e-2)" "unprognostic (1.80e-1)" "unprognostic (5.04e-3)" "unprognostic (3.77e-2)" "unprognostic (1.01e-2)" "unprognostic (5.56e-3)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" "unprognostic (8.10e-2)" "unprognostic (5.78e-2)" "unprognostic (8.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" 15.8 40.5 25.7 10.6 29.4 14.5 19.3 16.2 36.3 30.3 19.2 19.8 34.6 18.7 15.5 29.7 14.6 25.9 27.8 31.7 24.5 23.6 36.1 90.8 19.4 22.9 25.2 21.9 21.7 50.5 52.4 21.7 17.5 20.6 24.3 11.3 31.8 28.6 28.4 30.0 15.0 18.2 16.9 21.4 14.2 17.2 23.1 13.2 11.1 46.6 15.4 13.3 21.3 13.1 21.9 43.1 11.0 71.0 10.4 14.8 32.1 19.3 48.1 5.9 20.1 11.8 14.2 11.2 7.4 17.1 16.2 12.7 14.6 6.2 17.4 44.9 14.9 16.1 19.9 8.5 22.2 10.9 20.4 8.1 4.6 16.7 23.9 29.8 7.8 14.9 13.4 22.7 10.4 17.4 16.3 19.5 16.7 14.0 74.6 10.0 49.0 11.7 21.9 10.6 25.3 36.9 11.1 9.2 46.0 39.4 35.1 10.7 16.3 7.8 32.1 18.0 7.4 27.9 22.8 11.4 20.4 7.8 22.2 16.4 44.5 44.3 10.3 19.7 35.1 15.6 5.2 71.0 7.1 14.6 29.8 14.8 21.9 12.2 12.8 43.1 18.4 9.8 11.8 11.0 10.4 17.5 31.0 14.6 32.1 25.7 29.4 16.2 36.3 24.5 23.6 25.2 21.9 20.6 13.2 62.5 59.8 25.2 116.9 45.7 27.8 62.3 178.3 58.9 89.9 144.8 11.8 101.4 51.4 137.3 396.4 66.1 62.3 0.0 143.8 66.1 80.7 116.5 28.8 417.5 85.9 25.4 113.0 63.3 78.3 488.1 74.8 50.9 91.1 31.5 72.5 72.5 99.5 66.6 64.0 180.1 27.1 45.3 59.3 30.7 14.9 47.2 80.9 37.9 73.4 104.8 TMEM215 ENSG00000188133 "Transmembrane protein 215" Q68D42 9 32783499-32787399 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 8.0;retina: 6.5;testis: 17.9" "Cell type enhanced" "Detected in some" 32 "Bipolar cells: 564.3;Early spermatids: 108.6;Late spermatids: 188.4" "Cancer enriched" "Detected in single" 14 "thyroid cancer: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NTERA-2: 6.6;SH-SY5Y: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052804, HPA063207" Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA052804: AB_2681957, HPA063207: AB_2732697" "unprognostic (1.31e-2)" "unprognostic (4.57e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-2)" "unprognostic (5.85e-2)" "unprognostic (4.38e-3)" "unprognostic (2.17e-3)" "unprognostic (2.82e-1)" "unprognostic (2.72e-1)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" "unprognostic (2.32e-2)" 0.1 0.0 1.8 0.4 1.5 0.0 0.1 0.1 0.9 1.9 0.0 0.0 0.0 0.0 8.0 0.9 0.1 0.1 0.0 0.9 0.9 1.5 0.0 0.0 0.1 0.0 1.7 0.2 0.7 0.0 0.0 0.1 0.0 0.6 0.1 0.0 6.5 0.1 0.0 0.3 0.1 0.1 0.0 1.0 0.0 0.0 17.9 0.0 0.0 3.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.1 0.8 0.9 1.5 1.7 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 564.3 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 108.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 188.4 2.6 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.7 0.0 21.9 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 TMEM223 MGC3196 ENSG00000168569 "Transmembrane protein 223" A0PJW6 11 62771629-62792021 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014504 Approved Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA014504: AB_1853881" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.87e-1)" "unprognostic (3.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-2)" "unprognostic (3.20e-3)" "unprognostic (1.97e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-3)" "unprognostic (1.29e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (7.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.14e-3)" "unprognostic (9.75e-2)" 10.9 20.6 12.8 13.4 19.5 8.7 11.6 11.1 25.5 11.7 15.2 13.4 12.0 16.6 12.7 15.5 12.3 11.9 11.8 21.7 12.6 12.8 19.5 20.4 10.5 16.2 12.4 15.6 12.5 38.7 10.4 13.0 10.9 13.2 14.8 11.6 13.9 22.4 15.0 21.3 16.2 18.2 8.4 11.1 16.1 16.2 8.2 11.6 19.0 13.4 10.6 14.2 11.1 10.2 32.4 28.0 8.9 16.6 23.1 30.7 15.3 15.3 13.2 7.9 10.8 6.3 7.3 10.8 8.3 7.3 9.4 7.9 11.5 18.9 11.6 20.5 5.9 12.4 23.5 9.5 10.2 5.4 18.3 17.8 8.6 14.8 13.7 11.7 10.5 10.2 7.8 10.4 6.2 7.8 11.1 7.2 15.4 13.0 8.7 6.9 22.4 10.5 23.4 15.6 16.1 16.0 13.1 9.6 25.8 14.5 9.8 13.5 17.9 8.7 17.7 21.9 8.4 26.4 9.9 7.5 11.3 13.6 10.3 9.8 17.9 14.2 13.2 13.4 9.5 11.7 7.3 16.1 8.9 28.4 16.6 27.2 28.2 28.1 27.6 17.5 32.4 30.7 29.8 7.5 23.1 10.5 28.0 23.9 15.3 12.8 19.5 11.1 25.5 12.6 12.8 12.4 15.6 13.2 11.6 11.9 3.5 22.6 13.7 11.9 18.5 16.8 40.8 36.1 13.6 19.2 11.8 41.9 53.0 32.8 1.9 17.5 26.1 0.0 38.3 35.7 20.6 16.0 19.6 34.8 32.6 6.4 19.8 31.3 19.6 2.6 30.2 16.6 18.6 16.2 29.2 14.8 31.4 14.0 24.8 47.6 17.3 19.4 9.6 6.3 21.2 12.2 11.9 29.9 38.6 14.5 TMEM260 "C14orf101, FLJ20392" ENSG00000070269 "Transmembrane protein 260" Q9NX78 14 56488354-56650606 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 61.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 69.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003502 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA003502: AB_1078314" "unprognostic (4.63e-2)" "unprognostic (2.41e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (2.51e-1)" "unprognostic (3.58e-2)" "unprognostic (2.04e-1)" "prognostic favorable (7.11e-4)" "unprognostic (7.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-3)" "unprognostic (3.22e-1)" "unprognostic (2.23e-3)" "unprognostic (5.81e-2)" "unprognostic (8.11e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-2)" 7.8 7.4 7.3 11.0 10.6 3.8 9.1 13.3 9.9 61.0 8.8 13.7 11.6 8.1 11.8 12.1 6.7 11.4 10.3 6.0 8.9 8.6 10.7 8.7 8.4 8.8 10.8 7.5 14.8 13.6 12.4 17.2 8.7 9.7 8.7 9.1 8.7 7.4 13.0 5.2 8.6 10.7 8.9 12.2 9.2 8.4 10.1 8.3 17.6 12.6 4.6 8.8 10.1 9.7 2.0 4.6 2.9 2.8 6.3 3.5 2.0 7.4 5.2 4.0 8.6 14.4 11.9 7.9 7.9 8.8 5.2 6.3 2.4 5.5 6.0 7.8 5.9 5.9 8.6 9.3 5.8 8.3 7.5 4.7 3.9 2.4 3.3 10.1 5.4 9.4 14.5 10.4 2.9 10.1 9.6 6.8 4.7 4.8 6.5 6.8 4.9 2.8 2.0 3.7 12.2 8.3 4.0 6.4 2.0 8.8 11.0 8.5 4.2 8.9 6.5 5.2 7.9 8.2 8.4 9.5 10.6 4.1 7.9 3.9 3.9 3.1 3.5 6.7 4.0 5.2 0.0 2.8 2.9 3.5 1.9 2.4 1.8 2.4 1.8 2.2 2.0 3.2 2.3 1.4 6.3 1.7 4.6 2.9 2.0 7.3 10.6 13.3 9.9 8.9 8.6 10.8 7.5 9.7 8.3 17.9 12.1 4.2 7.4 4.7 14.2 2.9 0.0 17.4 5.7 21.0 3.9 7.9 1.7 6.8 69.7 4.7 6.3 0.0 3.3 6.5 6.7 8.2 11.5 7.5 5.5 6.4 17.2 8.6 13.9 25.8 14.1 7.8 1.7 5.4 10.8 5.6 5.0 7.0 10.3 3.7 17.1 0.0 4.2 7.9 8.5 4.8 9.3 5.7 10.8 6.8 TMEM37 "PR, PR1" ENSG00000171227 "Transmembrane protein 37" Q8WXS4 2 119429901-119438520 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 110.5;kidney: 82.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 276.4;Hepatocytes: 166.8;Muller glia cells: 140.1;Proximal tubular cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.8;naive CD4 T-cell: 3.3" "Group enriched" "Detected in many" 31 "monocytes: 2.8;T-cells: 3.3" "Group enriched" "Detected in some" 5 "EFO-21: 13.4;Hep G2: 35.1;RPTEC TERT1: 29.4" "Low region specificity" "Detected in many" HPA053794 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA053794: AB_2682265" "unprognostic (2.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.01e-1)" "unprognostic (4.59e-3)" "unprognostic (2.56e-1)" "unprognostic (9.60e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.36e-1)" "unprognostic (2.83e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-2)" "unprognostic (2.99e-1)" "unprognostic (2.61e-2)" 18.5 5.2 0.6 5.9 1.0 0.0 10.0 0.5 1.2 6.7 60.3 1.8 3.8 16.2 3.1 3.8 2.8 1.4 18.5 5.7 1.0 0.4 82.5 40.8 9.5 8.7 0.9 0.7 5.9 5.8 20.1 0.7 13.4 1.3 4.5 5.6 6.3 2.8 6.5 1.6 4.4 110.5 1.9 1.4 11.5 6.6 6.4 0.7 1.2 21.0 1.6 2.2 3.4 2.4 0.0 0.0 0.0 2.8 0.0 3.3 0.6 0.0 3.5 0.3 0.1 2.2 0.2 0.5 0.1 0.0 0.0 0.0 5.4 3.1 0.0 13.4 1.6 0.3 0.8 1.4 0.0 0.0 0.0 1.4 0.4 2.0 35.1 3.0 0.0 0.0 4.9 0.0 0.0 0.0 0.1 2.8 0.0 0.1 5.3 0.0 0.3 0.0 0.3 2.6 0.0 0.1 0.0 0.0 4.6 29.4 2.3 0.4 0.2 0.1 1.4 0.0 2.6 0.6 0.8 1.8 0.0 5.3 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.6 1.0 0.5 1.2 1.0 0.4 0.9 0.7 1.3 0.7 23.8 8.1 15.4 0.2 1.8 2.6 1.2 86.6 1.4 3.4 17.4 0.0 40.2 43.1 18.4 0.1 2.9 276.4 0.0 47.2 3.4 14.1 0.1 1.1 166.8 54.9 6.4 8.7 82.3 51.8 0.9 46.1 4.3 1.7 1.0 14.5 140.1 16.0 45.6 3.5 167.4 17.7 0.0 1.9 0.0 1.0 2.5 87.1 1.8 12.4 1.6 TMEM41A MGC15397 ENSG00000163900 "Transmembrane protein 41A" Q96HV5 3 185476496-185499057 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 54.4" "Cell type enhanced" "Detected in many" 4 "monocytes: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059101, HPA059790" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059101: AB_2683905, HPA059790: AB_2684125" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.99e-2)" "prognostic unfavorable (6.70e-6)" "unprognostic (2.67e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (3.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.73e-1)" "unprognostic (3.68e-1)" "unprognostic (1.46e-2)" "unprognostic (1.02e-2)" 8.1 23.9 7.8 4.8 10.2 9.3 10.1 4.9 11.5 10.6 26.8 11.7 6.3 24.5 9.1 11.1 20.6 9.0 8.6 8.3 7.5 8.4 15.8 26.1 11.3 9.0 8.1 5.4 14.2 10.7 6.7 5.7 9.0 8.6 10.1 8.6 11.9 11.2 9.4 8.3 16.6 54.4 8.0 8.7 12.4 8.7 11.2 7.4 11.3 9.0 18.1 16.7 8.8 12.5 12.8 16.4 7.8 8.4 8.5 16.7 6.5 20.9 7.6 5.1 6.2 8.1 8.7 15.0 8.1 7.1 10.2 7.5 19.8 8.3 6.5 15.5 7.5 14.5 14.6 14.0 8.6 10.4 10.9 12.9 11.3 4.6 19.9 9.0 12.1 6.4 8.1 12.9 9.2 10.6 6.5 7.8 8.3 20.0 16.3 6.5 8.1 7.4 7.0 8.4 16.6 12.1 7.5 7.8 11.9 8.8 15.4 5.1 6.6 7.0 18.0 12.3 7.6 21.5 9.5 5.6 6.1 7.6 12.6 16.8 24.0 36.6 13.1 9.3 7.3 7.3 7.8 6.3 5.1 13.2 6.6 16.7 12.8 13.6 14.3 7.0 12.4 15.0 16.1 2.4 8.5 8.4 16.4 11.1 6.5 7.8 10.2 4.9 11.5 7.5 8.4 8.1 5.4 8.6 7.4 8.9 26.2 17.6 29.0 47.2 17.7 11.3 22.9 4.0 14.8 19.2 17.7 23.4 6.6 28.6 0.4 17.9 38.7 0.0 48.5 20.2 16.7 43.7 8.1 34.2 16.5 15.9 17.9 14.1 11.1 1.8 13.3 14.3 8.5 100.0 26.4 14.6 45.8 15.9 12.7 22.4 29.5 19.4 17.2 23.7 14.2 74.0 38.4 15.2 30.8 81.8 TMSB4X "TB4X, TMSB4" ENSG00000205542 "Thymosin beta 4, X-linked" P62328 X 12975108-12977227 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 1074.5" "Cell type enhanced" "Detected in all" 9 "Hofbauer cells: 27421.6;monocytes: 60748.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" CAB033806 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 400000000 "Nucleoplasm, Vesicles, Cytosol" "CAB033806: AB_2256019" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.72e-2)" "unprognostic (3.27e-2)" "unprognostic (7.98e-3)" "unprognostic (1.71e-2)" "unprognostic (2.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (6.20e-4)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (3.77e-2)" "unprognostic (1.98e-1)" 122.3 97.5 79.8 105.4 76.4 169.0 87.1 33.2 74.8 92.3 93.3 62.0 59.7 38.5 83.7 67.2 62.7 53.0 92.5 54.9 90.8 67.8 69.6 50.8 134.4 205.2 111.4 84.0 61.9 51.0 4.4 23.4 53.4 74.3 46.6 86.6 31.2 42.3 100.4 28.9 39.6 71.5 75.1 195.6 205.7 98.9 26.4 63.8 96.8 34.4 48.6 154.5 112.2 62.1 296.5 495.3 775.0 554.0 272.7 521.9 1074.5 144.7 121.2 238.2 375.3 292.0 320.2 0.5 76.7 200.8 59.6 102.7 24.9 121.8 34.7 74.2 232.8 107.2 63.8 35.2 51.4 80.2 202.6 2.0 43.2 71.9 0.3 68.1 168.5 358.6 149.0 73.7 70.5 61.7 146.2 358.0 92.6 5.4 0.5 210.8 51.5 200.3 365.8 85.6 69.8 83.6 154.4 84.3 141.5 354.7 42.4 25.3 10.8 111.2 5.2 14.1 184.0 139.7 171.2 287.9 87.0 43.2 493.2 76.2 113.1 82.0 67.2 133.1 69.9 62.7 544.9 512.5 775.0 364.8 524.7 309.6 296.5 407.3 391.0 495.3 275.6 345.8 349.0 576.0 272.7 554.0 204.1 521.9 1074.5 79.8 76.4 33.2 74.8 90.8 67.8 111.4 84.0 74.3 63.8 4880.5 5161.6 6027.5 2141.8 7849.2 355.4 69.7 3189.8 1104.2 2643.4 6528.7 21.6 260.6 1848.6 14106.6 104.1 8207.2 4374.5 256.9 19960.8 448.9 5187.8 2457.6 4102.8 814.3 27421.6 58.8 1698.6 5862.6 15729.2 176.0 3640.8 24463.6 6022.8 60748.0 4889.5 45.5 20394.3 5909.2 5673.8 362.6 82.8 5639.7 7491.8 44.2 114.3 8329.0 380.3 13550.6 2818.5 7177.4 TNFSF15 "MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A" ENSG00000181634 "TNF superfamily member 15" O95150 9 114784635-114806126 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.0;kidney: 16.2;salivary gland: 28.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.9;monocytes: 9.0;Proximal tubular cells: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "myeloid DC: 2.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8" "Cell line enhanced" "Detected in some" "HaCaT: 11.1;hTEC/SVTERT24-B: 7.3;HUVEC TERT2: 14.0;OE19: 13.1;RT4: 13.7;TIME: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012948, HPA046522" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted to blood" NA NA 1110000 "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA012948: AB_1858024, HPA046522: AB_2679683" "unprognostic (3.41e-1)" "unprognostic (2.06e-2)" "unprognostic (3.76e-1)" "unprognostic (1.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.67e-2)" "unprognostic (1.64e-1)" "unprognostic (2.29e-2)" "unprognostic (5.40e-2)" "unprognostic (1.38e-1)" "unprognostic (7.78e-2)" "unprognostic (2.09e-1)" "unprognostic (8.64e-5)" "unprognostic (1.97e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-3)" "unprognostic (4.46e-3)" 1.2 1.3 0.3 3.1 0.5 0.0 0.7 0.2 0.9 1.9 7.3 0.1 1.3 10.8 0.9 1.3 2.8 0.8 2.0 0.3 1.7 0.3 16.2 0.5 5.2 0.5 0.4 0.1 0.7 1.4 0.2 0.5 6.0 0.7 9.8 2.2 0.6 28.7 4.4 0.3 0.6 15.0 2.0 0.4 1.5 3.0 0.6 0.1 0.9 1.3 1.8 2.4 6.4 1.6 0.3 2.8 1.2 1.8 0.3 0.1 0.4 0.4 3.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.1 0.2 2.5 1.3 0.0 0.0 0.4 11.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 7.3 0.0 0.0 14.0 0.0 0.0 0.8 0.4 0.5 0.0 0.0 0.2 13.1 0.0 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.0 0.6 0.0 5.0 1.0 0.0 6.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.8 0.1 0.1 1.8 0.0 0.3 0.1 0.0 2.8 0.3 0.1 0.1 1.2 0.3 0.2 1.5 0.0 0.4 0.3 0.5 0.2 0.9 1.7 0.3 0.4 0.1 0.7 0.1 11.9 8.9 0.0 4.4 0.5 0.1 0.5 0.0 0.0 1.2 7.0 0.0 0.5 0.0 4.0 0.2 0.0 6.9 0.0 1.8 0.1 0.8 4.6 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 9.0 1.8 0.2 1.1 0.0 0.4 9.6 0.1 0.0 1.0 0.0 0.0 0.5 0.2 0.0 3.9 5.1 TNKS "PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1" ENSG00000173273 Tankyrase O95271 8 9555914-9782346 "Enzymes, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 118.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025690 Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA Nucleoplasm "Nuclear membrane, Nuclear bodies" "HPA025690: AB_10602249" "unprognostic (2.07e-1)" "unprognostic (1.72e-2)" "unprognostic (5.45e-3)" "unprognostic (8.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-2)" "unprognostic (4.75e-2)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (8.01e-2)" "unprognostic (6.21e-2)" "unprognostic (9.10e-2)" "unprognostic (4.14e-2)" "unprognostic (1.12e-1)" "unprognostic (5.43e-1)" "unprognostic (7.76e-2)" "unprognostic (5.36e-2)" 9.1 13.4 17.8 8.7 19.6 14.6 14.0 26.5 22.3 18.1 8.9 17.0 12.5 8.5 14.9 25.3 7.7 11.9 8.9 9.5 18.6 17.9 9.0 9.1 10.3 12.9 28.7 17.2 19.2 10.2 23.9 20.0 11.0 20.1 11.5 10.0 10.9 9.4 11.7 22.1 15.6 9.8 11.0 21.0 8.7 10.1 26.3 21.8 15.6 13.7 4.4 11.7 10.8 13.6 6.8 3.6 7.4 2.8 2.9 4.8 1.2 6.1 8.1 20.8 12.5 13.2 17.7 7.7 9.5 10.8 7.7 8.8 4.8 4.9 13.2 3.9 9.3 10.4 6.5 11.8 8.9 11.2 3.4 6.1 9.2 7.4 10.8 11.9 4.7 5.7 12.5 10.8 8.0 15.8 12.6 10.4 10.3 8.6 14.1 14.2 4.0 11.9 7.2 13.6 6.7 4.7 9.6 12.9 3.8 9.3 12.5 21.2 15.6 7.4 7.1 13.4 13.2 4.7 7.1 13.9 12.7 7.8 8.6 7.0 4.9 7.9 9.4 13.7 6.7 12.2 4.8 2.3 1.8 4.4 2.2 2.4 4.2 3.5 4.2 2.8 6.8 4.2 4.8 7.4 2.9 2.8 3.6 1.7 1.2 17.8 19.6 26.5 22.3 18.6 17.9 28.7 17.2 20.1 21.8 14.9 9.4 11.0 11.2 10.2 32.0 14.3 17.8 26.8 9.1 8.7 13.7 9.0 1.7 9.8 118.1 10.9 9.0 0.0 7.4 7.7 14.9 11.9 9.3 15.8 6.2 39.7 13.3 20.9 9.4 58.4 15.5 7.3 11.8 1.8 13.5 18.4 11.2 13.1 17.0 6.0 36.2 0.0 9.9 30.7 13.5 13.6 10.3 11.5 11.7 10.2 TNNC1 TNNC ENSG00000114854 "Troponin C1, slow skeletal and cardiac type" P63316 3 52451102-52454070 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "heart muscle: 431.6;skeletal muscle: 765.7" "Cell type enriched" "Detected in many" 8 "Cardiomyocytes: 2506.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.0" "Lineage enriched" "Detected in single" 7 "T-cells: 4.0" "Cell line enhanced" "Detected in some" "CACO-2: 24.3;CAPAN-2: 12.2;EFO-21: 24.4;HeLa: 16.0;Hep G2: 16.2;HSkMC: 25.3;U-2 OS: 37.5" "Region enriched" "Detected in many" 4 "cerebral cortex: 88.3" "Not detected" "Not detected" "CAB002450, HPA044848, HPA056897" Enhanced Approved "Nucleoplasm,Actin filaments,Mitochondria" NA NA 260000 "Nucleoplasm, Actin filaments, Mitochondria" "CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269" "unprognostic (2.18e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (3.43e-1)" "unprognostic (4.00e-2)" "unprognostic (1.88e-2)" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.15e-2)" "unprognostic (4.95e-2)" "unprognostic (2.31e-1)" "unprognostic (4.15e-2)" "unprognostic (4.86e-1)" 2.0 0.3 0.1 0.0 0.1 0.0 0.7 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 17.8 12.8 0.1 0.0 431.6 0.1 0.1 0.6 0.1 2.6 0.0 0.1 0.0 0.1 0.2 0.0 0.6 0.2 0.5 5.5 0.1 0.7 10.4 0.0 765.7 0.4 0.1 0.1 0.7 0.1 0.1 0.7 0.0 0.0 3.0 86.9 8.7 0.4 0.2 0.2 0.6 0.0 0.0 0.0 4.0 0.5 0.2 1.8 1.3 0.2 0.0 0.2 2.9 0.1 0.1 0.1 0.1 24.3 12.2 0.2 24.4 3.5 0.0 0.1 0.0 0.1 0.0 0.4 0.6 0.1 16.0 16.2 0.1 0.1 0.0 25.3 0.4 0.0 0.2 0.2 0.0 0.7 0.0 1.9 0.7 0.0 0.0 0.2 0.2 5.4 0.2 0.0 1.0 0.8 1.2 4.6 0.0 0.0 0.1 2.5 0.0 1.5 9.8 0.2 0.0 0.0 37.5 0.3 0.0 1.0 0.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.0 4.0 0.2 0.9 0.5 0.0 0.1 1.4 0.5 0.0 0.0 0.0 0.6 2.5 0.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.5 0.0 116.1 13.0 0.0 0.6 1.3 0.2 2506.5 0.0 0.0 7.9 3.5 2.0 44.2 23.2 6.6 0.6 0.0 0.7 0.0 11.8 4.0 14.0 0.6 0.0 0.6 4.1 0.0 318.5 0.6 0.0 3.6 20.8 1.0 5.0 0.0 0.3 1.5 4.4 0.0 166.9 0.5 0.0 0.0 15.5 1.2 0.4 0.6 26.0 0.8 1.5 4.1 TNNT1 "ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS" ENSG00000105048 "Troponin T1, slow skeletal type" P13805 19 55132794-55149354 "Disease related genes, Predicted intracellular proteins" "Muscle protein" "Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 1047.7" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 54.4;Cardiomyocytes: 49.6;Spermatogonia: 26.7;Suprabasal keratinocytes: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "eosinophil: 53.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 53.3" "Cell line enhanced" "Detected in many" "HMC-1: 121.8;RH-30: 91.7" "Region enriched" "Detected in many" 5 "thalamus: 136.6" "Low region specificity" "Detected in some" "CAB015168, HPA058448" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "CAB015168: AB_2206426, HPA058448: AB_2683720" "unprognostic (1.88e-1)" "unprognostic (7.23e-2)" "prognostic unfavorable (4.66e-4)" "prognostic unfavorable (4.66e-4)" "unprognostic (3.47e-3)" "unprognostic (3.92e-3)" "unprognostic (1.35e-3)" "unprognostic (1.03e-3)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (3.23e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.91e-2)" "unprognostic (4.01e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-2)" 3.2 0.0 1.6 0.0 1.0 0.1 0.1 0.1 1.0 0.0 0.1 0.0 0.0 0.1 0.0 24.4 22.3 0.4 0.1 6.1 0.9 0.4 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 7.2 0.0 0.0 11.5 0.0 1047.7 1.8 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 9.2 124.4 17.8 0.3 0.1 0.1 9.9 53.3 11.6 0.1 0.1 2.6 24.8 14.6 0.1 3.2 0.0 0.2 4.8 1.1 4.3 1.6 4.8 5.3 16.6 0.3 9.7 0.4 13.0 12.7 3.4 10.8 1.3 1.6 27.6 4.7 1.5 0.9 0.5 0.3 121.8 5.4 17.6 0.5 18.7 18.5 0.0 5.0 23.6 23.1 1.5 23.7 0.4 0.0 3.1 6.3 29.0 15.9 91.7 2.9 3.8 0.8 0.9 7.2 1.5 0.2 8.0 1.3 15.1 14.5 0.5 24.1 35.9 0.9 1.8 0.1 0.9 1.2 25.4 3.7 7.3 0.5 11.6 53.3 0.0 5.9 0.1 0.0 0.1 0.0 9.9 0.1 0.1 0.1 0.5 0.1 2.6 0.2 0.0 2.6 1.6 1.0 0.1 1.0 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.4 1.5 49.6 0.0 6.7 0.0 0.0 0.0 1.3 0.0 1.8 1.3 0.0 0.0 0.0 0.0 14.0 8.0 0.0 0.0 0.0 13.2 0.0 2.4 1.8 12.0 6.0 0.3 4.2 3.3 0.0 0.2 0.8 0.4 0.0 0.0 0.0 0.6 0.0 0.9 2.8 26.7 26.6 3.0 0.0 0.3 0.1 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377762 "Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 241 "heart muscle: 679.2" "Cell type enriched" "Detected in many" 289 "Cardiomyocytes: 11884.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "RH-30: 189.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB015371, HPA015774, HPA017888" Enhanced Uncertain "Nucleoplasm,Nucleoli,Focal adhesion sites" No No 50000 "Nucleoplasm, Nucleoli" "Focal adhesion sites" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 0.1 0.3 0.1 0.1 0.7 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.2 679.2 0.9 0.0 1.9 0.0 0.7 0.3 0.1 1.1 0.1 0.3 0.0 0.2 0.7 0.1 0.7 0.0 0.0 0.2 0.1 2.0 1.3 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.4 0.5 0.0 0.0 189.8 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 10.5 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.1 0.9 0.0 0.1 1.1 0.1 0.0 3.0 4.0 0.0 1.1 3.1 1.0 11884.8 0.0 0.0 1.2 1.8 0.0 2.3 0.0 0.5 9.4 0.0 1.6 0.0 0.3 0.9 41.1 0.5 0.0 0.0 2.7 0.0 0.0 0.0 0.0 13.6 0.6 0.0 0.0 4.6 0.5 0.0 0.7 0.8 1.1 0.8 0.5 0.0 0.4 0.0 0.2 6.4 3.5 0.0 2.8 1.4 TNPO1 "IPO2, KPNB2, MIP, MIP1, TRN" ENSG00000083312 "Transportin 1" Q92973 5 72816312-72916733 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016325 Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA 47000 Nucleoplasm "Cytosol, Cytoplasmic bodies" "CAB016325: AB_675691" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-3)" "unprognostic (1.43e-1)" "unprognostic (3.15e-1)" "unprognostic (6.43e-3)" "prognostic unfavorable (6.55e-5)" "unprognostic (8.93e-3)" "unprognostic (9.03e-2)" "unprognostic (3.40e-3)" "unprognostic (2.09e-1)" "unprognostic (3.07e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.76e-1)" "unprognostic (1.27e-2)" "unprognostic (2.49e-2)" 23.9 29.3 20.1 26.2 24.5 20.7 52.3 18.5 21.9 18.5 21.6 15.7 32.3 16.4 25.4 25.4 26.5 17.9 22.8 21.9 22.5 16.5 26.2 20.8 24.2 22.4 22.9 16.4 22.5 28.9 54.1 36.5 34.9 27.0 21.2 24.4 19.4 26.1 35.3 38.0 15.9 19.9 32.0 31.2 21.7 25.3 30.9 20.8 25.2 32.6 18.0 23.6 27.5 30.8 11.1 10.7 8.9 13.3 14.1 18.3 10.6 21.8 28.8 42.0 25.1 31.3 38.9 24.8 25.9 35.4 25.9 26.6 24.5 18.8 25.6 17.8 40.7 30.9 16.0 28.6 23.1 37.4 14.8 15.8 15.8 38.3 12.4 21.2 17.4 11.6 28.1 16.7 34.6 49.2 18.7 62.7 10.8 23.5 13.7 73.4 10.4 15.8 6.6 22.6 8.1 22.1 19.2 37.8 16.0 15.9 29.3 21.8 22.5 41.7 13.4 30.6 24.1 16.5 14.3 59.4 22.0 25.8 33.1 29.0 12.6 19.5 34.2 17.4 17.8 40.2 7.3 8.3 6.9 13.4 11.5 18.3 11.1 12.2 10.0 10.7 11.0 13.4 13.4 8.9 14.1 13.3 5.0 8.1 10.6 20.1 24.5 18.5 21.9 22.5 16.5 22.9 16.4 27.0 20.8 11.9 20.6 52.7 32.3 52.5 99.6 47.6 35.7 16.0 21.6 26.2 92.3 65.2 14.9 34.0 73.5 57.3 27.7 23.3 35.6 40.7 52.1 43.3 20.9 35.0 37.7 84.2 51.1 55.3 37.6 46.9 43.1 33.6 23.6 44.1 45.5 134.9 48.6 21.0 56.6 30.6 174.6 25.8 39.2 47.7 78.6 46.5 109.8 24.9 30.8 51.9 TNRC6A "CAGH26, GW182, KIAA1460, TNRC6" ENSG00000090905 "Trinucleotide repeat containing 6A" Q8NDV7 16 24610209-24827632 "Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Horizontal cells: 166.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015305, HPA017869" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA015305: AB_1850454, HPA017869: AB_1850456" "unprognostic (2.64e-1)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.86e-1)" "unprognostic (5.00e-2)" "unprognostic (1.10e-3)" "unprognostic (1.62e-1)" "unprognostic (3.22e-3)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (7.44e-3)" "unprognostic (2.63e-3)" "unprognostic (1.78e-1)" "unprognostic (9.18e-2)" "unprognostic (5.77e-2)" "unprognostic (2.31e-1)" "unprognostic (3.35e-2)" 17.3 23.6 14.7 23.2 15.1 10.2 17.0 25.0 19.3 20.8 17.0 15.6 17.2 10.5 26.6 23.1 12.5 20.2 12.6 13.4 11.3 9.4 13.0 17.0 14.0 16.7 14.5 10.9 26.7 20.1 42.6 25.4 12.6 16.2 16.4 12.8 17.8 16.6 18.6 26.5 16.5 16.0 27.5 19.4 14.2 15.8 11.4 14.7 15.9 19.6 14.9 13.8 16.4 16.4 5.4 5.2 2.3 2.7 3.3 3.9 1.3 11.5 16.2 19.2 10.4 16.6 22.1 10.9 19.8 16.1 14.5 15.9 11.8 9.7 11.7 8.6 19.8 14.9 13.1 23.8 16.7 21.9 11.9 12.3 11.7 17.8 16.2 14.3 11.9 8.3 22.1 8.7 18.9 12.5 17.9 19.8 7.8 17.7 7.5 18.7 13.6 10.0 7.9 27.4 5.6 8.1 19.6 14.9 10.6 11.0 10.8 9.4 13.1 13.9 8.6 7.6 15.2 9.9 7.9 18.1 18.6 12.8 9.1 13.9 16.5 13.0 19.6 17.3 7.5 13.3 2.3 2.7 1.9 3.0 1.6 2.5 5.2 2.9 2.7 1.0 5.4 3.9 2.7 1.5 3.3 1.6 5.2 2.9 1.3 14.7 15.1 25.0 19.3 11.3 9.4 14.5 10.9 16.2 14.7 35.7 51.8 48.1 14.8 31.0 84.5 67.4 58.6 22.7 38.7 43.6 111.9 18.0 14.9 20.3 16.0 35.8 32.0 23.3 21.0 12.6 36.1 20.9 38.1 104.9 18.0 166.8 53.7 65.1 54.2 8.1 63.9 27.5 28.7 23.4 36.7 48.9 23.3 33.4 76.4 12.2 83.3 19.4 26.9 44.2 27.2 25.1 6.9 31.7 32.1 14.0 TOX4 "C14orf92, KIAA0737, LCP1" ENSG00000092203 "TOX high mobility group box family member 4" O94842 14 21476597-21499175 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017880, HPA027551" Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA017880: AB_1845573, HPA027551: AB_10601701" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.46e-2)" "unprognostic (9.30e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (3.46e-4)" "unprognostic (8.05e-3)" "unprognostic (2.58e-1)" "unprognostic (5.00e-2)" "unprognostic (3.23e-2)" "unprognostic (2.94e-1)" "prognostic favorable (8.38e-5)" "unprognostic (1.84e-1)" "unprognostic (2.48e-1)" "unprognostic (9.03e-2)" "unprognostic (2.48e-3)" 16.5 15.1 18.0 13.4 24.7 18.8 16.9 19.9 29.8 19.8 17.3 21.0 10.9 12.7 18.9 16.2 21.8 15.6 14.7 19.2 17.0 18.4 14.3 15.8 15.8 13.7 19.3 15.9 17.0 17.0 23.2 15.5 21.3 25.3 15.6 15.9 16.0 19.7 19.2 46.0 20.2 20.0 20.5 17.3 14.7 16.9 18.0 13.3 19.5 17.7 16.6 21.6 18.2 14.4 18.4 23.7 34.1 19.9 19.1 21.4 17.6 13.1 14.0 11.7 11.0 17.0 16.3 15.6 12.8 25.3 27.3 26.4 13.5 16.0 8.0 9.0 21.0 21.8 16.0 19.1 19.7 35.0 14.1 7.7 8.9 9.5 18.7 22.0 16.5 14.7 21.2 20.4 21.4 20.6 18.7 19.3 15.3 11.0 13.8 19.4 11.2 16.2 9.1 6.5 19.7 22.1 14.6 12.1 9.3 12.7 16.8 10.8 11.1 12.6 13.5 11.0 16.2 12.8 6.3 12.6 13.8 13.0 12.4 11.2 18.2 19.6 18.0 6.7 8.0 14.6 25.2 19.6 27.0 17.3 19.9 18.6 17.0 15.3 16.2 17.7 18.4 16.4 17.9 34.1 19.1 17.7 23.7 21.4 17.6 18.0 24.7 19.9 29.8 17.0 18.4 19.3 15.9 25.3 13.3 62.5 50.7 37.3 55.5 77.5 75.7 44.9 30.6 56.2 53.4 43.6 27.5 65.5 53.0 41.6 55.4 48.4 49.5 0.0 45.0 53.5 45.5 50.9 59.0 40.3 38.8 39.7 66.1 33.2 39.0 26.6 45.1 51.1 37.1 54.1 38.1 47.5 41.6 40.7 41.4 44.0 47.2 32.3 52.0 104.2 54.7 77.7 222.3 66.1 37.7 58.6 TPX2 "C20orf1, C20orf2, DIL-2, p100" ENSG00000088325 "TPX2, microtubule nucleation factor" Q9ULW0 20 31739271-31801805 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 92.7" "Group enriched" "Detected in many" 5 "Erythroid cells: 70.0;Extravillous trophoblasts: 57.2;Spermatocytes: 121.8;Spermatogonia: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Group enriched" "Detected in many" 5 "granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005487 Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes Yes Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA005487: AB_1858223" "unprognostic (2.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.43e-6)" "unprognostic (2.99e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (8.07e-7)" "prognostic unfavorable (6.46e-4)" "unprognostic (3.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.68e-5)" "unprognostic (5.99e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.56e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.39e-1)" 1.8 1.7 1.0 13.4 2.0 21.7 1.2 2.2 1.7 2.2 5.7 0.5 0.3 4.6 1.2 2.3 13.3 0.5 1.9 1.5 0.8 0.7 1.2 2.7 2.6 12.9 0.7 1.1 0.8 0.5 0.0 0.7 6.6 0.9 0.7 7.4 0.5 2.3 0.5 2.2 5.9 4.7 3.2 0.9 5.9 3.2 22.0 0.6 92.7 0.7 11.0 16.2 2.2 3.8 1.0 1.4 4.0 0.1 4.8 10.4 1.3 70.8 23.8 28.8 22.5 2.3 4.2 27.8 29.8 16.9 43.3 32.7 50.5 30.7 33.4 17.6 16.6 32.4 37.5 32.8 27.0 49.5 14.4 12.7 65.4 22.8 34.4 0.7 25.1 16.8 1.4 1.5 27.1 19.8 6.2 23.3 25.3 48.3 30.5 33.9 29.1 41.9 19.5 32.1 27.4 25.8 23.9 77.8 20.2 11.6 11.6 20.9 14.1 45.6 17.3 13.5 20.7 30.0 15.3 15.7 48.6 29.9 22.2 45.7 12.2 21.1 29.9 15.2 89.5 31.6 4.0 0.0 0.5 0.6 0.0 0.3 1.0 1.9 2.3 0.6 0.4 0.4 0.7 0.4 4.8 0.1 1.4 10.4 1.3 1.0 2.0 2.2 1.7 0.8 0.7 0.7 1.1 0.9 0.6 0.0 6.2 16.2 0.8 6.2 0.8 0.8 7.6 0.0 5.7 0.0 0.0 4.4 0.0 1.0 6.4 0.3 0.6 70.0 0.4 57.2 2.9 0.6 0.0 2.5 15.9 1.6 1.2 9.8 5.3 10.6 0.9 5.1 0.0 3.6 2.6 0.3 1.2 0.6 0.0 0.0 0.3 0.0 2.1 121.8 68.8 5.4 3.9 6.9 7.3 1.4 TRA2A "AWMS1, htra-2-alpha, tra2a" ENSG00000164548 "Transformer 2 alpha homolog" Q13595 7 23504780-23532041 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054018 Uncertain Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoli "Nucleoplasm, Vesicles" "HPA054018: AB_2682344" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.24e-1)" "unprognostic (6.77e-3)" "unprognostic (8.05e-2)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.28e-2)" "unprognostic (2.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.87e-3)" "unprognostic (6.04e-2)" "prognostic unfavorable (1.79e-6)" "unprognostic (1.46e-2)" "unprognostic (1.52e-2)" "unprognostic (8.74e-2)" "unprognostic (1.36e-3)" 23.4 29.4 27.8 29.5 34.1 70.6 27.4 38.1 27.5 30.3 22.9 29.0 31.6 19.8 32.7 34.5 29.4 25.9 17.6 18.7 28.6 29.3 21.3 21.8 28.6 32.2 35.8 18.5 36.8 27.4 14.9 46.6 24.4 28.2 26.4 30.1 23.7 21.9 26.7 15.7 31.6 22.6 35.2 30.4 33.8 21.1 25.9 37.3 35.6 24.7 20.5 38.0 25.0 31.8 15.5 23.9 20.4 23.0 14.7 21.7 8.2 19.3 21.4 33.3 52.1 17.9 11.3 21.5 24.7 11.7 24.8 20.5 17.6 26.6 36.6 14.3 18.3 29.6 32.2 39.9 23.0 31.3 22.0 23.3 22.4 23.7 27.8 18.7 26.1 21.1 13.3 15.9 18.7 23.5 22.5 28.2 16.3 43.5 18.0 28.1 18.9 31.5 43.8 29.9 24.0 22.2 36.1 26.3 21.9 28.7 28.0 28.9 23.5 23.1 26.7 16.5 25.7 21.0 29.4 25.4 19.8 28.3 18.1 28.6 20.1 25.1 30.0 17.0 35.6 26.3 11.5 14.9 18.5 21.7 23.0 18.7 15.5 20.3 19.8 16.8 14.4 17.7 20.9 20.4 14.7 20.4 23.9 20.0 8.2 27.8 34.1 38.1 27.5 28.6 29.3 35.8 18.5 28.2 37.3 56.6 68.2 70.3 85.9 92.7 49.7 37.0 48.4 77.6 60.3 83.7 49.1 76.6 21.6 48.0 48.5 63.2 67.9 70.0 38.1 71.1 87.2 68.2 83.3 62.7 48.6 35.0 113.5 70.0 86.5 17.7 60.1 73.9 54.0 60.5 57.4 42.4 49.0 80.7 63.6 32.1 101.0 71.1 79.3 92.3 54.5 98.9 98.6 97.5 61.7 73.5 TRAF4 "CART1, MLN62, RNF83" ENSG00000076604 "TNF receptor associated factor 4" Q9BUZ4 17 28743984-28750958 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Urothelial cells: 265.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 27.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 27.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009055, HPA021904, HPA052377" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB009055: AB_2209701, HPA021904: , HPA052377: AB_2681804" "unprognostic (1.77e-1)" "unprognostic (9.05e-2)" "unprognostic (1.31e-2)" "unprognostic (2.51e-3)" "unprognostic (1.76e-1)" "unprognostic (7.38e-3)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.09e-2)" "unprognostic (2.33e-1)" "unprognostic (7.13e-2)" "unprognostic (7.55e-2)" "unprognostic (1.74e-3)" "unprognostic (6.98e-2)" "unprognostic (9.26e-2)" "unprognostic (2.77e-2)" "unprognostic (5.58e-3)" 5.0 8.1 13.8 13.1 14.5 19.9 15.9 6.3 12.4 7.9 22.2 24.7 14.0 32.8 6.8 5.7 15.4 9.5 17.1 2.8 12.7 7.6 20.7 30.1 13.5 12.5 17.9 7.7 7.2 33.8 3.1 8.1 11.8 12.4 16.7 16.0 6.0 32.2 10.4 0.9 7.5 31.4 5.1 10.9 10.2 21.7 7.4 16.4 5.9 16.4 7.1 16.5 15.9 6.0 5.3 27.7 2.7 0.6 0.8 1.4 0.9 11.4 18.4 25.3 12.4 3.6 4.3 39.5 7.8 6.7 8.5 11.3 14.6 14.8 18.0 11.6 8.7 5.7 17.5 11.6 17.9 3.5 5.6 16.2 6.4 30.4 16.6 14.1 3.1 7.2 8.1 17.7 10.0 12.0 7.7 6.5 8.6 16.7 1.6 7.7 19.3 9.7 6.4 19.7 23.1 4.2 14.4 11.6 8.8 24.1 33.8 16.0 18.5 12.3 54.3 23.5 22.9 20.6 4.9 4.4 5.3 11.3 6.1 10.9 2.4 5.8 22.4 4.2 5.1 24.2 2.7 0.2 0.9 0.6 0.6 1.4 5.3 1.0 1.0 1.5 5.3 0.7 0.7 0.1 0.8 0.4 27.7 0.5 0.9 13.8 14.5 6.3 12.4 12.7 7.6 17.9 7.7 12.4 16.4 20.8 24.1 21.9 160.2 122.2 2.8 0.4 38.2 29.4 23.9 19.2 5.9 92.4 36.5 78.4 44.7 11.2 113.0 0.0 94.8 110.0 25.1 171.6 6.9 35.6 12.1 7.9 80.7 9.2 1.2 8.6 3.4 4.6 37.1 10.8 58.2 18.9 100.9 95.4 1.4 24.8 1.7 0.0 33.0 5.7 20.4 68.6 104.0 6.4 64.4 265.8 TRAK2 "ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98" ENSG00000115993 "Trafficking kinesin protein 2" O60296 2 201377207-201451579 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 96.9" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 130.8;Cone photoreceptor cells: 68.7;Horizontal cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015827, HPA062163" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA015827: AB_1858238, HPA062163: AB_2684702" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-2)" "unprognostic (4.31e-2)" "unprognostic (2.78e-1)" "unprognostic (1.76e-1)" "unprognostic (2.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.24e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "prognostic favorable (7.42e-5)" "unprognostic (1.48e-1)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "unprognostic (9.82e-3)" 16.9 13.4 20.4 9.9 23.9 28.0 14.5 11.8 19.4 11.3 14.1 31.5 5.4 7.8 9.1 9.4 10.6 8.9 11.5 42.7 25.6 21.8 15.8 9.2 12.9 9.8 43.1 12.2 6.7 9.0 17.2 11.8 15.0 31.0 8.4 15.5 9.6 14.0 10.2 8.4 5.9 9.4 13.1 96.9 10.8 8.0 4.7 23.2 5.6 22.1 7.1 8.6 10.1 18.8 14.6 3.9 4.6 6.4 10.3 11.3 5.3 3.9 5.7 3.8 13.9 25.9 37.4 4.1 14.4 12.7 10.6 12.4 8.3 3.7 2.5 5.9 20.0 10.6 3.9 8.0 4.5 18.3 7.3 4.3 5.7 10.4 6.2 14.3 4.4 6.9 20.0 4.4 11.1 9.0 11.7 15.4 3.9 4.5 11.0 22.5 5.7 3.5 2.7 4.2 4.4 11.5 4.4 9.3 4.0 9.1 5.6 7.0 9.2 7.8 6.3 24.4 6.0 4.5 4.6 18.0 17.1 6.4 11.7 8.9 6.1 10.5 3.1 14.5 7.0 8.8 1.8 4.7 4.6 7.6 6.4 6.9 8.0 9.6 6.5 3.9 14.6 6.5 7.0 2.6 10.3 5.4 2.2 11.3 5.3 20.4 23.9 11.8 19.4 25.6 21.8 43.1 12.2 31.0 23.2 14.9 24.3 7.1 3.4 7.3 34.1 130.8 30.6 17.4 15.9 8.7 68.7 8.1 6.6 12.5 1.5 13.7 23.4 0.0 12.6 3.8 11.8 6.3 18.5 11.4 9.4 73.1 28.4 17.8 11.4 2.4 7.5 9.4 25.3 10.0 20.9 3.7 9.9 10.5 12.0 8.2 21.7 12.9 16.9 7.1 14.4 3.6 4.7 10.2 20.4 5.4 TRAPPC2 "hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L" ENSG00000196459 "Trafficking protein particle complex 2" "P0DI81, P0DI82" X 13712244-13734635 "Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004665, HPA063308" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoplasm "CAB004665: AB_425678, HPA063308: AB_2684982" "unprognostic (1.97e-1)" "prognostic favorable (8.09e-4)" "unprognostic (2.13e-1)" "unprognostic (4.18e-1)" "unprognostic (2.11e-1)" "unprognostic (2.70e-2)" "unprognostic (1.04e-2)" "unprognostic (2.08e-3)" "unprognostic (1.76e-2)" "prognostic favorable (6.35e-4)" "unprognostic (3.50e-2)" "unprognostic (8.24e-2)" "unprognostic (1.93e-1)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (2.36e-1)" "prognostic favorable (7.89e-5)" 6.5 6.4 15.6 9.5 13.7 9.5 9.4 24.1 16.1 10.5 9.4 10.1 8.8 8.2 16.4 8.7 8.5 9.4 7.6 6.4 14.4 14.2 10.1 10.1 7.8 16.1 10.4 13.0 11.7 11.2 8.9 19.5 7.2 11.5 8.9 9.1 10.2 8.1 8.3 4.9 10.3 8.8 16.0 11.5 11.1 10.7 4.3 11.1 4.3 8.8 4.2 16.4 8.1 9.4 11.2 10.7 13.7 6.6 18.5 16.1 9.0 6.8 5.3 8.2 20.9 6.3 4.8 3.3 6.4 5.5 5.1 5.5 4.5 8.5 11.6 10.3 5.3 6.7 9.0 10.8 9.2 7.0 11.7 16.2 8.6 12.5 3.6 4.8 11.8 16.6 6.3 5.2 10.9 14.9 10.3 4.5 8.5 10.8 20.0 5.2 11.3 11.6 15.6 7.9 5.7 9.5 11.4 10.8 11.3 8.0 5.1 8.7 11.6 11.8 9.5 8.2 13.0 11.8 7.9 5.9 5.2 4.6 9.2 4.0 10.3 10.1 14.5 4.8 8.4 5.2 13.7 4.9 8.6 16.1 6.6 16.0 11.2 12.8 15.8 4.3 11.1 10.8 15.5 10.0 18.5 5.4 10.7 15.3 9.0 15.6 13.7 24.1 16.1 14.4 14.2 10.4 13.0 11.5 11.1 8.9 6.2 22.8 8.2 13.5 14.5 9.8 20.4 4.0 11.4 8.7 11.8 12.7 18.3 9.2 12.6 7.7 9.1 0.0 11.8 15.8 11.6 9.3 9.2 11.3 10.0 19.1 11.6 11.1 9.5 3.8 11.8 9.5 8.5 9.0 14.7 8.3 15.9 17.6 10.6 20.2 13.6 6.5 11.4 4.5 3.3 15.4 15.0 27.7 13.4 10.5 TRAPPC2B "MIP-2A, SEDLP, SEDLP1, TRAPPC2P1" ENSG00000256060 "Trafficking protein particle complex 2B" P0DI82 19 57363511-57365353 "Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 32.7;Syncytiotrophoblasts: 76.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA063308 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA063308: AB_2684982" "unprognostic (8.55e-2)" "unprognostic (1.07e-2)" "unprognostic (4.24e-1)" "unprognostic (5.27e-2)" "unprognostic (1.93e-1)" "unprognostic (6.69e-2)" "unprognostic (1.12e-1)" "unprognostic (4.47e-2)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.05e-1)" "prognostic favorable (1.28e-4)" "unprognostic (1.26e-1)" "unprognostic (4.49e-2)" "unprognostic (9.74e-2)" "unprognostic (1.39e-2)" 14.6 23.3 13.4 9.9 17.1 11.6 17.2 23.8 16.7 11.5 12.5 6.7 12.1 7.0 12.2 15.1 15.4 11.4 13.7 26.5 18.0 14.0 12.9 14.5 12.4 15.0 11.6 14.5 15.8 9.7 12.2 16.4 16.9 18.1 14.3 7.9 9.0 11.4 10.4 28.8 11.5 8.6 12.7 15.1 14.3 10.2 31.2 9.6 12.7 17.6 16.8 13.7 15.4 9.5 26.7 21.5 32.2 13.2 22.8 15.5 13.4 9.2 7.6 10.4 6.6 9.7 10.9 9.5 6.2 14.6 9.6 29.1 3.6 7.1 7.1 9.0 8.5 16.6 3.3 5.2 10.5 10.3 3.4 36.4 7.4 12.4 8.0 10.2 7.8 11.4 11.8 13.2 7.6 5.3 11.2 7.0 8.1 2.2 0.1 11.3 2.6 11.4 6.8 3.5 0.6 15.0 5.7 9.9 10.6 10.7 14.5 11.1 8.6 6.6 6.7 5.7 9.4 10.6 10.1 7.5 8.9 7.8 4.4 10.3 11.4 14.5 14.2 12.8 4.8 9.1 32.2 13.2 16.3 7.5 11.6 14.7 25.0 15.5 12.3 14.8 26.7 15.0 12.0 15.3 22.8 10.3 21.5 13.4 13.4 13.4 17.1 23.8 16.7 18.0 14.0 11.6 14.5 18.1 9.6 8.9 12.5 0.0 0.0 0.0 0.0 20.1 0.0 24.1 18.2 17.4 0.0 32.7 21.6 26.8 0.0 0.0 0.0 0.0 19.3 17.8 10.3 0.0 19.8 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 20.8 0.0 0.0 21.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 76.9 0.0 0.0 0.0 TRAPPC9 "IKBKBBP, KIAA1882, MRT13, NIBP, T1, TRS120" ENSG00000167632 "Trafficking protein particle complex 9" Q96Q05 8 139730343-140458579 "Disease related genes, Predicted intracellular proteins" Differentiation "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 44.7;Late spermatids: 78.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026579 Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA026579: AB_1854459" "unprognostic (1.82e-2)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.14e-2)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.76e-2)" "unprognostic (2.31e-1)" "prognostic favorable (5.11e-6)" "unprognostic (2.09e-1)" "unprognostic (9.97e-2)" "unprognostic (2.40e-1)" "unprognostic (1.62e-1)" 9.7 12.0 13.0 14.7 17.9 13.8 8.3 18.3 22.0 11.3 10.3 17.2 12.5 11.3 11.4 9.8 12.1 17.4 12.8 14.7 13.0 13.7 12.2 10.0 9.5 10.6 14.5 11.7 11.5 15.4 42.0 28.2 14.1 15.1 10.4 9.0 17.2 12.7 12.7 38.3 8.8 12.7 10.5 13.2 10.5 11.1 7.9 9.1 24.8 14.2 10.0 15.3 10.1 8.3 6.3 6.3 14.2 5.0 7.5 7.1 4.6 6.7 12.0 5.5 14.8 11.7 7.0 3.7 4.2 7.2 2.4 3.9 4.3 7.9 8.2 10.3 8.6 3.5 8.6 7.3 6.9 2.5 11.8 4.4 13.0 7.1 4.3 8.2 3.3 10.4 6.7 6.6 1.9 6.1 8.2 9.4 9.5 4.6 7.2 3.8 18.6 19.8 4.1 1.6 21.8 10.6 8.5 2.0 13.4 8.2 8.2 13.7 7.8 7.1 3.4 7.4 5.9 10.9 4.7 5.5 3.3 5.9 7.7 3.4 10.1 7.5 5.6 7.0 7.0 5.3 14.2 4.9 4.0 6.5 5.0 7.1 4.5 4.5 5.1 5.1 6.3 4.7 5.5 7.8 7.5 4.7 6.3 3.3 4.6 13.0 17.9 18.3 22.0 13.0 13.7 14.5 11.7 15.1 9.1 3.0 8.8 3.7 3.6 2.1 12.5 11.7 2.5 16.0 5.7 10.4 19.6 9.3 8.3 6.3 44.7 7.1 12.3 0.0 5.3 3.7 2.7 4.9 8.1 8.2 6.4 27.0 29.2 4.3 9.9 78.2 5.5 4.1 10.1 1.0 10.4 12.8 5.3 5.9 7.4 17.6 12.9 6.5 4.3 2.6 5.9 2.6 12.2 9.6 8.5 4.7 TRERF1 "BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132" ENSG00000124496 "Transcriptional regulating factor 1" Q96PN7 6 42224931-42452051 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 20.8;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 55.1" "Low region specificity" "Detected in all" "HPA027771, HPA051273, HPA059943" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173" "unprognostic (5.85e-3)" "unprognostic (4.38e-2)" "unprognostic (2.39e-1)" "unprognostic (3.28e-3)" "unprognostic (6.64e-2)" "unprognostic (3.92e-3)" "unprognostic (1.19e-1)" "unprognostic (1.58e-2)" "unprognostic (2.05e-4)" "unprognostic (2.67e-1)" "unprognostic (1.16e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (3.67e-5)" "unprognostic (8.60e-2)" "unprognostic (5.39e-2)" "unprognostic (6.05e-2)" "unprognostic (2.78e-2)" 4.9 8.7 9.3 7.7 8.7 16.7 4.0 18.1 10.8 12.0 5.1 2.9 9.7 4.2 10.0 4.0 12.6 7.2 6.9 2.8 4.5 3.9 5.2 1.4 4.0 9.2 2.5 4.7 10.2 2.5 7.5 9.3 3.4 3.5 8.8 4.7 7.3 3.7 5.2 1.3 8.4 6.6 8.6 4.9 9.0 5.6 11.2 4.8 23.4 3.3 3.6 12.7 13.3 11.0 0.4 1.4 8.1 1.1 2.7 3.0 1.1 5.2 3.6 4.1 5.2 1.9 4.3 5.8 4.0 6.4 4.6 3.8 0.0 2.8 4.9 0.8 6.0 6.3 6.3 5.2 4.9 3.7 55.1 0.4 5.2 3.0 0.0 1.3 9.6 16.9 1.7 6.9 4.1 1.6 4.1 0.0 3.3 0.0 1.6 2.0 1.1 2.4 16.4 4.5 3.8 3.8 4.5 0.3 1.8 2.7 6.5 3.3 1.7 2.4 0.0 0.4 2.3 2.3 13.1 1.7 2.6 3.0 4.2 1.1 0.6 3.5 5.3 1.7 8.8 0.0 2.1 1.1 8.1 3.0 0.4 2.9 0.4 2.2 2.7 1.4 0.0 1.9 2.0 3.8 2.7 0.2 1.2 2.1 1.1 9.3 8.7 18.1 10.8 4.5 3.9 2.5 4.7 3.5 4.8 3.0 2.2 0.8 2.6 7.3 10.8 1.6 2.5 4.0 5.7 5.2 0.0 2.7 0.0 1.3 2.3 3.8 2.3 0.0 0.9 0.7 7.0 1.7 11.5 0.0 2.7 7.9 2.9 8.0 4.4 2.0 13.0 5.8 3.3 1.8 1.9 4.9 0.9 2.9 20.8 0.2 0.5 25.8 4.4 2.4 6.1 6.5 1.0 7.0 2.8 3.4 TRIM25 "EFP, RNF147, ZNF147" ENSG00000121060 "Tripartite motif containing 25" Q14258 17 56887909-56914038 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Ligase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 20.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 20.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005909 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 35000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA005909: AB_1078722" "unprognostic (8.73e-3)" "unprognostic (1.57e-2)" "unprognostic (2.06e-2)" "unprognostic (6.06e-2)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (1.53e-1)" "unprognostic (4.23e-1)" "unprognostic (1.15e-1)" "prognostic favorable (3.36e-4)" "unprognostic (3.23e-1)" "unprognostic (3.11e-2)" "prognostic favorable (9.35e-4)" "unprognostic (5.21e-2)" "unprognostic (5.13e-2)" "unprognostic (7.39e-2)" 20.0 19.7 7.5 23.6 8.9 32.6 19.3 11.6 7.8 15.3 22.5 5.0 8.0 15.3 13.4 12.6 17.7 15.3 18.4 8.3 5.8 6.3 10.1 27.0 20.8 15.9 6.7 5.5 13.3 15.3 13.6 11.5 55.0 7.4 12.2 14.3 12.5 14.5 11.5 11.7 23.1 20.7 10.1 5.2 35.8 14.1 12.8 6.5 26.2 11.8 15.1 18.5 10.6 35.9 1.7 2.4 20.0 2.3 0.8 1.5 0.7 28.5 14.2 3.5 11.8 26.5 22.4 0.0 11.3 22.9 27.1 23.3 13.8 15.7 27.9 23.5 10.8 29.6 17.0 17.0 15.2 15.2 23.8 13.5 18.0 11.0 15.3 22.7 21.5 13.0 10.0 25.6 14.1 30.0 12.9 17.9 19.2 4.4 17.1 13.7 19.1 24.0 15.5 2.2 23.7 27.6 17.2 11.7 17.6 15.8 22.6 6.8 6.4 8.9 14.3 26.2 2.3 19.4 17.5 11.9 12.7 9.1 19.5 11.7 9.7 18.5 4.6 12.3 14.8 4.9 3.0 2.3 0.9 0.9 1.9 1.1 1.7 0.8 0.8 2.4 1.4 0.6 0.8 20.0 0.8 1.4 1.7 1.5 0.7 7.5 8.9 11.6 7.8 5.8 6.3 6.7 5.5 7.4 6.5 32.8 17.5 11.5 7.3 16.5 8.7 7.0 12.7 20.1 20.5 8.7 27.5 4.1 0.0 16.7 2.1 22.4 32.6 0.0 18.7 8.3 7.8 14.6 3.5 28.7 12.5 3.2 17.9 28.3 31.6 1.2 8.9 23.3 13.5 5.4 26.1 5.2 26.1 26.4 8.9 6.3 19.2 6.5 6.4 0.3 0.0 26.7 13.3 8.6 21.8 16.6 TRIM29 "ATDC, FLJ36085" ENSG00000137699 "Tripartite motif containing 29" Q14134 11 120111275-120185529 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 97.6;Basal keratinocytes: 241.7;Suprabasal keratinocytes: 402.6;Urothelial cells: 144.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 93.4" "Region enriched" "Detected in single" 8 "pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 54.2;hTCEpi: 72.1;RT4: 28.5;SiHa: 40.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020053, HPA074841" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA020053: AB_1858280, HPA074841: " "unprognostic (1.10e-1)" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (2.88e-4)" "unprognostic (9.79e-3)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (5.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.37e-2)" "unprognostic (4.29e-3)" "prognostic favorable (4.93e-4)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.15e-2)" 0.3 0.2 0.1 0.0 0.1 0.1 7.3 0.0 0.1 30.4 0.6 0.2 1.6 0.3 3.1 2.9 176.3 3.7 0.8 0.1 0.1 0.1 0.5 0.4 1.4 0.0 0.0 0.0 0.4 0.2 0.0 2.2 24.4 1.1 11.1 0.5 0.0 25.5 4.8 0.9 90.1 0.2 1.6 0.3 0.0 0.2 0.7 0.0 7.5 0.1 113.6 93.6 9.6 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 3.4 0.0 0.8 0.0 0.1 54.2 0.0 12.4 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.0 72.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 28.5 0.2 0.9 40.5 5.7 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 1.0 0.0 97.6 241.7 0.0 1.1 2.5 33.5 13.6 0.0 0.0 37.9 0.0 1.3 21.4 0.4 2.1 0.0 3.9 5.0 5.4 34.5 1.1 0.0 4.4 0.0 2.4 0.0 0.0 78.0 0.6 1.7 21.9 0.0 2.3 0.0 33.2 0.8 0.0 0.2 0.0 0.0 7.2 0.6 1.4 402.6 20.7 0.0 1.4 144.0 TRIM60 "FLJ35882, RNF129, RNF33" ENSG00000176979 "Tripartite motif containing 60" Q495X7 4 165031953-165041744 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "placenta: 5.0;testis: 6.6" "Cell type enhanced" "Detected in some" 11 "Cytotrophoblasts: 4.8;Extravillous trophoblasts: 8.2;Spermatocytes: 3.8;Spermatogonia: 6.4;Syncytiotrophoblasts: 4.7" "Cancer enriched" "Detected in single" 103 "testis cancer: 5.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "BEWO: 18.0" "Not detected" "Not detected" "HPA035809, HPA035810, HPA061496" Uncertain Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540" "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 1.1 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 0.1 0.2 1.1 0.2 0.3 0.0 0.5 0.3 0.2 1.1 0.1 0.1 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.5 0.0 1.4 0.0 0.0 0.0 4.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 8.2 0.2 0.2 0.0 0.8 0.4 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.0 0.0 3.8 6.4 0.3 4.7 0.5 0.0 0.0 TRIM65 ENSG00000141569 "Tripartite motif containing 65" Q6PJ69 17 75880335-75897003 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021575, HPA021578, HPA064820" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: AB_2685359" "unprognostic (1.82e-1)" "unprognostic (1.47e-1)" "unprognostic (3.47e-2)" "unprognostic (1.36e-1)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (4.74e-6)" "unprognostic (5.36e-2)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-2)" "unprognostic (6.00e-3)" "prognostic unfavorable (1.82e-5)" "unprognostic (2.86e-3)" "unprognostic (7.18e-2)" "unprognostic (4.24e-3)" "unprognostic (7.50e-3)" 15.5 8.2 12.8 12.1 20.0 10.8 13.6 26.7 16.6 15.7 12.7 17.6 11.9 13.9 15.7 9.3 14.0 14.4 12.9 11.0 16.5 12.3 11.3 8.2 13.3 14.6 22.4 8.1 17.7 15.7 14.9 12.7 8.1 16.1 12.4 12.0 15.8 14.7 15.2 16.5 21.6 12.8 13.0 11.4 17.2 12.7 5.4 21.3 11.7 13.1 11.0 14.8 12.7 15.4 5.3 3.4 4.4 3.0 5.2 5.9 1.6 13.6 14.8 5.3 14.9 9.8 13.6 2.6 5.5 7.3 9.3 6.9 5.3 11.7 14.7 4.0 5.8 10.5 9.5 11.1 12.3 4.0 6.6 19.8 11.9 13.5 7.9 10.4 12.5 12.7 9.8 9.8 6.2 10.0 6.6 20.5 18.5 18.2 14.8 5.6 14.7 22.6 20.1 12.2 13.3 12.3 21.1 7.1 23.2 6.8 5.1 11.9 11.4 8.7 13.3 14.6 6.8 15.8 15.1 11.0 19.5 9.0 8.7 10.2 12.5 4.6 3.8 12.4 20.2 8.3 2.8 3.0 4.4 5.2 2.7 5.9 4.1 3.9 5.3 2.7 5.3 4.3 4.2 3.1 5.2 1.5 3.4 3.5 1.6 12.8 20.0 26.7 16.6 16.5 12.3 22.4 8.1 16.1 21.3 6.0 4.5 7.6 5.3 2.6 15.0 3.4 5.1 1.4 3.4 8.7 11.8 0.7 1.7 3.3 0.3 5.2 2.3 23.3 3.0 3.0 4.1 4.2 6.9 3.2 8.0 4.8 0.0 6.2 5.6 0.0 12.7 7.9 8.5 1.0 6.9 7.1 4.7 2.9 8.9 4.0 12.2 0.0 3.8 0.5 2.5 3.1 0.5 5.0 4.8 2.5 TRIM7 "GNIP, RNF90" ENSG00000146054 "Tripartite motif containing 7" Q9C029 5 181193924-181205293 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 81.8;tongue: 34.0" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 15.9;Cardiomyocytes: 22.9;Sertoli cells: 12.9;Suprabasal keratinocytes: 24.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 16 "cerebellum: 21.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 4.9;T-cells: 2.2" "Cell line enhanced" "Detected in many" "HaCaT: 11.4;HDLM-2: 24.1;PC-3: 13.3;TIME: 11.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039213 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA039213: AB_10795173" "unprognostic (6.58e-2)" "unprognostic (1.17e-1)" "unprognostic (5.20e-2)" "unprognostic (1.10e-2)" "unprognostic (6.85e-2)" "unprognostic (1.80e-2)" "unprognostic (3.89e-4)" "unprognostic (3.45e-2)" "unprognostic (3.72e-1)" "unprognostic (1.64e-1)" "unprognostic (3.48e-2)" "unprognostic (1.97e-1)" "unprognostic (7.16e-3)" "unprognostic (1.26e-1)" "unprognostic (3.90e-2)" "unprognostic (6.17e-2)" "unprognostic (1.15e-2)" 1.3 0.9 0.1 0.9 0.5 0.5 3.4 21.7 1.3 2.5 0.8 0.3 1.1 0.5 1.0 6.4 13.0 0.6 1.7 2.2 0.1 0.8 2.2 0.5 0.9 0.6 0.2 0.2 0.6 4.2 1.6 1.9 0.5 0.5 2.0 0.6 0.6 5.9 1.1 81.8 9.5 0.6 0.9 0.3 0.8 1.4 0.9 0.2 0.1 3.3 34.0 13.5 1.6 2.9 0.7 0.8 0.1 4.9 0.5 2.2 1.1 6.1 3.0 0.0 0.3 0.5 0.5 0.2 1.4 0.0 0.5 1.2 0.3 8.1 0.4 4.3 1.7 2.6 11.4 3.3 9.3 0.1 24.1 1.3 0.5 7.9 0.1 1.6 0.0 1.4 0.1 7.2 0.2 4.6 1.8 2.6 1.1 0.3 1.3 0.2 0.8 0.3 0.2 0.0 9.7 13.3 0.3 4.2 0.9 3.3 0.0 0.3 0.7 2.9 0.2 4.1 0.1 0.7 0.2 11.0 0.1 2.4 0.4 4.3 1.9 0.2 0.7 0.3 0.4 1.0 0.0 4.9 0.1 1.4 1.9 2.2 0.4 1.2 1.4 0.8 0.7 2.2 1.8 0.1 0.5 1.4 0.6 2.2 1.1 0.1 0.5 21.7 1.3 0.1 0.8 0.2 0.2 0.5 0.2 0.0 1.4 0.0 3.9 15.9 5.7 22.9 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.4 0.6 1.4 2.4 0.0 2.0 0.4 0.8 1.8 0.0 0.2 1.1 0.0 0.0 1.8 9.4 0.0 0.9 1.6 1.7 0.0 3.1 0.5 3.2 8.5 1.4 1.1 2.7 12.9 9.0 0.9 0.4 24.8 0.0 0.0 2.2 2.4 TRIM8 "GERP, RNF27" ENSG00000171206 "Tripartite motif containing 8" Q9BZR9 10 102642310-102660680 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023560, HPA023561" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA023560: AB_10600414, HPA023561: AB_10601861" "unprognostic (4.32e-2)" "unprognostic (6.90e-2)" "unprognostic (3.02e-3)" "unprognostic (1.45e-1)" "unprognostic (1.78e-1)" "unprognostic (5.03e-1)" "unprognostic (3.82e-2)" "unprognostic (1.03e-1)" "unprognostic (2.15e-3)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (1.52e-1)" "unprognostic (9.55e-2)" "unprognostic (1.48e-1)" "unprognostic (3.12e-2)" "unprognostic (8.34e-2)" "unprognostic (1.36e-2)" 31.7 18.4 26.1 23.9 25.2 17.0 18.0 26.1 31.6 31.8 19.5 22.9 15.4 15.8 18.0 14.3 17.8 21.6 19.8 25.0 23.2 18.0 27.2 21.9 23.0 25.4 20.1 20.0 19.3 35.9 24.7 14.7 17.5 16.3 17.4 8.1 19.4 28.5 18.5 34.8 14.6 23.7 13.6 15.7 22.5 21.2 11.7 21.9 48.3 26.6 14.5 30.3 21.4 15.9 9.0 11.9 17.8 5.3 5.5 7.2 3.9 26.9 6.3 6.3 10.2 6.9 14.1 5.8 9.7 19.7 10.5 8.5 11.4 32.6 8.7 26.0 21.5 4.6 9.9 4.2 13.0 8.7 8.8 8.2 21.9 5.3 26.0 17.6 4.9 8.8 16.1 7.2 23.1 13.7 35.0 14.0 4.5 4.1 13.1 8.2 17.5 9.3 16.4 3.4 9.8 12.9 4.6 14.1 4.3 12.5 19.0 3.8 7.4 5.3 6.6 12.8 7.4 18.8 9.8 25.9 14.2 6.3 7.9 21.7 11.9 7.8 5.0 21.6 12.3 3.6 10.7 4.8 2.6 6.8 4.4 6.7 9.0 7.2 5.3 4.1 7.0 6.4 5.5 17.8 5.5 5.3 11.9 6.9 3.9 26.1 25.2 26.1 31.6 23.2 18.0 20.1 20.0 16.3 21.9 53.6 64.6 14.3 12.5 27.9 37.2 34.1 33.1 37.5 36.4 83.7 7.9 10.3 34.9 50.3 0.9 21.5 18.8 0.0 39.1 2.9 23.8 18.6 8.1 24.1 21.7 27.0 20.7 26.4 31.7 0.4 28.7 27.1 16.9 46.9 30.1 22.7 48.9 17.5 32.2 40.0 14.3 12.9 24.3 2.3 5.3 19.9 9.2 17.5 20.4 18.7 TRMT1 "FLJ20244, TRM1" ENSG00000104907 "TRNA methyltransferase 1" Q9NXH9 19 13104902-13117567 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041130, HPA041380" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041130: AB_10803995, HPA041380: AB_10793873" "unprognostic (2.10e-2)" "unprognostic (2.40e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (5.54e-2)" "unprognostic (1.08e-3)" "unprognostic (2.19e-2)" "unprognostic (1.59e-1)" "unprognostic (7.62e-2)" "unprognostic (1.91e-2)" "unprognostic (8.74e-3)" "prognostic unfavorable (9.87e-7)" "unprognostic (1.19e-3)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-2)" 15.5 15.0 19.1 19.8 23.5 23.1 16.6 19.5 22.6 15.0 16.3 17.3 15.5 14.9 19.2 19.0 17.6 19.6 19.4 13.2 15.7 13.4 14.4 17.3 13.5 26.8 22.1 14.7 29.1 23.8 16.3 14.4 14.4 21.9 18.1 14.5 10.9 14.9 15.6 21.4 22.1 16.1 16.5 12.4 25.0 16.3 16.8 20.1 12.2 15.6 12.1 19.6 17.3 18.8 11.2 14.9 3.1 15.7 4.3 10.2 8.5 15.4 10.4 11.3 19.2 11.5 14.8 16.2 17.4 8.7 19.2 16.7 11.1 12.7 19.4 22.8 9.3 10.0 14.3 18.9 15.3 8.9 12.6 26.4 15.4 26.8 18.7 20.9 30.8 18.2 20.9 20.6 19.9 18.8 12.3 14.1 14.5 33.3 6.2 11.9 17.1 12.5 33.3 26.8 9.8 24.5 21.1 14.6 26.7 11.9 15.7 26.9 12.2 10.8 22.6 18.1 8.6 8.8 17.3 15.6 27.7 10.8 16.7 30.4 10.8 20.8 17.9 12.9 32.7 14.4 1.2 15.7 0.5 8.1 11.9 7.7 10.4 8.6 7.7 14.9 11.2 10.2 7.7 3.1 4.3 7.5 8.8 5.6 8.5 19.1 23.5 19.5 22.6 15.7 13.4 22.1 14.7 21.9 20.1 11.9 16.2 35.0 22.3 21.3 8.0 6.4 12.7 10.7 4.5 12.2 2.0 19.4 5.0 14.1 16.4 17.5 6.3 0.0 12.8 18.8 13.9 10.4 28.9 8.6 41.5 7.9 6.9 7.4 88.1 36.5 13.0 39.6 16.9 23.4 9.6 5.8 12.2 5.8 12.0 11.2 11.1 12.9 16.5 21.7 18.3 18.1 12.9 18.7 17.4 18.4 TSEN2 "MGC2776, SEN2, SEN2L" ENSG00000154743 "TRNA splicing endonuclease subunit 2" Q8NCE0 3 12484432-12539623 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027120, HPA027125, HPA027268" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347" "unprognostic (5.58e-2)" "unprognostic (4.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.71e-2)" "unprognostic (9.59e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.42e-1)" "unprognostic (5.66e-2)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "unprognostic (6.15e-2)" "unprognostic (1.41e-2)" "unprognostic (6.99e-2)" "unprognostic (4.90e-2)" "unprognostic (6.06e-2)" "prognostic favorable (3.49e-4)" 8.8 10.6 9.7 8.8 19.1 6.7 10.9 16.5 14.0 10.4 9.8 12.7 8.4 5.8 14.0 9.9 7.9 12.8 10.3 14.3 10.5 12.3 9.8 7.3 7.3 10.9 11.5 7.6 18.0 11.9 14.3 15.3 4.9 10.2 10.5 10.9 13.5 7.2 13.1 16.7 15.3 6.1 12.3 12.3 6.1 8.5 11.3 9.1 9.9 12.5 9.6 8.1 8.6 8.3 8.5 7.1 2.6 4.2 5.0 13.7 5.6 7.8 13.7 7.4 9.6 12.5 13.3 17.0 7.4 6.6 8.0 5.8 7.7 8.4 9.4 5.2 6.0 9.5 7.3 12.3 12.7 9.1 7.4 15.2 10.3 18.3 7.9 9.6 16.2 4.0 11.5 14.8 14.5 17.8 5.9 6.4 13.8 15.3 5.2 9.2 14.8 12.4 7.4 10.4 22.2 16.5 9.4 5.1 18.9 11.9 8.1 4.8 8.4 6.9 6.2 5.8 5.3 11.2 11.3 5.7 5.1 5.0 6.9 11.5 4.9 12.5 11.8 6.8 16.4 6.3 2.4 4.2 0.3 6.4 4.2 10.9 8.5 9.8 7.4 5.9 8.3 13.7 11.7 2.6 5.0 3.6 7.1 3.5 5.6 9.7 19.1 16.5 14.0 10.5 12.3 11.5 7.6 10.2 9.1 3.0 3.5 10.9 9.7 2.6 27.2 6.2 15.3 9.4 2.3 10.4 41.2 7.4 1.7 4.9 1.3 5.6 2.6 0.0 3.7 3.2 3.8 5.0 4.7 5.5 4.1 9.5 4.1 3.1 4.0 2.1 8.3 3.2 3.3 1.0 4.7 8.7 3.5 3.5 9.6 5.0 33.9 6.5 5.1 10.3 19.3 4.3 1.6 5.7 8.2 8.0 TSNAX TRAX ENSG00000116918 "Translin associated factor X" Q99598 1 231528653-231566524 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024613, HPA031054, HPA031055, CAB034263" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 100000 Nucleoplasm "Golgi apparatus, Cytosol" "CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314" "unprognostic (6.28e-3)" "unprognostic (5.48e-2)" "unprognostic (1.62e-1)" "unprognostic (1.12e-1)" "unprognostic (5.55e-2)" "unprognostic (2.27e-1)" "unprognostic (2.96e-2)" "unprognostic (2.05e-1)" "unprognostic (1.22e-1)" "unprognostic (2.42e-3)" "unprognostic (4.51e-2)" "unprognostic (1.91e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-2)" "unprognostic (6.52e-3)" "unprognostic (2.70e-2)" 27.4 29.9 23.9 17.1 26.7 12.0 23.4 28.0 33.1 19.7 16.2 21.9 17.2 15.8 20.0 24.6 18.0 16.4 16.7 22.7 25.1 23.9 29.1 23.0 18.4 22.6 22.1 22.1 18.6 14.6 32.3 36.0 18.3 28.5 21.3 18.0 19.6 17.5 19.9 52.5 20.6 14.8 18.9 28.2 24.0 15.5 17.5 24.4 24.5 26.7 25.4 22.0 19.1 17.3 10.0 11.7 54.6 17.5 18.7 13.5 11.0 11.0 9.1 13.9 11.4 10.3 12.7 15.8 12.6 19.1 16.2 14.0 7.8 15.6 15.6 21.3 13.7 6.0 12.1 11.0 11.4 21.1 13.9 19.2 15.0 9.4 10.3 14.2 24.7 31.9 15.5 12.6 15.6 12.1 10.2 11.7 11.4 24.2 11.1 21.9 4.5 15.9 12.1 20.5 9.3 11.1 15.8 15.3 21.1 18.1 12.8 13.3 25.6 13.1 16.7 42.4 5.9 24.3 42.0 10.9 11.2 10.2 22.4 22.6 18.9 24.9 17.4 18.3 19.6 30.6 54.6 11.2 29.2 11.4 13.5 10.8 10.0 12.3 11.2 11.7 9.9 13.2 12.7 11.4 18.7 17.5 6.8 13.5 11.0 23.9 26.7 28.0 33.1 25.1 23.9 22.1 22.1 28.5 24.4 26.8 32.9 25.4 17.9 38.9 58.2 20.9 38.2 26.8 17.0 40.1 27.5 39.1 46.4 25.0 7.5 33.3 20.5 46.7 27.1 39.0 28.8 14.4 75.1 26.0 42.6 62.0 27.7 27.6 51.1 7.5 31.1 45.0 25.3 37.9 29.8 64.5 23.0 23.4 33.9 36.6 45.9 38.8 35.6 28.1 70.9 44.9 30.3 35.8 22.4 12.2 TSPAN9 NET-5 ENSG00000011105 "Tetraspanin 9" O75954 12 3077355-3286564 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.2;heart muscle: 58.5" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 66.4;Extravillous trophoblasts: 79.2;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 58.2" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RH-30: 63.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 125.3" HPA014002 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 1900000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA014002: AB_2304038" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-2)" "unprognostic (3.53e-2)" "unprognostic (3.11e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" "unprognostic (1.26e-2)" "unprognostic (1.89e-1)" "unprognostic (6.70e-2)" "unprognostic (1.57e-1)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" 12.7 5.3 2.6 4.0 5.9 0.3 16.2 58.2 11.5 17.6 6.6 3.0 16.1 3.6 20.9 11.2 6.8 8.8 13.8 58.5 2.9 2.7 21.3 25.3 13.6 3.9 2.8 3.3 15.3 6.5 17.4 3.8 27.7 4.5 10.7 2.7 21.8 8.4 17.7 7.1 13.3 5.4 9.5 2.6 8.4 5.6 5.7 2.3 6.0 9.4 9.4 4.3 8.1 13.6 0.0 0.0 0.6 0.1 0.0 1.1 3.6 0.4 3.5 6.0 5.1 4.9 4.7 14.1 6.8 20.6 4.4 5.8 8.2 3.2 0.2 6.8 3.9 4.2 0.9 2.4 2.5 2.6 1.1 2.7 9.3 2.7 5.8 13.5 0.0 0.7 6.0 2.2 9.1 4.2 14.8 15.0 0.3 0.2 0.2 3.8 5.3 0.0 0.2 8.4 2.1 1.9 2.7 63.6 0.8 18.4 1.6 10.7 7.2 4.5 11.5 4.4 12.9 4.0 0.0 8.8 2.4 7.3 3.9 6.4 0.0 0.0 0.0 6.1 0.1 2.6 0.0 0.1 0.0 1.1 0.1 0.3 0.0 0.2 0.6 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 3.6 2.6 5.9 58.2 11.5 2.9 2.7 2.8 3.3 4.5 2.3 0.0 2.6 0.9 10.8 17.1 66.4 45.8 10.2 1.4 3.4 12.2 2.0 49.9 5.0 16.1 1.4 32.2 2.4 0.0 7.8 79.2 21.2 16.1 0.0 33.3 5.4 31.8 5.8 38.1 3.3 2.4 16.1 0.9 11.8 1.0 2.6 3.3 9.1 0.0 16.3 18.2 4.2 19.4 19.5 1.4 3.4 10.5 67.5 0.0 1.9 9.7 TSPYL6 ENSG00000178021 "TSPY like 6" Q8N831 2 54253184-54256272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 41.1" "Group enriched" "Detected in some" 9 "Spermatocytes: 27.4;Spermatogonia: 22.4" "Cancer enriched" "Detected in single" 27 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 66 "K-562: 13.4" "HPA034699, HPA034700" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034699: AB_2674288, HPA034700: AB_10670159" "unprognostic (8.21e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (1.00e-1)" "unprognostic (5.54e-6)" "unprognostic (4.50e-2)" "unprognostic (1.77e-1)" "unprognostic (5.73e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 27.4 22.4 0.0 0.0 0.0 0.0 0.0 TSSK3 "SPOGA3, STK22C" ENSG00000162526 "Testis specific serine kinase 3" Q96PN8 1 32351521-32364312 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 68.1" "Group enriched" "Detected in some" 52 "Early spermatids: 242.3;Late spermatids: 839.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA037516 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA037516: AB_2675517" "unprognostic (5.71e-2)" "unprognostic (1.42e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-1)" "unprognostic (7.69e-2)" "unprognostic (2.02e-4)" "unprognostic (2.06e-1)" "unprognostic (1.98e-3)" "unprognostic (2.05e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (9.20e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.68e-3)" 1.1 2.0 0.8 1.7 0.8 8.2 1.1 3.9 0.8 1.3 0.9 0.8 1.4 2.5 1.8 2.9 0.8 1.3 1.0 0.9 0.8 0.0 0.9 1.3 1.4 2.4 0.8 0.8 2.0 1.2 0.0 0.8 0.8 1.0 1.0 0.0 0.8 1.4 0.8 1.7 3.4 2.9 0.8 0.8 3.4 1.2 68.1 0.8 0.8 1.3 0.8 0.8 0.9 1.1 0.6 0.1 0.1 0.7 0.3 2.3 0.1 2.3 2.3 6.0 3.5 0.0 1.2 5.4 0.7 1.1 0.0 0.0 0.5 1.2 1.2 0.9 0.0 1.0 3.7 0.0 0.0 0.0 3.5 7.2 2.7 9.8 3.7 4.4 1.1 3.4 0.1 0.9 0.0 1.3 6.3 0.0 4.6 3.1 5.8 0.0 0.6 1.4 1.5 1.5 0.4 1.2 1.9 1.7 4.4 0.0 1.9 1.8 3.8 0.8 2.8 4.1 4.4 1.9 2.7 2.9 2.1 3.4 3.0 2.4 8.5 2.8 1.8 3.7 3.9 0.5 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.2 0.0 0.1 0.6 2.3 0.9 0.1 0.3 0.5 0.0 0.0 0.1 0.8 0.8 3.9 0.8 0.8 0.0 0.8 0.8 1.0 0.8 0.0 0.3 0.0 0.4 0.1 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.2 242.3 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 839.4 8.6 0.0 0.0 0.0 0.3 0.9 0.2 0.0 8.9 0.6 1.4 6.5 0.0 10.3 3.8 0.0 0.2 0.0 0.2 0.2 TTC3 "DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII" ENSG00000182670 "Tetratricopeptide repeat domain 3" P53804 21 37073226-37203112 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016810, HPA023964, HPA036304" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.37e-2)" "unprognostic (8.52e-2)" "unprognostic (9.29e-2)" "unprognostic (8.71e-2)" "unprognostic (1.61e-1)" "unprognostic (2.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (6.74e-2)" 22.9 22.1 34.0 18.7 36.5 12.0 23.4 39.2 40.0 34.9 20.6 15.9 26.7 13.0 21.6 33.3 15.3 19.5 19.0 21.5 29.1 16.5 21.4 17.0 15.4 14.3 17.7 27.5 34.5 25.8 27.4 50.4 15.2 34.7 28.9 19.9 16.1 24.5 25.4 21.6 16.1 16.8 21.6 21.7 13.6 21.3 19.5 19.9 19.7 35.4 11.1 15.1 23.3 18.9 10.6 12.8 4.8 5.7 9.1 18.6 3.8 21.7 7.8 36.3 6.8 35.0 51.1 12.6 24.0 29.9 10.8 14.7 10.2 11.0 18.8 8.4 40.2 10.1 7.2 10.9 14.8 15.3 19.9 7.8 38.0 11.6 13.4 12.8 21.2 12.3 26.4 9.1 11.0 9.8 21.8 16.0 16.7 22.8 22.1 20.3 16.8 20.6 5.5 10.3 14.5 13.2 27.6 17.4 9.9 12.6 16.9 27.7 21.1 29.8 17.1 15.4 8.7 19.4 8.3 20.9 15.5 6.2 19.0 9.0 22.2 15.9 18.8 25.6 21.2 11.7 2.9 4.4 4.8 9.1 4.8 13.6 9.5 10.6 12.3 7.9 10.6 18.6 11.3 0.7 9.1 5.7 12.8 7.2 3.8 34.0 36.5 39.2 40.0 29.1 16.5 17.7 27.5 34.7 19.9 116.1 118.5 109.7 81.2 58.5 344.6 127.3 56.0 75.0 101.2 71.5 214.0 39.6 140.9 74.9 160.4 67.6 60.1 0.0 65.5 79.7 132.8 164.9 62.4 80.5 56.3 311.4 182.6 102.5 80.0 149.3 194.5 74.4 200.8 61.3 133.8 187.6 72.0 84.2 245.4 81.7 228.9 51.8 103.8 264.1 280.4 54.8 44.1 76.7 118.3 90.4 TTC33 OSRF ENSG00000113638 "Tetratricopeptide repeat domain 33" Q6PID6 5 40512333-40755975 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038252, HPA038253" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA038252: AB_10674551, HPA038253: AB_10671739" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.04e-3)" "unprognostic (3.01e-2)" "unprognostic (1.99e-1)" "unprognostic (2.01e-1)" "unprognostic (2.60e-1)" "prognostic favorable (1.83e-4)" "unprognostic (8.50e-2)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (4.28e-3)" 11.0 11.8 13.5 6.9 27.7 1.5 11.0 20.4 20.1 11.7 9.9 6.4 8.1 8.2 12.3 7.8 9.1 10.1 9.0 13.4 11.5 12.1 14.7 15.0 9.0 8.9 8.8 19.4 15.2 8.6 15.6 15.1 9.0 13.1 11.5 9.2 7.3 9.3 10.6 24.2 6.4 9.1 10.5 9.5 8.4 8.7 9.0 9.8 14.3 12.8 5.5 9.2 10.8 9.0 7.2 5.3 15.9 10.8 7.8 10.0 8.2 5.2 4.6 9.0 11.5 6.3 9.1 4.1 7.2 7.6 7.9 8.1 2.3 5.5 16.6 4.4 5.4 9.3 2.8 8.6 3.9 13.1 18.7 6.5 3.6 15.6 6.5 6.4 9.3 5.3 5.4 7.4 7.4 7.6 9.9 10.9 10.5 8.4 12.8 9.5 1.3 16.4 9.1 2.7 3.6 4.5 15.9 17.9 9.3 8.4 3.2 6.5 7.4 18.1 8.9 9.7 7.3 7.1 10.6 7.5 9.5 8.6 6.0 5.9 10.5 11.3 9.0 6.4 12.5 7.5 15.9 6.1 11.1 8.1 9.0 8.7 7.2 8.5 7.5 5.3 6.9 10.0 8.0 9.0 7.8 10.8 3.9 9.0 8.2 13.5 27.7 20.4 20.1 11.5 12.1 8.8 19.4 13.1 9.8 14.9 6.1 11.5 4.6 12.8 12.1 15.9 5.1 14.7 4.5 7.0 5.9 4.5 16.6 6.9 9.6 11.3 5.8 0.0 5.4 3.4 12.8 5.9 12.7 7.9 4.6 4.8 2.9 11.1 8.2 5.9 13.0 6.3 10.1 18.0 6.8 17.3 6.6 7.0 13.1 8.5 20.6 12.9 11.3 27.0 15.7 15.9 2.2 7.5 5.8 4.0 TTC9B FLJ30373 ENSG00000174521 "Tetratricopeptide repeat domain 9B" Q8N6N2 19 40216058-40218399 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 47.9" "Cell type enhanced" "Detected in some" 26 "Bipolar cells: 37.7;Horizontal cells: 17.5;Rod photoreceptor cells: 7.3" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 19 "SCLC-21H: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042496 Approved Approved Nucleoplasm,Vesicles,Mitochondria "Secreted in brain" NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA042496: AB_10795506" "unprognostic (2.31e-1)" "unprognostic (1.39e-4)" "unprognostic (5.09e-2)" "unprognostic (5.24e-2)" "unprognostic (8.47e-2)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (7.95e-2)" "unprognostic (2.78e-1)" "unprognostic (1.54e-2)" "unprognostic (3.69e-1)" "unprognostic (8.75e-6)" "unprognostic (1.39e-1)" "unprognostic (8.23e-2)" "unprognostic (1.95e-1)" "unprognostic (5.24e-2)" 1.0 1.8 45.5 1.4 10.3 1.0 1.0 24.6 47.9 1.0 1.2 1.2 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 22.3 14.0 1.0 1.0 1.0 1.0 7.5 9.9 1.0 1.0 1.0 0.0 1.0 7.1 1.0 1.0 0.3 1.0 1.0 1.0 1.0 1.2 1.1 2.5 1.0 1.1 1.1 1.0 0.0 1.0 0.0 1.0 1.0 0.0 0.1 0.5 0.0 1.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 25.1 1.3 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.4 0.1 0.0 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.3 0.0 45.5 10.3 24.6 31.3 22.3 14.0 7.5 9.9 7.1 1.0 0.0 0.0 0.0 0.0 0.0 37.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 17.5 1.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 1.3 0.1 0.2 0.7 0.0 7.3 0.0 0.0 1.0 2.3 0.0 0.0 0.0 0.2 0.1 TULP3 TUBL3 ENSG00000078246 "Tubby like protein 3" O75386 12 2877223-2941140 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015285, HPA018496" Uncertain Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Secreted - unknown location" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA015285: AB_1858460, HPA018496: AB_2669889" "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (4.80e-2)" "prognostic favorable (2.99e-4)" "unprognostic (2.45e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (7.97e-5)" "unprognostic (2.44e-1)" "unprognostic (4.09e-2)" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (7.18e-4)" "unprognostic (7.52e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-2)" "unprognostic (3.19e-2)" 14.0 12.0 8.1 6.9 12.9 2.4 13.0 21.2 11.1 22.7 13.6 19.6 12.6 5.3 27.7 11.7 14.1 20.9 11.5 12.7 12.1 5.3 12.1 6.5 9.5 7.2 11.0 7.7 37.1 6.8 13.5 15.4 12.7 10.9 12.5 8.1 17.2 9.8 14.0 9.9 19.8 7.0 17.5 9.7 7.3 11.7 13.2 13.8 4.4 13.3 6.3 9.2 11.6 28.4 3.5 2.8 0.6 1.5 4.8 6.3 1.7 9.1 7.8 14.9 12.3 15.0 22.4 14.1 14.4 24.2 15.6 17.3 9.9 8.5 6.8 2.2 21.2 13.3 7.7 8.8 9.3 18.1 8.8 6.5 4.1 9.7 6.3 19.4 4.3 4.7 13.1 11.0 23.6 32.3 19.2 12.0 8.7 3.8 6.4 13.0 8.2 6.4 3.8 20.1 7.3 5.8 6.9 14.6 2.5 9.8 7.7 3.8 10.0 12.6 7.5 8.2 28.4 9.4 4.3 9.6 11.5 13.9 23.3 13.9 2.0 2.4 5.9 11.6 2.4 17.5 0.0 1.5 0.5 4.0 1.5 6.3 2.9 3.1 4.0 1.3 3.5 3.8 5.2 0.6 4.8 0.8 2.8 5.5 1.7 8.1 12.9 21.2 11.1 12.1 5.3 11.0 7.7 10.9 13.8 6.0 8.0 4.2 14.7 18.0 5.6 5.0 12.7 52.2 17.0 1.8 2.0 7.8 19.9 14.2 2.5 13.6 3.2 0.0 6.4 8.8 23.1 19.1 0.0 3.8 4.6 38.1 3.5 19.0 2.2 2.4 37.7 4.7 18.6 9.0 5.0 46.7 9.7 0.0 23.3 13.5 9.5 38.8 23.7 30.7 52.5 17.7 9.7 5.3 5.6 11.1 TXLNA DKFZp451J0118 ENSG00000084652 "Taxilin alpha" P40222 1 32179686-32198285 "Cancer-related genes, Predicted intracellular proteins" Exocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045383, HPA072477" Supported Approved Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA045383: AB_10967649, HPA072477: AB_2686525" "prognostic favorable (6.24e-4)" "unprognostic (1.19e-2)" "unprognostic (3.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.04e-2)" "prognostic favorable (5.53e-4)" "prognostic unfavorable (1.57e-6)" "unprognostic (3.67e-3)" "unprognostic (2.75e-1)" "unprognostic (5.25e-3)" "prognostic favorable (8.69e-5)" "unprognostic (5.06e-2)" "prognostic unfavorable (7.21e-7)" "unprognostic (3.94e-3)" "unprognostic (3.28e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" 22.5 29.4 20.2 19.4 27.5 14.0 17.9 23.2 26.4 20.3 23.7 17.0 23.4 16.6 30.4 24.7 24.2 25.0 24.6 16.4 18.5 13.9 20.9 44.8 19.0 19.9 25.6 13.4 26.5 23.6 31.5 35.9 19.3 21.8 24.6 18.5 20.8 23.9 23.3 16.5 31.0 18.9 28.3 19.9 23.5 21.2 38.4 22.9 17.0 22.8 18.8 26.0 19.3 23.5 8.0 14.3 8.4 12.2 14.2 13.9 9.0 19.5 16.8 17.5 19.7 22.8 30.0 14.2 28.1 22.4 27.2 26.1 18.7 21.3 22.4 11.5 27.2 8.9 22.2 23.9 18.4 24.8 25.6 18.5 35.5 24.4 24.4 24.2 25.7 28.2 30.0 24.8 28.7 13.6 20.1 21.4 27.3 14.4 23.2 22.2 10.9 18.8 16.6 25.5 14.0 15.5 22.2 26.6 19.7 18.6 25.1 18.4 18.9 29.1 18.5 29.8 22.5 17.1 15.7 22.2 28.8 24.9 37.9 35.8 34.7 26.8 20.4 29.8 35.1 26.5 8.4 9.0 4.5 13.9 9.7 11.9 7.3 9.6 10.3 6.9 8.0 8.4 9.1 1.3 14.2 12.2 14.3 7.0 9.0 20.2 27.5 23.2 26.4 18.5 13.9 25.6 13.4 21.8 22.9 20.8 21.3 7.7 9.2 7.8 13.9 7.7 10.2 28.1 19.4 14.0 37.3 8.8 1.7 15.8 11.5 15.8 11.9 0.0 14.2 12.0 17.1 10.3 12.7 28.6 15.9 25.4 25.2 16.0 12.4 13.3 22.2 11.7 5.0 20.8 15.4 13.8 18.6 2.9 19.4 11.8 24.5 12.9 21.1 21.8 24.5 10.7 5.7 10.2 12.1 6.7 TXNL4A "DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD" ENSG00000141759 "Thioredoxin like 4A" P83876 18 79970811-80033949 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing" Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041324 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA041324: AB_2677410" "unprognostic (7.56e-2)" "unprognostic (1.06e-3)" "unprognostic (5.94e-2)" "unprognostic (2.67e-2)" "unprognostic (6.99e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.45e-1)" "unprognostic (9.39e-2)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (4.94e-2)" "unprognostic (3.11e-2)" "unprognostic (1.35e-1)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" 28.2 35.8 57.2 27.7 43.9 36.7 30.2 21.7 43.4 22.0 29.4 30.7 22.9 23.9 15.8 38.9 26.5 21.0 21.8 33.5 47.9 42.7 29.0 42.5 18.4 35.1 52.6 25.4 14.1 64.9 22.1 38.4 23.2 32.7 21.1 25.2 24.0 46.8 20.5 35.5 26.6 25.1 19.0 37.7 26.9 23.2 41.6 20.8 40.2 28.8 26.8 32.2 23.5 16.9 12.7 25.0 8.4 9.6 11.3 12.7 4.4 21.8 29.5 26.3 25.0 21.5 22.7 23.3 23.8 19.3 32.4 29.5 27.4 15.6 26.7 8.9 22.7 22.0 18.6 31.6 27.7 21.5 31.1 40.1 19.1 44.8 64.4 27.5 54.8 31.4 21.1 24.6 23.0 29.6 20.7 30.4 33.2 16.7 39.0 22.5 39.6 38.8 37.2 20.5 16.7 63.9 23.7 17.6 55.0 31.8 34.7 40.3 29.3 11.8 35.2 43.4 23.7 17.2 32.7 14.3 28.6 35.1 13.0 29.0 17.3 65.0 43.9 26.8 41.8 26.2 8.4 8.4 6.8 12.2 9.6 8.4 12.3 10.0 9.6 11.4 12.7 10.2 11.9 6.8 11.3 9.5 25.0 12.7 4.4 57.2 43.9 21.7 43.4 47.9 42.7 52.6 25.4 32.7 20.8 17.9 41.8 50.0 60.5 77.4 32.4 73.1 63.7 25.4 52.4 62.8 33.4 96.1 305.1 118.9 207.4 51.7 39.3 23.3 108.6 136.0 58.6 137.6 10.5 80.8 109.4 42.9 54.1 37.4 48.3 186.2 38.9 65.4 89.4 102.8 78.3 48.2 121.8 56.1 42.5 211.1 37.3 45.3 91.2 74.9 65.0 96.0 80.9 50.7 65.4 100.5 TYSND1 "MGC34695, NET41" ENSG00000156521 "Trypsin domain containing 1" Q2T9J0 10 70137981-70146676 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.7" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 90.7;Late spermatids: 154.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 18.0;PC-3: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030304 Approved Uncertain Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA030304: AB_10670560" "unprognostic (4.75e-3)" "unprognostic (4.30e-2)" "unprognostic (2.44e-2)" "unprognostic (7.69e-2)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.02e-2)" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-1)" "unprognostic (1.59e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-1)" "unprognostic (9.26e-3)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" 15.2 8.2 4.7 7.0 6.8 3.0 8.0 6.7 7.3 6.0 6.7 5.9 6.9 10.1 5.3 8.4 13.9 5.4 5.2 3.5 3.7 2.8 7.4 7.4 3.5 7.2 3.7 3.6 5.6 9.0 3.3 4.5 4.7 3.5 6.9 2.7 6.9 8.0 5.7 5.3 12.5 8.5 4.8 4.7 9.0 8.2 40.7 3.4 6.2 8.5 6.6 10.1 6.5 7.6 6.1 1.4 1.2 1.6 2.9 6.3 2.3 9.5 6.9 0.5 4.1 0.8 0.6 2.5 1.2 0.9 1.4 1.3 4.3 6.1 8.6 4.0 0.3 0.3 18.0 0.7 2.7 0.3 5.4 6.2 0.5 1.9 2.1 1.7 0.7 0.0 1.3 5.2 1.2 2.2 0.8 1.0 3.1 0.0 2.6 0.6 4.2 3.2 3.5 2.2 2.3 27.7 5.7 1.6 3.8 0.6 1.6 5.0 2.6 4.2 9.4 3.6 0.2 6.1 0.7 1.7 1.6 1.1 3.0 5.4 9.8 5.9 4.2 1.9 3.6 1.2 0.0 1.3 1.2 6.3 1.6 4.1 5.1 3.7 4.9 1.4 6.1 5.3 4.4 0.4 2.9 1.1 1.0 4.0 2.3 4.7 6.8 6.7 7.3 3.7 2.8 3.7 3.6 3.5 3.4 8.9 4.0 13.7 13.8 12.7 6.8 4.3 25.5 1.4 5.7 10.4 0.0 30.0 14.9 6.8 90.7 6.7 14.8 0.0 8.3 6.8 6.3 10.9 13.8 14.3 10.7 0.0 13.7 6.7 9.5 154.7 8.6 8.0 11.8 2.8 10.6 6.2 5.1 10.5 7.4 12.4 4.5 6.5 4.7 41.1 11.1 16.2 14.0 11.8 20.3 5.2 TYW1 "FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W" ENSG00000198874 "TRNA-yW synthesizing protein 1 homolog" Q9NV66 7 66995173-67239519 "Enzymes, Predicted membrane proteins" "tRNA processing" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (1.53e-1)" "unprognostic (5.49e-3)" "unprognostic (1.62e-1)" "unprognostic (3.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.20e-1)" "unprognostic (1.83e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.86e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-2)" "unprognostic (4.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (1.79e-2)" 15.4 19.1 10.2 12.3 15.4 11.9 15.1 14.9 15.3 18.8 12.9 21.2 18.2 14.1 22.7 15.3 12.0 15.5 10.8 12.9 10.8 9.8 15.2 17.7 11.1 15.5 14.1 10.8 19.4 23.9 22.9 28.0 13.2 14.5 14.9 16.5 17.8 15.3 14.7 26.2 14.4 12.8 14.0 13.9 15.1 12.6 13.7 13.4 19.7 19.0 13.6 23.3 15.3 15.2 9.6 8.3 3.6 9.1 11.2 11.8 5.3 10.6 13.6 8.3 17.2 12.5 8.7 9.7 11.4 8.7 9.0 8.5 15.5 13.9 18.5 17.5 10.5 12.7 12.6 17.2 14.0 13.1 14.5 13.2 8.0 11.3 10.5 12.4 18.4 10.6 8.9 14.2 12.2 18.8 7.1 8.2 13.5 21.0 11.2 10.3 10.5 11.6 15.5 14.6 18.0 12.2 13.2 11.6 23.3 12.2 10.8 12.8 12.7 13.7 26.6 11.4 16.6 18.1 13.1 9.6 10.4 7.4 8.2 15.5 11.3 15.9 22.3 8.5 17.4 14.3 2.0 7.0 3.6 8.6 7.8 11.7 8.5 9.4 9.8 8.3 9.6 11.5 11.8 2.0 11.2 9.1 6.6 6.8 5.3 10.2 15.4 14.9 15.3 10.8 9.8 14.1 10.8 14.5 13.4 6.0 15.4 4.5 4.9 9.3 9.0 8.1 10.2 9.4 4.5 10.4 3.9 16.5 0.0 6.6 5.5 6.7 4.7 0.0 6.0 10.7 7.7 4.9 33.5 12.5 6.9 3.2 4.6 6.7 4.3 3.1 7.8 8.9 8.5 10.0 12.1 7.7 6.1 3.5 7.8 2.1 11.7 19.4 7.1 17.0 22.7 14.8 12.7 8.5 9.7 2.8 TYW1B "LINC00069, MGC87315, NCRNA00069, RSAFD2" ENSG00000277149 "TRNA-yW synthesizing protein 1 homolog B" 7 72558744-72828198 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 8.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (2.61e-1)" "unprognostic (3.54e-1)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (1.91e-2)" "unprognostic (6.22e-3)" "unprognostic (3.88e-2)" "unprognostic (1.64e-2)" "unprognostic (1.19e-2)" "unprognostic (8.96e-3)" "unprognostic (5.78e-2)" "unprognostic (2.90e-2)" "unprognostic (4.33e-4)" "unprognostic (1.02e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" 2.7 1.6 1.8 4.5 3.8 4.4 4.2 6.0 3.3 5.6 2.9 5.8 7.4 1.5 6.0 5.2 3.4 4.1 1.5 2.3 1.9 3.1 7.9 2.9 2.4 3.9 1.7 10.1 5.7 2.0 11.6 3.0 3.4 4.1 4.4 4.7 4.1 5.9 4.4 2.5 2.9 3.6 4.7 3.0 3.1 7.2 3.8 6.0 5.9 1.8 6.0 3.1 1.1 7.5 5.4 5.7 3.5 2.4 3.0 0.9 2.3 2.5 1.0 2.0 1.6 0.5 1.1 1.2 0.5 1.1 1.1 8.0 4.2 7.3 0.7 0.8 1.0 1.1 1.9 0.8 1.3 7.9 2.3 0.7 1.2 4.7 0.8 7.4 2.1 3.8 0.6 1.3 0.9 0.7 0.7 1.6 10.0 7.7 1.1 1.0 2.4 3.8 1.8 3.1 4.6 1.4 5.5 2.6 1.1 0.8 1.8 0.9 1.5 8.4 4.3 3.3 2.1 2.6 3.2 1.8 4.3 9.7 1.4 6.7 8.1 8.3 0.5 2.1 9.7 4.0 3.5 5.7 3.0 1.8 2.8 7.5 2.0 1.8 1.4 5.2 2.3 2.7 4.3 2.4 1.7 5.4 2.0 0.9 0.0 1.3 4.7 1.8 0.0 3.4 4.8 2.5 2.7 1.2 0.0 9.8 3.5 0.0 2.0 3.3 1.4 1.2 0.0 0.6 1.5 2.1 1.6 1.1 1.5 2.9 1.6 0.0 1.3 1.5 0.4 0.9 0.7 0.0 2.8 2.3 1.6 1.0 0.3 0.7 0.5 8.1 0.0 1.7 5.5 5.1 0.0 1.6 2.2 1.1 0.9 UAP1 "AgX, AGX1, SPAG2" ENSG00000117143 "UDP-N-acetylglucosamine pyrophosphorylase 1" Q16222 1 162561506-162599842 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 107.8;U-251 MG: 70.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014659 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No Yes 19000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA014659: AB_1857409" "unprognostic (2.32e-2)" "unprognostic (2.45e-1)" "unprognostic (2.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.71e-2)" "unprognostic (1.46e-2)" "unprognostic (1.37e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (1.29e-3)" "unprognostic (4.96e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "unprognostic (3.51e-1)" "unprognostic (3.45e-2)" 38.4 18.5 7.0 17.4 9.8 17.2 24.8 9.0 13.4 16.1 26.9 5.7 45.7 17.2 10.9 19.4 23.6 15.7 18.3 22.5 7.7 7.8 11.0 67.1 16.0 7.4 6.6 8.9 20.4 31.4 5.1 16.0 21.5 9.1 13.9 26.9 7.8 43.9 62.5 19.4 12.4 33.4 28.8 7.1 8.1 23.0 37.7 3.7 5.6 12.4 13.5 15.3 24.4 16.7 8.3 5.6 8.1 1.6 6.2 16.1 4.8 30.5 2.2 6.1 4.9 29.8 23.9 4.2 44.9 16.6 34.7 28.3 5.8 14.4 1.2 10.1 34.4 12.5 5.3 6.9 13.1 57.2 4.8 10.3 5.4 7.0 11.4 14.0 9.2 3.7 11.0 6.2 38.0 107.8 15.9 21.2 9.6 30.5 12.6 46.4 5.6 5.3 5.9 4.5 31.4 10.0 4.8 11.9 14.9 5.4 3.6 6.6 6.8 19.6 12.2 10.4 7.5 6.0 10.5 36.0 17.5 16.1 44.0 70.2 21.2 7.4 10.1 10.0 4.3 11.0 1.0 1.6 8.1 13.0 1.6 16.1 8.3 7.9 13.3 3.4 6.5 7.6 9.5 1.6 6.2 0.8 5.6 3.9 4.8 7.0 9.8 9.0 13.4 7.7 7.8 6.6 8.9 9.1 3.7 6.0 30.4 17.9 120.0 119.7 10.0 26.6 17.8 53.5 38.7 15.7 7.9 22.4 61.3 24.8 36.3 23.3 84.7 0.0 56.9 52.1 141.3 91.8 33.4 88.9 14.0 6.4 52.6 21.5 7.0 11.8 46.9 15.2 81.0 27.9 124.5 14.0 55.8 69.1 38.9 20.2 12.3 19.4 160.3 182.9 121.8 71.5 81.7 20.1 59.9 111.6 UBA7 "D8, UBA1B, UBE1L, UBE2" ENSG00000182179 "Ubiquitin like modifier activating enzyme 7" P41226 3 49805207-49813946 "Plasma proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 22.7;HEL: 21.2;HMC-1: 41.2;HSkMC: 19.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB015444, HPA058182" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA 1400000 "Nucleoplasm, Vesicles" Cytosol "CAB015444: AB_793598, HPA058182: AB_2683631" "prognostic favorable (1.55e-4)" "unprognostic (7.07e-3)" "unprognostic (1.59e-2)" "unprognostic (1.61e-2)" "unprognostic (3.77e-1)" "unprognostic (2.31e-2)" "unprognostic (5.08e-3)" "unprognostic (3.61e-2)" "unprognostic (6.33e-2)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.04e-5)" "unprognostic (9.11e-2)" "unprognostic (3.81e-2)" "unprognostic (1.57e-1)" "prognostic favorable (1.48e-4)" 11.3 12.1 6.8 22.0 7.5 16.0 11.5 2.0 6.7 10.8 12.7 14.4 25.4 19.6 17.2 31.6 17.7 12.9 33.1 9.1 6.7 3.9 15.9 11.9 18.8 28.2 6.0 6.2 19.1 9.5 1.4 8.4 8.9 9.4 18.5 12.1 14.2 24.5 34.2 3.3 9.0 25.5 11.3 7.7 35.9 13.2 3.4 5.9 20.4 17.8 18.4 23.5 12.6 13.1 12.4 14.3 24.8 21.7 11.1 11.8 13.0 4.3 0.0 0.3 0.1 12.2 12.9 1.4 2.3 10.6 16.9 22.7 0.0 9.3 0.1 1.9 8.6 7.3 2.4 0.0 4.2 1.5 11.3 0.0 21.2 0.2 1.3 9.0 2.0 41.2 19.8 0.2 6.6 0.4 11.8 8.5 0.7 0.0 1.3 3.9 0.1 4.3 5.1 0.0 0.0 0.4 5.5 0.4 0.7 3.5 8.6 0.0 0.3 2.8 4.2 1.4 0.2 0.4 14.1 3.7 3.3 0.4 1.4 0.9 0.0 0.0 0.1 9.2 7.5 0.7 13.9 14.7 24.8 11.8 21.7 10.3 12.3 10.8 10.5 14.3 12.4 9.9 8.9 4.6 11.1 17.2 5.2 10.6 13.0 6.8 7.5 2.0 6.7 6.7 3.9 6.0 6.2 9.4 5.9 29.8 23.6 22.9 5.9 3.4 0.1 6.9 15.3 2.7 13.6 12.2 0.0 4.5 0.0 7.6 4.5 14.3 35.5 0.0 6.9 2.2 8.9 5.1 80.8 6.7 18.2 0.0 9.1 17.8 21.9 24.1 10.3 10.6 0.0 10.8 19.5 2.9 5.1 12.9 10.6 4.1 1.1 6.5 7.1 0.9 0.4 4.1 2.4 27.4 15.3 5.0 UBALD1 FAM100A ENSG00000153443 "UBA like domain containing 1" Q8TB05 16 4608883-4615027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066771 Approved Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA066771: AB_2685717" "unprognostic (7.09e-2)" "unprognostic (2.21e-2)" "unprognostic (1.55e-1)" "unprognostic (7.67e-3)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.54e-1)" "unprognostic (4.37e-3)" "unprognostic (2.63e-3)" "unprognostic (8.06e-2)" "unprognostic (1.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.99e-2)" "unprognostic (6.20e-2)" "unprognostic (1.35e-2)" 23.0 16.7 20.5 17.9 25.0 37.5 11.9 32.4 39.2 12.1 19.3 15.1 11.7 23.7 20.4 11.0 15.0 13.9 12.4 14.8 20.9 14.2 19.6 32.9 15.7 13.8 12.0 22.2 14.8 27.2 9.0 12.1 27.9 16.9 18.9 5.3 13.6 19.4 18.1 38.3 16.7 19.5 14.2 11.5 23.9 25.9 13.2 13.0 9.9 17.3 11.3 11.6 17.8 12.8 1.9 2.8 11.3 4.5 1.5 2.6 1.5 5.4 15.9 3.8 5.9 2.5 3.3 17.0 8.3 3.4 3.2 4.6 7.8 6.5 8.2 9.3 2.6 2.4 15.2 2.4 8.4 0.9 17.1 24.2 7.6 16.6 12.0 5.2 4.7 13.1 4.7 6.3 4.9 2.4 3.7 3.4 6.3 11.5 8.6 1.2 27.1 7.9 26.0 14.2 4.9 14.1 11.4 4.7 26.4 2.8 8.0 11.0 10.1 9.8 15.2 13.0 2.3 9.7 7.8 10.1 6.5 7.4 26.1 5.3 16.8 13.5 9.2 2.6 6.5 3.4 1.3 2.3 11.3 2.5 3.5 1.6 1.9 2.0 2.6 2.8 1.8 2.1 2.2 3.9 1.5 4.5 1.8 2.4 1.5 20.5 25.0 32.4 39.2 20.9 14.2 12.0 22.2 16.9 13.0 8.9 8.0 9.8 49.6 97.9 8.9 3.6 7.6 2.7 7.9 17.4 3.9 58.7 26.6 19.0 30.4 15.8 17.3 0.0 20.4 54.1 23.1 30.9 10.4 31.6 20.8 9.5 81.1 15.4 16.8 89.2 15.0 18.1 20.3 17.2 21.3 12.0 21.6 17.5 18.7 33.8 8.7 45.3 30.6 11.5 17.7 89.8 90.2 15.3 12.8 32.8 UBE2R2 "CDC34B, FLJ20419, MGC10481, UBC3B" ENSG00000107341 "Ubiquitin conjugating enzyme E2 R2" Q712K3 9 33817567-33920404 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 295.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 21.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061000, HPA074334" Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA061000: AB_2684408, HPA074334: " "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (7.08e-2)" "unprognostic (1.53e-1)" "unprognostic (6.55e-2)" "unprognostic (5.15e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.82e-3)" "unprognostic (4.61e-3)" "unprognostic (3.05e-3)" "unprognostic (2.22e-2)" "unprognostic (4.19e-1)" "unprognostic (2.01e-2)" "unprognostic (4.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (1.43e-1)" 26.1 19.7 29.4 19.7 26.8 13.9 39.3 23.7 32.3 25.6 24.1 27.9 16.3 28.0 26.1 18.4 25.3 22.3 21.8 29.2 25.5 20.3 22.1 34.5 23.0 27.1 30.5 23.2 29.8 44.5 15.7 13.9 24.6 21.6 21.0 21.4 19.3 18.7 20.8 56.1 28.1 25.7 28.5 24.2 21.6 20.8 34.5 29.6 36.7 19.5 22.5 25.7 35.8 30.5 3.3 4.2 21.9 11.6 5.0 2.1 2.4 16.5 18.1 35.0 15.2 19.3 31.5 10.8 14.7 20.5 17.3 17.3 14.5 12.4 14.1 6.0 20.5 12.6 7.4 18.3 16.8 19.0 23.2 9.7 12.2 20.0 18.4 27.5 14.4 13.3 26.7 25.0 14.1 26.8 27.7 29.0 17.0 11.4 15.2 17.1 9.6 27.1 38.0 19.9 14.2 15.1 25.3 10.6 7.3 18.3 12.5 16.4 19.7 17.2 15.4 11.0 23.2 13.5 17.6 21.7 16.7 15.2 11.5 13.6 9.7 9.1 19.8 15.9 8.4 35.9 12.4 7.5 4.1 2.0 7.5 1.3 3.1 1.9 1.6 4.2 3.3 1.9 1.7 21.9 5.0 11.6 2.6 2.1 2.4 29.4 26.8 23.7 32.3 25.5 20.3 30.5 23.2 21.6 29.6 20.8 30.7 29.5 39.6 93.8 61.0 106.8 56.0 22.7 25.0 21.0 13.7 52.6 13.3 43.8 295.7 77.1 60.6 23.3 59.7 65.2 54.0 68.4 12.7 72.1 68.5 57.2 69.2 77.3 105.2 195.4 62.2 81.9 33.7 49.5 57.3 87.1 69.4 38.6 71.5 49.6 30.1 58.2 41.9 90.2 66.2 105.3 69.2 30.5 49.0 79.7 UBE3C "KIAA0010, KIAA10" ENSG00000009335 "Ubiquitin protein ligase E3C" Q15386 7 157138913-157269372 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039915 Approved Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA039915: AB_10795264" "unprognostic (2.83e-2)" "unprognostic (9.27e-3)" "unprognostic (2.41e-1)" "unprognostic (2.29e-1)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (1.36e-1)" "unprognostic (7.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.58e-1)" "unprognostic (3.01e-3)" "unprognostic (8.64e-2)" "prognostic favorable (9.18e-6)" "unprognostic (9.74e-2)" "unprognostic (1.86e-1)" "unprognostic (1.87e-1)" "unprognostic (3.60e-2)" 24.7 21.0 14.0 17.9 23.1 12.4 19.8 25.5 29.9 21.3 23.4 17.2 15.3 17.4 28.8 16.8 26.8 18.8 24.8 31.8 14.4 13.8 21.2 30.5 16.7 16.7 14.5 15.1 20.7 22.1 29.6 20.3 21.3 22.3 19.0 21.0 20.2 31.7 21.5 51.2 21.2 23.9 25.7 16.1 20.5 21.8 35.9 11.1 20.3 15.6 24.5 24.4 23.1 19.1 2.5 4.0 2.1 4.6 3.7 6.6 2.9 22.8 18.2 11.7 23.3 21.0 22.1 12.9 25.3 21.9 21.4 21.7 16.3 19.1 12.4 22.5 27.9 27.9 14.5 18.1 23.3 25.4 22.5 16.6 12.6 12.7 11.7 20.9 18.8 18.5 19.5 21.6 23.7 19.7 16.3 24.9 10.4 18.3 13.8 30.2 20.0 18.4 11.9 18.5 20.5 21.9 10.6 13.1 25.4 22.1 25.2 18.7 19.3 24.9 21.5 18.5 13.6 11.1 13.2 22.3 27.0 5.8 66.1 31.3 13.9 13.9 12.5 31.0 28.1 30.8 0.5 3.5 2.1 4.8 4.6 6.6 2.5 5.2 5.2 4.0 2.5 4.9 5.9 1.3 3.7 4.5 3.6 5.2 2.9 14.0 23.1 25.5 29.9 14.4 13.8 14.5 15.1 22.3 11.1 20.8 19.5 9.7 13.9 24.5 31.4 31.5 28.1 16.0 9.1 24.4 62.8 12.2 8.3 17.0 8.4 19.9 22.1 0.0 15.2 14.4 14.7 19.9 9.2 39.2 13.9 30.2 23.5 24.5 21.2 8.5 14.4 15.0 5.0 12.6 20.6 10.9 22.5 10.5 24.1 16.5 42.8 0.0 17.6 20.4 27.4 29.1 12.6 13.8 22.4 27.3 UBLCP1 "CPUB1, MGC10067" ENSG00000164332 "Ubiquitin like domain containing CTD phosphatase 1" Q8WVY7 5 159263081-159286040 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039615 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA039615: AB_10674425" "unprognostic (1.25e-1)" "unprognostic (3.10e-1)" "unprognostic (6.04e-3)" "unprognostic (3.45e-2)" "unprognostic (7.08e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (4.46e-5)" "unprognostic (4.01e-1)" "unprognostic (2.14e-2)" "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (1.87e-1)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (2.51e-2)" 17.1 16.0 16.7 18.4 19.7 16.7 16.3 20.2 33.0 18.5 12.5 12.2 11.4 9.8 22.5 13.1 22.2 14.7 14.5 13.1 20.9 19.1 17.5 14.4 17.8 24.1 19.7 22.7 16.8 12.6 18.0 23.9 19.6 36.7 14.7 14.7 10.9 15.4 17.6 15.3 14.2 13.8 19.5 20.4 22.2 13.3 24.2 15.4 26.8 14.4 16.1 30.1 18.8 16.8 11.9 10.8 21.9 13.9 25.5 19.2 8.2 14.6 10.7 22.2 24.1 23.1 21.4 13.1 16.0 24.5 16.5 22.0 8.7 10.2 13.1 17.7 20.0 23.7 11.2 13.7 30.8 28.8 26.2 13.5 10.1 9.4 7.9 29.2 22.8 15.9 18.9 28.9 14.9 29.9 13.2 15.6 13.9 13.8 17.8 22.9 4.7 12.3 6.9 15.4 7.3 6.5 15.7 21.8 15.3 16.3 11.3 11.8 15.7 16.2 10.8 37.7 14.0 11.4 15.2 16.7 17.0 14.2 8.8 20.2 14.3 14.3 20.0 18.0 15.8 25.1 21.9 6.5 16.1 16.6 13.5 18.6 11.9 15.8 17.3 8.5 10.9 18.5 19.2 19.4 25.5 13.9 10.8 16.9 8.2 16.7 19.7 20.2 33.0 20.9 19.1 19.7 22.7 36.7 15.4 11.9 38.2 22.7 8.2 14.2 9.9 12.2 10.2 34.8 30.7 14.0 3.9 27.7 29.9 18.9 3.4 20.0 9.5 46.7 21.7 14.9 21.7 11.4 43.9 14.0 33.1 19.1 10.3 30.7 42.1 2.2 19.0 27.8 16.9 25.2 14.0 17.9 18.8 8.6 23.3 23.8 13.4 19.4 14.4 70.2 48.5 18.1 14.9 21.7 13.9 7.9 UBR1 ENSG00000159459 "Ubiquitin protein ligase E3 component n-recognin 1" Q8IWV7 15 42942897-43106113 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038838, HPA038839" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA038838: AB_10673120, HPA038839: " "unprognostic (1.07e-2)" "unprognostic (5.02e-2)" "unprognostic (9.77e-2)" "unprognostic (1.55e-2)" "unprognostic (1.89e-2)" "unprognostic (1.29e-1)" "unprognostic (2.67e-1)" "unprognostic (1.49e-1)" "unprognostic (4.79e-1)" "unprognostic (2.97e-2)" "unprognostic (1.93e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (1.89e-1)" 16.7 13.2 13.7 18.3 16.7 28.4 18.8 21.8 18.1 18.2 16.2 14.8 10.5 11.3 21.0 12.9 10.8 15.9 14.2 19.7 10.0 15.4 14.4 10.6 16.6 14.9 11.8 10.5 16.3 16.4 26.3 25.6 16.2 18.9 15.3 12.9 12.5 11.8 16.8 23.6 11.0 14.4 18.2 12.1 14.7 13.8 13.7 14.7 23.2 18.8 9.7 14.3 17.3 19.7 4.6 5.0 5.5 4.2 6.2 7.2 1.8 5.0 7.3 8.4 6.9 13.4 10.4 8.0 12.4 13.6 10.9 14.1 9.3 3.9 5.9 7.3 12.6 13.7 8.8 12.2 10.8 13.0 12.1 5.9 23.3 14.7 4.5 9.3 16.4 11.2 11.2 6.1 13.4 10.9 10.7 12.3 12.0 13.3 9.0 13.5 2.8 8.8 4.9 4.8 13.4 7.6 11.7 11.6 5.1 11.0 11.9 8.6 7.6 16.2 8.6 5.7 10.2 8.3 8.6 16.8 13.5 8.3 12.0 12.5 10.6 18.0 17.1 9.2 10.4 12.1 4.4 3.0 5.2 5.7 4.2 6.5 4.1 5.9 6.9 2.9 4.6 5.9 7.2 5.5 6.2 3.4 5.0 4.1 1.8 13.7 16.7 21.8 18.1 10.0 15.4 11.8 10.5 18.9 14.7 44.7 27.8 14.6 10.3 9.4 26.8 24.5 17.8 17.4 25.0 8.7 25.5 10.4 0.0 8.8 11.6 17.9 10.8 0.0 12.5 6.2 15.0 9.4 27.7 8.5 7.3 30.2 13.8 14.7 16.2 13.2 15.0 10.5 8.5 10.0 10.0 15.6 8.9 9.1 19.4 6.7 39.2 12.9 19.1 25.3 14.9 6.4 30.9 20.8 10.0 7.4 UBR4 "KIAA0462, KIAA1307, RBAF600, ZUBR1" ENSG00000127481 "Ubiquitin protein ligase E3 component n-recognin 4" Q5T4S7 1 19074506-19210276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" "Calmodulin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 240.8;Suprabasal keratinocytes: 220.9;Urothelial cells: 215.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013394, HPA021046" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA013394: , HPA021046: AB_1858578" "unprognostic (1.37e-1)" "unprognostic (2.57e-2)" "unprognostic (2.82e-2)" "unprognostic (2.02e-1)" "unprognostic (8.78e-2)" "unprognostic (9.77e-2)" "unprognostic (1.14e-3)" "unprognostic (3.09e-1)" "unprognostic (1.96e-1)" "unprognostic (9.14e-3)" "unprognostic (7.48e-2)" "unprognostic (2.53e-1)" "unprognostic (7.68e-3)" "unprognostic (4.30e-1)" "unprognostic (1.19e-1)" "unprognostic (5.58e-2)" "unprognostic (1.52e-1)" 24.4 25.4 22.4 29.0 25.4 58.3 23.7 28.5 32.5 22.4 28.5 26.3 31.5 18.2 34.0 32.5 22.7 20.3 27.3 20.5 23.3 15.9 25.5 29.7 31.2 20.3 21.0 20.9 35.5 21.0 40.9 31.4 28.4 25.0 30.7 20.5 30.6 24.7 27.1 55.9 69.0 25.5 39.3 20.2 26.5 30.2 41.1 21.6 37.7 26.1 17.3 25.9 43.4 29.0 4.6 9.1 18.3 18.5 2.7 3.4 4.6 22.2 22.5 20.4 15.0 38.1 19.7 17.6 17.3 18.4 18.9 17.3 35.9 19.2 13.4 16.3 22.9 16.6 15.3 15.9 17.3 17.7 11.1 14.1 30.7 21.7 23.3 26.9 18.8 20.4 17.6 22.2 38.5 37.2 18.5 20.7 23.9 21.0 12.5 17.9 15.9 8.9 22.9 16.5 45.7 12.7 12.4 15.9 11.2 17.1 13.1 14.4 14.3 20.5 11.8 14.8 19.5 8.2 14.8 32.0 22.2 13.9 26.2 19.4 14.9 9.0 15.6 15.2 29.1 18.8 18.3 18.5 2.9 3.4 3.8 2.9 4.6 3.0 1.9 9.1 2.9 2.7 2.5 9.8 2.7 1.3 4.3 2.1 4.6 22.4 25.4 28.5 32.5 23.3 15.9 21.0 20.9 25.0 21.6 32.8 42.3 16.3 79.1 240.8 54.0 15.6 40.8 30.8 26.1 29.6 143.3 19.2 11.6 31.4 14.7 21.1 36.4 23.3 35.5 14.1 29.1 39.1 18.5 77.9 54.8 74.7 16.8 28.8 47.4 19.9 28.4 42.8 47.2 36.1 30.4 30.7 51.2 14.0 33.6 88.2 48.0 19.4 26.8 37.4 17.9 220.9 28.4 21.0 19.5 215.5 UBXN8 "D8S2298E, REP8, UBXD6" ENSG00000104691 "UBX domain protein 8" O00124 8 30732247-30767006 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 30.6" "Group enriched" "Detected in many" 4 "Early spermatids: 162.1;Hepatocytes: 56.2;Late spermatids: 132.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017725, HPA077538" Enhanced Supported "Nucleoplasm,Nucleoli,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nucleoli" "HPA017725: AB_1847462, HPA077538: AB_2686844" "unprognostic (3.00e-2)" "unprognostic (2.30e-1)" "prognostic favorable (6.13e-4)" "unprognostic (7.71e-2)" "unprognostic (2.24e-1)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (1.84e-2)" "unprognostic (1.90e-1)" "unprognostic (5.13e-2)" "unprognostic (1.58e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.25e-5)" "unprognostic (2.49e-1)" "unprognostic (1.96e-1)" "unprognostic (1.51e-1)" "unprognostic (6.88e-2)" 5.0 5.3 3.9 1.4 4.8 1.4 4.3 1.5 9.2 3.0 3.5 4.0 6.7 3.1 3.8 14.3 4.1 3.6 3.8 2.8 5.7 8.2 21.5 2.1 3.9 7.6 4.0 30.6 10.3 6.2 3.5 6.2 6.2 4.8 4.7 1.6 1.8 6.1 1.7 4.1 2.9 2.9 7.1 5.7 3.3 11.5 6.1 0.9 9.1 2.8 2.3 2.9 3.7 6.0 8.2 1.0 6.1 3.3 8.4 3.4 7.6 7.7 5.6 5.8 9.1 12.2 6.3 13.7 8.0 7.5 9.2 12.2 2.8 12.2 11.3 11.1 12.4 6.8 1.1 7.6 11.6 6.4 12.5 34.3 6.3 14.9 13.7 7.8 19.4 9.6 7.9 12.0 5.9 6.4 6.5 5.6 33.5 9.2 16.5 7.2 7.9 6.0 10.8 22.8 5.8 9.5 5.4 8.5 12.8 10.0 3.2 8.1 3.8 11.3 24.7 7.0 8.4 13.6 8.3 8.5 3.7 3.8 12.7 4.0 12.5 9.2 7.6 12.6 12.1 0.0 6.0 0.7 8.4 6.1 7.3 6.0 4.5 8.0 6.7 2.9 4.4 7.4 1.0 3.3 3.0 8.2 4.3 3.4 3.0 8.0 3.0 4.1 0.0 1.9 3.2 15.3 1.4 5.7 14.0 19.6 20.6 6.6 7.1 162.1 6.2 6.3 0.0 4.5 16.0 9.4 4.1 13.9 56.2 19.0 11.1 8.2 27.0 14.2 132.0 13.3 6.9 0.0 10.0 6.4 6.6 3.9 3.5 9.2 22.0 1.8 6.5 3.9 14.1 20.4 0.0 12.7 7.2 10.0 2.4 UCHL5 "CGI-70, INO80R, UCH37" ENSG00000116750 "Ubiquitin C-terminal hydrolase L5" Q9Y5K5 1 193012250-193060080 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005908, HPA006069" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA005908: AB_1858585, HPA006069: " "unprognostic (3.66e-2)" "unprognostic (3.84e-3)" "unprognostic (5.17e-2)" "unprognostic (5.98e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (7.41e-2)" "unprognostic (1.96e-2)" "unprognostic (1.04e-3)" "unprognostic (3.44e-3)" "unprognostic (6.92e-2)" "unprognostic (6.41e-3)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "prognostic unfavorable (7.10e-5)" "unprognostic (4.33e-2)" 15.7 18.3 20.1 16.1 26.2 16.0 18.2 30.1 34.8 10.9 17.7 11.5 12.6 19.0 12.5 14.7 26.1 10.7 11.9 22.0 21.6 20.6 21.6 28.3 12.4 19.9 21.3 29.4 13.4 24.8 15.6 16.2 17.8 33.3 17.8 18.8 10.3 19.3 12.9 29.1 16.7 18.0 13.9 20.1 17.3 14.0 9.9 17.5 20.0 15.1 19.1 23.0 14.8 14.8 22.5 20.8 23.8 21.1 35.6 30.9 20.9 33.6 18.7 16.2 16.6 9.5 9.6 19.3 19.8 10.1 19.0 16.5 17.7 22.9 26.4 19.2 11.0 11.5 20.9 21.6 25.6 25.2 27.2 15.5 31.3 24.2 23.4 15.2 49.1 17.6 8.9 11.4 27.3 24.2 8.7 18.7 26.6 68.6 21.6 16.1 27.2 36.1 18.2 15.0 23.1 11.8 21.0 18.2 51.4 17.7 19.8 16.5 20.3 17.8 25.8 27.6 17.9 21.0 24.8 12.2 17.8 5.4 18.0 31.5 16.8 26.0 29.8 10.7 30.6 30.3 23.8 16.5 19.0 28.3 19.5 30.9 22.5 25.9 26.9 19.4 18.0 28.2 30.5 10.0 35.6 21.1 20.8 24.8 20.9 20.1 26.2 30.1 34.8 21.6 20.6 21.3 29.4 33.3 17.5 8.9 24.6 13.7 12.3 21.6 18.3 68.2 15.3 26.8 29.6 26.2 41.2 31.3 38.1 21.6 1.8 20.4 19.5 0.0 24.6 27.1 16.4 17.3 53.3 22.2 24.8 23.8 10.4 18.4 20.3 3.4 13.8 24.5 16.9 19.8 18.3 25.7 20.3 7.0 16.3 30.8 41.8 19.4 17.0 14.0 16.8 26.2 21.1 27.7 20.6 10.5 UCP3 SLC25A9 ENSG00000175564 "Uncoupling protein 3" P55916 11 74000281-74009435 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 99.6" "Group enriched" "Detected in some" 5 "Early spermatids: 14.7;Late spermatids: 10.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 4 "HDLM-2: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010771, HPA072225" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB010771: AB_261839, HPA072225: AB_2686498" "unprognostic (3.76e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-1)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-2)" "unprognostic (3.95e-3)" "unprognostic (6.61e-2)" "unprognostic (1.25e-1)" "unprognostic (8.58e-2)" "unprognostic (2.13e-4)" "unprognostic (1.61e-2)" "unprognostic (3.25e-6)" "unprognostic (2.68e-1)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.50e-4)" 0.9 0.2 0.2 0.3 0.2 0.6 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.5 0.9 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 1.0 0.2 99.6 0.3 0.2 0.2 0.2 0.5 0.1 0.6 0.2 0.2 0.6 6.4 0.8 0.2 0.2 0.8 0.1 0.7 0.3 0.2 2.1 0.4 0.2 2.1 2.1 1.8 0.8 0.4 0.4 0.5 0.5 0.5 0.3 0.5 0.4 1.1 0.3 0.4 0.3 2.2 0.8 0.4 0.8 18.3 0.7 0.4 2.4 0.2 0.6 1.2 1.7 0.5 1.4 1.3 0.1 0.4 0.7 1.0 0.5 1.4 0.7 1.2 0.8 1.6 1.0 1.6 1.4 1.6 4.3 0.6 1.1 0.6 1.2 1.3 0.5 0.9 0.7 0.4 0.2 1.1 0.4 0.3 1.4 0.7 1.3 1.6 1.7 0.8 0.3 1.1 0.7 0.0 0.3 0.7 2.1 0.1 0.9 0.0 1.5 1.8 0.0 0.8 0.6 1.2 0.1 0.2 0.0 0.1 0.4 0.4 0.2 0.2 1.1 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.5 0.1 0.1 2.2 0.5 0.0 2.7 1.2 0.0 0.0 0.3 0.0 0.3 14.7 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.6 0.8 10.7 0.0 0.0 0.0 0.0 0.6 0.7 0.3 0.0 0.7 0.0 1.6 0.0 0.1 1.2 0.7 0.3 0.2 2.2 0.6 0.0 UFD1 UFD1L ENSG00000070010 "Ubiquitin recognition factor in ER associated degradation 1" Q92890 22 19449910-19479215 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 105.1;Ductal cells: 98.8;Exocrine glandular cells: 123.6;monocytes: 132.6;Pancreatic endocrine cells: 115.9;Syncytiotrophoblasts: 142.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 131.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030286, HPA030287" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA030286: , HPA030287: AB_10601830" "unprognostic (2.52e-1)" "unprognostic (5.41e-2)" "unprognostic (1.95e-3)" "unprognostic (7.61e-2)" "unprognostic (3.50e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-3)" "unprognostic (8.82e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.50e-8)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" 27.8 28.0 22.7 24.3 38.0 38.7 23.9 25.3 30.4 21.1 28.9 23.3 24.7 21.7 32.8 40.3 31.6 21.3 21.7 35.6 21.9 22.9 28.0 46.6 24.6 34.8 44.3 15.9 22.4 34.7 22.5 22.6 31.6 33.0 21.7 27.7 21.9 26.7 24.4 57.9 27.3 24.7 28.3 39.7 26.7 26.2 31.8 29.9 37.8 27.8 26.9 31.7 23.9 23.7 27.7 35.3 53.5 42.8 31.1 67.6 37.5 31.8 23.2 19.8 30.0 16.3 11.5 15.2 26.4 26.4 36.5 33.8 25.7 13.9 22.3 20.5 22.1 16.8 27.7 23.2 23.1 31.8 41.0 24.5 23.5 16.4 20.3 15.5 37.2 32.1 10.5 23.8 31.1 15.3 10.7 29.2 11.8 131.8 43.0 22.2 46.3 23.9 22.8 14.2 40.2 19.7 29.1 46.9 8.6 22.4 30.1 16.3 18.3 20.7 22.5 20.7 21.6 13.5 17.9 31.7 30.8 41.9 25.6 28.3 18.4 36.6 29.0 25.9 19.0 28.1 39.8 29.0 47.8 36.1 42.8 34.7 27.7 41.6 37.3 25.5 23.9 35.9 35.1 53.5 31.1 41.1 35.3 67.6 37.5 22.7 38.0 25.3 30.4 21.9 22.9 44.3 15.9 33.0 29.9 23.8 34.6 0.0 0.0 0.0 0.0 0.0 0.0 50.9 30.7 26.2 0.0 105.1 71.3 98.8 0.0 0.0 0.0 0.0 123.6 90.9 0.0 0.0 25.6 0.0 79.3 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 132.6 0.0 0.0 115.9 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 142.5 0.0 0.0 0.0 UGP2 "UGP1, UGPP1" ENSG00000169764 "UDP-glucose pyrophosphorylase 2" Q16851 2 63840940-63891562 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 185.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 93.6;T-reg: 29.9" "Group enriched" "Detected in all" 5 "granulocytes: 93.6;T-cells: 29.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034696, HPA034697, HPA064836" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria NA NA 12000000 "Centrosome, Mitochondria" Nucleoplasm "HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365" "unprognostic (1.00e-2)" "unprognostic (6.93e-2)" "unprognostic (5.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.65e-2)" "unprognostic (1.91e-1)" "prognostic favorable (2.50e-5)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-2)" "unprognostic (8.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (3.93e-2)" "unprognostic (3.81e-1)" "unprognostic (8.44e-2)" 58.2 14.7 23.3 13.6 22.5 7.8 25.2 12.4 30.4 13.3 38.2 6.7 7.4 12.3 15.5 12.5 19.8 12.7 12.2 46.3 18.8 13.2 33.0 185.5 12.7 15.2 17.3 18.3 12.0 13.4 17.1 22.9 31.0 19.3 11.0 33.1 5.7 18.5 12.9 104.1 11.0 17.2 16.8 8.6 9.9 13.0 8.1 10.5 31.0 17.4 75.5 12.7 19.7 19.5 6.4 5.9 93.6 7.8 12.7 29.9 11.0 27.5 14.5 13.9 9.3 47.4 61.5 58.3 35.6 29.1 19.2 22.9 37.1 23.4 28.9 10.7 38.2 17.5 12.1 16.8 22.3 31.2 19.3 7.1 18.3 10.3 25.3 22.7 16.1 16.1 40.3 40.9 18.0 18.6 25.9 26.6 9.8 9.1 11.7 80.1 10.8 21.8 15.2 33.3 45.0 10.2 17.9 27.6 16.6 34.0 16.0 7.3 6.0 28.4 36.6 13.5 44.1 10.4 11.5 36.3 20.1 31.7 29.9 18.7 21.0 9.4 36.6 24.1 25.3 61.3 93.6 7.0 9.7 9.9 7.8 10.3 6.4 11.4 10.3 5.9 6.2 12.6 11.2 9.0 12.7 7.6 5.5 29.9 11.0 23.3 22.5 12.4 30.4 18.8 13.2 17.3 18.3 19.3 10.5 26.8 52.5 51.7 74.0 67.3 48.5 238.8 89.2 73.6 69.4 45.4 60.9 359.1 205.6 116.3 61.0 61.3 412.6 0.0 90.6 369.3 148.4 77.6 65.8 448.9 107.3 82.6 42.9 66.3 100.6 64.7 73.4 90.8 91.1 173.1 112.3 37.4 81.0 167.8 72.9 209.2 49.4 71.1 124.3 71.2 57.5 50.6 395.3 112.8 144.5 90.3 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035017-36071358 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Region enhanced" "Detected in single" "pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: AB_2684031" "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.1 1.1 0.1 0.0 0.2 6.4 1.6 0.1 0.6 0.1 0.1 0.5 0.4 0.0 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.6 5.6 0.8 0.1 0.0 0.5 0.0 0.2 0.0 0.0 1.7 0.2 2.0 0.6 0.0 2.9 0.1 0.0 0.1 14.4 0.1 0.0 0.3 1.4 0.1 13.2 0.0 37.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.0 0.0 0.4 5.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 9.3 0.0 3.9 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 5.7 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.6 0.1 0.6 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 UHMK1 "KIS, Kist" ENSG00000152332 "U2AF homology motif kinase 1" Q8TAS1 1 162497251-162529629 "Enzymes, Predicted intracellular proteins" "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071190 Approved "Nucleoplasm,Golgi apparatus,Midbody" Yes No "Nucleoplasm, Golgi apparatus" Midbody "HPA071190: AB_2686358" "unprognostic (6.69e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.08e-2)" "unprognostic (8.16e-2)" "unprognostic (9.63e-2)" "unprognostic (1.82e-1)" "unprognostic (7.81e-3)" "unprognostic (9.10e-2)" "unprognostic (3.11e-1)" "unprognostic (3.44e-2)" "unprognostic (9.08e-2)" "unprognostic (8.77e-2)" "unprognostic (4.66e-2)" 21.6 22.0 23.5 18.9 26.2 30.1 23.5 10.8 30.5 14.3 16.3 17.2 30.8 16.3 11.5 12.9 16.0 12.9 12.1 11.4 27.0 31.8 27.9 32.4 16.9 24.3 30.6 20.3 12.1 11.8 25.0 12.5 16.5 33.4 14.7 17.4 14.1 15.9 22.9 30.6 11.5 21.8 9.6 20.5 21.3 16.8 10.4 14.1 23.0 17.1 11.7 24.1 16.1 12.8 5.7 4.3 4.5 9.2 5.9 8.5 4.0 21.1 9.9 5.2 12.7 14.9 11.8 11.7 28.0 15.3 23.0 16.6 6.4 13.3 17.3 24.5 20.9 11.2 12.3 9.9 15.5 37.1 23.7 7.2 17.1 12.3 5.8 11.5 24.9 20.0 12.1 16.4 22.6 21.7 16.1 13.2 12.0 14.9 24.1 39.4 8.9 13.2 6.6 6.9 15.9 13.4 8.5 23.3 14.4 15.3 21.9 9.5 8.8 24.7 23.0 18.0 7.5 19.9 28.0 20.5 26.3 14.9 18.1 39.0 25.0 34.7 20.5 21.9 12.2 23.8 4.5 3.3 3.7 8.2 8.6 8.5 5.4 6.2 6.8 3.6 5.7 6.3 7.1 2.0 5.9 9.2 4.3 4.9 4.0 23.5 26.2 10.8 30.5 27.0 31.8 30.6 20.3 33.4 14.1 17.9 32.1 50.1 25.7 26.2 21.7 29.4 56.0 41.5 50.0 50.6 11.8 22.6 48.0 23.2 35.7 30.8 40.7 0.0 20.2 32.6 19.3 44.8 45.0 71.0 27.6 22.3 32.1 35.0 64.6 34.6 19.8 51.7 27.0 44.1 35.0 13.6 28.8 34.8 18.4 49.4 21.6 0.0 27.3 23.4 22.0 21.5 18.8 52.2 31.1 52.1 UHRF1BP1 "C6orf107, dJ349A12.1, FLJ20302, ICBP90" ENSG00000065060 "UHRF1 binding protein 1" Q6BDS2 6 34792015-34883138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032099, HPA032100" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA032099: AB_10696057, HPA032100: AB_10671087" "unprognostic (2.30e-2)" "unprognostic (9.52e-2)" "unprognostic (4.58e-3)" "unprognostic (1.28e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.58e-2)" "unprognostic (4.39e-3)" "unprognostic (9.82e-2)" "unprognostic (4.68e-1)" "unprognostic (1.30e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (1.98e-1)" "unprognostic (1.90e-1)" "unprognostic (4.24e-2)" 7.6 9.3 7.6 7.6 8.2 18.7 6.7 18.5 10.9 4.8 5.9 7.1 4.7 5.1 5.5 4.4 6.0 5.3 4.5 13.7 6.1 5.8 6.1 10.9 8.0 6.9 5.5 6.8 6.6 13.1 15.1 9.5 8.1 7.7 6.0 6.3 6.8 8.6 5.1 22.2 4.9 5.5 6.4 7.6 6.8 7.2 22.5 5.5 8.5 9.4 3.2 6.8 5.9 10.8 1.5 1.2 1.1 4.5 1.4 1.3 0.8 8.5 6.1 5.5 17.7 2.9 2.1 9.9 5.0 3.4 4.9 7.0 12.1 2.3 12.9 5.5 5.2 8.6 6.5 19.9 2.8 6.7 6.6 6.4 11.4 5.9 10.1 11.8 10.3 7.2 4.8 8.3 3.9 8.4 4.6 6.1 11.3 19.0 5.1 2.1 8.1 7.9 6.7 2.5 6.2 4.3 4.8 8.8 7.7 6.6 7.9 6.6 6.7 12.6 6.6 16.9 5.9 12.7 13.5 3.7 2.4 9.0 3.8 5.5 7.7 11.9 8.2 1.3 14.4 6.0 0.5 1.2 1.1 1.3 1.7 1.3 1.3 1.2 1.3 1.2 1.5 0.6 1.0 0.7 1.4 4.5 0.5 0.4 0.8 7.6 8.2 18.5 10.9 6.1 5.8 5.5 6.8 7.7 5.5 14.9 4.6 1.5 2.5 0.9 9.5 14.6 5.1 4.0 10.3 0.0 19.6 5.6 1.7 5.1 8.0 4.5 3.5 0.0 5.0 3.0 3.5 8.1 1.1 5.1 12.9 4.8 9.1 17.8 11.7 11.0 5.2 8.2 0.0 10.8 3.4 5.6 7.9 2.9 2.5 3.8 11.3 12.9 3.4 13.7 11.9 2.5 4.1 2.6 3.7 5.4 UHRF1BP1L KIAA0701 ENSG00000111647 "UHRF1 binding protein 1 like" A0JNW5 12 100028455-100142848 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039671, HPA075150" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA039671: AB_10794201, HPA075150: " "unprognostic (4.80e-2)" "unprognostic (3.17e-1)" "unprognostic (2.34e-2)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (7.36e-2)" "unprognostic (8.10e-2)" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (5.43e-2)" "unprognostic (1.88e-2)" "unprognostic (2.53e-1)" "unprognostic (2.94e-3)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.28e-2)" 14.9 13.9 15.9 11.4 19.9 31.9 10.8 16.9 26.0 9.5 10.0 8.7 5.3 9.9 9.3 8.8 10.2 8.0 10.6 10.4 18.0 13.7 14.7 28.0 10.6 9.7 14.8 12.0 11.1 4.7 21.5 15.3 13.7 22.6 11.1 9.6 6.9 8.7 11.2 26.2 8.4 11.1 11.2 13.7 11.8 9.0 15.2 9.8 10.0 13.0 8.1 8.1 16.7 8.4 3.8 8.4 22.9 8.4 3.7 3.7 3.4 11.3 12.4 6.9 7.1 10.7 15.3 13.8 17.8 17.9 14.4 10.6 9.2 3.9 9.9 4.7 18.1 8.4 4.4 12.9 6.0 14.0 26.2 6.4 6.6 9.9 10.6 9.9 12.4 10.8 8.6 5.1 17.3 12.0 13.4 10.0 6.9 5.2 10.3 14.0 6.3 7.9 10.7 11.9 3.9 11.3 9.0 12.3 9.7 7.4 20.1 11.8 7.4 13.5 15.6 5.3 6.2 13.9 14.2 7.9 16.0 8.5 13.7 12.4 12.2 20.8 13.9 8.0 9.4 9.6 12.5 7.6 4.9 2.6 8.4 3.7 3.8 2.9 2.9 8.4 3.4 2.5 3.0 22.9 3.7 6.8 5.1 3.2 3.4 15.9 19.9 16.9 26.0 18.0 13.7 14.8 12.0 22.6 9.8 26.8 8.3 9.8 13.2 11.3 10.8 11.5 2.5 30.8 19.4 8.7 3.9 3.9 5.0 4.8 17.2 6.8 8.0 0.0 5.0 7.4 14.6 16.5 23.1 17.4 9.8 14.3 5.2 6.2 17.7 2.1 6.6 20.6 10.1 8.2 2.8 5.8 4.2 7.0 7.4 12.2 11.3 0.0 9.7 19.8 21.5 10.2 9.2 12.5 4.7 10.2 ULK4 "FAM7C1, FLJ20574, REC01035" ENSG00000168038 "Unc-51 like kinase 4" Q96C45 3 41246599-41962430 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 279.5;Late spermatids: 329.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017930 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA017930: AB_1858615" "unprognostic (3.16e-2)" "unprognostic (2.98e-3)" "unprognostic (9.72e-3)" "unprognostic (3.46e-2)" "unprognostic (2.58e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-1)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.75e-3)" "unprognostic (3.43e-1)" "unprognostic (1.91e-2)" "unprognostic (5.46e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (6.12e-2)" 4.3 4.8 5.1 4.7 8.3 10.3 4.2 4.3 5.4 11.9 2.8 5.9 6.0 2.1 10.7 10.9 2.8 12.3 3.1 13.1 5.2 3.0 5.4 3.4 5.5 4.2 3.1 4.2 4.5 3.6 13.5 19.7 9.0 5.8 4.4 2.8 6.7 4.2 4.5 1.4 3.5 3.3 5.1 5.7 4.4 3.4 27.5 3.4 6.3 7.1 1.7 8.4 4.0 6.0 6.4 5.1 10.7 6.3 2.6 10.3 5.2 7.3 1.7 2.7 3.0 1.1 1.7 4.6 2.5 2.6 3.1 2.6 0.9 2.2 8.6 1.4 5.8 3.0 3.7 3.2 1.9 2.8 1.1 0.9 1.6 5.4 2.9 3.9 5.6 1.7 1.6 2.2 15.0 3.1 3.9 2.1 5.9 1.9 7.2 2.2 5.9 7.0 4.5 3.3 1.8 3.1 1.6 8.5 3.7 6.5 7.1 1.4 9.9 2.6 1.2 2.1 1.8 3.0 1.8 6.2 2.0 2.2 13.2 2.1 4.3 8.0 3.6 11.0 5.9 2.4 5.7 5.8 5.8 8.0 6.3 6.5 5.6 8.6 7.2 5.1 6.4 6.5 9.2 10.7 2.6 3.2 4.6 10.3 5.2 5.1 8.3 4.3 5.4 5.2 3.0 3.1 4.2 5.8 3.4 8.9 5.8 1.9 2.8 1.8 5.4 12.8 5.1 53.5 4.5 3.5 51.1 2.8 0.0 2.3 279.5 4.4 1.1 0.0 2.1 3.9 3.3 1.2 1.1 5.9 6.5 11.1 1.7 1.8 4.1 329.6 6.1 5.6 0.0 6.4 1.1 11.2 2.8 0.0 3.9 5.0 25.1 6.5 3.3 29.9 8.7 3.1 3.5 4.4 1.7 0.8 UPF3A "HUPF3A, RENT3A, UPF3" ENSG00000169062 "UPF3A, regulator of nonsense mediated mRNA decay" Q9H1J1 13 114281584-114305817 "Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 503.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018325, HPA061316" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA018325: AB_1858638, HPA061316: AB_2684477" "unprognostic (9.08e-3)" "unprognostic (1.99e-1)" "unprognostic (1.93e-1)" "unprognostic (3.43e-2)" "unprognostic (2.51e-2)" "unprognostic (1.16e-2)" "unprognostic (6.48e-2)" "unprognostic (1.98e-1)" "unprognostic (9.80e-3)" "unprognostic (1.44e-1)" "prognostic favorable (7.09e-5)" "unprognostic (1.39e-3)" "unprognostic (1.52e-2)" "unprognostic (2.34e-2)" "unprognostic (9.21e-3)" "unprognostic (1.76e-1)" "prognostic favorable (3.71e-4)" 11.3 16.3 16.9 10.9 20.2 11.9 10.9 32.8 21.9 10.4 9.9 18.6 13.0 13.8 13.1 12.3 10.1 13.2 9.2 7.1 16.1 14.9 11.0 7.5 9.2 12.0 20.2 16.0 12.7 15.4 8.1 12.8 8.5 17.2 12.1 8.7 10.0 11.9 16.1 16.1 11.9 11.9 10.2 23.6 11.8 11.2 34.5 16.7 10.7 24.0 7.4 7.9 11.2 9.3 11.7 15.6 4.1 5.5 11.1 9.5 4.3 23.3 6.9 15.3 13.7 7.3 12.8 9.8 18.1 13.1 11.6 13.0 10.4 8.3 23.0 5.3 8.3 7.8 12.6 7.5 6.0 14.7 16.8 14.8 19.8 19.6 11.4 12.8 34.3 8.9 8.6 12.5 7.8 9.2 12.3 9.2 6.0 12.0 10.7 11.6 7.1 13.9 9.2 20.4 15.6 6.9 18.3 8.6 13.4 10.4 7.5 17.4 19.2 14.4 22.3 12.9 10.8 16.5 30.9 11.8 12.4 20.7 6.7 11.3 23.4 16.2 31.9 22.8 19.8 10.1 1.9 5.5 4.1 6.8 4.4 5.3 11.7 7.1 7.0 6.0 9.1 7.4 6.7 0.8 11.1 5.1 15.6 9.5 4.3 16.9 20.2 32.8 21.9 16.1 14.9 20.2 16.0 17.2 16.7 62.5 46.2 54.7 55.8 61.0 74.4 18.2 43.3 133.8 69.4 55.8 78.5 57.6 87.9 47.2 134.0 84.2 27.6 0.0 61.9 38.0 72.4 48.5 52.2 59.5 40.0 74.7 55.2 57.7 33.2 66.4 93.2 41.0 52.3 48.7 45.2 66.8 45.9 35.1 82.4 45.3 72.8 84.1 54.5 503.7 176.2 62.9 33.9 57.5 58.3 32.4 UPF3B "HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X" ENSG00000125351 "UPF3B, regulator of nonsense mediated mRNA decay" Q9BZI7 X 119805311-119852998 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001592, HPA001800, HPA001882" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No Cytosol "Nucleoplasm, Nucleoli" "HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474" "unprognostic (1.79e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.64e-3)" "unprognostic (8.58e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.52e-6)" "unprognostic (6.61e-2)" "prognostic unfavorable (5.39e-4)" "unprognostic (5.74e-2)" "unprognostic (4.51e-2)" "unprognostic (8.63e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (8.67e-2)" "unprognostic (1.04e-1)" "unprognostic (2.34e-1)" "unprognostic (8.95e-2)" 9.7 10.3 19.4 11.5 21.9 14.5 10.8 34.1 24.0 10.2 13.0 9.3 12.8 14.2 14.6 13.5 13.0 8.8 8.4 7.8 16.9 17.5 10.0 12.4 9.0 17.2 16.5 21.7 14.8 8.7 14.3 26.7 10.5 17.2 12.4 13.2 9.1 9.7 14.4 14.5 18.6 11.1 14.2 21.7 12.9 9.9 15.0 21.0 9.9 12.5 11.5 18.3 12.6 12.9 17.5 10.0 7.1 5.9 7.9 8.1 2.7 11.9 7.2 15.1 12.2 6.9 4.5 9.7 11.5 6.5 9.0 8.0 13.5 8.6 21.5 9.8 4.8 12.9 11.4 19.5 6.9 11.5 12.2 14.3 19.9 24.0 7.1 7.9 21.5 9.9 3.9 5.3 15.4 18.8 8.2 8.3 12.9 19.2 18.0 7.5 14.5 15.1 27.0 29.1 15.3 19.8 14.8 17.3 15.8 7.3 6.0 20.1 13.9 23.5 9.5 17.2 16.4 5.0 12.6 7.2 9.4 7.2 15.0 24.3 9.9 11.0 29.1 7.5 31.7 10.9 7.1 5.3 6.8 7.5 5.1 5.7 13.8 7.0 5.9 3.8 17.5 7.6 8.1 5.9 7.9 5.9 10.0 7.8 2.7 19.4 21.9 34.1 24.0 16.9 17.5 16.5 21.7 17.2 21.0 29.8 25.5 28.9 28.2 33.5 47.9 17.1 15.3 42.8 47.8 24.4 53.0 33.2 5.0 27.3 107.2 24.5 27.1 0.0 22.8 39.7 29.2 18.5 57.7 19.2 25.4 27.0 26.6 20.3 15.4 17.6 28.1 32.2 23.6 49.5 21.8 39.5 18.6 31.7 30.8 12.4 94.7 12.9 36.2 32.2 32.4 33.2 53.8 34.8 32.2 21.3 UPP2 "UDRPASE2, UP2, UPASE2" ENSG00000007001 "Uridine phosphorylase 2" O95045 2 157876702-158136154 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 40.1;liver: 22.1" "Group enriched" "Detected in some" 4 "Distal tubular cells: 11.6;Proximal tubular cells: 23.3" "Cancer enriched" "Detected in some" 6 "liver cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;GAMG: 2.0;hTERT-RPE1: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035225, HPA035226" Approved Nucleoplasm,Vesicles,Mitochondria NA NA Nucleoplasm "Vesicles, Mitochondria" "HPA035225: AB_10604002, HPA035226: AB_10696503" "unprognostic (1.87e-1)" "unprognostic (2.33e-1)" "unprognostic (4.22e-3)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (5.51e-2)" "unprognostic (5.11e-2)" "unprognostic (1.23e-2)" "unprognostic (4.65e-3)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (4.89e-2)" "unprognostic (2.78e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-2)" 1.2 0.4 1.8 0.3 4.1 0.3 1.6 6.9 2.0 0.4 0.3 1.5 0.7 0.3 1.2 2.4 1.0 0.4 2.5 0.8 2.9 1.2 40.1 22.1 0.3 0.4 1.2 0.9 0.6 0.4 0.3 3.9 0.4 1.3 2.3 0.3 1.1 1.7 0.7 0.3 0.6 0.4 0.3 2.3 0.3 0.3 0.4 1.0 0.0 0.5 0.0 0.7 0.4 0.2 0.8 0.0 1.0 0.1 0.0 0.2 0.0 0.3 0.2 0.6 0.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 1.8 0.2 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.9 0.0 0.7 0.8 0.9 0.0 0.0 0.0 0.1 1.1 0.6 1.2 1.4 0.3 0.0 0.3 0.6 0.6 0.4 0.4 0.5 0.0 0.4 0.8 0.1 0.0 0.2 0.2 0.0 0.0 1.2 0.1 0.4 0.3 1.2 0.4 1.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 1.8 4.1 6.9 2.0 2.9 1.2 1.2 0.9 1.3 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.6 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 UQCC1 "BFZB, C20orf44, CBP3, FLJ10850, UQCC" ENSG00000101019 "Ubiquinol-cytochrome c reductase complex assembly factor 1" Q9NVA1 20 35302566-35412141 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.2" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034875 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA034875: AB_10603226" "unprognostic (9.66e-2)" "unprognostic (3.93e-1)" "unprognostic (3.45e-1)" "unprognostic (8.72e-3)" "unprognostic (4.01e-1)" "unprognostic (1.31e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (2.82e-2)" "unprognostic (7.66e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "unprognostic (6.72e-3)" "unprognostic (3.23e-1)" "unprognostic (3.60e-1)" "unprognostic (5.27e-2)" "unprognostic (1.34e-2)" 12.6 19.2 13.7 10.6 24.5 2.5 10.1 19.6 23.9 10.9 13.3 15.7 12.1 13.0 14.2 14.2 10.5 11.7 8.4 34.3 13.5 15.9 20.0 17.2 8.7 10.9 16.6 18.2 11.9 10.8 19.8 17.0 10.1 20.1 11.9 17.5 15.8 12.1 12.9 70.2 9.2 11.3 15.5 15.5 11.2 12.2 13.2 13.4 8.9 14.2 17.1 13.8 11.0 9.9 13.5 13.5 16.3 11.9 19.7 15.2 9.6 6.9 10.1 11.4 10.5 11.6 12.7 1.6 13.2 14.4 23.7 16.5 32.7 13.8 22.3 25.1 8.3 20.1 18.5 20.1 22.9 18.1 6.6 7.9 29.9 13.5 26.2 7.4 17.9 8.9 12.5 23.5 12.7 15.9 17.6 8.0 18.1 12.8 7.4 16.5 9.1 20.4 6.4 9.6 13.8 20.8 11.2 17.9 12.2 21.9 7.9 16.1 10.8 11.3 54.1 11.7 10.1 8.0 11.4 7.5 16.2 10.3 8.5 12.0 11.4 12.3 9.2 29.0 10.4 13.0 16.3 7.7 11.0 12.7 11.9 15.2 10.3 12.1 12.5 13.5 13.5 14.6 13.2 0.3 19.7 7.7 11.5 11.2 9.6 13.7 24.5 19.6 23.9 13.5 15.9 16.6 18.2 20.1 13.4 0.0 5.6 3.7 8.0 5.7 19.3 39.9 7.6 13.4 5.7 15.7 7.9 18.9 51.4 16.0 8.7 7.0 10.5 0.0 11.2 11.9 8.0 6.7 8.1 12.5 10.1 17.5 11.5 4.3 5.9 7.9 9.8 7.0 13.5 17.2 8.9 14.0 16.8 3.5 11.3 14.0 21.4 6.5 8.2 18.4 16.4 4.5 14.5 7.0 12.8 8.8 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673687 "Disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA046851: AB_2679839" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 10.0 13.4 8.9 11.4 8.5 10.6 14.7 8.7 9.9 7.3 15.4 4.7 19.7 16.5 7.3 8.5 14.5 6.5 12.4 13.2 8.0 8.7 10.7 13.4 5.6 8.3 8.5 8.7 9.5 15.4 5.3 7.6 6.2 7.7 12.3 4.9 7.1 22.9 14.1 27.8 8.6 14.8 6.0 6.2 9.6 12.2 5.7 5.4 6.4 13.5 12.3 9.1 8.0 18.1 23.7 21.2 15.2 20.8 14.0 19.4 15.5 12.0 24.5 3.6 5.6 2.2 2.2 3.0 4.8 1.6 3.6 3.6 14.3 10.5 7.8 10.0 1.6 4.9 12.0 3.4 5.6 1.1 3.9 12.7 4.4 12.8 9.1 3.0 7.1 3.6 2.1 4.8 3.2 3.6 2.3 2.8 3.8 9.4 5.7 2.0 36.8 6.9 17.5 4.0 4.8 13.9 8.1 5.5 13.9 2.7 6.0 7.3 7.4 5.3 19.4 7.1 1.1 18.4 6.7 3.6 7.9 9.3 8.2 10.6 8.8 4.8 8.1 6.5 6.2 5.7 9.1 20.8 15.2 18.1 14.4 17.1 23.5 18.0 15.9 15.8 23.7 16.6 13.3 8.9 14.0 12.7 21.2 19.4 15.5 8.9 8.5 8.7 9.9 8.0 8.7 8.5 8.7 7.7 5.4 41.7 23.5 61.4 42.6 0.0 20.8 31.7 66.2 22.7 29.6 61.1 15.7 44.7 119.3 51.7 1.4 26.8 115.3 46.7 67.1 41.2 21.0 70.4 4.7 99.1 47.7 17.5 33.9 39.9 38.4 2.3 44.8 22.9 0.0 43.3 98.1 39.6 57.0 91.2 33.9 137.3 26.2 38.8 31.1 2.7 33.7 0.0 24.3 25.9 101.8 45.4 USF3 KIAA2018 ENSG00000176542 "Upstream transcription factor family member 3" Q68DE3 3 113648385-113696646 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029243, HPA029245" Uncertain Uncertain Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Nucleoli" Centrosome "HPA029243: AB_10611114, HPA029245: AB_10600443" "unprognostic (2.80e-2)" "unprognostic (2.80e-1)" "unprognostic (4.21e-2)" "unprognostic (7.80e-2)" "unprognostic (2.25e-2)" "unprognostic (1.96e-2)" "unprognostic (3.53e-1)" "unprognostic (2.62e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (8.74e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (3.28e-1)" "unprognostic (5.55e-2)" 9.0 5.1 8.8 11.0 7.3 13.8 11.4 13.9 7.5 7.2 12.2 5.3 5.4 4.8 5.8 13.3 7.0 6.3 5.3 8.1 7.6 5.5 12.7 24.0 6.1 9.2 6.3 5.6 6.9 10.8 14.4 8.9 4.9 6.5 6.2 6.7 6.4 8.3 5.4 28.7 11.4 14.7 8.3 11.2 12.0 7.3 4.8 6.9 13.3 7.1 11.5 8.9 6.1 6.0 5.9 5.1 6.9 3.7 2.6 3.1 1.4 5.2 4.0 5.0 4.7 12.1 4.7 3.4 2.1 3.4 2.1 2.0 3.7 2.2 9.3 3.9 5.4 3.4 3.3 5.3 4.2 4.0 2.8 2.2 6.6 2.5 6.1 3.6 12.1 7.4 6.7 7.7 3.9 4.4 3.2 5.0 7.1 3.1 5.0 4.4 7.4 6.7 6.7 3.6 7.1 4.1 2.9 3.9 3.7 7.5 7.4 2.4 3.6 5.1 2.9 6.1 3.6 3.9 9.0 6.8 3.3 7.2 1.8 3.0 5.8 3.2 11.1 3.8 5.1 2.4 4.1 2.4 3.5 3.1 2.8 2.3 2.2 2.2 2.3 1.7 5.9 2.7 2.8 6.9 2.6 3.7 5.1 1.1 1.4 8.8 7.3 13.9 7.5 7.6 5.5 6.3 5.6 6.5 6.9 20.8 10.8 4.8 9.6 0.0 20.4 0.0 10.2 22.7 11.4 24.4 13.7 6.7 21.6 7.4 4.6 10.8 9.7 0.0 10.3 3.1 5.4 14.9 4.7 36.5 6.7 12.7 5.8 20.3 16.4 9.1 12.0 10.4 0.0 3.6 13.2 11.3 10.2 16.5 13.1 18.7 17.2 6.5 0.0 9.5 3.9 0.0 12.1 13.4 13.3 17.8 USP20 KIAA1003 ENSG00000136878 "Ubiquitin specific peptidase 20" Q9Y2K6 9 129834698-129881838 "Enzymes, Predicted intracellular proteins" "Endocytosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 42.3;K-562: 25.9;MOLT-4: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006287, HPA007008" Uncertain Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA006287: AB_1080510, HPA007008: " "unprognostic (2.64e-2)" "prognostic favorable (8.01e-4)" "prognostic unfavorable (2.48e-4)" "prognostic favorable (4.01e-4)" "unprognostic (4.69e-1)" "unprognostic (1.89e-2)" "unprognostic (2.25e-1)" "unprognostic (2.55e-3)" "unprognostic (1.24e-1)" "unprognostic (7.89e-2)" "prognostic favorable (1.54e-7)" "unprognostic (2.09e-1)" "prognostic favorable (5.65e-5)" "unprognostic (1.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.19e-2)" "unprognostic (1.24e-2)" 7.8 13.2 10.5 15.2 14.6 24.4 8.5 23.0 19.6 13.2 12.1 12.7 10.2 9.7 13.3 6.2 9.3 11.6 12.5 8.8 10.5 13.7 8.0 7.3 9.1 19.6 9.6 16.1 16.8 12.9 11.5 19.0 8.0 11.9 14.9 6.1 10.8 13.7 17.2 10.2 14.0 11.8 20.0 8.8 14.6 10.2 14.0 8.8 51.5 19.3 4.2 15.3 15.6 10.0 3.8 2.4 4.8 1.7 9.0 10.7 5.4 2.5 2.5 4.4 6.0 5.8 5.0 6.3 4.1 3.5 3.2 2.2 2.1 2.8 3.5 3.6 4.0 3.6 6.5 2.6 3.0 1.3 19.0 3.5 6.5 6.8 1.4 4.1 6.1 4.8 4.4 4.4 4.2 3.1 5.6 3.4 42.3 25.9 4.4 1.9 6.8 23.8 14.5 3.5 5.4 6.0 4.0 5.0 5.9 2.5 2.8 1.0 4.9 4.8 6.2 3.9 2.7 6.4 8.5 5.0 3.5 1.6 4.7 2.7 4.3 6.3 2.4 7.0 8.0 3.3 1.0 1.7 4.8 8.6 1.4 9.3 3.7 8.8 8.3 2.4 3.8 10.4 8.9 2.8 9.0 1.3 2.1 10.7 5.4 10.5 14.6 23.0 19.6 10.5 13.7 9.6 16.1 11.9 8.8 8.9 8.6 3.2 2.3 2.5 7.9 5.9 2.5 4.0 2.3 1.8 3.9 5.1 3.3 2.2 1.1 2.4 4.0 0.0 3.4 2.1 3.8 3.0 1.1 5.6 3.0 9.5 8.1 7.4 2.1 2.8 5.8 3.1 3.3 3.6 4.6 5.8 2.3 3.7 4.6 2.2 5.9 0.0 6.2 12.2 4.4 1.8 5.1 11.3 5.1 1.4 USP21 "USP16, USP23" ENSG00000143258 "Ubiquitin specific peptidase 21" Q9UK80 1 161159450-161165723 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028397 Uncertain Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028397: AB_10603227" "unprognostic (9.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.95e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (1.22e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (5.35e-2)" "unprognostic (6.73e-2)" "unprognostic (2.76e-2)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (9.50e-6)" "unprognostic (2.45e-1)" "unprognostic (3.28e-1)" "unprognostic (2.13e-2)" "prognostic favorable (3.35e-5)" 11.8 16.4 22.1 12.8 21.2 15.3 19.1 23.6 24.8 18.1 16.1 25.5 14.0 15.5 19.7 14.6 18.3 33.3 14.1 13.7 20.9 12.1 15.4 10.6 14.0 16.7 26.4 14.1 28.3 19.0 24.4 17.2 15.2 20.5 18.1 13.1 17.1 19.0 25.3 19.4 23.5 15.4 15.1 17.0 18.7 16.0 17.0 22.9 16.0 24.5 9.6 15.6 17.9 19.2 14.1 12.0 18.3 11.1 13.4 17.2 10.7 7.4 12.9 16.9 16.3 13.5 11.3 10.4 5.5 9.0 15.2 11.9 11.8 14.7 9.8 9.5 6.8 9.5 12.9 10.9 10.7 8.4 18.6 18.4 11.6 18.6 9.2 9.8 10.3 8.7 9.5 14.4 10.4 15.1 17.2 10.7 21.7 17.2 13.6 9.7 13.7 18.2 16.2 15.8 14.6 16.4 17.3 5.6 16.4 8.9 8.9 15.4 19.9 10.3 10.9 8.3 13.2 23.9 16.7 6.3 10.9 9.8 7.6 9.4 27.6 21.3 14.5 10.0 8.9 9.8 13.0 11.1 18.3 14.9 7.1 17.2 12.8 13.8 15.4 12.0 14.1 16.0 14.6 9.6 13.4 7.7 12.0 13.3 10.7 22.1 21.2 23.6 24.8 20.9 12.1 26.4 14.1 20.5 22.9 0.0 3.0 1.7 1.5 1.3 3.9 2.2 10.2 10.7 3.4 1.8 5.9 3.6 1.7 1.4 0.6 2.8 2.0 0.0 2.0 2.1 2.4 2.0 2.3 1.7 1.9 0.0 5.2 6.2 7.6 0.4 4.6 1.7 1.7 0.0 4.1 3.0 1.7 2.9 3.9 1.8 4.4 6.5 1.9 3.6 2.7 1.3 2.6 2.5 3.7 1.4 USP38 "HP43.8KD, KIAA1891" ENSG00000170185 "Ubiquitin specific peptidase 38" Q8NB14 4 143184917-143223830 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036990, HPA047948" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA036990: AB_2675419, HPA047948: AB_2680220" "unprognostic (5.01e-2)" "unprognostic (2.45e-1)" "unprognostic (2.04e-3)" "unprognostic (2.99e-2)" "unprognostic (1.87e-1)" "unprognostic (2.61e-2)" "unprognostic (1.67e-1)" "unprognostic (7.49e-2)" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (8.03e-2)" "unprognostic (7.72e-3)" "prognostic favorable (1.20e-4)" "unprognostic (3.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" 7.7 7.8 6.6 6.6 6.5 19.1 8.3 7.4 7.8 7.9 12.1 8.6 8.8 8.8 8.3 7.1 8.6 7.1 7.6 12.5 6.6 5.3 9.3 15.2 12.7 11.1 10.3 5.1 6.3 8.8 10.0 6.2 11.4 5.9 6.6 6.6 7.1 7.2 7.0 45.3 8.9 13.2 6.5 10.8 10.6 7.4 7.5 8.2 22.6 8.6 10.2 8.4 7.8 8.8 6.3 8.1 12.5 5.7 12.3 9.9 5.0 4.8 4.5 4.0 6.9 5.3 5.3 3.0 7.7 7.5 7.2 6.1 13.1 7.2 6.0 5.5 6.5 4.6 3.8 9.5 7.7 5.9 14.6 6.1 5.5 5.4 2.8 7.3 11.1 5.5 6.4 7.1 7.3 5.9 5.1 7.1 6.9 11.9 18.9 4.7 7.7 14.5 2.1 3.6 9.8 8.9 9.5 6.0 5.7 4.6 5.6 8.2 7.4 6.0 10.5 6.7 3.1 6.4 4.2 8.4 6.6 5.4 5.7 8.0 21.1 35.7 10.9 6.7 8.5 5.5 12.5 5.4 11.7 7.5 5.7 9.6 6.3 6.6 6.5 8.1 5.7 6.7 5.7 5.4 12.3 5.7 3.5 9.9 5.0 6.6 6.5 7.4 7.7 6.6 5.3 10.3 5.1 5.9 8.2 20.8 13.7 10.5 16.5 47.6 7.5 15.1 7.6 13.4 14.8 0.0 11.8 10.9 1.7 7.5 27.8 12.0 18.4 0.0 6.6 5.8 9.7 16.1 3.5 32.7 9.2 7.9 29.4 17.8 14.5 15.4 6.4 12.2 11.8 1.8 19.9 13.6 8.5 11.5 8.9 14.2 8.2 12.9 15.1 9.5 5.1 51.7 22.3 13.4 14.5 38.1 USP48 "FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31" ENSG00000090686 "Ubiquitin specific peptidase 48" Q86UV5 1 21678298-21783606 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030045, HPA030046" Approved Supported Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA030045: AB_10670833, HPA030046: AB_10603325" "unprognostic (1.35e-1)" "unprognostic (3.72e-1)" "unprognostic (5.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (6.09e-8)" "unprognostic (1.04e-2)" "unprognostic (3.01e-3)" "unprognostic (9.30e-2)" "unprognostic (7.54e-2)" "unprognostic (4.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-1)" "unprognostic (5.70e-2)" "unprognostic (2.80e-2)" 20.1 38.8 18.6 28.9 30.9 30.9 22.1 48.2 27.5 19.9 18.4 25.6 15.4 17.6 21.3 17.6 19.0 17.4 20.5 17.8 16.9 15.8 15.5 18.3 18.3 26.2 26.6 22.5 27.0 19.8 24.6 35.4 23.1 26.8 21.6 22.0 22.1 24.5 16.3 17.0 23.9 22.2 22.2 19.7 29.1 26.2 15.8 23.6 25.8 23.9 14.0 29.0 19.8 21.0 13.7 10.5 33.7 9.6 5.6 11.2 5.6 14.9 7.1 16.8 12.1 14.6 18.0 16.6 18.8 12.8 12.7 16.8 6.5 15.3 16.8 12.7 17.0 9.9 13.8 20.6 15.2 19.3 16.3 14.1 35.9 26.5 11.8 13.0 18.0 19.2 14.6 13.1 12.8 14.3 17.4 37.2 12.8 28.2 47.5 15.5 7.4 14.9 23.4 10.5 15.3 12.8 21.0 16.9 19.6 14.5 12.6 20.5 12.8 17.7 16.3 42.5 23.5 8.3 21.8 26.4 13.7 11.2 16.7 10.9 38.2 27.1 16.7 13.2 22.3 20.0 33.7 9.6 16.7 6.4 4.6 7.6 13.7 9.5 9.5 10.5 12.8 11.2 7.0 8.9 5.6 5.0 7.7 10.1 5.6 18.6 30.9 48.2 27.5 16.9 15.8 26.6 22.5 26.8 23.6 50.6 38.5 34.3 22.6 19.7 74.8 58.2 22.9 32.1 20.5 19.2 58.9 51.8 21.6 25.0 51.8 24.5 18.7 70.0 17.5 50.1 30.9 20.6 47.5 21.2 26.0 47.7 20.8 28.3 22.2 33.0 32.2 24.7 55.6 47.7 26.9 29.1 20.0 17.5 48.4 16.5 69.2 32.3 25.0 42.9 48.2 22.5 27.2 35.5 30.2 17.1 UTY "KDM6AL, KDM6C" ENSG00000183878 "Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked" O14607 Y 13248379-13480673 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.9;U-266/84: 11.4;U-698: 14.9" "HPA000568, HPA001165" Supported Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA Nucleoplasm "Nucleoli, Nucleoli rim" "HPA000568: AB_1858705, HPA001165: AB_1080541" "unprognostic (7.52e-2)" "unprognostic (6.60e-2)" "unprognostic (4.04e-6)" "unprognostic (6.47e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (1.41e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.46e-2)" 5.3 5.1 3.0 15.4 10.3 9.0 5.1 6.1 11.0 0.4 8.4 18.0 18.4 4.3 0.4 16.5 7.2 0.4 6.5 4.7 3.5 3.4 5.0 6.9 11.9 19.0 3.3 0.0 0.5 15.1 0.4 6.3 5.9 13.0 14.0 10.6 16.8 10.9 16.1 9.3 7.4 10.1 18.6 4.8 17.4 5.7 6.7 0.0 37.7 6.3 10.3 22.0 7.2 0.0 6.1 4.8 6.6 3.8 9.9 6.7 1.3 0.0 1.8 0.0 0.0 0.0 0.0 6.6 3.3 5.7 3.7 5.7 0.0 0.0 9.0 0.0 3.8 0.0 0.0 0.0 0.0 5.3 4.9 0.0 14.9 0.1 0.0 4.9 0.0 0.0 6.0 5.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 4.1 0.0 5.1 0.1 0.0 0.0 0.0 0.0 2.4 4.0 4.1 6.1 3.7 0.0 0.0 0.0 10.7 6.8 0.0 3.2 4.3 6.6 0.0 0.0 2.3 10.2 11.4 14.9 0.6 0.0 0.0 1.8 2.8 5.8 4.7 3.4 6.7 5.0 4.6 3.6 3.0 6.1 6.5 4.7 6.6 9.9 3.8 4.8 5.3 1.3 3.0 10.3 6.1 11.0 3.5 3.4 3.3 0.0 13.0 0.0 14.9 22.3 25.2 17.2 10.1 30.4 5.2 2.5 10.7 13.6 17.4 60.9 8.5 0.0 2.9 0.3 7.7 1.0 0.0 0.0 2.7 7.6 12.2 15.1 0.0 2.4 35.0 1.7 8.6 13.3 0.9 10.0 15.3 8.5 10.8 0.0 18.3 2.5 0.0 11.0 1.3 38.6 0.0 6.2 1.8 5.9 13.4 11.1 21.3 0.0 16.0 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 172.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 82.0;NB-4: 128.2;THP-1: 63.7;U-937: 85.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 210000 "Golgi apparatus, Plasma membrane" Nucleoplasm "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favorable (8.07e-9)" "prognostic favorable (1.59e-6)" 16.5 8.2 7.1 20.7 11.2 27.6 24.2 1.9 6.2 16.3 49.4 5.7 43.5 24.1 6.0 25.5 65.4 17.1 28.8 13.0 4.7 3.8 67.7 46.5 53.1 48.0 10.5 3.2 7.1 58.0 15.4 8.3 108.1 11.9 22.1 31.9 7.7 90.7 40.4 9.0 43.3 87.1 6.8 10.4 53.5 28.7 5.5 8.4 24.5 47.5 35.4 34.9 20.6 30.4 39.2 172.5 37.7 69.7 41.4 51.3 100.9 23.9 3.1 0.2 0.2 0.2 0.1 23.9 0.0 0.0 0.0 0.0 17.8 22.0 5.3 17.4 0.1 1.8 17.0 0.2 42.9 0.0 21.8 16.6 27.6 10.6 20.2 0.3 82.0 28.6 0.2 30.5 0.0 7.1 0.1 5.5 0.1 19.7 1.1 9.8 33.6 0.0 128.2 0.3 30.0 2.5 0.5 0.9 36.0 49.7 36.0 0.8 0.3 11.7 62.1 1.9 13.0 22.8 63.7 11.0 0.0 1.5 0.3 0.2 0.3 13.5 31.4 0.3 85.1 0.1 37.7 69.7 25.2 40.4 57.7 38.8 39.2 46.8 39.5 63.5 37.8 37.3 39.1 4.5 41.4 34.3 172.5 51.3 100.9 7.1 11.2 1.9 6.2 4.7 3.8 10.5 3.2 11.9 8.4 345.4 256.8 171.2 244.0 230.2 1.1 5.5 331.2 341.3 271.8 347.2 0.0 869.6 648.2 536.4 20.3 29.2 900.3 0.0 637.4 386.9 34.1 294.8 263.2 244.8 1050.6 0.0 124.1 155.3 836.3 34.0 8.6 660.7 334.0 762.0 322.8 2.4 674.2 501.5 7.1 797.0 1.6 45.3 25.8 28.4 6.4 288.3 734.1 248.2 230.6 528.7 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383528 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "U-2197: 126.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" NA Yes 2400000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: AB_2732418" "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 22.4 10.2 4.9 7.7 6.7 3.8 28.6 1.6 6.5 19.9 5.1 5.6 6.4 5.1 14.3 13.6 16.2 9.9 10.2 12.9 4.4 1.8 21.6 14.1 17.2 5.2 2.7 2.9 21.0 9.8 1.7 5.9 30.2 4.8 12.9 2.0 33.6 7.9 13.1 7.0 16.0 4.0 9.4 3.6 7.9 6.5 14.7 3.5 0.0 15.2 5.5 8.2 16.6 19.0 0.3 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 2.8 3.2 1.2 5.3 5.2 1.6 2.7 0.3 0.6 0.0 1.9 3.5 0.2 0.0 0.0 0.1 0.2 1.2 0.1 0.1 1.5 1.6 10.2 0.0 0.0 3.3 0.0 4.0 0.1 2.7 0.0 0.0 0.2 0.0 0.2 1.8 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.9 2.5 4.2 0.0 0.2 0.9 0.2 0.0 4.9 1.3 126.7 0.6 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 6.7 1.6 6.5 4.4 1.8 2.7 2.9 4.8 3.5 6.0 12.5 0.9 6.0 8.5 0.0 12.9 35.7 1.4 3.4 22.7 0.0 3.0 6.6 10.3 1.0 3.3 0.2 0.0 2.6 6.4 108.9 7.4 3.5 12.9 2.8 0.0 0.0 4.9 0.3 1.8 46.3 1.2 13.5 0.0 0.4 16.3 17.4 0.0 57.3 12.5 0.7 97.0 96.8 0.5 5.1 6.6 8.4 1.8 0.2 3.3 VDR "NR1I1, PPP1R163" ENSG00000111424 "Vitamin D receptor" P11473 12 47841537-47943048 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 57.1;parathyroid gland: 45.8" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 101.9;Paneth cells: 43.0;Undifferentiated cells: 54.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9" "Group enriched" "Detected in many" 8 "dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 23.0;HDLM-2: 32.4;U-937: 31.8" "Region enhanced" "Detected in single" "olfactory region: 2.5" "Not detected" "Not detected" "CAB004617, HPA047740, HPA072102" Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Intermediate filaments, Cytosol" "CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: " "unprognostic (1.11e-2)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (7.59e-3)" "unprognostic (3.33e-3)" "unprognostic (2.74e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (6.72e-2)" "prognostic favorable (4.89e-6)" "unprognostic (1.46e-1)" "unprognostic (8.76e-2)" "unprognostic (3.28e-1)" "unprognostic (3.82e-2)" 3.0 9.2 0.2 10.0 0.3 2.5 7.8 0.3 0.6 3.5 40.9 0.4 4.1 21.2 1.2 7.7 10.2 1.1 10.7 1.5 0.5 0.3 13.0 0.6 8.3 3.8 0.5 0.1 1.3 6.5 45.8 11.7 4.4 0.6 2.1 12.6 0.4 4.9 2.8 5.3 15.2 57.1 1.2 1.5 3.1 2.6 1.5 0.2 2.0 1.9 9.4 8.2 4.0 5.2 0.7 5.7 7.5 7.0 0.2 0.8 1.2 5.5 0.9 0.0 0.0 4.8 7.0 0.1 6.8 3.5 5.8 5.0 4.0 4.7 1.4 7.4 4.6 4.1 10.4 0.2 23.0 2.7 32.4 1.7 2.4 1.3 0.3 3.5 4.9 7.8 9.4 10.8 6.4 10.5 9.2 0.4 0.5 0.7 1.5 2.6 3.7 0.1 2.4 0.0 13.8 7.5 0.1 0.0 3.5 5.2 5.5 2.6 0.1 5.8 16.7 2.1 0.0 18.8 2.7 0.4 11.1 2.9 3.2 3.8 0.9 0.0 1.2 3.4 31.8 2.8 0.2 3.7 2.1 0.0 7.0 0.1 0.7 0.3 0.0 5.7 0.1 0.1 0.0 7.5 0.2 6.9 0.6 0.8 1.2 0.2 0.3 0.3 0.6 0.5 0.3 0.5 0.1 0.6 0.2 11.9 15.3 1.9 8.2 32.1 0.4 1.2 0.0 9.4 11.4 7.0 0.0 0.1 6.6 3.7 0.1 0.8 101.9 0.0 9.4 0.1 7.8 3.9 6.9 0.4 3.6 0.0 20.8 0.0 6.6 0.0 0.0 18.7 8.5 6.4 30.0 0.2 14.7 43.0 0.4 17.5 0.2 0.0 2.8 0.7 0.3 35.5 0.2 3.2 54.4 8.4 VEPH1 "FLJ12604, KIAA1692" ENSG00000197415 "Ventricular zone expressed PH domain containing 1" Q14D04 3 157259742-157533619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 38.1;pituitary gland: 70.3" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 247.1;Alveolar cells type 2: 124.4;Early spermatids: 67.1;Late spermatids: 63.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 2.2;pons and medulla: 5.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.5;hTERT-RPE1: 26.3;HUVEC TERT2: 65.1;TIME: 38.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026645 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA026645: AB_1858741" "unprognostic (4.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-1)" "unprognostic (5.17e-2)" "unprognostic (3.30e-3)" "unprognostic (2.87e-3)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (1.75e-3)" "unprognostic (3.57e-3)" "unprognostic (1.99e-2)" "prognostic favorable (7.75e-9)" "unprognostic (2.03e-1)" "unprognostic (2.57e-1)" "unprognostic (1.15e-4)" "unprognostic (7.49e-2)" 0.5 16.0 0.3 0.2 0.3 1.1 1.4 2.2 3.5 1.9 0.4 0.7 2.0 0.2 0.4 12.1 0.2 3.4 1.1 0.4 0.8 0.5 20.7 0.6 38.1 0.1 0.7 0.1 1.1 8.6 0.7 70.3 1.6 5.5 1.2 0.3 17.7 6.9 4.9 0.2 0.7 0.2 0.1 0.3 2.3 0.6 1.7 0.2 0.1 1.1 0.5 0.6 0.5 0.8 0.0 0.0 1.5 0.7 0.0 0.0 5.1 1.8 0.2 4.3 0.0 2.5 9.4 0.0 11.0 24.5 3.3 4.8 0.3 1.7 0.0 4.3 11.8 0.5 0.0 0.1 0.2 18.3 0.0 0.0 1.8 0.2 0.0 0.8 0.0 0.0 2.7 0.1 14.0 2.8 26.3 65.1 0.0 0.6 0.0 8.9 0.2 0.0 0.0 1.7 0.5 1.6 0.0 0.3 0.0 1.6 0.9 0.1 0.0 0.3 0.5 4.3 0.0 18.9 0.0 38.7 13.1 0.4 4.5 15.1 0.0 0.0 0.0 10.5 0.0 3.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.1 0.3 0.3 2.2 0.4 0.8 0.5 0.7 0.1 5.5 0.2 247.1 124.4 0.0 0.2 1.5 0.0 0.3 12.7 14.7 26.1 29.6 2.0 1.6 39.7 5.5 67.1 0.0 0.0 0.0 8.7 0.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 63.8 1.4 0.4 27.0 1.0 0.2 0.8 2.0 2.8 0.4 24.1 0.3 0.0 0.0 0.3 0.6 0.4 0.0 0.0 0.6 0.1 VILL ENSG00000136059 "Villin like" O15195 3 37988059-38007188 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 46.3;stomach 1: 52.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 130.9;Paneth cells: 94.7" "Cancer enhanced" "Detected in many" "pancreatic cancer: 22.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.2;OE19: 40.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA035675, HPA035676" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA035675: AB_10671223, HPA035676: " "unprognostic (7.86e-3)" "unprognostic (7.37e-3)" "unprognostic (1.43e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (1.35e-4)" "prognostic favorable (1.75e-4)" "unprognostic (1.69e-1)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.95e-2)" "unprognostic (3.66e-3)" "unprognostic (5.55e-2)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (7.43e-3)" 2.7 2.1 7.1 12.3 7.2 6.3 3.4 4.7 5.3 5.3 28.0 1.7 3.9 33.2 6.2 3.2 3.8 4.1 21.8 3.3 5.3 4.1 2.8 0.6 7.0 7.3 2.9 4.6 3.9 2.2 0.6 3.4 3.6 2.9 8.5 14.8 4.5 3.8 4.8 1.0 5.1 46.3 3.8 3.4 6.3 52.5 3.5 3.5 12.1 4.5 3.1 9.6 15.0 3.8 5.4 4.6 0.1 3.9 4.0 9.2 4.8 4.2 0.0 0.1 0.2 1.5 1.2 0.4 1.2 1.0 1.2 1.2 3.2 13.2 2.0 1.9 0.8 0.0 1.0 0.9 0.1 0.2 0.4 0.0 3.7 0.0 0.3 1.9 3.9 5.1 1.8 1.2 1.2 0.0 0.0 2.4 8.5 3.7 1.2 1.4 0.0 6.2 4.4 0.1 40.5 0.0 2.4 0.0 1.0 0.4 5.1 0.0 0.1 0.0 0.3 0.9 0.0 0.3 6.4 1.4 0.5 0.2 1.6 0.0 0.7 1.5 0.6 0.3 5.6 2.6 0.0 3.9 0.0 8.7 2.4 9.2 4.4 5.8 4.9 2.6 5.4 7.4 5.4 0.1 4.0 1.6 4.6 6.8 4.8 7.1 7.2 4.7 5.3 5.3 4.1 2.9 4.6 2.9 3.5 8.9 9.0 0.5 5.1 2.1 0.8 1.5 10.2 12.0 14.8 0.0 0.0 2.4 0.0 2.1 4.9 3.7 130.9 0.0 15.4 2.8 3.7 5.4 8.1 0.0 2.0 1.6 9.2 3.1 1.0 14.5 3.4 2.7 1.7 1.8 40.6 26.2 22.9 94.7 2.5 1.4 0.4 0.0 3.8 4.5 2.4 1.3 0.8 10.0 38.0 23.8 VPS13D "FLJ10619, KIAA0453" ENSG00000048707 "Vacuolar protein sorting 13 homolog D" Q5THJ4 1 12230032-12512047 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 141.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027332, HPA051621" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA027332: AB_2672223, HPA051621: AB_2681555" "unprognostic (2.97e-1)" "unprognostic (8.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.75e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-3)" "unprognostic (3.33e-1)" "unprognostic (2.00e-2)" "unprognostic (1.57e-1)" "unprognostic (7.77e-2)" "prognostic favorable (7.42e-12)" "unprognostic (5.13e-1)" "unprognostic (1.72e-1)" "unprognostic (4.04e-2)" "unprognostic (8.31e-2)" 11.7 9.8 16.6 8.5 16.4 8.0 16.6 18.5 19.7 19.9 12.5 17.0 11.7 6.9 12.8 15.3 16.1 10.8 10.2 15.8 15.7 13.2 15.4 11.0 12.3 9.9 16.5 13.8 15.9 11.9 28.1 14.1 9.2 13.3 18.6 11.3 14.0 15.1 16.8 30.3 39.2 9.7 17.3 14.8 10.2 12.8 11.6 13.6 8.6 21.7 11.3 14.4 10.8 17.9 4.1 3.9 6.0 1.9 1.7 3.6 0.9 8.2 4.7 5.3 4.1 14.3 11.4 2.5 4.0 7.0 6.9 6.6 3.1 5.8 7.7 5.1 11.4 5.8 7.5 9.2 7.9 9.7 4.2 3.1 6.6 7.3 2.5 6.0 9.5 3.5 9.6 11.2 8.8 8.7 8.6 10.9 7.5 13.5 4.0 6.3 3.8 5.6 3.7 2.1 4.5 6.0 4.9 6.4 2.3 4.9 4.9 2.6 3.6 11.7 8.7 8.3 5.3 7.4 3.2 11.9 4.3 4.5 11.1 3.3 3.5 2.9 12.3 4.9 6.8 6.5 6.0 1.9 1.4 3.3 1.9 3.5 2.5 3.6 2.3 1.5 4.1 3.2 2.5 2.6 1.7 1.4 3.9 1.7 0.9 16.6 16.4 18.5 19.7 15.7 13.2 16.5 13.8 13.3 13.6 17.9 18.9 9.8 42.5 19.3 35.3 67.8 12.7 20.1 25.0 17.4 68.7 6.1 3.3 7.4 81.4 17.1 17.2 23.3 12.3 6.0 9.9 29.1 11.6 18.1 10.0 44.5 13.8 19.0 16.5 141.6 21.3 14.3 11.8 6.4 14.6 23.4 13.5 10.5 20.5 8.4 33.6 45.3 33.0 16.7 11.3 27.5 12.4 12.5 10.4 35.6 VTA1 "C6orf55, HSPC228, My012" ENSG00000009844 "Vesicle trafficking 1" Q9NP79 6 142147162-142224689 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030968, HPA030969" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA 22000 "Nucleoplasm, Vesicles, Cytosol" "HPA030968: AB_10602585, HPA030969: AB_2673679" "prognostic unfavorable (7.02e-4)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.17e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" "prognostic unfavorable (6.58e-6)" "unprognostic (2.83e-2)" "unprognostic (3.61e-1)" "unprognostic (5.18e-2)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (3.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" "unprognostic (1.96e-1)" "unprognostic (3.24e-1)" 18.8 19.5 20.5 15.5 28.2 17.2 20.6 25.0 39.3 17.2 22.0 18.5 9.6 24.2 16.0 17.1 31.4 17.9 14.9 21.2 19.8 20.3 24.9 29.9 13.5 19.3 20.1 20.7 15.3 15.6 16.3 21.7 30.5 30.7 16.8 26.3 11.2 19.4 13.5 48.6 20.9 32.7 17.0 24.0 20.8 14.6 12.9 18.2 33.6 18.0 24.3 24.0 18.4 19.7 29.0 30.9 58.6 38.1 30.9 30.1 36.1 18.4 15.9 26.0 39.8 23.0 25.3 18.0 42.0 25.1 38.5 36.8 26.9 14.5 30.2 28.4 37.6 29.3 23.7 27.6 28.6 53.4 20.4 24.3 32.7 17.1 32.1 17.0 50.7 19.0 20.9 33.6 38.4 24.9 20.7 24.6 23.6 30.3 15.2 32.1 27.0 32.9 26.4 19.5 23.9 18.3 30.3 20.9 18.4 29.6 20.6 27.3 21.2 23.6 18.2 21.1 22.7 19.7 34.6 17.8 17.4 24.2 29.0 30.1 15.0 25.9 34.4 11.4 28.4 26.4 58.6 31.0 49.5 23.5 38.1 30.1 29.0 26.8 27.4 30.9 26.6 29.8 29.9 19.1 30.9 37.4 19.0 25.7 36.1 20.5 28.2 25.0 39.3 19.8 20.3 20.1 20.7 30.7 18.2 20.8 16.9 15.6 15.3 22.3 9.1 37.0 10.2 40.2 25.0 15.7 0.0 28.5 14.9 26.8 2.2 15.7 29.3 0.0 24.4 30.4 20.0 13.7 11.6 22.7 24.3 11.1 20.7 8.0 20.8 2.1 10.9 15.6 8.5 18.0 24.5 21.3 24.7 17.5 11.7 24.5 10.8 6.5 8.2 20.6 25.7 27.0 26.5 16.2 23.7 15.3 VWCE "FLJ32009, URG11, VWC1" ENSG00000167992 "Von Willebrand factor C and EGF domains" Q96DN2 11 61258286-61295424 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 19.8;ovary: 10.7" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 27.5;Hepatocytes: 14.0;Rod photoreceptor cells: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 5.7;Hep G2: 19.3;HSkMC: 11.4;REH: 10.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA040401, HPA043921" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" NA NA 1300000 Nucleoplasm "Vesicles, Cytosol" "HPA040401: AB_2676963, HPA043921: AB_2678731" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (1.15e-1)" "unprognostic (3.96e-3)" "unprognostic (9.27e-4)" "unprognostic (1.21e-2)" "unprognostic (4.01e-4)" "unprognostic (3.04e-2)" "unprognostic (3.42e-2)" "unprognostic (6.58e-4)" "unprognostic (7.20e-2)" "unprognostic (3.01e-1)" "unprognostic (1.25e-2)" "unprognostic (1.92e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-1)" 2.9 1.1 0.9 0.6 1.3 2.3 3.1 0.7 1.3 2.8 1.0 1.4 3.4 0.5 1.4 2.9 1.5 5.7 1.4 1.0 1.3 1.2 0.6 19.8 0.8 0.3 0.4 1.1 10.7 0.1 0.5 0.5 9.1 0.3 1.8 0.6 1.3 1.7 1.0 1.9 0.9 1.1 1.2 0.2 0.9 0.3 1.8 0.5 6.5 0.8 1.0 1.0 1.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.2 1.1 0.4 0.2 1.8 0.0 0.3 5.7 0.0 0.3 0.0 0.4 0.1 0.0 2.0 0.0 0.1 0.4 0.0 0.5 0.0 19.3 1.1 0.0 0.1 11.4 0.5 0.5 0.0 0.1 1.8 2.6 0.2 0.3 0.3 0.1 4.2 0.0 1.6 0.0 0.0 10.9 0.1 0.0 0.1 0.1 0.4 0.9 0.0 0.1 0.6 2.0 0.7 0.0 0.5 0.2 0.3 0.5 0.1 0.2 0.4 0.9 0.8 0.2 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.7 1.3 1.3 1.2 0.4 1.1 0.3 0.5 3.0 1.7 0.0 1.5 1.5 3.2 0.7 0.0 5.3 2.3 0.0 27.5 0.9 0.0 0.1 0.4 2.2 0.0 0.0 0.4 2.2 1.4 0.4 3.5 14.0 1.1 0.0 1.7 3.1 4.0 0.0 6.4 2.2 1.7 1.8 0.0 3.2 0.0 0.0 1.8 0.3 17.1 0.0 0.5 0.9 3.0 1.9 3.7 0.5 0.1 0.7 WBP4 "FBP21, MGC117310" ENSG00000120688 "WW domain binding protein 4" O75554 13 41061274-41084006 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038965, HPA058738" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA038965: AB_10672836, HPA058738: AB_2683803" "unprognostic (2.56e-1)" "unprognostic (3.69e-3)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (1.76e-3)" "unprognostic (1.54e-2)" "unprognostic (2.13e-2)" "unprognostic (1.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.71e-3)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "unprognostic (8.52e-2)" "unprognostic (7.65e-3)" "prognostic favorable (2.89e-4)" "unprognostic (2.52e-1)" 14.0 14.2 17.2 7.9 22.1 11.4 11.5 15.8 17.2 12.0 10.7 8.6 8.9 9.6 16.6 14.1 10.9 10.1 8.0 18.8 14.7 15.8 10.5 13.4 8.7 9.0 14.7 19.0 11.8 7.5 8.8 11.3 15.9 15.9 12.5 8.0 4.8 7.2 13.2 76.2 9.4 9.6 14.7 15.0 7.9 8.1 10.0 12.8 12.7 9.6 12.6 9.3 13.3 11.1 10.9 15.2 22.7 16.2 9.7 12.9 5.0 8.9 5.9 16.5 10.6 10.9 16.6 10.1 20.3 14.3 16.0 12.3 9.3 9.6 12.8 8.2 14.2 19.6 12.6 6.2 10.1 20.6 13.2 8.8 18.0 5.8 9.4 16.7 11.2 11.8 13.6 15.5 11.6 16.5 13.3 13.4 12.4 9.6 5.7 16.7 7.5 16.0 12.3 10.0 13.9 4.9 15.1 10.2 5.0 14.5 8.8 3.8 9.2 6.4 7.0 9.5 14.0 5.7 17.6 11.8 10.1 9.2 13.8 11.6 3.8 4.1 8.9 12.4 8.2 13.6 13.0 11.0 9.7 9.3 9.6 8.5 10.9 11.8 9.9 8.9 10.6 12.9 12.6 22.7 9.7 16.2 15.2 11.3 5.0 17.2 22.1 15.8 17.2 14.7 15.8 14.7 19.0 15.9 12.8 47.6 24.8 31.2 52.4 48.3 47.0 92.8 28.1 20.1 28.4 24.4 31.4 49.2 64.6 45.6 4.7 45.0 27.6 116.8 36.7 51.6 45.6 38.5 45.0 61.4 36.2 42.9 36.4 33.7 22.5 5.0 44.3 37.8 30.4 80.2 20.9 62.1 40.8 34.5 49.5 46.9 43.4 25.8 50.5 63.7 97.3 39.3 41.8 21.3 24.9 37.1 WDR13 ENSG00000101940 "WD repeat domain 13" Q9H1Z4 X 48590042-48608867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000913 Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA000913: AB_1858795" "unprognostic (5.03e-2)" "unprognostic (6.53e-3)" "unprognostic (3.65e-3)" "unprognostic (2.10e-3)" "unprognostic (3.50e-1)" "unprognostic (1.54e-3)" "unprognostic (3.54e-2)" "unprognostic (6.76e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-1)" "unprognostic (1.58e-2)" "unprognostic (1.33e-1)" "unprognostic (2.82e-1)" "unprognostic (2.99e-1)" "unprognostic (1.66e-1)" "unprognostic (2.65e-1)" "unprognostic (4.32e-2)" 24.5 30.4 39.9 13.9 36.9 15.7 19.1 14.4 33.9 18.6 25.5 17.6 41.5 23.0 26.0 41.2 23.1 30.8 21.1 49.8 30.2 18.9 24.2 50.2 19.3 11.1 20.0 35.8 35.0 74.7 21.8 24.4 23.9 17.0 19.6 14.4 16.5 30.4 35.8 48.5 21.7 22.0 20.2 17.5 17.4 22.7 11.0 20.5 8.6 21.9 21.1 10.5 17.9 19.7 16.8 21.1 29.2 28.2 17.3 13.8 15.9 15.0 22.0 11.0 34.1 15.2 22.4 8.5 10.4 19.0 12.1 11.1 13.0 24.1 10.4 10.0 21.3 9.8 12.9 5.5 22.8 4.3 12.4 9.7 7.1 26.0 23.6 34.7 6.1 19.5 21.2 32.6 17.2 31.6 21.3 16.6 6.1 7.0 13.4 16.8 21.6 8.4 10.8 8.0 6.5 17.4 8.1 11.7 18.9 21.4 12.0 12.8 15.9 11.8 24.6 24.1 8.1 15.7 11.9 27.4 12.6 18.8 19.9 10.0 15.6 5.7 3.8 18.7 9.2 17.3 29.2 23.1 12.7 11.9 24.7 9.5 16.8 12.6 11.3 21.1 13.4 10.0 11.4 16.0 17.3 28.2 13.3 13.8 15.9 39.9 36.9 14.4 33.9 30.2 18.9 20.0 35.8 17.0 20.5 41.7 42.0 25.3 61.2 31.1 44.1 67.8 58.6 60.2 33.0 19.2 51.1 39.7 87.9 76.1 5.1 50.7 69.1 0.0 103.3 29.1 47.2 41.1 30.0 41.4 38.7 31.8 48.5 54.6 33.6 15.2 47.8 29.6 55.6 47.7 52.9 50.7 86.4 59.6 40.7 122.9 50.2 45.3 55.3 9.7 15.3 26.1 59.2 20.8 54.6 57.8 WDR26 "FLJ21016, GID7" ENSG00000162923 "WD repeat domain 26" Q9H7D7 1 224385143-224437033 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.9" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 178.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028538, HPA028539, HPA061094" Enhanced Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427" "unprognostic (4.09e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.31e-2)" "unprognostic (6.67e-2)" "unprognostic (2.27e-1)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (8.42e-2)" "unprognostic (6.32e-2)" "unprognostic (5.59e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.31e-6)" "unprognostic (8.40e-3)" "unprognostic (4.00e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" 8.2 7.2 6.7 6.7 6.7 18.5 7.2 8.2 7.3 7.8 7.0 6.7 6.7 4.0 6.8 9.3 13.0 5.9 7.0 7.5 6.7 5.0 6.7 9.3 9.0 7.2 6.7 6.7 7.0 6.9 9.2 6.7 8.7 6.7 7.0 6.7 6.7 7.2 6.7 15.2 9.9 6.7 7.1 6.7 10.2 6.3 63.9 6.7 6.7 7.0 6.7 7.4 6.7 8.3 1.5 2.1 8.3 3.9 2.7 2.7 1.3 11.9 6.2 19.3 8.9 25.8 29.4 13.9 17.6 28.8 16.1 15.2 9.8 13.6 14.2 17.7 28.3 6.2 10.9 11.3 15.1 26.5 11.1 12.9 9.8 8.1 9.2 28.1 10.2 17.2 27.3 21.9 17.0 16.1 26.7 26.8 8.7 12.9 14.7 21.1 6.6 10.5 9.9 18.6 12.4 7.2 9.7 20.2 11.2 19.6 12.1 7.0 17.9 20.0 27.1 21.5 21.1 31.1 16.8 28.1 13.8 6.3 12.9 21.1 15.7 7.5 9.7 15.7 7.3 17.0 4.1 1.9 3.3 2.7 2.4 1.5 1.5 1.9 2.1 1.8 1.4 1.4 2.1 8.3 2.7 3.9 2.1 1.6 1.3 6.7 6.7 8.2 6.7 6.7 5.0 6.7 6.7 6.7 6.7 98.3 43.8 19.4 25.3 99.0 23.8 42.4 45.9 41.5 50.0 33.2 29.5 23.4 5.0 19.2 178.7 37.6 21.6 0.0 20.3 11.8 51.5 39.3 46.2 31.0 44.5 36.5 34.0 44.2 119.9 79.7 34.2 49.8 43.9 12.6 40.3 16.9 26.6 25.9 26.5 17.0 22.9 19.4 41.9 36.4 24.6 107.0 57.1 31.6 23.8 59.3 WDR41 FLJ10904 ENSG00000164253 "WD repeat domain 41" Q9HAD4 5 77425970-77620611 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043124 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA043124: AB_10793990" "unprognostic (1.81e-1)" "unprognostic (9.42e-2)" "unprognostic (2.52e-3)" "unprognostic (9.69e-2)" "unprognostic (1.52e-1)" "unprognostic (4.56e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (1.28e-3)" "unprognostic (1.43e-1)" "unprognostic (1.68e-2)" "unprognostic (2.30e-3)" "unprognostic (1.49e-1)" "unprognostic (4.15e-3)" "unprognostic (6.11e-2)" "unprognostic (4.90e-1)" "unprognostic (1.85e-1)" "unprognostic (2.90e-3)" 16.2 12.8 18.8 13.1 21.7 17.3 16.2 19.5 23.3 15.1 12.6 17.7 9.4 9.4 13.3 13.3 20.6 17.5 12.2 16.9 18.8 17.5 15.8 14.8 14.0 13.9 21.4 20.0 9.4 21.3 14.4 15.8 11.4 28.9 12.0 13.8 11.5 13.7 12.0 19.7 12.8 11.2 19.2 23.3 12.5 11.5 26.6 19.8 8.1 23.1 12.9 16.6 13.5 13.6 8.9 24.8 24.0 18.1 15.8 5.7 7.3 6.8 11.8 16.6 24.2 17.3 24.8 13.0 21.8 23.6 10.3 19.2 10.7 11.5 20.8 10.1 20.6 17.8 8.9 12.4 29.8 11.1 25.0 14.2 8.3 13.8 9.2 26.5 17.5 20.7 15.7 38.4 11.7 25.5 11.4 16.5 11.8 8.2 22.7 16.8 14.7 9.2 11.3 6.1 6.9 4.7 22.2 22.7 14.6 11.3 5.8 9.7 11.9 18.6 11.7 18.1 20.8 11.7 22.0 14.4 14.0 11.4 7.6 15.9 20.7 16.8 37.2 19.2 7.9 23.3 11.4 14.0 24.0 5.7 16.3 5.5 8.9 3.4 5.1 24.8 5.4 2.3 4.2 6.8 15.8 18.1 11.1 2.6 7.3 18.8 21.7 19.5 23.3 18.8 17.5 21.4 20.0 28.9 19.8 35.7 10.5 11.5 21.9 10.6 34.7 14.7 12.7 20.1 9.1 17.4 19.6 7.4 31.5 19.8 146.0 11.7 3.5 0.0 18.1 22.6 22.6 18.9 15.1 11.1 24.0 22.3 5.8 8.0 22.7 78.8 8.9 25.0 16.9 8.2 7.6 12.9 15.9 5.8 7.8 14.0 16.3 6.5 18.7 46.9 43.9 12.4 5.3 17.3 10.3 21.6 WDR45B "WDR45L, WIPI3" ENSG00000141580 "WD repeat domain 45B" Q5MNZ6 17 82614562-82648553 "Predicted intracellular proteins" Autophagy "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 316.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017886 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA017886: AB_1858810" "unprognostic (1.91e-1)" "unprognostic (7.77e-2)" "unprognostic (5.13e-2)" "unprognostic (3.78e-2)" "unprognostic (1.42e-1)" "unprognostic (3.88e-2)" "prognostic unfavorable (2.98e-5)" "unprognostic (1.23e-1)" "unprognostic (6.38e-2)" "unprognostic (1.22e-2)" "unprognostic (4.41e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-2)" "unprognostic (9.93e-3)" "unprognostic (8.89e-2)" "unprognostic (4.27e-2)" "unprognostic (1.02e-1)" 25.4 31.0 37.1 17.2 39.0 38.7 38.9 30.3 38.1 27.4 23.5 35.3 19.9 21.8 25.6 24.9 39.9 32.7 29.5 29.4 36.6 29.2 26.6 22.9 23.5 26.6 38.2 28.5 32.8 35.6 29.9 24.2 19.6 39.2 26.6 21.2 18.8 32.6 23.8 20.9 28.4 25.0 29.3 53.3 19.3 29.5 47.7 39.1 6.8 26.5 23.3 23.5 23.3 24.8 10.0 15.6 22.1 19.3 8.9 12.6 11.9 29.2 20.1 17.0 15.5 15.7 14.6 20.2 21.9 24.7 35.9 30.8 24.0 15.6 8.4 13.7 19.5 22.9 16.3 16.3 18.6 33.1 5.3 32.4 17.1 11.5 18.6 20.7 13.5 13.1 15.8 19.6 19.1 18.0 15.5 28.9 11.3 12.7 7.9 20.0 18.8 9.6 9.2 21.7 23.5 26.8 10.5 30.7 8.6 19.4 29.3 22.1 32.6 21.6 22.2 25.6 20.8 26.4 10.3 19.7 37.3 29.3 26.2 39.0 20.4 8.7 12.4 24.3 13.6 27.3 16.5 19.3 22.1 12.3 19.2 12.6 10.0 9.7 10.4 15.6 9.9 8.7 7.9 16.2 8.9 14.8 8.0 7.6 11.9 37.1 39.0 30.3 38.1 36.6 29.2 38.2 28.5 39.2 39.1 29.8 45.5 39.3 40.6 53.1 35.0 17.3 63.7 66.9 76.2 40.1 11.8 45.7 74.6 105.9 126.0 49.0 65.0 0.0 119.7 62.3 43.4 67.1 71.6 61.8 40.3 42.9 45.5 45.4 49.5 316.4 52.9 44.0 54.0 54.1 58.5 56.9 135.0 52.0 45.3 50.9 30.8 32.3 51.5 70.5 153.1 63.2 90.4 39.5 52.5 79.5 WDR49 FLJ33620 ENSG00000174776 "WD repeat domain 49" Q8IV35 3 167478684-167653983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 21.6;fallopian tube: 20.7" "Group enriched" "Detected in some" 5 "Ciliated cells: 50.9;Club cells: 18.2" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2" "Group enriched" "Detected in many" 24 "dendritic cells: 5.2;monocytes: 5.6" "Cell line enhanced" "Detected in some" "AF22: 3.4;NTERA-2: 3.8;THP-1: 17.1;U-937: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036225, HPA036226" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA036225: AB_10696652, HPA036226: AB_2675007" "unprognostic (1.68e-3)" "unprognostic (1.24e-3)" "unprognostic (2.48e-2)" "unprognostic (1.96e-1)" "unprognostic (5.67e-2)" "unprognostic (5.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.02e-2)" "unprognostic (9.28e-3)" "unprognostic (1.34e-1)" "unprognostic (4.60e-9)" "unprognostic (1.79e-4)" "unprognostic (3.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.07e-1)" 0.5 0.7 6.5 1.1 6.8 3.6 0.6 12.6 5.0 1.2 0.9 8.5 0.0 3.9 1.2 4.4 2.1 20.7 0.7 4.7 12.3 5.4 1.0 0.4 4.0 0.9 7.6 2.8 3.2 0.9 0.4 1.7 0.4 21.6 0.7 0.6 0.0 0.7 0.4 0.4 0.5 8.0 0.7 17.6 1.1 0.8 1.5 14.2 0.0 0.5 0.0 1.0 0.8 0.6 0.2 5.2 0.0 5.6 0.0 0.0 0.7 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.1 0.0 0.0 5.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 6.5 6.8 12.6 3.7 12.3 5.4 7.6 2.8 21.6 14.2 0.0 1.1 0.0 0.8 0.0 0.0 1.0 0.0 50.9 18.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 WDR77 "MEP50, p44" ENSG00000116455 "WD repeat domain 77" Q9BQA1 1 111439890-111449376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 68.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026437, HPA026448, HPA027271" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004" "unprognostic (1.84e-1)" "unprognostic (7.01e-2)" "unprognostic (6.26e-3)" "unprognostic (1.19e-3)" "unprognostic (1.12e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.06e-6)" "unprognostic (5.14e-1)" "unprognostic (3.88e-3)" "prognostic favorable (7.88e-4)" "unprognostic (6.16e-2)" "unprognostic (1.72e-3)" "unprognostic (1.63e-2)" "unprognostic (8.13e-2)" "unprognostic (1.92e-1)" "unprognostic (6.17e-2)" "unprognostic (1.23e-2)" 11.2 16.5 10.0 17.3 16.2 5.9 9.7 8.5 18.1 9.8 10.9 14.3 5.7 9.5 13.9 15.7 19.0 68.6 15.7 16.6 9.9 10.8 13.6 19.2 9.9 16.8 12.1 9.6 14.6 14.0 15.1 11.7 12.1 15.8 12.6 16.6 10.3 16.4 13.4 27.2 8.9 11.1 13.0 7.9 16.5 14.5 12.9 9.3 19.3 9.9 23.2 22.7 19.1 11.0 24.9 25.7 6.2 17.7 26.7 16.1 11.9 20.7 18.2 17.4 14.3 10.5 6.1 24.2 15.7 8.4 24.1 15.9 26.7 7.8 35.4 15.4 13.3 15.6 15.1 31.4 30.1 29.2 14.0 24.6 21.1 21.3 38.4 11.8 21.6 36.1 7.5 21.6 23.6 15.2 6.4 16.0 15.8 28.1 9.4 23.2 26.2 27.7 11.3 34.2 19.5 30.5 27.7 27.4 13.5 21.4 36.8 14.4 10.5 13.8 17.4 12.5 23.3 14.0 14.9 11.6 13.4 26.9 25.9 33.3 7.8 9.8 31.8 16.9 24.3 39.1 6.2 11.6 2.9 13.9 17.7 15.5 24.9 15.1 15.5 25.7 21.6 16.1 15.0 1.7 26.7 15.5 16.1 12.5 11.9 10.0 16.2 8.5 18.1 9.9 10.8 12.1 9.6 15.8 9.3 11.9 10.7 30.3 21.0 18.4 11.9 21.5 12.7 37.5 9.1 17.4 23.6 49.7 21.6 29.8 2.7 9.8 7.4 0.0 11.8 45.7 9.9 13.5 15.1 13.4 41.0 7.9 15.1 8.0 19.6 2.7 6.9 17.8 5.0 10.8 16.5 8.4 20.0 7.0 8.5 24.4 9.2 12.9 13.1 12.3 22.6 16.2 38.1 17.5 21.3 22.3 WDR81 "CAMRQ2, FLJ33817, PPP1R166, SORF-2" ENSG00000167716 "WD repeat domain 81" Q562E7 17 1716523-1738599 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023044, HPA063703" Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Vesicles, Cytosol" "HPA023044: AB_1858822, HPA063703: " "unprognostic (1.00e-1)" "unprognostic (4.67e-2)" "unprognostic (6.63e-2)" "unprognostic (4.90e-3)" "unprognostic (6.10e-2)" "unprognostic (7.75e-3)" "unprognostic (2.01e-1)" "unprognostic (2.09e-1)" "unprognostic (3.06e-2)" "unprognostic (1.60e-2)" "prognostic favorable (3.30e-4)" "unprognostic (3.26e-1)" "unprognostic (8.72e-2)" "unprognostic (2.25e-1)" "unprognostic (8.43e-2)" "unprognostic (7.99e-2)" "unprognostic (3.90e-2)" 12.7 12.2 8.9 12.1 8.4 10.7 22.9 7.0 11.7 12.6 9.1 10.5 26.4 11.3 14.9 11.6 7.4 12.8 9.3 9.0 8.4 4.3 9.6 22.7 17.2 21.4 9.2 4.4 18.5 8.3 3.5 9.9 8.9 8.5 11.9 4.6 10.6 10.1 21.8 13.1 16.7 12.7 11.6 5.0 19.0 8.4 6.3 8.2 17.3 8.1 5.2 10.3 11.6 16.2 2.8 6.9 5.1 5.0 4.2 3.0 1.9 0.5 10.8 1.5 7.3 10.5 5.8 8.0 0.6 0.1 0.4 0.0 1.4 4.0 4.2 5.8 4.3 5.6 10.2 5.3 7.2 0.3 7.9 11.3 0.1 7.4 4.9 18.0 3.4 6.6 14.5 7.4 5.2 3.2 2.1 4.0 3.4 0.3 5.4 6.0 5.2 1.1 5.8 3.4 3.2 7.6 5.5 2.5 5.6 3.0 1.5 2.1 4.6 3.9 3.3 12.6 0.1 4.9 5.0 6.0 4.2 5.0 6.7 5.5 0.4 0.9 2.4 6.5 5.5 2.9 0.0 3.1 5.1 2.6 5.0 3.0 2.8 2.7 2.6 3.8 2.3 1.8 2.4 0.6 4.2 4.3 6.9 2.4 1.9 8.9 8.4 7.0 11.7 8.4 4.3 9.2 4.4 8.5 8.2 11.9 9.3 4.7 2.5 2.3 4.7 2.6 5.1 4.0 3.4 0.0 3.9 2.1 1.7 2.5 0.5 2.9 5.9 0.0 3.8 1.7 3.1 2.4 4.6 20.9 20.3 4.8 1.2 5.5 17.2 0.4 15.3 9.1 0.0 5.4 4.0 2.8 4.7 3.4 14.2 11.1 1.7 19.4 2.0 0.5 1.5 1.5 1.9 2.9 3.5 1.3 WDR83 MORG1 ENSG00000123154 "WD repeat domain 83" Q9BRX9 19 12666800-12675832 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042629, HPA042838" Uncertain Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA042629: AB_10794763, HPA042838: AB_10794173" "unprognostic (1.12e-2)" "unprognostic (3.15e-3)" "unprognostic (1.43e-3)" "unprognostic (1.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (3.60e-3)" "unprognostic (2.52e-1)" "unprognostic (1.56e-2)" "prognostic favorable (5.44e-4)" "unprognostic (1.30e-2)" "unprognostic (4.07e-2)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "prognostic favorable (3.12e-4)" 6.4 7.8 10.2 6.2 9.1 8.8 6.5 17.2 14.5 7.1 5.2 9.1 2.3 4.9 5.8 6.1 5.9 11.3 5.2 9.2 8.5 8.9 8.1 5.9 6.0 8.3 12.4 11.6 9.2 11.6 9.4 6.7 4.9 9.1 6.9 2.6 7.7 14.6 6.9 4.6 11.3 6.3 3.8 7.0 7.4 7.1 9.2 10.6 11.7 9.2 2.6 5.8 6.0 5.7 8.8 19.4 5.4 11.1 17.6 11.3 8.6 4.9 8.3 4.7 6.5 9.3 3.5 3.8 4.7 4.4 5.7 6.0 9.6 4.3 7.5 6.9 4.2 3.2 5.6 5.5 7.3 1.0 7.6 12.2 5.9 5.5 6.0 7.4 8.2 7.0 6.4 5.9 4.6 3.8 3.8 5.7 16.3 5.2 0.8 2.6 18.8 11.9 6.7 3.8 5.8 14.4 8.5 6.1 7.0 5.4 5.9 9.9 6.6 5.1 7.0 4.1 2.7 3.9 8.1 3.1 6.4 2.0 5.1 4.9 19.1 12.8 3.3 10.0 6.3 4.1 4.5 11.1 4.6 9.2 9.6 10.7 8.1 8.9 8.6 11.1 8.8 8.7 11.3 5.4 17.6 4.7 19.4 9.8 8.6 10.2 9.1 17.2 14.5 8.5 8.9 12.4 11.6 9.1 10.6 0.0 15.6 12.6 11.4 13.7 20.5 4.2 12.7 10.7 7.9 17.4 11.8 11.1 14.9 13.6 13.8 10.5 9.3 0.0 15.2 11.6 11.0 13.4 13.9 7.2 11.5 19.1 9.2 9.2 11.6 43.7 14.7 14.8 15.1 18.0 6.7 15.0 11.1 5.9 17.0 22.6 20.4 19.4 13.2 25.0 16.9 14.1 7.6 16.2 8.1 12.2 WDSUB1 "FLJ36175, UBOX6, WDSAM1" ENSG00000196151 "WD repeat, sterile alpha motif and U-box domain containing 1" Q8N9V3 2 159235793-159286799 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036840, HPA058172" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA036840: AB_10670926, HPA058172: AB_2683628" "unprognostic (1.37e-2)" "prognostic favorable (3.35e-4)" "unprognostic (2.56e-1)" "unprognostic (7.33e-3)" "unprognostic (3.44e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.76e-3)" "unprognostic (4.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (6.75e-2)" "unprognostic (3.46e-3)" "unprognostic (8.49e-2)" "unprognostic (1.72e-1)" "unprognostic (1.00e-2)" "unprognostic (2.87e-2)" 10.3 14.2 9.7 6.6 12.7 10.9 14.8 18.9 14.0 10.3 8.5 8.9 10.6 5.8 9.8 22.1 11.1 11.8 9.9 11.5 9.7 10.6 27.7 8.2 10.7 16.1 11.5 7.0 16.4 15.5 19.4 23.8 15.7 9.2 11.3 9.2 16.0 11.8 8.7 7.7 8.2 7.7 9.9 9.5 10.5 9.0 7.7 10.2 8.5 22.2 6.1 9.2 10.0 15.0 9.8 10.3 2.8 9.3 16.2 13.0 6.2 6.1 4.6 4.2 6.6 7.6 8.8 14.2 4.8 9.5 8.8 15.5 9.9 10.0 8.2 5.1 7.2 15.1 3.7 11.7 4.4 12.4 3.2 9.7 8.4 5.3 10.0 9.3 7.1 11.7 5.1 16.4 10.8 8.9 16.9 7.2 10.9 11.1 6.2 8.3 6.3 5.1 13.2 5.7 10.4 9.9 8.0 6.2 4.4 10.1 8.9 7.8 5.1 5.0 6.5 11.2 20.4 5.0 12.6 3.0 6.3 4.6 8.8 4.6 3.2 5.3 7.6 11.1 8.9 3.9 2.7 9.3 2.8 13.0 7.0 9.8 9.8 5.2 8.1 10.3 8.9 6.3 7.4 0.6 16.2 6.3 9.7 2.6 6.2 9.7 12.7 18.9 14.0 9.7 10.6 11.5 7.0 9.2 10.2 11.9 5.0 6.7 7.4 4.7 6.4 10.7 10.2 17.4 9.1 19.2 2.0 20.1 29.9 7.2 3.0 6.6 5.1 0.0 3.1 7.7 8.8 6.6 11.5 1.7 15.4 4.8 5.2 6.2 13.9 2.1 11.8 9.5 5.0 3.6 5.5 6.0 4.7 9.0 10.6 17.4 8.9 0.0 7.1 10.5 20.2 5.5 19.2 10.1 7.0 5.1 WIPI1 "ATG18, ATG18A, FLJ10055, WIPI49" ENSG00000070540 "WD repeat domain, phosphoinositide interacting 1" Q5MNZ9 17 68420948-68457513 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 132.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 25.0;eosinophil: 53.0" "Lineage enriched" "Detected in all" 9 "granulocytes: 53.0" "Cell line enhanced" "Detected in many" "ASC diff: 52.6;ASC TERT1: 40.2;HHSteC: 50.7;HSkMC: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007493, CAB037230" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB037230: AB_1841265, HPA007493: AB_1848642" "unprognostic (2.83e-2)" "unprognostic (7.85e-2)" "unprognostic (1.05e-3)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-2)" "unprognostic (3.97e-3)" "unprognostic (1.78e-2)" "prognostic favorable (3.11e-4)" "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (3.06e-1)" "unprognostic (6.32e-3)" "unprognostic (6.56e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (1.89e-3)" 18.4 11.0 6.0 6.5 10.0 10.5 19.6 7.6 9.6 16.1 15.9 7.8 39.7 5.7 9.0 12.9 8.1 6.7 10.7 34.8 5.3 3.7 20.2 11.5 14.4 12.2 8.5 5.3 6.9 23.9 10.0 10.2 33.5 9.4 8.4 17.9 11.5 30.2 19.3 49.3 11.8 7.7 10.0 7.5 8.9 14.5 4.6 6.5 1.6 10.0 25.2 9.8 10.3 10.3 1.1 2.2 53.0 5.7 2.5 3.1 3.3 1.0 2.2 1.9 2.8 52.6 40.2 10.7 7.7 36.8 3.1 10.0 1.6 1.6 0.5 3.5 16.5 11.0 0.8 0.7 4.9 5.5 0.9 0.9 7.6 0.7 9.4 50.7 0.5 11.0 42.3 9.1 12.3 16.8 10.3 13.9 1.1 0.4 19.2 9.3 6.5 0.1 1.5 0.4 2.8 3.2 0.1 6.7 7.4 4.7 3.7 0.5 2.6 1.7 24.1 39.1 10.7 12.4 2.1 13.2 15.3 2.2 7.0 1.9 16.8 19.0 2.2 23.1 3.6 6.8 25.0 4.6 53.0 3.1 5.5 1.4 1.1 0.8 3.0 2.2 0.4 0.0 1.5 9.7 2.5 5.7 1.5 0.6 3.3 6.0 10.0 7.6 9.6 5.3 3.7 8.5 5.3 9.4 6.5 8.9 11.5 11.1 11.2 6.9 11.0 6.7 25.5 53.5 33.0 15.7 2.0 35.8 26.6 25.2 5.6 10.8 13.4 70.0 49.5 132.1 43.1 46.3 6.9 10.6 31.2 9.5 11.5 41.1 15.3 3.6 42.8 14.5 40.5 47.7 56.7 12.4 33.5 11.5 39.6 54.2 12.4 25.8 15.5 4.4 4.5 5.9 104.6 17.5 25.7 23.5 WRAP53 "FLJ10385, TCAB1, WDR79" ENSG00000141499 "WD repeat containing antisense to TP53" Q9BUR4 17 7686071-7703502 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Chaperone, RNA-binding" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023026, HPA028130, HPA029928" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257" "unprognostic (1.45e-1)" "unprognostic (3.50e-3)" "unprognostic (6.81e-2)" "unprognostic (2.53e-3)" "unprognostic (3.86e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (4.70e-4)" "unprognostic (8.69e-2)" "unprognostic (3.29e-1)" "unprognostic (1.41e-1)" "prognostic favorable (8.26e-4)" "unprognostic (2.68e-2)" "unprognostic (5.67e-2)" "unprognostic (7.23e-2)" "unprognostic (2.47e-1)" "unprognostic (2.93e-2)" "unprognostic (4.04e-1)" 6.9 6.9 8.1 10.3 8.0 13.3 6.8 11.8 10.7 7.4 7.2 10.6 6.8 6.8 8.4 8.4 7.9 25.6 7.7 6.8 7.5 6.6 9.4 6.6 8.7 12.7 7.9 5.8 7.8 12.0 6.1 7.6 8.1 7.8 5.3 7.3 7.8 6.6 6.6 9.8 8.1 7.7 7.8 5.4 12.5 7.2 11.4 8.3 22.8 7.6 6.6 12.8 7.5 6.2 4.7 6.6 20.0 5.8 4.2 8.5 3.5 11.2 21.1 15.2 15.2 4.6 4.3 8.9 7.3 7.8 24.0 22.4 12.2 7.0 13.5 7.7 6.5 10.6 12.5 17.4 12.9 18.5 8.1 22.6 6.2 14.0 10.2 4.1 4.8 8.1 3.4 5.0 21.1 4.8 3.6 15.5 16.2 5.9 4.4 9.5 10.2 13.8 11.6 8.1 8.9 10.6 18.3 10.0 7.9 8.8 4.0 7.0 10.6 11.5 6.2 6.1 7.9 8.4 5.1 5.4 9.5 10.1 0.0 18.8 3.5 8.9 7.1 8.6 8.2 11.6 20.0 5.2 4.6 5.4 5.8 6.3 3.3 4.2 6.0 4.7 4.7 3.8 4.4 2.7 4.2 2.3 6.6 8.5 3.5 8.1 8.0 11.8 10.7 7.5 6.6 7.9 5.8 7.8 8.3 3.0 4.3 9.3 4.9 3.4 4.6 2.3 2.5 32.1 3.4 10.4 5.9 9.2 3.3 8.2 2.6 4.0 3.4 0.0 8.8 14.2 3.8 1.7 1.1 4.9 6.8 1.6 2.9 3.1 7.0 1.3 2.3 4.4 3.3 9.0 5.2 6.3 5.5 3.5 2.1 5.6 6.2 0.0 4.7 13.3 6.7 4.0 3.4 5.3 6.3 3.1 WWTR1 "DKFZp586I1419, TAZ" ENSG00000018408 "WW domain containing transcription regulator 1" Q9GZV5 3 149517235-149736714 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 158.0;Endothelial cells: 172.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.6;memory CD8 T-cell: 2.8" "Lineage enriched" "Detected in single" 4 "T-cells: 2.8" "Cell line enhanced" "Detected in many" "EFO-21: 60.9;SK-MEL-30: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007415, CAB017483, CAB068248" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602" "unprognostic (1.85e-2)" "unprognostic (2.24e-2)" "unprognostic (3.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.41e-2)" "unprognostic (2.22e-1)" "unprognostic (1.74e-2)" "unprognostic (2.34e-1)" "unprognostic (1.63e-2)" "unprognostic (3.32e-1)" "unprognostic (1.17e-3)" "unprognostic (2.76e-2)" "unprognostic (2.53e-1)" "unprognostic (3.98e-2)" "unprognostic (1.01e-3)" 25.1 9.9 9.3 16.0 18.6 0.2 20.4 7.7 10.5 27.2 38.5 18.4 15.0 5.6 27.2 17.6 41.2 16.4 25.8 20.6 14.7 9.0 31.0 13.1 29.8 6.2 15.2 5.6 30.9 21.7 10.4 8.5 29.0 20.7 34.6 9.1 29.4 15.8 22.4 12.1 13.4 11.7 81.5 25.8 13.8 20.8 12.0 16.4 0.7 18.2 13.2 7.1 68.4 31.0 0.2 0.1 0.6 0.1 0.1 2.8 0.4 16.8 20.0 10.6 14.2 12.7 22.7 11.2 9.8 14.4 4.4 4.7 11.2 14.3 0.0 60.9 11.0 13.6 10.0 6.9 7.1 4.4 4.7 5.3 0.0 5.2 9.3 7.2 0.0 0.0 12.0 1.8 15.4 6.8 17.0 34.5 0.0 0.0 0.0 15.3 2.2 0.0 0.0 2.4 0.0 25.3 0.0 14.3 0.1 37.8 2.5 0.0 0.1 6.5 4.6 42.0 8.3 7.8 0.3 28.0 8.7 4.2 7.0 19.1 0.2 0.1 0.2 18.7 0.0 22.2 0.4 0.1 0.1 2.6 0.0 0.0 0.0 0.3 2.8 0.0 0.2 0.1 1.3 0.6 0.1 0.0 0.1 1.9 0.4 9.3 18.6 7.7 10.5 14.7 9.0 15.2 5.6 20.7 16.4 59.6 79.0 0.0 158.0 45.9 2.0 42.0 147.7 60.2 128.5 47.1 3.9 10.5 6.6 55.4 14.8 172.1 0.7 0.0 23.5 70.1 58.9 72.2 7.0 20.3 3.7 0.0 0.0 92.7 6.4 3.6 53.5 8.0 28.7 3.6 0.0 10.4 31.6 0.0 118.8 48.8 2.0 58.2 48.4 1.7 0.7 31.0 12.4 5.3 0.0 80.1 XAF1 "BIRC4BP, HSXIAPAF1, XIAPAF1" ENSG00000132530 "XIAP associated factor 1" Q6GPH4 17 6755447-6775647 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 56.6;Club cells: 50.0;granulocytes: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 33.1;BJ hTERT+ SV40 Large T+ RasG12V: 34.2;HHSteC: 15.2" HPA057302 Approved Supported "Nucleoplasm,Mitochondria,Rods & Rings" Yes NA Mitochondria "Nucleoplasm, Rods & Rings" "HPA057302: AB_2683405" "unprognostic (6.28e-2)" "unprognostic (1.71e-1)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.09e-3)" "unprognostic (4.89e-2)" "unprognostic (1.39e-1)" "unprognostic (8.08e-3)" "unprognostic (3.34e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.73e-7)" "unprognostic (2.33e-1)" "unprognostic (1.74e-2)" "unprognostic (2.31e-1)" "unprognostic (6.15e-3)" 32.8 7.5 12.2 27.0 13.2 17.5 14.4 4.3 14.0 12.8 10.5 8.9 11.4 15.3 15.6 22.4 11.8 12.0 20.1 13.1 10.7 7.9 19.1 37.9 25.1 15.8 11.0 9.6 34.6 2.7 2.2 8.6 15.2 16.4 13.2 10.1 9.9 26.4 9.0 9.1 10.7 14.4 14.7 10.8 35.0 14.0 5.4 11.0 17.3 10.5 9.2 11.3 12.0 13.4 4.3 7.7 13.1 11.6 7.7 8.5 5.3 2.0 0.1 0.2 0.5 2.8 6.3 0.2 2.5 10.4 33.1 34.2 0.2 3.0 0.5 0.8 3.8 11.9 1.2 0.0 0.5 3.8 4.5 0.1 0.7 0.3 0.4 15.2 0.4 3.1 2.9 0.0 4.4 0.1 0.1 2.7 9.6 0.2 10.8 1.0 0.1 2.2 8.8 0.2 0.1 0.8 4.3 0.1 0.2 0.0 1.9 0.2 0.2 1.2 0.2 5.5 0.2 0.3 12.1 0.3 0.4 0.3 0.9 0.2 1.6 0.5 0.2 0.9 7.2 0.8 13.1 8.8 4.2 7.5 11.6 5.7 3.3 5.9 5.2 7.7 4.3 4.0 4.1 10.6 7.7 10.7 0.8 8.5 5.3 12.2 13.2 4.3 14.0 10.7 7.9 11.0 9.6 16.4 11.0 56.6 31.7 5.4 5.3 4.6 0.2 1.6 12.7 36.1 50.0 0.0 0.0 0.1 0.0 1.1 3.1 24.8 8.1 23.3 1.7 3.5 8.7 2.7 46.3 13.6 15.0 0.0 1.7 28.8 16.4 0.6 33.6 22.5 5.0 3.6 8.4 1.0 6.2 0.0 25.8 0.2 0.3 19.4 3.9 0.3 0.6 2.4 0.3 13.8 6.6 5.4 XIAP "API3, BIRC4, hILP" ENSG00000101966 "X-linked inhibitor of apoptosis" P98170 X 123859724-123913979 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway, Wnt signaling pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB009203, HPA042428" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009203: AB_2257167, HPA042428: AB_2677993" "prognostic unfavorable (9.21e-4)" "unprognostic (8.43e-2)" "unprognostic (1.50e-2)" "unprognostic (2.14e-1)" "unprognostic (1.40e-1)" "unprognostic (9.41e-2)" "unprognostic (1.95e-2)" "unprognostic (8.51e-2)" "unprognostic (9.17e-2)" "unprognostic (3.90e-2)" "unprognostic (7.50e-2)" "unprognostic (4.41e-2)" "unprognostic (3.15e-3)" "unprognostic (8.21e-3)" "unprognostic (2.26e-1)" "unprognostic (4.99e-2)" "unprognostic (4.65e-2)" 17.4 14.4 20.0 18.1 20.2 12.0 15.9 21.3 18.9 17.2 19.4 14.5 22.9 16.1 17.4 17.0 18.9 12.6 14.7 15.7 18.9 22.1 19.8 19.4 16.5 15.5 18.8 14.6 13.9 19.7 36.6 26.1 18.2 15.9 15.6 16.8 16.9 14.6 22.9 21.5 14.2 23.4 17.0 19.0 15.8 16.2 7.0 12.3 13.9 24.3 11.4 14.0 15.4 20.5 5.7 4.3 11.1 3.9 3.3 5.5 1.9 11.7 10.0 7.9 6.8 9.4 12.1 10.3 12.8 9.5 7.0 6.0 4.5 13.8 11.0 19.0 10.9 13.3 4.4 11.7 8.0 12.9 11.4 6.4 7.4 8.4 6.8 11.9 13.4 15.4 8.3 12.5 11.6 15.0 8.1 9.6 8.3 11.7 12.7 13.5 12.2 7.5 6.5 6.5 11.7 7.9 8.0 9.2 11.6 10.5 17.1 5.4 7.9 17.5 10.1 10.3 7.3 6.2 6.6 11.9 0.4 4.8 21.0 14.2 10.7 10.7 12.2 14.4 9.6 8.8 11.1 2.6 3.5 5.0 2.3 4.7 4.6 3.8 5.5 1.4 5.7 4.4 3.0 8.2 3.3 3.9 4.3 2.5 1.9 20.0 20.2 21.3 18.9 18.9 22.1 18.8 14.6 15.9 12.3 74.5 82.4 26.9 28.9 23.7 71.7 36.7 56.0 46.8 63.7 50.6 90.3 15.7 23.2 32.6 2.2 45.7 74.1 0.0 46.9 25.4 27.8 42.3 57.9 73.4 26.6 71.5 45.5 66.3 41.2 1.5 39.4 43.8 8.5 27.9 52.4 42.8 52.8 48.9 48.4 48.2 129.5 64.7 27.8 10.4 19.9 31.0 31.8 33.1 39.8 58.3 XIRP1 "CMYA1, DKFZp451D042, Xin" ENSG00000168334 "Xin actin binding repeat containing 1" Q702N8 3 39183210-39192596 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "heart muscle: 95.0;skeletal muscle: 219.0" "Cell type enriched" "Detected in single" 1478 "Cardiomyocytes: 827.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 9.3;LHCN-M2: 2.3;RH-30: 6.2;SuSa: 1.9" "HPA016750, HPA018458, CAB026391" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885" "unprognostic (2.19e-1)" "unprognostic (6.40e-2)" "unprognostic (1.13e-1)" "unprognostic (9.75e-2)" "unprognostic (2.76e-1)" "unprognostic (2.43e-2)" "unprognostic (4.94e-2)" "unprognostic (2.66e-3)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (5.30e-2)" "unprognostic (6.26e-2)" "unprognostic (1.02e-5)" "unprognostic (2.08e-2)" "unprognostic (2.78e-2)" "unprognostic (6.86e-4)" "unprognostic (4.12e-2)" 1.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 1.7 1.9 0.0 0.4 95.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.2 0.3 1.1 0.0 0.0 1.3 0.0 219.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 4.9 18.2 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 827.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 XK "Kx, NA, NAC, X1k, XKR1" ENSG00000047597 "X-linked Kx blood group" P51811 X 37685756-37732130 "Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Blood group antigen" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.6" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 21.1;Erythroid cells: 23.3;Mucus-secreting cells: 12.1;Undifferentiated cells: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 40 "basophil: 9.4;eosinophil: 6.8" "Lineage enriched" "Detected in single" 94 "granulocytes: 9.4" "Cell line enhanced" "Detected in many" "HEL: 25.2;HL-60: 13.0;K-562: 16.2;NB-4: 11.9;RPMI-8226: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019036 Approved Approved Nucleoplasm,Vesicles,Mitochondria No No Mitochondria "Nucleoplasm, Vesicles" "HPA019036: AB_1846286" "unprognostic (2.37e-2)" "unprognostic (7.13e-3)" "unprognostic (5.03e-2)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "unprognostic (4.56e-1)" "unprognostic (3.59e-2)" "unprognostic (4.00e-2)" "unprognostic (4.77e-3)" "unprognostic (5.07e-2)" "unprognostic (6.63e-2)" "unprognostic (5.90e-2)" "unprognostic (4.44e-8)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" 0.6 2.9 4.9 3.0 5.1 14.0 1.1 10.2 8.3 1.8 16.5 1.2 0.0 12.9 1.2 0.8 2.7 4.8 2.0 8.1 4.7 6.6 1.4 2.1 1.5 0.7 3.0 5.9 1.2 7.9 2.2 3.8 1.4 4.4 2.1 13.8 1.0 8.6 1.5 5.9 1.2 23.6 3.2 1.6 1.2 13.3 3.5 0.2 0.1 1.4 5.9 0.8 2.9 2.5 0.0 0.0 9.4 0.0 0.0 0.0 0.7 9.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 8.4 0.1 0.0 0.4 1.6 8.9 0.0 0.0 0.0 2.4 25.2 1.4 0.0 0.0 13.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 16.2 6.4 0.1 0.9 0.1 11.9 3.2 0.4 3.2 0.0 0.0 11.4 0.0 0.6 2.4 0.0 0.4 0.8 0.0 0.5 1.2 3.2 0.0 0.0 0.4 0.0 1.4 5.5 9.1 0.0 0.1 6.9 0.0 9.4 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 4.9 5.1 10.2 8.3 4.7 6.6 3.0 5.9 4.4 0.2 0.0 0.6 0.0 0.2 0.3 0.5 5.9 0.0 1.4 0.0 0.0 5.9 0.1 0.0 0.0 0.9 0.0 21.1 23.3 2.6 0.1 0.0 1.1 0.0 0.8 0.1 3.2 5.8 0.0 0.0 0.2 0.0 0.0 1.7 0.0 12.1 0.0 1.2 8.6 0.7 0.0 0.9 0.0 1.7 4.6 4.3 1.0 0.0 0.0 10.8 0.4 YIPF1 "DJ167A19.1, FinGER1" ENSG00000058799 "Yip1 domain family member 1" Q9Y548 1 53851719-53889834 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014716, HPA073931" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA014716: AB_1847686, HPA073931: " "unprognostic (4.94e-2)" "unprognostic (4.50e-1)" "unprognostic (6.37e-2)" "unprognostic (2.06e-2)" "unprognostic (3.93e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.96e-1)" "unprognostic (6.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.49e-1)" "unprognostic (2.76e-1)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.38e-1)" "unprognostic (5.39e-3)" "unprognostic (6.35e-1)" 10.1 15.6 12.8 9.1 13.9 8.0 18.2 6.9 12.8 11.2 12.1 8.8 11.5 11.0 6.6 12.2 14.0 10.2 10.8 13.4 10.6 12.1 16.1 31.8 11.9 14.1 12.4 9.1 11.8 13.7 7.2 15.5 15.4 14.4 17.8 14.4 10.2 17.1 14.3 18.7 13.9 10.6 9.4 10.6 13.3 13.0 10.8 11.1 10.3 33.5 9.8 15.7 12.9 16.2 8.1 11.4 26.7 14.5 6.9 16.0 10.2 6.9 4.2 6.7 4.7 7.9 8.9 6.0 5.0 7.9 9.3 12.2 4.8 2.1 2.3 8.5 6.0 14.3 8.3 8.8 11.1 9.6 17.6 7.0 5.8 4.7 7.2 10.9 6.4 5.5 8.9 10.5 7.4 9.0 7.9 10.0 8.7 6.0 6.7 9.0 5.9 6.5 9.3 4.9 8.2 7.0 4.1 6.3 9.9 7.9 3.6 3.0 3.8 4.7 9.0 23.0 22.1 13.9 7.2 4.5 3.8 3.9 6.7 4.3 13.5 15.4 4.3 5.8 5.3 3.3 12.5 12.5 13.2 8.5 11.3 8.0 8.1 7.3 8.5 11.4 7.7 7.1 6.7 26.7 6.9 14.5 7.8 16.0 10.2 12.8 13.9 6.9 12.8 10.6 12.1 12.4 9.1 14.4 11.1 6.0 13.0 10.7 15.1 7.6 6.5 8.5 28.1 14.7 15.9 8.7 0.0 65.7 10.0 23.6 22.9 8.7 11.7 0.0 28.3 23.0 8.3 37.4 9.2 17.4 34.5 9.5 9.2 13.5 19.9 41.4 5.5 15.8 10.1 16.2 23.0 16.2 25.6 12.9 8.9 13.5 5.4 0.0 6.2 12.7 18.3 9.5 108.4 13.8 9.5 22.0 YOD1 "DKFZp451J1719, DUBA8, OTUD2" ENSG00000180667 "YOD1 deubiquitinase" Q5VVQ6 1 207043849-207052980 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Unfolded protein response" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 44.7" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 69.8;Urothelial cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 40.3;K-562: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028400, HPA028439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 40000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA028400: AB_10599854, HPA028439: AB_10600994" "unprognostic (3.69e-2)" "unprognostic (8.72e-2)" "unprognostic (1.17e-1)" "unprognostic (2.39e-1)" "unprognostic (2.03e-2)" "unprognostic (3.28e-2)" "unprognostic (9.87e-3)" "unprognostic (9.38e-2)" "unprognostic (2.31e-3)" "unprognostic (8.96e-2)" "unprognostic (1.47e-3)" "unprognostic (1.03e-2)" "unprognostic (6.07e-2)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (1.79e-2)" "unprognostic (3.62e-1)" 4.5 4.6 4.0 4.0 5.3 44.7 6.6 4.8 7.5 6.1 3.9 7.6 2.6 4.1 4.0 3.1 24.5 3.7 3.5 5.0 4.0 2.2 4.5 5.2 9.4 4.2 7.1 4.4 3.5 3.6 2.5 5.1 6.3 5.1 3.4 4.0 3.4 9.7 3.0 6.5 14.9 4.8 2.7 8.5 5.2 8.4 5.6 6.9 14.3 5.8 10.0 8.2 5.8 12.3 0.5 1.3 3.9 1.5 1.2 1.8 0.9 5.4 2.9 4.6 2.7 1.6 2.1 9.0 3.6 2.8 2.7 2.8 5.5 5.6 2.8 1.5 2.2 1.3 6.0 0.0 4.4 3.1 2.3 4.9 40.3 11.9 2.6 1.5 5.2 14.2 1.5 3.4 2.2 8.6 3.2 2.4 5.9 28.0 0.0 2.3 0.0 4.6 2.9 4.4 2.2 6.5 2.3 0.2 2.1 2.7 6.1 2.4 5.3 5.9 6.9 7.7 4.2 2.4 3.7 1.1 2.4 6.2 1.9 4.7 4.6 0.2 4.2 2.8 0.0 1.6 3.9 1.2 2.0 1.1 1.5 1.5 0.4 1.7 0.9 1.3 0.5 1.4 1.8 2.9 1.2 1.0 0.7 0.8 0.9 4.0 5.3 4.8 7.5 4.0 2.2 7.1 4.4 5.1 6.9 38.7 9.8 0.8 21.4 28.0 7.8 5.3 5.1 13.4 5.7 1.8 3.9 2.3 1.7 3.8 28.6 3.5 9.8 46.7 9.3 2.7 5.7 29.8 8.1 5.4 2.4 11.1 8.5 3.7 8.5 69.8 1.4 6.4 13.5 1.8 3.5 4.2 15.5 4.9 2.1 5.4 16.2 6.5 3.1 8.8 4.1 35.1 1.5 7.5 5.4 62.9 YTHDC2 "DKFZp564A186, FLJ10053, FLJ2194" ENSG00000047188 "YTH domain containing 2" Q9H6S0 5 113513683-113595285 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 92.8;Spermatocytes: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037364, HPA072678" Approved Approved "Nucleoplasm,Nuclear bodies,Cytoplasmic bodies" NA NA Nucleoplasm "Nuclear bodies, Cytoplasmic bodies" "HPA037364: AB_10672788, HPA072678: AB_2686548" "unprognostic (2.09e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.82e-5)" "unprognostic (4.33e-3)" "unprognostic (1.45e-1)" "unprognostic (6.48e-3)" "unprognostic (1.96e-1)" "unprognostic (7.82e-3)" "unprognostic (3.55e-2)" "unprognostic (8.56e-3)" "unprognostic (4.61e-2)" "unprognostic (2.03e-1)" "unprognostic (4.15e-2)" "unprognostic (3.05e-1)" "unprognostic (9.96e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" 15.2 16.3 12.4 18.5 16.8 12.8 15.3 25.2 26.1 16.5 12.7 11.7 9.0 13.6 17.7 14.6 16.1 14.2 12.2 13.0 10.4 10.5 14.3 18.3 12.4 18.7 12.8 10.2 19.9 14.7 35.5 26.2 10.3 18.6 12.8 15.3 14.9 15.5 13.3 18.5 16.5 16.5 13.2 13.7 19.3 13.4 20.5 13.3 19.7 16.2 15.4 18.4 14.7 14.8 9.5 5.5 4.2 4.9 5.7 5.7 1.7 11.1 10.1 13.1 22.2 7.3 9.7 14.4 8.7 9.6 11.1 17.4 7.0 6.3 20.4 6.2 7.2 14.3 10.9 15.8 19.4 14.6 8.8 14.3 11.1 18.1 9.5 10.8 8.8 9.8 7.9 7.5 7.0 12.8 10.5 15.4 9.3 10.8 9.4 9.8 3.7 12.2 6.3 6.1 3.3 6.7 5.2 11.4 15.8 9.3 14.8 10.5 8.8 11.6 8.5 8.9 8.6 12.0 8.0 13.4 17.1 6.0 8.8 11.7 9.7 12.1 12.8 9.8 10.1 7.2 0.0 4.3 4.2 4.5 2.8 5.3 9.5 5.3 4.8 3.6 8.1 5.7 4.7 1.8 5.7 4.9 5.5 3.7 1.7 12.4 16.8 25.2 26.1 10.4 10.5 12.8 10.2 18.6 13.3 26.8 29.1 18.2 17.4 11.7 58.8 17.3 12.7 28.1 30.7 12.2 78.5 11.1 0.0 15.3 22.0 18.5 11.2 23.3 16.5 8.1 14.7 12.8 11.6 19.7 14.4 49.3 6.9 20.9 27.6 37.6 18.4 18.8 11.8 17.2 13.0 25.3 13.7 7.0 13.8 15.2 92.8 25.8 19.4 97.9 24.0 12.5 15.1 21.2 13.6 15.2 YWHAB YWHAA ENSG00000166913 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta" P31946 20 44885676-44908532 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003759, HPA007925, HPA011212, HPA061603" Enhanced Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 210000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334, HPA061603: " "prognostic unfavorable (9.18e-4)" "unprognostic (1.48e-1)" "unprognostic (9.06e-2)" "prognostic unfavorable (5.46e-4)" "unprognostic (3.80e-1)" "prognostic unfavorable (6.14e-4)" "prognostic unfavorable (1.91e-6)" "prognostic unfavorable (6.01e-4)" "unprognostic (8.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.53e-2)" "unprognostic (2.35e-1)" "prognostic favorable (2.52e-5)" "unprognostic (6.72e-2)" "unprognostic (2.40e-1)" "unprognostic (6.60e-3)" "unprognostic (8.59e-2)" 39.3 38.6 65.5 39.4 79.2 28.6 33.0 60.1 87.9 34.0 47.5 27.7 28.7 37.9 35.2 26.4 48.1 30.2 29.6 40.3 68.7 63.4 47.3 36.5 37.4 46.8 49.8 76.2 25.8 18.9 41.1 18.4 36.7 50.1 31.4 53.4 22.9 30.7 43.2 28.3 38.4 39.3 43.3 38.4 53.7 36.7 16.8 33.6 48.2 36.1 31.8 60.2 41.2 34.9 30.9 41.9 37.3 58.4 26.8 43.5 26.6 52.4 39.8 32.1 30.7 53.4 47.3 43.5 47.8 46.6 58.9 51.7 82.8 59.4 56.0 50.1 63.1 64.1 55.9 45.2 88.8 70.5 21.4 27.6 41.7 35.0 49.1 35.4 67.5 40.4 36.9 66.5 46.1 59.6 40.4 58.9 34.5 44.9 27.1 60.4 62.0 52.7 55.6 30.3 60.2 61.9 41.4 46.5 43.5 63.1 58.7 34.3 36.6 81.0 86.6 55.7 39.1 63.0 65.0 66.8 91.6 47.0 51.6 48.6 18.1 33.0 51.4 66.9 45.2 46.5 34.8 40.1 34.4 29.7 52.2 30.2 30.9 37.7 36.3 41.9 28.6 30.8 36.6 37.3 26.8 58.4 26.5 43.5 26.6 65.5 79.2 60.1 87.9 68.7 63.4 49.8 76.2 50.1 33.6 235.2 267.7 257.8 195.0 245.8 236.2 168.2 214.0 242.2 213.9 235.5 47.1 316.7 195.6 394.2 12.6 314.4 343.6 0.0 427.4 513.3 214.8 235.2 219.7 140.9 363.9 276.5 286.2 292.8 365.8 16.1 174.9 402.5 210.9 466.1 277.5 222.2 471.9 382.0 197.7 259.3 98.3 226.4 208.3 50.5 174.0 284.4 444.3 286.3 279.8 359.2 YWHAE FLJ45465 ENSG00000108953 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon" P62258 17 1344272-1400378 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008445, CAB016200, CAB021109, CAB047350, HPA061603" Approved Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 160000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336, HPA061603: " "unprognostic (1.29e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-2)" "prognostic favorable (6.48e-6)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (2.73e-2)" "unprognostic (4.77e-3)" "unprognostic (4.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.92e-3)" "unprognostic (8.33e-2)" "unprognostic (2.57e-1)" "unprognostic (3.24e-2)" "unprognostic (8.94e-2)" 55.2 54.3 107.5 35.3 87.1 32.7 37.3 71.5 118.4 28.4 40.2 60.9 23.8 40.2 35.9 54.1 43.1 44.2 23.4 57.7 92.3 81.9 64.5 50.9 32.8 25.4 94.1 77.9 40.2 40.2 41.0 37.9 45.1 73.7 35.0 42.5 27.9 42.4 27.7 135.9 36.8 36.2 32.2 101.1 26.2 38.5 46.0 53.6 30.9 47.5 36.5 37.2 31.6 32.1 19.2 41.5 17.2 36.2 15.0 23.3 31.5 79.3 59.3 71.9 60.4 31.8 36.8 69.1 51.3 30.3 45.8 35.6 106.0 32.6 53.9 60.4 42.5 36.3 55.2 60.9 51.9 65.1 37.2 113.5 37.6 49.5 45.3 38.0 36.0 38.6 33.3 38.3 45.9 70.4 41.5 55.1 39.3 43.1 39.0 58.9 38.6 47.6 28.7 65.9 49.5 38.5 57.9 34.0 38.2 46.6 46.0 40.1 60.8 61.8 25.3 40.2 42.5 48.1 33.3 52.1 44.5 37.9 56.2 90.6 24.5 45.2 45.2 53.4 43.1 64.3 17.2 31.8 8.6 12.4 36.2 15.6 19.2 18.7 13.9 41.5 16.1 17.0 14.3 10.8 15.0 30.9 28.8 23.3 31.5 107.5 87.1 71.5 90.2 92.3 81.9 94.1 77.9 73.7 53.6 276.9 161.5 157.1 381.2 509.9 135.0 437.9 257.4 539.4 243.4 352.4 47.1 418.8 631.6 405.9 192.2 338.4 245.3 70.0 366.4 587.8 367.2 359.0 204.6 255.7 335.2 104.9 338.5 239.4 235.4 296.2 260.1 221.5 403.2 401.2 274.5 253.1 384.5 266.5 277.2 497.3 121.5 239.3 263.7 441.4 573.9 512.8 434.5 126.4 277.6 415.5 YWHAG PPP1R170 ENSG00000170027 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma" P61981 7 76326794-76359031 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 117.8;skeletal muscle: 91.8" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 363.1;Suprabasal keratinocytes: 371.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013274, CAB018389, HPA026918, HPA061603" Approved Approved Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 160000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: " "unprognostic (3.71e-2)" "prognostic unfavorable (4.53e-4)" "unprognostic (3.88e-2)" "unprognostic (1.25e-2)" "unprognostic (6.28e-3)" "unprognostic (2.40e-3)" "unprognostic (8.98e-3)" "prognostic unfavorable (5.34e-4)" "unprognostic (1.63e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.03e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (9.31e-2)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (1.70e-1)" 52.4 31.2 46.3 17.7 54.6 7.3 17.2 36.2 117.8 13.4 14.2 13.3 4.6 14.4 15.0 7.0 18.6 9.0 17.0 33.1 50.2 56.2 15.9 22.0 12.9 12.1 45.9 49.8 13.3 18.0 14.8 7.8 16.6 74.6 14.7 14.0 8.6 10.0 13.3 91.8 11.7 12.5 20.2 22.8 12.7 11.2 8.9 13.5 6.8 8.8 13.8 14.3 14.7 13.2 3.1 5.9 3.2 5.0 1.1 3.3 1.7 37.4 47.2 41.7 53.0 42.8 24.7 18.9 43.6 21.6 27.1 29.4 29.6 40.4 52.9 15.0 38.7 45.1 35.1 52.3 48.1 38.1 35.8 22.8 50.1 32.3 32.8 39.1 61.1 49.0 27.1 46.2 31.6 65.5 28.8 42.9 28.8 68.7 59.9 40.3 35.3 43.6 45.2 46.3 30.3 33.1 51.1 42.3 58.4 42.4 25.6 22.4 62.3 48.3 62.0 30.8 56.2 43.1 37.0 45.3 52.9 30.7 46.9 58.2 19.9 37.2 81.5 47.5 57.8 56.3 3.2 5.0 1.1 2.1 4.6 3.3 3.1 2.4 2.6 5.2 1.8 1.8 2.0 1.1 1.1 3.8 5.9 2.0 1.7 46.3 54.6 36.2 88.9 50.2 56.2 45.9 49.8 74.6 13.5 29.8 23.7 44.7 105.7 363.1 100.2 200.1 43.3 22.7 45.5 36.6 11.8 29.7 31.5 43.8 87.4 64.2 34.1 46.7 32.8 61.5 84.6 106.7 66.8 81.5 75.7 117.6 81.9 48.5 90.6 18.9 42.8 83.5 89.4 41.5 31.5 23.8 60.8 28.8 40.7 41.0 26.9 32.3 122.6 10.3 16.7 371.9 56.2 18.7 33.8 146.6 YWHAQ "14-3-3, HS1" ENSG00000134308 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta" P27348 2 9583972-9631014 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007925, CAB010286, HPA061603" Approved Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 120000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB010286: AB_2218221, HPA007925: AB_1844340, HPA061603: " "unprognostic (2.65e-2)" "unprognostic (3.99e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (1.53e-1)" "unprognostic (5.78e-3)" "prognostic unfavorable (9.83e-6)" "unprognostic (4.90e-3)" "unprognostic (2.98e-2)" "unprognostic (5.51e-2)" "unprognostic (6.18e-2)" "unprognostic (1.45e-1)" "unprognostic (2.95e-2)" "unprognostic (6.74e-2)" "unprognostic (9.75e-2)" "unprognostic (1.63e-1)" "unprognostic (4.39e-3)" 40.5 47.3 77.8 32.1 60.8 48.0 50.8 88.5 82.5 52.2 44.0 82.5 25.0 37.9 60.5 48.2 57.6 45.3 40.0 68.5 73.7 76.2 45.9 37.2 35.0 38.2 74.3 54.8 55.9 64.4 39.2 39.0 39.3 69.8 54.2 44.1 31.2 38.9 48.8 17.6 33.3 36.5 57.9 72.2 29.8 36.9 44.3 63.5 58.8 45.4 56.7 43.3 47.7 46.3 31.5 30.9 24.8 28.9 51.4 58.4 60.9 43.6 65.8 59.7 57.5 47.0 65.1 56.1 59.9 59.1 63.0 52.9 49.4 38.4 56.5 31.3 85.8 65.8 41.1 66.2 65.3 81.4 139.0 53.8 52.8 42.9 52.8 35.9 50.8 32.0 43.9 38.5 68.7 44.9 57.7 70.6 40.7 51.8 34.1 77.3 30.3 89.9 51.9 101.2 49.2 75.8 65.8 77.4 69.1 69.4 39.1 56.8 96.2 54.5 56.6 43.3 52.3 35.2 26.2 64.3 79.2 56.1 68.5 91.3 34.9 47.7 74.5 67.7 53.1 65.6 17.1 22.2 24.8 47.8 28.9 58.4 31.5 45.1 50.8 30.9 28.8 24.7 39.9 6.8 51.4 27.2 15.7 43.1 60.9 77.8 60.8 88.5 69.0 73.7 76.2 74.3 54.8 69.8 63.5 47.6 54.2 118.7 293.0 281.3 203.3 78.7 73.9 77.6 76.2 129.1 25.5 223.0 353.1 336.2 171.2 152.5 136.5 93.5 248.0 498.0 248.0 243.9 124.5 87.6 192.8 540.3 179.5 67.5 94.8 285.3 161.1 114.1 280.0 283.1 112.7 196.5 233.6 132.5 235.5 197.6 82.9 194.1 334.9 246.8 203.3 310.7 199.5 181.1 168.3 364.8 YWHAZ "14-3-3-zeta, KCIP-1, YWHAD" ENSG00000164924 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta" P63104 8 100916525-100953388 "Plasma proteins, Predicted intracellular proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 1590.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005065, HPA061603" Approved Approved "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 760000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB005065: AB_2218378, HPA061603: " "unprognostic (4.70e-3)" "unprognostic (7.38e-3)" "unprognostic (8.09e-2)" "prognostic unfavorable (3.91e-4)" "unprognostic (1.83e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (2.28e-5)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.65e-1)" "unprognostic (3.72e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.03e-6)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" 54.6 40.9 89.9 51.8 104.6 70.8 39.6 55.8 117.7 52.4 69.6 38.7 25.3 47.4 43.5 37.6 141.8 38.3 51.9 29.1 81.7 67.0 44.1 32.9 40.7 60.0 50.1 66.7 46.4 27.5 37.8 25.2 69.0 78.2 42.5 70.3 31.7 55.2 47.2 19.7 63.0 71.4 53.5 43.8 56.3 51.5 34.1 31.5 89.4 46.0 74.9 83.2 53.6 70.2 58.6 57.2 129.4 77.9 57.0 78.4 104.9 135.5 66.0 125.8 36.1 31.3 39.8 62.4 63.7 82.9 86.3 84.1 45.9 89.0 60.9 69.1 101.2 71.9 59.0 79.1 90.8 131.5 53.9 31.2 57.5 49.9 29.7 41.2 24.0 66.0 36.9 123.8 71.3 113.7 73.1 77.5 43.6 65.4 59.8 73.7 49.2 99.1 42.6 42.5 171.2 69.1 42.2 36.6 41.9 83.0 76.6 70.5 50.3 48.4 48.1 100.9 93.7 69.7 28.4 63.0 43.8 64.3 52.7 57.1 38.1 45.2 74.8 72.4 45.4 179.2 129.4 45.0 81.2 69.1 66.5 70.3 58.6 59.0 66.5 57.2 48.0 44.8 56.4 74.6 57.0 77.9 35.4 78.4 104.9 89.9 104.6 55.8 117.7 81.7 67.0 50.1 66.7 78.2 31.5 232.3 218.0 255.7 330.0 894.5 96.7 77.9 206.4 306.5 335.5 249.5 84.4 219.2 102.8 385.1 1094.8 171.9 335.2 46.7 365.6 441.5 215.1 349.2 432.9 89.1 253.4 127.1 254.5 172.5 286.2 1590.1 116.2 345.3 371.2 266.9 443.9 100.4 544.8 334.6 138.3 122.2 86.4 129.4 256.3 148.6 68.6 1035.6 342.0 343.9 282.9 758.7 YY1 "DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1" ENSG00000100811 "YY1 transcription factor" P25490 14 100238298-100282792 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001119, CAB009392" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA Nucleoplasm "Nucleoli fibrillar center, Vesicles" "CAB009392: AB_2218501, HPA001119: AB_1858930" "unprognostic (7.67e-2)" "unprognostic (8.08e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (6.75e-3)" "unprognostic (8.31e-3)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.09e-1)" "unprognostic (4.26e-2)" "unprognostic (7.68e-3)" "unprognostic (1.40e-1)" "unprognostic (1.51e-1)" "unprognostic (3.72e-2)" "unprognostic (4.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.30e-1)" "unprognostic (4.30e-1)" 32.7 28.8 26.3 27.0 25.8 45.3 33.8 33.6 26.4 28.1 37.6 24.9 34.6 26.4 29.5 33.7 34.1 24.4 27.4 38.3 27.6 21.9 31.4 42.8 31.8 30.6 26.5 21.1 26.9 27.7 32.5 23.6 35.2 24.1 29.3 28.2 21.5 25.6 23.1 39.9 27.2 31.0 25.9 26.5 30.6 25.3 22.6 25.8 60.2 40.9 23.3 35.2 29.7 47.0 8.2 6.3 14.2 7.0 12.0 9.0 3.0 23.8 12.6 25.9 20.6 20.7 25.9 28.2 23.7 21.4 25.8 26.1 15.2 40.1 36.5 33.8 20.7 15.6 25.0 28.2 24.4 35.2 28.4 22.8 33.9 14.7 19.5 19.2 40.5 29.7 15.7 29.3 17.8 24.5 23.6 24.5 26.9 26.3 25.5 24.4 29.6 44.1 22.1 27.1 38.6 21.7 36.0 36.1 19.8 28.9 23.7 27.6 20.6 31.6 22.9 32.1 23.6 35.1 37.2 22.3 16.0 20.1 39.0 20.7 26.8 27.2 50.6 22.3 26.3 20.8 5.1 7.0 14.2 5.5 5.9 7.0 6.3 7.6 7.7 6.1 8.2 7.1 6.8 12.2 12.0 4.5 6.3 9.0 3.0 26.3 25.8 33.6 26.4 27.6 21.9 26.5 21.1 24.1 25.8 50.6 53.8 77.0 90.1 211.3 79.2 72.5 61.1 36.1 38.7 64.6 76.6 101.0 61.3 59.0 8.2 94.0 85.8 23.3 70.8 103.7 89.5 134.5 70.4 100.7 71.3 120.8 105.6 87.2 94.9 11.0 87.8 94.4 72.6 45.1 80.2 80.6 70.0 88.8 94.7 71.8 75.3 90.5 110.2 79.0 66.8 212.4 146.8 81.6 102.0 131.5 ZADH2 MGC45594 ENSG00000180011 "Zinc binding alcohol dehydrogenase domain containing 2" Q8N4Q0 18 75195108-75209348 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021468, HPA053646" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Vesicles "Nucleoplasm, Golgi apparatus" "HPA021468: AB_1858932, HPA053646: AB_2682216" "unprognostic (3.22e-2)" "unprognostic (1.03e-2)" "unprognostic (7.14e-2)" "unprognostic (1.13e-1)" "unprognostic (4.79e-1)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (1.49e-1)" "unprognostic (3.62e-3)" "unprognostic (1.42e-1)" "unprognostic (3.05e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.02e-6)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.94e-4)" "unprognostic (2.23e-1)" 14.1 12.1 15.6 12.5 22.5 12.7 28.1 19.1 24.1 15.5 18.9 10.8 13.6 13.7 12.8 19.0 18.1 13.5 15.7 24.4 17.4 11.3 18.0 23.4 13.3 12.7 12.9 18.4 19.6 19.5 22.4 20.5 26.2 19.3 13.8 21.4 13.5 16.3 14.1 34.5 15.8 24.0 16.9 12.1 15.0 15.5 7.1 11.2 11.2 20.7 15.5 14.5 17.4 15.5 2.7 3.3 12.1 5.2 2.5 4.8 2.3 9.4 6.3 6.7 13.8 10.5 13.6 7.4 17.2 20.0 6.8 8.5 3.8 13.5 6.6 2.8 17.0 8.0 12.9 8.3 14.5 4.8 41.3 12.2 14.9 13.9 7.5 7.5 25.1 15.2 15.0 14.6 5.4 12.5 12.6 13.9 15.8 8.0 24.5 12.9 11.1 6.3 12.4 1.7 9.2 14.4 13.5 10.8 21.9 13.2 16.1 12.5 10.3 9.5 9.8 10.9 5.0 9.8 12.5 12.3 13.4 10.2 4.2 5.4 4.0 17.4 4.5 8.8 21.8 10.7 1.9 5.0 12.1 4.8 4.2 3.8 2.7 4.1 4.5 3.3 2.5 2.3 3.5 2.7 2.5 5.2 2.5 4.4 2.3 15.6 22.5 19.1 24.1 17.4 11.3 12.9 18.4 19.3 11.2 32.8 14.1 10.4 16.0 8.7 56.1 45.6 17.8 5.3 10.3 26.2 5.9 8.2 16.6 10.1 0.4 23.3 27.4 0.0 18.6 5.9 16.9 16.0 6.9 20.7 14.3 23.8 22.5 19.6 18.6 1.1 33.9 14.8 11.8 14.4 25.7 20.9 12.7 21.0 59.4 14.6 39.1 19.4 9.8 0.3 6.3 9.7 5.6 10.0 27.0 18.3 ZBED1 "ALTE, DREF, hDREF, KIAA0785, TRAMP" ENSG00000214717 "Zinc finger BED-type containing 1" O96006 X 2486414-2500967 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 43.3" "Low region specificity" "Detected in all" HPA077591 Approved Approved "Nucleoplasm,Nuclear membrane,Centrosome" NA NA "Nucleoplasm, Centrosome" "Nuclear membrane" "HPA077591: AB_2686847" "unprognostic (7.66e-3)" "unprognostic (3.79e-2)" "unprognostic (2.39e-2)" "unprognostic (4.92e-3)" "unprognostic (4.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (3.95e-2)" "unprognostic (3.27e-1)" 8.5 10.5 24.8 6.0 30.7 3.1 63.7 24.8 29.0 36.8 8.1 1.7 1.7 10.6 28.9 2.8 6.1 6.4 7.1 43.4 27.3 7.2 39.6 13.6 5.9 6.0 25.1 19.6 28.7 10.4 6.8 27.8 37.5 32.5 6.8 6.4 1.7 7.7 6.3 29.5 9.5 11.2 5.1 30.4 7.9 6.6 3.4 27.1 1.7 5.4 1.7 4.8 5.8 31.4 12.7 13.7 13.0 12.4 5.4 11.5 10.2 5.2 13.1 9.6 10.5 6.1 6.5 43.3 7.4 8.2 4.4 5.1 16.7 4.6 10.4 8.6 9.9 12.1 2.5 9.1 7.7 3.3 12.2 12.2 7.7 11.2 14.2 8.0 4.7 16.2 9.6 6.1 4.6 3.5 6.6 10.4 7.1 9.8 3.4 8.5 3.7 7.9 3.8 23.5 3.4 7.8 6.4 9.4 4.9 7.4 10.2 11.4 11.2 6.3 17.1 11.8 11.2 4.7 10.2 14.2 9.5 5.0 5.2 8.1 4.2 0.0 17.2 3.8 6.8 5.3 1.8 11.6 9.7 11.5 12.4 10.3 9.4 6.8 6.5 13.7 12.7 6.6 5.4 13.0 5.4 9.3 10.1 6.6 10.2 24.8 30.7 24.8 29.0 27.3 7.2 25.1 19.6 32.5 27.1 11.9 9.4 11.5 14.3 13.5 56.5 22.9 48.4 14.7 7.9 24.4 13.7 13.2 10.0 21.0 0.2 17.9 19.8 0.0 20.2 15.4 16.9 18.3 14.9 33.1 15.5 9.5 14.9 13.5 11.8 0.8 18.4 17.7 8.5 19.0 19.5 19.9 20.8 17.3 21.5 15.8 22.4 6.5 14.4 0.0 3.2 9.8 31.8 12.5 21.9 11.5 ZBED5 Buster1 ENSG00000236287 "Zinc finger BED-type containing 5" Q49AG3 11 10812074-10858796 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048472, HPA050994" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA048472: AB_2680408, HPA050994: AB_2681300" "unprognostic (7.74e-2)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (4.72e-2)" "unprognostic (3.40e-1)" "unprognostic (9.05e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (5.69e-2)" "unprognostic (4.61e-2)" "unprognostic (2.23e-2)" "unprognostic (2.25e-2)" "unprognostic (3.27e-2)" "unprognostic (8.77e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic favorable (3.87e-4)" 21.6 18.5 20.4 32.6 21.6 21.5 27.5 43.2 30.2 35.6 24.7 22.0 17.2 18.4 34.7 27.6 22.5 30.8 19.8 32.7 21.3 13.1 24.0 13.0 24.5 38.1 24.0 23.4 40.2 24.4 42.0 44.6 20.9 27.1 30.1 22.7 16.3 24.9 19.1 32.6 36.8 29.4 22.4 30.5 35.6 22.2 17.2 25.3 45.0 34.9 17.7 32.3 30.0 26.4 18.4 12.4 5.8 8.4 13.4 14.5 6.2 20.1 16.3 28.5 18.5 15.5 24.4 14.7 16.5 17.2 11.4 11.2 11.6 44.0 22.4 12.5 12.2 15.6 25.0 17.7 17.2 15.4 21.5 16.0 5.7 34.2 7.1 12.8 18.3 7.7 16.4 25.2 8.5 18.9 20.1 14.0 11.2 15.0 25.4 16.2 10.2 17.8 19.9 15.4 14.8 21.7 27.1 15.8 11.8 13.3 28.4 14.1 25.1 17.1 22.1 13.1 16.9 20.9 10.3 13.8 24.4 17.6 16.2 11.5 12.5 15.4 17.6 21.1 13.0 18.5 0.7 6.7 5.8 9.3 7.3 12.0 16.7 11.1 11.7 9.6 18.4 14.5 14.0 5.6 13.4 8.4 12.4 9.4 6.2 20.4 21.6 43.2 30.2 21.3 13.1 24.0 23.4 27.1 25.3 53.6 24.1 23.3 40.9 30.8 31.1 31.9 17.8 56.2 47.8 21.0 27.5 14.5 19.9 19.1 5.8 16.5 10.2 0.0 14.1 8.6 17.9 19.1 8.1 5.7 10.6 27.0 26.6 23.9 15.9 4.9 25.3 17.7 15.1 11.8 15.8 20.1 15.4 17.5 25.8 12.4 32.3 19.4 24.0 41.8 17.0 31.1 10.4 17.3 16.0 21.0 ZBED9 "Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452" ENSG00000232040 "Zinc finger BED-type containing 9" Q6R2W3 6 28570535-28616212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 13.2;testis: 17.6" "Group enriched" "Detected in many" 4 "Early spermatids: 17.9;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 7.8;hTCEpi: 7.1;K-562: 12.5;U-266/84: 6.0" HPA007246 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA007246: AB_1080727" "unprognostic (1.01e-1)" "unprognostic (5.16e-5)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (3.96e-2)" "unprognostic (9.46e-3)" "unprognostic (3.40e-1)" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (2.34e-3)" "unprognostic (8.21e-3)" "unprognostic (4.31e-1)" "unprognostic (2.42e-2)" "unprognostic (1.14e-2)" "unprognostic (7.66e-3)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 0.8 1.8 2.6 0.4 7.2 0.4 2.3 9.5 4.7 2.3 1.1 0.3 9.3 0.7 1.6 7.5 1.0 3.1 0.7 1.2 2.4 2.3 2.3 3.2 1.9 0.5 1.3 2.9 4.1 3.4 3.2 6.9 3.0 3.5 3.4 1.5 0.8 2.4 13.2 0.5 0.7 0.8 1.1 0.8 0.6 1.0 17.6 0.7 0.0 4.1 0.0 0.6 1.4 1.2 0.5 0.7 1.1 0.7 0.4 1.4 0.2 1.8 1.8 1.9 0.0 0.0 0.0 2.3 0.4 0.0 0.4 1.2 0.0 1.2 0.0 7.8 0.1 3.8 1.0 0.0 2.1 0.4 0.0 5.2 0.5 1.2 1.8 1.3 0.0 0.0 1.1 7.1 0.1 3.5 1.1 0.0 0.0 12.5 0.0 0.1 1.4 0.0 0.1 1.8 0.0 0.9 0.7 0.8 0.1 2.0 2.2 2.0 4.9 0.0 2.0 0.0 2.8 0.0 0.6 0.0 0.0 2.2 0.0 1.2 0.0 6.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.3 0.4 0.1 0.2 0.4 0.4 0.2 0.5 1.4 1.0 1.1 0.4 0.7 0.7 0.1 0.2 2.6 7.2 9.5 4.7 2.4 2.3 1.3 2.9 3.5 0.7 0.0 2.7 0.0 0.8 0.0 1.6 1.6 5.1 1.4 1.2 0.0 2.0 2.0 1.7 1.7 17.9 0.0 0.4 0.0 1.2 1.1 0.4 1.1 0.0 1.6 0.3 0.0 1.2 0.0 0.0 3.2 2.3 0.0 0.0 0.0 1.4 1.1 0.6 0.0 0.0 0.7 1.1 0.0 0.0 27.7 2.9 0.0 0.8 0.0 0.9 0.6 ZBTB14 "ZFP161, ZNF478" ENSG00000198081 "Zinc finger and BTB domain containing 14" O43829 18 5289019-5297053 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050758, HPA070819" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA050758: AB_2681226, HPA070819: AB_2686316" "unprognostic (5.28e-2)" "unprognostic (4.37e-2)" "unprognostic (4.25e-2)" "unprognostic (2.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-2)" "unprognostic (2.95e-2)" "unprognostic (8.64e-2)" "unprognostic (1.19e-3)" "unprognostic (4.72e-3)" "unprognostic (3.25e-2)" "unprognostic (1.49e-1)" "unprognostic (3.70e-2)" "unprognostic (2.03e-1)" "unprognostic (2.53e-1)" "unprognostic (3.73e-1)" "unprognostic (2.90e-2)" 11.2 9.1 13.1 11.6 13.4 6.8 10.8 24.3 12.8 8.7 8.7 10.7 10.8 7.2 12.5 14.9 10.8 9.3 10.3 7.1 13.1 10.2 9.8 11.3 11.0 19.5 14.5 7.6 14.2 12.1 12.8 8.7 8.5 7.3 9.8 8.7 10.3 9.8 11.1 6.9 11.8 12.7 7.5 16.4 17.4 9.8 10.8 8.2 30.8 15.9 7.0 18.1 11.2 11.8 10.1 8.6 14.3 8.2 7.5 13.4 7.6 7.1 9.5 12.5 9.2 9.4 12.4 8.3 7.1 10.6 10.1 8.9 9.1 9.4 25.1 6.3 8.6 11.6 6.7 9.1 10.7 10.2 4.9 4.9 9.9 8.7 8.3 6.6 12.4 12.0 9.9 9.1 7.0 6.6 10.9 15.6 18.2 6.3 8.3 10.2 7.8 18.6 8.3 11.0 8.9 4.9 11.1 8.0 7.2 8.5 8.8 11.1 10.9 10.9 7.2 11.5 13.0 8.6 14.3 8.7 13.1 10.9 10.1 10.6 5.3 5.3 15.5 13.8 10.7 11.5 10.9 5.7 14.3 9.9 8.2 9.9 8.3 12.7 11.4 8.6 10.1 13.4 12.7 1.3 7.5 7.3 6.5 7.9 7.6 13.1 13.4 24.3 12.8 13.1 10.2 14.5 7.6 7.3 8.2 6.0 4.1 11.1 1.3 2.2 6.5 2.8 2.5 1.4 1.2 5.2 0.0 4.0 5.0 4.2 0.8 6.3 4.0 0.0 2.9 4.9 4.5 2.5 16.1 5.7 6.2 4.8 1.2 9.2 5.9 1.7 5.5 5.2 1.7 4.6 5.1 8.2 3.2 4.2 5.3 4.0 5.8 0.0 4.1 0.7 11.7 2.6 1.8 4.4 4.4 0.6 ZBTB24 "BIF1, KIAA0441, PATZ2, ZNF450" ENSG00000112365 "Zinc finger and BTB domain containing 24" O43167 6 109462594-109483237 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017872, HPA049003" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Centrosome" Yes No Nucleoplasm "Cytokinetic bridge, Centrosome" "HPA017872: AB_2669673, HPA049003: AB_2680596" "unprognostic (8.15e-2)" "unprognostic (1.56e-1)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" "unprognostic (4.80e-2)" "unprognostic (1.98e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (4.53e-2)" "unprognostic (5.09e-2)" "unprognostic (3.31e-2)" "unprognostic (1.22e-3)" "unprognostic (1.37e-1)" "unprognostic (1.75e-3)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (2.60e-1)" "unprognostic (6.77e-2)" 9.6 7.1 6.6 13.8 13.7 16.6 10.1 12.7 11.5 9.5 7.5 11.4 6.8 7.6 9.8 7.5 8.4 8.4 6.4 5.5 7.0 6.8 9.1 6.6 8.5 16.9 11.5 8.8 8.3 8.2 19.1 10.0 12.4 8.8 8.8 8.5 9.6 9.8 9.1 9.7 12.2 11.1 8.5 7.7 13.7 8.6 9.0 12.1 17.4 10.8 5.2 17.1 10.0 10.2 5.7 2.2 1.7 1.5 2.4 5.3 1.0 3.9 4.1 3.8 9.4 6.1 6.2 6.2 4.5 6.3 5.8 6.6 5.7 3.1 16.9 5.9 5.7 6.9 5.2 9.5 7.1 8.7 10.4 9.3 13.7 5.5 4.3 4.5 11.1 7.0 6.2 5.9 5.8 10.1 4.0 4.7 8.0 11.4 9.5 5.9 6.8 15.8 7.5 9.3 4.0 4.6 10.0 5.3 7.0 7.1 6.8 6.4 5.6 5.8 6.2 14.4 5.5 4.3 12.1 4.6 4.7 4.7 3.9 9.8 4.6 3.6 17.3 6.1 8.8 7.8 0.1 1.2 1.7 1.5 1.1 0.9 5.7 3.0 1.8 1.4 5.6 3.9 2.2 0.8 2.4 1.5 2.2 5.3 1.0 6.6 13.7 12.7 11.5 7.0 6.8 11.5 8.8 8.8 12.1 11.9 7.8 15.9 6.2 9.0 17.3 3.3 7.6 8.1 5.7 3.5 29.5 7.0 3.3 6.8 1.3 4.5 5.5 0.0 7.9 9.4 7.3 5.9 9.2 5.0 6.9 9.5 9.2 3.1 12.6 1.1 6.6 8.9 8.5 22.6 11.1 8.1 5.5 3.5 6.0 6.1 63.1 0.0 4.2 4.6 29.8 8.4 6.5 14.9 7.8 5.8 ZBTB33 "kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348" ENSG00000177485 "Zinc finger and BTB domain containing 33" Q86T24 X 120250752-120258398 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000755, CAB001980, HPA005732" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166" "unprognostic (9.14e-3)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.47e-2)" "unprognostic (6.13e-2)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.51e-2)" "unprognostic (5.08e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (6.44e-2)" "unprognostic (2.59e-2)" 15.4 10.4 12.8 9.3 15.5 20.2 18.0 16.3 13.9 9.6 8.5 11.6 9.1 9.1 7.7 11.5 14.9 10.0 9.0 6.0 12.6 15.0 8.0 22.5 10.7 14.0 13.4 11.6 12.2 11.6 17.7 15.5 10.2 16.7 10.5 7.9 6.2 15.0 10.0 9.5 21.6 10.2 6.0 18.6 12.7 9.9 6.9 14.8 29.3 17.4 5.3 14.6 10.3 9.7 3.4 8.9 14.2 8.9 5.1 7.2 5.2 9.3 10.4 14.2 12.9 11.2 12.8 16.7 7.2 9.7 8.5 10.5 6.3 8.2 13.7 13.8 7.3 11.3 14.4 22.4 11.4 10.8 15.1 16.1 14.3 15.8 8.5 8.5 14.2 16.3 9.1 13.9 8.6 12.8 12.1 14.4 13.8 9.2 16.0 10.4 11.2 13.3 9.3 17.3 14.0 11.3 15.1 10.8 21.8 8.6 16.7 26.0 11.0 15.3 15.1 17.0 11.1 8.1 20.1 14.1 6.8 5.0 10.1 12.8 9.0 9.1 17.4 9.5 20.4 8.4 14.2 6.1 7.7 4.4 8.9 7.2 3.4 5.6 5.5 8.9 3.3 7.1 4.8 1.2 5.1 5.6 8.5 4.9 5.2 12.8 15.5 16.3 13.9 12.6 15.0 13.4 11.6 16.7 14.8 14.9 6.5 4.2 6.8 11.3 4.3 4.5 10.2 12.0 15.9 1.8 0.0 6.6 1.7 4.9 0.1 6.9 4.6 23.3 5.8 6.9 5.4 6.9 0.0 16.6 6.8 3.2 8.1 8.0 9.9 0.0 4.0 9.8 3.3 10.0 7.8 6.5 6.4 5.7 2.5 2.8 1.4 6.5 3.1 2.9 11.7 11.4 7.8 9.6 6.5 10.1 ZBTB37 "MGC2629, ZNF908" ENSG00000185278 "Zinc finger and BTB domain containing 37" Q5TC79 1 173868082-173903549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 49.0;Rod photoreceptor cells: 67.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023438 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA023438: AB_1858954" "unprognostic (1.18e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.46e-2)" "unprognostic (2.66e-4)" "unprognostic (2.93e-1)" "unprognostic (1.57e-2)" "unprognostic (9.86e-2)" "unprognostic (2.41e-1)" "unprognostic (3.72e-2)" "unprognostic (9.53e-2)" "unprognostic (7.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (1.96e-2)" 6.4 4.0 6.9 6.5 9.8 11.1 5.8 6.4 7.9 5.3 4.0 11.2 3.7 4.0 9.1 5.5 3.4 4.6 4.7 5.6 7.2 3.7 5.3 4.8 6.0 7.7 9.9 5.2 7.6 4.5 6.8 9.2 4.7 7.8 5.3 3.9 10.6 4.6 4.9 4.0 7.0 5.2 6.8 9.5 7.9 5.1 18.4 8.8 7.7 6.1 2.8 6.3 4.8 5.5 1.8 2.4 6.0 1.0 2.3 2.8 0.8 2.4 3.7 5.6 2.4 3.5 2.8 6.2 2.2 1.6 4.0 2.9 4.6 3.1 6.6 4.7 3.4 2.1 3.1 4.8 2.4 3.4 3.7 3.0 9.1 3.9 2.2 2.1 5.3 5.8 2.5 1.7 6.0 4.0 2.5 2.0 4.7 8.0 4.4 4.2 1.8 3.6 1.4 5.4 1.8 0.9 2.4 5.0 2.2 2.2 6.1 4.2 5.3 3.1 4.3 4.4 6.2 6.2 5.6 3.6 5.3 5.7 2.6 3.5 8.0 5.9 10.6 3.5 3.0 3.2 0.4 1.0 3.4 2.8 1.0 1.2 0.7 1.3 2.0 0.6 1.8 0.7 1.8 6.0 2.3 1.0 2.4 1.0 0.8 6.9 9.8 6.4 7.9 7.2 3.7 9.9 5.2 7.8 8.8 6.0 4.6 11.9 3.1 2.6 26.9 8.4 12.7 9.4 2.3 10.4 31.4 6.8 6.6 2.8 40.4 5.2 3.9 0.0 3.3 3.4 4.3 4.2 2.3 4.3 4.2 17.5 3.4 13.5 15.1 49.0 8.1 7.6 10.1 2.8 3.6 11.9 2.5 3.5 12.4 4.4 67.3 6.5 6.2 17.6 13.3 5.1 7.7 12.9 3.3 2.7 ZBTB4 "KAISO-L1, KIAA1538, ZNF903" ENSG00000174282 "Zinc finger and BTB domain containing 4" Q9P1Z0 17 7459366-7484263 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008980, HPA064763" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB008980: , HPA064763: AB_2685347" "unprognostic (2.23e-1)" "unprognostic (3.95e-1)" "unprognostic (7.17e-2)" "unprognostic (2.92e-2)" "unprognostic (5.32e-2)" "unprognostic (7.62e-3)" "unprognostic (2.43e-1)" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.63e-3)" "prognostic favorable (2.53e-4)" "unprognostic (1.73e-1)" "prognostic favorable (1.65e-9)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.88e-1)" "unprognostic (6.04e-3)" 20.1 23.5 20.1 10.9 22.7 4.7 20.6 27.9 38.3 26.3 21.8 19.8 13.7 9.2 22.8 22.7 16.6 22.5 15.1 22.3 19.6 18.3 15.6 6.3 21.4 10.7 21.0 19.4 35.1 16.3 70.1 15.4 14.6 25.8 22.3 9.9 26.2 19.9 30.0 21.4 14.8 11.3 22.3 20.2 18.7 14.2 10.6 14.7 8.2 23.9 9.5 12.7 23.4 24.7 1.8 1.3 1.4 4.6 2.0 3.5 1.5 6.3 8.7 2.2 4.2 23.5 12.2 4.0 8.9 12.9 8.1 8.1 2.9 3.1 0.6 7.1 16.9 5.9 10.1 2.2 12.5 5.9 10.1 3.8 3.2 7.1 2.0 6.6 0.6 7.6 8.5 13.1 7.8 10.0 19.1 7.0 2.4 1.0 2.1 8.9 4.2 2.2 1.3 0.9 2.6 4.2 4.0 3.8 0.9 9.9 5.4 1.3 3.3 3.9 2.8 4.1 4.1 5.2 1.4 9.7 9.1 3.6 8.6 7.3 3.8 2.6 0.4 9.8 2.0 4.7 1.1 0.9 1.4 3.2 1.4 3.5 1.6 2.6 2.6 0.7 1.8 3.4 3.1 0.6 2.0 4.6 1.3 1.3 1.5 20.1 22.7 27.9 38.3 19.6 18.3 21.0 19.4 25.8 14.7 47.6 49.8 8.2 16.6 27.2 75.9 76.7 22.9 17.4 19.4 19.2 64.8 8.5 3.3 13.6 34.6 26.1 5.4 0.0 12.4 1.9 17.3 18.9 12.8 7.8 11.9 69.9 16.7 22.1 26.3 41.2 48.1 17.7 16.9 5.4 10.3 24.7 16.4 7.0 65.7 8.9 38.5 32.3 30.9 5.4 4.1 20.6 4.3 20.1 7.6 11.1 ZBTB41 "DKFZp686C06120, FLJ36199, FRBZ1, ZNF924" ENSG00000177888 "Zinc finger and BTB domain containing 41" Q5SVQ8 1 197153680-197200542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034841, HPA034842" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" Nucleoplasm "HPA034841: AB_2674355, HPA034842: AB_10669995" "unprognostic (2.36e-1)" "unprognostic (5.58e-3)" "unprognostic (8.01e-3)" "unprognostic (6.07e-2)" "unprognostic (4.14e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.43e-1)" "unprognostic (1.81e-2)" "unprognostic (2.81e-1)" "unprognostic (7.51e-3)" "unprognostic (2.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.58e-1)" 2.6 3.8 4.1 1.8 4.0 0.2 5.9 10.8 5.0 4.5 2.2 2.1 3.2 3.8 2.4 2.8 3.2 2.3 4.0 4.7 4.3 3.3 2.3 2.4 4.2 5.9 2.9 5.6 3.8 2.2 3.3 2.5 2.9 2.6 3.3 2.4 1.8 2.2 4.8 3.0 3.2 2.6 6.4 2.2 3.1 2.1 1.5 1.4 1.7 0.7 1.8 2.2 0.7 7.3 4.1 5.5 4.4 8.8 13.3 4.4 4.4 7.3 4.7 4.5 2.6 6.2 2.7 6.5 10.1 2.8 6.1 3.8 3.9 7.5 2.4 2.3 2.2 5.6 2.4 7.8 4.3 2.2 5.4 10.2 4.7 8.2 9.6 3.2 3.1 5.1 3.3 12.0 3.6 3.2 2.4 2.1 5.1 1.5 2.2 7.7 4.8 5.8 4.2 7.9 7.0 8.0 14.1 8.4 4.2 10.7 3.3 5.2 9.3 5.4 7.3 5.8 3.8 1.9 2.9 4.4 1.6 12.9 1.7 0.7 0.4 1.2 0.4 2.2 1.5 1.6 1.6 1.4 1.4 2.2 2.0 0.0 1.8 0.6 0.7 1.0 0.7 17.9 6.2 7.2 4.6 6.6 13.6 12.8 7.6 10.7 10.3 15.7 2.0 3.3 1.7 6.1 2.9 5.5 3.8 0.0 4.9 3.2 6.1 8.3 1.1 8.3 3.7 23.8 12.6 8.0 7.9 2.7 14.4 4.6 11.8 6.4 6.5 30.0 6.0 0.0 11.3 9.1 8.1 6.5 6.1 6.5 4.5 8.8 2.9 4.5 7.6 5.2 ZBTB49 "FLJ38559, ZNF509" ENSG00000168826 "Zinc finger and BTB domain containing 49" Q6ZSB9 4 4290251-4321786 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024450 Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA024450: AB_1859311" "unprognostic (4.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.30e-1)" "unprognostic (2.49e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.24e-4)" "unprognostic (3.56e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.11e-1)" "prognostic favorable (1.76e-4)" "unprognostic (5.54e-3)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (9.09e-2)" "unprognostic (1.98e-1)" "prognostic favorable (2.88e-5)" 7.3 5.4 5.0 6.0 9.0 11.8 6.8 9.2 8.7 7.2 6.2 9.9 3.4 4.5 9.5 7.0 5.6 6.3 5.3 6.2 6.1 5.1 4.7 5.9 6.5 7.5 6.8 5.3 10.6 7.7 6.0 13.3 5.6 8.9 7.9 4.4 7.1 10.0 6.5 10.1 4.8 6.3 6.5 6.1 9.2 6.0 10.3 6.7 6.7 8.1 5.0 8.5 7.8 5.8 2.9 1.9 12.1 2.7 3.2 6.4 1.8 2.0 3.4 4.3 7.2 5.8 6.1 5.1 2.6 5.1 5.7 4.4 3.0 4.0 7.4 2.7 2.8 7.0 3.6 7.5 4.3 5.9 2.4 2.9 8.6 2.3 4.2 4.9 5.2 3.2 3.9 3.6 5.2 3.4 3.2 5.7 8.0 4.4 4.0 5.3 3.4 10.2 10.2 7.3 3.0 4.6 6.1 5.6 4.6 2.2 3.7 5.2 5.0 5.7 2.2 5.7 6.0 3.1 5.1 5.5 5.1 2.3 3.4 5.5 4.9 4.8 6.3 3.7 4.4 5.0 3.7 2.6 12.1 6.4 2.7 5.0 2.2 3.6 6.0 1.9 2.9 4.1 4.7 6.2 3.2 2.2 0.4 3.2 1.8 5.0 9.0 9.2 8.7 6.1 5.1 6.8 5.3 8.9 6.7 0.0 1.4 2.7 1.6 2.3 2.4 1.6 0.0 1.4 2.3 1.8 3.9 1.6 0.0 1.8 1.5 2.2 0.9 0.0 2.2 1.2 2.0 1.5 1.1 1.5 1.6 1.6 1.2 3.7 2.6 0.0 1.4 2.1 3.3 3.6 1.7 1.7 1.0 2.9 2.1 0.8 7.8 0.0 1.1 9.5 5.3 2.3 1.3 2.9 1.3 1.0 ZBTB5 KIAA0354 ENSG00000168795 "Zinc finger and BTB domain containing 5" O15062 9 37438114-37465399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021521 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA021521: AB_2670736" "unprognostic (2.36e-2)" "unprognostic (2.78e-2)" "unprognostic (5.22e-2)" "unprognostic (6.35e-2)" "unprognostic (1.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.96e-3)" "unprognostic (5.81e-2)" "unprognostic (3.95e-2)" "unprognostic (1.43e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" "unprognostic (1.27e-3)" "unprognostic (5.73e-3)" "unprognostic (2.30e-1)" "unprognostic (2.77e-3)" "unprognostic (1.80e-1)" 7.9 9.2 6.7 10.8 9.5 16.0 10.6 12.8 11.2 10.6 10.0 15.9 7.0 8.7 11.8 11.5 24.6 8.8 7.7 8.4 8.7 5.9 11.0 17.2 11.3 11.7 14.0 6.9 12.5 12.4 11.4 7.9 11.8 9.9 11.3 8.4 9.8 11.9 16.5 7.4 16.6 11.1 7.6 10.4 10.8 10.1 20.4 11.7 15.2 14.8 7.8 17.8 9.5 12.7 2.7 2.6 0.4 1.2 1.1 3.2 1.2 6.6 7.7 19.9 12.3 5.1 3.6 8.5 5.5 4.3 6.8 5.6 5.7 4.9 13.6 6.0 4.1 5.0 8.1 12.9 4.6 5.2 10.0 6.7 5.0 19.8 6.6 5.0 6.1 4.4 3.5 11.6 3.4 7.2 7.7 7.5 10.9 11.7 11.6 5.0 4.2 12.8 4.5 5.0 7.2 3.9 11.7 9.6 5.1 6.5 6.0 9.2 16.5 5.4 8.7 4.2 10.5 13.9 6.0 5.1 4.8 13.3 2.8 5.2 6.2 6.8 11.9 4.4 5.3 5.0 0.4 1.2 0.2 2.2 0.9 2.6 2.7 1.9 1.9 2.6 2.7 2.9 3.2 0.1 1.1 0.1 0.8 1.5 1.2 6.7 9.5 12.8 11.2 8.7 5.9 14.0 6.9 9.9 11.7 14.9 6.2 4.2 6.7 12.7 1.8 3.1 5.1 4.0 11.4 1.8 5.9 3.1 0.0 3.4 1.8 3.3 3.3 0.0 2.8 1.9 4.3 8.9 1.1 7.4 2.1 12.7 8.1 5.5 2.8 3.3 3.7 1.8 3.3 2.8 4.5 3.9 3.3 3.5 3.5 2.6 4.8 0.0 5.1 7.5 7.2 15.8 4.8 1.9 4.5 6.5 ZBTB9 "MGC23166, ZNF919" ENSG00000213588 "Zinc finger and BTB domain containing 9" Q96C00 6 33453970-33457548 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 3.9;Intestinal endocrine cells: 1.7;Melanocytes: 1.7;Suprabasal keratinocytes: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.3;GAMG: 15.7;U-698: 11.6" "Low region specificity" "Detected in all" "HPA036767, HPA058171" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA036767: AB_10696787, HPA058171: " "unprognostic (1.79e-2)" "unprognostic (1.46e-1)" "unprognostic (6.86e-2)" "unprognostic (2.89e-1)" "unprognostic (2.18e-1)" "unprognostic (9.16e-2)" "unprognostic (1.85e-4)" "unprognostic (4.20e-1)" "unprognostic (2.73e-1)" "unprognostic (2.13e-1)" "unprognostic (1.70e-2)" "unprognostic (4.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (2.47e-1)" "unprognostic (2.95e-1)" 4.5 7.1 5.5 5.4 5.9 4.4 3.3 4.9 7.4 5.4 4.4 6.4 2.4 6.6 4.5 8.7 5.4 4.8 4.2 4.4 5.9 5.1 7.7 5.4 3.7 6.6 4.4 4.5 10.6 11.3 8.5 17.3 4.5 4.2 5.9 7.1 4.6 6.3 3.9 5.7 5.0 3.9 3.8 3.5 5.4 3.7 12.7 3.8 9.7 6.8 4.0 13.7 7.8 4.3 0.8 2.6 8.5 2.2 1.9 4.3 1.0 0.1 0.1 4.6 0.7 2.3 0.1 10.3 0.1 0.2 0.0 0.0 1.6 0.0 1.6 1.5 0.1 15.7 0.0 4.4 1.8 0.6 1.8 0.0 6.1 0.0 0.0 0.0 2.3 6.0 0.2 0.2 2.7 2.7 0.0 0.0 0.3 2.5 0.5 2.0 0.5 0.4 0.0 2.9 0.2 0.4 3.0 2.8 2.0 2.4 2.1 0.5 0.3 3.0 0.1 1.0 0.2 0.5 0.4 1.5 0.3 0.1 0.9 1.1 0.0 1.7 11.6 0.2 1.9 0.0 8.5 1.5 0.5 3.9 1.5 1.9 0.3 1.9 4.3 2.6 0.8 3.6 3.2 1.4 1.9 2.2 0.3 3.2 1.0 5.5 5.9 4.9 7.4 5.9 5.1 4.4 4.5 4.2 3.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.8 0.0 0.0 1.7 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 3.1 0.0 0.0 0.7 0.0 ZCCHC2 "C18orf49, FLJ20222, FLJ20281, KIAA1744" ENSG00000141664 "Zinc finger CCHC-type containing 2" Q9C0B9 18 62523007-62587709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 99.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 114.5;Late spermatids: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040943 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA040943: AB_10795496" "unprognostic (9.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.84e-3)" "unprognostic (1.40e-1)" "unprognostic (4.07e-2)" "unprognostic (4.79e-2)" "unprognostic (2.60e-1)" "unprognostic (1.93e-1)" "unprognostic (8.25e-2)" "unprognostic (2.32e-2)" "unprognostic (1.30e-1)" "unprognostic (5.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.72e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 12.6 5.0 6.8 7.0 7.5 22.8 16.0 8.0 6.8 7.5 8.5 6.0 5.3 6.8 6.9 7.1 6.5 7.4 9.0 8.5 5.3 5.7 5.8 23.0 10.1 7.6 8.1 5.7 8.8 6.3 7.8 8.5 8.2 5.5 8.1 5.8 4.5 99.1 5.9 16.8 11.3 7.5 7.6 5.6 8.9 6.5 13.4 8.9 10.8 7.8 4.3 6.4 11.0 19.3 1.6 1.0 4.9 1.6 0.6 2.0 0.4 6.0 5.2 4.5 8.9 13.8 5.9 8.6 3.4 5.2 8.3 8.3 2.8 3.7 17.0 4.6 5.7 6.8 10.2 14.5 7.6 3.4 11.7 6.8 4.4 12.1 19.0 4.7 8.5 6.5 5.8 9.9 5.2 9.8 6.0 15.5 7.7 4.7 5.7 2.7 4.9 5.5 3.6 2.9 4.4 5.2 7.4 4.8 0.1 5.7 6.1 5.7 3.5 5.8 13.1 5.1 8.5 4.6 6.8 6.6 8.1 5.6 3.2 4.9 2.2 4.3 7.3 6.1 3.6 3.0 0.0 1.0 2.4 1.7 1.6 1.2 0.5 1.1 1.5 0.3 1.6 2.0 1.3 4.9 0.6 0.3 1.0 1.2 0.4 6.8 7.5 8.0 6.8 5.3 5.7 8.1 5.7 5.5 8.9 23.8 19.7 4.2 13.1 23.7 27.6 18.8 15.3 9.4 14.8 15.7 51.1 6.3 3.3 5.4 114.5 20.9 7.7 0.0 5.3 10.1 7.6 13.8 2.3 28.0 12.5 41.3 12.1 17.8 39.8 110.8 7.5 21.1 6.8 4.6 13.2 9.2 4.8 10.5 7.4 4.3 19.1 6.5 15.3 11.5 6.6 16.2 5.7 7.5 10.3 10.5 ZDHHC16 APH2 ENSG00000171307 "Zinc finger DHHC-type containing 16" Q969W1 10 97446131-97457370 "Enzymes, Predicted membrane proteins" "Apoptosis, DNA damage" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039893, HPA040214" Uncertain Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA039893: AB_10794757, HPA040214: AB_2676886" "unprognostic (4.44e-2)" "unprognostic (3.14e-2)" "unprognostic (3.34e-1)" "unprognostic (1.20e-2)" "unprognostic (8.75e-2)" "unprognostic (8.35e-3)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (1.57e-1)" "unprognostic (2.31e-1)" "unprognostic (6.34e-2)" "unprognostic (1.93e-3)" "unprognostic (1.34e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-1)" 12.0 13.7 15.9 10.8 17.3 6.4 17.9 17.6 24.6 17.1 17.9 15.6 18.1 15.1 15.5 21.2 17.6 11.5 14.4 18.1 13.2 11.0 23.3 37.4 20.8 11.1 10.9 13.0 15.1 22.5 21.8 15.4 30.7 10.5 16.0 18.9 18.1 28.5 14.1 20.7 14.0 15.7 17.6 8.5 13.2 19.4 16.4 10.8 14.7 19.6 15.4 16.1 15.1 20.0 9.3 14.2 9.4 10.4 13.0 12.0 5.8 21.7 25.5 17.0 21.0 27.3 18.7 17.8 23.9 31.9 27.6 26.5 19.8 19.5 19.2 27.6 34.9 24.2 25.6 21.4 33.8 24.7 19.0 24.8 12.2 17.9 18.8 21.9 14.4 17.9 20.9 22.4 32.3 23.3 30.0 28.3 17.8 9.7 14.6 35.0 20.7 21.8 19.8 13.9 19.8 22.2 15.0 17.3 17.6 23.4 10.1 8.3 11.8 14.6 15.1 12.9 17.7 19.9 14.2 17.3 17.4 16.2 11.2 27.9 14.0 22.6 11.8 20.1 22.5 9.1 0.3 9.8 9.4 7.0 10.4 8.0 8.2 12.0 11.1 14.2 9.3 9.9 9.8 0.5 13.0 10.4 10.9 9.4 5.8 15.9 17.3 17.6 24.6 13.2 11.0 10.9 13.0 10.5 10.8 17.9 17.2 14.5 15.7 4.6 15.1 9.7 15.3 6.7 27.3 12.2 3.9 35.3 21.6 31.3 20.3 9.2 12.9 0.0 28.4 55.1 10.0 16.3 6.9 15.8 21.8 12.7 6.9 8.0 7.3 5.7 8.1 7.5 3.3 24.4 16.7 10.4 30.7 10.5 3.5 17.8 10.6 6.5 4.9 16.1 12.7 3.8 31.7 7.5 17.9 14.1 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144524583 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.6" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 626.1;Kupffer cells: 357.2;Macrophages: 271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.1;THP-1: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 30.2 23.7 48.0 27.8 42.4 55.5 16.6 6.7 36.6 29.4 12.3 72.9 3.4 11.3 15.6 11.1 14.4 11.1 22.6 22.5 52.5 28.8 9.9 11.6 20.7 19.6 54.4 26.4 37.5 3.6 5.0 3.1 31.5 37.6 10.9 16.3 15.7 5.7 12.5 9.6 7.7 12.8 17.2 76.6 32.6 9.3 8.2 38.7 1.9 8.3 7.5 12.4 21.5 14.8 5.0 12.7 9.7 21.6 3.6 10.7 7.4 0.4 0.5 22.5 0.0 26.9 13.7 0.0 9.2 9.4 10.4 10.1 0.0 0.2 1.7 0.0 10.0 2.8 0.1 3.8 0.0 13.0 9.6 2.6 39.1 1.6 0.0 6.1 6.7 31.1 11.2 0.2 12.9 6.2 8.8 7.8 0.0 10.9 1.1 12.2 0.0 0.0 20.5 3.2 0.0 0.5 11.5 15.5 0.0 0.1 0.2 0.2 5.9 1.1 0.0 24.3 7.5 0.0 46.5 12.1 12.0 0.2 23.3 2.9 12.7 0.0 1.9 17.9 20.2 32.2 9.7 21.6 5.7 10.7 20.8 1.0 4.4 1.4 5.3 12.7 5.0 1.1 4.0 7.5 3.6 19.5 10.2 0.3 7.4 48.0 42.4 6.7 35.6 52.5 28.8 54.4 26.4 37.6 38.7 6.0 25.8 45.8 1.2 22.0 178.1 50.1 2.5 6.7 18.2 5.2 3.9 1.3 1.7 0.6 2.0 23.8 0.0 23.3 0.7 1.6 146.0 1.5 150.5 2.1 126.8 626.1 0.0 81.0 357.2 4.0 111.7 271.2 97.8 46.9 0.0 84.2 0.2 0.0 62.6 7.3 8.6 181.1 167.0 2.3 7.0 17.1 3.9 99.2 0.0 2.0 ZFAND5 "ZA20D2, ZFAND5A, ZNF216" ENSG00000107372 "Zinc finger AN1-type containing 5" O76080 9 72351425-72365235 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 207.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 83.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018129, HPA077824" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA018129: AB_1859012, HPA077824: " "unprognostic (1.97e-1)" "unprognostic (5.79e-2)" "unprognostic (1.91e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.53e-1)" "unprognostic (2.24e-1)" "unprognostic (3.39e-3)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.34e-1)" "unprognostic (2.47e-1)" "unprognostic (3.90e-2)" "unprognostic (6.85e-2)" "unprognostic (3.92e-2)" "unprognostic (3.86e-2)" "unprognostic (7.03e-2)" 82.5 57.6 26.9 15.5 35.2 36.6 57.1 31.7 34.3 28.6 23.1 20.3 31.4 10.8 25.7 35.5 29.0 27.4 28.7 33.0 24.3 22.6 32.6 56.5 31.6 23.6 24.3 21.1 59.3 20.9 17.0 45.4 22.4 25.1 24.0 15.1 22.4 17.2 52.7 207.5 17.6 15.8 28.4 25.9 24.1 23.2 26.7 21.7 14.6 23.1 29.5 16.5 39.2 29.3 7.0 13.6 15.4 32.1 8.6 6.8 7.8 22.2 22.8 26.9 11.9 34.8 16.6 20.3 26.3 36.7 14.2 11.1 2.8 21.0 12.4 16.0 41.2 20.1 24.9 62.0 10.3 21.3 83.9 9.6 9.8 13.1 13.9 25.7 14.0 14.6 21.7 19.1 14.8 16.6 33.1 25.1 12.0 9.4 16.4 16.6 5.9 18.3 8.0 34.7 20.9 15.9 14.3 14.0 13.1 46.2 21.6 19.7 17.6 16.6 18.3 21.5 29.2 8.1 12.3 19.1 11.8 14.6 20.8 18.0 23.7 20.6 6.5 15.9 9.6 29.2 15.1 13.6 15.4 5.2 21.6 5.7 7.0 6.8 6.6 13.6 6.2 6.3 5.6 12.2 8.6 32.1 2.9 4.8 7.8 26.9 35.2 31.7 34.3 24.3 22.6 24.3 21.1 25.1 21.7 163.8 158.6 37.3 496.3 301.3 88.2 288.5 91.7 88.3 127.4 125.6 70.7 117.4 126.0 118.6 62.4 115.1 102.1 46.7 122.4 145.8 149.1 300.6 109.4 271.5 176.8 38.1 131.1 95.2 243.2 35.2 109.6 177.8 197.4 297.6 71.5 51.7 193.5 79.3 87.7 95.7 65.3 84.1 204.0 123.7 99.9 254.7 189.3 64.8 81.2 398.4 ZFP82 "KIAA1948, MGC45380, ZNF545" ENSG00000181007 "ZFP82 zinc finger protein" Q8N141 19 36383120-36418656 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 21.6;Horizontal cells: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051669, HPA060470" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA051669: AB_2732568, HPA060470: AB_2684290" "unprognostic (1.52e-1)" "unprognostic (2.38e-2)" "unprognostic (6.03e-2)" "unprognostic (4.14e-4)" "unprognostic (9.63e-2)" "unprognostic (9.17e-4)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (2.61e-3)" "unprognostic (4.91e-1)" "unprognostic (3.69e-2)" "unprognostic (6.00e-2)" "unprognostic (3.21e-2)" "unprognostic (3.81e-2)" "unprognostic (3.05e-1)" 4.3 5.0 9.8 8.8 9.3 1.5 8.7 15.0 13.9 9.9 5.2 5.3 2.4 2.4 9.1 12.4 2.7 9.0 5.4 7.3 8.5 9.7 5.5 1.8 4.9 7.8 8.3 6.3 13.8 2.7 8.0 10.1 7.0 8.3 7.4 3.3 3.6 4.1 6.8 2.1 2.2 3.6 7.8 6.8 6.3 3.1 6.4 8.7 9.3 10.8 1.6 8.6 5.8 6.9 9.6 3.1 1.1 1.1 4.7 9.2 2.9 0.0 2.6 8.4 8.8 2.9 3.7 2.8 3.4 4.3 7.0 9.0 1.6 1.2 7.4 5.8 4.1 5.8 0.2 0.0 0.9 8.8 6.9 4.2 6.6 1.9 2.1 6.7 0.0 5.8 5.7 1.3 5.0 1.5 0.0 3.2 9.2 0.0 0.0 6.8 0.0 11.4 0.0 7.8 0.0 1.5 9.6 5.7 2.2 3.4 4.2 0.1 8.7 0.0 0.5 5.4 8.4 1.6 5.1 0.4 2.5 4.4 4.4 5.7 5.0 3.4 11.3 0.0 0.0 5.4 0.0 0.9 1.1 6.0 1.1 6.0 9.6 5.9 6.8 2.7 9.0 9.2 8.1 0.1 4.7 1.1 3.1 3.6 2.9 9.8 9.3 15.0 13.9 8.5 9.7 8.3 6.3 8.3 8.7 0.0 8.3 1.9 2.5 0.9 19.2 3.5 2.5 8.1 3.4 5.2 21.6 6.8 8.3 4.5 4.8 4.2 0.0 0.0 1.2 5.4 4.5 1.7 5.8 0.5 3.7 31.8 2.9 2.5 1.9 1.3 5.5 3.5 5.0 1.0 0.3 9.4 1.4 0.0 7.1 4.5 10.4 19.4 4.2 10.8 6.3 0.5 1.1 4.9 1.0 0.9 ZFPM1 "FOG, FOG1, ZC2HC11A, ZNF89A" ENSG00000179588 "Zinc finger protein, FOG family member 1" Q8IX07 16 88453317-88537016 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 30.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 19.6;Cone photoreceptor cells: 27.5;Horizontal cells: 33.4;Muller glia cells: 36.6" "Cancer enhanced" "Detected in all" "stomach cancer: 12.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 14.5;K-562: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046603 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA046603: AB_2679718" "unprognostic (1.29e-1)" "unprognostic (2.42e-1)" "unprognostic (3.08e-2)" "unprognostic (3.32e-2)" "unprognostic (1.13e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-1)" "unprognostic (7.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (5.58e-2)" "unprognostic (3.05e-2)" "unprognostic (2.49e-4)" "unprognostic (1.99e-2)" "unprognostic (3.32e-1)" "unprognostic (4.89e-2)" "prognostic favorable (4.24e-4)" 4.3 3.7 3.7 7.9 2.9 12.0 2.2 6.8 3.3 2.9 11.2 1.6 4.7 18.5 3.8 4.5 2.8 3.7 30.4 4.7 3.9 3.0 2.7 15.2 5.4 5.5 2.7 1.9 7.3 24.5 1.5 5.6 1.8 2.1 7.0 1.7 7.7 6.9 7.3 2.2 3.8 15.4 1.5 2.1 12.7 21.5 12.7 0.8 15.7 3.8 1.4 9.4 4.8 2.2 0.3 0.6 1.5 0.3 0.6 1.3 0.3 1.1 2.9 2.2 4.5 0.4 0.1 9.3 3.1 0.4 1.0 0.3 9.2 1.1 4.5 2.4 0.4 1.1 7.2 0.1 2.5 0.2 3.4 1.9 14.5 5.7 8.0 1.7 0.8 4.9 1.0 1.7 1.1 0.4 1.1 1.0 1.2 21.5 0.3 0.8 5.5 5.1 5.2 1.5 7.0 2.5 1.5 1.0 2.1 1.0 3.6 6.0 10.1 3.8 0.2 3.0 1.2 2.4 2.4 3.6 3.9 2.5 1.7 0.6 1.1 0.7 0.4 1.1 1.7 3.7 0.0 0.1 1.5 0.9 0.2 0.2 0.1 0.4 1.3 0.2 0.3 0.3 0.5 0.9 0.6 0.3 0.6 0.1 0.3 3.7 2.9 6.8 3.3 3.9 3.0 2.7 1.9 2.1 0.8 3.0 2.1 0.5 4.4 0.8 19.6 11.8 7.6 0.0 0.0 1.8 27.5 0.3 1.7 1.2 0.5 1.9 5.1 0.0 4.3 0.1 2.1 2.3 0.0 5.9 0.8 33.4 5.8 4.9 4.8 0.7 0.9 0.9 1.7 0.0 6.7 36.6 2.9 4.5 1.4 1.1 17.4 0.0 1.9 0.3 0.4 1.3 0.2 0.0 4.1 1.8 ZFYVE27 "FLJ32919, SPG33" ENSG00000155256 "Zinc finger FYVE-type containing 27" Q5T4F4 10 97737121-97760907 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037523, HPA069876" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA037523: AB_10672351, HPA069876: AB_2686218" "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.30e-2)" "unprognostic (2.48e-2)" "unprognostic (7.15e-2)" "unprognostic (2.05e-3)" "unprognostic (5.24e-2)" "unprognostic (3.38e-3)" "prognostic favorable (7.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.26e-2)" "prognostic favorable (7.80e-4)" 10.1 22.6 16.1 12.7 20.8 20.7 11.8 28.6 33.0 10.3 17.4 15.7 17.4 25.6 11.6 25.4 9.8 17.9 14.1 12.8 17.6 20.7 15.5 18.2 11.3 15.2 15.1 23.4 17.1 15.4 19.6 24.3 14.3 17.6 13.3 17.5 25.6 14.0 11.8 7.9 17.1 24.0 9.4 14.7 18.1 14.9 14.2 13.3 12.2 13.1 5.5 14.7 8.5 10.4 11.2 8.5 13.4 12.6 9.0 15.2 11.7 10.4 12.9 7.8 17.2 8.9 6.2 10.6 10.7 11.3 12.5 12.3 11.4 21.8 16.2 12.3 7.7 16.1 23.5 11.3 10.4 6.7 16.7 11.3 7.6 12.7 10.6 11.4 12.2 15.4 10.1 12.6 12.3 9.5 20.2 7.0 13.7 11.4 11.0 9.3 8.1 9.8 23.3 6.3 9.1 10.0 11.4 7.8 7.6 12.0 6.5 6.3 12.2 7.2 6.1 27.8 7.4 13.3 12.2 7.4 6.3 7.5 9.6 20.3 12.8 10.7 8.5 15.8 15.8 7.2 7.1 8.4 13.4 15.2 9.1 13.1 10.9 10.5 12.0 8.0 11.2 12.1 12.9 12.1 9.0 12.6 8.5 13.4 11.7 16.1 20.8 28.6 33.0 17.6 20.7 15.1 23.4 17.6 13.3 3.0 10.7 11.5 10.1 7.2 28.2 7.7 15.3 6.7 3.4 14.0 55.0 6.5 6.6 13.2 4.6 9.5 29.9 0.0 13.9 5.2 6.2 10.4 13.9 9.6 7.3 35.0 19.4 6.2 8.6 1.3 8.9 8.4 10.1 11.8 12.3 15.2 11.2 22.8 8.5 7.0 41.6 19.4 7.8 6.6 7.7 4.8 11.3 15.0 12.0 14.8 ZFYVE28 KIAA1643 ENSG00000159733 "Zinc finger FYVE-type containing 28" Q9HCC9 4 2269582-2418663 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 63.6" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 28.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 11.2;NB-4: 12.1;U-266/70: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038175, HPA057587" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA038175: AB_10697244, HPA057587: AB_2683477" "unprognostic (1.59e-1)" "unprognostic (4.60e-2)" "unprognostic (7.68e-2)" "unprognostic (3.08e-3)" "unprognostic (9.89e-3)" "unprognostic (3.79e-2)" "unprognostic (3.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.64e-2)" "prognostic favorable (1.35e-6)" "unprognostic (6.05e-2)" "unprognostic (5.27e-2)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" 4.5 8.6 7.7 5.1 15.8 3.1 3.7 63.6 15.1 3.7 7.4 4.6 1.8 10.4 4.1 3.1 3.4 4.3 5.9 2.4 7.1 5.5 5.7 4.2 4.4 6.1 7.9 8.0 3.4 7.3 7.9 7.5 1.8 9.9 2.9 5.1 5.8 9.5 5.4 4.3 5.7 11.9 2.8 9.4 7.0 7.5 7.9 6.7 1.2 5.3 3.1 4.0 4.5 3.2 3.1 0.7 0.9 0.4 0.3 4.4 1.3 0.8 1.0 0.2 3.7 2.2 0.7 0.1 1.8 3.1 1.0 0.3 0.1 6.7 0.0 1.9 3.2 2.6 3.8 1.2 0.3 0.6 9.7 1.3 0.2 4.3 0.3 4.4 0.7 11.2 3.0 0.6 1.1 0.1 7.0 3.1 1.0 1.8 8.2 0.9 2.2 0.1 12.1 0.1 2.0 8.2 0.0 0.0 3.9 1.5 0.5 5.8 0.4 1.8 0.1 1.0 0.1 2.5 0.3 0.5 1.8 0.0 5.5 0.1 12.8 9.3 0.2 5.4 2.3 1.8 0.9 0.4 0.1 4.4 0.0 1.9 0.9 2.3 3.2 0.7 3.1 3.2 3.2 0.1 0.3 0.3 0.2 4.0 1.3 7.7 15.8 63.6 15.1 7.1 5.5 7.9 8.0 9.9 6.7 0.0 1.7 0.0 3.2 5.3 10.7 3.3 5.1 1.4 3.4 10.4 17.7 0.3 6.6 2.7 28.4 4.5 16.9 0.0 2.0 0.2 1.9 1.5 9.2 4.9 1.8 7.9 2.4 5.5 1.9 5.8 1.4 7.1 6.8 4.6 5.9 1.4 2.1 9.0 2.1 3.1 16.3 0.0 2.8 2.1 9.0 4.3 0.2 21.0 5.2 4.1 ZKSCAN1 "KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33" ENSG00000106261 "Zinc finger with KRAB and SCAN domains 1" P17029 7 100015572-100041689 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 212.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006672 Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" Yes No "Nuclear bodies" "Nucleoplasm, Mitochondria" "HPA006672: AB_1080707" "unprognostic (2.58e-1)" "unprognostic (1.59e-2)" "unprognostic (3.57e-2)" "unprognostic (4.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.24e-2)" "unprognostic (1.47e-2)" "unprognostic (4.76e-3)" "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.34e-3)" "unprognostic (8.59e-2)" "unprognostic (1.27e-3)" "unprognostic (7.75e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "unprognostic (9.09e-3)" 11.7 19.5 16.1 12.1 23.9 8.1 23.6 15.0 23.9 16.8 21.2 38.9 16.3 18.1 16.2 18.3 19.8 23.0 25.1 10.8 18.8 15.2 14.2 47.6 11.7 12.2 26.1 27.3 20.6 26.7 18.3 14.3 11.1 27.6 24.3 24.3 14.7 25.0 19.4 11.9 32.5 16.5 14.3 23.6 13.5 33.0 16.4 23.1 17.3 12.5 11.4 12.1 14.4 17.5 6.1 7.3 13.3 10.0 11.7 7.5 4.5 9.2 6.8 18.1 19.8 18.7 22.8 6.8 10.4 12.7 6.2 6.3 4.1 8.8 10.5 13.3 11.6 11.0 7.7 10.4 9.0 12.0 10.1 6.4 8.5 8.3 10.6 10.6 16.1 10.2 15.3 14.4 8.4 28.3 17.0 13.7 12.5 19.5 9.2 12.3 12.3 15.3 9.6 7.3 17.4 8.6 9.1 9.2 9.4 10.5 14.6 21.1 25.2 16.2 21.3 18.3 10.8 10.8 10.8 20.6 13.7 13.4 15.9 10.5 10.7 18.5 10.9 9.3 11.6 17.9 13.3 4.7 5.0 6.8 4.0 6.7 5.1 5.4 6.7 7.3 6.1 7.5 5.3 5.3 11.7 10.0 5.2 4.3 4.5 16.1 23.9 15.0 23.9 18.8 15.2 26.1 27.3 27.6 23.1 23.8 39.4 30.6 38.6 13.4 91.6 37.3 142.7 161.9 56.9 43.6 141.4 32.1 13.3 46.0 35.7 43.9 59.0 0.0 38.3 12.7 32.9 84.1 33.6 124.6 17.1 84.2 212.3 35.6 28.8 14.6 47.5 27.1 38.8 27.9 82.8 74.9 41.8 84.2 50.2 23.0 68.3 19.4 22.2 28.9 14.6 18.7 55.2 18.7 98.9 47.9 ZKSCAN2 "FLJ23199, ZNF694, ZSCAN34" ENSG00000155592 "Zinc finger with KRAB and SCAN domains 2" Q63HK3 16 25236001-25257931 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 14.9;Cone photoreceptor cells: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049141 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus" "HPA049141: AB_2680652" "unprognostic (2.71e-1)" "unprognostic (4.99e-2)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.03e-1)" "unprognostic (1.65e-1)" "unprognostic (1.26e-1)" "unprognostic (5.14e-2)" "unprognostic (1.01e-1)" "unprognostic (9.14e-2)" "unprognostic (8.28e-4)" "unprognostic (2.63e-1)" "prognostic favorable (1.70e-6)" "unprognostic (2.33e-1)" "unprognostic (2.29e-1)" "unprognostic (1.97e-1)" "unprognostic (4.03e-2)" 3.4 4.0 5.9 2.6 5.8 4.5 4.8 6.2 7.6 6.1 3.7 7.3 3.5 2.0 6.4 4.4 2.2 4.9 2.9 5.0 5.3 6.5 4.4 4.5 3.4 5.6 5.2 5.1 10.5 3.3 11.8 8.0 4.7 5.4 4.7 3.0 5.5 4.0 5.0 7.5 2.0 3.0 5.2 5.1 3.3 3.1 12.7 4.6 6.7 5.8 4.4 3.2 4.1 3.0 0.7 1.6 0.9 0.6 2.0 1.4 0.5 2.3 2.3 10.6 6.6 4.3 4.1 4.3 2.6 3.9 3.8 3.7 6.0 1.7 7.6 2.8 2.9 4.2 1.7 7.0 3.4 4.6 4.2 4.8 4.5 4.2 9.2 5.7 3.6 2.4 5.4 4.2 3.6 6.1 4.1 3.0 5.6 8.1 3.8 3.6 2.4 8.9 3.9 5.8 0.8 2.2 10.6 7.8 1.6 3.1 3.3 8.4 8.4 3.2 2.8 2.8 5.3 3.4 5.9 2.9 6.2 4.1 2.4 4.0 5.2 4.2 9.2 2.1 2.9 3.7 0.0 0.6 0.9 0.7 0.4 1.0 0.5 1.1 0.8 0.8 0.7 1.1 1.4 0.0 2.0 0.5 1.6 0.2 0.5 5.9 5.8 6.2 7.6 5.3 6.5 5.2 5.1 5.4 4.6 14.9 2.9 1.5 2.2 0.7 6.8 2.8 0.0 1.4 0.0 1.8 13.7 3.0 0.0 1.3 3.2 2.2 0.9 0.0 0.8 1.7 1.9 1.9 1.1 2.6 1.3 6.4 4.7 0.6 1.5 1.3 4.6 0.8 1.7 1.0 1.5 3.7 1.9 0.0 3.5 1.1 8.8 0.0 1.4 9.8 7.9 0.5 3.4 0.8 1.3 1.3 ZMYM4 "KIAA0425, MYM, ZNF198L3, ZNF262" ENSG00000146463 "Zinc finger MYM-type containing 4" Q5VZL5 1 35268967-35422058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051301, HPA054802" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA051301: AB_2681431, HPA054802: AB_2682605" "unprognostic (8.95e-2)" "unprognostic (6.80e-2)" "unprognostic (1.51e-2)" "unprognostic (1.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (9.75e-9)" "unprognostic (9.76e-2)" "unprognostic (4.35e-3)" "unprognostic (4.44e-2)" "unprognostic (6.70e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.18e-1)" "unprognostic (2.04e-1)" "unprognostic (9.18e-2)" "unprognostic (2.21e-1)" 16.6 15.9 17.9 17.3 22.1 13.6 19.7 28.1 24.7 22.0 14.8 17.1 18.3 10.2 19.8 18.2 15.0 17.9 15.7 13.1 17.6 19.0 15.8 14.4 14.1 15.0 15.8 14.6 27.0 15.7 26.1 22.6 19.6 22.2 21.0 13.6 18.2 18.0 26.8 15.9 12.9 12.5 16.6 15.2 16.0 15.4 36.3 13.6 26.7 21.6 13.0 18.8 17.2 14.7 4.2 9.8 3.5 8.2 9.6 4.4 2.5 12.8 10.4 32.1 16.2 9.4 20.4 11.8 15.3 23.1 18.7 24.4 11.2 12.9 23.9 9.4 19.1 9.1 8.3 22.2 11.3 27.0 13.5 15.4 29.2 12.2 9.5 17.0 25.0 13.2 15.4 10.1 18.1 17.2 15.6 20.7 13.3 31.8 6.6 22.6 7.7 21.1 13.9 26.7 6.7 10.0 23.7 20.6 11.6 13.4 17.0 18.5 18.0 18.4 13.5 20.9 21.1 10.9 19.0 24.9 17.4 18.1 7.6 16.4 7.2 13.4 18.4 12.6 19.1 16.6 2.4 5.0 3.5 4.3 7.1 4.4 4.2 4.2 3.8 4.8 3.7 4.1 3.9 1.0 9.6 8.2 9.8 3.1 2.5 17.9 22.1 28.1 24.7 17.6 19.0 15.8 14.6 22.2 13.6 11.9 15.0 11.0 16.2 10.2 27.2 29.5 35.7 22.7 22.7 26.2 29.5 12.4 5.0 19.4 48.6 21.1 5.3 0.0 20.5 10.2 15.8 19.3 13.9 16.1 11.2 22.3 21.5 17.2 18.4 69.6 24.5 13.7 5.0 13.6 13.8 20.1 18.6 9.0 21.5 9.1 33.8 19.4 15.5 22.9 10.4 9.9 11.8 11.7 12.2 24.5 ZNF10 KOX1 ENSG00000256223 "Zinc finger protein 10" P21506 12 133130575-133159465 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 57.6" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003204 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA003204: AB_1080663" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (2.67e-3)" "unprognostic (1.87e-1)" "unprognostic (6.39e-3)" "unprognostic (4.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.35e-3)" "unprognostic (2.50e-2)" "unprognostic (3.94e-2)" "unprognostic (3.41e-1)" "unprognostic (1.52e-1)" "unprognostic (4.36e-2)" "unprognostic (5.13e-3)" 4.8 12.7 5.7 4.9 11.5 6.3 10.5 13.0 9.9 9.3 7.9 7.8 14.4 3.0 12.7 20.7 5.1 10.2 9.9 6.7 5.0 5.6 7.3 7.6 6.4 4.4 8.5 6.4 18.2 10.3 22.6 57.6 4.2 8.3 12.2 5.4 8.8 6.2 16.4 5.1 7.2 5.6 12.3 8.8 5.0 8.2 12.1 7.9 6.8 17.3 5.1 5.6 8.1 7.2 4.4 4.4 1.8 0.7 8.6 8.8 2.4 3.1 2.0 10.0 0.0 11.3 4.7 6.1 4.1 3.7 5.1 3.5 3.6 2.2 0.0 5.7 4.1 2.8 1.6 6.4 3.4 3.7 0.0 5.9 7.4 9.4 3.7 3.4 4.5 2.5 4.9 3.2 5.5 6.1 7.6 4.1 5.8 5.3 0.0 6.0 1.1 10.8 9.5 10.3 2.0 4.1 8.9 6.4 5.0 3.9 7.3 10.2 6.4 8.1 1.1 3.4 4.8 6.3 4.4 4.0 3.7 3.4 3.5 3.4 0.2 0.0 11.8 1.2 1.6 3.4 1.1 0.6 1.8 4.0 0.7 4.5 4.2 4.6 5.5 1.7 4.4 8.8 4.4 0.7 8.6 0.5 4.4 1.2 2.4 5.7 11.5 13.0 9.9 5.0 5.6 8.5 6.4 8.3 7.9 0.0 7.0 3.7 4.2 3.4 16.5 6.7 2.5 1.4 9.1 0.0 29.5 3.5 1.7 1.7 11.6 2.3 1.7 0.0 1.2 1.7 3.1 4.1 10.4 3.8 2.1 4.8 12.1 1.3 3.1 4.7 2.6 2.8 3.3 1.8 3.0 6.1 0.9 2.3 6.3 1.7 16.3 0.0 11.3 13.7 13.8 3.3 3.2 4.4 3.0 1.4 ZNF106 "SH3BP3, ZFP106, ZNF474" ENSG00000103994 "Zinc finger protein 106" Q9H2Y7 15 42412823-42491123 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 64.8;skeletal muscle: 111.1" "Cell type enriched" "Detected in all" 9 "Cardiomyocytes: 1626.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 48.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054267 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA054267: AB_2682431" "unprognostic (2.15e-2)" "unprognostic (3.31e-1)" "unprognostic (7.10e-2)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" "unprognostic (2.49e-1)" "unprognostic (3.96e-1)" "unprognostic (1.33e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-3)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-1)" "unprognostic (4.09e-3)" 14.9 5.4 8.8 6.6 10.4 9.0 10.3 6.3 9.1 7.1 7.8 4.5 4.5 3.9 7.4 6.3 12.7 5.4 6.1 64.8 9.2 6.3 6.4 3.7 7.8 6.0 7.6 6.4 6.6 4.4 8.4 7.1 5.0 11.9 7.8 5.6 11.3 6.0 5.7 111.1 4.3 5.9 10.9 8.0 6.3 6.0 5.7 7.2 3.4 5.7 46.9 6.8 7.0 17.7 8.3 10.8 48.5 19.6 3.9 5.1 4.5 14.4 8.4 14.7 16.2 37.2 32.8 9.0 11.8 11.2 10.3 11.0 19.7 4.2 9.7 10.5 14.4 11.8 16.6 15.2 12.0 15.8 15.7 7.3 18.6 19.6 7.0 10.7 22.2 11.1 24.7 8.1 15.7 17.5 9.2 16.5 12.2 22.0 1.3 16.7 5.7 8.5 5.4 6.2 11.4 8.6 8.1 26.7 5.3 5.4 16.3 9.4 5.0 23.8 11.2 13.2 12.0 10.3 14.5 24.9 11.1 17.1 14.7 17.2 8.1 15.6 36.4 9.9 17.8 19.2 19.9 19.6 7.6 5.1 15.9 4.5 6.7 4.2 4.2 10.5 8.3 3.8 3.4 48.5 3.9 18.5 10.8 3.8 4.5 8.8 10.4 6.3 9.1 9.2 6.3 7.6 6.4 11.9 7.2 125.0 90.2 37.8 49.6 34.2 58.0 1626.8 56.0 188.7 61.4 27.9 90.3 31.5 34.9 37.0 133.3 49.8 30.9 23.3 36.8 30.7 62.9 79.6 42.8 32.7 46.8 33.4 38.7 57.1 104.1 80.0 34.8 64.4 62.4 28.9 28.5 43.3 51.2 23.0 87.0 34.8 75.4 45.3 46.4 55.4 37.4 26.1 25.6 29.4 33.7 64.4 ZNF121 "D19S204, ZHC32, ZNF20" ENSG00000197961 "Zinc finger protein 121" P58317 19 9560353-9584533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA054961 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Centrosome" Nucleoli "HPA054961: AB_2682651" "unprognostic (3.06e-1)" "unprognostic (9.38e-3)" "unprognostic (9.51e-2)" "unprognostic (7.49e-2)" "unprognostic (3.07e-2)" "unprognostic (3.91e-3)" "unprognostic (3.68e-2)" "unprognostic (1.76e-1)" "unprognostic (6.80e-3)" "prognostic favorable (6.59e-5)" "unprognostic (9.36e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (1.01e-4)" "unprognostic (8.75e-3)" "unprognostic (2.83e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.75e-5)" 13.8 8.9 10.4 11.0 12.3 21.0 14.0 16.1 11.8 10.6 8.9 6.2 12.5 6.7 9.4 10.0 16.5 12.4 7.6 10.3 10.3 5.0 9.2 13.2 14.6 13.0 13.6 6.3 13.8 12.5 22.3 20.2 8.3 11.0 11.8 10.6 5.3 14.1 13.7 9.4 18.6 12.3 12.3 14.8 12.4 11.1 6.2 13.0 12.2 11.3 10.4 12.1 15.8 12.7 6.0 4.6 2.9 4.5 7.1 6.8 1.8 7.7 5.0 6.0 12.5 2.8 3.3 9.3 2.7 2.4 4.0 5.0 8.7 3.4 8.8 7.7 2.1 2.2 7.7 12.2 7.1 5.7 4.2 19.8 27.5 12.3 7.7 3.5 13.6 13.8 4.5 6.3 4.0 10.5 3.6 2.9 9.7 9.8 15.0 2.9 6.5 10.1 31.3 14.8 3.1 8.7 6.5 8.2 6.1 3.9 33.0 10.7 5.4 5.3 5.2 3.1 12.5 4.3 4.4 4.2 12.8 7.2 4.4 6.9 16.0 8.7 10.4 3.5 8.0 4.4 2.9 3.6 2.1 5.5 4.4 6.8 4.0 4.9 5.1 4.1 6.0 6.1 6.8 2.8 7.1 4.5 4.6 4.3 1.8 10.4 12.3 16.1 11.8 10.3 5.0 13.6 6.3 11.0 13.0 6.0 8.0 14.1 29.6 20.0 6.5 9.7 7.6 10.7 17.0 8.7 11.8 10.7 6.6 9.0 1.1 7.1 3.3 23.3 4.7 9.4 7.3 18.2 14.0 9.6 4.6 6.4 13.1 9.2 8.9 0.4 5.8 9.2 8.5 1.8 9.2 2.5 9.4 3.5 7.8 4.2 7.0 6.5 6.6 5.4 11.3 27.7 8.8 13.8 12.3 32.8 ZNF174 ZSCAN8 ENSG00000103343 "Zinc finger protein 174" Q15697 16 3401235-3409370 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009656 Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA Nucleoplasm "Actin filaments, Cytosol" "HPA009656: AB_1080679" "unprognostic (4.33e-2)" "unprognostic (6.81e-3)" "unprognostic (2.08e-1)" "unprognostic (7.68e-2)" "unprognostic (1.94e-3)" "unprognostic (5.19e-2)" "unprognostic (2.03e-3)" "unprognostic (6.39e-3)" "unprognostic (2.41e-1)" "unprognostic (4.25e-3)" "unprognostic (2.06e-3)" "unprognostic (4.35e-2)" "unprognostic (6.28e-2)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (2.55e-1)" "unprognostic (1.83e-1)" 10.0 11.6 11.1 9.0 16.0 5.7 12.8 15.8 24.3 13.0 14.8 18.1 9.4 9.6 16.8 18.8 11.0 17.7 13.4 15.3 11.8 12.0 11.1 9.9 8.7 11.6 15.1 10.5 21.0 9.1 28.5 15.2 8.2 15.7 14.7 11.7 16.1 12.2 18.2 14.1 11.4 9.7 16.8 13.3 11.9 10.5 13.5 15.7 18.8 12.2 9.1 12.8 14.8 10.8 9.5 6.9 23.1 6.4 6.8 11.5 6.7 6.3 10.5 12.1 13.6 14.7 10.6 8.3 6.0 14.8 13.0 11.9 8.3 11.1 22.0 9.5 10.5 11.8 9.2 11.2 10.0 12.3 13.9 11.5 11.3 9.9 10.0 10.6 12.9 13.7 12.7 11.8 11.0 11.0 12.6 11.0 15.4 17.9 9.9 13.3 10.6 12.8 10.8 13.2 9.4 13.0 18.4 13.6 17.3 9.5 3.2 11.4 8.8 11.7 13.0 10.0 12.0 12.7 14.4 8.8 9.7 10.6 7.8 7.8 12.3 13.3 17.3 5.2 8.1 9.1 13.1 5.7 23.1 9.1 6.4 8.7 9.5 9.4 10.2 6.9 7.1 11.5 8.5 6.8 6.8 4.2 3.6 8.8 6.7 11.1 16.0 15.8 24.3 11.8 12.0 15.1 10.5 15.7 15.7 3.0 1.3 1.4 1.4 1.6 6.9 4.4 7.6 1.4 1.2 0.0 5.9 5.3 3.3 4.4 4.3 3.8 3.3 0.0 3.7 3.5 2.8 1.7 1.1 3.2 3.8 3.2 3.5 2.5 1.8 3.1 8.1 1.3 3.3 1.8 2.0 7.4 3.6 3.2 9.2 3.7 8.1 0.0 1.5 11.8 9.5 1.6 2.4 3.8 3.4 0.6 ZNF175 OTK18 ENSG00000105497 "Zinc finger protein 175" Q9Y473 19 51571298-51592508 "Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 25.5;RT4: 23.2;TIME: 23.4" "Low region specificity" "Detected in all" HPA002717 Uncertain Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Intermediate filaments" "HPA002717: AB_1080681" "unprognostic (9.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (9.50e-3)" "unprognostic (2.44e-1)" "unprognostic (1.84e-1)" "unprognostic (7.33e-3)" "unprognostic (9.94e-2)" "unprognostic (6.33e-3)" "unprognostic (6.20e-2)" "unprognostic (1.35e-3)" "unprognostic (1.50e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (3.50e-3)" 6.1 6.7 11.2 6.1 12.6 4.7 8.4 26.2 16.0 7.7 6.5 7.1 9.4 8.4 9.2 8.5 5.5 7.6 4.9 6.6 12.7 7.4 7.3 6.4 8.0 8.7 11.1 10.3 14.5 7.3 19.8 10.9 12.1 11.4 7.6 6.1 6.4 9.1 9.5 6.4 5.5 7.9 8.1 8.8 9.7 6.7 15.0 11.7 9.2 10.8 5.0 9.2 8.7 11.9 2.1 4.6 0.6 1.3 0.9 2.2 0.7 1.8 3.2 3.3 3.4 3.5 4.8 0.0 4.1 5.3 3.9 4.7 3.3 2.8 3.3 2.4 4.1 2.4 3.1 3.5 2.8 7.0 0.0 5.2 25.5 5.0 1.1 3.0 4.2 16.4 1.9 2.7 7.9 3.9 19.8 6.2 3.3 8.5 3.5 4.2 0.0 4.5 3.2 1.8 2.2 3.3 0.0 4.2 1.6 2.1 23.2 4.1 3.0 3.9 1.3 2.5 2.7 1.0 3.5 23.4 6.0 2.7 1.4 4.0 4.6 8.4 3.4 16.6 2.5 3.0 0.1 1.3 0.0 1.7 0.5 1.8 1.9 1.6 1.4 1.4 2.1 2.2 1.7 0.6 0.9 0.3 4.6 0.3 0.7 11.2 12.6 26.2 16.0 12.7 7.4 11.1 10.3 11.4 11.7 6.0 4.8 2.4 1.5 1.0 6.1 3.1 2.5 5.3 7.9 5.2 2.0 6.3 1.7 1.6 9.5 2.9 2.0 0.0 1.4 1.2 2.6 1.6 13.9 2.1 2.7 15.9 1.7 5.5 6.6 7.0 3.1 2.0 3.3 1.8 1.2 2.3 4.5 0.0 2.5 1.4 7.4 0.0 2.1 5.8 4.1 1.3 10.1 1.8 2.1 0.7 ZNF2 "A1-5, Zfp661, ZNF661" ENSG00000275111 "Zinc finger protein 2" Q9BSG1 2 95165432-95184317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041358 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041358: AB_10795539" "unprognostic (1.18e-1)" "unprognostic (6.41e-3)" "unprognostic (5.81e-2)" "unprognostic (9.29e-2)" "unprognostic (4.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.13e-3)" "prognostic favorable (4.69e-5)" "unprognostic (1.47e-2)" "unprognostic (1.78e-1)" "unprognostic (2.37e-2)" "unprognostic (2.63e-2)" "unprognostic (2.66e-3)" "unprognostic (2.57e-2)" "unprognostic (6.78e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" 5.1 4.1 5.2 3.2 6.3 0.7 4.0 6.4 6.1 5.3 2.6 6.4 2.5 3.3 5.4 5.7 3.5 4.8 2.3 4.6 5.1 4.2 2.7 3.5 4.3 5.3 5.0 6.5 2.8 6.5 7.1 3.1 5.2 4.8 2.5 4.9 3.7 5.5 4.2 4.7 2.2 4.1 6.1 4.3 3.5 4.3 5.9 4.3 5.0 4.5 5.0 4.3 4.0 7.2 5.0 15.1 6.2 4.2 8.6 4.5 5.4 5.2 6.5 10.8 9.7 7.6 4.2 6.1 8.0 8.4 11.0 5.6 3.7 3.5 4.3 5.7 5.9 4.5 6.9 4.6 8.8 7.6 5.9 8.0 4.3 7.0 7.9 4.1 5.2 6.5 6.5 7.6 11.9 9.3 7.2 6.6 5.3 2.9 8.6 4.9 5.9 5.7 2.8 4.8 7.2 5.7 11.2 4.5 4.8 3.2 5.5 7.5 5.7 8.2 6.9 5.7 5.1 6.3 5.8 10.1 5.9 8.0 5.1 5.0 4.3 4.3 6.8 5.4 7.7 5.9 4.4 15.1 8.6 6.2 6.2 7.2 7.0 7.5 5.0 6.9 8.5 8.6 3.6 4.2 4.7 4.1 7.6 4.5 0.0 1.7 0.5 0.6 0.9 2.8 2.4 2.5 4.0 2.3 1.8 0.0 1.3 5.0 1.5 1.6 1.6 0.7 0.0 1.6 1.1 1.2 0.7 1.1 1.6 2.2 1.6 0.0 1.3 3.2 0.4 2.0 1.7 0.0 0.0 0.7 3.6 0.8 0.0 2.8 2.2 2.9 6.5 1.9 4.2 6.8 1.0 1.4 2.1 1.2 0.6 ZNF232 ZSCAN11 ENSG00000167840 "Zinc finger protein 232" Q9UNY5 17 5105541-5123116 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027309, HPA028611" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA027309: AB_10603464, HPA028611: AB_2672700" "unprognostic (4.20e-2)" "unprognostic (2.06e-3)" "unprognostic (3.69e-1)" "unprognostic (5.59e-3)" "unprognostic (5.21e-2)" "unprognostic (5.90e-3)" "prognostic unfavorable (4.66e-4)" "unprognostic (3.12e-2)" "unprognostic (5.46e-3)" "unprognostic (2.49e-2)" "prognostic favorable (6.55e-4)" "unprognostic (3.28e-2)" "unprognostic (3.49e-3)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (1.11e-1)" "unprognostic (8.61e-3)" 6.7 5.2 6.5 6.7 9.5 2.0 7.4 14.3 11.1 6.6 8.2 11.1 7.8 4.5 8.9 10.1 5.5 9.9 5.5 5.9 7.3 5.4 6.6 6.3 6.3 7.0 9.8 5.7 14.3 10.0 3.8 8.7 6.2 8.7 7.6 5.9 6.5 8.8 6.4 7.7 5.5 6.3 8.5 6.2 6.9 7.2 7.5 10.7 6.4 8.0 5.4 6.1 6.3 6.2 11.8 7.4 1.9 2.1 5.4 7.8 3.9 5.4 4.1 6.8 6.9 2.4 1.0 3.7 2.7 1.4 2.7 3.7 6.4 1.3 11.0 3.3 0.9 3.9 3.8 4.7 2.7 1.6 4.3 7.2 1.9 9.5 5.7 3.5 0.0 3.4 2.0 3.0 2.8 2.5 1.9 1.9 13.3 9.2 4.1 3.2 2.6 9.3 3.8 13.3 4.7 4.5 8.0 4.3 7.4 2.2 0.8 7.1 4.6 5.3 2.1 4.3 5.4 1.1 2.7 3.1 2.7 4.6 2.1 5.2 5.5 8.6 2.8 6.9 0.3 4.4 1.4 2.1 1.9 4.7 1.9 5.5 11.8 5.2 6.2 4.0 11.0 7.8 7.2 0.1 5.4 1.2 7.4 4.2 3.9 6.5 9.5 14.3 11.1 7.3 5.4 9.8 5.7 8.7 10.7 0.0 1.6 2.2 3.1 3.8 5.0 5.0 0.0 5.3 4.5 5.2 0.0 3.2 3.3 5.3 6.0 4.0 2.1 0.0 3.5 4.0 2.4 2.0 0.0 3.2 5.1 0.0 1.2 3.1 2.7 4.8 3.4 1.8 0.0 1.0 2.7 3.8 3.5 5.8 4.9 2.6 2.8 0.0 4.1 12.1 10.9 4.1 1.7 1.5 3.3 1.6 ZNF236 ENSG00000130856 "Zinc finger protein 236" Q9UL36 18 76822607-76970727 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008600 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA008600: AB_1080696" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (3.13e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (9.88e-3)" "unprognostic (5.51e-2)" "unprognostic (1.77e-1)" "unprognostic (2.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "unprognostic (2.95e-2)" "unprognostic (9.40e-2)" "unprognostic (1.74e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" 5.7 5.2 7.0 9.1 11.2 10.8 10.0 15.3 11.0 7.2 5.8 7.3 6.7 5.0 7.6 7.1 5.6 7.6 6.3 5.1 8.3 5.7 4.7 4.3 6.4 6.2 8.3 3.5 11.3 7.1 12.2 8.9 5.6 7.3 6.2 4.1 5.4 6.6 12.6 5.7 9.9 5.5 5.8 6.5 5.5 5.8 16.6 10.6 10.4 6.5 1.9 10.0 6.2 12.7 9.0 4.6 5.9 3.4 3.0 5.4 1.2 4.2 5.7 8.0 5.9 6.2 6.0 3.6 3.3 4.6 5.3 4.2 4.0 4.0 6.0 1.6 4.3 5.6 7.8 5.5 4.6 4.4 6.4 5.6 5.7 6.6 4.7 3.8 9.1 6.6 5.9 5.1 5.0 7.7 5.7 5.3 9.6 5.4 5.1 5.3 4.0 11.2 5.1 4.4 1.3 4.5 7.1 8.3 4.0 3.9 6.7 4.6 4.8 5.9 3.6 4.1 3.9 4.3 6.4 5.4 9.1 3.7 2.4 4.9 3.5 4.7 7.8 6.0 5.0 6.8 1.1 3.4 5.9 5.4 2.9 5.2 9.0 4.0 3.7 2.2 8.1 4.6 4.8 3.7 3.0 2.7 4.6 3.9 1.2 7.0 11.2 15.3 11.0 8.3 5.7 8.3 3.5 7.3 10.6 8.9 6.4 3.7 7.4 6.4 14.6 6.9 10.2 14.7 6.8 7.0 9.8 6.9 1.7 4.3 6.0 7.5 4.3 23.3 3.4 6.0 7.7 6.0 1.1 5.7 5.3 23.8 5.8 7.4 8.7 3.3 9.8 5.3 6.8 5.4 4.7 10.8 3.9 2.9 6.7 2.2 14.3 6.5 8.2 27.0 18.5 7.3 5.0 5.1 5.2 5.8 ZNF263 "FPM315, ZKSCAN12, ZSCAN44" ENSG00000006194 "Zinc finger protein 263" O14978 16 3263800-3301401 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035085, HPA035086" Approved Supported "Nucleoplasm,Mitotic spindle,Cytosol" Yes No Cytosol "Nucleoplasm, Mitotic spindle" "HPA035085: AB_10671099, HPA035086: AB_10603244" "unprognostic (2.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (3.33e-1)" "unprognostic (2.25e-1)" "unprognostic (6.42e-2)" "unprognostic (7.00e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (6.39e-2)" "unprognostic (2.30e-3)" "unprognostic (2.98e-3)" "unprognostic (5.10e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (2.66e-1)" 28.3 17.8 21.5 16.9 25.7 15.0 23.3 26.4 23.5 21.9 19.2 18.1 14.0 13.8 30.4 23.4 15.4 24.2 17.6 14.6 15.7 14.2 16.9 17.1 18.5 20.4 20.3 18.1 30.7 23.0 36.4 24.8 20.1 16.8 21.8 16.8 20.2 19.5 21.1 15.8 22.7 18.2 18.6 14.0 23.6 20.5 17.3 16.5 18.9 20.1 14.5 28.8 20.2 27.6 6.6 5.5 9.6 5.0 6.7 9.2 3.3 8.6 11.2 13.4 19.4 10.7 14.1 17.4 11.9 18.3 14.3 15.6 12.2 13.6 31.9 12.4 15.3 13.3 11.0 18.2 12.1 14.4 17.5 18.2 14.5 15.0 11.7 12.5 21.4 17.8 16.2 25.4 13.0 19.2 16.1 12.2 20.6 16.3 21.7 11.7 11.9 19.7 16.5 24.9 10.2 9.6 32.1 13.6 25.1 10.0 8.7 19.4 20.3 13.0 14.1 14.5 16.3 15.6 25.6 12.6 15.2 14.6 11.2 11.1 23.3 24.7 38.5 5.9 10.8 10.7 2.1 3.9 9.6 6.0 4.2 6.9 4.5 7.3 8.0 5.5 6.6 9.2 6.8 5.0 6.7 5.0 4.6 4.9 3.3 21.5 25.7 26.4 23.5 15.7 14.2 20.3 18.1 16.8 16.5 0.0 14.4 9.1 14.5 15.5 10.2 3.6 12.7 4.0 4.5 1.8 0.0 9.7 6.6 8.9 41.6 11.1 6.0 0.0 8.6 8.9 10.8 11.4 6.9 5.8 8.0 3.2 12.7 5.5 8.9 26.2 7.5 8.0 15.1 8.2 9.2 10.1 8.2 3.5 7.4 5.0 9.0 12.9 18.6 11.4 10.4 18.1 9.3 10.0 11.7 11.9 ZNF266 HZF1 ENSG00000174652 "Zinc finger protein 266" Q14584 19 9412598-9435578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 46.5" "HPA026836, HPA054110" Uncertain Supported "Nucleoplasm,Vesicles,Rods & Rings" NA NA Vesicles "Nucleoplasm, Rods & Rings" "HPA026836: AB_2672018, HPA054110: AB_2682383" "unprognostic (2.50e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (7.60e-2)" "prognostic favorable (3.94e-6)" "unprognostic (1.72e-2)" "prognostic favorable (4.47e-4)" "unprognostic (4.59e-2)" "unprognostic (9.00e-3)" "prognostic favorable (3.03e-5)" "unprognostic (2.92e-3)" "prognostic unfavorable (1.82e-4)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" "prognostic favorable (9.15e-5)" 14.7 12.1 11.0 21.5 12.5 12.8 17.6 19.0 10.0 21.8 15.7 13.1 9.6 8.6 17.2 55.8 12.7 14.6 12.8 11.7 8.2 5.4 10.9 10.4 15.8 21.0 14.5 4.9 18.9 11.2 12.5 19.8 13.0 11.4 23.8 15.7 14.4 14.4 13.5 9.3 19.1 20.8 17.0 10.9 31.3 13.5 13.0 11.4 34.6 20.8 7.3 23.4 14.4 14.2 6.9 3.8 5.6 5.5 12.6 13.0 5.1 10.8 2.8 8.1 15.3 5.8 11.3 6.5 12.0 10.2 9.9 16.6 5.8 4.7 12.1 7.7 5.9 3.7 4.1 10.2 6.4 11.9 3.4 16.8 16.6 14.8 8.5 5.2 9.5 10.2 10.7 8.8 5.4 8.3 9.9 8.0 14.5 8.6 0.1 9.2 1.0 13.8 46.5 8.4 4.9 9.1 6.2 8.4 8.4 7.8 13.5 6.9 10.8 5.5 6.5 6.7 8.4 4.8 7.3 7.2 9.3 3.6 14.0 6.1 19.8 26.3 14.4 2.9 9.1 7.0 4.8 4.1 5.6 13.0 4.8 8.5 6.0 7.2 9.2 3.3 6.9 10.6 10.2 3.6 12.6 5.5 3.8 8.7 5.1 11.0 12.5 19.0 10.0 8.2 5.4 14.5 4.9 11.4 11.4 0.0 11.0 14.5 6.3 3.5 8.1 5.0 2.5 4.0 7.9 3.5 11.8 3.8 3.3 4.8 0.7 5.2 6.2 23.3 3.2 2.7 4.7 6.2 11.5 2.5 4.2 7.9 9.1 12.3 11.7 1.4 5.8 7.9 5.0 8.2 6.4 4.3 3.4 5.1 4.2 1.1 9.3 6.5 5.6 3.5 7.8 4.1 3.9 14.1 6.3 5.4 ZNF322 "bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489" ENSG00000181315 "Zinc finger protein 322" Q6U7Q0 6 26634383-26659752 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043161, HPA046692" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA043161: AB_2678346, HPA046692: AB_2679755" "unprognostic (1.01e-2)" "unprognostic (2.81e-1)" "unprognostic (5.20e-2)" "unprognostic (3.39e-3)" "prognostic favorable (1.28e-4)" "unprognostic (1.21e-1)" "unprognostic (9.35e-2)" "prognostic favorable (8.57e-4)" "unprognostic (5.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.53e-1)" "unprognostic (2.50e-1)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "unprognostic (3.55e-1)" "unprognostic (3.24e-2)" "unprognostic (5.71e-2)" 8.8 9.7 7.7 5.4 10.9 0.4 10.1 10.6 15.4 13.1 8.6 7.9 9.5 6.9 12.7 10.8 6.8 9.2 11.5 13.3 8.4 6.9 9.5 7.0 7.9 6.7 8.8 7.0 14.8 6.9 15.0 18.0 8.6 11.8 12.3 8.6 8.6 8.2 15.5 7.7 5.0 7.9 9.7 10.7 8.7 7.6 8.2 12.5 4.3 13.6 6.7 7.2 11.8 8.4 11.2 7.9 10.5 11.2 17.6 11.4 4.9 5.8 4.4 17.5 20.1 11.5 15.4 6.3 7.8 10.4 10.9 13.2 8.6 3.6 7.1 18.9 6.8 13.7 7.4 13.0 5.1 13.7 10.9 11.8 12.5 5.8 8.4 13.1 0.0 11.4 9.4 18.0 7.2 8.2 13.7 9.4 8.8 14.3 7.6 12.0 3.3 8.8 10.5 5.1 5.4 5.4 9.8 12.4 10.1 6.7 9.3 14.2 15.0 9.3 8.8 16.4 8.9 8.2 8.1 9.3 18.2 7.3 7.4 7.9 8.0 16.0 6.8 3.9 2.0 18.3 3.3 8.7 10.5 11.4 7.4 8.3 11.2 5.8 7.4 7.0 10.5 6.8 9.9 8.3 17.6 11.2 7.9 4.4 4.9 7.7 10.9 10.6 15.4 8.4 6.9 8.8 7.0 11.8 12.5 6.0 8.0 16.7 14.7 3.5 32.6 4.8 10.2 10.7 15.9 8.7 7.9 10.4 29.9 14.8 2.6 13.5 8.7 0.0 8.9 9.8 12.8 21.0 12.7 6.0 11.3 44.5 18.9 14.1 6.5 2.5 27.9 10.4 8.5 8.2 12.9 25.0 13.2 11.8 24.8 11.1 12.6 32.3 14.6 17.0 10.2 5.6 8.0 8.5 9.4 21.0 ZNF324 "ZF5128, ZNF324A" ENSG00000083812 "Zinc finger protein 324" O75467 19 58467045-58475436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 35.6;Horizontal cells: 31.8;Rod photoreceptor cells: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 35.6" HPA039774 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" No No "Nucleoplasm, Nuclear membrane, Cytosol" "HPA039774: AB_10673149" "unprognostic (8.60e-2)" "unprognostic (7.42e-3)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.12e-3)" "unprognostic (3.69e-3)" "unprognostic (2.36e-2)" "unprognostic (5.09e-3)" "unprognostic (2.84e-1)" "unprognostic (1.57e-1)" "prognostic favorable (4.74e-5)" "unprognostic (6.39e-2)" "prognostic favorable (1.34e-7)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (6.99e-4)" "unprognostic (3.56e-1)" 7.7 8.0 8.9 11.5 10.8 12.6 7.4 15.8 14.0 9.8 8.8 11.9 10.2 8.5 12.0 9.1 12.7 10.5 9.2 7.6 9.9 9.3 6.5 10.5 7.7 10.5 10.4 11.5 14.6 15.0 10.2 12.7 7.1 7.1 10.6 6.0 7.2 11.2 13.3 5.8 11.9 7.3 8.2 9.3 8.3 8.6 8.0 9.7 16.8 11.9 8.1 10.7 9.3 7.2 6.4 6.4 13.1 5.0 6.0 11.8 3.4 4.1 5.2 3.6 5.4 4.1 3.6 3.9 3.3 4.2 3.4 3.1 4.6 2.1 6.5 3.2 2.8 4.9 5.3 4.6 4.6 1.6 5.6 35.6 4.5 4.0 2.2 3.3 7.5 5.3 2.7 5.8 4.8 2.2 3.9 2.4 5.6 6.3 4.2 3.7 3.3 6.7 4.1 2.8 4.4 7.9 7.2 4.5 4.1 2.4 8.3 7.3 5.7 3.7 6.0 2.6 2.9 3.0 5.5 4.2 10.3 2.3 3.6 5.7 6.2 6.2 3.3 5.2 3.6 3.2 2.3 4.7 7.2 9.5 5.0 10.7 5.3 7.6 10.5 3.2 6.4 11.8 8.9 13.1 6.0 3.9 6.4 7.2 3.4 8.9 10.8 15.8 14.0 9.9 9.3 10.4 11.5 7.1 9.7 0.0 1.7 5.1 4.5 8.0 35.6 5.6 2.5 2.7 3.4 0.0 23.6 4.1 0.0 4.0 0.9 4.2 9.2 0.0 3.6 3.2 4.6 5.2 1.1 2.9 2.5 31.8 7.5 5.5 1.8 0.7 11.8 3.6 3.3 1.8 5.0 16.4 3.2 7.4 13.8 1.4 57.5 6.5 7.8 10.7 13.8 11.7 5.6 8.7 5.6 4.1 ZNF326 "FLJ20403, ZAN75, Zfp326, ZIRD" ENSG00000162664 "Zinc finger protein 326" Q5BKZ1 1 89995112-90035531 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 134.9;Cone photoreceptor cells: 351.5;Rod photoreceptor cells: 448.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028450, HPA028461, HPA028466" Supported Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677" "prognostic favorable (9.46e-4)" "unprognostic (2.45e-1)" "unprognostic (7.25e-3)" "unprognostic (1.09e-1)" "unprognostic (5.28e-3)" "unprognostic (1.67e-2)" "unprognostic (8.61e-3)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (3.17e-2)" "unprognostic (3.66e-2)" "unprognostic (1.33e-2)" "unprognostic (2.62e-2)" "unprognostic (8.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-1)" "prognostic favorable (2.84e-4)" 12.7 13.4 18.4 12.7 27.8 45.2 17.7 20.2 18.5 11.8 14.1 23.2 16.3 18.5 18.3 17.1 17.5 11.9 13.9 12.5 19.2 15.2 13.4 15.2 11.5 15.3 26.1 14.1 21.8 20.2 14.4 18.0 14.5 22.8 13.3 20.7 23.9 15.7 9.4 19.2 14.5 18.9 17.8 31.3 11.0 14.6 10.6 27.8 17.3 14.1 10.5 15.1 11.9 17.2 6.8 8.4 3.6 6.1 7.8 4.3 2.2 17.2 15.8 24.6 11.7 11.0 5.2 26.0 17.5 6.8 14.5 9.1 14.6 12.6 21.6 12.5 9.0 16.0 15.6 25.6 11.4 20.0 12.6 12.3 19.5 15.4 13.3 3.7 22.9 9.6 4.6 5.4 14.4 9.2 10.2 8.4 10.1 26.0 9.4 11.7 8.2 23.6 13.0 23.1 14.6 18.0 16.8 24.9 5.8 12.0 19.4 21.6 14.0 20.1 18.7 8.5 18.2 10.3 6.0 11.4 17.1 17.2 14.4 17.3 8.0 7.9 21.6 4.1 18.1 10.9 2.1 5.1 3.6 4.0 6.1 3.2 4.2 3.2 3.4 4.0 6.8 3.2 4.3 2.5 7.8 4.6 8.4 2.8 2.2 18.4 27.8 20.2 18.5 19.2 15.2 26.1 14.1 22.8 27.8 20.8 44.0 32.0 53.5 57.9 134.9 34.4 15.3 45.5 44.3 22.7 351.5 36.5 16.6 45.3 3.4 38.7 63.7 0.0 48.0 73.0 29.8 46.9 48.7 28.0 22.6 65.2 67.4 24.5 16.4 4.2 40.0 32.7 37.1 46.9 33.4 49.5 37.7 66.6 31.8 14.7 448.1 25.8 38.7 58.0 40.9 39.5 41.3 22.4 36.2 68.1 ZNF341 dJ553F4.3 ENSG00000131061 "Zinc finger protein 341" Q9BYN7 20 33731657-33792269 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Club cells: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023240, HPA024607, HPA067108" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: AB_2685780" "unprognostic (1.74e-1)" "unprognostic (2.18e-1)" "unprognostic (3.73e-1)" "unprognostic (2.10e-1)" "unprognostic (9.31e-2)" "prognostic favorable (3.93e-4)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (1.80e-1)" "unprognostic (7.38e-2)" "unprognostic (9.31e-2)" "unprognostic (8.17e-5)" "unprognostic (4.84e-2)" "unprognostic (2.90e-1)" "unprognostic (8.67e-3)" "unprognostic (3.68e-2)" 4.5 4.3 7.3 6.9 10.4 7.7 5.1 10.4 9.1 6.5 4.9 7.2 2.1 5.8 6.5 3.5 6.7 5.4 5.2 4.5 6.8 3.1 3.1 3.6 4.7 5.5 8.8 6.3 5.5 5.4 4.0 5.2 5.4 4.9 4.9 4.9 3.7 5.7 6.9 7.2 8.2 5.0 4.9 4.2 5.8 4.5 7.4 6.9 4.9 4.9 2.9 4.7 6.5 5.5 2.6 1.5 5.9 2.4 2.2 2.4 1.4 1.8 8.3 3.0 4.0 3.0 2.1 11.2 2.8 1.7 2.7 1.3 6.2 5.3 3.8 3.8 2.0 3.0 3.6 2.8 4.9 0.9 3.7 2.8 4.3 3.4 2.9 1.1 2.4 4.7 2.1 3.0 2.1 1.2 2.3 2.7 4.5 2.2 1.6 2.4 3.8 2.2 1.0 2.6 3.5 4.2 2.6 1.3 1.8 1.5 6.4 2.1 1.9 8.2 5.5 1.0 2.4 6.3 2.2 2.1 3.5 1.2 0.9 2.2 1.2 1.6 2.9 4.3 1.6 2.7 3.5 1.9 5.9 1.9 2.4 1.6 2.6 1.2 1.3 1.5 2.5 1.1 2.4 3.8 2.2 1.5 1.1 1.0 1.4 7.3 10.4 10.4 9.1 6.8 3.1 8.8 6.3 4.9 6.9 3.0 6.1 4.7 1.0 0.3 2.3 2.0 2.5 5.3 6.8 1.8 2.0 2.2 0.0 1.5 0.5 0.7 4.2 0.0 1.2 2.6 1.3 1.9 2.3 0.8 1.2 1.6 1.2 1.3 2.2 0.0 0.6 2.5 0.0 0.0 2.1 0.2 1.6 0.8 0.4 0.3 2.1 0.0 0.6 1.1 2.2 0.9 1.7 0.0 1.3 1.8 ZNF354A "EZNF, HKL1, KID-1, KID1, TCF17" ENSG00000169131 "Zinc finger protein 354A" O60765 5 178694605-178730702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052043 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA052043: AB_2681706" "unprognostic (2.79e-1)" "unprognostic (3.44e-2)" "unprognostic (7.06e-3)" "unprognostic (1.78e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (3.25e-2)" "unprognostic (1.41e-1)" "unprognostic (7.66e-3)" "prognostic favorable (8.28e-4)" "unprognostic (4.06e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (8.71e-2)" "unprognostic (4.13e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" 14.0 7.0 13.0 12.1 13.6 14.2 14.2 13.3 14.4 12.6 15.0 6.7 11.4 7.1 13.7 13.3 10.4 11.7 9.8 14.5 13.2 9.3 18.0 6.2 10.8 12.7 16.7 16.1 10.9 15.0 11.7 14.1 14.0 13.4 13.3 10.0 7.1 8.8 15.1 11.9 12.3 10.6 13.6 12.9 17.1 10.4 14.0 14.4 13.1 15.1 8.6 14.2 17.0 25.1 5.7 5.3 15.0 5.8 6.0 6.4 3.6 4.3 3.4 7.1 18.8 12.4 10.1 29.4 5.0 6.7 7.0 7.5 5.0 7.3 5.8 6.6 4.5 12.9 8.6 2.6 21.3 10.8 7.7 8.1 1.7 4.2 0.6 9.4 0.0 4.9 7.9 13.7 6.1 12.5 9.0 6.6 7.9 1.4 0.0 10.1 8.7 8.7 5.8 6.2 4.0 8.8 6.5 1.2 3.6 6.5 4.4 7.8 8.5 6.3 7.2 9.7 9.8 5.9 8.5 5.1 7.9 5.2 4.5 4.2 1.9 4.0 3.6 0.2 1.3 9.9 4.4 5.8 14.5 5.1 3.8 6.4 5.7 4.6 5.7 5.3 3.6 5.3 3.8 15.0 6.0 3.9 1.9 4.1 3.6 13.0 13.6 13.3 14.4 13.2 9.3 16.7 16.1 13.4 14.4 11.9 6.1 3.2 10.0 4.4 8.9 5.5 0.0 12.0 10.3 7.0 13.7 10.6 11.6 9.8 9.2 8.0 2.1 0.0 6.6 10.6 6.1 5.3 5.8 0.8 8.0 6.4 4.6 6.2 8.2 3.2 6.4 7.8 10.1 3.6 2.2 7.4 6.7 0.0 9.9 13.5 9.7 6.5 9.2 22.3 9.8 4.8 10.2 10.9 4.3 6.9 ZNF44 "KOX7, ZNF504, ZNF55, ZNF58" ENSG00000197857 "Zinc finger protein 44" P15621 19 12224686-12294887 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 81.2;Early spermatids: 95.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003146 Supported Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA003146: AB_1080723" "unprognostic (1.51e-1)" "unprognostic (2.47e-3)" "unprognostic (7.07e-2)" "unprognostic (4.60e-2)" "unprognostic (9.63e-2)" "prognostic favorable (8.74e-4)" "unprognostic (8.39e-2)" "prognostic favorable (7.54e-4)" "unprognostic (5.65e-3)" "unprognostic (9.17e-2)" "unprognostic (1.75e-3)" "unprognostic (3.56e-3)" "unprognostic (7.30e-3)" "unprognostic (2.75e-1)" "unprognostic (2.09e-1)" "unprognostic (5.69e-2)" "prognostic favorable (9.21e-6)" 10.5 8.4 9.6 7.3 13.1 20.2 13.6 19.3 9.8 9.8 11.6 7.9 20.8 8.2 9.6 13.2 10.3 9.5 8.1 7.0 8.5 4.6 11.7 15.2 9.6 9.6 12.2 6.9 15.9 11.1 8.7 12.1 7.0 9.4 11.1 13.0 9.1 9.2 18.1 17.3 15.4 11.1 14.1 11.6 13.9 9.6 13.8 12.8 6.5 11.3 6.5 10.5 10.7 10.8 4.7 3.1 15.1 3.0 11.5 9.5 3.5 3.6 1.0 2.8 4.9 2.8 2.8 12.0 5.2 2.3 8.3 7.4 4.9 2.0 3.6 6.5 4.9 2.4 3.8 3.5 3.6 7.2 0.0 3.3 3.4 4.8 12.9 3.8 0.0 9.3 2.9 5.7 5.1 6.6 3.4 3.2 4.4 2.2 0.7 5.2 3.7 5.2 6.0 2.7 3.6 6.2 3.6 6.2 4.4 5.0 8.6 3.1 3.7 6.6 2.6 1.6 7.8 5.5 5.8 3.7 10.0 2.7 9.7 4.5 7.7 9.7 3.5 0.2 3.1 2.9 9.8 1.6 15.1 8.0 3.0 9.4 4.7 8.6 8.6 1.4 3.2 9.5 9.2 5.3 11.5 3.0 3.1 5.7 3.5 9.6 13.1 19.3 9.8 8.5 4.6 12.2 6.9 9.4 12.8 26.8 14.5 9.3 5.4 8.0 16.5 15.1 22.9 32.1 17.0 61.1 35.3 14.0 81.2 8.3 95.8 7.1 14.2 0.0 8.0 6.3 8.0 6.5 23.1 11.1 7.2 15.9 15.0 14.1 7.9 23.8 13.0 10.8 10.1 3.6 11.5 10.6 7.3 11.5 5.6 9.1 35.3 19.4 9.8 17.6 17.9 10.2 7.2 19.2 11.8 8.6 ZNF445 "ZKSCAN15, ZNF168, ZSCAN47" ENSG00000185219 "Zinc finger protein 445" P59923 3 44431720-44477670 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 34.4;Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006678 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA006678: AB_10603329" "unprognostic (7.72e-2)" "unprognostic (2.55e-1)" "unprognostic (1.12e-2)" "unprognostic (1.42e-1)" "unprognostic (7.14e-2)" "unprognostic (1.67e-2)" "unprognostic (1.79e-2)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.62e-1)" "unprognostic (1.03e-2)" "unprognostic (4.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.76e-1)" "unprognostic (2.48e-1)" "unprognostic (4.40e-3)" "unprognostic (1.05e-1)" 6.8 6.4 8.3 6.4 10.9 4.5 7.5 16.5 10.9 8.6 7.1 11.7 8.0 5.1 13.6 7.7 5.2 8.3 6.1 6.3 7.7 7.0 6.3 7.5 6.7 6.6 11.3 10.5 13.0 7.6 16.1 13.9 7.1 7.9 8.6 6.6 9.9 8.1 8.2 11.2 8.2 5.7 12.3 6.6 7.0 7.3 6.5 8.9 14.2 6.9 4.8 8.1 6.7 8.2 1.1 1.1 4.1 2.5 1.9 1.5 0.5 2.5 2.9 9.1 7.1 5.1 5.2 4.1 3.5 2.9 5.3 5.3 4.4 2.3 4.5 2.2 3.6 3.4 2.1 6.1 2.4 6.4 4.9 2.3 8.3 5.9 4.3 3.2 10.5 7.0 3.6 3.0 5.9 3.8 4.5 3.7 6.4 6.4 3.4 4.2 1.7 10.0 7.1 6.2 1.6 2.7 4.5 5.7 2.2 2.9 5.3 4.5 5.6 5.4 2.8 1.4 7.1 5.2 4.6 4.4 7.5 6.7 4.6 4.4 2.7 2.0 3.8 2.8 5.3 4.5 2.7 1.3 2.3 1.2 0.8 1.1 0.7 0.9 0.9 0.9 1.1 1.5 1.1 4.1 1.9 2.5 1.1 0.4 0.5 8.3 10.9 16.5 10.9 7.7 7.0 11.3 10.5 7.9 8.9 11.9 16.7 7.3 4.1 3.7 34.4 7.8 2.5 12.0 10.3 10.4 35.3 3.3 1.7 4.4 1.9 6.8 2.6 0.0 7.3 1.5 6.1 5.2 10.5 8.5 4.7 27.0 6.9 10.4 14.0 1.6 8.6 7.7 0.0 1.0 6.5 13.4 4.4 3.5 9.2 2.3 30.0 12.9 6.1 5.7 6.1 2.3 1.1 5.7 6.9 3.4 ZNF461 "GIOT-1, MGC33911" ENSG00000197808 "Zinc finger protein 461" Q8TAF7 19 36637192-36666853 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 31.6;Club cells: 21.6;granulocytes: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021139 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA021139: AB_10961418" "unprognostic (8.37e-3)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.08e-2)" "unprognostic (6.32e-2)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-3)" "unprognostic (2.11e-1)" "unprognostic (7.01e-3)" "unprognostic (2.43e-2)" "unprognostic (1.51e-1)" "unprognostic (4.21e-2)" "unprognostic (4.54e-2)" "unprognostic (5.86e-2)" "unprognostic (5.11e-3)" 6.0 8.7 8.1 5.6 12.3 6.3 7.2 13.5 12.0 7.1 5.9 8.5 4.7 1.5 10.2 7.1 5.2 7.6 5.8 5.0 6.9 7.5 6.8 5.1 5.4 6.9 7.0 8.6 10.8 4.0 7.9 12.1 8.7 8.7 6.7 4.7 5.7 4.8 6.3 4.1 5.9 5.4 8.5 7.4 7.9 5.4 8.1 9.2 5.9 10.6 3.1 7.6 6.2 7.3 3.3 2.3 1.0 2.3 2.2 6.2 1.6 2.9 5.3 4.0 5.1 2.8 6.3 2.5 3.1 3.5 4.9 6.8 0.9 1.3 0.4 6.7 4.4 4.8 0.5 2.8 3.4 5.3 5.4 4.0 4.6 0.7 2.0 4.5 3.9 5.6 3.9 6.2 1.6 4.4 5.8 3.0 2.5 0.2 0.4 4.9 3.1 6.1 1.0 2.3 0.4 2.0 0.4 3.9 0.9 1.5 6.7 4.7 6.7 0.3 2.3 4.2 4.3 2.5 1.5 3.0 3.0 3.8 1.9 3.8 8.8 13.0 1.6 0.0 0.8 3.8 0.0 0.8 1.0 2.5 2.3 3.1 2.8 4.1 6.2 2.3 3.3 3.1 2.2 0.1 2.2 0.4 0.7 3.5 1.6 8.1 12.3 13.5 12.0 6.9 7.5 7.0 8.6 8.7 9.2 26.8 31.6 1.3 1.7 3.0 5.5 1.6 5.1 14.7 21.6 3.5 0.0 2.4 1.7 1.2 17.7 3.4 0.2 0.0 0.8 2.4 3.0 1.7 31.3 1.0 1.5 3.2 2.9 4.3 2.2 4.1 0.9 1.9 0.0 0.0 1.0 1.9 0.7 0.0 1.8 1.5 3.2 0.0 3.1 7.7 4.2 3.0 2.4 4.3 1.2 1.5 ZNF484 "BA526D8.4, FLJ33884" ENSG00000127081 "Zinc finger protein 484" Q5JVG2 9 92845031-92878038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.0" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 6.7;Club cells: 7.9;Horizontal cells: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA028973 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA028973: AB_10610703" "unprognostic (5.52e-2)" "unprognostic (3.05e-2)" "unprognostic (1.72e-1)" "unprognostic (6.05e-2)" "unprognostic (5.69e-2)" "unprognostic (3.86e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-1)" "unprognostic (6.04e-2)" "unprognostic (9.84e-2)" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (4.03e-2)" "unprognostic (3.74e-1)" "unprognostic (4.77e-1)" "unprognostic (6.49e-2)" "unprognostic (1.51e-1)" 6.5 6.6 9.9 5.4 14.6 10.1 6.5 33.0 13.9 7.7 4.8 7.8 4.7 3.7 7.0 5.3 4.2 6.2 4.7 4.9 11.7 7.0 7.3 5.2 5.8 6.6 12.5 7.1 9.1 4.5 12.1 14.0 7.9 12.6 7.0 5.2 4.6 5.0 6.3 3.7 4.2 5.0 6.2 17.1 7.7 6.0 4.8 13.5 2.8 9.0 1.9 7.9 7.3 5.8 5.6 2.5 5.3 3.5 4.5 7.4 3.0 4.1 5.1 6.7 4.3 3.5 4.3 0.0 3.4 5.5 6.1 6.7 1.6 3.2 3.6 3.0 2.7 4.3 6.8 4.9 5.1 6.5 5.8 2.1 3.1 4.1 3.3 5.4 2.5 5.6 4.8 3.9 6.7 7.1 4.5 5.3 4.0 3.3 14.6 6.5 4.2 3.7 1.2 5.6 4.7 2.5 3.1 8.2 2.6 3.2 4.8 4.7 4.2 6.0 1.7 3.4 5.3 0.4 2.0 5.7 5.5 5.3 2.8 2.4 5.5 2.7 2.1 3.6 2.1 4.3 1.4 2.5 5.3 5.3 3.5 6.5 3.7 5.4 4.4 2.2 5.6 7.4 6.7 1.4 4.5 3.1 2.5 4.4 3.0 9.9 14.6 33.0 13.9 11.7 7.0 12.5 7.1 12.6 13.5 0.0 1.0 0.0 0.5 0.1 4.2 1.7 0.0 6.7 7.9 1.8 0.0 0.9 1.7 1.1 0.5 0.9 0.8 0.0 0.4 0.9 0.7 0.4 2.3 0.2 0.7 4.8 0.0 0.0 0.8 0.0 0.6 0.2 0.0 0.0 0.9 3.1 0.7 0.9 1.4 1.3 3.5 0.0 1.0 0.5 0.8 0.1 0.6 1.3 0.5 0.5 ZNF487 "KRBO1, ZNF487P" ENSG00000243660 "Zinc finger protein 487" B1APH4 10 43436841-43483179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 78.9;Early spermatids: 155.2;Late spermatids: 196.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA037820 Approved "Nucleoplasm,Nuclear membrane,Cytosol" Yes No "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA037820: AB_10697083" "unprognostic (1.97e-1)" "unprognostic (1.69e-3)" "unprognostic (1.49e-1)" "unprognostic (3.42e-3)" "unprognostic (7.40e-2)" "unprognostic (1.42e-2)" "unprognostic (7.10e-2)" "unprognostic (4.84e-1)" "unprognostic (4.00e-2)" "unprognostic (1.05e-2)" "unprognostic (6.97e-4)" "unprognostic (5.85e-2)" "unprognostic (3.97e-4)" "unprognostic (2.91e-1)" "unprognostic (4.42e-2)" "unprognostic (2.52e-2)" "unprognostic (5.92e-2)" 4.1 2.7 4.8 2.7 5.3 5.1 3.9 11.1 9.1 4.6 3.5 3.3 2.2 3.3 5.1 3.1 2.8 7.9 4.9 3.2 6.6 5.0 3.3 3.1 4.0 2.9 5.6 7.4 6.1 2.3 3.7 6.9 2.6 11.2 3.3 2.7 4.0 2.5 4.0 1.7 3.3 3.5 4.2 8.1 3.1 3.0 32.1 6.4 4.3 4.4 2.0 2.9 4.3 3.4 3.2 5.1 13.9 3.9 3.5 4.7 2.6 2.4 2.3 2.8 3.0 3.6 7.2 0.7 4.0 6.9 3.7 4.0 3.6 6.6 6.1 0.7 4.7 3.7 3.9 0.9 1.5 4.6 0.6 1.5 1.9 0.5 2.0 4.4 1.9 2.8 7.1 3.3 6.0 4.5 7.5 1.3 1.3 1.0 1.2 2.7 4.1 3.9 1.6 0.8 1.3 2.5 2.0 1.0 2.4 8.2 2.6 2.8 1.9 3.4 2.0 2.2 1.8 3.1 2.3 2.0 3.4 2.4 1.9 1.1 0.5 1.6 6.7 8.2 2.7 1.3 2.5 3.9 5.8 4.7 2.8 4.0 2.8 3.5 4.3 5.1 3.2 3.0 3.6 13.9 3.5 1.5 3.9 1.8 2.6 4.8 5.3 11.1 9.1 6.6 5.0 5.6 7.4 11.2 6.4 20.8 3.7 7.2 5.4 1.5 4.9 3.1 5.1 78.9 9.1 5.2 7.9 1.4 10.0 3.7 155.2 4.9 5.2 0.0 1.8 3.3 4.0 5.1 0.0 2.4 3.0 6.4 7.5 3.7 5.7 196.9 4.4 5.6 1.7 2.8 4.6 8.0 1.7 3.7 6.3 9.1 17.1 0.0 3.6 6.7 7.6 2.5 1.4 5.0 3.0 5.5 ZNF503 "FLJ45745, MGC2555, Nlz2" ENSG00000165655 "Zinc finger protein 503" Q96F45 10 75397830-75401906 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Smooth muscle cells: 105.0" "Cancer enhanced" "Detected in all" "ovarian cancer: 62.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.6;myeloid DC: 1.4" "Group enriched" "Detected in many" 16 "dendritic cells: 1.4;monocytes: 1.6" "Cell line enhanced" "Detected in many" "HEK 293: 39.0;PC-3: 50.6;U-87 MG: 15.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026848 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA026848: AB_10610704" "unprognostic (1.18e-1)" "unprognostic (8.56e-2)" "unprognostic (8.63e-3)" "unprognostic (7.41e-2)" "unprognostic (2.82e-1)" "unprognostic (3.57e-2)" "unprognostic (9.63e-2)" "unprognostic (7.42e-2)" "unprognostic (3.42e-2)" "unprognostic (3.22e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (3.50e-4)" "prognostic favorable (1.97e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" 9.4 23.1 2.3 6.2 7.2 2.2 14.1 0.8 4.7 47.8 10.2 3.0 20.8 9.0 28.1 15.1 27.8 14.1 15.3 5.8 3.4 3.0 22.1 5.7 16.5 2.6 4.8 1.5 38.1 19.4 4.0 3.0 4.8 7.5 21.3 2.5 18.5 6.4 50.7 2.9 3.2 6.6 10.1 8.0 7.6 9.4 7.3 2.9 0.5 7.7 8.5 3.7 14.4 25.0 0.0 1.4 0.0 1.6 0.0 0.0 0.1 1.7 1.6 0.3 2.1 3.7 2.5 0.5 1.6 0.9 0.6 0.6 2.5 6.9 0.0 4.6 1.5 0.3 3.1 0.2 1.6 0.4 0.0 39.0 0.0 4.2 8.1 2.9 2.0 4.4 6.7 1.6 1.2 0.7 5.7 0.1 0.2 0.0 0.0 0.9 0.8 0.0 6.1 0.0 1.2 50.6 0.0 1.9 0.0 0.9 1.3 1.4 1.8 2.8 0.2 8.4 0.3 0.3 1.4 1.3 5.1 5.8 10.5 4.2 0.0 0.0 0.0 15.7 9.0 4.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.3 7.2 0.8 3.6 3.4 3.0 4.8 1.5 7.5 2.9 35.7 12.3 2.2 37.9 24.2 18.3 13.2 7.6 0.0 9.1 38.4 19.6 0.5 49.7 39.4 0.0 21.8 0.8 23.3 30.0 0.4 30.7 20.3 5.8 8.9 12.0 6.4 3.5 39.9 27.3 1.1 55.3 16.3 23.6 5.4 6.1 5.6 32.4 0.0 46.3 28.3 21.2 38.8 105.0 0.2 2.4 12.2 0.2 0.0 7.2 12.7 ZNF511 MGC30006 ENSG00000198546 "Zinc finger protein 511" Q8NB15 10 133308475-133313162 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA035360 Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Intracellular and membrane" NA NA "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA035360: AB_10601931" "unprognostic (3.35e-2)" "unprognostic (2.19e-1)" "unprognostic (1.91e-1)" "unprognostic (8.84e-2)" "unprognostic (1.31e-1)" "unprognostic (1.16e-1)" "unprognostic (3.04e-1)" "unprognostic (1.68e-2)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (1.40e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.94e-2)" "unprognostic (3.91e-2)" "unprognostic (2.55e-1)" "unprognostic (4.52e-2)" 11.4 11.2 10.1 13.2 10.3 14.8 20.5 16.9 11.0 12.0 18.3 8.7 17.1 8.2 16.8 13.2 13.1 15.4 11.7 20.6 9.4 7.7 13.8 21.2 11.4 16.4 9.6 8.7 21.2 30.1 9.9 13.6 9.7 8.2 17.4 10.9 11.4 17.3 13.6 25.9 9.3 19.1 15.5 8.8 12.7 12.1 21.3 10.8 12.3 16.0 23.2 11.9 12.2 16.8 21.5 19.3 21.6 18.9 12.8 15.6 15.3 11.2 13.0 7.3 9.0 7.6 6.4 6.9 6.4 10.6 15.4 13.0 21.3 11.6 14.1 5.3 7.2 9.4 10.3 11.5 9.9 6.0 9.6 32.7 7.3 5.8 10.8 6.1 13.2 10.6 6.3 5.4 11.7 5.5 8.6 6.9 5.6 11.4 3.9 5.3 18.4 3.8 16.9 7.9 9.2 24.2 6.3 9.5 2.9 7.8 4.1 4.3 6.9 5.3 5.9 7.6 4.3 5.0 7.5 6.7 6.4 6.3 5.5 15.3 5.0 7.6 16.3 7.6 6.3 2.5 10.6 18.9 21.6 14.3 14.9 11.8 21.5 12.5 15.6 18.9 14.7 14.4 13.5 2.9 12.8 14.7 19.3 10.4 15.3 10.1 10.3 16.9 11.0 9.4 7.7 9.6 8.7 8.2 10.8 14.9 12.6 26.7 38.9 26.3 19.5 20.6 22.9 17.4 13.6 21.0 7.9 51.6 59.7 31.3 18.3 19.9 31.6 0.0 35.6 53.1 31.6 36.6 77.2 44.5 43.0 20.6 51.3 13.5 23.5 4.5 38.6 44.9 15.1 70.3 85.0 25.5 31.4 45.6 28.7 56.4 18.9 25.8 29.9 56.3 46.2 31.5 23.6 29.9 64.1 35.3 ZNF511-PRAP1 ENSG00000283496 "ZNF511-PRAP1 readthrough" 10 133309410-133352529 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 31.6;liver: 23.8" "Cell type enriched" "Detected in single" 12 "Club cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 16.1;OE19: 11.5" "HPA035360, HPA038713, HPA052451" Supported Uncertain "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839" 2.1 1.6 1.1 5.0 1.7 1.2 6.2 3.0 2.7 3.1 11.9 1.9 4.9 31.6 3.9 3.5 3.5 1.3 3.0 4.8 1.8 13.7 23.8 2.1 4.7 2.2 1.9 4.9 9.7 0.9 2.1 1.5 1.7 5.1 7.6 2.9 5.0 3.0 5.8 1.3 28.1 4.4 0.8 3.0 3.4 6.5 2.7 3.2 4.6 7.1 3.0 2.0 4.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.2 3.1 5.0 0.0 0.0 6.7 0.0 1.4 0.0 0.0 6.7 2.1 0.0 3.2 1.7 0.2 0.1 0.8 0.0 2.1 0.3 0.0 0.9 0.0 16.1 0.0 1.2 1.8 0.0 0.0 1.5 4.8 0.0 0.0 0.6 0.3 6.1 0.0 0.0 3.2 5.2 0.3 11.5 0.0 0.9 1.2 2.9 0.2 0.3 0.5 5.4 0.3 2.7 2.3 3.3 0.0 0.5 0.0 0.0 3.0 2.5 0.1 1.5 0.0 0.8 0.3 1.1 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF526 "KIAA1951, MGC4267" ENSG00000167625 "Zinc finger protein 526" Q8TF50 19 42220271-42228201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 41.9;Club cells: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023070, HPA056609" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA023070: AB_2671057, HPA056609: AB_2683189" "unprognostic (2.04e-1)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.46e-1)" "unprognostic (5.86e-2)" "unprognostic (9.09e-3)" "unprognostic (1.79e-1)" "unprognostic (8.84e-2)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (2.14e-1)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (2.30e-1)" 10.1 7.0 5.9 12.3 9.1 8.5 8.5 14.5 10.0 10.6 8.5 8.6 9.2 8.3 12.2 6.4 8.4 9.3 5.0 6.8 7.5 4.3 7.0 7.6 7.3 9.1 8.7 6.6 12.0 9.0 10.1 11.7 8.6 6.2 9.9 5.6 7.5 11.1 9.1 11.7 13.0 10.1 6.3 4.6 9.1 7.9 11.6 8.1 13.8 7.6 6.1 11.5 9.0 10.3 6.9 6.1 2.5 7.1 4.5 10.7 4.3 7.1 23.3 6.9 6.1 7.9 7.6 6.0 8.4 7.8 8.9 9.8 12.2 5.2 11.7 6.1 8.9 4.0 5.3 7.3 9.1 5.6 6.9 8.7 11.7 10.9 11.7 7.3 7.4 7.6 7.5 7.4 8.9 9.3 5.5 5.5 6.3 11.1 7.4 5.6 10.0 7.4 4.8 4.5 6.3 8.4 8.7 8.4 5.2 4.0 13.1 7.0 6.2 9.6 9.7 7.0 5.5 3.9 13.3 7.4 11.0 7.6 4.6 10.5 9.0 5.3 8.1 7.3 7.3 9.1 2.5 5.1 1.9 7.0 5.4 10.7 6.9 5.5 6.3 4.2 6.7 6.7 8.3 1.2 4.5 7.1 6.1 5.4 4.3 5.9 9.1 14.5 10.0 7.5 4.3 8.7 6.6 6.2 8.1 20.8 41.9 6.4 4.0 4.8 7.6 2.0 0.0 14.7 28.4 3.5 13.7 6.4 3.3 3.3 4.6 4.7 4.7 0.0 2.4 7.0 4.1 2.5 23.3 3.2 3.9 6.4 13.2 4.3 4.7 5.5 6.6 4.6 0.0 4.6 5.0 3.3 2.6 3.5 2.8 2.4 8.7 0.0 4.2 5.8 9.8 4.4 8.6 5.0 4.9 2.1 ZNF540 DKFZp547B0714 ENSG00000171817 "Zinc finger protein 540" Q8NDQ6 19 37551406-37614097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 30.7" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 23.5;Early spermatids: 14.0;Horizontal cells: 17.5;Rod photoreceptor cells: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 6.8" HPA003444 Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA003444: AB_1080732" "unprognostic (2.51e-2)" "unprognostic (2.30e-4)" "unprognostic (4.92e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-4)" "unprognostic (4.24e-4)" "unprognostic (3.44e-3)" "unprognostic (8.88e-4)" "unprognostic (2.65e-1)" "unprognostic (3.17e-1)" "unprognostic (3.38e-5)" "unprognostic (1.50e-1)" "unprognostic (1.09e-6)" "unprognostic (2.74e-1)" "unprognostic (4.75e-2)" "unprognostic (8.08e-2)" "unprognostic (8.33e-5)" 2.8 9.3 8.6 3.9 29.9 1.2 6.0 23.7 16.7 5.8 4.4 5.0 5.3 3.9 6.0 9.4 3.0 4.2 3.6 9.1 8.6 12.1 6.3 2.6 5.0 6.3 9.0 9.1 13.8 3.8 13.3 30.7 2.3 11.0 7.1 3.6 9.0 6.1 8.9 2.9 6.0 4.5 3.8 7.9 6.3 4.6 11.5 9.5 2.7 14.4 3.1 6.0 3.4 4.0 3.1 0.3 1.2 0.1 3.0 7.1 1.8 0.4 0.0 2.6 2.6 6.8 4.1 0.2 0.9 0.9 1.1 2.1 0.2 0.0 1.2 0.3 2.4 0.6 1.0 1.8 0.9 0.9 3.7 2.6 0.9 1.2 0.0 1.8 1.2 2.0 1.8 2.4 0.7 0.0 0.5 0.1 5.1 0.4 0.0 1.6 0.1 1.7 0.7 0.9 0.3 0.5 1.4 1.6 0.8 0.6 0.4 2.7 3.0 1.0 0.3 0.3 1.9 1.3 0.7 0.0 1.0 3.1 1.2 0.9 3.6 2.0 2.5 0.0 0.4 0.6 0.0 0.0 1.2 3.9 0.1 3.9 2.9 4.1 4.4 0.1 3.1 6.8 7.1 0.2 3.0 0.0 0.3 4.2 1.8 8.6 29.9 23.7 16.7 8.6 12.1 9.0 9.1 11.0 9.5 3.0 1.6 0.8 1.1 1.4 23.5 8.7 0.0 0.0 2.3 1.8 5.9 0.2 6.6 0.1 14.0 0.9 0.4 0.0 0.4 0.3 0.9 0.4 3.5 0.8 0.7 17.5 0.0 2.5 0.3 4.3 2.3 0.9 3.3 0.0 0.0 5.2 0.3 0.0 5.3 2.1 19.7 6.5 3.3 4.4 2.7 1.1 0.1 3.5 0.2 0.0 ZNF557 MGC4054 ENSG00000130544 "Zinc finger protein 557" Q8N988 19 7069444-7087968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003151, HPA029291" Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" No No "Nucleoplasm, Intermediate filaments" Cytosol "HPA003151: AB_1859344, HPA029291: AB_10602357" "unprognostic (1.05e-1)" "unprognostic (2.96e-3)" "unprognostic (5.29e-2)" "prognostic favorable (5.70e-4)" "unprognostic (2.56e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.32e-1)" "prognostic favorable (2.62e-4)" "unprognostic (2.51e-2)" "unprognostic (2.51e-2)" "prognostic favorable (1.51e-4)" "unprognostic (2.28e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-3)" "unprognostic (4.71e-2)" "unprognostic (6.18e-2)" "unprognostic (2.81e-3)" 6.8 9.2 7.2 8.1 9.4 13.1 8.5 12.4 9.9 7.0 6.5 11.1 7.2 5.1 9.5 7.7 8.7 8.5 6.0 5.5 5.9 5.6 6.9 10.3 6.8 9.7 7.6 8.1 9.8 9.0 7.0 12.9 6.7 9.2 7.5 6.4 7.2 9.2 10.5 5.3 7.2 7.6 7.6 6.7 11.7 8.0 8.4 9.8 21.7 9.0 4.0 11.3 7.0 7.1 10.7 11.1 9.3 6.7 13.7 11.5 4.0 3.6 4.4 4.1 8.4 6.3 4.7 3.4 3.9 5.0 5.1 6.9 5.1 2.5 7.1 6.9 4.8 3.6 5.0 8.0 5.1 4.8 9.1 4.9 10.2 7.9 2.7 4.5 10.3 10.9 6.2 6.0 5.6 7.6 4.5 4.7 6.6 4.2 12.8 7.5 5.3 7.9 3.1 3.9 3.9 6.2 5.6 6.1 4.2 3.2 9.5 4.8 5.9 5.8 4.3 4.4 3.9 3.5 6.3 7.0 4.4 3.3 8.6 4.1 12.2 9.3 6.8 4.9 5.5 3.5 9.3 6.7 8.6 9.5 5.5 10.6 7.6 10.3 8.6 7.2 10.7 11.5 9.6 7.4 13.7 5.2 11.1 9.3 4.0 7.2 9.4 12.4 9.9 5.9 5.6 7.6 8.1 9.2 9.8 3.0 4.1 8.8 5.9 1.3 8.3 4.5 2.5 5.3 7.9 7.0 0.0 5.2 13.3 6.0 0.8 5.3 4.5 23.3 5.4 3.8 4.0 5.1 8.1 4.0 5.3 15.9 5.2 7.4 7.3 0.0 4.0 6.4 0.0 4.6 6.6 5.2 5.0 3.7 5.3 6.7 6.4 0.0 4.8 15.9 16.4 1.1 4.8 6.4 5.1 6.4 ZNF569 "FLJ32053, ZAP1" ENSG00000196437 "Zinc finger protein 569" Q5MCW4 19 37411155-37469275 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 29.5;Early spermatids: 102.9;Rod photoreceptor cells: 31.0;Spermatocytes: 35.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052994 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA052994: AB_2682007" "unprognostic (1.40e-1)" "unprognostic (3.37e-1)" "unprognostic (4.95e-2)" "unprognostic (2.18e-2)" "unprognostic (5.44e-2)" "unprognostic (4.79e-2)" "unprognostic (2.95e-2)" "unprognostic (4.00e-1)" "unprognostic (5.08e-2)" "unprognostic (6.50e-3)" "unprognostic (4.01e-3)" "unprognostic (9.41e-2)" "unprognostic (9.70e-2)" "unprognostic (3.04e-2)" "unprognostic (5.77e-2)" "unprognostic (1.91e-2)" "unprognostic (1.37e-1)" 5.8 7.8 10.9 6.1 11.1 7.7 6.6 20.9 10.6 6.9 5.0 6.4 3.8 3.2 7.2 9.5 4.4 6.5 4.5 7.7 8.0 11.2 6.9 6.0 4.6 7.2 8.6 8.7 10.9 3.7 8.8 18.5 5.5 10.6 6.6 3.5 5.2 4.5 5.6 7.2 6.5 4.1 6.3 10.2 6.2 4.2 20.1 11.3 9.6 10.5 3.8 5.9 6.4 4.7 7.2 3.2 7.1 4.0 6.2 11.3 3.2 2.8 5.8 6.7 11.0 5.5 4.9 3.3 5.2 3.1 5.7 6.1 1.9 1.2 3.3 7.6 3.8 5.6 1.0 7.4 2.0 6.0 7.6 4.4 8.6 1.4 3.2 3.3 1.6 3.6 3.4 1.3 5.7 0.1 5.5 4.5 10.7 2.8 0.6 8.0 1.7 10.9 3.7 7.8 0.2 4.1 7.1 8.4 3.5 4.0 2.8 5.7 8.9 0.2 1.3 2.9 6.8 4.9 6.9 4.4 4.4 9.1 3.4 8.3 9.5 16.0 13.1 0.3 3.6 7.0 4.9 2.6 7.1 8.7 3.3 7.7 6.1 7.8 8.1 2.8 7.2 11.3 8.9 2.7 6.2 4.0 3.2 7.8 3.2 10.9 11.1 20.9 10.6 8.0 11.2 8.6 8.7 10.6 11.3 0.0 1.7 0.0 1.9 1.4 15.7 13.7 0.0 6.7 7.9 1.8 29.5 2.7 1.7 1.5 102.9 3.8 0.5 0.0 1.7 3.0 3.4 1.0 2.3 1.7 2.4 3.2 0.0 3.7 2.2 27.5 4.4 4.1 0.0 3.6 0.3 7.5 1.2 0.0 7.1 4.2 31.0 0.0 4.4 35.4 11.9 1.8 0.7 7.9 0.8 1.0 ZNF571 HSPC059 ENSG00000180479 "Zinc finger protein 571" Q7Z3V5 19 37554782-37594790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.8" "Cell type enhanced" "Detected in many" 4 "granulocytes: 15.0;Rod photoreceptor cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA054762 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA054762: " "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (3.92e-2)" "unprognostic (1.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.19e-1)" "unprognostic (9.03e-4)" "unprognostic (5.77e-2)" "unprognostic (9.82e-2)" "unprognostic (1.22e-3)" "unprognostic (3.90e-2)" "unprognostic (2.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.62e-1)" "unprognostic (4.89e-2)" "unprognostic (2.71e-4)" 6.5 6.7 8.6 3.2 12.9 6.1 12.5 12.5 12.8 5.9 4.2 9.8 4.4 2.3 6.7 8.7 3.9 6.0 4.5 4.2 10.4 7.2 6.4 4.2 4.1 4.4 15.3 9.4 8.5 3.8 11.5 12.2 4.8 13.4 7.1 3.4 5.1 3.6 4.5 3.5 7.1 3.7 7.7 14.3 4.8 3.5 8.5 15.8 3.7 61.8 3.3 5.0 6.6 5.3 9.4 4.1 4.9 1.3 3.7 8.4 3.2 1.8 1.0 6.3 9.1 4.7 4.8 2.0 2.7 4.4 6.6 8.2 1.9 1.7 9.6 8.6 2.8 4.6 2.4 2.0 2.9 11.0 2.1 7.9 5.1 2.7 1.1 5.4 1.9 5.8 2.6 5.3 6.3 5.8 4.7 1.3 8.7 2.4 0.8 5.3 1.7 9.6 2.1 15.8 2.9 3.5 4.8 3.0 5.1 9.1 11.6 13.6 9.5 6.4 2.1 3.2 13.2 9.7 1.3 0.8 3.0 3.9 3.3 6.9 7.7 15.8 13.2 0.5 0.8 6.6 1.8 0.8 4.9 6.7 1.3 6.1 8.7 6.3 6.5 2.7 9.4 7.8 8.4 1.5 3.7 1.2 4.1 4.2 3.2 8.6 12.9 12.5 12.8 10.4 7.2 15.3 9.4 13.4 15.8 0.0 1.3 4.5 1.1 1.5 9.3 1.1 2.5 4.0 5.7 5.2 9.8 1.8 3.3 1.7 10.5 2.5 0.8 0.0 1.4 1.3 2.3 1.7 15.0 0.8 1.4 12.7 1.2 2.5 1.3 2.5 4.0 1.3 5.0 0.0 2.1 4.5 0.8 0.0 2.5 2.6 16.6 12.9 1.7 7.2 5.7 2.3 1.0 6.2 1.3 0.5 ZNF575 FLJ32567 ENSG00000176472 "Zinc finger protein 575" Q86XF7 19 43525497-43536130 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Paneth cells: 5.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051865 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA051865: AB_2681643" "unprognostic (1.77e-3)" "unprognostic (2.73e-2)" "unprognostic (1.07e-1)" "unprognostic (1.98e-1)" "unprognostic (8.56e-2)" "unprognostic (6.53e-4)" "unprognostic (1.23e-1)" "unprognostic (2.37e-1)" "unprognostic (2.36e-2)" "unprognostic (2.21e-1)" "unprognostic (3.87e-5)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (7.83e-2)" "unprognostic (2.75e-1)" 8.8 3.9 10.5 3.8 10.0 2.5 3.2 12.3 13.5 4.9 13.8 6.8 2.9 5.6 4.7 4.0 2.4 3.6 4.6 3.6 6.6 4.2 3.9 3.2 3.6 3.9 5.4 6.2 6.3 2.3 3.0 5.2 2.0 6.7 5.5 7.1 5.1 5.0 4.1 12.9 4.8 6.4 3.4 6.0 5.8 4.7 1.9 6.5 2.4 3.3 2.3 4.2 3.5 3.7 3.0 1.9 0.8 0.9 7.0 4.4 1.3 2.9 2.6 0.6 0.8 4.0 3.4 0.2 1.9 1.3 0.7 1.0 0.6 1.1 0.6 1.3 1.4 0.3 1.6 0.1 0.3 0.3 4.2 0.5 2.2 0.9 0.5 0.9 0.9 2.7 1.9 1.2 1.0 0.2 2.1 0.6 4.2 0.9 4.1 1.2 1.9 11.7 0.3 0.2 2.1 1.4 6.4 0.0 1.5 0.7 1.7 0.6 1.0 1.5 2.0 1.9 0.5 0.5 1.1 2.0 3.7 2.5 0.8 1.4 2.2 3.2 1.8 2.3 2.7 3.9 0.1 0.9 0.6 3.0 0.5 1.2 1.5 2.8 2.9 1.3 3.0 4.4 3.2 0.8 7.0 0.3 1.9 2.3 1.3 10.5 10.0 12.3 13.5 6.6 4.2 5.4 6.2 6.7 6.5 6.0 0.6 0.0 0.5 0.1 1.1 1.5 0.0 0.0 1.2 0.0 3.9 1.0 3.3 0.4 0.0 1.0 2.6 0.0 0.6 0.7 1.9 0.4 0.0 2.0 1.4 0.0 1.2 2.5 1.0 0.0 2.3 1.7 1.7 0.0 2.0 0.3 0.1 5.3 3.2 1.9 0.0 0.0 2.4 0.1 0.9 1.5 0.2 1.0 2.3 0.3 ZNF599 FLJ30663 ENSG00000153896 "Zinc finger protein 599" Q96NL3 19 34758076-34773229 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 28.2;Early spermatids: 64.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014701 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA014701: AB_1859371" "unprognostic (3.52e-3)" "unprognostic (1.42e-3)" "unprognostic (1.99e-2)" "unprognostic (9.35e-3)" "unprognostic (9.20e-2)" "unprognostic (5.16e-3)" "unprognostic (3.95e-3)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (7.35e-3)" "unprognostic (1.77e-3)" "unprognostic (5.03e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-2)" "unprognostic (8.12e-3)" 5.9 8.1 10.0 5.2 12.5 2.4 8.5 16.8 8.0 10.1 6.5 11.7 5.8 4.5 12.2 21.4 4.4 14.1 6.5 5.8 10.3 6.8 9.7 4.9 6.0 5.7 10.5 5.7 11.4 5.7 14.3 13.2 6.0 8.1 10.4 5.5 11.6 7.4 9.5 5.5 8.0 5.4 7.1 8.1 6.5 5.9 19.9 11.2 10.4 13.2 6.0 6.2 6.4 7.2 4.3 3.8 6.4 4.8 5.7 6.7 2.9 5.2 2.6 5.9 5.4 6.5 8.7 3.2 1.9 5.4 4.8 5.7 2.3 3.6 0.6 5.6 3.7 4.4 2.7 3.8 2.5 6.0 0.6 4.8 4.1 5.4 6.5 5.0 0.9 4.6 7.8 3.6 2.2 2.3 8.9 5.5 9.9 6.8 0.5 7.5 2.1 10.1 4.2 2.5 7.2 0.2 5.5 5.5 3.3 6.0 1.2 7.0 9.9 6.5 1.2 3.8 4.5 3.4 0.5 2.9 4.8 5.4 3.6 2.0 6.1 6.6 0.5 2.9 0.1 4.5 3.1 1.1 6.4 6.1 2.5 4.0 2.0 6.5 3.5 1.7 4.3 6.7 5.9 0.6 5.7 4.8 3.8 4.9 2.9 10.0 12.5 16.8 8.0 10.3 6.8 10.5 5.7 8.1 11.2 0.0 3.0 0.8 5.4 2.7 3.1 3.7 2.5 22.7 10.3 17.4 2.0 6.8 28.2 3.7 64.0 4.9 1.6 0.0 2.0 3.8 6.0 6.5 0.0 2.5 3.2 0.0 1.2 6.2 1.5 24.3 9.5 1.3 5.0 1.0 3.1 11.2 2.5 0.0 4.6 11.5 2.4 6.5 4.4 22.1 5.5 1.4 1.6 4.3 3.4 4.7 ZNF614 FLJ21941 ENSG00000142556 "Zinc finger protein 614" Q8N883 19 52012765-52030240 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 37.9;Late spermatids: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021197 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA021197: AB_1859380" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (3.24e-2)" "unprognostic (1.30e-1)" "unprognostic (7.67e-3)" "unprognostic (2.68e-1)" "unprognostic (4.74e-3)" "unprognostic (5.07e-3)" "unprognostic (1.09e-1)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.74e-2)" "unprognostic (1.66e-2)" "unprognostic (3.06e-2)" "unprognostic (1.57e-1)" "unprognostic (2.30e-1)" "unprognostic (7.15e-3)" 7.7 7.1 9.9 5.6 9.4 10.1 10.1 15.6 12.5 9.2 7.3 6.6 5.8 4.5 9.5 7.3 6.3 8.8 6.0 7.0 7.9 8.5 6.9 4.7 6.3 8.2 9.3 7.1 14.0 5.1 6.5 13.7 14.2 9.7 16.4 5.5 5.5 5.4 8.9 11.1 7.6 6.3 8.9 13.5 9.7 5.8 13.8 10.7 18.2 14.3 5.1 7.5 8.5 9.6 6.0 5.5 4.3 5.9 9.6 8.1 3.2 3.8 2.9 7.4 9.5 5.2 5.9 1.0 5.2 3.7 4.9 5.9 3.7 2.2 9.7 2.9 4.4 4.5 1.7 10.8 6.9 7.2 2.6 15.5 14.6 5.2 7.3 4.3 3.0 7.4 4.5 3.8 4.9 6.9 4.9 5.6 8.6 7.7 2.2 6.4 1.5 12.5 6.0 8.4 0.6 5.2 8.3 14.1 8.0 5.0 9.8 9.9 5.9 3.1 3.9 3.2 9.5 5.2 7.7 5.7 4.8 6.6 2.7 6.2 4.4 6.8 14.9 4.6 4.2 6.3 4.3 4.3 3.0 6.5 5.9 7.8 6.0 5.7 6.1 5.5 6.0 8.1 5.3 3.3 9.6 4.5 3.1 5.9 3.2 9.9 9.4 15.6 12.5 7.9 8.5 9.3 7.1 9.7 10.7 0.0 2.1 0.9 3.8 2.9 5.5 5.3 2.5 0.0 6.8 5.2 3.9 4.6 0.0 2.4 37.9 4.4 1.6 0.0 0.8 4.7 3.7 3.9 6.9 1.5 2.1 15.9 5.2 5.5 6.4 32.8 3.7 2.2 1.7 1.0 2.0 4.1 1.0 0.0 6.7 1.8 5.1 0.0 6.4 2.2 4.7 2.4 12.0 2.5 2.2 4.4 ZNF626 ENSG00000188171 "Zinc finger protein 626" Q68DY1 19 20620061-20661596 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 13.8" HPA045631 Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" Nucleoplasm "HPA045631: AB_2679397" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-2)" "unprognostic (2.18e-2)" "unprognostic (6.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-2)" "unprognostic (6.51e-3)" "unprognostic (1.92e-1)" "unprognostic (2.49e-1)" "unprognostic (5.10e-2)" "unprognostic (1.73e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (2.31e-1)" 8.1 13.9 10.2 6.0 15.6 4.1 18.5 15.2 14.8 11.2 8.3 12.0 21.6 2.4 13.0 9.5 8.0 14.0 10.7 10.8 10.1 10.1 12.7 6.5 7.2 12.4 10.9 11.1 29.2 9.6 36.3 14.8 8.3 11.0 12.8 4.4 13.6 8.9 23.9 7.3 10.8 6.0 11.9 12.1 7.8 9.1 5.8 11.9 13.6 26.9 4.9 10.7 21.3 9.7 11.4 4.2 11.6 4.3 9.1 8.6 4.2 0.1 0.0 4.3 0.7 5.3 6.9 0.5 4.9 0.5 7.0 6.2 0.2 0.2 0.7 2.6 6.0 8.1 0.8 0.0 0.2 8.9 0.0 0.2 0.0 0.1 1.7 9.4 0.1 0.1 12.9 2.2 4.1 2.2 0.2 3.3 0.2 3.0 0.5 7.3 0.1 0.8 1.1 9.3 0.0 2.2 4.3 3.2 1.6 7.0 5.3 1.5 8.3 0.2 0.5 4.4 8.7 10.3 0.4 0.0 3.2 0.2 12.7 0.5 6.9 13.8 6.2 0.1 0.1 0.5 0.8 1.1 6.0 7.6 1.0 7.3 7.9 8.0 8.6 3.2 11.4 7.7 6.6 11.6 9.1 4.3 4.2 3.7 4.2 10.2 15.6 15.2 14.8 10.1 10.1 10.9 11.1 11.0 11.9 3.0 8.0 18.2 11.4 8.4 11.1 9.0 10.2 12.0 4.5 26.2 9.8 14.9 26.6 6.8 0.8 9.0 0.0 0.0 8.4 19.4 10.3 16.3 6.9 6.4 9.3 12.7 2.4 19.0 3.1 1.5 17.3 6.3 5.0 3.6 0.7 14.2 7.6 0.0 14.5 21.3 7.9 12.9 9.2 7.2 15.8 11.0 36.3 10.1 0.1 13.4 ZNF646 KIAA0296 ENSG00000167395 "Zinc finger protein 646" O15015 16 31074422-31084196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042364, HPA066468" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA042364: AB_10794796, HPA066468: AB_2732746" "unprognostic (1.61e-2)" "unprognostic (2.18e-1)" "unprognostic (8.08e-2)" "unprognostic (1.18e-2)" "unprognostic (4.66e-1)" "unprognostic (6.20e-3)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.23e-2)" "unprognostic (4.21e-2)" "unprognostic (6.96e-2)" "unprognostic (1.16e-2)" "unprognostic (9.83e-2)" "unprognostic (2.07e-2)" "unprognostic (2.65e-1)" "unprognostic (1.93e-1)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" 9.8 6.4 5.9 10.4 7.6 13.4 7.3 12.2 7.8 10.2 6.8 10.4 8.2 10.6 9.8 6.8 7.5 8.6 7.6 5.9 6.8 5.5 6.9 6.1 13.5 11.3 10.6 5.6 10.3 8.2 10.1 9.4 8.0 7.2 7.9 4.9 5.8 9.8 14.2 12.4 10.6 9.6 6.5 7.4 12.9 9.1 36.1 9.2 24.7 7.7 5.2 11.5 7.8 10.8 4.0 5.2 19.8 3.7 3.4 4.3 1.5 6.1 12.9 8.5 6.6 6.1 4.8 11.2 6.8 7.2 8.2 7.6 9.4 5.9 12.0 10.9 5.7 5.4 8.3 7.0 7.4 3.2 13.8 6.6 8.9 11.4 7.8 6.3 11.4 13.9 6.1 6.8 8.8 5.0 6.4 4.9 10.3 14.1 7.1 6.2 9.8 12.6 7.8 11.4 2.8 6.7 20.4 16.6 12.1 2.6 5.9 12.3 12.4 7.8 8.3 4.1 3.9 6.9 10.0 9.8 10.4 5.9 6.9 6.3 11.9 10.9 12.2 9.4 12.4 8.1 5.9 3.7 9.4 4.3 3.3 2.2 3.3 2.0 1.7 3.5 4.0 2.2 2.5 19.8 3.4 2.1 5.2 2.0 1.5 5.9 7.6 12.2 7.8 6.8 5.5 10.6 5.6 7.2 9.2 3.0 2.2 2.4 0.9 3.0 3.0 1.2 2.5 1.4 1.2 1.8 3.9 1.5 1.7 3.8 19.8 2.9 5.2 0.0 2.9 1.7 2.1 2.2 1.1 1.5 4.1 1.6 5.8 0.6 2.4 2.7 2.6 4.4 0.0 3.6 3.7 3.7 3.6 5.8 4.2 1.9 1.0 0.0 1.1 10.4 6.7 3.4 2.1 2.2 3.5 2.0 ZNF668 FLJ13479 ENSG00000167394 "Zinc finger protein 668" Q96K58 16 31060843-31074320 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043048 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA043048: AB_10962503" "unprognostic (2.71e-2)" "unprognostic (4.95e-2)" "unprognostic (6.42e-2)" "unprognostic (1.48e-1)" "unprognostic (3.27e-1)" "unprognostic (7.20e-3)" "unprognostic (6.73e-5)" "unprognostic (4.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-1)" "unprognostic (7.71e-3)" "prognostic unfavorable (6.24e-4)" "unprognostic (1.72e-3)" "unprognostic (2.00e-1)" "unprognostic (2.23e-1)" "unprognostic (4.83e-3)" "unprognostic (7.25e-2)" 7.1 8.2 8.2 8.9 10.0 18.5 5.9 11.1 15.4 8.3 10.2 6.6 5.1 11.8 9.4 5.6 8.0 6.1 9.6 5.1 8.6 7.4 5.9 6.9 7.3 8.6 7.6 5.2 5.7 10.6 4.6 6.7 10.1 9.2 8.1 4.2 4.9 7.2 7.6 12.6 9.0 10.3 9.5 6.5 8.6 8.8 10.0 6.1 16.9 5.4 8.8 7.5 6.6 6.5 5.6 7.3 8.6 4.8 8.4 13.9 5.4 3.6 12.6 2.8 7.0 3.0 3.1 9.7 10.4 7.6 5.2 4.4 5.7 5.1 5.9 8.4 6.1 3.3 6.7 1.9 5.6 1.3 7.5 8.2 3.6 7.8 9.1 3.7 5.7 9.1 3.8 2.3 9.0 1.8 1.7 3.8 6.5 6.8 3.7 9.5 12.4 12.0 12.3 10.1 2.6 10.7 16.0 21.3 8.6 2.8 8.1 9.9 11.7 6.6 9.3 3.2 1.1 7.1 8.3 6.4 13.1 5.4 9.9 4.5 6.2 10.2 8.3 8.7 6.0 8.4 7.6 4.8 8.6 13.9 4.7 9.2 5.6 4.1 8.4 7.3 4.4 4.5 5.6 1.7 8.4 3.8 3.9 4.3 5.4 8.2 10.0 11.1 15.4 8.6 7.4 7.6 5.2 9.2 6.1 0.0 5.1 2.2 2.6 7.4 2.9 0.5 5.1 1.4 2.3 0.0 0.0 5.4 6.6 8.2 31.1 3.1 6.3 0.0 4.1 9.5 6.0 2.2 4.6 1.8 6.0 11.1 4.6 3.7 3.2 12.7 5.8 4.4 3.3 4.6 3.8 4.8 6.4 4.2 14.2 4.7 1.9 0.0 2.5 2.9 13.3 7.8 5.8 6.4 4.7 1.7 ZNF688 ENSG00000229809 "Zinc finger protein 688" P0C7X2 16 30569346-30572734 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 132.4;Late spermatids: 434.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048922 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA048922: AB_2680557" "prognostic favorable (5.90e-4)" "prognostic favorable (7.74e-4)" "unprognostic (1.68e-1)" "prognostic favorable (4.58e-5)" "unprognostic (1.37e-1)" "unprognostic (1.76e-2)" "unprognostic (4.01e-1)" "prognostic favorable (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "prognostic favorable (6.61e-4)" "unprognostic (7.75e-2)" "unprognostic (5.14e-2)" "unprognostic (7.08e-2)" "unprognostic (2.48e-1)" "unprognostic (4.12e-2)" "unprognostic (4.03e-2)" 10.7 11.9 14.2 11.8 11.8 13.7 8.0 13.8 16.7 8.8 15.3 15.5 12.1 20.5 11.5 9.6 12.0 13.5 14.5 17.2 13.1 10.6 11.2 12.4 10.3 19.9 12.1 11.5 12.9 14.7 8.4 14.0 7.8 11.2 11.8 9.0 11.0 13.8 10.1 32.5 9.5 14.4 14.2 11.0 13.9 13.0 24.6 8.3 21.6 13.7 8.3 10.0 10.4 13.3 6.1 5.4 12.6 5.4 15.1 6.8 2.8 7.8 5.9 6.0 6.3 11.4 2.9 2.5 4.5 6.2 3.8 3.0 1.8 11.9 4.1 9.1 5.6 5.2 5.8 1.7 2.8 4.1 12.2 3.6 2.8 2.3 1.4 3.0 3.9 12.7 5.9 6.3 4.0 4.9 6.5 3.8 5.6 2.9 9.6 4.2 4.7 11.1 4.3 2.2 7.7 1.9 9.5 2.4 6.2 6.6 2.5 8.6 9.6 1.6 11.8 9.9 1.8 12.9 6.5 2.9 3.3 3.6 3.8 3.5 13.8 9.6 4.4 10.1 3.4 5.6 12.6 3.9 8.3 4.8 3.9 5.8 5.5 5.6 5.4 3.9 6.1 4.8 4.4 6.0 15.1 5.4 5.4 6.8 2.8 14.2 11.8 13.8 16.7 13.1 10.6 12.1 11.5 11.2 8.3 6.0 1.9 17.1 10.5 5.7 19.5 8.5 17.8 20.1 6.8 15.7 17.7 6.3 41.4 19.2 132.4 11.1 34.5 0.0 27.4 7.9 13.1 9.8 4.7 18.7 21.4 20.6 19.5 14.1 22.9 434.2 18.4 15.6 16.9 28.9 25.1 28.0 19.6 32.3 18.7 38.4 25.5 6.5 12.5 25.3 7.9 6.1 3.9 20.3 22.1 5.7 ZNF691 Zfp691 ENSG00000164011 "Zinc finger protein 691" Q5VV52 1 42846573-42852477 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062527 Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA062527: AB_2684791" "unprognostic (4.34e-2)" "unprognostic (4.05e-2)" "unprognostic (1.09e-1)" "unprognostic (4.32e-2)" "unprognostic (4.86e-2)" "unprognostic (5.50e-2)" "prognostic unfavorable (7.33e-6)" "unprognostic (1.40e-3)" "unprognostic (2.65e-3)" "unprognostic (5.12e-2)" "prognostic favorable (6.25e-5)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" 7.8 14.6 13.6 11.2 15.5 2.9 15.6 10.8 14.4 12.9 12.6 18.3 14.1 8.8 16.9 21.8 9.1 14.2 8.4 11.4 11.9 9.8 14.2 24.1 9.9 16.0 12.2 12.1 18.6 13.4 19.2 17.3 12.7 12.3 16.8 10.2 12.3 15.2 18.5 10.9 12.8 10.6 13.5 11.9 17.7 10.8 13.9 14.8 17.9 19.3 6.4 16.8 11.8 10.0 20.5 12.5 18.2 11.2 18.4 19.3 12.8 4.5 6.3 12.8 10.5 11.6 8.9 1.6 5.4 6.5 8.8 8.8 4.4 6.6 11.1 8.4 5.0 4.4 8.0 12.3 7.1 7.6 19.8 12.4 11.6 17.3 7.9 8.6 4.4 2.5 7.7 8.7 11.0 9.1 10.8 8.9 11.0 11.2 4.8 8.6 3.6 13.2 5.9 19.1 4.9 4.7 9.0 16.1 7.6 8.2 4.3 9.2 9.2 5.5 10.0 9.3 20.0 5.5 15.2 4.6 8.8 9.3 4.9 5.8 11.7 9.2 3.2 6.2 5.4 7.4 18.2 11.2 16.0 12.2 9.7 15.7 15.9 16.4 16.4 11.1 20.5 15.8 15.7 6.3 18.4 10.0 12.5 19.3 12.8 13.6 15.5 10.8 14.4 11.9 9.8 12.2 12.1 12.3 14.8 6.0 2.4 3.0 2.1 1.5 2.4 5.7 5.1 4.0 2.3 5.2 3.9 5.4 6.6 3.9 3.0 3.6 1.7 0.0 3.3 4.4 4.0 2.4 4.7 6.4 6.4 1.6 2.9 6.2 3.3 2.5 6.6 3.5 1.7 3.6 2.7 5.2 2.4 2.9 6.7 6.8 4.2 0.0 3.9 9.1 6.4 0.6 2.7 6.4 2.3 1.0 ZNF717 "X17, ZNF838" ENSG00000227124 "Zinc finger protein 717" 3 75709643-75785583 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 38.5" HPA044549 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA044549: AB_10964630" "unprognostic (2.49e-1)" "unprognostic (4.44e-2)" "unprognostic (1.52e-1)" "unprognostic (2.49e-2)" "unprognostic (2.61e-1)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (3.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (3.60e-6)" "unprognostic (3.88e-2)" "unprognostic (2.08e-2)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" 8.1 8.6 11.9 7.2 14.4 4.6 11.2 12.1 12.4 7.7 6.7 11.7 7.3 6.9 11.0 24.6 7.7 11.3 8.1 8.2 10.9 8.3 13.4 10.5 6.8 6.2 16.2 7.1 12.6 12.7 14.7 22.8 7.3 12.6 9.4 8.9 10.8 9.9 9.6 6.1 13.7 7.3 10.9 15.6 10.1 10.1 11.2 13.6 8.4 16.2 5.3 8.4 8.6 7.8 9.5 6.2 6.8 5.3 4.0 10.2 3.2 7.4 4.7 4.5 2.7 4.9 6.9 2.7 2.5 4.9 3.1 3.9 6.3 6.4 4.0 4.3 4.6 4.9 3.7 7.1 5.3 2.8 0.4 6.8 7.8 7.1 0.7 9.6 0.3 6.9 6.7 4.4 7.5 11.4 3.2 0.6 0.8 38.5 9.5 4.1 2.4 0.8 10.3 5.1 5.5 8.3 5.9 4.3 21.9 5.0 3.6 3.7 17.4 2.1 4.3 9.2 7.3 15.3 3.5 0.9 7.9 10.8 6.5 1.1 11.4 13.9 4.7 4.3 0.8 4.8 1.5 4.0 6.8 3.6 5.3 1.8 7.6 5.1 3.4 4.1 9.5 10.2 6.2 1.0 4.0 4.9 6.2 1.9 3.2 11.9 14.4 12.1 12.4 10.9 8.3 16.2 7.1 12.6 13.6 3.0 1.9 3.0 3.6 2.9 8.3 5.3 10.2 5.3 3.4 7.0 2.0 3.3 10.0 4.0 2.6 4.5 2.6 0.0 3.8 1.6 4.3 4.9 9.2 6.6 6.1 9.5 5.1 6.7 3.8 1.3 2.3 3.8 1.7 5.4 7.2 5.7 3.8 0.0 2.8 12.5 8.0 0.0 3.8 9.5 7.4 3.9 2.9 2.6 5.5 3.9 ZNF786 DKFZp762I137 ENSG00000197362 "Zinc finger protein 786" Q8N393 7 149069643-149090782 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 17.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021518, HPA053459" Uncertain Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA021518: AB_2670734, HPA053459: AB_2682159" "unprognostic (3.13e-2)" "unprognostic (2.72e-1)" "unprognostic (5.61e-2)" "unprognostic (5.39e-2)" "unprognostic (1.87e-1)" "unprognostic (2.84e-2)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.62e-2)" "unprognostic (1.09e-3)" "unprognostic (8.85e-2)" "prognostic favorable (2.01e-4)" "unprognostic (3.97e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (3.44e-1)" "unprognostic (1.47e-2)" 3.9 4.3 8.7 6.1 9.6 3.3 5.1 10.4 15.2 6.0 5.1 4.2 6.4 4.6 6.9 6.1 6.8 6.7 4.8 3.2 6.4 6.1 4.5 5.4 7.3 8.2 4.8 5.8 8.3 6.0 7.6 8.5 3.8 4.0 6.8 3.4 5.4 5.3 5.8 4.1 13.0 5.1 6.6 3.4 7.7 5.1 2.9 4.2 8.4 6.1 5.8 6.5 6.2 6.1 7.2 4.5 2.9 5.0 8.4 12.1 5.3 4.5 8.2 6.6 11.1 4.0 1.7 9.4 2.7 2.9 3.1 2.5 4.3 4.3 6.4 6.8 1.9 5.4 5.2 4.0 3.8 2.0 7.0 6.1 3.2 4.8 5.4 3.4 6.2 4.3 2.3 4.3 3.9 2.8 3.2 2.9 4.7 5.6 3.7 2.9 14.1 10.5 10.6 12.0 4.3 6.2 7.9 3.2 4.2 2.5 6.3 7.8 12.4 6.9 6.5 5.1 4.3 4.2 2.9 3.7 3.7 2.1 6.3 4.0 13.4 9.9 3.5 6.1 4.0 4.0 1.7 3.7 2.9 12.1 5.0 9.8 7.2 8.5 10.7 4.5 7.1 11.3 9.5 1.1 8.4 3.9 3.9 5.1 5.3 8.7 9.6 10.4 15.2 6.4 6.1 4.8 5.8 4.0 4.2 0.0 0.6 2.4 2.1 2.4 9.4 2.5 0.0 2.7 0.0 3.5 2.0 2.1 3.3 3.7 0.3 1.5 1.3 0.0 1.3 1.9 1.9 1.2 4.6 2.1 1.9 17.5 4.6 2.5 1.2 0.0 2.8 2.0 0.0 2.8 1.0 2.7 1.8 2.9 3.9 1.8 5.7 0.0 1.9 3.1 8.3 1.5 1.6 4.9 2.6 1.7 ZNF787 ENSG00000142409 "Zinc finger protein 787" 19 56087366-56121280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 52.1;Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035140 Supported Approved Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoplasm "Nucleoli, Mitochondria" "HPA035140: AB_10602358" "unprognostic (1.97e-2)" "unprognostic (5.86e-2)" "unprognostic (8.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.26e-1)" "unprognostic (1.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.96e-3)" 7.4 8.0 4.3 7.8 5.2 18.8 7.1 4.7 7.0 8.0 9.8 5.1 8.5 12.8 5.8 6.5 9.8 8.7 8.7 10.2 4.0 4.3 6.4 18.0 6.9 7.7 4.8 4.0 8.7 13.9 3.3 6.6 4.8 4.6 10.0 3.9 7.9 9.6 7.2 28.2 9.3 10.5 6.8 3.1 14.9 11.0 6.8 4.6 4.8 10.0 8.2 5.7 8.7 10.1 3.0 5.5 4.9 2.1 1.2 1.6 0.7 12.0 11.9 3.9 8.1 1.1 2.5 10.1 6.2 2.4 4.3 4.8 7.0 7.5 8.6 0.4 2.6 3.8 9.5 2.4 5.0 1.9 11.4 43.9 13.7 6.0 10.5 6.3 13.1 12.0 3.3 5.0 3.5 6.2 2.6 3.1 4.9 16.3 9.7 2.5 7.6 8.1 16.5 12.3 11.1 22.4 10.2 5.7 10.9 4.3 8.0 14.9 14.4 6.6 13.0 11.5 2.3 8.0 18.6 6.7 16.1 11.5 6.7 17.1 20.6 15.1 8.3 9.3 8.8 7.5 1.7 2.1 2.6 1.2 1.5 1.6 2.3 0.8 1.0 2.2 3.0 1.3 0.7 4.9 1.2 1.4 5.5 1.3 0.7 4.3 5.2 4.7 7.0 4.0 4.3 4.8 4.0 4.6 4.6 11.9 2.4 6.7 8.9 5.5 52.1 9.0 12.7 0.0 4.5 10.4 104.1 2.9 1.7 5.9 1.5 6.7 15.4 0.0 14.2 4.0 5.0 8.6 5.7 28.4 7.5 33.4 8.7 12.9 6.5 2.9 4.6 6.8 1.7 4.6 17.1 29.5 12.9 15.3 4.2 3.7 60.0 6.5 6.2 2.5 7.9 6.4 1.6 3.2 16.9 11.7 ZNF79 pT7 ENSG00000196152 "Zinc finger protein 79" Q15937 9 127424374-127445372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 5.1;Spermatocytes: 5.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028977 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028977: AB_10602359" "unprognostic (4.56e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "prognostic favorable (6.83e-5)" "unprognostic (2.84e-2)" "unprognostic (2.45e-2)" "unprognostic (2.11e-1)" "prognostic favorable (5.96e-4)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "prognostic favorable (5.42e-5)" "unprognostic (4.53e-3)" "prognostic favorable (6.04e-7)" "unprognostic (6.09e-3)" "unprognostic (5.01e-1)" "unprognostic (5.23e-2)" "unprognostic (1.32e-1)" 9.9 11.0 7.6 6.7 7.8 6.7 8.1 18.3 8.5 9.2 9.6 10.3 6.9 5.6 12.9 10.4 7.0 9.4 5.6 6.8 6.8 5.3 6.8 9.5 6.8 8.3 7.5 5.2 9.1 9.5 13.2 11.8 8.1 8.4 11.2 8.2 10.7 12.2 8.3 13.2 8.7 7.7 8.3 6.1 10.2 8.8 21.1 8.6 12.8 8.5 4.8 10.5 13.3 9.9 8.5 7.5 7.4 6.0 9.4 11.8 4.9 2.3 4.6 6.2 3.6 6.9 4.1 17.2 5.7 6.9 6.8 7.9 4.9 2.1 4.9 2.3 4.2 9.1 7.1 4.6 6.9 5.4 4.9 3.0 3.4 7.4 5.4 8.1 8.0 5.4 4.1 7.8 8.4 6.9 4.4 7.1 5.7 5.7 7.4 6.4 5.0 6.2 3.0 4.9 5.7 5.9 5.2 8.5 7.0 2.9 3.3 7.0 4.7 10.8 5.6 3.2 5.5 7.4 4.6 4.9 4.4 4.0 4.3 4.4 9.9 21.2 6.3 5.6 2.5 7.2 3.3 4.9 7.4 9.3 6.0 10.6 7.4 6.4 11.8 7.0 8.5 8.4 9.1 6.5 9.4 4.0 7.5 7.9 4.9 7.6 7.8 18.3 8.5 6.8 5.3 7.5 5.2 8.4 8.6 0.0 0.3 0.0 1.0 1.3 0.8 1.6 5.1 0.0 2.3 0.0 0.0 1.8 1.7 1.7 2.1 0.7 0.6 0.0 0.5 0.6 1.1 0.5 0.0 1.0 1.7 1.6 0.0 1.3 0.6 3.7 0.6 0.9 0.0 0.0 0.6 1.3 0.4 0.0 1.8 0.7 1.4 0.0 1.2 5.1 1.3 0.9 2.2 0.8 0.9 0.7 ZNF793 ENSG00000188227 "Zinc finger protein 793" Q6ZN11 19 37506939-37548762 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 29.5;Early spermatids: 32.2;Horizontal cells: 46.1;Rod photoreceptor cells: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.5;RT4: 9.8;U-266/70: 17.0;U-266/84: 11.3" HPA034781 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034781: AB_10602784" "unprognostic (4.80e-2)" "unprognostic (4.70e-2)" "unprognostic (3.26e-1)" "unprognostic (7.13e-2)" "unprognostic (4.08e-2)" "unprognostic (5.72e-2)" "unprognostic (1.05e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-1)" "unprognostic (2.69e-3)" "unprognostic (4.16e-3)" "unprognostic (1.03e-4)" "unprognostic (4.94e-3)" "unprognostic (1.38e-1)" "unprognostic (4.62e-1)" "unprognostic (1.24e-2)" "unprognostic (8.12e-3)" 3.1 7.7 12.5 4.9 11.9 2.1 6.4 22.1 14.0 6.4 4.2 12.8 4.6 3.0 9.3 6.9 5.2 6.7 4.6 6.8 10.3 8.0 6.2 1.1 3.3 5.6 8.3 10.0 14.1 4.0 15.7 18.4 4.5 11.2 7.5 6.0 8.1 3.6 5.8 3.7 10.7 3.6 6.1 10.1 5.6 5.3 12.3 9.6 2.1 11.0 3.2 4.9 4.9 5.7 4.0 2.1 7.2 1.6 4.0 2.8 1.4 0.1 0.2 4.2 11.5 0.9 0.9 0.2 3.3 0.2 0.7 0.3 0.2 1.3 2.9 5.5 1.7 1.0 0.4 0.3 2.9 0.3 0.8 4.2 0.3 0.4 0.3 2.1 0.2 2.6 3.4 2.6 0.6 0.1 0.3 0.1 0.3 0.1 0.5 0.5 3.2 0.3 0.4 6.9 0.0 0.3 0.1 0.1 0.6 2.9 9.8 3.1 6.7 0.2 0.2 0.0 8.1 6.4 0.3 0.4 0.1 1.8 0.3 3.3 17.0 11.3 0.3 0.0 0.2 0.5 7.2 1.6 1.2 1.5 0.6 2.3 2.0 2.8 2.5 1.2 4.0 1.9 2.4 4.2 4.0 0.6 2.1 2.2 1.4 12.5 11.9 22.1 14.0 10.3 8.0 8.3 10.0 11.2 9.6 3.0 7.2 0.8 3.4 3.0 28.0 7.3 12.7 6.7 5.7 12.2 29.5 4.8 3.3 3.1 32.2 6.3 1.4 0.0 1.3 3.6 3.1 2.6 2.3 0.4 0.8 46.1 8.6 6.2 0.0 7.7 4.6 2.0 0.0 1.8 3.4 16.2 1.6 0.0 9.6 1.5 33.5 0.0 5.1 5.4 6.4 2.9 1.6 4.3 3.4 1.4 ZNF860 ENSG00000197385 "Zinc finger protein 860" A6NHJ4 3 31981771-31991628 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.2" "Cell type enhanced" "Detected in some" 9 "B-cells: 3.4;Ciliated cells: 6.7;Club cells: 4.5;Intestinal endocrine cells: 3.4;Syncytiotrophoblasts: 3.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 61 "memory B-cell: 9.1;naive B-cell: 6.4" "Lineage enriched" "Detected in single" 71 "B-cells: 9.1" "Cell line enriched" "Detected in many" 4 "BEWO: 31.9" HPA063386 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063386: AB_2684999" "unprognostic (1.19e-1)" "unprognostic (2.46e-2)" "unprognostic (2.88e-1)" "unprognostic (1.64e-2)" "unprognostic (1.51e-1)" "unprognostic (8.01e-2)" "unprognostic (1.23e-2)" "unprognostic (1.94e-2)" "unprognostic (3.15e-1)" "unprognostic (4.15e-3)" "unprognostic (1.51e-2)" "unprognostic (6.38e-2)" "unprognostic (1.30e-4)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.74e-2)" "unprognostic (3.75e-3)" 2.0 1.0 0.7 11.2 1.0 0.1 2.8 0.8 1.5 4.3 1.1 0.0 1.7 0.3 4.1 4.9 6.2 1.9 3.6 1.3 0.6 1.6 7.2 0.4 3.7 8.3 1.6 0.6 1.8 0.6 0.1 5.5 8.1 1.1 6.0 1.6 1.6 5.6 2.6 0.4 2.3 3.7 6.7 0.5 9.6 1.1 2.2 0.0 0.5 1.8 4.2 20.2 6.4 3.6 9.1 0.0 0.1 0.0 0.0 0.0 0.2 2.1 0.7 0.0 1.6 0.0 0.0 31.9 0.2 0.1 0.2 0.2 2.1 2.5 2.3 2.3 0.0 1.0 1.9 0.7 3.1 0.2 0.0 0.3 0.0 3.2 1.0 0.0 0.0 0.0 0.1 1.4 0.2 6.1 0.2 0.6 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.8 5.6 3.4 0.0 0.0 0.1 7.2 0.9 0.2 0.0 0.5 3.8 0.0 1.6 2.9 0.0 1.2 0.2 2.6 0.0 0.2 0.0 0.0 3.6 0.3 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 1.0 0.8 1.5 0.6 1.6 1.6 0.6 1.1 0.0 0.0 0.0 3.4 0.4 0.8 0.2 0.6 0.0 6.7 4.5 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.0 0.0 0.5 3.0 0.5 0.9 0.0 0.0 0.3 0.0 3.4 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.4 1.1 0.0 0.0 0.3 0.1 0.1 0.3 3.5 0.0 0.3 0.6 ZNF880 ENSG00000221923 "Zinc finger protein 880" Q6PDB4 19 52369917-52385795 "Predicted intracellular proteins, Transcription factors" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 21.2;SuSa: 20.9" HPA077316 Approved "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "HPA077316: AB_2686833" "unprognostic (2.66e-3)" "unprognostic (2.19e-2)" "unprognostic (2.55e-1)" "unprognostic (3.99e-2)" "unprognostic (7.72e-2)" "unprognostic (1.54e-2)" "unprognostic (7.61e-2)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.26e-2)" "unprognostic (3.94e-2)" "unprognostic (2.52e-1)" "prognostic favorable (4.33e-8)" "unprognostic (4.14e-2)" "unprognostic (4.99e-1)" "unprognostic (1.77e-1)" "unprognostic (5.60e-3)" 14.7 12.7 12.4 12.2 21.8 17.3 16.3 22.9 14.6 16.5 13.0 13.6 10.8 6.9 16.0 20.3 13.3 14.7 12.5 20.1 13.9 10.5 13.0 4.4 13.3 15.9 12.2 7.4 22.7 9.4 4.0 18.2 12.4 14.3 20.8 10.8 18.1 12.9 16.8 11.3 12.6 11.6 16.8 13.4 16.1 11.6 11.2 13.3 24.5 22.2 12.1 16.5 27.9 11.4 25.4 20.3 27.7 7.2 12.1 20.4 8.7 0.1 0.8 10.7 8.3 5.8 16.5 11.6 7.0 7.6 4.9 9.8 0.2 4.7 0.1 2.5 12.2 10.3 1.6 0.0 6.4 8.3 0.1 12.6 0.3 0.5 0.0 6.9 0.2 8.8 12.3 8.1 9.2 0.0 0.6 7.8 0.9 0.8 0.3 9.4 0.6 1.1 0.7 14.4 0.0 1.7 0.7 21.2 0.7 13.8 11.0 7.9 10.0 0.0 2.0 3.0 20.9 0.4 2.1 6.2 0.3 0.2 2.1 6.4 0.4 3.9 0.3 0.2 0.2 13.6 27.7 6.6 15.1 13.3 6.2 17.3 23.2 16.9 14.6 10.2 25.4 20.4 17.8 2.7 12.1 7.2 20.3 17.2 8.7 12.4 21.8 22.9 14.6 13.9 10.5 12.2 7.4 14.3 13.3 11.9 3.8 10.7 13.7 5.3 16.5 11.7 7.6 10.7 18.2 19.2 11.8 8.8 24.9 14.7 10.6 10.8 2.1 0.0 12.9 12.5 7.8 21.9 9.3 1.0 5.9 22.3 0.0 9.8 5.9 3.1 12.7 11.0 8.5 16.2 5.1 11.3 17.7 7.0 6.0 6.3 15.7 19.4 13.0 3.3 7.9 6.1 12.0 12.5 3.1 22.2 ZNRF2 RNF202 ENSG00000180233 "Zinc and ring finger 2" Q8NHG8 7 30284307-30367692 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072244 Approved Uncertain "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nucleoli fibrillar center" "HPA072244: AB_2732197" "unprognostic (9.44e-2)" "unprognostic (2.38e-2)" "unprognostic (8.64e-2)" "prognostic unfavorable (7.68e-4)" "unprognostic (4.46e-2)" "unprognostic (1.24e-1)" "unprognostic (3.06e-1)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (5.93e-2)" "prognostic favorable (2.29e-4)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "prognostic favorable (8.71e-4)" "unprognostic (8.67e-2)" 7.8 8.0 10.0 9.3 10.6 9.7 16.2 12.8 10.0 5.8 16.1 10.5 7.6 11.3 7.7 9.7 14.2 5.2 8.7 8.4 9.6 6.1 19.3 24.0 7.9 12.0 10.0 7.4 5.8 14.0 8.0 9.9 9.6 11.0 7.0 14.3 5.8 10.5 13.7 17.5 11.5 12.7 8.3 10.5 9.2 12.4 20.6 9.1 7.9 13.3 9.8 10.9 9.4 11.8 1.3 5.8 1.4 1.1 0.7 2.4 0.5 6.7 2.5 2.0 1.8 2.3 1.6 10.7 2.6 2.7 2.9 3.9 1.2 11.3 7.1 6.8 2.1 7.5 6.6 6.7 4.4 3.1 6.9 6.1 4.4 5.2 3.3 1.2 3.4 8.4 2.5 7.5 2.0 4.9 3.0 2.4 5.5 5.4 14.2 3.1 2.6 6.9 9.0 4.7 6.7 3.1 6.0 4.4 12.1 8.7 14.6 7.0 6.6 5.2 22.0 4.3 12.4 5.9 13.8 2.7 2.8 4.8 2.7 5.4 24.3 20.8 9.3 3.1 7.4 4.1 0.5 0.9 1.1 1.0 0.9 1.5 1.3 1.2 1.4 0.8 0.8 0.7 1.1 1.4 0.7 1.1 5.8 2.4 0.5 10.0 10.6 12.8 10.0 9.6 6.1 10.0 7.4 11.0 9.1 8.9 6.7 5.2 5.8 14.2 11.0 3.2 17.8 2.7 4.5 15.7 39.3 7.5 6.6 4.9 4.3 4.5 42.5 0.0 8.9 8.0 4.4 5.5 3.5 33.4 9.4 1.6 30.1 9.2 18.9 7.6 2.6 11.2 11.8 9.0 14.5 4.3 6.7 14.4 2.1 26.0 5.7 6.5 7.2 20.9 7.9 16.6 9.6 8.7 19.6 10.8 ZSCAN29 "FLJ35867, Zfp690, ZNF690" ENSG00000140265 "Zinc finger and SCAN domain containing 29" Q8IWY8 15 43358172-43371025 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007241, HPA011109" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA Nucleoplasm "Plasma membrane, Actin filaments" "HPA007241: AB_10600420, HPA011109: AB_10611525" "unprognostic (3.90e-2)" "unprognostic (2.70e-1)" "unprognostic (1.15e-1)" "unprognostic (4.06e-2)" "unprognostic (2.21e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (5.25e-1)" "unprognostic (2.12e-2)" "unprognostic (4.77e-3)" "unprognostic (1.64e-1)" "unprognostic (1.44e-3)" "unprognostic (9.61e-2)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (8.33e-2)" "unprognostic (3.43e-2)" 8.3 8.9 13.5 14.2 14.2 6.6 9.4 15.9 15.2 11.0 9.8 12.1 9.3 11.8 12.6 12.5 11.0 9.6 11.9 7.2 14.7 8.0 8.1 10.3 9.2 13.2 19.1 12.0 10.7 15.4 12.5 13.9 13.0 15.4 9.7 10.5 7.9 11.2 9.5 13.6 7.7 13.0 9.0 13.3 11.9 11.8 20.9 15.0 16.8 11.1 9.4 13.7 11.0 12.5 2.1 1.0 6.9 1.0 2.3 1.9 0.6 7.6 8.4 19.8 12.2 7.0 7.4 10.7 6.0 9.4 10.7 11.2 13.0 5.5 7.5 10.1 7.4 8.6 22.7 14.5 7.4 9.7 19.4 8.0 16.5 12.6 10.1 7.8 11.2 14.5 6.5 13.0 7.2 10.3 7.6 5.4 11.7 15.3 9.2 8.6 4.8 10.8 9.3 9.9 11.3 6.5 16.8 11.0 9.1 6.2 9.3 14.1 15.3 9.3 15.3 7.1 10.4 10.7 17.6 6.0 12.6 10.0 9.5 10.8 17.7 24.4 14.5 7.4 11.2 9.5 1.1 0.7 6.9 1.2 1.0 1.0 2.1 1.2 0.8 1.0 1.6 0.6 1.7 1.8 2.3 0.8 0.9 1.9 0.6 13.5 14.2 15.9 15.2 14.7 8.0 19.1 12.0 15.4 15.0 6.0 9.3 2.9 2.3 3.2 8.7 6.7 2.5 5.3 10.3 7.0 25.5 4.4 0.0 5.2 81.1 2.9 7.8 0.0 6.2 3.7 4.1 3.3 0.0 6.0 4.9 12.7 5.8 4.3 9.7 13.8 6.4 4.1 5.0 3.6 7.8 5.4 7.6 5.8 5.6 2.1 18.7 0.0 2.9 9.9 6.4 2.8 3.2 4.3 6.8 1.8 ZWINT "KNTC2AP, SIP30, Zwint1" ENSG00000122952 "ZW10 interacting kinetochore protein" O95229 10 56357228-56361275 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.6;testis: 37.1" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 87.4;Late spermatids: 149.1;Spermatocytes: 124.1;Spermatogonia: 125.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 15.2" "Lineage enriched" "Detected in many" 5 "T-cells: 15.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA005757, HPA022264" Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No Yes "Nucleoplasm, Nuclear bodies" Cytosol "HPA005757: AB_10600224, HPA022264: AB_10600995" "unprognostic (5.59e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (9.38e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.77e-8)" "unprognostic (6.36e-3)" "unprognostic (5.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.58e-3)" "unprognostic (1.86e-2)" "prognostic unfavorable (3.72e-12)" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (5.47e-2)" "unprognostic (3.46e-1)" 1.7 3.5 3.4 14.6 3.1 18.4 3.0 0.9 2.8 3.3 9.4 1.3 2.1 6.8 2.0 4.5 14.1 1.1 6.3 1.6 2.7 1.8 4.6 2.9 2.6 12.8 2.4 3.4 1.7 2.8 2.8 1.9 7.3 1.9 1.8 11.8 1.5 4.2 1.4 0.9 5.2 8.8 3.1 2.5 9.0 6.2 37.1 0.7 35.6 1.9 12.7 17.2 3.1 4.6 1.6 1.3 0.6 2.6 2.9 15.2 3.0 39.9 31.8 22.7 25.2 1.6 2.3 18.5 29.5 22.3 35.7 32.5 56.2 24.0 20.6 11.3 10.1 16.7 20.6 31.8 22.2 33.3 52.3 16.6 20.5 25.6 26.0 0.1 33.8 27.6 1.1 1.4 33.2 13.7 4.4 17.9 27.7 27.7 25.3 31.3 32.3 29.8 21.4 16.1 27.5 39.3 30.5 44.1 11.0 11.1 17.9 21.1 12.9 27.9 63.5 7.4 13.7 41.1 33.1 9.7 15.6 40.3 16.1 45.1 22.3 10.7 35.8 22.1 42.6 19.6 0.0 0.7 0.6 2.2 2.6 0.3 1.6 5.3 3.6 1.3 0.3 6.4 3.6 0.0 2.9 2.0 1.0 15.2 3.0 3.4 3.1 0.9 2.8 2.7 1.8 2.4 3.4 1.9 0.7 3.0 1.7 4.5 4.8 16.4 1.3 0.8 5.1 1.4 3.4 5.2 0.0 36.2 0.0 9.4 58.5 2.3 7.0 46.7 11.7 87.4 2.8 1.3 0.0 3.4 41.1 0.0 0.0 9.8 8.3 149.1 4.6 7.4 6.8 2.8 11.6 1.2 6.7 11.8 2.5 4.6 1.1 0.0 0.9 124.1 125.8 7.2 19.3 7.9 22.7 2.0